Citrus Sinensis ID: 007260
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 611 | 2.2.26 [Sep-21-2011] | |||||||
| Q0DCT8 | 589 | Protein kinase G11A OS=Or | no | no | 0.797 | 0.826 | 0.788 | 0.0 | |
| A2YBX5 | 589 | Protein kinase G11A OS=Or | N/A | no | 0.797 | 0.826 | 0.786 | 0.0 | |
| P15792 | 609 | Protein kinase PVPK-1 OS= | N/A | no | 0.767 | 0.770 | 0.726 | 0.0 | |
| Q05999 | 578 | Serine/threonine-protein | no | no | 0.808 | 0.854 | 0.647 | 1e-178 | |
| Q9LFA2 | 934 | Serine/threonine-protein | no | no | 0.805 | 0.526 | 0.557 | 1e-162 | |
| Q64FQ2 | 525 | Protein kinase PINOID 2 O | no | no | 0.718 | 0.836 | 0.457 | 1e-116 | |
| Q94E49 | 493 | Protein kinase PINOID 2 O | no | no | 0.617 | 0.764 | 0.512 | 1e-111 | |
| O64682 | 438 | Protein kinase PINOID OS= | no | no | 0.617 | 0.860 | 0.487 | 1e-106 | |
| Q2QM77 | 484 | Protein kinase PINOID OS= | no | no | 0.582 | 0.735 | 0.476 | 1e-105 | |
| Q9ST27 | 907 | Phototropin-2 OS=Oryza sa | no | no | 0.551 | 0.371 | 0.455 | 1e-96 |
| >sp|Q0DCT8|G11A_ORYSJ Protein kinase G11A OS=Oryza sativa subsp. japonica GN=Os06g0291600 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 800 bits (2065), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 399/506 (78%), Positives = 432/506 (85%), Gaps = 19/506 (3%)
Query: 116 VDQEKKTSE----YGSVKNSSVSGKVSDGTSSLAKTSGSAKISDRLDYVESG-KSSICRG 170
D+EK E GS+K+SS GK +A SGSA++ R + E G SS CR
Sbjct: 93 ADEEKGVVEDGIANGSLKSSSALGK----EHGIASASGSARLVGRSETGERGFSSSRCRP 148
Query: 171 STSSDVSDESTCSSFSSSINKPHKANDLRWEAIQAVRARDGVLGLSHFRLLKRLGCGDIG 230
STSSDVSDES CSS SS + KPHKAND RWEAIQ +R RDG+LGLSHF+LLK+LGCGDIG
Sbjct: 149 STSSDVSDESACSSISS-VTKPHKANDSRWEAIQMIRTRDGILGLSHFKLLKKLGCGDIG 207
Query: 231 SVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKF 290
SVYLSELSGTK YFAMKVMDKASLA RKKLLRAQTE+EILQ LDHPFLPTLYTHFET+KF
Sbjct: 208 SVYLSELSGTKSYFAMKVMDKASLASRKKLLRAQTEKEILQCLDHPFLPTLYTHFETDKF 267
Query: 291 SCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVL 350
SCLVMEFCPGGDLHTLRQ+Q GKYFPEQAV+FYVAE+LLA+EYLHMLGIIYRDLKPENVL
Sbjct: 268 SCLVMEFCPGGDLHTLRQRQRGKYFPEQAVKFYVAEILLAMEYLHMLGIIYRDLKPENVL 327
Query: 351 VREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRK-NPVYCVQPACIEPSC-IQPSCV 408
VREDGHIMLSDFDLSLRCAVSPTLI++S+ DAE LRK N YCVQPAC+EPSC IQPSC
Sbjct: 328 VREDGHIMLSDFDLSLRCAVSPTLIRSSNPDAEALRKNNQAYCVQPACVEPSCMIQPSCA 387
Query: 409 TP-TCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIK 467
TP TCF PR F SKSKKDRKPK E+ NQVSP PELIAEP++ARSMSFVGTHEYLAPEIIK
Sbjct: 388 TPTTCFGPRFF-SKSKKDRKPKPEVVNQVSPWPELIAEPSDARSMSFVGTHEYLAPEIIK 446
Query: 468 GEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLI 527
GEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNV+GQPLRFPE PVVSF+ARDLI
Sbjct: 447 GEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVIGQPLRFPEYPVVSFSARDLI 506
Query: 528 RGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIRCATPPEIPKPVEIERIPAPTSSTS 587
RGLLVKEPQ RL KRGATEIKQHPFFEGVNWALIRCA+PPE+P+PVEIER P STS
Sbjct: 507 RGLLVKEPQQRLGCKRGATEIKQHPFFEGVNWALIRCASPPEVPRPVEIERPPKQPVSTS 566
Query: 588 EKTAPTMVPPN--QRGSDNYLEFDFF 611
E P P + Q+ SD+YLEFDFF
Sbjct: 567 E---PAAAPSDAAQKSSDSYLEFDFF 589
|
May play a role in the regulation of metabolism and signal transduction processes. Oryza sativa subsp. japonica (taxid: 39947) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|A2YBX5|G11A_ORYSI Protein kinase G11A OS=Oryza sativa subsp. indica GN=OsI_021818 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 798 bits (2062), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 398/506 (78%), Positives = 432/506 (85%), Gaps = 19/506 (3%)
Query: 116 VDQEKKTSE----YGSVKNSSVSGKVSDGTSSLAKTSGSAKISDRLDYVESG-KSSICRG 170
D+EK E GS+K+SS GK +A SGSA++ R + E G SS CR
Sbjct: 93 ADEEKGVVEDGIANGSLKSSSALGK----EHGIASASGSARLVGRSETGERGFSSSRCRP 148
Query: 171 STSSDVSDESTCSSFSSSINKPHKANDLRWEAIQAVRARDGVLGLSHFRLLKRLGCGDIG 230
STSSDVSDES CSS SS + KPHKAND RWEAIQ +R RDG+LGLSHF+LLK+LGCGDIG
Sbjct: 149 STSSDVSDESACSSISS-VTKPHKANDSRWEAIQMIRTRDGILGLSHFKLLKKLGCGDIG 207
Query: 231 SVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKF 290
SVYLSEL+GTK YFAMKVMDKASLA RKKLLRAQTE+EILQ LDHPFLPTLYTHFET+KF
Sbjct: 208 SVYLSELNGTKSYFAMKVMDKASLASRKKLLRAQTEKEILQCLDHPFLPTLYTHFETDKF 267
Query: 291 SCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVL 350
SCLVMEFCPGGDLHTLRQ+Q GKYFPEQAV+FYVAE+LLA+EYLHMLGIIYRDLKPENVL
Sbjct: 268 SCLVMEFCPGGDLHTLRQRQRGKYFPEQAVKFYVAEILLAMEYLHMLGIIYRDLKPENVL 327
Query: 351 VREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRK-NPVYCVQPACIEPSC-IQPSCV 408
VREDGHIMLSDFDLSLRCAVSPTLI++S+ DAE LRK N YCVQPAC+EPSC IQPSC
Sbjct: 328 VREDGHIMLSDFDLSLRCAVSPTLIRSSNPDAEALRKNNQAYCVQPACVEPSCMIQPSCA 387
Query: 409 TP-TCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIK 467
TP TCF PR F SKSKKDRKPK E+ NQVSP PELIAEP++ARSMSFVGTHEYLAPEIIK
Sbjct: 388 TPTTCFGPRFF-SKSKKDRKPKPEVVNQVSPWPELIAEPSDARSMSFVGTHEYLAPEIIK 446
Query: 468 GEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLI 527
GEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNV+GQPLRFPE PVVSF+ARDLI
Sbjct: 447 GEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVIGQPLRFPEYPVVSFSARDLI 506
Query: 528 RGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIRCATPPEIPKPVEIERIPAPTSSTS 587
RGLLVKEPQ RL KRGATEIKQHPFFEGVNWALIRCA+PPE+P+PVEIER P STS
Sbjct: 507 RGLLVKEPQQRLGCKRGATEIKQHPFFEGVNWALIRCASPPEVPRPVEIERPPKQPVSTS 566
Query: 588 EKTAPTMVPPN--QRGSDNYLEFDFF 611
E P P + Q+ SD+YLEFDFF
Sbjct: 567 E---PAAAPSDAAQKSSDSYLEFDFF 589
|
May play a role in the regulation of metabolism and signal transduction processes. Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P15792|KPK1_PHAVU Protein kinase PVPK-1 OS=Phaseolus vulgaris PE=2 SV=1 | Back alignment and function description |
|---|
Score = 705 bits (1819), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 356/490 (72%), Positives = 399/490 (81%), Gaps = 21/490 (4%)
Query: 125 YGSVKNSSVSGKVSDGTSSLAKTSGSAKISDRLDYVESGKSSICRGSTSSDVSDESTCSS 184
Y K S + +VS+ S S +++++ D+ ES K+SICR ST SD SDES+ SS
Sbjct: 138 YSEAKESFTNTEVSECAS--VDKSCESEVANSSDFNESRKTSICRASTGSDASDESSTSS 195
Query: 185 FSSSINKPHKANDLRWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYF 244
SS + KPHKAND+RWEAIQAVR RDG+L + HFRLLK+LGCGDIGSVYL+ELSGT+ F
Sbjct: 196 LSSVLYKPHKANDIRWEAIQAVRTRDGMLEMRHFRLLKKLGCGDIGSVYLAELSGTRTSF 255
Query: 245 AMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLH 304
AMKVM+K LA RKKLLRAQTEREILQSLDHPFLPTLYTHFETE FSCLVMEFCPGGDLH
Sbjct: 256 AMKVMNKTELANRKKLLRAQTEREILQSLDHPFLPTLYTHFETEIFSCLVMEFCPGGDLH 315
Query: 305 TLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDL 364
LRQ+QPGKYF E AVRFYVAEVLL+LEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDL
Sbjct: 316 ALRQRQPGKYFSEHAVRFYVAEVLLSLEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDL 375
Query: 365 SLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCI-QPSCVTPTCFSPRLF--SSK 421
SLRC+VSPTL+K+S+ K+ YCVQP+CIEP+C+ QP C+ P+CF+PR SK
Sbjct: 376 SLRCSVSPTLVKSSN---NLQTKSSGYCVQPSCIEPTCVMQPDCIKPSCFTPRFLSGKSK 432
Query: 422 SKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFG 481
K KPKN++ NQV+PLPELIAEPT ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFG
Sbjct: 433 KDKKSKPKNDMHNQVTPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFG 492
Query: 482 IFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAY 541
IFLYELLFG+TPFKGS NRATLFNV+GQPLRFPESP VSFAARDLIRGLLVKEPQHRLAY
Sbjct: 493 IFLYELLFGRTPFKGSANRATLFNVIGQPLRFPESPTVSFAARDLIRGLLVKEPQHRLAY 552
Query: 542 KRGATEIKQHPFFEGVNWALIRCATPPEIPKPVEIERIPAPTSSTSEKTAPTMVPPNQRG 601
+RGATEIKQHPFF+ VNWALIRCATPPE+P+ V I P + P
Sbjct: 553 RRGATEIKQHPFFQNVNWALIRCATPPEVPRQV----INLPQTEKDLGVKP--------- 599
Query: 602 SDNYLEFDFF 611
S NYL+ DFF
Sbjct: 600 SGNYLDIDFF 609
|
Phaseolus vulgaris (taxid: 3885) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q05999|KPK7_ARATH Serine/threonine-protein kinase AtPK7 OS=Arabidopsis thaliana GN=PK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 627 bits (1616), Expect = e-178, Method: Compositional matrix adjust.
Identities = 331/511 (64%), Positives = 390/511 (76%), Gaps = 17/511 (3%)
Query: 114 VSVDQEKKTSE---YGSVKNSSVS-GKVSDGTSSLAKTSGSAKISDRLDYVESGKSSICR 169
+S+ ++KK SE Y S N+ + K S + ++ + + I +E I R
Sbjct: 72 ISIIRKKKQSEPRFYSSPTNTFYTEAKQSFTNTEFSECASISTIGIGGIDLEKNGVMIYR 131
Query: 170 GSTSSDVSDESTCSSFSSSINKPHK-ANDLRWEAIQAVRARDGV-LGLSHFRLLKRLGCG 227
GS SDVSDES+ S S++ KPH+ ND RW AIQ VR+R G L F+L+K+LG G
Sbjct: 132 GSIGSDVSDESSSSGLSNAAYKPHRDNNDKRWVAIQEVRSRVGSSLEAKDFKLIKKLGGG 191
Query: 228 DIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET 287
DIG+VYL+EL GT FA+KVM+KA++A RKKL+RAQTE+EILQSLDHPFLPTLY+HFET
Sbjct: 192 DIGNVYLAELIGTGVSFAVKVMEKAAIAARKKLVRAQTEKEILQSLDHPFLPTLYSHFET 251
Query: 288 EKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPE 347
E SCLVMEFCPGGDLH+LRQKQ GKYFPEQA RFYVAEVLLA+EYLHMLGIIYRDLKPE
Sbjct: 252 EMNSCLVMEFCPGGDLHSLRQKQRGKYFPEQAARFYVAEVLLAMEYLHMLGIIYRDLKPE 311
Query: 348 NVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACI-EPSCI-QP 405
NVLVREDGHIMLSDFDLSLRCAVSPTL++ +++ E K+ YC+QP C+ + SCI QP
Sbjct: 312 NVLVREDGHIMLSDFDLSLRCAVSPTLVRFAAITLE--SKSSSYCIQPTCVDQSSCIVQP 369
Query: 406 SCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEI 465
C+ P CF+PR S K RK N++ Q+ PLPELIAEPT ARSMSFVGTHEYLAPEI
Sbjct: 370 DCIQPVCFTPRFLS--KGKHRKKSNDMSRQIRPLPELIAEPTSARSMSFVGTHEYLAPEI 427
Query: 466 IKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARD 525
IKGEGHGSAVDWWTFGIFLYELLFG TPF+G NRATLFNVVGQPLRFPE P VSFAARD
Sbjct: 428 IKGEGHGSAVDWWTFGIFLYELLFGITPFRGGDNRATLFNVVGQPLRFPEHPNVSFAARD 487
Query: 526 LIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIRCATPPEIPKPVE-IERIPAPTS 584
LIRGLLVKEPQHRLAY+RGATEIKQHPFF+ VNWALIRC +PP+IP+PV+ +++ +
Sbjct: 488 LIRGLLVKEPQHRLAYRRGATEIKQHPFFQSVNWALIRCTSPPQIPQPVKPMDQAHSVRH 547
Query: 585 STSEKTAPTMV--PP--NQRGSDNYLEFDFF 611
S+ PP + + S NYLE DFF
Sbjct: 548 GFSQGHGHVGYDKPPTVDVKPSGNYLEIDFF 578
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFA2|KIPK_ARATH Serine/threonine-protein kinase KIPK OS=Arabidopsis thaliana GN=KIPK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 571 bits (1471), Expect = e-162, Method: Compositional matrix adjust.
Identities = 300/538 (55%), Positives = 373/538 (69%), Gaps = 46/538 (8%)
Query: 87 KSNSSSLGLEQASNVDSVVSENRGSQDVSVDQEKKTSEYGSVKNSSVSGKVSDGTSSLAK 146
+++S S + Q+S D V+ + QDVS S NS + V K
Sbjct: 430 ENSSGSCNVSQSSEADIVIMK----QDVS-----------SSNNSGIGAMVE-------K 467
Query: 147 TSGSAKISDRLDYVESGKSSICRGSTSSDVSDESTCSSFSSSINKPHKANDLRWEAIQAV 206
+ + S++ ++ S K S+ S S+ +S+ES S FS NKPH + D+RWEAI+ +
Sbjct: 468 ETENPTSSEKFEFSLSSKDSLGDYSRSTSISEESNLSRFSCG-NKPHMSMDVRWEAIKHI 526
Query: 207 RARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTE 266
+ + G LGL HF LLK+LGCGDIG+VYL+EL GT C FA+KVMD LA RKK RAQ E
Sbjct: 527 KVQYGSLGLRHFNLLKKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKSPRAQAE 586
Query: 267 REILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAE 326
REIL+ LDHPFLPTLY F ++ SCLVME+CPGGDLH LRQKQ G+ FPE A RFYVAE
Sbjct: 587 REILKMLDHPFLPTLYAQFTSDNLSCLVMEYCPGGDLHVLRQKQLGRCFPEPAARFYVAE 646
Query: 327 VLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLR 386
+LLALEYLHMLGIIYRDLKPEN+LVREDGHIML+DFDLSLRCAV+PTL++++S P
Sbjct: 647 ILLALEYLHMLGIIYRDLKPENILVREDGHIMLTDFDLSLRCAVNPTLVRSNS----PPG 702
Query: 387 KNPVYCVQP----ACIEPSCI-QPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVS---- 437
K+P P CI+P CI +PSC +CFSPRL SS ++ RKPK G+ +S
Sbjct: 703 KDPARISGPYNTSNCIQPFCITEPSCQV-SCFSPRL-SSNQQQGRKPKR--GDHLSKTQQ 758
Query: 438 ----PLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTP 493
LP+L+AEPTEARS SFVGTHEYLAPEIIKGEGHG+AVDWWTFG+ LYELL+GKTP
Sbjct: 759 HLSRSLPQLVAEPTEARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGVLLYELLYGKTP 818
Query: 494 FKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPF 553
FKG N TL NVV Q L+FP+SP+VSF A+DLIRGLLVKEP++RL ++G+ EIK+HPF
Sbjct: 819 FKGYNNDETLANVVLQNLKFPDSPLVSFQAKDLIRGLLVKEPENRLGSEKGSVEIKRHPF 878
Query: 554 FEGVNWALIRCATPPEIPKPVEIERIPAPTSSTSEKTAPTMVPPNQRGSDNYLEFDFF 611
FEG+NWALIRCA PPE+P E P + + + + G ++LEF+ F
Sbjct: 879 FEGLNWALIRCAIPPELPDFYEYGGGPEAAADSPGGSNNRYLECKAIG--DHLEFELF 934
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q64FQ2|PID2_ARATH Protein kinase PINOID 2 OS=Arabidopsis thaliana GN=PID2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 420 bits (1079), Expect = e-116, Method: Compositional matrix adjust.
Identities = 226/494 (45%), Positives = 288/494 (58%), Gaps = 55/494 (11%)
Query: 173 SSDVSDESTCSSFSSSIN---------KPHKANDLRWEAIQAVRARDG-VLGLSHFRLLK 222
SS + +CSS S N KPHKAN + WEA+ +R G +GL HFRLLK
Sbjct: 32 SSSFTASPSCSSISHLSNHGLNSYNQSKPHKANQVAWEAMARLRRCCGRAVGLEHFRLLK 91
Query: 223 RLGCGDIGSVYLSELSGT--KCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPT 280
RLG GDIGSVYL ++ G+ ++AMKV+DK ++A +KKL RA+ E++IL LDHPF PT
Sbjct: 92 RLGSGDIGSVYLCQIRGSPETAFYAMKVVDKEAVAVKKKLGRAEMEKKILGMLDHPFCPT 151
Query: 281 LYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGII 340
LY FE +S LVME+CPGGDL+ +R +QP K F + RFY AE L+ALEYLHM+GI+
Sbjct: 152 LYAAFEASHYSFLVMEYCPGGDLYAVRLRQPSKRFTISSTRFYAAETLVALEYLHMMGIV 211
Query: 341 YRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEP 400
YRDLKPENVL+REDGH+MLSDFDLS +C V P + + D + ++ C P
Sbjct: 212 YRDLKPENVLIREDGHVMLSDFDLSFKCDVVPQFLSDNDRDRGHQEDDDDISIRRKCSTP 271
Query: 401 SC-IQPSCVTPTCFSP--------------------------------RLFSSKSKKDRK 427
SC P +CFSP R FS +
Sbjct: 272 SCTTTPLNPVISCFSPTSSRRRKKNVVTTTIHENAAGTSDSVKSNDVSRTFSRSPSSCSR 331
Query: 428 PKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYEL 487
N + + P + AEP ARS SFVGTHEYLAPE+I G+GHGSAVDWWT+GIFLYE+
Sbjct: 332 VSNGLRDISGGCPSIFAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTYGIFLYEM 391
Query: 488 LFGKTPFKGSGNRATLFNVVGQPLRFPESPVVS-------FAARDLIRGLLVKEPQHRLA 540
+FG+TPFKG N TL N++ PL FP+ V S A+DLI LLVK P+ RL
Sbjct: 392 IFGRTPFKGDNNEKTLVNILKAPLTFPKVIVNSPKEYEDMVNAQDLIIKLLVKNPKKRLG 451
Query: 541 YKRGATEIKQHPFFEGVNWALIRCATPPEIPKPVEIERIPAPTSSTSEKTAPTMVPPNQR 600
+G+ EIK+H FFEGVNWALIR PP +PK + S + P + +
Sbjct: 452 SLKGSIEIKRHEFFEGVNWALIRSIKPPWVPKEETSHKTKGDNRSVNYYLPPRFMMSRKE 511
Query: 601 GSDNYL---EFDFF 611
++ Y FD+F
Sbjct: 512 RNEPYHVSNYFDYF 525
|
Serine/threonine-protein kinase involved in the regulation of auxin signaling. Plays a minor role in the regulation of cellular auxin efflux and cotyledon organogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94E49|PID2_ORYSJ Protein kinase PINOID 2 OS=Oryza sativa subsp. japonica GN=PID2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 401 bits (1031), Expect = e-111, Method: Compositional matrix adjust.
Identities = 208/406 (51%), Positives = 265/406 (65%), Gaps = 29/406 (7%)
Query: 186 SSSINKPHKANDLRWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSEL-------- 237
SS KPHKAN WEAI+ +RA G +GL HFRL++RLG GD+G+VYL L
Sbjct: 48 SSCRYKPHKANQAEWEAIRRLRAGAGRVGLEHFRLVRRLGSGDLGNVYLCRLREPWSSSS 107
Query: 238 ---SGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294
+ C +AMKV+DK +LA RKKL RA+ ER+IL++LDHPFLPTLY FE ++CLV
Sbjct: 108 MTTTAGGCLYAMKVVDKDALAFRKKLRRAEVERDILRTLDHPFLPTLYADFEASHYACLV 167
Query: 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRED 354
MEFCPGGDLH RQ+QPG+ F + RFYVAE +LALEYLHM+G++YRDLKPENVLVR D
Sbjct: 168 MEFCPGGDLHVARQRQPGRRFTVSSTRFYVAETVLALEYLHMMGVVYRDLKPENVLVRGD 227
Query: 355 GHIMLSDFDLSLRCAVSPTLI---KASSLDAEPLRKNPVYCVQPACIEP--SCI----QP 405
GHIMLSDFDLSL+C V P L+ ++++ +P P CV P I+P SCI
Sbjct: 228 GHIMLSDFDLSLKCDVVPKLLRPARSAAAGGKPPLPPPSSCVPPT-IQPVLSCIFRGVHK 286
Query: 406 SCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEI 465
C + + E + + ++ EP ARS SFVGTHEYLAPE+
Sbjct: 287 CHHAKECAGGGAAAGNNGDGDGNDEEAETETAEPEVVVVEPVAARSKSFVGTHEYLAPEV 346
Query: 466 IKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSF---- 521
I G+GHGSAVDWWT G+F+YE+L+G+TPFKG N TL N++ QP+ FP +
Sbjct: 347 ISGQGHGSAVDWWTLGVFMYEMLYGRTPFKGESNEKTLINIIKQPVTFPRLAGAAAAGEW 406
Query: 522 ----AARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIR 563
A+DL+ LL K P+ RL G+ E+K+HPFF+GVNWAL+R
Sbjct: 407 EEMKTAQDLMLQLLAKNPKKRLGSTMGSAEVKRHPFFKGVNWALVR 452
|
Serine/threonine-protein kinase involved in the regulation of auxin signaling. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64682|PID_ARATH Protein kinase PINOID OS=Arabidopsis thaliana GN=PID PE=1 SV=1 | Back alignment and function description |
|---|
Score = 386 bits (992), Expect = e-106, Method: Compositional matrix adjust.
Identities = 210/431 (48%), Positives = 272/431 (63%), Gaps = 54/431 (12%)
Query: 170 GSTSSDVSDES-TCSSFS--------SSIN--------KPHKANDLRWEAIQAVRARDGV 212
G+T+S +S + +CSSFS S+I KPH+++D + I+ R +
Sbjct: 12 GTTNSPISSGTESCSSFSRLSFDAPPSTIPEEESFLSLKPHRSSDFAYAEIR--RRKKQG 69
Query: 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTK-----CYFAMKVMDKASLAGRKKLLRAQTER 267
L FRL++R+G GDIG+VYL L+G + YFAMKV+DK +LA +KK+ RA+ E+
Sbjct: 70 LTFRDFRLMRRIGAGDIGTVYLCRLAGDEEESRSSYFAMKVVDKEALALKKKMHRAEMEK 129
Query: 268 EILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEV 327
IL+ LDHPFLPTLY FE FSC+VME+C GGDLH+LR +QP + F + RFY AEV
Sbjct: 130 TILKMLDHPFLPTLYAEFEASHFSCIVMEYCSGGDLHSLRHRQPHRRFSLSSARFYAAEV 189
Query: 328 LLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRK 387
L+ALEYLHMLGIIYRDLKPEN+LVR DGHIMLSDFDLSL C+ S +++SS E
Sbjct: 190 LVALEYLHMLGIIYRDLKPENILVRSDGHIMLSDFDLSL-CSDSIAAVESSSSSPE---- 244
Query: 388 NPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKK-DRKPKNEIGNQVSPLPELIAEP 446
SPR F+ ++ R +++ + P +AEP
Sbjct: 245 ---------------------NQQLRSPRRFTRLARLFQRVLRSKKVQTLEPTRLFVAEP 283
Query: 447 TEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNV 506
ARS SFVGTHEY+APE+ G HG+AVDWW FG+FLYE+++GKTPF N L N+
Sbjct: 284 VTARSGSFVGTHEYVAPEVASGGSHGNAVDWWAFGVFLYEMIYGKTPFVAPTNDVILRNI 343
Query: 507 VGQPLRFP-ESPVVSFA--ARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIR 563
V + L FP +SP F AR+LI GLL K+P RL +RGA E+K HPFF+G+N+ALIR
Sbjct: 344 VKRQLSFPTDSPATMFELHARNLISGLLNKDPTKRLGSRRGAAEVKVHPFFKGLNFALIR 403
Query: 564 CATPPEIPKPV 574
TPPEIP V
Sbjct: 404 TLTPPEIPSSV 414
|
Serine/threonine-protein kinase involved in the regulation of auxin signaling. Acts as a positive regulator of cellular auxin efflux and regulates organ development by enhancing polar auxin transport. Phosphorylates conserved serine residues in the PIN auxin efflux carriers. Phosphorylation of PIN proteins is required and sufficient for apical-basal PIN polarity that enables directional intercellular auxin fluxes, which mediate differential growth, tissue patterning and organogenesis. Acts in association with PIN1 to control the establishment of bilateral symmetry and promotion of cotyledon outgrowth. Regulates root gravitropism through modulation of PIN2-dependent basipetal auxin transport. Required for polarization of PIN3-dependent auxin transport for hypocotyl gravitropic response. The protein kinase activity of PID is essential for its auxin efflux regulatory function. PID kinase and PP2A phosphatase activities antagonistically regulate phosphorylation of PIN proteins, affecting PIN sorting. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2QM77|PID_ORYSJ Protein kinase PINOID OS=Oryza sativa subsp. japonica GN=PID PE=2 SV=1 | Back alignment and function description |
|---|
Score = 381 bits (979), Expect = e-105, Method: Compositional matrix adjust.
Identities = 189/397 (47%), Positives = 253/397 (63%), Gaps = 41/397 (10%)
Query: 186 SSSINKPHKANDLRWEAIQAVRARDGV-LGLSHFRLLKRLGCGDIGSVYLSELSGTK--- 241
+S + +PH++ D+ W AI+A LG F+L++R+G GDIG+VYL L +
Sbjct: 78 ASVLLRPHRSGDVAWAAIRAASTTSAAPLGPRDFKLVRRIGGGDIGTVYLCRLRSSPERE 137
Query: 242 --CYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFE-TEKFSCLVMEFC 298
C +AMKV+D+ ++A ++KL RA E+ IL+ LDHPFLPTL+ F+ T FSC VMEFC
Sbjct: 138 SPCMYAMKVVDRRAVARKQKLGRAAAEKRILRQLDHPFLPTLFADFDATPHFSCAVMEFC 197
Query: 299 PGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIM 358
PGGDLH+LR + P + FP + RFY AEVLLA+EYLHM+GI+YRDLKPENVL+R DGHIM
Sbjct: 198 PGGDLHSLRHRMPSRRFPLPSARFYAAEVLLAIEYLHMMGIVYRDLKPENVLIRADGHIM 257
Query: 359 LSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLF 418
L+DFDLSL+ SP+L + D E + +CF L
Sbjct: 258 LTDFDLSLQSTTSPSLDGDTDTDDE----------------------ASGGASCFPDHLL 295
Query: 419 SSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWW 478
K + +N + +P P +AEP +ARS SFVGTHEY+APE+ G HG+AVDWW
Sbjct: 296 RFKRR-----RNAVA---APRPRFVAEPVDARSCSFVGTHEYVAPEVASGGAHGAAVDWW 347
Query: 479 TFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESP----VVSFAARDLIRGLLVKE 534
+G+FLYEL++G+TPF G+ N ATL N+V +PL FP ARDLI LL K+
Sbjct: 348 AYGVFLYELIYGRTPFAGATNEATLRNIVRRPLAFPSGSGSCGPADADARDLIARLLAKD 407
Query: 535 PQHRLAYKRGATEIKQHPFFEGVNWALIRCATPPEIP 571
P RL +RGA ++K HPFF+ +N AL+R + PP +P
Sbjct: 408 PAARLGSRRGAADVKSHPFFKSLNLALLRSSRPPVVP 444
|
Serine/threonine-protein kinase involved in the regulation of auxin signaling. May control polar auxin transport and probably plays a role in the pattern formation and organogenesis in the rice shoot. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ST27|PHOT2_ORYSJ Phototropin-2 OS=Oryza sativa subsp. japonica GN=PHOT2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 354 bits (909), Expect = 1e-96, Method: Compositional matrix adjust.
Identities = 176/386 (45%), Positives = 233/386 (60%), Gaps = 49/386 (12%)
Query: 191 KPHKANDLRWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMD 250
KPHK N+ W AI+ +GL HF+ +K LGCGD GSV+L EL G+ FAMK MD
Sbjct: 549 KPHKRNNPSWIAIEKATNLGEKIGLKHFKPVKPLGCGDTGSVHLVELQGSGELFAMKAMD 608
Query: 251 KASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQ 310
K+ + R K+ RA EREI LDHPFLPTLYT F+T CL+ +FCPGG+L + +Q
Sbjct: 609 KSVMLNRNKVHRACIEREIYALLDHPFLPTLYTSFQTPTHVCLITDFCPGGELFAVLDRQ 668
Query: 311 PGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAV 370
P K F E+ RFY AEV++ LEYLH LGIIYRDLKPEN+L++ DGHI+L+DFDLS
Sbjct: 669 PMKIFREECARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQADGHIVLTDFDLSFLTTS 728
Query: 371 SPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKN 430
P +IK S+ S K R+ +
Sbjct: 729 KPHVIKNST------------------------------------------SLKRRRSQE 746
Query: 431 EIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFG 490
+ P ++EP+ S SFVGT EY+APE+I G GH SA+DWW GI LYE+L+G
Sbjct: 747 FLP------PTFVSEPSTP-SNSFVGTEEYIAPEVITGAGHTSAIDWWALGILLYEMLYG 799
Query: 491 KTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQ 550
+TPF+G + T +N++ + L FP S VS AA+ LI GLL ++P +R+ GA +IKQ
Sbjct: 800 RTPFRGKNRKKTFYNILHKDLTFPSSIPVSLAAKQLIHGLLQRDPSNRIGSNAGANDIKQ 859
Query: 551 HPFFEGVNWALIRCATPPEIPKPVEI 576
H FF+ +NW LIRC +PPE+ P+++
Sbjct: 860 HSFFQDINWPLIRCMSPPELDVPLKL 885
|
Protein kinase that acts as a blue-light photoreceptor in a signal-transduction pathway for phototropic responses. Regulates a wide range of physiological activities in plants that maximize the efficiency of photosynthesis, such as chloroplast relocations, stomata opening, and leaf expansion. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 611 | ||||||
| 359494858 | 620 | PREDICTED: protein kinase G11A-like [Vit | 0.996 | 0.982 | 0.831 | 0.0 | |
| 255579150 | 612 | serine/threonine protein kinase, putativ | 0.996 | 0.995 | 0.835 | 0.0 | |
| 356532843 | 608 | PREDICTED: protein kinase G11A-like [Gly | 0.990 | 0.995 | 0.799 | 0.0 | |
| 356555777 | 608 | PREDICTED: LOW QUALITY PROTEIN: protein | 0.990 | 0.995 | 0.804 | 0.0 | |
| 357448091 | 604 | Protein kinase [Medicago truncatula] gi| | 0.978 | 0.990 | 0.790 | 0.0 | |
| 225461963 | 611 | PREDICTED: protein kinase G11A-like [Vit | 0.993 | 0.993 | 0.803 | 0.0 | |
| 224137196 | 493 | predicted protein [Populus trichocarpa] | 0.805 | 0.997 | 0.919 | 0.0 | |
| 224086314 | 501 | predicted protein [Populus trichocarpa] | 0.803 | 0.980 | 0.914 | 0.0 | |
| 449434050 | 612 | PREDICTED: protein kinase G11A-like [Cuc | 0.996 | 0.995 | 0.768 | 0.0 | |
| 449443506 | 607 | PREDICTED: protein kinase G11A-like [Cuc | 0.991 | 0.998 | 0.763 | 0.0 |
| >gi|359494858|ref|XP_003634855.1| PREDICTED: protein kinase G11A-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1018 bits (2632), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 517/622 (83%), Positives = 556/622 (89%), Gaps = 13/622 (2%)
Query: 1 MASKAVAKASSKEQQKTAGVQKIGADEPVSLPLNGSKTNKPELVSPKQLPKSVDKTPKQV 60
MASK+ +K+SS++++ T+G Q +GA+E LPL SKT+KPELVS +Q KSV TPKQV
Sbjct: 1 MASKSCSKSSSQQRKLTSGAQAVGANELKPLPLEVSKTSKPELVSTEQ--KSVQTTPKQV 58
Query: 61 AVEASQSKTSSNSNQKGPVDSLINQLKSNSSSLGLEQASN-VDSVVSENRGSQDVSVDQE 119
VEAS+ K S S QKG D L + S+SSS G EQAS VD V+ +RGS + SVDQE
Sbjct: 59 TVEASEIKKSPTSGQKGSADLLPIKFDSSSSSAGAEQASTEVDPSVNGSRGSLEASVDQE 118
Query: 120 KKTSEYGSVKNSSVSGKVSDGTSSLAKTSGSAKISDRLDYVESGKSSICRGSTSSDVSDE 179
KKTSEYGSVK+SSVS KVSDG SSLAKTSGSAK+SDR D+VESGKSS+CRGSTSSDVSDE
Sbjct: 119 KKTSEYGSVKDSSVSAKVSDGASSLAKTSGSAKVSDRGDFVESGKSSMCRGSTSSDVSDE 178
Query: 180 STCSSFSSSINKPHKANDLRWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSG 239
STCSSFSSSINKPHKAND RWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSG
Sbjct: 179 STCSSFSSSINKPHKANDSRWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSG 238
Query: 240 TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCP 299
TK YFAMKVMDK SLA RKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCP
Sbjct: 239 TKSYFAMKVMDKGSLASRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCP 298
Query: 300 GGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIML 359
GGDLHTLRQ+QPGK+F EQAV+FYVAEVLLALEYLHMLGI+YRDLKPENVLVR+DGHIML
Sbjct: 299 GGDLHTLRQRQPGKHFTEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRDDGHIML 358
Query: 360 SDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTP-TCFSPRLF 418
SDFDLSLRCAVSPTL+K SL+++P RKNPVYCVQPACIEPSCIQPSCV P TCF+PRLF
Sbjct: 359 SDFDLSLRCAVSPTLVKTCSLESDPFRKNPVYCVQPACIEPSCIQPSCVAPTTCFTPRLF 418
Query: 419 SSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWW 478
SSKS+KDRKPKNE+GNQVSPLPELIAEPT ARSMSFVGTHEYLAPEIIKGEGHGSAVDWW
Sbjct: 419 SSKSRKDRKPKNEVGNQVSPLPELIAEPTGARSMSFVGTHEYLAPEIIKGEGHGSAVDWW 478
Query: 479 TFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHR 538
TFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSF+ARDLIRGLLVKEPQHR
Sbjct: 479 TFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFSARDLIRGLLVKEPQHR 538
Query: 539 LAYKRGATEIKQHPFFEGVNWALIRCATPPEIPKPVEIERIPAPTSSTSEKT-------- 590
LA+KRGATEIKQHPFFEGVNWALIRCATPPEIPKPVEIERIPAPT+STSEK
Sbjct: 539 LAFKRGATEIKQHPFFEGVNWALIRCATPPEIPKPVEIERIPAPTASTSEKVPPAAKATA 598
Query: 591 -APTMVPPNQRGSDNYLEFDFF 611
V P+Q+ SDNYLEFDFF
Sbjct: 599 PIAAAVVPDQKSSDNYLEFDFF 620
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255579150|ref|XP_002530422.1| serine/threonine protein kinase, putative [Ricinus communis] gi|223530030|gb|EEF31953.1| serine/threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1003 bits (2593), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 512/613 (83%), Positives = 558/613 (91%), Gaps = 4/613 (0%)
Query: 1 MASKAVAKASSKEQQKTAGVQKIGADEPVSLPLNGSKTNKPELVSPKQLPKSVDKTPKQV 60
MASK +KAS K Q K+ GVQK A+ +L S+T+K +L++ ++ +S++ TPKQV
Sbjct: 2 MASKG-SKASPKPQLKSVGVQKAEANNLKTLSSQVSETSKSDLINHDKVQRSIENTPKQV 60
Query: 61 AVEASQSKTSSNSNQKGPVDSLINQLKSNSSSLGLEQASNV-DSVVSENRGSQDVSVDQE 119
+E S+ K SNSN+K DSL +L S+SS LE AS V DS ++E RGSQDVS+DQE
Sbjct: 61 MLEFSEDKKLSNSNKKETADSLSIKLGSSSSIPTLEHASIVADSSINETRGSQDVSLDQE 120
Query: 120 KKTSEYGSVKNSSVSGKVSDGTSSLAKTSGSAKISDRLDYVESGKSSICRGSTSSDVSDE 179
KKTSEYGSVK+SSVS KVSDG SSLAKTSGSAKISDR++YVESGKSS+CRGSTSSD+SDE
Sbjct: 121 KKTSEYGSVKSSSVSAKVSDGASSLAKTSGSAKISDRVEYVESGKSSLCRGSTSSDISDE 180
Query: 180 STCSSFSSSINKPHKANDLRWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSG 239
STCSSFSSSI+KPHKANDLRWEAIQAVRA+DGVLGLSHFRLLKRLGCGDIGSVYLSELSG
Sbjct: 181 STCSSFSSSISKPHKANDLRWEAIQAVRAKDGVLGLSHFRLLKRLGCGDIGSVYLSELSG 240
Query: 240 TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCP 299
TKCYFAMKVMDK SLA RKKLLRAQTEREILQSLDHPFLPTLYTHFET+KFSCLVMEFCP
Sbjct: 241 TKCYFAMKVMDKGSLASRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCP 300
Query: 300 GGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIML 359
GGDLHTLRQ+QPGK+FPEQAV+FY+AEVLLALEYLHMLGIIYRDLKPENVLVREDGHIML
Sbjct: 301 GGDLHTLRQRQPGKHFPEQAVKFYIAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIML 360
Query: 360 SDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTP-TCFSPRLF 418
SDFDLSLRCAVSPTL+K SSL++EPLRKNPVYCVQPACIEPSCIQPSCV P TCFSPRLF
Sbjct: 361 SDFDLSLRCAVSPTLVKTSSLESEPLRKNPVYCVQPACIEPSCIQPSCVAPTTCFSPRLF 420
Query: 419 SSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWW 478
SSKSKKDRKPK+E+GNQVSPLPELIAEPT+ARSMSFVGTHEYLAPEIIKGEGHGSAVDWW
Sbjct: 421 SSKSKKDRKPKSELGNQVSPLPELIAEPTDARSMSFVGTHEYLAPEIIKGEGHGSAVDWW 480
Query: 479 TFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHR 538
TFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHR
Sbjct: 481 TFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHR 540
Query: 539 LAYKRGATEIKQHPFFEGVNWALIRCATPPEIPKPVEIERIPAPTSSTSEKTAPTMVPPN 598
LAYKRGATEIKQHPFFEGVNWALIRCATPPEIPKPVE+ER+P P +STSEK P+
Sbjct: 541 LAYKRGATEIKQHPFFEGVNWALIRCATPPEIPKPVEVERVPVP-ASTSEKATSAPAVPD 599
Query: 599 QRGSDNYLEFDFF 611
++GSDNYLEFDFF
Sbjct: 600 KKGSDNYLEFDFF 612
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356532843|ref|XP_003534979.1| PREDICTED: protein kinase G11A-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 988 bits (2554), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 491/614 (79%), Positives = 527/614 (85%), Gaps = 9/614 (1%)
Query: 1 MASKAVAKASSKEQQKTAGVQKIGADEPVSLPLNGSKTNKPELVSPKQLPKSVDKTPKQV 60
M SK +++ K QKTAG++ + S + K K EL +P L KS KQ
Sbjct: 1 MDSKTSSRSLPKHHQKTAGIRTPETKDAGS---SFQKMGKTELAAPVDLLKSAANASKQN 57
Query: 61 AVEASQSKTSSNSNQKGPVDSLINQLKSNSSSLGLEQASNVDSVVSENRGSQDVSVDQEK 120
E ++ K KG DSL N+ S +SS L+++ +EN GSQ+ +DQ+K
Sbjct: 58 TGETAEIKKLGGLTLKGSADSLSNKSGSGASSYVLDKSVRA---ANENIGSQESPIDQDK 114
Query: 121 KTSEYGSVKNSSVSGKVSDGTSSLAKTSGSAKISDRLDYVESGKSSICRGSTSSDVSDES 180
KTSE GSVKNSSVS KVSDG SSLAKTSGSAKIS+R D+VESGKSSICRGSTSSDVSDES
Sbjct: 115 KTSEDGSVKNSSVSAKVSDGASSLAKTSGSAKISNRADFVESGKSSICRGSTSSDVSDES 174
Query: 181 TCSSFSSSINKPHKANDLRWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGT 240
TCSSFSS+INKPHKANDLRWEAIQAVR+RDGVLGL HFRLLKRLGCGDIGSVYLSELSGT
Sbjct: 175 TCSSFSSTINKPHKANDLRWEAIQAVRSRDGVLGLGHFRLLKRLGCGDIGSVYLSELSGT 234
Query: 241 KCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPG 300
KCYFAMKVMDK SLA RKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPG
Sbjct: 235 KCYFAMKVMDKGSLASRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPG 294
Query: 301 GDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLS 360
GDLHTLRQKQPGK+FPEQAV+FYVAEVLLALEYLHMLGI+YRDLKPENVLVR+DGHIMLS
Sbjct: 295 GDLHTLRQKQPGKHFPEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRDDGHIMLS 354
Query: 361 DFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIE-PSCIQPSCVTP-TCFSPRLF 418
DFDLSLRCAVSPTL+K SS D+EPLRKN YCVQPACIE PSCIQPSCV P TCFSPRLF
Sbjct: 355 DFDLSLRCAVSPTLVKTSSTDSEPLRKNSAYCVQPACIEPPSCIQPSCVAPTTCFSPRLF 414
Query: 419 SSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWW 478
SSKSKKDRKPK EIGNQVSPLPELIAEPT+ARSMSFVGTHEYLAPEIIKGEGHGSAVDWW
Sbjct: 415 SSKSKKDRKPKTEIGNQVSPLPELIAEPTDARSMSFVGTHEYLAPEIIKGEGHGSAVDWW 474
Query: 479 TFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHR 538
TFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPE+PVVSFAARDLIRGLLVKEPQHR
Sbjct: 475 TFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPEAPVVSFAARDLIRGLLVKEPQHR 534
Query: 539 LAYKRGATEIKQHPFFEGVNWALIRCATPPEIPKPVEIERIPAPTSST-SEKTAPTMVPP 597
LAYKRGATEIKQHPFFEGVNWALIRCATPPEIPK VE E+IP+P SS+ EK A +
Sbjct: 535 LAYKRGATEIKQHPFFEGVNWALIRCATPPEIPKAVEFEKIPSPASSSGGEKAANHISIA 594
Query: 598 NQRGSDNYLEFDFF 611
NQ+GSDNYLEFDFF
Sbjct: 595 NQKGSDNYLEFDFF 608
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356555777|ref|XP_003546206.1| PREDICTED: LOW QUALITY PROTEIN: protein kinase G11A-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 972 bits (2512), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 494/614 (80%), Positives = 526/614 (85%), Gaps = 9/614 (1%)
Query: 1 MASKAVAKASSKEQQKTAGVQKIGADEPVSLPLNGSKTNKPELVSPKQLPKSVDKTPKQV 60
M SK ++A K QKTAG+Q + A + S G KT EL +P L KQ
Sbjct: 1 MDSKTSSRALPKHHQKTAGIQTLEAKDTGSSLQKGEKT---ELAAPVDLSMYAANASKQN 57
Query: 61 AVEASQSKTSSNSNQKGPVDSLINQLKSNSSSLGLEQASNVDSVVSENRGSQDVSVDQEK 120
E ++ K KG DS+ + S +SS L++ V +EN GSQ+ S+D +K
Sbjct: 58 TGETAEIKKLGGLTLKGSADSMSIKSGSGASSSVLDK---VVHAANENIGSQESSIDLDK 114
Query: 121 KTSEYGSVKNSSVSGKVSDGTSSLAKTSGSAKISDRLDYVESGKSSICRGSTSSDVSDES 180
KTSE GSVKNSSVS KVSDG SSLAKTSGSAKIS+R D+VESGKSSICRGSTSSDVSDES
Sbjct: 115 KTSEDGSVKNSSVSAKVSDGASSLAKTSGSAKISNRADFVESGKSSICRGSTSSDVSDES 174
Query: 181 TCSSFSSSINKPHKANDLRWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGT 240
TCSSFSSSINKPHKANDLRWEAIQAVR+RDGVLGL HFRLLKRLGCGDIGSVYLSELSGT
Sbjct: 175 TCSSFSSSINKPHKANDLRWEAIQAVRSRDGVLGLGHFRLLKRLGCGDIGSVYLSELSGT 234
Query: 241 KCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPG 300
KCYFAMKVMDK SLA RKKLLR QTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPG
Sbjct: 235 KCYFAMKVMDKGSLASRKKLLRXQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPG 294
Query: 301 GDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLS 360
GDLHTLRQKQPGK+FPEQAV+FYVAEVLLALEYLHMLGI+YRDLKPENVLVR+DGHIMLS
Sbjct: 295 GDLHTLRQKQPGKHFPEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRDDGHIMLS 354
Query: 361 DFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIE-PSCIQPSCVTP-TCFSPRLF 418
DFDLSLRCAVSPTL+K SS D+EPLRKN VYCVQPACIE PSCIQPSCV P TCFSPRLF
Sbjct: 355 DFDLSLRCAVSPTLVKTSSTDSEPLRKNAVYCVQPACIEPPSCIQPSCVAPTTCFSPRLF 414
Query: 419 SSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWW 478
SSKSKKDRKPKNEIGNQVSPLPELIAEPT+ARSMSFVGTHEYLAPEIIKGEGHGSAVDWW
Sbjct: 415 SSKSKKDRKPKNEIGNQVSPLPELIAEPTDARSMSFVGTHEYLAPEIIKGEGHGSAVDWW 474
Query: 479 TFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHR 538
TFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPE+PVVSFAARDLIRGLLVKEPQHR
Sbjct: 475 TFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPEAPVVSFAARDLIRGLLVKEPQHR 534
Query: 539 LAYKRGATEIKQHPFFEGVNWALIRCATPPEIPKPVEIERIPAPTSST-SEKTAPTMVPP 597
LAYKRGATEIKQHPFFEGVNWALIRCATPPEIPK VE E+IP+P SS+ EK M
Sbjct: 535 LAYKRGATEIKQHPFFEGVNWALIRCATPPEIPKAVEFEKIPSPASSSGGEKAVNHMSIA 594
Query: 598 NQRGSDNYLEFDFF 611
NQ+GSDNYLEFDFF
Sbjct: 595 NQKGSDNYLEFDFF 608
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357448091|ref|XP_003594321.1| Protein kinase [Medicago truncatula] gi|355483369|gb|AES64572.1| Protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 965 bits (2494), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 488/617 (79%), Positives = 531/617 (86%), Gaps = 19/617 (3%)
Query: 1 MASKAVAKASSKEQQKTAGVQKIGADEPVSLPLNGSKTNKPELVSPKQLPKSVDKTPKQV 60
M SK+ A++ SK+ QKT+G+Q A + L+ KT K E P+ L KSV T KQ
Sbjct: 1 MDSKSSARSLSKQHQKTSGIQTPEAKDLKFSSLSLQKTGKSE---PEDLSKSVQNTSKQN 57
Query: 61 AVEASQSKTSSNSNQKGP-VDSLINQLKSNSSSLGLEQASNVDSVVSENRGSQDVSVDQE 119
E +SK +QKG DSL ++ S +SS SVV+ N GSQ+ S+DQ+
Sbjct: 58 IGEIYESKKFGVPSQKGSSADSLSSKFGSGASS----------SVVNVNTGSQESSIDQD 107
Query: 120 KKTSEYGSVKNSSVSGKVSDGTSSLAKTSGSAKISDRLDYVESGKSSICRGSTSSDVSDE 179
KKTSEYGSVKNSSVS K SDG SS+AKTSGSAKISDR D+VESGKSSICRGSTSSDVSDE
Sbjct: 108 KKTSEYGSVKNSSVSAKASDGASSIAKTSGSAKISDRADFVESGKSSICRGSTSSDVSDE 167
Query: 180 STCSSFSSSINKPHKANDLRWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSG 239
STCSSFSSS+NKPHKAND+RWEAIQ VR RDG LGL HFRLLKRLGCGDIGSVYLSELSG
Sbjct: 168 STCSSFSSSVNKPHKANDMRWEAIQVVRTRDGALGLGHFRLLKRLGCGDIGSVYLSELSG 227
Query: 240 TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCP 299
TKCYFAMKVMDK SLA RKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCP
Sbjct: 228 TKCYFAMKVMDKGSLASRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCP 287
Query: 300 GGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIML 359
GGDLHTLRQKQPGK+FPEQAV+FYVAEVLLA+EYLHMLGI+YRDLKPENVLVR+DGHIML
Sbjct: 288 GGDLHTLRQKQPGKHFPEQAVKFYVAEVLLAMEYLHMLGIVYRDLKPENVLVRDDGHIML 347
Query: 360 SDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIE-PSCIQPSCVTPT-CFSPRL 417
SDFDLSLRCAVSPTL+K+SS+D+EPLRKN YC QPACIE PSCIQPSCV PT CFSPRL
Sbjct: 348 SDFDLSLRCAVSPTLVKSSSIDSEPLRKNTGYCAQPACIEPPSCIQPSCVAPTSCFSPRL 407
Query: 418 FSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDW 477
FSSKSKK+RK K E+GNQVSPLPELIAEPT+ARSMSFVGTHEYLAPEIIKGEGHGSAVDW
Sbjct: 408 FSSKSKKERKAKTELGNQVSPLPELIAEPTDARSMSFVGTHEYLAPEIIKGEGHGSAVDW 467
Query: 478 WTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQH 537
WT+GIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPE+PVVSFAARDLIRGLLVKEPQH
Sbjct: 468 WTYGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPEAPVVSFAARDLIRGLLVKEPQH 527
Query: 538 RLAYKRGATEIKQHPFFEGVNWALIRCATPPEIPKPVEIERIPAPTSSTSEKTAPT---M 594
RLAYKRGATEIKQHPFFEGVNWALIRCATPPEIPK VE E+IP+P +S++ + A
Sbjct: 528 RLAYKRGATEIKQHPFFEGVNWALIRCATPPEIPKAVEFEKIPSPAASSAGEKAVVNHMS 587
Query: 595 VPPNQRGSDNYLEFDFF 611
PNQ+GSDNYLEFDFF
Sbjct: 588 TAPNQKGSDNYLEFDFF 604
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225461963|ref|XP_002266700.1| PREDICTED: protein kinase G11A-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 958 bits (2477), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 494/615 (80%), Positives = 536/615 (87%), Gaps = 8/615 (1%)
Query: 1 MASKAVAKASSKEQQKTAGVQKIGADEPVSLPLNGSKTNKPELVSPKQLPKSVDKTP-KQ 59
MASK+ A+ S Q++T G Q + + PL +KT+K E V+PK+ P+SV KQ
Sbjct: 1 MASKSGARTSPDRQKRTFGSQTLEGNSRRPSPLQITKTSKSEPVTPKKTPRSVQPVALKQ 60
Query: 60 VAVEASQSKTSSNSNQKGPVDSLINQLKSNSSSLGLEQASN--VDSVVSENRGSQDVSVD 117
V VEAS K S +S+QKG +SL ++L S S SLG Q + V V SE GS D D
Sbjct: 61 VDVEASDDKNSLSSHQKGSANSLTDKLGS-SLSLGDSQQTPTIVTPVASEVTGSLDGGAD 119
Query: 118 QEKKTSEYGSVKNSSVSGKVSDGTSSLAKTSGSAKISDRLDYVESGKSSICRGSTSSDVS 177
QEKKTSE+G +S+V+ KVSDGT SLAKTSGSAKISDR+++VESGKSS+CRGSTSSDVS
Sbjct: 120 QEKKTSEHG---HSTVAAKVSDGTGSLAKTSGSAKISDRVEFVESGKSSMCRGSTSSDVS 176
Query: 178 DESTCSSFSSSINKPHKANDLRWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSEL 237
DESTCSS SSSI+KPHKAND RWEAIQ VRA+DG LGL+HFRLLKRLGCGDIGSVYLSEL
Sbjct: 177 DESTCSSLSSSISKPHKANDSRWEAIQVVRAKDGALGLNHFRLLKRLGCGDIGSVYLSEL 236
Query: 238 SGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEF 297
GTKCYFAMKVMDK SLA RKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEF
Sbjct: 237 KGTKCYFAMKVMDKGSLASRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEF 296
Query: 298 CPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHI 357
CPGGDLHTLRQ+QPGK+F EQAV+FYVAEVLLALEYLHMLGI+YRDLKPENVLVREDGHI
Sbjct: 297 CPGGDLHTLRQRQPGKHFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHI 356
Query: 358 MLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTP-TCFSPR 416
MLSDFDLSLRC VSPTL+K+SS D EPLR+NPVYCVQP CIEPSCIQPSCV P TCFSPR
Sbjct: 357 MLSDFDLSLRCTVSPTLVKSSSFDTEPLRRNPVYCVQPTCIEPSCIQPSCVAPTTCFSPR 416
Query: 417 LFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVD 476
LFSSKSKKDRKPKNEIGNQVSPLPELIAEPT ARSMSFVGTHEYLAPEIIKGEGHGSAVD
Sbjct: 417 LFSSKSKKDRKPKNEIGNQVSPLPELIAEPTGARSMSFVGTHEYLAPEIIKGEGHGSAVD 476
Query: 477 WWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQ 536
WWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSF+ARDLIRGLLVKEPQ
Sbjct: 477 WWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFSARDLIRGLLVKEPQ 536
Query: 537 HRLAYKRGATEIKQHPFFEGVNWALIRCATPPEIPKPVEIERIPAPTSSTSEKTAPTMVP 596
HRLAYKRGATEIKQHPFFEGVNWALIRCA+PPEIPKPVEIER+PAP +S+SEK A M
Sbjct: 537 HRLAYKRGATEIKQHPFFEGVNWALIRCASPPEIPKPVEIERVPAPAASSSEKAAAAMAG 596
Query: 597 PNQRGSDNYLEFDFF 611
P+Q+ DNYLEFDFF
Sbjct: 597 PDQKSCDNYLEFDFF 611
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224137196|ref|XP_002322497.1| predicted protein [Populus trichocarpa] gi|222867127|gb|EEF04258.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 930 bits (2404), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 454/494 (91%), Positives = 472/494 (95%), Gaps = 2/494 (0%)
Query: 119 EKKTSEYGSVKNSSVSGKVSDGTSSLAKTSGSAKISDRLDYVESGKSSICRGSTSSDVSD 178
EKK SEYGSVKNSSVS KVSDGTSSLAKTSGSAK+SDR+DY ESGK S+CRGSTSSDVSD
Sbjct: 1 EKKISEYGSVKNSSVSAKVSDGTSSLAKTSGSAKMSDRVDYAESGKRSLCRGSTSSDVSD 60
Query: 179 ESTCSSFSSSINKPHKANDLRWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELS 238
ESTCSSFSSSINKPHKANDLRWEAIQAVRA+DGVLGLSHFRLLKRLGCGDIGSVYLSELS
Sbjct: 61 ESTCSSFSSSINKPHKANDLRWEAIQAVRAKDGVLGLSHFRLLKRLGCGDIGSVYLSELS 120
Query: 239 GTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFC 298
GTKCYFAMKVMDK SLA RKKLLRAQTEREILQSLDHPFLP+LYTHFET+KFSCLVMEFC
Sbjct: 121 GTKCYFAMKVMDKGSLASRKKLLRAQTEREILQSLDHPFLPSLYTHFETDKFSCLVMEFC 180
Query: 299 PGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIM 358
PGGDLHTLRQ+QPGK+F EQAV+FYVAEVLLALEYLHMLGIIYRDLKPENVLVR+DGHIM
Sbjct: 181 PGGDLHTLRQRQPGKHFLEQAVKFYVAEVLLALEYLHMLGIIYRDLKPENVLVRDDGHIM 240
Query: 359 LSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTP-TCFSPRL 417
LSDFDLSLRCAVSPTL+K +SL+A+P RKNPVYCVQPACIEPSCIQPSCV P TCF PRL
Sbjct: 241 LSDFDLSLRCAVSPTLVKTASLEADPFRKNPVYCVQPACIEPSCIQPSCVAPTTCFGPRL 300
Query: 418 FSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDW 477
FSSKSKKDRKPKNE+GNQVSPLPELIAEPT+ARSMSFVGTHEYLAPEIIKGEGHGSAVDW
Sbjct: 301 FSSKSKKDRKPKNELGNQVSPLPELIAEPTDARSMSFVGTHEYLAPEIIKGEGHGSAVDW 360
Query: 478 WTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQH 537
WTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQH
Sbjct: 361 WTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQH 420
Query: 538 RLAYKRGATEIKQHPFFEGVNWALIRCATPPEIPKPVEIERIPAPTSSTSEKTAPTMVPP 597
RLA KRGATEIKQHPFFEGVNWALIRCATPPEIPKPVEIERIPAP +STSEK P
Sbjct: 421 RLASKRGATEIKQHPFFEGVNWALIRCATPPEIPKPVEIERIPAP-ASTSEKATTVAAAP 479
Query: 598 NQRGSDNYLEFDFF 611
Q+GSDNYLEFDFF
Sbjct: 480 GQKGSDNYLEFDFF 493
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224086314|ref|XP_002307848.1| predicted protein [Populus trichocarpa] gi|222853824|gb|EEE91371.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 925 bits (2390), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 451/493 (91%), Positives = 471/493 (95%), Gaps = 2/493 (0%)
Query: 120 KKTSEYGSVKNSSVSGKVSDGTSSLAKTSGSAKISDRLDYVESGKSSICRGSTSSDVSDE 179
KKTSEYGSVKNSSVS KVSDGTSSL KTSGSAKISDR+DY E GK S+CRGSTSSDVSDE
Sbjct: 10 KKTSEYGSVKNSSVSAKVSDGTSSLGKTSGSAKISDRVDYAEGGKRSMCRGSTSSDVSDE 69
Query: 180 STCSSFSSSINKPHKANDLRWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSG 239
STCSSFSSSI+KPHKANDLRWEAIQAVRA+DGVLGLSHFRLLKRLGCGDIGSVYLSELSG
Sbjct: 70 STCSSFSSSISKPHKANDLRWEAIQAVRAKDGVLGLSHFRLLKRLGCGDIGSVYLSELSG 129
Query: 240 TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCP 299
TKCYFAMKVMDK SLA RKKLLRAQTEREILQSLDHPFLPTLYTHFET+KFSCL+MEFCP
Sbjct: 130 TKCYFAMKVMDKGSLASRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLLMEFCP 189
Query: 300 GGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIML 359
GGDLHTLRQ+QPGK+F EQAV+FYVAEVLLALEYLHMLGIIYRDLKPENVLVR+DGHIML
Sbjct: 190 GGDLHTLRQRQPGKHFQEQAVKFYVAEVLLALEYLHMLGIIYRDLKPENVLVRDDGHIML 249
Query: 360 SDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTP-TCFSPRLF 418
SDFDLSLRC VSPTL+K +SL++EPLRKNPVYCVQPACIEPSCIQPSCV P TCF PRLF
Sbjct: 250 SDFDLSLRCTVSPTLVKTASLESEPLRKNPVYCVQPACIEPSCIQPSCVAPTTCFGPRLF 309
Query: 419 SSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWW 478
SSKSKKDRKPKNE+GNQVSPLPEL+AEPT+ARSMSFVGTHEYLAPEIIKGEGHGSAVDWW
Sbjct: 310 SSKSKKDRKPKNELGNQVSPLPELMAEPTDARSMSFVGTHEYLAPEIIKGEGHGSAVDWW 369
Query: 479 TFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHR 538
TFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHR
Sbjct: 370 TFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHR 429
Query: 539 LAYKRGATEIKQHPFFEGVNWALIRCATPPEIPKPVEIERIPAPTSSTSEKTAPTMVPPN 598
LAYKRGATEIKQHPFFEGVNWALIRCATPPEIPKPVEIERIP P +STSEK A P
Sbjct: 430 LAYKRGATEIKQHPFFEGVNWALIRCATPPEIPKPVEIERIPGP-ASTSEKAATVAAAPG 488
Query: 599 QRGSDNYLEFDFF 611
Q+GS+NYLEFDFF
Sbjct: 489 QKGSENYLEFDFF 501
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449434050|ref|XP_004134809.1| PREDICTED: protein kinase G11A-like [Cucumis sativus] gi|449520159|ref|XP_004167101.1| PREDICTED: protein kinase G11A-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 919 bits (2375), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 472/614 (76%), Positives = 521/614 (84%), Gaps = 5/614 (0%)
Query: 1 MASKAVAKASSKEQQKTAGVQKIGADEPVSLPLNGSKTNKPELVSPKQLPKSVDKTPKQV 60
MAS A +KASS + Q+ A + + SLP SK +KP V Q + K V
Sbjct: 1 MASIAGSKASSNQPQQPANGEMANGKDTGSLPPQISKLSKPVSVISDQSKSVKSISKKDV 60
Query: 61 AVEASQSKTSSNSNQKGPVDSLINQLKSNSSSLGLEQA-SNVDSVVSENRGSQDVSVDQE 119
E S K S SNQ G L + + SS GL+Q + VDS ++E + S S+DQE
Sbjct: 61 --ELSSDKKSPVSNQNGSAKLLTEKFNFSISSPGLKQTPTEVDSPLNEAKCSPGSSLDQE 118
Query: 120 KKTSEYGSVKNSSVSGKVSDGTSSLAKTSGSAKISDRLDYVESGKSSICRGSTSSDVSDE 179
KKTSEYGSVK+SS SGKVSDGTS LAKTSGS K+SD ++VESGKSSICRGSTSSD+SDE
Sbjct: 119 KKTSEYGSVKSSSFSGKVSDGTSCLAKTSGSTKVSDHGNFVESGKSSICRGSTSSDISDE 178
Query: 180 STCSSFSSSINKPHKANDLRWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSG 239
S+CSSFSSSI+KPHKANDLRWEAIQ VRA+DG +GL HFRLLK+LGCGDIGSVYLSEL G
Sbjct: 179 SSCSSFSSSISKPHKANDLRWEAIQVVRAKDGAMGLGHFRLLKKLGCGDIGSVYLSELRG 238
Query: 240 TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCP 299
TKC+FAMKVMDK +LA RKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCP
Sbjct: 239 TKCHFAMKVMDKNTLASRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCP 298
Query: 300 GGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIML 359
GGDLHTLRQ+QPGK+F EQAV+FYVAEVLLALEYLHMLGI+YRDLKPENVLVREDGHIML
Sbjct: 299 GGDLHTLRQRQPGKHFAEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIML 358
Query: 360 SDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTP-TCFSPRLF 418
SDFDLSLRCAV+PTL+K S ++E LRKN YCVQPACIEPSCIQPSCV P TCFSPRLF
Sbjct: 359 SDFDLSLRCAVNPTLVKNLSAESEALRKNTGYCVQPACIEPSCIQPSCVVPTTCFSPRLF 418
Query: 419 SSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWW 478
SSKSKK+RKPK ++GNQVSPLPELIAEPT+ARSMSFVGTHEYLAPEIIKGEGHGSAVDWW
Sbjct: 419 SSKSKKERKPKIDLGNQVSPLPELIAEPTDARSMSFVGTHEYLAPEIIKGEGHGSAVDWW 478
Query: 479 TFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHR 538
TFGIFLYELLFGKTPFKGSGNRATLFN+VGQPLRFP++PVVSFAA+DLIRGLLVKEPQ R
Sbjct: 479 TFGIFLYELLFGKTPFKGSGNRATLFNIVGQPLRFPDAPVVSFAAKDLIRGLLVKEPQQR 538
Query: 539 LAYKRGATEIKQHPFFEGVNWALIRCATPPEIPKPVEIERIPAPTSSTSEK-TAPTMVPP 597
LAYKRGATEIKQHPFFEGVNWALIRCATPPEIP+PVEIERIP +STSEK A + P
Sbjct: 539 LAYKRGATEIKQHPFFEGVNWALIRCATPPEIPRPVEIERIPHAVASTSEKAVAIAAIAP 598
Query: 598 NQRGSDNYLEFDFF 611
+++ SDNYLEFDFF
Sbjct: 599 DKKASDNYLEFDFF 612
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449443506|ref|XP_004139518.1| PREDICTED: protein kinase G11A-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 916 bits (2367), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 467/612 (76%), Positives = 512/612 (83%), Gaps = 6/612 (0%)
Query: 1 MASKAVAKASSKEQQKTAGVQKIGADEPVSLPLNGSKTNKPELVSPKQLPKSVDKTPKQV 60
MASK+ + S+K+ GV+ SLP S NK V + K+ Q
Sbjct: 1 MASKSNLRPSAKQPTGITGVKGTDVSVLKSLPSQTSLGNKIGSVVSGDVLNYTQKSLNQS 60
Query: 61 AVEASQSKTSSNSNQKGPVDSLINQLKSNSSSLGLEQASNVDSVVSENRGSQDVSVDQEK 120
+ S + SS+ N K +S +K NSS ++ ++ +G + S+D +K
Sbjct: 61 TLIDSSNSKSSSLNHKESTESCNQIIKENSS-----KSDAKTEGLNGTQGLAEDSIDSKK 115
Query: 121 KTSEYGSVKNSSVSGKVSDGTSSLAKTSGSAKISDRLDYVESGKSSICRGSTSSDVSDES 180
K SE GS K+SSVS KVSDGT+S++KTSGSAKISDR++ VESGKSS+CRGSTSSD+SDES
Sbjct: 116 KISECGSGKDSSVSAKVSDGTNSISKTSGSAKISDRIEMVESGKSSMCRGSTSSDISDES 175
Query: 181 TCSSFSSSINKPHKANDLRWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGT 240
TCSSFSSSI+KPHKANDLRWEAIQAVRARDG+LGL HFRLLKRLGCGDIGSVYLSELSGT
Sbjct: 176 TCSSFSSSISKPHKANDLRWEAIQAVRARDGILGLGHFRLLKRLGCGDIGSVYLSELSGT 235
Query: 241 KCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPG 300
KCYFAMKVMDK SLA RKKLLRAQTEREILQSLDHPFLPTLYTHFET+KFSCLVMEFCPG
Sbjct: 236 KCYFAMKVMDKGSLASRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPG 295
Query: 301 GDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLS 360
GDLHTLRQ+QPGK+F EQAV+FYVAEVLLALEYLHMLGI+YRDLKPENVLVREDGHIMLS
Sbjct: 296 GDLHTLRQRQPGKHFTEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLS 355
Query: 361 DFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTP-TCFSPRLFS 419
DFDLSLRCAVSPTL+K S ++EPLRKN YCVQPACIEPSCIQPSCV P TCF+PRLFS
Sbjct: 356 DFDLSLRCAVSPTLVKGSCSESEPLRKNSTYCVQPACIEPSCIQPSCVVPTTCFTPRLFS 415
Query: 420 SKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWT 479
SKSKKDRKPK EIGNQV+PLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWT
Sbjct: 416 SKSKKDRKPKTEIGNQVTPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWT 475
Query: 480 FGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRL 539
FGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRL
Sbjct: 476 FGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRL 535
Query: 540 AYKRGATEIKQHPFFEGVNWALIRCATPPEIPKPVEIERIPAPTSSTSEKTAPTMVPPNQ 599
AYKRGATEIKQHPFFEGVNWALIRCA+PPE+PKPVEIERIP+P S K P+
Sbjct: 536 AYKRGATEIKQHPFFEGVNWALIRCASPPEVPKPVEIERIPSPAPPVSGKAIMARPGPDS 595
Query: 600 RGSDNYLEFDFF 611
+ SDNYLEFDFF
Sbjct: 596 KSSDNYLEFDFF 607
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 611 | ||||||
| TAIR|locus:2160922 | 586 | D6PKL2 "D6 protein kinase like | 0.826 | 0.861 | 0.789 | 3.8e-220 | |
| TAIR|locus:2133837 | 506 | D6PKL1 "D6 protein kinase like | 0.743 | 0.897 | 0.758 | 1.8e-190 | |
| TAIR|locus:2178388 | 498 | D6PK "D6 protein kinase" [Arab | 0.746 | 0.915 | 0.75 | 1.3e-187 | |
| UNIPROTKB|Q5I6E9 | 700 | Adi3 "AvrPto-dependent Pto-int | 0.764 | 0.667 | 0.696 | 3.8e-181 | |
| TAIR|locus:2055017 | 765 | AT2G44830 [Arabidopsis thalian | 0.762 | 0.609 | 0.635 | 2.2e-162 | |
| TAIR|locus:2091443 | 578 | ATPK7 [Arabidopsis thaliana (t | 0.826 | 0.873 | 0.623 | 7.3e-162 | |
| TAIR|locus:2174885 | 499 | AT5G40030 [Arabidopsis thalian | 0.675 | 0.827 | 0.679 | 4.4e-154 | |
| TAIR|locus:2207470 | 555 | AGC1.7 "AGC kinase 1.7" [Arabi | 0.621 | 0.684 | 0.705 | 5.1e-145 | |
| TAIR|locus:2085191 | 934 | KIPK "KCBP-interacting protein | 0.679 | 0.444 | 0.629 | 1e-141 | |
| TAIR|locus:2144598 | 926 | AT5G03640 [Arabidopsis thalian | 0.625 | 0.412 | 0.649 | 5.6e-141 |
| TAIR|locus:2160922 D6PKL2 "D6 protein kinase like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2126 (753.4 bits), Expect = 3.8e-220, P = 3.8e-220
Identities = 404/512 (78%), Positives = 443/512 (86%)
Query: 103 SVVSENRGSQDVSVDQEKKTSEYXXXXXXXXXXXXXDGTSSLAKTSGSAKISDRLDYVES 162
S V E+ S +++D EKKTS + DGTSSL KTSGSAK+S RLD++ES
Sbjct: 79 STVLEHVDS--LTID-EKKTSGFGSVKTSSASAKLSDGTSSLGKTSGSAKLSGRLDFMES 135
Query: 163 GKSSICRGXXXXXXXXXXXXXXXXXXINKPHKANDLRWEAIQAVRARDGVLGLSHFRLLK 222
GKSSICRG +NKPHKANDLRWEAIQAVR RDG+LGLSHFRLLK
Sbjct: 136 GKSSICRGSTSSDVSDESSCSSFSSTVNKPHKANDLRWEAIQAVRVRDGLLGLSHFRLLK 195
Query: 223 RLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLY 282
RLGCGDIGSVYLSELSGTKCYFAMKVMDK SLA RKKLLRAQTEREILQSLDHPFLPTLY
Sbjct: 196 RLGCGDIGSVYLSELSGTKCYFAMKVMDKTSLASRKKLLRAQTEREILQSLDHPFLPTLY 255
Query: 283 THFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYR 342
THFETEKFSCLVMEFCPGGDLHTLRQ+QPGK+F EQAV+FY+AE LLALEYLHMLGI+YR
Sbjct: 256 THFETEKFSCLVMEFCPGGDLHTLRQRQPGKHFSEQAVKFYIAESLLALEYLHMLGIVYR 315
Query: 343 DLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSC 402
DLKPENVLVREDGHIMLSDFDLSLRC VSPTL+K+++++++PLRKN VYCVQPACIEPSC
Sbjct: 316 DLKPENVLVREDGHIMLSDFDLSLRCLVSPTLVKSAAIESDPLRKN-VYCVQPACIEPSC 374
Query: 403 IQPSCVTPT-CFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYL 461
IQPSC PT CFSPRLFSSKSKKDRKPKN+ NQV PLPEL+AEPT+ARSMSFVGTHEYL
Sbjct: 375 IQPSCTVPTTCFSPRLFSSKSKKDRKPKNDTANQVRPLPELVAEPTDARSMSFVGTHEYL 434
Query: 462 APEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSF 521
APEIIKGEGHGSAVDWWTFGIFLYELLFG+TPFKGSGNR TLFNVVGQPLRFPE+PVVSF
Sbjct: 435 APEIIKGEGHGSAVDWWTFGIFLYELLFGRTPFKGSGNRQTLFNVVGQPLRFPETPVVSF 494
Query: 522 AARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIRCATPPEIPKPVEIER--I 579
AARDLIRGLL+KEPQ RL +KRGATE+KQHPFFEGVNWALIRCATPPEIPKPVE+E+ +
Sbjct: 495 AARDLIRGLLMKEPQQRLGFKRGATEVKQHPFFEGVNWALIRCATPPEIPKPVELEKGAV 554
Query: 580 PAPTSSTSEKTAPTMVPPNQRGSDNYLEFDFF 611
+ +S+KTA +V Q+GSDNYLEFDFF
Sbjct: 555 SVAEAPSSQKTAAGLVLNAQKGSDNYLEFDFF 586
|
|
| TAIR|locus:2133837 D6PKL1 "D6 protein kinase like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1846 (654.9 bits), Expect = 1.8e-190, P = 1.8e-190
Identities = 359/473 (75%), Positives = 399/473 (84%)
Query: 142 SSLAKTSGSAKISDRLDYVESGKSSICRGXXXXXXXXXXXXXXXXXXINKPHKANDLRWE 201
SS +KT G K +++ D +SGKS+ CR NKPHKAND+RWE
Sbjct: 50 SSDSKTGGEVKFNEKSD--QSGKSNTCRPSTSSDISDESTCSSFSGN-NKPHKANDVRWE 106
Query: 202 AIQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLL 261
AIQAVR + GVLGL+HFRLLKRLGCGDIG+V+L+EL GT+C+FAMKVMDK +LA RKKLL
Sbjct: 107 AIQAVRTKHGVLGLNHFRLLKRLGCGDIGTVHLAELHGTRCFFAMKVMDKGALASRKKLL 166
Query: 262 RAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVR 321
RAQTEREILQ LDHPFLPTLY+HFETEKFSCLVMEFCPGGDLHTLRQ+QPGK F EQA +
Sbjct: 167 RAQTEREILQCLDHPFLPTLYSHFETEKFSCLVMEFCPGGDLHTLRQRQPGKRFSEQAAK 226
Query: 322 FYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLD 381
FYVAEVLLA+EYLHMLGIIYRDLKPENVLVR+DGH+MLSDFDLSLRC VSPT+++++ L
Sbjct: 227 FYVAEVLLAMEYLHMLGIIYRDLKPENVLVRDDGHVMLSDFDLSLRCTVSPTVVRSTVLA 286
Query: 382 AEPLRKNPVYCVQPACIEPSCIQPSCVT-PT-CFSPRLFSSKSKKDRKPKNEIGNQVSPL 439
+E +KN YC QPACI+ QPSC++ PT CFSPR FSSKSKKD+K KNE GNQVSPL
Sbjct: 287 SEG-QKNSGYCAQPACIQ----QPSCISAPTTCFSPRYFSSKSKKDKKMKNETGNQVSPL 341
Query: 440 PELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGN 499
PEL+AEPT ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGN
Sbjct: 342 PELVAEPTSARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGN 401
Query: 500 RATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNW 559
RATLFNVVGQPLRFPESPVVSFAARDLIR LLVKEPQHRLAYKRGATE+KQHPFFEGVNW
Sbjct: 402 RATLFNVVGQPLRFPESPVVSFAARDLIRSLLVKEPQHRLAYKRGATEMKQHPFFEGVNW 461
Query: 560 ALIRCATPPEIPKPVEIERIPA-PTSSTSEKTAPTMVPPNQRGSDNYLEFDFF 611
AL+RCA+PPEIPKPV+ E PA P ++TS T V +Q NYLEFDFF
Sbjct: 462 ALVRCASPPEIPKPVDYESAPATPAAATS-----TSVKSDQ---SNYLEFDFF 506
|
|
| TAIR|locus:2178388 D6PK "D6 protein kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1819 (645.4 bits), Expect = 1.3e-187, P = 1.3e-187
Identities = 357/476 (75%), Positives = 400/476 (84%)
Query: 142 SSLAKTSGSAKISDRLDYVESGKSSICRGXXXXXXXXXXXXXXXXXXINKPHKANDLRWE 201
SS KT G++KI+++ ESGKSS CR INKPHKAND+RWE
Sbjct: 37 SSDGKT-GNSKINEQ---GESGKSSTCRPSTSSDISDESTCSSFSSSINKPHKANDVRWE 92
Query: 202 AIQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLL 261
AIQAVR + G LGL+HFRLLKRLGCGDIG+V+L+EL+GT+CYFAMKVMDK +LA RKKLL
Sbjct: 93 AIQAVRTKHGGLGLNHFRLLKRLGCGDIGTVHLAELNGTRCYFAMKVMDKTALASRKKLL 152
Query: 262 RAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVR 321
RAQTEREILQ LDHPFLPTLY+HFETEKFSCLVMEFCPGGDLHTLRQ+QPGK F EQA +
Sbjct: 153 RAQTEREILQCLDHPFLPTLYSHFETEKFSCLVMEFCPGGDLHTLRQRQPGKRFTEQAAK 212
Query: 322 FYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLD 381
FYVAEVLLA+EYLHMLGIIYRDLKPENVLVR+DGH+MLSDFDLSLRC VS ++++++++
Sbjct: 213 FYVAEVLLAMEYLHMLGIIYRDLKPENVLVRDDGHVMLSDFDLSLRCTVSLSIVRSANVG 272
Query: 382 AEPLRKNPVYCVQ-PACIEPSCIQPSCVT--PT-CFSPRLFSSKSKKDRKPKNEIGN-QV 436
+E L KN V C Q PACI+ QPSC++ PT CF PR FSSKSKKD+KPK E GN QV
Sbjct: 273 SEGLSKNSVSCSQQPACIQ----QPSCISMAPTSCFGPRFFSSKSKKDKKPKTENGNHQV 328
Query: 437 SPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKG 496
+PLPEL+AEPT ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKG
Sbjct: 329 TPLPELVAEPTGARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKG 388
Query: 497 SGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556
SGNRATLFNVVGQPLRFPESPVVSFAARDLIR LLVKEPQHRLAYKRGATEIKQHPFFEG
Sbjct: 389 SGNRATLFNVVGQPLRFPESPVVSFAARDLIRSLLVKEPQHRLAYKRGATEIKQHPFFEG 448
Query: 557 VNWALIRCATPPEIPKPVEIERI-PAPTSSTSEKTAPTMVPPNQRGSDNYLEFDFF 611
VNWAL+RCA+PPEIPKPV++E + P PT + A + V +Q NYLEFDFF
Sbjct: 449 VNWALVRCASPPEIPKPVDLEALNPTPTVPAA---ASSSVRSDQ---SNYLEFDFF 498
|
|
| UNIPROTKB|Q5I6E9 Adi3 "AvrPto-dependent Pto-interacting protein 3" [Solanum lycopersicum (taxid:4081)] | Back alignment and assigned GO terms |
|---|
Score = 1736 (616.2 bits), Expect = 3.8e-181, Sum P(2) = 3.8e-181
Identities = 333/478 (69%), Positives = 382/478 (79%)
Query: 139 DGTSSLAKTSGSAKISDRLDYVESGKSSICRGXXXXXXXXXXXXXXXXXXINKPHKANDL 198
DG S+ + S K S R D +ESGK+S+ R NKPHK ND
Sbjct: 229 DGMLSVDRNYESTKGSIRGDSLESGKTSLSRASDSSGLSDDSNWSNITGSANKPHKGNDP 288
Query: 199 RWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRK 258
RW+AI A+RARDG+LG+SHF+LLKRLGCGDIGSVYLSELSGT+CYFAMKVMDKASLA RK
Sbjct: 289 RWKAILAIRARDGILGMSHFKLLKRLGCGDIGSVYLSELSGTRCYFAMKVMDKASLASRK 348
Query: 259 KLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQ 318
KL RAQTEREILQ LDHPFLPTLYTHFET++FSCLVME+CPGGDLHTLRQ+QPGK+F E
Sbjct: 349 KLTRAQTEREILQLLDHPFLPTLYTHFETDRFSCLVMEYCPGGDLHTLRQRQPGKHFSEY 408
Query: 319 AVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKAS 378
A RFY AEVLLALEYLHMLG++YRDLKPENVLVR+DGHIMLSDFDLSLRCAVSPTLI+ S
Sbjct: 409 AARFYAAEVLLALEYLHMLGVVYRDLKPENVLVRDDGHIMLSDFDLSLRCAVSPTLIRIS 468
Query: 379 SLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDR-KPKNEIGNQVS 437
S D P ++ +CVQPACIEP+ + C+ P CF PRLF KSKK KP+ + G Q +
Sbjct: 469 SDD--PSKRGAAFCVQPACIEPTTV---CMQPACFLPRLFPQKSKKKTPKPRADSGFQAN 523
Query: 438 PLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGS 497
+PEL+AEPT ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFL+ELL+GKTPFKGS
Sbjct: 524 SMPELVAEPTSARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLHELLYGKTPFKGS 583
Query: 498 GNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557
GNRATLFNVVGQ L+FP+SP S+A+RDLIRGLLVKEPQ+RL KRGATEIKQHPFFEGV
Sbjct: 584 GNRATLFNVVGQQLKFPDSPATSYASRDLIRGLLVKEPQNRLGVKRGATEIKQHPFFEGV 643
Query: 558 NWALIRCATPPEIPKPVEIERIPAPTSSTSE----KTAPTMVPPNQRGSDNYLEFDFF 611
NWALIRC+TPPE+P+PVE + PA + T+ +V + + YL+F+FF
Sbjct: 644 NWALIRCSTPPEVPRPVEPD-YPAKYGQVNPVGVGNTSKRVVGADAKSGGKYLDFEFF 700
|
|
| TAIR|locus:2055017 AT2G44830 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1581 (561.6 bits), Expect = 2.2e-162, P = 2.2e-162
Identities = 311/489 (63%), Positives = 369/489 (75%)
Query: 139 DGTSSLAKTSGSAKISDRLDYVESGKSSICRGXXXXXXXXXXXXXXXXXXINKPHKANDL 198
D S+ K IS LD ES K+S R +NKPHK ND
Sbjct: 284 DVVLSMDKNYFDRSISMVLDSFESTKTSASRASDSSGLSEESSWSNFTGSLNKPHKGNDP 343
Query: 199 RWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRK 258
W AI A+R RDG+LG+SHF+LLKRLGCGDIGSVYL+ELSGT+C+FA+KVMDKASL RK
Sbjct: 344 WWNAILAIRTRDGILGMSHFKLLKRLGCGDIGSVYLAELSGTRCHFAVKVMDKASLEDRK 403
Query: 259 KLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQ 318
KL RAQTER+ILQ LDHPFLPTLYTHFET++FSCLVME+CPGGDLHTLRQ+QPGK+F E
Sbjct: 404 KLNRAQTERDILQLLDHPFLPTLYTHFETDRFSCLVMEYCPGGDLHTLRQRQPGKHFSEY 463
Query: 319 AVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKAS 378
A RFY AEVLLALEYLHMLG++YRDLKPENVLVR+DGHIMLSDFDLSLRCAVSPTLIK
Sbjct: 464 AARFYAAEVLLALEYLHMLGVVYRDLKPENVLVRDDGHIMLSDFDLSLRCAVSPTLIK-- 521
Query: 379 SLDAEPLRKNPVYCVQPACIEPSCIQPSCVT-PTCFSPR-LFSSKSKKDRKPKNEIG--- 433
+ D++P R+ +CVQPAC+EP+ +C+ P+CF PR +F +K+KK++ K +
Sbjct: 522 TFDSDPSRRG-AFCVQPACMEPTS---ACIIQPSCFLPRSIFPNKNKKNKSRKTQADFFK 577
Query: 434 NQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTP 493
+ LPEL+AEP RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIF++ELL+GKTP
Sbjct: 578 SHSGSLPELVAEPN-TRSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFVHELLYGKTP 636
Query: 494 FKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPF 553
FKGSGNRATLFNVVG+ L+FPESP S+A RDLI+ LLVK+P++RL KRGATEIKQHPF
Sbjct: 637 FKGSGNRATLFNVVGEQLKFPESPATSYAGRDLIQALLVKDPKNRLGTKRGATEIKQHPF 696
Query: 554 FEGVNWALIRCATPPEIPKPVEIERIP--APTSSTS--EKTAPTMVPP-------NQRGS 602
FEGVNWALIRC+TPPE+P+ +E E P P + M PP + +
Sbjct: 697 FEGVNWALIRCSTPPEVPRQMETEPPPKYGPIDPVGFGSNSKRMMGPPAVSAAAADTKSG 756
Query: 603 DNYLEFDFF 611
+L+F+FF
Sbjct: 757 GKFLDFEFF 765
|
|
| TAIR|locus:2091443 ATPK7 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1576 (559.8 bits), Expect = 7.3e-162, P = 7.3e-162
Identities = 329/528 (62%), Positives = 384/528 (72%)
Query: 99 SNVDSVVSENRGSQDVSVDQEKKTSEYXXXXXXXXXXXXXDGTSSLAKTSGS--AKISD- 155
S+V SV +E+ +S+ ++KK SE + S T S A IS
Sbjct: 59 SSVSSVSAESE--TPISIIRKKKQSE-PRFYSSPTNTFYTEAKQSFTNTEFSECASISTI 115
Query: 156 ---RLDYVESGKSSICRGXXXXXXXXXXXXXXXXXXINKPHKAN-DLRWEAIQAVRARDG 211
+D ++G I RG KPH+ N D RW AIQ VR+R G
Sbjct: 116 GIGGIDLEKNGVM-IYRGSIGSDVSDESSSSGLSNAAYKPHRDNNDKRWVAIQEVRSRVG 174
Query: 212 V-LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREIL 270
L F+L+K+LG GDIG+VYL+EL GT FA+KVM+KA++A RKKL+RAQTE+EIL
Sbjct: 175 SSLEAKDFKLIKKLGGGDIGNVYLAELIGTGVSFAVKVMEKAAIAARKKLVRAQTEKEIL 234
Query: 271 QSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLA 330
QSLDHPFLPTLY+HFETE SCLVMEFCPGGDLH+LRQKQ GKYFPEQA RFYVAEVLLA
Sbjct: 235 QSLDHPFLPTLYSHFETEMNSCLVMEFCPGGDLHSLRQKQRGKYFPEQAARFYVAEVLLA 294
Query: 331 LEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPV 390
+EYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL++ +++ E K+
Sbjct: 295 MEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLVRFAAITLES--KSSS 352
Query: 391 YCVQPACIEPS-CI-QPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTE 448
YC+QP C++ S CI QP C+ P CF+PR F SK K RK N++ Q+ PLPELIAEPT
Sbjct: 353 YCIQPTCVDQSSCIVQPDCIQPVCFTPR-FLSKGKH-RKKSNDMSRQIRPLPELIAEPTS 410
Query: 449 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG 508
ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFG TPF+G NRATLFNVVG
Sbjct: 411 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGITPFRGGDNRATLFNVVG 470
Query: 509 QPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIRCATPP 568
QPLRFPE P VSFAARDLIRGLLVKEPQHRLAY+RGATEIKQHPFF+ VNWALIRC +PP
Sbjct: 471 QPLRFPEHPNVSFAARDLIRGLLVKEPQHRLAYRRGATEIKQHPFFQSVNWALIRCTSPP 530
Query: 569 EIPKPVE-IERIPAPTSSTSEKTAPTMV--PP--NQRGSDNYLEFDFF 611
+IP+PV+ +++ + S+ PP + + S NYLE DFF
Sbjct: 531 QIPQPVKPMDQAHSVRHGFSQGHGHVGYDKPPTVDVKPSGNYLEIDFF 578
|
|
| TAIR|locus:2174885 AT5G40030 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1487 (528.5 bits), Expect = 4.4e-154, Sum P(2) = 4.4e-154
Identities = 288/424 (67%), Positives = 337/424 (79%)
Query: 190 NKPHKANDLRWEAIQAVR-ARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKV 248
+KPHK NDLRW+AIQ V+ +++ LGL HFRLLK+LGCGDIGSVYL+EL C+FAMKV
Sbjct: 85 SKPHKGNDLRWDAIQNVKCSKNEDLGLGHFRLLKKLGCGDIGSVYLAELREMGCFFAMKV 144
Query: 249 MDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQ 308
MDK L GRKKL+RAQTEREIL LDHPFLPTLY+HFETEKFSCL+MEFC GGDLH LRQ
Sbjct: 145 MDKGMLIGRKKLVRAQTEREILGLLDHPFLPTLYSHFETEKFSCLLMEFCSGGDLHILRQ 204
Query: 309 KQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRC 368
KQPGK+F E A RFY +EVLLALEYLHM+G++YRDLKPENV+VREDGHIMLSDFDLSL+
Sbjct: 205 KQPGKHFSELAARFYASEVLLALEYLHMMGVVYRDLKPENVMVREDGHIMLSDFDLSLQS 264
Query: 369 AVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQP-SCVTPTCFSPRLFSSKSKKDRK 427
VSPTLI+++S +P YC+QP CI+PSC P +C+ P+CF PR ++K RK
Sbjct: 265 FVSPTLIQSTS---QPSCHIASYCIQPPCIDPSCKLPVACIQPSCFKPRFLNNKP---RK 318
Query: 428 PKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYEL 487
K E S LP LIAEPT ARSMSFVGTHEYLAPEII+G+GHGS+VDWWTFGIFLYEL
Sbjct: 319 AKTEKAGSDS-LPMLIAEPTAARSMSFVGTHEYLAPEIIRGDGHGSSVDWWTFGIFLYEL 377
Query: 488 LFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATE 547
L GKTPFKG+GNR TLFNVVGQPL+FPE + SFAA+DLIRGLL K+P+ RL +K+GATE
Sbjct: 378 LTGKTPFKGNGNRETLFNVVGQPLKFPEGSI-SFAAKDLIRGLLTKDPKKRLGFKKGATE 436
Query: 548 IKQHPFFEGVNWALIRCATPPEIPKPVEIERIPAPTSSTSEKTAPTMVPPNQRGSDNYLE 607
IKQHPFF VNWALIR TPPEIPKP+++ I T +S + + S YL+
Sbjct: 437 IKQHPFFNNVNWALIRSTTPPEIPKPIDLS-ILNETLKSSVQQQGKHSKQSDSSSGPYLD 495
Query: 608 FDFF 611
F+FF
Sbjct: 496 FEFF 499
|
|
| TAIR|locus:2207470 AGC1.7 "AGC kinase 1.7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1417 (503.9 bits), Expect = 5.1e-145, P = 5.1e-145
Identities = 275/390 (70%), Positives = 318/390 (81%)
Query: 190 NKPHKANDLRWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVM 249
+KPH D+RW+A+ + ++ LG+S FRLLKRLG GDIGSVYL EL GT YFAMKVM
Sbjct: 118 SKPHTGGDIRWDAVNTLTSKGVQLGISDFRLLKRLGYGDIGSVYLVELRGTITYFAMKVM 177
Query: 250 DKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQK 309
DKASLA R KLLRAQTEREIL LDHPFLPTLY+HFET+KF CLVMEFC GG+L++LRQK
Sbjct: 178 DKASLASRNKLLRAQTEREILSQLDHPFLPTLYSHFETDKFYCLVMEFCGGGNLYSLRQK 237
Query: 310 QPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369
QP K F E A RF+ +EVLLALEYLHMLGI+YRDLKPENVLVR+DGHIMLSDFDLSLRC+
Sbjct: 238 QPNKCFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDDGHIMLSDFDLSLRCS 297
Query: 370 VSPTLIKASSLDAE---PLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDR 426
VSPTL+K+SS+ A PV + E + +Q C+ P+ F PR+ S SKK+R
Sbjct: 298 VSPTLVKSSSVHAAGGGSGSSRPVGLID----EDAAVQ-GCIQPSTFFPRILQS-SKKNR 351
Query: 427 KPKNEIGNQVS-PLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLY 485
K K++ G V+ +PEL+AEPT +SMSFVGTHEYLAPEII+GEGHGSAVDWWTFGIF+Y
Sbjct: 352 KAKSDFGLFVNGSMPELMAEPTNVKSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFGIFIY 411
Query: 486 ELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGA 545
ELL+G TPFKG GNRATL NV+GQ LRFPE P VS AARDLI+GLLVKEPQ R+AYKRGA
Sbjct: 412 ELLYGATPFKGQGNRATLHNVIGQALRFPEVPHVSSAARDLIKGLLVKEPQKRIAYKRGA 471
Query: 546 TEIKQHPFFEGVNWALIRCATPPEIPKPVE 575
TEIKQHPFFEGVNWALIR ATPP +P+PV+
Sbjct: 472 TEIKQHPFFEGVNWALIRSATPPHVPEPVD 501
|
|
| TAIR|locus:2085191 KIPK "KCBP-interacting protein kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1367 (486.3 bits), Expect = 1.0e-141, Sum P(2) = 1.0e-141
Identities = 272/432 (62%), Positives = 328/432 (75%)
Query: 190 NKPHKANDLRWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVM 249
NKPH + D+RWEAI+ ++ + G LGL HF LLK+LGCGDIG+VYL+EL GT C FA+KVM
Sbjct: 510 NKPHMSMDVRWEAIKHIKVQYGSLGLRHFNLLKKLGCGDIGTVYLAELIGTNCLFAIKVM 569
Query: 250 DKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQK 309
D LA RKK RAQ EREIL+ LDHPFLPTLY F ++ SCLVME+CPGGDLH LRQK
Sbjct: 570 DNEFLARRKKSPRAQAEREILKMLDHPFLPTLYAQFTSDNLSCLVMEYCPGGDLHVLRQK 629
Query: 310 QPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369
Q G+ FPE A RFYVAE+LLALEYLHMLGIIYRDLKPEN+LVREDGHIML+DFDLSLRCA
Sbjct: 630 QLGRCFPEPAARFYVAEILLALEYLHMLGIIYRDLKPENILVREDGHIMLTDFDLSLRCA 689
Query: 370 VSPTLIKASSLDA-EPLRKNPVYCVQPACIEPSCI-QPSCVTPTCFSPRLFSSKSKKDRK 427
V+PTL++++S +P R + Y CI+P CI +PSC +CFSPRL SS ++ RK
Sbjct: 690 VNPTLVRSNSPPGKDPARISGPYNTSN-CIQPFCITEPSCQV-SCFSPRL-SSNQQQGRK 746
Query: 428 PKNEIGNQVSP--------LPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWT 479
PK G+ +S LP+L+AEPTEARS SFVGTHEYLAPEIIKGEGHG+AVDWWT
Sbjct: 747 PKR--GDHLSKTQQHLSRSLPQLVAEPTEARSNSFVGTHEYLAPEIIKGEGHGAAVDWWT 804
Query: 480 FGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRL 539
FG+ LYELL+GKTPFKG N TL NVV Q L+FP+SP+VSF A+DLIRGLLVKEP++RL
Sbjct: 805 FGVLLYELLYGKTPFKGYNNDETLANVVLQNLKFPDSPLVSFQAKDLIRGLLVKEPENRL 864
Query: 540 AYKRGATEIKQHPFFEGVNWALIRCATPPEIPKPVEIERIPAPTSSTSEKTAPTMVPPNQ 599
++G+ EIK+HPFFEG+NWALIRCA PPE+P E P + + + +
Sbjct: 865 GSEKGSVEIKRHPFFEGLNWALIRCAIPPELPDFYEYGGGPEAAADSPGGSNNRYLECKA 924
Query: 600 RGSDNYLEFDFF 611
G ++LEF+ F
Sbjct: 925 IG--DHLEFELF 934
|
|
| TAIR|locus:2144598 AT5G03640 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1332 (473.9 bits), Expect = 5.6e-141, Sum P(3) = 5.6e-141
Identities = 250/385 (64%), Positives = 306/385 (79%)
Query: 190 NKPHKANDLRWEAIQAVRARDGV--LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMK 247
N+PH + D+RWEAIQ +RA+ G+ LGL HF LLK+LGCGDIG+VYL+EL+GT C FA+K
Sbjct: 511 NRPHMSKDVRWEAIQHIRAQHGLGSLGLRHFNLLKKLGCGDIGTVYLAELTGTNCLFAIK 570
Query: 248 VMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLR 307
VMD L R K+ RAQTE++IL+ LDHPFLPTLY HF ++ SCLVME CPGGDLH LR
Sbjct: 571 VMDNEFLERRNKMSRAQTEKDILKMLDHPFLPTLYAHFTSDNLSCLVMECCPGGDLHVLR 630
Query: 308 QKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLR 367
QKQPG++FPE A RFYVAEVLLALEYLHMLG+IYRDLKPEN+LVR+DGHIM++DFDLSLR
Sbjct: 631 QKQPGRWFPEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRDDGHIMVTDFDLSLR 690
Query: 368 CAVSPTLIKASS-LDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDR 426
C VSPTL+ +SS L A+ +R + CIEPSC +P + + + +
Sbjct: 691 CTVSPTLLNSSSPLHADAMRLSSGSRTGSNCIEPSCFRPKLSRGSGPKKKGKQHRMMMKK 750
Query: 427 KPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYE 486
K+++ + LP+L+AEPT+ARS SFVGTHEYLAPEIIKGEGHG+AVDWWTFGIFLYE
Sbjct: 751 LKKSDLIARFKSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYE 810
Query: 487 LLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGAT 546
LL+GKTPFKG+ N T+ NVV Q L+FP++P VSF A+DLIRGLLVKEP++RL ++GA
Sbjct: 811 LLYGKTPFKGATNEETIANVVLQSLKFPDNPNVSFQAKDLIRGLLVKEPENRLGTEKGAA 870
Query: 547 EIKQHPFFEGVNWALIRCATPPEIP 571
EIK+H FFEG+NWALIRCA PPE+P
Sbjct: 871 EIKRHAFFEGLNWALIRCAIPPELP 895
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| A2YBX5 | G11A_ORYSI | 2, ., 7, ., 1, 1, ., 1 | 0.7865 | 0.7970 | 0.8268 | N/A | no |
| P15792 | KPK1_PHAVU | 2, ., 7, ., 1, 1, ., 1 | 0.7265 | 0.7675 | 0.7701 | N/A | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | gw1.XVI.574.1 | hypothetical protein (493 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 611 | |||
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 0.0 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-77 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-62 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-62 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-61 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-58 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-56 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-53 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-50 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-49 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-48 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-45 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-45 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-44 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-41 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-40 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-38 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-37 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-37 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-36 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-35 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-35 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-34 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-34 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 9e-34 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-33 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-33 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-33 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-33 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-33 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-33 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-32 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-32 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-32 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-31 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-30 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-30 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-30 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-30 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-30 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-29 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-29 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-29 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-29 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-28 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-28 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-28 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-28 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-28 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-28 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-27 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-27 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-27 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-26 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-26 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-26 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-26 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-26 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-26 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-26 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-25 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-25 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-25 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-25 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-25 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-25 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-25 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-25 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-25 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-25 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-25 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-25 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-25 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-25 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-25 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-24 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-24 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-24 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-24 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-24 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-24 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-24 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-24 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-24 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-24 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-24 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 9e-24 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-23 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-23 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-23 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-23 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-23 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-23 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-23 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-23 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-23 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-22 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-22 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-22 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-22 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-22 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-22 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-21 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-21 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-21 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-21 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-21 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-21 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-21 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-21 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-21 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-21 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-21 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 7e-21 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-20 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-20 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-20 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-19 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-19 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-19 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-19 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-19 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-19 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-19 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-18 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-18 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-18 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-18 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-18 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-18 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-18 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-18 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 8e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-18 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-17 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-17 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-17 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-16 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-16 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-16 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-16 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-16 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-16 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 9e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-15 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-15 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-15 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-15 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-14 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-14 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-14 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-14 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-13 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-13 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-13 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-12 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-12 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-11 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-11 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-11 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-11 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 8e-11 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-10 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-10 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-10 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-10 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 7e-10 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 9e-10 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-09 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-09 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-09 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-09 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-09 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-09 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-09 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 9e-09 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 9e-09 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-08 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-08 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-08 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-08 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-08 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-08 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-08 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-08 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-08 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-08 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-08 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-08 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-08 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-08 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-08 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-08 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-08 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 8e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 8e-08 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 9e-08 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-07 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-07 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-07 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-07 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-07 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-07 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-07 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-07 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-07 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-07 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-07 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-07 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-07 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 9e-07 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 9e-07 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-07 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-06 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-06 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-06 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-06 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-06 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-06 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-06 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-06 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-06 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-06 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-06 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-06 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-06 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-06 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-06 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-06 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-06 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-06 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-06 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-06 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-06 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-06 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-06 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-06 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-06 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-06 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 9e-06 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 9e-06 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-05 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-05 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-05 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-05 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-05 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-05 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-05 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-05 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-05 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-05 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 3e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-05 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-05 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-05 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-05 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-05 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-05 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-05 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-05 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-05 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-05 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-05 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-05 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-05 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-05 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-05 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-05 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 8e-05 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 9e-05 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 9e-05 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 9e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 9e-05 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-04 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-04 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-04 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-04 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-04 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-04 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-04 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-04 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-04 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-04 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-04 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-04 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-04 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-04 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-04 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-04 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-04 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-04 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-04 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-04 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-04 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-04 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-04 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-04 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-04 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-04 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-04 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-04 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-04 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-04 | |
| pfam13885 | 45 | pfam13885, Keratin_B2_2, Keratin, high sulfur B2 p | 7e-04 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-04 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-04 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-04 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-04 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 0.001 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 0.001 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 0.001 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 0.001 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 0.001 | |
| pfam13885 | 45 | pfam13885, Keratin_B2_2, Keratin, high sulfur B2 p | 0.001 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 0.001 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 0.002 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 0.002 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 0.002 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 0.002 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 0.002 | |
| pfam13885 | 45 | pfam13885, Keratin_B2_2, Keratin, high sulfur B2 p | 0.002 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 0.002 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 0.002 | |
| pfam01500 | 161 | pfam01500, Keratin_B2, Keratin, high sulfur B2 pro | 0.002 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 0.003 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 0.003 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.003 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.003 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.003 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 0.004 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 0.004 | |
| COG0478 | 304 | COG0478, COG0478, RIO-like serine/threonine protei | 0.004 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 0.004 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.004 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 0.004 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 518 bits (1337), Expect = 0.0
Identities = 183/362 (50%), Positives = 222/362 (61%), Gaps = 47/362 (12%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH 275
HF+ +K LG GD+G V+L L GT FA+KV+DK + R K+ R TE+EIL +LDH
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 276 PFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLH 335
PFLPTLY F+TE + CLVM++CPGG+L L Q+QPGK E+ RFY AEVLLALEYLH
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120
Query: 336 MLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQP 395
+LGI+YRDLKPEN+L+ E GHIMLSDFDLS + V P + +
Sbjct: 121 LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS--------- 171
Query: 396 ACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455
+ S E +E RS SFV
Sbjct: 172 --------------------------------------SVNSIPSETFSEEPSFRSNSFV 193
Query: 456 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPE 515
GT EY+APE+I G+GHGSAVDWWT GI LYE+L+G TPFKGS T N++ + + FP
Sbjct: 194 GTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPG 253
Query: 516 SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIRCATPPEIPKPVE 575
SP VS +ARDLIR LLVK+P RL KRGA EIKQHPFF GVNWALIR TPP IP+P +
Sbjct: 254 SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRHTTPPIIPRPDD 313
Query: 576 IE 577
Sbjct: 314 GI 315
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 249 bits (637), Expect = 2e-77
Identities = 121/357 (33%), Positives = 180/357 (50%), Gaps = 55/357 (15%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF 277
F ++K +G G G V+L T +AMKV+ K+ + R ++ + ER+IL D P+
Sbjct: 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPW 62
Query: 278 LPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHML 337
+ LY F+ E+ LVME+ PGGDL L ++ FPE+ RFY+AE++LAL+ +H L
Sbjct: 63 IVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKL 120
Query: 338 GIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPAC 397
G I+RD+KP+N+L+ DGHI L+DF L + + KA N +
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCKK------MNKA---KDREYYLNDSH------ 165
Query: 398 IEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGT 457
LF R+ + R+ S VGT
Sbjct: 166 -----------------NLLFRDNVLVRRRDHKQ---------------RRVRANSTVGT 193
Query: 458 HEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG--QPLRFPE 515
+Y+APE+++G +G DWW+ G+ LYE+L+G PF + T ++ + LRFP
Sbjct: 194 PDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPP 253
Query: 516 SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIRCATPPEIPK 572
P VS A DLI LL +P+ RL EIK HPFF+G++W +R PP +P+
Sbjct: 254 DPPVSPEAIDLICRLLC-DPEDRL---GSFEEIKSHPFFKGIDWENLRETKPPFVPE 306
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 211 bits (538), Expect = 1e-62
Identities = 118/359 (32%), Positives = 177/359 (49%), Gaps = 48/359 (13%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF 277
F +K +G G G V L + T +AMK + K+ + ++++ + ER+IL D+P+
Sbjct: 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW 62
Query: 278 LPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHML 337
+ LY F+ E + L+ME+ PGGD+ TL K+ F E+ RFY+AE +LA++ +H L
Sbjct: 63 VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKL 120
Query: 338 GIIYRDLKPENVLVREDGHIMLSDFDLS--LRCAVSPTLIKASSLDAEPLRKNPVYCVQP 395
G I+RD+KP+N+L+ GHI LSDF L L+ + L
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE-------FYRILSHAL------ 167
Query: 396 ACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455
PS P SSK K + +N A + S V
Sbjct: 168 ---------PSNFLDFISKPM--SSKRKAETWKRNRR----------------ALAYSTV 200
Query: 456 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG--QPLRF 513
GT +Y+APE+ G+ DWW+ G+ +YE+L G PF + T ++ + L+F
Sbjct: 201 GTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQF 260
Query: 514 PESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIRCATPPEIPK 572
P+ +S A+DLI+ L E + RL G EIK HPFF+GV+W IR P IP+
Sbjct: 261 PDEVPLSPEAKDLIKRLCC-EAERRLG-NNGVNEIKSHPFFKGVDWEHIRERPAPIIPE 317
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 209 bits (534), Expect = 5e-62
Identities = 125/395 (31%), Positives = 186/395 (47%), Gaps = 62/395 (15%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF 277
F +K +G G G V L + T +AMK + K+ + + +L + ER++L D P+
Sbjct: 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPW 62
Query: 278 LPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHML 337
+ +LY F+ ++ L+MEF PGGDL T+ K F E RFY+AE +LA+E +H L
Sbjct: 63 VVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKL 120
Query: 338 GIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPAC 397
G I+RD+KP+N+L+ GHI LSDF L S + Y
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGL--------------STGFHKQHDSAYY------ 160
Query: 398 IEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPK------NEIGNQVSPLPELIAEPTEARS 451
+L KS K+R + I +S ++ R
Sbjct: 161 -----------------QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRL 203
Query: 452 MSF--VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG- 508
M++ VGT +Y+APEI +G+G DWW+ G ++E L G PF + T ++
Sbjct: 204 MAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINW 263
Query: 509 -QPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIRCATP 567
+ L FP+ +S A DLIR L+ ++RL + GA EIK HPFF GV+W IR
Sbjct: 264 RETLYFPDDIHLSVEAEDLIRRLIT-NAENRLG-RGGAHEIKSHPFFRGVDWDTIRQIRA 321
Query: 568 PEIPK----------PVEIERIPAPTSSTSEKTAP 592
P IP+ P + E P + ++ AP
Sbjct: 322 PFIPQLKSITDTSYFPTD-ELEQVPEAPALKQAAP 355
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 203 bits (520), Expect = 5e-61
Identities = 107/342 (31%), Positives = 154/342 (45%), Gaps = 69/342 (20%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD-HP 276
F+ K +G G +V L++ T +A+K++DK L KK+ + E+E+L L+ HP
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 277 FLPTLYTHFETEKFSCL--VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYL 334
+ LY F+ E L V+E+ P G+L +K E+ RFY AE+LLALEYL
Sbjct: 63 GIIKLYYTFQDE--ENLYFVLEYAPNGELLQYIRKYGS--LDEKCTRFYAAEILLALEYL 118
Query: 335 HMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQ 394
H GII+RDLKPEN+L+ +D HI ++DF + V
Sbjct: 119 HSKGIIHRDLKPENILLDKDMHIKITDFGTA--------------------------KVL 152
Query: 395 PACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIG--NQVSPLPELIAEPTEARSM 452
S + + T + S K R+ + +G VS PEL+ E +
Sbjct: 153 D---PNSSPESNKGDATN----IDSQIEKNRRRFASFVGTAEYVS--PELLNE----KPA 199
Query: 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLR 512
+ D W G +Y++L GK PF+GS T ++
Sbjct: 200 GK-------------------SSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYS 240
Query: 513 FPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
FP P A+DLI LLV +PQ RL G E+K HPFF
Sbjct: 241 FP--PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 196 bits (500), Expect = 5e-58
Identities = 118/351 (33%), Positives = 164/351 (46%), Gaps = 68/351 (19%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH 275
F +K + G G+VYL T+ FAMK ++K +L R ++ + ER+IL ++
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 276 PFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLH 335
PF+ +++ FET++ C+VME+ GGD TL K G P R Y AE +LALEYLH
Sbjct: 61 PFVVSMFCSFETKRHLCMVMEYVEGGDCATL-LKNIGA-LPVDMARMYFAETVLALEYLH 118
Query: 336 MLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS-PTLIKASSLDAEPLRKNPVYCVQ 394
GI++RDLKP+N+L+ GHI L+DF LS +S T + ++ +
Sbjct: 119 NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKD----------- 167
Query: 395 PACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454
R F K QV PE IA
Sbjct: 168 --------------------TREFLDK-------------QVCGTPEYIA---------- 184
Query: 455 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFP 514
PE+I +G+G VDWW GI LYE L G PF G V+ + +P
Sbjct: 185 --------PEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP 236
Query: 515 ES-PVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNW-ALIR 563
E + A+DLI LL + P RL GA E+KQH FF G++W L+R
Sbjct: 237 EGDEALPADAQDLISRLLRQNPLERLG-TGGAFEVKQHRFFLGLDWNGLLR 286
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 190 bits (486), Expect = 2e-56
Identities = 69/142 (48%), Positives = 92/142 (64%), Gaps = 2/142 (1%)
Query: 224 LGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYT 283
LG G G V L T +AMKV+ K + RK++ TER IL ++HPF+ L+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 284 HFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRD 343
F+TE+ LV+E+ PGG+L + K+ F E+ RFY AE++LALEYLH LGIIYRD
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRD 118
Query: 344 LKPENVLVREDGHIMLSDFDLS 365
LKPEN+L+ DGHI L+DF L+
Sbjct: 119 LKPENILLDADGHIKLTDFGLA 140
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 1e-53
Identities = 66/148 (44%), Positives = 91/148 (61%), Gaps = 4/148 (2%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF 277
+ +L++LG G G VYL+ T A+KV+ K + +K R E +IL+ L HP
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI--KKDRERILREIKILKKLKHPN 58
Query: 278 LPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHML 337
+ LY FE E LVME+C GGDL L +K+ E RFY+ ++L ALEYLH
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKR--GRLSEDEARFYLRQILSALEYLHSK 116
Query: 338 GIIYRDLKPENVLVREDGHIMLSDFDLS 365
GI++RDLKPEN+L+ EDGH+ L+DF L+
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLA 144
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 177 bits (450), Expect = 5e-50
Identities = 124/412 (30%), Positives = 194/412 (47%), Gaps = 52/412 (12%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH 275
S F +K LG G G V L+ T +AMK + K + R ++ + ER+IL D+
Sbjct: 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADN 60
Query: 276 PFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLH 335
++ LY F+ + VM++ PGGD+ +L + + FPE RFY+AE+ LA+E +H
Sbjct: 61 EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVH 118
Query: 336 MLGIIYRDLKPENVLVREDGHIMLSDFDL--SLRCAVSPTLIKASSLDAEPLRKNPVYCV 393
+G I+RD+KP+N+L+ DGHI L+DF L R + + S +
Sbjct: 119 KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSH------------I 166
Query: 394 QPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMS 453
+ +EPS + C RL + + + ++ + + + S
Sbjct: 167 RQDSMEPSDLWDDVSNCRC-GDRLKTLEQRATKQHQRCLAH------------------S 207
Query: 454 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG--QPL 511
VGT Y+APE++ +G+ DWW+ G+ L+E+L G+ PF T V+ L
Sbjct: 208 LVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTL 267
Query: 512 RFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWAL-IRCATPPEI 570
P +S A DLI L + RL + GA +IK HPFF V+++ IR P +
Sbjct: 268 HIPPQVKLSPEAVDLI-TKLCCSAEERLG-RNGADDIKAHPFFSEVDFSSDIRTQPAPYV 325
Query: 571 PK-----------PVEIERIPAPTSSTSEKTAPTMVPPNQRGSDN-YLEFDF 610
PK PVE E S S +T T+ PN + ++ + EF F
Sbjct: 326 PKISHPMDTSNFDPVEEESPWNDASGDSTRTWDTLCSPNGKHPEHAFYEFTF 377
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 3e-49
Identities = 124/397 (31%), Positives = 191/397 (48%), Gaps = 52/397 (13%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF 277
F LK +G G G V L + T +AMK++ KA + ++++ + ER+IL D +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 278 LPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHML 337
+ ++ F+ ++ L+MEF PGGD+ TL K+ E+A +FY+AE +LA++ +H L
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQL 120
Query: 338 GIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLD-AEPLRKNPVYCVQPA 396
G I+RD+KP+N+L+ GH+ LSDF L C L KA + L NP
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGL---CT---GLKKAHRTEFYRNLTHNP------- 167
Query: 397 CIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVG 456
P+ FS + +SK K + KN + S VG
Sbjct: 168 -------------PSDFSFQNMNSKRKAETWKKNR----------------RQLAYSTVG 198
Query: 457 THEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG--QPLRFP 514
T +Y+APE+ G+ DWW+ G+ +YE+L G PF + T V+ + L FP
Sbjct: 199 TPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFP 258
Query: 515 ESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIRCATPPEIPKPV 574
+S A+DLI + ++R+ G EIK HPFFEGV+W IR P I P+
Sbjct: 259 PEVPISEKAKDLILRFCT-DSENRIG-SNGVEEIKSHPFFEGVDWGHIR-ERPAAI--PI 313
Query: 575 EIERIPAPTSSTSEKTAPTMVPPNQRGSDNYLEFDFF 611
EI+ I ++ + + P +Y D+
Sbjct: 314 EIKSIDDTSNFDEFPESDILQPAENTIEPDYKSKDWV 350
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 170 bits (434), Expect = 1e-48
Identities = 69/146 (47%), Positives = 94/146 (64%), Gaps = 4/146 (2%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF 277
F +K LG G G V L G+ Y+A+K++ KA + K++ E+ ILQS+ HPF
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62
Query: 278 LPTLYTHFETEKFSCLVMEFCPGGDL-HTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHM 336
L LY F+ + LVME+ PGG+L LR+ G+ FPE RFY A+V+LALEYLH
Sbjct: 63 LVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKS--GR-FPEPVARFYAAQVVLALEYLHS 119
Query: 337 LGIIYRDLKPENVLVREDGHIMLSDF 362
L I+YRDLKPEN+L+ DG+I ++DF
Sbjct: 120 LDIVYRDLKPENLLLDSDGYIKITDF 145
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 165 bits (418), Expect = 1e-45
Identities = 123/391 (31%), Positives = 189/391 (48%), Gaps = 61/391 (15%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF 277
F LK +G G G V L + T +AMK++ KA + ++++ + ER+IL D +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 278 LPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHML 337
+ ++ F+ + L+MEF PGGD+ TL K+ E+ +FY+AE +LA++ +H L
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQL 120
Query: 338 GIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPAC 397
G I+RD+KP+N+L+ GH+ LSDF L C L KA + +N + +
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGL---CT---GLKKAHRTE---FYRNLNHSL---- 167
Query: 398 IEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF--V 455
P+ F+ + +SK K + +N R ++F V
Sbjct: 168 ------------PSDFTFQNMNSKRKAETWKRNR------------------RQLAFSTV 197
Query: 456 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG--QPLRF 513
GT +Y+APE+ G+ DWW+ G+ +YE+L G PF + T V+ + L F
Sbjct: 198 GTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIF 257
Query: 514 PESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIRCATPPEIPKP 573
P +S A+DLI E +HR+ G EIK +PFFEGV+W IR P I P
Sbjct: 258 PPEVPISEKAKDLILRFCC-EWEHRIG-APGVEEIKTNPFFEGVDWEHIR-ERPAAI--P 312
Query: 574 VEIERIPA-------PTSSTSEKTAPTMVPP 597
+EI+ I P S + T T P
Sbjct: 313 IEIKSIDDTSNFDEFPDSDILKPTVATSNHP 343
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 164 bits (416), Expect = 4e-45
Identities = 117/370 (31%), Positives = 175/370 (47%), Gaps = 56/370 (15%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH 275
S F +K LG G G V L+ TK +AMK + K + R ++ + ER+IL D+
Sbjct: 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADN 60
Query: 276 PFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLH 335
++ LY F+ + VM++ PGGD+ +L + FPE RFY+AE+ A+E +H
Sbjct: 61 EWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVH 118
Query: 336 MLGIIYRDLKPENVLVREDGHIMLSDFDLSL--------RCAVSPTLIKASSLDAEPLRK 387
+G I+RD+KP+N+L+ DGHI L+DF L + S ++ S+D
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178
Query: 388 NPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPT 447
+P C G+++ PL E A
Sbjct: 179 DPANC--------------------------------------RCGDRLKPL-ERRAARQ 199
Query: 448 EARSM--SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFN 505
R + S VGT Y+APE++ G+ DWW+ G+ LYE+L G+ PF T
Sbjct: 200 HQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMK 259
Query: 506 VVG--QPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWAL-I 562
V+ L P +S A DLI L + P+ RL K GA EIK HPFF+ ++++ +
Sbjct: 260 VINWQTSLHIPPQAKLSPEASDLIIK-LCRGPEDRLG-KNGADEIKAHPFFKTIDFSSDL 317
Query: 563 RCATPPEIPK 572
R + P IPK
Sbjct: 318 RQQSAPYIPK 327
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 2e-44
Identities = 59/139 (42%), Positives = 88/139 (63%), Gaps = 2/139 (1%)
Query: 227 GDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFE 286
G G V+L++ T +A+KV+ KA + + ++ + TER+IL P++ LY F+
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63
Query: 287 TEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKP 346
+K LVME+ PGGDL +L + E R Y+AE++LALEYLH GII+RDLKP
Sbjct: 64 GKKNLYLVMEYLPGGDLASLLENV--GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKP 121
Query: 347 ENVLVREDGHIMLSDFDLS 365
+N+L+ +GH+ L+DF LS
Sbjct: 122 DNILIDSNGHLKLTDFGLS 140
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 1e-41
Identities = 59/149 (39%), Positives = 85/149 (57%), Gaps = 5/149 (3%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF 277
+ LL++LG G G+VY ++ GT A+K++ K KK A+ E IL+ L HP
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKK-RSEKSKKDQTARREIRILRRLSHPN 59
Query: 278 LPTLYTHFETEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQAVRFYVAEVLLALEYLHM 336
+ L FE + LVME+C GGDL L + P E + ++L LEYLH
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP---LSEDEAKKIALQILRGLEYLHS 116
Query: 337 LGIIYRDLKPENVLVREDGHIMLSDFDLS 365
GII+RDLKPEN+L+ E+G + ++DF L+
Sbjct: 117 NGIIHRDLKPENILLDENGVVKIADFGLA 145
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 1e-40
Identities = 56/109 (51%), Positives = 73/109 (66%), Gaps = 5/109 (4%)
Query: 447 TEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFN- 505
+R+ +F GT EYLAPE++ G+G+G AVDWW+ G+ LYE+L GK PF +R ++
Sbjct: 146 EGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAE-DRKEIYEK 204
Query: 506 VVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
++ PLRFPE +S ARDLI GLL K+P RL GA EIK HPFF
Sbjct: 205 ILKDPLRFPEF--LSPEARDLISGLLQKDPTKRLGS-GGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 5e-38
Identities = 58/143 (40%), Positives = 82/143 (57%), Gaps = 4/143 (2%)
Query: 224 LGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYT 283
LG G G+VYL+ T A+K++ K + + E EIL+ L+HP + LY
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLE--ELLREIEILKKLNHPNIVKLYG 58
Query: 284 HFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRD 343
FE E LVME+C GG L L ++ GK E + + ++L LEYLH GII+RD
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 344 LKPENVLV-REDGHIMLSDFDLS 365
LKPEN+L+ ++G + L+DF LS
Sbjct: 118 LKPENILLDSDNGKVKLADFGLS 140
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 4e-37
Identities = 60/140 (42%), Positives = 86/140 (61%), Gaps = 4/140 (2%)
Query: 224 LGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYT 283
LG G G V L ++ FA+K + K + + +E+EIL+ +HPF+ LY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 284 HFETEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYR 342
F+ +K+ ++ME+C GG+L T LR + G F E RFY+A V+LA EYLH GIIYR
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDR--GL-FDEYTARFYIACVVLAFEYLHNRGIIYR 117
Query: 343 DLKPENVLVREDGHIMLSDF 362
DLKPEN+L+ +G++ L DF
Sbjct: 118 DLKPENLLLDSNGYVKLVDF 137
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 6e-37
Identities = 62/151 (41%), Positives = 95/151 (62%), Gaps = 6/151 (3%)
Query: 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHP 276
HF LL+ +G G G V + + TK FAMK M+K + + ER ILQ L+HP
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 277 FLPTLYTHFETEKFSCLVMEFCPGGDL--HTLRQKQPGKYFPEQAVRFYVAEVLLALEYL 334
FL L+ F+ E+ LV++ GGDL H ++ + F E+ V+F++ E++LALEYL
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVK----FSEEQVKFWICEIVLALEYL 116
Query: 335 HMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
H GII+RD+KP+N+L+ E GH+ ++DF+++
Sbjct: 117 HSKGIIHRDIKPDNILLDEQGHVHITDFNIA 147
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 3e-36
Identities = 57/146 (39%), Positives = 90/146 (61%), Gaps = 3/146 (2%)
Query: 221 LKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLP 279
LK + G GSVYL++ T YFA+KV+ K+ + + ++ + ER I+ + P++
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 280 TLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGI 339
LY F+++ + LVME+ GGD +L + PE + Y+AEV+L +E LH GI
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGI 118
Query: 340 IYRDLKPENVLVREDGHIMLSDFDLS 365
I+RD+KPEN+L+ + GH+ L+DF LS
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLS 144
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 1e-35
Identities = 65/154 (42%), Positives = 101/154 (65%), Gaps = 9/154 (5%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTK---CYFAMKVMDKASLAGRKKLLR-AQTEREILQSL 273
F LL+ LG G G V+L G +AMKV+ KA++ + K +TER++L+++
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 274 DH-PFLPTLYTHFETEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQAVRFYVAEVLLAL 331
PFL TL+ F+T+ L++++ GG+L T L Q++ +F E VR Y+AE++LAL
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLAL 118
Query: 332 EYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
++LH LGIIYRD+K EN+L+ +GH++L+DF LS
Sbjct: 119 DHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLS 152
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 71/148 (47%), Positives = 101/148 (68%), Gaps = 6/148 (4%)
Query: 221 LKRLGCGDIGSVYL-SELSGTKC--YFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF 277
LK LG G G V+L +++G +AMKV+ KA+L R ++ R + ER+IL ++HPF
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRV-RTKMERDILAEVNHPF 59
Query: 278 LPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHML 337
+ L+ F+TE L+++F GGDL T K+ F E+ V+FY+AE+ LAL++LH L
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSL 117
Query: 338 GIIYRDLKPENVLVREDGHIMLSDFDLS 365
GIIYRDLKPEN+L+ E+GHI L+DF LS
Sbjct: 118 GIIYRDLKPENILLDEEGHIKLTDFGLS 145
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 55/127 (43%), Positives = 71/127 (55%), Gaps = 5/127 (3%)
Query: 450 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ 509
R+ + GT EYLAPEII +G+G AVDWW GI +YE+L G PF ++
Sbjct: 154 RTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG 213
Query: 510 PLRFPESPVVSFAARDLIRGLLVKEPQHRLAY-KRGATEIKQHPFFEGVNW-ALI-RCAT 566
+RFP S A+DLIR LL + RL K G +IK HP+F G++W AL+ R
Sbjct: 214 KVRFPSF--FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIE 271
Query: 567 PPEIPKP 573
P IPK
Sbjct: 272 APFIPKV 278
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 5e-34
Identities = 52/107 (48%), Positives = 67/107 (62%), Gaps = 6/107 (5%)
Query: 450 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ 509
+ +FVGT EY+APE++ G+G+G AVD W+ G+ LYELL GK PF G LF +G+
Sbjct: 152 KLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGK 211
Query: 510 PLRFPESPV--VSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
P P +S A+DLIR LLVK+P+ RL A E QHPFF
Sbjct: 212 PKPPFPPPEWDISPEAKDLIRKLLVKDPEKRL----TAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 9e-34
Identities = 50/119 (42%), Positives = 66/119 (55%), Gaps = 1/119 (0%)
Query: 441 ELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNR 500
++ E VGT +Y+APE+I G+GH VDWW+ G LYE L G PF G
Sbjct: 148 QINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE 207
Query: 501 ATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNW 559
N++ + +PE VS A DLI LLV +P+ RL K EIK HPFF+G++W
Sbjct: 208 EIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAK-SIEEIKNHPFFKGIDW 265
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 1e-33
Identities = 53/151 (35%), Positives = 86/151 (56%), Gaps = 3/151 (1%)
Query: 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHP 276
+ ++K++G G G VYL + +K +D S K+ A E +IL+ L+HP
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEID-LSNMSEKEREDALNEVKILKKLNHP 59
Query: 277 FLPTLYTHFETEKFSCLVMEFCPGGDLHTL--RQKQPGKYFPEQAVRFYVAEVLLALEYL 334
+ Y FE + C+VME+ GGDL +QK+ GK FPE+ + + ++ LAL+YL
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 335 HMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
H I++RD+KP+N+ + +G + L DF +S
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGIS 150
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 61/147 (41%), Positives = 86/147 (58%), Gaps = 7/147 (4%)
Query: 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREIL-QSLDHPFLPT 280
K LG G G V L+EL GT +A+KV+ K + + TE+ +L + HPFL
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 281 LYTHFETEKFSCLVMEFCPGGDL--HTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLG 338
L++ F+T+ VME+ GGDL H R + F E RFY AE++L L++LH G
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGR----FDEPRARFYAAEIVLGLQFLHERG 116
Query: 339 IIYRDLKPENVLVREDGHIMLSDFDLS 365
IIYRDLK +NVL+ +GHI ++DF +
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKIADFGMC 143
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 57/150 (38%), Positives = 79/150 (52%), Gaps = 6/150 (4%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQ---SLD 274
FR L LG G G V L+E T +A+K + K + R ++ E+ I + S
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 275 HPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYL 334
HPFL L+ F+TE C VME+ GGDL F E FY A V+L L+YL
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYL 117
Query: 335 HMLGIIYRDLKPENVLVREDGHIMLSDFDL 364
H I+YRDLK +N+L+ +G + ++DF L
Sbjct: 118 HENKIVYRDLKLDNLLLDTEGFVKIADFGL 147
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 52/153 (33%), Positives = 80/153 (52%), Gaps = 7/153 (4%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRA-QTEREILQSLDHP 276
+ + LG G GSVYL+ T A+K ++ + + ++ L A + E IL SL HP
Sbjct: 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS--EEELEALEREIRILSSLQHP 59
Query: 277 FLPTLYTHFETEKFSCL--VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYL 334
+ Y E+ + L +E+ GG L +L +K PE +R Y ++L L YL
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGK--LPEPVIRKYTRQILEGLAYL 117
Query: 335 HMLGIIYRDLKPENVLVREDGHIMLSDFDLSLR 367
H GI++RD+K N+LV DG + L+DF + R
Sbjct: 118 HSNGIVHRDIKGANILVDSDGVVKLADFGCAKR 150
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 2e-33
Identities = 54/148 (36%), Positives = 86/148 (58%), Gaps = 4/148 (2%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH 275
+K +G G G V+L ++ Y+A+KVM + K+ E+ +L+ + H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 276 PFLPTLYTHFETEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQAVRFYVAEVLLALEYL 334
PF+ L+ ++F ++ME+ PGG+L + LR G+ F FY +E++ ALEYL
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNS--GR-FSNSTGLFYASEIVCALEYL 117
Query: 335 HMLGIIYRDLKPENVLVREDGHIMLSDF 362
H I+YRDLKPEN+L+ ++GHI L+DF
Sbjct: 118 HSKEIVYRDLKPENILLDKEGHIKLTDF 145
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 8e-33
Identities = 56/149 (37%), Positives = 85/149 (57%), Gaps = 2/149 (1%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH 275
S F +K +G G G V L T +AMK + KA + R + + ER+IL D+
Sbjct: 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADN 60
Query: 276 PFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLH 335
++ LY F+ + VM++ PGGD+ +L + F E RFY+AE+ A+E +H
Sbjct: 61 EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVH 118
Query: 336 MLGIIYRDLKPENVLVREDGHIMLSDFDL 364
+G I+RD+KP+N+L+ DGHI L+DF L
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 67/166 (40%), Positives = 97/166 (58%), Gaps = 10/166 (6%)
Query: 441 ELIAEPTEARSMSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGN 499
E ++E E R+ SF GT EY+APEII+G+ GHG AVDWW+ GI ++ELL G +PF G
Sbjct: 154 EFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGE 212
Query: 500 RATLFNVVGQPLRF--PESPVVSFAARDLIRGLLVKEPQHRL-AYKRGATEIKQHPFFEG 556
R T V + L+ P + A+DL+ LL K+P+ RL A +GA+EIK+HPFF+G
Sbjct: 213 RNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272
Query: 557 VNW---ALIRCATP--PEIPKPVEIERIPAPTSSTSEKTAPTMVPP 597
++W AL + P P I +++ ++ +P PP
Sbjct: 273 LDWEALALRKVNPPFRPSIRNELDVGNFAEEFTNLEPVYSPAGTPP 318
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 5e-32
Identities = 68/154 (44%), Positives = 101/154 (65%), Gaps = 9/154 (5%)
Query: 218 FRLLKRLGCGDIGSVYL-SELSG--TKCYFAMKVMDKASLAGRKKLLR-AQTEREILQSL 273
F LLK LG G G V+L +++G T +AMKV+ KA+L + K + +TER +L+ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 274 -DHPFLPTLYTHFETEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQAVRFYVAEVLLAL 331
PFL TL+ F+TE L++++ GG++ T L Q+ F E VRFY E++LAL
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILAL 118
Query: 332 EYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
E+LH LGI+YRD+K EN+L+ +GH++L+DF LS
Sbjct: 119 EHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLS 152
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 5e-32
Identities = 60/154 (38%), Positives = 90/154 (58%), Gaps = 4/154 (2%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD 274
LS F + + LG G G V +++ GT Y+A+K + K + K++ E+ IL L
Sbjct: 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76
Query: 275 HPFLPTLYTHFETEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQAVRFYVAEVLLALEY 333
HPF+ + F+ E ++EF GG+L T LR+ G+ FP +FY AE++LA EY
Sbjct: 77 HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKA--GR-FPNDVAKFYHAELVLAFEY 133
Query: 334 LHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLR 367
LH IIYRDLKPEN+L+ GH+ ++DF + +
Sbjct: 134 LHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKK 167
|
Length = 329 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 7e-31
Identities = 56/139 (40%), Positives = 78/139 (56%), Gaps = 5/139 (3%)
Query: 439 LPELIAEPTEARSMSFVGTHEYLAPEIIKG--EGHGSAVDWWTFGIFLYELLFGKTPFKG 496
L + E R+ SF GT EY+APE+I+G GH AVDWW+ G+ +ELL G +PF
Sbjct: 151 LSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210
Query: 497 SGNRATLFNVVGQPLRF--PESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
G + + + + L+ P +S ARD I+ LL K+P+ RL GA EIK HPFF
Sbjct: 211 DGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGAN-GADEIKNHPFF 269
Query: 555 EGVNWALIRCATPPEIPKP 573
+G++W + P KP
Sbjct: 270 QGIDWDDLAAKRIPAPFKP 288
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 57/143 (39%), Positives = 82/143 (57%), Gaps = 2/143 (1%)
Query: 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTL 281
K LG G G V L T Y+AMK++ K + + ++ TE +LQ+ HPFL L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 282 YTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIY 341
F+T C VME+ GG+L ++ + F E RFY AE++ AL YLH ++Y
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCDVVY 118
Query: 342 RDLKPENVLVREDGHIMLSDFDL 364
RDLK EN+++ +DGHI ++DF L
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGL 141
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 58/150 (38%), Positives = 84/150 (56%), Gaps = 2/150 (1%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH 275
F++L ++G G G V+L++ T A+K M K+ L ++ TER+IL +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 276 PFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLH 335
+L L F+ +++ L ME+ PGGD TL E RFY+AE+ A++ LH
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALH 118
Query: 336 MLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
LG I+RDLKPEN L+ GHI L+DF LS
Sbjct: 119 ELGYIHRDLKPENFLIDASGHIKLTDFGLS 148
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 57/144 (39%), Positives = 87/144 (60%), Gaps = 3/144 (2%)
Query: 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREIL-QSLDHPFLPT 280
K +G G G V L++ ++A+KV+ K ++ +K+ ER +L +++ HPFL
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 281 LYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGII 340
L+ F+T V+++ GG+L Q++ + FPE RFY AE+ AL YLH L II
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLNII 118
Query: 341 YRDLKPENVLVREDGHIMLSDFDL 364
YRDLKPEN+L+ GH++L+DF L
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGL 142
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 4e-30
Identities = 67/155 (43%), Positives = 103/155 (66%), Gaps = 9/155 (5%)
Query: 217 HFRLLKRLGCGDIGSVYL-SELSG--TKCYFAMKVMDKASLAGRKKLLR-AQTEREILQS 272
+F LLK LG G G V+L ++SG + +AMKV+ KA++ + K +TER++L+
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 273 LDH-PFLPTLYTHFETEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQAVRFYVAEVLLA 330
+ PFL TL+ F+T+ L++++ GG+L T L Q++ F EQ V+ Y E++LA
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLA 117
Query: 331 LEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
LE+LH LGIIYRD+K EN+L+ +GH++L+DF LS
Sbjct: 118 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 152
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 5e-30
Identities = 100/410 (24%), Positives = 156/410 (38%), Gaps = 90/410 (21%)
Query: 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHP 276
+R+L++LG G G VYL+ + A+KV+ K + K++ R E +IL SL+HP
Sbjct: 1 SYRILRKLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 277 -FLPTLYTHFETEKFSCLVMEFCPGGDLHTL-RQKQPGKYFPEQAVRFYVAEVLLALEYL 334
+ LY F+ E LVME+ GG L L ++ E F +A++L ALEYL
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 335 HMLGIIYRDLKPENVLVREDGH-IMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCV 393
H GII+RD+KPEN+L+ DG + L DF L A L +
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGL------------AKLLPDPGSTSSIPA-- 163
Query: 394 QPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMS 453
S TP +P + S ++I
Sbjct: 164 --------LPSTSVGTPGYMAPEVLLGLSLAYASSSSDI--------------------- 194
Query: 454 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATL---------- 503
W+ GI LYELL G PF+G N +
Sbjct: 195 ------------------------WSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL 230
Query: 504 -FNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALI 562
+ PL ++S AA DL++ LL K+P++RL ++ H +
Sbjct: 231 PTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRL----SSSSDLSHDLLAHLKLKES 286
Query: 563 R--CATPPEIPKPVEIERIPAPTSSTSEKTAPTMVPPNQRGSDNYLEFDF 610
P+ P+ + P+ + S + + + + D+ +
Sbjct: 287 DLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKEL 336
|
Length = 384 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 7e-30
Identities = 58/144 (40%), Positives = 81/144 (56%), Gaps = 4/144 (2%)
Query: 224 LGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYT 283
LG G G V ++ T +A K +DK L RK A E++IL+ + F+ +L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 284 HFETEKFSCLVMEFCPGGDL--HTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIY 341
FET+ CLVM GGDL H +PG FPE FY A+++ LE+LH I+Y
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPG--FPEARAIFYAAQIICGLEHLHQRRIVY 118
Query: 342 RDLKPENVLVREDGHIMLSDFDLS 365
RDLKPENVL+ + G++ +SD L+
Sbjct: 119 RDLKPENVLLDDHGNVRISDLGLA 142
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 60/148 (40%), Positives = 88/148 (59%), Gaps = 6/148 (4%)
Query: 221 LKRLGCGDIGSVYLSE-LSGTKC--YFAMKVMDKASLA-GRKKLLRAQTEREILQSLDHP 276
LK LG G G V+ ++G FAMKV+ KA++ +K + ER IL+++ HP
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 277 FLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHM 336
F+ L F+T L++E+ GG+L +++ F E FY++E+ LALE+LH
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQ 118
Query: 337 LGIIYRDLKPENVLVREDGHIMLSDFDL 364
GIIYRDLKPEN+L+ GH+ L+DF L
Sbjct: 119 QGIIYRDLKPENILLDAQGHVKLTDFGL 146
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 46/117 (39%), Positives = 65/117 (55%), Gaps = 11/117 (9%)
Query: 450 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGN------RATL 503
++ +F GT EY+APEII +G+ +VD+W+ GI LYELL G+ PF L
Sbjct: 148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDIL 207
Query: 504 FNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAY-KRGATEIKQHPFFEGVNW 559
L FP + AA+DLI+ LL + P+ RL K G +IK+H +F G +W
Sbjct: 208 KGN--GKLEFP--NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDW 260
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 62/142 (43%), Positives = 83/142 (58%), Gaps = 3/142 (2%)
Query: 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQ-SLDHPFLPT 280
K LG G G V L+EL GT +A+KV+ K + + TE+ IL + HPFL
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 281 LYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGII 340
L+ F+T+ VME+ GGDL + Q Q + F E RFY AEV LAL +LH G+I
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDL--MFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVI 118
Query: 341 YRDLKPENVLVREDGHIMLSDF 362
YRDLK +N+L+ +GH L+DF
Sbjct: 119 YRDLKLDNILLDAEGHCKLADF 140
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 7e-29
Identities = 60/142 (42%), Positives = 84/142 (59%), Gaps = 3/142 (2%)
Query: 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQ-SLDHPFLPT 280
K LG G G V L+EL GT +FA+K + K + + ER +L + +HPFL
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 281 LYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGII 340
L+ F+T++ VME+ GGDL + Q F E RFY AE++ L++LH GII
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDL--MFHIQSSGRFDEARARFYAAEIICGLQFLHKKGII 118
Query: 341 YRDLKPENVLVREDGHIMLSDF 362
YRDLK +NVL+ +DGHI ++DF
Sbjct: 119 YRDLKLDNVLLDKDGHIKIADF 140
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 61/142 (42%), Positives = 86/142 (60%), Gaps = 7/142 (4%)
Query: 224 LGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREIL-QSLDHPFLPTLY 282
+G G V L EL T+ +AMKV+ K + + + QTE+ + + +HPFL L+
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 283 THFETEKFSCLVMEFCPGGDL--HTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGII 340
+ F+TE V+EF GGDL H RQ++ PE+ RFY AE+ LAL +LH GII
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQRK----LPEEHARFYSAEISLALNFLHERGII 118
Query: 341 YRDLKPENVLVREDGHIMLSDF 362
YRDLK +NVL+ +GHI L+D+
Sbjct: 119 YRDLKLDNVLLDAEGHIKLTDY 140
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 55/145 (37%), Positives = 86/145 (59%), Gaps = 1/145 (0%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF 277
F + +G G G V + T +AMKVM K+ L ++ + + ER+IL + P+
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 278 LPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHML 337
+P L F+ + LVME+ PGGDL +L + + F E +FY+AE++LA+ +H +
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQ-FDEDMAQFYLAELVLAIHSVHQM 121
Query: 338 GIIYRDLKPENVLVREDGHIMLSDF 362
G ++RD+KPENVL+ GHI L+DF
Sbjct: 122 GYVHRDIKPENVLIDRTGHIKLADF 146
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 48/128 (37%), Positives = 75/128 (58%), Gaps = 7/128 (5%)
Query: 449 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLF-NVV 507
+ +F GT +Y+APEI+ + +G AVDWW G+ LYE+L G++PF+G + LF +++
Sbjct: 151 VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD-DEDELFQSIL 209
Query: 508 GQPLRFPESPVVSFAARDLIRGLLVKEPQHRL-AYKRGATEIKQHPFFEGVNW-ALIRCA 565
+R+P +S A+ +++ L K P+ RL G +IK HPFF ++W L R
Sbjct: 210 EDEVRYPRW--LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKE 267
Query: 566 T-PPEIPK 572
PP PK
Sbjct: 268 IKPPFKPK 275
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 2e-28
Identities = 56/159 (35%), Positives = 76/159 (47%), Gaps = 15/159 (9%)
Query: 450 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ 509
R+ + GT EYLAPE+I+ +GHG AVDWWT G+ LYE + G PF ++
Sbjct: 171 RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG 230
Query: 510 PLRFPESPVVSFAARDLIRGLLVKEPQHRL-AYKRGATEIKQHPFFEGVNW-ALIRCATP 567
L+FP ARDL++GLL + RL K G ++K HP+F G NW L P
Sbjct: 231 RLKFPNW--FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYARYYP 288
Query: 568 PEIPKPVE-------IERIPAPTSSTSEKTAPTMVPPNQ 599
IP V+ E+ P + P + Q
Sbjct: 289 APIPVRVKSPGDTSNFEKYP----DSPVDRLPPLTAAQQ 323
|
Length = 329 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 59/145 (40%), Positives = 85/145 (58%), Gaps = 6/145 (4%)
Query: 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTL 281
K LG G G V L T Y+AMK++ K + + ++ TE +LQ+ HPFL L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 282 YTHFETEKFSCLVMEFCPGGDL--HTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGI 339
F+T C VME+ GG+L H R++ F E+ RFY AE++ ALEYLH +
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSRDV 116
Query: 340 IYRDLKPENVLVREDGHIMLSDFDL 364
+YRD+K EN+++ +DGHI ++DF L
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGL 141
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 5e-28
Identities = 60/155 (38%), Positives = 94/155 (60%), Gaps = 11/155 (7%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQT-----EREILQS 272
F +LK +G G G V + ++ T +AMK+++K + L RA+T ER++L +
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEM-----LKRAETACFREERDVLVN 57
Query: 273 LDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALE 332
D ++ L+ F+ E LVM++ GGDL TL K PE RFY+AE++LA++
Sbjct: 58 GDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAID 116
Query: 333 YLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLR 367
+H LG ++RD+KP+NVL+ ++GHI L+DF LR
Sbjct: 117 SVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLR 151
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 51/155 (32%), Positives = 81/155 (52%), Gaps = 8/155 (5%)
Query: 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHP 276
F +L+++G G G VY + T A+KV+ S ++K++ E +IL+ HP
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIIN---EIQILKKCKHP 57
Query: 277 FLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQ--KQPGKYFPEQAVRFYVAEVLLALEYL 334
+ Y + + +VMEFC GG +L+ K + E + + E+L LEYL
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGG---SLKDLLKSTNQTLTESQIAYVCKELLKGLEYL 114
Query: 335 HMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369
H GII+RD+K N+L+ DG + L DF LS + +
Sbjct: 115 HSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLS 149
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 59/145 (40%), Positives = 84/145 (57%), Gaps = 5/145 (3%)
Query: 224 LGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQS---LDHPFLPT 280
+G G G VY T+ +AMKV+ K + +K++ ER IL + PF+
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 281 LYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGII 340
L F+T+ LV ++ GG+L QK+ G+ F E +FY+AE++LALE+LH I+
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKE-GR-FSEDRAKFYIAELVLALEHLHKYDIV 118
Query: 341 YRDLKPENVLVREDGHIMLSDFDLS 365
YRDLKPEN+L+ GHI L DF LS
Sbjct: 119 YRDLKPENILLDATGHIALCDFGLS 143
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 4e-27
Identities = 57/152 (37%), Positives = 83/152 (54%), Gaps = 4/152 (2%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF 277
FR + LG G G V ++ T +A K ++K + RK A E++IL+ ++ F
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 278 LPTLYTHFETEKFSCLVMEFCPGGDL--HTLRQKQPGKYFPEQAVRFYVAEVLLALEYLH 335
+ +L +ET+ CLV+ GGDL H PG F E+ FY AE+ LE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPG--FDEERAVFYAAEITCGLEDLH 119
Query: 336 MLGIIYRDLKPENVLVREDGHIMLSDFDLSLR 367
I+YRDLKPEN+L+ + GHI +SD L++
Sbjct: 120 RERIVYRDLKPENILLDDYGHIRISDLGLAVE 151
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 50/126 (39%), Positives = 70/126 (55%), Gaps = 5/126 (3%)
Query: 450 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ 509
R+ + GT EYLAPE+I+ +GH AVDWW GI +YE+L G PF ++
Sbjct: 154 RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG 213
Query: 510 PLRFPESPVVSFAARDLIRGLLVKEPQHRLA-YKRGATEIKQHPFFEGVNWALI--RCAT 566
L FP + A+DLI+ LLV + RL K GA ++K H +F+ V+W + R
Sbjct: 214 KLEFPRH--LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLK 271
Query: 567 PPEIPK 572
PP +PK
Sbjct: 272 PPIVPK 277
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 58/171 (33%), Positives = 84/171 (49%), Gaps = 16/171 (9%)
Query: 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLF-NVVGQPL 511
+F GT EYLAPE+++ + + VDWW G LYE+L+G PF S + A ++ N++ +PL
Sbjct: 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFY-SRDTAEMYDNILNKPL 213
Query: 512 RFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWA--LIRCATPPE 569
R P +S +AR L+ GLL K+ RL K EIK H FF +NW + + TPP
Sbjct: 214 RLK--PNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITPPF 271
Query: 570 IPK----------PVEIERIPAPTSSTSEKTAPTMVPPNQRGSDNYLEFDF 610
P E P P S + + + D +L F +
Sbjct: 272 NPNVSGPMDLKHFDPEFTEEPVPNSVGKSPDSVLVSASVKEADDAFLGFSY 322
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 2e-26
Identities = 54/124 (43%), Positives = 74/124 (59%), Gaps = 5/124 (4%)
Query: 450 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ 509
++ +F GT EYLAPE++ G G+ AVDWWT G+ LYE+L G PF ++ +
Sbjct: 149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE 208
Query: 510 PLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWA--LIRCATP 567
PLRFP+ A+DL+ GLL ++P RL Y GA EIK HPFF ++W L++ P
Sbjct: 209 PLRFPDG--FDRDAKDLLIGLLSRDPTRRLGYN-GAQEIKNHPFFSQLSWKKLLMKGIQP 265
Query: 568 PEIP 571
P P
Sbjct: 266 PFKP 269
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 3e-26
Identities = 58/148 (39%), Positives = 85/148 (57%), Gaps = 2/148 (1%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF 277
F ++K + G G VYL +A+KV+ KA + + + + Q ER+ L PF
Sbjct: 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPF 65
Query: 278 LPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHML 337
+ LY ++ LVME+ GGD+ +L YF E+ Y++EV LAL+YLH
Sbjct: 66 IVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRH 123
Query: 338 GIIYRDLKPENVLVREDGHIMLSDFDLS 365
GII+RDLKP+N+L+ +GHI L+DF LS
Sbjct: 124 GIIHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 109 bits (272), Expect = 5e-26
Identities = 64/185 (34%), Positives = 98/185 (52%), Gaps = 19/185 (10%)
Query: 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTL 281
K LG G G V L + Y+AMK++ K + + ++ TE +L++ HPFL +L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 282 YTHFETEKFSCLVMEFCPGGDL--HTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGI 339
F+T+ C VME+ GG+L H R++ F E RFY AE++ AL+YLH I
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRER----VFSEDRTRFYGAEIVSALDYLHSGKI 116
Query: 340 IYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIE 399
+YRDLK EN+++ +DGHI ++DF L K DA ++ +C P +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLC----------KEGITDAATMK---TFCGTPEYLA 163
Query: 400 PSCIQ 404
P ++
Sbjct: 164 PEVLE 168
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 57/152 (37%), Positives = 83/152 (54%), Gaps = 4/152 (2%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF 277
FR + LG G G V ++ T +A K ++K + RK A E++IL+ ++ F
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 278 LPTLYTHFETEKFSCLVMEFCPGGDL--HTLRQKQPGKYFPEQAVRFYVAEVLLALEYLH 335
+ L +ET+ CLV+ GGDL H PG F E+ FY AE+L LE LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG--FEEERALFYAAEILCGLEDLH 119
Query: 336 MLGIIYRDLKPENVLVREDGHIMLSDFDLSLR 367
+YRDLKPEN+L+ + GHI +SD L+++
Sbjct: 120 RENTVYRDLKPENILLDDYGHIRISDLGLAVK 151
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 7e-26
Identities = 59/146 (40%), Positives = 85/146 (58%), Gaps = 7/146 (4%)
Query: 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTL 281
K LG G G V L + T Y+AMK++ K + + ++ TE +LQ+ HPFL L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 282 YTHFETEKFSCLVMEFCPGGDL--HTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHM-LG 338
F+T C VME+ GG+L H R+ + F E RFY AE++ AL+YLH
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEKN 116
Query: 339 IIYRDLKPENVLVREDGHIMLSDFDL 364
++YRDLK EN+++ +DGHI ++DF L
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGL 142
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 1e-25
Identities = 60/181 (33%), Positives = 96/181 (53%), Gaps = 18/181 (9%)
Query: 186 SSSINKPHKANDLRWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSEL-SGTKCYF 244
S S +P + N +++E F ++ LG G G V L+ +
Sbjct: 15 SDSTKEPKRKNKMKYE---------------DFNFIRTLGTGSFGRVILATYKNEDFPPV 59
Query: 245 AMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLH 304
A+K +K+ + +K++ +ER+IL ++HPF LY F+ E + LV+EF GG+
Sbjct: 60 AIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFF 119
Query: 305 TLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDL 364
T ++ K FP FY A+++L EYL L I+YRDLKPEN+L+ +DG I ++DF
Sbjct: 120 TFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGF 177
Query: 365 S 365
+
Sbjct: 178 A 178
|
Length = 340 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 56/144 (38%), Positives = 83/144 (57%), Gaps = 3/144 (2%)
Query: 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQ-SLDHPFLPT 280
K LG G G V+L+EL GT +FA+K + K + + E+ +L + +HPFL
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 281 LYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGII 340
LY F+T++ VME+ GGDL + Q F FY AE++ L++LH GI+
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIV 118
Query: 341 YRDLKPENVLVREDGHIMLSDFDL 364
YRDLK +N+L+ DGHI ++DF +
Sbjct: 119 YRDLKLDNILLDTDGHIKIADFGM 142
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 56/146 (38%), Positives = 80/146 (54%), Gaps = 3/146 (2%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHP- 276
F L LG G G V L+E GT +A+K++ K + + E+ +L P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61
Query: 277 FLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHM 336
FL L++ F+T VME+ GGDL +Q GK+ AV FY AE+ + L +LH
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDL-MYHIQQVGKFKEPHAV-FYAAEIAIGLFFLHS 119
Query: 337 LGIIYRDLKPENVLVREDGHIMLSDF 362
GIIYRDLK +NV++ +GHI ++DF
Sbjct: 120 KGIIYRDLKLDNVMLDAEGHIKIADF 145
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 54/140 (38%), Positives = 82/140 (58%), Gaps = 10/140 (7%)
Query: 441 ELIAEPTEARSMSFVGTHEYLAPEIIKG--EGHGSAVDWWTFGIFLYELLFGKTPFKGSG 498
E + E R+ SF GT EY+AP+I++G GH AVDWW+ G+ +YELL G +PF G
Sbjct: 154 EFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDG 212
Query: 499 NRATLFNVVGQPLR----FPESPVVSFAARDLIRGLLVKEPQHRLAY-KRGATEIKQHPF 553
+ + + + L+ +P+ +S A+D+I+ LL+K+P+ RL A EIK+HPF
Sbjct: 213 EKNSQAEISRRILKSEPPYPQE--MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPF 270
Query: 554 FEGVNWALIRCATPPEIPKP 573
F+ +NW + P KP
Sbjct: 271 FQKINWDDLAAKKVPAPFKP 290
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 47/127 (37%), Positives = 74/127 (58%), Gaps = 7/127 (5%)
Query: 448 EARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVV 507
E ++ +F GT +Y+APEI+KG+ + +VDWW+FG+ LYE+L G++PF G +++
Sbjct: 150 EGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL 209
Query: 508 GQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALI--RCA 565
FP +S A+D + L ++P RL +I+QHPFF G++W + R
Sbjct: 210 NDRPHFPRW--ISKEAKDCLSKLFERDPTKRLGVD---GDIRQHPFFRGIDWERLEKREI 264
Query: 566 TPPEIPK 572
PP PK
Sbjct: 265 PPPFKPK 271
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 54/151 (35%), Positives = 88/151 (58%), Gaps = 5/151 (3%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF 277
F ++K +G G G V L +K +AMK++ K + R ER+I+ + +
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEW 104
Query: 278 LPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKY-FPEQAVRFYVAEVLLALEYLHM 336
+ L+ F+ +K+ +VME+ PGGDL L Y PE+ RFY AEV+LAL+ +H
Sbjct: 105 IVQLHYAFQDDKYLYMVMEYMPGGDLVNLM----SNYDIPEKWARFYTAEVVLALDAIHS 160
Query: 337 LGIIYRDLKPENVLVREDGHIMLSDFDLSLR 367
+G I+RD+KP+N+L+ + GH+ L+DF ++
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 2e-25
Identities = 57/144 (39%), Positives = 86/144 (59%), Gaps = 3/144 (2%)
Query: 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREIL-QSLDHPFLPT 280
K +G G G V L++ +A+KV+ K + RK+ ER +L +++ HPFL
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 281 LYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGII 340
L+ F+T + V++F GG+L Q++ + FPE RFY AE+ AL YLH + I+
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSINIV 118
Query: 341 YRDLKPENVLVREDGHIMLSDFDL 364
YRDLKPEN+L+ GH++L+DF L
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGL 142
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 60/142 (42%), Positives = 86/142 (60%), Gaps = 3/142 (2%)
Query: 224 LGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREIL-QSLDHPFLPTLY 282
+G G V L L T+ +AMKV+ K + + + QTE+ + Q+ +HPFL L+
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 283 THFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYR 342
+ F+TE V+E+ GGDL Q+Q + PE+ RFY AE+ LAL YLH GIIYR
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 343 DLKPENVLVREDGHIMLSDFDL 364
DLK +NVL+ +GHI L+D+ +
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGM 142
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 49/152 (32%), Positives = 76/152 (50%), Gaps = 7/152 (4%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKAS-LAGRKKLLRAQTEREILQSLD 274
S +K LG G G VY T +A+K + RK+LLR E + L+S +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLR---ELKTLRSCE 57
Query: 275 HPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYL 334
P++ Y F E +V+E+ GG L L +K PE + + ++L L+YL
Sbjct: 58 SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGK--IPEPVLAYIARQILKGLDYL 115
Query: 335 H-MLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
H II+RD+KP N+L+ G + ++DF +S
Sbjct: 116 HTKRHIIHRDIKPSNLLINSKGEVKIADFGIS 147
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 57/147 (38%), Positives = 82/147 (55%), Gaps = 6/147 (4%)
Query: 224 LGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYT 283
LG G G V ++ T +A K ++K L RK A E+ IL + F+ +L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 284 HFETEKFSCLVMEFCPGGDL----HTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGI 339
F+T+ CLVM GGDL + + ++ PG FPE FY A+++ LE+LH I
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPG--FPEPRACFYTAQIISGLEHLHQRRI 118
Query: 340 IYRDLKPENVLVREDGHIMLSDFDLSL 366
IYRDLKPENVL+ DG++ +SD L++
Sbjct: 119 IYRDLKPENVLLDNDGNVRISDLGLAV 145
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 57/144 (39%), Positives = 87/144 (60%), Gaps = 3/144 (2%)
Query: 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREIL-QSLDHPFLPT 280
K +G G G V L++ ++A+KV+ K ++ +K+ ER +L ++L HPFL
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 281 LYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGII 340
L+ F+T + V+++ GG+L Q++ + F E RFY AEV A+ YLH L II
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLNII 118
Query: 341 YRDLKPENVLVREDGHIMLSDFDL 364
YRDLKPEN+L+ GH++L+DF L
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGL 142
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 55/150 (36%), Positives = 92/150 (61%), Gaps = 1/150 (0%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF 277
F ++K +G G G V + ++ T+ +AMK+++K + R + + ER +L + D +
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 278 LPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHML 337
+ TL+ F+ E + LVM++ GGDL TL K + PE RFY+AE++LA+ +H L
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYIAEMVLAIHSIHQL 121
Query: 338 GIIYRDLKPENVLVREDGHIMLSDFDLSLR 367
++RD+KP+NVL+ +GHI L+DF L+
Sbjct: 122 HYVHRDIKPDNVLLDMNGHIRLADFGSCLK 151
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 5e-25
Identities = 47/153 (30%), Positives = 80/153 (52%), Gaps = 7/153 (4%)
Query: 217 HFRLLKRLGCGDIGSVY--LSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD 274
+++L +G G G VY L+ +G + A+K + + + L E ++L++L
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGD--FVAIKQISLEKIK-EEALKSIMQEIDLLKNLK 57
Query: 275 HPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYL 334
HP + ET +++E+ G L + K+ G FPE V YV +VL L YL
Sbjct: 58 HPNIVKYIGSIETSDSLYIILEYAENGSLRQI-IKKFGP-FPESLVAVYVYQVLQGLAYL 115
Query: 335 HMLGIIYRDLKPENVLVREDGHIMLSDFDLSLR 367
H G+I+RD+K N+L +DG + L+DF ++ +
Sbjct: 116 HEQGVIHRDIKAANILTTKDGVVKLADFGVATK 148
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 46/109 (42%), Positives = 60/109 (55%), Gaps = 10/109 (9%)
Query: 452 MSFVGTHEYLAPEIIK-GEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNR---ATLFNVV 507
+FVGT Y+APE++ G G+G VD W+ G+ LYELL GK PF G + ++
Sbjct: 156 TTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRIL 215
Query: 508 GQPLRFPESPVVSF--AARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
G PL F E S A+DLI+ L K+P R A EI QHP+F
Sbjct: 216 GPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRP----TAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 6e-25
Identities = 61/173 (35%), Positives = 92/173 (53%), Gaps = 20/173 (11%)
Query: 450 RSMSFVGTHEYLAPEIIK----GEGH-GSAVDWWTFGIFLYELLFGKTPFKGSGNRATLF 504
+S VGT +Y++PEI++ G+G G DWW+ G+ +YE+L+G+TPF T
Sbjct: 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG 218
Query: 505 NVVGQPLRF---PESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWAL 561
++ F P+ VS A+DLIR L+ P+ RL + G + K HPFFEG++W
Sbjct: 219 KIMNHKEHFQFPPDVTDVSEEAKDLIRRLICS-PETRLG-RNGLQDFKDHPFFEGIDWDN 276
Query: 562 IRCATPPEIPKPVEIERIPAPTSS----TSEKTAPTMVPPNQRG--SDNYLEF 608
IR +T P +P E+ P TS+ + +PP+ G S N+L F
Sbjct: 277 IRNSTAPYVP---EVSS-PTDTSNFDVDDDDLRNTESLPPSSHGAFSGNHLPF 325
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 51/122 (41%), Positives = 69/122 (56%), Gaps = 5/122 (4%)
Query: 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLR 512
+F GT EY+APEI+ GHG AVDWW+ G +Y++L G PF + T+ ++ L
Sbjct: 159 TFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLN 218
Query: 513 FPESPVVSFAARDLIRGLLVKEPQHRLAYKRG-ATEIKQHPFFEGVNW--ALIRCATPPE 569
P P ++ ARDL++ LL + P RL G A E++ HPFF VNW L R PP
Sbjct: 219 LP--PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPPF 276
Query: 570 IP 571
P
Sbjct: 277 KP 278
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 60/142 (42%), Positives = 79/142 (55%), Gaps = 3/142 (2%)
Query: 224 LGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQ-SLDHPFLPTLY 282
LG G G V L+ L + +A+KV+ K + + TE+ IL + +HPFL LY
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 283 THFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYR 342
F+T VMEF GGDL QK + F E RFY AE+ AL +LH GIIYR
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 343 DLKPENVLVREDGHIMLSDFDL 364
DLK +NVL+ +GH L+DF +
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGM 142
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 56/175 (32%), Positives = 90/175 (51%), Gaps = 22/175 (12%)
Query: 450 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ 509
R+ +F GT E+LAPE++ + AVDWW G+ +YE+L G++PF G ++V
Sbjct: 157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND 216
Query: 510 PLRFPESPVVSFAARDLIRGLLVKEPQHRLAY-KRGATEIKQHPFFEGVNWA--LIRCAT 566
+R+P +S A ++R LL + P+ RL ++ A ++K+ PFF +NW L R
Sbjct: 217 EVRYPR--FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIK 274
Query: 567 PPEIPKPVEIERIPAPTSS-----TSEKTAPTMVPPN------QRGSDNYLEFDF 610
PP +P I + P S+ TSE P + PP + + + FD+
Sbjct: 275 PPFVP---TI-KGPEDVSNFDEEFTSEA--PVLTPPREPRLLTEEEQELFRGFDY 323
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 51/130 (39%), Positives = 82/130 (63%), Gaps = 13/130 (10%)
Query: 448 EARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVV 507
+A++ +F GT +Y+APEI+ G+ + ++VDWW+FG+ LYE+L G++PF G + LF
Sbjct: 150 DAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGH-DEEELF--- 205
Query: 508 GQPLRF--PESP-VVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALI-- 562
Q +R P P ++ A+D++ L V+EP+ RL K +I+QHPFF ++W+ +
Sbjct: 206 -QSIRMDNPCYPRWLTREAKDILVKLFVREPERRLGVK---GDIRQHPFFREIDWSALEE 261
Query: 563 RCATPPEIPK 572
R PP PK
Sbjct: 262 REIEPPFKPK 271
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 47/130 (36%), Positives = 66/130 (50%), Gaps = 10/130 (7%)
Query: 450 RSMSFVGTHEYLAPEIIKGEGH----GSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFN 505
R + VGT +Y++PE++K +G G DWW+ G+FLYE+L G TPF T
Sbjct: 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK 258
Query: 506 VVGQ--PLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF--EGVNWAL 561
++ L FP+ +S A+DLI L RL + G EIK HPFF + +
Sbjct: 259 IMDHKNSLTFPDDIEISKQAKDLICAFLTDRE-VRLG-RNGVDEIKSHPFFKNDQWTFDN 316
Query: 562 IRCATPPEIP 571
IR P +P
Sbjct: 317 IRETVAPVVP 326
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 58/144 (40%), Positives = 84/144 (58%), Gaps = 7/144 (4%)
Query: 224 LGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREIL-QSLDHPFLPTLY 282
+G G V L L +AMKV+ K + + + QTE+ + Q+ +PFL L+
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 283 THFETEKFSCLVMEFCPGGDL--HTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGII 340
+ F+T LV+E+ GGDL H RQ++ PE+ RFY AE+ +AL +LH GII
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQRK----LPEEHARFYAAEICIALNFLHERGII 118
Query: 341 YRDLKPENVLVREDGHIMLSDFDL 364
YRDLK +NVL+ DGHI L+D+ +
Sbjct: 119 YRDLKLDNVLLDADGHIKLTDYGM 142
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 4e-24
Identities = 56/144 (38%), Positives = 87/144 (60%), Gaps = 3/144 (2%)
Query: 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREIL-QSLDHPFLPT 280
K +G G G V L+ + ++A+KV+ K ++ +K+ +ER +L +++ HPFL
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 281 LYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGII 340
L+ F+T V+++ GG+L Q++ + F E RFY AE+ AL YLH L I+
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIV 118
Query: 341 YRDLKPENVLVREDGHIMLSDFDL 364
YRDLKPEN+L+ GHI+L+DF L
Sbjct: 119 YRDLKPENILLDSQGHIVLTDFGL 142
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 5e-24
Identities = 48/122 (39%), Positives = 74/122 (60%), Gaps = 4/122 (3%)
Query: 453 SFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPL 511
+F GT EYLAPE++ E G+ VD+W+ G+ ++E+ G +PF + N+ +
Sbjct: 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV 214
Query: 512 RFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALI--RCATPPE 569
RFP++ V+S R ++GLL + PQHRL R A E+K+HPFF ++W L+ + TPP
Sbjct: 215 RFPKN-VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQITPPF 273
Query: 570 IP 571
P
Sbjct: 274 KP 275
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 7e-24
Identities = 55/150 (36%), Positives = 92/150 (61%), Gaps = 1/150 (0%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF 277
F +LK +G G G V + +L FAMK+++K + R + + ER++L + D+ +
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 278 LPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHML 337
+ TL+ F+ E LVM++ GGDL TL K + PE RFY+AE+++A++ +H L
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVIAIDSVHQL 121
Query: 338 GIIYRDLKPENVLVREDGHIMLSDFDLSLR 367
++RD+KP+N+L+ +GHI L+DF L+
Sbjct: 122 HYVHRDIKPDNILMDMNGHIRLADFGSCLK 151
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 8e-24
Identities = 46/108 (42%), Positives = 58/108 (53%), Gaps = 3/108 (2%)
Query: 454 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRF 513
FVGT +YLAPE I G G DWW+ G ++E LFG PF A N++ + + +
Sbjct: 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINW 212
Query: 514 PESPV--VSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNW 559
PE S A DLI LL +P RL G EIK HPFF+ +NW
Sbjct: 213 PEEVKEFCSPEAVDLINRLLCMDPAKRLGAN-GYQEIKSHPFFKSINW 259
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 8e-24
Identities = 48/160 (30%), Positives = 81/160 (50%), Gaps = 14/160 (8%)
Query: 424 KDRKPKN----EIGN-QVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWW 478
+D KP+N + GN ++S L + + GT Y+APE+++GE + +VDW+
Sbjct: 119 RDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWF 178
Query: 479 TFGIFLYELLFGKTPFKGSG----NRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKE 534
G LYE++ G++PF+ + + +P+ S A+DL LL K+
Sbjct: 179 ALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDK--FSPEAKDLCEALLQKD 236
Query: 535 PQHRLAYK-RGATEIKQHPFFEGVNWALIRCA--TPPEIP 571
P+ RL + A E+++HP F+ +NW + PP IP
Sbjct: 237 PEKRLGCRGGSADEVREHPLFKDLNWRRLEAGMLEPPFIP 276
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 9e-24
Identities = 60/192 (31%), Positives = 102/192 (53%), Gaps = 19/192 (9%)
Query: 207 RARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTE 266
+ RD + + ++K +G G G V L T+ +AMK++ K + R E
Sbjct: 34 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 267 REILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAE 326
R+I+ + P++ L+ F+ +++ +VME+ PGGDL L PE+ RFY AE
Sbjct: 94 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD---VPEKWARFYTAE 150
Query: 327 VLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDF--------DLSLRCA--------V 370
V+LAL+ +H +G I+RD+KP+N+L+ + GH+ L+DF + +RC +
Sbjct: 151 VVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 210
Query: 371 SPTLIKASSLDA 382
SP ++K+ D
Sbjct: 211 SPEVLKSQGGDG 222
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 48/127 (37%), Positives = 74/127 (58%), Gaps = 5/127 (3%)
Query: 448 EARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVV 507
E ++ SF GT EY+APE++ GH + DWW+FG+ ++E+L G PF+G + T+ ++
Sbjct: 152 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL 211
Query: 508 GQPLRFPESPVVSFAARDLIRGLLVKEPQHRL-AYKRGATEIKQHPFFEGVNWALI--RC 564
L P+ +S A+ L+R L + P +RL A G EIK+HPFF ++W + R
Sbjct: 212 KAKLGMPQ--FLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRRE 269
Query: 565 ATPPEIP 571
PP P
Sbjct: 270 IKPPFKP 276
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-23
Identities = 60/172 (34%), Positives = 80/172 (46%), Gaps = 18/172 (10%)
Query: 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG--QP 510
S VGT Y+APE++ G+ DWW+ G+ LYE+L G+ PF T V+
Sbjct: 203 SLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETT 262
Query: 511 LRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWA-LIRCATPPE 569
L P +S A DLI L + RL K GA EIK HPFF+G+++A LIR P
Sbjct: 263 LHIPSQAKLSREASDLILR-LCCGAEDRLG-KNGADEIKAHPFFKGIDFASLIRRQKAPY 320
Query: 570 IPK-----------PVEIERIPAPTSSTSEKTAPTMVPPNQRGSDNYLEFDF 610
IPK PV+ E+ S V PN R + ++F
Sbjct: 321 IPKITHPTDTSNFDPVDPEK-LRSDDSGESSPDRN-VKPNNRKRTEHAFYEF 370
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-23
Identities = 58/175 (33%), Positives = 95/175 (54%), Gaps = 23/175 (13%)
Query: 447 TEARSMS-FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFN 505
++ +M F GT EYLAPE+++ +G AVDWW G+ +YE++ G+ PF + + LF
Sbjct: 147 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY-NQDHEKLFE 205
Query: 506 VV-GQPLRFPESPVVSFAARDLIRGLLVKEPQHRL-AYKRGATEIKQHPFFEGVNW-ALI 562
++ + +RFP + +S A+ L+ GLL K+P+ RL A EI +H FF +NW ++
Sbjct: 206 LILMEEIRFPRT--LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVV 263
Query: 563 RCATPPEIPKPVEIERIPAPTSST------SEKTAP--TMVPPNQRGSDNYLEFD 609
+ ++ P + P TS T E TA T+ PP++ S L+ +
Sbjct: 264 Q----KKLEPPFK----PQVTSETDTRYFDEEFTAQSITITPPDRYDSLGLLQLE 310
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 2e-23
Identities = 51/150 (34%), Positives = 89/150 (59%), Gaps = 3/150 (2%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF 277
+ ++K +G G G V L ++ +AMK++ K + R ER+I+ + P+
Sbjct: 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 278 LPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHML 337
+ L+ F+ +K+ +VME+ PGGDL L PE+ +FY AEV+LAL+ +H +
Sbjct: 105 VVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD---VPEKWAKFYTAEVVLALDAIHSM 161
Query: 338 GIIYRDLKPENVLVREDGHIMLSDFDLSLR 367
G+I+RD+KP+N+L+ + GH+ L+DF ++
Sbjct: 162 GLIHRDVKPDNMLLDKHGHLKLADFGTCMK 191
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 56/151 (37%), Positives = 82/151 (54%), Gaps = 4/151 (2%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF 277
FR + LG G G V ++ T +A K ++K + RK A E++IL+ ++ F
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 278 LPTLYTHFETEKFSCLVMEFCPGGDL--HTLRQKQPGKYFPEQAVRFYVAEVLLALEYLH 335
+ +L +ET+ CLV+ GGDL H + G F E FY AE+ LE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAG--FEEGRAVFYAAEICCGLEDLH 119
Query: 336 MLGIIYRDLKPENVLVREDGHIMLSDFDLSL 366
I+YRDLKPEN+L+ + GHI +SD L++
Sbjct: 120 QERIVYRDLKPENILLDDHGHIRISDLGLAV 150
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 5e-23
Identities = 62/175 (35%), Positives = 86/175 (49%), Gaps = 12/175 (6%)
Query: 445 EPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLF 504
EP E S +F GT EYLAPE+++ E + VDWW G LYE+L+G PF
Sbjct: 148 EPEETTS-TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYD 206
Query: 505 NVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALI-- 562
N++ +PL+ P V AA DL+ GLL K+ + RL K EIK H FF +NW +
Sbjct: 207 NILHKPLQLPGGKTV--AACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDLYH 264
Query: 563 -RCATP--PEIPKPVEIERI-PAPTS---STSEKTAPTMVPPNQRGSDNYLEFDF 610
R P P + P ++ P T S+S P + + S +L F +
Sbjct: 265 KRITPPYNPNVAGPADLRHFDPEFTQEAVSSSVGQTPDLTASSSSASSAFLGFSY 319
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 6e-23
Identities = 58/144 (40%), Positives = 85/144 (59%), Gaps = 3/144 (2%)
Query: 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQ-SLDHPFLPT 280
K LG G G V L+EL G YFA+K + K + + E+ +L + ++PFL
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 281 LYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGII 340
LY F+T++ VMEF GGDL Q + G++ +A FY AE++ L++LH GII
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDK-GRFDLYRAT-FYAAEIVCGLQFLHSKGII 118
Query: 341 YRDLKPENVLVREDGHIMLSDFDL 364
YRDLK +NV++ DGHI ++DF +
Sbjct: 119 YRDLKLDNVMLDRDGHIKIADFGM 142
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 7e-23
Identities = 45/126 (35%), Positives = 67/126 (53%), Gaps = 10/126 (7%)
Query: 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFN------V 506
S VG+ +Y+APE+++G+G+ VD+W+ G LYE L G PF GS T N
Sbjct: 157 SVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET 216
Query: 507 VGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIRCAT 566
+ +P+ +S A DLI L+ +P R +IK HPFF+ V+W +R
Sbjct: 217 LQRPVYDDPRFNLSDEAWDLITKLI-NDPSRRF---GSLEDIKNHPFFKEVDWNELRELK 272
Query: 567 PPEIPK 572
PP +P+
Sbjct: 273 PPFVPE 278
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 7e-23
Identities = 54/141 (38%), Positives = 78/141 (55%), Gaps = 2/141 (1%)
Query: 224 LGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYT 283
+G G G V T+ +A+K + KA + R ++ ER +L ++ PF+ L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 284 HFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRD 343
F++ + LV+ F GG+L Q++ G+ F RFY AE+L ALE LH +IYRD
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQRE-GR-FDLSRARFYTAELLCALENLHKFNVIYRD 118
Query: 344 LKPENVLVREDGHIMLSDFDL 364
LKPEN+L+ GHI L DF L
Sbjct: 119 LKPENILLDYQGHIALCDFGL 139
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 2e-22
Identities = 57/152 (37%), Positives = 81/152 (53%), Gaps = 9/152 (5%)
Query: 224 LGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL----DHPFLP 279
+G G G VY + T +AMK +DK + ++ A ER I+ SL D PF+
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNER-IMLSLVSTGDCPFIV 60
Query: 280 TLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGI 339
+ F T +++ GGDLH Q G F E +RFY AE++L LE++H +
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLH-YHLSQHG-VFSEAEMRFYAAEIILGLEHMHNRFV 118
Query: 340 IYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371
+YRDLKP N+L+ E GH+ +S DL L C S
Sbjct: 119 VYRDLKPANILLDEHGHVRIS--DLGLACDFS 148
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 3e-22
Identities = 54/166 (32%), Positives = 88/166 (53%), Gaps = 8/166 (4%)
Query: 448 EARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVV 507
A +F GT EYLAPE+++ +G AVDWW G+ +YE++ G+ PF + ++
Sbjct: 149 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL 208
Query: 508 GQPLRFPESPVVSFAARDLIRGLLVKEPQHRL-AYKRGATEIKQHPFFEGVNW--ALIRC 564
+ +RFP + +S A+ L+ GLL K+P+ RL A E+ +H FF +NW + +
Sbjct: 209 MEEIRFPRT--LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKK 266
Query: 565 ATPPEIPKPV-EIERIPAPTSSTSEKTAPTMVPPNQRGSDNYLEFD 609
PP P+ E++ T++ T+ PP++ S LE D
Sbjct: 267 LLPPFKPQVTSEVDTRYFDDEFTAQSI--TITPPDRYDSLGLLELD 310
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 4e-22
Identities = 47/133 (35%), Positives = 74/133 (55%), Gaps = 15/133 (11%)
Query: 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRAT--------LF 504
+F GT Y+APEI++GE +G +VDWW G+ ++E++ G++PF G LF
Sbjct: 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLF 214
Query: 505 NVV-GQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKR--GATEIKQHPFFEGVNWAL 561
V+ + +R P S +S A +++G L K+P+ RL G +IK HPFF ++W L
Sbjct: 215 QVILEKQIRIPRS--LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDL 272
Query: 562 I--RCATPPEIPK 572
+ + PP P
Sbjct: 273 LEQKQVLPPYKPN 285
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 5e-22
Identities = 57/152 (37%), Positives = 82/152 (53%), Gaps = 4/152 (2%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF 277
FR + LG G G V ++ T +A K ++K + RK A E+ IL+ ++ F
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 278 LPTLYTHFETEKFSCLVMEFCPGGDL--HTLRQKQPGKYFPEQAVRFYVAEVLLALEYLH 335
+ +L +ET+ CLV+ GGDL H PG F EQ FY AE+ LE L
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG--FDEQRAIFYAAELCCGLEDLQ 119
Query: 336 MLGIIYRDLKPENVLVREDGHIMLSDFDLSLR 367
I+YRDLKPEN+L+ + GHI +SD L+++
Sbjct: 120 RERIVYRDLKPENILLDDRGHIRISDLGLAVQ 151
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 6e-22
Identities = 48/130 (36%), Positives = 73/130 (56%), Gaps = 15/130 (11%)
Query: 451 SMSFVGTHEYLAPEI---IKGEG---HGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLF 504
S VGT +Y+APE+ + G+G +G DWW+ G+ YE+++G++PF G A +
Sbjct: 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH-EGTSAKTY 218
Query: 505 NVV---GQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWAL 561
N + + L+FPE P VS DLI+ LL + RL Y+ + HPFF ++W
Sbjct: 219 NNIMNFQRFLKFPEDPKVSSDFLDLIQSLLCG-QKERLGYEG----LCCHPFFSKIDWNN 273
Query: 562 IRCATPPEIP 571
IR + PP +P
Sbjct: 274 IRNSLPPFVP 283
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 6e-22
Identities = 49/136 (36%), Positives = 73/136 (53%), Gaps = 7/136 (5%)
Query: 441 ELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNR 500
E I R+ F GT +Y+APEII + +G +VDWW FG+ LYE+L G+ PF G
Sbjct: 150 ENIFGGKTTRT--FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED 207
Query: 501 ATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAY-KRGATEIKQHPFFEGVNW 559
+++ + +P+S +S A + +GLL K P RL G +I++H FF ++W
Sbjct: 208 ELFQSIMEHNVSYPKS--LSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW 265
Query: 560 ALI--RCATPPEIPKP 573
+ R PP PK
Sbjct: 266 EKLERREIQPPFKPKV 281
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 2e-21
Identities = 46/124 (37%), Positives = 64/124 (51%), Gaps = 5/124 (4%)
Query: 455 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFP 514
VGT Y+APE++K E + + DWW G +YE++ GK+PF+ + V +
Sbjct: 162 VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ 221
Query: 515 E--SPVVSFAARDLIRGLLVKEPQHRLAYKR-GATEIKQHPFFEGVNWALIRCA--TPPE 569
E S S AAR + R LL K+P RL + GA E+K HPFF N+ + PP
Sbjct: 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPPF 281
Query: 570 IPKP 573
P P
Sbjct: 282 CPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 2e-21
Identities = 48/126 (38%), Positives = 68/126 (53%), Gaps = 3/126 (2%)
Query: 451 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQP 510
+ +F GT EYLAPE+I+ + + + VDWW G LYE+L+G PF N++ +P
Sbjct: 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP 212
Query: 511 LRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWA-LIRCATPPE 569
L P S A ++ LL K+ Q RL K EI++HPFFE ++W L + PP
Sbjct: 213 LVL--RPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPPP 270
Query: 570 IPKPVE 575
VE
Sbjct: 271 FNPNVE 276
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 2e-21
Identities = 69/191 (36%), Positives = 95/191 (49%), Gaps = 18/191 (9%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHP- 276
F L LG G G V L+E GT +A+K++ K + + E+ +L D P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61
Query: 277 FLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHM 336
FL L++ F+T VME+ GGDL Q Q GK+ QAV FY AE+ + L +LH
Sbjct: 62 FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQ-QVGKFKEPQAV-FYAAEISVGLFFLHR 119
Query: 337 LGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPA 396
GIIYRDLK +NV++ +GHI ++DF + K +D R +C P
Sbjct: 120 RGIIYRDLKLDNVMLDSEGHIKIADFGMC----------KEHMVDGVTTR---TFCGTPD 166
Query: 397 CIEPSCI--QP 405
I P I QP
Sbjct: 167 YIAPEIIAYQP 177
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 2e-21
Identities = 47/158 (29%), Positives = 75/158 (47%), Gaps = 7/158 (4%)
Query: 220 LLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRA-QTEREILQSLDHPFL 278
++G G G VY + T A+K + K ++ E ++L+ L HP L
Sbjct: 4 RGNKIGGGTFGKVYTAVNLDTGELMAVKEI--RIQDNDPKTIKEIADEMKVLELLKHPNL 61
Query: 279 PTLY-THFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHML 337
Y EK + ME+C GG L L + G+ E +R Y ++L L YLH
Sbjct: 62 VKYYGVEVHREKV-YIFMEYCSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHSH 118
Query: 338 GIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375
GI++RD+KP N+ + +G I L DF +++ + T +
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 3e-21
Identities = 46/129 (35%), Positives = 74/129 (57%), Gaps = 11/129 (8%)
Query: 448 EARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVV 507
+ R+ +F GT +Y+APEI++G + +VDWW+FG+ LYE+L G++PF G + LF +
Sbjct: 150 DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD-DEDELFESI 208
Query: 508 GQPLRFPESPV-VSFAARDLIRGLLVKEPQHRLAYKRGAT-EIKQHPFFEGVNWALI--R 563
P P ++ ++D++ L ++P RL G I+ HPFF+ +NW + R
Sbjct: 209 RVDT--PHYPRWITKESKDILEKLFERDPTRRL----GVVGNIRGHPFFKTINWTALEKR 262
Query: 564 CATPPEIPK 572
PP PK
Sbjct: 263 ELDPPFKPK 271
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 3e-21
Identities = 48/150 (32%), Positives = 82/150 (54%), Gaps = 3/150 (2%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF 277
F++LK+LG G GSVY + ++A+K +D S++ +++ A E IL S++HP
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKERE-DAVNEIRILASVNHPN 60
Query: 278 LPTLYTHFETEKFSCLVMEFCPGGDLHTL--RQKQPGKYFPEQAVRFYVAEVLLALEYLH 335
+ + F C+VME+ P GDL ++K+ K PEQ + ++L L+ LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 336 MLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
I++RDLK N+L+ + + + D +S
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGIS 150
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 4e-21
Identities = 37/110 (33%), Positives = 53/110 (48%), Gaps = 3/110 (2%)
Query: 446 PTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFN 505
+ + S GT Y+APE++ +G+ AVDWW+ G+ YE L GK P++G
Sbjct: 151 TPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI 210
Query: 506 VVGQPLRFPESPVV-SFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
Q P S A D I LL ++PQ RL ++K HP+F
Sbjct: 211 RAKQETADVLYPATWSTEAIDAINKLLERDPQKRLGDN--LKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 94.4 bits (234), Expect = 4e-21
Identities = 49/130 (37%), Positives = 77/130 (59%), Gaps = 6/130 (4%)
Query: 447 TEARSM-SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFN 505
T+A +M +F GT EYLAPE+++ +G AVDWW G+ +YE++ G+ PF +
Sbjct: 147 TDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 206
Query: 506 VVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRL-AYKRGATEIKQHPFFEGVNWALI-- 562
++ + ++FP + +S A+ L+ GLL+K+P RL A EI +H FF GVNW +
Sbjct: 207 ILMEDIKFPRT--LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYD 264
Query: 563 RCATPPEIPK 572
+ PP P+
Sbjct: 265 KKLVPPFKPQ 274
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 4e-21
Identities = 52/130 (40%), Positives = 73/130 (56%), Gaps = 7/130 (5%)
Query: 445 EPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLF 504
E S +F GT EYLAPE++ + + VDWW G LYE+L+G PF S N A ++
Sbjct: 148 EHNGTTS-TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFY-SRNTAEMY 205
Query: 505 -NVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNW--AL 561
N++ +PL+ P ++ +AR L+ GLL K+ RL K EIK H FF +NW +
Sbjct: 206 DNILNKPLQL--KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLI 263
Query: 562 IRCATPPEIP 571
+ TPP P
Sbjct: 264 NKKITPPFNP 273
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 4e-21
Identities = 49/144 (34%), Positives = 70/144 (48%), Gaps = 4/144 (2%)
Query: 224 LGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREI--LQSLDHPFLPTL 281
LG G GSVY +FA+K + A + Q E+EI L L HP +
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 282 YTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIY 341
E + +E PGG L L +K FPE +R Y ++LL LEYLH ++
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRNTVH 125
Query: 342 RDLKPENVLVREDGHIMLSDFDLS 365
RD+K N+LV +G + L+DF ++
Sbjct: 126 RDIKGANILVDTNGVVKLADFGMA 149
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 6e-21
Identities = 55/158 (34%), Positives = 85/158 (53%), Gaps = 16/158 (10%)
Query: 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLR 512
+F GT EYLAPE+++ +G AVDWW G+ +YE++ G+ PF + ++ + +R
Sbjct: 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR 214
Query: 513 FPESPVVSFAARDLIRGLLVKEPQHRL-AYKRGATEIKQHPFFEGVNWALI--RCATPPE 569
FP + +S A+ L+ GLL K+P+ RL A EI QH FF G+ W + + PP
Sbjct: 215 FPRT--LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPF 272
Query: 570 IPKPVEIERIPAPTSS---TSEKTAP--TMVPPNQRGS 602
P+ + + T + E TA T+ PP+Q S
Sbjct: 273 KPQ------VTSETDTRYFDEEFTAQMITITPPDQDDS 304
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 6e-21
Identities = 61/182 (33%), Positives = 96/182 (52%), Gaps = 24/182 (13%)
Query: 443 IAEPTEARSMSFVGTHEYLAPEIIK----GEG-HGSAVDWWTFGIFLYELLFGKTPFKGS 497
+ E +S VGT +Y++PEI++ G+G +G DWW+ G+ +YE+L+G+TPF
Sbjct: 152 LMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211
Query: 498 GNRATLFNVVGQPLRF---PESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
T ++ RF + VS A+DLIR L+ +HRL + G + KQHPFF
Sbjct: 212 SLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSR-EHRLG-QNGIEDFKQHPFF 269
Query: 555 EGVNWALIRCATPPEIPKPVEIERIPAPTSSTS-------EKTAPTMVPPNQRG-SDNYL 606
G++W IR P IP+ + +PT +++ K + TM PP+ S ++L
Sbjct: 270 TGIDWDNIRNCEAPYIPE------VSSPTDTSNFDVDDDCLKNSETMPPPSHTAFSGHHL 323
Query: 607 EF 608
F
Sbjct: 324 PF 325
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 6e-21
Identities = 59/159 (37%), Positives = 84/159 (52%), Gaps = 9/159 (5%)
Query: 224 LGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL----DHPFLP 279
+G G G VY + T +AMK +DK + ++ A ER I+ SL D PF+
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNER-IMLSLVSTGDCPFIV 60
Query: 280 TLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGI 339
+ F T C +++ GGDLH Q G F E+ +RFY E++L LE++H +
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLH-YHLSQHG-VFSEKEMRFYATEIILGLEHMHNRFV 118
Query: 340 IYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKAS 378
+YRDLKP N+L+ E GH+ +S DL L C S AS
Sbjct: 119 VYRDLKPANILLDEHGHVRIS--DLGLACDFSKKKPHAS 155
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 7e-21
Identities = 56/148 (37%), Positives = 83/148 (56%), Gaps = 3/148 (2%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQ-SLDHP 276
F L LG G G V L+E GT +A+K++ K + + E+ +L S P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61
Query: 277 FLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHM 336
FL L++ F+T VME+ GGDL + +Q G++ AV FY AE+ + L +LH
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDL-MYQIQQVGRFKEPHAV-FYAAEIAIGLFFLHS 119
Query: 337 LGIIYRDLKPENVLVREDGHIMLSDFDL 364
GIIYRDLK +NV++ +GHI ++DF +
Sbjct: 120 KGIIYRDLKLDNVMLDSEGHIKIADFGM 147
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 8e-21
Identities = 46/131 (35%), Positives = 76/131 (58%), Gaps = 13/131 (9%)
Query: 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFK------GSGNRATLFNV 506
+F GT Y+APEI++GE +G +VDWW G+ ++E++ G++PF LF V
Sbjct: 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV 214
Query: 507 V-GQPLRFPESPVVSFAARDLIRGLLVKEPQHRLA--YKRGATEIKQHPFFEGVNWALI- 562
+ +P+R P +S A +++G L K+P+ RL + G ++IK H FF ++W L+
Sbjct: 215 ILEKPIRIPRF--LSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLE 272
Query: 563 -RCATPPEIPK 572
+ TPP P+
Sbjct: 273 KKQVTPPFKPQ 283
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 1e-20
Identities = 50/181 (27%), Positives = 86/181 (47%), Gaps = 10/181 (5%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF 277
F +L ++G G G V+ K +AMK +D + R++ A E +L LD +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSK-MNRREREEAIDEARVLAKLDSSY 60
Query: 278 LPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAV-RFYVAEVLLALEYLHM 336
+ Y F + +VME+ GDLH L + Q G+ PE V RF++ ++LL L +LH
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI-QILLGLAHLHS 119
Query: 337 LGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPA 396
I++RD+K N+ + ++ + D ++ L+ ++ A + P Y
Sbjct: 120 KKILHRDIKSLNLFLDAYDNVKIGDLGVA-------KLLSDNTNFANTIVGTPYYLSPEL 172
Query: 397 C 397
C
Sbjct: 173 C 173
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 3e-20
Identities = 49/152 (32%), Positives = 71/152 (46%), Gaps = 8/152 (5%)
Query: 219 RLLKRLGCGDIGSVYLSELSGTKCYFAMKV-----MDKASLAGRKKLLRAQTEREILQSL 273
L K+LG G G VY L G ++V + AS ++ LR E I++ L
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLR---EARIMRKL 58
Query: 274 DHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEY 333
DHP + L E+ +VME+ PGGDL +K K + + ++ +EY
Sbjct: 59 DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118
Query: 334 LHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
L I+RDL N LV E+ + +SDF LS
Sbjct: 119 LESKNFIHRDLAARNCLVGENLVVKISDFGLS 150
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 6e-20
Identities = 50/150 (33%), Positives = 79/150 (52%), Gaps = 7/150 (4%)
Query: 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLR 512
+F GT +Y+APEII + +G +VDWW FG+ LYE+L G+ PF+G +++ +
Sbjct: 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA 219
Query: 513 FPESPVVSFAARDLIRGLLVKEPQHRLAY-KRGATEIKQHPFFEGVNWALI--RCATPPE 569
+P+S +S A + +GL+ K P RL G +IK+H FF ++W + + PP
Sbjct: 220 YPKS--MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEVQPPY 277
Query: 570 IPKPVEIERIPAPTSSTSEKTAPTMVPPNQ 599
KP R + P + PP+Q
Sbjct: 278 --KPKACGRDAENFDKFFTRHPPVLTPPDQ 305
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 1e-19
Identities = 45/163 (27%), Positives = 85/163 (52%), Gaps = 19/163 (11%)
Query: 424 KDRKPKNEI----GN-QVSPLP---ELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAV 475
+D KP+N + GN ++S L EL ++ + + GT ++APE+++GE + +V
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKG--YAGTPGFMAPELLQGEEYDFSV 178
Query: 476 DWWTFGIFLYELLFGKTPFKGSG----NRATLFNVVGQPLRFPESPVVSFAARDLIRGLL 531
D++ G+ LYE++ + PF+ G N+ ++ + +P+ S A++ LL
Sbjct: 179 DYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDK--FSPASKSFCEALL 236
Query: 532 VKEPQHRLAYKRGA-TEIKQHPFFEGVNWALIRCA--TPPEIP 571
K+P+ RL ++ G ++ HP F +NW + PP +P
Sbjct: 237 AKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGMLPPPFVP 279
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-19
Identities = 52/165 (31%), Positives = 84/165 (50%), Gaps = 15/165 (9%)
Query: 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLR 512
+F GT +Y+APEII + +G +VDWW +G+ LYE+L G+ PF G +++ +
Sbjct: 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS 219
Query: 513 FPESPVVSFAARDLIRGLLVKEPQHRLAY-KRGATEIKQHPFFEGVNWALI--RCATPPE 569
+P+S +S A + +GL+ K P RL G +I++H FF ++W + R PP
Sbjct: 220 YPKS--LSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLENREIQPPF 277
Query: 570 IPKPVEIERIPAPTSSTSEK----TAPTMVPPNQRGSDNYLEFDF 610
PK + + +K P + PP+Q N + DF
Sbjct: 278 KPK------VCGKGAENFDKFFTRGQPVLTPPDQLVIANIDQADF 316
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 3e-19
Identities = 51/146 (34%), Positives = 77/146 (52%), Gaps = 4/146 (2%)
Query: 224 LGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYT 283
LG G G V ++ T +A K +DK L + A E+EIL+ ++ PF+ L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 284 HFETEKFSCLVMEFCPGGDL--HTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIY 341
FE++ CLVM GGDL H + G + V Y A++ + +LH + I+Y
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERG--LEMERVIHYSAQITCGILHLHSMDIVY 118
Query: 342 RDLKPENVLVREDGHIMLSDFDLSLR 367
RD+KPENVL+ + G+ LSD L++
Sbjct: 119 RDMKPENVLLDDQGNCRLSDLGLAVE 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (216), Expect = 4e-19
Identities = 47/153 (30%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 218 FRLLKRLGCGDIGSVYLSEL----SGTKCYFAMKVM-DKASLAGRKKLLRAQTEREILQS 272
L K+LG G G VY L GT+ A+K + + AS R++ L E I++
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLE---EASIMKK 57
Query: 273 LDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALE 332
L HP + L + +V E+ PGGDL +K K + ++ ++ +E
Sbjct: 58 LSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQM-ALQIAKGME 116
Query: 333 YLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
YL ++RDL N LV E+ + +SDF LS
Sbjct: 117 YLESKNFVHRDLAARNCLVTENLVVKISDFGLS 149
|
Length = 258 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 4e-19
Identities = 44/159 (27%), Positives = 77/159 (48%), Gaps = 12/159 (7%)
Query: 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKK-LLRAQTEREILQSLDH 275
+ +L+ +G G G+V K +D ++ ++K L + E IL+ L H
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVS--EVNILRELKH 58
Query: 276 PFLPTLYTHF--ETEKFSCLVMEFCPGGDLHTL--RQKQPGKYFPEQAVRFYVAEVLLAL 331
P + Y + + +VME+C GGDL L + K+ KY E+ + + ++LLAL
Sbjct: 59 PNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL 118
Query: 332 EYLHMLG-----IIYRDLKPENVLVREDGHIMLSDFDLS 365
H +++RDLKP N+ + + ++ L DF L+
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA 157
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 7e-19
Identities = 47/120 (39%), Positives = 69/120 (57%), Gaps = 5/120 (4%)
Query: 455 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFP 514
+GT +YLAPE++ G+ HG AVDWW G+ L+E L G PF + N++ + + +P
Sbjct: 541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600
Query: 515 E-SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIRCATPPEIPKP 573
E +S A++ I LL +P R K E+KQHP F GV+W ++ T P IP+P
Sbjct: 601 EGEEKLSVNAQNAIEILLTMDPTKRAGLK----ELKQHPLFHGVDWENLQNQTMPFIPQP 656
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 7e-19
Identities = 44/132 (33%), Positives = 70/132 (53%), Gaps = 8/132 (6%)
Query: 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFN-VVGQPL 511
+F GT +Y+APEI++ +G +VDWW G+ LYE+L G PF+ N LF ++ +
Sbjct: 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE-NEDDLFEAILNDEV 213
Query: 512 RFPESPVVSFAARDLIRGLLVKEPQHRLAY--KRGATEIKQHPFFEGVNWALI--RCATP 567
+P +S A D+++ + K P RL G I +HPFF+ ++W + R P
Sbjct: 214 VYPTW--LSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEP 271
Query: 568 PEIPKPVEIERI 579
P P+ E +
Sbjct: 272 PFRPRIKSREDV 283
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 47/160 (29%), Positives = 82/160 (51%), Gaps = 10/160 (6%)
Query: 424 KDRKPKNEIGN-----QVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWW 478
+D KP+N + + ++S L + P VGT Y+APE++ + + + D+W
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYW 185
Query: 479 TFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFA--ARDLIRGLLVKEPQ 536
G +YE++ G++PF+G + V + L E F+ A+ + + LL K+P+
Sbjct: 186 GLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPK 245
Query: 537 HRLAYKR-GATEIKQHPFFEGVNWALIRCAT--PPEIPKP 573
RL + GA E+K+HPFF +N+ + PP +P P
Sbjct: 246 QRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPFVPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 46/131 (35%), Positives = 74/131 (56%), Gaps = 15/131 (11%)
Query: 454 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRAT--------LFN 505
F GT Y+APEI++GE +G +VDWW G+ ++E++ G++PF G+ LF
Sbjct: 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ 215
Query: 506 VV-GQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAY--KRGATEIKQHPFFEGVNWALI 562
V+ + +R P S +S A +++ L K+P+ RL + G +I+ HPFF V+W L+
Sbjct: 216 VILEKQIRIPRS--LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLM 273
Query: 563 --RCATPPEIP 571
+ PP P
Sbjct: 274 EQKQVVPPFKP 284
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 1e-18
Identities = 53/158 (33%), Positives = 84/158 (53%), Gaps = 11/158 (6%)
Query: 424 KDRKPKN----EIGN-QVSPLPELIAEPTEARSMSFVGTHEYLAPEII-KGEGHGSAVDW 477
+D KP N E G+ ++S L L + ++ + + VGTH Y+APE++ KG + S+ DW
Sbjct: 121 RDLKPANILLDEHGHVRISDL-GLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADW 179
Query: 478 WTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESP-VVSFAARDLIRGLLVKEPQ 536
++ G L++LL G +PF+ + E P S R L+ GLL ++
Sbjct: 180 FSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVN 239
Query: 537 HRLAYK-RGATEIKQHPFFEGVNWALI--RCATPPEIP 571
RL RGA E+K+HPFF ++W ++ + PP IP
Sbjct: 240 RRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPPPLIP 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 43/149 (28%), Positives = 70/149 (46%), Gaps = 9/149 (6%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH 275
++ L+++G G G VY + T A+K M ++ E I++ H
Sbjct: 19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMR----LRKQNKELIINEILIMKDCKH 74
Query: 276 PFLPTLYTHFETEKFSCLVMEFCPGGDLHT--LRQKQPGKYFPEQAVRFYVAEVLLALEY 333
P + Y + +VME+ GG L T + Q E + + EVL LEY
Sbjct: 75 PNIVDYYDSYLVGDELWVVMEYMDGGSL-TDIITQNF--VRMNEPQIAYVCREVLQGLEY 131
Query: 334 LHMLGIIYRDLKPENVLVREDGHIMLSDF 362
LH +I+RD+K +N+L+ +DG + L+DF
Sbjct: 132 LHSQNVIHRDIKSDNILLSKDGSVKLADF 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 48/150 (32%), Positives = 68/150 (45%), Gaps = 6/150 (4%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKAS-LAGRKKLLRAQTEREILQSLDHP 276
L LG G+ G V T A+K + A +K++LR E +IL + P
Sbjct: 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILR---ELDILHKCNSP 59
Query: 277 FLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLH- 335
++ Y F + ME+ GG L + K+ PE+ + VL L YLH
Sbjct: 60 YIVGFYGAFYNNGDISICMEYMDGGSLDKIL-KEVQGRIPERILGKIAVAVLKGLTYLHE 118
Query: 336 MLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
II+RD+KP N+LV G I L DF +S
Sbjct: 119 KHKIIHRDVKPSNILVNSRGQIKLCDFGVS 148
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 84.5 bits (210), Expect = 3e-18
Identities = 49/153 (32%), Positives = 74/153 (48%), Gaps = 11/153 (7%)
Query: 219 RLLKRLGCGDIGSVYLSELSGTKCYFAMKV-----MDKASLAGRKKLLRAQTEREILQSL 273
L K+LG G G VY +L G ++V + AS ++ LR E I++ L
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLR---EARIMRKL 58
Query: 274 DHPFLPTLYTHFETEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQAVRFYVAEVLLALE 332
DHP + L E+ +VME+ GGDL + LR+ +P + + ++ +E
Sbjct: 59 DHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP--KLSLSDLLSFALQIARGME 116
Query: 333 YLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
YL I+RDL N LV E+ + +SDF LS
Sbjct: 117 YLESKNFIHRDLAARNCLVGENLVVKISDFGLS 149
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 4e-18
Identities = 41/117 (35%), Positives = 65/117 (55%), Gaps = 3/117 (2%)
Query: 444 AEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATL 503
A+ + R+ + GT EY+APEI+ GHG A DWWT GIF+YE+L G PF +
Sbjct: 178 AKVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIY 237
Query: 504 FNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLA-YKRGATEIKQHPFFEGVNW 559
++ + FP+ + + L++ LL + R K+GA +K+HP+F ++W
Sbjct: 238 QKILEGIIYFPK--FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDW 292
|
Length = 340 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 4e-18
Identities = 48/126 (38%), Positives = 70/126 (55%), Gaps = 10/126 (7%)
Query: 455 VGTHEYLAPEIIKGEG----HGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ- 509
VGT +Y++PE++K +G +G DWW+ G+FL+E+L G TPF T ++
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHK 263
Query: 510 -PLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG--VNWALIRCAT 566
L FPE +S A++LI L + + RL + G EIKQHPFF+ NW IR
Sbjct: 264 NSLNFPEDVEISKHAKNLICAFLT-DREVRLG-RNGVEEIKQHPFFKNDQWNWDNIRETA 321
Query: 567 PPEIPK 572
P +P+
Sbjct: 322 APVVPE 327
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 5e-18
Identities = 46/158 (29%), Positives = 72/158 (45%), Gaps = 17/158 (10%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTE-----REI- 269
+ L++ +G G VY + A+K +D L + QT +E+
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRID---------LEKCQTSVDELRKEVQ 51
Query: 270 -LQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGD-LHTLRQKQPGKYFPEQAVRFYVAEV 327
+ +HP + YT F LVM + GG L ++ P E + + EV
Sbjct: 52 AMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEV 111
Query: 328 LLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
L LEYLH G I+RD+K N+L+ EDG + ++DF +S
Sbjct: 112 LKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVS 149
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 8e-18
Identities = 47/126 (37%), Positives = 71/126 (56%), Gaps = 12/126 (9%)
Query: 455 VGTHEYLAPEIIK----GEG-HGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ 509
VGT +Y++PEI++ G G +G DWW+ G+ +YE+L+G+TPF T ++
Sbjct: 164 VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 223
Query: 510 PLRFPESPV----VSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIRCA 565
RF + P VS A+DLI+ L+ + RL + G + K+H FFEG++W IR
Sbjct: 224 EERF-QFPSHITDVSEEAKDLIQRLICSR-ERRLG-QNGIEDFKKHAFFEGIDWENIRNL 280
Query: 566 TPPEIP 571
P IP
Sbjct: 281 EAPYIP 286
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (208), Expect = 8e-18
Identities = 48/152 (31%), Positives = 79/152 (51%), Gaps = 10/152 (6%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL---- 273
++++K+LG G GSVYL+ T A+K M K ++ + RE+ +SL
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKM-KKKFYSWEECMN---LREV-KSLRKLN 55
Query: 274 DHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEY 333
+HP + L F V E+ G +L+ L + + GK F E +R + ++L L +
Sbjct: 56 EHPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 334 LHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+H G +RDLKPEN+LV + ++DF L+
Sbjct: 115 IHKHGFFHRDLKPENLLVSGPEVVKIADFGLA 146
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 2e-17
Identities = 45/126 (35%), Positives = 73/126 (57%), Gaps = 9/126 (7%)
Query: 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLF-NVVGQPL 511
+F GT +Y+APEI++ +G +VDWW G+ +YE++ G+ PF+ N LF +++ +
Sbjct: 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD-NEDDLFESILHDDV 213
Query: 512 RFPESPVVSFAARDLIRGLLVKEPQHRL---AYKRGATEIKQHPFFEGVNWALI--RCAT 566
+P +S A +++ + K P RL A + G IKQHPFF+ ++W L+ R
Sbjct: 214 LYP--VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRKIK 271
Query: 567 PPEIPK 572
PP PK
Sbjct: 272 PPFKPK 277
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-17
Identities = 46/131 (35%), Positives = 70/131 (53%), Gaps = 10/131 (7%)
Query: 450 RSMSFVGTHEYLAPEIIKGEG----HGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFN 505
R + VGT +Y++PE++K +G +G DWW+ G+FLYE+L G TPF T
Sbjct: 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK 258
Query: 506 VVGQ--PLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWAL-- 561
++ L FP+ +S A++LI L + + RL + G EIK+H FF+ WA
Sbjct: 259 IMNHKNSLTFPDDNDISKEAKNLICAFLT-DREVRLG-RNGVEEIKRHLFFKNDQWAWET 316
Query: 562 IRCATPPEIPK 572
+R P +P
Sbjct: 317 LRDTVAPVVPD 327
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 2e-17
Identities = 52/157 (33%), Positives = 74/157 (47%), Gaps = 18/157 (11%)
Query: 222 KRLGCGDIGSVY---LSELSGTKCYFAMKVM-DKASLAGRKKLLRAQTEREILQSLDHPF 277
K+LG G G VY L G A+K + + AS RK L+ E +++ L HP
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLK---EARVMKKLGHPN 57
Query: 278 LPTLYTHFETEKFS-CLVMEFCPGGDLHT-LRQKQPGKYFPE-------QAVRFYVAEVL 328
+ L TE+ LV+E+ GGDL LR+ +P PE + F ++
Sbjct: 58 VVRLL-GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSF-AIQIA 115
Query: 329 LALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+EYL ++RDL N LV ED + +SDF LS
Sbjct: 116 KGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLS 152
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 3e-17
Identities = 47/152 (30%), Positives = 73/152 (48%), Gaps = 14/152 (9%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMD-KASLAGRKKLLRAQTEREILQSLDHP 276
F +L++LG G GSVY + T A+KV+ + L K E IL+ D P
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIK------EISILKQCDSP 58
Query: 277 FLPTLYTHFETEKFSCLVMEFCPGG---DLHTLRQKQPGKYFPEQAVRFYVAEVLLALEY 333
++ Y + +VME+C G D+ + K E+ + + + L LEY
Sbjct: 59 YIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKT----LTEEEIAAILYQTLKGLEY 114
Query: 334 LHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
LH I+RD+K N+L+ E+G L+DF +S
Sbjct: 115 LHSNKKIHRDIKAGNILLNEEGQAKLADFGVS 146
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 47/157 (29%), Positives = 79/157 (50%), Gaps = 13/157 (8%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHP 276
F L++ +G G G VY + T A+K+MD + ++ + E IL+ +HP
Sbjct: 8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD--IIEDEEE--EIKEEYNILRKYSNHP 63
Query: 277 FLPTLYTHFETEKFSC------LVMEFCPGGDLHTLRQ--KQPGKYFPEQAVRFYVAEVL 328
+ T Y F + LVME C GG + L + ++ GK E+ + + + E L
Sbjct: 64 NIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETL 123
Query: 329 LALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
L YLH +I+RD+K +N+L+ ++ + L DF +S
Sbjct: 124 RGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 1e-16
Identities = 41/137 (29%), Positives = 73/137 (53%), Gaps = 4/137 (2%)
Query: 257 RKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFP 316
+ + L AQ E ++L+ L HP + Y +F +K +VME+ PGG L QK+
Sbjct: 40 KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLD 99
Query: 317 EQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIM-LSDFDLSLRCAVSPTLI 375
E + + ++LLAL ++H I++RDLK +N+L+ + ++ + DF +S + +
Sbjct: 100 EDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGIS---KILSSKS 156
Query: 376 KASSLDAEPLRKNPVYC 392
KA ++ P +P C
Sbjct: 157 KAYTVVGTPCYISPELC 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 51/155 (32%), Positives = 83/155 (53%), Gaps = 17/155 (10%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKL--LRAQTEREI--LQSL 273
+++L R+G G G V+ ++ T A+K +A R+ + Q REI LQ+
Sbjct: 2 YKILGRIGEGAHGIVFKAKDRETGETVALK-----KVALRRLEGGIPNQALREIKALQAC 56
Query: 274 DHPFLPTLYTHF-ETEKFSCLVMEFCPGGDLHTL--RQKQPGKYFPEQAVRFYVAEVLLA 330
HP++ L F F LVME+ P DL + +++P PE V+ Y+ +L
Sbjct: 57 QHPYVVKLLDVFPHGSGFV-LVMEYMPS-DLSEVLRDEERP---LPEAQVKSYMRMLLKG 111
Query: 331 LEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+ Y+H GI++RDLKP N+L+ DG + ++DF L+
Sbjct: 112 VAYMHANGIMHRDLKPANLLISADGVLKIADFGLA 146
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 49/160 (30%), Positives = 77/160 (48%), Gaps = 10/160 (6%)
Query: 424 KDRKPKNEIGN-----QVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWW 478
+D KP+N + + ++S L + P VGT Y+APE+I E + + DWW
Sbjct: 126 RDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWW 185
Query: 479 TFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFA--ARDLIRGLLVKEPQ 536
G +YE++ G++PF+ R V + E F+ A+ + R LL K P+
Sbjct: 186 GLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPK 245
Query: 537 HRLAYK-RGATEIKQHPFFEGVNWALIRCAT--PPEIPKP 573
RL + GA +KQHP F+ +N+ + PP P P
Sbjct: 246 ERLGCRGNGAAGVKQHPIFKNINFKRLEANMLEPPFCPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 45/150 (30%), Positives = 77/150 (51%), Gaps = 4/150 (2%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH 275
+ ++ LG G G VY ++ T + A K++ S ++L E +IL H
Sbjct: 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES---EEELEDFMVEIDILSECKH 61
Query: 276 PFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLH 335
P + LY + E +++EFC GG L ++ + + E +R+ ++L AL +LH
Sbjct: 62 PNIVGLYEAYFYENKLWILIEFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLH 120
Query: 336 MLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+I+RDLK N+L+ DG + L+DF +S
Sbjct: 121 SHKVIHRDLKAGNILLTLDGDVKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (196), Expect = 3e-16
Identities = 51/162 (31%), Positives = 74/162 (45%), Gaps = 31/162 (19%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRK---KLLRAQTE-------- 266
+ L++LG G G VY K DK + G K +R E
Sbjct: 1 YEKLEKLGEGTYGVVY-------------KARDKKT--GEIVALKKIRLDNEEEGIPSTA 45
Query: 267 -REI--LQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFY 323
REI L+ L HP + L TE+ LV E+C DL K+PG ++
Sbjct: 46 LREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGP-LSPNLIKSI 103
Query: 324 VAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+ ++L L Y H I++RDLKP+N+L+ DG + L+DF L+
Sbjct: 104 MYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLA 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 3e-16
Identities = 45/151 (29%), Positives = 79/151 (52%), Gaps = 7/151 (4%)
Query: 220 LLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRK--KLLRAQTEREILQSLDHPF 277
L +RLG G G+VYL + +KV+ + + + ++A E ++L LDHP
Sbjct: 4 LQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPA 63
Query: 278 LPTLYTHF-ETEKFSCLVMEFCPGGDLHTLRQ--KQPGKYFPEQAVRFYVAEVLLALEYL 334
+ + F E + F C++ E+C G DL + K GK E V + ++LL + Y+
Sbjct: 64 IVKFHASFLERDAF-CIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122
Query: 335 HMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
H I++RDLK +N+ ++ + + + DF +S
Sbjct: 123 HQRRILHRDLKAKNIFLKNN-LLKIGDFGVS 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 50/160 (31%), Positives = 79/160 (49%), Gaps = 10/160 (6%)
Query: 424 KDRKPKNEIGN-----QVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWW 478
+D KP+N + + ++S L + P VGT Y+APE++K E + + DWW
Sbjct: 126 RDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWW 185
Query: 479 TFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFA--ARDLIRGLLVKEPQ 536
G LYE++ G++PF+ + V E F+ AR L + LL K+P+
Sbjct: 186 ALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPK 245
Query: 537 HRLAYK-RGATEIKQHPFFEGVNWALIRCAT--PPEIPKP 573
RL + GA E+K+HP F+ +N+ + PP P P
Sbjct: 246 ERLGCQGGGAREVKEHPLFKQINFKRLEAGMLEPPFKPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (195), Expect = 4e-16
Identities = 45/162 (27%), Positives = 71/162 (43%), Gaps = 31/162 (19%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTERE--------- 268
+ + ++G G G VY + T A+K + R + E+E
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKI------------RMENEKEGFPITAIRE 48
Query: 269 --ILQSLDHPFLPTLY-THFETEKFSC-LVMEFCPGGDLHTLRQ--KQPGKYFPEQAVRF 322
+LQ L HP + L K S +V E+ H L P F E ++
Sbjct: 49 IKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD----HDLTGLLDSPEVKFTESQIKC 104
Query: 323 YVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDL 364
Y+ ++L L+YLH GI++RD+K N+L+ DG + L+DF L
Sbjct: 105 YMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGL 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 47/151 (31%), Positives = 71/151 (47%), Gaps = 4/151 (2%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD 274
+ L++R+G G G VY + T A+KV+ L Q E +L+
Sbjct: 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKECR 58
Query: 275 HPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYL 334
HP + + + +VME+C GG L + Q G E + + E L L YL
Sbjct: 59 HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGP-LSELQIAYVCRETLKGLAYL 117
Query: 335 HMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
H G I+RD+K N+L+ EDG + L+DF +S
Sbjct: 118 HETGKIHRDIKGANILLTEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 5e-16
Identities = 56/151 (37%), Positives = 79/151 (52%), Gaps = 10/151 (6%)
Query: 221 LKRLGCGDIGSVYLSELSGTKCYFAMK-VMDKASLAGRKKLLRAQTEREILQSLDHPFLP 279
L RLG G GSV L T FA+K + + +K++LR E EI +S P++
Sbjct: 6 LSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILR---ELEINKSCKSPYIV 62
Query: 280 TLYTHFETEKFSCL--VMEFCPGGDLHTL--RQKQPGKYFPEQAVRFYVAE-VLLALEYL 334
Y F E S + ME+C GG L ++ + K+ G E+ V +AE VL L YL
Sbjct: 63 KYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEK-VLGKIAESVLKGLSYL 121
Query: 335 HMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
H II+RD+KP N+L+ G + L DF +S
Sbjct: 122 HSRKIIHRDIKPSNILLTRKGQVKLCDFGVS 152
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 6e-16
Identities = 56/157 (35%), Positives = 80/157 (50%), Gaps = 23/157 (14%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTE-----REI--L 270
F LL+ +G G G VY + T A+KV+D L A+ E +EI L
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID---------LEEAEDEIEDIQQEIQFL 53
Query: 271 QSLDHPFLPTLYTHFETEKFSC-LVMEFCPGGD-LHTLRQKQPGKYFPEQAVRFYVAEVL 328
P++ Y F + ++ME+C GG L L+ PGK E + F + EVL
Sbjct: 54 SQCRSPYITKYYGSF-LKGSKLWIIMEYCGGGSCLDLLK---PGK-LDETYIAFILREVL 108
Query: 329 LALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
L LEYLH G I+RD+K N+L+ E+G + L+DF +S
Sbjct: 109 LGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVS 145
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 7e-16
Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 1/149 (0%)
Query: 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHP 276
H+ ++ LG G G L + K ++ L+ +++ A E IL L HP
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRD-ALNEIVILSLLQHP 59
Query: 277 FLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHM 336
+ Y HF + + ME+ GG L+ +Q G+ F E+ V +Y+ +++ A+ Y+H
Sbjct: 60 NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK 119
Query: 337 LGIIYRDLKPENVLVREDGHIMLSDFDLS 365
GI++RD+K N+ + + G I L DF +S
Sbjct: 120 AGILHRDIKTLNIFLTKAGLIKLGDFGIS 148
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 9e-16
Identities = 58/165 (35%), Positives = 89/165 (53%), Gaps = 25/165 (15%)
Query: 424 KDRKPKN----EIGN-QVSPLPELIAEPTEARSMSFVGTHEYLAPEII-KGEGHGSAVDW 477
+D KP N E G+ ++S L L + ++ + + VGTH Y+APE++ KG + S+ DW
Sbjct: 121 RDLKPANILLDEHGHVRISDL-GLACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADW 179
Query: 478 WTFGIFLYELLFGKTPF-------KGSGNRATLFNVVGQPLRF-PESPVVSFAARDLIRG 529
++ G L++LL G +PF K +R TL V P F PE + L+ G
Sbjct: 180 FSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPE-------LKSLLEG 232
Query: 530 LLVKEPQHRLA-YKRGATEIKQHPFFEGVNW--ALIRCATPPEIP 571
LL ++ RL RGA E+K+H FF+G++W ++ PP IP
Sbjct: 233 LLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYLQKYPPPLIP 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 49/150 (32%), Positives = 81/150 (54%), Gaps = 4/150 (2%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF 277
+ ++ LG G G VY ++ T A KV++ S ++L E EIL + +HP+
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCNHPY 70
Query: 278 LPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHML 337
+ L F + +++EFCPGG + + + + E ++ ++L AL+YLH +
Sbjct: 71 IVKLLGAFYWDGKLWIMIEFCPGGAVDAI-MLELDRGLTEPQIQVICRQMLEALQYLHSM 129
Query: 338 GIIYRDLKPENVLVREDGHIMLSDFDLSLR 367
II+RDLK NVL+ DG I L+DF +S +
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSAK 159
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 49/148 (33%), Positives = 71/148 (47%), Gaps = 8/148 (5%)
Query: 224 LGCGDIGSVYLSELSGTKCYFAMKVMD----KASLAGRKKLLRAQTEREI--LQSLDHPF 277
+G G GSVYL + + A+K ++ AS RK+ + REI L+ L H
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 278 LPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHML 337
+ + +E+ PGG + L F E VR +V ++L L YLH
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA--FEETLVRNFVRQILKGLNYLHNR 125
Query: 338 GIIYRDLKPENVLVREDGHIMLSDFDLS 365
GII+RD+K N+LV G I +SDF +S
Sbjct: 126 GIIHRDIKGANILVDNKGGIKISDFGIS 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 50/154 (32%), Positives = 77/154 (50%), Gaps = 8/154 (5%)
Query: 221 LKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREI--LQSLDHPFL 278
L ++G G G VY + T A+K K L + + REI L+ L+HP +
Sbjct: 4 LGKIGEGTYGVVYKARDKLTGEIVAIK---KIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 279 PTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLG 338
L F + LV EF ++ +Q G PE ++ Y+ ++L L + H G
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRG--LPESLIKSYLYQLLQGLAFCHSHG 118
Query: 339 IIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 372
I++RDLKPEN+L+ +G + L+DF L+ R SP
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLA-RSFGSP 151
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 57/150 (38%), Positives = 82/150 (54%), Gaps = 11/150 (7%)
Query: 224 LGCGDIGSVYLSELSGTKCYFAMK-VMDKASLAGRKKLLRAQT------EREILQSLDHP 276
+G G G VYL+ T A+K V A++AGR + E E L+ LDH
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 277 FLPTLYTHFE-TEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLH 335
+ Y FE TE++ + +E+ PGG + + + G+ F EQ VRF+ +VL L YLH
Sbjct: 69 NIVQ-YLGFETTEEYLSIFLEYVPGGSIGSCLRT-YGR-FEEQLVRFFTEQVLEGLAYLH 125
Query: 336 MLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
GI++RDLK +N+LV DG +SDF +S
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGIS 155
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 5e-15
Identities = 45/157 (28%), Positives = 81/157 (51%), Gaps = 7/157 (4%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKV--MDKASLAGRKKLLRAQTEREILQSLDH 275
+ +L+ +G G G L + + +AMK + K+S A ++ E +L + H
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVED----SRKEAVLLAKMKH 57
Query: 276 PFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLH 335
P + FE + +VME+C GGDL + Q GK FPE + + ++ L ++++H
Sbjct: 58 PNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH 117
Query: 336 MLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 372
+++RD+K +N+ + ++G + L DF S R SP
Sbjct: 118 EKRVLHRDIKSKNIFLTQNGKVKLGDFG-SARLLTSP 153
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 6e-15
Identities = 39/146 (26%), Positives = 79/146 (54%), Gaps = 2/146 (1%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF 277
+ ++K++G G G +YL++ + +K +D + ++K ++ E +L + HP
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKE-ASKKEVILLAKMKHPN 60
Query: 278 LPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHML 337
+ T + F+ +VME+C GGDL +Q G F E + + ++ L L+++H
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 338 GIIYRDLKPENVLVREDGHIM-LSDF 362
I++RD+K +N+ + ++G + L DF
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDF 146
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 8e-15
Identities = 54/153 (35%), Positives = 76/153 (49%), Gaps = 8/153 (5%)
Query: 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHP 276
+ ++ LG G G VY ++ T A KV+D S ++L E +IL S DHP
Sbjct: 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHP 62
Query: 277 FLPTLYTHFETEKFSCLVMEFCPGG--DLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYL 334
+ L F E +++EFC GG D L ++P E +R + L AL YL
Sbjct: 63 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP---LTEPQIRVVCKQTLEALNYL 119
Query: 335 HMLGIIYRDLKPENVLVREDGHIMLSDFDLSLR 367
H II+RDLK N+L DG I L+DF +S +
Sbjct: 120 HENKIIHRDLKAGNILFTLDGDIKLADFGVSAK 152
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 39/106 (36%), Positives = 54/106 (50%), Gaps = 5/106 (4%)
Query: 257 RKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFP 316
+K LR E ++L+ L H + L F + LV E+ L L G P
Sbjct: 44 KKTALR---EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGG--LP 98
Query: 317 EQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDF 362
AVR Y+ ++L A+ Y H II+RD+KPEN+LV E G + L DF
Sbjct: 99 PDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 47/167 (28%), Positives = 74/167 (44%), Gaps = 35/167 (20%)
Query: 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRA--------QTERE 268
++ L +G G G V + + T A+K KL R +T RE
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK-----------KLSRPFQSAIHAKRTYRE 64
Query: 269 I--LQSLDHP--------FLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQ 318
+ L+ +DH F P + E + LV G DL+ + + Q +
Sbjct: 65 LRLLKHMDHENVIGLLDVFTPA--SSLEDFQDVYLVTHLM-GADLNNIVKCQK---LSDD 118
Query: 319 AVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
++F V ++L L+Y+H GII+RDLKP N+ V ED + + DF L+
Sbjct: 119 HIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 165
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 39/145 (26%), Positives = 79/145 (54%), Gaps = 1/145 (0%)
Query: 221 LKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPT 280
+K++G G G L + + +K ++ + ++ +++ ++ E +L ++ HP +
Sbjct: 5 VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKERE-ESRKEVAVLSNMKHPNIVQ 63
Query: 281 LYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGII 340
FE +VM++C GGDL+ Q G FPE + + ++ LAL+++H I+
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKIL 123
Query: 341 YRDLKPENVLVREDGHIMLSDFDLS 365
+RD+K +N+ + +DG I L DF ++
Sbjct: 124 HRDIKSQNIFLTKDGTIKLGDFGIA 148
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 3e-14
Identities = 83/340 (24%), Positives = 125/340 (36%), Gaps = 84/340 (24%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVM--DKASLAGRKKLLRAQTEREILQSLDH 275
+R K LG G G VYL T A K + D S K++ + E ++L++L H
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63
Query: 276 PFLPTLYTHFE--TEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEY 333
+ Y EK + ME+ PGG + Q + E R Y ++L + Y
Sbjct: 64 ERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKD--QLKAYGALTESVTRKYTRQILEGMSY 121
Query: 334 LHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCV 393
LH I++RD+K N+L G++ L DF S R +
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKR-------------------------L 156
Query: 394 QPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMS 453
Q C+ + I+ TP SP + S
Sbjct: 157 QTICMSGTGIRSVTGTPYWMSPEVIS---------------------------------- 182
Query: 454 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRF 513
GEG+G D W+ G + E+L K P+ A +F + QP
Sbjct: 183 --------------GEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNP 228
Query: 514 PESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPF 553
+S ARD + + V E +HR + A E+ +HPF
Sbjct: 229 QLPSHISEHARDFLGCIFV-EARHRPS----AEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 42/150 (28%), Positives = 77/150 (51%), Gaps = 8/150 (5%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH 275
S ++ L+ +G G G+VY + T A+K+++ + + Q E +L L
Sbjct: 1 SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQ 58
Query: 276 PFLPTLYTHFET---EKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALE 332
P + ++ + ++ME+ GG + TL + P E+ + + EVL+AL+
Sbjct: 59 SQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP---IAEKYISVIIREVLVALK 115
Query: 333 YLHMLGIIYRDLKPENVLVREDGHIMLSDF 362
Y+H +G+I+RD+K N+LV G++ L DF
Sbjct: 116 YIHKVGVIHRDIKAANILVTNTGNVKLCDF 145
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 5e-14
Identities = 49/161 (30%), Positives = 81/161 (50%), Gaps = 6/161 (3%)
Query: 220 LLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLP 279
++ +G G G V L + +K ++ + A R++ A+ E ++L L HP +
Sbjct: 4 FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRN-ASRRERKAAEQEAQLLSQLKHPNIV 62
Query: 280 TLYTHFETEK-FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLG 338
+E E +VM FC GGDL+ ++Q GK PE V + ++ +AL+YLH
Sbjct: 63 AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH 122
Query: 339 IIYRDLKPENVLVREDGHIMLSDFD----LSLRCAVSPTLI 375
I++RDLK +NV + I + D L +C ++ TLI
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI 163
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 6e-14
Identities = 36/111 (32%), Positives = 57/111 (51%), Gaps = 11/111 (9%)
Query: 265 TEREI-----LQSLDHPFLPTLYT-----HFETEKFSCLVMEFCPGGDLHTLRQKQPGKY 314
T REI L+S +HP + L + E LV E DL T K P
Sbjct: 45 TLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPG 103
Query: 315 FPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
P + ++ + ++L +++LH I++RDLKP+N+LV DG + ++DF L+
Sbjct: 104 LPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLA 154
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 7e-14
Identities = 45/148 (30%), Positives = 68/148 (45%), Gaps = 10/148 (6%)
Query: 222 KRLGCGDIGSV---YLSELSGTKCYFAMKVM-DKASLAGRKKLLRAQTEREILQSLDHPF 277
K LG G+ GSV SG + A+K + + AG+K+ LR E ++ LDHP
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLR---EASVMAQLDHPC 57
Query: 278 LPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHML 337
+ L + E LVME P G L +K+ P ++ +V + + YL
Sbjct: 58 IVRLIGVCKGEPL-MLVMELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESK 114
Query: 338 GIIYRDLKPENVLVREDGHIMLSDFDLS 365
++RDL NVL+ +SDF +S
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMS 142
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 8e-14
Identities = 30/104 (28%), Positives = 46/104 (44%), Gaps = 5/104 (4%)
Query: 451 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVV-GQ 509
+ VGT ++APE+I G+ + D W+ GI EL GK P+ LF +
Sbjct: 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNG 213
Query: 510 PLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPF 553
P S +D ++ L K P+ R A ++ +HPF
Sbjct: 214 PPGLRNPEKWSDEFKDFLKKCLQKNPEKRP----TAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 8e-14
Identities = 45/160 (28%), Positives = 79/160 (49%), Gaps = 12/160 (7%)
Query: 424 KDRKPKN----EIGN-QVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWW 478
+D KP+N + GN ++S L + GT+ Y+APEI+K E + VDW+
Sbjct: 119 RDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWF 178
Query: 479 TFGIFLYELLFGKTPFKGSGNRATLFNVVGQPL----RFPESPVVSFAARDLIRGLLVKE 534
G +YE++ G+TPFK + + + L +F E + ++D+ R L K+
Sbjct: 179 AMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF-EHQNFTEESKDICRLFLAKK 237
Query: 535 PQHRLAYKRGATEIKQHPFFEGVNWALIRCA--TPPEIPK 572
P+ RL + + ++H FF+ +N+ + PP +P
Sbjct: 238 PEDRLGSREKNDDPRKHEFFKTINFPRLEAGLIPPPFVPD 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 1e-13
Identities = 48/161 (29%), Positives = 80/161 (49%), Gaps = 23/161 (14%)
Query: 217 HFRLLKRLGCGDIGSVYLS--ELSGTKCYFAMK----VMDKASLAGRKKLLRAQTEREIL 270
+ LLK +G G G V + + +G K A+K V D A K++LR E ++L
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRK--VAIKKISNVFDDLIDA--KRILR---EIKLL 53
Query: 271 QSLDHPF---LPTLYTHFETEKFS--CLVMEFCPGGDLHT-LRQKQPGKYFPEQAVRFYV 324
+ L H L + E F+ +V E DLH ++ QP + +++++
Sbjct: 54 RHLRHENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQP---LTDDHIQYFL 109
Query: 325 AEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
++L L+YLH +I+RDLKP N+LV + + + DF L+
Sbjct: 110 YQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLA 150
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 2e-13
Identities = 38/114 (33%), Positives = 54/114 (47%), Gaps = 7/114 (6%)
Query: 443 IAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNR-- 500
+ E T + +FVGT Y++PE I+GE + A D W+ G+ L E GK PF G
Sbjct: 149 VLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSF 208
Query: 501 -ATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPF 553
+ + P + S RD I L K+P+ R + A E+ QHPF
Sbjct: 209 FELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPS----AAELLQHPF 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 51/180 (28%), Positives = 80/180 (44%), Gaps = 10/180 (5%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD 274
L +F++ K++G G VY + A+K + + K E ++L+ LD
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 275 HPFLPTLYTHFETEKFSCLVMEFCPGGDL-----HTLRQKQPGKYFPEQAVRFYVAEVLL 329
HP + F +V+E GDL H +QK+ PE+ + Y ++
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRL---IPERTIWKYFVQLCS 117
Query: 330 ALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNP 389
ALE++H I++RD+KP NV + G + L D L R S T A SL P +P
Sbjct: 118 ALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLG-RFFSSKT-TAAHSLVGTPYYMSP 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 81/343 (23%), Positives = 128/343 (37%), Gaps = 88/343 (25%)
Query: 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVM--DKASLAGRKKLLRAQTEREILQSLD 274
++RL K LG G G VYL + T A+K + D S K++ + E ++L++L
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 275 HPFLPTLYTHFE--TEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALE 332
H + Y EK + +E+ PGG + Q + E R Y ++L +
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKD--QLKAYGALTENVTRRYTRQILQGVS 120
Query: 333 YLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYC 392
YLH I++RD+K N+L G++ L DF S R
Sbjct: 121 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKR------------------------- 155
Query: 393 VQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452
+Q C+ + I+ TP SP + S
Sbjct: 156 IQTICMSGTGIKSVTGTPYWMSPEVIS--------------------------------- 182
Query: 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPL- 511
GEG+G D W+ + E+L K P+ A +F + QP
Sbjct: 183 ---------------GEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTK 227
Query: 512 -RFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPF 553
P+ VS A RD ++ + V+E + A + +HPF
Sbjct: 228 PMLPDG--VSDACRDFLKQIFVEEKRRPT-----AEFLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 79/342 (23%), Positives = 126/342 (36%), Gaps = 84/342 (24%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVM--DKASLAGRKKLLRAQTEREILQSL 273
+++RL K LG G G VYL + T A+K + D S K++ + E ++L++L
Sbjct: 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61
Query: 274 DHPFLPTLYTHFE--TEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLAL 331
H + Y E+ + ME PGG + Q + E R Y ++L +
Sbjct: 62 LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKD--QLKSYGALTENVTRKYTRQILEGV 119
Query: 332 EYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVY 391
YLH I++RD+K N+L G++ L DF S R
Sbjct: 120 SYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKR------------------------ 155
Query: 392 CVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451
+Q C+ + ++ TP SP + S
Sbjct: 156 -LQTICLSGTGMKSVTGTPYWMSPEVIS-------------------------------- 182
Query: 452 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPL 511
GEG+G D W+ G + E+L K P+ A +F + QP
Sbjct: 183 ----------------GEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT 226
Query: 512 RFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPF 553
P VS RD ++ + V+ + A E+ +H F
Sbjct: 227 NPVLPPHVSDHCRDFLKRIFVEAKL-----RPSADELLRHTF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 5e-13
Identities = 50/162 (30%), Positives = 70/162 (43%), Gaps = 21/162 (12%)
Query: 221 LKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREI--LQSLDHPFL 278
K+LG G VY + T A+K + K + REI LQ L HP +
Sbjct: 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNI 64
Query: 279 PTLYTHFETEKFSCLVMEFCPGGDL-HTLRQKQPGKYFPEQAVRFYVAEV-------LLA 330
L F + LV EF DL ++ K ++ A++ L
Sbjct: 65 IGLLDVFGHKSNINLVFEFMET-DLEKVIKDK---------SIVLTPADIKSYMLMTLRG 114
Query: 331 LEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 372
LEYLH I++RDLKP N+L+ DG + L+DF L+ SP
Sbjct: 115 LEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFG-SP 155
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 9e-13
Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 4/98 (4%)
Query: 267 REI--LQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYV 324
REI L+ L HP L L F ++ LV E+C L+ L + G PE ++ +
Sbjct: 49 REIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG--VPEHLIKKII 106
Query: 325 AEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDF 362
+ L A+ + H I+RD+KPEN+L+ + G I L DF
Sbjct: 107 WQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 37/106 (34%), Positives = 54/106 (50%), Gaps = 9/106 (8%)
Query: 453 SFVGTHEYLAPEIIKG---EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNR-ATLFNV-V 507
S GT Y+APE+I G +GHG A D W+ G + E+ GK P+ N +F+V
Sbjct: 162 SLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA 221
Query: 508 GQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPF 553
G P+S +S +D + L +P+ R A+E+ QHPF
Sbjct: 222 GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPT----ASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (168), Expect = 1e-12
Identities = 37/104 (35%), Positives = 51/104 (49%), Gaps = 11/104 (10%)
Query: 456 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNR----ATLFNVVGQPL 511
GT +Y +PE IKG + + DWW G+ YELL GK PFK + +L + L
Sbjct: 168 GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKL 227
Query: 512 RFPESPVVSFAARDLIRGLLVKEPQHRL-AYKRGATEIKQHPFF 554
F + VS A D ++ +L +RL Y EI +HPF
Sbjct: 228 PFIK--NVSKNANDFVQSMLKYNINYRLTNYN----EIIKHPFL 265
|
Length = 267 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 48/150 (32%), Positives = 70/150 (46%), Gaps = 9/150 (6%)
Query: 219 RLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTERE--ILQSLDHP 276
+ LG G+ GSV + T A KV+ G K +R Q RE I+ P
Sbjct: 8 ETISDLGAGNGGSVSKVKHIPTGTVMAKKVV----HIGAKSSVRKQILRELQIMHECRSP 63
Query: 277 FLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLH- 335
++ + Y F E C+ MEF G L + +K G P + + V+ L YL+
Sbjct: 64 YIVSFYGAFLNENNICMCMEFMDCGSLDRIYKK--GGPIPVEILGKIAVAVVEGLTYLYN 121
Query: 336 MLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+ I++RD+KP N+LV G I L DF +S
Sbjct: 122 VHRIMHRDIKPSNILVNSRGQIKLCDFGVS 151
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (165), Expect = 2e-12
Identities = 35/104 (33%), Positives = 50/104 (48%), Gaps = 9/104 (8%)
Query: 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFN--VVGQP 510
+ VGT YL+PE+ + + + D W+ G LYEL K PF+G N L + GQ
Sbjct: 162 TVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE-NLLELALKILKGQY 220
Query: 511 LRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
P S R+L+ LL K+P+ R + +I Q PF
Sbjct: 221 PPIPSQ--YSSELRNLVSSLLQKDPEERPS----IAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 50/177 (28%), Positives = 82/177 (46%), Gaps = 4/177 (2%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD 274
L++FR+ K++G G VY + A+K + L K E ++L+ L+
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60
Query: 275 HPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQ--KQPGKYFPEQAVRFYVAEVLLALE 332
HP + Y F + +V+E GDL + + K+ + PE+ V Y ++ ALE
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120
Query: 333 YLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNP 389
++H +++RD+KP NV + G + L DL L S A SL P +P
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLG--DLGLGRFFSSKTTAAHSLVGTPYYMSP 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 48/173 (27%), Positives = 79/173 (45%), Gaps = 9/173 (5%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF 277
F L++R+G G G VY + T A+KV+ L + Q E +++ H
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVI---KLEPGEDFAVVQQEIIMMKDCKHSN 67
Query: 278 LPTLYTHFETEKFSCLVMEFCPGGDLHTLRQ-KQPGKYFPEQAVRFYVAEVLLALEYLHM 336
+ + + + MEFC GG L + P E + + E L L YLH
Sbjct: 68 IVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGP---LSESQIAYVSRETLQGLYYLHS 124
Query: 337 LGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNP 389
G ++RD+K N+L+ ++GH+ L+DF +S + ++ T+ K S P P
Sbjct: 125 KGKMHRDIKGANILLTDNGHVKLADFGVSAQ--ITATIAKRKSFIGTPYWMAP 175
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 5e-12
Identities = 49/149 (32%), Positives = 76/149 (51%), Gaps = 12/149 (8%)
Query: 219 RLLKRLGCGDIGSVYLSELSGTKCYFAMKVMD-KASLAGRKKLLRAQTEREILQSLDHPF 277
+ + LG G+ G+VY + T+ A+KV+ ++ +K+++ +E EIL D P+
Sbjct: 4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIM---SELEILYKCDSPY 60
Query: 278 LPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAV-RFYVAEVLLALEYLHM 336
+ Y F E + EF GG L R+ PE + R VA V+ L YL
Sbjct: 61 IIGFYGAFFVENRISICTEFMDGGSLDVYRK------IPEHVLGRIAVA-VVKGLTYLWS 113
Query: 337 LGIIYRDLKPENVLVREDGHIMLSDFDLS 365
L I++RD+KP N+LV G + L DF +S
Sbjct: 114 LKILHRDVKPSNMLVNTRGQVKLCDFGVS 142
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 45/152 (29%), Positives = 61/152 (40%), Gaps = 16/152 (10%)
Query: 222 KRLGCGDIGSVYLSELS---GTKCYFAMKVMDKASLAGRKKLLRAQT----EREILQSLD 274
K+LG G G V E S G A+K + KL E I+ SLD
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCL------KSDKLSDIMDDFLKEAAIMHSLD 54
Query: 275 HPFLPTLYTHFETEKFSCLVMEFCPGGDL-HTLRQKQPGKYFPEQAVRFYVAEVLLALEY 333
H L LY T +V E P G L LR+ G +F + Y ++ + Y
Sbjct: 55 HENLIRLYGVVLTHPLM-MVTELAPLGSLLDRLRKDALG-HFLISTLCDYAVQIANGMRY 112
Query: 334 LHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
L I+RDL N+L+ D + + DF L
Sbjct: 113 LESKRFIHRDLAARNILLASDDKVKIGDFGLM 144
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 38/140 (27%), Positives = 64/140 (45%), Gaps = 5/140 (3%)
Query: 225 GCGDIGSVYLSELSGTKCYFAMKV--MDKASLAGRKKLLRAQTEREILQSLDHPFLPTLY 282
D+ V+L++ T A+K +D S ++ L Q E + L HP +
Sbjct: 9 CFEDLMIVHLAKHKPTNTLVAVKKINLDSCS---KEDLKLLQQEIITSRQLQHPNILPYV 65
Query: 283 THFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYR 342
T F + +V G L + + PE A+ F + +VL AL+Y+H G I+R
Sbjct: 66 TSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHR 125
Query: 343 DLKPENVLVREDGHIMLSDF 362
+K ++L+ DG ++LS
Sbjct: 126 SVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 45/161 (27%), Positives = 77/161 (47%), Gaps = 14/161 (8%)
Query: 218 FRLLKRLGCGDIGSVYLSELS---GTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD 274
+L K LG G+ GSV +LS G++ A+K M K + ++ +E ++ D
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDFD 59
Query: 275 HPFLPTL----YTHFETEKFS--CLVMEFCPGGDLHTL----RQKQPGKYFPEQAVRFYV 324
HP + L + +K +++ F GDLH+ R + P Q + ++
Sbjct: 60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119
Query: 325 AEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
++ L +EYL I+RDL N ++RED + ++DF LS
Sbjct: 120 VDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 44/197 (22%), Positives = 80/197 (40%), Gaps = 32/197 (16%)
Query: 217 HFRLLKRLGCGDIGSVYLSELS----GTKCYFAMKV----MDKASLAGRKKLLRAQTERE 268
H + +K+LG G G V L T A+K ++ + ++ E E
Sbjct: 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFER------EIE 58
Query: 269 ILQSLDHPFLPTL--YTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAE 326
IL++LDH + + L+ME+ P G L Q+ + ++ + F +
Sbjct: 59 ILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSS-Q 117
Query: 327 VLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAE--- 383
+ ++YL I+RDL N+LV + + +SDF L+ K D +
Sbjct: 118 ICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLA----------KVLPEDKDYYY 167
Query: 384 --PLRKNPVYCVQPACI 398
++P++ P C+
Sbjct: 168 VKEPGESPIFWYAPECL 184
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 45/162 (27%), Positives = 84/162 (51%), Gaps = 16/162 (9%)
Query: 218 FRLLKRLGCGDIGSVY-LSELSGTKCYFAMKVMDKASLA-GRKKLLRAQTEREIL----- 270
+ +L+ LG G G VY + + + + A+K ++ + A G+ K R ++ +I+
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 271 --QSLDHPFLPTLYTHF-ETEKFSCLVMEF---CPGGDLHTLRQKQPGKYFPEQAVRFYV 324
+ L HP + Y F E ++ +VM+ P G+ H K+ + F E+ +
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLY-IVMDLIEGAPLGE-HFNSLKEKKQRFTEERIWNIF 119
Query: 325 AEVLLALEYLHMLG-IIYRDLKPENVLVREDGHIMLSDFDLS 365
+++LAL YLH I++RDL P N+++ ED + ++DF L+
Sbjct: 120 VQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLA 161
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 48/160 (30%), Positives = 76/160 (47%), Gaps = 26/160 (16%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKAS---LAGRKKLLRAQTE-------R 267
F+ ++++G G G VY K +K + +A +K L +TE R
Sbjct: 2 FQKVEKIGEGTYGVVY-------------KARNKLTGEVVALKKIRLDTETEGVPSTAIR 48
Query: 268 EI--LQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVA 325
EI L+ L+HP + L TE LV EF DL P P ++ Y+
Sbjct: 49 EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLF 107
Query: 326 EVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
++L L + H +++RDLKP+N+L+ +G I L+DF L+
Sbjct: 108 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 147
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 44/163 (26%), Positives = 78/163 (47%), Gaps = 15/163 (9%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKAS--LAGRKKLLRAQTEREILQSL 273
S ++ ++ +G G G V + + + A+K + A K+ LR E +IL+
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR---ELKILRHF 61
Query: 274 DHPFLPTLYTHFETE----KFSCLVMEFCPGGDLH-TLRQKQPGKYFPEQAVRFYVAEVL 328
H + + K +VM+ DLH + QP E+ +R+++ ++L
Sbjct: 62 KHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQP---LTEEHIRYFLYQLL 117
Query: 329 LALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371
L+Y+H +I+RDLKP N+LV ED + + DF ++ R S
Sbjct: 118 RGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMA-RGLSS 159
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 47/161 (29%), Positives = 70/161 (43%), Gaps = 23/161 (14%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD--- 274
F L++ +G G G VY T A+KVMD + E EI ++
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----------VTEDEEEEIKLEINMLK 67
Query: 275 ----HPFLPTLYTHFETEKFS------CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYV 324
H + T Y F + LVMEFC G + L + G E + +
Sbjct: 68 KYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYIC 127
Query: 325 AEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
E+L L +LH +I+RD+K +NVL+ E+ + L DF +S
Sbjct: 128 REILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS 168
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-11
Identities = 46/153 (30%), Positives = 73/153 (47%), Gaps = 6/153 (3%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVM--DKASLAGRKKLLRAQTEREILQSLDH 275
+R K LG G G VYL T A+K + D S +K++ + E ++L++L H
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH 63
Query: 276 PFLPTLYTHFETEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQAVRFYVAEVLLALEYL 334
+ Y ++ + ME+ PGG + L+ E R Y ++L +EYL
Sbjct: 64 ERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGA---LTETVTRKYTRQILEGVEYL 120
Query: 335 HMLGIIYRDLKPENVLVREDGHIMLSDFDLSLR 367
H I++RD+K N+L G++ L DF S R
Sbjct: 121 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKR 153
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 4e-11
Identities = 46/150 (30%), Positives = 80/150 (53%), Gaps = 12/150 (8%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREI--LQSL-D 274
+++L ++G G V ++ T Y+A+K M K K L + REI L+ L
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHF----KSLEQVNNLREIQALRRLSP 56
Query: 275 HPFLPTLYTHFETEKFSC--LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALE 332
HP + L K LV E +L+ L + + + PE+ V+ Y+ ++L +L+
Sbjct: 57 HPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRK-RPLPEKRVKSYMYQLLKSLD 114
Query: 333 YLHMLGIIYRDLKPENVLVREDGHIMLSDF 362
++H GI +RD+KPEN+L+++D + L+DF
Sbjct: 115 HMHRNGIFHRDIKPENILIKDD-ILKLADF 143
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 51/179 (28%), Positives = 83/179 (46%), Gaps = 7/179 (3%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF 277
F L+R+G G G VY + TK A+K++D ++ Q E +L D P+
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPY 63
Query: 278 LPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHML 337
+ Y + ++ME+ GG L + P E + + E+L L+YLH
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP---LEETYIATILREILKGLDYLHSE 120
Query: 338 GIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPA 396
I+RD+K NVL+ E G + L+DF ++ + ++ T IK ++ P P Q A
Sbjct: 121 RKIHRDIKAANVLLSEQGDVKLADFGVAGQ--LTDTQIKRNTFVGTPFWMAPEVIKQSA 177
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 5e-11
Identities = 32/93 (34%), Positives = 46/93 (49%), Gaps = 3/93 (3%)
Query: 274 DHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEY 333
D+P LY T K L+M++ GDL L +K+ E V+ + +++ AL
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALND 124
Query: 334 LHMLGIIYRDLKPENVL-VREDGHIMLSDFDLS 365
LH II+ D+K ENVL R I L D+ L
Sbjct: 125 LHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLC 157
|
Length = 267 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 5e-11
Identities = 48/161 (29%), Positives = 72/161 (44%), Gaps = 23/161 (14%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD--- 274
F L++ +G G G VY T A+KVMD + E EI Q ++
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----------VTGDEEEEIKQEINMLK 57
Query: 275 ----HPFLPTLYTHF------ETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYV 324
H + T Y F + LVMEFC G + L + G E+ + +
Sbjct: 58 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYIC 117
Query: 325 AEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
E+L L +LH +I+RD+K +NVL+ E+ + L DF +S
Sbjct: 118 REILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 158
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 50/179 (27%), Positives = 84/179 (46%), Gaps = 7/179 (3%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF 277
F L+R+G G G V+ + T+ A+K++D ++ Q E +L D P+
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPY 63
Query: 278 LPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHML 337
+ Y + ++ME+ GG L + P F E + + E+L L+YLH
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP---FDEFQIATMLKEILKGLDYLHSE 120
Query: 338 GIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPA 396
I+RD+K NVL+ E G + L+DF ++ + ++ T IK ++ P P Q A
Sbjct: 121 KKIHRDIKAANVLLSEQGDVKLADFGVAGQ--LTDTQIKRNTFVGTPFWMAPEVIQQSA 177
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 6e-11
Identities = 45/148 (30%), Positives = 74/148 (50%), Gaps = 4/148 (2%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF 277
+ L++LG G +VY + A+KV+ G A E +L+ L H
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTP--FTAIREASLLKGLKHAN 64
Query: 278 LPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHML 337
+ L+ T++ LV E+ DL K PG PE V+ ++ ++L L Y+H
Sbjct: 65 IVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPEN-VKLFLFQLLRGLSYIHQR 122
Query: 338 GIIYRDLKPENVLVREDGHIMLSDFDLS 365
I++RDLKP+N+L+ + G + L+DF L+
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 7e-11
Identities = 32/102 (31%), Positives = 50/102 (49%), Gaps = 4/102 (3%)
Query: 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLR 512
S GT +++PE+I GEG+G D W+ G + E+L K P+ A +F + QP
Sbjct: 166 SVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN 225
Query: 513 FPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
VS AR+ +R V+ + R + A E+ +H F
Sbjct: 226 PQLPSHVSPDARNFLRRTFVENAKKRPS----AEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 8e-11
Identities = 40/136 (29%), Positives = 59/136 (43%), Gaps = 19/136 (13%)
Query: 447 TEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNV 506
T ++ +FVGT ++APE+IK G+ D W+ GI EL G+ P LF +
Sbjct: 151 TMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLI 210
Query: 507 VGQPLRFP---ESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIR 563
P P E S +D + L K+P+ R + A E+ +H F I+
Sbjct: 211 ---PKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPS----AKELLKHKF--------IK 255
Query: 564 CATPPEIPKPVEIERI 579
A + IERI
Sbjct: 256 KAKKTSYLTLL-IERI 270
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 1e-10
Identities = 40/106 (37%), Positives = 59/106 (55%), Gaps = 11/106 (10%)
Query: 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNR-ATLFNV--VGQ 509
S GT ++APE+I+GE +G A D W+ G + E+ GK P+ GN A L+ + G+
Sbjct: 162 SVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGE 221
Query: 510 PLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRG-ATEIKQHPFF 554
P PE +S A+D +R L ++P+ KR A E+ QHPF
Sbjct: 222 PPEIPEH--LSEEAKDFLRKCLRRDPK-----KRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 34/106 (32%), Positives = 52/106 (49%), Gaps = 13/106 (12%)
Query: 453 SFVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPL 511
SF G+ ++APE+I +G +G A D W+ G + E+ GK P+ A +F +
Sbjct: 160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIG---- 215
Query: 512 RFPESPVV----SFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPF 553
R E P + S A+D I L ++P R A E+ +HPF
Sbjct: 216 RSKELPPIPDHLSDEAKDFILKCLQRDPSLRPT----AAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-10
Identities = 43/136 (31%), Positives = 68/136 (50%), Gaps = 10/136 (7%)
Query: 227 GDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFE 286
G I V L + T+ F +K + K+S R ER + P + L+ +
Sbjct: 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSR--------ERLTIIPHCVPNMVCLHKYIV 55
Query: 287 TEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKP 346
+E LV++ GG L + K PE+ V+ + AE+++AL+ LH GI+ RDL P
Sbjct: 56 SEDSVFLVLQHAEGGKLWSHISKF--LNIPEECVKRWAAEMVVALDALHREGIVCRDLNP 113
Query: 347 ENVLVREDGHIMLSDF 362
N+L+ + GHI L+ F
Sbjct: 114 NNILLDDRGHIQLTYF 129
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 38/136 (27%), Positives = 56/136 (41%), Gaps = 35/136 (25%)
Query: 450 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ 509
R S VGT ++APE+I +G+ VD W+ GI + E++ G+ P+ FN
Sbjct: 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPY---------FNE--P 219
Query: 510 PL------------RFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557
PL + VS R + +LV++P R A E+ HPF
Sbjct: 220 PLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRAT----AAELLNHPF---- 271
Query: 558 NWALIRCATPPEIPKP 573
+ A PP P
Sbjct: 272 ----LAKAGPPSSIVP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 55/183 (30%), Positives = 81/183 (44%), Gaps = 37/183 (20%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTERE------ 268
L +F ++G G G V ++ T A+K MD LR Q RE
Sbjct: 21 LDNF---VKIGEGSTGIVCIATDKSTGRQVAVKKMD----------LRKQQRRELLFNEV 67
Query: 269 -ILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDL-----HTLRQKQPGKYFPEQAVRF 322
I++ HP + +Y+ + +VMEF GG L HT E+ +
Sbjct: 68 VIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMN--------EEQIAT 119
Query: 323 YVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA-VSPTLIKASSLD 381
VL AL +LH G+I+RD+K +++L+ DG + LSDF CA VS + + SL
Sbjct: 120 VCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGF---CAQVSKEVPRRKSLV 176
Query: 382 AEP 384
P
Sbjct: 177 GTP 179
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 48/179 (26%), Positives = 84/179 (46%), Gaps = 7/179 (3%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF 277
F L+++G G G V+ + T+ A+K++D ++ Q E +L D P+
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPY 63
Query: 278 LPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHML 337
+ Y + + ++ME+ GG L + P E + + E+L L+YLH
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHSE 120
Query: 338 GIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPA 396
I+RD+K NVL+ E G + L+DF ++ + ++ T IK ++ P P Q A
Sbjct: 121 KKIHRDIKAANVLLSEHGEVKLADFGVAGQ--LTDTQIKRNTFVGTPFWMAPEVIKQSA 177
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 46/177 (25%), Positives = 82/177 (46%), Gaps = 4/177 (2%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD 274
L++F++ K++G G VY + + A+K + + K E ++L+ L+
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 275 HPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQ--KQPGKYFPEQAVRFYVAEVLLALE 332
HP + F + +V+E GDL + + K+ + PE+ V Y ++ A+E
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 333 YLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNP 389
++H +++RD+KP NV + G + L DL L S A SL P +P
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLG--DLGLGRFFSSKTTAAHSLVGTPYYMSP 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 7e-10
Identities = 41/99 (41%), Positives = 49/99 (49%), Gaps = 13/99 (13%)
Query: 460 YLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKG--SG-NRATLFNVVGQPLRFPES 516
Y APE+ A DWW+ G L+ELL GKT + SG N T N+ PE
Sbjct: 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNI-------PEW 200
Query: 517 PVVSFAARDLIRGLLVKEPQHRL-AYKRGATEIKQHPFF 554
VS AR L++ LL P RL A G +IK HPFF
Sbjct: 201 --VSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 8e-10
Identities = 52/183 (28%), Positives = 85/183 (46%), Gaps = 12/183 (6%)
Query: 224 LGCGDIGSVYLSELSGTKCYFAMK--VMDKAS-LAGRKKLLRAQTEREILQSLDHPFLPT 280
LG G G+VY L+ A+K +D ++ LA K+ + Q E ++L+SL H +
Sbjct: 8 LGKGAYGTVYCG-LTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 281 LYTHFETEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGI 339
+ + MEF PGG + + L + P PE Y ++L + YLH +
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGP---LPEPVFCKYTKQILDGVAYLHNNCV 123
Query: 340 IYRDLKPENVLVREDGHIMLSDFDLSLR-CAVSPTLIKASSLDAEPLRKNPVYCVQPACI 398
++RD+K NV++ +G I L DF + R V ++ L + + P Y + P I
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKS--MHGTP-YWMAPEVI 180
Query: 399 EPS 401
S
Sbjct: 181 NES 183
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 9e-10
Identities = 45/150 (30%), Positives = 65/150 (43%), Gaps = 12/150 (8%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF 277
F L+ +G G G+VY + T A+K M + +K E LQ L HP
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 278 LPTLYTHFETEKFSCLVMEFCPGG-----DLHTLRQKQPGKYFPEQAVRFYVAEVLLALE 332
+ E + LVME+C G ++H K+P E + L L
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASDILEVH----KKP---LQEVEIAAICHGALQGLA 129
Query: 333 YLHMLGIIYRDLKPENVLVREDGHIMLSDF 362
YLH I+RD+K N+L+ E G + L+DF
Sbjct: 130 YLHSHERIHRDIKAGNILLTEPGTVKLADF 159
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 29/99 (29%), Positives = 49/99 (49%), Gaps = 6/99 (6%)
Query: 444 AEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSG-NRAT 502
++ T A S+ VGT Y++PE I G+ D W+ G LYE+ ++PF G N +
Sbjct: 158 SKTTAAHSL--VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS 215
Query: 503 LFNVVGQPLRFPESPVVSFAA--RDLIRGLLVKEPQHRL 539
L + + +P P ++ RDL+ + +P+ R
Sbjct: 216 LCKKIEK-CDYPPLPADHYSEELRDLVSRCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 44/207 (21%)
Query: 224 LGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREI-----LQSLDHPFL 278
+G G G+VY + + + A+K + + L T RE+ L++ DHP +
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALK---SVRVQTNEDGLPLSTVREVALLKRLEAFDHPNI 64
Query: 279 -------PTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLAL 331
T T ET+ LV E DL T K P P + ++ + + L L
Sbjct: 65 VRLMDVCATSRTDRETK--VTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGL 121
Query: 332 EYLHMLGIIYRDLKPENVLVREDGHIMLSDFDL----SLRCAVSPTLIK----------- 376
++LH I++RDLKPEN+LV G + L+DF L S + A++P ++
Sbjct: 122 DFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQ 181
Query: 377 ---ASSLD--------AEPLRKNPVYC 392
A+ +D AE R+ P++C
Sbjct: 182 STYATPVDMWSVGCIFAEMFRRKPLFC 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 47/164 (28%), Positives = 75/164 (45%), Gaps = 19/164 (11%)
Query: 214 GLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMK--VMDKASLAGRKKLLRAQTEREILQ 271
+S + L ++G G G V+ + TK A+K +M+ LR E +ILQ
Sbjct: 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR---EIKILQ 66
Query: 272 SLDHP----------FLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVR 321
L H T Y ++ + LV EFC DL L + K F ++
Sbjct: 67 LLKHENVVNLIEICRTKATPYNRYKGSFY--LVFEFCEH-DLAGLLSNKNVK-FTLSEIK 122
Query: 322 FYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+ +L L Y+H I++RD+K N+L+ +DG + L+DF L+
Sbjct: 123 KVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLA 166
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 39/106 (36%), Positives = 55/106 (51%), Gaps = 4/106 (3%)
Query: 259 KLLRAQTEREI--LQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFP 316
K+++ REI L+ L H L L F +K LV EF L L + G
Sbjct: 41 KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG--LD 98
Query: 317 EQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDF 362
E VR Y+ ++L +E+ H II+RD+KPEN+LV + G + L DF
Sbjct: 99 ESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (143), Expect = 2e-09
Identities = 37/131 (28%), Positives = 50/131 (38%), Gaps = 37/131 (28%)
Query: 457 THE-----YLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSGNRATL---FNVV 507
THE Y APEI+ G H +AVD W+ G E++ GK F G L F ++
Sbjct: 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQIL 215
Query: 508 GQP---------------LRFPESPVVSF---------AARDLIRGLLVKEPQHRLAYKR 543
G P FP+ P DL+ +L P R+
Sbjct: 216 GTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRI---- 271
Query: 544 GATEIKQHPFF 554
A E +HP+F
Sbjct: 272 SAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 45/146 (30%), Positives = 73/146 (50%), Gaps = 6/146 (4%)
Query: 220 LLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLP 279
LK LG G G V+L + G K A+K++ + +++ + E +++ L HP L
Sbjct: 8 FLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAMSEDDFI----EEAKVMMKLSHPNLV 62
Query: 280 TLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGI 339
LY ++ +V E+ G L +++ GK E + ++V A+EYL G
Sbjct: 63 QLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDM-CSDVCEAMEYLESNGF 121
Query: 340 IYRDLKPENVLVREDGHIMLSDFDLS 365
I+RDL N LV ED + +SDF L+
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLA 147
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 43/150 (28%), Positives = 71/150 (47%), Gaps = 5/150 (3%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREI--LQSLDH 275
+ ++++G G G VY T AMK K L ++ + + REI L+ L H
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMK---KIRLESEEEGVPSTAIREISLLKELQH 58
Query: 276 PFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLH 335
P + L E L+ EF L G+Y + V+ Y+ ++L + + H
Sbjct: 59 PNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH 118
Query: 336 MLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+++RDLKP+N+L+ G I L+DF L+
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLA 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 58/189 (30%), Positives = 80/189 (42%), Gaps = 22/189 (11%)
Query: 221 LKRLGCGDIGSVYLSELSGTKCYFAMK----VMDKASLAGRKKLLRAQTEREILQSLDHP 276
L LG G+ GSVY T AMK +D++ E +IL P
Sbjct: 6 LDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIM------ELDILHKAVSP 59
Query: 277 FLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKY-FPEQAVRFYVAEVLLALEYL- 334
++ Y F E + ME+ G L L PE +R V+ L++L
Sbjct: 60 YIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK 119
Query: 335 HMLGIIYRDLKPENVLVREDGHIMLSDFDLS--LRCAVSPTLIKASSLDAEPLR------ 386
II+RD+KP NVLV +G + L DF +S L +++ T I S A P R
Sbjct: 120 EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMA-PERIKSGGP 178
Query: 387 -KNPVYCVQ 394
+NP Y VQ
Sbjct: 179 NQNPTYTVQ 187
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 50/158 (31%), Positives = 80/158 (50%), Gaps = 15/158 (9%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREI--LQS 272
++ F L R+G G G VY + + + A+K K + + + + REI L +
Sbjct: 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALK---KVRMDNERDGIPISSLREITLLLN 62
Query: 273 LDHPFLPTLY-----THFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEV 327
L HP + L H ++ F LVME+C DL +L P F E V+ + ++
Sbjct: 63 LRHPNIVELKEVVVGKHLDS-IF--LVMEYCEQ-DLASLLDNMPTP-FSESQVKCLMLQL 117
Query: 328 LLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
L L+YLH II+RDLK N+L+ + G + ++DF L+
Sbjct: 118 LRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLA 155
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 52/203 (25%), Positives = 84/203 (41%), Gaps = 30/203 (14%)
Query: 224 LGCGDIGSVY--LSELSGTKCYFAMKVMDKASLAGRKKLLRAQ--TEREILQSLDHPFLP 279
LG G+ G V + ++ + A+KV+ +K +R + E EI+ LD+P++
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKN----ENEKSVRDEMMREAEIMHQLDNPYIV 58
Query: 280 TLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGI 339
+ E E LVME GG L+ + + V + +V + ++YL
Sbjct: 59 RMIGVCEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVEL-MHQVSMGMKYLEGKNF 116
Query: 340 IYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIE 399
++RDL NVL+ + +SDF LS + KA S PL+
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLK------------- 163
Query: 400 PSCIQPSCVTPTCFSPRLFSSKS 422
P C + R FSS+S
Sbjct: 164 -------WYAPECINFRKFSSRS 179
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 39/153 (25%), Positives = 69/153 (45%), Gaps = 12/153 (7%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF 277
F+ L++LG G +VY T A+K + + G A E +++ L H
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPS--TAIREISLMKELKHEN 59
Query: 278 LPTLYTHFETEKFSCLVMEFCPGG-----DLHTLRQKQPGKYFPEQAVRFYVAEVLLALE 332
+ L+ TE LV E+ D H +R V+ + ++L +
Sbjct: 60 IVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGA-----LDPNTVKSFTYQLLKGIA 114
Query: 333 YLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+ H +++RDLKP+N+L+ + G + L+DF L+
Sbjct: 115 FCHENRVLHRDLKPQNLLINKRGELKLADFGLA 147
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 45/143 (31%), Positives = 64/143 (44%), Gaps = 4/143 (2%)
Query: 221 LKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPT 280
L +G G G+VY + S T A+K M + +K E + LQ L HP
Sbjct: 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE 85
Query: 281 LYTHFETEKFSCLVMEFCPGGDLHTLR-QKQPGKYFPEQAVRFYVAEVLLALEYLHMLGI 339
+ E + LVME+C G L K+P E + L L YLH +
Sbjct: 86 YKGCYLKEHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAITHGALQGLAYLHSHNM 142
Query: 340 IYRDLKPENVLVREDGHIMLSDF 362
I+RD+K N+L+ E G + L+DF
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADF 165
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 26/159 (16%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKAS---LAGRKKLLRAQTE-------R 267
++ ++++G G G VY K DK + +A +K L + E R
Sbjct: 1 YQKVEKIGEGTYGVVY-------------KARDKLTGEIVALKKIRLETEDEGVPSTAIR 47
Query: 268 EI--LQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVA 325
EI L+ L+HP + L +E LV EF DL P ++ Y+
Sbjct: 48 EISLLKELNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLY 106
Query: 326 EVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDL 364
++L + Y H +++RDLKP+N+L+ +G + L+DF L
Sbjct: 107 QLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGL 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 54/175 (30%), Positives = 76/175 (43%), Gaps = 24/175 (13%)
Query: 223 RLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTERE-------ILQSLDH 275
++G G G V ++ T A+K MD LR Q RE I++ H
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMD----------LRKQQRRELLFNEVVIMRDYHH 78
Query: 276 PFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLH 335
+ +Y + +VMEF GG L + E+ + VL AL YLH
Sbjct: 79 ENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLH 135
Query: 336 MLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA-VSPTLIKASSLDAEPLRKNP 389
G+I+RD+K +++L+ DG I LSDF CA VS + K SL P P
Sbjct: 136 NQGVIHRDIKSDSILLTSDGRIKLSDFGF---CAQVSKEVPKRKSLVGTPYWMAP 187
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 5e-09
Identities = 44/146 (30%), Positives = 65/146 (44%), Gaps = 4/146 (2%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF 277
F L+ +G G G+VY + T A+K M + +K E + LQ + HP
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 278 LPTLYTHFETEKFSCLVMEFCPGGDLHTLR-QKQPGKYFPEQAVRFYVAEVLLALEYLHM 336
+ E + LVME+C G L K+P E + L L YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAITHGALQGLAYLHS 143
Query: 337 LGIIYRDLKPENVLVREDGHIMLSDF 362
+I+RD+K N+L+ E G + L+DF
Sbjct: 144 HNMIHRDIKAGNILLTEPGQVKLADF 169
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 69/301 (22%), Positives = 110/301 (36%), Gaps = 87/301 (28%)
Query: 222 KRLGCGDIGSV---YLSELSGTKCYFAMKVM--DKASLAGRKKLLRAQTEREILQSLDHP 276
LG G+ G+V K A+K++ D A + +LLR E ++Q LD+P
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKT-VAVKILKNDNNDPALKDELLR---EANVMQQLDNP 56
Query: 277 FLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHM 336
++ + E E + LVME G L+ QK K+ E+ + V +V + ++YL
Sbjct: 57 YIVRMIGICEAESW-MLVMELAELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEE 113
Query: 337 LGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPA 396
++RDL NVL+ + +SDF LS KA + P++
Sbjct: 114 TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVK---------- 163
Query: 397 CIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVG 456
P C + FSSKS
Sbjct: 164 ----------WYAPECMNYYKFSSKS---------------------------------- 179
Query: 457 THEYLAPEIIKGEGHGSAVDWWTFGIFLYELL-FGKTPFKG-SGNRATLFNVVGQPLRFP 514
D W+FG+ ++E +G+ P+KG GN T G+ + P
Sbjct: 180 -------------------DVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECP 220
Query: 515 E 515
+
Sbjct: 221 Q 221
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 6e-09
Identities = 35/114 (30%), Positives = 56/114 (49%), Gaps = 13/114 (11%)
Query: 452 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRAT-----LFNV 506
+FVGT Y+APE I+G + D W+ G+ L EL G+ P+ + L +
Sbjct: 157 KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI 216
Query: 507 VGQPLRFPESPVVSFAA--RDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVN 558
V +P P P F+ +D + L+K+P+ R +YK E+ +HPF +
Sbjct: 217 VNEPP--PRLPSGKFSPDFQDFVNLCLIKDPRERPSYK----ELLEHPFIKKYE 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 7e-09
Identities = 39/125 (31%), Positives = 63/125 (50%), Gaps = 18/125 (14%)
Query: 246 MKVMDKASLAGRK----KLLRAQTEREILQSLDHPFL-PTLYTHFETEKFSCLVMEFCPG 300
MK LA R KLL+ E + SL F+ P +F TE G
Sbjct: 44 MKPFSTPVLAKRTYRELKLLK-HLRHENIISLSDIFISPLEDIYFVTELL---------G 93
Query: 301 GDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLS 360
DLH L +P +Q +++++ ++L L+Y+H G+++RDLKP N+L+ E+ + +
Sbjct: 94 TDLHRLLTSRP---LEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKIC 150
Query: 361 DFDLS 365
DF L+
Sbjct: 151 DFGLA 155
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 8e-09
Identities = 49/154 (31%), Positives = 75/154 (48%), Gaps = 18/154 (11%)
Query: 221 LKRLGCGDIGSV--YLSELSGTKCYFAMKVMDK-------ASLAGRKKLLRAQTEREILQ 271
LK++G G GSV + + +G K A+K + + A A R+ L + E +
Sbjct: 20 LKQVGSGAYGSVCSAIDKRTGEKV--AIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVI 77
Query: 272 SLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLAL 331
L F + E + F LVM + + T QK G E V++ V ++L L
Sbjct: 78 GLLDVFTSAVSGD-EFQDFY-LVMPY-----MQTDLQKIMGHPLSEDKVQYLVYQMLCGL 130
Query: 332 EYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+Y+H GII+RDLKP N+ V ED + + DF L+
Sbjct: 131 KYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLA 164
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 8e-09
Identities = 46/156 (29%), Positives = 76/156 (48%), Gaps = 12/156 (7%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHP 276
+ +++ +G G G VY A+K++D S + + E ILQSL +HP
Sbjct: 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEE----IEAEYNILQSLPNHP 79
Query: 277 FLPTLYTHF-ETEKFS----CLVMEFCPGGDLHTLRQK--QPGKYFPEQAVRFYVAEVLL 329
+ Y F + +K LV+E C GG + L + G+ E + + + LL
Sbjct: 80 NVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALL 139
Query: 330 ALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
L++LH II+RD+K N+L+ +G + L DF +S
Sbjct: 140 GLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS 175
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 9e-09
Identities = 45/147 (30%), Positives = 75/147 (51%), Gaps = 8/147 (5%)
Query: 221 LKRLGCGDIGSVY--LSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFL 278
L++LG G +VY +S ++G A+KV+ + G A E +L+ L H +
Sbjct: 10 LEKLGEGSYATVYKGISRINGQ--LVALKVISMKTEEGVP--FTAIREASLLKGLKHANI 65
Query: 279 PTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLG 338
L+ T++ V E+ DL + PG P VR ++ ++L L Y+H
Sbjct: 66 VLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYN-VRLFMFQLLRGLAYIHGQH 123
Query: 339 IIYRDLKPENVLVREDGHIMLSDFDLS 365
I++RDLKP+N+L+ G + L+DF L+
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 9e-09
Identities = 37/105 (35%), Positives = 55/105 (52%), Gaps = 9/105 (8%)
Query: 453 SFVGTHEYLAPEII-KG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSGN-RATLFNVVGQ 509
+F GT +Y+APE+I KG G+G+ D W+ G + E+ GK PF G +A +F VG
Sbjct: 168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK-VGM 226
Query: 510 PLRFPESP-VVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPF 553
PE P +S A++ I +P R + A ++ Q PF
Sbjct: 227 FKIHPEIPESLSAEAKNFILRCFEPDPDKRAS----AHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 9e-09
Identities = 47/161 (29%), Positives = 75/161 (46%), Gaps = 16/161 (9%)
Query: 214 GLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREI-LQS 272
L+ L +G G G VY T A+K M + K R + ++ L+S
Sbjct: 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENK--RILMDLDVVLKS 70
Query: 273 LDHPFLPTLYTHF--ETEKFSCL-VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLL 329
D P++ Y +F +++ F C+ +M C D R + P PE + ++
Sbjct: 71 HDCPYIVKCYGYFITDSDVFICMELMSTC--LDKLLKRIQGP---IPEDILGKMTVAIVK 125
Query: 330 ALEYL---HMLGIIYRDLKPENVLVREDGHIMLSDFDLSLR 367
AL YL H G+I+RD+KP N+L+ G++ L DF +S R
Sbjct: 126 ALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGR 164
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 33/77 (42%), Positives = 43/77 (55%), Gaps = 2/77 (2%)
Query: 295 MEFCPGGDLHTL-RQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRE 353
ME PGG L L R K EQ + FY ++L L+YLH I++RD+K +NVLV
Sbjct: 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNT 143
Query: 354 -DGHIMLSDFDLSLRCA 369
G + +SDF S R A
Sbjct: 144 YSGVVKISDFGTSKRLA 160
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 37/116 (31%), Positives = 56/116 (48%), Gaps = 7/116 (6%)
Query: 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTP-FKGSGNRATLFNVVGQPL 511
S VGT ++APE+I +G+ VD W+ GI + E++ G+ P F S +A P
Sbjct: 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPP 235
Query: 512 RFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIRCATP 567
+ + +S RD + +L +EPQ R A E+ HPF + L C P
Sbjct: 236 KLKNAHKISPVLRDFLERMLTREPQERAT----AQELLDHPFL--LQTGLPECLVP 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 48/171 (28%), Positives = 78/171 (45%), Gaps = 23/171 (13%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSG-----TKCYFAMKVM-DKASLAGRKKLLRAQTERE 268
LS R L+ LG G G VY EL+G + A+K + + A +++ + E E
Sbjct: 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQ---EAE 60
Query: 269 ILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHT-LRQKQP------------GKYF 315
++ L HP + L E+ +C++ E+ GDLH L + P K
Sbjct: 61 LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS 120
Query: 316 PEQAVRFYVA-EVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+ + ++A ++ +EYL ++RDL N LV E + +SDF LS
Sbjct: 121 LDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLS 171
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 44/168 (26%), Positives = 75/168 (44%), Gaps = 28/168 (16%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH 275
S + L+ LGCG G V+ + S A+K K L + + A E +I++ LDH
Sbjct: 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVK---KIVLTDPQSVKHALREIKIIRRLDH 61
Query: 276 PFLPTLY-----------------THFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQ 318
+ +Y T + +V E DL + ++ P E+
Sbjct: 62 DNIVKVYEVLGPSGSDLTEDVGSLTELNS---VYIVQE-YMETDLANVLEQGP---LSEE 114
Query: 319 AVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVR-EDGHIMLSDFDLS 365
R ++ ++L L+Y+H +++RDLKP NV + ED + + DF L+
Sbjct: 115 HARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLA 162
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 44/146 (30%), Positives = 62/146 (42%), Gaps = 4/146 (2%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF 277
F L+ +G G G+VY + A+K M + +K E LQ L HP
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 278 LPTLYTHFETEKFSCLVMEFCPGGDLHTLR-QKQPGKYFPEQAVRFYVAEVLLALEYLHM 336
+ E + LVME+C G L K+P E + L L YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAYLHS 133
Query: 337 LGIIYRDLKPENVLVREDGHIMLSDF 362
+I+RD+K N+L+ E G + L DF
Sbjct: 134 HNMIHRDVKAGNILLSEPGLVKLGDF 159
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 49/165 (29%), Positives = 66/165 (40%), Gaps = 37/165 (22%)
Query: 424 KDRKPKNEIGNQVSPLPEL---IAEPTEARSMSFVGTHEYLAPEIIKGEGHGS-AVDWWT 479
+D KP N N+ L L +A T+ +V T Y APEI+ H + VD W+
Sbjct: 142 RDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWS 201
Query: 480 FGIFLYELLFGKTPFKGSGNRATL---FNVVGQPLR-----------------FPESPVV 519
G + ELL GKT F GS + L N+VG P P+ P
Sbjct: 202 VGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKK 261
Query: 520 SFA---------ARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFE 555
F A DL+ +LV +P R+ A E HP+
Sbjct: 262 DFKEVFSGANPLAIDLLEKMLVLDPDKRIT----AAEALAHPYLA 302
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 38/123 (30%), Positives = 59/123 (47%), Gaps = 13/123 (10%)
Query: 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ-PL 511
S VGT ++APE+I +G+ VD W+ GI + E++ G+ P+ + + P
Sbjct: 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPP 236
Query: 512 RFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIRCATPPEIP 571
R +S VS R + +LV+EP R A E+ QHPF ++ A PP
Sbjct: 237 RVKDSHKVSSVLRGFLDLMLVREPSQRAT----AQELLQHPF--------LKLAGPPSCI 284
Query: 572 KPV 574
P+
Sbjct: 285 VPL 287
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 40/178 (22%), Positives = 67/178 (37%), Gaps = 14/178 (7%)
Query: 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQ---------TERE--IL 270
LG G G V + + T A+K + ++ R T RE I+
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 271 QSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLA 330
+ H + L + F LVM+ DL + ++ E V+ + ++L
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRK--IRLTESQVKCILLQILNG 131
Query: 331 LEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKN 388
L LH ++RDL P N+ + G ++DF L+ R P S + R+
Sbjct: 132 LNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189
|
Length = 335 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 2e-08
Identities = 79/328 (24%), Positives = 127/328 (38%), Gaps = 89/328 (27%)
Query: 210 DGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREI 269
DG L+ + ++K++G G G V+L + T+ +F K + L R+K + E +
Sbjct: 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREK-SQLVIEVNV 65
Query: 270 LQSLDHPFLPTLYTHF--ETEKFSCLVMEFCPGGDLHTLRQ---KQPGKYFPEQAVRFYV 324
++ L H + F + + ++MEFC GDL Q K GK E A+
Sbjct: 66 MRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGK-IEEHAIVDIT 124
Query: 325 AEVLLALEYLHMLG-------IIYRDLKPENVL----VREDGHIMLSDFDLSLRCAVSPT 373
++L AL Y H L +++RDLKP+N+ +R G I
Sbjct: 125 RQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT--------------- 169
Query: 374 LIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCV-TPTCFSPRLF--SSKSKKDRKPKN 430
+A++L+ P+ K + + I + SCV TP +SP L +KS D+
Sbjct: 170 -AQANNLNGRPIAKIGDFGLSKN-IGIESMAHSCVGTPYYWSPELLLHETKSYDDKS--- 224
Query: 431 EIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFG 490
D W G +YEL G
Sbjct: 225 ---------------------------------------------DMWALGCIIYELCSG 239
Query: 491 KTPFKGSGNRATLFNVVGQPLRFPESPV 518
KTPF + N + L + + R P+ P+
Sbjct: 240 KTPFHKANNFSQL---ISELKRGPDLPI 264
|
Length = 1021 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 39/155 (25%), Positives = 72/155 (46%), Gaps = 10/155 (6%)
Query: 216 SHFRLLKRLGCGDIGSVY----LSELSGTKCYFAMKVM-DKASLAGRKKLLRAQTEREIL 270
+ +K LG G G+VY + E K A+KV+ ++ S K++L E ++
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILD---EAYVM 63
Query: 271 QSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLA 330
S+DHP + L + + L+ + P G L + + + + V ++
Sbjct: 64 ASVDHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCV-QIAKG 121
Query: 331 LEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+ YL +++RDL NVLV+ H+ ++DF L+
Sbjct: 122 MSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 36/111 (32%), Positives = 56/111 (50%), Gaps = 3/111 (2%)
Query: 263 AQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRF 322
A E +L++L H + TL+ TE+ LV E+ L G V+
Sbjct: 50 AIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYL--DNCGNLMSMHNVKI 107
Query: 323 YVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 373
++ ++L L Y H I++RDLKP+N+L+ E G + L+DF L+ R PT
Sbjct: 108 FMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLA-RAKSVPT 157
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 30/178 (16%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTERE-------IL 270
+ +++G G G+VY + T A+K M+ L+ Q ++E ++
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN----------LQQQPKKELIINEILVM 70
Query: 271 QSLDHPFLPTLYTHFETEKFSCLVMEFCPGG---DLHTLRQKQPGKYFPEQAVRFYVAEV 327
+ HP + + +VME+ GG D+ T G+ + E
Sbjct: 71 RENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ------IAAVCREC 124
Query: 328 LLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA-VSPTLIKASSLDAEP 384
L ALE+LH +I+RD+K +N+L+ DG + L+DF CA ++P K S++ P
Sbjct: 125 LQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGF---CAQITPEQSKRSTMVGTP 179
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (134), Expect = 3e-08
Identities = 38/116 (32%), Positives = 60/116 (51%), Gaps = 9/116 (7%)
Query: 444 AEPTEARSM--SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTP-FKGSGNR 500
A+ T+ +S S VGT ++APE+IK + +G VD W+ GI E+ G+ P + R
Sbjct: 164 AQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR 223
Query: 501 ATLFNVVGQPL-RFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFE 555
A LF + + + S +D + LVK+P+ R + A E+ QHPF +
Sbjct: 224 A-LFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPS----AEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 47/155 (30%), Positives = 71/155 (45%), Gaps = 9/155 (5%)
Query: 221 LKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPT 280
L +LG G +VY T A+K + G A E +L+ L H + T
Sbjct: 11 LDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAP--CTAIREVSLLKDLKHANIVT 68
Query: 281 LYTHFETEKFSCLVMEFCPGGDLHTLRQ--KQPGKYFPEQAVRFYVAEVLLALEYLHMLG 338
L+ TEK LV E+ L+Q G V+ ++ ++L L Y H
Sbjct: 69 LHDIIHTEKSLTLVFEYLD----KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK 124
Query: 339 IIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 373
+++RDLKP+N+L+ E G + L+DF L+ R PT
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLA-RAKSIPT 158
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 3e-08
Identities = 37/147 (25%), Positives = 65/147 (44%), Gaps = 15/147 (10%)
Query: 221 LKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH--PFL 278
+K L G VYL + +K+ R+K + E ILQ L +
Sbjct: 3 IKLLKGGLTNRVYLLGTKDED--YVLKI-----NPSREKGADREREVAILQLLARKGLPV 55
Query: 279 PTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLG 338
P + E++ +S L+ME+ G L ++ + EQ +AE+L L L +L
Sbjct: 56 PKVLASGESDGWSYLLMEWIEGETL-DEVSEEEKEDIAEQ-----LAELLAKLHQLPLLV 109
Query: 339 IIYRDLKPENVLVREDGHIMLSDFDLS 365
+ + DL P N+LV + + + D++ +
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYA 136
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 30/106 (28%), Positives = 52/106 (49%), Gaps = 11/106 (10%)
Query: 454 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPF---KGSGNRATLFNVVG-- 508
+GT ++APE+++GE +G + D W+ G + E+ K P+ K S + A +F +
Sbjct: 168 LLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT 227
Query: 509 QPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
PE +S RD+ L +P+ R + E+ +HP F
Sbjct: 228 TAPSIPEH--LSPGLRDVTLRCLELQPEDR----PPSRELLKHPVF 267
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 43/158 (27%), Positives = 85/158 (53%), Gaps = 16/158 (10%)
Query: 218 FRLLKRLGCGDIGSVY--LSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-D 274
+ +++ +G G G V+ L++ +G+K A+K++D + + E IL++L D
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKA--AVKILDPIHDIDEE----IEAEYNILKALSD 73
Query: 275 HPFLPTLY-THFETEKFS----CLVMEFCPGGDLHTLRQK--QPGKYFPEQAVRFYVAEV 327
HP + Y +++ + + LV+E C GG + L + + G+ E + + + E
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 328 LLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
L+ L++LH+ I+RD+K N+L+ +G + L DF +S
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS 171
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 50/175 (28%), Positives = 79/175 (45%), Gaps = 24/175 (13%)
Query: 223 RLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTERE-------ILQSLDH 275
++G G G V ++ + A+K+MD LR Q RE I++ H
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMD----------LRKQQRRELLFNEVVIMRDYQH 77
Query: 276 PFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLH 335
+ +Y + + ++MEF GG L + + E+ + VL AL YLH
Sbjct: 78 QNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLH 134
Query: 336 MLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA-VSPTLIKASSLDAEPLRKNP 389
G+I+RD+K +++L+ DG + LSDF CA +S + K SL P P
Sbjct: 135 SQGVIHRDIKSDSILLTLDGRVKLSDFGF---CAQISKDVPKRKSLVGTPYWMAP 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 50/175 (28%), Positives = 76/175 (43%), Gaps = 24/175 (13%)
Query: 223 RLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTERE-------ILQSLDH 275
++G G G V ++ + + A+K MD LR Q RE I++ H
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMD----------LRKQQRRELLFNEVVIMRDYQH 76
Query: 276 PFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLH 335
+ +Y + +VMEF GG L + E+ + VL AL LH
Sbjct: 77 ENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLH 133
Query: 336 MLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA-VSPTLIKASSLDAEPLRKNP 389
G+I+RD+K +++L+ DG + LSDF CA VS + + SL P P
Sbjct: 134 AQGVIHRDIKSDSILLTHDGRVKLSDFGF---CAQVSKEVPRRKSLVGTPYWMAP 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 34/108 (31%), Positives = 57/108 (52%), Gaps = 18/108 (16%)
Query: 267 REI--LQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYF-------PE 317
REI L+ L H + LY ++K LV E+C DL KYF
Sbjct: 48 REICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC-DQDLK--------KYFDSCNGDIDP 98
Query: 318 QAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+ V+ ++ ++L L + H +++RDLKP+N+L+ ++G + L+DF L+
Sbjct: 99 EIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLA 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 44/142 (30%), Positives = 68/142 (47%), Gaps = 4/142 (2%)
Query: 224 LGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYT 283
LG G+ G V+ L K A+K K L K+ + +E IL+ DHP + L
Sbjct: 3 LGKGNFGEVFKGTLK-DKTPVAVKTC-KEDLPQELKI-KFLSEARILKQYDHPNIVKLIG 59
Query: 284 HFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRD 343
+ +VME PGGD + +K+ + +Q V+F + + + YL I+RD
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFAL-DAAAGMAYLESKNCIHRD 118
Query: 344 LKPENVLVREDGHIMLSDFDLS 365
L N LV E+ + +SDF +S
Sbjct: 119 LAARNCLVGENNVLKISDFGMS 140
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 43/173 (24%), Positives = 79/173 (45%), Gaps = 9/173 (5%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF 277
+ L++R+G G G VY + T A+K++ L Q E +++ H
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKII---KLEPGDDFSLIQQEIFMVKECKHCN 67
Query: 278 LPTLYTHFETEKFSCLVMEFCPGGDLHTLRQ-KQPGKYFPEQAVRFYVAEVLLALEYLHM 336
+ + + + + + ME+C GG L + P E + + E L L YLH
Sbjct: 68 IVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGP---LSELQIAYVCRETLQGLAYLHS 124
Query: 337 LGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNP 389
G ++RD+K N+L+ ++G + L+DF ++ + ++ T+ K S P P
Sbjct: 125 KGKMHRDIKGANILLTDNGDVKLADFGVAAK--ITATIAKRKSFIGTPYWMAP 175
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 45/155 (29%), Positives = 73/155 (47%), Gaps = 9/155 (5%)
Query: 221 LKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPT 280
L++LG G +V+ T+ A+K + G A E +L+ L H + T
Sbjct: 11 LEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAP--CTAIREVSLLKDLKHANIVT 68
Query: 281 LYTHFETEKFSCLVMEFCPGGDLHTLRQKQP--GKYFPEQAVRFYVAEVLLALEYLHMLG 338
L+ T+K LV E+ L+Q G V+ ++ ++L L Y H
Sbjct: 69 LHDIVHTDKSLTLVFEYLD----KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK 124
Query: 339 IIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 373
+++RDLKP+N+L+ E G + L+DF L+ R PT
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLA-RAKSVPT 158
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 5e-08
Identities = 30/103 (29%), Positives = 43/103 (41%), Gaps = 38/103 (36%)
Query: 451 SMSFVGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ 509
+ VGT Y+APE++ G+G+ D W+ G+ LYEL
Sbjct: 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------- 187
Query: 510 PLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHP 552
PE +DLIR +L K+P+ R A EI +H
Sbjct: 188 ----PE-------LKDLIRKMLQKDPEKRP----SAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 5e-08
Identities = 32/103 (31%), Positives = 49/103 (47%), Gaps = 7/103 (6%)
Query: 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQP-L 511
S VGT ++APE+I+ G +A D W+ G + ELL G P+ A LF +V
Sbjct: 158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHP 217
Query: 512 RFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
PE +S +D + K+P R A ++ +HP+
Sbjct: 218 PLPEG--ISPELKDFLMQCFQKDPNLRPT----AKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 47/160 (29%), Positives = 68/160 (42%), Gaps = 27/160 (16%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKAS--LAGRKKL-------LRAQTERE 268
F L LG G+ G V KV+ + S + RK + +R Q RE
Sbjct: 3 FEKLGELGAGNGGVV-------------TKVLHRPSGLIMARKLIHLEIKPAIRNQIIRE 49
Query: 269 --ILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAE 326
+L + P++ Y F ++ + ME GG L + +K PE +
Sbjct: 50 LKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPENILGKISIA 107
Query: 327 VLLALEYLH-MLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
VL L YL I++RD+KP N+LV G I L DF +S
Sbjct: 108 VLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 147
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 6e-08
Identities = 45/137 (32%), Positives = 56/137 (40%), Gaps = 34/137 (24%)
Query: 448 EARSMSF-VGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSGNRATL-- 503
E R S V T Y APE++ G VD W G ELL G F G + L
Sbjct: 153 EPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAI 212
Query: 504 -FNVVGQP----------------LRFPES---------PVVSFAARDLIRGLLVKEPQH 537
F +G P + FPES P S A DL++GLLV +P
Sbjct: 213 VFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSK 272
Query: 538 RLAYKRGATEIKQHPFF 554
RL+ A E +HP+F
Sbjct: 273 RLS----AAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 6e-08
Identities = 31/98 (31%), Positives = 46/98 (46%), Gaps = 13/98 (13%)
Query: 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPF-------KGSGNRATLFN 505
+FVGT Y++PE I+G + D W+ GI + EL GK PF G + + +
Sbjct: 161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILD 220
Query: 506 VVGQ-----PLRFPESPVVSFAARDLIRGLLVKEPQHR 538
++ Q P R P S RD + L+K+P R
Sbjct: 221 LLQQIVQEPPPRLPSSD-FPEDLRDFVDACLLKDPTER 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 6e-08
Identities = 34/125 (27%), Positives = 55/125 (44%), Gaps = 6/125 (4%)
Query: 245 AMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE-KFSCLVMEFCPGGDL 303
A+K++ + + R + E + L HP + L E V E+ PG L
Sbjct: 7 AIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTL 66
Query: 304 HTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDG---HIMLS 360
+ G + R + +VL AL H GI++RDLKP+N++V + G H +
Sbjct: 67 REVLAAD-GALPAGETGRL-MLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVL 124
Query: 361 DFDLS 365
DF +
Sbjct: 125 DFGIG 129
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 6e-08
Identities = 45/148 (30%), Positives = 70/148 (47%), Gaps = 12/148 (8%)
Query: 222 KRLGCGDIGSVYLSELSGTKCYFAMK---VMDKASLAGRKKLLRAQTEREILQSLDHPFL 278
+++G G+ G VY L G A+K L ++K L+ E EIL+ DHP +
Sbjct: 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDL--KRKFLQ---EAEILKQYDHPNI 54
Query: 279 PTLYTHFETEKFSCL-VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHML 337
L +K VME PGG L T +K+ + ++ ++ + +EYL
Sbjct: 55 VKL-IGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQM-SLDAAAGMEYLESK 112
Query: 338 GIIYRDLKPENVLVREDGHIMLSDFDLS 365
I+RDL N LV E+ + +SDF +S
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMS 140
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 49/157 (31%), Positives = 78/157 (49%), Gaps = 17/157 (10%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDK---ASLAGRKKLLRAQTEREILQSLD 274
+R LK++G G G+V + T A+K + + + L + RA E +L+ +
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAK----RAYRELRLLKHMK 72
Query: 275 HPFLPTLYTHFETE----KFS--CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVL 328
H + L F + +F LVM F G DL L + + E ++F V ++L
Sbjct: 73 HENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEK---LSEDRIQFLVYQML 128
Query: 329 LALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
L+Y+H GII+RDLKP N+ V ED + + DF L+
Sbjct: 129 KGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 165
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 8e-08
Identities = 42/162 (25%), Positives = 76/162 (46%), Gaps = 18/162 (11%)
Query: 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMD--KASLAGRKKLLRA-QTEREILQSLDHPFL 278
++LG G S Y + T A+K + + + + +++++ A + E ++ L+HP +
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 279 PTLY------THFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALE 332
+ +HF L +E+ GG + L K F E + Y ++L L
Sbjct: 66 IRMLGATCEDSHFN------LFVEWMAGGSVSHLLSKYGA--FKEAVIINYTEQLLRGLS 117
Query: 333 YLHMLGIIYRDLKPENVLVREDGHIM-LSDFDLSLRCAVSPT 373
YLH II+RD+K N+L+ G + ++DF + R A T
Sbjct: 118 YLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT 159
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 8e-08
Identities = 38/125 (30%), Positives = 64/125 (51%), Gaps = 18/125 (14%)
Query: 259 KLLRAQTE---------REI-----LQSLDHPFLPTLY---THFETEKFSCLVMEF-CPG 300
K +R QT RE+ L++ +HP + L+ T T++ + L + F
Sbjct: 33 KRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD 92
Query: 301 GDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLS 360
DL T K P P + ++ + ++L L++LH +++RDLKP+N+LV G I L+
Sbjct: 93 QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLA 152
Query: 361 DFDLS 365
DF L+
Sbjct: 153 DFGLA 157
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 8e-08
Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 2/100 (2%)
Query: 266 EREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVA 325
E +L+ L H + TL+ T+K LV E+ DL G VR ++
Sbjct: 53 EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHN-VRLFLF 110
Query: 326 EVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
++L L Y H +++RDLKP+N+L+ E G + L+DF L+
Sbjct: 111 QLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 54.1 bits (131), Expect = 8e-08
Identities = 51/171 (29%), Positives = 80/171 (46%), Gaps = 37/171 (21%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGR----KKLLRA------- 263
L + +L++LG G G V+ K +D+ + KK+ A
Sbjct: 6 LRKYEILQKLGKGAYGIVW-------------KAIDRRT--KEVVALKKIFDAFRNATDA 50
Query: 264 -QTEREI--LQSL-DHPFLPTLYTHF--ETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPE 317
+T REI LQ L DHP + L E +K LV E+ DLH + + +
Sbjct: 51 QRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRA---NILED 106
Query: 318 QAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRC 368
R+ + ++L AL+Y+H +I+RDLKP N+L+ D + L+DF L+ R
Sbjct: 107 VHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLA-RS 156
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 9e-08
Identities = 42/158 (26%), Positives = 75/158 (47%), Gaps = 13/158 (8%)
Query: 220 LLKRLGCGDIGSVYLSELSGTKCYF--AMKVMDKASLAGRKKLLRAQTEREILQSLDHP- 276
L K LG G+ GSV +L+ A+K M K ++ R ++ +E ++ DHP
Sbjct: 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTM-KIAICTRSEMEDFLSEAVCMKEFDHPN 61
Query: 277 ---FLPTLYTHFETEKFSC--LVMEFCPGGDLHTL----RQKQPGKYFPEQAVRFYVAEV 327
+ E+E + +++ F GDLH+ R +Y P Q + ++ ++
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDI 121
Query: 328 LLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+EYL I+RDL N ++ E+ ++ ++DF LS
Sbjct: 122 ASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 40/150 (26%), Positives = 67/150 (44%), Gaps = 5/150 (3%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH 275
+L ++LG G G V++ +GT A+K + +++ L AQ I++ L H
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGT-TKVAVKTLKPGTMSPEAFLQEAQ----IMKKLRH 60
Query: 276 PFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLH 335
L LY E+ +V E+ G L + GK + A++ + YL
Sbjct: 61 DKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE 120
Query: 336 MLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
I+RDL N+LV E+ ++DF L+
Sbjct: 121 SRNYIHRDLAARNILVGENLVCKIADFGLA 150
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 40/136 (29%), Positives = 68/136 (50%), Gaps = 8/136 (5%)
Query: 254 LAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHT-----LRQ 308
L ++ A++E L + DH + + F+++ L+ME+ GGDL+ L++
Sbjct: 103 LNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKE 162
Query: 309 KQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRC 368
P F E V +++LAL+ +H +++RDLK N+ + G I L DF S +
Sbjct: 163 HLP---FQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219
Query: 369 AVSPTLIKASSLDAEP 384
+ S +L ASS P
Sbjct: 220 SDSVSLDVASSFCGTP 235
|
Length = 478 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 47/151 (31%), Positives = 67/151 (44%), Gaps = 8/151 (5%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH 275
S +K LG G G V+L + +KV KA G E +++ L H
Sbjct: 4 SELTFMKELGSGQFGVVHLGKWRAQ-----IKVAIKAINEGAMSEEDFIEEAKVMMKLSH 58
Query: 276 PFLPTLYTHFETEKFSCLVMEFCPGGDL-HTLRQKQPGKYFPEQAVRFYVAEVLLALEYL 334
P L LY +K +V EF G L + LRQ+Q GK + + +V +EYL
Sbjct: 59 PKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQ-GKLSKDMLLSM-CQDVCEGMEYL 116
Query: 335 HMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
I+RDL N LV G + +SDF ++
Sbjct: 117 ERNSFIHRDLAARNCLVSSTGVVKVSDFGMT 147
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 42/162 (25%), Positives = 71/162 (43%), Gaps = 21/162 (12%)
Query: 220 LLKRLGCGDIGSVY-------LSELSGTKCYFAMK-VMDKASLAGRKKLLRAQTEREILQ 271
L++ LG G G VY + T+ A+K V + AS+ R + L E +++
Sbjct: 10 LIRELGQGSFGMVYEGLAKGVVKGEPETRV--AIKTVNENASMRERIEFLN---EASVMK 64
Query: 272 SLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHT-LRQKQP-----GKYFPEQAVRFY-- 323
+ + L T + + +VME GDL + LR ++P P +F
Sbjct: 65 EFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM 124
Query: 324 VAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
AE+ + YL ++RDL N +V ED + + DF ++
Sbjct: 125 AAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMT 166
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 44/168 (26%), Positives = 69/168 (41%), Gaps = 23/168 (13%)
Query: 211 GVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREI- 269
G L + +L +LG G G VY + T A+K K + K REI
Sbjct: 3 GCSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALK---KILMHNEKDGFPITALREIK 59
Query: 270 -LQSLDHP-FLPTL---YTHFETEKFS--CLVMEFCP------GGDLHTLRQKQPGKYFP 316
L+ L HP +P + + K + M P G L K
Sbjct: 60 ILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVT-PYMDHDLSGLLENPSVK-----LT 113
Query: 317 EQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDL 364
E ++ Y+ ++L + YLH I++RD+K N+L+ G + ++DF L
Sbjct: 114 ESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGL 161
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 46/173 (26%), Positives = 76/173 (43%), Gaps = 31/173 (17%)
Query: 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHP 276
+ L+K LG G G V + + T + + K + KK+L + RE+
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAI-KKITNVFSKKILAKRALREL------- 52
Query: 277 FLPTLYTHFETEK-FSCLV-MEFC-PGG-------------DLHT-LRQKQPGKYFPEQA 319
L HF K +CL M+ PG DLH +R QP +
Sbjct: 53 ---KLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQP---LTDAH 106
Query: 320 VRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 372
+ ++ ++L L+Y+H +++RDLKP N+LV D + + DF L+ + +P
Sbjct: 107 FQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 42/152 (27%), Positives = 74/152 (48%), Gaps = 10/152 (6%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVM-DKASLAGRKKLLRAQTEREILQSL 273
LS + R+G G G+VY T +A+KV+ R+++ R E EIL+ +
Sbjct: 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICR---EIEILRDV 129
Query: 274 DHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEY 333
+HP + + F+ +++EF GG L EQ + ++L + Y
Sbjct: 130 NHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIAD------EQFLADVARQILSGIAY 183
Query: 334 LHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
LH I++RD+KP N+L+ ++ ++DF +S
Sbjct: 184 LHRRHIVHRDIKPSNLLINSAKNVKIADFGVS 215
|
Length = 353 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 31/107 (28%), Positives = 48/107 (44%), Gaps = 9/107 (8%)
Query: 453 SFVGTHEYLAPEIIK-GEGHGSAVDWWTFGIFLYELLFGKTPF-KGSGNRATLFNVVGQP 510
+FVGT ++APE+++ G+ D W+FGI EL G P+ K + + + P
Sbjct: 165 TFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDP 224
Query: 511 LRFPE---SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
S + R +I L K+P R A E+ +H FF
Sbjct: 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPT----AEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 34/87 (39%), Positives = 45/87 (51%), Gaps = 3/87 (3%)
Query: 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVV-GQPL 511
SF GT YLAPE+ + + + D W+ G+ LYELL PFKG R + V+ G+
Sbjct: 230 SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD 289
Query: 512 RFPESPVVSFAARDLIRGLLVKEPQHR 538
FP VS + L+ LL K P R
Sbjct: 290 PFPCP--VSSGMKALLDPLLSKNPALR 314
|
Length = 478 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 42/150 (28%), Positives = 67/150 (44%), Gaps = 8/150 (5%)
Query: 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHP 276
LK LG G G V + G + A+K++ + S++ + + A+ ++ L H
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAK----VMMKLSHE 59
Query: 277 FLPTLYTHFETEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQAVRFYVAEVLLALEYLH 335
L LY ++ +V E+ G L LR+ GK F + +V + YL
Sbjct: 60 KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLE 117
Query: 336 MLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
I+RDL N LV + G + +SDF LS
Sbjct: 118 SKQFIHRDLAARNCLVDDQGCVKVSDFGLS 147
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 38/150 (25%), Positives = 65/150 (43%), Gaps = 4/150 (2%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH 275
F L ++LG G G V+ L + A+K++ L ++ Q E + L+ L H
Sbjct: 6 EEFTLERKLGSGYFGEVW-EGLWKNRVRVAIKILKSDDLLKQQDF---QKEVQALKRLRH 61
Query: 276 PFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLH 335
L +L+ + ++ E G L + G+ P ++ +V + YL
Sbjct: 62 KHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE 121
Query: 336 MLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
I+RDL N+LV ED ++DF L+
Sbjct: 122 EQNSIHRDLAARNILVGEDLVCKVADFGLA 151
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 28/86 (32%), Positives = 40/86 (46%), Gaps = 1/86 (1%)
Query: 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLR 512
+ VGT Y++PE+ +G + D W G LYELL K F + N L + Q
Sbjct: 160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT-NPLNLVVKIVQGNY 218
Query: 513 FPESPVVSFAARDLIRGLLVKEPQHR 538
P V S L+ LL ++P+ R
Sbjct: 219 TPVVSVYSSELISLVHSLLQQDPEKR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 23/58 (39%), Positives = 33/58 (56%), Gaps = 1/58 (1%)
Query: 309 KQPGKYFPEQAVRFYVAEVLLALEYLH-MLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
G PE + ++ ALEYLH L +I+RD+KP NVL+ +G + L DF +S
Sbjct: 94 YDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGIS 151
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 51.3 bits (122), Expect = 6e-07
Identities = 36/116 (31%), Positives = 60/116 (51%), Gaps = 15/116 (12%)
Query: 446 PTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFN 505
P +++ + VGT ++APE++ + +G VD W+ GI E++ G+ P+ L+
Sbjct: 167 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL 226
Query: 506 VV--GQP-LRFPE--SPVVSFAARDLIRGLLVKEPQHRLAYKRG-ATEIKQHPFFE 555
+ G P L+ PE SP+ RD + L + + KRG A E+ QHPF +
Sbjct: 227 IATNGTPELQNPEKLSPIF----RDFLNRCLEMDVE-----KRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 7e-07
Identities = 43/159 (27%), Positives = 72/159 (45%), Gaps = 18/159 (11%)
Query: 217 HFRLLKRLGCGDIGSVYLSELS----GTKCYFAMKVMDKASLAGRKKLLRAQTEREILQS 272
H + +++LG G+ GSV L T A+K K + + L + E EIL+S
Sbjct: 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVK---KLQHSTAEHLRDFEREIEILKS 61
Query: 273 LDHPFLPTLYTHFETEKFSC------LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAE 326
L H + ++ +S LVME+ P G L QK + + + Y ++
Sbjct: 62 LQHDNI----VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLL-LYASQ 116
Query: 327 VLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+ +EYL ++RDL N+LV + + + DF L+
Sbjct: 117 ICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLT 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 8e-07
Identities = 26/66 (39%), Positives = 41/66 (62%), Gaps = 3/66 (4%)
Query: 300 GGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIML 359
G DL+ + + Q ++ V+F + ++L L+Y+H GII+RDLKP NV V ED + +
Sbjct: 103 GADLNNIVKCQK---LSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRI 159
Query: 360 SDFDLS 365
DF L+
Sbjct: 160 LDFGLA 165
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 9e-07
Identities = 43/151 (28%), Positives = 70/151 (46%), Gaps = 8/151 (5%)
Query: 216 SHFRLLKRLGCGDIGSVYL-SELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD 274
S L++ +G G G V+L L K A+K + + +++ + E +++ L
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEKRKV--AIKTIREGAMSEEDFI----EEAQVMMKLS 57
Query: 275 HPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYL 334
HP L LY CLV EF G L + Q GK F ++ + +V + YL
Sbjct: 58 HPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGK-FSQETLLGMCLDVCEGMAYL 116
Query: 335 HMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+I+RDL N LV E+ + +SDF ++
Sbjct: 117 ESSNVIHRDLAARNCLVGENQVVKVSDFGMT 147
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 9e-07
Identities = 44/155 (28%), Positives = 65/155 (41%), Gaps = 8/155 (5%)
Query: 212 VLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQ 271
+ +L +G G+ G V L + G K A+K + S A + L A +
Sbjct: 2 AINSKELKLGATIGKGEFGDVMLGDYRGQKV--AVKCLKDDSTAAQAFLAEASV----MT 55
Query: 272 SLDHPFLPTLYTHFETEKFSCLVMEFCPGGDL-HTLRQKQPGKYFPEQAVRFYVAEVLLA 330
+L HP L L +V E+ G L LR + Q + F + +V
Sbjct: 56 TLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFAL-DVCEG 114
Query: 331 LEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+EYL ++RDL NVLV ED +SDF L+
Sbjct: 115 MEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLA 149
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 9e-07
Identities = 41/148 (27%), Positives = 68/148 (45%), Gaps = 6/148 (4%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF 277
RL +LG G G V++ +GT A+K + ++ L AQ I++ L H
Sbjct: 8 LRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTMMPEAFLQEAQ----IMKKLRHDK 62
Query: 278 LPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHML 337
L LY E +V EF G L ++ GKY + A++ + Y+ +
Sbjct: 63 LVPLYAVVSEEPIY-IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM 121
Query: 338 GIIYRDLKPENVLVREDGHIMLSDFDLS 365
I+RDL+ N+LV ++ ++DF L+
Sbjct: 122 NYIHRDLRAANILVGDNLVCKIADFGLA 149
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 9e-07
Identities = 33/113 (29%), Positives = 57/113 (50%), Gaps = 9/113 (7%)
Query: 446 PTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFN 505
P +++ + VGT ++APE++ + +G VD W+ GI E++ G+ P+ L+
Sbjct: 167 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL 226
Query: 506 VV--GQP-LRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFE 555
+ G P L+ PE +S RD + L + R + A E+ QHPF +
Sbjct: 227 IATNGTPELQNPER--LSAVFRDFLNRCLEMDVDRRGS----AKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 45/168 (26%), Positives = 66/168 (39%), Gaps = 43/168 (25%)
Query: 424 KDRKPKNEIGNQVSPLPELIAEPTEARSMS--------FVGTHEYLAPEIIKG-EGHGSA 474
+D KP+N + N L +A+ ARS +V T Y APE++ G +G+ +
Sbjct: 122 RDLKPENLLINTEGVLK--LADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTP 179
Query: 475 VDWWTFGIFLYELLFGKTPFKGSGNRATLF---NVVGQP----------------LRFPE 515
VD W+ G ELL + F G LF +G P FP+
Sbjct: 180 VDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPK 239
Query: 516 S---------PVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
P S A DL+ +L +P R+ A + HP+F
Sbjct: 240 KAGMPLPKLFPNASPQALDLLSQMLHYDPHKRIT----AEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (122), Expect = 1e-06
Identities = 34/144 (23%), Positives = 52/144 (36%), Gaps = 35/144 (24%)
Query: 445 EPTEARSMS-FVGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSGNRAT 502
+ E ++ +V T Y APE++ A+D W+ G ELL K F G
Sbjct: 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ 215
Query: 503 L---FNVVGQP-----------------LRFPESPVVSFA---------ARDLIRGLLVK 533
L V+G P P+ P + A DL+ +LV
Sbjct: 216 LNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVF 275
Query: 534 EPQHRLAYKRGATEIKQHPFFEGV 557
+P+ R+ A E HP+ +
Sbjct: 276 DPKKRIT----ADEALAHPYLAQL 295
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 35/113 (30%), Positives = 53/113 (46%), Gaps = 21/113 (18%)
Query: 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPF-KGSGNRATLFNVVGQPL 511
++VGT+ Y+APE I GE +G D W+ GI EL G+ P+ + N+ +L PL
Sbjct: 152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM-----PL 206
Query: 512 RF---------PESPVVSFAAR--DLIRGLLVKEPQHRLAYKRGATEIKQHPF 553
+ P PV F+ + I + K+P+ R A + HPF
Sbjct: 207 QLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPA----PENLMDHPF 255
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 32/124 (25%), Positives = 57/124 (45%), Gaps = 15/124 (12%)
Query: 446 PTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFN 505
P +++ + VGT ++APE++ + +G VD W+ GI E++ G+ P+ L+
Sbjct: 167 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL 226
Query: 506 VV--GQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIR 563
+ G P +S RD + L + + R + A E+ QHPF ++
Sbjct: 227 IATNGTP-ELQNPEKLSAIFRDFLNRCLEMDVEKRGS----AKELLQHPF--------LK 273
Query: 564 CATP 567
A P
Sbjct: 274 IAKP 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 33/106 (31%), Positives = 51/106 (48%), Gaps = 5/106 (4%)
Query: 450 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTP-FKGSGNRATLFNVVG 508
R S VGT ++APE+I +G VD W+ GI + E++ G+ P F +A
Sbjct: 172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN 231
Query: 509 QPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
P + VS + + + LLV++P R A E+ +HPF
Sbjct: 232 LPPKLKNLHKVSPSLKGFLDRLLVRDPAQRAT----AAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 43/150 (28%), Positives = 71/150 (47%), Gaps = 7/150 (4%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMD-KASLAGRKKLLRAQTEREILQSLDHP 276
F + LG G+ G V + + A K++ + A R +++R E ++L + P
Sbjct: 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIR---ELQVLHECNSP 63
Query: 277 FLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYL-H 335
++ Y F ++ + ME GG L + ++ K PE+ + VL L YL
Sbjct: 64 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKE--AKRIPEEILGKVSIAVLRGLAYLRE 121
Query: 336 MLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
I++RD+KP N+LV G I L DF +S
Sbjct: 122 KHQIMHRDVKPSNILVNSRGEIKLCDFGVS 151
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 46/160 (28%), Positives = 73/160 (45%), Gaps = 27/160 (16%)
Query: 224 LGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYT 283
LG G G+V ++ FA+KV+D ++ K RAQ E L + D F +
Sbjct: 40 LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKN-RAQAEVCCLLNCD--FFSIVKC 96
Query: 284 HFETEKFS-------------CLVMEFCPGGDLHTLRQK-----QPGKYFPEQAVRFYVA 325
H E F+ LV+++ GDL RQ+ + + F E
Sbjct: 97 H---EDFAKKDPRNPENVLMIALVLDYANAGDL---RQEIKSRAKTNRTFREHEAGLLFI 150
Query: 326 EVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+VLLA+ ++H +I+RD+K N+L+ +G + L DF S
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFS 190
|
Length = 496 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 36/100 (36%), Positives = 47/100 (47%), Gaps = 5/100 (5%)
Query: 455 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFP 514
VGT YL+PEI + + + D W+ G LYEL K PF+G+ N L + Q P
Sbjct: 163 VGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN-NLHQLVLKICQGYFAP 221
Query: 515 ESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
SP S R LI L P+ R + T I + PF
Sbjct: 222 ISPNFSRDLRSLISQLFKVSPRDRPS----ITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 28/95 (29%), Positives = 50/95 (52%), Gaps = 3/95 (3%)
Query: 447 TEARSMSFVGTHEYLAPEII-KGEGHGSAVDWWTFGIFLYELLFGKTPFKG-SGNRATLF 504
++ +FVGT ++APE+I +G+ + + D W+ GI +YE+ G P+ RA +
Sbjct: 154 NSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML 213
Query: 505 NVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRL 539
+P R ++ S R+ + L +EP+ RL
Sbjct: 214 IPKSKPPRLEDNG-YSKLLREFVAACLDEEPKERL 247
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 32/107 (29%), Positives = 50/107 (46%), Gaps = 11/107 (10%)
Query: 450 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLF---NV 506
+SM GT ++APE+I G+G D W+ G ++E+ GK P A +F
Sbjct: 166 KSMH--GTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAH 223
Query: 507 VGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPF 553
G R P+S S AA D + L ++ R + A ++ +H F
Sbjct: 224 RGLMPRLPDS--FSAAAIDFVTSCLTRDQHERPS----ALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 44/150 (29%), Positives = 72/150 (48%), Gaps = 7/150 (4%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMD-KASLAGRKKLLRAQTEREILQSLDHP 276
F + LG G+ G V+ + A K++ + A R +++R E ++L + P
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIR---ELQVLHECNSP 63
Query: 277 FLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYL-H 335
++ Y F ++ + ME GG L + +K G+ PEQ + V+ L YL
Sbjct: 64 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GR-IPEQILGKVSIAVIKGLTYLRE 121
Query: 336 MLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
I++RD+KP N+LV G I L DF +S
Sbjct: 122 KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 151
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 32/100 (32%), Positives = 51/100 (51%), Gaps = 7/100 (7%)
Query: 265 TEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCP--GGDLHTLRQKQPGKYFPEQAVRF 322
TE IL++++HP + L F KF+CL++ P DL+ + + +
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLIL---PRYKTDLYCYLAAK--RNIAICDILA 186
Query: 323 YVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDF 362
VL A++YLH II+RD+K EN+ + G + L DF
Sbjct: 187 IERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDF 226
|
Length = 391 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 24/66 (36%), Positives = 39/66 (59%), Gaps = 3/66 (4%)
Query: 300 GGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIML 359
G DL+ + + Q + V+F + ++L L+Y+H II+RDLKP N+ V ED + +
Sbjct: 105 GADLNNIVKCQK---LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 161
Query: 360 SDFDLS 365
DF L+
Sbjct: 162 LDFGLA 167
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 44/147 (29%), Positives = 65/147 (44%), Gaps = 5/147 (3%)
Query: 219 RLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFL 278
+LL++LG G G V+ + T A+K + K K L E +I++ L HP L
Sbjct: 9 QLLRKLGAGQFGEVWEGLWNNTTP-VAVKTL-KPGTMDPKDFLA---EAQIMKKLRHPKL 63
Query: 279 PTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLG 338
LY E+ +V E G L Q G+ + A+V + YL
Sbjct: 64 IQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN 123
Query: 339 IIYRDLKPENVLVREDGHIMLSDFDLS 365
I+RDL NVLV E+ ++DF L+
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLA 150
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 43/180 (23%), Positives = 76/180 (42%), Gaps = 13/180 (7%)
Query: 219 RLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFL 278
+L+K+LG G G V++ +G A+K + + S++ L E +++ L HP L
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNGHT-KVAIKSLKQGSMSPEAFL----AEANLMKQLQHPRL 63
Query: 279 PTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLG 338
LY E ++ E+ G L + G + A++ + ++
Sbjct: 64 VRLYAVVTQEPIY-IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN 122
Query: 339 IIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACI 398
I+RDL+ N+LV E ++DF L+ LI+ + A K P+ P I
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLA-------RLIEDNEYTAREGAKFPIKWTAPEAI 175
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 40/157 (25%), Positives = 74/157 (47%), Gaps = 16/157 (10%)
Query: 221 LKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREI--LQSLDH-PF 277
L+++G G G VY + T A+K K L ++ + REI LQ L +
Sbjct: 6 LEKIGEGTYGKVYKARDKNTGKLVALK---KTRLEMDEEGIPPTALREISLLQMLSESIY 62
Query: 278 LPTLYTHFETEKFS-----CLVMEFCPGGDLHT---LRQKQPGKYFPEQAVRFYVAEVLL 329
+ L E+ + LV E+ DL + PG+ P + ++ ++ ++L
Sbjct: 63 IVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLK 121
Query: 330 ALEYLHMLGIIYRDLKPENVLVREDGHIM-LSDFDLS 365
+ + H G+++RDLKP+N+LV + ++ ++D L
Sbjct: 122 GVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 38/148 (25%), Positives = 67/148 (45%), Gaps = 6/148 (4%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF 277
+L+K+LG G G V++ +G A+K + +++ L AQ I++ L H
Sbjct: 8 LQLIKKLGNGQFGEVWMGTWNGNT-KVAVKTLKPGTMSPESFLEEAQ----IMKKLRHDK 62
Query: 278 LPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHML 337
L LY E +V E+ G L + G+ + A+V + Y+ +
Sbjct: 63 LVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM 121
Query: 338 GIIYRDLKPENVLVREDGHIMLSDFDLS 365
I+RDL+ N+LV + ++DF L+
Sbjct: 122 NYIHRDLRSANILVGDGLVCKIADFGLA 149
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 50/201 (24%), Positives = 78/201 (38%), Gaps = 32/201 (15%)
Query: 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKL---------LRA 263
L LS R ++ LG G +Y K + + MD A L K L
Sbjct: 2 LPLSAVRFMEELGECAFGKIY-------KGHLYLPGMDHAQLVAIKTLKDINNPQQWGEF 54
Query: 264 QTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHT-LRQKQPG---------- 312
Q E ++ L HP + L E+ C++ E+ GDLH L + P
Sbjct: 55 QQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDED 114
Query: 313 ---KYFPEQAVRFYVA-EVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRC 368
K + ++A ++ +EYL +++DL N+L+ E H+ +SD LS R
Sbjct: 115 GTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLS-RE 173
Query: 369 AVSPTLIKASSLDAEPLRKNP 389
S + P+R P
Sbjct: 174 IYSADYYRVQPKSLLPIRWMP 194
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 30/101 (29%), Positives = 47/101 (46%), Gaps = 11/101 (10%)
Query: 455 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFP 514
+GT Y+APE+ KG + D W+ G LYE+ PF+ + L V Q ++P
Sbjct: 162 IGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR-SMQDLRYKV-QRGKYP 219
Query: 515 ESPVVSFAARDL---IRGLLVKEPQHRLAYKRGATEIKQHP 552
P+ ++DL IR +L +P+ R +I P
Sbjct: 220 --PIPPIYSQDLQNFIRSMLQVKPKLRP----NCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 4e-06
Identities = 35/113 (30%), Positives = 58/113 (51%), Gaps = 13/113 (11%)
Query: 447 TEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNV 506
T A+ + +GT ++APE+I+ G+ + D W+ GI E+ GK P+ +F +
Sbjct: 152 TMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI 211
Query: 507 VGQP---LRFPE--SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
+P L PE SP + D ++ LVK+P+ R + A ++ QHPF
Sbjct: 212 PNKPPPTLSDPEKWSPEFN----DFVKKCLVKDPEERPS----AIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 4e-06
Identities = 30/102 (29%), Positives = 52/102 (50%), Gaps = 7/102 (6%)
Query: 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVV-GQPL 511
+F GT Y++PE +K +G+ S D W+ G LYE+ F+G + + +V G
Sbjct: 164 TFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTP 223
Query: 512 RFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPF 553
PE+ + +++ +L K+P R + A EI ++PF
Sbjct: 224 SLPETYSRQLNS--IMQSMLNKDPSLRPS----AAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 48.6 bits (115), Expect = 4e-06
Identities = 45/160 (28%), Positives = 74/160 (46%), Gaps = 15/160 (9%)
Query: 238 SGTKCYFAMKVMDKASLAGRKKLLRAQTERE-------ILQSLDHPFLPTLYTHFETEKF 290
SGT Y AM V +A R+ L+ Q ++E +++ +P + +
Sbjct: 33 SGT-VYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDE 91
Query: 291 SCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVL 350
+VME+ GG L + + E + E L ALE+LH +I+RD+K +N+L
Sbjct: 92 LWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNIL 148
Query: 351 VREDGHIMLSDFDLSLRCA-VSPTLIKASSLDAEPLRKNP 389
+ DG + L+DF CA ++P K S++ P P
Sbjct: 149 LGMDGSVKLTDFGF---CAQITPEQSKRSTMVGTPYWMAP 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 41/164 (25%), Positives = 61/164 (37%), Gaps = 21/164 (12%)
Query: 220 LLKRLGCGDIGSVYLSELS-----GTKCYFAMKVM-DKASLAGRKKLLRAQTEREILQSL 273
L + LG G G V+L E K A+K + + AS RK R E E+L +
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFER---EAELLTNF 65
Query: 274 DHPFLPTLYTHFETEKFSCLVMEFCPGGDLHT-LR-----------QKQPGKYFPEQAVR 321
H + Y +V E+ GDL+ LR P +
Sbjct: 66 QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125
Query: 322 FYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
++ + YL ++RDL N LV D + + DF +S
Sbjct: 126 QIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMS 169
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 47/151 (31%), Positives = 66/151 (43%), Gaps = 12/151 (7%)
Query: 221 LKR-LGCGDIGSVY---LSELSGTKCYFAMKVMDK-ASLAGRKKLLRAQTEREILQSLDH 275
L R +G G G VY K A+K S + R+K L+ E I++ DH
Sbjct: 10 LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQ---EAYIMRQFDH 66
Query: 276 PFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKY-FPEQAVRFYVAEVLLALEYL 334
P + L TE +VME P G+L + Q KY ++ Y ++ AL YL
Sbjct: 67 PHIVKL-IGVITENPVWIVMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYL 123
Query: 335 HMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
++RD+ NVLV + L DF LS
Sbjct: 124 ESKRFVHRDIAARNVLVSSPDCVKLGDFGLS 154
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 39/148 (26%), Positives = 69/148 (46%), Gaps = 6/148 (4%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF 277
RL +LG G G V++ +GT A+K + +++ L AQ +++ L H
Sbjct: 8 LRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQ----VMKKLRHEK 62
Query: 278 LPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHML 337
L LY E +V E+ G L + + GKY + A++ + Y+ +
Sbjct: 63 LVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 121
Query: 338 GIIYRDLKPENVLVREDGHIMLSDFDLS 365
++RDL+ N+LV E+ ++DF L+
Sbjct: 122 NYVHRDLRAANILVGENLVCKVADFGLA 149
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 5e-06
Identities = 44/165 (26%), Positives = 66/165 (40%), Gaps = 37/165 (22%)
Query: 424 KDRKPKNEIGNQVSPLPEL---IAEPTEARSMSFVGTHEYLAPEIIKGEGHGS-AVDWWT 479
+D KP N N+ L L +A T++ +V T Y APE+I H + VD W+
Sbjct: 142 RDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWS 201
Query: 480 FGIFLYELLFGKTPFKGSGNRATL---FNVVGQPLR-----------------FPES--- 516
G + E+L GK FKG + L V G P + P
Sbjct: 202 VGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKK 261
Query: 517 ------PVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFE 555
P + A +++ +LV + + R+ A E HP+FE
Sbjct: 262 DFRSLLPNANPLAVNVLEKMLVLDAESRIT----AAEALAHPYFE 302
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 41/158 (25%), Positives = 72/158 (45%), Gaps = 8/158 (5%)
Query: 212 VLGLSHFRLLKRLGCGDIGSVY----LSELSGTKCYFAMKVMDKASLAGRKKLLRAQTER 267
+L + + +K LG G G+VY + E K A+K++++ + G K + E
Sbjct: 3 ILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEA 60
Query: 268 EILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEV 327
I+ S+DHP L L + LV + P G L + Q + + ++
Sbjct: 61 LIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDN-IGSQLLLNWCVQI 118
Query: 328 LLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+ YL +++RDL NVLV+ H+ ++DF L+
Sbjct: 119 AKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 43/176 (24%), Positives = 68/176 (38%), Gaps = 29/176 (16%)
Query: 216 SHFRLLKRLGCGDIGSVYLSE---LSGTKCY-------------FAMKVM-DKASLAGRK 258
+++LG G G V+L E L A+KV+ AS R+
Sbjct: 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARE 64
Query: 259 KLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDL-HTLRQKQPGKYFPE 317
L+ E +IL L P + L + C++ME+ GDL L++
Sbjct: 65 DFLK---EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLA 121
Query: 318 QAVRFYVAEVLL--------ALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+ LL + YL L ++RDL N LV ++ I ++DF +S
Sbjct: 122 CNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 6e-06
Identities = 47/165 (28%), Positives = 65/165 (39%), Gaps = 37/165 (22%)
Query: 424 KDRKPKNEIGNQVSPLPEL---IAEPTEARSMSFVGTHEYLAPEIIKGEGH-GSAVDWWT 479
+D KP N N+ L L +A +A +V T Y APE+I H VD W+
Sbjct: 141 RDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWS 200
Query: 480 FGIFLYELLFGKTPFKGS---GNRATLFNVVGQP--------------------LRFPES 516
G + E+L GKT FKG + V G P ++P
Sbjct: 201 VGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRK 260
Query: 517 ------PVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFE 555
P S A DL+ +L + RL ATE +HP+F+
Sbjct: 261 DFSTLFPKASPQAVDLLEKMLELDVDKRLT----ATEALEHPYFD 301
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 6e-06
Identities = 49/195 (25%), Positives = 82/195 (42%), Gaps = 18/195 (9%)
Query: 173 SSDVSDESTCSSFSSSINKPHKANDLRWEAIQAVRARDGVLGLS-HFRLLKRLGCGDIGS 231
D D + + + + D+ E + + D + + +L L G G
Sbjct: 48 LGDSDDVTHATDYDADEESLSPQTDVCQEPCETTSSSDPASVVRMQYNILSSLTPGSEGE 107
Query: 232 VYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFS 291
V++ G + KV+ KA G+ E +IL+++ H + L + +
Sbjct: 108 VFVCTKHGDEQ--RKKVIVKAVTGGKT----PGREIDILKTISHRAIINLIHAYRWKSTV 161
Query: 292 CLVMEF--CPGGDLHT-LRQKQPGKYFPEQAVRFYVAEVLL-ALEYLHMLGIIYRDLKPE 347
C+VM C DL T + + P P + + LL AL YLH GII+RD+K E
Sbjct: 162 CMVMPKYKC---DLFTYVDRSGP---LPLEQA-ITIQRRLLEALAYLHGRGIIHRDVKTE 214
Query: 348 NVLVREDGHIMLSDF 362
N+ + E + +L DF
Sbjct: 215 NIFLDEPENAVLGDF 229
|
Length = 392 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (115), Expect = 7e-06
Identities = 36/145 (24%), Positives = 52/145 (35%), Gaps = 43/145 (29%)
Query: 449 ARSMSFVG---------THEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSG 498
AR + T Y PE++ G G VD W+ G L EL GK F+GS
Sbjct: 147 ARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST 206
Query: 499 NRATL---FNVVGQP----------------LRFPESPVVSF----------AARDLIRG 529
L F + G P L+ + +A DL+
Sbjct: 207 ELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDK 266
Query: 530 LLVKEPQHRLAYKRGATEIKQHPFF 554
LL +P+ R++ A + QH +F
Sbjct: 267 LLTLDPKKRIS----ADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 7e-06
Identities = 43/181 (23%), Positives = 67/181 (37%), Gaps = 31/181 (17%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTK----CYFAMKVMDKASLAGRKKLLRAQT------ 265
H ++LG G G V+L E+ + F V L K+LR
Sbjct: 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARN 64
Query: 266 ----EREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDL------HTLRQKQ----- 310
E +IL L P + L E C++ E+ GDL H L K+
Sbjct: 65 DFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGND 124
Query: 311 ------PGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDL 364
++ ++ ++YL L ++RDL N LV E+ I ++DF +
Sbjct: 125 AVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGM 184
Query: 365 S 365
S
Sbjct: 185 S 185
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 8e-06
Identities = 34/107 (31%), Positives = 47/107 (43%), Gaps = 13/107 (12%)
Query: 456 GTHEYLAPEIIKGEGHGSAV----DWWTFGIFLYELLFGKTPFKGSGNR-ATLFNVVGQP 510
G Y+APE I E + D W+ GI + EL G+ P+ L VV +P
Sbjct: 165 GCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP 224
Query: 511 LRFPESPVVSFAA--RDLIRGLLVKEPQHRLAYKRGATEIKQHPFFE 555
P+ P F+ +D + L K + R Y E+ QHPFFE
Sbjct: 225 S--PQLPAEKFSPEFQDFVNKCLKKNYKERPNY----PELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 9e-06
Identities = 38/111 (34%), Positives = 52/111 (46%), Gaps = 17/111 (15%)
Query: 453 SFVGTHEYLAPEII-----KGEGHGSAVDWWTFGIFLYELLFGKTPFKGS--GNRATLFN 505
S VGT Y++PE I G G A D W+ G+ + E G+ PF G+ A+L
Sbjct: 227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC 286
Query: 506 VV--GQPLRFPESPV-VSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPF 553
+ QP PE+P S R I L +EP R + A ++ QHPF
Sbjct: 287 AICMSQP---PEAPATASREFRHFISCCLQREPAKRWS----AMQLLQHPF 330
|
Length = 353 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 9e-06
Identities = 44/163 (26%), Positives = 76/163 (46%), Gaps = 17/163 (10%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKK--LLRAQTEREILQS 272
+ F ++ ++G G G VY + T A+K K L K+ + A E +IL+
Sbjct: 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALK---KVRLDNEKEGFPITAIREIKILRQ 62
Query: 273 LDHPFLPTLY---------THFETEKFSC-LVMEFCPGGDLHTLRQKQPGKYFPEQAVRF 322
L+H + L F+ +K + LV E+ DL L + +F E ++
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-DHDLMGLLESGL-VHFSEDHIKS 120
Query: 323 YVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
++ ++L L Y H ++RD+K N+L+ G I L+DF L+
Sbjct: 121 FMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLA 163
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 34/114 (29%), Positives = 57/114 (50%), Gaps = 11/114 (9%)
Query: 446 PTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFN 505
P +++ + VGT ++APE++ + +G VD W+ GI E++ G+ P+ L+
Sbjct: 168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL 227
Query: 506 VV--GQP-LRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRG-ATEIKQHPFFE 555
+ G P L+ PE F RD + L + + KRG A E+ QH F +
Sbjct: 228 IATNGTPELQNPEKLSAIF--RDFLNRCLDMDVE-----KRGSAKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 33/116 (28%), Positives = 50/116 (43%), Gaps = 18/116 (15%)
Query: 449 ARSMSFVGTHEYLAPEII---KGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFN 505
A++ G Y+APE I +G+ D W+ GI LYE+ GK P+ + +F+
Sbjct: 163 AKTRD-AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS---VFD 218
Query: 506 -----VVGQPLRFPESPVVSFAAR--DLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
V G P S F+ + I L+K+ R YK + +HPF
Sbjct: 219 QLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKE----LLEHPFI 270
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 21/54 (38%), Positives = 31/54 (57%), Gaps = 1/54 (1%)
Query: 313 KYFPEQAVRFYVAEVLLALEYL-HMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
PE+ + + AL YL L II+RD+KP N+L+ +G+I L DF +S
Sbjct: 102 SVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS 155
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 44/172 (25%), Positives = 72/172 (41%), Gaps = 23/172 (13%)
Query: 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKC-----YFAMKVM-DKASLAGRKKLLRAQTE 266
+ LS R ++ LG G VY L GT A+K + DKA R++
Sbjct: 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMM 61
Query: 267 REILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHT-LRQKQP----GKYFPEQAVR 321
R LQ HP + L E+ ++ +C DLH L + P G ++ V+
Sbjct: 62 RSRLQ---HPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 322 ---------FYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDL 364
V ++ +E+L ++++DL NVLV + ++ +SD L
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGL 170
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 27/93 (29%), Positives = 43/93 (46%), Gaps = 9/93 (9%)
Query: 449 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNV-- 506
A ++ VGT YL+PE+ + + + D W G+ LYE GK PF + A + +
Sbjct: 158 ANTI--VGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR 215
Query: 507 -VGQPLRFPESPVVSFAARDLIRGLLVKEPQHR 538
V P+ S ++ LI L K+ + R
Sbjct: 216 GVFPPVSQMYSQQLA----QLIDQCLTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 2e-05
Identities = 40/140 (28%), Positives = 57/140 (40%), Gaps = 37/140 (26%)
Query: 448 EARSM----SFVGTHEYLAPEII-KGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRAT 502
E RS +V T Y APEI+ + + S VD W G + EL + F GS
Sbjct: 148 EIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ 207
Query: 503 LF---NVVGQP----------------LRFPESPVVSF---------AARDLIRGLLVKE 534
L+ +V+G P RFP+ S A DLI+ +L +
Sbjct: 208 LYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWD 267
Query: 535 PQHRLAYKRGATEIKQHPFF 554
P+ R A++ QHP+F
Sbjct: 268 PKKRPT----ASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 30/114 (26%), Positives = 50/114 (43%), Gaps = 10/114 (8%)
Query: 447 TEARSMSFVGTHEYLAPEII-----KGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRA 501
T + +F+GT ++APE++ K + D W+ GI L EL + P
Sbjct: 156 TLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR 215
Query: 502 TLFNVV-GQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
L ++ +P + S + D ++ LVK+P R A E+ +HPF
Sbjct: 216 VLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPT----AAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 31/95 (32%), Positives = 44/95 (46%), Gaps = 8/95 (8%)
Query: 448 EARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATL---- 503
E++ S VGT Y PEI+K E +G D W FG LY++ + PF S N +L
Sbjct: 167 ESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFY-STNMLSLATKI 225
Query: 504 FNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHR 538
V +PL + S D+I L + + R
Sbjct: 226 VEAVYEPL---PEGMYSEDVTDVITSCLTPDAEAR 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 27/92 (29%), Positives = 47/92 (51%), Gaps = 3/92 (3%)
Query: 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLR 512
+F GT Y+APEI + + + D ++ G+ LYELL K PF G + + R
Sbjct: 204 TFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG--R 261
Query: 513 F-PESPVVSFAARDLIRGLLVKEPQHRLAYKR 543
+ P P +S ++++ LL +P+ R + +
Sbjct: 262 YDPLPPSISPEMQEIVTALLSSDPKRRPSSSK 293
|
Length = 496 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 40/151 (26%), Positives = 65/151 (43%), Gaps = 8/151 (5%)
Query: 219 RLLKRLGCGDIGSVYLSELS--GTKCYF-AMKVM-DKASLAGRKKLLRAQTEREILQSLD 274
+ K +G G+ G V L G K A+K + +S R L TE I+ D
Sbjct: 7 TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFL---TEASIMGQFD 63
Query: 275 HPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYL 334
HP + L + ++ E+ G L ++ GK+ Q V + + ++YL
Sbjct: 64 HPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGM-LRGIASGMKYL 122
Query: 335 HMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+ ++RDL N+LV + +SDF LS
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLS 153
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 55/195 (28%), Positives = 80/195 (41%), Gaps = 29/195 (14%)
Query: 219 RLLKR---LGCGDIGSV----YLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQ 271
R LKR LG G G V Y E T A+K + S G + + E EIL+
Sbjct: 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILR 61
Query: 272 SLDHPFLPTLYTHFETEKFSC---LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVL 328
+L H + Y TE L+MEF P G L + K +Q ++ Y ++
Sbjct: 62 NLYHENI-VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLK-YAVQIC 119
Query: 329 LALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPL--- 385
++YL ++RDL NVLV + + + DF L+ KA D E
Sbjct: 120 KGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT----------KAIETDKEYYTVK 169
Query: 386 --RKNPVYCVQPACI 398
+PV+ P C+
Sbjct: 170 DDLDSPVFWYAPECL 184
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 8/100 (8%)
Query: 266 EREILQSLDHP-FLPTLYTHFETEKFSCLVMEFCPG--GDLHTLRQKQPGKYFPEQAVRF 322
E +L+ L HP L L +CLV+ P DL+T + Q V
Sbjct: 210 EARLLRRLSHPAVLALLDVR-VVGGLTCLVL---PKYRSDLYTYLGARLRPLGLAQ-VTA 264
Query: 323 YVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDF 362
++L A++Y+H GII+RD+K ENVLV I L DF
Sbjct: 265 VARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDF 304
|
Length = 461 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 39/148 (26%), Positives = 68/148 (45%), Gaps = 7/148 (4%)
Query: 219 RLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFL 278
+L+K+LG G G V++ + + KV K G + E ++++L H L
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNNS-----TKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKL 63
Query: 279 PTLYTHFETEKFSCLVMEFCPGGDL-HTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHML 337
LY E+ ++ E+ G L L+ + GK + + F A++ + Y+
Sbjct: 64 VRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDF-SAQIAEGMAYIERK 122
Query: 338 GIIYRDLKPENVLVREDGHIMLSDFDLS 365
I+RDL+ NVLV E ++DF L+
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADFGLA 150
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 19/37 (51%), Positives = 27/37 (72%)
Query: 326 EVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDF 362
+VL L LH +GI++RD+KPEN+LV DG + + DF
Sbjct: 317 QVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDF 353
|
Length = 507 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 17/44 (38%), Positives = 31/44 (70%)
Query: 322 FYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+ + ++L +++LH GII+RDLKP N++V+ D + + DF L+
Sbjct: 122 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 165
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 41/161 (25%), Positives = 70/161 (43%), Gaps = 14/161 (8%)
Query: 218 FRLLKRLGCGDIGSV---YLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD 274
F L + LG G+ GSV L G+ A+K++ KA + + E ++ D
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFD 59
Query: 275 HPFLPTLY---THFETEK---FSCLVMEFCPGGDLHTL----RQKQPGKYFPEQAVRFYV 324
HP + L + +++ F GDLHT R + P Q + ++
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 325 AEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
++ +EYL I+RDL N ++ E+ + ++DF LS
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 37/140 (26%), Positives = 64/140 (45%), Gaps = 9/140 (6%)
Query: 225 GCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTH 284
G ++ SVYL+ + T +++ D + + L Q E + HP + T +T
Sbjct: 9 GFCNLTSVYLARHTPTGTLVTVRITDLEN-CTEEHLKALQNEVVLSHFFRHPNIMTSWTV 67
Query: 285 FETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLL----ALEYLHMLGII 340
F T + ++ F G ++L + YFPE + +L L YLH G I
Sbjct: 68 FTTGSWLWVISPFMAYGSANSLLKT----YFPEGMSEALIGNILFGALRGLNYLHQNGYI 123
Query: 341 YRDLKPENVLVREDGHIMLS 360
+R++K ++L+ DG + LS
Sbjct: 124 HRNIKASHILISGDGLVSLS 143
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 4e-05
Identities = 33/98 (33%), Positives = 50/98 (51%), Gaps = 7/98 (7%)
Query: 293 LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVR 352
+VME+ GG L + + E + E L ALE+LH +I+RD+K +NVL+
Sbjct: 93 VVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLG 149
Query: 353 EDGHIMLSDFDLSLRCA-VSPTLIKASSLDAEPLRKNP 389
DG + L+DF CA ++P K S++ P P
Sbjct: 150 MDGSVKLTDFGF---CAQITPEQSKRSTMVGTPYWMAP 184
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 4e-05
Identities = 42/170 (24%), Positives = 78/170 (45%), Gaps = 10/170 (5%)
Query: 221 LKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPT 280
+++G G G+VY + T A+K M+ ++ ++ E +++ +P +
Sbjct: 24 FEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELII---NEILVMRENKNPNIVN 80
Query: 281 LYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGII 340
+ +VME+ GG L + + E + E L AL++LH +I
Sbjct: 81 YLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQVI 137
Query: 341 YRDLKPENVLVREDGHIMLSDFDLSLRCA-VSPTLIKASSLDAEPLRKNP 389
+RD+K +N+L+ DG + L+DF CA ++P K S++ P P
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGF---CAQITPEQSKRSTMVGTPYWMAP 184
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 42/160 (26%), Positives = 76/160 (47%), Gaps = 12/160 (7%)
Query: 212 VLGLSHFRLLKRLGCGDIGSVY----LSELSGTKCYFAMKVMDKA-SLAGRKKLLRAQTE 266
+L + F+ +K LG G G+VY + E K A+K + +A S K++L E
Sbjct: 3 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL---DE 59
Query: 267 REILQSLDHPFLPTLYTHFETEKFSCLVMEFCP-GGDLHTLRQKQPGKYFPEQAVRFYVA 325
++ S+D+P + L T L+ + P G L +R+ + Q + +
Sbjct: 60 AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCV 116
Query: 326 EVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
++ + YL +++RDL NVLV+ H+ ++DF L+
Sbjct: 117 QIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 4e-05
Identities = 45/155 (29%), Positives = 72/155 (46%), Gaps = 10/155 (6%)
Query: 212 VLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQ 271
+L L L + +G G+ G+V E +G K A+K + K + + L E ++
Sbjct: 2 LLNLQKLTLGEIIGEGEFGAVLQGEYTGQKV--AVKNI-KCDVTAQAFL----EETAVMT 54
Query: 272 SLDHPFLPTLYTHFETEKFSCLVMEFCPGGDL-HTLRQKQPGKYFPEQAVRFYVAEVLLA 330
L H L L +VME G+L + LR + Q ++F + +V
Sbjct: 55 KLHHKNLVRLLGVILHNGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSL-DVAEG 112
Query: 331 LEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+EYL +++RDL N+LV EDG +SDF L+
Sbjct: 113 MEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLA 147
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 49/194 (25%), Positives = 74/194 (38%), Gaps = 34/194 (17%)
Query: 224 LGCGDIGSVYLSELSGT-----KCYFAMKVM-DKASLAGRKKLLRAQTEREILQSLDHPF 277
+G G G V+ + G A+K++ ++AS + R E ++ DHP
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR---EAALMAEFDHPN 69
Query: 278 LPTLYTHFETEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQAVRFYV------------ 324
+ L K CL+ E+ GDL+ LR + P
Sbjct: 70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSP--RAQCSLSHSTSSARKCGLNPLPL 127
Query: 325 ---------AEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375
+V + YL ++RDL N LV E+ + ++DF LS R S
Sbjct: 128 SCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS-RNIYSADYY 186
Query: 376 KASSLDAEPLRKNP 389
KAS DA P+R P
Sbjct: 187 KASENDAIPIRWMP 200
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 44.9 bits (107), Expect = 5e-05
Identities = 26/102 (25%), Positives = 45/102 (44%), Gaps = 7/102 (6%)
Query: 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLR 512
++VGT Y++PE + + D W+ G +YEL PF N+ L + + + +
Sbjct: 169 TYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR-NQLQLASKIKEG-K 226
Query: 513 FPESPVV-SFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPF 553
F P S ++I+ +L +P R E+ Q P
Sbjct: 227 FRRIPYRYSSELNEVIKSMLNVDPDKR----PSTEELLQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 5e-05
Identities = 33/116 (28%), Positives = 48/116 (41%), Gaps = 16/116 (13%)
Query: 447 TEARSMSFVGTHEYLAPEII---KGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATL 503
T A+ SF+GT ++APE+ + G+ D W GI EL + P L
Sbjct: 154 TIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL 213
Query: 504 FNVVGQPLRFPESPVV------SFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPF 553
F + P + S D I+ L K+P+ R AT++ QHPF
Sbjct: 214 FLI---SKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPT----ATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 5e-05
Identities = 43/164 (26%), Positives = 67/164 (40%), Gaps = 39/164 (23%)
Query: 424 KDRKPKNEIGNQVSPLPEL---IAEPTEARSMSFVGTHEYLAPEI-IKGEGHGSAVDWWT 479
+D KP N + N+ L +A + + +V T Y APEI + + + VD W+
Sbjct: 132 RDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWS 191
Query: 480 FGIFLYELLFGKTPFKGSGNRATLFNVV----GQP-------------LRFPES------ 516
G E+L GK F G + F+++ G P LRF +S
Sbjct: 192 AGCIFAEMLEGKPLFPGK-DHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREP 250
Query: 517 -------PVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPF 553
+A DL+ +LV +PQ R++ A E HP+
Sbjct: 251 VPFSEKFKNADPSAIDLLEKMLVFDPQKRIS----AAEALAHPY 290
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 44/164 (26%), Positives = 65/164 (39%), Gaps = 37/164 (22%)
Query: 424 KDRKPKNEIGNQVSPLPEL---IAEPTEARSMSFVGTHEYLAPEIIKGEGH-GSAVDWWT 479
+D KP N N+ L L +A T+ +V T Y APEI+ H VD W+
Sbjct: 144 RDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWS 203
Query: 480 FGIFLYELLFGKTPFKGSGNRATL---FNVVGQP-----------------LRFPESPVV 519
G + ELL G+T F G+ + L +VG P + P +
Sbjct: 204 VGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKM 263
Query: 520 SFA---------ARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
+FA A DL+ +LV + R+ A + H +F
Sbjct: 264 NFANVFIGANPLAVDLLEKMLVLDSDKRIT----AAQALAHAYF 303
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 39/145 (26%), Positives = 64/145 (44%), Gaps = 5/145 (3%)
Query: 222 KRLGCGDIGSVYLSELSGTKCYFAMK-VMDKASLAGRKKLLRAQTEREILQSLDHPFLPT 280
+R+G G+ G V+ L A+K + + K L+ E IL+ HP +
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQ---EARILKQYSHPNIVR 57
Query: 281 LYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGII 340
L ++ +VME GGD T + + + ++ ++ V +EYL I
Sbjct: 58 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQM-VENAAAGMEYLESKHCI 116
Query: 341 YRDLKPENVLVREDGHIMLSDFDLS 365
+RDL N LV E + +SDF +S
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMS 141
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 5e-05
Identities = 44/170 (25%), Positives = 65/170 (38%), Gaps = 38/170 (22%)
Query: 217 HFRLLKR---LGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREI--LQ 271
H R LK+ LG G G V L V K + + ++EI L+
Sbjct: 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILK 61
Query: 272 SLDHPFLPTLYTHFETEKFSC---------LVMEFCPGGDLHTLRQKQPGKYFPEQAVRF 322
+L H + K C L+ME+ P G L Y P+ +
Sbjct: 62 TLYH-------ENIVKYKGCCSEQGGKGLQLIMEYVPLGSLR--------DYLPKHKLN- 105
Query: 323 YVAEVLL-------ALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+A++LL + YLH I+RDL NVL+ D + + DF L+
Sbjct: 106 -LAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLA 154
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 5e-05
Identities = 25/78 (32%), Positives = 42/78 (53%), Gaps = 6/78 (7%)
Query: 293 LVMEFCPGGDLHTL--RQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVL 350
+VME+ DL +L KQP F + V+ + ++L + +LH I++RDLK N+L
Sbjct: 83 MVMEYVEH-DLKSLMETMKQP---FLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLL 138
Query: 351 VREDGHIMLSDFDLSLRC 368
+ G + + DF L+
Sbjct: 139 LNNRGILKICDFGLAREY 156
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 6e-05
Identities = 39/132 (29%), Positives = 51/132 (38%), Gaps = 34/132 (25%)
Query: 454 FVGTHEYLAPEIIKGEGHGS-AVDWWTFGIFLYELLFGKTPFKG---------------- 496
+V T Y APEI+ G + VD W+ G L E+L GK F G
Sbjct: 172 YVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGP 231
Query: 497 ----------SGNRATLFNVVGQPLRFPES---PVVSFAARDLIRGLLVKEPQHRLAYKR 543
S AT+ + + R P P S A DL++ LLV P RL
Sbjct: 232 PSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLT--- 288
Query: 544 GATEIKQHPFFE 555
A E +HP+
Sbjct: 289 -AEEALEHPYVA 299
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 7e-05
Identities = 35/143 (24%), Positives = 64/143 (44%), Gaps = 4/143 (2%)
Query: 223 RLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLY 282
+LG G G VY A+K + + ++ ++ L+ E +++ + HP L L
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLK---EAAVMKEIKHPNLVQLL 68
Query: 283 THFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYR 342
E ++ EF G+L ++ + + + ++ A+EYL I+R
Sbjct: 69 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 128
Query: 343 DLKPENVLVREDGHIMLSDFDLS 365
DL N LV E+ + ++DF LS
Sbjct: 129 DLAARNCLVGENHLVKVADFGLS 151
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 7e-05
Identities = 42/160 (26%), Positives = 69/160 (43%), Gaps = 20/160 (12%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRA-QTERE------ 268
S ++ K +G G+ G V C +K+ K + K L+A TE++
Sbjct: 4 SCIKIEKVIGAGEFGEV---------CSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLS 54
Query: 269 ---ILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVA 325
I+ DHP + L K +V E+ G L +K G++ Q V +
Sbjct: 55 EASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGM-LR 113
Query: 326 EVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+ ++YL +G ++RDL N+LV + +SDF LS
Sbjct: 114 GIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLS 153
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 8e-05
Identities = 40/167 (23%), Positives = 71/167 (42%), Gaps = 23/167 (13%)
Query: 222 KRLGCGDIGSVYLSELSGTKCY----FAMKVMDKASLAGRKKLLRAQT----------ER 267
++LG G G V+L E G + + F++ V + K+LR E
Sbjct: 11 EKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEI 70
Query: 268 EILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQA-------- 319
+I+ L P + L T C++ E+ GDL+ + + E+A
Sbjct: 71 KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYS 130
Query: 320 -VRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+ F ++ ++YL L ++RDL N LV ++ I ++DF +S
Sbjct: 131 TLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 9e-05
Identities = 30/109 (27%), Positives = 51/109 (46%), Gaps = 10/109 (9%)
Query: 451 SMSFVGTHEYLAPEII--KGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG 508
+MS G+ ++APE+I +G+ + VD W+ G + E+ G+ P+ A +F +
Sbjct: 167 NMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGN 226
Query: 509 Q----PLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPF 553
+ P+ S +S A D + P +R A E+ QHPF
Sbjct: 227 KRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPT----ARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 9e-05
Identities = 30/109 (27%), Positives = 51/109 (46%), Gaps = 9/109 (8%)
Query: 447 TEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNV 506
T+ + +FVGT ++APE+I+ + S D W+ GI EL G+ P LF +
Sbjct: 154 TQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI 213
Query: 507 VGQPLRFPESPVVSFAA--RDLIRGLLVKEPQHRLAYKRGATEIKQHPF 553
P + F+ ++ I L K+P +++ A E+ +H F
Sbjct: 214 PKNN---PPTLTGEFSKPFKEFIDACLNKDP----SFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 9e-05
Identities = 42/155 (27%), Positives = 72/155 (46%), Gaps = 17/155 (10%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF 277
++L +G G G VY + T A+K + + ++LL I+++L+H
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELL-------IMKNLNHIN 120
Query: 278 LPTLYTHFETEKFS--------CLVMEFCPGGDLHTLRQ-KQPGKYFPEQAVRFYVAEVL 328
+ L ++ TE F +VMEF P ++ + P V+ Y ++
Sbjct: 121 IIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLC 180
Query: 329 LALEYLHMLGIIYRDLKPENVLVREDGHIM-LSDF 362
AL Y+H I +RDLKP+N+L+ + H + L DF
Sbjct: 181 RALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF 215
|
Length = 440 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 9e-05
Identities = 40/160 (25%), Positives = 64/160 (40%), Gaps = 21/160 (13%)
Query: 224 LGCGDIGSVYLSELSG-----TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFL 278
LG G G V+L+E K A+K + +AS + R+ Q E E+L L H +
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDF---QREAELLTVLQHQHI 69
Query: 279 PTLYTHFETEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQA------------VRFYVA 325
Y + +V E+ GDL+ LR P + +
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 326 EVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
++ + YL L ++RDL N LV + + + DF +S
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMS 169
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 9e-05
Identities = 29/90 (32%), Positives = 44/90 (48%), Gaps = 7/90 (7%)
Query: 424 KDRKPKNEI--GNQVSPLPEL-----IAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVD 476
+D KP+N + N V L + ++E + A +V T Y +PE++ G +G AVD
Sbjct: 124 RDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVD 183
Query: 477 WWTFGIFLYELLFGKTPFKGSGNRATLFNV 506
W+ G L EL G+ F G LF +
Sbjct: 184 MWSVGCILGELSDGQPLFPGESEIDQLFTI 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 27/95 (28%), Positives = 47/95 (49%), Gaps = 7/95 (7%)
Query: 447 TEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNV 506
+++++ + VGT Y++PE+ +G+ + D W G LYEL K F+ A L +
Sbjct: 154 SKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA----ANLPAL 209
Query: 507 VGQPLRFPESPV---VSFAARDLIRGLLVKEPQHR 538
V + + +P+ S R LI +L +P R
Sbjct: 210 VLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 30/97 (30%), Positives = 47/97 (48%), Gaps = 2/97 (2%)
Query: 442 LIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRA 501
L+ P A + ++VGT Y+ PEI + + + D W+ G LYEL K PF+ + +
Sbjct: 149 LLTSPG-AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQ-ANSWK 206
Query: 502 TLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHR 538
L V Q P S+ R LI+ + + P+ R
Sbjct: 207 NLILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSR 243
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 41/167 (24%), Positives = 70/167 (41%), Gaps = 42/167 (25%)
Query: 424 KDRKPKNEIGNQVSPLPELIAEPTEARSM--------SFVGTHEYLAPEIIKG-EGHGSA 474
+D KP+N + N+ L +A+ AR+ + V T Y AP+++ G + ++
Sbjct: 124 RDLKPQNLLINKRGELK--LADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTS 181
Query: 475 VDWWTFGIFLYELLFGKTPFKGSGNRATL---FNVVGQP---------------LRFPES 516
+D W+ G + E++ G+ F G+ N L F ++G P FP
Sbjct: 182 IDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRY 241
Query: 517 PVVSFA---------ARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
P DL+ LL P+ R++ A + QHP+F
Sbjct: 242 PPQDLQQLFPHADPLGIDLLHRLLQLNPELRIS----AHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 35/131 (26%), Positives = 48/131 (36%), Gaps = 37/131 (28%)
Query: 457 THE-----YLAPEIIKGEGHGS-AVDWWTFGIFLYELLFGKTPFKGSGNRATL---FNVV 507
THE Y APEI+ G S VD W+ G E++ + F G L F +
Sbjct: 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTL 216
Query: 508 GQP---------------LRFP-------ESPVVSF--AARDLIRGLLVKEPQHRLAYKR 543
G P FP V + DL+ +LV +P R++ K
Sbjct: 217 GTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKA 276
Query: 544 GATEIKQHPFF 554
QHP+F
Sbjct: 277 AL----QHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 21/72 (29%), Positives = 32/72 (44%), Gaps = 4/72 (5%)
Query: 451 SM--SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPF--KGSGNRATLFNV 506
SM SFVGT Y++PE ++G + D W+ G+ L E+ G+ P + +F
Sbjct: 153 SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGR 212
Query: 507 VGQPLRFPESPV 518
ES
Sbjct: 213 PVSEGEAKESHR 224
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 28/97 (28%), Positives = 49/97 (50%), Gaps = 2/97 (2%)
Query: 266 EREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVA 325
E ++L++L + L F LV E+ L L + G P + VR Y+
Sbjct: 50 ELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGV--PPEKVRSYIY 107
Query: 326 EVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDF 362
+++ A+ + H I++RD+KPEN+L+ + + L DF
Sbjct: 108 QLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 52/189 (27%), Positives = 77/189 (40%), Gaps = 33/189 (17%)
Query: 197 DLRWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGT-----KCYFAMKVMDK 251
D WE L L K LG G G V +E G A+K M K
Sbjct: 4 DPEWE-----------LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVK-MLK 51
Query: 252 ASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEKFSCLVMEFCPGGDLHT-LRQK 309
A K L +E E+++ + H + L E +V+E+ G+L LR +
Sbjct: 52 DD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRAR 110
Query: 310 QP-GKYF-------PEQAVRFY-----VAEVLLALEYLHMLGIIYRDLKPENVLVREDGH 356
+P G+Y PE+ + +V +E+L I+RDL NVLV ED
Sbjct: 111 RPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHV 170
Query: 357 IMLSDFDLS 365
+ ++DF L+
Sbjct: 171 MKIADFGLA 179
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 19/65 (29%), Positives = 38/65 (58%), Gaps = 4/65 (6%)
Query: 302 DLHT-LRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLS 360
DLH +R Q + ++++ ++L L+Y+H +++RDLKP N+L+ + + +
Sbjct: 94 DLHQIIRSSQT---LSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKIC 150
Query: 361 DFDLS 365
DF L+
Sbjct: 151 DFGLA 155
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 46/155 (29%), Positives = 71/155 (45%), Gaps = 10/155 (6%)
Query: 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQS 272
L + +LL+ +G G+ G V L + G K A+K + + A + L E ++
Sbjct: 3 LNMKELKLLQTIGKGEFGDVMLGDYRGNKV--AVKCIKNDATA--QAFL---AEASVMTQ 55
Query: 273 LDHPFLPTLYTHFETEKFSC-LVMEFCPGGDL-HTLRQKQPGKYFPEQAVRFYVAEVLLA 330
L H L L EK +V E+ G L LR + + ++F + +V A
Sbjct: 56 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL-DVCEA 114
Query: 331 LEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+EYL ++RDL NVLV ED +SDF L+
Sbjct: 115 MEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLT 149
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 18/46 (39%), Positives = 32/46 (69%)
Query: 320 VRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
V+ ++ ++L L+YLH GI++RD+KP N+LV + + + DF L+
Sbjct: 105 VKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLA 150
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 48/166 (28%), Positives = 71/166 (42%), Gaps = 20/166 (12%)
Query: 217 HFRLLKR-LGCGDIGSVYLSEL-----SGTKCYFAMKVMDKASLAGRKKLLRAQTEREIL 270
H +LKR LG G G V+L+E K A+K + AS RK R E E+L
Sbjct: 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHR---EAELL 61
Query: 271 QSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPE---------QAV 320
+L H + Y +V E+ GDL+ LR P Q+
Sbjct: 62 TNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQ 121
Query: 321 RFYVAEVLLA-LEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
++A+ + A + YL ++RDL N LV E+ + + DF +S
Sbjct: 122 MLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMS 167
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 41/172 (23%), Positives = 71/172 (41%), Gaps = 24/172 (13%)
Query: 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAM---KVMDKASLAGRKKLLRAQT-------- 265
RL ++LG G G V+L E G + + + L K+LRA
Sbjct: 6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVA-VKMLRADVTKTARNDF 64
Query: 266 --EREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPE----- 317
E +I+ L +P + L ++ C++ E+ GDL+ L Q++ F
Sbjct: 65 LKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIP 124
Query: 318 ----QAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+ + ++ ++YL L ++RDL N LV I ++DF +S
Sbjct: 125 SVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 2e-04
Identities = 37/128 (28%), Positives = 52/128 (40%), Gaps = 31/128 (24%)
Query: 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTP-FKGSGNRATL---FNVVG 508
S V T Y APE++ + + VD W+ G E LF + P F+G+ L F+V+G
Sbjct: 165 SVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAE-LFRRRPLFRGTSEADQLDKIFDVIG 223
Query: 509 QPLR-------------FPESPVVSFA---------ARDLIRGLLVKEPQHRLAYKRGAT 546
P FP SF DL++ +L P R+ A
Sbjct: 224 LPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRI----SAF 279
Query: 547 EIKQHPFF 554
E QHP+F
Sbjct: 280 EALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 31/109 (28%), Positives = 53/109 (48%), Gaps = 9/109 (8%)
Query: 447 TEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNV 506
T+ + +FVGT ++APE+IK + S D W+ GI EL G+ P LF +
Sbjct: 154 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI 213
Query: 507 VGQPLRFPESPVVSFAA--RDLIRGLLVKEPQHRLAYKRGATEIKQHPF 553
P P + +++ ++ + L KEP +++ A E+ +H F
Sbjct: 214 ---PKNNPPTLEGNYSKPLKEFVEACLNKEP----SFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 26/90 (28%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG--QP 510
S VGT Y++PE I G+ D W+ G LYE+ ++PF G++ LF++ +
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF--YGDKMNLFSLCQKIEQ 222
Query: 511 LRFPESPVVSFAA--RDLIRGLLVKEPQHR 538
+P P ++ R+L+ + +P R
Sbjct: 223 CDYPPLPTEHYSEKLRELVSMCIYPDPDQR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 35/134 (26%), Positives = 52/134 (38%), Gaps = 34/134 (25%)
Query: 452 MSFVGTHEYLAPE-IIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSG--NRATLF-NVV 507
+V T Y APE ++ + +A+D W+ G ELL K F G ++ L ++
Sbjct: 166 TEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELL 225
Query: 508 GQP----LRF-------------PESPVVSFAAR---------DLIRGLLVKEPQHRLAY 541
G P L F P +P SFA DL+ +LV +P R+
Sbjct: 226 GSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRIT- 284
Query: 542 KRGATEIKQHPFFE 555
E HP+
Sbjct: 285 ---VEEALAHPYLA 295
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 39/144 (27%), Positives = 58/144 (40%), Gaps = 36/144 (25%)
Query: 445 EPTEARSMSF-VGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSGNRAT 502
EP E++ M+ V T Y APEI+ G H SAVD W+ G ELL + F+
Sbjct: 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ 213
Query: 503 L---FNVVGQP----------------LRFPESPV-----------VSFAARDLIRGLLV 532
L +++G P LR P P + A L+ +LV
Sbjct: 214 LDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLV 273
Query: 533 KEPQHRLAYKRGATEIKQHPFFEG 556
+P R++ A + HP+ +
Sbjct: 274 FDPDKRIS----AADALAHPYLDE 293
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 49/225 (21%), Positives = 90/225 (40%), Gaps = 29/225 (12%)
Query: 139 DGTSSLAKTSGSAKISDRLDYVE-SGKSSICRGSTSSDVSDESTCSSFSSSINKPHKAND 197
D T L S S +D Y + S S+ SD+ +
Sbjct: 5 DTTPPLPPRSYSGGAADEDLYSDISDGDLEYSDDDSASESDDDDDDGLIPT--------- 55
Query: 198 LRWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGR 257
+ +A + V + LG + ++K L G G V+++ G +K+ K +
Sbjct: 56 -KQKAREVVAS----LG---YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---- 103
Query: 258 KKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPE 317
E +LQ+++HP + + + +C+V+ DL+T K+ +
Sbjct: 104 -----TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPID 157
Query: 318 QAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDF 362
QA+ ++L L YLH II+RD+K EN+ + + + + D
Sbjct: 158 QAL-IIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDL 201
|
Length = 357 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 48/165 (29%), Positives = 78/165 (47%), Gaps = 33/165 (20%)
Query: 218 FRLLKRLGCGDIGSV--YLSELSGTKCYFAMK----VMDKASLAGR----KKLLRAQTER 267
+++ + +G G G V + +G K A+K V + S A R KLLR
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKV--AIKKINDVFEHVSDATRILREIKLLRLLRHP 59
Query: 268 EILQSLDHPFLPT-------LYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAV 320
+I++ + H LP +Y FE +ME DLH + K PE
Sbjct: 60 DIVE-IKHIMLPPSRREFKDIYVVFE-------LME----SDLHQV-IKANDDLTPEHH- 105
Query: 321 RFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+F++ ++L AL+Y+H + +RDLKP+N+L D + + DF L+
Sbjct: 106 QFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 150
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 49/166 (29%), Positives = 72/166 (43%), Gaps = 23/166 (13%)
Query: 220 LLKR-LGCGDIGSVYLSE---LSGT--KCYFAMKVMDKASLAGRKKLLRAQTEREILQSL 273
+LKR LG G G V+L+E LS T K A+K + +LA RK Q E E+L +L
Sbjct: 8 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDF---QREAELLTNL 64
Query: 274 DHPFLPTLYTHFETEKFSCLVMEFCPGGDLHT-LRQKQPGKYF-----PEQA-------- 319
H + Y +V E+ GDL+ LR P P QA
Sbjct: 65 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124
Query: 320 VRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+ +++ + YL ++RDL N LV + + + DF +S
Sbjct: 125 MLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 29/116 (25%), Positives = 56/116 (48%), Gaps = 11/116 (9%)
Query: 262 RAQTEREILQSLDHPFLPTLYTHFETEKF------SCLVMEFCPGGDLHTLRQKQPGKYF 315
RA E +++ ++H + +L F +K LVME ++ +
Sbjct: 62 RAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQME-----L 116
Query: 316 PEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371
+ + + + ++L +++LH GII+RDLKP N++V+ D + + DF L+ S
Sbjct: 117 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 30/102 (29%), Positives = 47/102 (46%), Gaps = 7/102 (6%)
Query: 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLR 512
S G+ ++APE++K + D W+ G + E+L GK PF +F +G+
Sbjct: 171 SLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFK-IGENAS 229
Query: 513 FPESPV-VSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPF 553
PE P +S A D + E H + A E+ +HPF
Sbjct: 230 -PEIPSNISSEAIDFLEKTF--EIDHNK--RPTAAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 30/110 (27%), Positives = 45/110 (40%), Gaps = 18/110 (16%)
Query: 455 VGTHEYLAPEIIKGEGHGSAV------DWWTFGIFLYELLFGKTPFKGSGNRATLFN--- 505
+G Y+APE IK G D W+ G+ + E+ G+ P+ A +F
Sbjct: 162 IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE-TYANIFAQLS 220
Query: 506 --VVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPF 553
V G P P S A+D + L K P R Y ++ +HP+
Sbjct: 221 AIVDGDPPTLPSG--YSDDAQDFVAKCLNKIPNRRPTY----AQLLEHPW 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 40/162 (24%), Positives = 58/162 (35%), Gaps = 47/162 (29%)
Query: 449 ARSMS-FVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATL--- 503
A+ M+ V T Y APE++ G + +A+D W G L ELL K G L
Sbjct: 162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLI 221
Query: 504 -----------------------FNVVGQPLRF--PESPVVSFAARDLIRGLLVKEPQHR 538
F + QP + P +S A L+ LL+ +P+ R
Sbjct: 222 IQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKR 281
Query: 539 LAYKRGATEIKQHPFFEGVNWALIRCATPPEIPKPVEIERIP 580
A E + +F+ E P P E E +P
Sbjct: 282 AT----AEEALESSYFK-------------EKPLPCEPEMMP 306
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 37/132 (28%), Positives = 49/132 (37%), Gaps = 34/132 (25%)
Query: 454 FVGTHEYLAPEI-IKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLF---NVVGQ 509
+V T Y APEI + + + A+D W+ G L ELL K FKG L V+G
Sbjct: 169 YVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGT 228
Query: 510 P----LR-------------FPESPVVSFA---------ARDLIRGLLVKEPQHRLAYKR 543
P L P P F A DL+ LL +P R+
Sbjct: 229 PDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRI---- 284
Query: 544 GATEIKQHPFFE 555
E +HP+
Sbjct: 285 SVEEALEHPYLA 296
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 3e-04
Identities = 42/157 (26%), Positives = 65/157 (41%), Gaps = 22/157 (14%)
Query: 225 GCGDIGSVY---LSELSGTKCYFAMKVM--DKASLAGRKKLLRAQTEREI--LQSLDHPF 277
G G G VY K Y A+K DK G + REI L+ L H
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEY-AIKKFKGDKEQYTG----ISQSACREIALLRELKHEN 63
Query: 278 LPTLYTHF--ETEKFSCLVMEFCPGGDLHTL---RQKQPGKYFPEQAVRFYVAEVLLALE 332
+ +L F +K L+ ++ + RQ + P V+ + ++L +
Sbjct: 64 VVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAK-RVSIPPSMVKSLLWQILNGVH 122
Query: 333 YLHMLGIIYRDLKPENVLV----REDGHIMLSDFDLS 365
YLH +++RDLKP N+LV E G + + D L+
Sbjct: 123 YLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 30/110 (27%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 262 RAQTEREILQSLDHPFLPTLYTHFETEK----FS--CLVMEFCPGGDLHTLRQKQPGKYF 315
RA E +L+ ++H + +L F +K F LVME + +
Sbjct: 66 RAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHME-----L 120
Query: 316 PEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+ + + + ++L +++LH GII+RDLKP N++V+ D + + DF L+
Sbjct: 121 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 170
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 38/144 (26%), Positives = 56/144 (38%), Gaps = 37/144 (25%)
Query: 443 IAEPTEARSMSFVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSGNRA 501
+ + +V T Y APE++ G+ +G VD W G + ELL G+ F G +
Sbjct: 150 LRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID 209
Query: 502 TLF---NVVGQPL-----------------RFPESPV-----------VSFAARDLIRGL 530
L+ +G PL FPE VS A D ++
Sbjct: 210 QLYLIQKCLG-PLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKAC 268
Query: 531 LVKEPQHRLAYKRGATEIKQHPFF 554
L +P+ RL E+ QHP+F
Sbjct: 269 LRMDPKERLT----CDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 40/150 (26%), Positives = 72/150 (48%), Gaps = 11/150 (7%)
Query: 221 LKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREI--LQSLDHPFL 278
++++G G G VY + T A+K K L + + + REI L+ + H +
Sbjct: 7 VEKIGEGTYGVVYKARDRVTNETIALK---KIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 279 PTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPE--QAVRFYVAEVLLALEYLHM 336
L +EK LV E+ DL + F + + ++ Y+ ++L + Y H
Sbjct: 64 VRLQDVVHSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS 120
Query: 337 LGIIYRDLKPENVLV-REDGHIMLSDFDLS 365
+++RDLKP+N+L+ R + L+DF L+
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLA 150
|
Length = 294 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 18/54 (33%), Positives = 29/54 (53%)
Query: 445 EPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSG 498
E + + +F GT Y+APE I+G+ + D W+ G+ L E+ + PF G
Sbjct: 154 ELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEG 207
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 18/54 (33%), Positives = 34/54 (62%)
Query: 318 QAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371
+ + + + ++L +++LH GII+RDLKP N++V+ D + + DF L+ S
Sbjct: 126 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 37/149 (24%), Positives = 67/149 (44%), Gaps = 8/149 (5%)
Query: 218 FRLLKRLGCGDIGSVYLSELSG-TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHP 276
+L K+LG G G V+++ + TK A+K M S++ L E ++++L H
Sbjct: 8 LKLEKKLGAGQFGEVWMATYNKHTKV--AVKTMKPGSMSVEAFL----AEANVMKTLQHD 61
Query: 277 FLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHM 336
L L+ E ++ EF G L + G P + + A++ + ++
Sbjct: 62 KLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 120
Query: 337 LGIIYRDLKPENVLVREDGHIMLSDFDLS 365
I+RDL+ N+LV ++DF L+
Sbjct: 121 RNYIHRDLRAANILVSASLVCKIADFGLA 149
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 6e-04
Identities = 30/109 (27%), Positives = 50/109 (45%), Gaps = 9/109 (8%)
Query: 447 TEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNV 506
T+ + +FVGT ++APE+IK + D W+ GI EL G+ P LF +
Sbjct: 154 TQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI 213
Query: 507 VGQPLRFPESPVVSFAA--RDLIRGLLVKEPQHRLAYKRGATEIKQHPF 553
P P + ++ ++ + L K+P+ R A E+ +H F
Sbjct: 214 ---PKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPT----AKELLKHKF 255
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 6e-04
Identities = 27/110 (24%), Positives = 53/110 (48%), Gaps = 9/110 (8%)
Query: 261 LRAQTEREILQSLDHPFLPTLY-----THFETEKFSCLVMEFCPGGDLHTLRQKQPGKYF 315
R E +IL+ H + + FE+ +V E DL+ L + Q
Sbjct: 48 QRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQH---L 103
Query: 316 PEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+++++ ++L L+Y+H +++RDLKP N+L+ + + + DF L+
Sbjct: 104 SNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLA 153
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 7e-04
Identities = 27/87 (31%), Positives = 45/87 (51%), Gaps = 7/87 (8%)
Query: 455 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLR-- 512
+GT YL+PEI + + + D W G LYE+ K F+ +GN + N+V + +R
Sbjct: 162 IGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE-AGN---MKNLVLKIIRGS 217
Query: 513 FPESPV-VSFAARDLIRGLLVKEPQHR 538
+P S+ R+L+ L + P+ R
Sbjct: 218 YPPVSSHYSYDLRNLVSQLFKRNPRDR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|222435 pfam13885, Keratin_B2_2, Keratin, high sulfur B2 protein | Back alignment and domain information |
|---|
Score = 37.4 bits (87), Expect = 7e-04
Identities = 14/24 (58%), Positives = 17/24 (70%)
Query: 392 CVQPACIEPSCIQPSCVTPTCFSP 415
C QP+C +PSC QPSC P+C P
Sbjct: 6 CCQPSCCQPSCCQPSCCQPSCCQP 29
|
Length = 45 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 7e-04
Identities = 37/158 (23%), Positives = 70/158 (44%), Gaps = 8/158 (5%)
Query: 212 VLGLSHFRLLKRLGCGDIGSV----YLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTER 267
+L + R LK LG G G+V ++ E K A+K + S GR+
Sbjct: 3 ILKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHM 60
Query: 268 EILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEV 327
+ SLDH ++ L LV + P G L ++ P++ + + V ++
Sbjct: 61 LAMGSLDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCV-QI 118
Query: 328 LLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+ YL +++R+L N+L++ D + ++DF ++
Sbjct: 119 AKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVA 156
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 8e-04
Identities = 35/115 (30%), Positives = 49/115 (42%), Gaps = 14/115 (12%)
Query: 447 TEARSMSFVGTHEYLAPEIIKGEGHGSAV-----DWWTFGIFLYELLFGKTPFKGSGNRA 501
T R +F+GT ++APE+I + A D W+ GI EL GK P
Sbjct: 166 TLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR 225
Query: 502 TLFNVVGQP---LRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPF 553
LF + P L+ PE+ F D I L+K + R E+ +HPF
Sbjct: 226 ALFKIPRNPPPTLKSPENWSKKF--NDFISECLIKNYEQRPF----MEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 8e-04
Identities = 33/109 (30%), Positives = 49/109 (44%), Gaps = 17/109 (15%)
Query: 453 SFVGTHEYLAPEIIKG--EGH-GSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ 509
SFVGT ++APE+I EG VD W+ GI EL K P + L+++
Sbjct: 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN 229
Query: 510 PLRFPESPVV-----SFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPF 553
+SP + S R+ + L K PQ R + + E+ +H F
Sbjct: 230 -----DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPS----SEELLKHRF 269
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 8e-04
Identities = 33/131 (25%), Positives = 49/131 (37%), Gaps = 35/131 (26%)
Query: 455 VGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSGNRATL---FNVVGQP 510
V T Y APE++ G +A+D W+ G ELL K F G L F ++G P
Sbjct: 167 VVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTP 226
Query: 511 ----------------LRFPESPVVSFAAR-----------DLIRGLLVKEPQHRLAYKR 543
F + P + DL+ LL +P R++
Sbjct: 227 TEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRIS--- 283
Query: 544 GATEIKQHPFF 554
A + +HP+F
Sbjct: 284 -AEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 0.001
Identities = 30/122 (24%), Positives = 43/122 (35%), Gaps = 31/122 (25%)
Query: 460 YLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSGN---RATLFNVVGQP----- 510
Y APE++ G H G VD W+ G ELL G + +F +G P
Sbjct: 168 YRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENW 227
Query: 511 ---------LRFPESPVVSFAAR---------DLIRGLLVKEPQHRLAYKRGATEIKQHP 552
+ F P DL++ LL P R+ A + +HP
Sbjct: 228 PGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRIT----ARQALEHP 283
Query: 553 FF 554
+F
Sbjct: 284 YF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.001
Identities = 40/175 (22%), Positives = 66/175 (37%), Gaps = 48/175 (27%)
Query: 424 KDRKPKNEIGNQVSPLPELIAEPTEARSMS------------FVGTHEYLAPEII-KGEG 470
+D KP N + N+ L I + AR +S +V T Y APE++
Sbjct: 131 RDLKPSNLLVNEDCELR--IGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPE 188
Query: 471 HGSAVDWWTFGIFLYELLFGKTPFKGS---GNRATLFNVVGQP------------LR--- 512
+ +A+D W+ G E+L + F G + +V+G P +R
Sbjct: 189 YTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYI 248
Query: 513 --FPESPVVSFA---------ARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556
P V ++ A DL+ +L +P+ R+ + QHPF
Sbjct: 249 QNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERIT----VEQALQHPFLAQ 299
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.001
Identities = 38/142 (26%), Positives = 59/142 (41%), Gaps = 35/142 (24%)
Query: 443 IAEPTEARSMSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGS---- 497
+A P E + +V T Y APE++ G+ +G AVD W G + E+L G+ F G
Sbjct: 150 LAAPGEVYT-DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID 208
Query: 498 ---------GN----RATLF--NVVGQPLRFPES----------PVVSFAARDLIRGLLV 532
GN +F N + +R PE P +S DL + L
Sbjct: 209 QLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLR 268
Query: 533 KEPQHRLAYKRGATEIKQHPFF 554
+P R + ++++ H FF
Sbjct: 269 IDPDDRPS----SSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.001
Identities = 31/111 (27%), Positives = 45/111 (40%), Gaps = 11/111 (9%)
Query: 449 ARSMSFVGTHEYLAPEIIKGEGHGSA----VDWWTFGIFLYELLFGKTPFKGSGNRATLF 504
A++ S G Y+APE I D W+ GI L EL G+ P+K +
Sbjct: 170 AKTRS-AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVL 228
Query: 505 NVVGQ--PLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPF 553
+ Q P P + S + L K+ + R Y+ E+ QHPF
Sbjct: 229 TKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYR----ELLQHPF 275
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 40/129 (31%), Positives = 52/129 (40%), Gaps = 7/129 (5%)
Query: 424 KDRKPKNEIGNQVSPLPEL---IAEPTEARSMSFVGTHEYLAPEIIKGEGH-GSAVDWWT 479
+D KP N N+ L L +A + +V T Y APEI+ H VD W+
Sbjct: 142 RDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWS 201
Query: 480 FGIFLYELLFGKTPFKGS---GNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQ 536
G + ELL GK F G+ + VVG P + S AR I+ L Q
Sbjct: 202 VGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQ 261
Query: 537 HRLAYKRGA 545
RGA
Sbjct: 262 DLKKIFRGA 270
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|222435 pfam13885, Keratin_B2_2, Keratin, high sulfur B2 protein | Back alignment and domain information |
|---|
Score = 36.6 bits (85), Expect = 0.001
Identities = 14/24 (58%), Positives = 17/24 (70%)
Query: 392 CVQPACIEPSCIQPSCVTPTCFSP 415
C QP+C +PSC QPSC P+C P
Sbjct: 1 CCQPSCCQPSCCQPSCCQPSCCQP 24
|
Length = 45 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 38/167 (22%), Positives = 81/167 (48%), Gaps = 17/167 (10%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAG----RKKLLRAQTEREIL 270
+ + +++ +G G +G VYL+ A+K + + L+ +K+ LR E +I
Sbjct: 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIRE-DLSENPLLKKRFLR---EAKIA 56
Query: 271 QSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTL----RQKQ--PGKYFPEQAVRFYV 324
L HP + +Y+ M + G L +L QK+ + + +V ++
Sbjct: 57 ADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFL 116
Query: 325 A---EVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRC 368
+ ++ +EY+H G+++RDLKP+N+L+ G +++ D+ ++
Sbjct: 117 SIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFK 163
|
Length = 932 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 18/44 (40%), Positives = 25/44 (56%)
Query: 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKG 496
S VGT Y++PE I G+ D W+ G LYE+ ++PF G
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.002
Identities = 31/138 (22%), Positives = 48/138 (34%), Gaps = 33/138 (23%)
Query: 446 PTEARSMSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATL- 503
+ + V T Y PE++ GE + +AVD W G E+ + +G + L
Sbjct: 178 GGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLH 237
Query: 504 --FNVVGQPLR--------FPESPVVSFAAR-----------------DLIRGLLVKEPQ 536
F + G P P V DL+ LL +P
Sbjct: 238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPY 297
Query: 537 HRLAYKRGATEIKQHPFF 554
RL A++ +HP+F
Sbjct: 298 KRLT----ASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 17/41 (41%), Positives = 25/41 (60%)
Query: 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTP 493
SFVGT Y++PE ++G + D W+ G+ L EL G+ P
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 35/131 (26%), Positives = 53/131 (40%), Gaps = 36/131 (27%)
Query: 457 THE-----YLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSGNRATL---FNVV 507
THE Y APE++ G H + VD W+ G E+ + F G L F ++
Sbjct: 169 THEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLL 228
Query: 508 GQP----------LR----FPE---------SPVVSFAARDLIRGLLVKEPQHRLAYKRG 544
G P LR FP+ P +S DL++ +L +P R++
Sbjct: 229 GTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRIS---- 284
Query: 545 ATEIKQHPFFE 555
A HP+F+
Sbjct: 285 AKAALTHPYFD 295
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 36/140 (25%), Positives = 56/140 (40%), Gaps = 44/140 (31%)
Query: 454 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGN---RATLFNVVGQP 510
+V T Y APE+I G G+ VD W+ G + EL+ G F+G+ + + +G P
Sbjct: 182 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTP 241
Query: 511 -LRF---------------PESPVVSFA---------------------ARDLIRGLLVK 533
F P+ P +SF ARDL+ +LV
Sbjct: 242 SAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVI 301
Query: 534 EPQHRLAYKRGATEIKQHPF 553
+P R++ E +HP+
Sbjct: 302 DPDKRISVD----EALRHPY 317
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|222435 pfam13885, Keratin_B2_2, Keratin, high sulfur B2 protein | Back alignment and domain information |
|---|
Score = 36.2 bits (84), Expect = 0.002
Identities = 14/24 (58%), Positives = 17/24 (70%)
Query: 392 CVQPACIEPSCIQPSCVTPTCFSP 415
C QP+C +PSC QPSC P+C P
Sbjct: 21 CCQPSCCQPSCCQPSCCVPSCCQP 44
|
Length = 45 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 44/148 (29%), Positives = 67/148 (45%), Gaps = 5/148 (3%)
Query: 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHP-FLPT 280
K +G G G V L E++ + V + A ++ ++ E + +SL H L
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 281 LYTHFETEKFSCLVMEFCPGGDLHT-LR-QKQPGKYFPEQAVRFYVA-EVLLALEYLHML 337
L E + LVMEFCP GDL LR ++ P+ +A E+ L L +LH
Sbjct: 61 LGQCTEVTPY-LLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN 119
Query: 338 GIIYRDLKPENVLVREDGHIMLSDFDLS 365
I+ DL N L+ D + + D+ LS
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 38/159 (23%), Positives = 73/159 (45%), Gaps = 10/159 (6%)
Query: 212 VLGLSHFRLLKRLGCGDIGSVY----LSELSGTKCYFAMKVM-DKASLAGRKKLLRAQTE 266
+L + + +K LG G G+VY + + K A+KV+ + S K++L E
Sbjct: 3 ILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEIL---DE 59
Query: 267 REILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAE 326
++ + P++ L T LV + P G L ++ + Q + + +
Sbjct: 60 AYVMAGVGSPYVCRLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDR-IGSQDLLNWCVQ 117
Query: 327 VLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+ + YL + +++RDL NVLV+ H+ ++DF L+
Sbjct: 118 IAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|216535 pfam01500, Keratin_B2, Keratin, high sulfur B2 protein | Back alignment and domain information |
|---|
Score = 39.0 bits (90), Expect = 0.002
Identities = 13/30 (43%), Positives = 16/30 (53%)
Query: 392 CVQPACIEPSCIQPSCVTPTCFSPRLFSSK 421
C QP C + SC +PSC +C P F S
Sbjct: 24 CCQPCCCQSSCCRPSCCQTSCCQPTTFQSS 53
|
High sulfur proteins are cysteine-rich proteins synthesised during the differentiation of hair matrix cells, and form hair fibres in association with hair keratin intermediate filaments. This family has been divided up into four regions, with the second region containing 8 copies of a short repeat. This family is also known as B2 or KAP1. Length = 161 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.003
Identities = 37/132 (28%), Positives = 50/132 (37%), Gaps = 37/132 (28%)
Query: 457 THE-----YLAPEIIKGEGHGSA-VDWWTFGIFLYELLFGKTPFKGSGNRATL---FNVV 507
THE Y APEI+ G H S VD W+ G E++ K F G L F ++
Sbjct: 161 THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRIL 220
Query: 508 GQPLR---------------FPESPVVSFAAR---------DLIRGLLVKEPQHRLAYKR 543
G P FP+ P A DL+ +L +P R+ R
Sbjct: 221 GTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRIT-AR 279
Query: 544 GATEIKQHPFFE 555
A E H +F+
Sbjct: 280 AALE---HEYFK 288
|
Length = 294 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.003
Identities = 27/88 (30%), Positives = 42/88 (47%), Gaps = 4/88 (4%)
Query: 454 FVGTHEYLAPEI-IKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATL---FNVVGQ 509
+V T Y APEI + +G+ A+D W+ G L E+L + F G L V+G
Sbjct: 169 YVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGT 228
Query: 510 PLRFPESPVVSFAARDLIRGLLVKEPQH 537
P + + ++S AR+ I+ L K
Sbjct: 229 PSQEDLNCIISLRARNYIKSLPFKPKVP 256
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 19/79 (24%), Positives = 42/79 (53%), Gaps = 1/79 (1%)
Query: 313 KYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 372
K ++ ++ + ++L LEY+H GI + D+KPEN++V + + D+ ++ +
Sbjct: 121 KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHG 180
Query: 373 TLIKASSLDAEPLRKNPVY 391
I+ S + + L + +Y
Sbjct: 181 KHIEYSK-EQKDLHRGTLY 198
|
Length = 294 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.003
Identities = 35/144 (24%), Positives = 69/144 (47%), Gaps = 17/144 (11%)
Query: 223 RLGCGDIGSVYLSELSGTK--CYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPT 280
++G G G VY ++ K +A+K ++ ++ + A E +L+ L HP +
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS-----MSACREIALLRELKHPNVIA 62
Query: 281 LYTHF--ETEKFSCLVMEFCPGGDLHTLR-------QKQPGKYFPEQAVRFYVAEVLLAL 331
L F +++ L+ ++ H ++ K+P + P V+ + ++L +
Sbjct: 63 LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQ-LPRSMVKSLLYQILDGI 121
Query: 332 EYLHMLGIIYRDLKPENVLVREDG 355
YLH +++RDLKP N+LV +G
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEG 145
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 25/97 (25%), Positives = 44/97 (45%)
Query: 264 QTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFY 323
Q E + + +HP + F + +V F G L E A+ +
Sbjct: 47 QGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYI 106
Query: 324 VAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLS 360
+ VL AL+Y+H +G ++R +K ++L+ DG + LS
Sbjct: 107 LQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLS 143
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 41/169 (24%), Positives = 68/169 (40%), Gaps = 43/169 (25%)
Query: 424 KDRKPKNEIGNQVSPLPELIAEPTEARSMSF--------VGTHEYLAPEIIKGE-GHGSA 474
+D KP+N + N+ L +A+ AR+ S V T Y P+I+ G + +
Sbjct: 128 RDLKPQNLLINERGELK--LADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQ 185
Query: 475 VDWWTFGIFLYELLFGKTPFKGSGNRATL---FNVVGQPL-------------------R 512
+D W G YE+ G+ F GS L F ++G P +
Sbjct: 186 IDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPK 245
Query: 513 FPESPVVSFAAR------DLIRGLLVKEPQHRLAYKRGATEIKQHPFFE 555
+ + + A R +L+ LL E + R++ A E +HP+F
Sbjct: 246 YRADCLHNHAPRLDSDGAELLSKLLQFEGRKRIS----AEEAMKHPYFH 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.004
Identities = 24/99 (24%), Positives = 42/99 (42%), Gaps = 2/99 (2%)
Query: 443 IAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRAT 502
T R+ +GT Y APE ++GE D + +G+ E L G+ +G+
Sbjct: 138 ADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGASVAEI 197
Query: 503 LFNVVG-QPLRFPESPVVSFAARDLIRGLLVKEPQHRLA 540
L+ + + P + ++R L K+P+ R A
Sbjct: 198 LYQQLSPVDVSLPPW-IAGHPLGQVLRKALNKDPRQRAA 235
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|223554 COG0478, COG0478, RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 0.004
Identities = 30/105 (28%), Positives = 47/105 (44%), Gaps = 15/105 (14%)
Query: 261 LRAQTEREILQSLDHPF---LPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPE 317
L A+ E E LQ L +P +P +VME+ G +L+ LR E
Sbjct: 154 LAAEREFEALQRL-YPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLRLD------VE 202
Query: 318 QAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDF 362
++L + + GI++ DL N+LV EDG I++ D+
Sbjct: 203 NPDEIL-DKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDW 246
|
Length = 304 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.004
Identities = 42/162 (25%), Positives = 65/162 (40%), Gaps = 26/162 (16%)
Query: 224 LGCGDIGSVYLSEL------SGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHP- 276
LG G G VY A+K + K + KK E ++ + +HP
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLK--EAHLMSNFNHPN 60
Query: 277 FLPTLYTHFETEKFSCLVMEFCPGGDL-HTLRQKQPGKYFPEQAVRFYVAEVL-LALE-- 332
+ L E ++ME GGDL LR + ++ P + E+L + L+
Sbjct: 61 IVKLLGVCLLNEPQY-IIMELMEGGDLLSYLRDARVERFGPPL---LTLKELLDICLDVA 116
Query: 333 ----YLHMLGIIYRDLKPENVLVREDGH-----IMLSDFDLS 365
YL + I+RDL N LV E G+ + + DF L+
Sbjct: 117 KGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.004
Identities = 35/144 (24%), Positives = 69/144 (47%), Gaps = 17/144 (11%)
Query: 223 RLGCGDIGSVYLSELSGTK--CYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPT 280
++G G G VY ++ K +A+K ++ ++ + A E +L+ L HP + +
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS-----MSACREIALLRELKHPNVIS 62
Query: 281 LYTHF--ETEKFSCLVMEFCPGGDLHTLR-------QKQPGKYFPEQAVRFYVAEVLLAL 331
L F ++ L+ ++ H ++ K+P + P V+ + ++L +
Sbjct: 63 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQ-LPRGMVKSLLYQILDGI 121
Query: 332 EYLHMLGIIYRDLKPENVLVREDG 355
YLH +++RDLKP N+LV +G
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEG 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.004
Identities = 26/101 (25%), Positives = 45/101 (44%), Gaps = 2/101 (1%)
Query: 439 LPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELL-FGKTPFKGS 497
L + ++PT S+ + APE I SA D W++GI ++E++ +G+ P+
Sbjct: 156 LEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 215
Query: 498 GNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHR 538
N+ + N + Q R P A L+ K+ R
Sbjct: 216 SNQDVI-NAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNAR 255
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 611 | |||
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.98 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.96 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.96 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.9 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.9 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.89 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.88 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.88 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.85 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.84 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.82 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.82 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.81 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.8 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.8 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.8 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.8 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.78 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.76 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.73 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.7 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.65 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.57 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.54 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.54 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.47 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.45 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.45 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.44 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.33 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.3 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.3 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.26 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.1 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.1 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.1 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.07 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.91 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.86 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.85 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.75 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.67 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.64 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.51 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.46 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.46 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.45 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.38 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.27 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.26 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.13 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.13 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.1 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.1 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 98.07 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.05 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.04 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.88 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.79 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.76 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.75 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.74 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.66 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.6 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.51 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.46 | |
| PLN02236 | 344 | choline kinase | 97.3 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.14 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.04 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.04 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.03 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.94 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.89 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.84 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.58 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.57 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.5 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.47 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.31 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.26 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.89 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.82 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.6 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.53 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.24 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.02 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.01 |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-88 Score=701.63 Aligned_cols=430 Identities=70% Similarity=1.146 Sum_probs=369.3
Q ss_pred cCCCccccCCCCCCCCCCCCCCCCCCCCCCCCCCCcchHHHHHHhh-ccCccccccCeEEEeEecccCcEEEEEEEECCC
Q 007260 162 SGKSSICRGSTSSDVSDESTCSSFSSSINKPHKANDLRWEAIQAVR-ARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGT 240 (611)
Q Consensus 162 s~~~s~~~~s~ss~~S~~s~~ss~s~s~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t 240 (611)
+.+++.++++.+++.++.+..+..+++.+.||..+|.+|+++..++ .+++.+++++|+++++||+|+.|+||+|+++++
T Consensus 22 ~~~~~~~~~~~s~~~~~~s~~~~~s~~~~kph~~~d~~w~a~~~~~~~~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t 101 (459)
T KOG0610|consen 22 SGKSSASSSSRSSDLSDESSLSNPSSSGNKPHKGNDVRWEAISSIRNSKDGSLGLRHFRLLKRLGCGDIGTVYLVELRGT 101 (459)
T ss_pred cccccCCCccccCCccccccccccCcccCCCCCCCchhhhhhccccccCCCccCHHHHHHHHHcCCCCceeEEEEEecCC
Confidence 3334444444455566666677777888999999999999999988 689999999999999999999999999999999
Q ss_pred CeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHH
Q 007260 241 KCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAV 320 (611)
Q Consensus 241 ~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~ 320 (611)
++.||||+|+|..+..++++.|++.|.+||..++||++++||.+|+.++++|||||||+||||+.++++|+++.|++..+
T Consensus 102 ~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~a 181 (459)
T KOG0610|consen 102 NCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAA 181 (459)
T ss_pred CceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCC
Q 007260 321 RFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEP 400 (611)
Q Consensus 321 ~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (611)
++|+++|+.||+|||++|||+||||||||||.++|||+|+||+|+.+|...++.+.......... + +
T Consensus 182 RFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~--------~-----~ 248 (459)
T KOG0610|consen 182 RFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGS--------Q-----P 248 (459)
T ss_pred HHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCC--------C-----c
Confidence 99999999999999999999999999999999999999999999999988888876544322211 1 2
Q ss_pred CcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHH
Q 007260 401 SCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTF 480 (611)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSL 480 (611)
.|.. ..+.||+|+.+....+... ...... ..+|++++++...++++||||.+|+|||+|.|.+|+.++|||+|
T Consensus 249 ~~~~---~~~s~f~~r~~~~~~~~~k---~~~~~~-~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtf 321 (459)
T KOG0610|consen 249 SCRS---RQPSCFSPRCLSSSKKRKK---KDESAS-RSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTF 321 (459)
T ss_pred cccc---ccccccccchhcccccccc---cccccc-ccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHH
Confidence 2222 2367899986654433222 233333 78899999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCchh
Q 007260 481 GIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWA 560 (611)
Q Consensus 481 GviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~ 560 (611)
||+|||||+|.+||+|.++.+++.+|+.+++.||..+.++..++|||+++|.+||.+|+.++++|+||++||||++++|+
T Consensus 322 GIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWa 401 (459)
T KOG0610|consen 322 GIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWA 401 (459)
T ss_pred HHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCCCCCcCCCCCCCCCCCCC-------CCCCCCCCCCCCCCCCCCccCC
Q 007260 561 LIRCATPPEIPKPVEIERIPAPTSSTSEK-------TAPTMVPPNQRGSDNYLEFDFF 611 (611)
Q Consensus 561 ~~~~~~~p~~p~p~~~~~~~~~~s~~~~~-------~~p~~~~~~~~~~~~~~~~~~~ 611 (611)
++++..||.+|.+.+....+......... ..............+|++||||
T Consensus 402 Lir~~~PP~iP~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~F 459 (459)
T KOG0610|consen 402 LIRCARPPEIPKPVDGGLKPHASHKSDVKGLVSKKLKNMPSKLSDDKVSENYNPFEYF 459 (459)
T ss_pred heeccCCCcCCCccccCcccccccccccccccccccccccccccCCccccCCcCcccC
Confidence 99999999999998776531111000000 0011122345567789999998
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-63 Score=525.22 Aligned_cols=334 Identities=37% Similarity=0.658 Sum_probs=273.4
Q ss_pred HHHhhccCccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCccccc
Q 007260 203 IQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLY 282 (611)
Q Consensus 203 ~~~~~~~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~ 282 (611)
-+-++.+...+++++|.+++.||+|+||.||+|+.+.||.+||||+++|..+.....+..++.|..||...++|+||+||
T Consensus 128 te~lR~~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLy 207 (550)
T KOG0605|consen 128 TEYLRLRRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLY 207 (550)
T ss_pred HHHHHhccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEE
Confidence 44577777788999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ceeeccceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEec
Q 007260 283 THFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDF 362 (611)
Q Consensus 283 ~~~~~~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DF 362 (611)
..|++..++||||||++|||+.+++.+. ..|+|+.+++|+++++.||+.||.+|||||||||+|+||+..||+||+||
T Consensus 208 YsFQD~~~LYLiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDF 285 (550)
T KOG0605|consen 208 YSFQDKEYLYLIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDF 285 (550)
T ss_pred EEecCCCeeEEEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccc
Confidence 9999999999999999999999999886 67999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCC----CCccc-ccccccCCCCccccCCCCC
Q 007260 363 DLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCF----SPRLF-SSKSKKDRKPKNEIGNQVS 437 (611)
Q Consensus 363 GlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~~~~~~~ 437 (611)
||+.-+.......... .... .+.. .....+.-+ +++.. ..+...
T Consensus 286 GLs~gl~~~~~~~~~~---~~~~-------~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~------------- 334 (550)
T KOG0605|consen 286 GLSTGLDKKHRIESYR---LDEQ-------MQIN--------LSEAKPSDFPKFNTPRSTMSRREQL------------- 334 (550)
T ss_pred cccchhhhhhhhhhhc---chhh-------hhhh--------hccCCCccccccccccchhhHHHHH-------------
Confidence 9984332111100000 0000 0000 000000000 00000 000000
Q ss_pred CCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCC--CCCCC
Q 007260 438 PLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQP--LRFPE 515 (611)
Q Consensus 438 ~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~--l~~p~ 515 (611)
..+.........++||||.|||||++.+.+|+..+||||||||+||||.|.+||.+.+..++..+|+.-. +.+|.
T Consensus 335 ---~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~ 411 (550)
T KOG0605|consen 335 ---QTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE 411 (550)
T ss_pred ---HHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC
Confidence 0001111112346899999999999999999999999999999999999999999999999999988655 88999
Q ss_pred CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCchhhhccCCCCCCCCCC
Q 007260 516 SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIRCATPPEIPKPV 574 (611)
Q Consensus 516 ~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~p~~p~p~ 574 (611)
...++++++|||.+||+ ||++|+. ..+++||++||||++++|.-++...||-+|..-
T Consensus 412 ~~~~s~eA~DLI~rll~-d~~~RLG-~~G~~EIK~HPfF~~v~W~~l~~~~apfvP~v~ 468 (550)
T KOG0605|consen 412 EVDLSDEAKDLITRLLC-DPENRLG-SKGAEEIKKHPFFKGVDWDHLREMPAPFVPQVN 468 (550)
T ss_pred cCcccHHHHHHHHHHhc-CHHHhcC-cccHHHHhcCCccccCCcchhhcCCCCCCCCCC
Confidence 88999999999999999 9999998 788999999999999999999998888888643
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-62 Score=501.42 Aligned_cols=281 Identities=42% Similarity=0.748 Sum_probs=252.8
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSC 292 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~ 292 (611)
.+.++|++++.||.|+||+||+++.+.+++.||||+|+|..+...+...+...|+.||..++||+||.|+..|++...+|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 34579999999999999999999999999999999999999888888889999999999999999999999999999999
Q ss_pred EEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCc
Q 007260 293 LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 293 LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~ 372 (611)
||+||+.||+|+..++++ +.|+|..+++|+++|+.||.|||++|||||||||||||++.+||++|+||||++...
T Consensus 102 lVld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~--- 176 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL--- 176 (357)
T ss_pred EEEeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcc---
Confidence 999999999999999987 679999999999999999999999999999999999999999999999999984211
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
.....+.
T Consensus 177 -------------------------------------------------------------------------~~~~~t~ 183 (357)
T KOG0598|consen 177 -------------------------------------------------------------------------KDGDATR 183 (357)
T ss_pred -------------------------------------------------------------------------cCCCccc
Confidence 0122334
Q ss_pred ccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007260 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLV 532 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~ 532 (611)
+||||++|||||++.+.+|+.++|||||||++||||+|.+||.+.+....+.+|+.+++.++. ..++.++++||+++|.
T Consensus 184 tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p-~~ls~~ardll~~LL~ 262 (357)
T KOG0598|consen 184 TFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPP-GYLSEEARDLLKKLLK 262 (357)
T ss_pred cccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCC-ccCCHHHHHHHHHHhc
Confidence 689999999999999999999999999999999999999999999988999999988844433 2389999999999999
Q ss_pred cCccccCCchhcHHHHHcCCCCCCCchhhhc--cCCCCCCCC
Q 007260 533 KEPQHRLAYKRGATEIKQHPFFEGVNWALIR--CATPPEIPK 572 (611)
Q Consensus 533 ~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~--~~~~p~~p~ 572 (611)
+||.+|+....++.+|.+||||.+++|..+. .-.||..|.
T Consensus 263 rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~ 304 (357)
T KOG0598|consen 263 RDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPN 304 (357)
T ss_pred cCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCeecC
Confidence 9999999755679999999999999998754 334555554
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-61 Score=476.59 Aligned_cols=270 Identities=41% Similarity=0.768 Sum_probs=254.0
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSC 292 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~ 292 (611)
..+++|++++.||.|+||+|.+++++.++.+||+|++++.....-+......+|..||+.+.||+|++|++.|.+.+++|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 67789999999999999999999999999999999999999888888999999999999999999999999999999999
Q ss_pred EEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCc
Q 007260 293 LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 293 LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~ 372 (611)
|||||++||.|+.++++. ++|++..+++|++||+.||+|||+++|+||||||||||++.+|++||+|||+|++..
T Consensus 121 mvmeyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~--- 195 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS--- 195 (355)
T ss_pred EEEeccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec---
Confidence 999999999999999986 679999999999999999999999999999999999999999999999999996542
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
.+..
T Consensus 196 ----------------------------------------------------------------------------~rT~ 199 (355)
T KOG0616|consen 196 ----------------------------------------------------------------------------GRTW 199 (355)
T ss_pred ----------------------------------------------------------------------------CcEE
Confidence 2245
Q ss_pred ccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007260 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLV 532 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~ 532 (611)
+.||||+|+|||++...+|+.++|||||||++|||+.|.+||...+...++.+|+.+.++||.. ++.+++|||.++|+
T Consensus 200 TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~--fs~~~kdLl~~LL~ 277 (355)
T KOG0616|consen 200 TLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSY--FSSDAKDLLKKLLQ 277 (355)
T ss_pred EecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcc--cCHHHHHHHHHHHh
Confidence 6789999999999999999999999999999999999999999999999999999999999987 99999999999999
Q ss_pred cCccccCCc-hhcHHHHHcCCCCCCCchhhhccC
Q 007260 533 KEPQHRLAY-KRGATEIKQHPFFEGVNWALIRCA 565 (611)
Q Consensus 533 ~dP~~Rpt~-~~~a~elL~Hp~f~~~~~~~~~~~ 565 (611)
.|-.+|... +.+..+|+.||||++++|..+...
T Consensus 278 vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r 311 (355)
T KOG0616|consen 278 VDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQR 311 (355)
T ss_pred hhhHhhhcCcCCCccccccCcccccccHHHHhhc
Confidence 999999654 458999999999999999876443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-59 Score=493.53 Aligned_cols=288 Identities=39% Similarity=0.651 Sum_probs=258.6
Q ss_pred cccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeeccce
Q 007260 212 VLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEKF 290 (611)
Q Consensus 212 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~~~ 290 (611)
.....+|..++.||.|+|++||+|++..+++.||||++.|..+...++..-+.+|.++|.+| +||.|++||..|+++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 34467999999999999999999999999999999999999998888888889999999999 89999999999999999
Q ss_pred eeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccC
Q 007260 291 SCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAV 370 (611)
Q Consensus 291 ~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~ 370 (611)
+|+|+||+++|+|.++|.+. +.|+|..+++|++||+.||+|||++||||||||||||||+.||++||+|||-|..+..
T Consensus 149 LYFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred eEEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 99999999999999999997 6799999999999999999999999999999999999999999999999999865542
Q ss_pred CccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccc
Q 007260 371 SPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEAR 450 (611)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (611)
..... ..|. .......+
T Consensus 227 ~~~~~-------------------~~~~--------------------------------------------~~~~a~s~ 243 (604)
T KOG0592|consen 227 SQKSQ-------------------ENPV--------------------------------------------DPNQASSR 243 (604)
T ss_pred hhccc-------------------cCcc--------------------------------------------CcccccCc
Confidence 21100 0000 00011222
Q ss_pred ccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 007260 451 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGL 530 (611)
Q Consensus 451 ~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~ 530 (611)
..+||||-.|.+||++.....+..+|||+||||||.|+.|.+||.+.++..++.+|+...+.||.. +++.++|||.++
T Consensus 244 ~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~~--fp~~a~dLv~KL 321 (604)
T KOG0592|consen 244 RSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPEG--FPEDARDLIKKL 321 (604)
T ss_pred ccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCCC--CCHHHHHHHHHH
Confidence 468999999999999999999999999999999999999999999999999999999988888876 999999999999
Q ss_pred hhcCccccCCchhcHHHHHcCCCCCCCchhhhccCCCCCC
Q 007260 531 LVKEPQHRLAYKRGATEIKQHPFFEGVNWALIRCATPPEI 570 (611)
Q Consensus 531 L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~p~~ 570 (611)
|..||.+|+| +.+|++||||++++|.-+...+||.+
T Consensus 322 Lv~dp~~Rlt----~~qIk~HpFF~~Vdw~nlw~~~PP~l 357 (604)
T KOG0592|consen 322 LVRDPSDRLT----SQQIKAHPFFEGVDWENLWQQTPPKL 357 (604)
T ss_pred HccCcccccc----HHHHhhCcccccCChhhhhhcCCCcc
Confidence 9999999999 99999999999999998888887765
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-59 Score=481.27 Aligned_cols=261 Identities=32% Similarity=0.491 Sum_probs=229.2
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhh----HHHHHHHHHHHHHHHhCCCCCcccccceeeccce
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAG----RKKLLRAQTEREILQSLDHPFLPTLYTHFETEKF 290 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~----~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~ 290 (611)
.+.|.+.+.||+|+||.|-+|..+.|++.||||++.+..... ......+++|++||++|+|||||+++++|+..+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 358999999999999999999999999999999999876554 2234456899999999999999999999999999
Q ss_pred eeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccC---CcEEEEecccccc
Q 007260 291 SCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRED---GHIMLSDFDLSLR 367 (611)
Q Consensus 291 ~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~---g~vkL~DFGlA~~ 367 (611)
.||||||+.||+|++.+-.+ +.+.|+..+.|++|++.||.|||++||+||||||||||+..+ ..+||+|||+|+.
T Consensus 251 ~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred eEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 99999999999999988876 679999999999999999999999999999999999999866 6899999999943
Q ss_pred ccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcc
Q 007260 368 CAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPT 447 (611)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (611)
.+ .
T Consensus 329 ~g-----------------------------------------------------------------------------~ 331 (475)
T KOG0615|consen 329 SG-----------------------------------------------------------------------------E 331 (475)
T ss_pred cc-----------------------------------------------------------------------------c
Confidence 21 2
Q ss_pred cccccccccCCCccchhhhccCCC---CChhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHcCCCCC--CCCCCCCH
Q 007260 448 EARSMSFVGTHEYLAPEIIKGEGH---GSAVDWWTFGIFLYELLFGKTPFKGSGNRA-TLFNVVGQPLRF--PESPVVSF 521 (611)
Q Consensus 448 ~~~~~~~vGT~~Y~APEil~~~~~---~~~sDIWSLGviL~ELltG~~PF~~~~~~~-~l~~i~~~~l~~--p~~~~~s~ 521 (611)
...+.++||||.|.|||++.+.++ ..++|||||||+||-+|+|.+||.+..... ....|..+.+.| +.|..+++
T Consensus 332 ~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Ise 411 (475)
T KOG0615|consen 332 GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISE 411 (475)
T ss_pred ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhH
Confidence 334567899999999999998764 458899999999999999999998876555 445566666554 45677999
Q ss_pred HHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCc
Q 007260 522 AARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVN 558 (611)
Q Consensus 522 ~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 558 (611)
++++||.+||..||++||+ ++|+|+||||+.+.
T Consensus 412 ea~dlI~~mL~VdP~~R~s----~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 412 EALDLINWMLVVDPENRPS----ADEALNHPWFKDAP 444 (475)
T ss_pred HHHHHHHHhhEeCcccCcC----HHHHhcChhhhccc
Confidence 9999999999999999999 99999999998654
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-57 Score=495.14 Aligned_cols=281 Identities=40% Similarity=0.762 Sum_probs=254.6
Q ss_pred ccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC-CCCcccccceeeccc
Q 007260 211 GVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD-HPFLPTLYTHFETEK 289 (611)
Q Consensus 211 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~-HpnIv~l~~~~~~~~ 289 (611)
..+.+.+|+++++||+|.||+|++|+.++++++||||+++|..+-.+..+.....|..|+.... ||+++.|+..|++..
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 5678899999999999999999999999999999999999999888888889999999998885 999999999999999
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
++|+||||+.|||+..+.+ ...|+|..+++|+++|+.||.|||++||||||||.+|||++.+|++||+||||++...
T Consensus 443 ~l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred eEEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccC
Confidence 9999999999999544332 3569999999999999999999999999999999999999999999999999983211
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
....
T Consensus 520 ----------------------------------------------------------------------------~~g~ 523 (694)
T KOG0694|consen 520 ----------------------------------------------------------------------------GQGD 523 (694)
T ss_pred ----------------------------------------------------------------------------CCCC
Confidence 0223
Q ss_pred cccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHH
Q 007260 450 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRG 529 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~ 529 (611)
++.+|||||.|||||++.+..|+.++|||||||+|||||.|..||.|+++.+.+..|+.....+|.+ ++.++.++|++
T Consensus 524 ~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~--ls~ea~~il~~ 601 (694)
T KOG0694|consen 524 RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRF--LSKEAIAIMRR 601 (694)
T ss_pred ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCc--ccHHHHHHHHH
Confidence 5678999999999999999999999999999999999999999999999999999999999999887 99999999999
Q ss_pred hhhcCccccCCc-hhcHHHHHcCCCCCCCchhhhc--cCCCCCCCC
Q 007260 530 LLVKEPQHRLAY-KRGATEIKQHPFFEGVNWALIR--CATPPEIPK 572 (611)
Q Consensus 530 ~L~~dP~~Rpt~-~~~a~elL~Hp~f~~~~~~~~~--~~~~p~~p~ 572 (611)
+|.+||++|+.. .+++++|++||||++++|..+. .-.||-.|.
T Consensus 602 ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~ 647 (694)
T KOG0694|consen 602 LLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPT 647 (694)
T ss_pred HhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcc
Confidence 999999999987 3679999999999999998753 345655554
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-57 Score=489.06 Aligned_cols=256 Identities=32% Similarity=0.561 Sum_probs=242.7
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
.+|..++.||+|||+.||++++..+|+.||+|++.+..+.......++.+||+|.+.|+|||||++|++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 47999999999999999999999999999999999998888888889999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
|+|..++|..++++. +.++|.+++.|++||+.||.|||+++|||||||..|||++++.+|||+|||||.++.
T Consensus 98 ELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le------ 169 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE------ 169 (592)
T ss_pred EecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeec------
Confidence 999999999999865 789999999999999999999999999999999999999999999999999995543
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
....+.+++|
T Consensus 170 ----------------------------------------------------------------------~~~Erk~TlC 179 (592)
T KOG0575|consen 170 ----------------------------------------------------------------------YDGERKKTLC 179 (592)
T ss_pred ----------------------------------------------------------------------Ccccccceec
Confidence 2345667899
Q ss_pred cCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCc
Q 007260 456 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEP 535 (611)
Q Consensus 456 GT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP 535 (611)
|||.|+|||++...+|+..+||||+|||||-||+|++||...+-.+++.+|......+|.. ++.+++|||.+||..||
T Consensus 180 GTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~--ls~~A~dLI~~lL~~~P 257 (592)
T KOG0575|consen 180 GTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSH--LSAEAKDLIRKLLRPNP 257 (592)
T ss_pred CCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccc--cCHHHHHHHHHHhcCCc
Confidence 9999999999999999999999999999999999999999999999999999999999985 99999999999999999
Q ss_pred cccCCchhcHHHHHcCCCCC
Q 007260 536 QHRLAYKRGATEIKQHPFFE 555 (611)
Q Consensus 536 ~~Rpt~~~~a~elL~Hp~f~ 555 (611)
.+||+ +++||.|+||.
T Consensus 258 ~~Rps----l~~vL~h~Ff~ 273 (592)
T KOG0575|consen 258 SERPS----LDEVLDHPFFK 273 (592)
T ss_pred ccCCC----HHHHhcCHhhh
Confidence 99999 99999999993
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-54 Score=444.13 Aligned_cols=256 Identities=32% Similarity=0.499 Sum_probs=225.9
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc-eeeE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK-FSCL 293 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~-~~~L 293 (611)
.++.+.++.||+|..|+||+++|+.|++.||+|++... .......++.+|++||+.++|||||.+|+.|.++. .++|
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI 155 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISI 155 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEe
Confidence 45777889999999999999999999999999999332 23345567788999999999999999999999988 5999
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCeeccCCCCCcEEEccCCcEEEEeccccccccCCc
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHM-LGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~-~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~ 372 (611)
+||||+||+|..++... +.++|.....++.+|++||.|||. ++||||||||+||||+..|.|||||||.+..+..+
T Consensus 156 ~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred ehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 99999999999998876 669999999999999999999996 99999999999999999999999999998543211
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
...
T Consensus 233 -----------------------------------------------------------------------------~a~ 235 (364)
T KOG0581|consen 233 -----------------------------------------------------------------------------IAN 235 (364)
T ss_pred -----------------------------------------------------------------------------hcc
Confidence 234
Q ss_pred ccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC-----CcHHHHHHHHcCC-CCCCCCCCCCHHHHHH
Q 007260 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGS-----GNRATLFNVVGQP-LRFPESPVVSFAARDL 526 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~-----~~~~~l~~i~~~~-l~~p~~~~~s~~l~dL 526 (611)
+|+||..|||||.+.+..|+.++||||||++|+||++|+.||... ...+.+..|+.++ .++|.. .+|+++++|
T Consensus 236 tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~-~fS~ef~~F 314 (364)
T KOG0581|consen 236 TFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG-EFSPEFRSF 314 (364)
T ss_pred cccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc-cCCHHHHHH
Confidence 789999999999999999999999999999999999999999874 4456667777754 445554 699999999
Q ss_pred HHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 527 IRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 527 I~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
|..||.+||.+|++ +.||++|||+...
T Consensus 315 V~~CL~Kdp~~R~s----~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 315 VSCCLRKDPSERPS----AKQLLQHPFIKKF 341 (364)
T ss_pred HHHHhcCCcccCCC----HHHHhcCHHHhhc
Confidence 99999999999999 9999999999754
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-54 Score=430.77 Aligned_cols=260 Identities=28% Similarity=0.492 Sum_probs=222.4
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
++.|+.+.++|+|+||+||+|+++.||+.||||.+.... .+....+-+.+|+.+|+.|+|+|+|.|+++|...+.++||
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence 357899999999999999999999999999999986543 3344445568999999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
+|||+..-|++ +++.+ ..++.+.++.|++|++.|+.|||.++|||||||||||||+.+|.+||||||+|+.+...
T Consensus 80 FE~~dhTvL~e-Le~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p--- 154 (396)
T KOG0593|consen 80 FEYCDHTVLHE-LERYP-NGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP--- 154 (396)
T ss_pred eeecchHHHHH-HHhcc-CCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCC---
Confidence 99997655554 56655 45899999999999999999999999999999999999999999999999999654311
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
....+.+
T Consensus 155 -------------------------------------------------------------------------gd~YTDY 161 (396)
T KOG0593|consen 155 -------------------------------------------------------------------------GDNYTDY 161 (396)
T ss_pred -------------------------------------------------------------------------cchhhhh
Confidence 1122356
Q ss_pred ccCCCccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcC-------------------CCCCC
Q 007260 455 VGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ-------------------PLRFP 514 (611)
Q Consensus 455 vGT~~Y~APEil~~-~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~-------------------~l~~p 514 (611)
|.|.||+|||++.| ..||..+||||+||++.||++|.+.|.|.++.++++.|... .+++|
T Consensus 162 VATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP 241 (396)
T KOG0593|consen 162 VATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLP 241 (396)
T ss_pred hhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecC
Confidence 89999999999998 67999999999999999999999999999999988765421 12333
Q ss_pred CC----------CCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 515 ES----------PVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 515 ~~----------~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
.. +.++..+.||+.+||..||++|++ .+|+|.|+||.++
T Consensus 242 ~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~s----c~qll~H~yFd~~ 290 (396)
T KOG0593|consen 242 EPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLS----CEQLLHHPYFDGF 290 (396)
T ss_pred CCCCccchhhhcccchHHHHHHHHHHhcCCcccccc----HHHHhcChHHHHH
Confidence 32 457788999999999999999999 9999999999653
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-53 Score=437.23 Aligned_cols=258 Identities=29% Similarity=0.531 Sum_probs=226.4
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
.++|.+.+.||.|+||+||+|+++.++..||||.|.+..+ ..+..+.+..|+.||+.++|||||.|+++++.++++|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 4689999999999999999999999999999999998865 345666778999999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccC------CcEEEEeccccccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRED------GHIMLSDFDLSLRC 368 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~------g~vkL~DFGlA~~~ 368 (611)
||||.||||..++++. +.++|..++.++.||+.||++||+++||||||||+||||+.. -.+||+|||+|+.+
T Consensus 88 MEyC~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 9999999999999987 579999999999999999999999999999999999999864 35899999999665
Q ss_pred cCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccc
Q 007260 369 AVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTE 448 (611)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (611)
...
T Consensus 166 ~~~----------------------------------------------------------------------------- 168 (429)
T KOG0595|consen 166 QPG----------------------------------------------------------------------------- 168 (429)
T ss_pred Cch-----------------------------------------------------------------------------
Confidence 411
Q ss_pred ccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCC-CCCCCHHHHHHH
Q 007260 449 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPE-SPVVSFAARDLI 527 (611)
Q Consensus 449 ~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~-~~~~s~~l~dLI 527 (611)
....+.+|+|.|||||+++...|+.|+|+||+|+|||+|++|++||...+..+.+..+....-..|. ...++..+.+|+
T Consensus 169 ~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll 248 (429)
T KOG0595|consen 169 SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLRELL 248 (429)
T ss_pred hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchhhhh
Confidence 0112568999999999999999999999999999999999999999998888877665554433332 234777888999
Q ss_pred HHhhhcCccccCCchhcHHHHHcCCCCCC
Q 007260 528 RGLLVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 528 ~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
..+|.+|+.+|.+ ..+-+.|++...
T Consensus 249 ~~ll~~~~~~~~~----~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 249 ISLLQRNPKDRIS----FEDFFDHPFLAA 273 (429)
T ss_pred hHHHhcCccccCc----hHHhhhhhhccc
Confidence 9999999999999 788888888764
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-52 Score=448.70 Aligned_cols=261 Identities=34% Similarity=0.581 Sum_probs=233.1
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhh-h-HHHHHHHHHHHHHHHhCC-CCCcccccceeeccc
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLA-G-RKKLLRAQTEREILQSLD-HPFLPTLYTHFETEK 289 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~-~-~~~~~~~~~E~~iL~~l~-HpnIv~l~~~~~~~~ 289 (611)
...+.|++++.||+|+||+|++|.+..+++.||+|++++.... . ......+.+|+.+++++. ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3457999999999999999999999999999999988775222 1 133445678999999998 999999999999999
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccC-CcEEEEeccccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRED-GHIMLSDFDLSLRC 368 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~-g~vkL~DFGlA~~~ 368 (611)
.+|||||||.||+|++++... +.+.|..++.|++||+.||+|||++||+||||||||||++.+ +.+||+|||++..+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred eEEEEEEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 999999999999999999884 679999999999999999999999999999999999999999 99999999998332
Q ss_pred cCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccc
Q 007260 369 AVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTE 448 (611)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (611)
. ...
T Consensus 172 ~----------------------------------------------------------------------------~~~ 175 (370)
T KOG0583|consen 172 P----------------------------------------------------------------------------GED 175 (370)
T ss_pred C----------------------------------------------------------------------------CCC
Confidence 1 012
Q ss_pred ccccccccCCCccchhhhccCC-C-CChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 007260 449 ARSMSFVGTHEYLAPEIIKGEG-H-GSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDL 526 (611)
Q Consensus 449 ~~~~~~vGT~~Y~APEil~~~~-~-~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dL 526 (611)
....+++||+.|+|||++.+.. | +.++||||+||+||.|++|+.||........+..|....+.+|.+.. +.++++|
T Consensus 176 ~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~-S~~~~~L 254 (370)
T KOG0583|consen 176 GLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLL-SPEARSL 254 (370)
T ss_pred CcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcC-CHHHHHH
Confidence 2345678999999999999988 8 78999999999999999999999998888888889999999998833 9999999
Q ss_pred HHHhhhcCccccCCchhcHHHHHcCCCCCC
Q 007260 527 IRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 527 I~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
|.+||..||.+|++ +.+|+.||||+.
T Consensus 255 i~~mL~~~P~~R~t----~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 255 IEKMLVPDPSTRIT----LLEILEHPWFQK 280 (370)
T ss_pred HHHHcCCCcccCCC----HHHHhhChhhcc
Confidence 99999999999999 999999999985
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-53 Score=428.59 Aligned_cols=271 Identities=37% Similarity=0.690 Sum_probs=248.7
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSC 292 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~ 292 (611)
+.+++|..+++||+|.||+|.+++.+.++++||||+++|..+..+..+.....|-.+|+..+||++..|...|+..+++|
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC 244 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC 244 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence 34678999999999999999999999999999999999998888888888899999999999999999999999999999
Q ss_pred EEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCc
Q 007260 293 LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 293 LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~ 372 (611)
+||||+.||+|+-.+.+. +.|+|+.+++|-.+|+.||.|||+++||+||||.||+|++.|||+||+||||.+.--
T Consensus 245 FVMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I--- 319 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI--- 319 (516)
T ss_pred EEEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcc---
Confidence 999999999999888775 679999999999999999999999999999999999999999999999999972110
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
.......
T Consensus 320 -------------------------------------------------------------------------~~g~t~k 326 (516)
T KOG0690|consen 320 -------------------------------------------------------------------------KYGDTTK 326 (516)
T ss_pred -------------------------------------------------------------------------cccceec
Confidence 0123345
Q ss_pred ccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007260 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLV 532 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~ 532 (611)
+|||||+|+|||++....|+.++|||.+||++|||+||++||.+.++...+.-|+...++||.. ++++++.|+.++|.
T Consensus 327 TFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~--ls~eAktLLsGLL~ 404 (516)
T KOG0690|consen 327 TFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRT--LSPEAKTLLSGLLK 404 (516)
T ss_pred cccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCcc--CCHHHHHHHHHHhh
Confidence 7999999999999999999999999999999999999999999998888888888999999987 99999999999999
Q ss_pred cCccccCCch-hcHHHHHcCCCCCCCchhhhc
Q 007260 533 KEPQHRLAYK-RGATEIKQHPFFEGVNWALIR 563 (611)
Q Consensus 533 ~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~ 563 (611)
+||.+|+.-. ..|.||.+|+||.+++|...-
T Consensus 405 kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~ 436 (516)
T KOG0690|consen 405 KDPKKRLGGGPDDAKEIMRHRFFASVDWEATY 436 (516)
T ss_pred cChHhhcCCCchhHHHHHhhhhhccCCHHHHH
Confidence 9999999753 569999999999999997653
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-53 Score=478.55 Aligned_cols=285 Identities=38% Similarity=0.704 Sum_probs=257.2
Q ss_pred CccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc
Q 007260 210 DGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK 289 (611)
Q Consensus 210 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~ 289 (611)
.-.+..++|.|+++||+|+||.|.+++++.++++||||++.|.....+.....|..|..||...+.+-|+.|+..|.+++
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 34456689999999999999999999999999999999999977776677777889999999999999999999999999
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
++||||||++||||-.++.+.. .++|+-+++|+++|+.||.-||+.|+|||||||+||||+..||+||+|||-+.++.
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~ 226 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD 226 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcC
Confidence 9999999999999999999873 79999999999999999999999999999999999999999999999999875554
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
..+ .-
T Consensus 227 ~dG---------------------------------------------------------------------------~V 231 (1317)
T KOG0612|consen 227 ADG---------------------------------------------------------------------------TV 231 (1317)
T ss_pred CCC---------------------------------------------------------------------------cE
Confidence 222 22
Q ss_pred cccccccCCCccchhhhcc-----CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcC--CCCCCCCCCCCHH
Q 007260 450 RSMSFVGTHEYLAPEIIKG-----EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ--PLRFPESPVVSFA 522 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~-----~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~--~l~~p~~~~~s~~ 522 (611)
++..-||||.|++||++.. +.||..+|||||||++||||+|.+||+..+-.+++-+|... .+.||....+|.+
T Consensus 232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSee 311 (1317)
T KOG0612|consen 232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEE 311 (1317)
T ss_pred EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHH
Confidence 3345589999999999962 45899999999999999999999999999999999999876 6889977789999
Q ss_pred HHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCchhhhccCCCCCCCCC
Q 007260 523 ARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIRCATPPEIPKP 573 (611)
Q Consensus 523 l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~p~~p~p 573 (611)
+++||.++|+ +|+.|++ +.+++++..||||.+++|.-+|...||-+|.-
T Consensus 312 akdLI~~ll~-~~e~RLg-rngiedik~HpFF~g~~W~~iR~~~pP~vPev 360 (1317)
T KOG0612|consen 312 AKDLIEALLC-DREVRLG-RNGIEDIKNHPFFEGIDWDNIRESVPPVVPEV 360 (1317)
T ss_pred HHHHHHHHhc-Chhhhcc-cccHHHHHhCccccCCChhhhhhcCCCCCCcC
Confidence 9999999996 8899997 67899999999999999999999999888753
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-52 Score=452.98 Aligned_cols=259 Identities=31% Similarity=0.539 Sum_probs=232.3
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
++-|++++.||.|+-|.|.+|++..||+.+|||++.+...........+.+|+-||+.+.||||++||++|++..++|||
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 35799999999999999999999999999999999887433344455678899999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
+||++||.|++++.+. +.|+|.++++|++||+.||.|||..+|+||||||||+|++..+.+||+|||+|..-.
T Consensus 91 lEyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~----- 163 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEV----- 163 (786)
T ss_pred EEecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeeccc-----
Confidence 9999999999999886 679999999999999999999999999999999999999999999999999982110
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
.+...-+.
T Consensus 164 ------------------------------------------------------------------------~gklLeTS 171 (786)
T KOG0588|consen 164 ------------------------------------------------------------------------PGKLLETS 171 (786)
T ss_pred ------------------------------------------------------------------------CCcccccc
Confidence 01111234
Q ss_pred ccCCCccchhhhccCCC-CChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007260 455 VGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVK 533 (611)
Q Consensus 455 vGT~~Y~APEil~~~~~-~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~ 533 (611)
||+|.|.|||++.|.+| |.++||||+|||||.||+|++||++++-+..+.++..+.+.+|. .++.++++||++||..
T Consensus 172 CGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs--~Is~eaQdLLr~ml~V 249 (786)
T KOG0588|consen 172 CGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPS--NISSEAQDLLRRMLDV 249 (786)
T ss_pred CCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCC--cCCHHHHHHHHHHhcc
Confidence 79999999999999998 89999999999999999999999988778888888888888885 4999999999999999
Q ss_pred CccccCCchhcHHHHHcCCCCCCCc
Q 007260 534 EPQHRLAYKRGATEIKQHPFFEGVN 558 (611)
Q Consensus 534 dP~~Rpt~~~~a~elL~Hp~f~~~~ 558 (611)
||.+|+| .+||++|||+.+..
T Consensus 250 Dp~~RiT----~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 250 DPSTRIT----TEEILKHPFLSGYT 270 (786)
T ss_pred Ccccccc----HHHHhhCchhhcCC
Confidence 9999999 99999999998653
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-52 Score=436.84 Aligned_cols=260 Identities=31% Similarity=0.524 Sum_probs=225.5
Q ss_pred cccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC-CCCcccccceeeccc-ee
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD-HPFLPTLYTHFETEK-FS 291 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~-HpnIv~l~~~~~~~~-~~ 291 (611)
.+.+|.++++||.|+||.||+|+...++..||||.|++.... .+...+ .||+.-|++|+ |||||+|++++.+.+ .+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~n-LREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMN-LREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHH-HHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 357899999999999999999999999999999999765443 333333 57999999998 999999999998876 99
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCC
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~ 371 (611)
|+||||| ..+|.++++.+ ++.|++..++.|+.||+.||+|+|.+|++|||||||||||.....|||+|||||+.....
T Consensus 86 ~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 86 YFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred eeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccC
Confidence 9999999 67999999987 789999999999999999999999999999999999999998889999999999654321
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
+. .
T Consensus 164 pP-----------------------------------------------------------------------------Y 166 (538)
T KOG0661|consen 164 PP-----------------------------------------------------------------------------Y 166 (538)
T ss_pred CC-----------------------------------------------------------------------------c
Confidence 11 2
Q ss_pred cccccCCCccchhhhccCC-CCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH---cCC----------------C
Q 007260 452 MSFVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVV---GQP----------------L 511 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~~~-~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~---~~~----------------l 511 (611)
+.+|-|.||+|||++...+ |+.++||||+|||++|+++-++.|.|.++.+++++|. +.+ +
T Consensus 167 TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf 246 (538)
T KOG0661|consen 167 TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNF 246 (538)
T ss_pred chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhcc
Confidence 3568999999999987765 6999999999999999999999999999999998765 332 3
Q ss_pred CCCCC---------CCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCc
Q 007260 512 RFPES---------PVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVN 558 (611)
Q Consensus 512 ~~p~~---------~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 558 (611)
+||.. +..+.++.+||.+||.+||.+||| |.|+|+||||+...
T Consensus 247 ~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpT----A~~al~~pffq~~~ 298 (538)
T KOG0661|consen 247 RFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPT----ASQALQHPFFQVGR 298 (538)
T ss_pred CCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCcc----HHHHhcCccccccc
Confidence 34432 347889999999999999999999 99999999998543
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-51 Score=430.94 Aligned_cols=267 Identities=39% Similarity=0.757 Sum_probs=237.0
Q ss_pred cccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeE
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCL 293 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~L 293 (611)
.+++|++.+.||.|+||.||+|++..+++.||||++.+...........+.+|+.+|+.++||||++++++|..++.+|+
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 35799999999999999999999999999999999987655555556678899999999999999999999999999999
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcc
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 373 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~ 373 (611)
|||||+||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||++.....
T Consensus 96 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~--- 170 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD--- 170 (329)
T ss_pred EEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC---
Confidence 99999999999988875 5689999999999999999999999999999999999999999999999999843210
Q ss_pred ccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccc
Q 007260 374 LIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMS 453 (611)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (611)
....
T Consensus 171 ----------------------------------------------------------------------------~~~~ 174 (329)
T PTZ00263 171 ----------------------------------------------------------------------------RTFT 174 (329)
T ss_pred ----------------------------------------------------------------------------Ccce
Confidence 0112
Q ss_pred cccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007260 454 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVK 533 (611)
Q Consensus 454 ~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~ 533 (611)
.+||+.|+|||++.+..++.++|||||||++|||++|+.||.+......+..+....+.+|.. ++..+++||.+||..
T Consensus 175 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~--~~~~~~~li~~~L~~ 252 (329)
T PTZ00263 175 LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNW--FDGRARDLVKGLLQT 252 (329)
T ss_pred ecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCC--CCHHHHHHHHHHhhc
Confidence 469999999999999999999999999999999999999999888777788888777766654 899999999999999
Q ss_pred CccccCCc-hhcHHHHHcCCCCCCCchhhhc
Q 007260 534 EPQHRLAY-KRGATEIKQHPFFEGVNWALIR 563 (611)
Q Consensus 534 dP~~Rpt~-~~~a~elL~Hp~f~~~~~~~~~ 563 (611)
||.+|++. ...+++|+.||||.+++|....
T Consensus 253 dP~~R~~~~~~~~~~ll~hp~f~~~~~~~~~ 283 (329)
T PTZ00263 253 DHTKRLGTLKGGVADVKNHPYFHGANWDKLY 283 (329)
T ss_pred CHHHcCCCCCCCHHHHhcCCccCCCCHHHHH
Confidence 99999973 2347999999999999998653
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-50 Score=430.45 Aligned_cols=302 Identities=35% Similarity=0.593 Sum_probs=237.3
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
++|++++.||+|+||+||+|++..+++.||||++.+...........+++|+.++..++|+||+++++.|.+...+||||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998766555556667889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
|||+||+|.+++.+. +.+++..++.++.||+.||+|||++|||||||||+||||+.+|++||+|||++..+.......
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 81 EFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred cCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 999999999998875 569999999999999999999999999999999999999999999999999985443111000
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
.... . .... +..+.......+.. ...............+
T Consensus 159 ~~~~--------~------~~~~-----------~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~ 197 (363)
T cd05628 159 FYRN--------L------NHSL-----------PSDFTFQNMNSKRK----------------AETWKRNRRQLAFSTV 197 (363)
T ss_pred cccc--------c------cccc-----------cccccccccccccc----------------cchhhhcccccccccc
Confidence 0000 0 0000 00000000000000 0000000111224568
Q ss_pred cCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHc--CCCCCCCCCCCCHHHHHHHHHhhhc
Q 007260 456 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG--QPLRFPESPVVSFAARDLIRGLLVK 533 (611)
Q Consensus 456 GT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~--~~l~~p~~~~~s~~l~dLI~~~L~~ 533 (611)
||+.|+|||++.+..++.++|||||||+||||++|+.||.+....+.+.++.. ..+.+|....+++++++||.+|+.
T Consensus 198 Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~- 276 (363)
T cd05628 198 GTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC- 276 (363)
T ss_pred CCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-
Confidence 99999999999999999999999999999999999999998887777777765 345667666689999999999886
Q ss_pred Ccccc---CCchhcHHHHHcCCCCCCCchhhhccC
Q 007260 534 EPQHR---LAYKRGATEIKQHPFFEGVNWALIRCA 565 (611)
Q Consensus 534 dP~~R---pt~~~~a~elL~Hp~f~~~~~~~~~~~ 565 (611)
+|.+| |+ ++||++||||++++|..+...
T Consensus 277 ~~~~r~~r~~----~~ei~~hp~f~~~~~~~~~~~ 307 (363)
T cd05628 277 EWEHRIGAPG----VEEIKTNPFFEGVDWEHIRER 307 (363)
T ss_pred ChhhcCCCCC----HHHHhCCCCCCCCCHHHHHhC
Confidence 66665 56 999999999999999987654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-50 Score=435.20 Aligned_cols=308 Identities=33% Similarity=0.581 Sum_probs=235.0
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
+.|++++.||+|+||+||+|++..+++.||||++.+...........+.+|+.+|+.++|||||+++++|.+.+++||||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 36999999999999999999999999999999998876666666778889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
|||+||+|.+++.+. ..+++..++.++.||+.||+|||.+|||||||||+||||+.+|++||+|||++..+.......
T Consensus 81 E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 81 DYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred ecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 999999999998775 569999999999999999999999999999999999999999999999999985432111000
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCC---CCCCCCCcccccccccCCCCccccCCCCCCCcc-cccCcccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCV---TPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPE-LIAEPTEARS 451 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 451 (611)
. ......+...-..+... ...|....... .+.. ..........
T Consensus 159 ~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~ 205 (381)
T cd05626 159 Y---------------YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLK------------------TLEQRATKQHQRCLA 205 (381)
T ss_pred c---------------ccccccccccccCcccccccccccccccccc------------------hhhcccccccccccc
Confidence 0 00000000000000000 00000000000 0000 0000011123
Q ss_pred cccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHc--CCCCCCCCCCCCHHHHHHHHH
Q 007260 452 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG--QPLRFPESPVVSFAARDLIRG 529 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~--~~l~~p~~~~~s~~l~dLI~~ 529 (611)
.+++||+.|+|||++.+..++.++|||||||++|||++|+.||......+...+++. ..+.+|....++.++++||.+
T Consensus 206 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ 285 (381)
T cd05626 206 HSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITK 285 (381)
T ss_pred ccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHH
Confidence 467899999999999999999999999999999999999999998777766666664 345566666789999999999
Q ss_pred hhhc--CccccCCchhcHHHHHcCCCCCCCchhhh
Q 007260 530 LLVK--EPQHRLAYKRGATEIKQHPFFEGVNWALI 562 (611)
Q Consensus 530 ~L~~--dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~ 562 (611)
||.. ++..|++ +.+|++||||++++|...
T Consensus 286 ll~~~~~~~~R~~----~~~~l~hp~f~~~~~~~~ 316 (381)
T cd05626 286 LCCSAEERLGRNG----ADDIKAHPFFSEVDFSSD 316 (381)
T ss_pred HccCcccccCCCC----HHHHhcCcccCCCChhHH
Confidence 7654 4445999 999999999999999653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-50 Score=430.94 Aligned_cols=315 Identities=36% Similarity=0.629 Sum_probs=242.4
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
++|++++.||.|+||+||+|++..+++.||||++.+...........+++|+.+|+.++||||++++++|.++..+||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 37999999999999999999999999999999998765555556667889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
|||+||+|.+++... ..+++..++.|+.||+.||+|||++||+||||||+||||+.+|.++|+|||++..+.......
T Consensus 81 E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 81 EYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred CCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 999999999998765 469999999999999999999999999999999999999999999999999985432111000
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
........ .....+.+...... .. .................+
T Consensus 159 ~~~~~~~~---------------------~~~~~~~~~~~~~~-~~----------------~~~~~~~~~~~~~~~~~~ 200 (364)
T cd05599 159 FYRILSHA---------------------LPSNFLDFISKPMS-SK----------------RKAETWKRNRRALAYSTV 200 (364)
T ss_pred cccccccc---------------------cccccccccccccc-cc----------------ccccchhhcccccccccc
Confidence 00000000 00000000000000 00 000000000111223468
Q ss_pred cCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcC--CCCCCCCCCCCHHHHHHHHHhhhc
Q 007260 456 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ--PLRFPESPVVSFAARDLIRGLLVK 533 (611)
Q Consensus 456 GT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~--~l~~p~~~~~s~~l~dLI~~~L~~ 533 (611)
||+.|+|||++.+..++.++|||||||++|||++|..||.+......+.++... .+.+|....+++++++||.+||.
T Consensus 201 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~- 279 (364)
T cd05599 201 GTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC- 279 (364)
T ss_pred cCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-
Confidence 999999999999999999999999999999999999999988877777666643 34555555689999999999996
Q ss_pred CccccCCchhcHHHHHcCCCCCCCchhhhccCCCCCCCC
Q 007260 534 EPQHRLAYKRGATEIKQHPFFEGVNWALIRCATPPEIPK 572 (611)
Q Consensus 534 dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~p~~p~ 572 (611)
+|.+|++. ..+.++++||||.+++|...+...++.+|.
T Consensus 280 ~p~~R~~~-~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~ 317 (364)
T cd05599 280 EAERRLGN-NGVNEIKSHPFFKGVDWEHIRERPAPIIPE 317 (364)
T ss_pred CHhhcCCC-CCHHHHhcCCCcCCCCHHHHhhcCCCCCCC
Confidence 99999974 349999999999999998766555554443
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-50 Score=433.64 Aligned_cols=321 Identities=35% Similarity=0.608 Sum_probs=241.1
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
++|++++.||.|+||.||+|++..+++.||||++.+..........++.+|+++|+.++|||||+++++|.+..++||||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 37999999999999999999999999999999998765555556677889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
|||+||+|.+++... +.+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||++..+.......
T Consensus 81 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 81 EFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 999999999998765 569999999999999999999999999999999999999999999999999985432111000
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
.... ..... .+..+ .........+... ........ + ............+.+
T Consensus 159 ~~~~----~~~~~-------~~~~~------~~~~~~~~~~~~~----~~~~~~~~-------~-~~~~~~~~~~~~~~~ 209 (377)
T cd05629 159 YYQK----LLQGK-------SNKNR------IDNRNSVAVDSIN----LTMSSKDQ-------I-ATWKKNRRLMAYSTV 209 (377)
T ss_pred cccc----ccccc-------ccccc------ccccccccccccc----ccccchhh-------h-hhhhhcccccccccC
Confidence 0000 00000 00000 0000000000000 00000000 0 000000011122468
Q ss_pred cCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHc--CCCCCCCCCCCCHHHHHHHHHhhhc
Q 007260 456 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG--QPLRFPESPVVSFAARDLIRGLLVK 533 (611)
Q Consensus 456 GT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~--~~l~~p~~~~~s~~l~dLI~~~L~~ 533 (611)
||+.|+|||++.+..++.++|||||||+||||++|++||.+......+..+.. ..+.+|....++.++++||.+||.
T Consensus 210 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~- 288 (377)
T cd05629 210 GTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT- 288 (377)
T ss_pred CCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-
Confidence 99999999999999999999999999999999999999998777666666654 345566666689999999999997
Q ss_pred CccccC---CchhcHHHHHcCCCCCCCchhhhccCCCCCCCC
Q 007260 534 EPQHRL---AYKRGATEIKQHPFFEGVNWALIRCATPPEIPK 572 (611)
Q Consensus 534 dP~~Rp---t~~~~a~elL~Hp~f~~~~~~~~~~~~~p~~p~ 572 (611)
+|.+|+ + +.++++||||.+++|+..+...+|.+|.
T Consensus 289 ~~~~r~~r~~----~~~~l~hp~~~~~~~~~~~~~~~~~~~~ 326 (377)
T cd05629 289 NAENRLGRGG----AHEIKSHPFFRGVDWDTIRQIRAPFIPQ 326 (377)
T ss_pred CHhhcCCCCC----HHHHhcCCCcCCCCHHHHccCCCCcccC
Confidence 888775 6 9999999999999998887666666554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-52 Score=403.32 Aligned_cols=259 Identities=35% Similarity=0.594 Sum_probs=241.4
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSC 292 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~ 292 (611)
+.+++|.+++.||.|.||.||+|+.+.++-.||+|++.|..+.......++.+|++|-..|+||||+++|++|.++..+|
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riy 98 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIY 98 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeE
Confidence 34679999999999999999999999999999999999998877777778899999999999999999999999999999
Q ss_pred EEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCc
Q 007260 293 LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 293 LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~ 372 (611)
|++||.++|+|+..++.++.+.|++..+..|+.|++.||.|||..+||||||||||+|++.+|.+||+|||.+..
T Consensus 99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~----- 173 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVH----- 173 (281)
T ss_pred EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceee-----
Confidence 999999999999999987788999999999999999999999999999999999999999999999999998721
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
.+ ..+.+
T Consensus 174 ------------------------------------------------------------------------~p-~~kR~ 180 (281)
T KOG0580|consen 174 ------------------------------------------------------------------------AP-SNKRK 180 (281)
T ss_pred ------------------------------------------------------------------------cC-CCCce
Confidence 01 23445
Q ss_pred ccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007260 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLV 532 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~ 532 (611)
++|||..|++||+..+..++..+|+|++|++.||+|.|.+||......+++.+|....+.+|. .++.+++|||.+||.
T Consensus 181 tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~--~is~~a~dlI~~ll~ 258 (281)
T KOG0580|consen 181 TLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPS--TISGGAADLISRLLV 258 (281)
T ss_pred eeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCc--ccChhHHHHHHHHhc
Confidence 789999999999999999999999999999999999999999999988999999999888885 499999999999999
Q ss_pred cCccccCCchhcHHHHHcCCCCC
Q 007260 533 KEPQHRLAYKRGATEIKQHPFFE 555 (611)
Q Consensus 533 ~dP~~Rpt~~~~a~elL~Hp~f~ 555 (611)
++|.+|++ ..|++.|||..
T Consensus 259 ~~p~~r~~----l~~v~~hpwI~ 277 (281)
T KOG0580|consen 259 KNPIERLA----LTEVMDHPWIV 277 (281)
T ss_pred cCcccccc----HHHHhhhHHHH
Confidence 99999999 99999999975
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-51 Score=430.60 Aligned_cols=268 Identities=34% Similarity=0.605 Sum_probs=230.1
Q ss_pred ccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhH-----------HHHHHHHHHHHHHHhCCCCCcc
Q 007260 211 GVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGR-----------KKLLRAQTEREILQSLDHPFLP 279 (611)
Q Consensus 211 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~-----------~~~~~~~~E~~iL~~l~HpnIv 279 (611)
+...+++|++++.||.|.||.|-+|++..+++.||||++.|..+... .-+.++++||.||++|+|||||
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV 171 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV 171 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence 44557899999999999999999999999999999999988654321 1234778999999999999999
Q ss_pred cccceeec--cceeeEEeeeCCCCCHHHHHHhCCCCC-CCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCc
Q 007260 280 TLYTHFET--EKFSCLVMEFCPGGDLHTLRQKQPGKY-FPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGH 356 (611)
Q Consensus 280 ~l~~~~~~--~~~~~LVmE~~~gg~L~~ll~~~~~~~-l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~ 356 (611)
+|+++..+ .+.+|||+|||..|.+...- ..+. +++.+++.|+++++.||+|||.+|||||||||.|+||+++|+
T Consensus 172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 172 KLIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EEEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCc
Confidence 99999876 57899999999988886532 2344 999999999999999999999999999999999999999999
Q ss_pred EEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCC
Q 007260 357 IMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQV 436 (611)
Q Consensus 357 vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (611)
|||+|||.+.....+.
T Consensus 249 VKIsDFGVs~~~~~~~---------------------------------------------------------------- 264 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGS---------------------------------------------------------------- 264 (576)
T ss_pred EEeeccceeeecccCC----------------------------------------------------------------
Confidence 9999999873221000
Q ss_pred CCCcccccCcccccccccccCCCccchhhhccCC---C-CChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCC
Q 007260 437 SPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEG---H-GSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLR 512 (611)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~---~-~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~ 512 (611)
.+..+......+|||.|+|||.+.++. + +.+.|||||||+||.|++|+.||-+....+.+.+|+..++.
T Consensus 265 -------~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~pL~ 337 (576)
T KOG0585|consen 265 -------DEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDPLE 337 (576)
T ss_pred -------ccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCccc
Confidence 000111112358999999999998843 3 88999999999999999999999999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCC
Q 007260 513 FPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 513 ~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
||..+.+.+.++|||.+||.+||++|++ +.+|+.|||...
T Consensus 338 fP~~pe~~e~~kDli~~lL~KdP~~Ri~----l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 338 FPENPEINEDLKDLIKRLLEKDPEQRIT----LPDIKLHPWVTR 377 (576)
T ss_pred CCCcccccHHHHHHHHHHhhcChhheee----hhhheecceecc
Confidence 9999999999999999999999999999 899999999863
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-50 Score=418.24 Aligned_cols=265 Identities=36% Similarity=0.709 Sum_probs=233.9
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
++|++++.||.|+||.||+|.+..+++.||||++........+....+.+|+++|+.++||||+++++++.++..+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 37999999999999999999999999999999997665444445567788999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~----- 153 (291)
T cd05612 81 EYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD----- 153 (291)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC-----
Confidence 999999999998775 5689999999999999999999999999999999999999999999999999732210
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
.....+
T Consensus 154 --------------------------------------------------------------------------~~~~~~ 159 (291)
T cd05612 154 --------------------------------------------------------------------------RTWTLC 159 (291)
T ss_pred --------------------------------------------------------------------------Cccccc
Confidence 011246
Q ss_pred cCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCc
Q 007260 456 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEP 535 (611)
Q Consensus 456 GT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP 535 (611)
||+.|+|||++.+..++.++|||||||++|+|++|+.||.+......+..+......+|.. ++..+++||.+||..||
T Consensus 160 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~~~li~~~l~~dp 237 (291)
T cd05612 160 GTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRH--LDLYAKDLIKKLLVVDR 237 (291)
T ss_pred CChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCcc--CCHHHHHHHHHHcCCCH
Confidence 9999999999999999999999999999999999999999988777778888777777654 79999999999999999
Q ss_pred cccCC-chhcHHHHHcCCCCCCCchhhhc
Q 007260 536 QHRLA-YKRGATEIKQHPFFEGVNWALIR 563 (611)
Q Consensus 536 ~~Rpt-~~~~a~elL~Hp~f~~~~~~~~~ 563 (611)
.+|++ ++..+.++++||||..++|....
T Consensus 238 ~~R~~~~~~~~~~~l~h~~~~~~~~~~~~ 266 (291)
T cd05612 238 TRRLGNMKNGADDVKNHRWFKSVDWDDVP 266 (291)
T ss_pred HHccCCccCCHHHHhcCccccCCCHHHHh
Confidence 99994 22349999999999999997643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-50 Score=424.43 Aligned_cols=262 Identities=38% Similarity=0.706 Sum_probs=228.2
Q ss_pred eEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEeeeCCCC
Q 007260 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGG 301 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE~~~gg 301 (611)
+.||+|+||.||+|++..+++.||||++.+..........++.+|+.+|+.++||||++++++|...+.+||||||++|+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998766555556667788999999999999999999999999999999999999
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccccCC
Q 007260 302 DLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLD 381 (611)
Q Consensus 302 ~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~ 381 (611)
+|.+++... +.+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||++.....
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~----------- 147 (323)
T cd05571 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS----------- 147 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc-----------
Confidence 999988765 5699999999999999999999999999999999999999999999999999732110
Q ss_pred CCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCcc
Q 007260 382 AEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYL 461 (611)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~ 461 (611)
.......++||+.|+
T Consensus 148 -----------------------------------------------------------------~~~~~~~~~gt~~y~ 162 (323)
T cd05571 148 -----------------------------------------------------------------DGATMKTFCGTPEYL 162 (323)
T ss_pred -----------------------------------------------------------------CCCcccceecCcccc
Confidence 000112357999999
Q ss_pred chhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccCCc
Q 007260 462 APEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAY 541 (611)
Q Consensus 462 APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~ 541 (611)
|||++.+..++.++|||||||++|||++|+.||.+.+....+..+......+|. .++.++++||.+||.+||++||+.
T Consensus 163 aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~ 240 (323)
T cd05571 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR--TLSPEAKSLLAGLLKKDPKQRLGG 240 (323)
T ss_pred ChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHccCCHHHcCCC
Confidence 999999999999999999999999999999999987777777777777766665 489999999999999999999931
Q ss_pred h-hcHHHHHcCCCCCCCchhhhc
Q 007260 542 K-RGATEIKQHPFFEGVNWALIR 563 (611)
Q Consensus 542 ~-~~a~elL~Hp~f~~~~~~~~~ 563 (611)
. ..+.+|++||||.+++|....
T Consensus 241 ~~~~~~~ll~h~~f~~~~~~~~~ 263 (323)
T cd05571 241 GPEDAKEIMEHRFFASINWQDVV 263 (323)
T ss_pred CCCCHHHHHcCCCcCCCCHHHHH
Confidence 1 129999999999999998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-51 Score=414.67 Aligned_cols=261 Identities=27% Similarity=0.379 Sum_probs=222.0
Q ss_pred cccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec--ccee
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET--EKFS 291 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~--~~~~ 291 (611)
.++.|+.+.+|++|+||.||+|+++.|++.||+|.++... ..........+||.+|.+++|||||.+.++... -+.+
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc-ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 3568999999999999999999999999999999997654 222334455789999999999999999998874 4679
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCC
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~ 371 (611)
|||||||+ -||..++...+ ..|.+.+++.++.|+|.||+|||.++|+||||||+|+|++..|.+||+|||||+.++..
T Consensus 153 y~VMe~~E-hDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 153 YIVMEYVE-HDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred eeeHHHHH-hhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 99999995 59999999874 67999999999999999999999999999999999999999999999999999655411
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
. ...
T Consensus 231 ~----------------------------------------------------------------------------k~~ 234 (419)
T KOG0663|consen 231 L----------------------------------------------------------------------------KPY 234 (419)
T ss_pred c----------------------------------------------------------------------------ccC
Confidence 0 112
Q ss_pred cccccCCCccchhhhccCC-CCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH---cCC----------------C
Q 007260 452 MSFVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVV---GQP----------------L 511 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~~~-~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~---~~~----------------l 511 (611)
+..|-|+||+|||++.|.. |+.++|+||+|||+.||+++++.|.|.+..+++.+|. +.+ .
T Consensus 235 T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~ 314 (419)
T KOG0663|consen 235 TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKM 314 (419)
T ss_pred cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhcc
Confidence 3458999999999999875 8999999999999999999999999999888876654 322 1
Q ss_pred CCCCC-----------CCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 512 RFPES-----------PVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 512 ~~p~~-----------~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
.|+.. ..+++...+|++++|.+||.+|.| |.|.|+|.||.+.
T Consensus 315 ~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~t----A~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 315 TFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRIT----AEDGLKHEYFRET 367 (419)
T ss_pred ccCCCCchhhhhhccccccchhHHHHHHHHhccCcccccc----HHHhhcccccccC
Confidence 12111 126689999999999999999999 9999999999863
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-51 Score=437.46 Aligned_cols=256 Identities=32% Similarity=0.572 Sum_probs=233.5
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
+++|.+.+.||+|+||+||+|+.+.+.+.||||+++|.. ...+.+..+++|++|++.|+|||||.++++|++..++|+|
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g-r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG-RNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcC-CchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence 358999999999999999999999999999999998865 3446677889999999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
.|||.| +|++++... +.++|+.++.++.+++.||.|||+++|+|||+||.|||+..+|++||||||+|+.+....
T Consensus 80 te~a~g-~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t-- 154 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQD--GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT-- 154 (808)
T ss_pred ehhhhh-hHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCc--
Confidence 999966 999999886 569999999999999999999999999999999999999999999999999995443211
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
...+++
T Consensus 155 --------------------------------------------------------------------------~vltsi 160 (808)
T KOG0597|consen 155 --------------------------------------------------------------------------SVLTSI 160 (808)
T ss_pred --------------------------------------------------------------------------eeeeec
Confidence 112345
Q ss_pred ccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcC
Q 007260 455 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKE 534 (611)
Q Consensus 455 vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~d 534 (611)
-|||.|||||++.+..|+..+|+||||||||||+.|++||...+-.+.+..|+..+..+|.. .+..++.||.++|.+|
T Consensus 161 kGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~--~S~~f~nfl~gLL~kd 238 (808)
T KOG0597|consen 161 KGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPST--ASSSFVNFLQGLLIKD 238 (808)
T ss_pred cCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCccc--ccHHHHHHHHHHhhcC
Confidence 69999999999999999999999999999999999999999988888889999999888874 9999999999999999
Q ss_pred ccccCCchhcHHHHHcCCCCCC
Q 007260 535 PQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 535 P~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
|.+|++ ..+++.|||+++
T Consensus 239 P~~Rlt----W~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 239 PAQRLT----WTDLLGHPFWKG 256 (808)
T ss_pred hhhccc----HHHHhcChHHhh
Confidence 999999 899999999875
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-50 Score=398.42 Aligned_cols=258 Identities=30% Similarity=0.475 Sum_probs=220.6
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
.+|..+++||+|.||.||+|++..+++.||||.++...... .....+.||+++|+.++|+||+.|+++|.+...+.||+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd-Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD-GINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc-CccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 47888999999999999999999999999999997654332 23345688999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
||+ ..||...++.. ...|+...++.|+.++++||+|||.++|+||||||.|+||+.+|.+||+|||+|+.+...
T Consensus 81 Efm-~tdLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p---- 154 (318)
T KOG0659|consen 81 EFM-PTDLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP---- 154 (318)
T ss_pred Eec-cccHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCC----
Confidence 999 56999888765 478999999999999999999999999999999999999999999999999999544311
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
+......|
T Consensus 155 ------------------------------------------------------------------------~~~~~~~V 162 (318)
T KOG0659|consen 155 ------------------------------------------------------------------------NRIQTHQV 162 (318)
T ss_pred ------------------------------------------------------------------------Ccccccce
Confidence 01111237
Q ss_pred cCCCccchhhhccCC-CCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH---HcCCC--CCCCC-------------
Q 007260 456 GTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNV---VGQPL--RFPES------------- 516 (611)
Q Consensus 456 GT~~Y~APEil~~~~-~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i---~~~~l--~~p~~------------- 516 (611)
-|.||+|||++.|.. |+..+||||.|||+.||+.|.+-|.|.++.+++..| ++.+. .||+.
T Consensus 163 ~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P 242 (318)
T KOG0659|consen 163 VTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFP 242 (318)
T ss_pred eeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCC
Confidence 899999999999875 799999999999999999999999999998887554 44431 12211
Q ss_pred --------CCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCC
Q 007260 517 --------PVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 517 --------~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
+..+.++.||+.+||.+||.+|++ |.|+|+|+||.+
T Consensus 243 ~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rit----a~qaL~~~yf~~ 286 (318)
T KOG0659|consen 243 KPPLNNLFPAASSDALDLLSKMLTYNPKKRIT----ASQALKHPYFKS 286 (318)
T ss_pred CCccccccccccHHHHHHHHhhhccCchhccc----HHHHhcchhhhc
Confidence 236778899999999999999999 999999999974
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-50 Score=430.43 Aligned_cols=306 Identities=33% Similarity=0.580 Sum_probs=234.5
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
++|++++.||.|+||.||+|++..+++.||||++.+...........+.+|+++|+.++||||+++++.|.+++.+||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998766555555667889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
|||+||+|.+++.+. +.+++..++.++.||+.||+|||++|||||||||+||||+.++++||+|||++..+.......
T Consensus 81 E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 81 DYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 999999999998775 568999999999999999999999999999999999999999999999999984332111000
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCccc-ccCccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPEL-IAEPTEARSMSF 454 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 454 (611)
..... ...... .. . . +........ ....++... ...........+
T Consensus 159 ~~~~~--~~~~~~------~~-------~--------~-~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~ 204 (376)
T cd05598 159 YYQKG--DHHRQD------SM-------E--------P-SEEWSEIDR----------CRLKPLERRRKRQHQRCLAHSL 204 (376)
T ss_pred ccccc--cccccc------cc-------c--------c-ccccccccc----------ccccchhhhhhhhccccccccc
Confidence 00000 000000 00 0 0 000000000 000000000 000111223457
Q ss_pred ccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcC--CCCCCCCCCCCHHHHHHHHHhhh
Q 007260 455 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ--PLRFPESPVVSFAARDLIRGLLV 532 (611)
Q Consensus 455 vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~--~l~~p~~~~~s~~l~dLI~~~L~ 532 (611)
+||+.|||||++.+..++.++|||||||+||||++|+.||.+....+.+..+... .+.++....++.++.+||.+|+
T Consensus 205 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~- 283 (376)
T cd05598 205 VGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC- 283 (376)
T ss_pred CCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-
Confidence 8999999999999999999999999999999999999999988777666665543 3445555568999999999976
Q ss_pred cCccccC---CchhcHHHHHcCCCCCCCchhhh
Q 007260 533 KEPQHRL---AYKRGATEIKQHPFFEGVNWALI 562 (611)
Q Consensus 533 ~dP~~Rp---t~~~~a~elL~Hp~f~~~~~~~~ 562 (611)
.+|.+|+ + +.++++||||++++|...
T Consensus 284 ~~p~~R~~~~t----~~ell~h~~~~~~~~~~~ 312 (376)
T cd05598 284 CGAEDRLGKNG----ADEIKAHPFFKGIDFASL 312 (376)
T ss_pred cCHhhcCCCCC----HHHHhCCCCcCCCCHHHH
Confidence 5999999 7 999999999999999776
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=422.95 Aligned_cols=268 Identities=35% Similarity=0.716 Sum_probs=234.1
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCC-eEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecccee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTK-CYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFS 291 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~-~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~ 291 (611)
+..++|.+++.||.|+||.||+|.+..++ ..||+|++.+...........+.+|+.+|+.++||||++++++|.+++.+
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 106 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYL 106 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEE
Confidence 34578999999999999999999976654 68999999876655555666788999999999999999999999999999
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCC
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~ 371 (611)
||||||++||+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++.....
T Consensus 107 ~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~- 183 (340)
T PTZ00426 107 YLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT- 183 (340)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC-
Confidence 9999999999999998875 5699999999999999999999999999999999999999999999999999832210
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
..
T Consensus 184 ------------------------------------------------------------------------------~~ 185 (340)
T PTZ00426 184 ------------------------------------------------------------------------------RT 185 (340)
T ss_pred ------------------------------------------------------------------------------Cc
Confidence 01
Q ss_pred cccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 007260 452 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLL 531 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L 531 (611)
...+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+......++......+|.. ++..+++||++||
T Consensus 186 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~--~~~~~~~li~~~l 263 (340)
T PTZ00426 186 YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKF--LDNNCKHLMKKLL 263 (340)
T ss_pred ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCC--CCHHHHHHHHHHc
Confidence 13469999999999999999999999999999999999999999887777777887777666654 8999999999999
Q ss_pred hcCccccCCc-hhcHHHHHcCCCCCCCchhhhc
Q 007260 532 VKEPQHRLAY-KRGATEIKQHPFFEGVNWALIR 563 (611)
Q Consensus 532 ~~dP~~Rpt~-~~~a~elL~Hp~f~~~~~~~~~ 563 (611)
..||.+|++. +..++++++||||++++|....
T Consensus 264 ~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~ 296 (340)
T PTZ00426 264 SHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLL 296 (340)
T ss_pred ccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHH
Confidence 9999999731 1239999999999999997654
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=418.57 Aligned_cols=265 Identities=37% Similarity=0.698 Sum_probs=227.8
Q ss_pred eEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHH---HhCCCCCcccccceeeccceeeEE
Q 007260 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREIL---QSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 218 y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL---~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
|++++.||+|+||.||+|++..+++.||||++.+...........+.+|+.++ +.++||||++++++|...+.+|||
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78999999999999999999999999999999876544444555666676655 566899999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
|||++|++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~---- 153 (324)
T cd05589 81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG---- 153 (324)
T ss_pred EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC----
Confidence 999999999887754 4599999999999999999999999999999999999999999999999998732110
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
.......+
T Consensus 154 ------------------------------------------------------------------------~~~~~~~~ 161 (324)
T cd05589 154 ------------------------------------------------------------------------FGDRTSTF 161 (324)
T ss_pred ------------------------------------------------------------------------CCCccccc
Confidence 00011235
Q ss_pred ccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcC
Q 007260 455 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKE 534 (611)
Q Consensus 455 vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~d 534 (611)
+||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+.+..+......+|.. ++..+.+||.+||..|
T Consensus 162 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~--~~~~~~~li~~~L~~d 239 (324)
T cd05589 162 CGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRF--LSREAISIMRRLLRRN 239 (324)
T ss_pred ccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCC--CCHHHHHHHHHHhhcC
Confidence 79999999999999999999999999999999999999999888777777777776666654 8999999999999999
Q ss_pred ccccCCchh-cHHHHHcCCCCCCCchhhhc
Q 007260 535 PQHRLAYKR-GATEIKQHPFFEGVNWALIR 563 (611)
Q Consensus 535 P~~Rpt~~~-~a~elL~Hp~f~~~~~~~~~ 563 (611)
|.+||+... .+.++++||||+.++|....
T Consensus 240 P~~R~~~~~~~~~~l~~~~~f~~~~~~~~~ 269 (324)
T cd05589 240 PERRLGSGEKDAEDVKKQPFFRDINWDDLL 269 (324)
T ss_pred HhHcCCCCCCCHHHHhhCCCcCCCCHHHHH
Confidence 999996432 49999999999999987653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=424.09 Aligned_cols=305 Identities=35% Similarity=0.624 Sum_probs=238.9
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
++|++++.||+|+||.||+|++..+++.||||++.+..........++++|+.+|..++||||+++++.|.+++.+||||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 37999999999999999999999999999999998766555566677889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
|||+||+|.+++.+. ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|+++|+|||++..+.......
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 81 EFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred eCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 999999999998765 569999999999999999999999999999999999999999999999999985443111000
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
....... . .+..++...+..+.. .+.............+
T Consensus 159 ~~~~~~~----------------~---------~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~ 197 (360)
T cd05627 159 FYRNLTH----------------N---------PPSDFSFQNMNSKRK----------------AETWKKNRRQLAYSTV 197 (360)
T ss_pred ccccccc----------------C---------Ccccccccccccccc----------------cccccccccccccccC
Confidence 0000000 0 000000000000000 0000111112233568
Q ss_pred cCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHc--CCCCCCCCCCCCHHHHHHHHHhhhc
Q 007260 456 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG--QPLRFPESPVVSFAARDLIRGLLVK 533 (611)
Q Consensus 456 GT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~--~~l~~p~~~~~s~~l~dLI~~~L~~ 533 (611)
||+.|+|||++.+..++.++|||||||+||||++|++||.+......+.++.. ..+.+|....++.++++||.+|+ .
T Consensus 198 gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~ 276 (360)
T cd05627 198 GTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-T 276 (360)
T ss_pred CCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-c
Confidence 99999999999999999999999999999999999999998887777766664 33556665568999999999987 5
Q ss_pred CccccCCchhcHHHHHcCCCCCCCchhhhccC
Q 007260 534 EPQHRLAYKRGATEIKQHPFFEGVNWALIRCA 565 (611)
Q Consensus 534 dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~ 565 (611)
||.+|++. ..+.++++||||++++|..+...
T Consensus 277 ~p~~R~~~-~~~~ei~~hp~f~~~~~~~~~~~ 307 (360)
T cd05627 277 DSENRIGS-NGVEEIKSHPFFEGVDWGHIRER 307 (360)
T ss_pred ChhhcCCC-CCHHHHhcCCCCCCCCHHHHhcC
Confidence 99999962 23899999999999999887544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=421.13 Aligned_cols=303 Identities=38% Similarity=0.694 Sum_probs=243.3
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
++|++++.||.|+||+||+|++..+++.||||++.+...........+.+|+.+|..++||||++++++|.+++++|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999998766555455667788999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
||++|++|.+++.+. ..+++..++.++.||+.||+|||.+||+||||||+||||+.++.+||+|||++..........
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 999999999998876 569999999999999999999999999999999999999999999999999985543221000
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
..... .. .. .+........ .............+
T Consensus 159 ~~~~~---------~~-------~~----------~~~~~~~~~~---------------------~~~~~~~~~~~~~~ 191 (350)
T cd05573 159 YYLND---------SH-------NL----------LFRDNVLVRR---------------------RDHKQRRVRANSTV 191 (350)
T ss_pred ccccc---------cc-------cc----------cccccccccc---------------------cccccccccccccc
Confidence 00000 00 00 0000000000 00000111223457
Q ss_pred cCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHc--CCCCCCCCCCCCHHHHHHHHHhhhc
Q 007260 456 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG--QPLRFPESPVVSFAARDLIRGLLVK 533 (611)
Q Consensus 456 GT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~--~~l~~p~~~~~s~~l~dLI~~~L~~ 533 (611)
||+.|+|||++.+..++.++|||||||+||||++|+.||.+........++.. ..+.+|....++.++++||.+||.
T Consensus 192 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~- 270 (350)
T cd05573 192 GTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC- 270 (350)
T ss_pred cCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-
Confidence 99999999999999999999999999999999999999999887777777776 566677776689999999999997
Q ss_pred CccccCCchhcHHHHHcCCCCCCCchhhhccCCCCCCC
Q 007260 534 EPQHRLAYKRGATEIKQHPFFEGVNWALIRCATPPEIP 571 (611)
Q Consensus 534 dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~p~~p 571 (611)
||.+|++. +.++++||||++++|.......++.+|
T Consensus 271 dp~~R~~s---~~~ll~hp~~~~~~~~~~~~~~~~~~~ 305 (350)
T cd05573 271 DPEDRLGS---FEEIKSHPFFKGIDWENLRETKPPFVP 305 (350)
T ss_pred ChhhcCCC---HHHHhcCCCcCCCCHHHHhhCCCCcCC
Confidence 99999985 789999999999999877654444444
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-49 Score=409.69 Aligned_cols=270 Identities=34% Similarity=0.570 Sum_probs=226.2
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVME 296 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE 296 (611)
.|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+|..++|+||+.++++|.+++.+|+|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 38899999999999999999999999999999987655444444556789999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccc
Q 007260 297 FCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIK 376 (611)
Q Consensus 297 ~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~ 376 (611)
|+++|+|..++.......+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~----- 155 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG----- 155 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-----
Confidence 999999998876654456999999999999999999999999999999999999999999999999998432100
Q ss_pred cccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccccc
Q 007260 377 ASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVG 456 (611)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vG 456 (611)
......+|
T Consensus 156 ------------------------------------------------------------------------~~~~~~~g 163 (285)
T cd05631 156 ------------------------------------------------------------------------ETVRGRVG 163 (285)
T ss_pred ------------------------------------------------------------------------CeecCCCC
Confidence 00112469
Q ss_pred CCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHH---HHH-HHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007260 457 THEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRAT---LFN-VVGQPLRFPESPVVSFAARDLIRGLLV 532 (611)
Q Consensus 457 T~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~---l~~-i~~~~l~~p~~~~~s~~l~dLI~~~L~ 532 (611)
|+.|+|||++.+..++.++|||||||+||||++|+.||.+...... +.. +......+ ...++.++.+||++||.
T Consensus 164 ~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~~li~~~l~ 241 (285)
T cd05631 164 TVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEY--SEKFSEDAKSICRMLLT 241 (285)
T ss_pred CCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccC--CccCCHHHHHHHHHHhh
Confidence 9999999999999999999999999999999999999987654322 222 22222223 33489999999999999
Q ss_pred cCccccCCch-hcHHHHHcCCCCCCCchhhhccC
Q 007260 533 KEPQHRLAYK-RGATEIKQHPFFEGVNWALIRCA 565 (611)
Q Consensus 533 ~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~~~ 565 (611)
.||.+|++.. ..++++++||||.+++|..+...
T Consensus 242 ~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~ 275 (285)
T cd05631 242 KNPKERLGCRGNGAAGVKQHPIFKNINFKRLEAN 275 (285)
T ss_pred cCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhC
Confidence 9999999743 23899999999999999887544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=428.58 Aligned_cols=312 Identities=34% Similarity=0.604 Sum_probs=236.4
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
++|++++.||+|+||+||+|++..+++.||||++.+...........+.+|+.+|+.++|||||++++.|.+++.+||||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 36999999999999999999999999999999998766555566677889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
|||+||+|.+++.+. +.+++..++.++.||+.||+|||++|||||||||+||||+.+|++||+|||++..+.......
T Consensus 81 E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 81 DYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 999999999998775 568999999999999999999999999999999999999999999999999984332111000
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccc-cCccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELI-AEPTEARSMSF 454 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 454 (611)
.....+ ..+.... . ..........|.... ...+..... .........++
T Consensus 159 ~~~~~~--~~~~~~~--------~--~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~ 208 (382)
T cd05625 159 YYQSGD--HVRQDSM--------D--FSNEWGDPANCRCGD------------------RLKPLERRAARQHQRCLAHSL 208 (382)
T ss_pred cccccc--ccccccc--------c--ccccccccccccccc------------------cccchhhhhcccccccccccc
Confidence 000000 0000000 0 000000000000000 000000000 00011122457
Q ss_pred ccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHc--CCCCCCCCCCCCHHHHHHHHHhhh
Q 007260 455 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG--QPLRFPESPVVSFAARDLIRGLLV 532 (611)
Q Consensus 455 vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~--~~l~~p~~~~~s~~l~dLI~~~L~ 532 (611)
+||+.|+|||++.+..++.++|||||||+||||++|++||.+....+.+.+++. ..+.+|....+++++.+||.+|+
T Consensus 209 ~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~- 287 (382)
T cd05625 209 VGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC- 287 (382)
T ss_pred ccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-
Confidence 899999999999999999999999999999999999999998887777777665 34556666678999999999976
Q ss_pred cCccccCCchhcHHHHHcCCCCCCCchhh
Q 007260 533 KEPQHRLAYKRGATEIKQHPFFEGVNWAL 561 (611)
Q Consensus 533 ~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~ 561 (611)
.+|.+|++ +..++++++||||++++|..
T Consensus 288 ~~p~~R~~-~~~~~ei~~hp~f~~~~~~~ 315 (382)
T cd05625 288 RGPEDRLG-KNGADEIKAHPFFKTIDFSS 315 (382)
T ss_pred cCHhHcCC-CCCHHHHhcCCCcCCcChHH
Confidence 59999997 34589999999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=427.51 Aligned_cols=260 Identities=30% Similarity=0.459 Sum_probs=221.4
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecc--ceee
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE--KFSC 292 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~--~~~~ 292 (611)
.+.|+.+++||+|+||.||+|++..+++.||+|.++.+... .....-+.+||.||++|+||||++|.+...+. ..+|
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~-~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK-EGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC-CcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 46899999999999999999999999999999999876533 34455567899999999999999999998765 7899
Q ss_pred EEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCc
Q 007260 293 LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 293 LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~ 372 (611)
||+|||+. ||.-++.. ++-.|++.+++.|+.||+.||+|||.+||+|||||.+||||+.+|.+||+|||||+.+....
T Consensus 195 lVFeYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred EEEecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 99999955 88887765 45679999999999999999999999999999999999999999999999999996443211
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
....+
T Consensus 273 ---------------------------------------------------------------------------~~~~T 277 (560)
T KOG0600|consen 273 ---------------------------------------------------------------------------SAPYT 277 (560)
T ss_pred ---------------------------------------------------------------------------Ccccc
Confidence 11133
Q ss_pred ccccCCCccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH---cCCC-------CCCC------
Q 007260 453 SFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVV---GQPL-------RFPE------ 515 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~-~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~---~~~l-------~~p~------ 515 (611)
..|-|+||+|||++.|. .|+.++|+||+||||.||+.|++.|.|.++.+++..|. +.+- ++|.
T Consensus 278 ~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp 357 (560)
T KOG0600|consen 278 SRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKP 357 (560)
T ss_pred cceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCC
Confidence 56899999999999987 48999999999999999999999999999888876554 3321 1221
Q ss_pred -----------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCC
Q 007260 516 -----------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 516 -----------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
...++..+.+|+..||+.||.+|.| |.++|+|+||..
T Consensus 358 ~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~t----A~~aL~seyF~t 405 (560)
T KOG0600|consen 358 QQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGT----ASSALQSEYFTT 405 (560)
T ss_pred CCcccchHHHHhccCCHHHHHHHHHHhccCcccccc----HHHHhcCccccc
Confidence 1237888999999999999999999 999999999953
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-49 Score=415.62 Aligned_cols=262 Identities=38% Similarity=0.721 Sum_probs=226.4
Q ss_pred eEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEeeeCCCC
Q 007260 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGG 301 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE~~~gg 301 (611)
+.||+|+||.||+|++..+++.||||++.+..........++.+|+.+|+.++||||++++++|..++.+||||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765555556667788999999999999999999999999999999999999
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccccCC
Q 007260 302 DLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLD 381 (611)
Q Consensus 302 ~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~ 381 (611)
+|..++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++......
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~---------- 148 (328)
T cd05593 81 ELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD---------- 148 (328)
T ss_pred CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc----------
Confidence 999888765 56999999999999999999999999999999999999999999999999997321100
Q ss_pred CCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCcc
Q 007260 382 AEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYL 461 (611)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~ 461 (611)
......++||+.|+
T Consensus 149 ------------------------------------------------------------------~~~~~~~~gt~~y~ 162 (328)
T cd05593 149 ------------------------------------------------------------------AATMKTFCGTPEYL 162 (328)
T ss_pred ------------------------------------------------------------------ccccccccCCcCcc
Confidence 00012346999999
Q ss_pred chhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccCCc
Q 007260 462 APEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAY 541 (611)
Q Consensus 462 APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~ 541 (611)
|||++.+..++.++|||||||+||||++|+.||.+.+....+..+......+|. .++.++.+||.+||.+||.+|++.
T Consensus 163 aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~ 240 (328)
T cd05593 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR--TLSADAKSLLSGLLIKDPNKRLGG 240 (328)
T ss_pred ChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCC--CCCHHHHHHHHHHcCCCHHHcCCC
Confidence 999999999999999999999999999999999987777666666666666665 489999999999999999999821
Q ss_pred h-hcHHHHHcCCCCCCCchhhhc
Q 007260 542 K-RGATEIKQHPFFEGVNWALIR 563 (611)
Q Consensus 542 ~-~~a~elL~Hp~f~~~~~~~~~ 563 (611)
. ..+.++++||||.+++|..+.
T Consensus 241 ~~~~~~~il~h~~~~~~~~~~~~ 263 (328)
T cd05593 241 GPDDAKEIMRHSFFTGVNWQDVY 263 (328)
T ss_pred CCCCHHHHhcCCCcCCCCHHHHH
Confidence 1 129999999999999997653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-49 Score=416.89 Aligned_cols=272 Identities=38% Similarity=0.623 Sum_probs=234.4
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
++|++++.||.|+||.||+|++..+++.||||++.+...........+.+|+++|..++||||+++++++..++..||||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998765554455667788999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----- 153 (333)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----
Confidence 999999999998765 5689999999999999999999999999999999999999999999999999832210
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
.....+
T Consensus 154 --------------------------------------------------------------------------~~~~~~ 159 (333)
T cd05600 154 --------------------------------------------------------------------------YANSVV 159 (333)
T ss_pred --------------------------------------------------------------------------ccCCcc
Confidence 112346
Q ss_pred cCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCC--CCCCCC----CCCCHHHHHHHHH
Q 007260 456 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQP--LRFPES----PVVSFAARDLIRG 529 (611)
Q Consensus 456 GT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~--l~~p~~----~~~s~~l~dLI~~ 529 (611)
||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+.... +..|.. ..++.++.+||.+
T Consensus 160 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 239 (333)
T cd05600 160 GSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITK 239 (333)
T ss_pred cCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHH
Confidence 9999999999999999999999999999999999999999877666655554322 222222 2468999999999
Q ss_pred hhhcCccccCCchhcHHHHHcCCCCCCCchhhhccCCCCCCCC
Q 007260 530 LLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIRCATPPEIPK 572 (611)
Q Consensus 530 ~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~p~~p~ 572 (611)
||..+|.+|++ +.++++||||..++|.......++.+|.
T Consensus 240 ~l~~~~~rr~s----~~~ll~h~~~~~~~~~~~~~~~~~~~~~ 278 (333)
T cd05600 240 LINDPSRRFGS----LEDIKNHPFFKEVDWNELRELKPPFVPE 278 (333)
T ss_pred HhhChhhhcCC----HHHHHhCcccCCCCHHHHhhCCCCCCCC
Confidence 99999999999 9999999999999998877555554444
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-49 Score=414.08 Aligned_cols=262 Identities=38% Similarity=0.704 Sum_probs=227.0
Q ss_pred eEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEeeeCCCC
Q 007260 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGG 301 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE~~~gg 301 (611)
+.||+|+||.||++++..++..||+|++.+...........+.+|+.+|+.++||||++++++|...+.+||||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765555555667788999999999999999999999999999999999999
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccccCC
Q 007260 302 DLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLD 381 (611)
Q Consensus 302 ~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~ 381 (611)
+|..++.+. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++......
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~---------- 148 (323)
T cd05595 81 ELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD---------- 148 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC----------
Confidence 999888765 56999999999999999999999999999999999999999999999999987321000
Q ss_pred CCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCcc
Q 007260 382 AEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYL 461 (611)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~ 461 (611)
......++||+.|+
T Consensus 149 ------------------------------------------------------------------~~~~~~~~gt~~y~ 162 (323)
T cd05595 149 ------------------------------------------------------------------GATMKTFCGTPEYL 162 (323)
T ss_pred ------------------------------------------------------------------CCccccccCCcCcC
Confidence 00011346999999
Q ss_pred chhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccCCc
Q 007260 462 APEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAY 541 (611)
Q Consensus 462 APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~ 541 (611)
|||++.+..++.++|||||||++|||++|+.||.+.+....+..+......+|. .++.++++||.+||.+||.+|++.
T Consensus 163 aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~ 240 (323)
T cd05595 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR--TLSPEAKSLLAGLLKKDPKQRLGG 240 (323)
T ss_pred CcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCHHHHHHHHHHccCCHHHhCCC
Confidence 999999999999999999999999999999999988777777777777766665 489999999999999999999831
Q ss_pred h-hcHHHHHcCCCCCCCchhhhc
Q 007260 542 K-RGATEIKQHPFFEGVNWALIR 563 (611)
Q Consensus 542 ~-~~a~elL~Hp~f~~~~~~~~~ 563 (611)
. ..+.++++||||.+++|....
T Consensus 241 ~~~~~~~~l~h~~~~~~~~~~~~ 263 (323)
T cd05595 241 GPSDAKEVMEHRFFLSINWQDVV 263 (323)
T ss_pred CCCCHHHHHcCCCcCCCCHHHHH
Confidence 1 129999999999999997654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=421.85 Aligned_cols=284 Identities=36% Similarity=0.634 Sum_probs=250.7
Q ss_pred cccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeE
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCL 293 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~L 293 (611)
....|+.-++||.||||.||-++.+.||+.||+|.+.|..+..++.-..+.+|..||.+++.++||.|-..|++.+.+||
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 34689999999999999999999999999999999999998888777788999999999999999999999999999999
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcc
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 373 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~ 373 (611)
||..|+||||.-.+.+..+..|+|..+++|+++|+.||++||..+||+|||||+|||+|+.|||+|+|+|||..+..
T Consensus 263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~--- 339 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE--- 339 (591)
T ss_pred EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC---
Confidence 99999999999888887767899999999999999999999999999999999999999999999999999943220
Q ss_pred ccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccc
Q 007260 374 LIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMS 453 (611)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (611)
......
T Consensus 340 --------------------------------------------------------------------------g~~~~~ 345 (591)
T KOG0986|consen 340 --------------------------------------------------------------------------GKPIRG 345 (591)
T ss_pred --------------------------------------------------------------------------CCcccc
Confidence 011123
Q ss_pred cccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHcCCCCCCCCCCCCHHHHHHHHH
Q 007260 454 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGN----RATLFNVVGQPLRFPESPVVSFAARDLIRG 529 (611)
Q Consensus 454 ~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~----~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~ 529 (611)
.|||.+|||||++.++.|+..+|||+|||+||||+.|+.||+.... .+.-..++..+..+++ .+|+++++|.+.
T Consensus 346 rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~--kFS~eakslc~~ 423 (591)
T KOG0986|consen 346 RVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSD--KFSEEAKSLCEG 423 (591)
T ss_pred ccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhccc--ccCHHHHHHHHH
Confidence 3899999999999999999999999999999999999999986432 2334566677777775 499999999999
Q ss_pred hhhcCccccCCch-hcHHHHHcCCCCCCCchhhhc--cCCCCCCCCCCCc
Q 007260 530 LLVKEPQHRLAYK-RGATEIKQHPFFEGVNWALIR--CATPPEIPKPVEI 576 (611)
Q Consensus 530 ~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~--~~~~p~~p~p~~~ 576 (611)
+|++||.+|+..+ .+++++.+||||+++||..+. .-+||-+|.|-.+
T Consensus 424 LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp~aV 473 (591)
T KOG0986|consen 424 LLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDPGAV 473 (591)
T ss_pred HHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCcccc
Confidence 9999999999987 789999999999999998764 3467777776544
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-49 Score=414.67 Aligned_cols=276 Identities=36% Similarity=0.657 Sum_probs=237.2
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
++|.+.+.||+|+||+||+|++..+++.||||++.+...........+.+|+.+++.++|+||+++++++.+.+.+||||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 37999999999999999999999999999999998766545555667788999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
||++||+|.+++.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..+.....
T Consensus 81 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~-- 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-- 157 (330)
T ss_pred CCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc--
Confidence 9999999999988753 4699999999999999999999999999999999999999999999999999843221000
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
......+
T Consensus 158 -------------------------------------------------------------------------~~~~~~~ 164 (330)
T cd05601 158 -------------------------------------------------------------------------VNSKLPV 164 (330)
T ss_pred -------------------------------------------------------------------------eeeeccc
Confidence 0011236
Q ss_pred cCCCccchhhhc------cCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcC--CCCCCCCCCCCHHHHHHH
Q 007260 456 GTHEYLAPEIIK------GEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ--PLRFPESPVVSFAARDLI 527 (611)
Q Consensus 456 GT~~Y~APEil~------~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~--~l~~p~~~~~s~~l~dLI 527 (611)
||+.|+|||++. +..++.++|||||||++|||++|+.||........+.++... .+.+|....++.++++||
T Consensus 165 gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 244 (330)
T cd05601 165 GTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLI 244 (330)
T ss_pred CCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHH
Confidence 999999999997 456789999999999999999999999988777777766543 355676667899999999
Q ss_pred HHhhhcCccccCCchhcHHHHHcCCCCCCCchhhhccCCCCCCCC
Q 007260 528 RGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIRCATPPEIPK 572 (611)
Q Consensus 528 ~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~p~~p~ 572 (611)
.+||. ||.+|++ +.++++||||..++|..+....++..|.
T Consensus 245 ~~ll~-~p~~R~t----~~~l~~h~~~~~~~~~~~~~~~~~~~~~ 284 (330)
T cd05601 245 QSLLC-GQKERLG----YEGLCCHPFFSKIDWNNIRNSLPPFVPT 284 (330)
T ss_pred HHHcc-ChhhCCC----HHHHhCCCCcCCCCHHHHhhCCCCccCc
Confidence 99998 9999999 9999999999999999887655554443
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-49 Score=422.65 Aligned_cols=269 Identities=35% Similarity=0.658 Sum_probs=228.9
Q ss_pred ccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccce
Q 007260 211 GVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKF 290 (611)
Q Consensus 211 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~ 290 (611)
..+..++|++++.||.|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||++++++|.+++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 44556799999999999999999999999999999999987554444445567789999999999999999999999999
Q ss_pred eeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccC
Q 007260 291 SCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAV 370 (611)
Q Consensus 291 ~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~ 370 (611)
+|||||||+||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 99999999999999988753 489999999999999999999999999999999999999999999999999843210
Q ss_pred CccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccc
Q 007260 371 SPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEAR 450 (611)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (611)
. ....
T Consensus 195 ~---------------------------------------------------------------------------~~~~ 199 (370)
T cd05621 195 T---------------------------------------------------------------------------GMVR 199 (370)
T ss_pred C---------------------------------------------------------------------------Ccee
Confidence 0 0001
Q ss_pred ccccccCCCccchhhhccCC----CCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCC--CCCCCCCCCCHHHH
Q 007260 451 SMSFVGTHEYLAPEIIKGEG----HGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQP--LRFPESPVVSFAAR 524 (611)
Q Consensus 451 ~~~~vGT~~Y~APEil~~~~----~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~--l~~p~~~~~s~~l~ 524 (611)
....+||+.|+|||++.+.. ++.++|||||||+||||++|+.||.+.+....+.++.... +.+|....++..++
T Consensus 200 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~ 279 (370)
T cd05621 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAK 279 (370)
T ss_pred cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHH
Confidence 12356999999999998653 6889999999999999999999999888777777776543 56666667899999
Q ss_pred HHHHHhhhcCccc--cCCchhcHHHHHcCCCCCCCchhh
Q 007260 525 DLIRGLLVKEPQH--RLAYKRGATEIKQHPFFEGVNWAL 561 (611)
Q Consensus 525 dLI~~~L~~dP~~--Rpt~~~~a~elL~Hp~f~~~~~~~ 561 (611)
+||.+||..++.+ |++ +.++++||||+...|..
T Consensus 280 ~li~~~L~~~~~r~~R~~----~~e~l~hp~~~~~~~~~ 314 (370)
T cd05621 280 NLICAFLTDREVRLGRNG----VEEIKQHPFFKNDQWNW 314 (370)
T ss_pred HHHHHHccCchhccCCCC----HHHHhcCcccCCCCcCh
Confidence 9999999855543 778 99999999999866643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=411.32 Aligned_cols=267 Identities=35% Similarity=0.669 Sum_probs=230.7
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCC-CcccccceeeccceeeEEe
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHP-FLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~Hp-nIv~l~~~~~~~~~~~LVm 295 (611)
+|++++.||+|+||.||+|++..+++.||||++.+...........+..|+.++..+.|+ +|+.++++|...+.+||||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 589999999999999999999999999999999876554445556678899999999764 6889999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
||++||+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~---- 154 (324)
T cd05587 81 EYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG---- 154 (324)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC----
Confidence 999999999988765 46899999999999999999999999999999999999999999999999987321100
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
.......+
T Consensus 155 ------------------------------------------------------------------------~~~~~~~~ 162 (324)
T cd05587 155 ------------------------------------------------------------------------GKTTRTFC 162 (324)
T ss_pred ------------------------------------------------------------------------CCceeeec
Confidence 00112346
Q ss_pred cCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCc
Q 007260 456 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEP 535 (611)
Q Consensus 456 GT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP 535 (611)
||+.|+|||++.+..++.++|||||||++|||++|+.||.+......+..+......+|. .++.++.+||.+||.+||
T Consensus 163 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l~~~P 240 (324)
T cd05587 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK--SLSKEAVSICKGLLTKHP 240 (324)
T ss_pred CCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhhcCH
Confidence 999999999999999999999999999999999999999988887777788777766665 489999999999999999
Q ss_pred cccCCch-hcHHHHHcCCCCCCCchhhhc
Q 007260 536 QHRLAYK-RGATEIKQHPFFEGVNWALIR 563 (611)
Q Consensus 536 ~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~ 563 (611)
.+|++.. ....++++||||+.++|....
T Consensus 241 ~~R~~~~~~~~~~~~~hp~~~~~~~~~~~ 269 (324)
T cd05587 241 AKRLGCGPTGERDIREHAFFRRIDWEKLE 269 (324)
T ss_pred HHcCCCCCCCHHHHhcCCCcCCCCHHHHH
Confidence 9999842 235899999999999997653
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-51 Score=400.88 Aligned_cols=258 Identities=29% Similarity=0.519 Sum_probs=229.6
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
+.|.+.+.||+|.|+.||++.+..+|+.||+|+++-..+..+ ..+.+.+|+.|.+.|+|||||+|++.+..+.+.|||+
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 578888999999999999999999999999999987766655 5567789999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccC---CcEEEEeccccccccCCc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRED---GHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~---g~vkL~DFGlA~~~~~~~ 372 (611)
|++.|++|..-+-.+ ..++|..+-.+++|||+||.|||.+||||||+||+|+|+-.. --|||+|||+|..+. +.
T Consensus 90 e~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-~g 166 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-DG 166 (355)
T ss_pred ecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC-Cc
Confidence 999999997544433 468999999999999999999999999999999999999743 359999999995443 00
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
..-.
T Consensus 167 ----------------------------------------------------------------------------~~~~ 170 (355)
T KOG0033|consen 167 ----------------------------------------------------------------------------EAWH 170 (355)
T ss_pred ----------------------------------------------------------------------------cccc
Confidence 0112
Q ss_pred ccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCC--CCCCCCHHHHHHHHHh
Q 007260 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFP--ESPVVSFAARDLIRGL 530 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p--~~~~~s~~l~dLI~~~ 530 (611)
.++|||.|||||+++..+|+..+|||+.|||||-||.|.+||.+.+....+..|..+..+++ .++.+++++++||++|
T Consensus 171 G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrM 250 (355)
T KOG0033|consen 171 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRM 250 (355)
T ss_pred cccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHH
Confidence 46899999999999999999999999999999999999999999888888999998887765 5788999999999999
Q ss_pred hhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 531 LVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 531 L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
|..||.+|+| |.|+|+|||..+-
T Consensus 251 L~~dP~kRIt----a~EAL~HpWi~~r 273 (355)
T KOG0033|consen 251 LTVNPKKRIT----ADEALKHPWICNR 273 (355)
T ss_pred hccChhhhcc----HHHHhCCchhcch
Confidence 9999999999 9999999999753
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-51 Score=404.11 Aligned_cols=250 Identities=26% Similarity=0.416 Sum_probs=214.6
Q ss_pred cccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccc-eeeccce-e
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYT-HFETEKF-S 291 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~-~~~~~~~-~ 291 (611)
.+.+|+|++.||.|.||+||++.+..++..||.|.|.-.. .+.+.......|+.+|+.|+|||||++|+ .|..++. +
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~-md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl 95 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM-MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL 95 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh-ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence 3568999999999999999999999999999999997443 34455666778999999999999999999 4544444 8
Q ss_pred eEEeeeCCCCCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHH--cC--eeccCCCCCcEEEccCCcEEEEecccc
Q 007260 292 CLVMEFCPGGDLHTLRQK--QPGKYFPEQAVRFYVAEVLLALEYLHM--LG--IIYRDLKPENVLVREDGHIMLSDFDLS 365 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~--~~~~~l~e~~~~~i~~qll~aL~yLH~--~g--IVHRDLKPeNILv~~~g~vkL~DFGlA 365 (611)
+||||||.+|||..++++ ..++.++|..++.|+.|++.||.+||. .. |+||||||.||+++.+|.|||+||||+
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence 999999999999999874 345789999999999999999999999 44 999999999999999999999999999
Q ss_pred ccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccC
Q 007260 366 LRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAE 445 (611)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (611)
+.+...
T Consensus 176 r~l~s~-------------------------------------------------------------------------- 181 (375)
T KOG0591|consen 176 RFLSSK-------------------------------------------------------------------------- 181 (375)
T ss_pred hHhcch--------------------------------------------------------------------------
Confidence 654311
Q ss_pred cccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 007260 446 PTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARD 525 (611)
Q Consensus 446 ~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~d 525 (611)
.....++||||.||+||++.+.+|+.++|||||||++|||+.-++||.|.+-.....+|.++.+..-.....|.++..
T Consensus 182 --~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS~~l~~ 259 (375)
T KOG0591|consen 182 --TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYSTDLRE 259 (375)
T ss_pred --hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhhhHHHH
Confidence 112346899999999999999999999999999999999999999999996666667777775431111358999999
Q ss_pred HHHHhhhcCccccCC
Q 007260 526 LIRGLLVKEPQHRLA 540 (611)
Q Consensus 526 LI~~~L~~dP~~Rpt 540 (611)
||.-|++.||..||+
T Consensus 260 li~~ci~vd~~~RP~ 274 (375)
T KOG0591|consen 260 LINMCIAVDPEQRPD 274 (375)
T ss_pred HHHHHccCCcccCCC
Confidence 999999999999998
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-48 Score=406.08 Aligned_cols=311 Identities=59% Similarity=1.011 Sum_probs=257.7
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
.+|++.+.||.|+||.||+|.+..+++.||||.+.+..........++..|+++|+.++|+||+++++++..+...||||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 37999999999999999999999999999999998766555456667889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
||+.|++|.+++....+..+++..++.++.||+.||+|||.+||+||||||+||||+.++.++|+|||++..........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 99999999999987766789999999999999999999999999999999999999999999999999985432111100
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
.... ... ........+...............++
T Consensus 161 ~~~~-------------------------------------~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (316)
T cd05574 161 SKAL-------------------------------------RKG----------SRRSSVNSIPSETFSEEPSFRSNSFV 193 (316)
T ss_pred cccc-------------------------------------ccc----------cccccccccchhhhcccccCCCCCCc
Confidence 0000 000 00000001111222223333445678
Q ss_pred cCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCc
Q 007260 456 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEP 535 (611)
Q Consensus 456 GT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP 535 (611)
||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+.++......++....++..+++||.+||..||
T Consensus 194 g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 273 (316)
T cd05574 194 GTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDP 273 (316)
T ss_pred CccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCH
Confidence 99999999999999999999999999999999999999999888888888888777777766689999999999999999
Q ss_pred cccCCchhcHHHHHcCCCCCCCchhhhccCCCCCCCCC
Q 007260 536 QHRLAYKRGATEIKQHPFFEGVNWALIRCATPPEIPKP 573 (611)
Q Consensus 536 ~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~p~~p~p 573 (611)
++||+.+..++++|+||||++.+|..++..++|.+|.+
T Consensus 274 ~~R~s~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~ 311 (316)
T cd05574 274 SKRLGSKRGAAEIKQHPFFRGVNWALIRHTTPPIIPRP 311 (316)
T ss_pred hHCCCchhhHHHHHcCchhhcCChhhcccCCCCCCCCc
Confidence 99999999999999999999999999988777666544
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=411.21 Aligned_cols=267 Identities=36% Similarity=0.665 Sum_probs=232.0
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeeccceeeEEe
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~~~~~LVm 295 (611)
+|++++.||+|+||.||+|++..+++.||||++.+..............|+.++..+ +|++|+.++++|...+.+||||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 589999999999999999999999999999999876544444555667788888877 5899999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
||++||+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||++......
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~---- 154 (323)
T cd05616 81 EYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD---- 154 (323)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC----
Confidence 999999999988765 46999999999999999999999999999999999999999999999999997321100
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
......++
T Consensus 155 ------------------------------------------------------------------------~~~~~~~~ 162 (323)
T cd05616 155 ------------------------------------------------------------------------GVTTKTFC 162 (323)
T ss_pred ------------------------------------------------------------------------CCccccCC
Confidence 00112346
Q ss_pred cCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCc
Q 007260 456 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEP 535 (611)
Q Consensus 456 GT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP 535 (611)
||+.|+|||++.+..++.++|||||||++|||++|+.||.+......+..+......+|.. ++.++++||.+||.+||
T Consensus 163 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~--~s~~~~~li~~~l~~~p 240 (323)
T cd05616 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS--MSKEAVAICKGLMTKHP 240 (323)
T ss_pred CChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCc--CCHHHHHHHHHHcccCH
Confidence 9999999999999999999999999999999999999999988887788888777776654 89999999999999999
Q ss_pred cccCCch-hcHHHHHcCCCCCCCchhhhc
Q 007260 536 QHRLAYK-RGATEIKQHPFFEGVNWALIR 563 (611)
Q Consensus 536 ~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~ 563 (611)
.+|++.. ....++++||||+.++|....
T Consensus 241 ~~R~~~~~~~~~~i~~h~~~~~~~~~~~~ 269 (323)
T cd05616 241 GKRLGCGPEGERDIKEHAFFRYIDWEKLE 269 (323)
T ss_pred HhcCCCCCCCHHHHhcCCCcCCCCHHHHH
Confidence 9999853 346899999999999998764
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-50 Score=427.87 Aligned_cols=319 Identities=34% Similarity=0.612 Sum_probs=257.8
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSC 292 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~ 292 (611)
...+.|..++.||-|+||.|.+++...|...||+|.++|.....+.....+..|..||...+.+-||+||..|.+.+.+|
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY 705 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY 705 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence 34468999999999999999999999999999999999999888899999999999999999999999999999999999
Q ss_pred EEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccc--ccC
Q 007260 293 LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLR--CAV 370 (611)
Q Consensus 293 LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~--~~~ 370 (611)
+||+|++|||+-.|+-+. +.|+|+.+++|+++|..|++++|..|+|||||||+|||||.|||+||.||||+.- +..
T Consensus 706 FVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred EEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecc
Confidence 999999999999998876 6799999999999999999999999999999999999999999999999999732 222
Q ss_pred CccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcc-cc
Q 007260 371 SPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPT-EA 449 (611)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 449 (611)
...+... .+..+.. .+++. ....+.+.-+..|........ ..
T Consensus 784 dskYYq~----gdH~RqD--------Smep~-------------------------~e~~d~~~~lkvL~~ra~~~h~r~ 826 (1034)
T KOG0608|consen 784 DSKYYQE----GDHHRQD--------SMEPS-------------------------PEWADISKCLKVLERRAMRQHQRI 826 (1034)
T ss_pred ccccccC----CCccccc--------cCCCc-------------------------hhhccccccchHHHHHHHhhhhhh
Confidence 2222110 0111100 00000 000000010111110000000 11
Q ss_pred cccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH--cCCCCCCCCCCCCHHHHHHH
Q 007260 450 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVV--GQPLRFPESPVVSFAARDLI 527 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~--~~~l~~p~~~~~s~~l~dLI 527 (611)
...+.|||+.|+|||+|...+|+.-+|||+.|||||||+.|++||-..+..++.++|+ ...+.++....++.++.+||
T Consensus 827 ~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li 906 (1034)
T KOG0608|consen 827 LAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLI 906 (1034)
T ss_pred hhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHH
Confidence 2346899999999999999999999999999999999999999999988888776664 45688888889999999999
Q ss_pred HHhhhcCccccCCchhcHHHHHcCCCCCCCchhhhccCCCCCCCC
Q 007260 528 RGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIRCATPPEIPK 572 (611)
Q Consensus 528 ~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~p~~p~ 572 (611)
.+|. .+++.|+. +.++++|+.||||++++|..+|...++-+|.
T Consensus 907 ~kLc-~sad~RLG-kng~d~vKaHpfFkgIDfsslRkq~ApYIP~ 949 (1034)
T KOG0608|consen 907 QKLC-CSADSRLG-KNGADQVKAHPFFKGIDFSSLRKQRAPYIPR 949 (1034)
T ss_pred HHHh-cChhhhhc-ccchhhhhcCccccccchHhhhhccCCcCcc
Confidence 9865 58999998 6789999999999999999998887777765
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-49 Score=410.34 Aligned_cols=258 Identities=40% Similarity=0.738 Sum_probs=226.7
Q ss_pred ecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEeeeCCCCCH
Q 007260 224 LGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDL 303 (611)
Q Consensus 224 LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE~~~gg~L 303 (611)
||+|+||.||+|++..+++.||||++.+..........++.+|+.+|+.++||||++++++|...+.+||||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999999876555555666778899999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccccCCCC
Q 007260 304 HTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAE 383 (611)
Q Consensus 304 ~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~ 383 (611)
.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~------------ 146 (312)
T cd05585 81 FHHLQRE--GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD------------ 146 (312)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccC------------
Confidence 9988765 56999999999999999999999999999999999999999999999999997321100
Q ss_pred cCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCccch
Q 007260 384 PLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAP 463 (611)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~AP 463 (611)
.......+||+.|+||
T Consensus 147 ----------------------------------------------------------------~~~~~~~~gt~~y~aP 162 (312)
T cd05585 147 ----------------------------------------------------------------DDKTNTFCGTPEYLAP 162 (312)
T ss_pred ----------------------------------------------------------------CCccccccCCcccCCH
Confidence 0011234699999999
Q ss_pred hhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccCCchh
Q 007260 464 EIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKR 543 (611)
Q Consensus 464 Eil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~ 543 (611)
|++.+..++.++|||||||++|||++|+.||.+......+..+...+..++.. ++.++++||.+||..||.+|+++.
T Consensus 163 E~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~li~~~L~~dp~~R~~~~- 239 (312)
T cd05585 163 ELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDG--FDRDAKDLLIGLLSRDPTRRLGYN- 239 (312)
T ss_pred HHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCc--CCHHHHHHHHHHcCCCHHHcCCCC-
Confidence 99999999999999999999999999999999887777777888877777654 899999999999999999998632
Q ss_pred cHHHHHcCCCCCCCchhhh
Q 007260 544 GATEIKQHPFFEGVNWALI 562 (611)
Q Consensus 544 ~a~elL~Hp~f~~~~~~~~ 562 (611)
.+.++|.||||...+|...
T Consensus 240 ~~~e~l~hp~~~~~~~~~~ 258 (312)
T cd05585 240 GAQEIKNHPFFSQLSWKKL 258 (312)
T ss_pred CHHHHHcCCCcCCCCHHHH
Confidence 2899999999999988654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=413.45 Aligned_cols=261 Identities=30% Similarity=0.484 Sum_probs=218.7
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc--eeeE
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK--FSCL 293 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~--~~~L 293 (611)
.+|..++.||+|+||+||++.+..++..+|||.+...... ....+.+|+.+|..|+|||||++++...... .++|
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~---~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP---TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccch---hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 4678889999999999999999999999999998765211 1556788999999999999999999754433 7999
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEcc-CCcEEEEeccccccccCCc
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRE-DGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~-~g~vkL~DFGlA~~~~~~~ 372 (611)
+|||++||+|.+++.+..+ .|+|..++.|.+||++||+|||++|||||||||+||||+. +|.+||+|||++.......
T Consensus 94 ~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999999999866 7999999999999999999999999999999999999999 7999999999985433100
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
.......
T Consensus 173 -------------------------------------------------------------------------~~~~~~~ 179 (313)
T KOG0198|consen 173 -------------------------------------------------------------------------TKSDSEL 179 (313)
T ss_pred -------------------------------------------------------------------------ccccccc
Confidence 0111223
Q ss_pred ccccCCCccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCC-CCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 007260 453 SFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKG-SGNRATLFNVVGQPLRFPESPVVSFAARDLIRGL 530 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~-~~~~~sDIWSLGviL~ELltG~~PF~~-~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~ 530 (611)
.+.||+.|||||++... ..+.++|||||||++.||+||+.||.. ......+..+.......+.+..++.++++||.+|
T Consensus 180 ~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C 259 (313)
T KOG0198|consen 180 SVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKDFLRKC 259 (313)
T ss_pred cccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHHHHHHH
Confidence 56899999999999962 334599999999999999999999987 4555556666655422233445999999999999
Q ss_pred hhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 531 LVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 531 L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
|.+||.+||| |+++|+|||.+..
T Consensus 260 ~~~~p~~Rpt----a~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 260 FKRDPEKRPT----AEELLEHPFLKQN 282 (313)
T ss_pred hhcCcccCcC----HHHHhhChhhhcc
Confidence 9999999999 9999999998753
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=409.70 Aligned_cols=262 Identities=39% Similarity=0.707 Sum_probs=225.3
Q ss_pred eEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHH-HHHhCCCCCcccccceeeccceeeEEeeeCCC
Q 007260 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTERE-ILQSLDHPFLPTLYTHFETEKFSCLVMEFCPG 300 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~-iL~~l~HpnIv~l~~~~~~~~~~~LVmE~~~g 300 (611)
+.||.|+||+||+|++..+++.||||++.+..........++..|.. +++.++||||++++++|...+.+||||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999999999999999998765544444445556655 46789999999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccccC
Q 007260 301 GDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSL 380 (611)
Q Consensus 301 g~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~ 380 (611)
|+|..++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~---------- 148 (323)
T cd05575 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE---------- 148 (323)
T ss_pred CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc----------
Confidence 9999988765 5699999999999999999999999999999999999999999999999998732100
Q ss_pred CCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCc
Q 007260 381 DAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEY 460 (611)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y 460 (611)
.......++||+.|
T Consensus 149 ------------------------------------------------------------------~~~~~~~~~gt~~y 162 (323)
T cd05575 149 ------------------------------------------------------------------HSKTTSTFCGTPEY 162 (323)
T ss_pred ------------------------------------------------------------------CCCccccccCChhh
Confidence 00011234699999
Q ss_pred cchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccCC
Q 007260 461 LAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLA 540 (611)
Q Consensus 461 ~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt 540 (611)
+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+.++......++. .++..+.+||.+||++||.+|++
T Consensus 163 ~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~ 240 (323)
T cd05575 163 LAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKP--NISVSARHLLEGLLQKDRTKRLG 240 (323)
T ss_pred cChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhhcCHHhCCC
Confidence 9999999999999999999999999999999999988777777777777666554 47999999999999999999999
Q ss_pred chhcHHHHHcCCCCCCCchhhhc
Q 007260 541 YKRGATEIKQHPFFEGVNWALIR 563 (611)
Q Consensus 541 ~~~~a~elL~Hp~f~~~~~~~~~ 563 (611)
.+..+.+++.||||..++|..+.
T Consensus 241 ~~~~~~~il~~~~~~~~~~~~~~ 263 (323)
T cd05575 241 AKDDFLEIKNHVFFSSINWDDLV 263 (323)
T ss_pred CCCCHHHHHcCCCcCCCCHHHHh
Confidence 77677899999999999997653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=410.76 Aligned_cols=263 Identities=38% Similarity=0.736 Sum_probs=222.4
Q ss_pred eEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeeccceeeEEeeeCCC
Q 007260 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEKFSCLVMEFCPG 300 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~~~~~LVmE~~~g 300 (611)
+.||+|+||.||+|++..+++.||||++++...........+++|+.++..+ +||||++++++|.+.+.+|||||||+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876555555566778899999988 799999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccccC
Q 007260 301 GDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSL 380 (611)
Q Consensus 301 g~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~ 380 (611)
|+|..++.+. +.+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~---------- 148 (329)
T cd05588 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR---------- 148 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccccc----------
Confidence 9999888765 5699999999999999999999999999999999999999999999999998732100
Q ss_pred CCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCc
Q 007260 381 DAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEY 460 (611)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y 460 (611)
.......++||+.|
T Consensus 149 ------------------------------------------------------------------~~~~~~~~~gt~~y 162 (329)
T cd05588 149 ------------------------------------------------------------------PGDTTSTFCGTPNY 162 (329)
T ss_pred ------------------------------------------------------------------CCCccccccCCccc
Confidence 00011235799999
Q ss_pred cchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC--------cHH-HHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 007260 461 LAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSG--------NRA-TLFNVVGQPLRFPESPVVSFAARDLIRGLL 531 (611)
Q Consensus 461 ~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~--------~~~-~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L 531 (611)
+|||++.+..++.++|||||||++|||++|+.||.... ... ....+......+|. .++..+.+||.+||
T Consensus 163 ~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~li~~~L 240 (329)
T cd05588 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKASSVLKGFL 240 (329)
T ss_pred cCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHh
Confidence 99999999999999999999999999999999996321 112 23345555566665 48999999999999
Q ss_pred hcCccccCCch--hcHHHHHcCCCCCCCchhhhcc
Q 007260 532 VKEPQHRLAYK--RGATEIKQHPFFEGVNWALIRC 564 (611)
Q Consensus 532 ~~dP~~Rpt~~--~~a~elL~Hp~f~~~~~~~~~~ 564 (611)
.+||.+|++.. ..+.++++||||..++|.....
T Consensus 241 ~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~~~~ 275 (329)
T cd05588 241 NKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQ 275 (329)
T ss_pred ccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHh
Confidence 99999999743 2378999999999999987643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=417.82 Aligned_cols=271 Identities=35% Similarity=0.636 Sum_probs=233.2
Q ss_pred CccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc
Q 007260 210 DGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK 289 (611)
Q Consensus 210 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~ 289 (611)
...+..++|++++.||.|+||.||+|++..++..||||++.+...........+.+|+.+++.++||||++++++|.+++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~ 116 (370)
T cd05596 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK 116 (370)
T ss_pred cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 34456689999999999999999999999999999999998765544445556778999999999999999999999999
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
.+|||||||+||+|.+++... .+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||++....
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 999999999999999988653 48999999999999999999999999999999999999999999999999984321
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
.. ...
T Consensus 194 ~~---------------------------------------------------------------------------~~~ 198 (370)
T cd05596 194 AN---------------------------------------------------------------------------GMV 198 (370)
T ss_pred CC---------------------------------------------------------------------------Ccc
Confidence 00 000
Q ss_pred cccccccCCCccchhhhccC----CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcC--CCCCCCCCCCCHHH
Q 007260 450 RSMSFVGTHEYLAPEIIKGE----GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ--PLRFPESPVVSFAA 523 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~~----~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~--~l~~p~~~~~s~~l 523 (611)
.....+||+.|+|||++.+. .++.++|||||||+||||++|++||.+.+....+.++... .+.+|....++.++
T Consensus 199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 278 (370)
T cd05596 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQA 278 (370)
T ss_pred cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHH
Confidence 11234699999999999764 3788999999999999999999999998877777777654 35667766789999
Q ss_pred HHHHHHhhhcCccc--cCCchhcHHHHHcCCCCCCCchhhh
Q 007260 524 RDLIRGLLVKEPQH--RLAYKRGATEIKQHPFFEGVNWALI 562 (611)
Q Consensus 524 ~dLI~~~L~~dP~~--Rpt~~~~a~elL~Hp~f~~~~~~~~ 562 (611)
++||.+||..+|.+ |++ ++++++||||++.+|...
T Consensus 279 ~~li~~~L~~~p~r~~R~s----~~ell~h~~~~~~~~~~~ 315 (370)
T cd05596 279 KDLICAFLTDREVRLGRNG----VDEIKSHPFFKNDQWTFD 315 (370)
T ss_pred HHHHHHHccChhhccCCCC----HHHHhcCcccCCCChhhH
Confidence 99999999999988 999 999999999999888653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-49 Score=422.52 Aligned_cols=258 Identities=36% Similarity=0.590 Sum_probs=235.1
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC-CCCcccccceeeccceeeEE
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD-HPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~-HpnIv~l~~~~~~~~~~~LV 294 (611)
..|.+.+.||.|.||.||+|+++.+|+.||+|++.+...........+.+|+.||+.+. |||||.++++|++...+|||
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 58999999999999999999999999999999999887766555667789999999998 99999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccC----CcEEEEeccccccccC
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRED----GHIMLSDFDLSLRCAV 370 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~----g~vkL~DFGlA~~~~~ 370 (611)
||+|.||+|++.+.+. .++|..+..++.||+.|+.|||.+|||||||||||+|+... +.+|++|||++.....
T Consensus 115 mEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~ 191 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP 191 (382)
T ss_pred EEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence 9999999999998876 39999999999999999999999999999999999999742 4799999999954321
Q ss_pred CccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccc
Q 007260 371 SPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEAR 450 (611)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (611)
..+
T Consensus 192 -----------------------------------------------------------------------------~~~ 194 (382)
T KOG0032|consen 192 -----------------------------------------------------------------------------GER 194 (382)
T ss_pred -----------------------------------------------------------------------------Cce
Confidence 223
Q ss_pred ccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCC--CCCCCCHHHHHHHH
Q 007260 451 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFP--ESPVVSFAARDLIR 528 (611)
Q Consensus 451 ~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p--~~~~~s~~l~dLI~ 528 (611)
....+||+.|+|||++.+.+|+..+||||+||++|.||+|.+||.+.+......+|....+.|+ .+..++..+++||+
T Consensus 195 ~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~ 274 (382)
T KOG0032|consen 195 LHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDFIR 274 (382)
T ss_pred EeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHHH
Confidence 3467899999999999999999999999999999999999999999999999999999887664 45679999999999
Q ss_pred HhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 529 GLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 529 ~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
+||..||.+|++ |.++|+|||+.+.
T Consensus 275 ~ll~~dp~~R~t----a~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 275 KLLEFDPRKRLT----AAQALQHPWIKSI 299 (382)
T ss_pred HhcccCcccCCC----HHHHhcCccccCC
Confidence 999999999999 9999999998764
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-48 Score=409.92 Aligned_cols=277 Identities=36% Similarity=0.656 Sum_probs=232.4
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
++|++++.||+|+||.||++++..+++.||+|++.+...........+..|+.++..++|+||+.+++++.+...+||||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 37999999999999999999999999999999998755444445556778999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
||++||+|.+++.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||++.......
T Consensus 81 ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~--- 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG--- 156 (332)
T ss_pred eccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCC---
Confidence 9999999999987642 468999999999999999999999999999999999999999999999999974321000
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
.......+
T Consensus 157 ------------------------------------------------------------------------~~~~~~~~ 164 (332)
T cd05623 157 ------------------------------------------------------------------------TVQSSVAV 164 (332)
T ss_pred ------------------------------------------------------------------------cceecccc
Confidence 00011246
Q ss_pred cCCCccchhhhcc-----CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCC--CCCC-CCCCHHHHHHH
Q 007260 456 GTHEYLAPEIIKG-----EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLR--FPES-PVVSFAARDLI 527 (611)
Q Consensus 456 GT~~Y~APEil~~-----~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~--~p~~-~~~s~~l~dLI 527 (611)
||+.|+|||++.+ ..++.++|||||||+||||++|+.||.+.+....+.++.....+ +|.. ..++.++++||
T Consensus 165 gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li 244 (332)
T cd05623 165 GTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLI 244 (332)
T ss_pred cCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHHHHHH
Confidence 9999999999973 45788999999999999999999999988877777777765433 3332 35799999999
Q ss_pred HHhhhcCccc--cCCchhcHHHHHcCCCCCCCchhhhccCCCCCCCC
Q 007260 528 RGLLVKEPQH--RLAYKRGATEIKQHPFFEGVNWALIRCATPPEIPK 572 (611)
Q Consensus 528 ~~~L~~dP~~--Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~p~~p~ 572 (611)
++||..++.+ |++ +.++++||||.+++|..++...++.+|.
T Consensus 245 ~~ll~~~~~r~~r~~----~~~~~~h~~f~~~~~~~~~~~~~~~~~~ 287 (332)
T cd05623 245 RRLICSREHRLGQNG----IEDFKQHPFFTGIDWDNIRNCEAPYIPE 287 (332)
T ss_pred HHHccChhhhcCCCC----HHHHhCCCCcCCCCHHHHhhCCCCccCC
Confidence 9999875554 567 9999999999999998887666655554
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=416.75 Aligned_cols=269 Identities=35% Similarity=0.659 Sum_probs=229.3
Q ss_pred CccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc
Q 007260 210 DGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK 289 (611)
Q Consensus 210 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~ 289 (611)
+..+..++|++.+.||.|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++..+.
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 45566689999999999999999999999999999999998755444445556778999999999999999999999999
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
++|||||||+||+|.+++... .+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||++....
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~ 193 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 193 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence 999999999999999988763 48999999999999999999999999999999999999999999999999984321
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
.. ...
T Consensus 194 ~~---------------------------------------------------------------------------~~~ 198 (371)
T cd05622 194 KE---------------------------------------------------------------------------GMV 198 (371)
T ss_pred cC---------------------------------------------------------------------------Ccc
Confidence 00 000
Q ss_pred cccccccCCCccchhhhccCC----CCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCC--CCCCCCCCCCHHH
Q 007260 450 RSMSFVGTHEYLAPEIIKGEG----HGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQP--LRFPESPVVSFAA 523 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~~~----~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~--l~~p~~~~~s~~l 523 (611)
.....+||+.|+|||++.+.. ++.++|||||||+||||++|+.||.+.+....+.++.... +.+|....++..+
T Consensus 199 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 278 (371)
T cd05622 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEA 278 (371)
T ss_pred cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHH
Confidence 112357999999999998653 7889999999999999999999999887777777776543 5667766799999
Q ss_pred HHHHHHhhhcCccc---cCCchhcHHHHHcCCCCCCCchhh
Q 007260 524 RDLIRGLLVKEPQH---RLAYKRGATEIKQHPFFEGVNWAL 561 (611)
Q Consensus 524 ~dLI~~~L~~dP~~---Rpt~~~~a~elL~Hp~f~~~~~~~ 561 (611)
++||.+||. +|.. |++ +.++++|+||++..|..
T Consensus 279 ~~li~~~L~-~~~~r~~r~~----~~ei~~h~~~~~~~~~~ 314 (371)
T cd05622 279 KNLICAFLT-DREVRLGRNG----VEEIKRHLFFKNDQWAW 314 (371)
T ss_pred HHHHHHHcC-ChhhhcCCCC----HHHHhcCcccCCCChhH
Confidence 999999998 5554 556 99999999999876654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-48 Score=408.24 Aligned_cols=262 Identities=37% Similarity=0.696 Sum_probs=227.0
Q ss_pred eEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeeccceeeEEeeeCCC
Q 007260 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEKFSCLVMEFCPG 300 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~~~~~LVmE~~~g 300 (611)
+.||.|+||.||+|++..+++.||||++.+...........+..|++++..+ +||||++++++|...+.+||||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999999876554445556677899998866 799999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccccC
Q 007260 301 GDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSL 380 (611)
Q Consensus 301 g~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~ 380 (611)
++|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~--------- 149 (321)
T cd05591 81 GDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN--------- 149 (321)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccC---------
Confidence 9999888765 56999999999999999999999999999999999999999999999999987321100
Q ss_pred CCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCc
Q 007260 381 DAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEY 460 (611)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y 460 (611)
......++||+.|
T Consensus 150 -------------------------------------------------------------------~~~~~~~~gt~~y 162 (321)
T cd05591 150 -------------------------------------------------------------------GVTTTTFCGTPDY 162 (321)
T ss_pred -------------------------------------------------------------------CccccccccCccc
Confidence 0001234699999
Q ss_pred cchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccCC
Q 007260 461 LAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLA 540 (611)
Q Consensus 461 ~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt 540 (611)
+|||++.+..++.++|||||||++|||++|+.||.+.+....+..+......+|.. ++.++.+||.+||.+||.+|++
T Consensus 163 ~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~--~~~~~~~ll~~~L~~dp~~R~~ 240 (321)
T cd05591 163 IAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVW--LSKEAVSILKAFMTKNPNKRLG 240 (321)
T ss_pred cCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCHHHHHHHHHHhccCHHHcCC
Confidence 99999999999999999999999999999999999988888888888777666654 8999999999999999999994
Q ss_pred chh---cHHHHHcCCCCCCCchhhhc
Q 007260 541 YKR---GATEIKQHPFFEGVNWALIR 563 (611)
Q Consensus 541 ~~~---~a~elL~Hp~f~~~~~~~~~ 563 (611)
... .+.++++||||..++|....
T Consensus 241 ~~~~~~~~~~~~~hp~~~~~~~~~~~ 266 (321)
T cd05591 241 CVASQGGEDAIKQHPFFKEIDWVLLE 266 (321)
T ss_pred CCCCCCCHHHHhcCCccCCCCHHHHH
Confidence 322 39999999999999998764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=410.72 Aligned_cols=261 Identities=37% Similarity=0.675 Sum_probs=225.2
Q ss_pred eEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeeccceeeEEeeeCCC
Q 007260 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEKFSCLVMEFCPG 300 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~~~~~LVmE~~~g 300 (611)
+.||+|+||+||+|++..+++.||||++.+...........+..|+.++..+ +||||++++++|...+.+|||||||+|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999876544444555667888888876 699999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccccC
Q 007260 301 GDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSL 380 (611)
Q Consensus 301 g~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~ 380 (611)
|+|..++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--------- 149 (320)
T cd05590 81 GDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--------- 149 (320)
T ss_pred chHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC---------
Confidence 9999988765 56999999999999999999999999999999999999999999999999987321100
Q ss_pred CCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCc
Q 007260 381 DAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEY 460 (611)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y 460 (611)
......++||+.|
T Consensus 150 -------------------------------------------------------------------~~~~~~~~gt~~y 162 (320)
T cd05590 150 -------------------------------------------------------------------GKTTSTFCGTPDY 162 (320)
T ss_pred -------------------------------------------------------------------CCcccccccCccc
Confidence 0011234699999
Q ss_pred cchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccCC
Q 007260 461 LAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLA 540 (611)
Q Consensus 461 ~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt 540 (611)
+|||++.+..++.++|||||||++|||++|+.||.+.+....+..+......+|.. ++.++++||.+||.+||.+|++
T Consensus 163 ~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~~~li~~~L~~dP~~R~~ 240 (320)
T cd05590 163 IAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTW--LSQDAVDILKAFMTKNPTMRLG 240 (320)
T ss_pred cCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCC--CCHHHHHHHHHHcccCHHHCCC
Confidence 99999999999999999999999999999999999988877777777776666554 8999999999999999999999
Q ss_pred chh--cHHHHHcCCCCCCCchhhh
Q 007260 541 YKR--GATEIKQHPFFEGVNWALI 562 (611)
Q Consensus 541 ~~~--~a~elL~Hp~f~~~~~~~~ 562 (611)
... +.+++++||||..++|...
T Consensus 241 ~~~~~~~~~~~~h~~f~~~~~~~~ 264 (320)
T cd05590 241 SLTLGGEEAILRHPFFKELDWEKL 264 (320)
T ss_pred CCCCCCHHHHHcCCCcCCCCHHHH
Confidence 321 2389999999999999765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-48 Score=407.24 Aligned_cols=277 Identities=37% Similarity=0.674 Sum_probs=230.4
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
++|++++.||+|+||+||++++..+++.||||++.+...........+.+|+.++..++|+||+.++++|.+++++||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765555555666788999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
||++||+|.+++.+. +..+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--- 156 (331)
T cd05597 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG--- 156 (331)
T ss_pred ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC---
Confidence 999999999998764 3569999999999999999999999999999999999999999999999999984322100
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
.......+
T Consensus 157 ------------------------------------------------------------------------~~~~~~~~ 164 (331)
T cd05597 157 ------------------------------------------------------------------------TVQSNVAV 164 (331)
T ss_pred ------------------------------------------------------------------------Ccccccee
Confidence 00011236
Q ss_pred cCCCccchhhhcc-----CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCC--CCCCC-CCCCCHHHHHHH
Q 007260 456 GTHEYLAPEIIKG-----EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQP--LRFPE-SPVVSFAARDLI 527 (611)
Q Consensus 456 GT~~Y~APEil~~-----~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~--l~~p~-~~~~s~~l~dLI 527 (611)
||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+.+..+.... +.++. ...++..+++||
T Consensus 165 gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li 244 (331)
T cd05597 165 GTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLI 244 (331)
T ss_pred ccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHHHHHH
Confidence 9999999999974 346889999999999999999999999877666666665433 23332 234899999999
Q ss_pred HHhhhcCccc--cCCchhcHHHHHcCCCCCCCchhhhccCCCCCCCC
Q 007260 528 RGLLVKEPQH--RLAYKRGATEIKQHPFFEGVNWALIRCATPPEIPK 572 (611)
Q Consensus 528 ~~~L~~dP~~--Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~p~~p~ 572 (611)
++||..++.+ |++ +.++++||||.+++|.......++.+|.
T Consensus 245 ~~ll~~~~~r~~r~~----~~~~l~hp~~~~~~~~~~~~~~~~~~~~ 287 (331)
T cd05597 245 RRLICSPETRLGRNG----LQDFKDHPFFEGIDWDNIRNSTAPYVPE 287 (331)
T ss_pred HHHccCcccccCCCC----HHHHhcCCCCCCCCHHHHhhCCCCccCc
Confidence 9999764433 667 9999999999999998877665554443
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-48 Score=405.81 Aligned_cols=269 Identities=35% Similarity=0.669 Sum_probs=232.1
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC-CCCcccccceeeccceeeEEe
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD-HPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~-HpnIv~l~~~~~~~~~~~LVm 295 (611)
+|++.+.||.|+||+||+|++..+++.||||++.+...........+..|+.+++.+. |++|+.++++|...+.+||||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788999999999999999999999999999998765544445566778999998885 578889999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
||++||+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~---- 154 (323)
T cd05615 81 EYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD---- 154 (323)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCC----
Confidence 999999999988765 46999999999999999999999999999999999999999999999999987321100
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
.......+
T Consensus 155 ------------------------------------------------------------------------~~~~~~~~ 162 (323)
T cd05615 155 ------------------------------------------------------------------------GVTTRTFC 162 (323)
T ss_pred ------------------------------------------------------------------------CccccCcc
Confidence 00012346
Q ss_pred cCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCc
Q 007260 456 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEP 535 (611)
Q Consensus 456 GT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP 535 (611)
||+.|+|||++.+..++.++|||||||++|||++|+.||.+......+..+......+|.. ++.++++||.+||.+||
T Consensus 163 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~--~~~~~~~li~~~l~~~p 240 (323)
T cd05615 163 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKS--LSKEAVSICKGLMTKHP 240 (323)
T ss_pred CCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc--CCHHHHHHHHHHcccCH
Confidence 9999999999999999999999999999999999999999988777778888777766654 89999999999999999
Q ss_pred cccCCch-hcHHHHHcCCCCCCCchhhhccC
Q 007260 536 QHRLAYK-RGATEIKQHPFFEGVNWALIRCA 565 (611)
Q Consensus 536 ~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~~~ 565 (611)
.+|++.. ....++++||||+.++|..+...
T Consensus 241 ~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~ 271 (323)
T cd05615 241 SKRLGCGPEGERDIREHAFFRRIDWDKLENR 271 (323)
T ss_pred hhCCCCCCCCHHHHhcCcccCCCCHHHHhcC
Confidence 9999853 34789999999999999876543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-50 Score=411.12 Aligned_cols=253 Identities=30% Similarity=0.540 Sum_probs=234.3
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
.+|++.+.||.|.||.|-+|.....|+.||||.|+++.+...+.+.++++|++||..|+||||+.+|++|+..+.+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 47999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
||..+|+|.+++... +.|+|.+++.|++||+.|+.|||.++|||||||.||||++.++.+||+||||+-.+.
T Consensus 133 EYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~------ 204 (668)
T KOG0611|consen 133 EYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA------ 204 (668)
T ss_pred EecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhc------
Confidence 999999999999987 679999999999999999999999999999999999999999999999999983322
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
......+||
T Consensus 205 -----------------------------------------------------------------------~~kfLqTFC 213 (668)
T KOG0611|consen 205 -----------------------------------------------------------------------DKKFLQTFC 213 (668)
T ss_pred -----------------------------------------------------------------------cccHHHHhc
Confidence 111234789
Q ss_pred cCCCccchhhhccCCC-CChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcC
Q 007260 456 GTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKE 534 (611)
Q Consensus 456 GT~~Y~APEil~~~~~-~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~d 534 (611)
|+|-|.+||++.|.+| |+.+|-|||||+||-|++|.+||+|.+....+..|..+.++-|. -+..+.-||++||..|
T Consensus 214 GSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~---~PSdA~gLIRwmLmVN 290 (668)
T KOG0611|consen 214 GSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE---TPSDASGLIRWMLMVN 290 (668)
T ss_pred CCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC---CCchHHHHHHHHHhcC
Confidence 9999999999999999 99999999999999999999999999888888888888887776 4557889999999999
Q ss_pred ccccCCchhcHHHHHcCCCC
Q 007260 535 PQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 535 P~~Rpt~~~~a~elL~Hp~f 554 (611)
|++|.| +.+|-.|-|+
T Consensus 291 P~RRAT----ieDiAsHWWv 306 (668)
T KOG0611|consen 291 PERRAT----IEDIASHWWV 306 (668)
T ss_pred cccchh----HHHHhhhhee
Confidence 999999 9999999775
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-49 Score=412.24 Aligned_cols=262 Identities=39% Similarity=0.716 Sum_probs=225.9
Q ss_pred eEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEeeeCCCC
Q 007260 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGG 301 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE~~~gg 301 (611)
+.||+|+||.||+|++..+++.||+|++.+..........++.+|+.+++.++||||++++++|...+.+||||||++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998766555555667788999999999999999999999999999999999999
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccccC
Q 007260 302 DLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHM-LGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSL 380 (611)
Q Consensus 302 ~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~-~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~ 380 (611)
+|..++.+. +.+++..++.++.||+.||+|||+ +|||||||||+||||+.+|.+||+|||++......
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~--------- 149 (325)
T cd05594 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--------- 149 (325)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC---------
Confidence 999888765 569999999999999999999997 79999999999999999999999999987321100
Q ss_pred CCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCc
Q 007260 381 DAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEY 460 (611)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y 460 (611)
......++||+.|
T Consensus 150 -------------------------------------------------------------------~~~~~~~~gt~~y 162 (325)
T cd05594 150 -------------------------------------------------------------------GATMKTFCGTPEY 162 (325)
T ss_pred -------------------------------------------------------------------CcccccccCCccc
Confidence 0001134699999
Q ss_pred cchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccCC
Q 007260 461 LAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLA 540 (611)
Q Consensus 461 ~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt 540 (611)
+|||++.+..++.++|||||||+||||++|+.||.+......+..+......+|.. ++.++.+||.+||.+||++|++
T Consensus 163 ~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~--~~~~~~~li~~~L~~dP~~R~~ 240 (325)
T cd05594 163 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT--LSPEAKSLLSGLLKKDPKQRLG 240 (325)
T ss_pred CCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCC--CCHHHHHHHHHHhhcCHHHhCC
Confidence 99999999999999999999999999999999999887777777777777666654 8999999999999999999972
Q ss_pred ch-hcHHHHHcCCCCCCCchhhhc
Q 007260 541 YK-RGATEIKQHPFFEGVNWALIR 563 (611)
Q Consensus 541 ~~-~~a~elL~Hp~f~~~~~~~~~ 563 (611)
.. ..+.++++||||.++.|....
T Consensus 241 ~~~~~~~~il~h~~~~~~~~~~~~ 264 (325)
T cd05594 241 GGPDDAKEIMQHKFFAGIVWQDVY 264 (325)
T ss_pred CCCCCHHHHhcCCCcCCCCHHHHH
Confidence 11 119999999999999997553
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-48 Score=407.59 Aligned_cols=262 Identities=38% Similarity=0.679 Sum_probs=225.0
Q ss_pred eEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHH-HHHhCCCCCcccccceeeccceeeEEeeeCCC
Q 007260 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTERE-ILQSLDHPFLPTLYTHFETEKFSCLVMEFCPG 300 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~-iL~~l~HpnIv~l~~~~~~~~~~~LVmE~~~g 300 (611)
+.||.|+||+||+|++..+++.||||++.+...........+..|.. +++.++||||++++++|..++.+||||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999999999999999998765444444445555655 46779999999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccccC
Q 007260 301 GDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSL 380 (611)
Q Consensus 301 g~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~ 380 (611)
|+|..++.+. ..+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||++.....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~---------- 148 (325)
T cd05604 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA---------- 148 (325)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC----------
Confidence 9999888764 5699999999999999999999999999999999999999999999999999732100
Q ss_pred CCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCc
Q 007260 381 DAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEY 460 (611)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y 460 (611)
.......++||+.|
T Consensus 149 ------------------------------------------------------------------~~~~~~~~~gt~~y 162 (325)
T cd05604 149 ------------------------------------------------------------------QSDTTTTFCGTPEY 162 (325)
T ss_pred ------------------------------------------------------------------CCCCcccccCChhh
Confidence 00011235699999
Q ss_pred cchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccCC
Q 007260 461 LAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLA 540 (611)
Q Consensus 461 ~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt 540 (611)
+|||++.+..++.++|||||||++|||++|+.||...+....+.++....+.++. .++..+.++|.+||.+||.+||+
T Consensus 163 ~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ll~~ll~~~p~~R~~ 240 (325)
T cd05604 163 LAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRP--GASLTAWSILEELLEKDRQRRLG 240 (325)
T ss_pred CCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCC--CCCHHHHHHHHHHhccCHHhcCC
Confidence 9999999999999999999999999999999999988777777777776655543 48999999999999999999999
Q ss_pred chhcHHHHHcCCCCCCCchhhhc
Q 007260 541 YKRGATEIKQHPFFEGVNWALIR 563 (611)
Q Consensus 541 ~~~~a~elL~Hp~f~~~~~~~~~ 563 (611)
.+..+.+++.||||..+.|....
T Consensus 241 ~~~~~~~i~~h~~f~~~~~~~~~ 263 (325)
T cd05604 241 AKEDFLEIQEHPFFESLSWTDLE 263 (325)
T ss_pred CCCCHHHHhcCCCcCCCCHHHHH
Confidence 87778999999999999997654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-48 Score=404.30 Aligned_cols=259 Identities=39% Similarity=0.767 Sum_probs=220.9
Q ss_pred eEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeeccceeeEEeeeCCC
Q 007260 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEKFSCLVMEFCPG 300 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~~~~~LVmE~~~g 300 (611)
+.||+|+||.||+|++..+++.||||++.+...........+..|..++..+ +||||+++++++..+..+||||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999876543334444556677777654 899999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccccC
Q 007260 301 GDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSL 380 (611)
Q Consensus 301 g~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~ 380 (611)
|+|..++... ..+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~--------- 149 (316)
T cd05592 81 GDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG--------- 149 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCC---------
Confidence 9999988765 46999999999999999999999999999999999999999999999999998322100
Q ss_pred CCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCc
Q 007260 381 DAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEY 460 (611)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y 460 (611)
.......+||+.|
T Consensus 150 -------------------------------------------------------------------~~~~~~~~gt~~y 162 (316)
T cd05592 150 -------------------------------------------------------------------EGKASTFCGTPDY 162 (316)
T ss_pred -------------------------------------------------------------------CCccccccCCccc
Confidence 0011235699999
Q ss_pred cchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccCC
Q 007260 461 LAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLA 540 (611)
Q Consensus 461 ~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt 540 (611)
+|||++.+..++.++|||||||++|||++|+.||.+.+....+..+......+|. .++.++.+||.+||..||.+|++
T Consensus 163 ~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~ll~~~l~~~P~~R~~ 240 (316)
T cd05592 163 IAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPR--WISKEAKDCLSKLFERDPTKRLG 240 (316)
T ss_pred cCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHccCCHHHcCC
Confidence 9999999999999999999999999999999999988877777777665555554 48999999999999999999998
Q ss_pred chhcHHHHHcCCCCCCCchhhhc
Q 007260 541 YKRGATEIKQHPFFEGVNWALIR 563 (611)
Q Consensus 541 ~~~~a~elL~Hp~f~~~~~~~~~ 563 (611)
. +.++++||||..++|....
T Consensus 241 ~---~~~l~~h~~~~~~~~~~~~ 260 (316)
T cd05592 241 V---DGDIRQHPFFRGIDWERLE 260 (316)
T ss_pred C---hHHHHcCcccCCCCHHHHH
Confidence 4 4689999999999997654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-48 Score=405.17 Aligned_cols=261 Identities=39% Similarity=0.702 Sum_probs=224.4
Q ss_pred eEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHH-HHHhCCCCCcccccceeeccceeeEEeeeCCC
Q 007260 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTERE-ILQSLDHPFLPTLYTHFETEKFSCLVMEFCPG 300 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~-iL~~l~HpnIv~l~~~~~~~~~~~LVmE~~~g 300 (611)
+.||.|+||.||+|++..+++.||+|++.+..........++..|+. +++.++||||++++++|.+.+.+|||||||+|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999998765544444445555654 67889999999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccccC
Q 007260 301 GDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSL 380 (611)
Q Consensus 301 g~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~ 380 (611)
++|...+... ..+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||++.....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~---------- 148 (321)
T cd05603 81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE---------- 148 (321)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC----------
Confidence 9999887764 5689999999999999999999999999999999999999999999999998732100
Q ss_pred CCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCc
Q 007260 381 DAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEY 460 (611)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y 460 (611)
.......++||+.|
T Consensus 149 ------------------------------------------------------------------~~~~~~~~~gt~~y 162 (321)
T cd05603 149 ------------------------------------------------------------------PEETTSTFCGTPEY 162 (321)
T ss_pred ------------------------------------------------------------------CCCccccccCCccc
Confidence 00011234699999
Q ss_pred cchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccCC
Q 007260 461 LAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLA 540 (611)
Q Consensus 461 ~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt 540 (611)
+|||++.+..++.++|||||||++|||++|+.||.+.+.......+...++.+|. ..+.++.++|.+||++||.+|++
T Consensus 163 ~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~ 240 (321)
T cd05603 163 LAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPG--GKTVAACDLLVGLLHKDQRRRLG 240 (321)
T ss_pred CCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCHHHHHHHHHHccCCHhhcCC
Confidence 9999999999999999999999999999999999988777777777777766664 48899999999999999999998
Q ss_pred chhcHHHHHcCCCCCCCchhhh
Q 007260 541 YKRGATEIKQHPFFEGVNWALI 562 (611)
Q Consensus 541 ~~~~a~elL~Hp~f~~~~~~~~ 562 (611)
....+.++++|+||..++|...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~ 262 (321)
T cd05603 241 AKADFLEIKNHVFFSPINWDDL 262 (321)
T ss_pred CCCCHHHHhCCCCcCCCCHHHH
Confidence 6666789999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=404.87 Aligned_cols=267 Identities=29% Similarity=0.423 Sum_probs=231.8
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSC 292 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~ 292 (611)
+..++|++...||.|.-++||+|++..++.+||||+++-+..... +..+++|+..|..++||||++++..|..+..+|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LW 100 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELW 100 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEecceeE
Confidence 445799999999999999999999999999999999987765443 667889999999999999999999999999999
Q ss_pred EEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCc
Q 007260 293 LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 293 LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~ 372 (611)
+||.||.+|++.+++.......|+|..+..|++++|+||.|||.+|.||||||+.||||+.+|.|||+|||.+..+..+.
T Consensus 101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 99999999999999998766779999999999999999999999999999999999999999999999999873222110
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
.....+..
T Consensus 181 ------------------------------------------------------------------------~R~~~rf~ 188 (516)
T KOG0582|consen 181 ------------------------------------------------------------------------DRQVTRFN 188 (516)
T ss_pred ------------------------------------------------------------------------ceeeEeec
Confidence 00111225
Q ss_pred ccccCCCccchhhhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCC--------CCCCCHH
Q 007260 453 SFVGTHEYLAPEIIKG--EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPE--------SPVVSFA 522 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~--~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~--------~~~~s~~ 522 (611)
+|+||++|||||+++. .+|+.|+|||||||+..||.+|..||........+...+++....+. ....+..
T Consensus 189 tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ks 268 (516)
T KOG0582|consen 189 TFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKS 268 (516)
T ss_pred cccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHH
Confidence 7899999999999754 47899999999999999999999999998888887776666554333 2346678
Q ss_pred HHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 523 ARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 523 l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
++.+|..||++||.+||| |.++|+|+||+..
T Consensus 269 f~e~i~~CL~kDP~kRpt----AskLlkh~FFk~~ 299 (516)
T KOG0582|consen 269 FREMIALCLVKDPSKRPT----ASKLLKHAFFKKA 299 (516)
T ss_pred HHHHHHHHhhcCcccCCC----HHHHhccHHHhhc
Confidence 999999999999999999 9999999999864
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-48 Score=404.17 Aligned_cols=259 Identities=36% Similarity=0.709 Sum_probs=220.4
Q ss_pred eEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeeccceeeEEeeeCCC
Q 007260 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEKFSCLVMEFCPG 300 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~~~~~LVmE~~~g 300 (611)
+.||.|+||.||+|++..++..||||++.+..............|+.++..+ +||||++++++|.+.+++|||||||.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4799999999999999999999999999875443333444556788888754 899999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccccC
Q 007260 301 GDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSL 380 (611)
Q Consensus 301 g~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~ 380 (611)
|+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.++|+|||++.....
T Consensus 81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~---------- 148 (316)
T cd05620 81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF---------- 148 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc----------
Confidence 9999988764 5689999999999999999999999999999999999999999999999998732100
Q ss_pred CCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCc
Q 007260 381 DAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEY 460 (611)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y 460 (611)
.......++||+.|
T Consensus 149 ------------------------------------------------------------------~~~~~~~~~gt~~y 162 (316)
T cd05620 149 ------------------------------------------------------------------GDNRASTFCGTPDY 162 (316)
T ss_pred ------------------------------------------------------------------CCCceeccCCCcCc
Confidence 00011235699999
Q ss_pred cchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccCC
Q 007260 461 LAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLA 540 (611)
Q Consensus 461 ~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt 540 (611)
+|||++.+..++.++|||||||++|||++|+.||.+.+....+..+......+|. .++.++++||.+||..||.+|++
T Consensus 163 ~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~dP~~R~~ 240 (316)
T cd05620 163 IAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR--WITKESKDILEKLFERDPTRRLG 240 (316)
T ss_pred cCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCHHHHHHHHHHccCCHHHcCC
Confidence 9999999999999999999999999999999999988776666666655555554 48999999999999999999999
Q ss_pred chhcHHHHHcCCCCCCCchhhhc
Q 007260 541 YKRGATEIKQHPFFEGVNWALIR 563 (611)
Q Consensus 541 ~~~~a~elL~Hp~f~~~~~~~~~ 563 (611)
. ++++++||||+.++|....
T Consensus 241 ~---~~~~~~h~~f~~~~~~~~~ 260 (316)
T cd05620 241 V---VGNIRGHPFFKTINWTALE 260 (316)
T ss_pred C---hHHHHcCCCcCCCCHHHHH
Confidence 3 3689999999999997654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-49 Score=422.56 Aligned_cols=255 Identities=27% Similarity=0.487 Sum_probs=226.6
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
...|....+||+|+.|.||.|+...+++.||||.|+......++ .+.+|+.+|+..+|+|||.+++.|...+.+|+|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~ke---LilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKE---LLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchh---hhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 35799999999999999999999999999999999876544333 456899999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
|||++||+|.+++... .|+|.++..+++++|.||+|||.+||+|||||.+|||+..+|.+||+|||++..+..
T Consensus 349 MEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~---- 421 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE---- 421 (550)
T ss_pred EeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccc----
Confidence 9999999999998875 499999999999999999999999999999999999999999999999999743220
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
......++
T Consensus 422 ------------------------------------------------------------------------~~~KR~Tm 429 (550)
T KOG0578|consen 422 ------------------------------------------------------------------------EQSKRSTM 429 (550)
T ss_pred ------------------------------------------------------------------------ccCccccc
Confidence 11134467
Q ss_pred ccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH-cCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007260 455 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVV-GQPLRFPESPVVSFAARDLIRGLLVK 533 (611)
Q Consensus 455 vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~-~~~l~~p~~~~~s~~l~dLI~~~L~~ 533 (611)
||||+|||||++....||.++||||||++++||+-|++||-.......++.|. ++...+.....+|.+++|||++||+.
T Consensus 430 VGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~ 509 (550)
T KOG0578|consen 430 VGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVV 509 (550)
T ss_pred cCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhc
Confidence 99999999999999999999999999999999999999998777666666654 45566666677999999999999999
Q ss_pred CccccCCchhcHHHHHcCCCCC
Q 007260 534 EPQHRLAYKRGATEIKQHPFFE 555 (611)
Q Consensus 534 dP~~Rpt~~~~a~elL~Hp~f~ 555 (611)
|+++|++ |.|||+||||+
T Consensus 510 dv~~Ras----A~eLL~HpFl~ 527 (550)
T KOG0578|consen 510 DVEQRAS----AKELLEHPFLK 527 (550)
T ss_pred chhcCCC----HHHHhcChhhh
Confidence 9999999 99999999995
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=404.63 Aligned_cols=264 Identities=36% Similarity=0.698 Sum_probs=223.6
Q ss_pred eEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeeccceeeEEeeeCCC
Q 007260 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEKFSCLVMEFCPG 300 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~~~~~LVmE~~~g 300 (611)
+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.++..+ +||||+.++++|...+.+||||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999877655555666788899999888 699999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccccC
Q 007260 301 GDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSL 380 (611)
Q Consensus 301 g~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~ 380 (611)
|+|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~---------- 148 (327)
T cd05617 81 GDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG---------- 148 (327)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccC----------
Confidence 9999888765 4699999999999999999999999999999999999999999999999998732110
Q ss_pred CCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCc
Q 007260 381 DAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEY 460 (611)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y 460 (611)
.......++||+.|
T Consensus 149 ------------------------------------------------------------------~~~~~~~~~gt~~y 162 (327)
T cd05617 149 ------------------------------------------------------------------PGDTTSTFCGTPNY 162 (327)
T ss_pred ------------------------------------------------------------------CCCceecccCCccc
Confidence 00011235799999
Q ss_pred cchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC------CcHH-HHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007260 461 LAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGS------GNRA-TLFNVVGQPLRFPESPVVSFAARDLIRGLLVK 533 (611)
Q Consensus 461 ~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~------~~~~-~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~ 533 (611)
+|||++.+..++.++|||||||+||||++|+.||... .... ....+...+..+|.. ++..+.++|.+||.+
T Consensus 163 ~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~--~~~~~~~li~~~L~~ 240 (327)
T cd05617 163 IAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRF--LSVKASHVLKGFLNK 240 (327)
T ss_pred CCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCC--CCHHHHHHHHHHhcc
Confidence 9999999999999999999999999999999999642 1222 334455555566554 899999999999999
Q ss_pred CccccCCch--hcHHHHHcCCCCCCCchhhhccC
Q 007260 534 EPQHRLAYK--RGATEIKQHPFFEGVNWALIRCA 565 (611)
Q Consensus 534 dP~~Rpt~~--~~a~elL~Hp~f~~~~~~~~~~~ 565 (611)
||.+|++.. ....++++||||..++|......
T Consensus 241 dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~~~~ 274 (327)
T cd05617 241 DPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKK 274 (327)
T ss_pred CHHHcCCCCCCCCHHHHHcCCCCCCCCHHHHHhC
Confidence 999999843 34689999999999999886533
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-48 Score=406.83 Aligned_cols=277 Identities=35% Similarity=0.648 Sum_probs=231.2
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
++|++++.||+|+||.||++++..+++.||||++.+...........+.+|+.++..++|+||+.++++|.+++..||||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998755444455556788999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
||++||+|.+++.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..+....
T Consensus 81 Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--- 156 (331)
T cd05624 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG--- 156 (331)
T ss_pred eCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC---
Confidence 9999999999987642 468999999999999999999999999999999999999999999999999984332100
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
.......+
T Consensus 157 ------------------------------------------------------------------------~~~~~~~~ 164 (331)
T cd05624 157 ------------------------------------------------------------------------TVQSSVAV 164 (331)
T ss_pred ------------------------------------------------------------------------ceeecccc
Confidence 00011246
Q ss_pred cCCCccchhhhcc-----CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCC--CCC-CCCCCHHHHHHH
Q 007260 456 GTHEYLAPEIIKG-----EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLR--FPE-SPVVSFAARDLI 527 (611)
Q Consensus 456 GT~~Y~APEil~~-----~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~--~p~-~~~~s~~l~dLI 527 (611)
||+.|+|||++.+ ..++.++|||||||+||||++|+.||.+....+.+..+.....+ +|. ...++.++++||
T Consensus 165 gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li 244 (331)
T cd05624 165 GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLI 244 (331)
T ss_pred CCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHHHHHH
Confidence 9999999999986 45788999999999999999999999988777777777654433 332 234789999999
Q ss_pred HHhhhcCccc--cCCchhcHHHHHcCCCCCCCchhhhccCCCCCCCC
Q 007260 528 RGLLVKEPQH--RLAYKRGATEIKQHPFFEGVNWALIRCATPPEIPK 572 (611)
Q Consensus 528 ~~~L~~dP~~--Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~p~~p~ 572 (611)
.+||..++.+ |++ ++++++||||++++|..++...+|.+|.
T Consensus 245 ~~ll~~~~~~~~~~~----~~~~~~h~~f~~~~~~~~~~~~~~~~p~ 287 (331)
T cd05624 245 QRLICSRERRLGQNG----IEDFKKHAFFEGIDWENIRNLEAPYIPD 287 (331)
T ss_pred HHHccCchhhcCCCC----HHHHhcCCCcCCCCHHHHhhCCCCccCC
Confidence 9999976544 345 9999999999999998887665555554
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-50 Score=419.17 Aligned_cols=276 Identities=38% Similarity=0.674 Sum_probs=250.7
Q ss_pred cccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecccee
Q 007260 212 VLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFS 291 (611)
Q Consensus 212 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~ 291 (611)
.+.+++++++..||.||||.|-+++.......||+|+++|..+...+...++..|..||..++.|+||+||..|.+.+++
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv 495 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV 495 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence 34567899999999999999999998887778999999999988888888999999999999999999999999999999
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCC
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~ 371 (611)
||+||-|-||+|.+.++.. +.|.+..+++|+..+++|++|||++|||+|||||||+|++.+|-+||.|||+|+.+.
T Consensus 496 YmLmEaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~-- 571 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG-- 571 (732)
T ss_pred hhhHHhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhc--
Confidence 9999999999999999886 679999999999999999999999999999999999999999999999999996554
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
...++
T Consensus 572 ---------------------------------------------------------------------------~g~KT 576 (732)
T KOG0614|consen 572 ---------------------------------------------------------------------------SGRKT 576 (732)
T ss_pred ---------------------------------------------------------------------------cCCce
Confidence 12344
Q ss_pred cccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 007260 452 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLL 531 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L 531 (611)
-+|||||+|.|||++...+|+.++|.||||+++||||+|.+||.+.+...++..|+.+--.+..+..++..+.+||+++-
T Consensus 577 wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LC 656 (732)
T KOG0614|consen 577 WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLC 656 (732)
T ss_pred eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHHH
Confidence 57999999999999999999999999999999999999999999999988888888765443334569999999999999
Q ss_pred hcCccccCCch-hcHHHHHcCCCCCCCchhhhccCC
Q 007260 532 VKEPQHRLAYK-RGATEIKQHPFFEGVNWALIRCAT 566 (611)
Q Consensus 532 ~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~~~~ 566 (611)
..+|.+|+.+. .++.+|.+|-||.+++|.-++..+
T Consensus 657 r~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~ 692 (732)
T KOG0614|consen 657 RDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRT 692 (732)
T ss_pred hcCcHhhhccccCChHHHHhhhhhhcCChhhhhhcc
Confidence 99999999975 579999999999999998876553
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=403.99 Aligned_cols=262 Identities=37% Similarity=0.684 Sum_probs=223.9
Q ss_pred eEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHH-HHHhCCCCCcccccceeeccceeeEEeeeCCC
Q 007260 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTERE-ILQSLDHPFLPTLYTHFETEKFSCLVMEFCPG 300 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~-iL~~l~HpnIv~l~~~~~~~~~~~LVmE~~~g 300 (611)
+.||+|+||+||+|++..+++.||+|++.+...........+..|.. +++.++||||++++++|...+.+||||||++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999999999999999998755433333334444444 57889999999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccccC
Q 007260 301 GDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSL 380 (611)
Q Consensus 301 g~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~ 380 (611)
++|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 81 ~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~---------- 148 (325)
T cd05602 81 GELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE---------- 148 (325)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccccc----------
Confidence 9999988765 5689999999999999999999999999999999999999999999999999832110
Q ss_pred CCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCc
Q 007260 381 DAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEY 460 (611)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y 460 (611)
.......++||+.|
T Consensus 149 ------------------------------------------------------------------~~~~~~~~~gt~~y 162 (325)
T cd05602 149 ------------------------------------------------------------------HNGTTSTFCGTPEY 162 (325)
T ss_pred ------------------------------------------------------------------CCCCcccccCCccc
Confidence 00011235699999
Q ss_pred cchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccCC
Q 007260 461 LAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLA 540 (611)
Q Consensus 461 ~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt 540 (611)
+|||++.+..++.++|||||||++|||++|+.||.+....+.+..+...+..++. .++..+.+||.+||++||.+|++
T Consensus 163 ~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~ 240 (325)
T cd05602 163 LAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKP--NITNSARHLLEGLLQKDRTKRLG 240 (325)
T ss_pred cCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCC--CCCHHHHHHHHHHcccCHHHCCC
Confidence 9999999999999999999999999999999999988877777777776665543 48999999999999999999999
Q ss_pred chhcHHHHHcCCCCCCCchhhhc
Q 007260 541 YKRGATEIKQHPFFEGVNWALIR 563 (611)
Q Consensus 541 ~~~~a~elL~Hp~f~~~~~~~~~ 563 (611)
....+.++++|+||..++|..+.
T Consensus 241 ~~~~~~~i~~~~~~~~~~~~~~~ 263 (325)
T cd05602 241 AKDDFMEIKNHIFFSPINWDDLI 263 (325)
T ss_pred CCCCHHHHhcCcccCCCCHHHHH
Confidence 87778899999999999997653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=405.28 Aligned_cols=262 Identities=37% Similarity=0.714 Sum_probs=219.9
Q ss_pred eEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeeccceeeEEeeeCCC
Q 007260 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEKFSCLVMEFCPG 300 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~~~~~LVmE~~~g 300 (611)
+.||+|+||.||+|++..+++.||+|++.+...........+++|+.++..+ +||||++++++|..++.+||||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876554445556678899988776 899999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccccC
Q 007260 301 GDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSL 380 (611)
Q Consensus 301 g~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~ 380 (611)
|+|..++... +.+++..++.++.||+.||+|||++||+||||||+||||+.++++||+|||++.....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~---------- 148 (329)
T cd05618 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR---------- 148 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC----------
Confidence 9999887765 5699999999999999999999999999999999999999999999999999732100
Q ss_pred CCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCc
Q 007260 381 DAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEY 460 (611)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y 460 (611)
.......++||+.|
T Consensus 149 ------------------------------------------------------------------~~~~~~~~~gt~~y 162 (329)
T cd05618 149 ------------------------------------------------------------------PGDTTSTFCGTPNY 162 (329)
T ss_pred ------------------------------------------------------------------CCCccccccCCccc
Confidence 00011235699999
Q ss_pred cchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC--------CcHH-HHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 007260 461 LAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGS--------GNRA-TLFNVVGQPLRFPESPVVSFAARDLIRGLL 531 (611)
Q Consensus 461 ~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~--------~~~~-~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L 531 (611)
+|||++.+..++.++|||||||++|||++|+.||... .... ....+......+|. .++..+++||.+||
T Consensus 163 ~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~ll~~~L 240 (329)
T cd05618 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKAASVLKSFL 240 (329)
T ss_pred cCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCC--CCCHHHHHHHHHHh
Confidence 9999999999999999999999999999999999531 1112 23344555556665 48999999999999
Q ss_pred hcCccccCCch--hcHHHHHcCCCCCCCchhhhc
Q 007260 532 VKEPQHRLAYK--RGATEIKQHPFFEGVNWALIR 563 (611)
Q Consensus 532 ~~dP~~Rpt~~--~~a~elL~Hp~f~~~~~~~~~ 563 (611)
..||.+|++.. .++.++++||||..++|....
T Consensus 241 ~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~~~~ 274 (329)
T cd05618 241 NKDPKERLGCHPQTGFADIQGHPFFRNVDWDLME 274 (329)
T ss_pred cCCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHH
Confidence 99999999832 236899999999999997654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=400.58 Aligned_cols=261 Identities=38% Similarity=0.732 Sum_probs=225.0
Q ss_pred eEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeeccceeeEEeeeCCC
Q 007260 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEKFSCLVMEFCPG 300 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~~~~~LVmE~~~g 300 (611)
+.||.|+||+||+|++..++..||||++.+...........+.+|+.+++.+ +||||++++++|+..+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999877655555556677899999888 799999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccccC
Q 007260 301 GDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSL 380 (611)
Q Consensus 301 g~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~ 380 (611)
|+|..++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~---------- 148 (318)
T cd05570 81 GDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL---------- 148 (318)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCc----------
Confidence 9999888765 4699999999999999999999999999999999999999999999999998732100
Q ss_pred CCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCc
Q 007260 381 DAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEY 460 (611)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y 460 (611)
.......++||+.|
T Consensus 149 ------------------------------------------------------------------~~~~~~~~~g~~~y 162 (318)
T cd05570 149 ------------------------------------------------------------------GGVTTSTFCGTPDY 162 (318)
T ss_pred ------------------------------------------------------------------CCCcccceecCccc
Confidence 00011234699999
Q ss_pred cchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccCC
Q 007260 461 LAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLA 540 (611)
Q Consensus 461 ~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt 540 (611)
+|||++.+..++.++|||||||++|+|++|+.||.+......+..+......+|. .++..+++||.+||..||.+||+
T Consensus 163 ~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l~~dP~~R~s 240 (318)
T cd05570 163 IAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR--WLSKEAKSILKSFLTKNPEKRLG 240 (318)
T ss_pred cCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC--cCCHHHHHHHHHHccCCHHHcCC
Confidence 9999999999999999999999999999999999988777777777776666665 48999999999999999999999
Q ss_pred ch-hcHHHHHcCCCCCCCchhhh
Q 007260 541 YK-RGATEIKQHPFFEGVNWALI 562 (611)
Q Consensus 541 ~~-~~a~elL~Hp~f~~~~~~~~ 562 (611)
.. ..+.++++||||..++|...
T Consensus 241 ~~~~~~~~ll~~~~~~~~~~~~~ 263 (318)
T cd05570 241 CLPTGEQDIKGHPFFREIDWDKL 263 (318)
T ss_pred CCCCCHHHHhcCCCcCCCCHHHH
Confidence 21 11299999999999999754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=402.77 Aligned_cols=263 Identities=40% Similarity=0.720 Sum_probs=223.8
Q ss_pred EeEecccCcEEEEEEEEC---CCCeEEEEEEecchhhh-hHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEee
Q 007260 221 LKRLGCGDIGSVYLSELS---GTKCYFAMKVMDKASLA-GRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVME 296 (611)
Q Consensus 221 ~~~LG~G~fG~Vy~a~~~---~t~~~vAvKii~k~~~~-~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE 296 (611)
++.||+|+||.||+|++. .+++.||||++.+.... .......+.+|+.+|+.++||||++++++|..++.+|||||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999874 46889999999875442 22344566789999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccc
Q 007260 297 FCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIK 376 (611)
Q Consensus 297 ~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~ 376 (611)
|++|++|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----- 153 (323)
T cd05584 81 YLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE----- 153 (323)
T ss_pred CCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC-----
Confidence 99999999988775 56899999999999999999999999999999999999999999999999997321100
Q ss_pred cccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccccc
Q 007260 377 ASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVG 456 (611)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vG 456 (611)
.......+|
T Consensus 154 -----------------------------------------------------------------------~~~~~~~~g 162 (323)
T cd05584 154 -----------------------------------------------------------------------GTVTHTFCG 162 (323)
T ss_pred -----------------------------------------------------------------------CCcccccCC
Confidence 000113469
Q ss_pred CCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCcc
Q 007260 457 THEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQ 536 (611)
Q Consensus 457 T~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~ 536 (611)
|+.|+|||++.+..++.++|||||||++|||++|+.||.+......+..+......+|. .++..+++||.+||.+||+
T Consensus 163 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~ 240 (323)
T cd05584 163 TIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPP--YLTPEARDLLKKLLKRNPS 240 (323)
T ss_pred CccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHcccCHh
Confidence 99999999999999999999999999999999999999998887777788777666554 4899999999999999999
Q ss_pred ccCCch-hcHHHHHcCCCCCCCchhhhc
Q 007260 537 HRLAYK-RGATEIKQHPFFEGVNWALIR 563 (611)
Q Consensus 537 ~Rpt~~-~~a~elL~Hp~f~~~~~~~~~ 563 (611)
+|++.. ..+.++++||||....|....
T Consensus 241 ~R~~~~~~~~~~l~~h~~~~~~~~~~~~ 268 (323)
T cd05584 241 SRLGAGPGDAAEVQSHPFFRHVNWDDLL 268 (323)
T ss_pred HcCCCCCCCHHHHhcCCCcCCCCHHHHh
Confidence 999211 129999999999999997653
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=401.93 Aligned_cols=268 Identities=44% Similarity=0.801 Sum_probs=219.4
Q ss_pred CeEEEeEecccCcEEEEEEEEC---CCCeEEEEEEecchhhh-hHHHHHHHHHHHHHHHhC-CCCCcccccceeecccee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELS---GTKCYFAMKVMDKASLA-GRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEKFS 291 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~---~t~~~vAvKii~k~~~~-~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~~~~ 291 (611)
+|++++.||+|+||.||++++. .+++.||+|++.+.... ......++..|+.+|+.+ +||||+.++++|..++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999874 47889999999765433 223445677899999999 599999999999999999
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCC
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~ 371 (611)
|||||||+||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||++..+...
T Consensus 81 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 9999999999999988765 56999999999999999999999999999999999999999999999999998432100
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
.....
T Consensus 159 ---------------------------------------------------------------------------~~~~~ 163 (332)
T cd05614 159 ---------------------------------------------------------------------------EKERT 163 (332)
T ss_pred ---------------------------------------------------------------------------CCCcc
Confidence 00011
Q ss_pred cccccCCCccchhhhccCC-CCChhhHHHHHHHHHHHHhCCCCCCCCCc---HH-HHHHHHcCCCCCCCCCCCCHHHHHH
Q 007260 452 MSFVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSGN---RA-TLFNVVGQPLRFPESPVVSFAARDL 526 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~~~-~~~~sDIWSLGviL~ELltG~~PF~~~~~---~~-~l~~i~~~~l~~p~~~~~s~~l~dL 526 (611)
..++||+.|+|||++.+.. ++.++|||||||+||||++|+.||..... .. ....+......++ ..++..+++|
T Consensus 164 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l 241 (332)
T cd05614 164 YSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFP--SFIGPEAQDL 241 (332)
T ss_pred ccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCC--CCCCHHHHHH
Confidence 2357999999999998764 78999999999999999999999975332 22 2233444333333 3589999999
Q ss_pred HHHhhhcCccccCCch-hcHHHHHcCCCCCCCchhhhc
Q 007260 527 IRGLLVKEPQHRLAYK-RGATEIKQHPFFEGVNWALIR 563 (611)
Q Consensus 527 I~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~ 563 (611)
|.+||..||++|++.. ..++++++||||+..+|....
T Consensus 242 i~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~ 279 (332)
T cd05614 242 LHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALA 279 (332)
T ss_pred HHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHH
Confidence 9999999999999421 128999999999999997654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-47 Score=399.52 Aligned_cols=258 Identities=37% Similarity=0.748 Sum_probs=219.9
Q ss_pred eEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHh-CCCCCcccccceeeccceeeEEeeeCCC
Q 007260 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQS-LDHPFLPTLYTHFETEKFSCLVMEFCPG 300 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~-l~HpnIv~l~~~~~~~~~~~LVmE~~~g 300 (611)
+.||+|+||.||+|++..+++.||||++.+..............|..++.. ++||||+++++++.+.+.+||||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 479999999999999999999999999987644333344455678888876 4999999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccccC
Q 007260 301 GDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSL 380 (611)
Q Consensus 301 g~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~ 380 (611)
|+|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--------- 149 (316)
T cd05619 81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--------- 149 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC---------
Confidence 9999988764 46899999999999999999999999999999999999999999999999997321100
Q ss_pred CCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCc
Q 007260 381 DAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEY 460 (611)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y 460 (611)
.......+||+.|
T Consensus 150 -------------------------------------------------------------------~~~~~~~~gt~~y 162 (316)
T cd05619 150 -------------------------------------------------------------------DAKTCTFCGTPDY 162 (316)
T ss_pred -------------------------------------------------------------------CCceeeecCCccc
Confidence 0011234699999
Q ss_pred cchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccCC
Q 007260 461 LAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLA 540 (611)
Q Consensus 461 ~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt 540 (611)
+|||++.+..++.++|||||||++|||++|+.||.+.+....+..+......+|. .++.++++||.+||..||++|++
T Consensus 163 ~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l~~~P~~R~~ 240 (316)
T cd05619 163 IAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPR--WLTREAKDILVKLFVREPERRLG 240 (316)
T ss_pred cCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc--cCCHHHHHHHHHHhccCHhhcCC
Confidence 9999999999999999999999999999999999988776666666555544554 48999999999999999999999
Q ss_pred chhcH-HHHHcCCCCCCCchhhhc
Q 007260 541 YKRGA-TEIKQHPFFEGVNWALIR 563 (611)
Q Consensus 541 ~~~~a-~elL~Hp~f~~~~~~~~~ 563 (611)
+ +++++||||+.++|....
T Consensus 241 ----~~~~l~~h~~~~~~~~~~~~ 260 (316)
T cd05619 241 ----VKGDIRQHPFFREIDWSALE 260 (316)
T ss_pred ----ChHHHHcCcccCCCCHHHHH
Confidence 5 489999999999998654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=391.54 Aligned_cols=265 Identities=30% Similarity=0.479 Sum_probs=231.6
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhh-----hhHHHHHHHHHHHHHHHhC-CCCCcccccceeeccc
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASL-----AGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEK 289 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~-----~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~~ 289 (611)
..|.-.+.||.|..++|.++.++.++..+|+|+|.-... ..........+|+.||+++ .||+|++|.++|+++.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 467888999999999999999999999999999974321 2233444557899999998 7999999999999999
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
++|+|+|+|+.|.|++++... -.++|...+.+++||+.|++|||.++||||||||||||++++.++||+|||+|.++.
T Consensus 97 F~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred hhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC
Confidence 999999999999999999876 569999999999999999999999999999999999999999999999999996543
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
.+ .
T Consensus 175 ~G-----------------------------------------------------------------------------e 177 (411)
T KOG0599|consen 175 PG-----------------------------------------------------------------------------E 177 (411)
T ss_pred Cc-----------------------------------------------------------------------------h
Confidence 22 2
Q ss_pred cccccccCCCccchhhhccC------CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCC--CCCCCCCH
Q 007260 450 RSMSFVGTHEYLAPEIIKGE------GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRF--PESPVVSF 521 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~~------~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~--p~~~~~s~ 521 (611)
+....||||+|+|||.++.. +|+..+|+||+|||+|-||.|.+||........+..|..+.+.| |+|..++.
T Consensus 178 kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~ 257 (411)
T KOG0599|consen 178 KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISA 257 (411)
T ss_pred hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhccc
Confidence 23456899999999999753 68899999999999999999999999877777788888887665 77888999
Q ss_pred HHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCchhhhc
Q 007260 522 AARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIR 563 (611)
Q Consensus 522 ~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~ 563 (611)
.++|||.+||+.||.+|+| +.|+|+||||..+.....+
T Consensus 258 ~~KdLIsrlLqVdp~~Rit----ake~LaHpff~q~~~~~~r 295 (411)
T KOG0599|consen 258 TVKDLISRLLQVDPTKRIT----AKEALAHPFFIQIAQQQAR 295 (411)
T ss_pred cHHHHHHHHHeeCchhccc----HHHHhcChHHHHHHHhccc
Confidence 9999999999999999999 9999999999765444333
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=393.41 Aligned_cols=269 Identities=35% Similarity=0.580 Sum_probs=224.4
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVME 296 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE 296 (611)
.|++.+.||.|+||+||++.+..+++.||||++.+...........+.+|+.+|+.++||||+++++++..++.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48899999999999999999999999999999977654444444556789999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccc
Q 007260 297 FCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIK 376 (611)
Q Consensus 297 ~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~ 376 (611)
|+.||+|..++.......+++..++.++.||+.||.|||++|||||||||+|||+++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~----- 155 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG----- 155 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC-----
Confidence 999999998887654457999999999999999999999999999999999999999999999999997332100
Q ss_pred cccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccccc
Q 007260 377 ASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVG 456 (611)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vG 456 (611)
......+|
T Consensus 156 ------------------------------------------------------------------------~~~~~~~~ 163 (285)
T cd05605 156 ------------------------------------------------------------------------ETIRGRVG 163 (285)
T ss_pred ------------------------------------------------------------------------CccccccC
Confidence 00112369
Q ss_pred CCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH----HHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007260 457 THEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFN----VVGQPLRFPESPVVSFAARDLIRGLLV 532 (611)
Q Consensus 457 T~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~----i~~~~l~~p~~~~~s~~l~dLI~~~L~ 532 (611)
|+.|+|||++.+..++.++|||||||++|||++|+.||.+......... +......++ ..++..+++||.+||.
T Consensus 164 ~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~ 241 (285)
T cd05605 164 TVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYS--EKFSEAARSICRQLLT 241 (285)
T ss_pred CCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccC--cccCHHHHHHHHHHcc
Confidence 9999999999999999999999999999999999999987654332222 222222222 3489999999999999
Q ss_pred cCccccCCch-hcHHHHHcCCCCCCCchhhhcc
Q 007260 533 KEPQHRLAYK-RGATEIKQHPFFEGVNWALIRC 564 (611)
Q Consensus 533 ~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~~ 564 (611)
.||.+||+.. ..++++++||||...+|.....
T Consensus 242 ~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~ 274 (285)
T cd05605 242 KDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEA 274 (285)
T ss_pred CCHHHhcCCCCCCHHHHhcCcCccCCCHHHHhh
Confidence 9999999321 1299999999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=398.94 Aligned_cols=260 Identities=27% Similarity=0.432 Sum_probs=220.7
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec-----cce
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET-----EKF 290 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~-----~~~ 290 (611)
.+|..++.||.|+||.|..|.++.+++.||||.+.. .+...-..+|..+|+.+|+.++|+||+.+++++.. -+.
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~-~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILN-PFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhh-hhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 567778999999999999999999999999999853 34556677888999999999999999999999865 467
Q ss_pred eeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccC
Q 007260 291 SCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAV 370 (611)
Q Consensus 291 ~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~ 370 (611)
+|+|+|+| +-||+.+++.+ ..++++.++.+++|||+||.|+|+.||+||||||.|||++.+..+||+|||||+....
T Consensus 101 vYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred eEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccc
Confidence 89999999 88999999886 4599999999999999999999999999999999999999999999999999954321
Q ss_pred CccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccc
Q 007260 371 SPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEAR 450 (611)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (611)
. .....
T Consensus 178 ~--------------------------------------------------------------------------~~~~~ 183 (359)
T KOG0660|consen 178 F--------------------------------------------------------------------------FEDGF 183 (359)
T ss_pred c--------------------------------------------------------------------------Ccccc
Confidence 1 11222
Q ss_pred ccccccCCCccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH---cCC----------------
Q 007260 451 SMSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVV---GQP---------------- 510 (611)
Q Consensus 451 ~~~~vGT~~Y~APEil~~-~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~---~~~---------------- 510 (611)
.+.+|-|.||+|||++.. ..|+.++||||+||||.|||+|++.|.|.+...++..|+ +.+
T Consensus 184 mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~y 263 (359)
T KOG0660|consen 184 MTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPY 263 (359)
T ss_pred hhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHH
Confidence 346789999999999864 468999999999999999999999999987766664433 221
Q ss_pred ----CCCCC------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 511 ----LRFPE------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 511 ----l~~p~------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
...|. .+..++.+.||+.+||+.||.+|+| |+|+|+||||...
T Consensus 264 i~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRit----a~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 264 IKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRIT----AEEALAHPYLAPY 316 (359)
T ss_pred HHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCC----HHHHhcChhhhhh
Confidence 11111 1457899999999999999999999 9999999999754
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=392.10 Aligned_cols=261 Identities=33% Similarity=0.614 Sum_probs=218.8
Q ss_pred ecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEeeeCCCCCH
Q 007260 224 LGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDL 303 (611)
Q Consensus 224 LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE~~~gg~L 303 (611)
||+|+||+||++.+..+++.||+|++.+...........+..|+.+|+.++|+||++++++|..+..+||||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999999876655555556778899999999999999999999999999999999999999
Q ss_pred HHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccccCC
Q 007260 304 HTLRQKQ--PGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLD 381 (611)
Q Consensus 304 ~~ll~~~--~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~ 381 (611)
..++... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--------- 151 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--------- 151 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC---------
Confidence 8877432 23569999999999999999999999999999999999999999999999999984321000
Q ss_pred CCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCcc
Q 007260 382 AEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYL 461 (611)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~ 461 (611)
.....+.||+.|+
T Consensus 152 -------------------------------------------------------------------~~~~~~~g~~~y~ 164 (280)
T cd05608 152 -------------------------------------------------------------------SKTKGYAGTPGFM 164 (280)
T ss_pred -------------------------------------------------------------------ccccccCCCcCcc
Confidence 0011246999999
Q ss_pred chhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHH----HHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccc
Q 007260 462 APEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRA----TLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQH 537 (611)
Q Consensus 462 APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~----~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~ 537 (611)
|||++.+..++.++|||||||++|||++|+.||....... ....+......++ ..++..+.+||.+||..||++
T Consensus 165 aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~ 242 (280)
T cd05608 165 APELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYP--DKFSPASKSFCEALLAKDPEK 242 (280)
T ss_pred CHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCc--ccCCHHHHHHHHHHhcCCHHH
Confidence 9999999999999999999999999999999998754322 2233333333333 348999999999999999999
Q ss_pred cCCchh-cHHHHHcCCCCCCCchhhh
Q 007260 538 RLAYKR-GATEIKQHPFFEGVNWALI 562 (611)
Q Consensus 538 Rpt~~~-~a~elL~Hp~f~~~~~~~~ 562 (611)
|++++. .++++++||||++++|...
T Consensus 243 R~~~~~~~~~~~l~h~~~~~~~~~~~ 268 (280)
T cd05608 243 RLGFRDGNCDGLRTHPLFRDLNWRQL 268 (280)
T ss_pred hcCCCCCCHHHHhcChhhhcCCHhHH
Confidence 996543 4899999999999999865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=392.12 Aligned_cols=257 Identities=28% Similarity=0.428 Sum_probs=212.2
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
++|++++.||+|+||.||+|++..+++.||||++...... ......+.+|+.+++.++||||++++++|..++.+||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 3799999999999999999999999999999999754322 233446678999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
||++++.|..+.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 80 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--- 154 (287)
T cd07848 80 EYVEKNMLELLEEMP--NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS--- 154 (287)
T ss_pred ecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc---
Confidence 999887776554432 469999999999999999999999999999999999999999999999999984321000
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
.......+
T Consensus 155 ------------------------------------------------------------------------~~~~~~~~ 162 (287)
T cd07848 155 ------------------------------------------------------------------------NANYTEYV 162 (287)
T ss_pred ------------------------------------------------------------------------cccccccc
Confidence 00011346
Q ss_pred cCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCC-------------------CCCCC-
Q 007260 456 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQP-------------------LRFPE- 515 (611)
Q Consensus 456 GT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~-------------------l~~p~- 515 (611)
||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+.+..+.... ..++.
T Consensus 163 ~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (287)
T cd07848 163 ATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAV 242 (287)
T ss_pred cccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcc
Confidence 8999999999999999999999999999999999999999876655544332110 11111
Q ss_pred ----------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCC
Q 007260 516 ----------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 516 ----------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f 554 (611)
...++.++++||.+||.+||.+||+ ++++|+||||
T Consensus 243 ~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s----~~~~l~hp~f 287 (287)
T cd07848 243 NHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYL----TEQCLNHPAF 287 (287)
T ss_pred cCcccHHHhhhcccCHHHHHHHHHHccCCcccCCC----HHHHhcCCCC
Confidence 1136888999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=404.81 Aligned_cols=261 Identities=39% Similarity=0.713 Sum_probs=223.9
Q ss_pred ecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC---CCCCcccccceeeccceeeEEeeeCCC
Q 007260 224 LGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL---DHPFLPTLYTHFETEKFSCLVMEFCPG 300 (611)
Q Consensus 224 LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l---~HpnIv~l~~~~~~~~~~~LVmE~~~g 300 (611)
||+|+||+||+|++..+++.||||++.+..............|..++..+ +||||+.++++|.....+||||||++|
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999876555555555666788887766 699999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccccC
Q 007260 301 GDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSL 380 (611)
Q Consensus 301 g~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~ 380 (611)
|+|..++.+. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.++|+|||++.....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~---------- 148 (330)
T cd05586 81 GELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLT---------- 148 (330)
T ss_pred ChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC----------
Confidence 9999888765 5699999999999999999999999999999999999999999999999999732110
Q ss_pred CCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCc
Q 007260 381 DAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEY 460 (611)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y 460 (611)
.......++||+.|
T Consensus 149 ------------------------------------------------------------------~~~~~~~~~gt~~y 162 (330)
T cd05586 149 ------------------------------------------------------------------DNKTTNTFCGTTEY 162 (330)
T ss_pred ------------------------------------------------------------------CCCCccCccCCccc
Confidence 00011235699999
Q ss_pred cchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccC
Q 007260 461 LAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRL 539 (611)
Q Consensus 461 ~APEil~~~-~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rp 539 (611)
+|||++.+. .++.++|||||||++|||++|+.||.+......+.++......++.. .++.++++||.+||..||.+||
T Consensus 163 ~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~~~~li~~~L~~~P~~R~ 241 (330)
T cd05586 163 LAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKN-VLSDEGRQFVKGLLNRNPQHRL 241 (330)
T ss_pred cCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCc-cCCHHHHHHHHHHcCCCHHHCC
Confidence 999999765 47999999999999999999999999887777777777766666643 4799999999999999999999
Q ss_pred CchhcHHHHHcCCCCCCCchhhhc
Q 007260 540 AYKRGATEIKQHPFFEGVNWALIR 563 (611)
Q Consensus 540 t~~~~a~elL~Hp~f~~~~~~~~~ 563 (611)
+....+.++++||||..+.|....
T Consensus 242 ~~~~~~~~ll~h~~~~~~~~~~~~ 265 (330)
T cd05586 242 GAHRDAVELKEHPFFADIDWDLLS 265 (330)
T ss_pred CCCCCHHHHhcCccccCCCHHHHH
Confidence 766669999999999999997754
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-47 Score=398.71 Aligned_cols=262 Identities=42% Similarity=0.781 Sum_probs=224.9
Q ss_pred eEecccCcEEEEEEEE---CCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEeeeC
Q 007260 222 KRLGCGDIGSVYLSEL---SGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFC 298 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~---~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE~~ 298 (611)
+.||+|+||.||++++ ..+++.||+|++.+..... ....++.+|+++|+.++||||++++++|..++.+||||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 6799999999999986 3578899999998755432 23345678999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccc
Q 007260 299 PGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKAS 378 (611)
Q Consensus 299 ~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~ 378 (611)
+||+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++......
T Consensus 81 ~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~------- 151 (318)
T cd05582 81 RGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH------- 151 (318)
T ss_pred CCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC-------
Confidence 999999988765 46999999999999999999999999999999999999999999999999997322100
Q ss_pred cCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCC
Q 007260 379 SLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTH 458 (611)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~ 458 (611)
......++||+
T Consensus 152 ---------------------------------------------------------------------~~~~~~~~g~~ 162 (318)
T cd05582 152 ---------------------------------------------------------------------EKKAYSFCGTV 162 (318)
T ss_pred ---------------------------------------------------------------------CCceecccCCh
Confidence 00112356999
Q ss_pred CccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCcccc
Q 007260 459 EYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHR 538 (611)
Q Consensus 459 ~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~R 538 (611)
.|+|||++.+..++.++|||||||++|||++|+.||.+......+..+......+|.. ++..+++||.+||..||.+|
T Consensus 163 ~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~--~~~~~~~li~~~l~~~P~~R 240 (318)
T cd05582 163 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQF--LSPEAQSLLRALFKRNPANR 240 (318)
T ss_pred hhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCHHHHHHHHHHhhcCHhHc
Confidence 9999999999999999999999999999999999999888777777777776666654 89999999999999999999
Q ss_pred CCchh-cHHHHHcCCCCCCCchhhhcc
Q 007260 539 LAYKR-GATEIKQHPFFEGVNWALIRC 564 (611)
Q Consensus 539 pt~~~-~a~elL~Hp~f~~~~~~~~~~ 564 (611)
|+... .+.+++.||||..++|.....
T Consensus 241 ~~a~~~~~~~~~~~~~~~~~~~~~~~~ 267 (318)
T cd05582 241 LGAGPDGVEEIKRHPFFSTIDWNKLYR 267 (318)
T ss_pred CCCCCCCHHHHhCCCCcCCCCHHHHHh
Confidence 99543 478899999999999976543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=402.13 Aligned_cols=273 Identities=35% Similarity=0.656 Sum_probs=245.2
Q ss_pred cccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeeccce
Q 007260 212 VLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEKF 290 (611)
Q Consensus 212 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~~~ 290 (611)
.+...+|..+.+||.|+||.|.+|+.+++.+.||||+++++.+.....+.-...|..+|... +-|++++|+..|++-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 45567999999999999999999999999999999999998776666666667788888877 46899999999999999
Q ss_pred eeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccC
Q 007260 291 SCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAV 370 (611)
Q Consensus 291 ~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~ 370 (611)
+|+||||+.||||--.+++. +.|-|..+.+|+++|+-||=|||++|||+||||.+|||++.+||+||+|||+.+.-.
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni- 501 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI- 501 (683)
T ss_pred eeeEEEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccc-
Confidence 99999999999998877775 569999999999999999999999999999999999999999999999999973210
Q ss_pred CccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccc
Q 007260 371 SPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEAR 450 (611)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (611)
.....
T Consensus 502 ---------------------------------------------------------------------------~~~~T 506 (683)
T KOG0696|consen 502 ---------------------------------------------------------------------------FDGVT 506 (683)
T ss_pred ---------------------------------------------------------------------------cCCcc
Confidence 01223
Q ss_pred ccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 007260 451 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGL 530 (611)
Q Consensus 451 ~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~ 530 (611)
+.+|+|||.|+|||++...+|+..+||||+||+|||||.|++||.|.++.+.+..|......+|.. +|.++.+++.++
T Consensus 507 TkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKs--lSkEAv~ickg~ 584 (683)
T KOG0696|consen 507 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKS--LSKEAVAICKGL 584 (683)
T ss_pred eeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCccc--ccHHHHHHHHHH
Confidence 457999999999999999999999999999999999999999999999999999999999999987 999999999999
Q ss_pred hhcCccccCCch-hcHHHHHcCCCCCCCchhhhcc
Q 007260 531 LVKEPQHRLAYK-RGATEIKQHPFFEGVNWALIRC 564 (611)
Q Consensus 531 L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~~ 564 (611)
|.+.|.+|+... .+-.+|..||||+.++|..+..
T Consensus 585 ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~ 619 (683)
T KOG0696|consen 585 LTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLER 619 (683)
T ss_pred hhcCCccccCCCCccccchhhCcchhhccHHHHhh
Confidence 999999999864 4567899999999999987643
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-48 Score=406.00 Aligned_cols=259 Identities=31% Similarity=0.494 Sum_probs=235.0
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
+-|.+.+.||+|.|++|-+|+|--||..||||+++|..+..-.. -.+.+|+..|+.++|||||+||++..+...+|||+
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st-~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLST-GHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhh-hHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 57999999999999999999999999999999999988765333 35677999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEcc-CCcEEEEeccccccccCCccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRE-DGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~-~g~vkL~DFGlA~~~~~~~~~ 374 (611)
|+-+||||++++-++. ..+.|+.++.|++||+.|+.|||+..|||||||||||++-+ -|-|||.|||++-.+.+
T Consensus 97 ELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P---- 171 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP---- 171 (864)
T ss_pred EecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCC----
Confidence 9999999999998874 56999999999999999999999999999999999998874 78999999999833221
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
.....++
T Consensus 172 -------------------------------------------------------------------------G~kL~Ts 178 (864)
T KOG4717|consen 172 -------------------------------------------------------------------------GKKLTTS 178 (864)
T ss_pred -------------------------------------------------------------------------cchhhcc
Confidence 1223467
Q ss_pred ccCCCccchhhhccCCC-CChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007260 455 VGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVK 533 (611)
Q Consensus 455 vGT~~Y~APEil~~~~~-~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~ 533 (611)
||++.|-|||++.|..| .+++||||||||||-|+||++||...++-+++-.|+...+..|.. ++.+++|||..||+.
T Consensus 179 CGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPsh--vS~eCrdLI~sMLvR 256 (864)
T KOG4717|consen 179 CGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSH--VSKECRDLIQSMLVR 256 (864)
T ss_pred cchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchh--hhHHHHHHHHHHHhc
Confidence 89999999999999999 578999999999999999999999999999999999999888876 999999999999999
Q ss_pred CccccCCchhcHHHHHcCCCCCCCch
Q 007260 534 EPQHRLAYKRGATEIKQHPFFEGVNW 559 (611)
Q Consensus 534 dP~~Rpt~~~~a~elL~Hp~f~~~~~ 559 (611)
||++|.+ +++|..|+|++.++.
T Consensus 257 dPkkRAs----lEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 257 DPKKRAS----LEEIVSTSWLQAGDR 278 (864)
T ss_pred Cchhhcc----HHHHhccccccCCCC
Confidence 9999999 999999999997764
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-47 Score=392.56 Aligned_cols=257 Identities=28% Similarity=0.457 Sum_probs=212.1
Q ss_pred cccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeE
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCL 293 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~L 293 (611)
.+++|++++.||.|+||.||+|++..++..||+|+++..... .....+.+|+.+|+.++||||+++++++.+++..|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 80 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTL 80 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC--CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 357899999999999999999999999999999998654322 122345689999999999999999999999999999
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcc
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 373 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~ 373 (611)
||||++ ++|.+++... +..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 v~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~-- 156 (288)
T cd07871 81 VFEYLD-SDLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP-- 156 (288)
T ss_pred EEeCCC-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC--
Confidence 999996 5999888765 346899999999999999999999999999999999999999999999999998322100
Q ss_pred ccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccc
Q 007260 374 LIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMS 453 (611)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (611)
......
T Consensus 157 --------------------------------------------------------------------------~~~~~~ 162 (288)
T cd07871 157 --------------------------------------------------------------------------TKTYSN 162 (288)
T ss_pred --------------------------------------------------------------------------CccccC
Confidence 000112
Q ss_pred cccCCCccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHc---CCC----------------CC
Q 007260 454 FVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG---QPL----------------RF 513 (611)
Q Consensus 454 ~vGT~~Y~APEil~~-~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~---~~l----------------~~ 513 (611)
.+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+.+..+.. .+. .+
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (288)
T cd07871 163 EVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLF 242 (288)
T ss_pred ceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcccc
Confidence 358999999999876 4689999999999999999999999998776655543321 110 01
Q ss_pred CC---------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCC
Q 007260 514 PE---------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 514 p~---------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f 554 (611)
+. ...++.+++|||.+||.+||.+|+| +.|+|+||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t----~~~~l~hp~f 288 (288)
T cd07871 243 PQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRIS----AEAALRHSYF 288 (288)
T ss_pred CccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCC----HHHHhcCCCC
Confidence 11 1346889999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-47 Score=387.66 Aligned_cols=263 Identities=31% Similarity=0.528 Sum_probs=218.5
Q ss_pred ecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEeeeCCCCCH
Q 007260 224 LGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDL 303 (611)
Q Consensus 224 LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE~~~gg~L 303 (611)
||.|+||.||++++..+++.||+|++.+...........+..|+++|+.++||||++++++|+.+.++||||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999999765543332333455699999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccccCCCC
Q 007260 304 HTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAE 383 (611)
Q Consensus 304 ~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~ 383 (611)
..++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~----------- 149 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK----------- 149 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-----------
Confidence 988876555568999999999999999999999999999999999999999999999999984321000
Q ss_pred cCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCccch
Q 007260 384 PLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAP 463 (611)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~AP 463 (611)
......||+.|+||
T Consensus 150 ------------------------------------------------------------------~~~~~~~~~~y~aP 163 (277)
T cd05607 150 ------------------------------------------------------------------TITQRAGTNGYMAP 163 (277)
T ss_pred ------------------------------------------------------------------eeeccCCCCCccCH
Confidence 00123589999999
Q ss_pred hhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccC
Q 007260 464 EIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGN----RATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRL 539 (611)
Q Consensus 464 Eil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~----~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rp 539 (611)
|++.+..++.++|||||||++|||++|+.||.+... .............++. ..++.++++||.+||.+||++||
T Consensus 164 E~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~~P~~R~ 242 (277)
T cd05607 164 EILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEH-QNFTEESKDICRLFLAKKPEDRL 242 (277)
T ss_pred HHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccccc-ccCCHHHHHHHHHHhccCHhhCC
Confidence 999999999999999999999999999999976433 2223333443333332 35899999999999999999999
Q ss_pred CchhcHHHHHcCCCCCCCchhhhcc
Q 007260 540 AYKRGATEIKQHPFFEGVNWALIRC 564 (611)
Q Consensus 540 t~~~~a~elL~Hp~f~~~~~~~~~~ 564 (611)
+.++..++++.||||++++|.....
T Consensus 243 ~~~~~~~~~~~h~~f~~~~~~~~~~ 267 (277)
T cd05607 243 GSREKNDDPRKHEFFKTINFPRLEA 267 (277)
T ss_pred CCccchhhhhcChhhcCCCHHHHhc
Confidence 9666668999999999999976653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-47 Score=393.47 Aligned_cols=261 Identities=26% Similarity=0.412 Sum_probs=210.5
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
.++|++++.||.|+||.||+|++..+++.||||++...... .....+.+|+.+|+.++||||+++++++.++...|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE--GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc--ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 36899999999999999999999999999999999754322 1223456799999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
|||+ +++|.+++.... ..+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||++......
T Consensus 82 ~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--- 156 (303)
T cd07869 82 FEYV-HTDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP--- 156 (303)
T ss_pred EECC-CcCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC---
Confidence 9999 568888776653 46899999999999999999999999999999999999999999999999987321100
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
.......
T Consensus 157 -------------------------------------------------------------------------~~~~~~~ 163 (303)
T cd07869 157 -------------------------------------------------------------------------SHTYSNE 163 (303)
T ss_pred -------------------------------------------------------------------------CccCCCC
Confidence 0000123
Q ss_pred ccCCCccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHH---HcCCCC--CC-------------
Q 007260 455 VGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRAT-LFNV---VGQPLR--FP------------- 514 (611)
Q Consensus 455 vGT~~Y~APEil~~~-~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~-l~~i---~~~~l~--~p------------- 514 (611)
+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+..+... +..+ .+.+.. ++
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (303)
T cd07869 164 VVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERF 243 (303)
T ss_pred cccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccc
Confidence 589999999998764 578999999999999999999999988654322 2222 121100 00
Q ss_pred -----C-------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCch
Q 007260 515 -----E-------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNW 559 (611)
Q Consensus 515 -----~-------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 559 (611)
. ....+..+++||.+||++||.+|+| +.|+|+||||+.+.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s----~~~~l~h~~f~~~~~ 296 (303)
T cd07869 244 TLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLS----AQAALSHEYFSDLPP 296 (303)
T ss_pred cccCCccHHHHhhccCCChHHHHHHHHHhccCchhccC----HHHHhcCcccccCCh
Confidence 0 0124578899999999999999999 999999999998764
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-46 Score=411.58 Aligned_cols=254 Identities=26% Similarity=0.380 Sum_probs=202.3
Q ss_pred cccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC------CCCcccccceeec
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD------HPFLPTLYTHFET 287 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~------HpnIv~l~~~~~~ 287 (611)
..++|++++.||.|+||+||+|.+..+++.||||+++.... ....+..|+.+++.+. |.+|+.++++|..
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK----YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh----hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 35789999999999999999999999999999999965321 1223455777776664 4568889998876
Q ss_pred c-ceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCeeccCCCCCcEEEccCC----------
Q 007260 288 E-KFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHM-LGIIYRDLKPENVLVREDG---------- 355 (611)
Q Consensus 288 ~-~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~-~gIVHRDLKPeNILv~~~g---------- 355 (611)
+ .++|||||++ |++|.+++.+. +.+++..++.|+.||+.||+|||. .|||||||||+||||+.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence 4 6789999999 88898888765 569999999999999999999998 5999999999999998765
Q ss_pred ------cEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCc
Q 007260 356 ------HIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPK 429 (611)
Q Consensus 356 ------~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 429 (611)
.+||+|||++....
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~------------------------------------------------------------ 299 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDER------------------------------------------------------------ 299 (467)
T ss_pred cCCCCceEEECCCCccccCc------------------------------------------------------------
Confidence 49999999762110
Q ss_pred cccCCCCCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcC
Q 007260 430 NEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ 509 (611)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~ 509 (611)
.....++||+.|+|||++.+..|+.++|||||||+||||++|++||.+..+.+.+..+...
T Consensus 300 -------------------~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~ 360 (467)
T PTZ00284 300 -------------------HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKT 360 (467)
T ss_pred -------------------cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 0012357999999999999999999999999999999999999999987765544332211
Q ss_pred CCCCC------------------------C----------------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHH
Q 007260 510 PLRFP------------------------E----------------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIK 549 (611)
Q Consensus 510 ~l~~p------------------------~----------------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL 549 (611)
...+| . .......+.|||.+||++||.+||+ |+|+|
T Consensus 361 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t----a~e~L 436 (467)
T PTZ00284 361 LGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN----ARQMT 436 (467)
T ss_pred cCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC----HHHHh
Confidence 00000 0 0012456789999999999999999 99999
Q ss_pred cCCCCCCC
Q 007260 550 QHPFFEGV 557 (611)
Q Consensus 550 ~Hp~f~~~ 557 (611)
+||||...
T Consensus 437 ~Hp~~~~~ 444 (467)
T PTZ00284 437 THPYVLKY 444 (467)
T ss_pred cCcccccc
Confidence 99999754
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=393.43 Aligned_cols=262 Identities=26% Similarity=0.397 Sum_probs=209.9
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecc-----cee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE-----KFS 291 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~-----~~~ 291 (611)
+|++.+.||.|+||.||+|++..++..||||++.... .......++.+|+.+|+.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh-ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 5999999999999999999999999999999986432 2222334677899999999999999999988543 358
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCC
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~ 371 (611)
||||||| +++|.+++... ..+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||++......
T Consensus 80 ~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 80 YVVFELM-ESDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEEecC-CCCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 9999999 57999988765 45999999999999999999999999999999999999999999999999998432100
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
.. .....
T Consensus 157 ~~-------------------------------------------------------------------------~~~~~ 163 (338)
T cd07859 157 TP-------------------------------------------------------------------------TAIFW 163 (338)
T ss_pred cC-------------------------------------------------------------------------ccccc
Confidence 00 00001
Q ss_pred cccccCCCccchhhhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH---HcCC----------------
Q 007260 452 MSFVGTHEYLAPEIIKG--EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNV---VGQP---------------- 510 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~--~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i---~~~~---------------- 510 (611)
...+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+......+..+ .+.+
T Consensus 164 ~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 243 (338)
T cd07859 164 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRY 243 (338)
T ss_pred cCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHH
Confidence 23469999999999976 57899999999999999999999999876543332111 1110
Q ss_pred -------CCCC---CCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCch
Q 007260 511 -------LRFP---ESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNW 559 (611)
Q Consensus 511 -------l~~p---~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 559 (611)
...+ ..+.++..+.+||.+||..||++||+ +.++++||||+++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~e~l~hp~f~~~~~ 298 (338)
T cd07859 244 LSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPT----AEEALADPYFKGLAK 298 (338)
T ss_pred HHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCC----HHHHhcCchhhhcCc
Confidence 0000 11346788999999999999999999 999999999987654
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-47 Score=388.72 Aligned_cols=261 Identities=28% Similarity=0.465 Sum_probs=219.2
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCC-cccccceeeccc----
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF-LPTLYTHFETEK---- 289 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~Hpn-Iv~l~~~~~~~~---- 289 (611)
+..|..+++||+|+||+||+|+...+|+.||+|.++-.... +.....+.+|+.+|+.|+|+| ||.|++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 34677788999999999999999999999999999755321 113334578999999999999 999999998877
Q ss_pred --eeeEEeeeCCCCCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccc
Q 007260 290 --FSCLVMEFCPGGDLHTLRQKQPG--KYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365 (611)
Q Consensus 290 --~~~LVmE~~~gg~L~~ll~~~~~--~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA 365 (611)
.+||||||+ .-||..++...+. ..++...++.+++||+.||+|||++||+||||||+||||+++|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 899999999 7799999998753 36888999999999999999999999999999999999999999999999999
Q ss_pred ccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccC
Q 007260 366 LRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAE 445 (611)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (611)
+......
T Consensus 168 ra~~ip~------------------------------------------------------------------------- 174 (323)
T KOG0594|consen 168 RAFSIPM------------------------------------------------------------------------- 174 (323)
T ss_pred HHhcCCc-------------------------------------------------------------------------
Confidence 5332110
Q ss_pred cccccccccccCCCccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH---cCC--C--------
Q 007260 446 PTEARSMSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVV---GQP--L-------- 511 (611)
Q Consensus 446 ~~~~~~~~~vGT~~Y~APEil~~~-~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~---~~~--l-------- 511 (611)
......++|.||+|||++.|. .|+..+||||+|||++||+++++.|.|..+.+++..|. +.+ .
T Consensus 175 ---~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~ 251 (323)
T KOG0594|consen 175 ---RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSL 251 (323)
T ss_pred ---ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCcccc
Confidence 012245799999999999998 68999999999999999999999999999988876554 333 1
Q ss_pred -----CCCCC----------CCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 512 -----RFPES----------PVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 512 -----~~p~~----------~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
.|+.+ +..+....+++.+||+.+|.+|.+ |..+|.||||...
T Consensus 252 ~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~S----a~~al~h~yf~~~ 308 (323)
T KOG0594|consen 252 PDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRIS----AKGALTHPYFSEL 308 (323)
T ss_pred ccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcC----HHHHhcChhhccc
Confidence 12222 223458899999999999999999 9999999999875
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-46 Score=390.47 Aligned_cols=257 Identities=26% Similarity=0.412 Sum_probs=215.3
Q ss_pred cccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeE
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCL 293 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~L 293 (611)
..++|++++.||.|+||.||++++..++..||+|++.... ......++.+|+++|+.++||||+++++++..++.+||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 3478999999999999999999999999999999987542 22344567889999999999999999999999999999
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CeeccCCCCCcEEEccCCcEEEEeccccccccCCc
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHML-GIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~-gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~ 372 (611)
||||++|++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-- 156 (331)
T cd06649 81 CMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-- 156 (331)
T ss_pred EeecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc--
Confidence 99999999999998775 4689999999999999999999986 699999999999999999999999998732210
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
....
T Consensus 157 ----------------------------------------------------------------------------~~~~ 160 (331)
T cd06649 157 ----------------------------------------------------------------------------SMAN 160 (331)
T ss_pred ----------------------------------------------------------------------------cccc
Confidence 0011
Q ss_pred ccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCC----------------------
Q 007260 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQP---------------------- 510 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~---------------------- 510 (611)
.++||+.|+|||++.+..++.++|||||||++|||++|+.||......+ +..+++.+
T Consensus 161 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (331)
T cd06649 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE-LEAIFGRPVVDGEEGEPHSISPRPRPPGRP 239 (331)
T ss_pred cCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHhcccccccccCCccccCccccccccc
Confidence 2469999999999999999999999999999999999999997654332 22222211
Q ss_pred -------------------------CCCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 511 -------------------------LRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 511 -------------------------l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
........++.++++||.+||.+||++||+ +.+|++||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt----~~ell~h~~~~~~ 307 (331)
T cd06649 240 VSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERAD----LKMLMNHTFIKRS 307 (331)
T ss_pred ccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCC----HHHHhcChHHhhc
Confidence 000011247889999999999999999999 9999999999754
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-46 Score=382.02 Aligned_cols=270 Identities=34% Similarity=0.578 Sum_probs=223.3
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVME 296 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE 296 (611)
.|++.+.||.|+||.||+|.+..+++.||||.+.+...........+.+|+.+|+.++|+||+.+++.+.+++.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 37888999999999999999999999999999876554444444456789999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccc
Q 007260 297 FCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIK 376 (611)
Q Consensus 297 ~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~ 376 (611)
|++|++|.+++.......+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~----- 155 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG----- 155 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC-----
Confidence 999999999887655557999999999999999999999999999999999999999999999999987321100
Q ss_pred cccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccccc
Q 007260 377 ASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVG 456 (611)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vG 456 (611)
......+|
T Consensus 156 ------------------------------------------------------------------------~~~~~~~g 163 (285)
T cd05630 156 ------------------------------------------------------------------------QTIKGRVG 163 (285)
T ss_pred ------------------------------------------------------------------------ccccCCCC
Confidence 00012359
Q ss_pred CCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007260 457 THEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNR---ATLFNVVGQPLRFPESPVVSFAARDLIRGLLVK 533 (611)
Q Consensus 457 T~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~---~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~ 533 (611)
|+.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+... ........++.++++||.+||+.
T Consensus 164 ~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~ 242 (285)
T cd05630 164 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VQEEYSEKFSPDARSLCKMLLCK 242 (285)
T ss_pred CccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh-hhhhcCccCCHHHHHHHHHHhhc
Confidence 99999999999999999999999999999999999999875432 222222211 11112234889999999999999
Q ss_pred CccccCCch-hcHHHHHcCCCCCCCchhhhcc
Q 007260 534 EPQHRLAYK-RGATEIKQHPFFEGVNWALIRC 564 (611)
Q Consensus 534 dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~~ 564 (611)
||.+|+++. -.+.|+++||||..++|..+..
T Consensus 243 ~p~~R~s~~~~~~~~~~~h~~~~~~~~~~~~~ 274 (285)
T cd05630 243 DPKERLGCQGGGAREVKEHPLFKQINFKRLEA 274 (285)
T ss_pred CHHHccCCCCCchHHHHcChhhhccCHHHHhc
Confidence 999999843 2378999999999999987653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=389.19 Aligned_cols=254 Identities=28% Similarity=0.408 Sum_probs=206.2
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
+++|++++.||.|+||.||+|++..+++.||||++.... .......+.+|+++|+.++|+||++++++|..++.+|+|
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 150 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL 150 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence 457888999999999999999999999999999986543 223345678899999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
||||++++|... ..+.+..+..++.||+.||+|||++|||||||||+||||+.++.+||+|||++..+...
T Consensus 151 ~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~--- 221 (353)
T PLN00034 151 LEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT--- 221 (353)
T ss_pred EecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccc---
Confidence 999999998642 33678888999999999999999999999999999999999999999999998432100
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
.......
T Consensus 222 -------------------------------------------------------------------------~~~~~~~ 228 (353)
T PLN00034 222 -------------------------------------------------------------------------MDPCNSS 228 (353)
T ss_pred -------------------------------------------------------------------------ccccccc
Confidence 0001134
Q ss_pred ccCCCccchhhhcc-----CCCCChhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 007260 455 VGTHEYLAPEIIKG-----EGHGSAVDWWTFGIFLYELLFGKTPFKGSGN--RATLFNVVGQPLRFPESPVVSFAARDLI 527 (611)
Q Consensus 455 vGT~~Y~APEil~~-----~~~~~~sDIWSLGviL~ELltG~~PF~~~~~--~~~l~~i~~~~l~~p~~~~~s~~l~dLI 527 (611)
+||..|+|||++.. ...+.++|||||||+||||++|+.||..... ...+...+...........++.++++||
T Consensus 229 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 308 (353)
T PLN00034 229 VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFI 308 (353)
T ss_pred ccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHHHH
Confidence 69999999999853 2346789999999999999999999974332 2222222222222223345899999999
Q ss_pred HHhhhcCccccCCchhcHHHHHcCCCCCC
Q 007260 528 RGLLVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 528 ~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
.+||..||++||+ +.||++||||..
T Consensus 309 ~~~l~~~P~~Rpt----~~ell~hp~~~~ 333 (353)
T PLN00034 309 SCCLQREPAKRWS----AMQLLQHPFILR 333 (353)
T ss_pred HHHccCChhhCcC----HHHHhcCccccc
Confidence 9999999999999 999999999975
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=395.83 Aligned_cols=251 Identities=28% Similarity=0.462 Sum_probs=216.2
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc-eeeE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK-FSCL 293 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~-~~~L 293 (611)
..+..+.+.||.|+||+||++.++++. .||||++......... ...+.+|+.+|.+|+|||||++++++.... .++|
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~~g~~-~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~i 117 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKWRGTD-VVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCI 117 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEeCCce-eEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEE
Confidence 345566677999999999999998764 3999999876655444 678899999999999999999999999887 7999
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC-eeccCCCCCcEEEccCC-cEEEEeccccccccCC
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLG-IIYRDLKPENVLVREDG-HIMLSDFDLSLRCAVS 371 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~g-IVHRDLKPeNILv~~~g-~vkL~DFGlA~~~~~~ 371 (611)
||||+++|+|..++.....+.++...+..++.||+.||+|||+++ ||||||||+||||+.++ ++||+|||+++.....
T Consensus 118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 999999999999998844578999999999999999999999999 99999999999999998 9999999998433211
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
. ...
T Consensus 198 ~----------------------------------------------------------------------------~~~ 201 (362)
T KOG0192|consen 198 K----------------------------------------------------------------------------TSM 201 (362)
T ss_pred c----------------------------------------------------------------------------ccc
Confidence 0 011
Q ss_pred cccccCCCccchhhhc--cCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHH
Q 007260 452 MSFVGTHEYLAPEIIK--GEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRG 529 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~--~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~ 529 (611)
+...||+.|||||++. ...|+.++|||||||+||||+||+.||.+....+....++.+..+.+....++..+..||..
T Consensus 202 ~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~ 281 (362)
T KOG0192|consen 202 TSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSLMER 281 (362)
T ss_pred cCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHH
Confidence 1246999999999999 56899999999999999999999999999988777777776766666555699999999999
Q ss_pred hhhcCccccCCchh
Q 007260 530 LLVKEPQHRLAYKR 543 (611)
Q Consensus 530 ~L~~dP~~Rpt~~~ 543 (611)
||..||..||++..
T Consensus 282 CW~~dp~~RP~f~e 295 (362)
T KOG0192|consen 282 CWLVDPSRRPSFLE 295 (362)
T ss_pred hCCCCCCcCCCHHH
Confidence 99999999999543
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-48 Score=400.96 Aligned_cols=257 Identities=28% Similarity=0.446 Sum_probs=226.5
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
..|+.+.+||+|.||.||+|.+..+++.||+|+++-... ...+..+++|+.+|..++++||.++|+.|..+..++++|
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~--~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA--EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhc--chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 468888999999999999999999999999999986543 345667789999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
|||.||++.++++.. ..+.|..+..++++++.||.|||..+.+|||||+.||||..+|.|||+|||.+..+.
T Consensus 91 ey~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~------ 162 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLT------ 162 (467)
T ss_pred HHhcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeee------
Confidence 999999999998874 556999999999999999999999999999999999999999999999999983321
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
.+..+..+|+
T Consensus 163 ----------------------------------------------------------------------~~~~rr~tfv 172 (467)
T KOG0201|consen 163 ----------------------------------------------------------------------NTVKRRKTFV 172 (467)
T ss_pred ----------------------------------------------------------------------chhhcccccc
Confidence 1223346899
Q ss_pred cCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCc
Q 007260 456 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEP 535 (611)
Q Consensus 456 GT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP 535 (611)
|||.|||||++++.+|+.++||||||++.|||++|.+||........++.|-......-.. .++..+++||..||.+||
T Consensus 173 GTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~-~~S~~~kEFV~~CL~k~P 251 (467)
T KOG0201|consen 173 GTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDG-DFSPPFKEFVEACLDKNP 251 (467)
T ss_pred ccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCcccc-ccCHHHHHHHHHHhhcCc
Confidence 9999999999999999999999999999999999999999888766666555544332222 689999999999999999
Q ss_pred cccCCchhcHHHHHcCCCCCCC
Q 007260 536 QHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 536 ~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
+.||+ |.+||+|.|.+..
T Consensus 252 ~~Rps----A~~LLKh~FIk~a 269 (467)
T KOG0201|consen 252 EFRPS----AKELLKHKFIKRA 269 (467)
T ss_pred ccCcC----HHHHhhhHHHHhc
Confidence 99999 9999999999763
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=378.59 Aligned_cols=270 Identities=33% Similarity=0.559 Sum_probs=225.3
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVME 296 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE 296 (611)
.|+..+.||.|+||+||+|.+..+++.||+|++.+...........+.+|+++|+.++|+||+.+++.|..++..|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 47889999999999999999999999999999977655444444556789999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccc
Q 007260 297 FCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIK 376 (611)
Q Consensus 297 ~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~ 376 (611)
|+++++|..++.......+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~----- 155 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG----- 155 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC-----
Confidence 999999998887654457999999999999999999999999999999999999999999999999987432100
Q ss_pred cccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccccc
Q 007260 377 ASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVG 456 (611)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vG 456 (611)
.......|
T Consensus 156 ------------------------------------------------------------------------~~~~~~~g 163 (285)
T cd05632 156 ------------------------------------------------------------------------ESIRGRVG 163 (285)
T ss_pred ------------------------------------------------------------------------CcccCCCC
Confidence 00012359
Q ss_pred CCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCC--CCCCCCCCCHHHHHHHHHhhhcC
Q 007260 457 THEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPL--RFPESPVVSFAARDLIRGLLVKE 534 (611)
Q Consensus 457 T~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l--~~p~~~~~s~~l~dLI~~~L~~d 534 (611)
++.|+|||++.+..++.++|||||||++|||++|..||.+.........+..... .......++.++.+||.+||..|
T Consensus 164 ~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 243 (285)
T cd05632 164 TVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKD 243 (285)
T ss_pred CcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHccCC
Confidence 9999999999999999999999999999999999999987665443333322111 11222358899999999999999
Q ss_pred ccccCCch-hcHHHHHcCCCCCCCchhhhc
Q 007260 535 PQHRLAYK-RGATEIKQHPFFEGVNWALIR 563 (611)
Q Consensus 535 P~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~ 563 (611)
|++||+.. ..+.++++|+||..+.|..+.
T Consensus 244 P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~ 273 (285)
T cd05632 244 PKQRLGCQEEGAGEVKRHPFFRNMNFKRLE 273 (285)
T ss_pred HhHcCCCcccChHHHHcChhhhcCCHHHHh
Confidence 99999965 348899999999999887643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=376.62 Aligned_cols=265 Identities=43% Similarity=0.791 Sum_probs=231.7
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
++|++.+.||.|+||.||++.+..+++.||+|++.+......+...++.+|+++|++++||||+++++++..++.+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 37999999999999999999999999999999998766555556677889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||+|.||||+.+|.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---- 154 (290)
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence 999999999998876 56999999999999999999999999999999999999999999999999987332100
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
.....
T Consensus 155 ---------------------------------------------------------------------------~~~~~ 159 (290)
T cd05580 155 ---------------------------------------------------------------------------TYTLC 159 (290)
T ss_pred ---------------------------------------------------------------------------CCCCC
Confidence 11235
Q ss_pred cCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCc
Q 007260 456 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEP 535 (611)
Q Consensus 456 GT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP 535 (611)
|++.|+|||.+.+..++.++||||||+++|+|++|+.||..........++......+|.. ++..++++|.+||..||
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~~l~~~p 237 (290)
T cd05580 160 GTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSF--FSPDAKDLIRNLLQVDL 237 (290)
T ss_pred CCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCcc--CCHHHHHHHHHHccCCH
Confidence 8999999999998888999999999999999999999998877666666777666555544 79999999999999999
Q ss_pred cccCCc-hhcHHHHHcCCCCCCCchhhhc
Q 007260 536 QHRLAY-KRGATEIKQHPFFEGVNWALIR 563 (611)
Q Consensus 536 ~~Rpt~-~~~a~elL~Hp~f~~~~~~~~~ 563 (611)
.+|++. ...++++++||||+.+.|....
T Consensus 238 ~~R~~~~~~~~~~l~~~~~~~~~~~~~~~ 266 (290)
T cd05580 238 TKRLGNLKNGVNDIKNHPWFAGIDWIALL 266 (290)
T ss_pred HHccCcccCCHHHHHcCcccccCCHHHHh
Confidence 999921 1239999999999999997654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-46 Score=381.04 Aligned_cols=256 Identities=27% Similarity=0.412 Sum_probs=208.0
Q ss_pred cCeEEEeEecccCcEEEEEEEECC-CCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC---CCCCcccccceee-----
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSG-TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL---DHPFLPTLYTHFE----- 286 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~-t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l---~HpnIv~l~~~~~----- 286 (611)
.+|++++.||.|+||.||+|++.. ++..||||++....... .....+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 379999999999999999999854 46889999986543221 1122345677776665 6999999999875
Q ss_pred ccceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccc
Q 007260 287 TEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSL 366 (611)
Q Consensus 287 ~~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~ 366 (611)
....+||||||++ ++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 3467899999995 699998887666679999999999999999999999999999999999999999999999999984
Q ss_pred cccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCc
Q 007260 367 RCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEP 446 (611)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (611)
.....
T Consensus 159 ~~~~~--------------------------------------------------------------------------- 163 (290)
T cd07862 159 IYSFQ--------------------------------------------------------------------------- 163 (290)
T ss_pred eccCC---------------------------------------------------------------------------
Confidence 32100
Q ss_pred ccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCC-----CCCCC------
Q 007260 447 TEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQP-----LRFPE------ 515 (611)
Q Consensus 447 ~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~-----l~~p~------ 515 (611)
.......||+.|+|||++.+..++.++|||||||++|||++|++||.+....+.+..++... ..++.
T Consensus 164 --~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (290)
T cd07862 164 --MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 241 (290)
T ss_pred --cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccc
Confidence 01113469999999999999999999999999999999999999999988777766654321 01110
Q ss_pred --------------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCC
Q 007260 516 --------------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 516 --------------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f 554 (611)
.+.++..+++||.+||+.||++||+ +.++|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s----~~~~l~hp~f 290 (290)
T cd07862 242 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS----AYSALSHPYF 290 (290)
T ss_pred hhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCC----HHHHhcCCCC
Confidence 1347788999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=399.52 Aligned_cols=253 Identities=24% Similarity=0.352 Sum_probs=205.7
Q ss_pred cccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeE
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCL 293 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~L 293 (611)
...+|++++.||.|+||.||+|.+..+++.||||..... .+.+|+++|+.|+|||||+++++|..+...|+
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~~---------~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRG---------GTATEAHILRAINHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhhh---------hhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence 346899999999999999999999999999999975432 34679999999999999999999999999999
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcc
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 373 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~ 373 (611)
|||++ +++|..++... ..+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|......
T Consensus 161 v~e~~-~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~-- 235 (391)
T PHA03212 161 ILPRY-KTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI-- 235 (391)
T ss_pred EEecC-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc--
Confidence 99999 57898887664 46899999999999999999999999999999999999999999999999998321100
Q ss_pred ccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccc
Q 007260 374 LIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMS 453 (611)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (611)
.......
T Consensus 236 -------------------------------------------------------------------------~~~~~~~ 242 (391)
T PHA03212 236 -------------------------------------------------------------------------NANKYYG 242 (391)
T ss_pred -------------------------------------------------------------------------ccccccc
Confidence 0001123
Q ss_pred cccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC-------cHHHHHHHH---c---------------
Q 007260 454 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSG-------NRATLFNVV---G--------------- 508 (611)
Q Consensus 454 ~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~-------~~~~l~~i~---~--------------- 508 (611)
++||+.|+|||++.+..++.++|||||||+||||++|+.||.... ....+..++ +
T Consensus 243 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~ 322 (391)
T PHA03212 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLD 322 (391)
T ss_pred ccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHH
Confidence 579999999999999999999999999999999999998875421 111111111 1
Q ss_pred --------CCCCCC----CC---CCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 509 --------QPLRFP----ES---PVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 509 --------~~l~~p----~~---~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
.....+ .+ ..++.++.+||.+||++||.+||| |.|+|+||||+.+
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpt----a~elL~hp~f~~~ 382 (391)
T PHA03212 323 EIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPS----AEALLDFAAFQDI 382 (391)
T ss_pred HHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCC----HHHHhcChhhccC
Confidence 000001 00 125678999999999999999999 9999999999753
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=405.75 Aligned_cols=256 Identities=27% Similarity=0.447 Sum_probs=207.7
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec-------
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET------- 287 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~------- 287 (611)
..+|++++.||+|+||.||+|.+..+++.||||++..... ...+|+.+|+.++|||||+++++|..
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ-------YKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 4689999999999999999999999999999998865321 22469999999999999999988743
Q ss_pred -cceeeEEeeeCCCCCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCC-cEEEEecc
Q 007260 288 -EKFSCLVMEFCPGGDLHTLRQK--QPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDG-HIMLSDFD 363 (611)
Q Consensus 288 -~~~~~LVmE~~~gg~L~~ll~~--~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g-~vkL~DFG 363 (611)
..++|+|||||+ ++|.+++.. ..+..+++..++.|+.||+.||+|||++|||||||||+||||+.++ .+||+|||
T Consensus 138 ~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 138 KNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred CceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 235789999996 577776653 2346799999999999999999999999999999999999999665 69999999
Q ss_pred ccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccc
Q 007260 364 LSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELI 443 (611)
Q Consensus 364 lA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 443 (611)
+|..+...
T Consensus 217 la~~~~~~------------------------------------------------------------------------ 224 (440)
T PTZ00036 217 SAKNLLAG------------------------------------------------------------------------ 224 (440)
T ss_pred cchhccCC------------------------------------------------------------------------
Confidence 98432100
Q ss_pred cCcccccccccccCCCccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHc---CC---------
Q 007260 444 AEPTEARSMSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG---QP--------- 510 (611)
Q Consensus 444 ~~~~~~~~~~~vGT~~Y~APEil~~~-~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~---~~--------- 510 (611)
......+||+.|+|||++.+. .|+.++|||||||+||||++|.+||.+....+.+.+++. .+
T Consensus 225 -----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~ 299 (440)
T PTZ00036 225 -----QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMN 299 (440)
T ss_pred -----CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhc
Confidence 011234689999999998775 689999999999999999999999998877666655432 11
Q ss_pred -----CCCCC----------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCch
Q 007260 511 -----LRFPE----------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNW 559 (611)
Q Consensus 511 -----l~~p~----------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 559 (611)
+.+|. ....+.++++||.+||.+||.+|++ +.|+|+||||+.+.+
T Consensus 300 ~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~t----a~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 300 PNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLN----PIEALADPFFDDLRD 359 (440)
T ss_pred hhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcC----HHHHhCChhHHhhhc
Confidence 11221 1236789999999999999999999 999999999987544
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=390.81 Aligned_cols=255 Identities=27% Similarity=0.428 Sum_probs=208.8
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecc------
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE------ 288 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~------ 288 (611)
.++|++++.||+|+||.||+|.+..+++.||||++.+.. .......++.+|+.+++.++||||++++++|...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 479999999999999999999999999999999997543 2223345667899999999999999999987643
Q ss_pred ceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccc
Q 007260 289 KFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRC 368 (611)
Q Consensus 289 ~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~ 368 (611)
..+|+||||++ ++|..++.. .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 45799999995 577776654 3889999999999999999999999999999999999999999999999998432
Q ss_pred cCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccc
Q 007260 369 AVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTE 448 (611)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (611)
...
T Consensus 177 ~~~----------------------------------------------------------------------------- 179 (364)
T cd07875 177 GTS----------------------------------------------------------------------------- 179 (364)
T ss_pred CCC-----------------------------------------------------------------------------
Confidence 100
Q ss_pred ccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCC-----------------
Q 007260 449 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPL----------------- 511 (611)
Q Consensus 449 ~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l----------------- 511 (611)
......+||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+....+.+++....
T Consensus 180 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (364)
T cd07875 180 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 259 (364)
T ss_pred CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHH
Confidence 001124689999999999999999999999999999999999999998776665554432110
Q ss_pred -----C--------------CC----CCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCC
Q 007260 512 -----R--------------FP----ESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 512 -----~--------------~p----~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
. ++ .....+..+++||.+||..||.+||| +.++|+||||..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t----~~e~L~hp~~~~ 323 (364)
T cd07875 260 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS----VDEALQHPYINV 323 (364)
T ss_pred HhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCC----HHHHhcCccccc
Confidence 0 00 01123567899999999999999999 999999999963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=399.85 Aligned_cols=260 Identities=29% Similarity=0.515 Sum_probs=233.2
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccce-eeE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKF-SCL 293 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~-~~L 293 (611)
+++|..++.+|.|+||.+++++++..+..|++|.+.-.....+... .+.+|+.++.++.|||||.+++.|+.++. +||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~-~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERR-SAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhH-HHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 4689999999999999999999999999999999987665544333 67889999999999999999999998877 999
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcc
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 373 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~ 373 (611)
||+||+||+|.+++.++.+..|+|+.+..|+.|++.||.|||+++|+|||||+.||+++.++.|+|.|||+|+.+...
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~-- 159 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE-- 159 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCc--
Confidence 999999999999999998899999999999999999999999999999999999999999999999999999655311
Q ss_pred ccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccc
Q 007260 374 LIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMS 453 (611)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (611)
.....+
T Consensus 160 --------------------------------------------------------------------------~~~a~t 165 (426)
T KOG0589|consen 160 --------------------------------------------------------------------------DSLAST 165 (426)
T ss_pred --------------------------------------------------------------------------hhhhhe
Confidence 112346
Q ss_pred cccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007260 454 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVK 533 (611)
Q Consensus 454 ~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~ 533 (611)
.+||+.||.||++.+.+|+.++|||||||++|||++-+++|.+.+-...+.+|.... -.|.+...+.+++.||..||.+
T Consensus 166 vvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~-~~Plp~~ys~el~~lv~~~l~~ 244 (426)
T KOG0589|consen 166 VVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL-YSPLPSMYSSELRSLVKSMLRK 244 (426)
T ss_pred ecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc-CCCCCccccHHHHHHHHHHhhc
Confidence 789999999999999999999999999999999999999999987777777776665 4566666999999999999999
Q ss_pred CccccCCchhcHHHHHcCCCCCC
Q 007260 534 EPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 534 dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
+|..||+ |.+||.+|....
T Consensus 245 ~P~~RPs----a~~LL~~P~l~~ 263 (426)
T KOG0589|consen 245 NPEHRPS----ALELLRRPHLLR 263 (426)
T ss_pred CCccCCC----HHHHhhChhhhh
Confidence 9999999 999999988763
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=389.66 Aligned_cols=255 Identities=27% Similarity=0.443 Sum_probs=206.4
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecc------
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE------ 288 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~------ 288 (611)
.++|++++.||.|+||.||+|++..+++.||||++.+.. .......++.+|+.+++.++||||++++++|...
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 469999999999999999999999999999999996543 2233445677899999999999999999998644
Q ss_pred ceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccc
Q 007260 289 KFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRC 368 (611)
Q Consensus 289 ~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~ 368 (611)
..+|+||||+++ +|...+.. .+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 357999999954 66665543 3889999999999999999999999999999999999999999999999998321
Q ss_pred cCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccc
Q 007260 369 AVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTE 448 (611)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (611)
...
T Consensus 174 ~~~----------------------------------------------------------------------------- 176 (359)
T cd07876 174 CTN----------------------------------------------------------------------------- 176 (359)
T ss_pred ccC-----------------------------------------------------------------------------
Confidence 100
Q ss_pred ccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHc--------------------
Q 007260 449 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG-------------------- 508 (611)
Q Consensus 449 ~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~-------------------- 508 (611)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 177 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (359)
T cd07876 177 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNY 256 (359)
T ss_pred ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHH
Confidence 001123689999999999999999999999999999999999999988765443322211
Q ss_pred --CCCCCC---------C---------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCC
Q 007260 509 --QPLRFP---------E---------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 509 --~~l~~p---------~---------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
....++ . ....+..+++||.+||..||.+||+ +.|+|+||||..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t----~~e~l~hp~~~~ 320 (359)
T cd07876 257 VENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRIS----VDEALRHPYITV 320 (359)
T ss_pred HhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCC----HHHHhcCchhhh
Confidence 111110 0 1124678999999999999999999 999999999963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=401.38 Aligned_cols=253 Identities=30% Similarity=0.454 Sum_probs=216.7
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC-C-----CCcccccceeeccce
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD-H-----PFLPTLYTHFETEKF 290 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~-H-----pnIv~l~~~~~~~~~ 290 (611)
+|.+++.||+|+||.|.+|.+..|++.||||+++... ....+.+.|+.||..|+ | -|||+++++|...++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 8999999999999999999999999999999997653 44556788999999996 4 389999999999999
Q ss_pred eeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCC--cEEEEeccccccc
Q 007260 291 SCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDG--HIMLSDFDLSLRC 368 (611)
Q Consensus 291 ~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g--~vkL~DFGlA~~~ 368 (611)
+|||+|++ ..+|.++++.+.-..|+...++.++.|||.||.+||.+||||+|||||||||.+-+ .|||+|||.|...
T Consensus 263 lciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 263 LCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99999999 78999999998778899999999999999999999999999999999999998644 6999999987221
Q ss_pred cCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccc
Q 007260 369 AVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTE 448 (611)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (611)
.
T Consensus 342 ~------------------------------------------------------------------------------- 342 (586)
T KOG0667|consen 342 S------------------------------------------------------------------------------- 342 (586)
T ss_pred C-------------------------------------------------------------------------------
Confidence 1
Q ss_pred ccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHc---CCC--------------
Q 007260 449 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG---QPL-------------- 511 (611)
Q Consensus 449 ~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~---~~l-------------- 511 (611)
.+..+++.+..|+|||+|.|.+|+.+.||||||||++||++|.+.|.|.++.+++..|++ .+.
T Consensus 343 q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff 422 (586)
T KOG0667|consen 343 QRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFF 422 (586)
T ss_pred CcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceeh
Confidence 011146788999999999999999999999999999999999999999999888866542 110
Q ss_pred -----------------------------------CCC-CCC--------CCCHHHHHHHHHhhhcCccccCCchhcHHH
Q 007260 512 -----------------------------------RFP-ESP--------VVSFAARDLIRGLLVKEPQHRLAYKRGATE 547 (611)
Q Consensus 512 -----------------------------------~~p-~~~--------~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~e 547 (611)
..| ... .-...+.|||.+||.+||.+|+| +.+
T Consensus 423 ~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t----p~q 498 (586)
T KOG0667|consen 423 TSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT----PAQ 498 (586)
T ss_pred hccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC----HHH
Confidence 001 000 11235789999999999999999 999
Q ss_pred HHcCCCCCCC
Q 007260 548 IKQHPFFEGV 557 (611)
Q Consensus 548 lL~Hp~f~~~ 557 (611)
+|+||||.+.
T Consensus 499 al~Hpfl~~~ 508 (586)
T KOG0667|consen 499 ALNHPFLTGT 508 (586)
T ss_pred HhcCcccccc
Confidence 9999999854
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-45 Score=385.27 Aligned_cols=257 Identities=26% Similarity=0.411 Sum_probs=213.5
Q ss_pred cccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeE
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCL 293 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~L 293 (611)
..++|++.+.||.|+||.||+|.+..++..||+|++.... .......+.+|+++|+.++||||++++++|..++++||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 3468999999999999999999999999999999987542 22334567889999999999999999999999999999
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CeeccCCCCCcEEEccCCcEEEEeccccccccCCc
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHML-GIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~-gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~ 372 (611)
||||++|++|.+++... +.+++..++.++.||+.||.|||+. +|+||||||+|||++.+|.+||+|||++..+...
T Consensus 81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 81 CMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred EEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 99999999999998775 4689999999999999999999985 7999999999999999999999999997332100
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
...
T Consensus 158 -----------------------------------------------------------------------------~~~ 160 (333)
T cd06650 158 -----------------------------------------------------------------------------MAN 160 (333)
T ss_pred -----------------------------------------------------------------------------ccc
Confidence 001
Q ss_pred ccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHc------------------------
Q 007260 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG------------------------ 508 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~------------------------ 508 (611)
.++||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..+++
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (333)
T cd06650 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKEL-ELMFGCPVEGDPAESETSPRPRPPGRPLS 239 (333)
T ss_pred cCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHH-HHHhcCcccCCccccccCcccCCccchhh
Confidence 23689999999999999999999999999999999999999976543222 11111
Q ss_pred ---------------------CCCCCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 509 ---------------------QPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 509 ---------------------~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
..........++.++++||.+||++||++||+ +.||++||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt----~~ell~h~~~~~~ 305 (333)
T cd06650 240 SYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERAD----LKQLMVHAFIKRS 305 (333)
T ss_pred hhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcC----HHHHhhCHHHhcC
Confidence 11000111236789999999999999999999 9999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=379.35 Aligned_cols=260 Identities=27% Similarity=0.456 Sum_probs=212.5
Q ss_pred cccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeE
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCL 293 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~L 293 (611)
.+++|++++.||.|+||.||+|++..++..||+|+++...... ....+.+|+.+++.++||||+++++++..++..|+
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 81 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTL 81 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC--cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEE
Confidence 4578999999999999999999999999999999987543221 12245679999999999999999999999999999
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcc
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 373 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~ 373 (611)
||||++ ++|.+++... +..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 82 v~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 158 (309)
T cd07872 82 VFEYLD-KDLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT- 158 (309)
T ss_pred EEeCCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc-
Confidence 999996 5888877665 3468999999999999999999999999999999999999999999999999973221000
Q ss_pred ccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccc
Q 007260 374 LIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMS 453 (611)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (611)
.....
T Consensus 159 ---------------------------------------------------------------------------~~~~~ 163 (309)
T cd07872 159 ---------------------------------------------------------------------------KTYSN 163 (309)
T ss_pred ---------------------------------------------------------------------------ccccc
Confidence 00012
Q ss_pred cccCCCccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH---cCC----------------CCC
Q 007260 454 FVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVV---GQP----------------LRF 513 (611)
Q Consensus 454 ~vGT~~Y~APEil~~~-~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~---~~~----------------l~~ 513 (611)
.+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+. +.+ ..+
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (309)
T cd07872 164 EVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNF 243 (309)
T ss_pred ccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhc
Confidence 3588999999998764 57999999999999999999999998876655443332 111 111
Q ss_pred CC---------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 514 PE---------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 514 p~---------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
+. ...++.++++||.+||..||.+|+| +.|+|+||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t----~~e~l~h~~~~~~ 292 (309)
T cd07872 244 PKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRIS----AEEAMKHAYFRSL 292 (309)
T ss_pred CccCCCchhhhccCCCHHHHHHHHHhccCChhhCCC----HHHHhcChhhhhc
Confidence 11 1347889999999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=388.84 Aligned_cols=260 Identities=24% Similarity=0.398 Sum_probs=210.8
Q ss_pred ccCeEEEeEecccCcEEEEEEEECC--CCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceee
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSG--TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSC 292 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~--t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~ 292 (611)
..+|++++.||.|+||.||+|...+ ++..||+|.+.... ...+|+++|+.++|||||+++++|.....+|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 3589999999999999999998643 56789999986542 2356999999999999999999999999999
Q ss_pred EEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCc
Q 007260 293 LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 293 LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~ 372 (611)
+|||++ +++|.+++... ..+++..++.|+.||+.||+|||.+|||||||||+||||+.++.++|+|||++..+....
T Consensus 163 lv~e~~-~~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 163 MVMPKY-KCDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred EEehhc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 999999 57888888543 569999999999999999999999999999999999999999999999999984332110
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
......
T Consensus 240 --------------------------------------------------------------------------~~~~~~ 245 (392)
T PHA03207 240 --------------------------------------------------------------------------DTPQCY 245 (392)
T ss_pred --------------------------------------------------------------------------cccccc
Confidence 000112
Q ss_pred ccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHc----CCCCCCC----------
Q 007260 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGN---RATLFNVVG----QPLRFPE---------- 515 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~---~~~l~~i~~----~~l~~p~---------- 515 (611)
.++||+.|+|||++.+..|+.++|||||||+||||++|+.||.+... ...+..++. .+..++.
T Consensus 246 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~ 325 (392)
T PHA03207 246 GWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHF 325 (392)
T ss_pred ccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHH
Confidence 35799999999999999999999999999999999999999976432 222222221 1111110
Q ss_pred ------------------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCchhhhc
Q 007260 516 ------------------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIR 563 (611)
Q Consensus 516 ------------------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~ 563 (611)
...++.++++||.+||..||++||+ +.++|+||||....|..++
T Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rps----a~e~l~~p~f~~~~~~~~~ 387 (392)
T PHA03207 326 KQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPS----AQDILSLPLFTKEPINLLN 387 (392)
T ss_pred HhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCC----HHHHhhCchhhccchhhhc
Confidence 0135678999999999999999999 9999999999987776543
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=375.47 Aligned_cols=255 Identities=29% Similarity=0.451 Sum_probs=206.4
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC---CCCCcccccceeec-----c
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL---DHPFLPTLYTHFET-----E 288 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l---~HpnIv~l~~~~~~-----~ 288 (611)
+|++++.||.|+||+||+|++..+++.||+|++....... .....+.+|+.+++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 5899999999999999999999999999999987542211 1112334577766655 79999999998864 3
Q ss_pred ceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccc
Q 007260 289 KFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRC 368 (611)
Q Consensus 289 ~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~ 368 (611)
..+|+||||++ ++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 56899999996 58988888765566999999999999999999999999999999999999999999999999987322
Q ss_pred cCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccc
Q 007260 369 AVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTE 448 (611)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (611)
...
T Consensus 159 ~~~----------------------------------------------------------------------------- 161 (288)
T cd07863 159 SCQ----------------------------------------------------------------------------- 161 (288)
T ss_pred cCc-----------------------------------------------------------------------------
Confidence 100
Q ss_pred ccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHc---CCC--CCC---------
Q 007260 449 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG---QPL--RFP--------- 514 (611)
Q Consensus 449 ~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~---~~l--~~p--------- 514 (611)
......+||+.|+|||++.+..++.++|||||||++|+|++|++||.+......+.++.. .+. .++
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (288)
T cd07863 162 MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGA 241 (288)
T ss_pred ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccc
Confidence 000123589999999999999999999999999999999999999988776665544432 110 000
Q ss_pred -----------CCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCC
Q 007260 515 -----------ESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 515 -----------~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f 554 (611)
..+.++..+++||.+||++||++||+ +.+++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~~~l~hp~f 288 (288)
T cd07863 242 FSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRIS----AFRALQHPFF 288 (288)
T ss_pred cCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCC----HHHHhcCCCC
Confidence 01247888999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=371.95 Aligned_cols=273 Identities=38% Similarity=0.717 Sum_probs=238.7
Q ss_pred ccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeeccc
Q 007260 211 GVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEK 289 (611)
Q Consensus 211 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~~ 289 (611)
..+++.+|+++++||+|+|++|.++++..|.+.||||+++|.-....+.+.-+++|..++... +||++|-|+.+|+++.
T Consensus 245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes 324 (593)
T KOG0695|consen 245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES 324 (593)
T ss_pred cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc
Confidence 346788999999999999999999999999999999999988777777777788899988766 7999999999999999
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
.+++|.||++||||--.++++ +.++|+.+++|-.+|+.||.|||+.|||+||||.+|||++..|++||.|+|+.+.-.
T Consensus 325 rlffvieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred eEEEEEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCC
Confidence 999999999999998777776 569999999999999999999999999999999999999999999999999863210
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
....
T Consensus 403 ----------------------------------------------------------------------------~~gd 406 (593)
T KOG0695|consen 403 ----------------------------------------------------------------------------GPGD 406 (593)
T ss_pred ----------------------------------------------------------------------------CCCc
Confidence 0122
Q ss_pred cccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC-------CCcHHHH-HHHHcCCCCCCCCCCCCH
Q 007260 450 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKG-------SGNRATL-FNVVGQPLRFPESPVVSF 521 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~-------~~~~~~l-~~i~~~~l~~p~~~~~s~ 521 (611)
.+.+|+|||.|+|||++.|..|+..+|||+|||+++||+.|+.||+- .+..+.+ +-|+...+++|.. ++-
T Consensus 407 ~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprs--lsv 484 (593)
T KOG0695|consen 407 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRS--LSV 484 (593)
T ss_pred ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccce--eeh
Confidence 34578999999999999999999999999999999999999999962 1122333 4456777888876 888
Q ss_pred HHHHHHHHhhhcCccccCCch--hcHHHHHcCCCCCCCchhhhc
Q 007260 522 AARDLIRGLLVKEPQHRLAYK--RGATEIKQHPFFEGVNWALIR 563 (611)
Q Consensus 522 ~l~dLI~~~L~~dP~~Rpt~~--~~a~elL~Hp~f~~~~~~~~~ 563 (611)
.+..++.+.|.+||.+|+... .+..++..|+||+.++|.++.
T Consensus 485 kas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~le 528 (593)
T KOG0695|consen 485 KASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLE 528 (593)
T ss_pred hhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHh
Confidence 888999999999999998753 478999999999999998764
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=390.72 Aligned_cols=261 Identities=25% Similarity=0.346 Sum_probs=213.2
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc-----ee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK-----FS 291 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~-----~~ 291 (611)
+|++++.||.|+||.||+|.+..+++.||||++.... .......++.+|+++|+.++|+||+++++++.... .+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 4788999999999999999999999999999986532 22234456788999999999999999999998776 88
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCC
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~ 371 (611)
|+||||+. ++|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 80 ~lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 99999995 6888877654 56999999999999999999999999999999999999999999999999998432100
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
. ....
T Consensus 157 ~---------------------------------------------------------------------------~~~~ 161 (372)
T cd07853 157 E---------------------------------------------------------------------------SKHM 161 (372)
T ss_pred c---------------------------------------------------------------------------cccC
Confidence 0 0001
Q ss_pred cccccCCCccchhhhccCC-CCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHc----------------------
Q 007260 452 MSFVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG---------------------- 508 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~~~-~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~---------------------- 508 (611)
...+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+....+..+..
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 241 (372)
T cd07853 162 TQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHIL 241 (372)
T ss_pred CCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHH
Confidence 1235899999999998854 78999999999999999999999988766554433321
Q ss_pred -CCCCCC-------CCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCchh
Q 007260 509 -QPLRFP-------ESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWA 560 (611)
Q Consensus 509 -~~l~~p-------~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~ 560 (611)
.+...+ .....++++.+||.+||..||.+||+ +.|+|+||||.+..+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t----~~e~l~hp~~~~~~~~ 297 (372)
T cd07853 242 RGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRIS----AADALAHPYLDEGRLR 297 (372)
T ss_pred hCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcC----HHHHhcCHhhCCCcch
Confidence 111111 12346889999999999999999999 9999999999986554
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-46 Score=380.90 Aligned_cols=252 Identities=30% Similarity=0.535 Sum_probs=210.7
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec--c---cee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET--E---KFS 291 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~--~---~~~ 291 (611)
.|.-.+++|+|+||.||.|....+++.||||.+-.+.- . -.+|+.||+.++|||||+|..+|.. + -++
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~---knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----Y---KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----c---CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 68889999999999999999999999999998754331 1 1359999999999999999998863 2 256
Q ss_pred eEEeeeCCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccC-CcEEEEeccccccc
Q 007260 292 CLVMEFCPGGDLHTLRQKQ--PGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRED-GHIMLSDFDLSLRC 368 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~--~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~-g~vkL~DFGlA~~~ 368 (611)
.|||||+ ..+|..+++.. .+..++.-.++.|.+||++||.|||..||+||||||.|||||.+ |.+||||||-|+.+
T Consensus 98 nlVleym-P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 98 NLVLEYM-PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHHHHhc-hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 7999999 55898888741 23569999999999999999999999999999999999999965 89999999998654
Q ss_pred cCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccc
Q 007260 369 AVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTE 448 (611)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (611)
...
T Consensus 177 ~~~----------------------------------------------------------------------------- 179 (364)
T KOG0658|consen 177 VKG----------------------------------------------------------------------------- 179 (364)
T ss_pred ccC-----------------------------------------------------------------------------
Confidence 311
Q ss_pred ccccccccCCCccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH---cCC--------------
Q 007260 449 ARSMSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVV---GQP-------------- 510 (611)
Q Consensus 449 ~~~~~~vGT~~Y~APEil~~~-~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~---~~~-------------- 510 (611)
....++..|..|+|||++.|. .|+.+.||||.||++.||+-|++.|.|.+..+++..|+ +.+
T Consensus 180 epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~ 259 (364)
T KOG0658|consen 180 EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTE 259 (364)
T ss_pred CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccccc
Confidence 122456789999999999987 48999999999999999999999999988877775544 332
Q ss_pred CCCCC----------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 511 LRFPE----------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 511 l~~p~----------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
..+|. ...+++++.||+.++|.++|.+|.+ +.|++.||||...
T Consensus 260 ~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~----~~~~l~h~fFdel 312 (364)
T KOG0658|consen 260 FKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLS----ALEALAHPFFDEL 312 (364)
T ss_pred ccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCC----HHHHhcchhhHHh
Confidence 11121 2347899999999999999999999 9999999999864
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=385.77 Aligned_cols=255 Identities=28% Similarity=0.429 Sum_probs=206.9
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecc------
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE------ 288 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~------ 288 (611)
.++|++++.||.|+||.||+|.+..+++.||||++.+... ......++.+|+.+++.++||||++++++|...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4799999999999999999999999999999999875432 223445677899999999999999999988643
Q ss_pred ceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccc
Q 007260 289 KFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRC 368 (611)
Q Consensus 289 ~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~ 368 (611)
...|+||||+++ +|...+.. .+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++...
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 357999999954 67666654 3889999999999999999999999999999999999999999999999998432
Q ss_pred cCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccc
Q 007260 369 AVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTE 448 (611)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (611)
...
T Consensus 170 ~~~----------------------------------------------------------------------------- 172 (355)
T cd07874 170 GTS----------------------------------------------------------------------------- 172 (355)
T ss_pred CCc-----------------------------------------------------------------------------
Confidence 100
Q ss_pred ccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcC-------------------
Q 007260 449 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ------------------- 509 (611)
Q Consensus 449 ~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~------------------- 509 (611)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+......+..++..
T Consensus 173 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (355)
T cd07874 173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252 (355)
T ss_pred cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHH
Confidence 0011246899999999999999999999999999999999999999887654443322211
Q ss_pred ---CC-----CCC-------------CCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCC
Q 007260 510 ---PL-----RFP-------------ESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 510 ---~l-----~~p-------------~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
.. .++ .....+..+++||.+||..||.+||+ +.|+|+||||..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps----~~ell~hp~~~~ 316 (355)
T cd07874 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS----VDEALQHPYINV 316 (355)
T ss_pred HhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCC----HHHHhcCcchhc
Confidence 00 000 01124568899999999999999999 999999999963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=371.73 Aligned_cols=284 Identities=39% Similarity=0.680 Sum_probs=232.2
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
.+|++++.||.|+||.||++.+..+++.||||.+.+...........+.+|+++++.++||||+++++.+..++++||||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 37999999999999999999999999999999998765544455567788999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
||++|++|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.+|.++|+|||++.........
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~- 157 (305)
T cd05609 81 EYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT- 157 (305)
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccc-
Confidence 999999999998775 46899999999999999999999999999999999999999999999999987422110000
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
..+.... .............
T Consensus 158 ----------------------------------------~~~~~~~--------------------~~~~~~~~~~~~~ 177 (305)
T cd05609 158 ----------------------------------------NLYEGHI--------------------EKDTREFLDKQVC 177 (305)
T ss_pred ----------------------------------------ccccccc--------------------ccchhhccccCCc
Confidence 0000000 0000000011245
Q ss_pred cCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCC-CCCCHHHHHHHHHhhhcC
Q 007260 456 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPES-PVVSFAARDLIRGLLVKE 534 (611)
Q Consensus 456 GT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~-~~~s~~l~dLI~~~L~~d 534 (611)
|+..|+|||.+.+..++.++|||||||++|||++|..||.+....+.+..+......++.. ..++.++++||.+||..|
T Consensus 178 ~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 257 (305)
T cd05609 178 GTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQN 257 (305)
T ss_pred cCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccC
Confidence 8899999999999899999999999999999999999999887776676666655444443 257899999999999999
Q ss_pred ccccCCchhcHHHHHcCCCCCCCchhhhc
Q 007260 535 PQHRLAYKRGATEIKQHPFFEGVNWALIR 563 (611)
Q Consensus 535 P~~Rpt~~~~a~elL~Hp~f~~~~~~~~~ 563 (611)
|++||+.. .+.++++||||...+|+...
T Consensus 258 P~~R~~~~-~~~~ll~~~~~~~~~~~~~~ 285 (305)
T cd05609 258 PLERLGTG-GAFEVKQHRFFLGLDWNGLL 285 (305)
T ss_pred hhhccCcc-CHHHHHhCccccCCCHHHHh
Confidence 99999842 37899999999999998754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=363.43 Aligned_cols=260 Identities=29% Similarity=0.436 Sum_probs=221.9
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhh--hHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeE
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLA--GRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCL 293 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~--~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~L 293 (611)
+.|.+.+.||.|+||.||+|.+..+++.||||++...... .......+.+|++++++++||||++++++++.+..+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4689999999999999999999999999999998754322 23345567889999999999999999999999999999
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcc
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 373 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~ 373 (611)
||||++|++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||++........
T Consensus 82 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 99999999999988775 4689999999999999999999999999999999999999999999999999843210000
Q ss_pred ccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccc
Q 007260 374 LIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMS 453 (611)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (611)
.......
T Consensus 160 -------------------------------------------------------------------------~~~~~~~ 166 (263)
T cd06625 160 -------------------------------------------------------------------------SGTGMKS 166 (263)
T ss_pred -------------------------------------------------------------------------ccccccC
Confidence 0000012
Q ss_pred cccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007260 454 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVK 533 (611)
Q Consensus 454 ~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~ 533 (611)
..|+..|+|||++.+..++.++|||||||++|||++|+.||..........++............++..+.+||.+||.+
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 246 (263)
T cd06625 167 VTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVE 246 (263)
T ss_pred CCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHHHHHhhc
Confidence 35888999999999999999999999999999999999999887777666666655544444456899999999999999
Q ss_pred CccccCCchhcHHHHHcCCCC
Q 007260 534 EPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 534 dP~~Rpt~~~~a~elL~Hp~f 554 (611)
+|.+||+ +.++++|+||
T Consensus 247 ~p~~Rpt----~~~ll~~~~~ 263 (263)
T cd06625 247 NAKKRPS----AEELLRHFFV 263 (263)
T ss_pred CcccCCC----HHHHhhCCCC
Confidence 9999999 9999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=399.88 Aligned_cols=260 Identities=27% Similarity=0.399 Sum_probs=220.3
Q ss_pred cCeEEEeEecccCcEEEEEEEECCC-CeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGT-KCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t-~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
..|.+.+.||.|+||.||+|.+..+ +..||+|.+.... ......+++|+.+|+.++|||||+++++|..++.+|||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv 143 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND---ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI 143 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence 3599999999999999999998877 7889999875433 23334567899999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCc
Q 007260 295 MEFCPGGDLHTLRQKQ--PGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~--~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~ 372 (611)
|||++||+|.+++... ....+++..+..++.||+.||+|||++|||||||||+||||+.++.+||+|||++.......
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 9999999999877542 23468999999999999999999999999999999999999999999999999985432100
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
......
T Consensus 224 --------------------------------------------------------------------------~~~~~~ 229 (478)
T PTZ00267 224 --------------------------------------------------------------------------SLDVAS 229 (478)
T ss_pred --------------------------------------------------------------------------cccccc
Confidence 000112
Q ss_pred ccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007260 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLV 532 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~ 532 (611)
.++||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+.+..+...... +....++.++++||.+||.
T Consensus 230 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~li~~~L~ 308 (478)
T PTZ00267 230 SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD-PFPCPVSSGMKALLDPLLS 308 (478)
T ss_pred ccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCCccCCHHHHHHHHHHhc
Confidence 457999999999999999999999999999999999999999988777777776655432 2234589999999999999
Q ss_pred cCccccCCchhcHHHHHcCCCCCCC
Q 007260 533 KEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 533 ~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
.||++||+ +.+++.|+|++.+
T Consensus 309 ~dP~~Rps----~~~~l~~~~~~~~ 329 (478)
T PTZ00267 309 KNPALRPT----TQQLLHTEFLKYV 329 (478)
T ss_pred cChhhCcC----HHHHHhCHHHHHH
Confidence 99999999 9999999998754
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=399.04 Aligned_cols=260 Identities=30% Similarity=0.491 Sum_probs=228.0
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
.++|.|+..||.|+||.||+|..+.++...|.|+|.-. ..+.+..+..||+||..++||+||+|++.|..++.++|+
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwil 107 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWIL 107 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEE
Confidence 46899999999999999999999999988899998643 345677788899999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
.|||.||-+..++-.- ++.|.+..++.+++|+|.||.|||+++|||||||..|||++-||.++|+|||.+....
T Consensus 108 iEFC~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~----- 181 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK----- 181 (1187)
T ss_pred EeecCCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccch-----
Confidence 9999999998877665 5789999999999999999999999999999999999999999999999999872110
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
.+..+..+|
T Consensus 182 -----------------------------------------------------------------------~t~qkRDsF 190 (1187)
T KOG0579|consen 182 -----------------------------------------------------------------------STRQKRDSF 190 (1187)
T ss_pred -----------------------------------------------------------------------hHHhhhccc
Confidence 122334578
Q ss_pred ccCCCccchhhhcc-----CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcC-CCCCCCCCCCCHHHHHHHH
Q 007260 455 VGTHEYLAPEIIKG-----EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ-PLRFPESPVVSFAARDLIR 528 (611)
Q Consensus 455 vGT~~Y~APEil~~-----~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~-~l~~p~~~~~s~~l~dLI~ 528 (611)
+|||+|||||++.+ .+|+.++|||||||+|.||..+.+|-...+....+.+|... +..+-.+..++..+.||+.
T Consensus 191 IGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk 270 (1187)
T KOG0579|consen 191 IGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLK 270 (1187)
T ss_pred cCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHHH
Confidence 99999999999865 47899999999999999999999999888887777776643 4455555668999999999
Q ss_pred HhhhcCccccCCchhcHHHHHcCCCCCCCc
Q 007260 529 GLLVKEPQHRLAYKRGATEIKQHPFFEGVN 558 (611)
Q Consensus 529 ~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 558 (611)
+||.+||..||+ +.+||+||||+++.
T Consensus 271 ~cL~Knp~~Rp~----aaqll~Hpfv~~~~ 296 (1187)
T KOG0579|consen 271 RCLVKNPRNRPP----AAQLLKHPFVQNAP 296 (1187)
T ss_pred HHHhcCCccCCC----HHHHhhCcccccCC
Confidence 999999999999 99999999998653
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=381.45 Aligned_cols=258 Identities=21% Similarity=0.304 Sum_probs=206.0
Q ss_pred ccccCeEEEeEecccCcEEEEEEEEC-----CCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELS-----GTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFE 286 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~-----~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~ 286 (611)
+..++|++++.||.|+||.||+|.+. .++..||||++..... ......+.+|+.+|+.+ +|||||++++++.
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT--ASEHKALMSELKILIHIGNHLNVVNLLGACT 81 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc--hHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence 34468999999999999999999853 3456899999875321 23345678899999999 8999999999887
Q ss_pred cc-ceeeEEeeeCCCCCHHHHHHhCC------------------------------------------------------
Q 007260 287 TE-KFSCLVMEFCPGGDLHTLRQKQP------------------------------------------------------ 311 (611)
Q Consensus 287 ~~-~~~~LVmE~~~gg~L~~ll~~~~------------------------------------------------------ 311 (611)
.. ..+|+|||||+||+|.+++....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 54 56899999999999999887531
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccccCCCCcC
Q 007260 312 ------GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPL 385 (611)
Q Consensus 312 ------~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~ 385 (611)
...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~------------ 229 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD------------ 229 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcc------------
Confidence 13478889999999999999999999999999999999999999999999999843211000
Q ss_pred cCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCccchhh
Q 007260 386 RKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEI 465 (611)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEi 465 (611)
........+++.|+|||+
T Consensus 230 --------------------------------------------------------------~~~~~~~~~~~~y~aPE~ 247 (338)
T cd05102 230 --------------------------------------------------------------YVRKGSARLPLKWMAPES 247 (338)
T ss_pred --------------------------------------------------------------hhcccCCCCCccccCcHH
Confidence 000112346788999999
Q ss_pred hccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccCCchhc
Q 007260 466 IKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRG 544 (611)
Q Consensus 466 l~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~ 544 (611)
+.+..++.++|||||||+||||++ |..||.+......+...+...........++.++.+||.+||..||.+||+
T Consensus 248 ~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs---- 323 (338)
T cd05102 248 IFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPT---- 323 (338)
T ss_pred hhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcC----
Confidence 999999999999999999999996 999998865544444444333333334468999999999999999999999
Q ss_pred HHHHHc
Q 007260 545 ATEIKQ 550 (611)
Q Consensus 545 a~elL~ 550 (611)
+.+|++
T Consensus 324 ~~el~~ 329 (338)
T cd05102 324 FSALVE 329 (338)
T ss_pred HHHHHH
Confidence 777764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=400.22 Aligned_cols=263 Identities=26% Similarity=0.433 Sum_probs=221.6
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc-----
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK----- 289 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~----- 289 (611)
.++|++.+.||+|+||+||+|++..+++.||||++...... .....++.+|+.+|..++|+||+++++.|....
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 36999999999999999999999999999999999765433 344556788999999999999999988775322
Q ss_pred ---eeeEEeeeCCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccc
Q 007260 290 ---FSCLVMEFCPGGDLHTLRQKQ--PGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDL 364 (611)
Q Consensus 290 ---~~~LVmE~~~gg~L~~ll~~~--~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGl 364 (611)
.++|||||+++|+|.+++... ....+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGl 189 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGF 189 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEeccc
Confidence 478999999999999988643 235799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCccccc
Q 007260 365 SLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIA 444 (611)
Q Consensus 365 A~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (611)
++.+....
T Consensus 190 s~~~~~~~------------------------------------------------------------------------ 197 (496)
T PTZ00283 190 SKMYAATV------------------------------------------------------------------------ 197 (496)
T ss_pred Ceeccccc------------------------------------------------------------------------
Confidence 84432100
Q ss_pred CcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHH
Q 007260 445 EPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAAR 524 (611)
Q Consensus 445 ~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~ 524 (611)
.......++||+.|+|||++.+..++.++|||||||+||||++|+.||.+......+..+...... +....++.++.
T Consensus 198 --~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~ 274 (496)
T PTZ00283 198 --SDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD-PLPPSISPEMQ 274 (496)
T ss_pred --cccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC-CCCCCCCHHHH
Confidence 000112357999999999999999999999999999999999999999988777666666654432 33445899999
Q ss_pred HHHHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 525 DLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 525 dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
+||.+||..||.+||+ +.++++|||++..
T Consensus 275 ~li~~~L~~dP~~RPs----~~ell~~p~~~~~ 303 (496)
T PTZ00283 275 EIVTALLSSDPKRRPS----SSKLLNMPICKLF 303 (496)
T ss_pred HHHHHHcccChhhCcC----HHHHHhCHHHHHh
Confidence 9999999999999999 9999999998753
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=406.84 Aligned_cols=153 Identities=38% Similarity=0.643 Sum_probs=140.9
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
+++|+++++||.|+||.||+|++..+++.||||++.+..........++.+|+.++..++||||+++++++....++|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 46899999999999999999999999999999999876655555666788999999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
|||+.|++|.+++... +.+++..++.|+.||+.||+|||.+|||||||||+||||+.++++||+|||+++...
T Consensus 83 mEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~ 155 (669)
T cd05610 83 MEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTL 155 (669)
T ss_pred EeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCcccc
Confidence 9999999999998765 468999999999999999999999999999999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=367.09 Aligned_cols=259 Identities=31% Similarity=0.484 Sum_probs=215.5
Q ss_pred eEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeeccceeeEEeeeCCC
Q 007260 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEKFSCLVMEFCPG 300 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~~~~~LVmE~~~g 300 (611)
+.||+|+|+.|--|....++..||||+++|..-. ...|+.+|++++..+ .|+||++|++||+++..+|||||-+.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gH---sR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGH---SRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCch---HHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 5799999999999999999999999999987433 334778899999999 699999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCc---EEEEeccccccccCCcccccc
Q 007260 301 GDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGH---IMLSDFDLSLRCAVSPTLIKA 377 (611)
Q Consensus 301 g~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~---vkL~DFGlA~~~~~~~~~~~~ 377 (611)
|.|...++++ +.|+|.++..++++|+.||.|||.+||.||||||||||.....+ ||||||+|........
T Consensus 161 GplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~----- 233 (463)
T KOG0607|consen 161 GPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNN----- 233 (463)
T ss_pred chHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCC-----
Confidence 9999988887 78999999999999999999999999999999999999986554 8999999972111000
Q ss_pred ccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccC
Q 007260 378 SSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGT 457 (611)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT 457 (611)
.|. | . ......+-||+
T Consensus 234 ---------------------------------~~s-p---------------------a---------stP~L~tPvGS 249 (463)
T KOG0607|consen 234 ---------------------------------DCS-P---------------------A---------STPELLTPVGS 249 (463)
T ss_pred ---------------------------------CCC-C---------------------C---------CCccccCcccc
Confidence 000 0 0 00011234799
Q ss_pred CCccchhhhc-----cCCCCChhhHHHHHHHHHHHHhCCCCCCCCC---------------cHHHHHHHHcCCCCCCC--
Q 007260 458 HEYLAPEIIK-----GEGHGSAVDWWTFGIFLYELLFGKTPFKGSG---------------NRATLFNVVGQPLRFPE-- 515 (611)
Q Consensus 458 ~~Y~APEil~-----~~~~~~~sDIWSLGviL~ELltG~~PF~~~~---------------~~~~l~~i~~~~l~~p~-- 515 (611)
-+|||||++. ...|+.++|+||||||||-||+|.+||.|.- ....+..|-.+.+.||+
T Consensus 250 AEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkd 329 (463)
T KOG0607|consen 250 AEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKD 329 (463)
T ss_pred hhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhh
Confidence 9999999874 3357999999999999999999999997631 12344567778888886
Q ss_pred CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCc
Q 007260 516 SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVN 558 (611)
Q Consensus 516 ~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 558 (611)
|..+|.+++|||..+|.+|+.+|++ |.++++|||++.+.
T Consensus 330 WahIS~eakdlisnLlvrda~~rls----a~~vlnhPw~~~~~ 368 (463)
T KOG0607|consen 330 WAHISSEAKDLISNLLVRDAKQRLS----AAQVLNHPWVQRCA 368 (463)
T ss_pred hHHhhHHHHHHHHHHHhccHHhhhh----hhhccCCccccccc
Confidence 4559999999999999999999999 99999999998653
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=380.49 Aligned_cols=254 Identities=29% Similarity=0.439 Sum_probs=208.7
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecc------c
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE------K 289 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~------~ 289 (611)
++|++++.||.|+||.||+|.+..++..||||++.+... ......++.+|+.+|+.++||||++++++|... .
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 689999999999999999999999999999999976432 223344567899999999999999999988643 4
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
..|++||++ |++|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 94 ~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred cEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 579999999 8899887764 359999999999999999999999999999999999999999999999999984321
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
.
T Consensus 170 ~------------------------------------------------------------------------------- 170 (343)
T cd07878 170 D------------------------------------------------------------------------------- 170 (343)
T ss_pred C-------------------------------------------------------------------------------
Confidence 0
Q ss_pred cccccccCCCccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcC---C---------------
Q 007260 450 RSMSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ---P--------------- 510 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~-~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~---~--------------- 510 (611)
....++||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+......+..+... +
T Consensus 171 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (343)
T cd07878 171 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARK 250 (343)
T ss_pred CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHH
Confidence 0113469999999999987 46799999999999999999999999876655444333211 0
Q ss_pred -----CCCCC------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 511 -----LRFPE------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 511 -----l~~p~------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
...+. ....++.+.+||.+||..||.+||+ +.|+|+||||...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s----~~ell~hp~~~~~ 304 (343)
T cd07878 251 YIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRIS----ASEALAHPYFSQY 304 (343)
T ss_pred HhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCC----HHHHhcCcchhcc
Confidence 00010 1235677899999999999999999 9999999999753
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-44 Score=364.55 Aligned_cols=261 Identities=35% Similarity=0.607 Sum_probs=218.1
Q ss_pred ecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEeeeCCCCCH
Q 007260 224 LGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDL 303 (611)
Q Consensus 224 LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE~~~gg~L 303 (611)
||.|+||+||+|.+..+++.||+|++.+...........+..|+++|+.++||||++++++|...+..||||||++|++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999999875544444455667899999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccccCCCC
Q 007260 304 HTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAE 383 (611)
Q Consensus 304 ~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~ 383 (611)
.+++.......+++..++.++.|++.||.|||.+||+||||+|+|||++.++.++|+|||++......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~------------ 148 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG------------ 148 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC------------
Confidence 99988765457999999999999999999999999999999999999999999999999987332100
Q ss_pred cCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCccch
Q 007260 384 PLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAP 463 (611)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~AP 463 (611)
.......|+..|+||
T Consensus 149 -----------------------------------------------------------------~~~~~~~~~~~y~~P 163 (277)
T cd05577 149 -----------------------------------------------------------------KKIKGRAGTPGYMAP 163 (277)
T ss_pred -----------------------------------------------------------------CccccccCCCCcCCH
Confidence 000123478899999
Q ss_pred hhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcH---HHH-HHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccC
Q 007260 464 EIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNR---ATL-FNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRL 539 (611)
Q Consensus 464 Eil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~---~~l-~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rp 539 (611)
|++.+..++.++|||||||++|+|++|+.||...... ..+ ..+....... ...+++.++++|.+||..||.+||
T Consensus 164 E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~ 241 (277)
T cd05577 164 EVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEY--PDKFSPEAKDLCEALLQKDPEKRL 241 (277)
T ss_pred HHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccC--CccCCHHHHHHHHHHccCChhHcc
Confidence 9999888999999999999999999999999875442 222 2222222222 234799999999999999999999
Q ss_pred Cchh-cHHHHHcCCCCCCCchhhhc
Q 007260 540 AYKR-GATEIKQHPFFEGVNWALIR 563 (611)
Q Consensus 540 t~~~-~a~elL~Hp~f~~~~~~~~~ 563 (611)
+++. .+.+++.||||..++|....
T Consensus 242 ~~~~~~~~~ll~h~~~~~~~~~~~~ 266 (277)
T cd05577 242 GCRGGSADEVREHPLFKDLNWRRLE 266 (277)
T ss_pred CCCcccHHHHHhChhhhcCChhhhh
Confidence 6655 59999999999999997764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=363.78 Aligned_cols=255 Identities=29% Similarity=0.434 Sum_probs=213.1
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeec------c
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFET------E 288 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~------~ 288 (611)
+.|++.+.||.|+||.||+|.+..+++.||+|++..... ....+.+|+.+++.+ +|+||++++++|.. .
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 578899999999999999999999999999999875431 123556799999998 79999999999875 3
Q ss_pred ceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccc
Q 007260 289 KFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRC 368 (611)
Q Consensus 289 ~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~ 368 (611)
..+|+||||+++++|.+++....+..+++..+..++.||+.||+|||++||+||||||+|||+++++.++|+|||++...
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 56899999999999999988765567999999999999999999999999999999999999999999999999998432
Q ss_pred cCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccc
Q 007260 369 AVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTE 448 (611)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (611)
... .
T Consensus 162 ~~~----------------------------------------------------------------------------~ 165 (272)
T cd06637 162 DRT----------------------------------------------------------------------------V 165 (272)
T ss_pred ccc----------------------------------------------------------------------------c
Confidence 100 0
Q ss_pred ccccccccCCCccchhhhcc-----CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHH
Q 007260 449 ARSMSFVGTHEYLAPEIIKG-----EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAA 523 (611)
Q Consensus 449 ~~~~~~vGT~~Y~APEil~~-----~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l 523 (611)
.......|++.|+|||++.+ ..++.++|||||||++|||++|..||...........+............++.++
T Consensus 166 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (272)
T cd06637 166 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKF 245 (272)
T ss_pred ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCcCHHH
Confidence 01123469999999999973 4578899999999999999999999987665555554444443333344588999
Q ss_pred HHHHHHhhhcCccccCCchhcHHHHHcCCCC
Q 007260 524 RDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 524 ~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f 554 (611)
++||.+||..||.+||+ +.+++.||||
T Consensus 246 ~~li~~~l~~~p~~Rpt----~~~il~~~~~ 272 (272)
T cd06637 246 QSFIESCLVKNHSQRPT----TEQLMKHPFI 272 (272)
T ss_pred HHHHHHHcCCChhhCCC----HHHHhhCCCC
Confidence 99999999999999999 9999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=361.87 Aligned_cols=254 Identities=37% Similarity=0.655 Sum_probs=211.8
Q ss_pred eEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEeee
Q 007260 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEF 297 (611)
Q Consensus 218 y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE~ 297 (611)
|++++.||+|+||+||++++..+++.||+|++......... .....+|+.+++.++||||+++++++.+....|+||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence 89999999999999999999999999999999877644433 22335599999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccccc
Q 007260 298 CPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKA 377 (611)
Q Consensus 298 ~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~ 377 (611)
+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 80 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~------- 150 (260)
T PF00069_consen 80 CPGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE------- 150 (260)
T ss_dssp ETTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS-------
T ss_pred ccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-------
Confidence 9999999999843 5689999999999999999999999999999999999999999999999999742200
Q ss_pred ccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccC
Q 007260 378 SSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGT 457 (611)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT 457 (611)
.........||
T Consensus 151 ---------------------------------------------------------------------~~~~~~~~~~~ 161 (260)
T PF00069_consen 151 ---------------------------------------------------------------------NNENFNPFVGT 161 (260)
T ss_dssp ---------------------------------------------------------------------TTSEBSSSSSS
T ss_pred ---------------------------------------------------------------------ccccccccccc
Confidence 00111234689
Q ss_pred CCccchhhhc-cCCCCChhhHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHcCCCCCCC--CCCCCHHHHHHHHHhh
Q 007260 458 HEYLAPEIIK-GEGHGSAVDWWTFGIFLYELLFGKTPFKGSG---NRATLFNVVGQPLRFPE--SPVVSFAARDLIRGLL 531 (611)
Q Consensus 458 ~~Y~APEil~-~~~~~~~sDIWSLGviL~ELltG~~PF~~~~---~~~~l~~i~~~~l~~p~--~~~~s~~l~dLI~~~L 531 (611)
..|+|||++. +..++.++||||||+++|+|++|..||.... ....+.+.......... .......+.+||.+||
T Consensus 162 ~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 241 (260)
T PF00069_consen 162 PEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKML 241 (260)
T ss_dssp GGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHHc
Confidence 9999999998 7888999999999999999999999999873 22333333332222111 1123489999999999
Q ss_pred hcCccccCCchhcHHHHHcCCCC
Q 007260 532 VKEPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 532 ~~dP~~Rpt~~~~a~elL~Hp~f 554 (611)
..||++||+ +.++++||||
T Consensus 242 ~~~p~~R~~----~~~l~~~~~~ 260 (260)
T PF00069_consen 242 SKDPEQRPS----AEELLKHPWF 260 (260)
T ss_dssp SSSGGGSTT----HHHHHTSGGG
T ss_pred cCChhHCcC----HHHHhcCCCC
Confidence 999999999 9999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=369.18 Aligned_cols=265 Identities=29% Similarity=0.460 Sum_probs=221.1
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSC 292 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~ 292 (611)
...+.|++++.||.|+||.||+|++..++..||+|++.... ......+.+|+.+++.++|+||++++++|..+..+|
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLW 85 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEE
Confidence 33467999999999999999999999999999999987543 334556778999999999999999999999999999
Q ss_pred EEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCc
Q 007260 293 LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 293 LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~ 372 (611)
+||||++|++|..++.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 86 lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~- 163 (292)
T cd06644 86 IMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT- 163 (292)
T ss_pred EEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc-
Confidence 9999999999988776542 46899999999999999999999999999999999999999999999999987322100
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
.....
T Consensus 164 ---------------------------------------------------------------------------~~~~~ 168 (292)
T cd06644 164 ---------------------------------------------------------------------------LQRRD 168 (292)
T ss_pred ---------------------------------------------------------------------------ccccc
Confidence 00011
Q ss_pred ccccCCCccchhhhcc-----CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCC-CCCCCCCCCHHHHHH
Q 007260 453 SFVGTHEYLAPEIIKG-----EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPL-RFPESPVVSFAARDL 526 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~-----~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l-~~p~~~~~s~~l~dL 526 (611)
...|++.|+|||++.+ ..++.++|||||||++|||++|+.||........+.++..... .......++.++.+|
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 248 (292)
T cd06644 169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDF 248 (292)
T ss_pred eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHH
Confidence 3458899999999853 3467899999999999999999999987665555555544322 223334578899999
Q ss_pred HHHhhhcCccccCCchhcHHHHHcCCCCCCCchhh
Q 007260 527 IRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWAL 561 (611)
Q Consensus 527 I~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~ 561 (611)
|.+||..||++||+ +.++++||||..++|..
T Consensus 249 i~~~l~~~p~~Rp~----~~~il~~~~~~~~~~~~ 279 (292)
T cd06644 249 LKTALDKHPETRPS----AAQLLEHPFVSSVTSNR 279 (292)
T ss_pred HHHHhcCCcccCcC----HHHHhcCccccccccch
Confidence 99999999999999 99999999999888765
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=368.80 Aligned_cols=261 Identities=28% Similarity=0.455 Sum_probs=212.7
Q ss_pred cccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeE
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCL 293 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~L 293 (611)
.+++|++++.||.|+||.||+|++..++..||+|.+....... ....+.+|+.+++.++||||+++++++..++..|+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 81 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 81 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC--chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence 4578999999999999999999999999999999986543221 12345679999999999999999999999999999
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcc
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 373 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~ 373 (611)
||||++ ++|..++... +..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 82 v~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~- 158 (301)
T cd07873 82 VFEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 158 (301)
T ss_pred EEeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-
Confidence 999996 5898887764 3468999999999999999999999999999999999999999999999999973211000
Q ss_pred ccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccc
Q 007260 374 LIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMS 453 (611)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (611)
.....
T Consensus 159 ---------------------------------------------------------------------------~~~~~ 163 (301)
T cd07873 159 ---------------------------------------------------------------------------KTYSN 163 (301)
T ss_pred ---------------------------------------------------------------------------Ccccc
Confidence 00012
Q ss_pred cccCCCccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHc---CC----------------CCC
Q 007260 454 FVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG---QP----------------LRF 513 (611)
Q Consensus 454 ~vGT~~Y~APEil~~~-~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~---~~----------------l~~ 513 (611)
..+++.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+.+..+.. .+ ..+
T Consensus 164 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (301)
T cd07873 164 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNY 243 (301)
T ss_pred cceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccccccc
Confidence 2478899999998765 478899999999999999999999988765544432221 11 011
Q ss_pred CC---------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCc
Q 007260 514 PE---------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVN 558 (611)
Q Consensus 514 p~---------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 558 (611)
+. ...++..+++||.+||..||.+||| +.++|+||||+.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t----~~eil~h~~f~~~~ 293 (301)
T cd07873 244 PKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRIS----AEEAMKHPYFHCLG 293 (301)
T ss_pred CccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcC----HHHHhcCccccccc
Confidence 11 1347889999999999999999999 99999999997654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=355.12 Aligned_cols=256 Identities=25% Similarity=0.453 Sum_probs=217.3
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec-cceeeEEe
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET-EKFSCLVM 295 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~-~~~~~LVm 295 (611)
+|++++.||.|+||.||++.+..+++.||+|.+...... ......+.+|+++++.++|+||+++++.+.. +..+|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 489999999999999999999999999999998654332 2344567889999999999999999998864 55789999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
||+++++|.+++....+..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~--- 156 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC--- 156 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC---
Confidence 99999999998887655679999999999999999999999999999999999999999999999999873321000
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
.......
T Consensus 157 -------------------------------------------------------------------------~~~~~~~ 163 (257)
T cd08223 157 -------------------------------------------------------------------------DMASTLI 163 (257)
T ss_pred -------------------------------------------------------------------------Ccccccc
Confidence 0011245
Q ss_pred cCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCc
Q 007260 456 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEP 535 (611)
Q Consensus 456 GT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP 535 (611)
|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+....+. +....++.++.+||.+||..||
T Consensus 164 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p 242 (257)
T cd08223 164 GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP-PMPKDYSPELGELIATMLSKRP 242 (257)
T ss_pred CCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC-CCccccCHHHHHHHHHHhccCc
Confidence 899999999999999999999999999999999999999887766666666555432 2234588999999999999999
Q ss_pred cccCCchhcHHHHHcCCCC
Q 007260 536 QHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 536 ~~Rpt~~~~a~elL~Hp~f 554 (611)
++||+ +.++++||||
T Consensus 243 ~~Rp~----~~~~l~~~~~ 257 (257)
T cd08223 243 EKRPS----VKSILRQPYI 257 (257)
T ss_pred ccCCC----HHHHhcCCCC
Confidence 99999 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-44 Score=371.94 Aligned_cols=251 Identities=27% Similarity=0.420 Sum_probs=193.2
Q ss_pred EeEecccCcEEEEEEEEC--CCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec--cceeeEEee
Q 007260 221 LKRLGCGDIGSVYLSELS--GTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET--EKFSCLVME 296 (611)
Q Consensus 221 ~~~LG~G~fG~Vy~a~~~--~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~--~~~~~LVmE 296 (611)
+++||+|+||+||+|++. .+++.||+|++...... ..+.+|+.+|+.++||||++++++|.. +..+|+|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc-----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 468999999999999975 46789999998754322 235679999999999999999999854 567899999
Q ss_pred eCCCCCHHHHHHhCC-------CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEE----ccCCcEEEEecccc
Q 007260 297 FCPGGDLHTLRQKQP-------GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLV----REDGHIMLSDFDLS 365 (611)
Q Consensus 297 ~~~gg~L~~ll~~~~-------~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv----~~~g~vkL~DFGlA 365 (611)
|+ +++|..++.... ...+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred cc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 99 568888765321 2358999999999999999999999999999999999999 45678999999998
Q ss_pred ccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccC
Q 007260 366 LRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAE 445 (611)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (611)
........
T Consensus 160 ~~~~~~~~------------------------------------------------------------------------ 167 (317)
T cd07868 160 RLFNSPLK------------------------------------------------------------------------ 167 (317)
T ss_pred eccCCCCc------------------------------------------------------------------------
Confidence 43321000
Q ss_pred cccccccccccCCCccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCc---------HHHHH---HHHcCCCC
Q 007260 446 PTEARSMSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGN---------RATLF---NVVGQPLR 512 (611)
Q Consensus 446 ~~~~~~~~~vGT~~Y~APEil~~~-~~~~~sDIWSLGviL~ELltG~~PF~~~~~---------~~~l~---~i~~~~l~ 512 (611)
........+||+.|+|||++.+. .++.++|||||||++|||++|++||.+... ...+. ++.+.+..
T Consensus 168 -~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (317)
T cd07868 168 -PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPAD 246 (317)
T ss_pred -cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCCh
Confidence 00011234699999999999875 579999999999999999999999975432 11111 11111100
Q ss_pred --------CCC-------------------------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCC
Q 007260 513 --------FPE-------------------------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 513 --------~p~-------------------------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f 554 (611)
.+. ....+..+.+||.+||++||.+|+| ++|+|+||||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t----~~e~l~hp~f 317 (317)
T cd07868 247 KDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT----SEQAMQDPYF 317 (317)
T ss_pred HHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCC----HHHHhcCCCC
Confidence 000 0123567899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-44 Score=374.11 Aligned_cols=265 Identities=22% Similarity=0.349 Sum_probs=210.6
Q ss_pred EEeEeccc--CcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEeee
Q 007260 220 LLKRLGCG--DIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEF 297 (611)
Q Consensus 220 l~~~LG~G--~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE~ 297 (611)
++++||+| +||+||++.++.+++.||||+++..... ......+++|+.+++.++||||++++++|..++..|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 46789999 7899999999999999999999765332 23444667899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccccc
Q 007260 298 CPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKA 377 (611)
Q Consensus 298 ~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~ 377 (611)
+++|+|.+++.......+++..++.++.||+.||+|||++|||||||||+|||++.++.++|+||+............
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~-- 158 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL-- 158 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc--
Confidence 999999999876544569999999999999999999999999999999999999999999999998652211000000
Q ss_pred ccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccC
Q 007260 378 SSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGT 457 (611)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT 457 (611)
..........+++
T Consensus 159 -------------------------------------------------------------------~~~~~~~~~~~~~ 171 (327)
T cd08227 159 -------------------------------------------------------------------RVVHDFPKYSVKV 171 (327)
T ss_pred -------------------------------------------------------------------cccccccccccce
Confidence 0000001123578
Q ss_pred CCccchhhhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCC-----------------------
Q 007260 458 HEYLAPEIIKG--EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLR----------------------- 512 (611)
Q Consensus 458 ~~Y~APEil~~--~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~----------------------- 512 (611)
..|+|||++.+ ..++.++|||||||++|||++|+.||........+.........
T Consensus 172 ~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (327)
T cd08227 172 LPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGAN 251 (327)
T ss_pred ecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCc
Confidence 88999999986 45899999999999999999999999876554444333322110
Q ss_pred ---------------------CCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCc
Q 007260 513 ---------------------FPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVN 558 (611)
Q Consensus 513 ---------------------~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 558 (611)
.+....+++.+++||.+||..||.+||| +++|++||||+.+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt----~~ell~~p~f~~~~ 314 (327)
T cd08227 252 SGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPS----ASTLLNHSFFKQIK 314 (327)
T ss_pred CCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCC----HHHHhcChhhhhcc
Confidence 0111235678999999999999999999 99999999998653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=352.96 Aligned_cols=256 Identities=27% Similarity=0.451 Sum_probs=219.8
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVME 296 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE 296 (611)
+|.+.+.||+|+||.||+|.+..++..|++|.+...... ......+.+|+++++.++||||+++++++...+..|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 588999999999999999999999999999998754433 2344567889999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccc
Q 007260 297 FCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIK 376 (611)
Q Consensus 297 ~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~ 376 (611)
|++|++|.+++....+..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~---- 155 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT---- 155 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc----
Confidence 9999999999887656779999999999999999999999999999999999999999999999999874322100
Q ss_pred cccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccccc
Q 007260 377 ASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVG 456 (611)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vG 456 (611)
.......|
T Consensus 156 ------------------------------------------------------------------------~~~~~~~~ 163 (256)
T cd08529 156 ------------------------------------------------------------------------NFANTIVG 163 (256)
T ss_pred ------------------------------------------------------------------------chhhcccc
Confidence 00112358
Q ss_pred CCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCcc
Q 007260 457 THEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQ 536 (611)
Q Consensus 457 T~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~ 536 (611)
++.|+|||++.+..++.++|||||||++|+|++|+.||...........+....... ....++..+.++|.+||..+|+
T Consensus 164 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~ 242 (256)
T cd08529 164 TPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPP-VSQMYSQQLAQLIDQCLTKDYR 242 (256)
T ss_pred CccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-CccccCHHHHHHHHHHccCCcc
Confidence 899999999999999999999999999999999999998887666666665543322 2225889999999999999999
Q ss_pred ccCCchhcHHHHHcCCCC
Q 007260 537 HRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 537 ~Rpt~~~~a~elL~Hp~f 554 (611)
+||+ +.++++|||+
T Consensus 243 ~Rp~----~~~ll~~~~~ 256 (256)
T cd08529 243 QRPD----TFQLLRNPSL 256 (256)
T ss_pred cCcC----HHHHhhCCCC
Confidence 9999 9999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=363.51 Aligned_cols=259 Identities=34% Similarity=0.645 Sum_probs=205.7
Q ss_pred EecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHH---hCCCCCcccccceeeccceeeEEeeeCC
Q 007260 223 RLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQ---SLDHPFLPTLYTHFETEKFSCLVMEFCP 299 (611)
Q Consensus 223 ~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~---~l~HpnIv~l~~~~~~~~~~~LVmE~~~ 299 (611)
.||+|+||.||++.+..+++.||+|++.+...........+.+|..+++ ..+||||+.++++|..++..|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999999999999997654332222222334444443 4479999999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccccccc
Q 007260 300 GGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASS 379 (611)
Q Consensus 300 gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~ 379 (611)
|++|..++..+ +.+++..++.++.|++.||+|||.+||+||||||+|||++.++.++|+|||++......
T Consensus 81 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~-------- 150 (279)
T cd05633 81 GGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-------- 150 (279)
T ss_pred CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc--------
Confidence 99999888765 46999999999999999999999999999999999999999999999999987322100
Q ss_pred CCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCC
Q 007260 380 LDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHE 459 (611)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~ 459 (611)
......||+.
T Consensus 151 ----------------------------------------------------------------------~~~~~~~~~~ 160 (279)
T cd05633 151 ----------------------------------------------------------------------KPHASVGTHG 160 (279)
T ss_pred ----------------------------------------------------------------------CccCcCCCcC
Confidence 0011258999
Q ss_pred ccchhhhc-cCCCCChhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHH-HcCCCCCCCCCCCCHHHHHHHHHhhhcCc
Q 007260 460 YLAPEIIK-GEGHGSAVDWWTFGIFLYELLFGKTPFKGSGN--RATLFNV-VGQPLRFPESPVVSFAARDLIRGLLVKEP 535 (611)
Q Consensus 460 Y~APEil~-~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~--~~~l~~i-~~~~l~~p~~~~~s~~l~dLI~~~L~~dP 535 (611)
|+|||++. +..++.++|||||||++|+|++|+.||..... ...+... ......++ ..++.++++||.+||..||
T Consensus 161 y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p 238 (279)
T cd05633 161 YMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELP--DSFSPELKSLLEGLLQRDV 238 (279)
T ss_pred ccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCc--cccCHHHHHHHHHHhcCCH
Confidence 99999986 45689999999999999999999999976432 2222222 12222233 3489999999999999999
Q ss_pred cccCCc-hhcHHHHHcCCCCCCCchhhhc
Q 007260 536 QHRLAY-KRGATEIKQHPFFEGVNWALIR 563 (611)
Q Consensus 536 ~~Rpt~-~~~a~elL~Hp~f~~~~~~~~~ 563 (611)
.+|++. ...+.++++||||++++|....
T Consensus 239 ~~R~~~~~~~~~~~~~h~~~~~~~~~~~~ 267 (279)
T cd05633 239 SKRLGCLGRGAQEVKEHVFFKGIDWQQVY 267 (279)
T ss_pred HHhcCCCCCCHHHHHhCccccCCCHhHHh
Confidence 999931 1228999999999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=355.87 Aligned_cols=265 Identities=42% Similarity=0.747 Sum_probs=225.5
Q ss_pred ecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEeeeCCCCCH
Q 007260 224 LGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDL 303 (611)
Q Consensus 224 LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE~~~gg~L 303 (611)
||.|+||.||++++..+++.||+|++.............+.+|++++++++||||+++++.+..+...|+||||++|++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999999999999999877665556667788999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccccCCCC
Q 007260 304 HTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAE 383 (611)
Q Consensus 304 ~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~ 383 (611)
.+++.+. ..+++..+..++.||+.||+|||.+||+||||+|+|||++.++.++|+|||++...........
T Consensus 81 ~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~------- 151 (265)
T cd05579 81 ASLLENV--GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL------- 151 (265)
T ss_pred HHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc-------
Confidence 9998875 3689999999999999999999999999999999999999999999999999743211100000
Q ss_pred cCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCccch
Q 007260 384 PLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAP 463 (611)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~AP 463 (611)
..........+++..|++|
T Consensus 152 -------------------------------------------------------------~~~~~~~~~~~~~~~~~~P 170 (265)
T cd05579 152 -------------------------------------------------------------NDDEKEDKRIVGTPDYIAP 170 (265)
T ss_pred -------------------------------------------------------------ccccccccCcccCccccCH
Confidence 0001111234688899999
Q ss_pred hhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccCCchh
Q 007260 464 EIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKR 543 (611)
Q Consensus 464 Eil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~ 543 (611)
|++.+..++.++|||||||++|+|++|..||...........+..+...++....++..+.+||.+||..+|.+||++.
T Consensus 171 e~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~- 249 (265)
T cd05579 171 EVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAK- 249 (265)
T ss_pred HHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCc-
Confidence 9999988999999999999999999999999988777777777776666766655699999999999999999999921
Q ss_pred cHHHHHcCCCCCCCch
Q 007260 544 GATEIKQHPFFEGVNW 559 (611)
Q Consensus 544 ~a~elL~Hp~f~~~~~ 559 (611)
.+.++|+||||..++|
T Consensus 250 ~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 250 SIEEIKNHPFFKGIDW 265 (265)
T ss_pred cHHHHhcCccccCCCC
Confidence 1399999999999988
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=364.42 Aligned_cols=254 Identities=31% Similarity=0.469 Sum_probs=217.2
Q ss_pred ccCeEEEe-EecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeec----c
Q 007260 215 LSHFRLLK-RLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFET----E 288 (611)
Q Consensus 215 ~~~y~l~~-~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~----~ 288 (611)
+++|++-. +||-|-.|.|-.|.++.|++.||+|++.... ++++|+++.-.. .|||||.++++|++ .
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~--------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP--------KARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH--------HHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 46788765 7999999999999999999999999986433 566788875444 79999999999874 4
Q ss_pred ceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEcc---CCcEEEEecccc
Q 007260 289 KFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRE---DGHIMLSDFDLS 365 (611)
Q Consensus 289 ~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~---~g~vkL~DFGlA 365 (611)
+++.+|||+++||+|+..++.+....|+|.++..|++||..||.|||+.+|.||||||||+|... |..+||+|||+|
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccc
Confidence 78899999999999999999988888999999999999999999999999999999999999975 457999999999
Q ss_pred ccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccC
Q 007260 366 LRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAE 445 (611)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (611)
+.....
T Consensus 212 K~t~~~-------------------------------------------------------------------------- 217 (400)
T KOG0604|consen 212 KETQEP-------------------------------------------------------------------------- 217 (400)
T ss_pred cccCCC--------------------------------------------------------------------------
Confidence 543210
Q ss_pred cccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcH----HHHHHHHcCCCCCCC--CCCC
Q 007260 446 PTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNR----ATLFNVVGQPLRFPE--SPVV 519 (611)
Q Consensus 446 ~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~----~~l~~i~~~~l~~p~--~~~~ 519 (611)
...++-+-||+|.|||++..+.|+..+|+|||||++|-||||.+||...... ..-.+|..+.+.||. |..+
T Consensus 218 ---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~V 294 (400)
T KOG0604|consen 218 ---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCV 294 (400)
T ss_pred ---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHH
Confidence 1112336799999999999999999999999999999999999999875442 233566677777764 5679
Q ss_pred CHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 520 SFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 520 s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
|++++|+|++||..+|.+|+| +++++.|||..+.
T Consensus 295 Se~aKdlIR~LLkt~PteRlT----I~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 295 SEAAKDLIRKLLKTEPTERLT----IEEVMDHPWINQY 328 (400)
T ss_pred HHHHHHHHHHHhcCCchhhee----HHHhhcCchhccc
Confidence 999999999999999999999 9999999999754
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=376.05 Aligned_cols=249 Identities=24% Similarity=0.424 Sum_probs=201.5
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
.+|++++.||.|+||.||+|++..++..||+|+..+.. ...|+.+|+.++||||+++++++......|+||
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 57999999999999999999999999999999865432 245999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
||+ .++|.+++... ...+++..++.|+.||+.||.|||.+|||||||||+|||++.++.+||+|||++.....
T Consensus 137 e~~-~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~----- 209 (357)
T PHA03209 137 PHY-SSDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV----- 209 (357)
T ss_pred Ecc-CCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc-----
Confidence 999 56888877654 35699999999999999999999999999999999999999999999999998732100
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
........
T Consensus 210 ------------------------------------------------------------------------~~~~~~~~ 217 (357)
T PHA03209 210 ------------------------------------------------------------------------APAFLGLA 217 (357)
T ss_pred ------------------------------------------------------------------------Cccccccc
Confidence 00011346
Q ss_pred cCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCC-CCCCCCc---------HHHHHHHHcC----CCCCC-------
Q 007260 456 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKT-PFKGSGN---------RATLFNVVGQ----PLRFP------- 514 (611)
Q Consensus 456 GT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~-PF~~~~~---------~~~l~~i~~~----~l~~p------- 514 (611)
||+.|+|||++.+..++.++|||||||++|||+++.. +|..... ...+.+++.. +..++
T Consensus 218 gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 297 (357)
T PHA03209 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRL 297 (357)
T ss_pred ccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHH
Confidence 9999999999999999999999999999999998544 4443211 1112222111 11111
Q ss_pred ---------------------CCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCC
Q 007260 515 ---------------------ESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 515 ---------------------~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
....++..+.+||.+||..||.+||| |.|||+||||+.
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpt----a~e~l~hp~f~~ 356 (357)
T PHA03209 298 VRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPS----AEEILNYPMFAQ 356 (357)
T ss_pred HHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcC----HHHHhcCchhcc
Confidence 01235678889999999999999999 999999999975
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=361.93 Aligned_cols=256 Identities=28% Similarity=0.457 Sum_probs=209.3
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVME 296 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE 296 (611)
+|++++.||.|+||.||+|++..++..||||++...... ......+.+|+.+++.++||||+++++++..+..+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc-CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 589999999999999999999999999999998654322 1223456789999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 297 FCPGGDLHTLRQKQP-GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 297 ~~~gg~L~~ll~~~~-~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
|++ ++|.+++.... +..+++..++.++.||+.||+|||++||+||||||+|||++.+|.++|+|||++.......
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 155 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV--- 155 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc---
Confidence 996 68888876543 3578999999999999999999999999999999999999999999999999974321000
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
......+
T Consensus 156 -------------------------------------------------------------------------~~~~~~~ 162 (285)
T cd07861 156 -------------------------------------------------------------------------RVYTHEV 162 (285)
T ss_pred -------------------------------------------------------------------------ccccCCc
Confidence 0001225
Q ss_pred cCCCccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcC---CC---------------CCC--
Q 007260 456 GTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ---PL---------------RFP-- 514 (611)
Q Consensus 456 GT~~Y~APEil~~~-~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~---~l---------------~~p-- 514 (611)
|++.|+|||++.+. .++.++|||||||++|+|++|++||.+......+..+... +. .++
T Consensus 163 ~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (285)
T cd07861 163 VTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKW 242 (285)
T ss_pred ccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhcccc
Confidence 78899999998765 4689999999999999999999999987665544433211 00 000
Q ss_pred -------CCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCC
Q 007260 515 -------ESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 515 -------~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f 554 (611)
....++.++++||.+||..||.+||+ +.+|+.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt----~~~ll~~~~~ 285 (285)
T cd07861 243 KKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRIS----AKKALNHPYF 285 (285)
T ss_pred CcchhHHhcCCCCHHHHHHHHHHhcCChhhCCC----HHHHhcCCCC
Confidence 12347899999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=389.19 Aligned_cols=256 Identities=31% Similarity=0.503 Sum_probs=232.8
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
.+.|.+.+.||.|.|+.|.+|++..++..||||++++..+... .+..+.+|++||..|+|||||+|+.+.+....+|+|
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~-~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPS-KRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChH-HHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 4689999999999999999999999999999999999876543 334478999999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
|||+.+|+|++++.++ +.+.+..++.++.|++.||+|||+++|||||||++|||++.+..+||+|||++..+..
T Consensus 134 ~eya~~ge~~~yl~~~--gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~---- 207 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKH--GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY---- 207 (596)
T ss_pred EEeccCchhHHHHHhc--ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecc----
Confidence 9999999999999987 5688899999999999999999999999999999999999999999999999844321
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
.....++
T Consensus 208 -------------------------------------------------------------------------~~~lqt~ 214 (596)
T KOG0586|consen 208 -------------------------------------------------------------------------GLMLQTF 214 (596)
T ss_pred -------------------------------------------------------------------------ccccccc
Confidence 1122367
Q ss_pred ccCCCccchhhhccCCC-CChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007260 455 VGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVK 533 (611)
Q Consensus 455 vGT~~Y~APEil~~~~~-~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~ 533 (611)
+|++.|.|||++.|..| ++.+|+|+||++||-|++|.+||++..-...-.+++.+.++.|.. ++-++++||+++|..
T Consensus 215 cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~--ms~dce~lLrk~lvl 292 (596)
T KOG0586|consen 215 CGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFY--MSCDCEDLLRKFLVL 292 (596)
T ss_pred CCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccce--eechhHHHHHHhhcc
Confidence 89999999999999998 899999999999999999999999988777777888888888887 999999999999999
Q ss_pred CccccCCchhcHHHHHcCCCCCC
Q 007260 534 EPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 534 dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
+|.+|++ .+++..|.|...
T Consensus 293 ~Pskr~~----~dqim~~~W~n~ 311 (596)
T KOG0586|consen 293 NPSKRGP----CDQIMKDRWRND 311 (596)
T ss_pred CccccCC----HHHhhhhcccch
Confidence 9999999 999999999863
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=356.94 Aligned_cols=258 Identities=38% Similarity=0.712 Sum_probs=219.4
Q ss_pred ecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEeeeCCCCCH
Q 007260 224 LGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDL 303 (611)
Q Consensus 224 LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE~~~gg~L 303 (611)
||.|+||.||+|++..++..||+|++.+...........+.+|+.+++.++||||+++++++.++..+|+||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999999999999999876554444556788999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccccCCCC
Q 007260 304 HTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAE 383 (611)
Q Consensus 304 ~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~ 383 (611)
.+++.+. ..+++..++.++.||+.||+|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~------------ 146 (262)
T cd05572 81 WTILRDR--GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG------------ 146 (262)
T ss_pred HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc------------
Confidence 9998775 45899999999999999999999999999999999999999999999999987332100
Q ss_pred cCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCccch
Q 007260 384 PLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAP 463 (611)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~AP 463 (611)
......+|++.|++|
T Consensus 147 -----------------------------------------------------------------~~~~~~~~~~~~~~P 161 (262)
T cd05572 147 -----------------------------------------------------------------QKTWTFCGTPEYVAP 161 (262)
T ss_pred -----------------------------------------------------------------cccccccCCcCccCh
Confidence 001123588999999
Q ss_pred hhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccCCc
Q 007260 464 EIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSG--NRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAY 541 (611)
Q Consensus 464 Eil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~--~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~ 541 (611)
|.+.+..++.++|+|||||++|+|++|..||.... ....+.++............++.++++||.+||..||++|+++
T Consensus 162 E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~ 241 (262)
T cd05572 162 EIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGN 241 (262)
T ss_pred hHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCC
Confidence 99998889999999999999999999999998776 4555556663333333333468999999999999999999984
Q ss_pred h-hcHHHHHcCCCCCCCchh
Q 007260 542 K-RGATEIKQHPFFEGVNWA 560 (611)
Q Consensus 542 ~-~~a~elL~Hp~f~~~~~~ 560 (611)
. ..+.|+++||||.+.+|.
T Consensus 242 ~~~~~~~l~~~~~~~~~~~~ 261 (262)
T cd05572 242 LKGGIKDIKKHKWFNGFDWE 261 (262)
T ss_pred cccCHHHHhcChhhhCCCCC
Confidence 2 447999999999999884
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=366.29 Aligned_cols=253 Identities=28% Similarity=0.455 Sum_probs=211.6
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
++|++.+.||.|+||.||++.+..++..||+|++.... ......++.+|+++++.++||||++++++|..++.+||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 36999999999999999999999999999999986532 2234456778999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHM-LGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~-~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
||++|++|.+++.+. +.+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.++|+|||++.....
T Consensus 79 ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---- 152 (308)
T cd06615 79 EHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---- 152 (308)
T ss_pred eccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccc----
Confidence 999999999998875 568999999999999999999997 6999999999999999999999999998732110
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
.....+
T Consensus 153 --------------------------------------------------------------------------~~~~~~ 158 (308)
T cd06615 153 --------------------------------------------------------------------------SMANSF 158 (308)
T ss_pred --------------------------------------------------------------------------cccccC
Confidence 001134
Q ss_pred ccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCC-----------------------
Q 007260 455 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPL----------------------- 511 (611)
Q Consensus 455 vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l----------------------- 511 (611)
+|++.|+|||++.+..++.++|||||||++|+|++|+.||...... .+..+.....
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (308)
T cd06615 159 VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK-ELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPM 237 (308)
T ss_pred CCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh-hHHHhhcCccccccccCCcccccCCCCCccchh
Confidence 6899999999999888999999999999999999999999765432 2222221110
Q ss_pred ---------------CCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCC
Q 007260 512 ---------------RFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 512 ---------------~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
..|. ..++.++++||.+||..||++||+ +.+|++||||..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt----~~~ll~~~~~~~ 292 (308)
T cd06615 238 AIFELLDYIVNEPPPKLPS-GAFSDEFQDFVDKCLKKNPKERAD----LKELTKHPFIKR 292 (308)
T ss_pred hHHHHHHHHhcCCCccCcC-cccCHHHHHHHHHHccCChhhCcC----HHHHhcChhhhh
Confidence 0111 136788999999999999999999 999999999964
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=361.50 Aligned_cols=256 Identities=30% Similarity=0.436 Sum_probs=212.7
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceee------c
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFE------T 287 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~------~ 287 (611)
.+.|++.+.||.|+||.||+|++..+++.||+|++.... .....+..|+.+++++ +|+||++++++|. .
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 368999999999999999999999999999999986543 2223567799999988 7999999999985 3
Q ss_pred cceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccc
Q 007260 288 EKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLR 367 (611)
Q Consensus 288 ~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~ 367 (611)
...+|+||||+++|+|.+++....+..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++..
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 56889999999999999999876666789999999999999999999999999999999999999999999999998743
Q ss_pred ccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcc
Q 007260 368 CAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPT 447 (611)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (611)
....
T Consensus 171 ~~~~---------------------------------------------------------------------------- 174 (282)
T cd06636 171 LDRT---------------------------------------------------------------------------- 174 (282)
T ss_pred hhcc----------------------------------------------------------------------------
Confidence 2100
Q ss_pred cccccccccCCCccchhhhc-----cCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHH
Q 007260 448 EARSMSFVGTHEYLAPEIIK-----GEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFA 522 (611)
Q Consensus 448 ~~~~~~~vGT~~Y~APEil~-----~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~ 522 (611)
.......+|++.|+|||++. +..++.++|||||||++|||++|..||........+..+............++..
T Consensus 175 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (282)
T cd06636 175 VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWSKK 254 (282)
T ss_pred ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccccCHH
Confidence 00112346899999999986 3457889999999999999999999998766555555444333222223357899
Q ss_pred HHHHHHHhhhcCccccCCchhcHHHHHcCCCC
Q 007260 523 ARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 523 l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f 554 (611)
+.+||++||..||.+||+ +.||++||||
T Consensus 255 ~~~li~~cl~~~p~~Rp~----~~ell~~~~~ 282 (282)
T cd06636 255 FIDFIEGCLVKNYLSRPS----TEQLLKHPFI 282 (282)
T ss_pred HHHHHHHHhCCChhhCcC----HHHHhcCCCC
Confidence 999999999999999999 9999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=407.08 Aligned_cols=268 Identities=28% Similarity=0.413 Sum_probs=221.2
Q ss_pred cCccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec-
Q 007260 209 RDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET- 287 (611)
Q Consensus 209 ~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~- 287 (611)
.++...+.+|++++.||.|+||+||+|++..++..||+|++....... .....+..|+.+|+.|+|||||+++++|..
T Consensus 6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e-~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de 84 (1021)
T PTZ00266 6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE-REKSQLVIEVNVMRELKHKNIVRYIDRFLNK 84 (1021)
T ss_pred cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCH-HHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence 455566789999999999999999999999999999999997654332 334567889999999999999999998854
Q ss_pred -cceeeEEeeeCCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcC-------eeccCCCCCcEEEcc----
Q 007260 288 -EKFSCLVMEFCPGGDLHTLRQKQ--PGKYFPEQAVRFYVAEVLLALEYLHMLG-------IIYRDLKPENVLVRE---- 353 (611)
Q Consensus 288 -~~~~~LVmE~~~gg~L~~ll~~~--~~~~l~e~~~~~i~~qll~aL~yLH~~g-------IVHRDLKPeNILv~~---- 353 (611)
...+|||||||++++|.+++... ....+++..++.|+.||+.||.|||..+ ||||||||+||||+.
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 46789999999999999988753 1246999999999999999999999954 999999999999964
Q ss_pred -------------CCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCccccc
Q 007260 354 -------------DGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSS 420 (611)
Q Consensus 354 -------------~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (611)
.+.+||+|||++..+...
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~------------------------------------------------- 195 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIE------------------------------------------------- 195 (1021)
T ss_pred cccccccccccCCCCceEEccCCcccccccc-------------------------------------------------
Confidence 235899999998432100
Q ss_pred ccccCCCCccccCCCCCCCcccccCcccccccccccCCCccchhhhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCC
Q 007260 421 KSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGE--GHGSAVDWWTFGIFLYELLFGKTPFKGSG 498 (611)
Q Consensus 421 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~--~~~~~sDIWSLGviL~ELltG~~PF~~~~ 498 (611)
......+||+.|+|||++.+. .++.++||||||||||||++|+.||....
T Consensus 196 ----------------------------s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 196 ----------------------------SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ----------------------------ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 001134699999999999754 47899999999999999999999998877
Q ss_pred cHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCch
Q 007260 499 NRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNW 559 (611)
Q Consensus 499 ~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 559 (611)
....+...+.....++. ...+.++.+||..||..+|.+||+ +.|+|+|+||..+..
T Consensus 248 ~~~qli~~lk~~p~lpi-~~~S~eL~dLI~~~L~~dPeeRPS----a~QlL~h~~ik~i~~ 303 (1021)
T PTZ00266 248 NFSQLISELKRGPDLPI-KGKSKELNILIKNLLNLSAKERPS----ALQCLGYQIIKNVGP 303 (1021)
T ss_pred cHHHHHHHHhcCCCCCc-CCCCHHHHHHHHHHhcCChhHCcC----HHHHhccHHHhhcCC
Confidence 77666666655444433 347899999999999999999999 999999999986644
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=360.82 Aligned_cols=253 Identities=30% Similarity=0.446 Sum_probs=208.8
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
++|++++.||.|+||.||+|.+..++..||||++.+... ......+.+|+++|++++||||++++++|..++..+|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT--VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC--hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 368899999999999999999999999999999865421 223346778999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
||+++++|..+ ..+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++......
T Consensus 79 e~~~~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---- 148 (279)
T cd06619 79 EFMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---- 148 (279)
T ss_pred ecCCCCChHHh------hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----
Confidence 99999999654 23789999999999999999999999999999999999999999999999998322100
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
.....+
T Consensus 149 --------------------------------------------------------------------------~~~~~~ 154 (279)
T cd06619 149 --------------------------------------------------------------------------IAKTYV 154 (279)
T ss_pred --------------------------------------------------------------------------cccCCC
Confidence 011246
Q ss_pred cCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcH-------HHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 007260 456 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNR-------ATLFNVVGQPLRFPESPVVSFAARDLIR 528 (611)
Q Consensus 456 GT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~-------~~l~~i~~~~l~~p~~~~~s~~l~dLI~ 528 (611)
||..|+|||++.+..++.++|||||||++|+|++|+.||...... .....+.............+.++++||.
T Consensus 155 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (279)
T cd06619 155 GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFIT 234 (279)
T ss_pred CChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHH
Confidence 899999999999999999999999999999999999999753211 1122222222111122347889999999
Q ss_pred HhhhcCccccCCchhcHHHHHcCCCCCCCc
Q 007260 529 GLLVKEPQHRLAYKRGATEIKQHPFFEGVN 558 (611)
Q Consensus 529 ~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 558 (611)
+||..||++||+ ++++++||||...+
T Consensus 235 ~~l~~~P~~Rp~----~~eil~~~~~~~~~ 260 (279)
T cd06619 235 QCMRKQPKERPA----PENLMDHPFIVQYN 260 (279)
T ss_pred HHhhCChhhCCC----HHHHhcCccccccc
Confidence 999999999999 99999999997653
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=355.30 Aligned_cols=256 Identities=40% Similarity=0.730 Sum_probs=215.4
Q ss_pred eEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHH-HhCCCCCcccccceeeccceeeEEeeeCCC
Q 007260 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREIL-QSLDHPFLPTLYTHFETEKFSCLVMEFCPG 300 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL-~~l~HpnIv~l~~~~~~~~~~~LVmE~~~g 300 (611)
+.||.|+||.||+|.+..+++.||||++.+...........+..|..++ ..++|+||+++++++..++.+|+||||++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999999999999999999876544434444445565554 445899999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccccC
Q 007260 301 GDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSL 380 (611)
Q Consensus 301 g~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~ 380 (611)
++|.+++... ..+++..+..++.||+.||.|||++||+||||+|+|||++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---------- 149 (260)
T cd05611 82 GDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---------- 149 (260)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----------
Confidence 9999998765 4689999999999999999999999999999999999999999999999998732110
Q ss_pred CCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCc
Q 007260 381 DAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEY 460 (611)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y 460 (611)
...+.|++.|
T Consensus 150 ----------------------------------------------------------------------~~~~~~~~~y 159 (260)
T cd05611 150 ----------------------------------------------------------------------NKKFVGTPDY 159 (260)
T ss_pred ----------------------------------------------------------------------cccCCCCcCc
Confidence 0123588899
Q ss_pred cchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCC--CCCCHHHHHHHHHhhhcCcccc
Q 007260 461 LAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPES--PVVSFAARDLIRGLLVKEPQHR 538 (611)
Q Consensus 461 ~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~--~~~s~~l~dLI~~~L~~dP~~R 538 (611)
+|||.+.+..++.++||||||+++|+|++|..||........+..+......++.. ..++..+.++|.+||..||++|
T Consensus 160 ~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 239 (260)
T cd05611 160 LAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKR 239 (260)
T ss_pred cChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHc
Confidence 99999998889999999999999999999999999877766666665555444432 3478999999999999999999
Q ss_pred CCchhcHHHHHcCCCCCCCchh
Q 007260 539 LAYKRGATEIKQHPFFEGVNWA 560 (611)
Q Consensus 539 pt~~~~a~elL~Hp~f~~~~~~ 560 (611)
|+. ..+.|++.||||..++|.
T Consensus 240 ~~~-~~~~~~l~~~~~~~~~~~ 260 (260)
T cd05611 240 LGA-NGYQEIKSHPFFKSINWD 260 (260)
T ss_pred cCC-CcHHHHHcChHhhcCCCC
Confidence 962 126899999999999984
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-45 Score=386.55 Aligned_cols=253 Identities=29% Similarity=0.384 Sum_probs=226.5
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVME 296 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE 296 (611)
.|.-++.||.|+||.||.|++..+.+.||||.|....-...++...+..|+..|+.|.|||+|.+.++|..+...|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 46667899999999999999999999999999988777777788888899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccc
Q 007260 297 FCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIK 376 (611)
Q Consensus 297 ~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~ 376 (611)
|| -|+-.+++.-. .+++-|..+..|+.+.|.||.|||+++.||||||..|||+++.|.|||+|||-|...
T Consensus 107 YC-lGSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~-------- 176 (948)
T KOG0577|consen 107 YC-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIM-------- 176 (948)
T ss_pred HH-hccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhc--------
Confidence 99 56777877765 367999999999999999999999999999999999999999999999999987211
Q ss_pred cccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccccc
Q 007260 377 ASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVG 456 (611)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vG 456 (611)
...++|||
T Consensus 177 ------------------------------------------------------------------------~PAnsFvG 184 (948)
T KOG0577|consen 177 ------------------------------------------------------------------------APANSFVG 184 (948)
T ss_pred ------------------------------------------------------------------------CchhcccC
Confidence 12247899
Q ss_pred CCCccchhhhcc---CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007260 457 THEYLAPEIIKG---EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVK 533 (611)
Q Consensus 457 T~~Y~APEil~~---~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~ 533 (611)
||+|||||+|.. +.|+-++|||||||+..||.-.++|+-+.+....++.|......--....+++.++.||..||.+
T Consensus 185 TPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqK 264 (948)
T KOG0577|consen 185 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQK 264 (948)
T ss_pred CccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHhh
Confidence 999999999964 45899999999999999999999999988888888888876654444567899999999999999
Q ss_pred CccccCCchhcHHHHHcCCCCC
Q 007260 534 EPQHRLAYKRGATEIKQHPFFE 555 (611)
Q Consensus 534 dP~~Rpt~~~~a~elL~Hp~f~ 555 (611)
-|++||| .+++|.|+|+.
T Consensus 265 ipqeRpt----se~ll~H~fv~ 282 (948)
T KOG0577|consen 265 IPQERPT----SEELLKHRFVL 282 (948)
T ss_pred CcccCCc----HHHHhhcchhc
Confidence 9999999 99999999985
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=355.04 Aligned_cols=261 Identities=28% Similarity=0.433 Sum_probs=217.4
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhh------hHHHHHHHHHHHHHHHhCCCCCcccccceeeccce
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLA------GRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKF 290 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~------~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~ 290 (611)
+|.+.+.||.|+||.||+|.+..++..||+|.+...... ..+....+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 477889999999999999999988999999988654322 22344567889999999999999999999999999
Q ss_pred eeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccC
Q 007260 291 SCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAV 370 (611)
Q Consensus 291 ~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~ 370 (611)
.|+||||+++++|.+++... +.+++..++.++.|++.||+|||++||+||||||+|||++.++.++|+|||++..+..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 99999999999999999775 5689999999999999999999999999999999999999999999999999854321
Q ss_pred CccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccc
Q 007260 371 SPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEAR 450 (611)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (611)
.... ......
T Consensus 159 ~~~~----------------------------------------------------------------------~~~~~~ 168 (267)
T cd06628 159 NSLS----------------------------------------------------------------------TKTNGA 168 (267)
T ss_pred cccc----------------------------------------------------------------------CCcccc
Confidence 0000 000001
Q ss_pred ccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 007260 451 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGL 530 (611)
Q Consensus 451 ~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~ 530 (611)
...+.|+..|+|||++.+..++.++|||||||++|+|++|+.||.+......+.++.... .......++..++++|.+|
T Consensus 169 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~ 247 (267)
T cd06628 169 RPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA-SPEIPSNISSEAIDFLEKT 247 (267)
T ss_pred ccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC-CCcCCcccCHHHHHHHHHH
Confidence 113458899999999999889999999999999999999999999876666665554432 1122234889999999999
Q ss_pred hhcCccccCCchhcHHHHHcCCCC
Q 007260 531 LVKEPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 531 L~~dP~~Rpt~~~~a~elL~Hp~f 554 (611)
|..||.+||+ +.++++||||
T Consensus 248 l~~~p~~Rp~----~~~il~~~~~ 267 (267)
T cd06628 248 FEIDHNKRPT----AAELLKHPFL 267 (267)
T ss_pred ccCCchhCcC----HHHHhhCCCC
Confidence 9999999999 9999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=359.85 Aligned_cols=255 Identities=33% Similarity=0.609 Sum_probs=206.7
Q ss_pred EecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHH---HHHHHhCCCCCcccccceeeccceeeEEeeeCC
Q 007260 223 RLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTE---REILQSLDHPFLPTLYTHFETEKFSCLVMEFCP 299 (611)
Q Consensus 223 ~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E---~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE~~~ 299 (611)
.||.|+||.||+|++..+++.||||++.+...........+..| +.+++..+||||+.++++|...+.+|+||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999999999999999999976543322221222333 344555689999999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccccccc
Q 007260 300 GGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASS 379 (611)
Q Consensus 300 gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~ 379 (611)
|++|..++... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-------- 150 (278)
T cd05606 81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-------- 150 (278)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--------
Confidence 99999888764 56999999999999999999999999999999999999999999999999987322100
Q ss_pred CCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCC
Q 007260 380 LDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHE 459 (611)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~ 459 (611)
.....+|+..
T Consensus 151 ----------------------------------------------------------------------~~~~~~~~~~ 160 (278)
T cd05606 151 ----------------------------------------------------------------------KPHASVGTHG 160 (278)
T ss_pred ----------------------------------------------------------------------CCcCcCCCcC
Confidence 0012358999
Q ss_pred ccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCc
Q 007260 460 YLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGN---RATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEP 535 (611)
Q Consensus 460 Y~APEil~~~-~~~~~sDIWSLGviL~ELltG~~PF~~~~~---~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP 535 (611)
|+|||++.+. .++.++|||||||++|||++|+.||.+... ......+......++. .++..+.++|.+||..||
T Consensus 161 y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~~li~~~l~~~p 238 (278)
T cd05606 161 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD--SFSPELRSLLEGLLQRDV 238 (278)
T ss_pred CcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCC--cCCHHHHHHHHHHhhcCH
Confidence 9999999754 689999999999999999999999987532 2222222223333333 479999999999999999
Q ss_pred cccC-----CchhcHHHHHcCCCCCCCchhhhc
Q 007260 536 QHRL-----AYKRGATEIKQHPFFEGVNWALIR 563 (611)
Q Consensus 536 ~~Rp-----t~~~~a~elL~Hp~f~~~~~~~~~ 563 (611)
.+|+ + +.++++||||...+|....
T Consensus 239 ~~R~~~~~~~----~~~ll~~~~~~~~~~~~~~ 267 (278)
T cd05606 239 NRRLGCLGRG----AQEVKEHPFFRSLDWQMVF 267 (278)
T ss_pred HhccCCCCCC----HHHHHhCccccCCCchHhh
Confidence 9999 7 9999999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=360.70 Aligned_cols=259 Identities=28% Similarity=0.478 Sum_probs=218.9
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
++|++++.||.|+||.||++.+..++..||+|++.... ......+.+|+++++.++|+||+++++++..+...|+||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES---EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC---HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 57999999999999999999999899999999986543 233456778999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
||+++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~---- 156 (280)
T cd06611 82 EFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST---- 156 (280)
T ss_pred eccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc----
Confidence 9999999999887642 46999999999999999999999999999999999999999999999999987322100
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
........
T Consensus 157 ------------------------------------------------------------------------~~~~~~~~ 164 (280)
T cd06611 157 ------------------------------------------------------------------------LQKRDTFI 164 (280)
T ss_pred ------------------------------------------------------------------------ccccceee
Confidence 00112346
Q ss_pred cCCCccchhhhcc-----CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCC-CCCCCCCCCHHHHHHHHH
Q 007260 456 GTHEYLAPEIIKG-----EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPL-RFPESPVVSFAARDLIRG 529 (611)
Q Consensus 456 GT~~Y~APEil~~-----~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l-~~p~~~~~s~~l~dLI~~ 529 (611)
||+.|+|||++.. ..++.++|||||||++|||++|++||.+......+.++..... .+.....++.++.+||.+
T Consensus 165 ~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 244 (280)
T cd06611 165 GTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKS 244 (280)
T ss_pred cchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHHHHH
Confidence 8999999999863 3467799999999999999999999998776666666655432 233334588999999999
Q ss_pred hhhcCccccCCchhcHHHHHcCCCCCCCc
Q 007260 530 LLVKEPQHRLAYKRGATEIKQHPFFEGVN 558 (611)
Q Consensus 530 ~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 558 (611)
||..||.+||+ +.++++||||....
T Consensus 245 ~l~~~p~~Rps----~~~il~~~~~~~~~ 269 (280)
T cd06611 245 CLVKDPDDRPT----AAELLKHPFVSDQS 269 (280)
T ss_pred HhccChhhCcC----HHHHhcChhhcccc
Confidence 99999999999 99999999998653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=380.38 Aligned_cols=253 Identities=25% Similarity=0.339 Sum_probs=204.2
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
...|.+.+.||.|+||.||+|.+..+++.||||..... .+.+|+.+|++|+|+|||++++++..++..|||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~---------~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYA---------SSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccccc---------CHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 35899999999999999999999999999999964321 345799999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
||++ .++|..++.... ..+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||++..+....
T Consensus 239 ~e~~-~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~-- 314 (461)
T PHA03211 239 LPKY-RSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW-- 314 (461)
T ss_pred EEcc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccc--
Confidence 9999 578888876643 469999999999999999999999999999999999999999999999999984321000
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
.......+
T Consensus 315 ------------------------------------------------------------------------~~~~~~~~ 322 (461)
T PHA03211 315 ------------------------------------------------------------------------STPFHYGI 322 (461)
T ss_pred ------------------------------------------------------------------------cccccccc
Confidence 00001134
Q ss_pred ccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC-------cHHHHHHHHcCC-C---CCC---------
Q 007260 455 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSG-------NRATLFNVVGQP-L---RFP--------- 514 (611)
Q Consensus 455 vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~-------~~~~l~~i~~~~-l---~~p--------- 514 (611)
+||+.|+|||++.+..++.++|||||||+||||++|..|+.... ....+.+++... . .++
T Consensus 323 ~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~ 402 (461)
T PHA03211 323 AGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVS 402 (461)
T ss_pred CCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHH
Confidence 69999999999999999999999999999999999876643211 122233332210 0 011
Q ss_pred --------------------CCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCC
Q 007260 515 --------------------ESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 515 --------------------~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
....++..+.+||.+||..||.+||+ +.|||+||||+.
T Consensus 403 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPs----a~elL~hp~f~~ 460 (461)
T PHA03211 403 QYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPS----AAELLRLPLFQS 460 (461)
T ss_pred HHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcC----HHHHhhCcccCC
Confidence 11135668999999999999999999 999999999974
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=352.92 Aligned_cols=260 Identities=30% Similarity=0.442 Sum_probs=216.0
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchh--hhhHHHHHHHHHHHHHHHhCCCCCcccccceeec--ccee
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKAS--LAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET--EKFS 291 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~--~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~--~~~~ 291 (611)
.+|++.+.||+|+||.||++.+..++..||||++.... ....+....+.+|+.+++.++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47999999999999999999999999999999886432 1223445677889999999999999999998876 3578
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCC
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~ 371 (611)
|+||||++|++|.+++.+. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence 8999999999999988765 45899999999999999999999999999999999999999999999999988432100
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
.. .....
T Consensus 160 ~~-------------------------------------------------------------------------~~~~~ 166 (265)
T cd06652 160 CL-------------------------------------------------------------------------SGTGM 166 (265)
T ss_pred cc-------------------------------------------------------------------------ccccc
Confidence 00 00001
Q ss_pred cccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 007260 452 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLL 531 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L 531 (611)
....|+..|+|||++.+..++.++|||||||++|||++|+.||........+.++...+........++..+.++|.+||
T Consensus 167 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 246 (265)
T cd06652 167 KSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIF 246 (265)
T ss_pred ccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHh
Confidence 12358999999999999889999999999999999999999998876666666655554333333457889999999999
Q ss_pred hcCccccCCchhcHHHHHcCCCCC
Q 007260 532 VKEPQHRLAYKRGATEIKQHPFFE 555 (611)
Q Consensus 532 ~~dP~~Rpt~~~~a~elL~Hp~f~ 555 (611)
. +|++||+ ++++++|||+.
T Consensus 247 ~-~p~~Rp~----~~~il~~~~~~ 265 (265)
T cd06652 247 V-EAKLRPS----ADELLRHTFVH 265 (265)
T ss_pred c-ChhhCCC----HHHHhcCcccC
Confidence 5 9999999 99999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=357.77 Aligned_cols=254 Identities=28% Similarity=0.450 Sum_probs=212.2
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
.++|++.+.||.|+||.||+|++..+++.||+|+++.... .....+++|+.+++.++||||+++++.+...+..|+|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG---EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 3578899999999999999999999999999999865432 2334567899999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
|||+++++|.+++... +.+++..++.++.|++.||.|||.+||+||||||+|||++.++.++|+|||++......
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--- 159 (267)
T cd06645 85 MEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT--- 159 (267)
T ss_pred EeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc---
Confidence 9999999999988765 46999999999999999999999999999999999999999999999999997432100
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
.......
T Consensus 160 -------------------------------------------------------------------------~~~~~~~ 166 (267)
T cd06645 160 -------------------------------------------------------------------------IAKRKSF 166 (267)
T ss_pred -------------------------------------------------------------------------ccccccc
Confidence 0001123
Q ss_pred ccCCCccchhhhc---cCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCC---CCCCCHHHHHHHH
Q 007260 455 VGTHEYLAPEIIK---GEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPE---SPVVSFAARDLIR 528 (611)
Q Consensus 455 vGT~~Y~APEil~---~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~---~~~~s~~l~dLI~ 528 (611)
+||+.|+|||++. ...++.++|||||||++|+|++|..||........+..........+. ...++..+.+||.
T Consensus 167 ~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 246 (267)
T cd06645 167 IGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVK 246 (267)
T ss_pred cCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHH
Confidence 5899999999985 445788999999999999999999999766555444444333332222 2347889999999
Q ss_pred HhhhcCccccCCchhcHHHHHcCCC
Q 007260 529 GLLVKEPQHRLAYKRGATEIKQHPF 553 (611)
Q Consensus 529 ~~L~~dP~~Rpt~~~~a~elL~Hp~ 553 (611)
+||..||++||+ +++|++|||
T Consensus 247 ~~l~~~P~~R~~----~~~ll~~~~ 267 (267)
T cd06645 247 MALTKNPKKRPT----AEKLLQHPF 267 (267)
T ss_pred HHccCCchhCcC----HHHHhcCCC
Confidence 999999999999 999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=353.25 Aligned_cols=255 Identities=38% Similarity=0.696 Sum_probs=217.7
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVME 296 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE 296 (611)
+|++.+.||.|+||.||+|.+..++..||+|++.+...........+.+|++++++++||||+++++.+..+...|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58999999999999999999999999999999987665554566778899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccc
Q 007260 297 FCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIK 376 (611)
Q Consensus 297 ~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~ 376 (611)
|+.|++|..++... ..+++..+..++.||+.||.|||.+||+|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---- 154 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc----
Confidence 99999999988775 468999999999999999999999999999999999999999999999999873321000
Q ss_pred cccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccccc
Q 007260 377 ASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVG 456 (611)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vG 456 (611)
......|
T Consensus 155 -------------------------------------------------------------------------~~~~~~~ 161 (258)
T cd05578 155 -------------------------------------------------------------------------LTTSTSG 161 (258)
T ss_pred -------------------------------------------------------------------------cccccCC
Confidence 0012348
Q ss_pred CCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHc-CCCCCCCCCCCCHHHHHHHHHhhhc
Q 007260 457 THEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGN--RATLFNVVG-QPLRFPESPVVSFAARDLIRGLLVK 533 (611)
Q Consensus 457 T~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~--~~~l~~i~~-~~l~~p~~~~~s~~l~dLI~~~L~~ 533 (611)
+..|+|||++.+..++.++|+|||||++|+|++|+.||..... ...+..... ....++ ..++..+.++|.+||..
T Consensus 162 ~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~ 239 (258)
T cd05578 162 TPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYP--ATWSTEAIDAINKLLER 239 (258)
T ss_pred ChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCc--ccCcHHHHHHHHHHccC
Confidence 8899999999998899999999999999999999999987664 333333333 222333 35889999999999999
Q ss_pred CccccCCchhcHHHHHcCCCC
Q 007260 534 EPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 534 dP~~Rpt~~~~a~elL~Hp~f 554 (611)
||.+|++.. +.|+++||||
T Consensus 240 ~p~~R~~~~--~~~l~~~~~~ 258 (258)
T cd05578 240 DPQKRLGDN--LKDLKNHPYF 258 (258)
T ss_pred ChhHcCCcc--HHHHhcCCCC
Confidence 999999922 2999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=358.23 Aligned_cols=256 Identities=30% Similarity=0.454 Sum_probs=215.1
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVME 296 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE 296 (611)
.|++++.||.|+||.||++.+..++..+|+|.+.... ......+.+|+++++.++||||++++++|..++..|+|||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e 82 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 82 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence 4788899999999999999999999999999986543 2344567789999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccc
Q 007260 297 FCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIK 376 (611)
Q Consensus 297 ~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~ 376 (611)
|+++++|..++.+. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 83 ~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~----- 156 (282)
T cd06643 83 FCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT----- 156 (282)
T ss_pred ecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc-----
Confidence 99999999877653 246899999999999999999999999999999999999999999999999997432100
Q ss_pred cccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccccc
Q 007260 377 ASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVG 456 (611)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vG 456 (611)
......+.|
T Consensus 157 -----------------------------------------------------------------------~~~~~~~~~ 165 (282)
T cd06643 157 -----------------------------------------------------------------------IQRRDSFIG 165 (282)
T ss_pred -----------------------------------------------------------------------ccccccccc
Confidence 001113468
Q ss_pred CCCccchhhhc-----cCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCC-CCCCCCCCCCHHHHHHHHHh
Q 007260 457 THEYLAPEIIK-----GEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQP-LRFPESPVVSFAARDLIRGL 530 (611)
Q Consensus 457 T~~Y~APEil~-----~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~-l~~p~~~~~s~~l~dLI~~~ 530 (611)
|+.|+|||++. +..++.++|||||||++|||++|++||........+.++.... ...+....++.++++||.+|
T Consensus 166 ~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 245 (282)
T cd06643 166 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKC 245 (282)
T ss_pred cccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHHHH
Confidence 99999999984 3456789999999999999999999998877666665554432 22333345889999999999
Q ss_pred hhcCccccCCchhcHHHHHcCCCCCC
Q 007260 531 LVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 531 L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
|..||.+||+ +.++++||||..
T Consensus 246 l~~~p~~Rp~----~~~il~~~~~~~ 267 (282)
T cd06643 246 LEKNVDARWT----TTQLLQHPFVTV 267 (282)
T ss_pred ccCChhhCcC----HHHHhcCCCEec
Confidence 9999999999 999999999974
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-46 Score=368.04 Aligned_cols=255 Identities=27% Similarity=0.447 Sum_probs=224.3
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVME 296 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE 296 (611)
-|.++.+||+|+||.||+|.|+.+|..+|||.+.-+. .+..+..|+.|++.++.|+||++|+.+.....+|||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 3667789999999999999999999999999986542 34456779999999999999999999998899999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccc
Q 007260 297 FCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIK 376 (611)
Q Consensus 297 ~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~ 376 (611)
||..|++.++++.+ ++.|+|+++..+++..|.||+|||...-||||||..|||++-+|+.||+|||.|-.+.
T Consensus 109 YCGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT------- 180 (502)
T KOG0574|consen 109 YCGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLT------- 180 (502)
T ss_pred hcCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhh-------
Confidence 99999999988765 4789999999999999999999999999999999999999999999999999983321
Q ss_pred cccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccccc
Q 007260 377 ASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVG 456 (611)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vG 456 (611)
.+....++.+|
T Consensus 181 ---------------------------------------------------------------------DTMAKRNTVIG 191 (502)
T KOG0574|consen 181 ---------------------------------------------------------------------DTMAKRNTVIG 191 (502)
T ss_pred ---------------------------------------------------------------------hhHHhhCcccc
Confidence 23344567889
Q ss_pred CCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcC-CCCCCCCCCCCHHHHHHHHHhhhcCc
Q 007260 457 THEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ-PLRFPESPVVSFAARDLIRGLLVKEP 535 (611)
Q Consensus 457 T~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~-~l~~p~~~~~s~~l~dLI~~~L~~dP 535 (611)
||.|||||++..-+|+..+||||||++..||..|++||........++.|-.. +..|..+..++.++.|||+.||.++|
T Consensus 192 TPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~P 271 (502)
T KOG0574|consen 192 TPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKP 271 (502)
T ss_pred CcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCH
Confidence 99999999999999999999999999999999999999987766655555443 34455556689999999999999999
Q ss_pred cccCCchhcHHHHHcCCCCCCC
Q 007260 536 QHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 536 ~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
++|-| |.+|++|||.++.
T Consensus 272 E~R~T----A~~L~~H~FiknA 289 (502)
T KOG0574|consen 272 EERKT----ALRLCEHTFIKNA 289 (502)
T ss_pred HHHHH----HHHHhhhhhhcCC
Confidence 99999 9999999999864
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=352.74 Aligned_cols=261 Identities=27% Similarity=0.401 Sum_probs=214.7
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchh---hhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeE
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKAS---LAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCL 293 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~---~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~L 293 (611)
+|++.+.||.|+||.||+|... ++..+|+|++.... ........++.+|+++|+.++|+||+++++++...+..|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 5888999999999999999874 67789999886432 1223445567889999999999999999999999999999
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcc
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 373 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~ 373 (611)
||||++|++|.+++.+. ..+++..+..++.||+.||+|||+.||+|+||||+|||++.++.++|+|||++........
T Consensus 80 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 80 FMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 99999999999998765 4589999999999999999999999999999999999999999999999998843221000
Q ss_pred ccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccc
Q 007260 374 LIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMS 453 (611)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (611)
.. ........
T Consensus 158 ~~----------------------------------------------------------------------~~~~~~~~ 167 (265)
T cd06631 158 HG----------------------------------------------------------------------THSNMLKS 167 (265)
T ss_pred cc----------------------------------------------------------------------cccccccc
Confidence 00 00000123
Q ss_pred cccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCC-CCCCCCCCCCHHHHHHHHHhhh
Q 007260 454 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQP-LRFPESPVVSFAARDLIRGLLV 532 (611)
Q Consensus 454 ~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~-l~~p~~~~~s~~l~dLI~~~L~ 532 (611)
..|+..|+|||++.+..++.++|||||||++|+|++|..||...........+.... ...+....++.++.+||.+||.
T Consensus 168 ~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 247 (265)
T cd06631 168 MHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLT 247 (265)
T ss_pred cCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhc
Confidence 458999999999999999999999999999999999999998766655554444332 2122334589999999999999
Q ss_pred cCccccCCchhcHHHHHcCCCC
Q 007260 533 KEPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 533 ~dP~~Rpt~~~~a~elL~Hp~f 554 (611)
.+|.+||+ +.++++||||
T Consensus 248 ~~p~~Rp~----~~~~l~~~~~ 265 (265)
T cd06631 248 RDQHERPS----ALQLLRHDFL 265 (265)
T ss_pred CCcccCCC----HHHHhcCCCC
Confidence 99999999 9999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=353.41 Aligned_cols=259 Identities=30% Similarity=0.456 Sum_probs=214.4
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhh--hhHHHHHHHHHHHHHHHhCCCCCcccccceeec--cceee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASL--AGRKKLLRAQTEREILQSLDHPFLPTLYTHFET--EKFSC 292 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~--~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~--~~~~~ 292 (611)
+|++.+.||.|+||.||+|.+..++..||+|++..... ...+....+.+|+.+++.++||||+++++++.. +..+|
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 68899999999999999999999999999999865432 223445567889999999999999999998875 46789
Q ss_pred EEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCc
Q 007260 293 LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 293 LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~ 372 (611)
+||||+++++|.+++... ..+++..++.++.||+.||+|||.+||+||||||+||+++.++.++|+|||++.......
T Consensus 83 l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 160 (266)
T ss_pred EEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence 999999999999988765 458999999999999999999999999999999999999999999999999984331000
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
. ......
T Consensus 161 ~-------------------------------------------------------------------------~~~~~~ 167 (266)
T cd06651 161 M-------------------------------------------------------------------------SGTGIR 167 (266)
T ss_pred c-------------------------------------------------------------------------cCCccc
Confidence 0 000001
Q ss_pred ccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007260 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLV 532 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~ 532 (611)
...|+..|+|||++.+..++.++|||||||++|||++|+.||........+..+............++..+++|| .||.
T Consensus 168 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~ 246 (266)
T cd06651 168 SVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL-GCIF 246 (266)
T ss_pred cCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHHH-HHhc
Confidence 235889999999999988999999999999999999999999887666666655544433222334788999999 5777
Q ss_pred cCccccCCchhcHHHHHcCCCCC
Q 007260 533 KEPQHRLAYKRGATEIKQHPFFE 555 (611)
Q Consensus 533 ~dP~~Rpt~~~~a~elL~Hp~f~ 555 (611)
.+|++||+ +.||++||||+
T Consensus 247 ~~p~~Rp~----~~eil~hp~~~ 265 (266)
T cd06651 247 VEARHRPS----AEELLRHPFAQ 265 (266)
T ss_pred CChhhCcC----HHHHhcCcccc
Confidence 89999999 99999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=351.46 Aligned_cols=261 Identities=28% Similarity=0.410 Sum_probs=218.9
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
++|++++.||.|+||+||+|.+..++..+|+|++....... ....+.+|+++|+.++|+||+++++.+..++..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 37999999999999999999999899999999997544332 4456788999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 296 EFCPGGDLHTLRQKQPG-KYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~-~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
||++|++|.+++..... ..+++..++.++.||+.||+|||++||+||||||+||++++++.++|+|||++..+......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 99999999999876432 56899999999999999999999999999999999999999999999999998433211000
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
.......+
T Consensus 159 ------------------------------------------------------------------------~~~~~~~~ 166 (267)
T cd06610 159 ------------------------------------------------------------------------TRKVRKTF 166 (267)
T ss_pred ------------------------------------------------------------------------cccccccc
Confidence 00011234
Q ss_pred ccCCCccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCC-CCCCC---CCCCHHHHHHHHH
Q 007260 455 VGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPL-RFPES---PVVSFAARDLIRG 529 (611)
Q Consensus 455 vGT~~Y~APEil~~~-~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l-~~p~~---~~~s~~l~dLI~~ 529 (611)
+|+..|+|||++... .++.++|+|||||++|+|++|+.||........+.++..... .++.. ..++..+++||.+
T Consensus 167 ~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 246 (267)
T cd06610 167 VGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISL 246 (267)
T ss_pred cCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHHHHHHHHH
Confidence 689999999999877 789999999999999999999999988776666665554432 22221 2578999999999
Q ss_pred hhhcCccccCCchhcHHHHHcCCCC
Q 007260 530 LLVKEPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 530 ~L~~dP~~Rpt~~~~a~elL~Hp~f 554 (611)
||.+||++||+ +.+|++||||
T Consensus 247 ~l~~~p~~Rp~----~~~ll~~p~~ 267 (267)
T cd06610 247 CLQKDPSKRPT----AEELLKHKFF 267 (267)
T ss_pred HcCCChhhCcC----HHHHhhCCCC
Confidence 99999999999 9999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=356.22 Aligned_cols=256 Identities=29% Similarity=0.478 Sum_probs=210.1
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
++|++++.||.|+||.||+|++..+++.||+|++...... ......+.+|+.+++.++|+||++++++|......|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD-PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC-ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 3799999999999999999999999999999998654311 112234578999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
||++++.|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 80 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 154 (286)
T cd07847 80 EYCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG--- 154 (286)
T ss_pred eccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCc---
Confidence 999998888776553 458999999999999999999999999999999999999999999999999984321000
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
.......
T Consensus 155 -------------------------------------------------------------------------~~~~~~~ 161 (286)
T cd07847 155 -------------------------------------------------------------------------DDYTDYV 161 (286)
T ss_pred -------------------------------------------------------------------------ccccCcc
Confidence 0011235
Q ss_pred cCCCccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcC-------------------CCCCCC
Q 007260 456 GTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ-------------------PLRFPE 515 (611)
Q Consensus 456 GT~~Y~APEil~~~-~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~-------------------~l~~p~ 515 (611)
|+..|+|||++.+. .++.++|||||||++|||++|+.||.+....+.+..+... ....+.
T Consensus 162 ~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (286)
T cd07847 162 ATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPE 241 (286)
T ss_pred cccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCC
Confidence 78899999999874 5789999999999999999999999987766555443210 001111
Q ss_pred ----------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCC
Q 007260 516 ----------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 516 ----------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f 554 (611)
...++..+.+||.+||..||++||+ +.+++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~eil~~~~f 286 (286)
T cd07847 242 PETREPLESKFPNISSPALSFLKGCLQMDPTERLS----CEELLEHPYF 286 (286)
T ss_pred cccccCHHHHhccCCHHHHHHHHHHhcCCccccCC----HHHHhcCCCC
Confidence 1246888999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=358.57 Aligned_cols=255 Identities=27% Similarity=0.444 Sum_probs=204.5
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVME 296 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE 296 (611)
+|++.+.||.|+||.||+|++..++..||+|.+...... ......+.+|+++++.++||||+++++++.+...+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc-ccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 589999999999999999999999999999998654321 1222345679999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccc
Q 007260 297 FCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIK 376 (611)
Q Consensus 297 ~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~ 376 (611)
|+. ++|.+++.... ..+++..++.++.||+.||.|||.+||+||||||+|||++.++.++|+|||++.......
T Consensus 80 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---- 153 (284)
T cd07839 80 YCD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV---- 153 (284)
T ss_pred cCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC----
Confidence 995 58888776542 569999999999999999999999999999999999999999999999999984321000
Q ss_pred cccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccccc
Q 007260 377 ASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVG 456 (611)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vG 456 (611)
.......+
T Consensus 154 ------------------------------------------------------------------------~~~~~~~~ 161 (284)
T cd07839 154 ------------------------------------------------------------------------RCYSAEVV 161 (284)
T ss_pred ------------------------------------------------------------------------CCcCCCcc
Confidence 00012357
Q ss_pred CCCccchhhhccCC-CCChhhHHHHHHHHHHHHhCCCCCC-CCCcHHHHHHHHc---CC--------------CCCC---
Q 007260 457 THEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFK-GSGNRATLFNVVG---QP--------------LRFP--- 514 (611)
Q Consensus 457 T~~Y~APEil~~~~-~~~~sDIWSLGviL~ELltG~~PF~-~~~~~~~l~~i~~---~~--------------l~~p--- 514 (611)
++.|+|||++.+.. ++.++|||||||++|+|++|..||. +.+..+.+..+.. .+ ..++
T Consensus 162 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd07839 162 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYP 241 (284)
T ss_pred ccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCC
Confidence 88999999998754 6899999999999999999988854 4333333322211 10 0000
Q ss_pred -------CCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCC
Q 007260 515 -------ESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 515 -------~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f 554 (611)
..+.++.++++||.+||..||.+||| +.+++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t----~~~il~h~~f 284 (284)
T cd07839 242 ATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRIS----AEEALQHPYF 284 (284)
T ss_pred CcchhhhhcccCCHHHHHHHHHHhcCChhhcCC----HHHHhcCCCC
Confidence 11347889999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=348.24 Aligned_cols=256 Identities=29% Similarity=0.468 Sum_probs=221.1
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVME 296 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE 296 (611)
+|++++.||.|+||.||.+++..+++.+++|.+....... ....++.+|+++|++++|+||++++++|.+.+.+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 6999999999999999999999999999999987654332 334467789999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccc
Q 007260 297 FCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIK 376 (611)
Q Consensus 297 ~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~ 376 (611)
||++++|.+++.+..+..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~---- 155 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY---- 155 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc----
Confidence 9999999999987655678999999999999999999999999999999999999999999999999874321000
Q ss_pred cccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccccc
Q 007260 377 ASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVG 456 (611)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vG 456 (611)
......+|
T Consensus 156 ------------------------------------------------------------------------~~~~~~~~ 163 (256)
T cd08221 156 ------------------------------------------------------------------------SMAETVVG 163 (256)
T ss_pred ------------------------------------------------------------------------ccccccCC
Confidence 00112458
Q ss_pred CCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCcc
Q 007260 457 THEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQ 536 (611)
Q Consensus 457 T~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~ 536 (611)
++.|+|||++.+..++.++|||||||++|||++|..||......+....+....+. +....++.++.++|.+||..+|.
T Consensus 164 ~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~ 242 (256)
T cd08221 164 TPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYT-PVVSVYSSELISLVHSLLQQDPE 242 (256)
T ss_pred CccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC-CCccccCHHHHHHHHHHcccCcc
Confidence 99999999999888899999999999999999999999987777766666655433 22356899999999999999999
Q ss_pred ccCCchhcHHHHHcCCCC
Q 007260 537 HRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 537 ~Rpt~~~~a~elL~Hp~f 554 (611)
+||+ +.++++|+|+
T Consensus 243 ~R~s----~~~ll~~~~l 256 (256)
T cd08221 243 KRPT----ADEVLDQPLL 256 (256)
T ss_pred cCCC----HHHHhhCcCC
Confidence 9999 9999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=355.73 Aligned_cols=258 Identities=31% Similarity=0.486 Sum_probs=217.8
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
++|++.+.||.|+||.||+|++..++..||+|++.... .......+.+|+.+++.++|+||+++++++..+..+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 37899999999999999999999999999999987543 1233445678999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
||+++++|.+++... .+++..++.++.||+.||.|||.+||+||||+|+||+++.++.++|+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--- 152 (274)
T cd06609 79 EYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--- 152 (274)
T ss_pred EeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc---
Confidence 999999999988764 68999999999999999999999999999999999999999999999999984432100
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
......+
T Consensus 153 -------------------------------------------------------------------------~~~~~~~ 159 (274)
T cd06609 153 -------------------------------------------------------------------------SKRNTFV 159 (274)
T ss_pred -------------------------------------------------------------------------ccccccc
Confidence 0011245
Q ss_pred cCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCc
Q 007260 456 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEP 535 (611)
Q Consensus 456 GT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP 535 (611)
|++.|+|||++.+..++.++|||||||++|+|++|+.||........+..+............++.++.++|.+||..||
T Consensus 160 ~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p 239 (274)
T cd06609 160 GTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDP 239 (274)
T ss_pred CCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhhCCh
Confidence 88999999999998999999999999999999999999987665555444443322221222278899999999999999
Q ss_pred cccCCchhcHHHHHcCCCCCCCc
Q 007260 536 QHRLAYKRGATEIKQHPFFEGVN 558 (611)
Q Consensus 536 ~~Rpt~~~~a~elL~Hp~f~~~~ 558 (611)
++||+ +.++++||||....
T Consensus 240 ~~Rpt----~~~il~~~~~~~~~ 258 (274)
T cd06609 240 KERPS----AKELLKHKFIKKAK 258 (274)
T ss_pred hhCcC----HHHHhhChhhcCCC
Confidence 99999 99999999998653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=347.49 Aligned_cols=255 Identities=27% Similarity=0.456 Sum_probs=217.8
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVME 296 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE 296 (611)
+|++.+.||.|+||.||+|.+..++..||||.+....... .....+.+|+++|+.++||||+++++.+..++..|+|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 5899999999999999999999999999999997654433 334567889999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCC-cEEEEeccccccccCCcccc
Q 007260 297 FCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDG-HIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 297 ~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g-~vkL~DFGlA~~~~~~~~~~ 375 (611)
|++|++|.+++....+..+++..+..++.|++.||+|||++||+||||||+||+++.++ .++|+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~---- 155 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK---- 155 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC----
Confidence 99999999999876556789999999999999999999999999999999999998654 6899999998432100
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
......+
T Consensus 156 -------------------------------------------------------------------------~~~~~~~ 162 (256)
T cd08220 156 -------------------------------------------------------------------------SKAYTVV 162 (256)
T ss_pred -------------------------------------------------------------------------ccccccc
Confidence 0001235
Q ss_pred cCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCc
Q 007260 456 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEP 535 (611)
Q Consensus 456 GT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP 535 (611)
|+..|+|||++.+..++.++|||||||++|+|++|+.||.+.........+..... .+....++..+++||.+||..||
T Consensus 163 ~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p 241 (256)
T cd08220 163 GTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF-APISDRYSPDLRQLILSMLNLDP 241 (256)
T ss_pred cCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC-CCCCCCcCHHHHHHHHHHccCCh
Confidence 88999999999988889999999999999999999999988776665555554332 22334589999999999999999
Q ss_pred cccCCchhcHHHHHcCCCC
Q 007260 536 QHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 536 ~~Rpt~~~~a~elL~Hp~f 554 (611)
.+||+ +.++++||||
T Consensus 242 ~~Rpt----~~~ll~~p~~ 256 (256)
T cd08220 242 SKRPQ----LSQIMAQPIC 256 (256)
T ss_pred hhCCC----HHHHhhCCCC
Confidence 99999 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=348.05 Aligned_cols=256 Identities=25% Similarity=0.465 Sum_probs=219.2
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVME 296 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE 296 (611)
+|++++.||.|+||.||++++..+++.||+|.+....... .....+.+|+.+++.++||||+++++++...++.|||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh-HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 5899999999999999999999999999999987544332 234467889999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccc
Q 007260 297 FCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIK 376 (611)
Q Consensus 297 ~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~ 376 (611)
|+.+++|.+++.......+++..+..++.||+.||.|||++||+|+||+|+|||++.++.++|+|||++......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~----- 154 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST----- 154 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc-----
Confidence 999999999887755556899999999999999999999999999999999999999999999999988432100
Q ss_pred cccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccccc
Q 007260 377 ASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVG 456 (611)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vG 456 (611)
........|
T Consensus 155 -----------------------------------------------------------------------~~~~~~~~~ 163 (256)
T cd08218 155 -----------------------------------------------------------------------VELARTCIG 163 (256)
T ss_pred -----------------------------------------------------------------------hhhhhhccC
Confidence 000112358
Q ss_pred CCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCcc
Q 007260 457 THEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQ 536 (611)
Q Consensus 457 T~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~ 536 (611)
++.|+|||++.+..++.++|+|||||++|+|++|+.||......+.+..++.+.. .+....++.++.++|.+||..+|.
T Consensus 164 ~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~ 242 (256)
T cd08218 164 TPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSY-PPVSSHYSYDLRNLVSQLFKRNPR 242 (256)
T ss_pred CccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCC-CCCcccCCHHHHHHHHHHhhCChh
Confidence 8899999999998899999999999999999999999988777666666654432 223345889999999999999999
Q ss_pred ccCCchhcHHHHHcCCCC
Q 007260 537 HRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 537 ~Rpt~~~~a~elL~Hp~f 554 (611)
+||+ +.++++||||
T Consensus 243 ~Rp~----~~~vl~~~~~ 256 (256)
T cd08218 243 DRPS----VNSILEKNFI 256 (256)
T ss_pred hCcC----HHHHhhCcCC
Confidence 9999 9999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=354.31 Aligned_cols=254 Identities=25% Similarity=0.408 Sum_probs=210.6
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
..+|++++.||+|+||.||+|++..+++.||+|++..... .....+++|+.+++.++||||+++++++..+..+|+|
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc---chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 4589999999999999999999999999999999865432 2233567899999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
|||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++..+...
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~--- 159 (267)
T cd06646 85 MEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT--- 159 (267)
T ss_pred EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccc---
Confidence 9999999999988764 46899999999999999999999999999999999999999999999999998433200
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
.......
T Consensus 160 -------------------------------------------------------------------------~~~~~~~ 166 (267)
T cd06646 160 -------------------------------------------------------------------------IAKRKSF 166 (267)
T ss_pred -------------------------------------------------------------------------ccccCcc
Confidence 0001123
Q ss_pred ccCCCccchhhhcc---CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCC---CCCCCCHHHHHHHH
Q 007260 455 VGTHEYLAPEIIKG---EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFP---ESPVVSFAARDLIR 528 (611)
Q Consensus 455 vGT~~Y~APEil~~---~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p---~~~~~s~~l~dLI~ 528 (611)
.|++.|+|||++.+ ..++.++|||||||++|||++|+.||...........+....+..+ ....++..+.+||+
T Consensus 167 ~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 246 (267)
T cd06646 167 IGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVK 246 (267)
T ss_pred ccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHH
Confidence 58899999999853 4467899999999999999999999976554444433333332222 22347889999999
Q ss_pred HhhhcCccccCCchhcHHHHHcCCC
Q 007260 529 GLLVKEPQHRLAYKRGATEIKQHPF 553 (611)
Q Consensus 529 ~~L~~dP~~Rpt~~~~a~elL~Hp~ 553 (611)
+||..||++||+ +++|++|+|
T Consensus 247 ~~l~~~P~~Rp~----~~~il~~l~ 267 (267)
T cd06646 247 ISLTKNPKKRPT----AERLLTHLF 267 (267)
T ss_pred HHhhCChhhCcC----HHHHhcCCC
Confidence 999999999999 999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=359.02 Aligned_cols=242 Identities=15% Similarity=0.185 Sum_probs=205.3
Q ss_pred eEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec----cceeeEEeee
Q 007260 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET----EKFSCLVMEF 297 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~----~~~~~LVmE~ 297 (611)
..||+|++|.||+|.. +++.||||++.+...........+.+|+.+|++++|||||++++++.+ ...++|||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5789999999999988 577899999987654444445677899999999999999999999876 3578999999
Q ss_pred CCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccc
Q 007260 298 CPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHM-LGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIK 376 (611)
Q Consensus 298 ~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~-~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~ 376 (611)
|+||+|.+++... +.+++.....++.|++.||.|||. .+++||||||+|||++.++.+||+|||++..+...
T Consensus 104 ~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~----- 176 (283)
T PHA02988 104 CTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP----- 176 (283)
T ss_pred CCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc-----
Confidence 9999999998775 468999999999999999999998 59999999999999999999999999998432100
Q ss_pred cccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccccc
Q 007260 377 ASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVG 456 (611)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vG 456 (611)
....+|
T Consensus 177 --------------------------------------------------------------------------~~~~~~ 182 (283)
T PHA02988 177 --------------------------------------------------------------------------PFKNVN 182 (283)
T ss_pred --------------------------------------------------------------------------cccccC
Confidence 012358
Q ss_pred CCCccchhhhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcC
Q 007260 457 THEYLAPEIIKG--EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKE 534 (611)
Q Consensus 457 T~~Y~APEil~~--~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~d 534 (611)
|..|+|||++.+ ..++.++|||||||++|||++|+.||.+....+.+..++....+++....++.++++||.+||+.|
T Consensus 183 ~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~d 262 (283)
T PHA02988 183 FMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHD 262 (283)
T ss_pred cccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCC
Confidence 899999999987 678999999999999999999999999887776666665555555544468999999999999999
Q ss_pred ccccCCchhcHHHHHc
Q 007260 535 PQHRLAYKRGATEIKQ 550 (611)
Q Consensus 535 P~~Rpt~~~~a~elL~ 550 (611)
|.+||+ +.++++
T Consensus 263 p~~Rps----~~ell~ 274 (283)
T PHA02988 263 SIKRPN----IKEILY 274 (283)
T ss_pred cccCcC----HHHHHH
Confidence 999999 666664
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=359.27 Aligned_cols=255 Identities=24% Similarity=0.401 Sum_probs=216.2
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
.+|++++.||.|+||.||+|.+..++..||+|.+....... ...+.+|+.+++.++|+||+++++.|..+...|+||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~---~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch---HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 58999999999999999999999999999999987654332 345678999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
||++|++|.+++... .+++..+..++.|++.||+|||.+||+||||||+|||++.++.++|+|||++......
T Consensus 97 e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~---- 169 (296)
T cd06654 97 EYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---- 169 (296)
T ss_pred cccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccc----
Confidence 999999999988653 4899999999999999999999999999999999999999999999999987322100
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
........
T Consensus 170 ------------------------------------------------------------------------~~~~~~~~ 177 (296)
T cd06654 170 ------------------------------------------------------------------------QSKRSTMV 177 (296)
T ss_pred ------------------------------------------------------------------------ccccCccc
Confidence 00011235
Q ss_pred cCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCC-CCCCCCCCCCHHHHHHHHHhhhcC
Q 007260 456 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQP-LRFPESPVVSFAARDLIRGLLVKE 534 (611)
Q Consensus 456 GT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~-l~~p~~~~~s~~l~dLI~~~L~~d 534 (611)
|++.|+|||++.+..++.++|||||||++|+|++|+.||........+..+.... ...+....++..+.+||.+||..|
T Consensus 178 ~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 257 (296)
T cd06654 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMD 257 (296)
T ss_pred CCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCcCC
Confidence 8899999999999889999999999999999999999998876655544443322 122233458899999999999999
Q ss_pred ccccCCchhcHHHHHcCCCCCC
Q 007260 535 PQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 535 P~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
|++||+ +.++++||||..
T Consensus 258 p~~Rpt----~~eil~~~~~~~ 275 (296)
T cd06654 258 VEKRGS----AKELLQHQFLKI 275 (296)
T ss_pred cccCcC----HHHHhhChhhhc
Confidence 999999 999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=350.46 Aligned_cols=261 Identities=25% Similarity=0.400 Sum_probs=213.5
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhh---hhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeE
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASL---AGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCL 293 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~---~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~L 293 (611)
+|+..+.||.|+||.||++.+..++..||+|++..... ........+.+|+.+|+.++|+||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 47888999999999999999999999999999975432 122345678899999999999999999999999999999
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCC-cEEEEeccccccccCCc
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDG-HIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g-~vkL~DFGlA~~~~~~~ 372 (611)
||||++|++|.+++.+. +.+++..+..++.||+.||.|||++||+||||||+||+++.++ .++|+|||++.......
T Consensus 81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 99999999999998765 4689999999999999999999999999999999999998776 59999999974432100
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
. .......
T Consensus 159 ~------------------------------------------------------------------------~~~~~~~ 166 (268)
T cd06630 159 T------------------------------------------------------------------------GAGEFQG 166 (268)
T ss_pred c------------------------------------------------------------------------cCCcccc
Confidence 0 0000011
Q ss_pred ccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHcCCCCCCCCCCCCHHHHHHHHH
Q 007260 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNR---ATLFNVVGQPLRFPESPVVSFAARDLIRG 529 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~---~~l~~i~~~~l~~p~~~~~s~~l~dLI~~ 529 (611)
..+||..|+|||++.+..++.++|||||||++|+|++|+.||...... ..+..+............++.++.++|.+
T Consensus 167 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 246 (268)
T cd06630 167 QLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLR 246 (268)
T ss_pred ccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHHHHHHHH
Confidence 346899999999999988999999999999999999999999754432 22222222222222233478999999999
Q ss_pred hhhcCccccCCchhcHHHHHcCCCCC
Q 007260 530 LLVKEPQHRLAYKRGATEIKQHPFFE 555 (611)
Q Consensus 530 ~L~~dP~~Rpt~~~~a~elL~Hp~f~ 555 (611)
||..+|.+||+ +.++++||||+
T Consensus 247 ~l~~~p~~R~~----~~~ll~~~~~~ 268 (268)
T cd06630 247 CLELQPEDRPP----SRELLKHPVFR 268 (268)
T ss_pred HcCCCcccCcC----HHHHhcCcccC
Confidence 99999999999 99999999994
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=352.03 Aligned_cols=279 Identities=37% Similarity=0.616 Sum_probs=225.9
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC-CCCcccccceeeccceeeEE
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD-HPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~-HpnIv~l~~~~~~~~~~~LV 294 (611)
++|.+.+.||.|+||.||+|.+..++..||+|++.+...........+.+|+++++.++ |+||++++++|..++..|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 37999999999999999999999999999999998765544444566788999999998 99999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
|||+.+++|.+++.+. ..+++..++.++.||+.||.|||++|++|+||||+||+++.+|+++|+|||++.........
T Consensus 81 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 81 LEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred EcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 9999999999998876 46999999999999999999999999999999999999999999999999998543211000
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
... . .+.. ...............+
T Consensus 159 ~~~----------~----------------------~~~~------------------------~~~~~~~~~~~~~~~~ 182 (280)
T cd05581 159 ESN----------K----------------------GDAT------------------------NIDSQIEKNRRRFASF 182 (280)
T ss_pred ccC----------C----------------------CCCc------------------------cccccccccccccccc
Confidence 000 0 0000 0000000111223456
Q ss_pred ccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcC
Q 007260 455 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKE 534 (611)
Q Consensus 455 vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~d 534 (611)
+|+..|+|||++.+..++.++|||+|||++|+|++|+.||........+..+......++. .++..+.+||.+||..|
T Consensus 183 ~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~ 260 (280)
T cd05581 183 VGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSFPP--NFPPDAKDLIEKLLVLD 260 (280)
T ss_pred cCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCCCCCC--ccCHHHHHHHHHHhcCC
Confidence 7999999999999888999999999999999999999999988766666666654444444 47999999999999999
Q ss_pred ccccCCchhcHHHHHcCCCC
Q 007260 535 PQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 535 P~~Rpt~~~~a~elL~Hp~f 554 (611)
|.+||+......++|+||||
T Consensus 261 p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 261 PQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HhhCCCcccCHHHHhcCCCC
Confidence 99999922222999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=381.77 Aligned_cols=251 Identities=30% Similarity=0.483 Sum_probs=215.1
Q ss_pred EecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEeeeCCCCC
Q 007260 223 RLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGD 302 (611)
Q Consensus 223 ~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE~~~gg~ 302 (611)
+||.|.||+||.|++..|...+|||-+.... .....-+..||.+.++|+|.|||++++.+-.++++-|.||-++||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 6999999999999999999999999986543 2334456789999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCCC--CHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEcc-CCcEEEEeccccccccCCcccccccc
Q 007260 303 LHTLRQKQPGKYF--PEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRE-DGHIMLSDFDLSLRCAVSPTLIKASS 379 (611)
Q Consensus 303 L~~ll~~~~~~~l--~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~-~g~vkL~DFGlA~~~~~~~~~~~~~~ 379 (611)
|.++++... +++ +|..+-+|-+||++||.|||++.|||||||-+||||+- .|.+||+|||.++|++.-.
T Consensus 659 LSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin------- 730 (1226)
T KOG4279|consen 659 LSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN------- 730 (1226)
T ss_pred HHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCC-------
Confidence 999998765 456 89999999999999999999999999999999999984 8999999999998765211
Q ss_pred CCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCC
Q 007260 380 LDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHE 459 (611)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~ 459 (611)
| -+-+|.||+.
T Consensus 731 ----------------------------------------------------------P-----------~TETFTGTLQ 741 (1226)
T KOG4279|consen 731 ----------------------------------------------------------P-----------CTETFTGTLQ 741 (1226)
T ss_pred ----------------------------------------------------------c-----------cccccccchh
Confidence 0 1125779999
Q ss_pred ccchhhhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCcc
Q 007260 460 YLAPEIIKGE--GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRA-TLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQ 536 (611)
Q Consensus 460 Y~APEil~~~--~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~-~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~ 536 (611)
|||||+|..+ +||.++|||||||++.||.||++||...+... .++++---....|.+..++.+++.||.+|+..||.
T Consensus 742 YMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~ 821 (1226)
T KOG4279|consen 742 YMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPC 821 (1226)
T ss_pred hhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcc
Confidence 9999999765 58999999999999999999999998766543 44544333333444455999999999999999999
Q ss_pred ccCCchhcHHHHHcCCCCCCC
Q 007260 537 HRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 537 ~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
+||+ |.++|+.||++.-
T Consensus 822 ~R~s----A~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 822 DRPS----AKDLLQDPFLQHN 838 (1226)
T ss_pred cCcc----HHHhccCcccccC
Confidence 9999 9999999999854
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=378.22 Aligned_cols=256 Identities=31% Similarity=0.518 Sum_probs=221.0
Q ss_pred eEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEeeeCCCC
Q 007260 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGG 301 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE~~~gg 301 (611)
+.||+|-||+||-|+++.+|+.||||+|+|.++...+. ..+++|+.||+.++||.||.|...|++.+.+|+|||-+ .|
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqe-sqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQE-SQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchH-HHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 68999999999999999999999999999988765444 56789999999999999999999999999999999999 66
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCC---cEEEEeccccccccCCccccccc
Q 007260 302 DLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDG---HIMLSDFDLSLRCAVSPTLIKAS 378 (611)
Q Consensus 302 ~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g---~vkL~DFGlA~~~~~~~~~~~~~ 378 (611)
|+.+++..+..++|++...++++.|||.||.|||.+||||.||||||||+.... ++||||||+|+.+..
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE-------- 719 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE-------- 719 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecch--------
Confidence 877777776678899999999999999999999999999999999999998643 799999999954320
Q ss_pred cCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCC
Q 007260 379 SLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTH 458 (611)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~ 458 (611)
.....+.||||
T Consensus 720 ---------------------------------------------------------------------ksFRrsVVGTP 730 (888)
T KOG4236|consen 720 ---------------------------------------------------------------------KSFRRSVVGTP 730 (888)
T ss_pred ---------------------------------------------------------------------hhhhhhhcCCc
Confidence 11123679999
Q ss_pred CccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCC--CCCCCHHHHHHHHHhhhcCcc
Q 007260 459 EYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPE--SPVVSFAARDLIRGLLVKEPQ 536 (611)
Q Consensus 459 ~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~--~~~~s~~l~dLI~~~L~~dP~ 536 (611)
.|+|||++...+|+..-|+||+|||+|--|.|..||....+... .|-+..+-+|. |..++.++.|||..+|+..-.
T Consensus 731 AYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd--QIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~ 808 (888)
T KOG4236|consen 731 AYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND--QIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMR 808 (888)
T ss_pred cccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhH--HhhccccccCCCchhhcCHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999999986544332 33344444554 455999999999999999999
Q ss_pred ccCCchhcHHHHHcCCCCCCCc-hhhh
Q 007260 537 HRLAYKRGATEIKQHPFFEGVN-WALI 562 (611)
Q Consensus 537 ~Rpt~~~~a~elL~Hp~f~~~~-~~~~ 562 (611)
+|.+ +++.|.|||+++.. |..+
T Consensus 809 kRys----vdk~lsh~Wlq~yq~w~DL 831 (888)
T KOG4236|consen 809 KRYS----VDKSLSHPWLQDYQTWLDL 831 (888)
T ss_pred Hhcc----hHhhccchhhhcchHHHHH
Confidence 9999 99999999999764 5443
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=355.90 Aligned_cols=256 Identities=30% Similarity=0.470 Sum_probs=211.5
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVME 296 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE 296 (611)
+|++++.||.|+||.||+|++..++..||||.+...... ......+.+|++++++++||||+++++++.+++..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccc-cccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 489999999999999999999999999999998654322 2233456789999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccc
Q 007260 297 FCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIK 376 (611)
Q Consensus 297 ~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~ 376 (611)
|+. ++|..++....+..+++..++.++.||+.||+|||.+||+||||+|+||+++.++.+||+|||++.......
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~---- 154 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---- 154 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc----
Confidence 995 689988877666779999999999999999999999999999999999999999999999999873321000
Q ss_pred cccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccccc
Q 007260 377 ASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVG 456 (611)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vG 456 (611)
.......+
T Consensus 155 ------------------------------------------------------------------------~~~~~~~~ 162 (284)
T cd07860 155 ------------------------------------------------------------------------RTYTHEVV 162 (284)
T ss_pred ------------------------------------------------------------------------cccccccc
Confidence 00012247
Q ss_pred CCCccchhhhccCC-CCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcC---CC---------------CCCC--
Q 007260 457 THEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ---PL---------------RFPE-- 515 (611)
Q Consensus 457 T~~Y~APEil~~~~-~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~---~l---------------~~p~-- 515 (611)
++.|+|||++.+.. ++.++|||||||++|||++|+.||.+......+.++... +. .++.
T Consensus 163 ~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd07860 163 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWA 242 (284)
T ss_pred cccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhccccc
Confidence 88999999987755 588999999999999999999999887766555444321 10 0111
Q ss_pred -------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCC
Q 007260 516 -------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 516 -------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f 554 (611)
...++.++++||.+||..||.+||+ +.++++||||
T Consensus 243 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~~l~~~~f 284 (284)
T cd07860 243 RQDFSKVVPPLDEDGRDLLSQMLHYDPNKRIS----AKAALAHPFF 284 (284)
T ss_pred ccCHHHHcccCCHHHHHHHHHhcCCCcccCCC----HHHHhcCCCC
Confidence 1247889999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=357.69 Aligned_cols=256 Identities=25% Similarity=0.421 Sum_probs=218.0
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
.+|++++.||.|+||.||+|.+..+++.||||.+...... ....+.+|+.+++.++||||+++++++..++.+|+||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP---KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc---hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 4799999999999999999999999999999998654322 2345678999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
||+++++|..++... .+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++......
T Consensus 96 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~---- 168 (296)
T cd06655 96 EYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE---- 168 (296)
T ss_pred EecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc----
Confidence 999999999988653 5899999999999999999999999999999999999999999999999987322100
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
........
T Consensus 169 ------------------------------------------------------------------------~~~~~~~~ 176 (296)
T cd06655 169 ------------------------------------------------------------------------QSKRSTMV 176 (296)
T ss_pred ------------------------------------------------------------------------cccCCCcC
Confidence 00011235
Q ss_pred cCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCC-CCCCCCCCCCHHHHHHHHHhhhcC
Q 007260 456 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQP-LRFPESPVVSFAARDLIRGLLVKE 534 (611)
Q Consensus 456 GT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~-l~~p~~~~~s~~l~dLI~~~L~~d 534 (611)
|++.|+|||.+.+..++.++|||||||++|+|++|+.||.+......+..+.... ..+.....++..+++||.+||..|
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 256 (296)
T cd06655 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMD 256 (296)
T ss_pred CCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhhcC
Confidence 8899999999999889999999999999999999999999877766655544332 222334458899999999999999
Q ss_pred ccccCCchhcHHHHHcCCCCCCC
Q 007260 535 PQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 535 P~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
|++||+ +.++++||||...
T Consensus 257 p~~Rpt----~~~il~~~~~~~~ 275 (296)
T cd06655 257 VEKRGS----AKELLQHPFLKLA 275 (296)
T ss_pred hhhCCC----HHHHhhChHhhhc
Confidence 999999 9999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=359.40 Aligned_cols=256 Identities=24% Similarity=0.407 Sum_probs=215.2
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
.+|++++.||.|+||.||+|.+..+++.||||.+....... ...+.+|+.+++.++|+||++++++|..++..|+||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 68999999999999999999999999999999987544322 245678999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
||++|++|.+++.+. .+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 96 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~--- 169 (297)
T cd06656 96 EYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--- 169 (297)
T ss_pred cccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc---
Confidence 999999999988763 48999999999999999999999999999999999999999999999999873221000
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
.......
T Consensus 170 -------------------------------------------------------------------------~~~~~~~ 176 (297)
T cd06656 170 -------------------------------------------------------------------------SKRSTMV 176 (297)
T ss_pred -------------------------------------------------------------------------cCcCccc
Confidence 0001235
Q ss_pred cCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcC-CCCCCCCCCCCHHHHHHHHHhhhcC
Q 007260 456 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ-PLRFPESPVVSFAARDLIRGLLVKE 534 (611)
Q Consensus 456 GT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~-~l~~p~~~~~s~~l~dLI~~~L~~d 534 (611)
|++.|+|||.+.+..++.++|||||||++|+|++|+.||.+......+..+... .........++..+++||.+||..|
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 256 (297)
T cd06656 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMD 256 (297)
T ss_pred CCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHccCC
Confidence 889999999999998999999999999999999999999876554443333222 2222233457889999999999999
Q ss_pred ccccCCchhcHHHHHcCCCCCCC
Q 007260 535 PQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 535 P~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
|++||+ +.++++||||+..
T Consensus 257 p~~Rps----~~~il~~~~~~~~ 275 (297)
T cd06656 257 VDRRGS----AKELLQHPFLKLA 275 (297)
T ss_pred hhhCcC----HHHHhcCchhccc
Confidence 999999 9999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=350.24 Aligned_cols=256 Identities=30% Similarity=0.474 Sum_probs=212.9
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeecc-----
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETE----- 288 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~----- 288 (611)
.++|++.+.||.|+||.||+|.+..+++.|++|++..... ....+.+|+.+++++ +|+||++++++|...
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 3689999999999999999999998999999999876542 224577899999999 799999999999654
Q ss_pred -ceeeEEeeeCCCCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccc
Q 007260 289 -KFSCLVMEFCPGGDLHTLRQKQP--GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365 (611)
Q Consensus 289 -~~~~LVmE~~~gg~L~~ll~~~~--~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA 365 (611)
..+|+||||+++++|.+++.... +..+++..++.++.|++.||.|||++||+||||+|+||+++.++.++|+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 45899999999999999887543 467999999999999999999999999999999999999999999999999987
Q ss_pred ccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccC
Q 007260 366 LRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAE 445 (611)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (611)
......
T Consensus 161 ~~~~~~-------------------------------------------------------------------------- 166 (275)
T cd06608 161 AQLDST-------------------------------------------------------------------------- 166 (275)
T ss_pred eecccc--------------------------------------------------------------------------
Confidence 432100
Q ss_pred cccccccccccCCCccchhhhccC-----CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCC-CCCCCCCC
Q 007260 446 PTEARSMSFVGTHEYLAPEIIKGE-----GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPL-RFPESPVV 519 (611)
Q Consensus 446 ~~~~~~~~~vGT~~Y~APEil~~~-----~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l-~~p~~~~~ 519 (611)
........|++.|+|||++.+. .++.++|||||||+||+|++|+.||........+..+..... .......+
T Consensus 167 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (275)
T cd06608 167 --LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSPENW 244 (275)
T ss_pred --hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCchhhc
Confidence 0001123589999999998653 357789999999999999999999987766666666555432 22222337
Q ss_pred CHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCC
Q 007260 520 SFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 520 s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f 554 (611)
+.++++||.+||..||++||+ +.++++|||+
T Consensus 245 ~~~~~~li~~~l~~dp~~Rpt----~~~ll~~~~~ 275 (275)
T cd06608 245 SKKFNDFISECLIKNYEQRPF----MEELLEHPFI 275 (275)
T ss_pred CHHHHHHHHHHhhcChhhCcC----HHHHhcCCCC
Confidence 889999999999999999999 9999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=377.30 Aligned_cols=251 Identities=25% Similarity=0.420 Sum_probs=215.1
Q ss_pred ccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccce
Q 007260 211 GVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKF 290 (611)
Q Consensus 211 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~ 290 (611)
+.+..+.+++++.||+|-||.||+|.+.++. .||+|.+....+... .+.+|++||++|+|+|||+|++++..++.
T Consensus 201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~-~vavk~ik~~~m~~~----~f~~Ea~iMk~L~H~~lV~l~gV~~~~~p 275 (468)
T KOG0197|consen 201 WEIPREELKLIRELGSGQFGEVWLGKWNGST-KVAVKTIKEGSMSPE----AFLREAQIMKKLRHEKLVKLYGVCTKQEP 275 (468)
T ss_pred eeecHHHHHHHHHhcCCccceEEEEEEcCCC-cccceEEeccccChh----HHHHHHHHHHhCcccCeEEEEEEEecCCc
Confidence 3444567788899999999999999998763 499999977654443 34579999999999999999999999889
Q ss_pred eeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccC
Q 007260 291 SCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAV 370 (611)
Q Consensus 291 ~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~ 370 (611)
+||||||++.|+|.++++...+..+.......++.||+.|++||+++++|||||...||||+++..+||+|||||+....
T Consensus 276 iyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 276 IYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGD 355 (468)
T ss_pred eEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCC
Confidence 99999999999999999987678899999999999999999999999999999999999999999999999999963221
Q ss_pred CccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccc
Q 007260 371 SPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEAR 450 (611)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (611)
+ .|.....-
T Consensus 356 ~------------------~Y~~~~~~----------------------------------------------------- 364 (468)
T KOG0197|consen 356 D------------------EYTASEGG----------------------------------------------------- 364 (468)
T ss_pred C------------------ceeecCCC-----------------------------------------------------
Confidence 1 01110000
Q ss_pred ccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHH
Q 007260 451 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRG 529 (611)
Q Consensus 451 ~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~ 529 (611)
--..-|.|||.+....++.++|||||||+||||+| |+.||.+.++.+.+.. +.+..++|.+..+|+++.+|+..
T Consensus 365 ----kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~-le~GyRlp~P~~CP~~vY~lM~~ 439 (468)
T KOG0197|consen 365 ----KFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLEL-LERGYRLPRPEGCPDEVYELMKS 439 (468)
T ss_pred ----CCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHH-HhccCcCCCCCCCCHHHHHHHHH
Confidence 01235999999999999999999999999999997 9999999999887755 55667888888899999999999
Q ss_pred hhhcCccccCCch
Q 007260 530 LLVKEPQHRLAYK 542 (611)
Q Consensus 530 ~L~~dP~~Rpt~~ 542 (611)
||..+|++||||.
T Consensus 440 CW~~~P~~RPtF~ 452 (468)
T KOG0197|consen 440 CWHEDPEDRPTFE 452 (468)
T ss_pred HhhCCcccCCCHH
Confidence 9999999999965
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=352.92 Aligned_cols=257 Identities=33% Similarity=0.512 Sum_probs=212.9
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVME 296 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE 296 (611)
+|++++.||.|+||.||+|.+..++..||+|++...... ......+.+|+.+++.++||||+++++++..+...|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 589999999999999999999999999999999765432 2334567789999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccc
Q 007260 297 FCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIK 376 (611)
Q Consensus 297 ~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~ 376 (611)
|+ |++|.+++.... ..+++..++.++.||+.||+|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 80 ~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~---- 153 (286)
T cd07832 80 YM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE---- 153 (286)
T ss_pred cc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC----
Confidence 99 999999887653 569999999999999999999999999999999999999999999999999874321000
Q ss_pred cccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccccc
Q 007260 377 ASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVG 456 (611)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vG 456 (611)
.......+|
T Consensus 154 -----------------------------------------------------------------------~~~~~~~~~ 162 (286)
T cd07832 154 -----------------------------------------------------------------------PRLYSHQVA 162 (286)
T ss_pred -----------------------------------------------------------------------CCccccccC
Confidence 000112358
Q ss_pred CCCccchhhhccCC-CCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcC---C----------------CCCCC-
Q 007260 457 THEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ---P----------------LRFPE- 515 (611)
Q Consensus 457 T~~Y~APEil~~~~-~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~---~----------------l~~p~- 515 (611)
+..|+|||++.+.. ++.++|||||||++|||++|.+||.+..+...+..+... + ..++.
T Consensus 163 ~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (286)
T cd07832 163 TRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPES 242 (286)
T ss_pred cccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCC
Confidence 99999999987654 589999999999999999999999887766555443321 1 01111
Q ss_pred --------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCC
Q 007260 516 --------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFE 555 (611)
Q Consensus 516 --------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 555 (611)
....+.++.+||.+||..||.+||+ ++++++||||.
T Consensus 243 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~----~~~~l~h~~~~ 286 (286)
T cd07832 243 KPIPLEEIFPDASPEALDLLKGLLVYDPSKRLS----AAEALRHPYFT 286 (286)
T ss_pred CcchHHHhCCCccHHHHHHHHHHhccChhhCCC----HHHHhhCcCcC
Confidence 1246789999999999999999999 99999999994
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=346.21 Aligned_cols=253 Identities=30% Similarity=0.485 Sum_probs=215.3
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
++|++.+.||.|+||.||+|.+..++..||+|.+..... ...+.+|+++++.++|+||+++++++..+...|+||
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 479999999999999999999999889999999865432 456788999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
||+++++|.+++... +..+++..++.++.||+.||.|||.+||+||||+|+||+++.++.++|+|||++......
T Consensus 78 e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~---- 152 (256)
T cd06612 78 EYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT---- 152 (256)
T ss_pred ecCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccC----
Confidence 999999999998764 356899999999999999999999999999999999999999999999999997432100
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
........
T Consensus 153 ------------------------------------------------------------------------~~~~~~~~ 160 (256)
T cd06612 153 ------------------------------------------------------------------------MAKRNTVI 160 (256)
T ss_pred ------------------------------------------------------------------------cccccccc
Confidence 00011234
Q ss_pred cCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCC-CCCCCCCCCHHHHHHHHHhhhcC
Q 007260 456 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPL-RFPESPVVSFAARDLIRGLLVKE 534 (611)
Q Consensus 456 GT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l-~~p~~~~~s~~l~dLI~~~L~~d 534 (611)
|+..|+|||++.+..++.++|||||||++|+|++|+.||...........+..... .+.....++..+.+||.+||..|
T Consensus 161 ~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 240 (256)
T cd06612 161 GTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKD 240 (256)
T ss_pred CCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHHhcC
Confidence 88899999999999999999999999999999999999987766555444433221 22233357889999999999999
Q ss_pred ccccCCchhcHHHHHcCCCC
Q 007260 535 PQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 535 P~~Rpt~~~~a~elL~Hp~f 554 (611)
|.+||+ +.++|+||||
T Consensus 241 P~~Rps----~~~il~~~~~ 256 (256)
T cd06612 241 PEERPS----AIQLLQHPFI 256 (256)
T ss_pred hhhCcC----HHHHhcCCCC
Confidence 999999 9999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=349.68 Aligned_cols=258 Identities=30% Similarity=0.480 Sum_probs=213.8
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhh-------hHHHHHHHHHHHHHHHhCCCCCcccccceeeccc
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLA-------GRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK 289 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~-------~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~ 289 (611)
+|.+.+.||.|+||.||+|.+..+++.||||.+...... .......+..|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 588999999999999999999989999999988642211 1223445678999999999999999999999999
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
.+++||||++|++|.+++.+. ..+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 999999999999999998776 568999999999999999999999999999999999999999999999999873221
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
... ...
T Consensus 160 ~~~--------------------------------------------------------------------------~~~ 165 (272)
T cd06629 160 DIY--------------------------------------------------------------------------DND 165 (272)
T ss_pred ccc--------------------------------------------------------------------------ccc
Confidence 000 000
Q ss_pred cccccccCCCccchhhhccCC--CCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCC--CCC--CCCCCHHH
Q 007260 450 RSMSFVGTHEYLAPEIIKGEG--HGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLR--FPE--SPVVSFAA 523 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~~~--~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~--~p~--~~~~s~~l 523 (611)
......|+..|+|||++.... ++.++|+|||||++|+|++|..||........+.++...... ++. ...++..+
T Consensus 166 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (272)
T cd06629 166 QNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVA 245 (272)
T ss_pred ccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccCCHHH
Confidence 012245889999999998765 789999999999999999999999876666556555443322 222 23468999
Q ss_pred HHHHHHhhhcCccccCCchhcHHHHHcCCCC
Q 007260 524 RDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 524 ~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f 554 (611)
++||.+||..+|++||+ ++++++||||
T Consensus 246 ~~li~~~l~~~p~~Rps----~~~il~~~~~ 272 (272)
T cd06629 246 LDFLNACFTINPDNRPT----ARELLQHPFI 272 (272)
T ss_pred HHHHHHHhcCChhhCCC----HHHHhhCCCC
Confidence 99999999999999999 9999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=366.22 Aligned_cols=254 Identities=28% Similarity=0.459 Sum_probs=207.0
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecc------
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE------ 288 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~------ 288 (611)
..+|++++.||.|+||.||+|.+..+++.||||++.+.. .......++.+|+.+++.++||||++++++|...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc-cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 468999999999999999999999999999999986532 2223344567899999999999999999988643
Q ss_pred ceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccc
Q 007260 289 KFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRC 368 (611)
Q Consensus 289 ~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~ 368 (611)
...||||||+. ++|.+.+... +++..+..++.||+.||+|||.+||+||||||+|||++.++.+||+|||++...
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 35799999994 5888877653 899999999999999999999999999999999999999999999999998432
Q ss_pred cCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccc
Q 007260 369 AVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTE 448 (611)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (611)
...
T Consensus 169 ~~~----------------------------------------------------------------------------- 171 (353)
T cd07850 169 GTS----------------------------------------------------------------------------- 171 (353)
T ss_pred CCC-----------------------------------------------------------------------------
Confidence 100
Q ss_pred ccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHc---CC---------------
Q 007260 449 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG---QP--------------- 510 (611)
Q Consensus 449 ~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~---~~--------------- 510 (611)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+....+.+++. .+
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (353)
T cd07850 172 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNY 251 (353)
T ss_pred CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHH
Confidence 001123588999999999999999999999999999999999999987765444333321 10
Q ss_pred ----CC--------------CCC-----CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCC
Q 007260 511 ----LR--------------FPE-----SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFE 555 (611)
Q Consensus 511 ----l~--------------~p~-----~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 555 (611)
.. ++. ....+..+++||.+||..||.+||+ +.|+|+||||+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~eiL~~~~~~ 315 (353)
T cd07850 252 VENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRIS----VDDALQHPYIN 315 (353)
T ss_pred hhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcC----HHHHhcChhHh
Confidence 00 000 1124667899999999999999999 99999999997
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=349.56 Aligned_cols=254 Identities=20% Similarity=0.256 Sum_probs=209.5
Q ss_pred cccCeEEEeEecccCcEEEEEEEEC---CCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccce
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELS---GTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKF 290 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~---~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~ 290 (611)
...+|++.+.||+|+||.||+|.+. ..+..||+|.++.... ......+.+|+.+|+.++||||+++++++..++.
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS--DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 3468999999999999999999875 4567899999876432 2334567889999999999999999999999999
Q ss_pred eeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccC
Q 007260 291 SCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAV 370 (611)
Q Consensus 291 ~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~ 370 (611)
.||||||+++|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999999887653 4689999999999999999999999999999999999999999999999997622110
Q ss_pred CccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccc
Q 007260 371 SPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEAR 450 (611)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (611)
.. ...
T Consensus 160 ~~---------------------------------------------------------------------------~~~ 164 (266)
T cd05064 160 EA---------------------------------------------------------------------------IYT 164 (266)
T ss_pred cc---------------------------------------------------------------------------hhc
Confidence 00 000
Q ss_pred ccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHH
Q 007260 451 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRG 529 (611)
Q Consensus 451 ~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~ 529 (611)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||.+....+.+..+.. ....+....++..+.++|.+
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~ 243 (266)
T cd05064 165 TMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVED-GFRLPAPRNCPNLLHQLMLD 243 (266)
T ss_pred ccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC-CCCCCCCCCCCHHHHHHHHH
Confidence 011235678999999999999999999999999999774 9999998776665555443 34455556689999999999
Q ss_pred hhhcCccccCCchhcHHHHHc
Q 007260 530 LLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 530 ~L~~dP~~Rpt~~~~a~elL~ 550 (611)
||..+|.+||+ +.+|++
T Consensus 244 c~~~~p~~RP~----~~~i~~ 260 (266)
T cd05064 244 CWQKERGERPR----FSQIHS 260 (266)
T ss_pred HcCCCchhCCC----HHHHHH
Confidence 99999999999 667654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=354.09 Aligned_cols=256 Identities=30% Similarity=0.445 Sum_probs=210.6
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
++|++++.||.|+||.||+|.+..+++.||+|++.+..... .....+.+|+++|+.++||||++++++|..++..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 37999999999999999999999999999999986543222 23345678999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
||++++.|..+.... ..+++..++.++.||+.||.|||+.||+||||+|+||++++++.++|+|||++.......
T Consensus 80 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--- 154 (286)
T cd07846 80 EFVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--- 154 (286)
T ss_pred ecCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc---
Confidence 999999998876553 348999999999999999999999999999999999999999999999999974321000
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
......+
T Consensus 155 -------------------------------------------------------------------------~~~~~~~ 161 (286)
T cd07846 155 -------------------------------------------------------------------------EVYTDYV 161 (286)
T ss_pred -------------------------------------------------------------------------cccCccc
Confidence 0011245
Q ss_pred cCCCccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcC-------------------CCCCCC
Q 007260 456 GTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ-------------------PLRFPE 515 (611)
Q Consensus 456 GT~~Y~APEil~~~-~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~-------------------~l~~p~ 515 (611)
|+..|+|||++.+. .++.++|||||||++|||++|++||.+....+.+..+... ....+.
T Consensus 162 ~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (286)
T cd07846 162 ATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPE 241 (286)
T ss_pred ceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcccccc
Confidence 88999999999864 4688999999999999999999999876655444333310 011111
Q ss_pred ----------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCC
Q 007260 516 ----------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 516 ----------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f 554 (611)
.+.++..+.+||.+||..||++||+ +.++++||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~----~~~il~~~~~ 286 (286)
T cd07846 242 VKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS----SSQLLHHEFF 286 (286)
T ss_pred ccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchh----HHHHhcCCCC
Confidence 2347889999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=353.37 Aligned_cols=270 Identities=21% Similarity=0.314 Sum_probs=213.9
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECC-----CCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSG-----TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET 287 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~-----t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~ 287 (611)
+..++|++.+.||.|+||.||+|.+.. .+..||+|.+...... .....+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL--RERIEFLNEASVMKGFTCHHVVRLLGVVSK 80 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCH--HHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 345689999999999999999997653 3558999998654321 223356789999999999999999999999
Q ss_pred cceeeEEeeeCCCCCHHHHHHhCC--------CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEE
Q 007260 288 EKFSCLVMEFCPGGDLHTLRQKQP--------GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIML 359 (611)
Q Consensus 288 ~~~~~LVmE~~~gg~L~~ll~~~~--------~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL 359 (611)
....|+||||+++|+|.+++.... ...++...+..++.||+.||.|||++||+||||||+|||++.++.++|
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEE
Confidence 999999999999999999987532 123467788899999999999999999999999999999999999999
Q ss_pred EeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCC
Q 007260 360 SDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPL 439 (611)
Q Consensus 360 ~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (611)
+|||+++.+.....
T Consensus 161 ~Dfg~~~~~~~~~~------------------------------------------------------------------ 174 (288)
T cd05061 161 GDFGMTRDIYETDY------------------------------------------------------------------ 174 (288)
T ss_pred CcCCcccccccccc------------------------------------------------------------------
Confidence 99999843210000
Q ss_pred cccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCC
Q 007260 440 PELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPV 518 (611)
Q Consensus 440 ~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~ 518 (611)
........++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+.+..+..... .+....
T Consensus 175 --------~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~ 245 (288)
T cd05061 175 --------YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY-LDQPDN 245 (288)
T ss_pred --------ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CCCCCC
Confidence 000011246778999999999899999999999999999998 8999988776665555544322 222234
Q ss_pred CCHHHHHHHHHhhhcCccccCCchhcHHHHHc--CCCCCCCch
Q 007260 519 VSFAARDLIRGLLVKEPQHRLAYKRGATEIKQ--HPFFEGVNW 559 (611)
Q Consensus 519 ~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~--Hp~f~~~~~ 559 (611)
++..+++||.+||..||++||++.+.++.+.. ||||.+++|
T Consensus 246 ~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 246 CPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCCC
Confidence 78999999999999999999994443333333 999999988
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=346.15 Aligned_cols=254 Identities=30% Similarity=0.472 Sum_probs=215.3
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
++|++.+.||.|+||.||+|.+..++..+|+|++...... ....+.+|+++++.++||||+++++++...+.+|+||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD---DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh---hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 5899999999999999999999988999999999754322 3456778999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
||+++++|.+++.... ..+++..+..++.|++.||.|||.+||+||||||+||+++.++.++|+|||++......
T Consensus 80 e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~---- 154 (262)
T cd06613 80 EYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT---- 154 (262)
T ss_pred eCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh----
Confidence 9999999999887642 46999999999999999999999999999999999999999999999999987432100
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
.......+
T Consensus 155 ------------------------------------------------------------------------~~~~~~~~ 162 (262)
T cd06613 155 ------------------------------------------------------------------------IAKRKSFI 162 (262)
T ss_pred ------------------------------------------------------------------------hhcccccc
Confidence 00011246
Q ss_pred cCCCccchhhhccC---CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCC---CCCCCCCHHHHHHHHH
Q 007260 456 GTHEYLAPEIIKGE---GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRF---PESPVVSFAARDLIRG 529 (611)
Q Consensus 456 GT~~Y~APEil~~~---~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~---p~~~~~s~~l~dLI~~ 529 (611)
|+..|+|||++.+. .++.++|||||||++|||++|+.||.+.........+....+.. .....++.++++||.+
T Consensus 163 ~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 242 (262)
T cd06613 163 GTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKK 242 (262)
T ss_pred CCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHH
Confidence 88999999999877 78899999999999999999999998877666555544442222 1223467889999999
Q ss_pred hhhcCccccCCchhcHHHHHcCCC
Q 007260 530 LLVKEPQHRLAYKRGATEIKQHPF 553 (611)
Q Consensus 530 ~L~~dP~~Rpt~~~~a~elL~Hp~ 553 (611)
||..||.+||+ +.+++.|+|
T Consensus 243 ~l~~~p~~Rpt----~~~il~~~~ 262 (262)
T cd06613 243 CLTKDPKKRPT----ATKLLQHPF 262 (262)
T ss_pred HcCCChhhCCC----HHHHhcCCC
Confidence 99999999999 999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=372.76 Aligned_cols=258 Identities=20% Similarity=0.289 Sum_probs=209.5
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCC-----CeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGT-----KCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFE 286 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t-----~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~ 286 (611)
+..++|++++.||+|+||.||+|.+..+ ...||||++...... .....+.+|+.+|+.+ +|+|||+++++|.
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT--DEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH--HHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 3446899999999999999999986443 357999999754322 2345677899999999 8999999999999
Q ss_pred ccceeeEEeeeCCCCCHHHHHHhCC-------------------------------------------------------
Q 007260 287 TEKFSCLVMEFCPGGDLHTLRQKQP------------------------------------------------------- 311 (611)
Q Consensus 287 ~~~~~~LVmE~~~gg~L~~ll~~~~------------------------------------------------------- 311 (611)
..+.+|||||||++|+|.+++....
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 9999999999999999999876431
Q ss_pred -------------CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccc
Q 007260 312 -------------GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKAS 378 (611)
Q Consensus 312 -------------~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~ 378 (611)
...+++..++.|+.||+.||+|||++||+||||||+|||+++++++||+|||++........
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~----- 267 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN----- 267 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc-----
Confidence 13478889999999999999999999999999999999999999999999999843211000
Q ss_pred cCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCC
Q 007260 379 SLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTH 458 (611)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~ 458 (611)
........+++
T Consensus 268 ---------------------------------------------------------------------~~~~~~~~~~~ 278 (374)
T cd05106 268 ---------------------------------------------------------------------YVVKGNARLPV 278 (374)
T ss_pred ---------------------------------------------------------------------eeeccCCCCcc
Confidence 00001123567
Q ss_pred CccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccc
Q 007260 459 EYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQH 537 (611)
Q Consensus 459 ~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~ 537 (611)
.|+|||++.+..++.++|||||||++|||++ |+.||........+..++......+....++.++++||.+||..||.+
T Consensus 279 ~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 358 (374)
T cd05106 279 KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTE 358 (374)
T ss_pred ceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcCCChhh
Confidence 8999999999999999999999999999997 999998876655566666555444444557899999999999999999
Q ss_pred cCCchhcHHHHHc
Q 007260 538 RLAYKRGATEIKQ 550 (611)
Q Consensus 538 Rpt~~~~a~elL~ 550 (611)
||+ +.+|++
T Consensus 359 RPs----~~~l~~ 367 (374)
T cd05106 359 RPT----FSQISQ 367 (374)
T ss_pred CcC----HHHHHH
Confidence 999 666654
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=357.86 Aligned_cols=251 Identities=25% Similarity=0.417 Sum_probs=191.8
Q ss_pred EeEecccCcEEEEEEEECC--CCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceee--ccceeeEEee
Q 007260 221 LKRLGCGDIGSVYLSELSG--TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFE--TEKFSCLVME 296 (611)
Q Consensus 221 ~~~LG~G~fG~Vy~a~~~~--t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~--~~~~~~LVmE 296 (611)
+.+||.|+||.||+|++.. ++..||+|.+...... ..+.+|+.+|+.++||||++++++|. .+..+|+|||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS-----MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc-----HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 4689999999999999754 5678999998764322 24567999999999999999999885 4578899999
Q ss_pred eCCCCCHHHHHHhC-------CCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEE----ccCCcEEEEecccc
Q 007260 297 FCPGGDLHTLRQKQ-------PGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLV----REDGHIMLSDFDLS 365 (611)
Q Consensus 297 ~~~gg~L~~ll~~~-------~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv----~~~g~vkL~DFGlA 365 (611)
|+. ++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 81 YAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 995 5787776432 12358999999999999999999999999999999999999 45679999999998
Q ss_pred ccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccC
Q 007260 366 LRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAE 445 (611)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (611)
........
T Consensus 160 ~~~~~~~~------------------------------------------------------------------------ 167 (317)
T cd07867 160 RLFNSPLK------------------------------------------------------------------------ 167 (317)
T ss_pred eccCCCcc------------------------------------------------------------------------
Confidence 43321000
Q ss_pred cccccccccccCCCccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCcH---------HHH---HHHHcCCC-
Q 007260 446 PTEARSMSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGNR---------ATL---FNVVGQPL- 511 (611)
Q Consensus 446 ~~~~~~~~~vGT~~Y~APEil~~~-~~~~~sDIWSLGviL~ELltG~~PF~~~~~~---------~~l---~~i~~~~l- 511 (611)
........+||+.|+|||++.+. .++.++|||||||++|||++|++||....+. ..+ ..+++.+.
T Consensus 168 -~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (317)
T cd07867 168 -PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPAD 246 (317)
T ss_pred -cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCCh
Confidence 00001234689999999999875 4799999999999999999999999754321 111 11111000
Q ss_pred ----------CC----------------------CCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCC
Q 007260 512 ----------RF----------------------PESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 512 ----------~~----------------------p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f 554 (611)
.+ ......+..+.+||.+||..||.+||| +.|+|+||||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t----~~e~l~hp~f 317 (317)
T cd07867 247 KDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRIT----SEQALQDPYF 317 (317)
T ss_pred hhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccC----HHHHhcCCCC
Confidence 00 001124567889999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=349.87 Aligned_cols=255 Identities=30% Similarity=0.465 Sum_probs=214.4
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVME 296 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE 296 (611)
+|++.+.||.|+||.||+|.+..+++.||+|++...... ....++.+|+++++.++||||+++++++..+...|||||
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh--HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 688889999999999999999999999999998765422 344567789999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 297 FCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHM-LGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 297 ~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~-~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
|+++++|.+++.... ..+++..+..++.||+.||+|||. .||+||||||+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~---- 154 (265)
T cd06605 80 YMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS---- 154 (265)
T ss_pred ecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH----
Confidence 999999999988753 568999999999999999999999 99999999999999999999999999987322100
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
......
T Consensus 155 --------------------------------------------------------------------------~~~~~~ 160 (265)
T cd06605 155 --------------------------------------------------------------------------LAKTFV 160 (265)
T ss_pred --------------------------------------------------------------------------Hhhccc
Confidence 000145
Q ss_pred cCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC-----cHHHHHHHHcCCC-CCCCCCCCCHHHHHHHHH
Q 007260 456 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSG-----NRATLFNVVGQPL-RFPESPVVSFAARDLIRG 529 (611)
Q Consensus 456 GT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~-----~~~~l~~i~~~~l-~~p~~~~~s~~l~dLI~~ 529 (611)
|+..|+|||++.+..++.++|||||||++|+|++|+.||.... ....+..+..... ..+.. .++.++++||.+
T Consensus 161 ~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~ 239 (265)
T cd06605 161 GTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSG-KFSPDFQDFVNL 239 (265)
T ss_pred CChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChh-hcCHHHHHHHHH
Confidence 8889999999999999999999999999999999999997642 2233333333322 22221 278999999999
Q ss_pred hhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 530 LLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 530 ~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
||..||.+||+ +.+++.||||+..
T Consensus 240 ~l~~~p~~Rpt----~~~ll~~~~~~~~ 263 (265)
T cd06605 240 CLIKDPRERPS----YKELLEHPFIKKY 263 (265)
T ss_pred HcCCCchhCcC----HHHHhhCchhhcc
Confidence 99999999999 9999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=351.54 Aligned_cols=257 Identities=29% Similarity=0.429 Sum_probs=211.3
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeecc-----
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETE----- 288 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~----- 288 (611)
.++|.+.+.||.|+||.||+|.+..+++.||+|++..... ....+.+|+.+++++ +||||++++++|...
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD----VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc----HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 4689999999999999999999999999999999865432 123456799999998 899999999998643
Q ss_pred ceeeEEeeeCCCCCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccc
Q 007260 289 KFSCLVMEFCPGGDLHTLRQK--QPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSL 366 (611)
Q Consensus 289 ~~~~LVmE~~~gg~L~~ll~~--~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~ 366 (611)
...|+||||++|++|.+++.. ..+..+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++.
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~ 176 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA 176 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccch
Confidence 468999999999999998763 224568999999999999999999999999999999999999999999999999874
Q ss_pred cccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCc
Q 007260 367 RCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEP 446 (611)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (611)
.....
T Consensus 177 ~~~~~--------------------------------------------------------------------------- 181 (291)
T cd06639 177 QLTST--------------------------------------------------------------------------- 181 (291)
T ss_pred hcccc---------------------------------------------------------------------------
Confidence 32100
Q ss_pred ccccccccccCCCccchhhhccCC-----CCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCC-CCCCCCCCC
Q 007260 447 TEARSMSFVGTHEYLAPEIIKGEG-----HGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPL-RFPESPVVS 520 (611)
Q Consensus 447 ~~~~~~~~vGT~~Y~APEil~~~~-----~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l-~~p~~~~~s 520 (611)
.......+|+..|+|||++.... ++.++|||||||++|||++|+.||........+..+..... .......++
T Consensus 182 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (291)
T cd06639 182 -RLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWC 260 (291)
T ss_pred -cccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCcccccC
Confidence 00011235889999999986543 57899999999999999999999988766666666554422 222233477
Q ss_pred HHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCC
Q 007260 521 FAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFE 555 (611)
Q Consensus 521 ~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 555 (611)
..+.+||.+||..||++||+ +.+|++||||+
T Consensus 261 ~~l~~li~~~l~~~p~~Rps----~~~il~~~~~~ 291 (291)
T cd06639 261 RSFNHFISQCLIKDFEARPS----VTHLLEHPFIK 291 (291)
T ss_pred HHHHHHHHHHhhcChhhCcC----HHHHhcCcccC
Confidence 88999999999999999999 99999999994
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=344.81 Aligned_cols=252 Identities=27% Similarity=0.495 Sum_probs=214.4
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVME 296 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE 296 (611)
+|++.+.||.|+||.||++.+..++..||+|.++.... ......+.+|+.+++.++|+||+++++.|.+++.+|+|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 58999999999999999999999999999999865432 2234566789999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccc
Q 007260 297 FCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIK 376 (611)
Q Consensus 297 ~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~ 376 (611)
|+++++|.+++....+..+++..++.++.||+.||.|||++||+|+||||+|||+++++.++|+|||++......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~----- 153 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP----- 153 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc-----
Confidence 999999999887765667899999999999999999999999999999999999999999999999987432100
Q ss_pred cccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccccc
Q 007260 377 ASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVG 456 (611)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vG 456 (611)
......+.|
T Consensus 154 -----------------------------------------------------------------------~~~~~~~~~ 162 (255)
T cd08219 154 -----------------------------------------------------------------------GAYACTYVG 162 (255)
T ss_pred -----------------------------------------------------------------------ccccccccC
Confidence 000113468
Q ss_pred CCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCcc
Q 007260 457 THEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQ 536 (611)
Q Consensus 457 T~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~ 536 (611)
++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+...... +....++..+++||.+||..||+
T Consensus 163 ~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~ 241 (255)
T cd08219 163 TPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK-PLPSHYSYELRSLIKQMFKRNPR 241 (255)
T ss_pred CccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCC-CCCcccCHHHHHHHHHHHhCCcc
Confidence 99999999999999999999999999999999999999987666655555544332 23345889999999999999999
Q ss_pred ccCCchhcHHHHHcC
Q 007260 537 HRLAYKRGATEIKQH 551 (611)
Q Consensus 537 ~Rpt~~~~a~elL~H 551 (611)
+||+ +.+|+.-
T Consensus 242 ~Rp~----~~~il~~ 252 (255)
T cd08219 242 SRPS----ATTILSR 252 (255)
T ss_pred cCCC----HHHHhhc
Confidence 9999 8888763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=386.77 Aligned_cols=265 Identities=23% Similarity=0.353 Sum_probs=198.3
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCC-eEEEEE--------------EecchhhhhHHHHHHHHHHHHHHHhCCCCCcc
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTK-CYFAMK--------------VMDKASLAGRKKLLRAQTEREILQSLDHPFLP 279 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~-~~vAvK--------------ii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv 279 (611)
.++|++++.||+|+||+||+|.++... ..+++| ++.+...........+++|+.+|+.++|||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 469999999999999999999765432 222222 11111111223345678899999999999999
Q ss_pred cccceeeccceeeEEeeeCCCCCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCc
Q 007260 280 TLYTHFETEKFSCLVMEFCPGGDLHTLRQKQP---GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGH 356 (611)
Q Consensus 280 ~l~~~~~~~~~~~LVmE~~~gg~L~~ll~~~~---~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~ 356 (611)
++++++...+..|+|||++ +++|..++.... ........++.|+.||+.||+|||++|||||||||+||||+.+|.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 227 KIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred cEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 9999999999999999999 567777665421 123446778899999999999999999999999999999999999
Q ss_pred EEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCC
Q 007260 357 IMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQV 436 (611)
Q Consensus 357 vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (611)
+||+|||++..+...
T Consensus 306 vkL~DFGla~~~~~~----------------------------------------------------------------- 320 (501)
T PHA03210 306 IVLGDFGTAMPFEKE----------------------------------------------------------------- 320 (501)
T ss_pred EEEEeCCCceecCcc-----------------------------------------------------------------
Confidence 999999998433210
Q ss_pred CCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCC-CCCC--CcHHHHHHHHcCC---
Q 007260 437 SPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTP-FKGS--GNRATLFNVVGQP--- 510 (611)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~P-F~~~--~~~~~l~~i~~~~--- 510 (611)
.......++||+.|+|||++.+..++.++|||||||+||||++|..+ |... .....+.+++...
T Consensus 321 ----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 390 (501)
T PHA03210 321 ----------REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVC 390 (501)
T ss_pred ----------cccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccC
Confidence 00111235799999999999999999999999999999999998764 4322 1222333322110
Q ss_pred -CCCCC--------------------------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCch
Q 007260 511 -LRFPE--------------------------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNW 559 (611)
Q Consensus 511 -l~~p~--------------------------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 559 (611)
..+|. ...++..+.++|.+||.+||.+||+ |.|+|.||||....+
T Consensus 391 ~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rps----a~elL~hp~f~~~~~ 462 (501)
T PHA03210 391 DEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPG----AAELLALPLFSAEEE 462 (501)
T ss_pred hhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcC----HHHHhhChhhhcCCc
Confidence 01110 1135677889999999999999999 999999999987654
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=343.31 Aligned_cols=255 Identities=31% Similarity=0.503 Sum_probs=215.5
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhh--hhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASL--AGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~--~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
+|+..+.||.|+||.||+|.+..++..|++|++..... ...+....+.+|+.+++.++|+||+++++++..+..+|+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 47788999999999999999998899999999865432 2234456778899999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
|||++|++|.+++.+. ..+++..+..++.||+.||+|||++||+|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-- 156 (258)
T ss_pred EEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc--
Confidence 9999999999998775 458999999999999999999999999999999999999999999999999874321000
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
.....
T Consensus 157 ---------------------------------------------------------------------------~~~~~ 161 (258)
T cd06632 157 ---------------------------------------------------------------------------FAKSF 161 (258)
T ss_pred ---------------------------------------------------------------------------ccccc
Confidence 01123
Q ss_pred ccCCCccchhhhccCC-CCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007260 455 VGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVK 533 (611)
Q Consensus 455 vGT~~Y~APEil~~~~-~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~ 533 (611)
.|++.|++||.+.... ++.++|+|||||++|+|++|+.||...........+............++..+++||.+||..
T Consensus 162 ~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 241 (258)
T cd06632 162 KGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQR 241 (258)
T ss_pred CCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhhc
Confidence 5889999999998776 899999999999999999999999877655555555442222222345889999999999999
Q ss_pred CccccCCchhcHHHHHcCCCC
Q 007260 534 EPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 534 dP~~Rpt~~~~a~elL~Hp~f 554 (611)
+|.+||+ +.+++.|||+
T Consensus 242 ~p~~Rp~----~~~~l~~~~~ 258 (258)
T cd06632 242 DPSLRPT----AAELLEHPFV 258 (258)
T ss_pred CcccCcC----HHHHhcCCCC
Confidence 9999999 9999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=353.21 Aligned_cols=258 Identities=30% Similarity=0.433 Sum_probs=211.8
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhh--hHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLA--GRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~--~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
+|.+++.||.|+||.||+|.+..+++.||||.+...... .......+..|+++++.++|+||+++++++.+.+.+|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 488999999999999999999999999999999765433 122234556799999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
|||+ +++|.+++.... ..+++..++.++.||+.||.|||.+||+||||||+|||++.+|.++|+|||++..+....
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-- 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN-- 156 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC--
Confidence 9999 999999987653 369999999999999999999999999999999999999999999999999984332100
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
......
T Consensus 157 --------------------------------------------------------------------------~~~~~~ 162 (298)
T cd07841 157 --------------------------------------------------------------------------RKMTHQ 162 (298)
T ss_pred --------------------------------------------------------------------------cccccc
Confidence 000112
Q ss_pred ccCCCccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcC---CC--CCC--------------
Q 007260 455 VGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ---PL--RFP-------------- 514 (611)
Q Consensus 455 vGT~~Y~APEil~~~-~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~---~l--~~p-------------- 514 (611)
.+++.|+|||++.+. .++.++|||||||++|||++|.+||.+......+.++... +. .++
T Consensus 163 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (298)
T cd07841 163 VVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPF 242 (298)
T ss_pred ccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccccccccc
Confidence 478889999998654 5689999999999999999999999887766555444321 00 000
Q ss_pred -------CCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCC
Q 007260 515 -------ESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 515 -------~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
.....+..+.+||.+||.+||.+||+ +.+++.|+||++
T Consensus 243 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s----~~e~l~~~~~~~ 287 (298)
T cd07841 243 PPTPLKQIFPAASDDALDLLQRLLTLNPNKRIT----ARQALEHPYFSN 287 (298)
T ss_pred CCcchhhhcccccHHHHHHHHHHhcCCcccCcC----HHHHhhCccccC
Confidence 01235788999999999999999999 999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=370.77 Aligned_cols=257 Identities=19% Similarity=0.287 Sum_probs=210.0
Q ss_pred ccCeEEEeEecccCcEEEEEEEE-----CCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeecc
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSEL-----SGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETE 288 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~-----~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~ 288 (611)
.++|++.+.||+|+||.||+|.+ ..++..||||+++..... .....+.+|+.+|+.+ +|||||++++++...
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc--HHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 45899999999999999999974 346778999999654322 2334567899999999 899999999999999
Q ss_pred ceeeEEeeeCCCCCHHHHHHhCC---------------------------------------------------------
Q 007260 289 KFSCLVMEFCPGGDLHTLRQKQP--------------------------------------------------------- 311 (611)
Q Consensus 289 ~~~~LVmE~~~gg~L~~ll~~~~--------------------------------------------------------- 311 (611)
...|||||||+||+|.+++....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 99999999999999999886532
Q ss_pred ----------------CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 312 ----------------GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 312 ----------------~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~- 270 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY- 270 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc-
Confidence 124788899999999999999999999999999999999999999999999998433210000
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
.......
T Consensus 271 -------------------------------------------------------------------------~~~~~~~ 277 (375)
T cd05104 271 -------------------------------------------------------------------------VVKGNAR 277 (375)
T ss_pred -------------------------------------------------------------------------cccCCCC
Confidence 0001123
Q ss_pred cCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcC
Q 007260 456 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKE 534 (611)
Q Consensus 456 GT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~d 534 (611)
++..|+|||++.+..++.++|||||||++|||++ |..||.+......+.+++............+.++++||.+||..|
T Consensus 278 ~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 357 (375)
T cd05104 278 LPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDAD 357 (375)
T ss_pred CCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHHHHccCC
Confidence 5678999999999999999999999999999997 999998876666666666655444444557899999999999999
Q ss_pred ccccCCchhcHHHHHcC
Q 007260 535 PQHRLAYKRGATEIKQH 551 (611)
Q Consensus 535 P~~Rpt~~~~a~elL~H 551 (611)
|++||+ +.+|++.
T Consensus 358 P~~RPs----~~eil~~ 370 (375)
T cd05104 358 PLKRPT----FKQIVQL 370 (375)
T ss_pred hhHCcC----HHHHHHH
Confidence 999999 7777753
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=350.98 Aligned_cols=257 Identities=24% Similarity=0.363 Sum_probs=212.2
Q ss_pred cccCeEEEeEecccCcEEEEEEEECCCC-----eEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecc
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSGTK-----CYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE 288 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~t~-----~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~ 288 (611)
.+++|++++.||.|+||.||+|.+...+ ..||+|.+..... ......+.+|+.+|..++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE--PKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCC--HHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 3568999999999999999999986655 6899999865432 23344678899999999999999999999999
Q ss_pred ceeeEEeeeCCCCCHHHHHHhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccC
Q 007260 289 KFSCLVMEFCPGGDLHTLRQKQPG--------------KYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRED 354 (611)
Q Consensus 289 ~~~~LVmE~~~gg~L~~ll~~~~~--------------~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~ 354 (611)
+..|+||||+++++|.+++..... ..+++..+..++.||+.||+|||.+||+||||||+|||++++
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 999999999999999998876421 458899999999999999999999999999999999999999
Q ss_pred CcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCC
Q 007260 355 GHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGN 434 (611)
Q Consensus 355 g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (611)
+.++|+|||++........
T Consensus 161 ~~~~L~dfg~~~~~~~~~~------------------------------------------------------------- 179 (283)
T cd05048 161 LTVKISDFGLSRDIYSADY------------------------------------------------------------- 179 (283)
T ss_pred CcEEECCCcceeecccccc-------------------------------------------------------------
Confidence 9999999999843210000
Q ss_pred CCCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCC
Q 007260 435 QVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRF 513 (611)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~ 513 (611)
........+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+.... ..
T Consensus 180 -------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~-~~ 245 (283)
T cd05048 180 -------------YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQ-LL 245 (283)
T ss_pred -------------ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-cC
Confidence 000112347889999999998899999999999999999997 999999877666555554433 33
Q ss_pred CCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcC
Q 007260 514 PESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 514 p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~H 551 (611)
+....++.++.+||.+||..||.+||+ +.+|+++
T Consensus 246 ~~~~~~~~~~~~l~~~c~~~~p~~Rp~----~~~i~~~ 279 (283)
T cd05048 246 PCPEDCPARVYALMIECWNEIPARRPR----FKDIHTR 279 (283)
T ss_pred CCcccCCHHHHHHHHHHccCChhhCcC----HHHHHHH
Confidence 344568999999999999999999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=350.53 Aligned_cols=257 Identities=27% Similarity=0.424 Sum_probs=208.8
Q ss_pred cccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceee-----c
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFE-----T 287 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~-----~ 287 (611)
..++|++++.||.|+||.||+|++..++..||+|++...... ...+.+|+.+++.+ +||||+++++++. .
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 91 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI----DEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccch----HHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence 346899999999999999999999999999999998653221 23456799999999 7999999999873 4
Q ss_pred cceeeEEeeeCCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccc
Q 007260 288 EKFSCLVMEFCPGGDLHTLRQKQ--PGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365 (611)
Q Consensus 288 ~~~~~LVmE~~~gg~L~~ll~~~--~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA 365 (611)
+..+|+||||++|++|.+++... .+..+++..++.++.|++.||.|||+++|+||||||+||+++.++.++|+|||++
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~ 171 (286)
T cd06638 92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS 171 (286)
T ss_pred CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCce
Confidence 56789999999999999887532 2356899999999999999999999999999999999999999999999999997
Q ss_pred ccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccC
Q 007260 366 LRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAE 445 (611)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (611)
......
T Consensus 172 ~~~~~~-------------------------------------------------------------------------- 177 (286)
T cd06638 172 AQLTST-------------------------------------------------------------------------- 177 (286)
T ss_pred eecccC--------------------------------------------------------------------------
Confidence 432100
Q ss_pred cccccccccccCCCccchhhhcc-----CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCC-CCCCCCCCC
Q 007260 446 PTEARSMSFVGTHEYLAPEIIKG-----EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQP-LRFPESPVV 519 (611)
Q Consensus 446 ~~~~~~~~~vGT~~Y~APEil~~-----~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~-l~~p~~~~~ 519 (611)
.......+|++.|+|||++.. ..++.++|||||||++|||++|+.||........+.++.... ........+
T Consensus 178 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (286)
T cd06638 178 --RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELW 255 (286)
T ss_pred --CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccCCCCc
Confidence 000112358999999999853 447889999999999999999999998776555544433221 122223346
Q ss_pred CHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCC
Q 007260 520 SFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 520 s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f 554 (611)
+..+.+||.+||..||++||+ +.+|++|+||
T Consensus 256 ~~~~~~li~~~l~~~p~~Rps----~~ell~~~~~ 286 (286)
T cd06638 256 SNEFNDFIRKCLTKDYEKRPT----VSDLLQHVFI 286 (286)
T ss_pred CHHHHHHHHHHccCCcccCCC----HHHHhhcccC
Confidence 889999999999999999999 9999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=344.60 Aligned_cols=259 Identities=29% Similarity=0.432 Sum_probs=217.7
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchh--hhhHHHHHHHHHHHHHHHhCCCCCcccccceeecc--cee
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKAS--LAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE--KFS 291 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~--~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~--~~~ 291 (611)
.+|++.+.||+|+||.||+|++..++..||+|++.... .........+.+|+++++.++|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47999999999999999999999999999999875431 12234556788999999999999999999998763 568
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCC
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~ 371 (611)
++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence 9999999999999988765 45899999999999999999999999999999999999999999999999998432100
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
. ......
T Consensus 160 ~-------------------------------------------------------------------------~~~~~~ 166 (264)
T cd06653 160 C-------------------------------------------------------------------------MSGTGI 166 (264)
T ss_pred c-------------------------------------------------------------------------ccCccc
Confidence 0 000001
Q ss_pred cccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 007260 452 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLL 531 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L 531 (611)
..+.|+..|+|||++.+..++.++|||||||++|+|++|+.||........+.++...+.....+..+++++.++|.+||
T Consensus 167 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l 246 (264)
T cd06653 167 KSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIF 246 (264)
T ss_pred cccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHHHHHHHh
Confidence 23468999999999999889999999999999999999999999877777777766665544444568999999999999
Q ss_pred hcCccccCCchhcHHHHHcCCCC
Q 007260 532 VKEPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 532 ~~dP~~Rpt~~~~a~elL~Hp~f 554 (611)
. +|..||+ +.+++.|||.
T Consensus 247 ~-~~~~r~~----~~~~~~~~~~ 264 (264)
T cd06653 247 V-EEKRRPT----AEFLLRHPFV 264 (264)
T ss_pred c-CcccCcc----HHHHhcCCCC
Confidence 9 5799999 9999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=354.53 Aligned_cols=256 Identities=21% Similarity=0.291 Sum_probs=203.7
Q ss_pred ccCeEEEeEecccCcEEEEEEEECC----------------CCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCc
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSG----------------TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFL 278 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~----------------t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnI 278 (611)
.++|++.++||+|+||.||+|.+.. ++..||||++..... ......+.+|+.+|.+++||||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN--KNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC--HHHHHHHHHHHHHHhhcCCCCe
Confidence 3589999999999999999998632 445799999876432 2334567789999999999999
Q ss_pred ccccceeeccceeeEEeeeCCCCCHHHHHHhCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHHcCeec
Q 007260 279 PTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQP-----------------GKYFPEQAVRFYVAEVLLALEYLHMLGIIY 341 (611)
Q Consensus 279 v~l~~~~~~~~~~~LVmE~~~gg~L~~ll~~~~-----------------~~~l~e~~~~~i~~qll~aL~yLH~~gIVH 341 (611)
+++++++...+..||||||+++++|.+++.... ...+++..+..++.||+.||.|||++||+|
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 999999999999999999999999999886532 124677889999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccc
Q 007260 342 RDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSK 421 (611)
Q Consensus 342 RDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (611)
|||||+|||++.++.+||+|||++........
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~------------------------------------------------ 193 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDY------------------------------------------------ 193 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCce------------------------------------------------
Confidence 99999999999999999999999843211000
Q ss_pred cccCCCCccccCCCCCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh--CCCCCCCCCc
Q 007260 422 SKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF--GKTPFKGSGN 499 (611)
Q Consensus 422 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt--G~~PF~~~~~ 499 (611)
........++..|+|||++.+..++.++|||||||++|||++ +..||.+...
T Consensus 194 --------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 247 (304)
T cd05096 194 --------------------------YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTD 247 (304)
T ss_pred --------------------------eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCH
Confidence 000112346788999999999999999999999999999986 6788987665
Q ss_pred HHHHHHHHc------CCCCCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 500 RATLFNVVG------QPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 500 ~~~l~~i~~------~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
...+.++.. ........+.++..+.+||.+||..||.+||+ +.+|.+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs----~~~i~~ 300 (304)
T cd05096 248 EQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPS----FSDIHA 300 (304)
T ss_pred HHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcC----HHHHHH
Confidence 554433321 11112223457899999999999999999999 777743
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=355.71 Aligned_cols=260 Identities=29% Similarity=0.414 Sum_probs=210.6
Q ss_pred cccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecc--cee
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE--KFS 291 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~--~~~ 291 (611)
..++|++++.||.|+||.||+|.+..++..||+|++....... .....+.+|+.+|+.++|+||+++++++... +.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 3568999999999999999999999999999999986543221 1222345799999999999999999998754 568
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCC
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~ 371 (611)
|+||||+. ++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 84 ~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 84 FLVMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEEEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 99999995 58888877643 56899999999999999999999999999999999999999999999999998432210
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
. ...
T Consensus 162 ~----------------------------------------------------------------------------~~~ 165 (309)
T cd07845 162 A----------------------------------------------------------------------------KPM 165 (309)
T ss_pred c----------------------------------------------------------------------------CCC
Confidence 0 000
Q ss_pred cccccCCCccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCC-------------------C
Q 007260 452 MSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQP-------------------L 511 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~-~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~-------------------l 511 (611)
....+++.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+.+..+.... .
T Consensus 166 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (309)
T cd07845 166 TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKF 245 (309)
T ss_pred CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccc
Confidence 11236788999999876 457999999999999999999999999887776665544310 0
Q ss_pred CCCC---------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCC
Q 007260 512 RFPE---------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 512 ~~p~---------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
..+. ...++..+.+||.+||..||++||+ +.++++||||+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t----~~~il~h~~f~~ 295 (309)
T cd07845 246 TLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRAT----AEEALESSYFKE 295 (309)
T ss_pred cccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcC----HHHHhcChhhcc
Confidence 1111 1225888999999999999999999 999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=352.05 Aligned_cols=257 Identities=28% Similarity=0.411 Sum_probs=210.4
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
++|++++.||.|+||.||+|.+..++..||+|.+.... .......+.+|+.+|++++|+||+++++.+..++.+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 36899999999999999999999999999999886432 2233456778999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHH-cCeeccCCCCCcEEEccCCcEEEEeccccccccCCcc
Q 007260 296 EFCPGGDLHTLRQKQ-PGKYFPEQAVRFYVAEVLLALEYLHM-LGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 373 (611)
Q Consensus 296 E~~~gg~L~~ll~~~-~~~~l~e~~~~~i~~qll~aL~yLH~-~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~ 373 (611)
||++|++|..++... ....+++..++.++.||+.||.|||. .||+||||||+|||++.++.++|+|||++......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 156 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-- 156 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence 999999999888753 12368999999999999999999997 59999999999999999999999999987322100
Q ss_pred ccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccc
Q 007260 374 LIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMS 453 (611)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (611)
....
T Consensus 157 ----------------------------------------------------------------------------~~~~ 160 (286)
T cd06622 157 ----------------------------------------------------------------------------LAKT 160 (286)
T ss_pred ----------------------------------------------------------------------------cccc
Confidence 0012
Q ss_pred cccCCCccchhhhccCC------CCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHH---HHHHcCCCCCCCCCCCCHHHH
Q 007260 454 FVGTHEYLAPEIIKGEG------HGSAVDWWTFGIFLYELLFGKTPFKGSGNRATL---FNVVGQPLRFPESPVVSFAAR 524 (611)
Q Consensus 454 ~vGT~~Y~APEil~~~~------~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l---~~i~~~~l~~p~~~~~s~~l~ 524 (611)
.+|++.|+|||++.+.. ++.++|||||||++|+|++|+.||......... ..+.... .......++.++.
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 239 (286)
T cd06622 161 NIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGD-PPTLPSGYSDDAQ 239 (286)
T ss_pred CCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcC-CCCCCcccCHHHH
Confidence 35888999999986543 478999999999999999999999765443322 2222222 1122234899999
Q ss_pred HHHHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 525 DLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 525 dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
+||.+||..+|++||+ +.++++||||...
T Consensus 240 ~li~~~l~~~p~~Rp~----~~~l~~~~~~~~~ 268 (286)
T cd06622 240 DFVAKCLNKIPNRRPT----YAQLLEHPWLVKY 268 (286)
T ss_pred HHHHHHcccCcccCCC----HHHHhcChhhhhc
Confidence 9999999999999999 9999999999643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=352.14 Aligned_cols=256 Identities=29% Similarity=0.479 Sum_probs=205.3
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
+++|++++.||.|+||.||+|.+..+++.||||.+....... ....+.+|+++++.++|+||+++++++..++..|+|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 568999999999999999999999899999999986543211 112346799999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
|||+. ++|.+++.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 82 ~e~~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-- 157 (291)
T cd07844 82 FEYLD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS-- 157 (291)
T ss_pred EecCC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCC--
Confidence 99996 59999887654 468999999999999999999999999999999999999999999999999873211000
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
......
T Consensus 158 --------------------------------------------------------------------------~~~~~~ 163 (291)
T cd07844 158 --------------------------------------------------------------------------KTYSNE 163 (291)
T ss_pred --------------------------------------------------------------------------cccccc
Confidence 000112
Q ss_pred ccCCCccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHH---HcCCC----------------CC
Q 007260 455 VGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNR-ATLFNV---VGQPL----------------RF 513 (611)
Q Consensus 455 vGT~~Y~APEil~~-~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~-~~l~~i---~~~~l----------------~~ 513 (611)
+++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.... +.+..+ ++.+. .+
T Consensus 164 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (291)
T cd07844 164 VVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSF 243 (291)
T ss_pred ccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccc
Confidence 46888999999876 45789999999999999999999999776522 222211 11110 00
Q ss_pred CC---------CCCCC--HHHHHHHHHhhhcCccccCCchhcHHHHHcCCCC
Q 007260 514 PE---------SPVVS--FAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 514 p~---------~~~~s--~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f 554 (611)
+. ...++ ..+.++|.+||..||.+||+ +.++++||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps----~~e~l~~~~f 291 (291)
T cd07844 244 PFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRIS----AAEAMKHPYF 291 (291)
T ss_pred cccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccC----HHHHhcCCCC
Confidence 00 01234 78899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=351.75 Aligned_cols=258 Identities=25% Similarity=0.413 Sum_probs=208.0
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC-CCCcccccceeeccce----
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD-HPFLPTLYTHFETEKF---- 290 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~-HpnIv~l~~~~~~~~~---- 290 (611)
++|++.+.||.|+||.||+|.+..+++.||||++..... .......+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 379999999999999999999999999999999865432 1122345677999999995 6999999999887655
Q ss_pred -eeEEeeeCCCCCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEcc-CCcEEEEecccc
Q 007260 291 -SCLVMEFCPGGDLHTLRQKQP---GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRE-DGHIMLSDFDLS 365 (611)
Q Consensus 291 -~~LVmE~~~gg~L~~ll~~~~---~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~-~g~vkL~DFGlA 365 (611)
.|+||||+++ +|.+++.... +..+++..++.++.||+.||.|||.+||+||||||+|||++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999975 8888776532 246899999999999999999999999999999999999998 889999999998
Q ss_pred ccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccC
Q 007260 366 LRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAE 445 (611)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (611)
..+....
T Consensus 159 ~~~~~~~------------------------------------------------------------------------- 165 (295)
T cd07837 159 RAFSIPV------------------------------------------------------------------------- 165 (295)
T ss_pred eecCCCc-------------------------------------------------------------------------
Confidence 4332100
Q ss_pred cccccccccccCCCccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcC---CC--C-------
Q 007260 446 PTEARSMSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ---PL--R------- 512 (611)
Q Consensus 446 ~~~~~~~~~vGT~~Y~APEil~~~-~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~---~l--~------- 512 (611)
.......+++.|+|||++.+. .++.++|||||||++|+|++|..||.+.+....+.++... +. .
T Consensus 166 ---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T cd07837 166 ---KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKL 242 (295)
T ss_pred ---cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhc
Confidence 000112478899999998764 5689999999999999999999999988776666554321 00 0
Q ss_pred -----CCC---------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCC
Q 007260 513 -----FPE---------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFE 555 (611)
Q Consensus 513 -----~p~---------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 555 (611)
++. .+.++.++.+||.+||..||.+||+ +.+++.||||+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~----~~eil~~~~~~ 295 (295)
T cd07837 243 RDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRIS----AKAALTHPYFD 295 (295)
T ss_pred cchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCC----HHHHhcCCCcC
Confidence 000 1347889999999999999999999 99999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=349.64 Aligned_cols=259 Identities=29% Similarity=0.404 Sum_probs=208.1
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHH-HHhCCCCCcccccceeeccceeeEE
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREI-LQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~i-L~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
++|++++.||+|+||.||+|++..++..||||++........ ..++..|+.+ ++.++||||+++++++..++.+|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE--QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH--HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 379999999999999999999999999999999876532221 1234446554 6677999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHc-CeeccCCCCCcEEEccCCcEEEEeccccccccCC
Q 007260 295 MEFCPGGDLHTLRQKQ--PGKYFPEQAVRFYVAEVLLALEYLHML-GIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~--~~~~l~e~~~~~i~~qll~aL~yLH~~-gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~ 371 (611)
|||++ ++|.+++... ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99995 6887776542 235799999999999999999999997 9999999999999999999999999997432100
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
...
T Consensus 158 -----------------------------------------------------------------------------~~~ 160 (283)
T cd06617 158 -----------------------------------------------------------------------------VAK 160 (283)
T ss_pred -----------------------------------------------------------------------------ccc
Confidence 000
Q ss_pred cccccCCCccchhhhcc----CCCCChhhHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHcCC-CCCCCCCCCCHHHHH
Q 007260 452 MSFVGTHEYLAPEIIKG----EGHGSAVDWWTFGIFLYELLFGKTPFKGS-GNRATLFNVVGQP-LRFPESPVVSFAARD 525 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~----~~~~~~sDIWSLGviL~ELltG~~PF~~~-~~~~~l~~i~~~~-l~~p~~~~~s~~l~d 525 (611)
....|+..|+|||++.+ ..++.++|+|||||++|+|++|+.||... ...+.+..+.... ..++. ..++.++++
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~ 239 (283)
T cd06617 161 TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPA-EKFSPEFQD 239 (283)
T ss_pred ccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCc-cccCHHHHH
Confidence 12358889999999875 45688999999999999999999999753 3344454544432 22222 347899999
Q ss_pred HHHHhhhcCccccCCchhcHHHHHcCCCCCCCch
Q 007260 526 LIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNW 559 (611)
Q Consensus 526 LI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 559 (611)
||.+||..+|++||+ +.++++||||....+
T Consensus 240 li~~~l~~~p~~Rp~----~~~il~~~~~~~~~~ 269 (283)
T cd06617 240 FVNKCLKKNYKERPN----YPELLQHPFFELHLS 269 (283)
T ss_pred HHHHHccCChhhCcC----HHHHhcCchhhhccc
Confidence 999999999999999 999999999986543
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=353.35 Aligned_cols=257 Identities=29% Similarity=0.412 Sum_probs=214.0
Q ss_pred cccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeE
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCL 293 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~L 293 (611)
..++|++++.||+|+||+||++++..++..||+|++.... ......++.+|+++++.++||||+++++++.....+||
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 3468999999999999999999999999999999986542 22344567889999999999999999999999999999
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCeeccCCCCCcEEEccCCcEEEEeccccccccCCc
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHM-LGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~-~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~ 372 (611)
||||+++++|..++... +.+++..++.++.|++.||.|||+ .||+||||||+|||++.++.++|+|||++......
T Consensus 81 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~- 157 (284)
T cd06620 81 CMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS- 157 (284)
T ss_pred EEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence 99999999999988764 568999999999999999999997 69999999999999999999999999987322100
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
...
T Consensus 158 -----------------------------------------------------------------------------~~~ 160 (284)
T cd06620 158 -----------------------------------------------------------------------------IAD 160 (284)
T ss_pred -----------------------------------------------------------------------------ccC
Confidence 001
Q ss_pred ccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcH-----------HHHHHHHcCCCCCCCCCCCCH
Q 007260 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNR-----------ATLFNVVGQPLRFPESPVVSF 521 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~-----------~~l~~i~~~~l~~p~~~~~s~ 521 (611)
..+|+..|+|||++.+..++.++|||||||++|+|++|+.||...... ..+..++...........++.
T Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd06620 161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPE 240 (284)
T ss_pred ccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCH
Confidence 235899999999999888999999999999999999999999865432 222333332221111223788
Q ss_pred HHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCC
Q 007260 522 AARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 522 ~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
.+.+||.+||..||++||+ +.|+++|+||..
T Consensus 241 ~~~~li~~~l~~dp~~Rpt----~~e~~~~~~~~~ 271 (284)
T cd06620 241 DLRDFVDACLLKDPTERPT----PQQLCAMPPFIQ 271 (284)
T ss_pred HHHHHHHHHhcCCcccCcC----HHHHhcCccccc
Confidence 9999999999999999999 999999999954
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=352.15 Aligned_cols=261 Identities=26% Similarity=0.398 Sum_probs=213.2
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
++|++.+.||.|++|.||+|++..+++.||||++...... ......+.+|+++++.++||||+++++++..+...|+||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 5899999999999999999999999999999998654322 223345678999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEcc-CCcEEEEeccccccccCCccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRE-DGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~-~g~vkL~DFGlA~~~~~~~~~ 374 (611)
||++ ++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.......
T Consensus 81 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~-- 157 (294)
T PLN00009 81 EYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV-- 157 (294)
T ss_pred eccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc--
Confidence 9995 58888777665556789999999999999999999999999999999999985 5679999999984322100
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
......
T Consensus 158 --------------------------------------------------------------------------~~~~~~ 163 (294)
T PLN00009 158 --------------------------------------------------------------------------RTFTHE 163 (294)
T ss_pred --------------------------------------------------------------------------cccccC
Confidence 000123
Q ss_pred ccCCCccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHc---CCCC---------------CC-
Q 007260 455 VGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG---QPLR---------------FP- 514 (611)
Q Consensus 455 vGT~~Y~APEil~~~-~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~---~~l~---------------~p- 514 (611)
+|++.|+|||++.+. .++.++|||||||++|+|++|++||......+.+.++.. .+.. ++
T Consensus 164 ~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (294)
T PLN00009 164 VVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPK 243 (294)
T ss_pred ceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhccc
Confidence 578899999998764 578999999999999999999999998777666655432 1100 00
Q ss_pred --------CCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCc
Q 007260 515 --------ESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVN 558 (611)
Q Consensus 515 --------~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 558 (611)
..+.++.+++++|.+||..||++||+ +.+++.||||+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps----~~~~l~~~~~~~~~ 291 (294)
T PLN00009 244 WPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRIT----ARAALEHEYFKDLG 291 (294)
T ss_pred CCCCCHHHhCcCCChHHHHHHHHHccCChhhCcC----HHHHhcCchHhHHh
Confidence 01347889999999999999999999 99999999998754
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=341.59 Aligned_cols=256 Identities=29% Similarity=0.506 Sum_probs=217.3
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVME 296 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE 296 (611)
+|.+.+.||.|+||.||++.+..++..||+|.+....... .....+.+|+.+++.++|+||+++++.+..+...|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 5899999999999999999999999999999987654322 233456789999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCC-cEEEEeccccccccCCcccc
Q 007260 297 FCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDG-HIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 297 ~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g-~vkL~DFGlA~~~~~~~~~~ 375 (611)
|+++++|.+++.+..+..+++..++.++.||+.||.|||.+||+|+||||+|||+++++ .++|+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~--- 156 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM--- 156 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc---
Confidence 99999999998876555689999999999999999999999999999999999999886 46999999874321000
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
.......
T Consensus 157 -------------------------------------------------------------------------~~~~~~~ 163 (257)
T cd08225 157 -------------------------------------------------------------------------ELAYTCV 163 (257)
T ss_pred -------------------------------------------------------------------------ccccccC
Confidence 0001235
Q ss_pred cCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCc
Q 007260 456 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEP 535 (611)
Q Consensus 456 GT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP 535 (611)
|++.|+|||++.+..++.++|+|||||++|||++|..||........+..+...... +..+.++..++++|.+||..+|
T Consensus 164 ~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p 242 (257)
T cd08225 164 GTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA-PISPNFSRDLRSLISQLFKVSP 242 (257)
T ss_pred CCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCC-CCCCCCCHHHHHHHHHHhccCh
Confidence 889999999999888999999999999999999999999887666666655544332 2334578999999999999999
Q ss_pred cccCCchhcHHHHHcCCCC
Q 007260 536 QHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 536 ~~Rpt~~~~a~elL~Hp~f 554 (611)
++||+ +.++++||||
T Consensus 243 ~~Rpt----~~~ll~~~~~ 257 (257)
T cd08225 243 RDRPS----ITSILKRPFL 257 (257)
T ss_pred hhCcC----HHHHhhCCCC
Confidence 99999 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=343.26 Aligned_cols=257 Identities=30% Similarity=0.476 Sum_probs=217.8
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVME 296 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE 296 (611)
+|++.+.||.|++|.||+|.+..+++.||||++...... .....+.+|+.++..++|+||+++++++......|+|||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 689999999999999999999999999999998765432 334567889999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 297 FCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHM-LGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 297 ~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~-~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
|+++++|.+++... ..+++..+..++.||+.||+|||. +||+||||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~--- 154 (264)
T cd06623 80 YMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL--- 154 (264)
T ss_pred ecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC---
Confidence 99999999998875 568999999999999999999999 999999999999999999999999999873321000
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
.......
T Consensus 155 -------------------------------------------------------------------------~~~~~~~ 161 (264)
T cd06623 155 -------------------------------------------------------------------------DQCNTFV 161 (264)
T ss_pred -------------------------------------------------------------------------Cccccee
Confidence 0001235
Q ss_pred cCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC--cH-HHHHHHHcCCCCCCCCCC-CCHHHHHHHHHhh
Q 007260 456 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSG--NR-ATLFNVVGQPLRFPESPV-VSFAARDLIRGLL 531 (611)
Q Consensus 456 GT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~--~~-~~l~~i~~~~l~~p~~~~-~s~~l~dLI~~~L 531 (611)
|+..|+|||.+.+..++.++||||||+++|+|++|+.||.... .. +.+..+... ........ ++..+.++|.+||
T Consensus 162 ~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l 240 (264)
T cd06623 162 GTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG-PPPSLPAEEFSPEFRDFISACL 240 (264)
T ss_pred ecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcC-CCCCCCcccCCHHHHHHHHHHc
Confidence 8899999999999989999999999999999999999998774 33 333344433 22233334 7899999999999
Q ss_pred hcCccccCCchhcHHHHHcCCCCCCCc
Q 007260 532 VKEPQHRLAYKRGATEIKQHPFFEGVN 558 (611)
Q Consensus 532 ~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 558 (611)
..+|.+||+ +.++++||||+.++
T Consensus 241 ~~~p~~R~~----~~~ll~~~~~~~~~ 263 (264)
T cd06623 241 QKDPKKRPS----AAELLQHPFIKKAD 263 (264)
T ss_pred cCChhhCCC----HHHHHhCHHHHhcc
Confidence 999999999 99999999998653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=349.13 Aligned_cols=257 Identities=31% Similarity=0.485 Sum_probs=211.1
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
++|++.+.||.|+||.||+|.+..+++.||||+++.... .......+.+|+++|+.++|+||+++++++..++..|+||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 379999999999999999999999999999999865432 2233456778999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
||++++.|..++.+. ..+++..+..++.||+.||.|||.+||+||||+|+||+++.++.+||+|||++.......
T Consensus 80 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~--- 154 (288)
T cd07833 80 EYVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARP--- 154 (288)
T ss_pred ecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCc---
Confidence 999887776665543 458999999999999999999999999999999999999999999999999974322100
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
......++
T Consensus 155 ------------------------------------------------------------------------~~~~~~~~ 162 (288)
T cd07833 155 ------------------------------------------------------------------------ASPLTDYV 162 (288)
T ss_pred ------------------------------------------------------------------------cccccCcc
Confidence 00112346
Q ss_pred cCCCccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHc---C----------------CCCCCC
Q 007260 456 GTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG---Q----------------PLRFPE 515 (611)
Q Consensus 456 GT~~Y~APEil~~~-~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~---~----------------~l~~p~ 515 (611)
|+..|+|||++.+. .++.++|||||||++|+|++|++||.+....+.+..+.. . ...++.
T Consensus 163 ~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (288)
T cd07833 163 ATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPE 242 (288)
T ss_pred cccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCC
Confidence 88999999999988 789999999999999999999999987765554433221 0 001110
Q ss_pred -----------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCC
Q 007260 516 -----------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 516 -----------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f 554 (611)
...++.++++||.+||..||++||+ +.++++||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~il~~~~f 288 (288)
T cd07833 243 PSQPESLERRYPGKVSSPALDFLKACLRMDPKERLT----CDELLQHPYF 288 (288)
T ss_pred CCCcHHHHHhcCCccchHHHHHHHHHhccCchhccc----HHHHhcCCCC
Confidence 1125889999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=355.13 Aligned_cols=254 Identities=30% Similarity=0.466 Sum_probs=213.0
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVME 296 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE 296 (611)
.|.....||.|+||.||++.+..++..||||.+.... ......+.+|+.+++.++|+||+++++.+...+..|+|||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 4555678999999999999999999999999986533 2334457789999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccc
Q 007260 297 FCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIK 376 (611)
Q Consensus 297 ~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~ 376 (611)
|+++++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 100 ~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~----- 171 (292)
T cd06658 100 FLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE----- 171 (292)
T ss_pred CCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc-----
Confidence 9999999998765 34899999999999999999999999999999999999999999999999987322100
Q ss_pred cccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccccc
Q 007260 377 ASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVG 456 (611)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vG 456 (611)
.......+|
T Consensus 172 -----------------------------------------------------------------------~~~~~~~~~ 180 (292)
T cd06658 172 -----------------------------------------------------------------------VPKRKSLVG 180 (292)
T ss_pred -----------------------------------------------------------------------cccCceeec
Confidence 000112458
Q ss_pred CCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcC-CCCCCCCCCCCHHHHHHHHHhhhcCc
Q 007260 457 THEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ-PLRFPESPVVSFAARDLIRGLLVKEP 535 (611)
Q Consensus 457 T~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~-~l~~p~~~~~s~~l~dLI~~~L~~dP 535 (611)
++.|+|||++.+..++.++|||||||++|||++|+.||........+..+... +...+....++..+.+||.+||..||
T Consensus 181 ~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 260 (292)
T cd06658 181 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREP 260 (292)
T ss_pred CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHccCCh
Confidence 99999999999888999999999999999999999999887665555444332 12223334578899999999999999
Q ss_pred cccCCchhcHHHHHcCCCCCC
Q 007260 536 QHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 536 ~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
.+||+ +.++++||||..
T Consensus 261 ~~Rpt----~~~il~~~~~~~ 277 (292)
T cd06658 261 SQRAT----AQELLQHPFLKL 277 (292)
T ss_pred hHCcC----HHHHhhChhhhc
Confidence 99999 999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=343.81 Aligned_cols=253 Identities=22% Similarity=0.346 Sum_probs=211.8
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSC 292 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~ 292 (611)
+..++|+++++||.|+||.||+|.+.. +..||+|.+..... ....+.+|+.+++.++|+||+++++.+...+..|
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~-~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYNN-STKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEecC-CceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 345789999999999999999998764 45799998865432 2346778999999999999999999999999999
Q ss_pred EEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCc
Q 007260 293 LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 293 LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~ 372 (611)
|||||+++++|.+++....+..+++..+..++.||+.||+|||.+||+||||||+|||++.++.++|+|||++.......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 99999999999999987666778999999999999999999999999999999999999999999999999984321100
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
. ....
T Consensus 158 ~---------------------------------------------------------------------------~~~~ 162 (261)
T cd05072 158 Y---------------------------------------------------------------------------TARE 162 (261)
T ss_pred e---------------------------------------------------------------------------eccC
Confidence 0 0001
Q ss_pred ccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 007260 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLL 531 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L 531 (611)
...++..|+|||++.+..++.++|||||||++|+|++ |+.||.+.........+... ..++....++.++.+||.+||
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l 241 (261)
T cd05072 163 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG-YRMPRMENCPDELYDIMKTCW 241 (261)
T ss_pred CCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHc
Confidence 1236778999999998889999999999999999998 99999887766666555443 445555568999999999999
Q ss_pred hcCccccCCchhcHHHHHc
Q 007260 532 VKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 532 ~~dP~~Rpt~~~~a~elL~ 550 (611)
..+|++||+ ++++++
T Consensus 242 ~~~p~~Rp~----~~~i~~ 256 (261)
T cd05072 242 KEKAEERPT----FDYLQS 256 (261)
T ss_pred cCCcccCcC----HHHHHH
Confidence 999999999 677654
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=343.51 Aligned_cols=253 Identities=21% Similarity=0.302 Sum_probs=210.8
Q ss_pred cccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeE
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCL 293 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~L 293 (611)
...+|.+.+.||.|+||.||+|.+..+++.||+|++.+... ....+.+|+++|+.++|+||+++++++..+..+|+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (263)
T cd05052 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 79 (263)
T ss_pred chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch----HHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEE
Confidence 34679999999999999999999999999999999875432 23456789999999999999999999999999999
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcc
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 373 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~ 373 (611)
||||+++++|.+++.......+++..++.++.|++.||+|||.+||+||||||+|||+++++.+||+|||++........
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 99999999999998776556789999999999999999999999999999999999999999999999999843210000
Q ss_pred ccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccc
Q 007260 374 LIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMS 453 (611)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (611)
.....
T Consensus 160 ---------------------------------------------------------------------------~~~~~ 164 (263)
T cd05052 160 ---------------------------------------------------------------------------TAHAG 164 (263)
T ss_pred ---------------------------------------------------------------------------eccCC
Confidence 00001
Q ss_pred cccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007260 454 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLV 532 (611)
Q Consensus 454 ~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~ 532 (611)
..++..|+|||++.+..++.++|||||||++|||++ |..||.+....+.... +......+....++.++.+||.+||.
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~cl~ 243 (263)
T cd05052 165 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-LEKGYRMERPEGCPPKVYELMRACWQ 243 (263)
T ss_pred CCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HHCCCCCCCCCCCCHHHHHHHHHHcc
Confidence 124668999999999999999999999999999998 9999988655444443 33334444445689999999999999
Q ss_pred cCccccCCchhcHHHHHc
Q 007260 533 KEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 533 ~dP~~Rpt~~~~a~elL~ 550 (611)
.||++||+ +.++++
T Consensus 244 ~~p~~Rp~----~~~l~~ 257 (263)
T cd05052 244 WNPSDRPS----FAEIHQ 257 (263)
T ss_pred CCcccCCC----HHHHHH
Confidence 99999999 666654
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=348.46 Aligned_cols=267 Identities=41% Similarity=0.753 Sum_probs=215.7
Q ss_pred CeEEEeEecccCcEEEEEEEEC---CCCeEEEEEEecchhhhh-HHHHHHHHHHHHHHHhC-CCCCcccccceeecccee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELS---GTKCYFAMKVMDKASLAG-RKKLLRAQTEREILQSL-DHPFLPTLYTHFETEKFS 291 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~---~t~~~vAvKii~k~~~~~-~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~~~~ 291 (611)
+|++.+.||.|+||.||+|++. .++..||+|++....... .....++.+|+.+|+.+ +|+||+.+++.|+.+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4889999999999999999985 478899999997644322 22345667899999999 699999999999999999
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCC
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~ 371 (611)
|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+++++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 81 HLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 9999999999999988765 46899999999999999999999999999999999999999999999999998432100
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
. ....
T Consensus 159 ~---------------------------------------------------------------------------~~~~ 163 (290)
T cd05613 159 E---------------------------------------------------------------------------VERA 163 (290)
T ss_pred c---------------------------------------------------------------------------cccc
Confidence 0 0001
Q ss_pred cccccCCCccchhhhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHH----HHHHHHcCCCCCCCCCCCCHHHHH
Q 007260 452 MSFVGTHEYLAPEIIKGE--GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRA----TLFNVVGQPLRFPESPVVSFAARD 525 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~~--~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~----~l~~i~~~~l~~p~~~~~s~~l~d 525 (611)
..+.|+..|+|||++.+. .++.++|||||||++|+|++|+.||....... ....+......+ ...++..+.+
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 241 (290)
T cd05613 164 YSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY--PQEMSALAKD 241 (290)
T ss_pred ccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCC--CccCCHHHHH
Confidence 134689999999999763 46789999999999999999999997543322 222222332223 3348899999
Q ss_pred HHHHhhhcCccccCCc-hhcHHHHHcCCCCCCCchhhh
Q 007260 526 LIRGLLVKEPQHRLAY-KRGATEIKQHPFFEGVNWALI 562 (611)
Q Consensus 526 LI~~~L~~dP~~Rpt~-~~~a~elL~Hp~f~~~~~~~~ 562 (611)
||.+||..||++|++. ...+++++.||||+.++|...
T Consensus 242 ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~ 279 (290)
T cd05613 242 IIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDL 279 (290)
T ss_pred HHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHHH
Confidence 9999999999999832 123999999999999999765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=340.45 Aligned_cols=256 Identities=26% Similarity=0.421 Sum_probs=213.5
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec--cceeeEE
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET--EKFSCLV 294 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~--~~~~~LV 294 (611)
+|++++.||.|+||.||+|.+..++..||+|++...... .....++..|+.+++.++|+||+++++++.. +...|+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 589999999999999999999999999999998765433 3344567789999999999999999998753 5678999
Q ss_pred eeeCCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHH-----HcCeeccCCCCCcEEEccCCcEEEEecccccc
Q 007260 295 MEFCPGGDLHTLRQKQ--PGKYFPEQAVRFYVAEVLLALEYLH-----MLGIIYRDLKPENVLVREDGHIMLSDFDLSLR 367 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~--~~~~l~e~~~~~i~~qll~aL~yLH-----~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~ 367 (611)
|||+++++|.+++... ....+++..++.++.||+.||+||| ..+|+||||||+|||++.++.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 9999999999988653 2356899999999999999999999 89999999999999999999999999998733
Q ss_pred ccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcc
Q 007260 368 CAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPT 447 (611)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (611)
....
T Consensus 160 ~~~~---------------------------------------------------------------------------- 163 (265)
T cd08217 160 LGHD---------------------------------------------------------------------------- 163 (265)
T ss_pred ccCC----------------------------------------------------------------------------
Confidence 2100
Q ss_pred cccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 007260 448 EARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLI 527 (611)
Q Consensus 448 ~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI 527 (611)
.......+|++.|+|||++.+..++.++|+||||+++|+|++|+.||...........+..... ......++..+.+||
T Consensus 164 ~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~ 242 (265)
T cd08217 164 SSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKF-RRIPYRYSSELNEVI 242 (265)
T ss_pred cccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCC-CCCccccCHHHHHHH
Confidence 0001123589999999999998899999999999999999999999998765444444443332 222335789999999
Q ss_pred HHhhhcCccccCCchhcHHHHHcCCCC
Q 007260 528 RGLLVKEPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 528 ~~~L~~dP~~Rpt~~~~a~elL~Hp~f 554 (611)
.+||..+|.+||+ +.+|++|||+
T Consensus 243 ~~~l~~~p~~Rp~----~~~il~~~~~ 265 (265)
T cd08217 243 KSMLNVDPDKRPS----TEELLQLPLI 265 (265)
T ss_pred HHHccCCcccCCC----HHHHhhCCCC
Confidence 9999999999999 9999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=384.77 Aligned_cols=272 Identities=29% Similarity=0.388 Sum_probs=216.4
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC-CCCcccccc-eeec---
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD-HPFLPTLYT-HFET--- 287 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~-HpnIv~l~~-~~~~--- 287 (611)
++.-+++|.+.|.+|||+.||+|++...+..||+|.|--. +...+..+.+|+++|+.|. |+|||.+++ ....
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~ 110 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS 110 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence 4456788999999999999999999998889999988544 3456667789999999996 999999999 3321
Q ss_pred ---cceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--eeccCCCCCcEEEccCCcEEEEec
Q 007260 288 ---EKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLG--IIYRDLKPENVLVREDGHIMLSDF 362 (611)
Q Consensus 288 ---~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~g--IVHRDLKPeNILv~~~g~vkL~DF 362 (611)
.-.++|.||||.||.|-+++..+-...|+|.++..|++|+++||.+||.+. |||||||-|||||..+|+.|||||
T Consensus 111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred CCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcc
Confidence 245789999999999999998655566999999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCccc
Q 007260 363 DLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPEL 442 (611)
Q Consensus 363 GlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (611)
|-|...-..++.. .+ +..+
T Consensus 191 GSatt~~~~~~~~------------------------------------------------------~e----~~~v--- 209 (738)
T KOG1989|consen 191 GSATTKILSPTSA------------------------------------------------------QE----VNYV--- 209 (738)
T ss_pred cccccccCCCccH------------------------------------------------------HH----HHHH---
Confidence 9873221111000 00 0000
Q ss_pred ccCcccccccccccCCCccchhhh---ccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCC
Q 007260 443 IAEPTEARSMSFVGTHEYLAPEII---KGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVV 519 (611)
Q Consensus 443 ~~~~~~~~~~~~vGT~~Y~APEil---~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~ 519 (611)
.......-|+.|+|||+| .+.+.+.|+|||||||+||.|++...||.+.+.. .|+...+.||..+..
T Consensus 210 ------e~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l----aIlng~Y~~P~~p~y 279 (738)
T KOG1989|consen 210 ------EEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL----AILNGNYSFPPFPNY 279 (738)
T ss_pred ------HHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----eEEeccccCCCCccH
Confidence 001122478999999987 4677899999999999999999999999986554 567888999999999
Q ss_pred CHHHHHHHHHhhhcCccccCCchhcHHHHH----cCCCCCCCc
Q 007260 520 SFAARDLIRGLLVKEPQHRLAYKRGATEIK----QHPFFEGVN 558 (611)
Q Consensus 520 s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL----~Hp~f~~~~ 558 (611)
+..+++||+.||+.||.+||...+...++. .+.|+..+.
T Consensus 280 s~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~~ 322 (738)
T KOG1989|consen 280 SDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDIY 322 (738)
T ss_pred HHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccccc
Confidence 999999999999999999999433222222 345555443
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=346.74 Aligned_cols=267 Identities=42% Similarity=0.762 Sum_probs=216.6
Q ss_pred CeEEEeEecccCcEEEEEEEEC---CCCeEEEEEEecchhhhh-HHHHHHHHHHHHHHHhC-CCCCcccccceeecccee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELS---GTKCYFAMKVMDKASLAG-RKKLLRAQTEREILQSL-DHPFLPTLYTHFETEKFS 291 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~---~t~~~vAvKii~k~~~~~-~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~~~~ 291 (611)
+|++.+.||.|+||.||++++. .++..||||++.+..... .....++.+|+.++..+ +||||+.+++.|..+..+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4889999999999999999864 356789999997654322 23345677899999999 699999999999999999
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCC
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~ 371 (611)
||||||+++++|.+++... ..+++..++.++.|++.||+|||..||+||||||.|||++.++.++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 9999999999999988764 46899999999999999999999999999999999999999999999999987332100
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
.....
T Consensus 159 ---------------------------------------------------------------------------~~~~~ 163 (288)
T cd05583 159 ---------------------------------------------------------------------------EEERA 163 (288)
T ss_pred ---------------------------------------------------------------------------ccccc
Confidence 00001
Q ss_pred cccccCCCccchhhhccCC--CCChhhHHHHHHHHHHHHhCCCCCCCCCcH----HHHHHHHcCCCCCCCCCCCCHHHHH
Q 007260 452 MSFVGTHEYLAPEIIKGEG--HGSAVDWWTFGIFLYELLFGKTPFKGSGNR----ATLFNVVGQPLRFPESPVVSFAARD 525 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~~~--~~~~sDIWSLGviL~ELltG~~PF~~~~~~----~~l~~i~~~~l~~p~~~~~s~~l~d 525 (611)
..+.|+..|+|||.+.+.. ++.++||||||+++|||++|..||...... .....+..... +....++..+++
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~ 241 (288)
T cd05583 164 YSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKP--PFPKTMSAEARD 241 (288)
T ss_pred ccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCC--CCCcccCHHHHH
Confidence 1245889999999998765 688999999999999999999999653322 22233333332 333448899999
Q ss_pred HHHHhhhcCccccCCchhcHHHHHcCCCCCCCchhhhc
Q 007260 526 LIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIR 563 (611)
Q Consensus 526 LI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~ 563 (611)
||.+||..||++||+.. .+.++|+||||+.++|..+.
T Consensus 242 li~~~l~~~p~~R~t~~-~~~~~l~~~~~~~~~~~~~~ 278 (288)
T cd05583 242 FIQKLLEKDPKKRLGAN-GADEIKNHPFFQGIDWDDLA 278 (288)
T ss_pred HHHHHhcCCHhhccCcc-hHHHHhcCcccccCCHHHHh
Confidence 99999999999999843 47889999999999997663
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=343.42 Aligned_cols=255 Identities=25% Similarity=0.383 Sum_probs=209.6
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
++|++.+.||.|+||.||+|++..+++.||||.+........+....+.+|+++|+.++||||+++++++...+..|+||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 58999999999999999999999999999999887644444455566788999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcc
Q 007260 296 EFCPGGDLHTLRQKQ--PGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 373 (611)
Q Consensus 296 E~~~gg~L~~ll~~~--~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~ 373 (611)
||+++++|.+++... ....+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~- 160 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh-
Confidence 999999999887642 23458999999999999999999999999999999999999999999999999874321000
Q ss_pred ccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccc
Q 007260 374 LIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMS 453 (611)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (611)
.....
T Consensus 161 ---------------------------------------------------------------------------~~~~~ 165 (267)
T cd08228 161 ---------------------------------------------------------------------------TAAHS 165 (267)
T ss_pred ---------------------------------------------------------------------------HHHhc
Confidence 00012
Q ss_pred cccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHcCCCCCCC-CCCCCHHHHHHHHHhh
Q 007260 454 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGN-RATLFNVVGQPLRFPE-SPVVSFAARDLIRGLL 531 (611)
Q Consensus 454 ~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~-~~~l~~i~~~~l~~p~-~~~~s~~l~dLI~~~L 531 (611)
..|++.|+|||.+.+..++.++|+|||||++|||++|+.||..... ...+...+......+. ...++..+++||.+||
T Consensus 166 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl 245 (267)
T cd08228 166 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCI 245 (267)
T ss_pred CCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHC
Confidence 3588899999999998899999999999999999999999975432 2233333332211111 2247789999999999
Q ss_pred hcCccccCCchhcHHHHHc
Q 007260 532 VKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 532 ~~dP~~Rpt~~~~a~elL~ 550 (611)
..+|.+||+ +.++++
T Consensus 246 ~~~p~~Rp~----~~~vl~ 260 (267)
T cd08228 246 YPDPDQRPD----IGYVHQ 260 (267)
T ss_pred CCCcccCcC----HHHHHH
Confidence 999999999 888876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=340.22 Aligned_cols=259 Identities=31% Similarity=0.540 Sum_probs=216.6
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVME 296 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE 296 (611)
+|.+.+.||.|+||.||++.+..+++.||+|++...... ......+..|+.+++.++|+||+++++++...+.+++|||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 589999999999999999999989999999999765533 4566778899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccc
Q 007260 297 FCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIK 376 (611)
Q Consensus 297 ~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~ 376 (611)
|+++++|.+++... ..+++..++.++.|++.||.|||++||+||||+|+||+++.++.+||+|||++.........
T Consensus 80 ~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~-- 155 (264)
T cd06626 80 YCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT-- 155 (264)
T ss_pred cCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc--
Confidence 99999999998764 45899999999999999999999999999999999999999999999999998443211000
Q ss_pred cccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccccc
Q 007260 377 ASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVG 456 (611)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vG 456 (611)
.........|
T Consensus 156 ----------------------------------------------------------------------~~~~~~~~~~ 165 (264)
T cd06626 156 ----------------------------------------------------------------------MGEEVQSLAG 165 (264)
T ss_pred ----------------------------------------------------------------------ccccccCCcC
Confidence 0000012358
Q ss_pred CCCccchhhhccCC---CCChhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHH-cCCCCCCCCCCCCHHHHHHHHHhh
Q 007260 457 THEYLAPEIIKGEG---HGSAVDWWTFGIFLYELLFGKTPFKGSGNRAT-LFNVV-GQPLRFPESPVVSFAARDLIRGLL 531 (611)
Q Consensus 457 T~~Y~APEil~~~~---~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~-l~~i~-~~~l~~p~~~~~s~~l~dLI~~~L 531 (611)
++.|+|||++.+.. ++.++|||||||++|+|++|+.||........ ...+. .....+|....++..+.+||.+||
T Consensus 166 ~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 245 (264)
T cd06626 166 TPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCL 245 (264)
T ss_pred CcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHc
Confidence 88999999998776 78999999999999999999999976543333 33332 223445555557999999999999
Q ss_pred hcCccccCCchhcHHHHHcCCCC
Q 007260 532 VKEPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 532 ~~dP~~Rpt~~~~a~elL~Hp~f 554 (611)
..||.+||+ +.+++.|||+
T Consensus 246 ~~~p~~R~~----~~~i~~~~~~ 264 (264)
T cd06626 246 ESDPKKRPT----ASELLQHPFV 264 (264)
T ss_pred cCCcccCCC----HHHHhcCCCC
Confidence 999999999 9999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=351.78 Aligned_cols=261 Identities=25% Similarity=0.347 Sum_probs=209.3
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC-CCCcccccceeeccceeeEE
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD-HPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~-HpnIv~l~~~~~~~~~~~LV 294 (611)
++|...+.||.|+||.||++.+..+++.||||.+.+.... .....+.+|+.++.++. |+||+++++++..+...|+|
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 4677788999999999999999999999999998765432 33446778999999996 99999999999999999999
Q ss_pred eeeCCCCCHHHHHH---hCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CeeccCCCCCcEEEccCCcEEEEeccccccccC
Q 007260 295 MEFCPGGDLHTLRQ---KQPGKYFPEQAVRFYVAEVLLALEYLHML-GIIYRDLKPENVLVREDGHIMLSDFDLSLRCAV 370 (611)
Q Consensus 295 mE~~~gg~L~~ll~---~~~~~~l~e~~~~~i~~qll~aL~yLH~~-gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~ 370 (611)
|||+. ++|.++.. ......+++..+..++.|++.||+|||+. ||+||||||+|||++.++.++|+|||++.....
T Consensus 82 ~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 82 MELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred Eeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 99994 56655432 22335799999999999999999999974 999999999999999999999999999843210
Q ss_pred CccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccc
Q 007260 371 SPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEAR 450 (611)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (611)
. ..
T Consensus 161 ~-----------------------------------------------------------------------------~~ 163 (288)
T cd06616 161 S-----------------------------------------------------------------------------IA 163 (288)
T ss_pred C-----------------------------------------------------------------------------Cc
Confidence 0 00
Q ss_pred ccccccCCCccchhhhccC---CCCChhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHcCC-CCCC--CCCCCCHHH
Q 007260 451 SMSFVGTHEYLAPEIIKGE---GHGSAVDWWTFGIFLYELLFGKTPFKGSGNR-ATLFNVVGQP-LRFP--ESPVVSFAA 523 (611)
Q Consensus 451 ~~~~vGT~~Y~APEil~~~---~~~~~sDIWSLGviL~ELltG~~PF~~~~~~-~~l~~i~~~~-l~~p--~~~~~s~~l 523 (611)
.....|++.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+.++.... ...+ ....++.++
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 243 (288)
T cd06616 164 KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSF 243 (288)
T ss_pred cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHH
Confidence 0122488999999999876 6899999999999999999999999865422 2233333221 1222 123488999
Q ss_pred HHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCchh
Q 007260 524 RDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWA 560 (611)
Q Consensus 524 ~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~ 560 (611)
.+||.+||.+||.+||+ +++|+.||||+...|.
T Consensus 244 ~~li~~~l~~~p~~Rpt----~~~i~~~~~~~~~~~~ 276 (288)
T cd06616 244 VNFINLCLIKDESKRPK----YKELLEHPFIKDYEER 276 (288)
T ss_pred HHHHHHHccCChhhCcC----HHHHhcChhhhchhhc
Confidence 99999999999999999 9999999999876553
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=373.67 Aligned_cols=244 Identities=28% Similarity=0.495 Sum_probs=215.7
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSC 292 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~ 292 (611)
+-++...-++.||+|+.|.||+++... +.||||.++.-. .++|+.|++|+||||+.+.++|...-.+|
T Consensus 121 iPFe~IsELeWlGSGaQGAVF~Grl~n--etVAVKKV~elk----------ETdIKHLRkLkH~NII~FkGVCtqsPcyC 188 (904)
T KOG4721|consen 121 IPFEEISELEWLGSGAQGAVFLGRLHN--ETVAVKKVRELK----------ETDIKHLRKLKHPNIITFKGVCTQSPCYC 188 (904)
T ss_pred CCHHHhhhhhhhccCcccceeeeeccC--ceehhHHHhhhh----------hhhHHHHHhccCcceeeEeeeecCCceeE
Confidence 333444456789999999999998874 569999875322 35888899999999999999999999999
Q ss_pred EEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCc
Q 007260 293 LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 293 LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~ 372 (611)
||||||..|-|.++++.. ..+.......|..+|+.|+.|||.+.|||||||.-||||..+..|||+|||.++.+.
T Consensus 189 IiMEfCa~GqL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~--- 263 (904)
T KOG4721|consen 189 IIMEFCAQGQLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELS--- 263 (904)
T ss_pred EeeeccccccHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhh---
Confidence 999999999999998875 568888889999999999999999999999999999999999999999999873321
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
.....|
T Consensus 264 --------------------------------------------------------------------------~~STkM 269 (904)
T KOG4721|consen 264 --------------------------------------------------------------------------DKSTKM 269 (904)
T ss_pred --------------------------------------------------------------------------hhhhhh
Confidence 113457
Q ss_pred ccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007260 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLV 532 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~ 532 (611)
+|+||..|||||+|+.++.+.++|||||||+|||||||..||.+-+..++++-+-...+.+|.+..+++.++-||+.||.
T Consensus 270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~ 349 (904)
T KOG4721|consen 270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWN 349 (904)
T ss_pred hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHh
Confidence 89999999999999999999999999999999999999999999888888887777778888888899999999999999
Q ss_pred cCccccCCchhcHHHHHcC
Q 007260 533 KEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 533 ~dP~~Rpt~~~~a~elL~H 551 (611)
-.|..||+ ..+||.|
T Consensus 350 sKpRNRPS----Frqil~H 364 (904)
T KOG4721|consen 350 SKPRNRPS----FRQILLH 364 (904)
T ss_pred cCCCCCcc----HHHHHHH
Confidence 99999999 7788877
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=352.38 Aligned_cols=260 Identities=26% Similarity=0.374 Sum_probs=204.2
Q ss_pred CeEEEeEecccCcEEEEEEEECC--CCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecc--ceee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSG--TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE--KFSC 292 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~--t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~--~~~~ 292 (611)
+|++.+.||.|+||.||+|.+.. ++..||||++.............+.+|+.++..++||||+++++++... ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48999999999999999999988 8899999999764322223334567799999999999999999999987 8899
Q ss_pred EEeeeCCCCCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEcc----CCcEEEEecccc
Q 007260 293 LVMEFCPGGDLHTLRQKQP---GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRE----DGHIMLSDFDLS 365 (611)
Q Consensus 293 LVmE~~~gg~L~~ll~~~~---~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~----~g~vkL~DFGlA 365 (611)
|||||++ ++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 9999995 57776664321 236899999999999999999999999999999999999999 899999999998
Q ss_pred ccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccC
Q 007260 366 LRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAE 445 (611)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (611)
..+.....
T Consensus 160 ~~~~~~~~------------------------------------------------------------------------ 167 (316)
T cd07842 160 RLFNAPLK------------------------------------------------------------------------ 167 (316)
T ss_pred cccCCCcc------------------------------------------------------------------------
Confidence 43321000
Q ss_pred cccccccccccCCCccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHH---------HHHHH---HcC---
Q 007260 446 PTEARSMSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRA---------TLFNV---VGQ--- 509 (611)
Q Consensus 446 ~~~~~~~~~vGT~~Y~APEil~~~-~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~---------~l~~i---~~~--- 509 (611)
........+||+.|+|||++.+. .++.++|||||||+||+|++|++||.+..... .+..+ +..
T Consensus 168 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 246 (316)
T cd07842 168 -PLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTE 246 (316)
T ss_pred -cccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCch
Confidence 00001124689999999998775 57899999999999999999999998654321 11111 110
Q ss_pred --------------------CCCCCC---------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCC
Q 007260 510 --------------------PLRFPE---------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 510 --------------------~l~~p~---------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f 554 (611)
...++. ....+..+.++|.+||..||++||+ +.|+++||||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps----~~eil~~~~f 316 (316)
T cd07842 247 KDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRIT----AEEALEHPYF 316 (316)
T ss_pred hHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcC----HHHHhcCCCC
Confidence 001110 0146778999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=325.71 Aligned_cols=258 Identities=27% Similarity=0.477 Sum_probs=215.6
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVME 296 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE 296 (611)
.|.-+++||+|.||+||+|+...+.+.||+|.++-+.. .......+.+|+.+|+.|+|.|||+|+++...++.+-||+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 56667899999999999999999999999999875432 22233456789999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccc
Q 007260 297 FCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIK 376 (611)
Q Consensus 297 ~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~ 376 (611)
|| ..+|..+...-. +.++.+.++.++.|+++||.|+|++++.||||||.|+||+.+|.+||+|||+++.++..-.
T Consensus 82 ~c-dqdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvr--- 156 (292)
T KOG0662|consen 82 FC-DQDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR--- 156 (292)
T ss_pred Hh-hHHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceE---
Confidence 99 679988877764 6799999999999999999999999999999999999999999999999999965542110
Q ss_pred cccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccccc
Q 007260 377 ASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVG 456 (611)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vG 456 (611)
|.+ .-|-
T Consensus 157 -----------------------------------cys--------------------------------------aevv 163 (292)
T KOG0662|consen 157 -----------------------------------CYS--------------------------------------AEVV 163 (292)
T ss_pred -----------------------------------eee--------------------------------------ceee
Confidence 211 2368
Q ss_pred CCCccchhhhccCC-CCChhhHHHHHHHHHHHH-hCCCCCCCCCcHHHHHHHH---cCCC--CCCC------------C-
Q 007260 457 THEYLAPEIIKGEG-HGSAVDWWTFGIFLYELL-FGKTPFKGSGNRATLFNVV---GQPL--RFPE------------S- 516 (611)
Q Consensus 457 T~~Y~APEil~~~~-~~~~sDIWSLGviL~ELl-tG~~PF~~~~~~~~l~~i~---~~~l--~~p~------------~- 516 (611)
|.||++|.++.|.. |+...|+||.|||+.||. .|++.|.|.+-.+++.+|. +.+. .||. .
T Consensus 164 tlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~yp 243 (292)
T KOG0662|consen 164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYP 243 (292)
T ss_pred eeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCcc
Confidence 99999999999886 688999999999999999 5999999988887776654 3321 1111 1
Q ss_pred ---------CCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 517 ---------PVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 517 ---------~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
+.++...+||++++|..+|.+|++ |+++++||||...
T Consensus 244 attswsqivp~lns~grdllqkll~cnp~qris----aeaalqhpyf~d~ 289 (292)
T KOG0662|consen 244 ATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRIS----AEAALQHPYFSDF 289 (292)
T ss_pred ccchHHHHhhhhcchhHHHHHHHhccCcccccC----HHHHhcCcccccc
Confidence 234456789999999999999999 9999999999753
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=348.88 Aligned_cols=256 Identities=28% Similarity=0.429 Sum_probs=203.4
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
..+|++++.||.|+||.||+|.+..++..||||++....... ....+.+|+.+|+.++|+||+++++++..+...|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG--VPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC--CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 368999999999999999999999999999999986543221 122456799999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
|||+. ++|.+++.... ..+++..++.++.||+.||+|||.+||+||||||+|||++.++.++|+|||++......
T Consensus 82 ~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--- 156 (291)
T cd07870 82 FEYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP--- 156 (291)
T ss_pred Eeccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCC---
Confidence 99995 67777665543 45788899999999999999999999999999999999999999999999987321100
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
.......
T Consensus 157 -------------------------------------------------------------------------~~~~~~~ 163 (291)
T cd07870 157 -------------------------------------------------------------------------SQTYSSE 163 (291)
T ss_pred -------------------------------------------------------------------------CCCCCCc
Confidence 0000123
Q ss_pred ccCCCccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHH---cCCC-----------C-----C
Q 007260 455 VGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGNR-ATLFNVV---GQPL-----------R-----F 513 (611)
Q Consensus 455 vGT~~Y~APEil~~~-~~~~~sDIWSLGviL~ELltG~~PF~~~~~~-~~l~~i~---~~~l-----------~-----~ 513 (611)
++++.|+|||++.+. .++.++|||||||++|||++|+.||.+.... +.+.+++ +.+. . +
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (291)
T cd07870 164 VVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWF 243 (291)
T ss_pred cccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhc
Confidence 578999999998764 5788999999999999999999999865432 2222221 1100 0 0
Q ss_pred ----CC-------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCC
Q 007260 514 ----PE-------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 514 ----p~-------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f 554 (611)
+. ....+..+.+||.+||..||.+||| +.|++.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t----~~~~l~h~~~ 291 (291)
T cd07870 244 LPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRIS----AQDALLHPYF 291 (291)
T ss_pred cccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcC----HHHHhcCCCC
Confidence 00 0113578999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=347.59 Aligned_cols=256 Identities=28% Similarity=0.422 Sum_probs=214.9
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
..|+.++.||.|+||.||+|.+..++..||||++..... ......+.+|+.+++.++|+||+++++++.++...||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 368888999999999999999999999999999875432 234457788999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
||++|++|.+++... .+++..+..++.|++.||+|||++||+|+||+|+||+++.++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~---- 154 (277)
T cd06640 82 EYLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT---- 154 (277)
T ss_pred ecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCC----
Confidence 999999999988653 5899999999999999999999999999999999999999999999999998432100
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
........
T Consensus 155 ------------------------------------------------------------------------~~~~~~~~ 162 (277)
T cd06640 155 ------------------------------------------------------------------------QIKRNTFV 162 (277)
T ss_pred ------------------------------------------------------------------------cccccccc
Confidence 00011235
Q ss_pred cCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCc
Q 007260 456 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEP 535 (611)
Q Consensus 456 GT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP 535 (611)
|+..|+|||++.+..++.++|+|||||++|||++|..||...........+.... .......++..+.+||.+||..+|
T Consensus 163 ~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p 241 (277)
T cd06640 163 GTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN-PPTLTGEFSKPFKEFIDACLNKDP 241 (277)
T ss_pred CcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCC-CCCCchhhhHHHHHHHHHHcccCc
Confidence 8889999999998889999999999999999999999998776555444432221 111223477889999999999999
Q ss_pred cccCCchhcHHHHHcCCCCCCC
Q 007260 536 QHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 536 ~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
++||+ +.++++|+||...
T Consensus 242 ~~Rp~----~~~il~~~~~~~~ 259 (277)
T cd06640 242 SFRPT----AKELLKHKFIVKN 259 (277)
T ss_pred ccCcC----HHHHHhChHhhhc
Confidence 99999 9999999999653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=349.92 Aligned_cols=261 Identities=29% Similarity=0.408 Sum_probs=203.9
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecc------
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE------ 288 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~------ 288 (611)
+++|++++.||.|+||.||+|++..++..||||++...... ......+.+|+.++++++||||+++++++...
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc-CCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 46899999999999999999999999999999998654321 12223456799999999999999999987654
Q ss_pred --ceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccc
Q 007260 289 --KFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSL 366 (611)
Q Consensus 289 --~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~ 366 (611)
...|+||||+. ++|..++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 34599999994 58888776542 468999999999999999999999999999999999999999999999999984
Q ss_pred cccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCc
Q 007260 367 RCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEP 446 (611)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (611)
........
T Consensus 168 ~~~~~~~~------------------------------------------------------------------------ 175 (310)
T cd07865 168 AFSLSKNS------------------------------------------------------------------------ 175 (310)
T ss_pred cccCCccc------------------------------------------------------------------------
Confidence 33210000
Q ss_pred ccccccccccCCCccchhhhccCC-CCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH---HHcCC------------
Q 007260 447 TEARSMSFVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFN---VVGQP------------ 510 (611)
Q Consensus 447 ~~~~~~~~vGT~~Y~APEil~~~~-~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~---i~~~~------------ 510 (611)
........+++..|+|||++.+.. ++.++|||||||++|||++|++||.+......+.. +.+..
T Consensus 176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (310)
T cd07865 176 KPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLE 255 (310)
T ss_pred CCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchh
Confidence 000001235889999999987754 68899999999999999999999987665433222 11110
Q ss_pred ----CCCCC-----------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCC
Q 007260 511 ----LRFPE-----------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 511 ----l~~p~-----------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f 554 (611)
..++. ....+..+++||.+||..||.+||+ ++++++||||
T Consensus 256 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t----~~e~l~h~~f 310 (310)
T cd07865 256 LFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRID----ADTALNHDFF 310 (310)
T ss_pred hhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccC----HHHHhcCCCC
Confidence 00111 0123567889999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=340.41 Aligned_cols=250 Identities=23% Similarity=0.350 Sum_probs=207.6
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
.++|++++.||.|+||.||++++.. +..+|+|.+.+..... ..+.+|+.+|+.++||||+++++++......|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMSE----EDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCccH----HHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence 3579999999999999999998865 4579999987544322 3466799999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
|||++||+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~-- 154 (256)
T cd05114 78 TEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE-- 154 (256)
T ss_pred EEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCc--
Confidence 99999999999887643 358999999999999999999999999999999999999999999999999874321000
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
.......
T Consensus 155 -------------------------------------------------------------------------~~~~~~~ 161 (256)
T cd05114 155 -------------------------------------------------------------------------YTSSSGA 161 (256)
T ss_pred -------------------------------------------------------------------------eeccCCC
Confidence 0000112
Q ss_pred ccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007260 455 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVK 533 (611)
Q Consensus 455 vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~ 533 (611)
.++..|+|||++.+..++.++|||||||++|||++ |+.||........+..+..+. ........+.++.+||.+||..
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~li~~c~~~ 240 (256)
T cd05114 162 KFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF-RLYRPKLASMTVYEVMYSCWHE 240 (256)
T ss_pred CCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-CCCCCCCCCHHHHHHHHHHccC
Confidence 35678999999998899999999999999999999 999999887777766666543 2222334788999999999999
Q ss_pred CccccCCchhcHHHHHc
Q 007260 534 EPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 534 dP~~Rpt~~~~a~elL~ 550 (611)
||++||+ +.++++
T Consensus 241 ~p~~Rps----~~~l~~ 253 (256)
T cd05114 241 KPEGRPT----FAELLR 253 (256)
T ss_pred CcccCcC----HHHHHH
Confidence 9999999 788775
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=360.44 Aligned_cols=257 Identities=21% Similarity=0.306 Sum_probs=207.3
Q ss_pred ccCeEEEeEecccCcEEEEEEEECC-----CCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeec-
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSG-----TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFET- 287 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~-----t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~- 287 (611)
.++|++++.||.|+||.||+|.+.+ +++.||+|+++.... ......+..|+.+++++ +|+||+++++++..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT--ASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC--HHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 4589999999999999999997544 457899999865332 23344567899999999 89999999998764
Q ss_pred cceeeEEeeeCCCCCHHHHHHhCCC-------------------------------------------------------
Q 007260 288 EKFSCLVMEFCPGGDLHTLRQKQPG------------------------------------------------------- 312 (611)
Q Consensus 288 ~~~~~LVmE~~~gg~L~~ll~~~~~------------------------------------------------------- 312 (611)
+..+|+||||+++++|.+++.....
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 5678999999999999998864321
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccccCCCCcCcCC
Q 007260 313 ----KYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKN 388 (611)
Q Consensus 313 ----~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~ 388 (611)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+.....
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~--------------- 228 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD--------------- 228 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcc---------------
Confidence 2588999999999999999999999999999999999999999999999999854321100
Q ss_pred CccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCccchhhhcc
Q 007260 389 PVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKG 468 (611)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~ 468 (611)
........|+..|+|||++.+
T Consensus 229 -----------------------------------------------------------~~~~~~~~~~~~y~aPE~~~~ 249 (337)
T cd05054 229 -----------------------------------------------------------YVRKGDARLPLKWMAPESIFD 249 (337)
T ss_pred -----------------------------------------------------------hhhccCCCCCccccCcHHhcC
Confidence 001112346778999999999
Q ss_pred CCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHH
Q 007260 469 EGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATE 547 (611)
Q Consensus 469 ~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~e 547 (611)
..++.++|||||||+||||++ |..||.+....+.+...+...........+++++.+++.+||+.+|++||+ +.+
T Consensus 250 ~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs----~~e 325 (337)
T cd05054 250 KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPT----FSE 325 (337)
T ss_pred CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcC----HHH
Confidence 999999999999999999997 999998765545554554444443334458899999999999999999999 888
Q ss_pred HHcC
Q 007260 548 IKQH 551 (611)
Q Consensus 548 lL~H 551 (611)
|++|
T Consensus 326 ll~~ 329 (337)
T cd05054 326 LVEI 329 (337)
T ss_pred HHHH
Confidence 8775
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=367.18 Aligned_cols=254 Identities=21% Similarity=0.302 Sum_probs=207.3
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCC-----CeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC-CCCcccccceee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGT-----KCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD-HPFLPTLYTHFE 286 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t-----~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~-HpnIv~l~~~~~ 286 (611)
+..++|+++++||.|+||.||+|.+... +..||||++..... ......+.+|+++|++++ |||||++++++.
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR--SSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 3456899999999999999999987543 34699999965432 223346788999999996 999999999999
Q ss_pred ccceeeEEeeeCCCCCHHHHHHhCC-------------------------------------------------------
Q 007260 287 TEKFSCLVMEFCPGGDLHTLRQKQP------------------------------------------------------- 311 (611)
Q Consensus 287 ~~~~~~LVmE~~~gg~L~~ll~~~~------------------------------------------------------- 311 (611)
....+|||||||++|+|.+++..+.
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 9999999999999999998876531
Q ss_pred ---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEc
Q 007260 312 ---------------------------------------GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVR 352 (611)
Q Consensus 312 ---------------------------------------~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~ 352 (611)
...+++..+..++.||+.||+|||.+||+||||||+|||++
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~ 271 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe
Confidence 13478888999999999999999999999999999999999
Q ss_pred cCCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCcccc
Q 007260 353 EDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEI 432 (611)
Q Consensus 353 ~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (611)
.++.+||+|||++..+.....
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~----------------------------------------------------------- 292 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSN----------------------------------------------------------- 292 (400)
T ss_pred CCCEEEEEeCCcceecccccc-----------------------------------------------------------
Confidence 999999999999843221000
Q ss_pred CCCCCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCC
Q 007260 433 GNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPL 511 (611)
Q Consensus 433 ~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l 511 (611)
........|++.|+|||++.+..++.++|||||||++|||++ |..||........+...+....
T Consensus 293 ---------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~ 357 (400)
T cd05105 293 ---------------YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGY 357 (400)
T ss_pred ---------------ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCC
Confidence 000112347888999999999999999999999999999996 9999987665555555555555
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCccccCCch
Q 007260 512 RFPESPVVSFAARDLIRGLLVKEPQHRLAYK 542 (611)
Q Consensus 512 ~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~ 542 (611)
..+....++.++.+||.+||..||++||++.
T Consensus 358 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 388 (400)
T cd05105 358 RMAKPDHATQEVYDIMVKCWNSEPEKRPSFL 388 (400)
T ss_pred CCCCCccCCHHHHHHHHHHCccCHhHCcCHH
Confidence 5555566899999999999999999999943
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=355.85 Aligned_cols=259 Identities=25% Similarity=0.406 Sum_probs=205.9
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecc-----ce
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE-----KF 290 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~-----~~ 290 (611)
++|++.+.||.|+||.||+|.+..++..||||++.... ......++.+|+.+|+.++|+||+++++++... ..
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 68999999999999999999999999999999986422 223345567899999999999999999987543 45
Q ss_pred eeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccC
Q 007260 291 SCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAV 370 (611)
Q Consensus 291 ~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~ 370 (611)
.|+||||+. ++|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 83 ~~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 83 VYIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred EEEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 899999995 588877754 4599999999999999999999999999999999999999999999999999843221
Q ss_pred CccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccc
Q 007260 371 SPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEAR 450 (611)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (611)
... ....
T Consensus 159 ~~~-------------------------------------------------------------------------~~~~ 165 (336)
T cd07849 159 EHD-------------------------------------------------------------------------HTGF 165 (336)
T ss_pred ccc-------------------------------------------------------------------------ccCC
Confidence 000 0000
Q ss_pred ccccccCCCccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH---HcCCC---------------
Q 007260 451 SMSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNV---VGQPL--------------- 511 (611)
Q Consensus 451 ~~~~vGT~~Y~APEil~~-~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i---~~~~l--------------- 511 (611)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+......+..+ ++.+.
T Consensus 166 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (336)
T cd07849 166 LTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNY 245 (336)
T ss_pred cCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhH
Confidence 112468999999998765 46799999999999999999999999876543332221 11110
Q ss_pred ----CC----C---CCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 512 ----RF----P---ESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 512 ----~~----p---~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
.. + ..+.++.++.+||.+||..||.+||+ +.++++||||+.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt----~~e~l~hp~~~~~ 298 (336)
T cd07849 246 IKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRIT----VEEALAHPYLEQY 298 (336)
T ss_pred HhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcC----HHHHhcCcccccc
Confidence 00 0 01236788999999999999999999 9999999999854
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=351.49 Aligned_cols=257 Identities=25% Similarity=0.422 Sum_probs=216.0
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
++|.+++.||.|+||.||++.+..++..||+|.+...... ....+.+|+.+++.++||||+++++.|...+..|+||
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP---KKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccch---HHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 5899999999999999999999888899999998654322 2345678999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
||+++++|.+++.+. .+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 96 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~---- 168 (293)
T cd06647 96 EYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---- 168 (293)
T ss_pred ecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc----
Confidence 999999999988753 4889999999999999999999999999999999999999999999999987322100
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
........
T Consensus 169 ------------------------------------------------------------------------~~~~~~~~ 176 (293)
T cd06647 169 ------------------------------------------------------------------------QSKRSTMV 176 (293)
T ss_pred ------------------------------------------------------------------------cccccccc
Confidence 00011235
Q ss_pred cCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH-cCCCCCCCCCCCCHHHHHHHHHhhhcC
Q 007260 456 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVV-GQPLRFPESPVVSFAARDLIRGLLVKE 534 (611)
Q Consensus 456 GT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~-~~~l~~p~~~~~s~~l~dLI~~~L~~d 534 (611)
|++.|+|||.+.+..++.++|||||||++|+|++|+.||........+..+. .....++....++..+++||.+||..+
T Consensus 177 ~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 256 (293)
T cd06647 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMD 256 (293)
T ss_pred CChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHccCC
Confidence 8899999999998889999999999999999999999998766554443332 222334444457889999999999999
Q ss_pred ccccCCchhcHHHHHcCCCCCCCc
Q 007260 535 PQHRLAYKRGATEIKQHPFFEGVN 558 (611)
Q Consensus 535 P~~Rpt~~~~a~elL~Hp~f~~~~ 558 (611)
|++||+ +.+++.|+||+...
T Consensus 257 p~~Rp~----~~~il~h~~~~~~~ 276 (293)
T cd06647 257 VEKRGS----AKELLQHPFLKIAK 276 (293)
T ss_pred hhhCcC----HHHHhcCHHHhcCc
Confidence 999999 99999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=350.22 Aligned_cols=257 Identities=28% Similarity=0.414 Sum_probs=213.9
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVME 296 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE 296 (611)
.|++++.||.|+||.||+|.+..++..||+|++...... .....+.+|+.+++.++||||++++++|..++..|+|||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccch--HHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 467778999999999999999999999999998754322 334567889999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccc
Q 007260 297 FCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIK 376 (611)
Q Consensus 297 ~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~ 376 (611)
|+++++|.+++.. ..+++..++.++.||+.||.|||.+||+|+||+|+||++++++.++|+|||++..+...
T Consensus 83 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~----- 154 (277)
T cd06642 83 YLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT----- 154 (277)
T ss_pred ccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCc-----
Confidence 9999999998764 35899999999999999999999999999999999999999999999999987432100
Q ss_pred cccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccccc
Q 007260 377 ASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVG 456 (611)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vG 456 (611)
......+.|
T Consensus 155 -----------------------------------------------------------------------~~~~~~~~~ 163 (277)
T cd06642 155 -----------------------------------------------------------------------QIKRNTFVG 163 (277)
T ss_pred -----------------------------------------------------------------------chhhhcccC
Confidence 000112358
Q ss_pred CCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCcc
Q 007260 457 THEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQ 536 (611)
Q Consensus 457 T~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~ 536 (611)
+..|+|||++.+..++.++|+|||||++|||++|+.||...........+.... .......++..+.+||.+||..+|+
T Consensus 164 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~ 242 (277)
T cd06642 164 TPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS-PPTLEGQYSKPFKEFVEACLNKDPR 242 (277)
T ss_pred cccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCC-CCCCCcccCHHHHHHHHHHccCCcc
Confidence 889999999999999999999999999999999999998665544444333222 1111234788999999999999999
Q ss_pred ccCCchhcHHHHHcCCCCCCCch
Q 007260 537 HRLAYKRGATEIKQHPFFEGVNW 559 (611)
Q Consensus 537 ~Rpt~~~~a~elL~Hp~f~~~~~ 559 (611)
+||+ +.++++||||....+
T Consensus 243 ~Rp~----~~~il~~~~~~~~~~ 261 (277)
T cd06642 243 FRPT----AKELLKHKFITRYTK 261 (277)
T ss_pred cCcC----HHHHHHhHHHHHHhh
Confidence 9999 999999999975543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=353.11 Aligned_cols=256 Identities=21% Similarity=0.303 Sum_probs=209.5
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCe----EEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecc
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKC----YFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE 288 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~----~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~ 288 (611)
+...+|++++.||+|+||.||+|++..++. .||||++.... ......++.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~ 81 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 81 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence 345689999999999999999999866554 48999986432 223445677899999999999999999998765
Q ss_pred ceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccc
Q 007260 289 KFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRC 368 (611)
Q Consensus 289 ~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~ 368 (611)
..++|+||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccc
Confidence 5789999999999999887653 45889999999999999999999999999999999999999999999999998543
Q ss_pred cCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccc
Q 007260 369 AVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTE 448 (611)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (611)
......
T Consensus 160 ~~~~~~-------------------------------------------------------------------------- 165 (316)
T cd05108 160 GADEKE-------------------------------------------------------------------------- 165 (316)
T ss_pred cCCCcc--------------------------------------------------------------------------
Confidence 211000
Q ss_pred ccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 007260 449 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLI 527 (611)
Q Consensus 449 ~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI 527 (611)
.......++..|+|||++.+..++.++|||||||++|||++ |+.||.+.... .+..++.....++....++..+.++|
T Consensus 166 ~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li 244 (316)
T cd05108 166 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-EISSILEKGERLPQPPICTIDVYMIM 244 (316)
T ss_pred eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHhCCCCCCCCCCCCHHHHHHH
Confidence 00001125678999999999999999999999999999997 99999876544 34566666666666667899999999
Q ss_pred HHhhhcCccccCCchhcHHHHHcC
Q 007260 528 RGLLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 528 ~~~L~~dP~~Rpt~~~~a~elL~H 551 (611)
.+||..||.+||+ +.+++.+
T Consensus 245 ~~cl~~~p~~Rps----~~~l~~~ 264 (316)
T cd05108 245 VKCWMIDADSRPK----FRELIIE 264 (316)
T ss_pred HHHccCChhhCcC----HHHHHHH
Confidence 9999999999999 6677664
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=345.59 Aligned_cols=257 Identities=22% Similarity=0.326 Sum_probs=208.9
Q ss_pred cccCeEEEeEecccCcEEEEEEEEC----CCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELS----GTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK 289 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~----~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~ 289 (611)
.+.+|++.+.||+|+||+||+|.+. .++..||+|.+.... .......+.+|+++++.++||||+++++++..+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 3568999999999999999999853 456789999987533 2334456788999999999999999999999999
Q ss_pred eeeEEeeeCCCCCHHHHHHhCC---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccC
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQP---------------GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRED 354 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~---------------~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~ 354 (611)
..|+||||+++++|.+++.... ...+++..+..++.|++.||+|||++||+||||||+|||++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 9999999999999999885321 1347889999999999999999999999999999999999999
Q ss_pred CcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCC
Q 007260 355 GHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGN 434 (611)
Q Consensus 355 g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (611)
+.+||+|||++........
T Consensus 161 ~~~kl~dfg~~~~~~~~~~------------------------------------------------------------- 179 (283)
T cd05090 161 LHVKISDLGLSREIYSADY------------------------------------------------------------- 179 (283)
T ss_pred CcEEeccccccccccCCcc-------------------------------------------------------------
Confidence 9999999999843321000
Q ss_pred CCCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCC
Q 007260 435 QVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRF 513 (611)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~ 513 (611)
........++..|+|||++.+..++.++|||||||+||||++ |..||.+.........+.. ....
T Consensus 180 -------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-~~~~ 245 (283)
T cd05090 180 -------------YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK-RQLL 245 (283)
T ss_pred -------------eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-CCcC
Confidence 000112346778999999998889999999999999999998 9999988765544444433 3334
Q ss_pred CCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcC
Q 007260 514 PESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 514 p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~H 551 (611)
+....++..++++|.+||..||++||+ +.+|+++
T Consensus 246 ~~~~~~~~~~~~li~~cl~~~p~~Rp~----~~~i~~~ 279 (283)
T cd05090 246 PCSEDCPPRMYSLMTECWQEGPSRRPR----FKDIHTR 279 (283)
T ss_pred CCCCCCCHHHHHHHHHHcccCcccCcC----HHHHHHH
Confidence 444568999999999999999999999 7777654
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=358.83 Aligned_cols=262 Identities=24% Similarity=0.354 Sum_probs=207.5
Q ss_pred eEeccc--CcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEeeeCC
Q 007260 222 KRLGCG--DIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCP 299 (611)
Q Consensus 222 ~~LG~G--~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE~~~ 299 (611)
..||.| +||+||+|++..+++.||||++...... .+....+.+|+.+++.++||||++++++|..++..|+||||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT-EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 345655 9999999999999999999998754432 2345677889999999999999999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccccccc
Q 007260 300 GGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASS 379 (611)
Q Consensus 300 gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~ 379 (611)
+++|.+++.+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+||+.+.........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~----- 157 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK----- 157 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc-----
Confidence 999999988765556999999999999999999999999999999999999999999999999865221100000
Q ss_pred CCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCC
Q 007260 380 LDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHE 459 (611)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~ 459 (611)
. ...........++..
T Consensus 158 --------~--------------------------------------------------------~~~~~~~~~~~~~~~ 173 (328)
T cd08226 158 --------A--------------------------------------------------------KVVYDFPQFSTSVLP 173 (328)
T ss_pred --------c--------------------------------------------------------cccccccccccCccC
Confidence 0 000000001235677
Q ss_pred ccchhhhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCC--------------------------
Q 007260 460 YLAPEIIKGE--GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPL-------------------------- 511 (611)
Q Consensus 460 Y~APEil~~~--~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l-------------------------- 511 (611)
|+|||++.+. .++.++|||||||++|||++|++||.+......+..++..+.
T Consensus 174 y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (328)
T cd08226 174 WLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSG 253 (328)
T ss_pred ccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcc
Confidence 9999999874 478999999999999999999999988765555444433221
Q ss_pred -------------------CCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 512 -------------------RFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 512 -------------------~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
..+....++..+++||++||..||++||| +.++|+||||+.+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt----a~e~l~~~~~~~~ 314 (328)
T cd08226 254 IGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPS----ASSLLSHAFFKQV 314 (328)
T ss_pred cccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCC----HHHHhhCHHHHHH
Confidence 11112235678999999999999999999 9999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=341.70 Aligned_cols=255 Identities=26% Similarity=0.394 Sum_probs=208.7
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
++|++.+.||.|+||.||+|++..++..||||.+.+...........+.+|+.+++.++|+||++++++|..++..|+||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57899999999999999999999999999999887655444455567788999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcc
Q 007260 296 EFCPGGDLHTLRQKQ--PGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 373 (611)
Q Consensus 296 E~~~gg~L~~ll~~~--~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~ 373 (611)
||++|++|.+++... ....+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC-
Confidence 999999999988642 23568999999999999999999999999999999999999999999999999873221000
Q ss_pred ccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccc
Q 007260 374 LIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMS 453 (611)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (611)
.....
T Consensus 161 ---------------------------------------------------------------------------~~~~~ 165 (267)
T cd08229 161 ---------------------------------------------------------------------------TAAHS 165 (267)
T ss_pred ---------------------------------------------------------------------------ccccc
Confidence 00012
Q ss_pred cccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcH-HHH-HHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 007260 454 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNR-ATL-FNVVGQPLRFPESPVVSFAARDLIRGLL 531 (611)
Q Consensus 454 ~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~-~~l-~~i~~~~l~~p~~~~~s~~l~dLI~~~L 531 (611)
..|+..|+|||.+.+..++.++|||||||++|+|++|..||.+.... ..+ ..+............++..+++||.+||
T Consensus 166 ~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 245 (267)
T cd08229 166 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCI 245 (267)
T ss_pred ccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHHHHhc
Confidence 35889999999999999999999999999999999999999765432 222 2222222111122347889999999999
Q ss_pred hcCccccCCchhcHHHHHc
Q 007260 532 VKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 532 ~~dP~~Rpt~~~~a~elL~ 550 (611)
..||++||+ +.+|++
T Consensus 246 ~~~p~~Rpt----~~~i~~ 260 (267)
T cd08229 246 NPDPEKRPD----ITYVYD 260 (267)
T ss_pred CCCcccCCC----HHHHHH
Confidence 999999999 666553
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=343.52 Aligned_cols=251 Identities=27% Similarity=0.449 Sum_probs=202.0
Q ss_pred eEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC-CCCcccccceeecc--ceeeEE
Q 007260 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD-HPFLPTLYTHFETE--KFSCLV 294 (611)
Q Consensus 218 y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~-HpnIv~l~~~~~~~--~~~~LV 294 (611)
|++++.||.|+||.||+|.+..++..||+|++.+..... ... ...+|+.+++++. |+||+++++++.+. +.+|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~-~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-EQV-NNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-hhh-hHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 788999999999999999999999999999987643221 111 2346888888885 99999999999987 899999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
|||++ ++|.+.+.... ..+++..++.++.||+.||+|||..||+||||||+||+++. +.+||+|||++......
T Consensus 79 ~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~--- 152 (282)
T cd07831 79 FELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK--- 152 (282)
T ss_pred EecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC---
Confidence 99996 57877776542 46899999999999999999999999999999999999999 99999999987432100
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
......
T Consensus 153 --------------------------------------------------------------------------~~~~~~ 158 (282)
T cd07831 153 --------------------------------------------------------------------------PPYTEY 158 (282)
T ss_pred --------------------------------------------------------------------------CCcCCC
Confidence 000123
Q ss_pred ccCCCccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHc---C---------------CCCCCC
Q 007260 455 VGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG---Q---------------PLRFPE 515 (611)
Q Consensus 455 vGT~~Y~APEil~~-~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~---~---------------~l~~p~ 515 (611)
.+++.|+|||++.. ..++.++|||||||++|||++|.+||.+.+..+.+..+.. . ...++.
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
T cd07831 159 ISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPS 238 (282)
T ss_pred CCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcc
Confidence 58889999998755 4468899999999999999999999988765554433321 1 111111
Q ss_pred ---------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCC
Q 007260 516 ---------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 516 ---------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f 554 (611)
...++.++++||.+||.+||++||+ +.++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~----~~~~l~~~~~ 282 (282)
T cd07831 239 KKGTGLRKLLPNASAEGLDLLKKLLAYDPDERIT----AKQALRHPYF 282 (282)
T ss_pred cccccHHHHcccccHHHHHHHHHHhccCcccccC----HHHHhhCCCC
Confidence 1246899999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=350.82 Aligned_cols=254 Identities=27% Similarity=0.455 Sum_probs=213.1
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVME 296 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE 296 (611)
-|.....||.|+||.||+|.+..++..||||++...... ....+.+|+.+++.++||||++++++|..++..|+|||
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc---hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 455566899999999999999989999999998654322 23356789999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccc
Q 007260 297 FCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIK 376 (611)
Q Consensus 297 ~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~ 376 (611)
|+++++|..++.. ..+++..++.++.|++.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 99 ~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~----- 170 (297)
T cd06659 99 FLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD----- 170 (297)
T ss_pred cCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccc-----
Confidence 9999999987755 35899999999999999999999999999999999999999999999999987322100
Q ss_pred cccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccccc
Q 007260 377 ASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVG 456 (611)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vG 456 (611)
.......+|
T Consensus 171 -----------------------------------------------------------------------~~~~~~~~~ 179 (297)
T cd06659 171 -----------------------------------------------------------------------VPKRKSLVG 179 (297)
T ss_pred -----------------------------------------------------------------------cccccceec
Confidence 000113468
Q ss_pred CCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCC-CCCCCCCCHHHHHHHHHhhhcCc
Q 007260 457 THEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLR-FPESPVVSFAARDLIRGLLVKEP 535 (611)
Q Consensus 457 T~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~-~p~~~~~s~~l~dLI~~~L~~dP 535 (611)
+..|+|||++.+..++.++|||||||++|||++|+.||........+..+...... +.....++..+.++|.+||..+|
T Consensus 180 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P 259 (297)
T cd06659 180 TPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREP 259 (297)
T ss_pred CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCCc
Confidence 99999999999989999999999999999999999999877666655554433221 22234578899999999999999
Q ss_pred cccCCchhcHHHHHcCCCCCC
Q 007260 536 QHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 536 ~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
++||+ +.++++||||..
T Consensus 260 ~~Rps----~~~ll~~~~~~~ 276 (297)
T cd06659 260 QERAT----AQELLDHPFLLQ 276 (297)
T ss_pred ccCcC----HHHHhhChhhcc
Confidence 99999 999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=351.26 Aligned_cols=255 Identities=29% Similarity=0.380 Sum_probs=213.8
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
..|++.+.||.|+||.||+|.+..+++.||+|++........+....+.+|+++++.++||||+++++++..++..||||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 56999999999999999999999999999999987554444455567788999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
||+. |+|.+++.... ..+++..+..++.||+.||.|||.+||+||||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~----- 167 (307)
T cd06607 95 EYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP----- 167 (307)
T ss_pred HhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC-----
Confidence 9995 57777665432 4589999999999999999999999999999999999999999999999998732110
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
...+.
T Consensus 168 ---------------------------------------------------------------------------~~~~~ 172 (307)
T cd06607 168 ---------------------------------------------------------------------------ANSFV 172 (307)
T ss_pred ---------------------------------------------------------------------------CCCcc
Confidence 01235
Q ss_pred cCCCccchhhhc---cCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007260 456 GTHEYLAPEIIK---GEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLV 532 (611)
Q Consensus 456 GT~~Y~APEil~---~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~ 532 (611)
|++.|+|||++. ...++.++|||||||++|||++|+.||.+......+..+............++..+++||.+||.
T Consensus 173 ~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 252 (307)
T cd06607 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQ 252 (307)
T ss_pred CCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc
Confidence 888999999985 34578899999999999999999999988776666555544332222223478899999999999
Q ss_pred cCccccCCchhcHHHHHcCCCCCC
Q 007260 533 KEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 533 ~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
.||++||+ +.+++.||||..
T Consensus 253 ~~p~~Rp~----~~~il~~~~~~~ 272 (307)
T cd06607 253 KIPQDRPS----SEELLKHRFVLR 272 (307)
T ss_pred CChhhCcC----HHHHhcChhhcc
Confidence 99999999 999999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=340.10 Aligned_cols=255 Identities=29% Similarity=0.412 Sum_probs=204.9
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
..+.....||+|+||.||+|++..++..||+|.+..... .....+.+|+.+++.++|+||+++++++..++..|+||
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS---RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 344445689999999999999999999999999875542 23346778999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCC--CHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEcc-CCcEEEEeccccccccCCc
Q 007260 296 EFCPGGDLHTLRQKQPGKYF--PEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRE-DGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l--~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~-~g~vkL~DFGlA~~~~~~~ 372 (611)
||+++++|.+++.... ..+ ++..+..++.||+.||+|||.+||+||||||+|||++. ++.++|+|||++.......
T Consensus 85 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~ 163 (268)
T cd06624 85 EQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN 163 (268)
T ss_pred ecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC
Confidence 9999999999887642 234 88889999999999999999999999999999999986 6799999999874321000
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
....
T Consensus 164 ----------------------------------------------------------------------------~~~~ 167 (268)
T cd06624 164 ----------------------------------------------------------------------------PCTE 167 (268)
T ss_pred ----------------------------------------------------------------------------Cccc
Confidence 0001
Q ss_pred ccccCCCccchhhhccCC--CCChhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHcCCCCCCCCCCCCHHHHHHHHH
Q 007260 453 SFVGTHEYLAPEIIKGEG--HGSAVDWWTFGIFLYELLFGKTPFKGSGNRAT-LFNVVGQPLRFPESPVVSFAARDLIRG 529 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~--~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~-l~~i~~~~l~~p~~~~~s~~l~dLI~~ 529 (611)
...|++.|+|||++.+.. ++.++|||||||++|+|++|+.||........ ...+............+++++++||.+
T Consensus 168 ~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 247 (268)
T cd06624 168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILR 247 (268)
T ss_pred cCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHH
Confidence 234889999999987654 78999999999999999999999976543222 222211111111223488999999999
Q ss_pred hhhcCccccCCchhcHHHHHcCCCC
Q 007260 530 LLVKEPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 530 ~L~~dP~~Rpt~~~~a~elL~Hp~f 554 (611)
||..+|.+||+ +.+++.||||
T Consensus 248 ~l~~~p~~Rpt----~~~ll~~~~~ 268 (268)
T cd06624 248 CFEPDPDKRAS----AHDLLQDPFL 268 (268)
T ss_pred HcCCCchhCCC----HHHHHhCCCC
Confidence 99999999999 9999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=344.60 Aligned_cols=255 Identities=21% Similarity=0.314 Sum_probs=210.5
Q ss_pred ccCeEEEeEecccCcEEEEEEEECC-----CCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSG-----TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK 289 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~-----t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~ 289 (611)
..+|.+.+.||.|+||.||+|.+.. ++..||||++..... .+....+.+|+++|+.++|+||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 4579999999999999999998753 467899999875432 223456788999999999999999999999999
Q ss_pred eeeEEeeeCCCCCHHHHHHhCC------------CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcE
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQP------------GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHI 357 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~------------~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~v 357 (611)
..|+||||++|++|.+++.... ...+++..+..++.||+.||.|||.+||+||||||+|||++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 9999999999999999987542 2357899999999999999999999999999999999999999999
Q ss_pred EEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCC
Q 007260 358 MLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVS 437 (611)
Q Consensus 358 kL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (611)
+|+|||++........
T Consensus 162 kl~d~g~~~~~~~~~~---------------------------------------------------------------- 177 (280)
T cd05049 162 KIGDFGMSRDVYTTDY---------------------------------------------------------------- 177 (280)
T ss_pred EECCcccceecccCcc----------------------------------------------------------------
Confidence 9999998732210000
Q ss_pred CCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCC
Q 007260 438 PLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPES 516 (611)
Q Consensus 438 ~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~ 516 (611)
........+++.|+|||++.+..++.++|||||||++|||++ |..||.+......+..+.......+ .
T Consensus 178 ----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~~~-~ 246 (280)
T cd05049 178 ----------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQR-P 246 (280)
T ss_pred ----------eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcCCC-C
Confidence 000012246788999999999999999999999999999998 9999988777766666665443332 2
Q ss_pred CCCCHHHHHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 517 PVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 517 ~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
..++..+++||.+||..||++||+ +.|+++
T Consensus 247 ~~~~~~~~~li~~~l~~~p~~Rp~----~~eil~ 276 (280)
T cd05049 247 RTCPSEVYDIMLGCWKRDPQQRIN----IKDIHE 276 (280)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCC----HHHHHH
Confidence 458999999999999999999999 777764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=343.22 Aligned_cols=258 Identities=30% Similarity=0.459 Sum_probs=209.6
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec--cceeeE
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET--EKFSCL 293 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~--~~~~~L 293 (611)
++|+..+.||.|++|.||+|.+..+++.||+|++...... ....++.+|+++++.++||||++++++|.. ...+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP--DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch--HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 3799999999999999999999999999999998754322 334567889999999999999999998864 457899
Q ss_pred EeeeCCCCCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCC
Q 007260 294 VMEFCPGGDLHTLRQK--QPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~--~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~ 371 (611)
||||++|++|.+++.. .....+++..+..++.||+.||.|||..||+|+||+|+||+++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999999987653 22356899999999999999999999999999999999999999999999999987322100
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
..
T Consensus 159 ------------------------------------------------------------------------------~~ 160 (287)
T cd06621 159 ------------------------------------------------------------------------------LA 160 (287)
T ss_pred ------------------------------------------------------------------------------cc
Confidence 00
Q ss_pred cccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC-----cHHHHHHHHcCCC-CCCCC----CCCCH
Q 007260 452 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSG-----NRATLFNVVGQPL-RFPES----PVVSF 521 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~-----~~~~l~~i~~~~l-~~p~~----~~~s~ 521 (611)
....++..|+|||.+.+..++.++|||||||++|+|++|+.||.... ..+....+..... .++.. ..++.
T Consensus 161 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (287)
T cd06621 161 GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSE 240 (287)
T ss_pred ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHH
Confidence 02347888999999999999999999999999999999999998652 1222222332111 11111 23567
Q ss_pred HHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 522 AARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 522 ~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
.+.+||.+||..||.+||+ +.|+++||||...
T Consensus 241 ~~~~li~~~l~~~p~~Rpt----~~eil~~~~~~~~ 272 (287)
T cd06621 241 EFKDFIKQCLEKDPTRRPT----PWDMLEHPWIKAQ 272 (287)
T ss_pred HHHHHHHHHcCCCcccCCC----HHHHHhCcccccc
Confidence 8999999999999999999 9999999999653
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=341.87 Aligned_cols=250 Identities=24% Similarity=0.360 Sum_probs=212.3
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
.+|++++.||.|+||.||+|.+.. +..+|+|++...... ....+.+|+.+|+.++|+||+++++++......|+||
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLL---KQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchh---hHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence 579999999999999999999988 788999998765432 2335678999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
||+++++|.+++....+..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~--- 158 (261)
T cd05148 82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV--- 158 (261)
T ss_pred eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcc---
Confidence 99999999999987666779999999999999999999999999999999999999999999999999984321000
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
.......
T Consensus 159 -------------------------------------------------------------------------~~~~~~~ 165 (261)
T cd05148 159 -------------------------------------------------------------------------YLSSDKK 165 (261)
T ss_pred -------------------------------------------------------------------------ccccCCC
Confidence 0000123
Q ss_pred cCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcC
Q 007260 456 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKE 534 (611)
Q Consensus 456 GT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~d 534 (611)
++..|+|||++.+..++.++|||||||++|+|++ |+.||.+....+.+..+.. ..+.+....++.++.++|.+||..|
T Consensus 166 ~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~ 244 (261)
T cd05148 166 IPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA-GYRMPCPAKCPQEIYKIMLECWAAE 244 (261)
T ss_pred CceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHh-CCcCCCCCCCCHHHHHHHHHHcCCC
Confidence 5678999999998889999999999999999998 8999988776666665553 3445555678999999999999999
Q ss_pred ccccCCchhcHHHHHc
Q 007260 535 PQHRLAYKRGATEIKQ 550 (611)
Q Consensus 535 P~~Rpt~~~~a~elL~ 550 (611)
|.+||+ +.+|++
T Consensus 245 p~~Rpt----~~~l~~ 256 (261)
T cd05148 245 PEDRPS----FKALRE 256 (261)
T ss_pred chhCcC----HHHHHH
Confidence 999999 666654
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=349.18 Aligned_cols=257 Identities=26% Similarity=0.376 Sum_probs=209.6
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecc--ceee
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE--KFSC 292 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~--~~~~ 292 (611)
.++|++.+.||.|+||.||+|.+..+++.||+|.++..... ......+.+|+.+++.++||||+++++++... ...|
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 35799999999999999999999999999999999754432 22333556799999999999999999998877 8999
Q ss_pred EEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCc
Q 007260 293 LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 293 LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~ 372 (611)
|||||+. ++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.++|+|||++..+....
T Consensus 83 lv~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 83 MVMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EEehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 9999996 59998887653 469999999999999999999999999999999999999999999999999884332100
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
....
T Consensus 161 ----------------------------------------------------------------------------~~~~ 164 (293)
T cd07843 161 ----------------------------------------------------------------------------KPYT 164 (293)
T ss_pred ----------------------------------------------------------------------------cccc
Confidence 0001
Q ss_pred ccccCCCccchhhhccCC-CCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcC---CC----------------C
Q 007260 453 SFVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ---PL----------------R 512 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~-~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~---~l----------------~ 512 (611)
...+++.|+|||++.+.. ++.++|||||||++|+|++|++||........+.++... +. .
T Consensus 165 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (293)
T cd07843 165 QLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKT 244 (293)
T ss_pred cccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccc
Confidence 234788999999998755 589999999999999999999999887665554433211 00 0
Q ss_pred ----------CCCCCC-CCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCC
Q 007260 513 ----------FPESPV-VSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 513 ----------~p~~~~-~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f 554 (611)
...... ++..+++||.+||..||++||+ +.|++.||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t----~~ell~~~~f 293 (293)
T cd07843 245 FTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRIS----AEDALKHPYF 293 (293)
T ss_pred cccccchhhhccccccCCChHHHHHHHHHhccCccccCC----HHHHhcCCCC
Confidence 000111 5888999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=344.98 Aligned_cols=254 Identities=28% Similarity=0.445 Sum_probs=213.6
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVME 296 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE 296 (611)
.|...+.||.|++|.||++.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch---hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 45556899999999999999999999999999864332 223456789999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccc
Q 007260 297 FCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIK 376 (611)
Q Consensus 297 ~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~ 376 (611)
|++|++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++......
T Consensus 97 ~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~----- 168 (285)
T cd06648 97 FLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE----- 168 (285)
T ss_pred ccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccC-----
Confidence 9999999998876 35899999999999999999999999999999999999999999999999987321100
Q ss_pred cccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccccc
Q 007260 377 ASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVG 456 (611)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vG 456 (611)
........|
T Consensus 169 -----------------------------------------------------------------------~~~~~~~~~ 177 (285)
T cd06648 169 -----------------------------------------------------------------------VPRRKSLVG 177 (285)
T ss_pred -----------------------------------------------------------------------CcccccccC
Confidence 000112458
Q ss_pred CCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCC-CCCCCCCHHHHHHHHHhhhcCc
Q 007260 457 THEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRF-PESPVVSFAARDLIRGLLVKEP 535 (611)
Q Consensus 457 T~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~-p~~~~~s~~l~dLI~~~L~~dP 535 (611)
++.|+|||++.+..++.++|||||||++|||++|+.||........+..+....... .....++..+.+||++||..+|
T Consensus 178 ~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 257 (285)
T cd06648 178 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDP 257 (285)
T ss_pred CccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccCh
Confidence 999999999999889999999999999999999999998876666665555443222 2223478999999999999999
Q ss_pred cccCCchhcHHHHHcCCCCCC
Q 007260 536 QHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 536 ~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
++||+ +.++++||||+.
T Consensus 258 ~~Rpt----~~~il~~~~~~~ 274 (285)
T cd06648 258 AQRAT----AAELLNHPFLAK 274 (285)
T ss_pred hhCcC----HHHHccCccccc
Confidence 99999 999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=335.27 Aligned_cols=250 Identities=49% Similarity=0.854 Sum_probs=215.3
Q ss_pred ecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEeeeCCCCCH
Q 007260 224 LGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDL 303 (611)
Q Consensus 224 LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE~~~gg~L 303 (611)
||.|+||.||++.+..+++.||+|++.+...........+..|+.+++.++|+||+++++.++.+...|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999988999999999887655555666788999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccccCCCC
Q 007260 304 HTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAE 383 (611)
Q Consensus 304 ~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~ 383 (611)
.+++... ..+++..+..++.||+.||.|||.+|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~----------- 147 (250)
T cd05123 81 FSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG----------- 147 (250)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-----------
Confidence 9998875 458999999999999999999999999999999999999999999999999874321000
Q ss_pred cCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCccch
Q 007260 384 PLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAP 463 (611)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~AP 463 (611)
.......|+..|++|
T Consensus 148 -----------------------------------------------------------------~~~~~~~~~~~~~~P 162 (250)
T cd05123 148 -----------------------------------------------------------------SRTNTFCGTPEYLAP 162 (250)
T ss_pred -----------------------------------------------------------------CcccCCcCCccccCh
Confidence 001123588899999
Q ss_pred hhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccCCchh
Q 007260 464 EIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKR 543 (611)
Q Consensus 464 Eil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~ 543 (611)
|.+.+..++.++|+|+||+++|+|++|..||...........+....+.++. .++..+.++|.+||..||++||+.+.
T Consensus 163 e~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 163 EVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPE--FLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 9999888899999999999999999999999877765556666654444444 47999999999999999999999322
Q ss_pred cHHHHHcCCCC
Q 007260 544 GATEIKQHPFF 554 (611)
Q Consensus 544 ~a~elL~Hp~f 554 (611)
+.++++||||
T Consensus 241 -~~~l~~~~~f 250 (250)
T cd05123 241 -AEEIKAHPFF 250 (250)
T ss_pred -HHHHHhCCCC
Confidence 2999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=343.09 Aligned_cols=257 Identities=19% Similarity=0.284 Sum_probs=208.1
Q ss_pred cccCeEEEeEecccCcEEEEEEEECC-----CCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecc
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSG-----TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE 288 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~-----t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~ 288 (611)
..++|++.+.||.|+||.||+|.+.+ ++..||||++..... ......+.+|+.+++.++||||+++++++..+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 34689999999999999999998753 356799999865322 22334577899999999999999999999999
Q ss_pred ceeeEEeeeCCCCCHHHHHHhCCC--------CCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEE
Q 007260 289 KFSCLVMEFCPGGDLHTLRQKQPG--------KYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLS 360 (611)
Q Consensus 289 ~~~~LVmE~~~gg~L~~ll~~~~~--------~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~ 360 (611)
...|+||||+++++|.+++..... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence 999999999999999998875321 235778899999999999999999999999999999999999999999
Q ss_pred eccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCc
Q 007260 361 DFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLP 440 (611)
Q Consensus 361 DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (611)
|||++..+......
T Consensus 162 dfg~~~~~~~~~~~------------------------------------------------------------------ 175 (277)
T cd05062 162 DFGMTRDIYETDYY------------------------------------------------------------------ 175 (277)
T ss_pred CCCCccccCCccee------------------------------------------------------------------
Confidence 99998433210000
Q ss_pred ccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCC
Q 007260 441 ELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVV 519 (611)
Q Consensus 441 ~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~ 519 (611)
.......+++.|+|||++.+..++.++|||||||++|||++ |..||.+......+..+..... .+....+
T Consensus 176 --------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~ 246 (277)
T cd05062 176 --------RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGL-LDKPDNC 246 (277)
T ss_pred --------ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc-CCCCCCC
Confidence 00001236788999999999899999999999999999998 7999988776666655554432 2223458
Q ss_pred CHHHHHHHHHhhhcCccccCCchhcHHHHHcC
Q 007260 520 SFAARDLIRGLLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 520 s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~H 551 (611)
+..+++||.+||..||++||+ +.+++++
T Consensus 247 ~~~~~~li~~~l~~~p~~Rps----~~e~l~~ 274 (277)
T cd05062 247 PDMLFELMRMCWQYNPKMRPS----FLEIISS 274 (277)
T ss_pred CHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 899999999999999999999 7887764
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=348.76 Aligned_cols=264 Identities=30% Similarity=0.456 Sum_probs=209.8
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCC----eEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec-cc
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTK----CYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET-EK 289 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~----~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~-~~ 289 (611)
+..|++++.||+|.||.||+|....++ ..||||.++... ........+.+|+.+++.|+||||+.|..+|.. +.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~k-d~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEK-DGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccC-CCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 357999999999999999999765543 268999886542 122333456789999999999999999999987 89
Q ss_pred eeeEEeeeCCCCCHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccC----CcEEEEec
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQ---PGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRED----GHIMLSDF 362 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~---~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~----g~vkL~DF 362 (611)
.++||+||.+. ||..++..+ .++.++...++.+++||+.||.|||++.|+||||||.||||..+ |+|||+||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999999955 787777643 23578999999999999999999999999999999999999988 89999999
Q ss_pred cccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCccc
Q 007260 363 DLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPEL 442 (611)
Q Consensus 363 GlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (611)
|+++.+...- .|
T Consensus 181 GlaR~~~~pl----------------------------------------------------------------kp---- 192 (438)
T KOG0666|consen 181 GLARLFNNPL----------------------------------------------------------------KP---- 192 (438)
T ss_pred cHHHHhhccc----------------------------------------------------------------cc----
Confidence 9996553110 00
Q ss_pred ccCcccccccccccCCCccchhhhccCC-CCChhhHHHHHHHHHHHHhCCCCCCCCC------------cHHHHHHHHcC
Q 007260 443 IAEPTEARSMSFVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSG------------NRATLFNVVGQ 509 (611)
Q Consensus 443 ~~~~~~~~~~~~vGT~~Y~APEil~~~~-~~~~sDIWSLGviL~ELltG~~PF~~~~------------~~~~l~~i~~~ 509 (611)
.......|.|.||+|||++.|.. |+.++||||+|||+.|||+-.+.|.+.. ..+.++++++.
T Consensus 193 -----l~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~ 267 (438)
T KOG0666|consen 193 -----LASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGT 267 (438)
T ss_pred -----cccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCC
Confidence 11123468999999999999987 5899999999999999999999998732 22334555655
Q ss_pred CCC--C------CCC------------------------CCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 510 PLR--F------PES------------------------PVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 510 ~l~--~------p~~------------------------~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
+-. | |++ ..-++.+.+|+.+||.+||.+|.| |+++|+|+||...
T Consensus 268 Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIt----a~qAleh~yF~~d 343 (438)
T KOG0666|consen 268 PTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRIT----AEQALEHPYFTED 343 (438)
T ss_pred CccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhcc----HHHHhcccccccC
Confidence 421 1 211 112445789999999999999999 9999999999864
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=333.61 Aligned_cols=256 Identities=32% Similarity=0.563 Sum_probs=218.4
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVME 296 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE 296 (611)
+|++.+.||.|+||.||++.+..++..||+|++...... ......+.+|+++++.++|+|++++++.+......++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 589999999999999999999999999999999765432 2334467789999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 297 FCPGGDLHTLRQKQP--GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 297 ~~~gg~L~~ll~~~~--~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
|+++++|.+++.... +..+++..+..++.|++.||.|||++||+|+||+|+|||++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 157 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-- 157 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence 999999999887753 4679999999999999999999999999999999999999999999999999873321000
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
......
T Consensus 158 --------------------------------------------------------------------------~~~~~~ 163 (258)
T cd08215 158 --------------------------------------------------------------------------DLAKTV 163 (258)
T ss_pred --------------------------------------------------------------------------ceecce
Confidence 001123
Q ss_pred ccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcC
Q 007260 455 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKE 534 (611)
Q Consensus 455 vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~d 534 (611)
.|++.|+|||.+.+..++.++|+|+||+++|+|++|+.||...........+..... .+....++..+.++|..||..+
T Consensus 164 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~ 242 (258)
T cd08215 164 VGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQY-PPIPSQYSSELRNLVSSLLQKD 242 (258)
T ss_pred eeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCC-CCCCCCCCHHHHHHHHHHcCCC
Confidence 588999999999999999999999999999999999999988766555555554432 2223358899999999999999
Q ss_pred ccccCCchhcHHHHHcCCCC
Q 007260 535 PQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 535 P~~Rpt~~~~a~elL~Hp~f 554 (611)
|++||+ +.++|+||||
T Consensus 243 p~~Rp~----~~~ll~~~~~ 258 (258)
T cd08215 243 PEERPS----IAQILQSPFI 258 (258)
T ss_pred hhhCcC----HHHHhcCCCC
Confidence 999999 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=357.70 Aligned_cols=258 Identities=29% Similarity=0.475 Sum_probs=205.9
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeeccceeeE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEKFSCL 293 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~~~~~L 293 (611)
...|++++.||+||.+.||++...+.+ .||+|.+... ..+...+.-+.+|+++|.+| +|.+||+||+|-..++++||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~-iyalkkv~~~-~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQ-IYALKKVVLL-EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCc-chhhhHHHHh-hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 357999999999999999999877655 4555544322 23456677789999999999 59999999999999999999
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcc
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 373 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~ 373 (611)
||||- ..||..++++.. ..++...+++|..|+|.|+.++|..||||.||||.|+|+- .|.+||+|||+|..+....+
T Consensus 438 vmE~G-d~DL~kiL~k~~-~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKKK-SIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred Eeecc-cccHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCcccc
Confidence 99986 679999888763 4455568999999999999999999999999999999996 68999999999954432222
Q ss_pred ccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccc
Q 007260 374 LIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMS 453 (611)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (611)
. ....+
T Consensus 515 s--------------------------------------------------------------------------I~kds 520 (677)
T KOG0596|consen 515 S--------------------------------------------------------------------------IVKDS 520 (677)
T ss_pred c--------------------------------------------------------------------------eeecc
Confidence 1 12235
Q ss_pred cccCCCccchhhhccCC-----------CCChhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHcC--CCCCCCCCCC
Q 007260 454 FVGTHEYLAPEIIKGEG-----------HGSAVDWWTFGIFLYELLFGKTPFKGSGNR-ATLFNVVGQ--PLRFPESPVV 519 (611)
Q Consensus 454 ~vGT~~Y~APEil~~~~-----------~~~~sDIWSLGviL~ELltG~~PF~~~~~~-~~l~~i~~~--~l~~p~~~~~ 519 (611)
.+||+.||+||.+.... .+.++||||||||||+|++|++||..-.+. ..+..|..- .+.||..+.
T Consensus 521 QvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~- 599 (677)
T KOG0596|consen 521 QVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIPE- 599 (677)
T ss_pred ccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCCCC-
Confidence 68999999999997443 367899999999999999999999864432 233333332 245665432
Q ss_pred CHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCC
Q 007260 520 SFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 520 s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
..++.+++..||.+||.+||+ +.+||+|||++.
T Consensus 600 ~~~li~~mK~CL~rdPkkR~s----i~eLLqhpFl~~ 632 (677)
T KOG0596|consen 600 NDELIDVMKCCLARDPKKRWS----IPELLQHPFLQI 632 (677)
T ss_pred chHHHHHHHHHHhcCcccCCC----cHHHhcCccccc
Confidence 234999999999999999999 999999999874
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=344.47 Aligned_cols=256 Identities=26% Similarity=0.454 Sum_probs=210.8
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC---CCCcccccceeeccceeeE
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD---HPFLPTLYTHFETEKFSCL 293 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~---HpnIv~l~~~~~~~~~~~L 293 (611)
.|++++.||.|+||.||+|.+..++..||+|++..... ......+.+|+.+++.++ ||||+++++++..+...|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP--DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 58888999999999999999999999999999875422 233446778999999986 9999999999999999999
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcc
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 373 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~ 373 (611)
||||++|++|.+++... .+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06917 80 IMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS- 155 (277)
T ss_pred EEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-
Confidence 99999999999988653 58999999999999999999999999999999999999999999999999884332100
Q ss_pred ccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccc
Q 007260 374 LIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMS 453 (611)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (611)
.....
T Consensus 156 ---------------------------------------------------------------------------~~~~~ 160 (277)
T cd06917 156 ---------------------------------------------------------------------------SKRST 160 (277)
T ss_pred ---------------------------------------------------------------------------ccccc
Confidence 00112
Q ss_pred cccCCCccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007260 454 FVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLV 532 (611)
Q Consensus 454 ~vGT~~Y~APEil~~~-~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~ 532 (611)
.+|+..|+|||++.+. .++.++|+|||||++|+|++|+.||.+.........+............++.++.++|.+||.
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 240 (277)
T cd06917 161 FVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLD 240 (277)
T ss_pred ccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHHHcC
Confidence 3589999999998754 468999999999999999999999987655444433222211111111378899999999999
Q ss_pred cCccccCCchhcHHHHHcCCCCCCC
Q 007260 533 KEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 533 ~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
.||++||+ +.+++.|+||+..
T Consensus 241 ~~p~~R~~----~~~il~~~~~~~~ 261 (277)
T cd06917 241 EEPKERLS----AEELLKSKWIKAH 261 (277)
T ss_pred CCcccCcC----HHHHhhChHhhcc
Confidence 99999999 9999999999753
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=338.35 Aligned_cols=253 Identities=25% Similarity=0.332 Sum_probs=210.2
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSC 292 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~ 292 (611)
+..++|++.+.||.|+||.||+|.+.. +..||||.+...... ...+.+|+.++++++||||+++++++...+..|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMD----PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCccc----HHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 345689999999999999999999765 457999998765432 234667999999999999999999999999999
Q ss_pred EEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCc
Q 007260 293 LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 293 LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~ 372 (611)
+||||++|++|.+++....+..+++..+..++.|++.||.|||.+||+||||||+|||++.++.++|+|||++..+....
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 99999999999999987655679999999999999999999999999999999999999999999999999985432000
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
. ....
T Consensus 158 ~---------------------------------------------------------------------------~~~~ 162 (261)
T cd05068 158 Y---------------------------------------------------------------------------EARE 162 (261)
T ss_pred c---------------------------------------------------------------------------cccC
Confidence 0 0000
Q ss_pred ccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 007260 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLL 531 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L 531 (611)
...++..|+|||++.+..++.++|||||||++|||++ |+.||.+......+..+... ...+....++..+.+||.+||
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l 241 (261)
T cd05068 163 GAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG-YRMPCPPGCPKELYDIMLDCW 241 (261)
T ss_pred CCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCCCcCCHHHHHHHHHHh
Confidence 0123457999999999999999999999999999998 99999987766666555443 344445568899999999999
Q ss_pred hcCccccCCchhcHHHHHc
Q 007260 532 VKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 532 ~~dP~~Rpt~~~~a~elL~ 550 (611)
..+|.+||+ +.+|++
T Consensus 242 ~~~P~~Rp~----~~~l~~ 256 (261)
T cd05068 242 KEDPDDRPT----FETLQW 256 (261)
T ss_pred hcCcccCCC----HHHHHH
Confidence 999999999 666653
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=350.01 Aligned_cols=255 Identities=23% Similarity=0.327 Sum_probs=206.7
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCe--EEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeeccc
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKC--YFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEK 289 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~--~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~~ 289 (611)
+..++|++.+.||.|+||.||+|++..++. .+|+|.+.... .......+.+|+++|.++ +|+||+++++++..++
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 81 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC--CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence 445789999999999999999999877664 45777765322 223445677899999999 8999999999999999
Q ss_pred eeeEEeeeCCCCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCC
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQP--------------GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDG 355 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~--------------~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g 355 (611)
.+|+||||+++++|.+++.... +..+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 161 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence 9999999999999999987542 23589999999999999999999999999999999999999999
Q ss_pred cEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCC
Q 007260 356 HIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQ 435 (611)
Q Consensus 356 ~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (611)
.+||+|||++......
T Consensus 162 ~~kl~dfg~~~~~~~~---------------------------------------------------------------- 177 (303)
T cd05088 162 VAKIADFGLSRGQEVY---------------------------------------------------------------- 177 (303)
T ss_pred cEEeCccccCcccchh----------------------------------------------------------------
Confidence 9999999987211000
Q ss_pred CCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCC
Q 007260 436 VSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFP 514 (611)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p 514 (611)
.......++..|+|||++.+..++.++|||||||++|||++ |.+||.+....+....+. ......
T Consensus 178 -------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~ 243 (303)
T cd05088 178 -------------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYRLE 243 (303)
T ss_pred -------------hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh-cCCcCC
Confidence 00001124667999999998889999999999999999998 999998776655444433 333333
Q ss_pred CCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcC
Q 007260 515 ESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 515 ~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~H 551 (611)
....++.++.+||.+||..+|++||+ +++++++
T Consensus 244 ~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~il~~ 276 (303)
T cd05088 244 KPLNCDDEVYDLMRQCWREKPYERPS----FAQILVS 276 (303)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 34457899999999999999999999 7777764
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=342.98 Aligned_cols=255 Identities=26% Similarity=0.434 Sum_probs=208.1
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVME 296 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE 296 (611)
+|++++.||.|++|.||+|++..++..||||++...... .....+.+|+.+++.++|+||+++++++...+..|||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE--GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc--cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 589999999999999999999999999999998764322 122345679999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 297 FCPGGDLHTLRQKQP-GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 297 ~~~gg~L~~ll~~~~-~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
|+++ +|.+++.... ...+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~--- 154 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV--- 154 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc---
Confidence 9964 8888776542 2468999999999999999999999999999999999999999999999999873221000
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
......+
T Consensus 155 -------------------------------------------------------------------------~~~~~~~ 161 (284)
T cd07836 155 -------------------------------------------------------------------------NTFSNEV 161 (284)
T ss_pred -------------------------------------------------------------------------ccccccc
Confidence 0001235
Q ss_pred cCCCccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcC---CC---------------CCCC-
Q 007260 456 GTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ---PL---------------RFPE- 515 (611)
Q Consensus 456 GT~~Y~APEil~~~-~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~---~l---------------~~p~- 515 (611)
+|+.|++||++.+. .++.++|||+|||++|+|++|+.||.+.+..+.+..+... +. .++.
T Consensus 162 ~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd07836 162 VTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRY 241 (284)
T ss_pred ccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCC
Confidence 78899999998765 4689999999999999999999999987766554433211 10 0110
Q ss_pred --------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCC
Q 007260 516 --------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 516 --------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f 554 (611)
.+.++..++++|.+||+.||.+||+ +.++++||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~----~~~~l~~~~f 284 (284)
T cd07836 242 PPQDLQQLFPHADPLGIDLLHRLLQLNPELRIS----AHDALQHPWF 284 (284)
T ss_pred ChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCC----HHHHhcCCCC
Confidence 1235788999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=344.11 Aligned_cols=255 Identities=28% Similarity=0.431 Sum_probs=210.4
Q ss_pred eEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEeee
Q 007260 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEF 297 (611)
Q Consensus 218 y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE~ 297 (611)
|++++.||.|++|.||+|.+..++..||+|++...... ......+.+|+++++.++||||+++++++.++...|+||||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 67889999999999999999999999999998754322 12233567799999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccccc
Q 007260 298 CPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKA 377 (611)
Q Consensus 298 ~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~ 377 (611)
+ +++|.+++.......+++..+..++.||+.||+|||++||+||||+|+|||++.++.++|+|||++.......
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~----- 153 (283)
T cd07835 80 L-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV----- 153 (283)
T ss_pred c-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc-----
Confidence 9 5689999887654579999999999999999999999999999999999999999999999999974321000
Q ss_pred ccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccC
Q 007260 378 SSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGT 457 (611)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT 457 (611)
......+++
T Consensus 154 -----------------------------------------------------------------------~~~~~~~~~ 162 (283)
T cd07835 154 -----------------------------------------------------------------------RTYTHEVVT 162 (283)
T ss_pred -----------------------------------------------------------------------cccCccccc
Confidence 000112478
Q ss_pred CCccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCC------------------CCC----
Q 007260 458 HEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPL------------------RFP---- 514 (611)
Q Consensus 458 ~~Y~APEil~~~-~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l------------------~~p---- 514 (611)
+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+....+.++..... .++
T Consensus 163 ~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (283)
T cd07835 163 LWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWAR 242 (283)
T ss_pred cCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccc
Confidence 899999988765 468899999999999999999999988776665555432100 011
Q ss_pred -----CCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCC
Q 007260 515 -----ESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 515 -----~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f 554 (611)
....++..+.+||.+||+.||.+||+ +.++++||||
T Consensus 243 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~il~~~~~ 283 (283)
T cd07835 243 QDLSKVVPNLDEDGLDLLSKMLVYDPAKRIS----AKAALQHPYF 283 (283)
T ss_pred cchhhhcCCCCHHHHHHHHHHhcCChhhCcC----HHHHhcCCCC
Confidence 12347789999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=386.11 Aligned_cols=269 Identities=20% Similarity=0.311 Sum_probs=209.7
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
+++|+++++||.|+||.||+|++..+++.||||++............++.+|+.+++.++||||+++++++.+++..|+|
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 36899999999999999999999999999999999765433444456788999999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCC---------CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccc
Q 007260 295 MEFCPGGDLHTLRQKQP---------GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~---------~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA 365 (611)
|||++|++|.+++.... ...++...+..++.||+.||+|||++||+||||||+|||++.+|.++|+|||++
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 99999999999886421 123566778889999999999999999999999999999999999999999998
Q ss_pred ccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccC
Q 007260 366 LRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAE 445 (611)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (611)
.............. ...... | .
T Consensus 161 k~i~~~~~~~~~l~-----------~~~~~s---------------~--------------------------------~ 182 (932)
T PRK13184 161 IFKKLEEEDLLDID-----------VDERNI---------------C--------------------------------Y 182 (932)
T ss_pred eecccccccccccc-----------cccccc---------------c--------------------------------c
Confidence 54421100000000 000000 0 0
Q ss_pred cccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH-HHHcCCCCCCCCCCCCHHHH
Q 007260 446 PTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLF-NVVGQPLRFPESPVVSFAAR 524 (611)
Q Consensus 446 ~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~-~i~~~~l~~p~~~~~s~~l~ 524 (611)
........++||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ..+..+........++..+.
T Consensus 183 s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~ 262 (932)
T PRK13184 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLS 262 (932)
T ss_pred cccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhccChhhccccccCCHHHH
Confidence 00011124579999999999999999999999999999999999999998755443322 22233333333346889999
Q ss_pred HHHHHhhhcCccccCCc
Q 007260 525 DLIRGLLVKEPQHRLAY 541 (611)
Q Consensus 525 dLI~~~L~~dP~~Rpt~ 541 (611)
+++.+||..||++|++.
T Consensus 263 ~LI~rcL~~DP~kR~ss 279 (932)
T PRK13184 263 QIAMKALAVDPAERYSS 279 (932)
T ss_pred HHHHHHccCChhhCcCH
Confidence 99999999999999884
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=332.30 Aligned_cols=254 Identities=30% Similarity=0.500 Sum_probs=218.7
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVME 296 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE 296 (611)
+|++.+.||.|++|.||++.+..+++.||+|.+...... ......+.+|++++++++|+||+++++++...+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 588999999999999999999999999999999876543 2345678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccc
Q 007260 297 FCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIK 376 (611)
Q Consensus 297 ~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~ 376 (611)
|+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++........
T Consensus 80 ~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 154 (254)
T cd06627 80 YAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--- 154 (254)
T ss_pred cCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc---
Confidence 99999999998875 5699999999999999999999999999999999999999999999999999854321000
Q ss_pred cccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccccc
Q 007260 377 ASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVG 456 (611)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vG 456 (611)
......|
T Consensus 155 -------------------------------------------------------------------------~~~~~~~ 161 (254)
T cd06627 155 -------------------------------------------------------------------------DDASVVG 161 (254)
T ss_pred -------------------------------------------------------------------------ccccccc
Confidence 0112358
Q ss_pred CCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCcc
Q 007260 457 THEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQ 536 (611)
Q Consensus 457 T~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~ 536 (611)
+..|+|||.+.+..++.++|||+||+++|+|++|+.||........+.++.... ..+....++..++++|.+||..+|+
T Consensus 162 ~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~ 240 (254)
T cd06627 162 TPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD-HPPLPEGISPELKDFLMQCFQKDPN 240 (254)
T ss_pred chhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccC-CCCCCCCCCHHHHHHHHHHHhCChh
Confidence 889999999998888999999999999999999999998777666665554322 2223345899999999999999999
Q ss_pred ccCCchhcHHHHHcCCCC
Q 007260 537 HRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 537 ~Rpt~~~~a~elL~Hp~f 554 (611)
+||+ +.+++.||||
T Consensus 241 ~R~~----~~~~l~~~~~ 254 (254)
T cd06627 241 LRPT----AKQLLKHPWI 254 (254)
T ss_pred hCcC----HHHHhcCCCC
Confidence 9999 9999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=347.20 Aligned_cols=258 Identities=19% Similarity=0.303 Sum_probs=214.0
Q ss_pred ccccCeEEEeEecccCcEEEEEEEE-----CCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSEL-----SGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFE 286 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~-----~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~ 286 (611)
+..++|.+.+.||.|+||.||+|.+ ..++..||||++++... ......+.+|+.+++++ +||||+++++++.
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 109 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH--SSEREALMSELKIMSHLGNHENIVNLLGACT 109 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC--hHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence 4456899999999999999999986 33456899999875432 23345678899999999 7999999999999
Q ss_pred ccceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccc
Q 007260 287 TEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSL 366 (611)
Q Consensus 287 ~~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~ 366 (611)
..+..||||||+++|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.
T Consensus 110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence 99999999999999999999876554558999999999999999999999999999999999999999999999999984
Q ss_pred cccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCc
Q 007260 367 RCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEP 446 (611)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (611)
.+......
T Consensus 190 ~~~~~~~~------------------------------------------------------------------------ 197 (302)
T cd05055 190 DIMNDSNY------------------------------------------------------------------------ 197 (302)
T ss_pred cccCCCce------------------------------------------------------------------------
Confidence 32110000
Q ss_pred ccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 007260 447 TEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARD 525 (611)
Q Consensus 447 ~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~d 525 (611)
.......+++.|+|||++.+..++.++|||||||++|||++ |..||.+......+.+.+......+....++.++.+
T Consensus 198 --~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (302)
T cd05055 198 --VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYD 275 (302)
T ss_pred --eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCCCHHHHH
Confidence 00011246788999999999999999999999999999998 999998877666666666555554444568899999
Q ss_pred HHHHhhhcCccccCCchhcHHHHHc
Q 007260 526 LIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 526 LI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
||.+||.++|++||+ +.++++
T Consensus 276 li~~cl~~~p~~Rpt----~~ell~ 296 (302)
T cd05055 276 IMKTCWDADPLKRPT----FKQIVQ 296 (302)
T ss_pred HHHHHcCCCchhCcC----HHHHHH
Confidence 999999999999999 777764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=342.96 Aligned_cols=245 Identities=31% Similarity=0.496 Sum_probs=200.7
Q ss_pred cCeEEEeEe--cccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeeccceee
Q 007260 216 SHFRLLKRL--GCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEKFSC 292 (611)
Q Consensus 216 ~~y~l~~~L--G~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~~~~~ 292 (611)
+.|.+.+.+ |.|+||.||++++..++..+|+|++.+..... .|+.+...+ +||||++++++|...+..|
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 466666665 99999999999999999999999987643221 123222222 7999999999999999999
Q ss_pred EEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCC-cEEEEeccccccccCC
Q 007260 293 LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDG-HIMLSDFDLSLRCAVS 371 (611)
Q Consensus 293 LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g-~vkL~DFGlA~~~~~~ 371 (611)
+||||++|++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++ .++|+|||++.....
T Consensus 86 iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~- 162 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT- 162 (267)
T ss_pred EEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC-
Confidence 999999999999998775 3799999999999999999999999999999999999999988 999999998732210
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
.
T Consensus 163 -------------------------------------------------------------------------------~ 163 (267)
T PHA03390 163 -------------------------------------------------------------------------------P 163 (267)
T ss_pred -------------------------------------------------------------------------------C
Confidence 0
Q ss_pred cccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHH----HHHHHHcCCCCCCCCCCCCHHHHHHH
Q 007260 452 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRA----TLFNVVGQPLRFPESPVVSFAARDLI 527 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~----~l~~i~~~~l~~p~~~~~s~~l~dLI 527 (611)
....|+..|+|||++.+..++.++|||||||++|||++|+.||....... .+........ +....++..+++||
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li 241 (267)
T PHA03390 164 SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKL--PFIKNVSKNANDFV 241 (267)
T ss_pred ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccC--CcccccCHHHHHHH
Confidence 11248899999999999999999999999999999999999998654332 2222222222 23335899999999
Q ss_pred HHhhhcCccccCCchhcHHHHHcCCCCC
Q 007260 528 RGLLVKEPQHRLAYKRGATEIKQHPFFE 555 (611)
Q Consensus 528 ~~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 555 (611)
.+||+.||.+|++. ++++|+||||.
T Consensus 242 ~~~l~~~p~~R~~~---~~~~l~h~~~~ 266 (267)
T PHA03390 242 QSMLKYNINYRLTN---YNEIIKHPFLK 266 (267)
T ss_pred HHHhccChhhCCch---HHHHhcCCccc
Confidence 99999999999961 59999999996
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=347.83 Aligned_cols=256 Identities=29% Similarity=0.397 Sum_probs=215.4
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVME 296 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE 296 (611)
.|...+.||.|+||+||+|++..++..||||++.............+.+|+++++.++||||+++++++.+....|+|||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 47778899999999999999999999999999976544444555677889999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccc
Q 007260 297 FCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIK 376 (611)
Q Consensus 297 ~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~ 376 (611)
|+. ++|.+++... ...+++..+..++.||+.||.|||.+||+||||||+||+++.++.++|+|||++....
T Consensus 102 ~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~------- 172 (313)
T cd06633 102 YCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS------- 172 (313)
T ss_pred cCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC-------
Confidence 995 5777777654 2568999999999999999999999999999999999999999999999999862100
Q ss_pred cccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccccc
Q 007260 377 ASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVG 456 (611)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vG 456 (611)
......|
T Consensus 173 -------------------------------------------------------------------------~~~~~~~ 179 (313)
T cd06633 173 -------------------------------------------------------------------------PANSFVG 179 (313)
T ss_pred -------------------------------------------------------------------------CCCCccc
Confidence 0012458
Q ss_pred CCCccchhhhc---cCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007260 457 THEYLAPEIIK---GEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVK 533 (611)
Q Consensus 457 T~~Y~APEil~---~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~ 533 (611)
+..|+|||++. +..++.++|||||||++|+|++|..||........+..+............++..+++||.+||.+
T Consensus 180 ~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 259 (313)
T cd06633 180 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQK 259 (313)
T ss_pred cccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccC
Confidence 89999999985 355788999999999999999999999887766666666544333323345788899999999999
Q ss_pred CccccCCchhcHHHHHcCCCCCCCc
Q 007260 534 EPQHRLAYKRGATEIKQHPFFEGVN 558 (611)
Q Consensus 534 dP~~Rpt~~~~a~elL~Hp~f~~~~ 558 (611)
+|.+||+ +.+++.||||+...
T Consensus 260 ~P~~Rp~----~~~~l~~~~~~~~~ 280 (313)
T cd06633 260 IPQERPA----SAELLRHDFVRRDR 280 (313)
T ss_pred ChhhCcC----HHHHhcCcccCCCc
Confidence 9999999 99999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=335.90 Aligned_cols=254 Identities=26% Similarity=0.388 Sum_probs=208.2
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
++|++.+.||.|+||.||+|.+..+++.||+|.++...........++.+|+++++.++|+||++++++|..++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 58999999999999999999999999999999987544444444567788999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcc
Q 007260 296 EFCPGGDLHTLRQKQ--PGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 373 (611)
Q Consensus 296 E~~~gg~L~~ll~~~--~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~ 373 (611)
||+++++|..++... .+..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~- 160 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC-
Confidence 999999999988642 23568999999999999999999999999999999999999999999999999874321000
Q ss_pred ccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccc
Q 007260 374 LIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMS 453 (611)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (611)
.....
T Consensus 161 ---------------------------------------------------------------------------~~~~~ 165 (267)
T cd08224 161 ---------------------------------------------------------------------------TAAHS 165 (267)
T ss_pred ---------------------------------------------------------------------------cccce
Confidence 00012
Q ss_pred cccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCc-HHHH-HHHHcCCCCCCCC-CCCCHHHHHHHHHh
Q 007260 454 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGN-RATL-FNVVGQPLRFPES-PVVSFAARDLIRGL 530 (611)
Q Consensus 454 ~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~-~~~l-~~i~~~~l~~p~~-~~~s~~l~dLI~~~ 530 (611)
..|++.|+|||++.+..++.++|||||||++|+|++|+.||..... ...+ ..+.... ..+.. ..++..+.++|.+|
T Consensus 166 ~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~c 244 (267)
T cd08224 166 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD-YPPLPADHYSEELRDLVSRC 244 (267)
T ss_pred ecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCC-CCCCChhhcCHHHHHHHHHH
Confidence 3588899999999999999999999999999999999999975432 2222 2222221 11221 25788999999999
Q ss_pred hhcCccccCCchhcHHHHHc
Q 007260 531 LVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 531 L~~dP~~Rpt~~~~a~elL~ 550 (611)
|..+|++||+ +.+|++
T Consensus 245 l~~~p~~Rp~----~~~il~ 260 (267)
T cd08224 245 INPDPEKRPD----ISYVLQ 260 (267)
T ss_pred cCCCcccCCC----HHHHHH
Confidence 9999999999 676664
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=338.63 Aligned_cols=251 Identities=25% Similarity=0.361 Sum_probs=206.6
Q ss_pred cccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeE
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCL 293 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~L 293 (611)
..++|++.++||.|+||.||+|++..+. .||||++.+..... .++.+|+++++.++||||+++++++. +...|+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~~----~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l 77 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYI 77 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccCH----HHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEE
Confidence 3468999999999999999999987665 59999997644321 35678999999999999999999875 456899
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcc
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 373 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~ 373 (611)
||||+++++|.+++....+..+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++..+.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 99999999999999876556789999999999999999999999999999999999999999999999999843321000
Q ss_pred ccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccc
Q 007260 374 LIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMS 453 (611)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (611)
.....
T Consensus 158 ---------------------------------------------------------------------------~~~~~ 162 (262)
T cd05071 158 ---------------------------------------------------------------------------TARQG 162 (262)
T ss_pred ---------------------------------------------------------------------------ccccC
Confidence 00001
Q ss_pred cccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007260 454 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLV 532 (611)
Q Consensus 454 ~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~ 532 (611)
..|+..|+|||++.+..++.++|||||||++|||++ |..||.+......+..+... ...+....++..+.+||.+||.
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~ 241 (262)
T cd05071 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHDLMCQCWR 241 (262)
T ss_pred CcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcC-CCCCCccccCHHHHHHHHHHcc
Confidence 236778999999999999999999999999999999 89999887766655554433 3344445689999999999999
Q ss_pred cCccccCCchhcHHHHHc
Q 007260 533 KEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 533 ~dP~~Rpt~~~~a~elL~ 550 (611)
+||++||+ +.++++
T Consensus 242 ~~p~~Rp~----~~~~~~ 255 (262)
T cd05071 242 KEPEERPT----FEYLQA 255 (262)
T ss_pred CCcccCCC----HHHHHH
Confidence 99999999 666553
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=354.34 Aligned_cols=255 Identities=31% Similarity=0.445 Sum_probs=209.9
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc-----
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK----- 289 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~----- 289 (611)
.++|++++.||.|+||.||+|.+..++..||||++.+.. .......++.+|+.+|+.++||||++++++|..+.
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 368999999999999999999999999999999986532 22333446778999999999999999999987653
Q ss_pred -eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccc
Q 007260 290 -FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRC 368 (611)
Q Consensus 290 -~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~ 368 (611)
.+||||||+ |++|..++.. ..+++..++.++.||+.||+|||.+||+||||||+|||++.++.++|+|||++...
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 458999999 8899988764 35899999999999999999999999999999999999999999999999988432
Q ss_pred cCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccc
Q 007260 369 AVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTE 448 (611)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (611)
..
T Consensus 169 ~~------------------------------------------------------------------------------ 170 (343)
T cd07880 169 DS------------------------------------------------------------------------------ 170 (343)
T ss_pred cc------------------------------------------------------------------------------
Confidence 10
Q ss_pred ccccccccCCCccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCC--------------
Q 007260 449 ARSMSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRF-------------- 513 (611)
Q Consensus 449 ~~~~~~vGT~~Y~APEil~~-~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~-------------- 513 (611)
......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+......+.++.......
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07880 171 -EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAK 249 (343)
T ss_pred -CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHH
Confidence 0012357889999999976 457899999999999999999999998876555444433211100
Q ss_pred ------C---------CCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 514 ------P---------ESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 514 ------p---------~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
+ ....++..+.++|.+||..||.+||+ +.+++.||||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t----~~~~l~~~~~~~~ 304 (343)
T cd07880 250 NYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRIT----AAEALAHPYFEEF 304 (343)
T ss_pred HHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCC----HHHHhcCccHhhh
Confidence 0 11347888999999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=337.60 Aligned_cols=251 Identities=23% Similarity=0.331 Sum_probs=207.7
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
.++|++++.||.|+||+||+|++.+. ..+|||.+...... ...+.+|+.+++.++||||+++++++......|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~-~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecCC-CcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 35899999999999999999987653 45999998754432 23467899999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
|||+.+++|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 78 ~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~-- 154 (256)
T cd05113 78 TEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE-- 154 (256)
T ss_pred EEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCc--
Confidence 99999999999987653 368999999999999999999999999999999999999999999999999874321000
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
.......
T Consensus 155 -------------------------------------------------------------------------~~~~~~~ 161 (256)
T cd05113 155 -------------------------------------------------------------------------YTSSVGS 161 (256)
T ss_pred -------------------------------------------------------------------------eeecCCC
Confidence 0000112
Q ss_pred ccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007260 455 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVK 533 (611)
Q Consensus 455 vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~ 533 (611)
.++..|++||++.+..++.++|||||||++|+|++ |..||...........+... ...+.....+..++++|.+||..
T Consensus 162 ~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~ 240 (256)
T cd05113 162 KFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQG-LRLYRPHLASEKVYAIMYSCWHE 240 (256)
T ss_pred ccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcC-CCCCCCCCCCHHHHHHHHHHcCC
Confidence 36678999999998889999999999999999998 99999887766555555544 33333345789999999999999
Q ss_pred CccccCCchhcHHHHHcC
Q 007260 534 EPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 534 dP~~Rpt~~~~a~elL~H 551 (611)
||.+||+ +.+|+.+
T Consensus 241 ~p~~Rp~----~~~ll~~ 254 (256)
T cd05113 241 KAEERPT----FQQLLSS 254 (256)
T ss_pred CcccCCC----HHHHHHh
Confidence 9999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=354.58 Aligned_cols=262 Identities=27% Similarity=0.427 Sum_probs=209.5
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec----ccee
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET----EKFS 291 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~----~~~~ 291 (611)
.+|.+.+.||.|+||.||+|.+..++..||+|++..... .......+.+|+.+|+.++||||++++++|.. ...+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 589999999999999999999999999999999875432 22334566789999999999999999998863 4578
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCC
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~ 371 (611)
|+||||+ +++|.+++... ..+++..++.++.||+.||.|||.+||+||||||+|||++.+|.+||+|||++......
T Consensus 84 ~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 84 YVVMDLM-ESDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred EEEEehh-hhhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 9999999 56898888654 45999999999999999999999999999999999999999999999999998432210
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
... .....
T Consensus 161 ~~~------------------------------------------------------------------------~~~~~ 168 (334)
T cd07855 161 PTE------------------------------------------------------------------------HKYFM 168 (334)
T ss_pred CcC------------------------------------------------------------------------CCccc
Confidence 000 00001
Q ss_pred cccccCCCccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH---cCCC----------------
Q 007260 452 MSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVV---GQPL---------------- 511 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~-~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~---~~~l---------------- 511 (611)
...+|+..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..+. +.+.
T Consensus 169 ~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~ 248 (334)
T cd07855 169 TEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYI 248 (334)
T ss_pred ccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHH
Confidence 13468999999999876 457999999999999999999999998765443332211 1100
Q ss_pred -CCC---C------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 512 -RFP---E------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 512 -~~p---~------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
.++ . ...++.++++||.+||..+|.+||+ +.++++||||+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~~l~~~~~~~~ 300 (334)
T cd07855 249 QNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERIT----VEQALQHPFLAQY 300 (334)
T ss_pred hhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcC----HHHHHhChhhhhc
Confidence 000 0 1346889999999999999999999 9999999999854
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=354.01 Aligned_cols=258 Identities=26% Similarity=0.395 Sum_probs=207.9
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecc-----ce
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE-----KF 290 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~-----~~ 290 (611)
.+|++++.||.|+||+||+|++..+++.||||.+..... ......++.+|+.+|+.++|+||+++++++... ..
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 589999999999999999999999999999999875422 222344567899999999999999999988654 35
Q ss_pred eeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccC
Q 007260 291 SCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAV 370 (611)
Q Consensus 291 ~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~ 370 (611)
+||||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 84 VYIVYELM-DTDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred EEEEEeCC-CCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 89999999 57898888764 5699999999999999999999999999999999999999999999999999843210
Q ss_pred CccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccc
Q 007260 371 SPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEAR 450 (611)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (611)
.. ..
T Consensus 161 ~~----------------------------------------------------------------------------~~ 164 (337)
T cd07858 161 KG----------------------------------------------------------------------------DF 164 (337)
T ss_pred Cc----------------------------------------------------------------------------cc
Confidence 00 00
Q ss_pred ccccccCCCccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH---HcCC----------------
Q 007260 451 SMSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNV---VGQP---------------- 510 (611)
Q Consensus 451 ~~~~vGT~~Y~APEil~~-~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i---~~~~---------------- 510 (611)
....+||..|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..+ .+.+
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (337)
T cd07858 165 MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRY 244 (337)
T ss_pred ccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHH
Confidence 112458899999999875 45899999999999999999999999876433222111 1110
Q ss_pred ----CCC------CCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 511 ----LRF------PESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 511 ----l~~------p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
... .....++.++++||.+||..||.+||+ +.++++||||..+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps----~~ell~h~~~~~~ 297 (337)
T cd07858 245 IRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRIT----VEEALAHPYLASL 297 (337)
T ss_pred HHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccC----HHHHHcCcchhhh
Confidence 000 012357899999999999999999999 9999999999754
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=342.09 Aligned_cols=254 Identities=28% Similarity=0.426 Sum_probs=213.7
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVME 296 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE 296 (611)
-|++++.||.|+||.||+|.+..++..||||++..... ......+.+|+.++..++||||++++++|..+...|+|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 47788999999999999999998999999999865432 2334567889999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccc
Q 007260 297 FCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIK 376 (611)
Q Consensus 297 ~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~ 376 (611)
|+++++|..++.. ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~----- 154 (277)
T cd06641 83 YLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT----- 154 (277)
T ss_pred eCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccc-----
Confidence 9999999998865 35899999999999999999999999999999999999999999999999987432100
Q ss_pred cccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccccc
Q 007260 377 ASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVG 456 (611)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vG 456 (611)
........|
T Consensus 155 -----------------------------------------------------------------------~~~~~~~~~ 163 (277)
T cd06641 155 -----------------------------------------------------------------------QIKRNTFVG 163 (277)
T ss_pred -----------------------------------------------------------------------hhhhccccC
Confidence 000112358
Q ss_pred CCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCcc
Q 007260 457 THEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQ 536 (611)
Q Consensus 457 T~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~ 536 (611)
+..|+|||++.+..++.++|+|||||++|+|++|..||...........+..... ......++.++.++|.+||..+|.
T Consensus 164 ~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~ 242 (277)
T cd06641 164 TPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP-PTLEGNYSKPLKEFVEACLNKEPS 242 (277)
T ss_pred CccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCC-CCCCcccCHHHHHHHHHHccCChh
Confidence 8899999999988889999999999999999999999987665554544433321 112234789999999999999999
Q ss_pred ccCCchhcHHHHHcCCCCCC
Q 007260 537 HRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 537 ~Rpt~~~~a~elL~Hp~f~~ 556 (611)
+||+ +.++++||||..
T Consensus 243 ~Rp~----~~~~l~~~~~~~ 258 (277)
T cd06641 243 FRPT----AKELLKHKFIVR 258 (277)
T ss_pred hCcC----HHHHHhCHHHhh
Confidence 9999 999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=329.52 Aligned_cols=252 Identities=32% Similarity=0.530 Sum_probs=215.1
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVME 296 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE 296 (611)
+|.+.+.||.|++|.||++.+..++..|++|++..... .....+.+|+++++.++|+||+++++++..+...|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 58899999999999999999998999999999976543 344567789999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccc
Q 007260 297 FCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIK 376 (611)
Q Consensus 297 ~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~ 376 (611)
|++|++|.+++.... ..+++..+..++.|++.||.|||.+|++||||+|+||+++.++.++|+|||++.......
T Consensus 78 ~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~---- 152 (253)
T cd05122 78 FCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK---- 152 (253)
T ss_pred cCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccc----
Confidence 999999999887753 568999999999999999999999999999999999999999999999999873321000
Q ss_pred cccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccccc
Q 007260 377 ASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVG 456 (611)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vG 456 (611)
......|
T Consensus 153 -------------------------------------------------------------------------~~~~~~~ 159 (253)
T cd05122 153 -------------------------------------------------------------------------ARNTMVG 159 (253)
T ss_pred -------------------------------------------------------------------------cccceec
Confidence 0123458
Q ss_pred CCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHHhhhcCc
Q 007260 457 THEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG-QPLRFPESPVVSFAARDLIRGLLVKEP 535 (611)
Q Consensus 457 T~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~-~~l~~p~~~~~s~~l~dLI~~~L~~dP 535 (611)
+..|++||++.+..++.++||||||+++|+|++|+.||...+....+..+.. .....+....++..+.++|.+||..||
T Consensus 160 ~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 239 (253)
T cd05122 160 TPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNP 239 (253)
T ss_pred CCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccCCh
Confidence 8999999999988899999999999999999999999988755555444433 222333333358999999999999999
Q ss_pred cccCCchhcHHHHHcCCC
Q 007260 536 QHRLAYKRGATEIKQHPF 553 (611)
Q Consensus 536 ~~Rpt~~~~a~elL~Hp~ 553 (611)
++||+ +.++++|||
T Consensus 240 ~~R~t----~~~~l~~~~ 253 (253)
T cd05122 240 EKRPT----AEQLLKHPF 253 (253)
T ss_pred hhCCC----HHHHhcCCC
Confidence 99999 999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=339.65 Aligned_cols=257 Identities=21% Similarity=0.289 Sum_probs=209.1
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCC-----CeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGT-----KCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET 287 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t-----~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~ 287 (611)
+..++|++.+.||.|+||.||+|.+... +..||+|.+...... .....+.+|+.+|+.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASM--RERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCH--HHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 3456899999999999999999998643 478999998654321 223456789999999999999999999999
Q ss_pred cceeeEEeeeCCCCCHHHHHHhCC--------CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEE
Q 007260 288 EKFSCLVMEFCPGGDLHTLRQKQP--------GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIML 359 (611)
Q Consensus 288 ~~~~~LVmE~~~gg~L~~ll~~~~--------~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL 359 (611)
....|+||||+++++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence 999999999999999999886532 224688899999999999999999999999999999999999999999
Q ss_pred EeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCC
Q 007260 360 SDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPL 439 (611)
Q Consensus 360 ~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (611)
+|||++........
T Consensus 161 ~dfg~~~~~~~~~~------------------------------------------------------------------ 174 (277)
T cd05032 161 GDFGMTRDIYETDY------------------------------------------------------------------ 174 (277)
T ss_pred CCcccchhhccCcc------------------------------------------------------------------
Confidence 99999843221000
Q ss_pred cccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCC
Q 007260 440 PELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPV 518 (611)
Q Consensus 440 ~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~ 518 (611)
........++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+....+..+. .....+....
T Consensus 175 --------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~ 245 (277)
T cd05032 175 --------YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-DGGHLDLPEN 245 (277)
T ss_pred --------cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh-cCCCCCCCCC
Confidence 000112347788999999998889999999999999999998 999998876655554444 3333333445
Q ss_pred CCHHHHHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 519 VSFAARDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 519 ~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
++..+.+||.+||..+|.+||+ +.+|++
T Consensus 246 ~~~~~~~li~~~l~~~p~~Rpt----~~~l~~ 273 (277)
T cd05032 246 CPDKLLELMRMCWQYNPKMRPT----FLEIVS 273 (277)
T ss_pred CCHHHHHHHHHHcCCChhhCCC----HHHHHH
Confidence 7999999999999999999999 777775
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=338.56 Aligned_cols=249 Identities=24% Similarity=0.368 Sum_probs=206.3
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
.+|++.+.||.|+||.||++.+.. +..+|+|++.+..... ..+.+|+++++.++||||+++++++...+..|+||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAMSE----DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecC-CccEEEEEeccCCCCH----HHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 478999999999999999998864 5579999987644322 24567999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
||++|++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 79 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-- 155 (256)
T cd05059 79 EYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-- 155 (256)
T ss_pred ecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccc--
Confidence 9999999999987653 3689999999999999999999999999999999999999999999999998743210000
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
.......
T Consensus 156 -------------------------------------------------------------------------~~~~~~~ 162 (256)
T cd05059 156 -------------------------------------------------------------------------TSSQGTK 162 (256)
T ss_pred -------------------------------------------------------------------------cccCCCC
Confidence 0000112
Q ss_pred cCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcC
Q 007260 456 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKE 534 (611)
Q Consensus 456 GT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~d 534 (611)
++..|+|||++.+..++.++|||||||++|||++ |+.||......+....+.. ....+....++.++.+||.+||..+
T Consensus 163 ~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~~ 241 (256)
T cd05059 163 FPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA-GYRLYRPKLAPTEVYTIMYSCWHEK 241 (256)
T ss_pred CCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHc-CCcCCCCCCCCHHHHHHHHHHhcCC
Confidence 4567999999999999999999999999999998 8999988776665555443 3334444558999999999999999
Q ss_pred ccccCCchhcHHHHHc
Q 007260 535 PQHRLAYKRGATEIKQ 550 (611)
Q Consensus 535 P~~Rpt~~~~a~elL~ 550 (611)
|++||+ +.++++
T Consensus 242 p~~Rpt----~~~~l~ 253 (256)
T cd05059 242 PEDRPA----FKKLLS 253 (256)
T ss_pred hhhCcC----HHHHHH
Confidence 999999 778775
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=338.00 Aligned_cols=255 Identities=24% Similarity=0.307 Sum_probs=210.4
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCC---CeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecccee
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGT---KCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFS 291 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t---~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~ 291 (611)
.++|++.+.||.|+||+||+|.+... ...||||+++.... ......+.+|+.+|+.++||||+++++++...+..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS--DKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC--hHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 35799999999999999999998643 56899999875432 22334567899999999999999999999999999
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCC
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~ 371 (611)
|+||||+++++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++..+...
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 81 MIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999999987754 46899999999999999999999999999999999999999999999999998543200
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
.. ....
T Consensus 160 ~~--------------------------------------------------------------------------~~~~ 165 (266)
T cd05033 160 EA--------------------------------------------------------------------------TYTT 165 (266)
T ss_pred cc--------------------------------------------------------------------------ceec
Confidence 00 0000
Q ss_pred cccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 007260 452 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGL 530 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~ 530 (611)
....+++.|+|||.+.+..++.++|||||||++|+|++ |..||...........+.. ....+....++..+.+||.+|
T Consensus 166 ~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~c 244 (266)
T cd05033 166 KGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVED-GYRLPPPMDCPSALYQLMLDC 244 (266)
T ss_pred cCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHH
Confidence 01135678999999999999999999999999999997 9999987776665555443 334444556899999999999
Q ss_pred hhcCccccCCchhcHHHHHcC
Q 007260 531 LVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 531 L~~dP~~Rpt~~~~a~elL~H 551 (611)
|..+|++||+ +.+++++
T Consensus 245 l~~~p~~Rp~----~~ei~~~ 261 (266)
T cd05033 245 WQKDRNERPT----FSQIVST 261 (266)
T ss_pred cCCCcccCcC----HHHHHHH
Confidence 9999999999 7777653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=331.19 Aligned_cols=257 Identities=33% Similarity=0.504 Sum_probs=215.8
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecc--ceeeEE
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE--KFSCLV 294 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~--~~~~LV 294 (611)
+|++.+.||.|++|.||+|.+..++..|++|++...... ......+.+|+.++++++|+||+++++++... ..+|+|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 588999999999999999999999999999999765432 34456778899999999999999999999988 899999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
|||+++++|.+++.... .+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus 80 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 80 LEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 99999999999988763 7999999999999999999999999999999999999999999999999987433211000
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
......
T Consensus 158 --------------------------------------------------------------------------~~~~~~ 163 (260)
T cd06606 158 --------------------------------------------------------------------------EGTGSV 163 (260)
T ss_pred --------------------------------------------------------------------------ccccCC
Confidence 001123
Q ss_pred ccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007260 455 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNR-ATLFNVVGQPLRFPESPVVSFAARDLIRGLLVK 533 (611)
Q Consensus 455 vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~-~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~ 533 (611)
.++..|++||.+.+..++.++||||||+++|+|++|..||....+. ..+..+............++..+++||.+||..
T Consensus 164 ~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~ 243 (260)
T cd06606 164 RGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRR 243 (260)
T ss_pred CCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHHhCcC
Confidence 5888999999999888999999999999999999999999887633 333333322222223334789999999999999
Q ss_pred CccccCCchhcHHHHHcCCCC
Q 007260 534 EPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 534 dP~~Rpt~~~~a~elL~Hp~f 554 (611)
||.+||+ +.++++||||
T Consensus 244 ~p~~Rp~----~~~ll~~~~~ 260 (260)
T cd06606 244 DPKKRPT----ADELLQHPFL 260 (260)
T ss_pred ChhhCCC----HHHHhhCCCC
Confidence 9999999 9999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=342.06 Aligned_cols=253 Identities=23% Similarity=0.338 Sum_probs=208.4
Q ss_pred cCeEEEeEecccCcEEEEEEEE-----CCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccce
Q 007260 216 SHFRLLKRLGCGDIGSVYLSEL-----SGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKF 290 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~-----~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~ 290 (611)
.+|.+.+.||.|+||.||++.+ ..++..+|+|.+.... ......+.+|+++|+.++||||+++++++...+.
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 81 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 5799999999999999999986 3356679999987543 2334467789999999999999999999999999
Q ss_pred eeEEeeeCCCCCHHHHHHhCC-----------CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEE
Q 007260 291 SCLVMEFCPGGDLHTLRQKQP-----------GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIML 359 (611)
Q Consensus 291 ~~LVmE~~~gg~L~~ll~~~~-----------~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL 359 (611)
+|+||||+++++|.+++..+. ...+++..+..++.||+.||+|||.+||+||||||+|||++.++.++|
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEe
Confidence 999999999999999987542 134899999999999999999999999999999999999999999999
Q ss_pred EeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCC
Q 007260 360 SDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPL 439 (611)
Q Consensus 360 ~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (611)
+|||++..+.....
T Consensus 162 ~dfg~~~~~~~~~~------------------------------------------------------------------ 175 (288)
T cd05093 162 GDFGMSRDVYSTDY------------------------------------------------------------------ 175 (288)
T ss_pred ccCCccccccCCce------------------------------------------------------------------
Confidence 99999843210000
Q ss_pred cccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCC
Q 007260 440 PELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPV 518 (611)
Q Consensus 440 ~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~ 518 (611)
........|++.|+|||++.+..++.++|||||||++|+|++ |..||........+..+..... .+....
T Consensus 176 --------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~-~~~~~~ 246 (288)
T cd05093 176 --------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV-LQRPRT 246 (288)
T ss_pred --------eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCc-CCCCCC
Confidence 000012246788999999999999999999999999999998 9999988777666666655442 222335
Q ss_pred CCHHHHHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 519 VSFAARDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 519 ~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
++.++.+||.+||..||.+||+ +.+++.
T Consensus 247 ~~~~l~~li~~~l~~~p~~Rpt----~~~v~~ 274 (288)
T cd05093 247 CPKEVYDLMLGCWQREPHMRLN----IKEIHS 274 (288)
T ss_pred CCHHHHHHHHHHccCChhhCCC----HHHHHH
Confidence 8899999999999999999999 666643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=343.46 Aligned_cols=260 Identities=28% Similarity=0.452 Sum_probs=220.7
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
...|.+.+.||.|+||.||++.+..++..||+|++..... ....+.+|+++++.++|+||+++++.+..+...|+|
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 3579999999999999999999998899999999976542 334567899999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
|||++|++|.+++.... ..+++..+..++.|++.||.|||.+||+|+||||+||+++.++.++|+|||++......
T Consensus 94 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~--- 169 (286)
T cd06614 94 MEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE--- 169 (286)
T ss_pred EeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccc---
Confidence 99999999999998763 37999999999999999999999999999999999999999999999999987322100
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
.......
T Consensus 170 -------------------------------------------------------------------------~~~~~~~ 176 (286)
T cd06614 170 -------------------------------------------------------------------------KSKRNSV 176 (286)
T ss_pred -------------------------------------------------------------------------hhhhccc
Confidence 0001123
Q ss_pred ccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCC-CCCCCCCCCHHHHHHHHHhhhc
Q 007260 455 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPL-RFPESPVVSFAARDLIRGLLVK 533 (611)
Q Consensus 455 vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l-~~p~~~~~s~~l~dLI~~~L~~ 533 (611)
.|+..|++||++.+..++.++|+|||||++|+|++|+.||...........+..... .++....++..+++||.+||..
T Consensus 177 ~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 256 (286)
T cd06614 177 VGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVK 256 (286)
T ss_pred cCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHHhcc
Confidence 478899999999988899999999999999999999999988766655555443332 2333334789999999999999
Q ss_pred CccccCCchhcHHHHHcCCCCCCCch
Q 007260 534 EPQHRLAYKRGATEIKQHPFFEGVNW 559 (611)
Q Consensus 534 dP~~Rpt~~~~a~elL~Hp~f~~~~~ 559 (611)
+|.+||+ +.+++.|+||+...|
T Consensus 257 ~p~~Rpt----~~~il~~~~~~~~~~ 278 (286)
T cd06614 257 DPEKRPS----AEELLQHPFLKKACP 278 (286)
T ss_pred ChhhCcC----HHHHhhChHhhccCc
Confidence 9999999 999999999988554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=334.63 Aligned_cols=247 Identities=24% Similarity=0.335 Sum_probs=201.6
Q ss_pred eEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEeeeCCCC
Q 007260 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGG 301 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE~~~gg 301 (611)
+.||.|+||.||+|.+..++..||+|++.... ..+....+.+|+++|+.++||||+++++++......||||||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 36999999999999999999999999886432 2233456788999999999999999999999999999999999999
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccccCC
Q 007260 302 DLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLD 381 (611)
Q Consensus 302 ~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~ 381 (611)
+|.+++... +..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 79 ~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-------- 149 (252)
T cd05084 79 DFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY-------- 149 (252)
T ss_pred cHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccc--------
Confidence 999988764 34689999999999999999999999999999999999999999999999999743210000
Q ss_pred CCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCcc
Q 007260 382 AEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYL 461 (611)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~ 461 (611)
. .......++..|+
T Consensus 150 ----------~--------------------------------------------------------~~~~~~~~~~~y~ 163 (252)
T cd05084 150 ----------A--------------------------------------------------------STGGMKQIPVKWT 163 (252)
T ss_pred ----------c--------------------------------------------------------ccCCCCCCceeec
Confidence 0 0000011345799
Q ss_pred chhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccCC
Q 007260 462 APEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLA 540 (611)
Q Consensus 462 APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt 540 (611)
|||++.+..++.++|||||||++|||++ |..||...........+.. ....+....++..+.+||.+||..||++||+
T Consensus 164 aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 242 (252)
T cd05084 164 APEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ-GVRLPCPELCPDAVYRLMERCWEYDPGQRPS 242 (252)
T ss_pred CchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc-CCCCCCcccCCHHHHHHHHHHcCCChhhCcC
Confidence 9999999999999999999999999997 9999987666554444433 3333444458899999999999999999999
Q ss_pred chhcHHHHHc
Q 007260 541 YKRGATEIKQ 550 (611)
Q Consensus 541 ~~~~a~elL~ 550 (611)
+.++++
T Consensus 243 ----~~~~~~ 248 (252)
T cd05084 243 ----FSTVHQ 248 (252)
T ss_pred ----HHHHHH
Confidence 777664
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=339.71 Aligned_cols=254 Identities=28% Similarity=0.448 Sum_probs=207.4
Q ss_pred eEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC---CCCCcccccceeeccce----
Q 007260 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL---DHPFLPTLYTHFETEKF---- 290 (611)
Q Consensus 218 y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l---~HpnIv~l~~~~~~~~~---- 290 (611)
|++++.||.|+||.||+|++..++..||||++...... ......+.+|+.+++++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE-EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEecccccc-chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 78899999999999999999988999999999754322 12223455677777666 69999999999987776
Q ss_pred -eeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 291 -SCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 291 -~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
+|+||||++ ++|.+++.......+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++....
T Consensus 80 ~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 999999996 589988877654569999999999999999999999999999999999999999999999999874321
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
.. .
T Consensus 159 ~~-----------------------------------------------------------------------------~ 161 (287)
T cd07838 159 FE-----------------------------------------------------------------------------M 161 (287)
T ss_pred CC-----------------------------------------------------------------------------c
Confidence 00 0
Q ss_pred cccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCC-----CCCC----------
Q 007260 450 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQP-----LRFP---------- 514 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~-----l~~p---------- 514 (611)
......|++.|+|||++.+..++.++|||||||++|||++|++||.+....+.+.++...- ..++
T Consensus 162 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (287)
T cd07838 162 ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSF 241 (287)
T ss_pred ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhc
Confidence 0012347889999999999999999999999999999999999999887766665554311 0000
Q ss_pred -C---------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCC
Q 007260 515 -E---------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 515 -~---------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f 554 (611)
. .+.++..+.+||.+||..||.+||+ +.++++||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~----~~~il~~~~~ 287 (287)
T cd07838 242 PSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRIS----AFEALQHPYF 287 (287)
T ss_pred ccccccchhhhhhhhhHHHHHHHHHHhccCCccCCC----HHHHhcCcCC
Confidence 0 1135678899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=344.01 Aligned_cols=268 Identities=26% Similarity=0.399 Sum_probs=207.2
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecc------
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE------ 288 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~------ 288 (611)
+++|++++.||.|+||.||+|.+..+++.||||++....... .....+.+|+++|+.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 579999999999999999999999999999999986543221 1122456799999999999999999987543
Q ss_pred --ceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccc
Q 007260 289 --KFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSL 366 (611)
Q Consensus 289 --~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~ 366 (611)
..+|+||||+. ++|...+... ...+++..++.++.||+.||+|||.+||+||||||+|||+++++.++|+|||++.
T Consensus 86 ~~~~~~lv~~~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 86 KRGSVYMVTPYMD-HDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred cCceEEEEEecCC-cCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccch
Confidence 45799999995 5777766543 3569999999999999999999999999999999999999999999999999985
Q ss_pred cccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCc
Q 007260 367 RCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEP 446 (611)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (611)
........... ....
T Consensus 164 ~~~~~~~~~~~-----------------------------------------------------------------~~~~ 178 (311)
T cd07866 164 PYDGPPPNPKG-----------------------------------------------------------------GGGG 178 (311)
T ss_pred hccCCCccccc-----------------------------------------------------------------CCcc
Confidence 43211000000 0000
Q ss_pred ccccccccccCCCccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHc---CCCC--CC------
Q 007260 447 TEARSMSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG---QPLR--FP------ 514 (611)
Q Consensus 447 ~~~~~~~~vGT~~Y~APEil~~~-~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~---~~l~--~p------ 514 (611)
........+|++.|+|||++.+. .++.++|||||||++|||++|++||.+.+.......+.. .+.. ++
T Consensus 179 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (311)
T cd07866 179 GTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLP 258 (311)
T ss_pred cccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcc
Confidence 01112345789999999998765 478999999999999999999999988776554443322 1100 00
Q ss_pred -----------------CCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCC
Q 007260 515 -----------------ESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 515 -----------------~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f 554 (611)
....+...+.+||.+||..||.+||+ +.+++.||||
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t----~~ell~~~~f 311 (311)
T cd07866 259 GCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLT----ASDALEHPYF 311 (311)
T ss_pred cccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcC----HHHHhcCCCC
Confidence 01234568899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=336.29 Aligned_cols=250 Identities=24% Similarity=0.365 Sum_probs=206.0
Q ss_pred cccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeE
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCL 293 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~L 293 (611)
..++|+++++||.|+||.||+|.+.. +..||+|.+....... ..+.+|+.++++++|+||+++++++. ....|+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~k~~~~~~~~~----~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l 77 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNG-NTKVAVKTLKPGTMSP----ESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYI 77 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecC-CceeEEEEecCCCCCH----HHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEE
Confidence 34689999999999999999998764 4569999987654322 24678999999999999999999875 456899
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcc
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 373 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~ 373 (611)
||||+++++|.+++.......+++..++.++.|++.||+|||++||+||||||+|||+++++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 99999999999998876556789999999999999999999999999999999999999999999999999843211000
Q ss_pred ccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccc
Q 007260 374 LIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMS 453 (611)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (611)
.....
T Consensus 158 ---------------------------------------------------------------------------~~~~~ 162 (260)
T cd05070 158 ---------------------------------------------------------------------------TARQG 162 (260)
T ss_pred ---------------------------------------------------------------------------ccccC
Confidence 00011
Q ss_pred cccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007260 454 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLV 532 (611)
Q Consensus 454 ~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~ 532 (611)
..++..|+|||++.+..++.++|||||||++|+|++ |.+||.+....+.+..+... ...+.....+..+.+||.+||.
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~ 241 (260)
T cd05070 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG-YRMPCPQDCPISLHELMLQCWK 241 (260)
T ss_pred CCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCCCcCCHHHHHHHHHHcc
Confidence 235678999999998889999999999999999999 99999887766666555443 3344445688999999999999
Q ss_pred cCccccCCchhcHHHHH
Q 007260 533 KEPQHRLAYKRGATEIK 549 (611)
Q Consensus 533 ~dP~~Rpt~~~~a~elL 549 (611)
+||++||+ +.+++
T Consensus 242 ~~p~~Rpt----~~~l~ 254 (260)
T cd05070 242 KDPEERPT----FEYLQ 254 (260)
T ss_pred cCcccCcC----HHHHH
Confidence 99999999 66665
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=347.40 Aligned_cols=254 Identities=29% Similarity=0.394 Sum_probs=216.0
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVME 296 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE 296 (611)
.|...+.||+|+||.||++++..++..||||++........+....+.+|+++++.++||||+++++++..+...|||||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 48889999999999999999999999999999976544444555677889999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccc
Q 007260 297 FCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIK 376 (611)
Q Consensus 297 ~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~ 376 (611)
|+. |+|.+++... ...+++..+..++.||+.||.|||.+||+||||+|+||+++.++.++|+|||++....
T Consensus 106 ~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~------- 176 (317)
T cd06635 106 YCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS------- 176 (317)
T ss_pred CCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccC-------
Confidence 996 5787776554 3568999999999999999999999999999999999999999999999999872210
Q ss_pred cccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccccc
Q 007260 377 ASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVG 456 (611)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vG 456 (611)
......|
T Consensus 177 -------------------------------------------------------------------------~~~~~~~ 183 (317)
T cd06635 177 -------------------------------------------------------------------------PANSFVG 183 (317)
T ss_pred -------------------------------------------------------------------------CcccccC
Confidence 0012358
Q ss_pred CCCccchhhhc---cCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007260 457 THEYLAPEIIK---GEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVK 533 (611)
Q Consensus 457 T~~Y~APEil~---~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~ 533 (611)
++.|+|||++. ...++.++|||||||++|||++|+.||........+..+............++..+++||.+||..
T Consensus 184 ~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 263 (317)
T cd06635 184 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQK 263 (317)
T ss_pred CccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHHccC
Confidence 88999999984 345788999999999999999999999887766667766665544444445788999999999999
Q ss_pred CccccCCchhcHHHHHcCCCCCC
Q 007260 534 EPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 534 dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
+|.+||+ +.++++|+|+..
T Consensus 264 ~p~~Rpt----~~~il~~~~~~~ 282 (317)
T cd06635 264 IPQDRPT----SEELLKHMFVLR 282 (317)
T ss_pred CcccCcC----HHHHHhChhhhc
Confidence 9999999 999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=339.01 Aligned_cols=256 Identities=20% Similarity=0.297 Sum_probs=208.1
Q ss_pred ccCeEEEeEecccCcEEEEEEEECC-----CCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSG-----TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK 289 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~-----t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~ 289 (611)
.+.|.+.+.||.|+||.||+|.+.. ++..||+|.+...... .....+.+|+.+++.++|+||+++++++.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE--QDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 3579999999999999999999987 7889999988644322 22345678999999999999999999999999
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCC-----CCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCC---cEEEEe
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPG-----KYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDG---HIMLSD 361 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~-----~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g---~vkL~D 361 (611)
..|+||||++|++|.+++..... ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence 99999999999999999876421 2589999999999999999999999999999999999998755 599999
Q ss_pred ccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcc
Q 007260 362 FDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPE 441 (611)
Q Consensus 362 FGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (611)
||++..+......
T Consensus 163 fg~~~~~~~~~~~------------------------------------------------------------------- 175 (277)
T cd05036 163 FGMARDIYRASYY------------------------------------------------------------------- 175 (277)
T ss_pred CccccccCCccce-------------------------------------------------------------------
Confidence 9998543100000
Q ss_pred cccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCC
Q 007260 442 LIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVS 520 (611)
Q Consensus 442 ~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s 520 (611)
.......++..|+|||++.+..++.++|||||||++|||++ |+.||.+......+..+... ........++
T Consensus 176 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~ 247 (277)
T cd05036 176 -------RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG-GRLDPPKGCP 247 (277)
T ss_pred -------ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CcCCCCCCCC
Confidence 00001124567999999999999999999999999999996 99999987766555444332 2333344588
Q ss_pred HHHHHHHHHhhhcCccccCCchhcHHHHHcC
Q 007260 521 FAARDLIRGLLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 521 ~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~H 551 (611)
..+.+||.+||..||++||+ +.++++|
T Consensus 248 ~~~~~~i~~cl~~~p~~Rps----~~~vl~~ 274 (277)
T cd05036 248 GPVYRIMTDCWQHTPEDRPN----FATILER 274 (277)
T ss_pred HHHHHHHHHHcCCCcccCcC----HHHHHHH
Confidence 99999999999999999999 8888876
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=342.57 Aligned_cols=256 Identities=22% Similarity=0.325 Sum_probs=209.0
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCC----------------eEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCc
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTK----------------CYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFL 278 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~----------------~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnI 278 (611)
.++|++++.||+|+||.||+|.+..++ ..||+|++...... .....+.+|+++|+.++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD--NAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH--HHHHHHHHHHHHHHhcCCCCE
Confidence 468999999999999999999876543 56899998765322 334567789999999999999
Q ss_pred ccccceeeccceeeEEeeeCCCCCHHHHHHhCC---------CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcE
Q 007260 279 PTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQP---------GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENV 349 (611)
Q Consensus 279 v~l~~~~~~~~~~~LVmE~~~gg~L~~ll~~~~---------~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNI 349 (611)
+++++++..+...|+||||+++++|.+++.... ...+++..++.++.|++.||+|||++||+||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 999999999999999999999999999987653 12689999999999999999999999999999999999
Q ss_pred EEccCCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCc
Q 007260 350 LVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPK 429 (611)
Q Consensus 350 Lv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 429 (611)
|++.++.++|+|||++.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~--------------------------------------------------------- 184 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSD--------------------------------------------------------- 184 (296)
T ss_pred eecCCCceEEccccceeecccCc---------------------------------------------------------
Confidence 99999999999999874321000
Q ss_pred cccCCCCCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh--CCCCCCCCCcHHHHHHHH
Q 007260 430 NEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF--GKTPFKGSGNRATLFNVV 507 (611)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt--G~~PF~~~~~~~~l~~i~ 507 (611)
.........+++.|+|||++.+..++.++|||||||++|||++ |..||........+.++.
T Consensus 185 -----------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~ 247 (296)
T cd05051 185 -----------------YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAG 247 (296)
T ss_pred -----------------ceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHH
Confidence 0000112347788999999998889999999999999999997 788998776666655544
Q ss_pred cC------CCCCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 508 GQ------PLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 508 ~~------~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
.. ....+....++.++.+||.+||..||.+||+ +.+|++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt----~~el~~ 292 (296)
T cd05051 248 HFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPT----FREIHL 292 (296)
T ss_pred hccccccccccCCCccCCCHHHHHHHHHHhccChhcCCC----HHHHHH
Confidence 22 2223334457899999999999999999999 888865
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=353.11 Aligned_cols=258 Identities=28% Similarity=0.425 Sum_probs=213.4
Q ss_pred ccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCC--C----Ccccccce
Q 007260 211 GVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH--P----FLPTLYTH 284 (611)
Q Consensus 211 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~H--p----nIv~l~~~ 284 (611)
+.....+|.+++.||+|.||.|-.+.+..++..||||||+.-. +....+.-|+++|+++.+ | -+|.+.+|
T Consensus 84 gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w 159 (415)
T KOG0671|consen 84 GDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQMRDW 159 (415)
T ss_pred ccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence 3333579999999999999999999999999999999996432 333455679999999942 2 37899999
Q ss_pred eeccceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEcc-----------
Q 007260 285 FETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRE----------- 353 (611)
Q Consensus 285 ~~~~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~----------- 353 (611)
|+..+++|||+|.+ |-++++++..+....|+..+++.+++||+.+|+|||+++++|-||||||||+..
T Consensus 160 FdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 160 FDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred hhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCC
Confidence 99999999999999 889999999988889999999999999999999999999999999999999832
Q ss_pred ---------CCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCccccccccc
Q 007260 354 ---------DGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKK 424 (611)
Q Consensus 354 ---------~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (611)
+..|+|+|||-|..-
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~-------------------------------------------------------- 262 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFD-------------------------------------------------------- 262 (415)
T ss_pred ccceeccCCCcceEEEecCCccee--------------------------------------------------------
Confidence 225889999976211
Q ss_pred CCCCccccCCCCCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHH--
Q 007260 425 DRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRAT-- 502 (611)
Q Consensus 425 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~-- 502 (611)
.....++|-|..|+|||++.|.+++..+||||+||||+||.+|...|...++.+.
T Consensus 263 -----------------------~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLa 319 (415)
T KOG0671|consen 263 -----------------------HEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLA 319 (415)
T ss_pred -----------------------ccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHH
Confidence 1112467899999999999999999999999999999999999999999887763
Q ss_pred -HHHHHcCC------------------CCCCCCC-----------------------CCCHHHHHHHHHhhhcCccccCC
Q 007260 503 -LFNVVGQP------------------LRFPESP-----------------------VVSFAARDLIRGLLVKEPQHRLA 540 (611)
Q Consensus 503 -l~~i~~~~------------------l~~p~~~-----------------------~~s~~l~dLI~~~L~~dP~~Rpt 540 (611)
+..|++.. ++|++.. ..-..+.|||++||..||.+|+|
T Consensus 320 MMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiT 399 (415)
T KOG0671|consen 320 MMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRIT 399 (415)
T ss_pred HHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccccc
Confidence 44555421 2222210 01124679999999999999999
Q ss_pred chhcHHHHHcCCCCCC
Q 007260 541 YKRGATEIKQHPFFEG 556 (611)
Q Consensus 541 ~~~~a~elL~Hp~f~~ 556 (611)
+.|+|.||||..
T Consensus 400 ----l~EAL~HpFF~~ 411 (415)
T KOG0671|consen 400 ----LREALSHPFFAR 411 (415)
T ss_pred ----HHHHhcCHHhhc
Confidence 999999999975
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=365.13 Aligned_cols=259 Identities=23% Similarity=0.361 Sum_probs=211.3
Q ss_pred CccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc
Q 007260 210 DGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK 289 (611)
Q Consensus 210 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~ 289 (611)
++.+-.+.+.++.+||+|.||+||+|++.++ ||||++....... +.++.|++|+.+|++-+|.||+-+.|++....
T Consensus 386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~-~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 386 EWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTP-EQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred ccccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCCH-HHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 4556667888999999999999999999876 9999998776554 48889999999999999999999999999888
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
. .||.-+|+|-+|+.++.... ..|.....+.|+.||+.|+.|||.++|||||||..||++.+++.|||+||||+..-.
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred e-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence 7 89999999999999988764 569999999999999999999999999999999999999999999999999982110
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
.+ ++.+
T Consensus 540 ----~w---------------~g~~------------------------------------------------------- 545 (678)
T KOG0193|consen 540 ----RW---------------SGEQ------------------------------------------------------- 545 (678)
T ss_pred ----ee---------------cccc-------------------------------------------------------
Confidence 00 0000
Q ss_pred cccccccCCCccchhhhccC---CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCC----CCCCCHH
Q 007260 450 RSMSFVGTHEYLAPEIIKGE---GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPE----SPVVSFA 522 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~~---~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~----~~~~s~~ 522 (611)
....-.|...|||||+++.. +|+..+|||||||++|||++|..||. ..+.+++.-++++.+-.|. ...++.+
T Consensus 546 q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifmVGrG~l~pd~s~~~s~~pk~ 624 (678)
T KOG0193|consen 546 QLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFMVGRGYLMPDLSKIRSNCPKA 624 (678)
T ss_pred ccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEEecccccCccchhhhccCHHH
Confidence 00011378899999999854 58999999999999999999999999 4555554444454433332 2347789
Q ss_pred HHHHHHHhhhcCccccCCchhcHHHHH
Q 007260 523 ARDLIRGLLVKEPQHRLAYKRGATEIK 549 (611)
Q Consensus 523 l~dLI~~~L~~dP~~Rpt~~~~a~elL 549 (611)
+++|+..||.+++++||.+.+....|+
T Consensus 625 mk~Ll~~C~~~~~~eRP~F~~il~~l~ 651 (678)
T KOG0193|consen 625 MKRLLSDCWKFDREERPLFPQLLSKLE 651 (678)
T ss_pred HHHHHHHHHhcCcccCccHHHHHHHHH
Confidence 999999999999999999554443333
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=342.75 Aligned_cols=256 Identities=20% Similarity=0.298 Sum_probs=209.1
Q ss_pred cccCeEEEeEecccCcEEEEEEEECCC-----CeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecc
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSGT-----KCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE 288 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~t-----~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~ 288 (611)
.+.+|++.+.||.|+||.||+|.+..+ +..||||++..... ......+.+|+.++..++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE--GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 356789999999999999999987543 57899999975431 23345677899999999999999999999999
Q ss_pred ceeeEEeeeCCCCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccC
Q 007260 289 KFSCLVMEFCPGGDLHTLRQKQP--------------GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRED 354 (611)
Q Consensus 289 ~~~~LVmE~~~gg~L~~ll~~~~--------------~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~ 354 (611)
...++++||+.+++|.+++.... ...+++..+..++.|++.||+|||++||+||||||+|||++++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 99999999999999999875321 2358889999999999999999999999999999999999999
Q ss_pred CcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCC
Q 007260 355 GHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGN 434 (611)
Q Consensus 355 g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (611)
+.+||+|||+++.......
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~------------------------------------------------------------- 179 (283)
T cd05091 161 LNVKISDLGLFREVYAADY------------------------------------------------------------- 179 (283)
T ss_pred CceEecccccccccccchh-------------------------------------------------------------
Confidence 9999999999743211000
Q ss_pred CCCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCC
Q 007260 435 QVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRF 513 (611)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~ 513 (611)
........+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+.+..+..... .
T Consensus 180 -------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~-~ 245 (283)
T cd05091 180 -------------YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQV-L 245 (283)
T ss_pred -------------eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc-C
Confidence 000012246788999999998889999999999999999997 9999988776666655555443 2
Q ss_pred CCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 514 PESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 514 p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
+....++..+.+||.+||+.+|.+||+ +++|++
T Consensus 246 ~~~~~~~~~~~~li~~cl~~~p~~RP~----~~~i~~ 278 (283)
T cd05091 246 PCPDDCPAWVYTLMLECWNEFPSRRPR----FKDIHS 278 (283)
T ss_pred CCCCCCCHHHHHHHHHHhCCCcccCCC----HHHHHH
Confidence 333458999999999999999999999 788876
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=331.77 Aligned_cols=249 Identities=26% Similarity=0.376 Sum_probs=209.5
Q ss_pred eEecccCcEEEEEEEECCC---CeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEeeeC
Q 007260 222 KRLGCGDIGSVYLSELSGT---KCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFC 298 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~~~t---~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE~~ 298 (611)
+.||.|+||.||+|.+... +..||+|++....... ....+.+|+++++.++|+||+++++++.....+||||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4699999999999999865 8899999997654332 4556788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhCC-------CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCC
Q 007260 299 PGGDLHTLRQKQP-------GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 299 ~gg~L~~ll~~~~-------~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~ 371 (611)
++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 9999999988742 356999999999999999999999999999999999999999999999999998433211
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
.. ....
T Consensus 159 ~~--------------------------------------------------------------------------~~~~ 164 (262)
T cd00192 159 DY--------------------------------------------------------------------------YRKK 164 (262)
T ss_pred cc--------------------------------------------------------------------------cccc
Confidence 00 0001
Q ss_pred cccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 007260 452 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGL 530 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~ 530 (611)
....+++.|+|||.+.+..++.++|||||||++|||++ |..||...........+.. ....+....++.++.++|.+|
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~ 243 (262)
T cd00192 165 TGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-GYRLPKPEYCPDELYELMLSC 243 (262)
T ss_pred cCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCccCChHHHHHHHHH
Confidence 12357889999999999889999999999999999998 6999998866655555554 334444456899999999999
Q ss_pred hhcCccccCCchhcHHHHHcC
Q 007260 531 LVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 531 L~~dP~~Rpt~~~~a~elL~H 551 (611)
|..||.+||+ +.++++|
T Consensus 244 l~~~p~~Rps----~~~l~~~ 260 (262)
T cd00192 244 WQLDPEDRPT----FSELVER 260 (262)
T ss_pred ccCCcccCcC----HHHHHHh
Confidence 9999999999 8998875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=336.50 Aligned_cols=255 Identities=23% Similarity=0.308 Sum_probs=208.7
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCC---CeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecccee
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGT---KCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFS 291 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t---~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~ 291 (611)
..+|++.+.||.|+||.||+|++..+ +..+|+|.++.... ......+.+|+.+|+.++||||+++++++..++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 45899999999999999999998644 34799999875432 22345678899999999999999999999999999
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCC
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~ 371 (611)
|+||||++|++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++..+...
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999999987753 46899999999999999999999999999999999999999999999999998433211
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
.... ...
T Consensus 160 ~~~~-------------------------------------------------------------------------~~~ 166 (267)
T cd05066 160 PEAA-------------------------------------------------------------------------YTT 166 (267)
T ss_pred ccee-------------------------------------------------------------------------eec
Confidence 0000 000
Q ss_pred cccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 007260 452 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGL 530 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~ 530 (611)
....++..|+|||.+.+..++.++|+|||||++|||++ |..||.+....+.+..+... ...+....++..+.++|.+|
T Consensus 167 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~ 245 (267)
T cd05066 167 RGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-YRLPAPMDCPAALHQLMLDC 245 (267)
T ss_pred CCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC-CcCCCCCCCCHHHHHHHHHH
Confidence 01224668999999999899999999999999999886 99999887665555544433 45555566899999999999
Q ss_pred hhcCccccCCchhcHHHHHc
Q 007260 531 LVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 531 L~~dP~~Rpt~~~~a~elL~ 550 (611)
|.++|.+||+ +.++++
T Consensus 246 l~~~p~~Rp~----~~~i~~ 261 (267)
T cd05066 246 WQKDRNERPK----FEQIVS 261 (267)
T ss_pred cccCchhCCC----HHHHHH
Confidence 9999999999 666654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=333.23 Aligned_cols=253 Identities=25% Similarity=0.356 Sum_probs=211.7
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSC 292 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~ 292 (611)
+..++|++.+.||.|+||.||+|.+.. ++.||||.+....... ..+.+|+.+++.++|+||+++++++..+...|
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTMSP----EAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCccCH----HHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 445789999999999999999999765 4679999987654322 34677999999999999999999999989999
Q ss_pred EEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCc
Q 007260 293 LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 293 LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~ 372 (611)
+||||+++++|.+++....+..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+....
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 99999999999999987766679999999999999999999999999999999999999999999999999984332100
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
. ....
T Consensus 158 ~---------------------------------------------------------------------------~~~~ 162 (261)
T cd05034 158 Y---------------------------------------------------------------------------TARE 162 (261)
T ss_pred h---------------------------------------------------------------------------hhhh
Confidence 0 0000
Q ss_pred ccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 007260 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLL 531 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L 531 (611)
...++..|+|||.+.+..++.++|||||||++|+|++ |+.||.+......+..+... ...+....++.++.++|.+||
T Consensus 163 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l 241 (261)
T cd05034 163 GAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG-YRMPRPPNCPEELYDLMLQCW 241 (261)
T ss_pred ccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHc
Confidence 1124568999999999999999999999999999998 99999887776666665543 344444557899999999999
Q ss_pred hcCccccCCchhcHHHHHc
Q 007260 532 VKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 532 ~~dP~~Rpt~~~~a~elL~ 550 (611)
..+|++||+ ++++++
T Consensus 242 ~~~p~~Rp~----~~~l~~ 256 (261)
T cd05034 242 DKDPEERPT----FEYLQS 256 (261)
T ss_pred ccCcccCCC----HHHHHH
Confidence 999999999 777664
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=341.96 Aligned_cols=258 Identities=22% Similarity=0.330 Sum_probs=209.9
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCC-----CeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGT-----KCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFE 286 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t-----~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~ 286 (611)
+..++|++.+.||+|+||.||++.+... ...||+|++..... .+...++.+|+++++.+ +|+||+++++++.
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 4456899999999999999999998643 37899999875432 23345678899999999 8999999999999
Q ss_pred ccceeeEEeeeCCCCCHHHHHHhC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEc
Q 007260 287 TEKFSCLVMEFCPGGDLHTLRQKQ--------------PGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVR 352 (611)
Q Consensus 287 ~~~~~~LVmE~~~gg~L~~ll~~~--------------~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~ 352 (611)
.++.+|+||||+++|+|..++... ....+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT 166 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc
Confidence 999999999999999999998652 245689999999999999999999999999999999999999
Q ss_pred cCCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCcccc
Q 007260 353 EDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEI 432 (611)
Q Consensus 353 ~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (611)
.++.+||+|||++..+......
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~---------------------------------------------------------- 188 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYY---------------------------------------------------------- 188 (293)
T ss_pred CCCeEEeCccccccccccccce----------------------------------------------------------
Confidence 9999999999998432210000
Q ss_pred CCCCCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCC
Q 007260 433 GNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPL 511 (611)
Q Consensus 433 ~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l 511 (611)
.......++..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+ ....
T Consensus 189 ----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~-~~~~ 251 (293)
T cd05053 189 ----------------RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL-KEGY 251 (293)
T ss_pred ----------------eccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHH-HcCC
Confidence 00001124567999999999999999999999999999997 99999877655544443 3333
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcC
Q 007260 512 RFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 512 ~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~H 551 (611)
.......++..+.+||.+||..||++||+ +.+++++
T Consensus 252 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~eil~~ 287 (293)
T cd05053 252 RMEKPQNCTQELYHLMRDCWHEVPSQRPT----FKQLVED 287 (293)
T ss_pred cCCCCCCCCHHHHHHHHHHcccCcccCcC----HHHHHHH
Confidence 44444568899999999999999999999 7888764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=337.53 Aligned_cols=256 Identities=20% Similarity=0.333 Sum_probs=215.0
Q ss_pred ccCeEEEeEecccCcEEEEEEEECC-----CCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSG-----TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK 289 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~-----t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~ 289 (611)
.++|++++.||.|+||.||+|+... ....||+|.+.... .......+.+|+.+|++++|+||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 3689999999999999999999753 35679999886543 2234556788999999999999999999999999
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCC-------CCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEec
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGK-------YFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDF 362 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~-------~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DF 362 (611)
..|+||||+++++|.+++...... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999998865421 5899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCccc
Q 007260 363 DLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPEL 442 (611)
Q Consensus 363 GlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (611)
|++......
T Consensus 162 ~~~~~~~~~----------------------------------------------------------------------- 170 (275)
T cd05046 162 SLSKDVYNS----------------------------------------------------------------------- 170 (275)
T ss_pred ccccccCcc-----------------------------------------------------------------------
Confidence 987321100
Q ss_pred ccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCH
Q 007260 443 IAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSF 521 (611)
Q Consensus 443 ~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~ 521 (611)
.........++..|+|||.+.+..++.++|||||||++|+|++ |..||........+..+..+...++....++.
T Consensus 171 ----~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (275)
T cd05046 171 ----EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPS 246 (275)
T ss_pred ----cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCCCCCCH
Confidence 0000112246778999999998889999999999999999998 89999887777777777766766666667899
Q ss_pred HHHHHHHHhhhcCccccCCchhcHHHHHcC
Q 007260 522 AARDLIRGLLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 522 ~l~dLI~~~L~~dP~~Rpt~~~~a~elL~H 551 (611)
.+.++|.+||..||.+||+ +.+++++
T Consensus 247 ~l~~~i~~~l~~~p~~Rp~----~~~~l~~ 272 (275)
T cd05046 247 RLYKLMTRCWAVNPKDRPS----FSELVSA 272 (275)
T ss_pred HHHHHHHHHcCCCcccCCC----HHHHHHH
Confidence 9999999999999999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=350.53 Aligned_cols=258 Identities=26% Similarity=0.389 Sum_probs=205.7
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecc-------
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE------- 288 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~------- 288 (611)
++|++.+.||.|+||.||+|.+..++..||+|++..... .....+.+|+++|+.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 689999999999999999999999999999999865443 2334567899999999999999999876643
Q ss_pred -------ceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEcc-CCcEEEE
Q 007260 289 -------KFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRE-DGHIMLS 360 (611)
Q Consensus 289 -------~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~-~g~vkL~ 360 (611)
...|+||||++ ++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.++|+
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEEC
Confidence 35799999995 689887764 35899999999999999999999999999999999999984 5678999
Q ss_pred eccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCc
Q 007260 361 DFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLP 440 (611)
Q Consensus 361 DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (611)
|||++........
T Consensus 158 dfg~~~~~~~~~~------------------------------------------------------------------- 170 (342)
T cd07854 158 DFGLARIVDPHYS------------------------------------------------------------------- 170 (342)
T ss_pred CcccceecCCccc-------------------------------------------------------------------
Confidence 9999843210000
Q ss_pred ccccCcccccccccccCCCccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCC---------
Q 007260 441 ELIAEPTEARSMSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQP--------- 510 (611)
Q Consensus 441 ~~~~~~~~~~~~~~vGT~~Y~APEil~~-~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~--------- 510 (611)
........+|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+......+..++...
T Consensus 171 ------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07854 171 ------HKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRN 244 (342)
T ss_pred ------cccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 0000011258889999998765 457889999999999999999999998776555544433211
Q ss_pred ----------------CCCC---CCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 511 ----------------LRFP---ESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 511 ----------------l~~p---~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
...+ ....++.++++||.+||..||.+||+ +.+++.||||+.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~ell~h~~~~~~ 306 (342)
T cd07854 245 ELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLT----AEEALMHPYMSCY 306 (342)
T ss_pred hhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccC----HHHHhCCCccccc
Confidence 0000 01247889999999999999999999 9999999999753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=350.81 Aligned_cols=260 Identities=27% Similarity=0.376 Sum_probs=213.0
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc-----ee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK-----FS 291 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~-----~~ 291 (611)
+|++.+.||.|+||.||+|++..++..||||++.+.. ........+.+|+.+++.++|+||+++++++.... .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 5899999999999999999999999999999987543 12234456788999999999999999999998765 78
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCC
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~ 371 (611)
|+||||++ ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 80 ~lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 80 YIVTELME-TDLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred EEEecchh-hhHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 99999996 5898888764 47999999999999999999999999999999999999999999999999998443211
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
... ....
T Consensus 157 ~~~-------------------------------------------------------------------------~~~~ 163 (330)
T cd07834 157 EDE-------------------------------------------------------------------------KGFL 163 (330)
T ss_pred ccc-------------------------------------------------------------------------cccc
Confidence 000 0001
Q ss_pred cccccCCCccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCC----------------
Q 007260 452 MSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFP---------------- 514 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~~-~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p---------------- 514 (611)
....||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+....-..+
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 243 (330)
T cd07834 164 TEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYL 243 (330)
T ss_pred cccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHH
Confidence 123589999999999988 789999999999999999999999988776554443332110000
Q ss_pred -------------CCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 515 -------------ESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 515 -------------~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
..+.++..+.+||.+||.+||.+||+ +.++++||||+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~ll~~~~~~~~ 295 (330)
T cd07834 244 KSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRIT----ADEALAHPYLAQL 295 (330)
T ss_pred hhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCC----HHHHHhCccHHhh
Confidence 01236889999999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=334.56 Aligned_cols=250 Identities=22% Similarity=0.359 Sum_probs=207.3
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
.++|+++++||.|+||.||+|.... ++.||+|.+....... ..+.+|+.+++.++|+||+++++++. .+..|+|
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGSMSP----EAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYII 78 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCC-CceEEEEEecCCCCcH----HHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEE
Confidence 4689999999999999999998654 5679999987654322 35677999999999999999999874 4578999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
|||+.+++|.+++....+..+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 157 (260)
T cd05067 79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY- 157 (260)
T ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc-
Confidence 9999999999998876667799999999999999999999999999999999999999999999999999743210000
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
......
T Consensus 158 --------------------------------------------------------------------------~~~~~~ 163 (260)
T cd05067 158 --------------------------------------------------------------------------TAREGA 163 (260)
T ss_pred --------------------------------------------------------------------------ccccCC
Confidence 000112
Q ss_pred ccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007260 455 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVK 533 (611)
Q Consensus 455 vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~ 533 (611)
.++..|+|||++.+..++.++|||||||++|||++ |++||.+.+....+..+.. ....+....++.++.+||.+||..
T Consensus 164 ~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~ 242 (260)
T cd05067 164 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLER-GYRMPRPDNCPEELYELMRLCWKE 242 (260)
T ss_pred cccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHccC
Confidence 36778999999999999999999999999999998 9999998776655554433 334455556889999999999999
Q ss_pred CccccCCchhcHHHHHc
Q 007260 534 EPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 534 dP~~Rpt~~~~a~elL~ 550 (611)
+|++||+ +++++.
T Consensus 243 ~p~~Rp~----~~~l~~ 255 (260)
T cd05067 243 KPEERPT----FEYLRS 255 (260)
T ss_pred ChhhCCC----HHHHHH
Confidence 9999999 777764
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=397.74 Aligned_cols=258 Identities=30% Similarity=0.513 Sum_probs=219.2
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVME 296 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE 296 (611)
+|.-+..||.|.||.||-|.+..+|...|+|-+.-.... .+.+....+|..+|..|+|||||++|++-.+.+..||.||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 566677999999999999999999999999988654433 4556667789999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccc
Q 007260 297 FCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIK 376 (611)
Q Consensus 297 ~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~ 376 (611)
||.||+|.++++.. +..+|...+.|..|++.||.|||+.|||||||||+|||++.+|.+|++|||.|..+......
T Consensus 1315 yC~~GsLa~ll~~g--ri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~-- 1390 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHG--RIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT-- 1390 (1509)
T ss_pred HhccCcHHHHHHhc--chhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhc--
Confidence 99999999998874 66889999999999999999999999999999999999999999999999998544311000
Q ss_pred cccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccccc
Q 007260 377 ASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVG 456 (611)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vG 456 (611)
.......++|
T Consensus 1391 ----------------------------------------------------------------------~~~el~~~~G 1400 (1509)
T KOG4645|consen 1391 ----------------------------------------------------------------------MPGELQSMMG 1400 (1509)
T ss_pred ----------------------------------------------------------------------CCHHHHhhcC
Confidence 0011125689
Q ss_pred CCCccchhhhcc---CCCCChhhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHcC-CCCCCCCCCCCHHHHHHHHHhh
Q 007260 457 THEYLAPEIIKG---EGHGSAVDWWTFGIFLYELLFGKTPFKGSGN-RATLFNVVGQ-PLRFPESPVVSFAARDLIRGLL 531 (611)
Q Consensus 457 T~~Y~APEil~~---~~~~~~sDIWSLGviL~ELltG~~PF~~~~~-~~~l~~i~~~-~l~~p~~~~~s~~l~dLI~~~L 531 (611)
|+.|||||++.| .+++.+.|||||||++.||+||+.||...++ .++++.+-.+ ...+|.. ++.+.+|||..||
T Consensus 1401 T~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~--ls~~g~dFle~Cl 1478 (1509)
T KOG4645|consen 1401 TPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPER--LSSEGRDFLEHCL 1478 (1509)
T ss_pred CchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchh--hhHhHHHHHHHHH
Confidence 999999999975 4689999999999999999999999987554 5556665443 3445554 9999999999999
Q ss_pred hcCccccCCchhcHHHHHcCCCCC
Q 007260 532 VKEPQHRLAYKRGATEIKQHPFFE 555 (611)
Q Consensus 532 ~~dP~~Rpt~~~~a~elL~Hp~f~ 555 (611)
..||.+|++ +.|||.|.|-+
T Consensus 1479 ~~dP~~Rw~----~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1479 EQDPKMRWT----ASQLLEHAFGK 1498 (1509)
T ss_pred hcCchhhhH----HHHHHHhhccc
Confidence 999999999 99999998865
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=336.10 Aligned_cols=254 Identities=24% Similarity=0.329 Sum_probs=204.3
Q ss_pred eEEEeEecccCcEEEEEEEECC---CCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc-----
Q 007260 218 FRLLKRLGCGDIGSVYLSELSG---TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK----- 289 (611)
Q Consensus 218 y~l~~~LG~G~fG~Vy~a~~~~---t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~----- 289 (611)
|++++.||.|+||.||+|.+.. ++..||||++...... ......+.+|+++|+.++||||+++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 6788999999999999998764 3478999998754322 334556788999999999999999999876544
Q ss_pred -eeeEEeeeCCCCCHHHHHHhC----CCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccc
Q 007260 290 -FSCLVMEFCPGGDLHTLRQKQ----PGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDL 364 (611)
Q Consensus 290 -~~~LVmE~~~gg~L~~ll~~~----~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGl 364 (611)
..++||||+++++|..++... ....+++..+..++.|++.||+|||++||+||||||+|||+++++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 379999999999999887543 224689999999999999999999999999999999999999999999999999
Q ss_pred cccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCccccc
Q 007260 365 SLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIA 444 (611)
Q Consensus 365 A~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (611)
+.........
T Consensus 160 ~~~~~~~~~~---------------------------------------------------------------------- 169 (273)
T cd05035 160 SKKIYSGDYY---------------------------------------------------------------------- 169 (273)
T ss_pred eeeccccccc----------------------------------------------------------------------
Confidence 8433211000
Q ss_pred CcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHH
Q 007260 445 EPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAA 523 (611)
Q Consensus 445 ~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l 523 (611)
.......++..|+|||++.+..++.++|||||||++|||++ |..||.+..+.+.+..+... ........++..+
T Consensus 170 ----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 244 (273)
T cd05035 170 ----RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG-NRLKQPEDCLDEL 244 (273)
T ss_pred ----cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCcCCCHHH
Confidence 00001125678999999998899999999999999999998 99999887766665555443 2333344589999
Q ss_pred HHHHHHhhhcCccccCCchhcHHHHHcC
Q 007260 524 RDLIRGLLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 524 ~dLI~~~L~~dP~~Rpt~~~~a~elL~H 551 (611)
.++|.+||..||++||+ +.+++++
T Consensus 245 ~~li~~~l~~~p~~Rp~----~~e~~~~ 268 (273)
T cd05035 245 YDLMYSCWRADPKDRPT----FTKLREV 268 (273)
T ss_pred HHHHHHHcCCChhhCcC----HHHHHHH
Confidence 99999999999999999 7777653
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=350.89 Aligned_cols=254 Identities=29% Similarity=0.429 Sum_probs=210.4
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccce----
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKF---- 290 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~---- 290 (611)
.++|++.+.||.|+||.||+|++..++..||||++.... ........+.+|+.+++.++||||+++++++.....
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 368999999999999999999999999999999986542 222334556789999999999999999998876654
Q ss_pred --eeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccc
Q 007260 291 --SCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRC 368 (611)
Q Consensus 291 --~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~ 368 (611)
.|+||||+ |++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++...
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 89999999 7799998875 35999999999999999999999999999999999999999999999999998322
Q ss_pred cCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccc
Q 007260 369 AVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTE 448 (611)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (611)
..
T Consensus 169 ~~------------------------------------------------------------------------------ 170 (343)
T cd07851 169 DD------------------------------------------------------------------------------ 170 (343)
T ss_pred cc------------------------------------------------------------------------------
Confidence 10
Q ss_pred ccccccccCCCccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCC---------------
Q 007260 449 ARSMSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLR--------------- 512 (611)
Q Consensus 449 ~~~~~~vGT~~Y~APEil~~~-~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~--------------- 512 (611)
......+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+......+..+......
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07851 171 -EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESAR 249 (343)
T ss_pred -cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHH
Confidence 01123588899999998764 5789999999999999999999999887766555444321100
Q ss_pred -------------C-CCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCC
Q 007260 513 -------------F-PESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 513 -------------~-p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
+ .....++.++.+||.+||..||++||+ +.+|++||||..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt----~~ell~h~~~~~ 303 (343)
T cd07851 250 NYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRIT----AAEALAHPYLAE 303 (343)
T ss_pred HHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCC----HHHHhcCCCccc
Confidence 0 001236889999999999999999999 999999999984
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=351.83 Aligned_cols=259 Identities=22% Similarity=0.312 Sum_probs=205.8
Q ss_pred ccccCeEEEeEecccCcEEEEEEEEC-----CCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELS-----GTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFE 286 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~-----~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~ 286 (611)
+..++|++++.||.|+||.||+|.+. .+++.||||+++.... ......+.+|+.+|..+ +||||+++++++.
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 34468999999999999999999853 4577899999975432 23345677899999999 6899999999876
Q ss_pred c-cceeeEEeeeCCCCCHHHHHHhCC------------------------------------------------------
Q 007260 287 T-EKFSCLVMEFCPGGDLHTLRQKQP------------------------------------------------------ 311 (611)
Q Consensus 287 ~-~~~~~LVmE~~~gg~L~~ll~~~~------------------------------------------------------ 311 (611)
. +..+|+|||||++|+|.+++....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 4 467899999999999999886532
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccccC
Q 007260 312 -----------GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSL 380 (611)
Q Consensus 312 -----------~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~ 380 (611)
...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~------ 235 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY------ 235 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcch------
Confidence 123678888999999999999999999999999999999999999999999998432110000
Q ss_pred CCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCc
Q 007260 381 DAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEY 460 (611)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y 460 (611)
.......+++.|
T Consensus 236 --------------------------------------------------------------------~~~~~~~~~~~y 247 (343)
T cd05103 236 --------------------------------------------------------------------VRKGDARLPLKW 247 (343)
T ss_pred --------------------------------------------------------------------hhcCCCCCCcce
Confidence 000112366789
Q ss_pred cchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccC
Q 007260 461 LAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRL 539 (611)
Q Consensus 461 ~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rp 539 (611)
+|||++.+..++.++|||||||++|+|++ |..||........+...+......+....++.++.+++..||..||++||
T Consensus 248 ~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rp 327 (343)
T cd05103 248 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 327 (343)
T ss_pred ECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCChhhCc
Confidence 99999999999999999999999999996 99999876544444444433333333445788999999999999999999
Q ss_pred CchhcHHHHHcC
Q 007260 540 AYKRGATEIKQH 551 (611)
Q Consensus 540 t~~~~a~elL~H 551 (611)
+ +.+|++|
T Consensus 328 s----~~eil~~ 335 (343)
T cd05103 328 T----FSELVEH 335 (343)
T ss_pred C----HHHHHHH
Confidence 9 8888876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=333.06 Aligned_cols=249 Identities=26% Similarity=0.359 Sum_probs=205.7
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
++|++.+.||.|+||.||+|.+..+. .+|+|++...... ...+.+|+.+++.++|+||+++++++. .+..|+||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTMM----PEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVT 79 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCcc----HHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEE
Confidence 57999999999999999999987765 5899988654322 235677999999999999999999875 45689999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
||+.+++|.+++....+..+++..+..++.||+.||+|||+.||+||||||+|||+++++.++|+|||++........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-- 157 (260)
T cd05069 80 EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-- 157 (260)
T ss_pred EcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc--
Confidence 999999999999876556689999999999999999999999999999999999999999999999999843211000
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
.......
T Consensus 158 -------------------------------------------------------------------------~~~~~~~ 164 (260)
T cd05069 158 -------------------------------------------------------------------------TARQGAK 164 (260)
T ss_pred -------------------------------------------------------------------------cccCCCc
Confidence 0000123
Q ss_pred cCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcC
Q 007260 456 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKE 534 (611)
Q Consensus 456 GT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~d 534 (611)
++..|+|||.+.+..++.++|||||||++|||++ |+.||.+......+..+... ...+....++..+++||.+||.+|
T Consensus 165 ~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~ 243 (260)
T cd05069 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG-YRMPCPQGCPESLHELMKLCWKKD 243 (260)
T ss_pred cchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCcccCHHHHHHHHHHccCC
Confidence 6778999999998889999999999999999999 99999987776666555443 333444468899999999999999
Q ss_pred ccccCCchhcHHHHHc
Q 007260 535 PQHRLAYKRGATEIKQ 550 (611)
Q Consensus 535 P~~Rpt~~~~a~elL~ 550 (611)
|.+||+ ++++++
T Consensus 244 p~~Rp~----~~~i~~ 255 (260)
T cd05069 244 PDERPT----FEYIQS 255 (260)
T ss_pred cccCcC----HHHHHH
Confidence 999999 677664
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=329.21 Aligned_cols=254 Identities=30% Similarity=0.475 Sum_probs=215.3
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVME 296 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE 296 (611)
+|++.+.||.|+||.||++++..++..||+|.+....... .....+.+|+.+++.++|+||+++++++......|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 5899999999999999999999999999999997654332 334566789999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 297 FCPGGDLHTLRQKQ--PGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 297 ~~~gg~L~~ll~~~--~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
|+++++|.+++.+. .+..+++..+..++.|++.||+|||++||+||||+|+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 99999999987652 2356899999999999999999999999999999999999999999999999998432100
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
.....
T Consensus 157 ---------------------------------------------------------------------------~~~~~ 161 (256)
T cd08530 157 ---------------------------------------------------------------------------MAKTQ 161 (256)
T ss_pred ---------------------------------------------------------------------------Ccccc
Confidence 00012
Q ss_pred ccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcC
Q 007260 455 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKE 534 (611)
Q Consensus 455 vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~d 534 (611)
.|++.|++||.+.+..++.++|+||||+++|+|++|+.||...+.......+...... +....++.+++++|.+||..+
T Consensus 162 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~ 240 (256)
T cd08530 162 IGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYP-PIPPIYSQDLQNFIRSMLQVK 240 (256)
T ss_pred cCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-CCchhhCHHHHHHHHHHcCCC
Confidence 4788999999999998999999999999999999999999987765555544443322 222358899999999999999
Q ss_pred ccccCCchhcHHHHHcCCCC
Q 007260 535 PQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 535 P~~Rpt~~~~a~elL~Hp~f 554 (611)
|++||+ +.++++||++
T Consensus 241 p~~Rp~----~~~~l~~p~~ 256 (256)
T cd08530 241 PKLRPN----CDKILASPAV 256 (256)
T ss_pred cccCCC----HHHHhcCCCC
Confidence 999999 9999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=345.29 Aligned_cols=256 Identities=25% Similarity=0.348 Sum_probs=201.5
Q ss_pred CcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEeeeCCCCCHHHHH
Q 007260 228 DIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLR 307 (611)
Q Consensus 228 ~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE~~~gg~L~~ll 307 (611)
++|.||.+++..+++.||||++..... ......++.+|+++|+.++|+||++++++|...+..|++|||+++++|.+++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence 445566666677899999999976532 2345567889999999999999999999999999999999999999999999
Q ss_pred HhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccccCCCCcCcC
Q 007260 308 QKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRK 387 (611)
Q Consensus 308 ~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~ 387 (611)
.......+++..++.++.||+.||+|||++|||||||||+|||++.+|.++|+|||.+..+.......
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~------------ 158 (314)
T cd08216 91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ------------ 158 (314)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccc------------
Confidence 87655679999999999999999999999999999999999999999999999999874332100000
Q ss_pred CCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCccchhhhc
Q 007260 388 NPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIK 467 (611)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~ 467 (611)
...........++..|+|||++.
T Consensus 159 ---------------------------------------------------------~~~~~~~~~~~~~~~y~aPE~~~ 181 (314)
T cd08216 159 ---------------------------------------------------------RVVHDFPKSSVKNLPWLSPEVLQ 181 (314)
T ss_pred ---------------------------------------------------------cccccccccccccccccCHHHhc
Confidence 00000112345888999999997
Q ss_pred cC--CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCC--------------------------------C
Q 007260 468 GE--GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLR--------------------------------F 513 (611)
Q Consensus 468 ~~--~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~--------------------------------~ 513 (611)
+. .++.++|||||||++|||++|+.||........+......... .
T Consensus 182 ~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (314)
T cd08216 182 QNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDH 261 (314)
T ss_pred CCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhc
Confidence 64 5789999999999999999999999876554443322221100 0
Q ss_pred CCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 514 PESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 514 p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
+....++.++.+||..||..||++||+ +.++|.||||+.+
T Consensus 262 ~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~ll~~p~~~~~ 301 (314)
T cd08216 262 PYTRTFSEHFHQFVELCLQRDPESRPS----ASQLLNHSFFKQC 301 (314)
T ss_pred chhhHHHHHHHHHHHHHhhcCCCcCcC----HHHHhcCchHhhh
Confidence 001124567899999999999999999 9999999999865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=336.61 Aligned_cols=255 Identities=21% Similarity=0.318 Sum_probs=206.5
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCe----EEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecc
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKC----YFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE 288 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~----~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~ 288 (611)
+...+|++++.||.|+||+||+|++..++. .||+|++..... ......+.+|+.+++.++||||+.+++++..
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~- 80 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS--PKANKEILDEAYVMAGVGSPYVCRLLGICLT- 80 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC--HHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-
Confidence 445789999999999999999999876665 489999865432 2233467789999999999999999998875
Q ss_pred ceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccc
Q 007260 289 KFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRC 368 (611)
Q Consensus 289 ~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~ 368 (611)
...+++|||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+
T Consensus 81 ~~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 81 STVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred CCcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeec
Confidence 45789999999999999887643 46899999999999999999999999999999999999999999999999998543
Q ss_pred cCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccc
Q 007260 369 AVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTE 448 (611)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (611)
......
T Consensus 160 ~~~~~~-------------------------------------------------------------------------- 165 (279)
T cd05109 160 DIDETE-------------------------------------------------------------------------- 165 (279)
T ss_pred ccccce--------------------------------------------------------------------------
Confidence 211000
Q ss_pred ccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 007260 449 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLI 527 (611)
Q Consensus 449 ~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI 527 (611)
.......+++.|+|||.+.+..++.++|||||||++|||++ |..||........ ...+......+....++..+.++|
T Consensus 166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li 244 (279)
T cd05109 166 YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI-PDLLEKGERLPQPPICTIDVYMIM 244 (279)
T ss_pred eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHCCCcCCCCccCCHHHHHHH
Confidence 00001125678999999999999999999999999999998 9999987655443 344444444455556899999999
Q ss_pred HHhhhcCccccCCchhcHHHHHc
Q 007260 528 RGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 528 ~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
.+||..||++||+ +.+++.
T Consensus 245 ~~~l~~dp~~Rp~----~~~l~~ 263 (279)
T cd05109 245 VKCWMIDSECRPR----FRELVD 263 (279)
T ss_pred HHHcCCChhhCcC----HHHHHH
Confidence 9999999999999 777774
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=351.09 Aligned_cols=255 Identities=31% Similarity=0.446 Sum_probs=206.9
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecc------c
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE------K 289 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~------~ 289 (611)
.+|.+.+.||.|+||.||+|.+..++..||||++.+... .......+.+|+.+++.++||||++++++|... .
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 589999999999999999999999999999999875422 222334567899999999999999999998754 3
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
.+|+||||+. .+|..++. ..+++..++.++.||+.||+|||.+||+||||||+|||++.++.++|+|||++....
T Consensus 94 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred eEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 4699999995 57776553 358999999999999999999999999999999999999999999999999873211
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
.
T Consensus 169 ~------------------------------------------------------------------------------- 169 (342)
T cd07879 169 A------------------------------------------------------------------------------- 169 (342)
T ss_pred C-------------------------------------------------------------------------------
Confidence 0
Q ss_pred cccccccCCCccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcC-------------------
Q 007260 450 RSMSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ------------------- 509 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~-~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~------------------- 509 (611)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+......+..++..
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (342)
T cd07879 170 EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKS 249 (342)
T ss_pred CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHH
Confidence 0012358889999999876 45789999999999999999999999987655444333221
Q ss_pred ----CCCCCC------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCch
Q 007260 510 ----PLRFPE------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNW 559 (611)
Q Consensus 510 ----~l~~p~------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 559 (611)
...++. .+.++..+.+||.+||..||.+||+ +.+++.||||+.+.+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~----~~e~l~h~~f~~~~~ 305 (342)
T cd07879 250 YIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLT----ATEALEHPYFDSFRD 305 (342)
T ss_pred HHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcC----HHHHhcCcchhhccc
Confidence 000110 1246788999999999999999999 999999999987654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=342.27 Aligned_cols=260 Identities=27% Similarity=0.394 Sum_probs=207.8
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc---
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK--- 289 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~--- 289 (611)
...++|++.+.||.|+||.||+|.+..+++.||||+++..... ......+.+|+++++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc-cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 3457899999999999999999999999999999999754321 122234567999999999999999999987654
Q ss_pred -------eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEec
Q 007260 290 -------FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDF 362 (611)
Q Consensus 290 -------~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DF 362 (611)
.+||||||+++ +|..++... ...+++..++.++.||+.||.|||++||+||||||+||++++++.+||+||
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcc
Confidence 89999999965 777766654 346899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCccc
Q 007260 363 DLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPEL 442 (611)
Q Consensus 363 GlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (611)
|++........
T Consensus 161 g~~~~~~~~~~--------------------------------------------------------------------- 171 (302)
T cd07864 161 GLARLYNSEES--------------------------------------------------------------------- 171 (302)
T ss_pred cccccccCCcc---------------------------------------------------------------------
Confidence 99843321000
Q ss_pred ccCcccccccccccCCCccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH---cCCCC--CC--
Q 007260 443 IAEPTEARSMSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVV---GQPLR--FP-- 514 (611)
Q Consensus 443 ~~~~~~~~~~~~vGT~~Y~APEil~~~-~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~---~~~l~--~p-- 514 (611)
.......++..|+|||++.+. .++.++|||||||++|||++|++||........+..+. +.+.. ++
T Consensus 172 ------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (302)
T cd07864 172 ------RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDV 245 (302)
T ss_pred ------cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccc
Confidence 000112467889999998754 46899999999999999999999998766555443332 22110 00
Q ss_pred ---------------------CCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCC
Q 007260 515 ---------------------ESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 515 ---------------------~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f 554 (611)
....++..+.+||.+||..||.+||+ +.+++.||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~----~~~il~~~~~ 302 (302)
T cd07864 246 IKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCT----AEEALNSPWL 302 (302)
T ss_pred cccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCC----HHHHhcCCCC
Confidence 11246889999999999999999999 9999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=349.97 Aligned_cols=253 Identities=27% Similarity=0.406 Sum_probs=206.2
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecc------c
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE------K 289 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~------~ 289 (611)
++|.+++.||+|+||.||+|.+..+++.||+|++.+... ......++.+|+.++++++||||+++++++... .
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence 689999999999999999999999999999999975432 222344567899999999999999999988643 4
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
..|+|++++ |++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||+++.+|.+||+|||++....
T Consensus 96 ~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~ 171 (345)
T cd07877 96 DVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 171 (345)
T ss_pred cEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence 578999998 8899888765 348999999999999999999999999999999999999999999999999873211
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
.
T Consensus 172 ~------------------------------------------------------------------------------- 172 (345)
T cd07877 172 D------------------------------------------------------------------------------- 172 (345)
T ss_pred c-------------------------------------------------------------------------------
Confidence 0
Q ss_pred cccccccCCCccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCC------------------
Q 007260 450 RSMSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQP------------------ 510 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~-~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~------------------ 510 (611)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+......+..++...
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (345)
T cd07877 173 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 252 (345)
T ss_pred cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHH
Confidence 0012358899999999877 467899999999999999999999998765544433322110
Q ss_pred -----CCCCC------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCC
Q 007260 511 -----LRFPE------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 511 -----l~~p~------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
...+. ....+.++++||.+||..||.+|++ +.+++.||||..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t----~~e~l~h~~f~~ 305 (345)
T cd07877 253 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT----AAQALAHAYFAQ 305 (345)
T ss_pred HHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCC----HHHHhcChhhhh
Confidence 00110 1135788999999999999999999 999999999975
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=337.96 Aligned_cols=254 Identities=22% Similarity=0.325 Sum_probs=207.9
Q ss_pred ccCeEEEeEecccCcEEEEEEEEC-----CCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELS-----GTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK 289 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~-----~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~ 289 (611)
..+|++.++||.|+||.||+++.. .++..+|+|.+.... ......+.+|+++++.++|+||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 357899999999999999999753 356789999886543 233446788999999999999999999999999
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCC-------------CCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPG-------------KYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGH 356 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~-------------~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~ 356 (611)
..|+||||+++++|.+++..... ..+++..+..++.||+.||+|||++||+||||||+|||+++++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence 99999999999999999876421 35889999999999999999999999999999999999999999
Q ss_pred EEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCC
Q 007260 357 IMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQV 436 (611)
Q Consensus 357 vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (611)
+||+|||++........
T Consensus 161 ~kL~dfg~~~~~~~~~~--------------------------------------------------------------- 177 (280)
T cd05092 161 VKIGDFGMSRDIYSTDY--------------------------------------------------------------- 177 (280)
T ss_pred EEECCCCceeEcCCCce---------------------------------------------------------------
Confidence 99999999843210000
Q ss_pred CCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCC
Q 007260 437 SPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPE 515 (611)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~ 515 (611)
........+++.|+|||++.+..++.++|||||||++|||++ |.+||........+..+.... ....
T Consensus 178 -----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~ 245 (280)
T cd05092 178 -----------YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR-ELER 245 (280)
T ss_pred -----------eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc-cCCC
Confidence 000012246788999999999999999999999999999998 999998877666665554432 2333
Q ss_pred CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 516 SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 516 ~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
...++..+.+||.+||+.||++||+ +.+|++
T Consensus 246 ~~~~~~~~~~li~~cl~~~P~~Rp~----~~~l~~ 276 (280)
T cd05092 246 PRTCPPEVYAIMQGCWQREPQQRMV----IKDIHS 276 (280)
T ss_pred CCCCCHHHHHHHHHHccCChhhCCC----HHHHHH
Confidence 3458899999999999999999999 777664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=331.17 Aligned_cols=249 Identities=24% Similarity=0.335 Sum_probs=206.7
Q ss_pred eEecccCcEEEEEEEECC-C--CeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEeeeC
Q 007260 222 KRLGCGDIGSVYLSELSG-T--KCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFC 298 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~~~-t--~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE~~ 298 (611)
+.||.|+||.||+|.+.. . ...||||++...... ....++.+|+.+|++++||||+++++++.. ...|+||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999999855 2 336999999876543 455677889999999999999999999988 8999999999
Q ss_pred CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccc
Q 007260 299 PGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKAS 378 (611)
Q Consensus 299 ~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~ 378 (611)
++++|.+++.......+++..++.++.|++.||+|||.+||+||||||+|||++.++.+||+|||++..+......
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~---- 153 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH---- 153 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccc----
Confidence 9999999988764356899999999999999999999999999999999999999999999999998543211000
Q ss_pred cCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCC
Q 007260 379 SLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTH 458 (611)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~ 458 (611)
+ .......++.
T Consensus 154 ------------~---------------------------------------------------------~~~~~~~~~~ 164 (257)
T cd05040 154 ------------Y---------------------------------------------------------VMEEHLKVPF 164 (257)
T ss_pred ------------e---------------------------------------------------------ecccCCCCCc
Confidence 0 0000234778
Q ss_pred CccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccc
Q 007260 459 EYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQH 537 (611)
Q Consensus 459 ~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~ 537 (611)
.|+|||++.+..++.++|||||||++|||++ |+.||......+.+..+......++....++..+.+||.+||..+|.+
T Consensus 165 ~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 244 (257)
T cd05040 165 AWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPAD 244 (257)
T ss_pred eecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCccc
Confidence 8999999999999999999999999999998 999998877766666655444444444558899999999999999999
Q ss_pred cCCchhcHHHHHc
Q 007260 538 RLAYKRGATEIKQ 550 (611)
Q Consensus 538 Rpt~~~~a~elL~ 550 (611)
||+ +.++++
T Consensus 245 Rps----~~~~~~ 253 (257)
T cd05040 245 RPT----FAALRE 253 (257)
T ss_pred CCC----HHHHHH
Confidence 999 777764
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=333.32 Aligned_cols=256 Identities=28% Similarity=0.507 Sum_probs=210.7
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhh--hHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLA--GRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~--~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
+|.+.+.||.|+||.||++++..++..+++|+++..... ......++.+|+.+++.++||||+++++++......|+|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 589999999999999999999888777888877543221 122334567799999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCc
Q 007260 295 MEFCPGGDLHTLRQK--QPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 295 mE~~~gg~L~~ll~~--~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~ 372 (611)
|||+++++|.+++.. ..+..+++..++.++.|++.||.|||++||+|+||||+||+++. +.++|+|||++.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999988764 23457999999999999999999999999999999999999974 679999999874321000
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
....
T Consensus 160 ----------------------------------------------------------------------------~~~~ 163 (260)
T cd08222 160 ----------------------------------------------------------------------------DLAT 163 (260)
T ss_pred ----------------------------------------------------------------------------cccc
Confidence 0011
Q ss_pred ccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007260 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLV 532 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~ 532 (611)
...|++.|+|||.+.+..++.++|+||||+++|+|++|..||...........+...... .....++.++.++|.+||.
T Consensus 164 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~ 242 (260)
T cd08222 164 TFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTP-SLPETYSRQLNSIMQSMLN 242 (260)
T ss_pred CCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCC-CCcchhcHHHHHHHHHHhc
Confidence 234888999999998888999999999999999999999999877666666555544322 1223578899999999999
Q ss_pred cCccccCCchhcHHHHHcCCCC
Q 007260 533 KEPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 533 ~dP~~Rpt~~~~a~elL~Hp~f 554 (611)
.||++||+ +.++++||||
T Consensus 243 ~~p~~Rp~----~~~il~~~~~ 260 (260)
T cd08222 243 KDPSLRPS----AAEILRNPFI 260 (260)
T ss_pred CChhhCcC----HHHHhhCCCC
Confidence 99999999 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=331.84 Aligned_cols=243 Identities=23% Similarity=0.312 Sum_probs=196.4
Q ss_pred EecccCcEEEEEEEE--CCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEeeeCCC
Q 007260 223 RLGCGDIGSVYLSEL--SGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPG 300 (611)
Q Consensus 223 ~LG~G~fG~Vy~a~~--~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE~~~g 300 (611)
.||+|+||.||+|.+ ..++..||||++.... ........+.+|+.+|+.++||||+++++++. ++..+|||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 689999999999965 4567899999986543 22334556788999999999999999999875 4567899999999
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccccC
Q 007260 301 GDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSL 380 (611)
Q Consensus 301 g~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~ 380 (611)
++|.+++... ..+++..+..++.|++.||+|||++||+||||||.|||++.++.+||+|||++..........
T Consensus 80 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~----- 152 (257)
T cd05116 80 GPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY----- 152 (257)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCee-----
Confidence 9999998765 468999999999999999999999999999999999999999999999999984332110000
Q ss_pred CCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCc
Q 007260 381 DAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEY 460 (611)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y 460 (611)
.......+++.|
T Consensus 153 --------------------------------------------------------------------~~~~~~~~~~~y 164 (257)
T cd05116 153 --------------------------------------------------------------------KAKTHGKWPVKW 164 (257)
T ss_pred --------------------------------------------------------------------eecCCCCCCccc
Confidence 000111356789
Q ss_pred cchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccC
Q 007260 461 LAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRL 539 (611)
Q Consensus 461 ~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rp 539 (611)
+|||++....++.++|||||||++|||++ |..||.+.........+. .....+....++.++++||.+||..||++||
T Consensus 165 ~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp 243 (257)
T cd05116 165 YAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE-SGERMECPQRCPPEMYDLMKLCWTYGVDERP 243 (257)
T ss_pred cCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHhccCchhCc
Confidence 99999988889999999999999999997 999998876655544443 3333444456899999999999999999999
Q ss_pred Cchh
Q 007260 540 AYKR 543 (611)
Q Consensus 540 t~~~ 543 (611)
++..
T Consensus 244 ~~~~ 247 (257)
T cd05116 244 GFAV 247 (257)
T ss_pred CHHH
Confidence 9543
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=334.61 Aligned_cols=254 Identities=22% Similarity=0.336 Sum_probs=202.3
Q ss_pred eEEEeEecccCcEEEEEEEECCCCe--EEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec------cc
Q 007260 218 FRLLKRLGCGDIGSVYLSELSGTKC--YFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET------EK 289 (611)
Q Consensus 218 y~l~~~LG~G~fG~Vy~a~~~~t~~--~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~------~~ 289 (611)
|.+.+.||.|+||.||+|++..++. .||+|.+.... ........+..|+.+|+.++|+||+++++++.. ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 3567899999999999999877765 68999986543 233445677889999999999999999987642 23
Q ss_pred eeeEEeeeCCCCCHHHHHHhC----CCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQ----PGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~----~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA 365 (611)
..++||||+.+|+|..++... ....+++..+..++.||+.||+|||.+||+||||||+|||++.++.+||+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 578999999999999876432 2245899999999999999999999999999999999999999999999999998
Q ss_pred ccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccC
Q 007260 366 LRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAE 445 (611)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (611)
.........
T Consensus 160 ~~~~~~~~~----------------------------------------------------------------------- 168 (272)
T cd05075 160 KKIYNGDYY----------------------------------------------------------------------- 168 (272)
T ss_pred cccCcccce-----------------------------------------------------------------------
Confidence 433210000
Q ss_pred cccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHH
Q 007260 446 PTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAAR 524 (611)
Q Consensus 446 ~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~ 524 (611)
.......+++.|++||++.+..++.++|||||||++|||++ |+.||.+.........+.... ..+....++..++
T Consensus 169 ---~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 244 (272)
T cd05075 169 ---RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN-RLKQPPDCLDGLY 244 (272)
T ss_pred ---ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHH
Confidence 00001236678999999999999999999999999999999 899998876665555444433 3334456889999
Q ss_pred HHHHHhhhcCccccCCchhcHHHHHcC
Q 007260 525 DLIRGLLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 525 dLI~~~L~~dP~~Rpt~~~~a~elL~H 551 (611)
++|.+||..||++||+ +.+|+++
T Consensus 245 ~li~~~l~~~p~~Rps----~~~l~~~ 267 (272)
T cd05075 245 SLMSSCWLLNPKDRPS----FETLRCE 267 (272)
T ss_pred HHHHHHcCCCcccCcC----HHHHHHH
Confidence 9999999999999999 7777653
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=342.65 Aligned_cols=255 Identities=22% Similarity=0.315 Sum_probs=205.3
Q ss_pred ccCeEEEeEecccCcEEEEEEEECC-------CCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceee
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSG-------TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFE 286 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~-------t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~ 286 (611)
.++|.+++.||+|+||.||+|++.+ +...||+|++.... .......+.+|+++++.+ +||||+++++++.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 4689999999999999999998743 23479999997542 123345677899999999 7999999999999
Q ss_pred ccceeeEEeeeCCCCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEc
Q 007260 287 TEKFSCLVMEFCPGGDLHTLRQKQP--------------GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVR 352 (611)
Q Consensus 287 ~~~~~~LVmE~~~gg~L~~ll~~~~--------------~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~ 352 (611)
..+..|+||||+++|+|.+++.... ...+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 174 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 174 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEc
Confidence 9999999999999999999987642 13588899999999999999999999999999999999999
Q ss_pred cCCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCcccc
Q 007260 353 EDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEI 432 (611)
Q Consensus 353 ~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (611)
.++.+||+|||++........
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~----------------------------------------------------------- 195 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDY----------------------------------------------------------- 195 (307)
T ss_pred CCCcEEECCCcccccccccch-----------------------------------------------------------
Confidence 999999999998743210000
Q ss_pred CCCCCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCC
Q 007260 433 GNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPL 511 (611)
Q Consensus 433 ~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l 511 (611)
........+++.|+|||++.+..++.++|||||||++|||++ |..||.+.... .+...+....
T Consensus 196 ---------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~-~~~~~~~~~~ 259 (307)
T cd05098 196 ---------------YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-ELFKLLKEGH 259 (307)
T ss_pred ---------------hhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH-HHHHHHHcCC
Confidence 000001124568999999999999999999999999999998 89999876544 4444444444
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 512 RFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 512 ~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
..+....++.++++||.+||..+|.+||+ +.++++
T Consensus 260 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~evl~ 294 (307)
T cd05098 260 RMDKPSNCTNELYMMMRDCWHAVPSQRPT----FKQLVE 294 (307)
T ss_pred CCCCCCcCCHHHHHHHHHHcccChhhCcC----HHHHHH
Confidence 44444558999999999999999999999 666665
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=349.02 Aligned_cols=273 Identities=26% Similarity=0.366 Sum_probs=211.6
Q ss_pred cCeEE-EeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHH-----------HHHHHHHHHHHHHhCCCCCcccccc
Q 007260 216 SHFRL-LKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRK-----------KLLRAQTEREILQSLDHPFLPTLYT 283 (611)
Q Consensus 216 ~~y~l-~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~-----------~~~~~~~E~~iL~~l~HpnIv~l~~ 283 (611)
++|.. .+.||.|+||+||+|.+..+++.||||++......... ....+.+|+++|+.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 46764 57799999999999999999999999998654322100 0124568999999999999999999
Q ss_pred eeeccceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecc
Q 007260 284 HFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFD 363 (611)
Q Consensus 284 ~~~~~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFG 363 (611)
+|..++..|+||||+. ++|.+++... ..+++..+..++.||+.||+|||..||+||||||+|||++.++.++|+|||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence 9999999999999995 6899888764 468999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccc
Q 007260 364 LSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELI 443 (611)
Q Consensus 364 lA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 443 (611)
++........ ..... . ..
T Consensus 165 ~~~~~~~~~~-~~~~~--------~------------------------------------------~~----------- 182 (335)
T PTZ00024 165 LARRYGYPPY-SDTLS--------K------------------------------------------DE----------- 182 (335)
T ss_pred ceeecccccc-ccccc--------c------------------------------------------cc-----------
Confidence 9854321100 00000 0 00
Q ss_pred cCcccccccccccCCCccchhhhccCC-CCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHc---CCCC--CCC--
Q 007260 444 AEPTEARSMSFVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG---QPLR--FPE-- 515 (611)
Q Consensus 444 ~~~~~~~~~~~vGT~~Y~APEil~~~~-~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~---~~l~--~p~-- 515 (611)
............+++.|+|||++.+.. ++.++|||||||++|||++|.+||.+.+..+.+..+.. .+.. ++.
T Consensus 183 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 262 (335)
T PTZ00024 183 TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAK 262 (335)
T ss_pred cccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchh
Confidence 000001112235789999999998754 68999999999999999999999998877666544432 2111 110
Q ss_pred -------------------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 516 -------------------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 516 -------------------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
....+..+.+||.+||..+|++||+ ++++|.||||+..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s----~~~~l~~~~~~~~ 319 (335)
T PTZ00024 263 KLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERIS----AKEALKHEYFKSD 319 (335)
T ss_pred hcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccC----HHHHhcCcccCCC
Confidence 1235788999999999999999999 9999999999854
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=345.68 Aligned_cols=260 Identities=28% Similarity=0.408 Sum_probs=205.0
Q ss_pred CeEEEeEecccCcEEEEEEEECCC--CeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeec----cc
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGT--KCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFET----EK 289 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t--~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~----~~ 289 (611)
+|++.+.||.|+||.||++++..+ +..||||++.... ........+.+|+.+++++ +||||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 589999999999999999999888 8899999986432 2222344567899999999 59999999987542 35
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
.+|++|||+ +++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+++++|+|||++..+.
T Consensus 80 ~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 80 ELYLYEELM-EADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred cEEEEEecc-cCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 678999999 57899888654 569999999999999999999999999999999999999999999999999985432
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
..... ...
T Consensus 157 ~~~~~------------------------------------------------------------------------~~~ 164 (332)
T cd07857 157 ENPGE------------------------------------------------------------------------NAG 164 (332)
T ss_pred ccccc------------------------------------------------------------------------ccc
Confidence 11000 000
Q ss_pred cccccccCCCccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHc---CC---------------
Q 007260 450 RSMSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG---QP--------------- 510 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~-~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~---~~--------------- 510 (611)
....++||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+......+..++. .+
T Consensus 165 ~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (332)
T cd07857 165 FMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQN 244 (332)
T ss_pred cccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHH
Confidence 1123579999999998876 4689999999999999999999999987654333322111 00
Q ss_pred ----------CCCC-CCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCC
Q 007260 511 ----------LRFP-ESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 511 ----------l~~p-~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
..+. ..+.++..+++||.+||..||.+||+ +.+++.||||+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t----~~~ll~~~~~~~ 297 (332)
T cd07857 245 YIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRIS----VEEALEHPYLAI 297 (332)
T ss_pred HHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCC----HHHHhcChhhhh
Confidence 0111 12346789999999999999999999 999999999964
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=343.79 Aligned_cols=254 Identities=28% Similarity=0.378 Sum_probs=213.7
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVME 296 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE 296 (611)
.|...+.||.|+||.||+|++..++..||||.+............++.+|+++++.++|+||+++++++......|+|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 47778899999999999999999999999999875433334445567789999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccc
Q 007260 297 FCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIK 376 (611)
Q Consensus 297 ~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~ 376 (611)
|+. |+|.+++... ...+++..+..++.|++.||.|||.+||+||||||+|||++.++.++|+|||++.....
T Consensus 96 ~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~------ 167 (308)
T cd06634 96 YCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ 167 (308)
T ss_pred ccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC------
Confidence 995 5787766544 25689999999999999999999999999999999999999999999999998732110
Q ss_pred cccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccccc
Q 007260 377 ASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVG 456 (611)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vG 456 (611)
.....|
T Consensus 168 --------------------------------------------------------------------------~~~~~~ 173 (308)
T cd06634 168 --------------------------------------------------------------------------ANXFVG 173 (308)
T ss_pred --------------------------------------------------------------------------cccccC
Confidence 012358
Q ss_pred CCCccchhhhcc---CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007260 457 THEYLAPEIIKG---EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVK 533 (611)
Q Consensus 457 T~~Y~APEil~~---~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~ 533 (611)
++.|+|||++.+ ..++.++|||||||++|+|++|..||........+..+............++..+++||.+||..
T Consensus 174 ~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~ 253 (308)
T cd06634 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQK 253 (308)
T ss_pred CccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHHhhC
Confidence 889999999853 45788999999999999999999999877666666665555443333345888999999999999
Q ss_pred CccccCCchhcHHHHHcCCCCCC
Q 007260 534 EPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 534 dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
+|.+||+ +.+++.||||..
T Consensus 254 ~P~~Rp~----~~~ll~~~~~~~ 272 (308)
T cd06634 254 IPQDRPT----SEVLLKHRFVLR 272 (308)
T ss_pred CcccCCC----HHHHhhCccccc
Confidence 9999999 999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=338.26 Aligned_cols=254 Identities=23% Similarity=0.338 Sum_probs=207.1
Q ss_pred ccCeEEEeEecccCcEEEEEEEECC-----CCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSG-----TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK 289 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~-----t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~ 289 (611)
..+|.+.+.||.|+||.||+|++.. ++..+++|.+...... ....+.+|+++++.++|+||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLA---ARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHH---HHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 3579999999999999999998643 4567999998654432 2345678999999999999999999999999
Q ss_pred eeeEEeeeCCCCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCC
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQP--------------GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDG 355 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~--------------~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g 355 (611)
..++||||+++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 9999999999999999987542 23489999999999999999999999999999999999999999
Q ss_pred cEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCC
Q 007260 356 HIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQ 435 (611)
Q Consensus 356 ~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (611)
.++|+|||++........
T Consensus 161 ~~~l~dfg~a~~~~~~~~-------------------------------------------------------------- 178 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDY-------------------------------------------------------------- 178 (291)
T ss_pred cEEECCCCcccccCCCce--------------------------------------------------------------
Confidence 999999999843210000
Q ss_pred CCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCC
Q 007260 436 VSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFP 514 (611)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p 514 (611)
........|++.|+|||++.+..++.++|||||||++|||++ |+.||........+..+..... ..
T Consensus 179 ------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~ 245 (291)
T cd05094 179 ------------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRV-LE 245 (291)
T ss_pred ------------eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCCC-CC
Confidence 000112347889999999999999999999999999999998 9999988776665555444332 22
Q ss_pred CCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 515 ESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 515 ~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
.....+..+.+||.+||..||.+||+ +.++++
T Consensus 246 ~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~v~~ 277 (291)
T cd05094 246 RPRVCPKEVYDIMLGCWQREPQQRLN----IKEIYK 277 (291)
T ss_pred CCccCCHHHHHHHHHHcccChhhCcC----HHHHHH
Confidence 23457899999999999999999999 666654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=340.40 Aligned_cols=257 Identities=20% Similarity=0.293 Sum_probs=208.3
Q ss_pred ccccCeEEEeEecccCcEEEEEEEEC-------CCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccce
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELS-------GTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTH 284 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~-------~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~ 284 (611)
+...+|.+.+.||.|+||.||+|++. ..+..||+|++.... .......+.+|+.+++.+ +||||++++++
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 89 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGA 89 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence 34568999999999999999999853 234579999986542 123345678899999999 89999999999
Q ss_pred eeccceeeEEeeeCCCCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEE
Q 007260 285 FETEKFSCLVMEFCPGGDLHTLRQKQP--------------GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVL 350 (611)
Q Consensus 285 ~~~~~~~~LVmE~~~gg~L~~ll~~~~--------------~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNIL 350 (611)
+......|+||||+++++|.+++.... ...++...+..++.||+.||.|||++||+||||||+|||
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil 169 (304)
T cd05101 90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVL 169 (304)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEE
Confidence 999999999999999999999987642 235788889999999999999999999999999999999
Q ss_pred EccCCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCcc
Q 007260 351 VREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKN 430 (611)
Q Consensus 351 v~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 430 (611)
++.++.+||+|||++..+......
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~-------------------------------------------------------- 193 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYY-------------------------------------------------------- 193 (304)
T ss_pred EcCCCcEEECCCccceeccccccc--------------------------------------------------------
Confidence 999999999999998543211000
Q ss_pred ccCCCCCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcC
Q 007260 431 EIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQ 509 (611)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~ 509 (611)
.......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+. .
T Consensus 194 ------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~ 254 (304)
T cd05101 194 ------------------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK-E 254 (304)
T ss_pred ------------------ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-c
Confidence 00011236678999999999999999999999999999998 899998876655554443 3
Q ss_pred CCCCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 510 PLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 510 ~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
.........++..+++||.+||..+|.+||+ +.++++
T Consensus 255 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps----~~e~l~ 291 (304)
T cd05101 255 GHRMDKPANCTNELYMMMRDCWHAIPSHRPT----FKQLVE 291 (304)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcccChhhCCC----HHHHHH
Confidence 3344444568899999999999999999999 677765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=339.97 Aligned_cols=251 Identities=22% Similarity=0.309 Sum_probs=204.2
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCe--EEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeeccceee
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKC--YFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEKFSC 292 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~--~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~~~~~ 292 (611)
++|++.+.||.|+||.||+|.+..++. .+++|.+.... .......+.+|+.++.++ +||||+++++++.....+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 579999999999999999999877654 47888876422 223345677899999999 7999999999999999999
Q ss_pred EEeeeCCCCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEE
Q 007260 293 LVMEFCPGGDLHTLRQKQP--------------GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIM 358 (611)
Q Consensus 293 LVmE~~~gg~L~~ll~~~~--------------~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vk 358 (611)
+||||+++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 9999999999999987542 13588999999999999999999999999999999999999999999
Q ss_pred EEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCC
Q 007260 359 LSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSP 438 (611)
Q Consensus 359 L~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (611)
|+|||++......
T Consensus 160 l~dfg~~~~~~~~------------------------------------------------------------------- 172 (297)
T cd05089 160 IADFGLSRGEEVY------------------------------------------------------------------- 172 (297)
T ss_pred ECCcCCCccccce-------------------------------------------------------------------
Confidence 9999987311000
Q ss_pred CcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCC
Q 007260 439 LPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESP 517 (611)
Q Consensus 439 ~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~ 517 (611)
.......++..|+|||++.+..++.++|||||||++|||++ |..||.+.........+..+ ...+...
T Consensus 173 ----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~-~~~~~~~ 241 (297)
T cd05089 173 ----------VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRMEKPR 241 (297)
T ss_pred ----------eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC-CCCCCCC
Confidence 00000113457999999999999999999999999999997 99999887766655554433 3334444
Q ss_pred CCCHHHHHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 518 VVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 518 ~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
.++.++++||.+||..||.+||+ ++++++
T Consensus 242 ~~~~~~~~li~~~l~~~p~~Rp~----~~~i~~ 270 (297)
T cd05089 242 NCDDEVYELMRQCWRDRPYERPP----FAQISV 270 (297)
T ss_pred CCCHHHHHHHHHHcCCChhhCcC----HHHHHH
Confidence 58999999999999999999999 666654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=336.18 Aligned_cols=255 Identities=30% Similarity=0.468 Sum_probs=207.3
Q ss_pred eEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecc--ceeeEEe
Q 007260 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE--KFSCLVM 295 (611)
Q Consensus 218 y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~--~~~~LVm 295 (611)
|.+++.||.|+||.||+|.+..++..||+|++.... ........+.+|+++++.++|+||+++++++... +..|+||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 788999999999999999999999999999998653 2223334567899999999999999999999987 8999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
||++ ++|.+++.... ..+++..++.++.||+.||+|||.+|++|+||||+|||+++++.++|+|||++........
T Consensus 80 e~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-- 155 (287)
T cd07840 80 EYMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-- 155 (287)
T ss_pred cccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc--
Confidence 9996 58988876643 4699999999999999999999999999999999999999999999999999843221000
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
.......
T Consensus 156 -------------------------------------------------------------------------~~~~~~~ 162 (287)
T cd07840 156 -------------------------------------------------------------------------ADYTNRV 162 (287)
T ss_pred -------------------------------------------------------------------------ccccccc
Confidence 0001124
Q ss_pred cCCCccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcC---C--CCCCCC-------------
Q 007260 456 GTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ---P--LRFPES------------- 516 (611)
Q Consensus 456 GT~~Y~APEil~~~-~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~---~--l~~p~~------------- 516 (611)
++..|+|||.+.+. .++.++|||||||++|||++|+.||........+..+... + ..++..
T Consensus 163 ~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (287)
T cd07840 163 ITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKK 242 (287)
T ss_pred cccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccc
Confidence 77889999988764 5789999999999999999999999887765554443321 1 001100
Q ss_pred ----------CC-CCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCC
Q 007260 517 ----------PV-VSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 517 ----------~~-~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f 554 (611)
.. ++..+.++|.+||..||.+||+ +.+++.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~----~~~~l~~~~~ 287 (287)
T cd07840 243 PYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRIS----ADQALQHEYF 287 (287)
T ss_pred cchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcC----HHHHhhCcCC
Confidence 11 3889999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=337.41 Aligned_cols=253 Identities=22% Similarity=0.345 Sum_probs=206.0
Q ss_pred CeEEEeEecccCcEEEEEEEECC-----CCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecccee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSG-----TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFS 291 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~-----t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~ 291 (611)
+|++.+.||.|+||.||+|.+.. ....+|+|++..... .....++.+|+.+|+.++||||+++++.+..++..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 58899999999999999998753 235799998865432 23345678899999999999999999999999999
Q ss_pred eEEeeeCCCCCHHHHHHhCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcE
Q 007260 292 CLVMEFCPGGDLHTLRQKQP----------------------GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENV 349 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~----------------------~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNI 349 (611)
|+||||+.+++|.+++.... ...+++..+..++.|++.||+|||++||+||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 99999999999999876421 13578999999999999999999999999999999999
Q ss_pred EEccCCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCc
Q 007260 350 LVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPK 429 (611)
Q Consensus 350 Lv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 429 (611)
|+++++.+||+|||++.........
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~------------------------------------------------------- 183 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSY------------------------------------------------------- 183 (290)
T ss_pred EEcCCCcEEeccccccccccCccch-------------------------------------------------------
Confidence 9999999999999998432210000
Q ss_pred cccCCCCCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHc
Q 007260 430 NEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVG 508 (611)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~ 508 (611)
.......++..|+|||++.+..++.++|||||||++|||++ |..||.+.... .+.+.+.
T Consensus 184 -------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~~~ 243 (290)
T cd05045 184 -------------------VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE-RLFNLLK 243 (290)
T ss_pred -------------------hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-HHHHHHh
Confidence 00011235678999999999999999999999999999998 99999876544 4445555
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 509 QPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 509 ~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
.....+....++.++.+||..||..||.+||+ +.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~----~~~i~~ 281 (290)
T cd05045 244 TGYRMERPENCSEEMYNLMLTCWKQEPDKRPT----FADISK 281 (290)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHccCCcccCCC----HHHHHH
Confidence 55555555668999999999999999999999 666654
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=333.15 Aligned_cols=257 Identities=23% Similarity=0.318 Sum_probs=208.9
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCe---EEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecccee
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKC---YFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFS 291 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~---~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~ 291 (611)
.++|++.+.||.|+||.||+|++..++. .||||++.... .......+..|+.+++.++||||+++++++..+...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 4579999999999999999999876654 69999987542 233445678899999999999999999999999999
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCC
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~ 371 (611)
|+||||+++++|.+++.... +.+++..++.++.|++.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 81 MIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 99999999999999887653 46899999999999999999999999999999999999999999999999987322110
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
... + .....
T Consensus 160 ~~~--------------~---------------------------------------------------------~~~~~ 168 (269)
T cd05065 160 TSD--------------P---------------------------------------------------------TYTSS 168 (269)
T ss_pred ccc--------------c---------------------------------------------------------ccccc
Confidence 000 0 00000
Q ss_pred cccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 007260 452 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGL 530 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~ 530 (611)
....++..|+|||++.+..++.++|||||||++|||++ |..||...........+ ......+....++..+.++|.+|
T Consensus 169 ~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i-~~~~~~~~~~~~~~~~~~li~~~ 247 (269)
T cd05065 169 LGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI-EQDYRLPPPMDCPTALHQLMLDC 247 (269)
T ss_pred cCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHH-HcCCcCCCcccCCHHHHHHHHHH
Confidence 00113457999999999999999999999999999886 99999887666555444 34445555556899999999999
Q ss_pred hhcCccccCCchhcHHHHHc
Q 007260 531 LVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 531 L~~dP~~Rpt~~~~a~elL~ 550 (611)
|..+|.+||+ +.+|+.
T Consensus 248 l~~~p~~Rp~----~~~i~~ 263 (269)
T cd05065 248 WQKDRNARPK----FGQIVS 263 (269)
T ss_pred cCCChhhCcC----HHHHHH
Confidence 9999999999 777765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=330.52 Aligned_cols=247 Identities=21% Similarity=0.340 Sum_probs=203.0
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCccccccee-ecccee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHF-ETEKFS 291 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~-~~~~~~ 291 (611)
+...+|++.+.||.|+||.||++... +..||+|.+.... ....+.+|+.+++.++|+||+++++++ ..+...
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 75 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence 34568999999999999999999876 4569999986543 123567899999999999999999975 456778
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCC
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~ 371 (611)
|+||||+++++|.+++.......+++..+..++.||+.||+|||.+||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 99999999999999988765556899999999999999999999999999999999999999999999999987322100
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
.
T Consensus 156 -------------------------------------------------------------------------------~ 156 (256)
T cd05082 156 -------------------------------------------------------------------------------Q 156 (256)
T ss_pred -------------------------------------------------------------------------------C
Confidence 0
Q ss_pred cccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 007260 452 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGL 530 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~ 530 (611)
....++..|+|||++.+..++.++|||||||++|||++ |+.||...........+. ..........++..+++||.+|
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~ 235 (256)
T cd05082 157 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPVVYDVMKQC 235 (256)
T ss_pred CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHH
Confidence 01124567999999999999999999999999999997 999998765544444433 3333333456899999999999
Q ss_pred hhcCccccCCchhcHHHHHc
Q 007260 531 LVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 531 L~~dP~~Rpt~~~~a~elL~ 550 (611)
|..+|.+||+ +.++++
T Consensus 236 l~~~p~~Rpt----~~~l~~ 251 (256)
T cd05082 236 WHLDAATRPS----FLQLRE 251 (256)
T ss_pred hcCChhhCcC----HHHHHH
Confidence 9999999999 667654
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=335.33 Aligned_cols=255 Identities=18% Similarity=0.266 Sum_probs=204.1
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCe----EEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecc
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKC----YFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE 288 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~----~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~ 288 (611)
+...+|++++.||.|+||+||+|.+..++. .|++|.+... ........+..|+.++..++||||+++++++. +
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~ 80 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-G 80 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-C
Confidence 345789999999999999999999877665 4777776432 22334456778888999999999999999876 4
Q ss_pred ceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccc
Q 007260 289 KFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRC 368 (611)
Q Consensus 289 ~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~ 368 (611)
...++||||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 55789999999999999987653 46899999999999999999999999999999999999999999999999998433
Q ss_pred cCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccc
Q 007260 369 AVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTE 448 (611)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (611)
..... .
T Consensus 160 ~~~~~--------------------------------------------------------------------------~ 165 (279)
T cd05111 160 YPDDK--------------------------------------------------------------------------K 165 (279)
T ss_pred cCCCc--------------------------------------------------------------------------c
Confidence 21000 0
Q ss_pred ccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 007260 449 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLI 527 (611)
Q Consensus 449 ~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI 527 (611)
.......|+..|+|||++.+..++.++|||||||++|||++ |+.||.+..... +..++......+....++..+.++|
T Consensus 166 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li 244 (279)
T cd05111 166 YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-VPDLLEKGERLAQPQICTIDVYMVM 244 (279)
T ss_pred cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHHCCCcCCCCCCCCHHHHHHH
Confidence 00112347778999999999899999999999999999998 999998765443 3344444333344445788999999
Q ss_pred HHhhhcCccccCCchhcHHHHHc
Q 007260 528 RGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 528 ~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
.+||..||.+||+ +.++++
T Consensus 245 ~~c~~~~p~~Rps----~~el~~ 263 (279)
T cd05111 245 VKCWMIDENVRPT----FKELAN 263 (279)
T ss_pred HHHcCCCcccCcC----HHHHHH
Confidence 9999999999999 666654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=356.68 Aligned_cols=258 Identities=20% Similarity=0.286 Sum_probs=210.8
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECC-----CCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC-CCCcccccceee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSG-----TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD-HPFLPTLYTHFE 286 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~-----t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~-HpnIv~l~~~~~ 286 (611)
+..++|.+++.||.|+||.||+|++.+ ++..||||++...... .....+.+|+.+|.++. |||||++++++.
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS--SEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh--hHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 334578899999999999999999643 4568999999754322 22345778999999997 999999999999
Q ss_pred ccceeeEEeeeCCCCCHHHHHHhCCC------------------------------------------------------
Q 007260 287 TEKFSCLVMEFCPGGDLHTLRQKQPG------------------------------------------------------ 312 (611)
Q Consensus 287 ~~~~~~LVmE~~~gg~L~~ll~~~~~------------------------------------------------------ 312 (611)
..+.+|||||||++|+|.+++.+...
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999998865321
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEE
Q 007260 313 ------------------------------------------KYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVL 350 (611)
Q Consensus 313 ------------------------------------------~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNIL 350 (611)
..+++..+..|+.||+.||+|||.+||+||||||+|||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiL 271 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVL 271 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEE
Confidence 24677788899999999999999999999999999999
Q ss_pred EccCCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCcc
Q 007260 351 VREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKN 430 (611)
Q Consensus 351 v~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 430 (611)
++.++.+||+|||++..+.....
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~--------------------------------------------------------- 294 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSN--------------------------------------------------------- 294 (401)
T ss_pred EeCCCEEEEEecCcceecccccc---------------------------------------------------------
Confidence 99999999999999843211000
Q ss_pred ccCCCCCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcC
Q 007260 431 EIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQ 509 (611)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~ 509 (611)
.......+|++.|+|||++.+..++.++|||||||++|||++ |..||......+.+...+..
T Consensus 295 -----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~ 357 (401)
T cd05107 295 -----------------YISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKR 357 (401)
T ss_pred -----------------cccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHc
Confidence 000112357889999999999999999999999999999998 99999887776666666655
Q ss_pred CCCCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 510 PLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 510 ~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
..+.+....++.++.+||.+||..+|.+||+ +.+|++
T Consensus 358 ~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs----~~ell~ 394 (401)
T cd05107 358 GYRMAKPAHASDEIYEIMQKCWEEKFEIRPD----FSQLVH 394 (401)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhHCcC----HHHHHH
Confidence 5555555568999999999999999999999 667665
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=330.95 Aligned_cols=255 Identities=22% Similarity=0.280 Sum_probs=208.0
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCC---eEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecccee
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTK---CYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFS 291 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~---~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~ 291 (611)
..+|...+.||.|+||.||+|.+..++ ..+|||++..... ......+..|+++++.++|+||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT--EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA 81 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC--HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence 457899999999999999999987554 3799999865432 22344677899999999999999999999999999
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCC
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~ 371 (611)
|+||||+++++|.+++.... ..+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||++..+...
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 82 MIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999999887643 56899999999999999999999999999999999999999999999999997433211
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
.... ...
T Consensus 161 ~~~~-------------------------------------------------------------------------~~~ 167 (268)
T cd05063 161 PEGT-------------------------------------------------------------------------YTT 167 (268)
T ss_pred cccc-------------------------------------------------------------------------eec
Confidence 0000 000
Q ss_pred cccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 007260 452 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGL 530 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~ 530 (611)
.....++.|+|||++.+..++.++|||||||++|||++ |+.||...........+.. ....+....++.++.+||.+|
T Consensus 168 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~li~~c 246 (268)
T cd05063 168 SGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND-GFRLPAPMDCPSAVYQLMLQC 246 (268)
T ss_pred cCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhc-CCCCCCCCCCCHHHHHHHHHH
Confidence 01123567999999998889999999999999999997 9999987766555555443 345555556889999999999
Q ss_pred hhcCccccCCchhcHHHHHc
Q 007260 531 LVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 531 L~~dP~~Rpt~~~~a~elL~ 550 (611)
|..+|++||+ +.+|++
T Consensus 247 ~~~~p~~Rp~----~~~i~~ 262 (268)
T cd05063 247 WQQDRARRPR----FVDIVN 262 (268)
T ss_pred cCCCcccCcC----HHHHHH
Confidence 9999999999 666654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=331.35 Aligned_cols=259 Identities=26% Similarity=0.406 Sum_probs=218.0
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeeccceeeE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEKFSCL 293 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~~~~~L 293 (611)
+++.+.+..||.|+.|.||+++.+.++...|||.|.+.. +.+...|+...+.++... ++|+||+.+++|..+..++|
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~I 168 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFI 168 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHH
Confidence 346677889999999999999999999999999998865 345566777788877666 49999999999999999999
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCeeccCCCCCcEEEccCCcEEEEeccccccccCCc
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHM-LGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~-~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~ 372 (611)
.||.| +..+..++.+. .+.++|..+-.+...++.||.||-. +||+|||+||+|||+++.|.+||||||++-++..+.
T Consensus 169 cMelM-s~C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 169 CMELM-STCAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHHHH-HHHHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccc
Confidence 99998 55666666655 3679999999999999999999986 589999999999999999999999999996554322
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
.+ +
T Consensus 247 Ah-----------------------------------------------------------------------------t 249 (391)
T KOG0983|consen 247 AH-----------------------------------------------------------------------------T 249 (391)
T ss_pred cc-----------------------------------------------------------------------------c
Confidence 11 1
Q ss_pred ccccCCCccchhhhccC---CCCChhhHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHcCC-CCCCCCCCCCHHHHHHH
Q 007260 453 SFVGTHEYLAPEIIKGE---GHGSAVDWWTFGIFLYELLFGKTPFKGS-GNRATLFNVVGQP-LRFPESPVVSFAARDLI 527 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~---~~~~~sDIWSLGviL~ELltG~~PF~~~-~~~~~l~~i~~~~-l~~p~~~~~s~~l~dLI 527 (611)
...|-+.|||||.+.-. .|+-++|||||||+|+||.||+.||.+. .+.+.+-++++.. ..+|....+|+.+++|+
T Consensus 250 rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv 329 (391)
T KOG0983|consen 250 RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFV 329 (391)
T ss_pred cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHH
Confidence 22488999999999754 5899999999999999999999999984 5667777777643 34455556999999999
Q ss_pred HHhhhcCccccCCchhcHHHHHcCCCCCCCc
Q 007260 528 RGLLVKEPQHRLAYKRGATEIKQHPFFEGVN 558 (611)
Q Consensus 528 ~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 558 (611)
..||.+|+.+||. -.+||+|||+...+
T Consensus 330 ~~CL~kd~r~RP~----Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 330 KDCLTKDHRKRPK----YNKLLEHPFIKRYE 356 (391)
T ss_pred HHHhhcCcccCcc----hHHHhcCcceeecc
Confidence 9999999999999 78999999997654
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=340.40 Aligned_cols=250 Identities=28% Similarity=0.467 Sum_probs=209.6
Q ss_pred EeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEeeeCCC
Q 007260 221 LKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPG 300 (611)
Q Consensus 221 ~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE~~~g 300 (611)
...||.|+||.||++.+..++..||||.+.... ......+.+|+.+++.++|+||++++++|..++..|+||||+++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 468999999999999999999999999985432 22344577899999999999999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccccC
Q 007260 301 GDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSL 380 (611)
Q Consensus 301 g~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~ 380 (611)
++|.+++.. ..+++..++.++.|++.||+|||++||+||||||+||+++.+++++|+|||++......
T Consensus 102 ~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~--------- 169 (292)
T cd06657 102 GALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--------- 169 (292)
T ss_pred CcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccc---------
Confidence 999998754 34899999999999999999999999999999999999999999999999987322100
Q ss_pred CCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCc
Q 007260 381 DAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEY 460 (611)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y 460 (611)
........|++.|
T Consensus 170 -------------------------------------------------------------------~~~~~~~~~~~~y 182 (292)
T cd06657 170 -------------------------------------------------------------------VPRRKSLVGTPYW 182 (292)
T ss_pred -------------------------------------------------------------------cccccccccCccc
Confidence 0001123588999
Q ss_pred cchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcC-CCCCCCCCCCCHHHHHHHHHhhhcCccccC
Q 007260 461 LAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ-PLRFPESPVVSFAARDLIRGLLVKEPQHRL 539 (611)
Q Consensus 461 ~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~-~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rp 539 (611)
+|||++.+..++.++|+|||||++|+|++|..||.+......+..+... +..+.....++..+.++|.+||..||.+||
T Consensus 183 ~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~ 262 (292)
T cd06657 183 MAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRA 262 (292)
T ss_pred cCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCc
Confidence 9999998888899999999999999999999999876655544433322 223333445789999999999999999999
Q ss_pred CchhcHHHHHcCCCCCC
Q 007260 540 AYKRGATEIKQHPFFEG 556 (611)
Q Consensus 540 t~~~~a~elL~Hp~f~~ 556 (611)
+ +.+++.||||..
T Consensus 263 ~----~~~ll~~~~~~~ 275 (292)
T cd06657 263 T----AAELLKHPFLAK 275 (292)
T ss_pred C----HHHHhcChHHhc
Confidence 9 999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=338.23 Aligned_cols=261 Identities=26% Similarity=0.390 Sum_probs=210.7
Q ss_pred cccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeeccce
Q 007260 212 VLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEKF 290 (611)
Q Consensus 212 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~~~ 290 (611)
.+..++|++.+.||.|+||.||+|.+..++..||||++.+.... .....+..|+.++..+ +|+||+++++++..+..
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 88 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD 88 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence 34567899999999999999999999999999999999764322 2233445677766666 59999999999999999
Q ss_pred eeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 291 SCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHM-LGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 291 ~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~-~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
.|+||||+ +++|.+++.... ..+++..+..++.||+.||.|||+ +||+||||+|+|||++.++.+||+|||++....
T Consensus 89 ~~~v~e~~-~~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 89 VFICMELM-STCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred EEEEeecc-CcCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 99999999 568888777643 478999999999999999999997 699999999999999999999999999874321
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
...
T Consensus 167 ~~~----------------------------------------------------------------------------- 169 (296)
T cd06618 167 DSK----------------------------------------------------------------------------- 169 (296)
T ss_pred CCC-----------------------------------------------------------------------------
Confidence 000
Q ss_pred cccccccCCCccchhhhccCC----CCChhhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHcCC-CCCCCCCCCCHHH
Q 007260 450 RSMSFVGTHEYLAPEIIKGEG----HGSAVDWWTFGIFLYELLFGKTPFKGSGN-RATLFNVVGQP-LRFPESPVVSFAA 523 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~~~----~~~~sDIWSLGviL~ELltG~~PF~~~~~-~~~l~~i~~~~-l~~p~~~~~s~~l 523 (611)
......|++.|+|||++.+.. ++.++|||||||++|+|++|+.||..... .+.+..+.... ..++....++.++
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 249 (296)
T cd06618 170 AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDF 249 (296)
T ss_pred cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHH
Confidence 001124788899999997664 78899999999999999999999976433 34444444443 2233333578999
Q ss_pred HHHHHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 524 RDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 524 ~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
.+||.+||..||++||+ ++++++||||+..
T Consensus 250 ~~li~~~l~~~p~~Rp~----~~~il~~~~~~~~ 279 (296)
T cd06618 250 CSFVDLCLTKDHRKRPK----YRELLQHPFIRRY 279 (296)
T ss_pred HHHHHHHccCChhhCCC----HHHHhcChhhhcc
Confidence 99999999999999999 9999999999753
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=328.75 Aligned_cols=247 Identities=21% Similarity=0.307 Sum_probs=207.0
Q ss_pred cccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeE
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCL 293 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~L 293 (611)
...+|++.+.||.|+||.||+|... ++.||||.+..... ...++.+|+.+++.++|+||+++++++......|+
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 77 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI 77 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence 3568999999999999999999875 57799999976542 34567889999999999999999999999999999
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcc
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 373 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~ 373 (611)
||||+++++|.+++.......+++..++.++.|++.||.|||.+||+||||||+|||++.++.++|+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~- 156 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ- 156 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc-
Confidence 9999999999999987655579999999999999999999999999999999999999999999999999984321000
Q ss_pred ccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccc
Q 007260 374 LIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMS 453 (611)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (611)
..
T Consensus 157 ------------------------------------------------------------------------------~~ 158 (256)
T cd05039 157 ------------------------------------------------------------------------------DS 158 (256)
T ss_pred ------------------------------------------------------------------------------cc
Confidence 01
Q ss_pred cccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007260 454 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLV 532 (611)
Q Consensus 454 ~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~ 532 (611)
..++..|+|||.+.+..++.++|||||||++|||++ |+.||...........+ ...........++..+.+||.+||.
T Consensus 159 ~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~ 237 (256)
T cd05039 159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHV-EKGYRMEAPEGCPPEVYKVMKDCWE 237 (256)
T ss_pred CCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-hcCCCCCCccCCCHHHHHHHHHHhc
Confidence 124567999999998889999999999999999997 99999877655444333 3333333334588999999999999
Q ss_pred cCccccCCchhcHHHHHc
Q 007260 533 KEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 533 ~dP~~Rpt~~~~a~elL~ 550 (611)
.+|++||+ +.++++
T Consensus 238 ~~p~~Rp~----~~~l~~ 251 (256)
T cd05039 238 LDPAKRPT----FKQLRE 251 (256)
T ss_pred cChhhCcC----HHHHHH
Confidence 99999999 777764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=329.36 Aligned_cols=246 Identities=22% Similarity=0.322 Sum_probs=199.3
Q ss_pred eEecccCcEEEEEEEECCCC---eEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEeeeC
Q 007260 222 KRLGCGDIGSVYLSELSGTK---CYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFC 298 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~~~t~---~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE~~ 298 (611)
++||+|+||.||+|....++ ..||+|.+...... .....+.+|+.+|+.++|+|||++++++. ....++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 47999999999999876554 78999999765543 23346778999999999999999999876 45679999999
Q ss_pred CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccc
Q 007260 299 PGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKAS 378 (611)
Q Consensus 299 ~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~ 378 (611)
++++|.+++... ..+++..+..++.|++.||+|||.+||+||||||+|||++.++.+||+|||++..+.......
T Consensus 78 ~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~--- 152 (257)
T cd05060 78 PLGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY--- 152 (257)
T ss_pred CCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccc---
Confidence 999999999875 368999999999999999999999999999999999999999999999999985432110000
Q ss_pred cCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCC
Q 007260 379 SLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTH 458 (611)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~ 458 (611)
.......++.
T Consensus 153 ----------------------------------------------------------------------~~~~~~~~~~ 162 (257)
T cd05060 153 ----------------------------------------------------------------------RATTAGRWPL 162 (257)
T ss_pred ----------------------------------------------------------------------ccccCccccc
Confidence 0000112556
Q ss_pred CccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccc
Q 007260 459 EYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQH 537 (611)
Q Consensus 459 ~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~ 537 (611)
.|+|||.+.+..++.++|||||||++|||++ |..||........... +......+....++..+++||.+||..||.+
T Consensus 163 ~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~ 241 (257)
T cd05060 163 KWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAM-LESGERLPRPEECPQEIYSIMLSCWKYRPED 241 (257)
T ss_pred cccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHH-HHcCCcCCCCCCCCHHHHHHHHHHhcCChhh
Confidence 8999999999999999999999999999997 9999987766544433 3333344455568899999999999999999
Q ss_pred cCCchhcHHHHHc
Q 007260 538 RLAYKRGATEIKQ 550 (611)
Q Consensus 538 Rpt~~~~a~elL~ 550 (611)
||+ +.+|++
T Consensus 242 Rp~----~~~l~~ 250 (257)
T cd05060 242 RPT----FSELES 250 (257)
T ss_pred CcC----HHHHHH
Confidence 999 666654
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=334.52 Aligned_cols=254 Identities=31% Similarity=0.500 Sum_probs=209.3
Q ss_pred eEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEeee
Q 007260 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEF 297 (611)
Q Consensus 218 y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE~ 297 (611)
|++.+.||.|++|.||+|.+..+++.+|+|.+...... ......+.+|+.+|+.++|+||+++++++..+...|+||||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 67789999999999999999989999999998765432 12344667899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccccc
Q 007260 298 CPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKA 377 (611)
Q Consensus 298 ~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~ 377 (611)
+++ +|..++.... ..+++..+..++.||+.||.|||.+||+|+||||+|||++.++.++|+|||++.......
T Consensus 80 ~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~----- 152 (283)
T cd05118 80 MDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV----- 152 (283)
T ss_pred cCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-----
Confidence 965 8888776643 568999999999999999999999999999999999999999999999999874322100
Q ss_pred ccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccC
Q 007260 378 SSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGT 457 (611)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT 457 (611)
.......++
T Consensus 153 -----------------------------------------------------------------------~~~~~~~~~ 161 (283)
T cd05118 153 -----------------------------------------------------------------------RPYTHYVVT 161 (283)
T ss_pred -----------------------------------------------------------------------ccccCccCc
Confidence 000113478
Q ss_pred CCccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcC---C----------------CCCC---
Q 007260 458 HEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ---P----------------LRFP--- 514 (611)
Q Consensus 458 ~~Y~APEil~~~-~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~---~----------------l~~p--- 514 (611)
..|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+... + ..++
T Consensus 162 ~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (283)
T cd05118 162 RWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKA 241 (283)
T ss_pred ccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhcccc
Confidence 899999999877 6899999999999999999999999887766655444321 1 0011
Q ss_pred ------CCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCC
Q 007260 515 ------ESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 515 ------~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f 554 (611)
....++.++++||.+||..||.+||+ +.+++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~----~~~ll~~~~~ 283 (283)
T cd05118 242 GMPLPKLFPNASPQALDLLSQMLHYDPHKRIT----AEQALAHPYF 283 (283)
T ss_pred ccCHHHhhhhhCHHHHHHHHHHhccCcccCcC----HHHHhhCCCC
Confidence 01236789999999999999999999 9999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=338.69 Aligned_cols=256 Identities=20% Similarity=0.300 Sum_probs=204.4
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCC--------------CeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCccc
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGT--------------KCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPT 280 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t--------------~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~ 280 (611)
..+|++.+.||+|+||.||+|++..+ ...||||++..... ......+.+|+++|+.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT--KTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC--HHHHHHHHHHHHHHHhCCCCCcCe
Confidence 35899999999999999999987543 34699999875422 233446788999999999999999
Q ss_pred ccceeeccceeeEEeeeCCCCCHHHHHHhCC----------CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEE
Q 007260 281 LYTHFETEKFSCLVMEFCPGGDLHTLRQKQP----------GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVL 350 (611)
Q Consensus 281 l~~~~~~~~~~~LVmE~~~gg~L~~ll~~~~----------~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNIL 350 (611)
+++++......|+||||+++++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 9999999999999999999999999886532 123688899999999999999999999999999999999
Q ss_pred EccCCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCcc
Q 007260 351 VREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKN 430 (611)
Q Consensus 351 v~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 430 (611)
++.++.+||+|||++.......
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~---------------------------------------------------------- 183 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGD---------------------------------------------------------- 183 (295)
T ss_pred EcCCCcEEecccccccccccCc----------------------------------------------------------
Confidence 9999999999999984321000
Q ss_pred ccCCCCCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh--CCCCCCCCCcHHHHHHHHc
Q 007260 431 EIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF--GKTPFKGSGNRATLFNVVG 508 (611)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt--G~~PF~~~~~~~~l~~i~~ 508 (611)
.........++..|+|||++.+..++.++|||||||++|+|++ |..||........+..+..
T Consensus 184 ----------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~ 247 (295)
T cd05097 184 ----------------YYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGE 247 (295)
T ss_pred ----------------ceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHH
Confidence 0000012246778999999999999999999999999999987 7789987766555443321
Q ss_pred ------CCCCCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 509 ------QPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 509 ------~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
..........++..+.+||.+||..||++||+ +++|++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs----~~~i~~ 291 (295)
T cd05097 248 FFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPT----FNKIHH 291 (295)
T ss_pred hhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcC----HHHHHH
Confidence 22222334457899999999999999999999 677654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=362.07 Aligned_cols=244 Identities=33% Similarity=0.488 Sum_probs=207.4
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeeccceeeE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEKFSCL 293 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~~~~~L 293 (611)
...|.+...||.|+|+.|-.+.+..+++.+++|++.+... ..++|+.++... +||||+++++.+.++.+.|+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCceeee
Confidence 4688999999999999999999999999999999987621 234577666655 79999999999999999999
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEE-ccCCcEEEEeccccccccCCc
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLV-REDGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv-~~~g~vkL~DFGlA~~~~~~~ 372 (611)
|||++.|+.|.+.+... +.+. ..+..|++||+.||.|||++|||||||||+|||+ +..|+++|+|||.+......
T Consensus 394 v~e~l~g~ell~ri~~~--~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSK--PEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred eehhccccHHHHHHHhc--chhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 99999999998877665 2344 7788899999999999999999999999999999 68999999999998432200
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
.+
T Consensus 470 ------------------------------------------------------------------------------~~ 471 (612)
T KOG0603|consen 470 ------------------------------------------------------------------------------CD 471 (612)
T ss_pred ------------------------------------------------------------------------------hc
Confidence 11
Q ss_pred ccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007260 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLV 532 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~ 532 (611)
+-+-|..|.|||++...+|+.++||||||++||+||+|+.||........+...++.+ +....+|++++|||++||+
T Consensus 472 tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~---~~s~~vS~~AKdLl~~LL~ 548 (612)
T KOG0603|consen 472 TPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMP---KFSECVSDEAKDLLQQLLQ 548 (612)
T ss_pred ccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCC---ccccccCHHHHHHHHHhcc
Confidence 2246788999999999999999999999999999999999999877774444443332 2225699999999999999
Q ss_pred cCccccCCchhcHHHHHcCCCC
Q 007260 533 KEPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 533 ~dP~~Rpt~~~~a~elL~Hp~f 554 (611)
.||.+|++ +.+++.||||
T Consensus 549 ~dP~~Rl~----~~~i~~h~w~ 566 (612)
T KOG0603|consen 549 VDPALRLG----ADEIGAHPWF 566 (612)
T ss_pred CChhhCcC----hhhhccCcch
Confidence 99999999 9999999999
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=329.60 Aligned_cols=243 Identities=22% Similarity=0.316 Sum_probs=195.2
Q ss_pred EecccCcEEEEEEEEC--CCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEeeeCCC
Q 007260 223 RLGCGDIGSVYLSELS--GTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPG 300 (611)
Q Consensus 223 ~LG~G~fG~Vy~a~~~--~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE~~~g 300 (611)
.||.|+||.||+|.+. .++..||+|++.... .......+.+|+.+|+.++||||+++++++.. ...|+||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 4899999999999775 456679999986543 23344567889999999999999999998864 578999999999
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccccC
Q 007260 301 GDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSL 380 (611)
Q Consensus 301 g~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~ 380 (611)
++|.+++... ...+++..+..++.||+.||+|||.+||+||||||+|||++.++.+||+|||++..........
T Consensus 79 ~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~----- 152 (257)
T cd05115 79 GPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY----- 152 (257)
T ss_pred CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccce-----
Confidence 9999988754 2568999999999999999999999999999999999999999999999999984322110000
Q ss_pred CCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCc
Q 007260 381 DAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEY 460 (611)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y 460 (611)
.......+++.|
T Consensus 153 --------------------------------------------------------------------~~~~~~~~~~~y 164 (257)
T cd05115 153 --------------------------------------------------------------------KARSAGKWPLKW 164 (257)
T ss_pred --------------------------------------------------------------------eccCCCCCCccc
Confidence 000001246789
Q ss_pred cchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccC
Q 007260 461 LAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRL 539 (611)
Q Consensus 461 ~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rp 539 (611)
+|||++.+..++.++|||||||++|||++ |..||.+.........+. .....+.....++++.+||.+||..||++||
T Consensus 165 ~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp 243 (257)
T cd05115 165 YAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE-QGKRLDCPAECPPEMYALMKDCWIYKWEDRP 243 (257)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHcCCChhhCc
Confidence 99999998889999999999999999996 999998876665554443 3333344456899999999999999999999
Q ss_pred Cchh
Q 007260 540 AYKR 543 (611)
Q Consensus 540 t~~~ 543 (611)
++..
T Consensus 244 ~~~~ 247 (257)
T cd05115 244 NFAK 247 (257)
T ss_pred CHHH
Confidence 9443
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=347.11 Aligned_cols=263 Identities=32% Similarity=0.457 Sum_probs=209.0
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeec--ccee
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFET--EKFS 291 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~--~~~~ 291 (611)
.++|.+.+.||.|+||.||+|.+..++..||||.+.+.. ........+.+|+.+++.+ +||||++++++|.. ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 368999999999999999999999899999999886432 1222334567899999999 99999999998864 3478
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCC
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~ 371 (611)
||||||++ ++|..++... .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 85 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred EEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 99999996 5999888663 5889999999999999999999999999999999999999999999999998433210
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
... ......
T Consensus 161 ~~~-----------------------------------------------------------------------~~~~~~ 169 (337)
T cd07852 161 EEN-----------------------------------------------------------------------PENPVL 169 (337)
T ss_pred ccc-----------------------------------------------------------------------ccCcch
Confidence 000 000011
Q ss_pred cccccCCCccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCC-------------------
Q 007260 452 MSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPL------------------- 511 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~-~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l------------------- 511 (611)
..++||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+......+..+.....
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (337)
T cd07852 170 TDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATML 249 (337)
T ss_pred hcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhh
Confidence 23569999999998865 4578899999999999999999999987665544333221100
Q ss_pred -------CC---CCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 512 -------RF---PESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 512 -------~~---p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
.. ...+.++.++.+||.+||..||++||+ +.++++||||+.+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps----~~~il~~~~~~~~ 301 (337)
T cd07852 250 DSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLT----AEEALEHPYVAQF 301 (337)
T ss_pred hhcccccccchhhhccCCCHHHHHHHHHhccCCcccccC----HHHHhhChhhhhh
Confidence 00 011236889999999999999999999 9999999999865
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=372.26 Aligned_cols=254 Identities=24% Similarity=0.379 Sum_probs=217.4
Q ss_pred ccccCeEEEeEecccCcEEEEEEEEC-----CCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELS-----GTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET 287 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~-----~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~ 287 (611)
+...+.+..+.||+|+||+||+|+.. .....||||.++.... .+....|++|+++|..|+|||||+|+|++..
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~--~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAE--NQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccccc--HHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 44567788899999999999999864 3467899999976543 3345678999999999999999999999999
Q ss_pred cceeeEEeeeCCCCCHHHHHHhCC--------CC----CCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCC
Q 007260 288 EKFSCLVMEFCPGGDLHTLRQKQP--------GK----YFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDG 355 (611)
Q Consensus 288 ~~~~~LVmE~~~gg~L~~ll~~~~--------~~----~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g 355 (611)
++.+|||+|||..|||++++.... +. .|+..+...|+.||+.|++||-++.+|||||...|+||.++-
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENL 640 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccce
Confidence 999999999999999999987532 22 388999999999999999999999999999999999999999
Q ss_pred cEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCC
Q 007260 356 HIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQ 435 (611)
Q Consensus 356 ~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (611)
.|||+||||++.. .+.++.+..+.+
T Consensus 641 ~VKIsDfGLsRdi-YssDYYk~~~~t------------------------------------------------------ 665 (774)
T KOG1026|consen 641 VVKISDFGLSRDI-YSSDYYKVRGNT------------------------------------------------------ 665 (774)
T ss_pred EEEecccccchhh-hhhhhhcccCCc------------------------------------------------------
Confidence 9999999998432 222222221111
Q ss_pred CCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCC
Q 007260 436 VSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFP 514 (611)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p 514 (611)
.-...||+||.|....|+.++||||+||+|||+++ |+.||.+.++.+.+..|..+.+ ++
T Consensus 666 -------------------~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l-L~ 725 (774)
T KOG1026|consen 666 -------------------LLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL-LS 725 (774)
T ss_pred -------------------eeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCc-cc
Confidence 12346999999999999999999999999999995 9999999999999999888887 77
Q ss_pred CCCCCCHHHHHHHHHhhhcCccccCCchh
Q 007260 515 ESPVVSFAARDLIRGLLVKEPQHRLAYKR 543 (611)
Q Consensus 515 ~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~ 543 (611)
.+..++.++.+|+..||+.+|++||++.+
T Consensus 726 ~Pe~CP~~vY~LM~~CW~~~P~~RPsF~e 754 (774)
T KOG1026|consen 726 CPENCPTEVYSLMLECWNENPKRRPSFKE 754 (774)
T ss_pred CCCCCCHHHHHHHHHHhhcCcccCCCHHH
Confidence 77789999999999999999999999544
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=332.70 Aligned_cols=254 Identities=24% Similarity=0.359 Sum_probs=201.6
Q ss_pred cCeEEEeEecccCcEEEEEEEE----CCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec--cc
Q 007260 216 SHFRLLKRLGCGDIGSVYLSEL----SGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET--EK 289 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~----~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~--~~ 289 (611)
.+|++++.||+|+||.||+|.. ..++..||||.+.... ......+.+|+++|+.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 4899999999999999999984 4568899999986543 2334567789999999999999999997643 45
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
.+||||||+++++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+.
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 7899999999999999987643 458999999999999999999999999999999999999999999999999984332
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
.......
T Consensus 160 ~~~~~~~------------------------------------------------------------------------- 166 (284)
T cd05081 160 QDKEYYK------------------------------------------------------------------------- 166 (284)
T ss_pred CCCccee-------------------------------------------------------------------------
Confidence 1100000
Q ss_pred cccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcH---------------HHHHHHHcCCCCCC
Q 007260 450 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNR---------------ATLFNVVGQPLRFP 514 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~---------------~~l~~i~~~~l~~p 514 (611)
......++..|+|||++.+..++.++|||||||++|||++|..++...... ..+.+++.....++
T Consensus 167 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (284)
T cd05081 167 VREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLP 246 (284)
T ss_pred ecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCCcCC
Confidence 000012445699999999989999999999999999999988776432211 11223344444455
Q ss_pred CCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 515 ESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 515 ~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
....++.++.+||.+||..+|++||| +.+|++
T Consensus 247 ~~~~~~~~~~~li~~cl~~~p~~Rpt----~~ei~~ 278 (284)
T cd05081 247 APPGCPAEIYAIMKECWNNDPSQRPS----FSELAL 278 (284)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCC----HHHHHH
Confidence 55668999999999999999999999 777765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=332.91 Aligned_cols=253 Identities=32% Similarity=0.511 Sum_probs=206.3
Q ss_pred eEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC-CCCcccccceeeccceeeEEee
Q 007260 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD-HPFLPTLYTHFETEKFSCLVME 296 (611)
Q Consensus 218 y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~-HpnIv~l~~~~~~~~~~~LVmE 296 (611)
|++.+.||.|+||+||+|....+++.||||.+.+..... . .....+|+..+++++ |+||+++++++..++..|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~-~-~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW-E-ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch-h-HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 678899999999999999999999999999986543211 1 122346899999998 9999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccc
Q 007260 297 FCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIK 376 (611)
Q Consensus 297 ~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~ 376 (611)
|+ +++|.+++....+..+++..+..++.||+.+|.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~----- 152 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR----- 152 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC-----
Confidence 99 889998887765457899999999999999999999999999999999999999999999999987332100
Q ss_pred cccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccccc
Q 007260 377 ASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVG 456 (611)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vG 456 (611)
......+|
T Consensus 153 ------------------------------------------------------------------------~~~~~~~~ 160 (283)
T cd07830 153 ------------------------------------------------------------------------PPYTDYVS 160 (283)
T ss_pred ------------------------------------------------------------------------CCcCCCCC
Confidence 00012358
Q ss_pred CCCccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHc---CCCC----------------CCC-
Q 007260 457 THEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG---QPLR----------------FPE- 515 (611)
Q Consensus 457 T~~Y~APEil~~-~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~---~~l~----------------~p~- 515 (611)
+..|+|||++.+ ..++.++|+||||+++|||++|++||......+.+..+.. .+.. ++.
T Consensus 161 ~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd07830 161 TRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQF 240 (283)
T ss_pred cccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccccccc
Confidence 899999998854 4578999999999999999999999988766555543321 1100 000
Q ss_pred --------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCC
Q 007260 516 --------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 516 --------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f 554 (611)
....+..+++||++||..||++||+ +.|++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt----~~ei~~~~~~ 283 (283)
T cd07830 241 APTSLHQLIPNASPEAIDLIKDMLRWDPKKRPT----ASQALQHPYF 283 (283)
T ss_pred ccccHHHHcccCCHHHHHHHHHhcccCcccCCC----HHHHhhCCCC
Confidence 1123678999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=333.52 Aligned_cols=252 Identities=22% Similarity=0.291 Sum_probs=197.6
Q ss_pred Ce-EEEeEecccCcEEEEEEE----ECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec--cc
Q 007260 217 HF-RLLKRLGCGDIGSVYLSE----LSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET--EK 289 (611)
Q Consensus 217 ~y-~l~~~LG~G~fG~Vy~a~----~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~--~~ 289 (611)
+| ++++.||.|+||+||++. ...++..||+|++..... ......+.+|+++|+.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK 81 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence 45 999999999999998865 345678999999875432 1233456789999999999999999998765 45
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
.+|+||||+++++|.+++... .+++..++.++.|++.||+|||++||+||||||+|||++.++.++|+|||++..+.
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred eEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccC
Confidence 689999999999999998764 49999999999999999999999999999999999999999999999999984332
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
...... .
T Consensus 159 ~~~~~~-------------------------------------------------------------------------~ 165 (283)
T cd05080 159 EGHEYY-------------------------------------------------------------------------R 165 (283)
T ss_pred Ccchhh-------------------------------------------------------------------------c
Confidence 100000 0
Q ss_pred cccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcH--------------HHHHHHHcCCCCCCC
Q 007260 450 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNR--------------ATLFNVVGQPLRFPE 515 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~--------------~~l~~i~~~~l~~p~ 515 (611)
......++..|+|||++.+..++.++|||||||++|||++|..||...... ..+...+......+.
T Consensus 166 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (283)
T cd05080 166 VREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPC 245 (283)
T ss_pred cCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCCC
Confidence 000112566799999999888999999999999999999999998653221 111112222233333
Q ss_pred CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 516 SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 516 ~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
...++.++++||..||..||.+||+ +.++++
T Consensus 246 ~~~~~~~~~~li~~cl~~~p~~Rps----~~~i~~ 276 (283)
T cd05080 246 PKNCPQEVYILMKNCWETEAKFRPT----FRSLIP 276 (283)
T ss_pred CCCCCHHHHHHHHHHhccChhhCCC----HHHHHH
Confidence 4557899999999999999999999 677664
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=327.55 Aligned_cols=250 Identities=21% Similarity=0.324 Sum_probs=206.0
Q ss_pred cccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeE
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCL 293 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~L 293 (611)
..++|++.+.||.|+||.||++.+.. +..||+|++..... ....+.+|+.+++.++|+||+++++++.. ...|+
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 77 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYI 77 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecC-CccEEEEecCCChh----HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEE
Confidence 35789999999999999999998654 44699998875432 23456789999999999999999999887 77899
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcc
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 373 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~ 373 (611)
||||+++++|.+++....+..+++..+..++.||+.||.|||..||+||||||+||+++.++.+||+|||++..+.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 99999999999999886666789999999999999999999999999999999999999999999999998843211000
Q ss_pred ccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccc
Q 007260 374 LIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMS 453 (611)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (611)
.....
T Consensus 158 ---------------------------------------------------------------------------~~~~~ 162 (260)
T cd05073 158 ---------------------------------------------------------------------------TAREG 162 (260)
T ss_pred ---------------------------------------------------------------------------ccccC
Confidence 00001
Q ss_pred cccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007260 454 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLV 532 (611)
Q Consensus 454 ~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~ 532 (611)
..++..|+|||++.+..++.++|||||||++|+|++ |+.||.+.+.......+.. ....+.....+.++.++|.+||.
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~ 241 (260)
T cd05073 163 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER-GYRMPRPENCPEELYNIMMRCWK 241 (260)
T ss_pred CcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC-CCCCCCcccCCHHHHHHHHHHcc
Confidence 135677999999998889999999999999999998 9999998766655554443 33444445688999999999999
Q ss_pred cCccccCCchhcHHHHH
Q 007260 533 KEPQHRLAYKRGATEIK 549 (611)
Q Consensus 533 ~dP~~Rpt~~~~a~elL 549 (611)
.||++||+ +.+++
T Consensus 242 ~~p~~Rp~----~~~l~ 254 (260)
T cd05073 242 NRPEERPT----FEYIQ 254 (260)
T ss_pred cCcccCcC----HHHHH
Confidence 99999999 55554
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=335.70 Aligned_cols=255 Identities=23% Similarity=0.315 Sum_probs=203.7
Q ss_pred cCeEEEeEecccCcEEEEEEEE----CCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecc--c
Q 007260 216 SHFRLLKRLGCGDIGSVYLSEL----SGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE--K 289 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~----~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~--~ 289 (611)
..|++++.||+|+||.||+|+. ..++..||+|.++... .......+.+|+.+|+.++||||+++++++... .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence 3588999999999999999984 4568899999986543 223445678999999999999999999998764 6
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
..||||||++|++|.+++.+.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+.
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence 7899999999999999987653 358999999999999999999999999999999999999999999999999984432
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
..... ..
T Consensus 161 ~~~~~-------------------------------------------------------------------------~~ 167 (284)
T cd05079 161 TDKEY-------------------------------------------------------------------------YT 167 (284)
T ss_pred cCccc-------------------------------------------------------------------------ee
Confidence 11000 00
Q ss_pred cccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC--------------CcHHHHHHHHcCCCCCCC
Q 007260 450 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGS--------------GNRATLFNVVGQPLRFPE 515 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~--------------~~~~~l~~i~~~~l~~p~ 515 (611)
......|+..|+|||++.+..++.++|||||||++|||++++.|+... .........+......+.
T Consensus 168 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (284)
T cd05079 168 VKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPR 247 (284)
T ss_pred ecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCccCCC
Confidence 001234777899999999888999999999999999999987765321 111222233333344555
Q ss_pred CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 516 SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 516 ~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
...++..+.+||.+||..||++||+ +.++++
T Consensus 248 ~~~~~~~~~~li~~~l~~~p~~Rpt----~~~il~ 278 (284)
T cd05079 248 PPNCPEEVYQLMRKCWEFQPSKRTT----FQNLIE 278 (284)
T ss_pred CCCCCHHHHHHHHHHccCCcccCcC----HHHHHH
Confidence 5568999999999999999999999 788876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=336.12 Aligned_cols=255 Identities=21% Similarity=0.328 Sum_probs=203.8
Q ss_pred cCeEEEeEecccCcEEEEEEEECC----------------CCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcc
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSG----------------TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLP 279 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~----------------t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv 279 (611)
++|++.+.||.|+||.||++++.. ++..||+|++.... .......+.+|+.+|+.++|+||+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcc
Confidence 579999999999999999996543 35579999987542 223344677899999999999999
Q ss_pred cccceeeccceeeEEeeeCCCCCHHHHHHhCCC---------CCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEE
Q 007260 280 TLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPG---------KYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVL 350 (611)
Q Consensus 280 ~l~~~~~~~~~~~LVmE~~~gg~L~~ll~~~~~---------~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNIL 350 (611)
++++++..++..|+||||+++++|.+++..... ..+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil 162 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL 162 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence 999999999999999999999999998876421 24778889999999999999999999999999999999
Q ss_pred EccCCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCcc
Q 007260 351 VREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKN 430 (611)
Q Consensus 351 v~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 430 (611)
++.++.++|+|||++..+.....
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~--------------------------------------------------------- 185 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDY--------------------------------------------------------- 185 (296)
T ss_pred EcCCCCEEeccCcccccccCCcc---------------------------------------------------------
Confidence 99999999999999843311000
Q ss_pred ccCCCCCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh--CCCCCCCCCcHHHHHHHH-
Q 007260 431 EIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF--GKTPFKGSGNRATLFNVV- 507 (611)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt--G~~PF~~~~~~~~l~~i~- 507 (611)
........+++.|++||++.+..++.++|||||||++|||++ |..||......+.+.+..
T Consensus 186 -----------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~ 248 (296)
T cd05095 186 -----------------YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGE 248 (296)
T ss_pred -----------------eeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHH
Confidence 000011235678999999998889999999999999999998 789998766555443321
Q ss_pred -----cCCCCCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 508 -----GQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 508 -----~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
.....++....++..+.+||..||..||.+||+ +.+|++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~----~~~i~~ 292 (296)
T cd05095 249 FFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPS----FQEIHA 292 (296)
T ss_pred HHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCC----HHHHHH
Confidence 122334445568899999999999999999999 666653
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=338.58 Aligned_cols=256 Identities=21% Similarity=0.289 Sum_probs=205.6
Q ss_pred cccCeEEEeEecccCcEEEEEEEECC-------CCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCccccccee
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSG-------TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHF 285 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~-------t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~ 285 (611)
..++|.+++.||+|+||.||+|++.. ....||+|++..... ......+..|+.+++.+ +||||+++++++
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT--DKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC--hHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 34689999999999999999998642 345799999875432 23345677899999999 699999999999
Q ss_pred eccceeeEEeeeCCCCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEE
Q 007260 286 ETEKFSCLVMEFCPGGDLHTLRQKQP--------------GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLV 351 (611)
Q Consensus 286 ~~~~~~~LVmE~~~gg~L~~ll~~~~--------------~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv 351 (611)
...+.+|+||||+++|+|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 167 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV 167 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence 99999999999999999999987642 2358899999999999999999999999999999999999
Q ss_pred ccCCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccc
Q 007260 352 REDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNE 431 (611)
Q Consensus 352 ~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (611)
+.++.+||+|||++.........
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~--------------------------------------------------------- 190 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYY--------------------------------------------------------- 190 (314)
T ss_pred cCCCcEEEccccccccccccccc---------------------------------------------------------
Confidence 99999999999998433210000
Q ss_pred cCCCCCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCC
Q 007260 432 IGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQP 510 (611)
Q Consensus 432 ~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~ 510 (611)
.......++..|+|||++.+..++.++|||||||++|||++ |..||.+......+..+.. .
T Consensus 191 -----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~ 252 (314)
T cd05099 191 -----------------KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLRE-G 252 (314)
T ss_pred -----------------cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-C
Confidence 00001124567999999999889999999999999999998 9999987765554444433 3
Q ss_pred CCCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 511 LRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 511 l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
........++.++++||.+||..||.+||+ +.++++
T Consensus 253 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps----~~~ll~ 288 (314)
T cd05099 253 HRMDKPSNCTHELYMLMRECWHAVPTQRPT----FKQLVE 288 (314)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCcccCcC----HHHHHH
Confidence 333333458899999999999999999999 677665
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=326.05 Aligned_cols=251 Identities=24% Similarity=0.368 Sum_probs=206.3
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
..+|++.+.||.|+||.||+|.+.. +..+|+|++....... ..+.+|+++++.++||||+++++++......|+|
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAMSE----EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCCCH----HHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence 4589999999999999999998864 5679999987654332 2456799999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
|||+.+++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-- 154 (256)
T cd05112 78 FEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-- 154 (256)
T ss_pred EEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCc--
Confidence 99999999999887653 458999999999999999999999999999999999999999999999999874321000
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
.......
T Consensus 155 -------------------------------------------------------------------------~~~~~~~ 161 (256)
T cd05112 155 -------------------------------------------------------------------------YTSSTGT 161 (256)
T ss_pred -------------------------------------------------------------------------ccccCCC
Confidence 0000112
Q ss_pred ccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007260 455 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVK 533 (611)
Q Consensus 455 vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~ 533 (611)
.++..|+|||++.+..++.++|||||||++|||++ |+.||........+..+... .........+.++.+|+.+||..
T Consensus 162 ~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~l~~ 240 (256)
T cd05112 162 KFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG-FRLYKPRLASQSVYELMQHCWKE 240 (256)
T ss_pred ccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCC-CCCCCCCCCCHHHHHHHHHHccc
Confidence 35678999999999889999999999999999998 99999877666555554332 22222344789999999999999
Q ss_pred CccccCCchhcHHHHHcC
Q 007260 534 EPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 534 dP~~Rpt~~~~a~elL~H 551 (611)
+|++||+ +.+++++
T Consensus 241 ~p~~Rp~----~~~~l~~ 254 (256)
T cd05112 241 RPEDRPS----FSLLLHQ 254 (256)
T ss_pred ChhhCCC----HHHHHHh
Confidence 9999999 8888763
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=331.94 Aligned_cols=254 Identities=31% Similarity=0.481 Sum_probs=209.1
Q ss_pred eEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEeee
Q 007260 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEF 297 (611)
Q Consensus 218 y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE~ 297 (611)
|++.+.||.|+||.||+|++..+++.||+|++.... ........+..|+.+++.++|+||+++++++......|+||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 677899999999999999999999999999997653 2223334567799999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccccc
Q 007260 298 CPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKA 377 (611)
Q Consensus 298 ~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~ 377 (611)
++ ++|.+++.+.. ..+++..++.++.|++.||.|||.+||+||||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~----- 152 (282)
T cd07829 80 CD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL----- 152 (282)
T ss_pred cC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc-----
Confidence 96 59999988753 469999999999999999999999999999999999999999999999999873321000
Q ss_pred ccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccC
Q 007260 378 SSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGT 457 (611)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT 457 (611)
.......++
T Consensus 153 -----------------------------------------------------------------------~~~~~~~~~ 161 (282)
T cd07829 153 -----------------------------------------------------------------------RTYTHEVVT 161 (282)
T ss_pred -----------------------------------------------------------------------cccCccccC
Confidence 000122467
Q ss_pred CCccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcC------------------CCCCCC---
Q 007260 458 HEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ------------------PLRFPE--- 515 (611)
Q Consensus 458 ~~Y~APEil~~~-~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~------------------~l~~p~--- 515 (611)
..|+|||++.+. .++.++|||||||++|||++|++||.+......+.++... ...++.
T Consensus 162 ~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (282)
T cd07829 162 LWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPP 241 (282)
T ss_pred cCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCc
Confidence 889999999877 7899999999999999999999999887765554443321 001111
Q ss_pred ------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCC
Q 007260 516 ------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 516 ------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f 554 (611)
.+.++..+.++|.+||..||.+||+ +.+++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~----~~~~l~~p~~ 282 (282)
T cd07829 242 KDLEKVLPRLDPEGIDLLSKMLQYNPAKRIS----AKEALKHPYF 282 (282)
T ss_pred cchHHhcccccHHHHHHHHHhhccCcccCCC----HHHHhhCcCC
Confidence 1235778999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=333.16 Aligned_cols=255 Identities=21% Similarity=0.323 Sum_probs=206.5
Q ss_pred ccCeEEEeEecccCcEEEEEEEECC-----CCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSG-----TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK 289 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~-----t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~ 289 (611)
..+|++++.||.|+||.||+|.+.+ ++..||||++..... ......+.+|+.+++.++||||+++++++..+.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC--HHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 4589999999999999999999753 678899999875432 223345778999999999999999999999999
Q ss_pred eeeEEeeeCCCCCHHHHHHhCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcE
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQP--------------------GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENV 349 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~--------------------~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNI 349 (611)
..|+||||+++++|.+++.... ...+++..+..++.||+.||+|||.+||+||||||+||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni 161 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC 161 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence 9999999999999999987431 12478889999999999999999999999999999999
Q ss_pred EEccCCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCc
Q 007260 350 LVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPK 429 (611)
Q Consensus 350 Lv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 429 (611)
|++.++.++|+|||++..+.....
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~-------------------------------------------------------- 185 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADY-------------------------------------------------------- 185 (288)
T ss_pred EecCCCceEECccccceecccCcc--------------------------------------------------------
Confidence 999999999999998743210000
Q ss_pred cccCCCCCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHc
Q 007260 430 NEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVG 508 (611)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~ 508 (611)
........++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+.+..+..
T Consensus 186 ------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~ 247 (288)
T cd05050 186 ------------------YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRD 247 (288)
T ss_pred ------------------ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Confidence 000001124567999999999999999999999999999997 8999988776666655554
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 509 QPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 509 ~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
... ++....++.++.+||.+||..||++||+ +.||++
T Consensus 248 ~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt----~~el~~ 284 (288)
T cd05050 248 GNV-LSCPDNCPLELYNLMRLCWSKLPSDRPS----FASINR 284 (288)
T ss_pred CCC-CCCCCCCCHHHHHHHHHHcccCcccCCC----HHHHHH
Confidence 432 2333458899999999999999999999 667654
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=327.62 Aligned_cols=246 Identities=23% Similarity=0.315 Sum_probs=202.8
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSC 292 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~ 292 (611)
+.+++|++.+.||.|+||.||++.. +++.||+|++.... ....+.+|+.+++.++||||+++++++..+ ..|
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 74 (254)
T cd05083 3 LNLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLY 74 (254)
T ss_pred ccHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcE
Confidence 3457899999999999999999864 56679999986532 123567899999999999999999998765 479
Q ss_pred EEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCc
Q 007260 293 LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 293 LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~ 372 (611)
+||||+++++|.+++.......+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~- 153 (254)
T cd05083 75 IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG- 153 (254)
T ss_pred EEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc-
Confidence 9999999999999998765567899999999999999999999999999999999999999999999999987321100
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
..
T Consensus 154 ------------------------------------------------------------------------------~~ 155 (254)
T cd05083 154 ------------------------------------------------------------------------------VD 155 (254)
T ss_pred ------------------------------------------------------------------------------CC
Confidence 00
Q ss_pred ccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 007260 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLL 531 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L 531 (611)
...++..|+|||++.+..++.++|||||||++|||++ |++||...........+. .....+....++..+.+||.+||
T Consensus 156 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l 234 (254)
T cd05083 156 NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-KGYRMEPPEGCPADVYVLMTSCW 234 (254)
T ss_pred CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHHc
Confidence 1123457999999998899999999999999999997 999998876655444433 33444444568899999999999
Q ss_pred hcCccccCCchhcHHHHHc
Q 007260 532 VKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 532 ~~dP~~Rpt~~~~a~elL~ 550 (611)
..+|++||+ +.+++.
T Consensus 235 ~~~p~~Rp~----~~~l~~ 249 (254)
T cd05083 235 ETEPKKRPS----FHKLRE 249 (254)
T ss_pred CCChhhCcC----HHHHHH
Confidence 999999999 666654
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=329.86 Aligned_cols=254 Identities=20% Similarity=0.302 Sum_probs=206.5
Q ss_pred cccCeEEEeEecccCcEEEEEEEECCCCe----EEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSGTKC----YFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK 289 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~----~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~ 289 (611)
...+|++++.||.|+||.||+|.+..++. .||+|++.+... ......+.+|+.+|+.++||||+++++++.. .
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 81 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-S 81 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence 34689999999999999999999876554 689998876542 3344567789999999999999999999887 7
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
..|+||||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 8899999999999999887653 458999999999999999999999999999999999999999999999999984432
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
......
T Consensus 161 ~~~~~~-------------------------------------------------------------------------- 166 (279)
T cd05057 161 VDEKEY-------------------------------------------------------------------------- 166 (279)
T ss_pred Ccccce--------------------------------------------------------------------------
Confidence 110000
Q ss_pred cccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 007260 450 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIR 528 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~ 528 (611)
......++..|+|||.+....++.++|||||||++|||++ |+.||.+....+.. ..+.....++.....+..+.++|.
T Consensus 167 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 245 (279)
T cd05057 167 HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP-DLLEKGERLPQPPICTIDVYMVLV 245 (279)
T ss_pred ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHH-HHHhCCCCCCCCCCCCHHHHHHHH
Confidence 0000124568999999998889999999999999999998 99999887554443 333343444555568899999999
Q ss_pred HhhhcCccccCCchhcHHHHHc
Q 007260 529 GLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 529 ~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
+||..||.+||+ +.++++
T Consensus 246 ~~l~~~p~~Rp~----~~~l~~ 263 (279)
T cd05057 246 KCWMIDAESRPT----FKELIN 263 (279)
T ss_pred HHcCCChhhCCC----HHHHHH
Confidence 999999999999 555553
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=341.49 Aligned_cols=258 Identities=21% Similarity=0.304 Sum_probs=207.3
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCC-------CeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccce
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGT-------KCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTH 284 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t-------~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~ 284 (611)
+...+|++++.||+|+||.||+|++... ...||+|++.... .......+.+|+++++++ +||||++++++
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 4446899999999999999999986432 3478999886432 223345678899999999 89999999999
Q ss_pred eeccceeeEEeeeCCCCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEE
Q 007260 285 FETEKFSCLVMEFCPGGDLHTLRQKQP--------------GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVL 350 (611)
Q Consensus 285 ~~~~~~~~LVmE~~~gg~L~~ll~~~~--------------~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNIL 350 (611)
+..++.+|+||||+++|+|.+++.+.. ...++...+..++.||+.||+|||.+||+||||||+|||
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil 166 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVL 166 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEE
Confidence 999999999999999999999987532 234778889999999999999999999999999999999
Q ss_pred EccCCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCcc
Q 007260 351 VREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKN 430 (611)
Q Consensus 351 v~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 430 (611)
++.++.+||+|||+++........
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~-------------------------------------------------------- 190 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHNIDYY-------------------------------------------------------- 190 (334)
T ss_pred EcCCCcEEECCcccceeccccccc--------------------------------------------------------
Confidence 999999999999998433210000
Q ss_pred ccCCCCCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcC
Q 007260 431 EIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQ 509 (611)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~ 509 (611)
.......++..|+|||++.+..++.++|||||||+||||++ |..||.+....+.+..+. .
T Consensus 191 ------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~ 251 (334)
T cd05100 191 ------------------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK-E 251 (334)
T ss_pred ------------------ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-c
Confidence 00001124567999999999999999999999999999998 899998876555544443 3
Q ss_pred CCCCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcC
Q 007260 510 PLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 510 ~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~H 551 (611)
....+....++.++.+||.+||..+|.+||+ +.+++++
T Consensus 252 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps----~~ell~~ 289 (334)
T cd05100 252 GHRMDKPANCTHELYMIMRECWHAVPSQRPT----FKQLVED 289 (334)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcccChhhCcC----HHHHHHH
Confidence 3344444568899999999999999999999 7777764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=329.66 Aligned_cols=256 Identities=17% Similarity=0.225 Sum_probs=208.4
Q ss_pred cccCeEEEeEecccCcEEEEEEEECC----CCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec-c
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSG----TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET-E 288 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~----t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~-~ 288 (611)
..++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+|+.++|+||+++++++.. .
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 34689999999999999999999876 36789999886432 23345567889999999999999999998665 5
Q ss_pred ceeeEEeeeCCCCCHHHHHHhCCC------CCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEec
Q 007260 289 KFSCLVMEFCPGGDLHTLRQKQPG------KYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDF 362 (611)
Q Consensus 289 ~~~~LVmE~~~gg~L~~ll~~~~~------~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DF 362 (611)
...++++||+++++|.+++..... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCC
Confidence 788999999999999998876422 45899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCccc
Q 007260 363 DLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPEL 442 (611)
Q Consensus 363 GlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (611)
|+++.+.......
T Consensus 162 g~~~~~~~~~~~~------------------------------------------------------------------- 174 (280)
T cd05043 162 ALSRDLFPMDYHC------------------------------------------------------------------- 174 (280)
T ss_pred CCcccccCCceEE-------------------------------------------------------------------
Confidence 9985432110000
Q ss_pred ccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCH
Q 007260 443 IAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSF 521 (611)
Q Consensus 443 ~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~ 521 (611)
......++..|+|||++.+..++.++|||||||++|||++ |++||....... +...+.....++....+++
T Consensus 175 -------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 246 (280)
T cd05043 175 -------LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE-MAAYLKDGYRLAQPINCPD 246 (280)
T ss_pred -------eCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH-HHHHHHcCCCCCCCCcCCH
Confidence 0001236678999999999999999999999999999998 999998765544 4444444445555556899
Q ss_pred HHHHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 522 AARDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 522 ~l~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
++.++|.+||..||++||+ +.++++
T Consensus 247 ~~~~li~~~l~~~p~~Rps----~~~~~~ 271 (280)
T cd05043 247 ELFAVMACCWALDPEERPS----FSQLVQ 271 (280)
T ss_pred HHHHHHHHHcCCChhhCCC----HHHHHH
Confidence 9999999999999999999 677664
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=341.85 Aligned_cols=256 Identities=28% Similarity=0.418 Sum_probs=206.9
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec-ccee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET-EKFS 291 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~-~~~~ 291 (611)
...++|++++.||.|+||.||+|.+..+++.||||++.+.... ......+.+|+++++.++||||++++++|.. ....
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST-PVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 3457899999999999999999999999999999988654221 2233456789999999999999999999875 5688
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCC
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~ 371 (611)
|+||||+ +++|..++.. ..+++..+..++.||+.||.|||++||+||||||.|||++.++.++|+|||++....
T Consensus 86 ~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~-- 159 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQD-- 159 (328)
T ss_pred EEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccC--
Confidence 9999999 6789888764 348899999999999999999999999999999999999999999999999873211
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
...
T Consensus 160 -----------------------------------------------------------------------------~~~ 162 (328)
T cd07856 160 -----------------------------------------------------------------------------PQM 162 (328)
T ss_pred -----------------------------------------------------------------------------CCc
Confidence 001
Q ss_pred cccccCCCccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH---HHHcCC-----------------
Q 007260 452 MSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLF---NVVGQP----------------- 510 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~-~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~---~i~~~~----------------- 510 (611)
...+|++.|+|||++.+ ..++.++|||||||++|+|++|++||.+........ ++.+.+
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd07856 163 TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFV 242 (328)
T ss_pred CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHH
Confidence 12357889999999876 568999999999999999999999998765432211 111110
Q ss_pred ------CCCCC---CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCC
Q 007260 511 ------LRFPE---SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 511 ------l~~p~---~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
...+. ...++..++++|.+||..+|++||+ +.+++.||||..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t----~~ell~~~~~~~ 293 (328)
T cd07856 243 QSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRIS----AAEALAHPYLAP 293 (328)
T ss_pred hhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCC----HHHHhcCCcccc
Confidence 01111 1347889999999999999999999 999999999963
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=323.73 Aligned_cols=251 Identities=27% Similarity=0.393 Sum_probs=208.6
Q ss_pred eEEEeEecccCcEEEEEEEECCCC----eEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeE
Q 007260 218 FRLLKRLGCGDIGSVYLSELSGTK----CYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCL 293 (611)
Q Consensus 218 y~l~~~LG~G~fG~Vy~a~~~~t~----~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~L 293 (611)
+.+.+.||.|+||.||+|++...+ ..||+|++...... .....+..|+.+|+.++|+||+++++++.+.+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE--QQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh--HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 356789999999999999998766 89999999655322 244567889999999999999999999999999999
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcc
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 373 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~ 373 (611)
||||+++++|.+++.......+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 99999999999998875433389999999999999999999999999999999999999999999999999843321100
Q ss_pred ccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccc
Q 007260 374 LIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMS 453 (611)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (611)
.....
T Consensus 159 ---------------------------------------------------------------------------~~~~~ 163 (258)
T smart00219 159 ---------------------------------------------------------------------------YKKKG 163 (258)
T ss_pred ---------------------------------------------------------------------------ccccc
Confidence 00000
Q ss_pred cccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007260 454 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLV 532 (611)
Q Consensus 454 ~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~ 532 (611)
..+++.|+|||.+.+..++.++|||||||++|+|++ |++||........+..+.... ..+....++.++.++|.+||.
T Consensus 164 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~ 242 (258)
T smart00219 164 GKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGY-RLPKPENCPPEIYKLMLQCWA 242 (258)
T ss_pred CCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-CCCCCCcCCHHHHHHHHHHCc
Confidence 126788999999988889999999999999999998 899998876666655555443 333344589999999999999
Q ss_pred cCccccCCchhcHHHHHc
Q 007260 533 KEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 533 ~dP~~Rpt~~~~a~elL~ 550 (611)
.||++||+ +.++++
T Consensus 243 ~~p~~Rpt----~~~ll~ 256 (258)
T smart00219 243 EDPEDRPT----FSELVE 256 (258)
T ss_pred CChhhCcC----HHHHHh
Confidence 99999999 888875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=357.72 Aligned_cols=262 Identities=25% Similarity=0.384 Sum_probs=224.5
Q ss_pred HHhhccCccccccCeEEEeEecccCcEEEEEEEECCCC----eEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcc
Q 007260 204 QAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTK----CYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLP 279 (611)
Q Consensus 204 ~~~~~~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~----~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv 279 (611)
.++..+.+++.-++-.+.++||+|+||.||+|+....+ ..||+|.+.......+..+..+.+|+++|+.++|||||
T Consensus 145 ~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVV 224 (474)
T KOG0194|consen 145 RPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVV 224 (474)
T ss_pred ccccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEE
Confidence 45555666777778888899999999999999986542 23899998754545677888899999999999999999
Q ss_pred cccceeeccceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEE
Q 007260 280 TLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIML 359 (611)
Q Consensus 280 ~l~~~~~~~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL 359 (611)
++||+...+..+|||||+|.||+|.+++++.++ .++..+...++.+.+.||+|||++++|||||-..|+|++.++.+||
T Consensus 225 r~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKI 303 (474)
T KOG0194|consen 225 RFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKI 303 (474)
T ss_pred EEEEEEcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEe
Confidence 999999999999999999999999999999753 6999999999999999999999999999999999999999999999
Q ss_pred EeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCC
Q 007260 360 SDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPL 439 (611)
Q Consensus 360 ~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (611)
+||||++... .|.....
T Consensus 304 SDFGLs~~~~--------------------~~~~~~~------------------------------------------- 320 (474)
T KOG0194|consen 304 SDFGLSRAGS--------------------QYVMKKF------------------------------------------- 320 (474)
T ss_pred CccccccCCc--------------------ceeeccc-------------------------------------------
Confidence 9999984321 0000000
Q ss_pred cccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCC
Q 007260 440 PELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPV 518 (611)
Q Consensus 440 ~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~ 518 (611)
..--...|+|||.+...-|+.++|||||||++||+++ |..||.+....+...+|+....+.+.+..
T Consensus 321 -------------~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~ 387 (474)
T KOG0194|consen 321 -------------LKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSK 387 (474)
T ss_pred -------------cccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCC
Confidence 0012346999999999999999999999999999997 89999999999888888888888887778
Q ss_pred CCHHHHHHHHHhhhcCccccCCch
Q 007260 519 VSFAARDLIRGLLVKEPQHRLAYK 542 (611)
Q Consensus 519 ~s~~l~dLI~~~L~~dP~~Rpt~~ 542 (611)
.+.++..++..||..||++|+++.
T Consensus 388 ~p~~~~~~~~~c~~~~p~~R~tm~ 411 (474)
T KOG0194|consen 388 TPKELAKVMKQCWKKDPEDRPTMS 411 (474)
T ss_pred CHHHHHHHHHHhccCChhhccCHH
Confidence 999999999999999999999943
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=321.59 Aligned_cols=245 Identities=24% Similarity=0.340 Sum_probs=200.0
Q ss_pred eEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEeeeCCCC
Q 007260 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGG 301 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE~~~gg 301 (611)
+.||.|+||.||+|.+. .+..||+|++..... ......+.+|+++++.++||||+++++++...+..|+||||++++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLP--QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 36899999999999865 577899999875432 223345778999999999999999999999999999999999999
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccccCC
Q 007260 302 DLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLD 381 (611)
Q Consensus 302 ~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~ 381 (611)
+|.+++.... ..+++..+..++.|++.||.|||.+|++||||||+||+++.++.++|+|||++........
T Consensus 78 ~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-------- 148 (250)
T cd05085 78 DFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-------- 148 (250)
T ss_pred cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccc--------
Confidence 9999887643 4589999999999999999999999999999999999999999999999998743210000
Q ss_pred CCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCcc
Q 007260 382 AEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYL 461 (611)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~ 461 (611)
.......+++.|+
T Consensus 149 -------------------------------------------------------------------~~~~~~~~~~~y~ 161 (250)
T cd05085 149 -------------------------------------------------------------------SSSGLKQIPIKWT 161 (250)
T ss_pred -------------------------------------------------------------------ccCCCCCCccccc
Confidence 0000112456799
Q ss_pred chhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccCC
Q 007260 462 APEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLA 540 (611)
Q Consensus 462 APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt 540 (611)
|||++.+..++.++|||||||++|+|++ |..||.+.........+... ........++..+.+||.+||..+|++||+
T Consensus 162 aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~ 240 (250)
T cd05085 162 APEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG-YRMSCPQKCPDDVYKVMQRCWDYKPENRPK 240 (250)
T ss_pred CHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHcccCcccCCC
Confidence 9999998889999999999999999998 99999887666555554433 333334458899999999999999999999
Q ss_pred chhcHHHHHc
Q 007260 541 YKRGATEIKQ 550 (611)
Q Consensus 541 ~~~~a~elL~ 550 (611)
+.++++
T Consensus 241 ----~~~l~~ 246 (250)
T cd05085 241 ----FSELQK 246 (250)
T ss_pred ----HHHHHH
Confidence 666654
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=329.40 Aligned_cols=251 Identities=30% Similarity=0.458 Sum_probs=201.4
Q ss_pred EEEeEecccCcEEEEEEEEC----CCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 219 RLLKRLGCGDIGSVYLSELS----GTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 219 ~l~~~LG~G~fG~Vy~a~~~----~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
.+.+.||.|.||.||+|.+. ..+..|+||++... ........+.+|+++|++++||||+++++++...+..++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence 46789999999999999988 45778999999542 2223356778899999999999999999999988889999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
||||++|+|.+++.......+++..+..++.||+.||.|||+++|+|+||++.||||+.++.+||+|||++.........
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999998875567999999999999999999999999999999999999999999999999998433100000
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
......
T Consensus 160 --------------------------------------------------------------------------~~~~~~ 165 (259)
T PF07714_consen 160 --------------------------------------------------------------------------KNDSSQ 165 (259)
T ss_dssp --------------------------------------------------------------------------EESTTS
T ss_pred --------------------------------------------------------------------------cccccc
Confidence 000112
Q ss_pred ccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007260 455 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVK 533 (611)
Q Consensus 455 vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~ 533 (611)
.+...|+|||++.+..++.++||||||+++|||++ |+.||...........+ ......+....++..+.+||..||..
T Consensus 166 ~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~C~~~ 244 (259)
T PF07714_consen 166 QLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-KQGQRLPIPDNCPKDIYSLIQQCWSH 244 (259)
T ss_dssp ESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-HTTEETTSBTTSBHHHHHHHHHHT-S
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccceeccchhHHHHHHHHHHcCC
Confidence 36678999999999999999999999999999999 78999988776666666 44444445556899999999999999
Q ss_pred CccccCCchhcHHHHHc
Q 007260 534 EPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 534 dP~~Rpt~~~~a~elL~ 550 (611)
||++||+ +.+|++
T Consensus 245 ~p~~RPs----~~~i~~ 257 (259)
T PF07714_consen 245 DPEKRPS----FQEILQ 257 (259)
T ss_dssp SGGGS------HHHHHH
T ss_pred ChhhCcC----HHHHHh
Confidence 9999999 777664
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=323.01 Aligned_cols=246 Identities=26% Similarity=0.358 Sum_probs=202.6
Q ss_pred eEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEeeeCCCC
Q 007260 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGG 301 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE~~~gg 301 (611)
++||.|+||.||+|.+.. ++.||+|++...... +....+.+|+++++.++|+||+++++++......|+||||++|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 479999999999999988 889999998765432 34456788999999999999999999999999999999999999
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccccCC
Q 007260 302 DLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLD 381 (611)
Q Consensus 302 ~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~ 381 (611)
+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++.........
T Consensus 78 ~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~------- 149 (251)
T cd05041 78 SLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT------- 149 (251)
T ss_pred cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcce-------
Confidence 9999887643 46889999999999999999999999999999999999999999999999998432100000
Q ss_pred CCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCcc
Q 007260 382 AEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYL 461 (611)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~ 461 (611)
.......++..|+
T Consensus 150 -------------------------------------------------------------------~~~~~~~~~~~y~ 162 (251)
T cd05041 150 -------------------------------------------------------------------VSDGLKQIPIKWT 162 (251)
T ss_pred -------------------------------------------------------------------eccccCcceeccC
Confidence 0000112456799
Q ss_pred chhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccCC
Q 007260 462 APEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLA 540 (611)
Q Consensus 462 APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt 540 (611)
|||++.+..++.++|||||||++|||++ |..||...........+.. ....+....++.++.+||.+||..+|++||+
T Consensus 163 ~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~ 241 (251)
T cd05041 163 APEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIES-GYRMPAPQLCPEEIYRLMLQCWAYDPENRPS 241 (251)
T ss_pred ChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhc-CCCCCCCccCCHHHHHHHHHHhccChhhCcC
Confidence 9999998899999999999999999998 8999988766554444433 3334444568899999999999999999999
Q ss_pred chhcHHHHHc
Q 007260 541 YKRGATEIKQ 550 (611)
Q Consensus 541 ~~~~a~elL~ 550 (611)
+.++++
T Consensus 242 ----~~ell~ 247 (251)
T cd05041 242 ----FSEIYN 247 (251)
T ss_pred ----HHHHHH
Confidence 888875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=330.12 Aligned_cols=239 Identities=21% Similarity=0.272 Sum_probs=193.1
Q ss_pred eEecccCcEEEEEEEECCCCe-------EEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 222 KRLGCGDIGSVYLSELSGTKC-------YFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~~~t~~-------~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
+.||.|+||.||+|.+...+. .||+|++.... ......+..|+.+|+.++||||+++++++..+...++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 368999999999999865543 38888876543 23344667899999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCc--------EEEEeccccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGH--------IMLSDFDLSL 366 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~--------vkL~DFGlA~ 366 (611)
|||+++|+|..++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++. ++|+|||++.
T Consensus 78 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 78 QEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred EecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999999999987653 46899999999999999999999999999999999999987765 6899999862
Q ss_pred cccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCc
Q 007260 367 RCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEP 446 (611)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (611)
...
T Consensus 157 ~~~----------------------------------------------------------------------------- 159 (258)
T cd05078 157 TVL----------------------------------------------------------------------------- 159 (258)
T ss_pred ccC-----------------------------------------------------------------------------
Confidence 211
Q ss_pred ccccccccccCCCccchhhhccC-CCCChhhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHH
Q 007260 447 TEARSMSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFG-KTPFKGSGNRATLFNVVGQPLRFPESPVVSFAAR 524 (611)
Q Consensus 447 ~~~~~~~~vGT~~Y~APEil~~~-~~~~~sDIWSLGviL~ELltG-~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~ 524 (611)
....+.|++.|+|||++.+. .++.++|||||||++|||++| .+||........ ..+......+|.. .+.++.
T Consensus 160 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~--~~~~~~ 233 (258)
T cd05078 160 ---PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-LQFYEDRHQLPAP--KWTELA 233 (258)
T ss_pred ---CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-HHHHHccccCCCC--CcHHHH
Confidence 00123578899999999874 478999999999999999998 566665544433 3334444444443 678899
Q ss_pred HHHHHhhhcCccccCCchhcHHHHHcC
Q 007260 525 DLIRGLLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 525 dLI~~~L~~dP~~Rpt~~~~a~elL~H 551 (611)
+||.+||+.||++||+ +++|++.
T Consensus 234 ~li~~~l~~~p~~Rps----~~~il~~ 256 (258)
T cd05078 234 NLINQCMDYEPDFRPS----FRAIIRD 256 (258)
T ss_pred HHHHHHhccChhhCCC----HHHHHHh
Confidence 9999999999999999 8888763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=326.36 Aligned_cols=233 Identities=33% Similarity=0.461 Sum_probs=191.1
Q ss_pred cCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEeeeCCCCCHHHH
Q 007260 227 GDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTL 306 (611)
Q Consensus 227 G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE~~~gg~L~~l 306 (611)
|.||.||+|++..+++.||+|.+.+... ..+|...+....||||+++++++...+..||||||++||+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 8999999999999999999999976531 12344455556799999999999999999999999999999998
Q ss_pred HHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccccCCCCcCc
Q 007260 307 RQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLR 386 (611)
Q Consensus 307 l~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~ 386 (611)
+.+. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 76 l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--------------- 138 (237)
T cd05576 76 ISKF--LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--------------- 138 (237)
T ss_pred HHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc---------------
Confidence 8765 35899999999999999999999999999999999999999999999999986322100
Q ss_pred CCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCccchhhh
Q 007260 387 KNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEII 466 (611)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil 466 (611)
.....++..|+|||++
T Consensus 139 ----------------------------------------------------------------~~~~~~~~~y~aPE~~ 154 (237)
T cd05576 139 ----------------------------------------------------------------CDGEAVENMYCAPEVG 154 (237)
T ss_pred ----------------------------------------------------------------cccCCcCccccCCccc
Confidence 0012356779999999
Q ss_pred ccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccCCch-hcH
Q 007260 467 KGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYK-RGA 545 (611)
Q Consensus 467 ~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~-~~a 545 (611)
.+..++.++|||||||++|||++|+.||........ ....+.+| ..++..+++||.+||..||++|++.. ..+
T Consensus 155 ~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~----~~~~~~~~--~~~~~~~~~li~~~l~~dp~~R~~~~~~~~ 228 (237)
T cd05576 155 GISEETEACDWWSLGAILFELLTGKTLVECHPSGIN----THTTLNIP--EWVSEEARSLLQQLLQFNPTERLGAGVAGV 228 (237)
T ss_pred CCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc----cccccCCc--ccCCHHHHHHHHHHccCCHHHhcCCCccch
Confidence 888899999999999999999999999865322100 01112233 34889999999999999999999842 235
Q ss_pred HHHHcCCCC
Q 007260 546 TEIKQHPFF 554 (611)
Q Consensus 546 ~elL~Hp~f 554 (611)
+++++||||
T Consensus 229 ~~~~~h~~~ 237 (237)
T cd05576 229 EDIKSHPFF 237 (237)
T ss_pred HHHHcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=327.72 Aligned_cols=245 Identities=23% Similarity=0.325 Sum_probs=197.5
Q ss_pred eEecccCcEEEEEEEECCCCe--EEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeeccceeeEEeeeC
Q 007260 222 KRLGCGDIGSVYLSELSGTKC--YFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEKFSCLVMEFC 298 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~~~t~~--~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~~~~~LVmE~~ 298 (611)
+.||.|+||.||+|++..++. .+|+|.+.... .......+.+|+++++++ +||||+++++++...+..|+||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 368999999999999987765 46888876432 223344677899999999 8999999999999999999999999
Q ss_pred CCCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccc
Q 007260 299 PGGDLHTLRQKQP--------------GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDL 364 (611)
Q Consensus 299 ~gg~L~~ll~~~~--------------~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGl 364 (611)
++++|.+++.... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999999987542 13578999999999999999999999999999999999999999999999998
Q ss_pred cccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCccccc
Q 007260 365 SLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIA 444 (611)
Q Consensus 365 A~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (611)
+......
T Consensus 159 ~~~~~~~------------------------------------------------------------------------- 165 (270)
T cd05047 159 SRGQEVY------------------------------------------------------------------------- 165 (270)
T ss_pred ccccchh-------------------------------------------------------------------------
Confidence 7211000
Q ss_pred CcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHH
Q 007260 445 EPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAA 523 (611)
Q Consensus 445 ~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l 523 (611)
.......++..|+|||++.+..++.++|||||||++|||++ |..||.+......+..+... ...+....++.++
T Consensus 166 ----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 240 (270)
T cd05047 166 ----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRLEKPLNCDDEV 240 (270)
T ss_pred ----hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC-CCCCCCCcCCHHH
Confidence 00000124567999999999899999999999999999996 99999877665555444332 3333344588999
Q ss_pred HHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 524 RDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 524 ~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
.+||.+||..||.+||+ +.++++
T Consensus 241 ~~li~~~l~~~p~~Rps----~~~il~ 263 (270)
T cd05047 241 YDLMRQCWREKPYERPS----FAQILV 263 (270)
T ss_pred HHHHHHHcccChhhCCC----HHHHHH
Confidence 99999999999999999 666654
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=324.83 Aligned_cols=252 Identities=25% Similarity=0.351 Sum_probs=205.1
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCC---CeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecccee
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGT---KCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFS 291 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t---~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~ 291 (611)
..+|.+.+.||.|+||.||+|.+... ...||||....... ......+.+|+.+++.++||||+++++++.+ ...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~ 81 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS--PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV 81 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence 45799999999999999999987543 45799998865431 2344567889999999999999999998875 457
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCC
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~ 371 (611)
|+||||+++++|.+++.... ..+++..+..++.||+.||+|||++|++||||||+|||++.++.++|+|||++..+...
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 89999999999999987643 45899999999999999999999999999999999999999999999999988432210
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
.. ...
T Consensus 161 ~~---------------------------------------------------------------------------~~~ 165 (270)
T cd05056 161 SY---------------------------------------------------------------------------YKA 165 (270)
T ss_pred cc---------------------------------------------------------------------------eec
Confidence 00 000
Q ss_pred cccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 007260 452 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGL 530 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~ 530 (611)
....++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+.+..+..+ ...+....++..+.+||.+|
T Consensus 166 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~ 244 (270)
T cd05056 166 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENG-ERLPMPPNCPPTLYSLMTKC 244 (270)
T ss_pred CCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-CcCCCCCCCCHHHHHHHHHH
Confidence 01124568999999998889999999999999999986 99999888776666554433 23344456899999999999
Q ss_pred hhcCccccCCchhcHHHHHc
Q 007260 531 LVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 531 L~~dP~~Rpt~~~~a~elL~ 550 (611)
|..+|.+||+ +.+++.
T Consensus 245 l~~~P~~Rpt----~~~~~~ 260 (270)
T cd05056 245 WAYDPSKRPR----FTELKA 260 (270)
T ss_pred cCCChhhCcC----HHHHHH
Confidence 9999999999 777665
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=322.75 Aligned_cols=266 Identities=24% Similarity=0.362 Sum_probs=212.3
Q ss_pred cccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecc---
Q 007260 212 VLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE--- 288 (611)
Q Consensus 212 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~--- 288 (611)
.+..++|++.++||.|||+.||+++...++..||+|.+.... .+....+++|++..++++||||++++++...+
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD 93 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence 345579999999999999999999999999999999987554 45566788999999999999999999987543
Q ss_pred --ceeeEEeeeCCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcC--eeccCCCCCcEEEccCCcEEEEec
Q 007260 289 --KFSCLVMEFCPGGDLHTLRQKQ--PGKYFPEQAVRFYVAEVLLALEYLHMLG--IIYRDLKPENVLVREDGHIMLSDF 362 (611)
Q Consensus 289 --~~~~LVmE~~~gg~L~~ll~~~--~~~~l~e~~~~~i~~qll~aL~yLH~~g--IVHRDLKPeNILv~~~g~vkL~DF 362 (611)
...||+++|...|+|.+.+++. .+..++|..+..|+.+|++||++||+.. +.||||||.|||+.+++.++|.||
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEec
Confidence 4589999999999999887643 3557999999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCccc
Q 007260 363 DLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPEL 442 (611)
Q Consensus 363 GlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (611)
|-+.... ++ ...... ...+.+.
T Consensus 174 GS~~~a~---------------------------------i~-------------i~~~~~------------a~~lQe~ 195 (302)
T KOG2345|consen 174 GSATQAP---------------------------------IQ-------------IEGSRQ------------ALRLQEW 195 (302)
T ss_pred cCccccc---------------------------------eE-------------eechHH------------HHHHHHH
Confidence 9762210 00 000000 0000000
Q ss_pred ccCcccccccccccCCCccchhhhccCC---CCChhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHcCCCCCCCCC
Q 007260 443 IAEPTEARSMSFVGTHEYLAPEIIKGEG---HGSAVDWWTFGIFLYELLFGKTPFKGSGNR--ATLFNVVGQPLRFPESP 517 (611)
Q Consensus 443 ~~~~~~~~~~~~vGT~~Y~APEil~~~~---~~~~sDIWSLGviL~ELltG~~PF~~~~~~--~~l~~i~~~~l~~p~~~ 517 (611)
..-..|..|+|||++.-.- .+.++|||||||+||+|++|..||...-.. .....+....+.+|...
T Consensus 196 ---------a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~ 266 (302)
T KOG2345|consen 196 ---------AEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQISIPNSS 266 (302)
T ss_pred ---------HHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccccccCCCC
Confidence 1123788999999987554 488999999999999999999999642110 11123445568889888
Q ss_pred CCCHHHHHHHHHhhhcCccccCCchhcHHHHHcC
Q 007260 518 VVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 518 ~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~H 551 (611)
..|+.+.+||..||+.||.+||+ +.+++.+
T Consensus 267 ~yse~l~~lik~mlqvdP~qRP~----i~~ll~~ 296 (302)
T KOG2345|consen 267 RYSEALHQLIKSMLQVDPNQRPT----IPELLSK 296 (302)
T ss_pred CccHHHHHHHHHHhcCCcccCCC----HHHHHHH
Confidence 89999999999999999999999 8888754
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=324.92 Aligned_cols=248 Identities=22% Similarity=0.333 Sum_probs=193.7
Q ss_pred eEecccCcEEEEEEEECC--CCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEeeeCC
Q 007260 222 KRLGCGDIGSVYLSELSG--TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCP 299 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~~~--t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE~~~ 299 (611)
+.||.|+||.||+|.... ....+|+|.+.... .......+.+|+.+++.++|+||+++++++......||||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 369999999999997533 44578999876432 22333456789999999999999999999999999999999999
Q ss_pred CCCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccc
Q 007260 300 GGDLHTLRQKQPG---KYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIK 376 (611)
Q Consensus 300 gg~L~~ll~~~~~---~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~ 376 (611)
+|+|.+++..... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~--- 155 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY--- 155 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchh---
Confidence 9999999876532 3356888899999999999999999999999999999999999999999998732110000
Q ss_pred cccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccccc
Q 007260 377 ASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVG 456 (611)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vG 456 (611)
........+
T Consensus 156 -----------------------------------------------------------------------~~~~~~~~~ 164 (269)
T cd05042 156 -----------------------------------------------------------------------YITKDCHAV 164 (269)
T ss_pred -----------------------------------------------------------------------eeccCCCCC
Confidence 000011246
Q ss_pred CCCccchhhhcc-------CCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcC-CCCCCC---CCCCCHHHH
Q 007260 457 THEYLAPEIIKG-------EGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQ-PLRFPE---SPVVSFAAR 524 (611)
Q Consensus 457 T~~Y~APEil~~-------~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~-~l~~p~---~~~~s~~l~ 524 (611)
++.|+|||++.. ..++.++|||||||++|||++ |..||....+.+.+..++.. ...++. ...++..+.
T Consensus 165 ~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (269)
T cd05042 165 PLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWY 244 (269)
T ss_pred cccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHH
Confidence 778999999853 346789999999999999998 88999887777666555433 223322 235788999
Q ss_pred HHHHHhhhcCccccCCchhcHHHHHc
Q 007260 525 DLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 525 dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
+++..|| .||++||+ +++|+.
T Consensus 245 ~~~~~~~-~dp~~Rpt----~~~v~~ 265 (269)
T cd05042 245 EVMQFCW-LDPETRPT----AEEVHE 265 (269)
T ss_pred HHHHHHh-cCcccccC----HHHHHH
Confidence 9999998 59999999 677664
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=327.15 Aligned_cols=255 Identities=25% Similarity=0.366 Sum_probs=207.1
Q ss_pred cCeEEEeEecccCcEEEEEEEEC----CCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec--cc
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELS----GTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET--EK 289 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~----~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~--~~ 289 (611)
.+|++.+.||.|+||.||+|++. .++..||||++...... .....+.+|+++++.+.|+||+++++++.. ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 57889999999999999999864 34789999999765432 345577889999999999999999999887 66
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
..|+||||+++++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 8999999999999999988753 358999999999999999999999999999999999999999999999999984332
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
...... .
T Consensus 161 ~~~~~~-------------------------------------------------------------------------~ 167 (284)
T cd05038 161 EDKDYY-------------------------------------------------------------------------Y 167 (284)
T ss_pred cCCcce-------------------------------------------------------------------------e
Confidence 110000 0
Q ss_pred cccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCc--------------HHHHHHHHcCCCCCCC
Q 007260 450 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGN--------------RATLFNVVGQPLRFPE 515 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~--------------~~~l~~i~~~~l~~p~ 515 (611)
......++..|++||.+.+..++.++|||||||++|||++|+.||..... ...+...+.....++.
T Consensus 168 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (284)
T cd05038 168 VKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPR 247 (284)
T ss_pred ccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCCcCCC
Confidence 00011255679999999988999999999999999999999999875322 2223344445555565
Q ss_pred CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 516 SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 516 ~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
...++.++.+||.+||..+|++||+ +.+|++
T Consensus 248 ~~~~~~~~~~li~~cl~~~p~~Rpt----~~ei~~ 278 (284)
T cd05038 248 PPSCPDEVYDLMKLCWEAEPQDRPS----FADLIL 278 (284)
T ss_pred CccCCHHHHHHHHHHhccChhhCCC----HHHHHH
Confidence 5668899999999999999999999 777664
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=326.50 Aligned_cols=248 Identities=22% Similarity=0.333 Sum_probs=199.7
Q ss_pred eEecccCcEEEEEEEECCCC------eEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 222 KRLGCGDIGSVYLSELSGTK------CYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~~~t~------~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
+.||.|+||.||+|++.... ..||||.+.+... ......+.+|+.+|+.++||||+++++++......|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc--hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 36899999999999986543 7899998865421 123446778999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhC-----CCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCC-----cEEEEecccc
Q 007260 296 EFCPGGDLHTLRQKQ-----PGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDG-----HIMLSDFDLS 365 (611)
Q Consensus 296 E~~~gg~L~~ll~~~-----~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g-----~vkL~DFGlA 365 (611)
||+++++|.+++... ....+++..+..++.||+.||+|||++||+|+||||+|||++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999988753 224578899999999999999999999999999999999999877 8999999998
Q ss_pred ccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccC
Q 007260 366 LRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAE 445 (611)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (611)
..+.....
T Consensus 159 ~~~~~~~~------------------------------------------------------------------------ 166 (269)
T cd05044 159 RDIYKSDY------------------------------------------------------------------------ 166 (269)
T ss_pred cccccccc------------------------------------------------------------------------
Confidence 43210000
Q ss_pred cccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHH
Q 007260 446 PTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAAR 524 (611)
Q Consensus 446 ~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~ 524 (611)
........++..|+|||++.+..++.++|||||||++|||++ |+.||....+......+.. ...+.....++..+.
T Consensus 167 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 243 (269)
T cd05044 167 --YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA-GGRLQKPENCPDKIY 243 (269)
T ss_pred --cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhc-CCccCCcccchHHHH
Confidence 000011236778999999999999999999999999999998 9999987766655544433 233334445889999
Q ss_pred HHHHHhhhcCccccCCchhcHHHHHc
Q 007260 525 DLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 525 dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
+||.+||..+|.+||+ +.++++
T Consensus 244 ~li~~~l~~~p~~Rp~----~~~i~~ 265 (269)
T cd05044 244 QLMTNCWAQDPSERPT----FDRIQE 265 (269)
T ss_pred HHHHHHcCCCcccCCC----HHHHHH
Confidence 9999999999999999 666654
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=355.43 Aligned_cols=253 Identities=26% Similarity=0.421 Sum_probs=215.0
Q ss_pred EEEeEecccCcEEEEEEEECCCCeEEEEEEecch-hhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc--eeeEEe
Q 007260 219 RLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKA-SLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK--FSCLVM 295 (611)
Q Consensus 219 ~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~-~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~--~~~LVm 295 (611)
+...+||+|+|-+||+|.+..+|..||--.+.-. .....+.+.++..|+.+|+.|+|||||++|++|.+.. .+.+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 3456899999999999999999988885444322 2345566789999999999999999999999998754 488999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--eeccCCCCCcEEEcc-CCcEEEEeccccccccCCc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLG--IIYRDLKPENVLVRE-DGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~g--IVHRDLKPeNILv~~-~g~vkL~DFGlA~~~~~~~ 372 (611)
|++..|+|+.++.+. +.++...++.|++|||.||.|||++. |||||||-+||+|+. .|.|||+|+|||....
T Consensus 123 EL~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r--- 197 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR--- 197 (632)
T ss_pred ecccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh---
Confidence 999999999999987 66999999999999999999999997 999999999999984 6899999999994322
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
.....
T Consensus 198 ---------------------------------------------------------------------------~s~ak 202 (632)
T KOG0584|consen 198 ---------------------------------------------------------------------------KSHAK 202 (632)
T ss_pred ---------------------------------------------------------------------------ccccc
Confidence 01123
Q ss_pred ccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCC-CCCCCCHHHHHHHHHhh
Q 007260 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFP-ESPVVSFAARDLIRGLL 531 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p-~~~~~s~~l~dLI~~~L 531 (611)
+.+|||+|||||++. +.|+..+||||||.+++||+|+..||..-.+.+++++.+...+... ....-.+++++||.+||
T Consensus 203 svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl 281 (632)
T KOG0584|consen 203 SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKCL 281 (632)
T ss_pred eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHh
Confidence 468999999999998 7899999999999999999999999999888888877665544322 22234679999999999
Q ss_pred hcCccccCCchhcHHHHHcCCCCCCC
Q 007260 532 VKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 532 ~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
.. ..+|++ |.|||+||||..-
T Consensus 282 ~~-~~~R~s----a~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 282 AT-KSERLS----AKELLKDPFFDED 302 (632)
T ss_pred cC-chhccC----HHHHhhChhhccc
Confidence 99 999999 9999999999853
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=330.95 Aligned_cols=255 Identities=22% Similarity=0.336 Sum_probs=205.3
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCe----EEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecc
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKC----YFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE 288 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~----~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~ 288 (611)
+..++|++++.||+|+||.||+|.+..++. .||+|++..... ......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~ 81 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSP 81 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence 345789999999999999999999876665 578998865432 22334567899999999999999999988754
Q ss_pred ceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccc
Q 007260 289 KFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRC 368 (611)
Q Consensus 289 ~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~ 368 (611)
..++||||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccc
Confidence 4679999999999999887653 45899999999999999999999999999999999999999999999999998433
Q ss_pred cCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccc
Q 007260 369 AVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTE 448 (611)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (611)
..... .
T Consensus 160 ~~~~~--------------------------------------------------------------------------~ 165 (303)
T cd05110 160 EGDEK--------------------------------------------------------------------------E 165 (303)
T ss_pred cCccc--------------------------------------------------------------------------c
Confidence 21000 0
Q ss_pred ccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 007260 449 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLI 527 (611)
Q Consensus 449 ~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI 527 (611)
.......++..|+|||++.+..++.++|||||||++|||++ |..||.+.... .+..++.....++.....+..+.++|
T Consensus 166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li 244 (303)
T cd05110 166 YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR-EIPDLLEKGERLPQPPICTIDVYMVM 244 (303)
T ss_pred cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHCCCCCCCCCCCCHHHHHHH
Confidence 00001235778999999999999999999999999999997 99999876543 34445555455555566889999999
Q ss_pred HHhhhcCccccCCchhcHHHHHc
Q 007260 528 RGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 528 ~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
..||..+|++||+ +.++++
T Consensus 245 ~~c~~~~p~~Rp~----~~~l~~ 263 (303)
T cd05110 245 VKCWMIDADSRPK----FKELAA 263 (303)
T ss_pred HHHcCCChhhCcC----HHHHHH
Confidence 9999999999999 566554
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=324.54 Aligned_cols=248 Identities=23% Similarity=0.306 Sum_probs=193.2
Q ss_pred eEecccCcEEEEEEEEC--CCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEeeeCC
Q 007260 222 KRLGCGDIGSVYLSELS--GTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCP 299 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~~--~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE~~~ 299 (611)
+.||+|+||.||+|... .++..+|+|.++.... ......+.+|+.+++.++||||+++++++.+....|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 46899999999999864 3556799998865432 1223457789999999999999999999999999999999999
Q ss_pred CCCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccc
Q 007260 300 GGDLHTLRQKQP---GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIK 376 (611)
Q Consensus 300 gg~L~~ll~~~~---~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~ 376 (611)
+|+|.+++.... ...+++..++.++.|++.||+|||++||+||||||+|||++.+++++|+|||++.......
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~---- 154 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED---- 154 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcc----
Confidence 999999887532 2346777888999999999999999999999999999999999999999999873211000
Q ss_pred cccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccccc
Q 007260 377 ASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVG 456 (611)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vG 456 (611)
.........|
T Consensus 155 ----------------------------------------------------------------------~~~~~~~~~~ 164 (269)
T cd05087 155 ----------------------------------------------------------------------YYVTPDQLWV 164 (269)
T ss_pred ----------------------------------------------------------------------eeecCCCcCC
Confidence 0000112357
Q ss_pred CCCccchhhhccC-------CCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH-cCCCCCCCC---CCCCHHHH
Q 007260 457 THEYLAPEIIKGE-------GHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVV-GQPLRFPES---PVVSFAAR 524 (611)
Q Consensus 457 T~~Y~APEil~~~-------~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~-~~~l~~p~~---~~~s~~l~ 524 (611)
++.|+|||++.+. .++.++|||||||++|||++ |+.||....+...+...+ .....++.. ...+..+.
T Consensus 165 ~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (269)
T cd05087 165 PLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWY 244 (269)
T ss_pred cccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHH
Confidence 8899999998643 35789999999999999996 999998766655443333 222333322 24678899
Q ss_pred HHHHHhhhcCccccCCchhcHHHHHc
Q 007260 525 DLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 525 dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
++|..|+ .+|++||+ +++|++
T Consensus 245 ~l~~~c~-~~P~~Rpt----~~~l~~ 265 (269)
T cd05087 245 EVMQFCW-LQPEQRPS----AEEVHL 265 (269)
T ss_pred HHHHHHh-cCcccCCC----HHHHHH
Confidence 9999998 68999999 777764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=324.12 Aligned_cols=253 Identities=26% Similarity=0.415 Sum_probs=206.6
Q ss_pred CeEEEeEecccCcEEEEEEEECC-CCeEEEEEEecchhh-------hhHHHHHHHHHHHHHHHh-CCCCCcccccceeec
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSG-TKCYFAMKVMDKASL-------AGRKKLLRAQTEREILQS-LDHPFLPTLYTHFET 287 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~-t~~~vAvKii~k~~~-------~~~~~~~~~~~E~~iL~~-l~HpnIv~l~~~~~~ 287 (611)
+|.+.+.||.|+||.||++.+.. +++.+|+|.+..... .......++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999987 678999998864321 223345566778888875 799999999999999
Q ss_pred cceeeEEeeeCCCCCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHH-cCeeccCCCCCcEEEccCCcEEEEeccc
Q 007260 288 EKFSCLVMEFCPGGDLHTLRQK--QPGKYFPEQAVRFYVAEVLLALEYLHM-LGIIYRDLKPENVLVREDGHIMLSDFDL 364 (611)
Q Consensus 288 ~~~~~LVmE~~~gg~L~~ll~~--~~~~~l~e~~~~~i~~qll~aL~yLH~-~gIVHRDLKPeNILv~~~g~vkL~DFGl 364 (611)
++..|+||||++|++|.+++.. ..+..+++..++.++.|++.||.|||. .||+||||||+|||++.++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999988754 223568999999999999999999996 7899999999999999999999999999
Q ss_pred cccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCccccc
Q 007260 365 SLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIA 444 (611)
Q Consensus 365 A~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (611)
+.......
T Consensus 161 ~~~~~~~~------------------------------------------------------------------------ 168 (269)
T cd08528 161 AKQKQPES------------------------------------------------------------------------ 168 (269)
T ss_pred eeeccccc------------------------------------------------------------------------
Confidence 84321000
Q ss_pred CcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHH
Q 007260 445 EPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAAR 524 (611)
Q Consensus 445 ~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~ 524 (611)
......|+..|++||++.+..++.++|||||||++|||++|+.||...........+............++..+.
T Consensus 169 -----~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 243 (269)
T cd08528 169 -----KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSEDVT 243 (269)
T ss_pred -----ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCCHHHH
Confidence 011235889999999999988999999999999999999999999876655555555544433223335789999
Q ss_pred HHHHHhhhcCccccCCchhcHHHHHc
Q 007260 525 DLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 525 dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
+||.+||..||++||+ +.|+..
T Consensus 244 ~li~~cl~~~p~~Rp~----~~e~~~ 265 (269)
T cd08528 244 DVITSCLTPDAEARPD----IIQVSA 265 (269)
T ss_pred HHHHHHCCCCCccCCC----HHHHHH
Confidence 9999999999999999 566543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=319.80 Aligned_cols=249 Identities=18% Similarity=0.284 Sum_probs=194.8
Q ss_pred eEecccCcEEEEEEEECC---CCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceee-ccceeeEEeee
Q 007260 222 KRLGCGDIGSVYLSELSG---TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFE-TEKFSCLVMEF 297 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~~~---t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~-~~~~~~LVmE~ 297 (611)
+.||.|+||.||+|.+.. .+..||||.+.... .......+.+|+.+++.++||||+++++++. .++..|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 468999999999998643 45679999885432 2233456778999999999999999999765 56678999999
Q ss_pred CCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccccc
Q 007260 298 CPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKA 377 (611)
Q Consensus 298 ~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~ 377 (611)
+.+++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 79 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~--- 154 (262)
T cd05058 79 MKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY--- 154 (262)
T ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcce---
Confidence 99999999987653 34678888899999999999999999999999999999999999999999998432110000
Q ss_pred ccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccC
Q 007260 378 SSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGT 457 (611)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT 457 (611)
.........++
T Consensus 155 ---------------------------------------------------------------------~~~~~~~~~~~ 165 (262)
T cd05058 155 ---------------------------------------------------------------------SVHNHTGAKLP 165 (262)
T ss_pred ---------------------------------------------------------------------eecccccCcCC
Confidence 00000112367
Q ss_pred CCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCcc
Q 007260 458 HEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQ 536 (611)
Q Consensus 458 ~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~ 536 (611)
..|+|||++.+..++.++|||||||++|||++ |.+||...........+... ...+....++..+.++|.+||..+|+
T Consensus 166 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~p~ 244 (262)
T cd05058 166 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG-RRLLQPEYCPDPLYEVMLSCWHPKPE 244 (262)
T ss_pred ccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC-CCCCCCCcCCHHHHHHHHHHcCCChh
Confidence 78999999999899999999999999999999 56778766555544444332 23333345789999999999999999
Q ss_pred ccCCchhcHHHHHc
Q 007260 537 HRLAYKRGATEIKQ 550 (611)
Q Consensus 537 ~Rpt~~~~a~elL~ 550 (611)
+||+ +.++++
T Consensus 245 ~Rp~----~~~il~ 254 (262)
T cd05058 245 MRPT----FSELVS 254 (262)
T ss_pred hCCC----HHHHHH
Confidence 9999 777765
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=327.04 Aligned_cols=238 Identities=24% Similarity=0.296 Sum_probs=190.9
Q ss_pred EecccCcEEEEEEEECC------------------------CCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCc
Q 007260 223 RLGCGDIGSVYLSELSG------------------------TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFL 278 (611)
Q Consensus 223 ~LG~G~fG~Vy~a~~~~------------------------t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnI 278 (611)
.||+|+||.||+|.... ....||+|++.... ......+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 69999999999997532 22468999986543 2333456779999999999999
Q ss_pred ccccceeeccceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCC---
Q 007260 279 PTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDG--- 355 (611)
Q Consensus 279 v~l~~~~~~~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g--- 355 (611)
+++++++..+...||||||+++|+|..++.+. ...+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999999888654 35689999999999999999999999999999999999998654
Q ss_pred ----cEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccc
Q 007260 356 ----HIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNE 431 (611)
Q Consensus 356 ----~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (611)
.+||+|||++.....
T Consensus 158 ~~~~~~kl~d~g~~~~~~~------------------------------------------------------------- 176 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALS------------------------------------------------------------- 176 (274)
T ss_pred CccceeeecCCcccccccc-------------------------------------------------------------
Confidence 489999998632110
Q ss_pred cCCCCCCCcccccCcccccccccccCCCccchhhhcc-CCCCChhhHHHHHHHHHHHH-hCCCCCCCCCcHHHHHHHHcC
Q 007260 432 IGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELL-FGKTPFKGSGNRATLFNVVGQ 509 (611)
Q Consensus 432 ~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~-~~~~~~sDIWSLGviL~ELl-tG~~PF~~~~~~~~l~~i~~~ 509 (611)
.....|+..|+|||++.+ ..++.++|||||||++|||+ +|+.||.+...... ......
T Consensus 177 -------------------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-~~~~~~ 236 (274)
T cd05076 177 -------------------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK-ERFYEK 236 (274)
T ss_pred -------------------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH-HHHHHh
Confidence 001247788999999876 45799999999999999995 79999987654433 233344
Q ss_pred CCCCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcC
Q 007260 510 PLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 510 ~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~H 551 (611)
...++.. ....+.+||.+||..+|++||+ +.+|+++
T Consensus 237 ~~~~~~~--~~~~~~~li~~cl~~~p~~Rps----~~~il~~ 272 (274)
T cd05076 237 KHRLPEP--SCKELATLISQCLTYEPTQRPS----FRTILRD 272 (274)
T ss_pred ccCCCCC--CChHHHHHHHHHcccChhhCcC----HHHHHHh
Confidence 4444433 5678999999999999999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=326.97 Aligned_cols=256 Identities=17% Similarity=0.244 Sum_probs=190.3
Q ss_pred cCeEEEeEecccCcEEEEEEEECCC---CeEEEEEEecchhhh--hHHH------HHHHHHHHHHHHhCCCCCcccccce
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGT---KCYFAMKVMDKASLA--GRKK------LLRAQTEREILQSLDHPFLPTLYTH 284 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t---~~~vAvKii~k~~~~--~~~~------~~~~~~E~~iL~~l~HpnIv~l~~~ 284 (611)
.+|++.++||+|+||+||+|.+..+ +..+|+|+....... .... ......+...+..++|+||++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 6899999999999999999999887 667888875432211 0000 0111223344567789999999987
Q ss_pred eeccc----eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEE
Q 007260 285 FETEK----FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLS 360 (611)
Q Consensus 285 ~~~~~----~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~ 360 (611)
+.... ..|++||++ ..++.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+
T Consensus 92 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~ 168 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKL-VENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYII 168 (294)
T ss_pred eeEecCCceEEEEEEehh-ccCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEE
Confidence 65432 458899988 55777776654 346888999999999999999999999999999999999999999999
Q ss_pred eccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCc
Q 007260 361 DFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLP 440 (611)
Q Consensus 361 DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (611)
|||+|..+........
T Consensus 169 DFGla~~~~~~~~~~~---------------------------------------------------------------- 184 (294)
T PHA02882 169 DYGIASHFIIHGKHIE---------------------------------------------------------------- 184 (294)
T ss_pred EcCCceeeccCCcccc----------------------------------------------------------------
Confidence 9999855431110000
Q ss_pred ccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHH---------HHHHcCCC
Q 007260 441 ELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATL---------FNVVGQPL 511 (611)
Q Consensus 441 ~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l---------~~i~~~~l 511 (611)
........+.||+.|+|||++.+..++.++|||||||+||||++|..||.+......+ .++.....
T Consensus 185 -----~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (294)
T PHA02882 185 -----YSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKI 259 (294)
T ss_pred -----cccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhhhhh
Confidence 0000112246999999999999999999999999999999999999999887432221 12222222
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 512 RFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 512 ~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
.. ...+..+.+++..||..+|++||+ .++|++
T Consensus 260 ~~---~~~~~~~~~~~~~~~~~~~~~rp~----~~~l~~ 291 (294)
T PHA02882 260 KI---KNANKFIYDFIECVTKLSYEEKPD----YDALIK 291 (294)
T ss_pred cc---CCCCHHHHHHHHHHHhCCCCCCCC----HHHHHH
Confidence 22 346889999999999999999999 667664
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=322.58 Aligned_cols=239 Identities=20% Similarity=0.273 Sum_probs=190.8
Q ss_pred eEecccCcEEEEEEEECC------------CCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc
Q 007260 222 KRLGCGDIGSVYLSELSG------------TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK 289 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~~~------------t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~ 289 (611)
+.||+|+||.||+|.... ....||+|++.... ......+.+|+.+|+.++||||+++++++..+.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 368999999999998542 23358999876543 233446678999999999999999999999999
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCc-------EEEEec
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGH-------IMLSDF 362 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~-------vkL~DF 362 (611)
..||||||+++++|..++.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++. ++|+||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999999988876542 45899999999999999999999999999999999999987664 899999
Q ss_pred cccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCccc
Q 007260 363 DLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPEL 442 (611)
Q Consensus 363 GlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (611)
|++.....
T Consensus 157 g~~~~~~~------------------------------------------------------------------------ 164 (262)
T cd05077 157 GIPITVLS------------------------------------------------------------------------ 164 (262)
T ss_pred CCCccccC------------------------------------------------------------------------
Confidence 98732110
Q ss_pred ccCcccccccccccCCCccchhhhc-cCCCCChhhHHHHHHHHHHHH-hCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCC
Q 007260 443 IAEPTEARSMSFVGTHEYLAPEIIK-GEGHGSAVDWWTFGIFLYELL-FGKTPFKGSGNRATLFNVVGQPLRFPESPVVS 520 (611)
Q Consensus 443 ~~~~~~~~~~~~vGT~~Y~APEil~-~~~~~~~sDIWSLGviL~ELl-tG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s 520 (611)
....+|+..|+|||++. +..++.++|||||||++|||+ .|..||......+ ........... ....+
T Consensus 165 --------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~~~~~--~~~~~ 233 (262)
T cd05077 165 --------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-KERFYEGQCML--VTPSC 233 (262)
T ss_pred --------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-HHHHHhcCccC--CCCCh
Confidence 01235788899999987 456899999999999999998 5899987654332 22333333222 22356
Q ss_pred HHHHHHHHHhhhcCccccCCchhcHHHHHcC
Q 007260 521 FAARDLIRGLLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 521 ~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~H 551 (611)
.++.+||.+||..||.+||+ +.+|+++
T Consensus 234 ~~~~~li~~cl~~dp~~Rp~----~~~il~~ 260 (262)
T cd05077 234 KELADLMTHCMNYDPNQRPF----FRAIMRD 260 (262)
T ss_pred HHHHHHHHHHcCCChhhCcC----HHHHHHh
Confidence 78999999999999999999 7888764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=319.09 Aligned_cols=236 Identities=21% Similarity=0.268 Sum_probs=191.5
Q ss_pred eEecccCcEEEEEEEECCCC----------eEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecccee
Q 007260 222 KRLGCGDIGSVYLSELSGTK----------CYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFS 291 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~~~t~----------~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~ 291 (611)
+.||.|+||.||+|.+..++ ..+++|++...... ...+.+|+.+|+.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD----SLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh----HHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 46899999999999998776 45888887654321 4567789999999999999999999888 778
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCC-------cEEEEeccc
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDG-------HIMLSDFDL 364 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g-------~vkL~DFGl 364 (611)
|+||||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 99999999999999988763 2689999999999999999999999999999999999999888 799999999
Q ss_pred cccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCccccc
Q 007260 365 SLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIA 444 (611)
Q Consensus 365 A~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (611)
+.....
T Consensus 155 a~~~~~-------------------------------------------------------------------------- 160 (259)
T cd05037 155 PITVLS-------------------------------------------------------------------------- 160 (259)
T ss_pred cccccc--------------------------------------------------------------------------
Confidence 833210
Q ss_pred CcccccccccccCCCccchhhhccC--CCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCH
Q 007260 445 EPTEARSMSFVGTHEYLAPEIIKGE--GHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSF 521 (611)
Q Consensus 445 ~~~~~~~~~~vGT~~Y~APEil~~~--~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~ 521 (611)
....+++..|+|||++.+. .++.++|||||||++|||++ |..||.......... ........+.. ...
T Consensus 161 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~-~~~~~~~~~~~--~~~ 231 (259)
T cd05037 161 ------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER-FYQDQHRLPMP--DCA 231 (259)
T ss_pred ------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH-HHhcCCCCCCC--Cch
Confidence 0112467789999999887 78999999999999999999 688887765333222 22222222322 337
Q ss_pred HHHHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 522 AARDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 522 ~l~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
.+.+||.+||..+|.+||+ +.++++
T Consensus 232 ~~~~li~~~l~~~p~~Rpt----~~~il~ 256 (259)
T cd05037 232 ELANLINQCWTYDPTKRPS----FRAILR 256 (259)
T ss_pred HHHHHHHHHhccChhhCCC----HHHHHH
Confidence 8999999999999999999 777775
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=325.85 Aligned_cols=263 Identities=27% Similarity=0.392 Sum_probs=211.4
Q ss_pred cccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec------
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET------ 287 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~------ 287 (611)
..+.|.-+.+||+|.||.||+|+.+.+++.||+|++-... ........+.+|+.||+.|.|+|++.|++.+..
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen-eKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~ 93 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTN 93 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc-cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence 3467888899999999999999999999999998654322 112233456789999999999999999998753
Q ss_pred --cceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccc
Q 007260 288 --EKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365 (611)
Q Consensus 288 --~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA 365 (611)
...+||||.+|+ -||+-++... ...|+..+++.++.+++.||.|+|++.|+|||+||+|+||+.+|.+||+|||++
T Consensus 94 r~r~t~ylVf~~ce-hDLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 94 RDRATFYLVFDFCE-HDLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred cccceeeeeHHHhh-hhHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence 245899999994 5899887764 356999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccC
Q 007260 366 LRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAE 445 (611)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (611)
+.+..+.+...
T Consensus 172 r~fs~~~n~~k--------------------------------------------------------------------- 182 (376)
T KOG0669|consen 172 RAFSTSKNVVK--------------------------------------------------------------------- 182 (376)
T ss_pred cceecccccCC---------------------------------------------------------------------
Confidence 65543222111
Q ss_pred cccccccccccCCCccchhhhccCC-CCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH--cCCC---CCCCC---
Q 007260 446 PTEARSMSFVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVV--GQPL---RFPES--- 516 (611)
Q Consensus 446 ~~~~~~~~~vGT~~Y~APEil~~~~-~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~--~~~l---~~p~~--- 516 (611)
.+.+..|.|+||++||.+.|.. |++..|||+.|||+.||++|.+.|.+.++..++.-|. .+.. .||..
T Consensus 183 ---prytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~l 259 (376)
T KOG0669|consen 183 ---PRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNL 259 (376)
T ss_pred ---CCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccc
Confidence 1122347899999999999875 8999999999999999999999999998887765442 1111 11110
Q ss_pred -------------------------CCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCC
Q 007260 517 -------------------------PVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFE 555 (611)
Q Consensus 517 -------------------------~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 555 (611)
..-.+++.||+.+||..||.+|+. ++++|+|.||.
T Consensus 260 pL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~----ad~alnh~~F~ 319 (376)
T KOG0669|consen 260 PLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRID----ADQALNHDFFW 319 (376)
T ss_pred hHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcc----hHhhhchhhhh
Confidence 112457889999999999999999 99999999995
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=357.13 Aligned_cols=257 Identities=30% Similarity=0.474 Sum_probs=227.2
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceee-----ccc
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFE-----TEK 289 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~-----~~~ 289 (611)
.-|+|...||.|.+|.||+++++.+++.+|+||+........ .+..|.+||+.+ +|||++.+|++|. .++
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~de----EiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEE----EIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccH----HHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 468999999999999999999999999999999987653332 344588888887 7999999999986 368
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
.+|||||||.||+.-++++...+..+.|..+..|++.++.||.+||.+.++|||||-.|||++.+|.|||+|||++..++
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 174 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence 89999999999999999998888899999999999999999999999999999999999999999999999999984432
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
.+..
T Consensus 175 ----------------------------------------------------------------------------sT~g 178 (953)
T KOG0587|consen 175 ----------------------------------------------------------------------------STVG 178 (953)
T ss_pred ----------------------------------------------------------------------------cccc
Confidence 2445
Q ss_pred cccccccCCCccchhhhccC-----CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCC-CCCCCCCCCHHH
Q 007260 450 RSMSFVGTHEYLAPEIIKGE-----GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPL-RFPESPVVSFAA 523 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~~-----~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l-~~p~~~~~s~~l 523 (611)
+.++++|||.|||||++... .|+.++|+||||++..||.-|.+||-.......++.|...|. +...+..++.++
T Consensus 179 rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~kWs~~F 258 (953)
T KOG0587|consen 179 RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKKWSKKF 258 (953)
T ss_pred cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhhHHHHH
Confidence 66788999999999999865 368899999999999999999999999988888888877653 334456689999
Q ss_pred HHHHHHhhhcCccccCCchhcHHHHHcCCCCCC
Q 007260 524 RDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 524 ~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
.|||..||.+|-.+||+ ..++|+|||...
T Consensus 259 ndFIs~cL~Kd~e~RP~----~~~ll~hpFi~e 287 (953)
T KOG0587|consen 259 NDFISTCLVKDYEQRPS----TEELLKHPFITE 287 (953)
T ss_pred HHHHHHHHhhccccCcc----hhhhccCCcccc
Confidence 99999999999999999 999999999974
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=320.45 Aligned_cols=253 Identities=23% Similarity=0.342 Sum_probs=200.4
Q ss_pred eEEEeEecccCcEEEEEEEEC---CCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc-----
Q 007260 218 FRLLKRLGCGDIGSVYLSELS---GTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK----- 289 (611)
Q Consensus 218 y~l~~~LG~G~fG~Vy~a~~~---~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~----- 289 (611)
|++.+.||+|+||.||+|.+. .+++.||||++.... .......++.+|+.+|+.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 677899999999999999864 467899999986543 22334556788999999999999999999886532
Q ss_pred -eeeEEeeeCCCCCHHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccc
Q 007260 290 -FSCLVMEFCPGGDLHTLRQKQP----GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDL 364 (611)
Q Consensus 290 -~~~LVmE~~~gg~L~~ll~~~~----~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGl 364 (611)
..++++||+.+|+|..++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 3478999999999988765321 12578999999999999999999999999999999999999999999999999
Q ss_pred cccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCccccc
Q 007260 365 SLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIA 444 (611)
Q Consensus 365 A~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (611)
+........
T Consensus 160 ~~~~~~~~~----------------------------------------------------------------------- 168 (273)
T cd05074 160 SKKIYSGDY----------------------------------------------------------------------- 168 (273)
T ss_pred cccccCCcc-----------------------------------------------------------------------
Confidence 854321000
Q ss_pred CcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHH
Q 007260 445 EPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAA 523 (611)
Q Consensus 445 ~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l 523 (611)
........+++.|++||.+.+..++.++|||||||++|||++ |++||.+.........+... .........+..+
T Consensus 169 ---~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 244 (273)
T cd05074 169 ---YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG-NRLKQPPDCLEDV 244 (273)
T ss_pred ---eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC-CcCCCCCCCCHHH
Confidence 000011235678999999999999999999999999999998 99999877665544444433 2233334578999
Q ss_pred HHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 524 RDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 524 ~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
.+|+.+||..+|.+||+ +.++++
T Consensus 245 ~~l~~~~l~~~p~~Rps----~~~~~~ 267 (273)
T cd05074 245 YELMCQCWSPEPKCRPS----FQHLRD 267 (273)
T ss_pred HHHHHHHcCCChhhCcC----HHHHHH
Confidence 99999999999999999 777765
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=341.00 Aligned_cols=250 Identities=27% Similarity=0.321 Sum_probs=195.1
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc-eeeE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK-FSCL 293 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~-~~~L 293 (611)
+++|.--.+||+|+||.||+|..... ..||||.+....... ...|.+|+++|.+++|||||+|+|||.+.+ ..+|
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~L 149 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLL 149 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEE
Confidence 36888889999999999999998875 789999887654321 234889999999999999999999999888 5999
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC---eeccCCCCCcEEEccCCcEEEEeccccccccC
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLG---IIYRDLKPENVLVREDGHIMLSDFDLSLRCAV 370 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~g---IVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~ 370 (611)
|+||+++|+|.+.+....+..++|.....|+.+++.||+|||... |||||||++|||+|+++..||+|||+|+....
T Consensus 150 VYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~ 229 (361)
T KOG1187|consen 150 VYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPE 229 (361)
T ss_pred EEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCc
Confidence 999999999999988764337899999999999999999999854 99999999999999999999999999832110
Q ss_pred CccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccc
Q 007260 371 SPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEAR 450 (611)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (611)
. ...
T Consensus 230 ~----------------------------------------------------------------------------~~~ 233 (361)
T KOG1187|consen 230 G----------------------------------------------------------------------------DTS 233 (361)
T ss_pred c----------------------------------------------------------------------------ccc
Confidence 0 000
Q ss_pred cccc-ccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC--cH---HHH-HHHHcC-CCC---CCCC--C
Q 007260 451 SMSF-VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSG--NR---ATL-FNVVGQ-PLR---FPES--P 517 (611)
Q Consensus 451 ~~~~-vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~--~~---~~l-~~i~~~-~l~---~p~~--~ 517 (611)
..+. .||.+|+|||++.....+.++|||||||+|+||++|+.+..... .. ..+ ...+.. .+. .|.. .
T Consensus 234 ~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~ 313 (361)
T KOG1187|consen 234 VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEG 313 (361)
T ss_pred eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCC
Confidence 0011 59999999999999889999999999999999999999887532 11 111 111111 110 0110 1
Q ss_pred CCC-----HHHHHHHHHhhhcCccccCCchhc
Q 007260 518 VVS-----FAARDLIRGLLVKEPQHRLAYKRG 544 (611)
Q Consensus 518 ~~s-----~~l~dLI~~~L~~dP~~Rpt~~~~ 544 (611)
... ..+..+...|+..+|..||++.+.
T Consensus 314 ~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~V 345 (361)
T KOG1187|consen 314 EYPDEKEVKKLAELALRCLRPDPKERPTMSQV 345 (361)
T ss_pred CCChHHHHHHHHHHHHHHcCcCCCcCcCHHHH
Confidence 122 235578889999999999995543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=328.16 Aligned_cols=160 Identities=31% Similarity=0.453 Sum_probs=139.8
Q ss_pred CCCCCCCCcchHHHHHHhhccCccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHH
Q 007260 189 INKPHKANDLRWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTERE 268 (611)
Q Consensus 189 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~ 268 (611)
....+..+||+....++++.+|.+-+ ++|.+.++||.|-|++||+|.+..+.++||||+.+... ...+.+..||+
T Consensus 52 ~~eqE~~~dY~kGGYHpV~IGD~F~~-gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIk 126 (590)
T KOG1290|consen 52 DEEQEDPEDYRKGGYHPVRIGDVFNG-GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIK 126 (590)
T ss_pred cccccChhhhhcCCCceeeccccccC-ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHH
Confidence 34456778999999999999887653 69999999999999999999999999999999997543 23345567999
Q ss_pred HHHhCC-----C---CCcccccceeec----cceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH
Q 007260 269 ILQSLD-----H---PFLPTLYTHFET----EKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHM 336 (611)
Q Consensus 269 iL~~l~-----H---pnIv~l~~~~~~----~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~ 336 (611)
+|+.++ | .+||+|+++|.. +.++|||+|++ |.+|..+|.+...+.++...++.|++|||.||.|||.
T Consensus 127 lL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ 205 (590)
T KOG1290|consen 127 LLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR 205 (590)
T ss_pred HHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH
Confidence 999882 3 479999999974 68999999999 8999999999888899999999999999999999996
Q ss_pred -cCeeccCCCCCcEEEccC
Q 007260 337 -LGIIYRDLKPENVLVRED 354 (611)
Q Consensus 337 -~gIVHRDLKPeNILv~~~ 354 (611)
+||||-||||||||+..+
T Consensus 206 ecgIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 206 ECGIIHTDLKPENVLLCST 224 (590)
T ss_pred hcCccccCCCcceeeeecc
Confidence 699999999999999654
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=317.97 Aligned_cols=248 Identities=18% Similarity=0.260 Sum_probs=191.9
Q ss_pred eEecccCcEEEEEEEECCC--CeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEeeeCC
Q 007260 222 KRLGCGDIGSVYLSELSGT--KCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCP 299 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~~~t--~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE~~~ 299 (611)
+.||+|+||.||+++.... ...+++|.+..... ......+.+|+.+++.++||||+++++++......||||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC--hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 3699999999999976433 34567777654332 2334567889999999999999999999999999999999999
Q ss_pred CCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccccc
Q 007260 300 GGDLHTLRQKQP--GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKA 377 (611)
Q Consensus 300 gg~L~~ll~~~~--~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~ 377 (611)
+|+|.+++.+.. ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.++|+|||++.......
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~----- 153 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED----- 153 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcch-----
Confidence 999999887642 2346778888999999999999999999999999999999999999999999873211000
Q ss_pred ccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccC
Q 007260 378 SSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGT 457 (611)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT 457 (611)
........+|+
T Consensus 154 ---------------------------------------------------------------------~~~~~~~~~~~ 164 (268)
T cd05086 154 ---------------------------------------------------------------------YIETEDDKCVP 164 (268)
T ss_pred ---------------------------------------------------------------------hhhcccCCcCc
Confidence 00001124588
Q ss_pred CCccchhhhccC-------CCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCC-CCC--C-CCCCCCHHHHH
Q 007260 458 HEYLAPEIIKGE-------GHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQP-LRF--P-ESPVVSFAARD 525 (611)
Q Consensus 458 ~~Y~APEil~~~-------~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~-l~~--p-~~~~~s~~l~d 525 (611)
..|+|||++... .++.++|||||||++|||++ |..||....+.+.+..++... ... | ....+++.+.+
T Consensus 165 ~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (268)
T cd05086 165 LRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYE 244 (268)
T ss_pred ccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHH
Confidence 899999998532 34678999999999999996 678998777766666554332 221 1 12347889999
Q ss_pred HHHHhhhcCccccCCchhcHHHHHc
Q 007260 526 LIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 526 LI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
+|..|| .+|++||+ +.+|++
T Consensus 245 l~~~c~-~~P~~Rp~----~~~i~~ 264 (268)
T cd05086 245 VLQFCW-LSPEKRAT----AEEVHR 264 (268)
T ss_pred HHHHHh-hCcccCCC----HHHHHH
Confidence 999999 68999999 777764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=348.86 Aligned_cols=244 Identities=31% Similarity=0.512 Sum_probs=196.3
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecc------ce
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE------KF 290 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~------~~ 290 (611)
-|..-+.||+|+||.||+++++.+|+.||||.+++.. ......+..+|++||++|+|+|||+++++-++. +.
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 4556689999999999999999999999999998754 223344567899999999999999999987654 35
Q ss_pred eeEEeeeCCCCCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEcc--CCc--EEEEecccc
Q 007260 291 SCLVMEFCPGGDLHTLRQKQ-PGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRE--DGH--IMLSDFDLS 365 (611)
Q Consensus 291 ~~LVmE~~~gg~L~~ll~~~-~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~--~g~--vkL~DFGlA 365 (611)
..+|||||.||||+.++++- +...|+|.+.+.++..|..||.|||++|||||||||+||++-. +|+ -||+|||.|
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 68999999999999988763 2357999999999999999999999999999999999999963 453 699999999
Q ss_pred ccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccC
Q 007260 366 LRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAE 445 (611)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (611)
+.+...
T Consensus 172 rel~d~-------------------------------------------------------------------------- 177 (732)
T KOG4250|consen 172 RELDDN-------------------------------------------------------------------------- 177 (732)
T ss_pred ccCCCC--------------------------------------------------------------------------
Confidence 644311
Q ss_pred cccccccccccCCCccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCC----cHHHHHHHHcCC----------
Q 007260 446 PTEARSMSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSG----NRATLFNVVGQP---------- 510 (611)
Q Consensus 446 ~~~~~~~~~vGT~~Y~APEil~~-~~~~~~sDIWSLGviL~ELltG~~PF~~~~----~~~~l~~i~~~~---------- 510 (611)
....+++||+.|++||++.. ..|+..+|.|||||++|+++||..||.... +.+.++.++.++
T Consensus 178 ---s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~ 254 (732)
T KOG4250|consen 178 ---SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQE 254 (732)
T ss_pred ---CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeec
Confidence 12347899999999999995 788999999999999999999999996533 344555554332
Q ss_pred -----C----CCCCCCCCCHH----HHHHHHHhhhcCccccC
Q 007260 511 -----L----RFPESPVVSFA----ARDLIRGLLVKEPQHRL 539 (611)
Q Consensus 511 -----l----~~p~~~~~s~~----l~dLI~~~L~~dP~~Rp 539 (611)
+ .+|.+..++.. +...+..+|..+|.+|.
T Consensus 255 ~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 255 EENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred ccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 1 13333334443 44678889999999998
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=360.61 Aligned_cols=254 Identities=22% Similarity=0.360 Sum_probs=214.3
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCC-----CeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGT-----KCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK 289 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t-----~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~ 289 (611)
...-.+++.||+|+||.||.|...+. ...||||.+.+.. ..+....|.+|..+|..++|||||+|++++.+..
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~--~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS--SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 46788899999999999999987653 3359999987643 4566678899999999999999999999999999
Q ss_pred eeeEEeeeCCCCCHHHHHHhCC-----CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQP-----GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDL 364 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~-----~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGl 364 (611)
..+|++|||.||||..+++... ...++......++.||+.|+.||+++++|||||...|+||+....|||+||||
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccch
Confidence 9999999999999999998751 35688999999999999999999999999999999999999999999999999
Q ss_pred cccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCccccc
Q 007260 365 SLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIA 444 (611)
Q Consensus 365 A~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (611)
|+.+-.. .+ |....
T Consensus 849 ArDiy~~-~y----------------yr~~~------------------------------------------------- 862 (1025)
T KOG1095|consen 849 ARDIYDK-DY----------------YRKHG------------------------------------------------- 862 (1025)
T ss_pred hHhhhhc-hh----------------eeccC-------------------------------------------------
Confidence 9632110 00 00000
Q ss_pred CcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHH
Q 007260 445 EPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAA 523 (611)
Q Consensus 445 ~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l 523 (611)
.-.-...|||||.++...++.++|||||||+|||+++ |..||.+.++.+.+..++.+. +++.+..+++.+
T Consensus 863 --------~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL~~P~~CP~~l 933 (1025)
T KOG1095|consen 863 --------EAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RLDPPSYCPEKL 933 (1025)
T ss_pred --------ccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-ccCCCCCCChHH
Confidence 0011236999999999999999999999999999997 999999999999988777666 677777799999
Q ss_pred HHHHHHhhhcCccccCCchhcH
Q 007260 524 RDLIRGLLVKEPQHRLAYKRGA 545 (611)
Q Consensus 524 ~dLI~~~L~~dP~~Rpt~~~~a 545 (611)
.+||..||..+|++||++....
T Consensus 934 y~lM~~CW~~~pe~RP~F~~i~ 955 (1025)
T KOG1095|consen 934 YQLMLQCWKHDPEDRPSFRTIV 955 (1025)
T ss_pred HHHHHHHccCChhhCccHHHHH
Confidence 9999999999999999965433
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=362.86 Aligned_cols=270 Identities=28% Similarity=0.415 Sum_probs=206.5
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceee---------
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFE--------- 286 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~--------- 286 (611)
.+|+.++.||+||||.||+++++-+|+.||||.|.-.. ..+...++.+|+.+|.+|+|||||++|..|.
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 57889999999999999999999999999999997654 4556667889999999999999999876540
Q ss_pred ---------------------------------------------------------------------c----------
Q 007260 287 ---------------------------------------------------------------------T---------- 287 (611)
Q Consensus 287 ---------------------------------------------------------------------~---------- 287 (611)
+
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence 0
Q ss_pred -----------------------c--------ceeeEEeeeCCCCCHHHHHHhCCCCCC-CHHHHHHHHHHHHHHHHHHH
Q 007260 288 -----------------------E--------KFSCLVMEFCPGGDLHTLRQKQPGKYF-PEQAVRFYVAEVLLALEYLH 335 (611)
Q Consensus 288 -----------------------~--------~~~~LVmE~~~gg~L~~ll~~~~~~~l-~e~~~~~i~~qll~aL~yLH 335 (611)
+ ..+||-||||+...|.+++.++. .. ....++++++||+.||.|+|
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~--~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH--FNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc--cchhhHHHHHHHHHHHHHHHHHH
Confidence 0 24689999999888888887752 22 47788999999999999999
Q ss_pred HcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCC
Q 007260 336 MLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSP 415 (611)
Q Consensus 336 ~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (611)
++|||||||||.||++++++.|||+|||+|.......+.. +...
T Consensus 715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~-----d~~~------------------------------- 758 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESI-----DQDL------------------------------- 758 (1351)
T ss_pred hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhH-----hhcc-------------------------------
Confidence 9999999999999999999999999999994321100000 0000
Q ss_pred cccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCccchhhhccCC---CCChhhHHHHHHHHHHHHhCCC
Q 007260 416 RLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEG---HGSAVDWWTFGIFLYELLFGKT 492 (611)
Q Consensus 416 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~---~~~~sDIWSLGviL~ELltG~~ 492 (611)
.+ -...........++.|||--|+|||++.+.. |+.++|||||||||+||+.
T Consensus 759 -----------~~-----------~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y--- 813 (1351)
T KOG1035|consen 759 -----------SF-----------STNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY--- 813 (1351)
T ss_pred -----------Cc-----------cccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---
Confidence 00 0011112233456789999999999998776 8999999999999999984
Q ss_pred CCCCCCcHHHH-HHHHcCCCCCC---CCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCC
Q 007260 493 PFKGSGNRATL-FNVVGQPLRFP---ESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFE 555 (611)
Q Consensus 493 PF~~~~~~~~l-~~i~~~~l~~p---~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 555 (611)
||...-++..+ .++....+.++ ..+.. .....+|++||.+||.+||| |.|||++.||-
T Consensus 814 PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~-~~e~slI~~Ll~hdP~kRPt----A~eLL~s~llp 875 (1351)
T KOG1035|consen 814 PFGTSMERASILTNLRKGSIPEPADFFDPEH-PEEASLIRWLLSHDPSKRPT----ATELLNSELLP 875 (1351)
T ss_pred cCCchHHHHHHHHhcccCCCCCCcccccccc-hHHHHHHHHHhcCCCccCCC----HHHHhhccCCC
Confidence 57655444443 33334444444 11222 34568999999999999999 99999999997
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=331.52 Aligned_cols=268 Identities=29% Similarity=0.448 Sum_probs=217.9
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEec--chh--hhhHHHHHHHHHHHHHHHhCCCCCcccccceee-c
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMD--KAS--LAGRKKLLRAQTEREILQSLDHPFLPTLYTHFE-T 287 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~--k~~--~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~-~ 287 (611)
+..++|-++.+||.|||+.||+|.+....++||+|+-. +.- .......+.+.+|..|.+.|+||.||++|++|. +
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 33468889999999999999999999999999999853 221 123345667889999999999999999999997 4
Q ss_pred cceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--eeccCCCCCcEEEcc---CCcEEEEec
Q 007260 288 EKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLG--IIYRDLKPENVLVRE---DGHIMLSDF 362 (611)
Q Consensus 288 ~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~g--IVHRDLKPeNILv~~---~g~vkL~DF 362 (611)
.+.+|-|+|||+|.||.-++..+ +.++|.+++.|+.||+.||.||.+.. |||-||||.|||+-. -|.+||.||
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred cccceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeec
Confidence 57789999999999998888776 77999999999999999999999875 999999999999964 467999999
Q ss_pred cccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCccc
Q 007260 363 DLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPEL 442 (611)
Q Consensus 363 GlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (611)
||++-++.....
T Consensus 618 GLSKIMdddSy~-------------------------------------------------------------------- 629 (775)
T KOG1151|consen 618 GLSKIMDDDSYN-------------------------------------------------------------------- 629 (775)
T ss_pred chhhhccCCccC--------------------------------------------------------------------
Confidence 999654422100
Q ss_pred ccCcccccccccccCCCccchhhhccC----CCCChhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHH-H-H-HcCCCCCC
Q 007260 443 IAEPTEARSMSFVGTHEYLAPEIIKGE----GHGSAVDWWTFGIFLYELLFGKTPFKGSGNR-ATLF-N-V-VGQPLRFP 514 (611)
Q Consensus 443 ~~~~~~~~~~~~vGT~~Y~APEil~~~----~~~~~sDIWSLGviL~ELltG~~PF~~~~~~-~~l~-~-i-~~~~l~~p 514 (611)
.......+.-+.||.||++||.+.-. ..+.++||||+|||+|.+|+|+.||...-.. +++. + | ......||
T Consensus 630 -~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP 708 (775)
T KOG1151|consen 630 -SVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFP 708 (775)
T ss_pred -cccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCC
Confidence 00112223346799999999987533 3488999999999999999999999864332 2221 1 2 23457789
Q ss_pred CCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCC
Q 007260 515 ESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFE 555 (611)
Q Consensus 515 ~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 555 (611)
.-+.++.++++||++||++.-++|.. +.+|-.||||.
T Consensus 709 ~KPvVsseAkaFIRRCLaYRKeDR~D----V~qLA~dpyll 745 (775)
T KOG1151|consen 709 PKPVVSSEAKAFIRRCLAYRKEDRID----VQQLACDPYLL 745 (775)
T ss_pred CCCccCHHHHHHHHHHHHhhhhhhhh----HHHHccCcccc
Confidence 88999999999999999999999999 99999999995
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=350.21 Aligned_cols=261 Identities=20% Similarity=0.260 Sum_probs=182.7
Q ss_pred cccccCeEEEeEecccCcEEEEEEEECCC----CeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCccccccee--
Q 007260 212 VLGLSHFRLLKRLGCGDIGSVYLSELSGT----KCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHF-- 285 (611)
Q Consensus 212 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t----~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~-- 285 (611)
.+..++|.+.+.||+|+||.||+|++..+ +..||||.+........ ...| .++...+.+++.++..|
T Consensus 128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~-----~~~e--~l~~~~~~~~~~~~~~~~~ 200 (566)
T PLN03225 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEI-----WMNE--RVRRACPNSCADFVYGFLE 200 (566)
T ss_pred CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHH-----HHHH--HHHhhchhhHHHHHHhhhc
Confidence 34567999999999999999999999988 89999998864321110 0111 12222333333333322
Q ss_pred ----eccceeeEEeeeCCCCCHHHHHHhCCC------------------CCCCHHHHHHHHHHHHHHHHHHHHcCeeccC
Q 007260 286 ----ETEKFSCLVMEFCPGGDLHTLRQKQPG------------------KYFPEQAVRFYVAEVLLALEYLHMLGIIYRD 343 (611)
Q Consensus 286 ----~~~~~~~LVmE~~~gg~L~~ll~~~~~------------------~~l~e~~~~~i~~qll~aL~yLH~~gIVHRD 343 (611)
..+..+||||||+.+++|.+++..... ....+..++.++.||+.||+|||++||||||
T Consensus 201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRD 280 (566)
T PLN03225 201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRD 280 (566)
T ss_pred ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCc
Confidence 356789999999999999998875421 1122445778999999999999999999999
Q ss_pred CCCCcEEEcc-CCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCccccccc
Q 007260 344 LKPENVLVRE-DGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKS 422 (611)
Q Consensus 344 LKPeNILv~~-~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (611)
|||+||||+. ++.+||+|||+|..+....
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~-------------------------------------------------- 310 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGI-------------------------------------------------- 310 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCcccccccc--------------------------------------------------
Confidence 9999999986 6899999999984321100
Q ss_pred ccCCCCccccCCCCCCCcccccCcccccccccccCCCccchhhhccCC----------------------CCChhhHHHH
Q 007260 423 KKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEG----------------------HGSAVDWWTF 480 (611)
Q Consensus 423 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~----------------------~~~~sDIWSL 480 (611)
......++||+.|+|||++.... ++.++|||||
T Consensus 311 -------------------------~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 311 -------------------------NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred -------------------------ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 00112457899999999765332 3345699999
Q ss_pred HHHHHHHHhCCCCCCCCCcHHHHHHHHcCC-CC-------------------CCCCCCCCHHHHHHHHHhhhcCccccCC
Q 007260 481 GIFLYELLFGKTPFKGSGNRATLFNVVGQP-LR-------------------FPESPVVSFAARDLIRGLLVKEPQHRLA 540 (611)
Q Consensus 481 GviL~ELltG~~PF~~~~~~~~l~~i~~~~-l~-------------------~p~~~~~s~~l~dLI~~~L~~dP~~Rpt 540 (611)
||+||||+++..++.. ....+..++... .. +.........+++||.+||++||.+||+
T Consensus 366 GviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~t 443 (566)
T PLN03225 366 GLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRIS 443 (566)
T ss_pred HHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCC
Confidence 9999999997766542 222222222110 00 0001112345669999999999999999
Q ss_pred chhcHHHHHcCCCCCCCchh
Q 007260 541 YKRGATEIKQHPFFEGVNWA 560 (611)
Q Consensus 541 ~~~~a~elL~Hp~f~~~~~~ 560 (611)
+.++|+||||.+..+.
T Consensus 444 ----a~e~L~Hpff~~~~~~ 459 (566)
T PLN03225 444 ----AKAALAHPYFDREGLL 459 (566)
T ss_pred ----HHHHhCCcCcCCCCcc
Confidence 9999999999987765
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=338.59 Aligned_cols=272 Identities=28% Similarity=0.430 Sum_probs=217.9
Q ss_pred chHHHHH-HhhccCccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC--
Q 007260 198 LRWEAIQ-AVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD-- 274 (611)
Q Consensus 198 ~~~~~~~-~~~~~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~-- 274 (611)
-.|...+ .++.+-|.+.-++|.+....|.|=|++|.+|.+...+..||||||+....... .-+.|++||++|+
T Consensus 413 DNWdDaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~K----tGl~EleiLkKL~~A 488 (752)
T KOG0670|consen 413 DNWDDAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHK----TGLKELEILKKLNDA 488 (752)
T ss_pred cCcccccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhh----hhhHHHHHHHHhhcc
Confidence 3565433 34555666667899999999999999999999999999999999987654332 2356999999994
Q ss_pred ----CCCcccccceeeccceeeEEeeeCCCCCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcE
Q 007260 275 ----HPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQP-GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENV 349 (611)
Q Consensus 275 ----HpnIv~l~~~~~~~~~~~LVmE~~~gg~L~~ll~~~~-~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNI 349 (611)
.-|+++|+.+|.+.+++|||||-+ .-+|.+++.+.. +-.|...+++.|+.|+..||..|-.+||+|.||||.||
T Consensus 489 D~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNi 567 (752)
T KOG0670|consen 489 DPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNI 567 (752)
T ss_pred CchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccce
Confidence 358999999999999999999999 789999998753 23688899999999999999999999999999999999
Q ss_pred EEccC-CcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCC
Q 007260 350 LVRED-GHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKP 428 (611)
Q Consensus 350 Lv~~~-g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 428 (611)
||++. ..+||||||-|.....
T Consensus 568 LVNE~k~iLKLCDfGSA~~~~e---------------------------------------------------------- 589 (752)
T KOG0670|consen 568 LVNESKNILKLCDFGSASFASE---------------------------------------------------------- 589 (752)
T ss_pred EeccCcceeeeccCcccccccc----------------------------------------------------------
Confidence 99975 4689999998732210
Q ss_pred ccccCCCCCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH-
Q 007260 429 KNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVV- 507 (611)
Q Consensus 429 ~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~- 507 (611)
++ -+-+..+..|+|||+|.|.+|+...|+||+||+||||+||+..|.|.++-..+.-..
T Consensus 590 -ne-------------------itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me 649 (752)
T KOG0670|consen 590 -NE-------------------ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFME 649 (752)
T ss_pred -cc-------------------ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHH
Confidence 00 011235667999999999999999999999999999999999999998877663222
Q ss_pred -cCCCC-------------------C---------------------C---------CCCCCC-------HHHHHHHHHh
Q 007260 508 -GQPLR-------------------F---------------------P---------ESPVVS-------FAARDLIRGL 530 (611)
Q Consensus 508 -~~~l~-------------------~---------------------p---------~~~~~s-------~~l~dLI~~~ 530 (611)
.+++. | | ....++ ..+++||.+|
T Consensus 650 ~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkm 729 (752)
T KOG0670|consen 650 LKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKM 729 (752)
T ss_pred hcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHH
Confidence 11110 0 0 000112 3588999999
Q ss_pred hhcCccccCCchhcHHHHHcCCCCCC
Q 007260 531 LVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 531 L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
|..||++|.+ +.++|+||||++
T Consensus 730 l~LdP~KRit----~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 730 LILDPEKRIT----VNQALKHPFITE 751 (752)
T ss_pred hccChhhcCC----HHHHhcCCcccC
Confidence 9999999999 999999999974
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=319.89 Aligned_cols=253 Identities=27% Similarity=0.436 Sum_probs=214.7
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec------c
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET------E 288 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~------~ 288 (611)
..+|.-++.+|.|+- .|-.|-+.-.++.||+|.+... +.......++.+|..++..+.|+||++++.+|.- .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 358999999999999 8888889889999999988655 5556677789999999999999999999999963 3
Q ss_pred ceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccc
Q 007260 289 KFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRC 368 (611)
Q Consensus 289 ~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~ 368 (611)
...|+||||+ ..+|...+.-. ++-..++.++.|++.|+.|||+.||+||||||+||+|..++.+||.|||+|++-
T Consensus 94 ~e~y~v~e~m-~~nl~~vi~~e----lDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 94 QEVYLVMELM-DANLCQVILME----LDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HhHHHHHHhh-hhHHHHHHHHh----cchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhccc
Confidence 5679999999 67999888743 788899999999999999999999999999999999999999999999998432
Q ss_pred cCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccc
Q 007260 369 AVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTE 448 (611)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (611)
. ..
T Consensus 169 ~-----------------------------------------------------------------------------~~ 171 (369)
T KOG0665|consen 169 D-----------------------------------------------------------------------------TD 171 (369)
T ss_pred C-----------------------------------------------------------------------------cc
Confidence 1 11
Q ss_pred ccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCC------------------
Q 007260 449 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQP------------------ 510 (611)
Q Consensus 449 ~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~------------------ 510 (611)
.+.+-+|.|..|+|||++.+.+|...+||||+||++.||++|+..|.|.+..+++.+++..-
T Consensus 172 ~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~y 251 (369)
T KOG0665|consen 172 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNY 251 (369)
T ss_pred cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHH
Confidence 23345789999999999999999999999999999999999999999988777766554321
Q ss_pred ---------C----CCCCC---------CCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCC
Q 007260 511 ---------L----RFPES---------PVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFE 555 (611)
Q Consensus 511 ---------l----~~p~~---------~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 555 (611)
+ .||+. ..-...++||+.+||..||++|.+ ++++|+||||+
T Consensus 252 v~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Ris----v~daL~HPY~~ 314 (369)
T KOG0665|consen 252 VENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRIS----VDDALRHPYIK 314 (369)
T ss_pred hhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhccc----HHHHhcCCeee
Confidence 0 12221 123456899999999999999999 99999999998
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=334.55 Aligned_cols=264 Identities=22% Similarity=0.265 Sum_probs=194.4
Q ss_pred ccccCeEEEeEecccCcEEEEEEEEC----------------CCCeEEEEEEecchhhhhHHHH-----------HHHHH
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELS----------------GTKCYFAMKVMDKASLAGRKKL-----------LRAQT 265 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~----------------~t~~~vAvKii~k~~~~~~~~~-----------~~~~~ 265 (611)
+..++|++.++||+|+||+||+|.+. ..++.||||.+........+.+ .....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 44679999999999999999999752 2346799999864332111111 12234
Q ss_pred HHHHHHhCCCCCc-----ccccceeec--------cceeeEEeeeCCCCCHHHHHHhCCC--------------------
Q 007260 266 EREILQSLDHPFL-----PTLYTHFET--------EKFSCLVMEFCPGGDLHTLRQKQPG-------------------- 312 (611)
Q Consensus 266 E~~iL~~l~HpnI-----v~l~~~~~~--------~~~~~LVmE~~~gg~L~~ll~~~~~-------------------- 312 (611)
|+.++.+++|.++ +.++++|.. ....||||||+++++|.+++....+
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 7777777766554 677777653 3568999999999999998864311
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccccCCCCcCcCCCc
Q 007260 313 --KYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPV 390 (611)
Q Consensus 313 --~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (611)
..+++..++.++.||+.||.|||.+||+||||||+|||++.++.+||+|||++........
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~----------------- 364 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN----------------- 364 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-----------------
Confidence 1245677899999999999999999999999999999999999999999999843210000
Q ss_pred cccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCccchhhhccCC
Q 007260 391 YCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEG 470 (611)
Q Consensus 391 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~ 470 (611)
.......+|+.|+|||++....
T Consensus 365 ----------------------------------------------------------~~~~~g~~tp~Y~aPE~l~~~~ 386 (507)
T PLN03224 365 ----------------------------------------------------------FNPLYGMLDPRYSPPEELVMPQ 386 (507)
T ss_pred ----------------------------------------------------------cCccccCCCcceeChhhhcCCC
Confidence 0000123588999999986432
Q ss_pred --------------------CC--ChhhHHHHHHHHHHHHhCCC-CCCCCCc-----------HHHHHHHHcCCCCCCCC
Q 007260 471 --------------------HG--SAVDWWTFGIFLYELLFGKT-PFKGSGN-----------RATLFNVVGQPLRFPES 516 (611)
Q Consensus 471 --------------------~~--~~sDIWSLGviL~ELltG~~-PF~~~~~-----------~~~l~~i~~~~l~~p~~ 516 (611)
|+ ...||||+||+||+|++|.. ||.+... ...+..+......++..
T Consensus 387 ~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~ 466 (507)
T PLN03224 387 SCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLL 466 (507)
T ss_pred CCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccc
Confidence 22 24799999999999999986 7754221 11122334456667777
Q ss_pred CCCCHHHHHHHHHhhhcCc---cccCCchhcHHHHHcCCCCC
Q 007260 517 PVVSFAARDLIRGLLVKEP---QHRLAYKRGATEIKQHPFFE 555 (611)
Q Consensus 517 ~~~s~~l~dLI~~~L~~dP---~~Rpt~~~~a~elL~Hp~f~ 555 (611)
..+++.++|||.+||.++| .+|++ |.|+|+||||.
T Consensus 467 d~~s~~~~dLi~~LL~~~~~~~~~RlS----a~eaL~Hp~f~ 504 (507)
T PLN03224 467 DRNKEAGWDLACKLITKRDQANRGRLS----VGQALSHRFFL 504 (507)
T ss_pred cccChHHHHHHHHHhccCCCCcccCCC----HHHHhCCCCcC
Confidence 7789999999999999876 68999 99999999995
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=296.76 Aligned_cols=242 Identities=48% Similarity=0.784 Sum_probs=204.0
Q ss_pred CcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEeeeCCCCCHHHHH
Q 007260 228 DIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLR 307 (611)
Q Consensus 228 ~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE~~~gg~L~~ll 307 (611)
+||.||+|.+..+++.||+|++........ ...+.+|++++++++|+||+++++++......++||||+++++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 589999999999999999999976543321 456778999999999999999999999999999999999999999998
Q ss_pred HhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccccCCCCcCcC
Q 007260 308 QKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRK 387 (611)
Q Consensus 308 ~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~ 387 (611)
.... .+++..+..++.+++.+|.|||..||+|+||+|.||+++.++.++|+|||++.......
T Consensus 79 ~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--------------- 141 (244)
T smart00220 79 KKRG--RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--------------- 141 (244)
T ss_pred Hhcc--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---------------
Confidence 7753 38999999999999999999999999999999999999999999999999984332100
Q ss_pred CCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCccchhhhc
Q 007260 388 NPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIK 467 (611)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~ 467 (611)
......|+..|++||++.
T Consensus 142 --------------------------------------------------------------~~~~~~~~~~~~~pE~~~ 159 (244)
T smart00220 142 --------------------------------------------------------------LLTTFVGTPEYMAPEVLL 159 (244)
T ss_pred --------------------------------------------------------------ccccccCCcCCCCHHHHc
Confidence 011235888999999999
Q ss_pred cCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCC-CCCCCC-CCHHHHHHHHHhhhcCccccCCchhcH
Q 007260 468 GEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLR-FPESPV-VSFAARDLIRGLLVKEPQHRLAYKRGA 545 (611)
Q Consensus 468 ~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~-~p~~~~-~s~~l~dLI~~~L~~dP~~Rpt~~~~a 545 (611)
+..++.++|||+||+++|+|++|..||........+.+.+..... ...... ++.++.++|.+||..+|++||+ +
T Consensus 160 ~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~----~ 235 (244)
T smart00220 160 GKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT----A 235 (244)
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccC----H
Confidence 888999999999999999999999999884555555554443332 222222 8899999999999999999999 9
Q ss_pred HHHHcCCCC
Q 007260 546 TEIKQHPFF 554 (611)
Q Consensus 546 ~elL~Hp~f 554 (611)
.++++||||
T Consensus 236 ~~~~~~~~~ 244 (244)
T smart00220 236 EEALQHPFF 244 (244)
T ss_pred HHHhhCCCC
Confidence 999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=300.20 Aligned_cols=254 Identities=27% Similarity=0.463 Sum_probs=208.1
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC-CCCcccccceeecc--cee
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD-HPFLPTLYTHFETE--KFS 291 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~-HpnIv~l~~~~~~~--~~~ 291 (611)
.++|++.+++|+|.|+.||.|.+..+++.++||+++.-. .+.+.+|+.||+.|. ||||++|+++..+. +..
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 469999999999999999999999999999999997532 235678999999996 99999999998764 567
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEcc-CCcEEEEeccccccccC
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRE-DGHIMLSDFDLSLRCAV 370 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~-~g~vkL~DFGlA~~~~~ 370 (611)
-||+||+.+.|...+... |+.-.++.|+.|||.||.|||++||+|||+||.|++|+. .-.++|+|+|||..+.+
T Consensus 111 aLiFE~v~n~Dfk~ly~t-----l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLYPT-----LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hhHhhhhccccHHHHhhh-----hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 899999999888876543 788999999999999999999999999999999999996 45799999999955432
Q ss_pred CccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccc
Q 007260 371 SPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEAR 450 (611)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (611)
... |+
T Consensus 186 ~~e-----------------Yn---------------------------------------------------------- 190 (338)
T KOG0668|consen 186 GKE-----------------YN---------------------------------------------------------- 190 (338)
T ss_pred Cce-----------------ee----------------------------------------------------------
Confidence 211 11
Q ss_pred ccccccCCCccchhhhccCC-CCChhhHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHc--------------------
Q 007260 451 SMSFVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPF-KGSGNRATLFNVVG-------------------- 508 (611)
Q Consensus 451 ~~~~vGT~~Y~APEil~~~~-~~~~sDIWSLGviL~ELltG~~PF-~~~~~~~~l~~i~~-------------------- 508 (611)
-.|.+..|--||++..-. |+..-|+|||||+|..|++.+.|| .|.++.+++.+|..
T Consensus 191 --VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp 268 (338)
T KOG0668|consen 191 --VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDP 268 (338)
T ss_pred --eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCCh
Confidence 225677899999987654 688999999999999999988885 67778777755431
Q ss_pred -------CCCC-----C--C-CCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCchh
Q 007260 509 -------QPLR-----F--P-ESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWA 560 (611)
Q Consensus 509 -------~~l~-----~--p-~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~ 560 (611)
+..+ | + ....+++++.|||.++|.+|-++|+| |.|++.||||..+.-+
T Consensus 269 ~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlT----akEam~HpyF~~~~~~ 331 (338)
T KOG0668|consen 269 QFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLT----AKEAMAHPYFAPVREA 331 (338)
T ss_pred hHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccc----hHHHhcCchHHHHHHH
Confidence 1111 0 0 11236799999999999999999999 9999999999865443
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=332.95 Aligned_cols=253 Identities=22% Similarity=0.347 Sum_probs=213.8
Q ss_pred cccCeEEEeEecccCcEEEEEEEECC---CCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccce
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSG---TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKF 290 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~---t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~ 290 (611)
..++.++.++||+|.||+|++|.+.. +-..||||+++.+.+.. .+..|.+|+.+|.+|+|+|+++||++..+ ..
T Consensus 108 pee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp 184 (1039)
T KOG0199|consen 108 PEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QP 184 (1039)
T ss_pred cHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-ch
Confidence 34566778999999999999999853 33468999998766543 56678899999999999999999999887 78
Q ss_pred eeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccC
Q 007260 291 SCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAV 370 (611)
Q Consensus 291 ~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~ 370 (611)
+.||||+++.|+|.+.+.+.....|.......|+.||+.|+.||..+++|||||...||||-....|||+||||.+-+..
T Consensus 185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 89999999999999998886667899999999999999999999999999999999999999988999999999865543
Q ss_pred CccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccc
Q 007260 371 SPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEAR 450 (611)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (611)
...+ |..++.
T Consensus 265 ned~----------------Yvm~p~------------------------------------------------------ 274 (1039)
T KOG0199|consen 265 NEDM----------------YVMAPQ------------------------------------------------------ 274 (1039)
T ss_pred CCcc----------------eEecCC------------------------------------------------------
Confidence 2221 111100
Q ss_pred ccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHH
Q 007260 451 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRG 529 (611)
Q Consensus 451 ~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~ 529 (611)
.--...|+|||.|+...++.++|+|++||+||||++ |+.||.|.....++.+|- ..-+++....+++++.+++..
T Consensus 275 ---rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~erLpRPk~csedIY~imk~ 350 (1039)
T KOG0199|consen 275 ---RKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGERLPRPKYCSEDIYQIMKN 350 (1039)
T ss_pred ---CcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-ccccCCCCCCChHHHHHHHHH
Confidence 012346999999999999999999999999999995 999999998888887766 555666666799999999999
Q ss_pred hhhcCccccCCchh
Q 007260 530 LLVKEPQHRLAYKR 543 (611)
Q Consensus 530 ~L~~dP~~Rpt~~~ 543 (611)
||+.+|++||+|..
T Consensus 351 cWah~paDRptFsa 364 (1039)
T KOG0199|consen 351 CWAHNPADRPTFSA 364 (1039)
T ss_pred hccCCccccccHHH
Confidence 99999999999643
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=305.03 Aligned_cols=260 Identities=26% Similarity=0.382 Sum_probs=210.5
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecc-----cee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE-----KFS 291 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~-----~~~ 291 (611)
+.+--+.||.|+||.||.+.+..+++.||+|.+.. .+.+-...+++.+|+++|...+|.|++..++...-. ..+
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pn-vfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPN-VFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcch-HHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 34445789999999999999999999999999853 344445566889999999999999999998876532 467
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCC
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~ 371 (611)
|+|.|++ ..||+.++-.- ..++.+.++-+++||++||+|||+.||.||||||.|+||+.+..+||||||||+.....
T Consensus 133 YV~TELm-QSDLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 133 YVLTELM-QSDLHKIIVSP--QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHHHH-HhhhhheeccC--CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchh
Confidence 9999999 67999877653 56999999999999999999999999999999999999999999999999999543211
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
. ...+
T Consensus 210 ~---------------------------------------------------------------------------~~hM 214 (449)
T KOG0664|consen 210 D---------------------------------------------------------------------------RLNM 214 (449)
T ss_pred h---------------------------------------------------------------------------hhhh
Confidence 0 1112
Q ss_pred cccccCCCccchhhhccCC-CCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH-----------------------
Q 007260 452 MSFVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVV----------------------- 507 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~~~-~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~----------------------- 507 (611)
+.-|-|-+|+|||+++|.. |+.++||||+|||+.|||-.+..|...+..+++.-|.
T Consensus 215 TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~L 294 (449)
T KOG0664|consen 215 THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVL 294 (449)
T ss_pred HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhh
Confidence 2357899999999999986 6899999999999999999999999887766654332
Q ss_pred cCCCCCCCCC---------CCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCch
Q 007260 508 GQPLRFPESP---------VVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNW 559 (611)
Q Consensus 508 ~~~l~~p~~~---------~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 559 (611)
..+.+.|... .-..+..+++..+|..||.+|.+ .++++.|+|..+...
T Consensus 295 R~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris----~~~A~~~~~~~e~R~ 351 (449)
T KOG0664|consen 295 RAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRIS----VEEALQHRYLEEGRL 351 (449)
T ss_pred ccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCccccc----Hhhhcccccccccce
Confidence 2223333221 13356789999999999999999 999999999976543
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=302.49 Aligned_cols=258 Identities=26% Similarity=0.373 Sum_probs=206.7
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHH-HhCCCCCcccccceeeccceeeEE
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREIL-QSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL-~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
.+.+-+..||.|+||+|++..++.+++..|||.++.... .+...++..|.+.. +.-+.||||++|+....++..||.
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiC 141 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWIC 141 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeee
Confidence 455667889999999999999999999999999987654 34445667788764 445799999999999999999999
Q ss_pred eeeCCCCCHHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHH-cCeeccCCCCCcEEEccCCcEEEEeccccccccC
Q 007260 295 MEFCPGGDLHTLRQK---QPGKYFPEQAVRFYVAEVLLALEYLHM-LGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAV 370 (611)
Q Consensus 295 mE~~~gg~L~~ll~~---~~~~~l~e~~~~~i~~qll~aL~yLH~-~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~ 370 (611)
||+| ..+|..+... -....++|..+-.|....+.||+||-. +.||||||||+|||++..|.|||||||++-.+..
T Consensus 142 MELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 142 MELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 9999 5676654321 123569999999999999999999975 6899999999999999999999999999733221
Q ss_pred CccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccc
Q 007260 371 SPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEAR 450 (611)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (611)
+- +
T Consensus 221 Si-----------------------------------------------------------------------A------ 223 (361)
T KOG1006|consen 221 SI-----------------------------------------------------------------------A------ 223 (361)
T ss_pred HH-----------------------------------------------------------------------H------
Confidence 10 0
Q ss_pred ccccccCCCccchhhhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHcCCCC-CCC---CCCCCHHH
Q 007260 451 SMSFVGTHEYLAPEIIKG--EGHGSAVDWWTFGIFLYELLFGKTPFKGSGN-RATLFNVVGQPLR-FPE---SPVVSFAA 523 (611)
Q Consensus 451 ~~~~vGT~~Y~APEil~~--~~~~~~sDIWSLGviL~ELltG~~PF~~~~~-~~~l~~i~~~~l~-~p~---~~~~s~~l 523 (611)
.+.-+|-..|||||.+.. .+|+-++|+||||++|||+.||+.|+++... .+++..++.+... +-. ...++..+
T Consensus 224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~ 303 (361)
T KOG1006|consen 224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSM 303 (361)
T ss_pred hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHH
Confidence 012258889999999964 4689999999999999999999999998654 4555555554322 211 23489999
Q ss_pred HHHHHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 524 RDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 524 ~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
+.+|.-||.+|-.+||. ..+|+.+||++-.
T Consensus 304 ~~fintCl~Kd~~~Rpk----y~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 304 VRFINTCLIKDRSDRPK----YDDLKKFPFYRMY 333 (361)
T ss_pred HHHHHHHhhcccccCcc----hhhhhcCchhhhh
Confidence 99999999999999999 7899999999754
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=312.74 Aligned_cols=256 Identities=22% Similarity=0.306 Sum_probs=210.3
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSC 292 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~ 292 (611)
+..+...+.++||+|-||.|.+|+..+ +..||+|.++..... .....|..|+++|.+|+|||||.|++++..++.+|
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~--~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATK--NARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC 611 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccch--hHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence 344678889999999999999998876 678999999876533 23456788999999999999999999999999999
Q ss_pred EEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCc
Q 007260 293 LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 293 LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~ 372 (611)
|||||++.|||.+++.++....+.......++.||+.|++||.+.+||||||.+.|+|++.++++||+|||+++.+-
T Consensus 612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly--- 688 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLY--- 688 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccc---
Confidence 99999999999999998743333444556699999999999999999999999999999999999999999985321
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
.++.|.+| .
T Consensus 689 --------------sg~yy~vq---------------------------------------------------------g 697 (807)
T KOG1094|consen 689 --------------SGDYYRVQ---------------------------------------------------------G 697 (807)
T ss_pred --------------cCCceeee---------------------------------------------------------c
Confidence 12222222 2
Q ss_pred ccccCCCccchhhhccCCCCChhhHHHHHHHHHHHH--hCCCCCCCCCcHHHHHHHHcC----C--CCCCCCCCCCHHHH
Q 007260 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELL--FGKTPFKGSGNRATLFNVVGQ----P--LRFPESPVVSFAAR 524 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELl--tG~~PF~~~~~~~~l~~i~~~----~--l~~p~~~~~s~~l~ 524 (611)
.+|-...|||+|.|.-..++.++|+|+||+++||++ |...||...++++.+.+.-.- . .-.+.++.++..+.
T Consensus 698 r~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~ly 777 (807)
T KOG1094|consen 698 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLY 777 (807)
T ss_pred ceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHH
Confidence 346677899999999999999999999999999986 689999998888777654321 1 12334456899999
Q ss_pred HHHHHhhhcCccccCCchhcHHHHH
Q 007260 525 DLIRGLLVKEPQHRLAYKRGATEIK 549 (611)
Q Consensus 525 dLI~~~L~~dP~~Rpt~~~~a~elL 549 (611)
+||.+||.+|-.+||+ .++|-
T Consensus 778 elml~Cw~~es~~RPs----Fe~lh 798 (807)
T KOG1094|consen 778 ELMLRCWRRESEQRPS----FEQLH 798 (807)
T ss_pred HHHHHHhchhhhcCCC----HHHHH
Confidence 9999999999999999 55553
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=316.16 Aligned_cols=251 Identities=21% Similarity=0.332 Sum_probs=216.2
Q ss_pred cccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecccee
Q 007260 212 VLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFS 291 (611)
Q Consensus 212 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~ 291 (611)
++...+..+-.+||.|-||.||.+.++.-...||||.++.+.+. +..|..|+.+|+.++|||+|+|+++|..+-.+
T Consensus 263 EmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe----veEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 263 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred hccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh----HHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 33445667788999999999999999999999999999876544 44667799999999999999999999999999
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCC
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~ 371 (611)
|||.|||..|+|.++++......++.-...+++.||..|++||..+++|||||...|+||.++..||++||||++.+..+
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD 418 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD 418 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCC
Confidence 99999999999999999887777888888888999999999999999999999999999999999999999999654321
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
++....
T Consensus 419 -TYTAHA------------------------------------------------------------------------- 424 (1157)
T KOG4278|consen 419 -TYTAHA------------------------------------------------------------------------- 424 (1157)
T ss_pred -ceeccc-------------------------------------------------------------------------
Confidence 111100
Q ss_pred cccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 007260 452 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGL 530 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~ 530 (611)
.---..-|.|||-+....++.++|||+|||+|||+.| |-.||.|. +..+++.++...+++..+..+++.+.+|++.|
T Consensus 425 -GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi-dlSqVY~LLEkgyRM~~PeGCPpkVYeLMraC 502 (1157)
T KOG4278|consen 425 -GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYGLLEKGYRMDGPEGCPPKVYELMRAC 502 (1157)
T ss_pred -CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc-cHHHHHHHHhccccccCCCCCCHHHHHHHHHH
Confidence 0012346999999999999999999999999999995 99999986 45567788888888888888999999999999
Q ss_pred hhcCccccCCch
Q 007260 531 LVKEPQHRLAYK 542 (611)
Q Consensus 531 L~~dP~~Rpt~~ 542 (611)
|.++|.+||+|+
T Consensus 503 W~WsPsDRPsFa 514 (1157)
T KOG4278|consen 503 WNWSPSDRPSFA 514 (1157)
T ss_pred hcCCcccCccHH
Confidence 999999999954
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=316.67 Aligned_cols=251 Identities=26% Similarity=0.402 Sum_probs=206.3
Q ss_pred ccccCeEEEeEecccCcEEEEEEEEC----CCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecc
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELS----GTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE 288 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~----~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~ 288 (611)
+..+...+.+.||.|-||.||.|... +.+--||||.-+.+.. .+..+.|..|..+|+.++|||||+|+|++.+
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t--~d~tekflqEa~iMrnfdHphIikLIGv~~e- 462 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT--PDDTEKFLQEASIMRNFDHPHIIKLIGVCVE- 462 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC--hhhHHHHHHHHHHHHhCCCcchhheeeeeec-
Confidence 33445556688999999999999853 3345689998865432 2235567889999999999999999999874
Q ss_pred ceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccc
Q 007260 289 KFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRC 368 (611)
Q Consensus 289 ~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~ 368 (611)
...|||||+++-|.|..+++.+. ..++......|+.||+.||.|||+..+|||||...||||.....|||+||||++.+
T Consensus 463 ~P~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 463 QPMWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred cceeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhc
Confidence 56899999999999999999874 56999999999999999999999999999999999999999999999999999655
Q ss_pred cCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccc
Q 007260 369 AVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTE 448 (611)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (611)
.... +..++
T Consensus 542 ed~~-yYkaS---------------------------------------------------------------------- 550 (974)
T KOG4257|consen 542 EDDA-YYKAS---------------------------------------------------------------------- 550 (974)
T ss_pred cccc-hhhcc----------------------------------------------------------------------
Confidence 4321 11110
Q ss_pred ccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHH-hCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 007260 449 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELL-FGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLI 527 (611)
Q Consensus 449 ~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELl-tG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI 527 (611)
...-..-|||||.+.-..++.++|||-|||++||+| .|..||.+-.+.+.+..+ .+.-+.|.++.+++.+..|+
T Consensus 551 ----~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i-EnGeRlP~P~nCPp~LYslm 625 (974)
T KOG4257|consen 551 ----RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI-ENGERLPCPPNCPPALYSLM 625 (974)
T ss_pred ----ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe-cCCCCCCCCCCCChHHHHHH
Confidence 001234699999999999999999999999999988 599999998777666443 44457788888999999999
Q ss_pred HHhhhcCccccCCchh
Q 007260 528 RGLLVKEPQHRLAYKR 543 (611)
Q Consensus 528 ~~~L~~dP~~Rpt~~~ 543 (611)
.+||++||.+||.+.+
T Consensus 626 skcWayeP~kRPrfte 641 (974)
T KOG4257|consen 626 SKCWAYEPSKRPRFTE 641 (974)
T ss_pred HHHhccCcccCCcHHH
Confidence 9999999999999643
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=324.81 Aligned_cols=267 Identities=24% Similarity=0.333 Sum_probs=224.9
Q ss_pred HHHhhccCccccccCeEEEeEecccCcEEEEEEEECCCC---eEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcc
Q 007260 203 IQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTK---CYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLP 279 (611)
Q Consensus 203 ~~~~~~~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~---~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv 279 (611)
.++++....++..+...|.++||.|-||.||+|+++..+ ..||||.++.... .+....|..|+.||-+.+||||+
T Consensus 616 nqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyt--ekqrrdFL~EAsIMGQFdHPNII 693 (996)
T KOG0196|consen 616 NQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNII 693 (996)
T ss_pred cHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCcc--HHHHhhhhhhhhhcccCCCCcEE
Confidence 345555555666778899999999999999999987654 4799999976542 34455788999999999999999
Q ss_pred cccceeeccceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEE
Q 007260 280 TLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIML 359 (611)
Q Consensus 280 ~l~~~~~~~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL 359 (611)
+|.++....+.+.||.|||++|.|..+++.+.+. |...+..-+++.|+.|+.||-+.|+|||||...||||+.+-.+|+
T Consensus 694 rLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKV 772 (996)
T KOG0196|consen 694 RLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKV 772 (996)
T ss_pred EEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEe
Confidence 9999999999999999999999999999988654 888888899999999999999999999999999999999999999
Q ss_pred EeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCC
Q 007260 360 SDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPL 439 (611)
Q Consensus 360 ~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (611)
+||||++.+..++.. .|...++
T Consensus 773 sDFGLSRvledd~~~---------------~ytt~GG------------------------------------------- 794 (996)
T KOG0196|consen 773 SDFGLSRVLEDDPEA---------------AYTTLGG------------------------------------------- 794 (996)
T ss_pred ccccceeecccCCCc---------------cccccCC-------------------------------------------
Confidence 999999765433210 0000000
Q ss_pred cccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHH-hCCCCCCCCCcHHHHHHHHcCCCCCCCCCC
Q 007260 440 PELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELL-FGKTPFKGSGNRATLFNVVGQPLRFPESPV 518 (611)
Q Consensus 440 ~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELl-tG~~PF~~~~~~~~l~~i~~~~l~~p~~~~ 518 (611)
--...|.|||.|....++.++||||+||++||.+ +|..||...+|.+.+. .+.+.+++|.+..
T Consensus 795 ---------------KIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIk-aIe~gyRLPpPmD 858 (996)
T KOG0196|consen 795 ---------------KIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIK-AIEQGYRLPPPMD 858 (996)
T ss_pred ---------------ccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHH-HHHhccCCCCCCC
Confidence 0124699999999999999999999999999987 6999999999887764 4566688888888
Q ss_pred CCHHHHHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 519 VSFAARDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 519 ~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
++..+..|+..||++|-.+||. ..||+.
T Consensus 859 CP~aL~qLMldCWqkdR~~RP~----F~qiV~ 886 (996)
T KOG0196|consen 859 CPAALYQLMLDCWQKDRNRRPK----FAQIVS 886 (996)
T ss_pred CcHHHHHHHHHHHHHHhhcCCC----HHHHHH
Confidence 9999999999999999999999 566665
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=323.94 Aligned_cols=256 Identities=28% Similarity=0.464 Sum_probs=220.4
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
.+|.++.++|+|+||.||+|++..+++..|+|+++-..- ..+.-.+.|+-+++.++|||||.+++.+.....++++|
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~---dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG---DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCC---ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 589999999999999999999999999999999975432 23345678999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
|||.||+|.+..+-. +.++|.++.+++++.+.||+|||++|-+|||||-.|||+++.|.+||+|||.+..+.
T Consensus 92 EycgggslQdiy~~T--gplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqit------ 163 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQIT------ 163 (829)
T ss_pred EecCCCcccceeeec--ccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhh------
Confidence 999999999876554 789999999999999999999999999999999999999999999999999873322
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
.+..+..+|+
T Consensus 164 ----------------------------------------------------------------------ati~Krksfi 173 (829)
T KOG0576|consen 164 ----------------------------------------------------------------------ATIAKRKSFI 173 (829)
T ss_pred ----------------------------------------------------------------------hhhhhhhccc
Confidence 1233455789
Q ss_pred cCCCccchhhhc---cCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcC---CCCCCCCCCCCHHHHHHHHH
Q 007260 456 GTHEYLAPEIIK---GEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ---PLRFPESPVVSFAARDLIRG 529 (611)
Q Consensus 456 GT~~Y~APEil~---~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~---~l~~p~~~~~s~~l~dLI~~ 529 (611)
||++|||||+.. ..+|+..+|||++|++..||---++|.........++-+... +....+....++.+.+|++.
T Consensus 174 GtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~ 253 (829)
T KOG0576|consen 174 GTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKG 253 (829)
T ss_pred CCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHH
Confidence 999999999874 567999999999999999999888886666565555554443 34444556689999999999
Q ss_pred hhhcCccccCCchhcHHHHHcCCCCCC
Q 007260 530 LLVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 530 ~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
+|.++|++||+ ++.+|+|||...
T Consensus 254 altknpKkRpt----aeklL~h~fvs~ 276 (829)
T KOG0576|consen 254 ALTKNPKKRPT----AEKLLQHPFVSQ 276 (829)
T ss_pred HhcCCCccCCC----hhhheeceeecc
Confidence 99999999999 999999999864
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=314.11 Aligned_cols=203 Identities=30% Similarity=0.486 Sum_probs=177.9
Q ss_pred cccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHH-----HHHHHHHHHHHHHhCC---CCCccccccee
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRK-----KLLRAQTEREILQSLD---HPFLPTLYTHF 285 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~-----~~~~~~~E~~iL~~l~---HpnIv~l~~~~ 285 (611)
.+.+|..++.||.|+||.|++|.++.+...|+||.|.|.+.--.- ++-.+--||.||..|+ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 356899999999999999999999999999999999887653211 1222345999999997 99999999999
Q ss_pred eccceeeEEeeeC-CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccc
Q 007260 286 ETEKFSCLVMEFC-PGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDL 364 (611)
Q Consensus 286 ~~~~~~~LVmE~~-~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGl 364 (611)
++++++||+||-- +|.||++++... ..++|.+++.|++||+.|+++||++||||||||-|||+|+.+|.+||+|||-
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccc
Confidence 9999999999974 678999999987 4599999999999999999999999999999999999999999999999998
Q ss_pred cccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCccccc
Q 007260 365 SLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIA 444 (611)
Q Consensus 365 A~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (611)
|...
T Consensus 717 aa~~---------------------------------------------------------------------------- 720 (772)
T KOG1152|consen 717 AAYT---------------------------------------------------------------------------- 720 (772)
T ss_pred hhhh----------------------------------------------------------------------------
Confidence 7211
Q ss_pred CcccccccccccCCCccchhhhccCCC-CChhhHHHHHHHHHHHHhCCCCCCC
Q 007260 445 EPTEARSMSFVGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKG 496 (611)
Q Consensus 445 ~~~~~~~~~~vGT~~Y~APEil~~~~~-~~~sDIWSLGviL~ELltG~~PF~~ 496 (611)
.......|+||..|.|||++.|..| |..-|||+|||+||-+++...||.+
T Consensus 721 --ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 721 --KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred --cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 1112236899999999999999998 8999999999999999999999874
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=302.63 Aligned_cols=297 Identities=25% Similarity=0.385 Sum_probs=210.7
Q ss_pred cccCeEEEeEecccCcEEEEEEEECC---CCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeeccc
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSG---TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEK 289 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~---t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~~ 289 (611)
....|+++.+||.|+|++||+|.+.. .+++||+|.+...... .++.+|+++|..+ .+.||+.+.+.+..++
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p-----~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP-----SRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc-----hHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 34689999999999999999999877 7889999998776533 3678899999999 5999999999999999
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEcc-CCcEEEEeccccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRE-DGHIMLSDFDLSLRC 368 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~-~g~vkL~DFGlA~~~ 368 (611)
..++||||++..+..++... ++...++.|++.++.||.++|.+|||||||||.|+|.+. .++-.|+|||||.+.
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~ 183 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY 183 (418)
T ss_pred eeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHH
Confidence 99999999999999887765 678899999999999999999999999999999999984 678899999999753
Q ss_pred cCCccccccccC---CCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccC
Q 007260 369 AVSPTLIKASSL---DAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAE 445 (611)
Q Consensus 369 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (611)
............ ...+. .+..+. |... .+..+ |..+-... ..
T Consensus 184 d~~~~~~~s~~~~~~~~~~~-~g~~~~----~~~~--~~~~~-------p~g~~~~~---------------------~~ 228 (418)
T KOG1167|consen 184 DGYQQTEHSRSYSGRHATPA-MGKDVH----CQSV--ATASK-------PAGYYRRC---------------------ND 228 (418)
T ss_pred HhhhhhhhhhhhhcccCCcc-ccCccc----cccc--ccccC-------CCCceecc---------------------CC
Confidence 221111100000 00000 000000 0000 00000 00000000 00
Q ss_pred cccccccccccCCCccchhhhccCC-CCChhhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHH---HH------------c
Q 007260 446 PTEARSMSFVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSGN-RATLFN---VV------------G 508 (611)
Q Consensus 446 ~~~~~~~~~vGT~~Y~APEil~~~~-~~~~sDIWSLGviL~ELltG~~PF~~~~~-~~~l~~---i~------------~ 508 (611)
..-.......||++|+|||++...+ .+.++||||.|||++-+++++.||-...+ ...+.. |. +
T Consensus 229 ~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g 308 (418)
T KOG1167|consen 229 GRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPG 308 (418)
T ss_pred CccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCC
Confidence 0111123457999999999998776 48899999999999999999999854322 111111 10 1
Q ss_pred C-----C---------------C--------CC------CCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCC
Q 007260 509 Q-----P---------------L--------RF------PESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 509 ~-----~---------------l--------~~------p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f 554 (611)
. + + +. ......+..+.||+++||..||.+|.+ |+++|+||||
T Consensus 309 ~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRit----AEeALkHpFF 384 (418)
T KOG1167|consen 309 RILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRIT----AEDALKHPFF 384 (418)
T ss_pred ceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhccc----HHHHhcCcCC
Confidence 1 0 0 00 001124557889999999999999999 9999999999
Q ss_pred CCCch
Q 007260 555 EGVNW 559 (611)
Q Consensus 555 ~~~~~ 559 (611)
...+-
T Consensus 385 ~~~~~ 389 (418)
T KOG1167|consen 385 DEADR 389 (418)
T ss_pred cchhh
Confidence 86554
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=341.25 Aligned_cols=238 Identities=19% Similarity=0.272 Sum_probs=185.7
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
..|...+.||+|+||.||+|++..++..||||.+...... ...|++++++++|||||++++++.+++..||||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 3566778999999999999999999999999998653311 124688999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HcCeeccCCCCCcEEEccCCcEEEEeccccccccCCc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLH---MLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH---~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~ 372 (611)
||+++|+|.++++. +++..+..++.||+.||+||| ..+|+||||||+|||++.++..++. ||.+....
T Consensus 763 Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~--- 833 (968)
T PLN00113 763 EYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC--- 833 (968)
T ss_pred eCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc---
Confidence 99999999999853 789999999999999999999 6699999999999999988887775 65541100
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
...
T Consensus 834 -----------------------------------------------------------------------------~~~ 836 (968)
T PLN00113 834 -----------------------------------------------------------------------------TDT 836 (968)
T ss_pred -----------------------------------------------------------------------------cCC
Confidence 001
Q ss_pred ccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHH----------cCCCC--CCCC
Q 007260 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGN----RATLFNVV----------GQPLR--FPES 516 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~----~~~l~~i~----------~~~l~--~p~~ 516 (611)
..+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........ ...+. .+..
T Consensus 837 ~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (968)
T PLN00113 837 KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVN 916 (968)
T ss_pred CccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCcc
Confidence 12588999999999999999999999999999999999999964211 11111110 00000 0001
Q ss_pred CCCCHHHHHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 517 PVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 517 ~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
.....++.+++.+||..||++||+ +.|+++
T Consensus 917 ~~~~~~~~~l~~~Cl~~~P~~RPt----~~evl~ 946 (968)
T PLN00113 917 QNEIVEVMNLALHCTATDPTARPC----ANDVLK 946 (968)
T ss_pred HHHHHHHHHHHHhhCcCCchhCcC----HHHHHH
Confidence 112235778999999999999999 777765
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=319.70 Aligned_cols=250 Identities=29% Similarity=0.428 Sum_probs=198.2
Q ss_pred eEEEeEecccCcE-EEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeeccceeeEEe
Q 007260 218 FRLLKRLGCGDIG-SVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 218 y~l~~~LG~G~fG-~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~~~~~LVm 295 (611)
|.--+.+|.|+-| .||+|... ++.||||.+-.. ....+++|+..|+.. +|||||++|+.-.+.+++||+.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC--CceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence 3344678999987 47999765 568999987543 344678999999999 5999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCC---CHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEcc---CC--cEEEEecccccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYF---PEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRE---DG--HIMLSDFDLSLR 367 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l---~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~---~g--~vkL~DFGlA~~ 367 (611)
|+| ..+|.+++... +..+ .....+.++.|++.||++||+.+||||||||.||||.. ++ +++|+|||++++
T Consensus 583 ELC-~~sL~dlie~~-~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 583 ELC-ACSLQDLIESS-GLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred hHh-hhhHHHHHhcc-ccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 999 67999999874 1111 11345778999999999999999999999999999986 34 689999999987
Q ss_pred ccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcc
Q 007260 368 CAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPT 447 (611)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (611)
+.......
T Consensus 661 l~~~~sS~------------------------------------------------------------------------ 668 (903)
T KOG1027|consen 661 LAGGKSSF------------------------------------------------------------------------ 668 (903)
T ss_pred cCCCcchh------------------------------------------------------------------------
Confidence 76433221
Q ss_pred cccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHcCCCCCCCC-CCCCHHHHH
Q 007260 448 EARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFG-KTPFKGSGNRATLFNVVGQPLRFPES-PVVSFAARD 525 (611)
Q Consensus 448 ~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG-~~PF~~~~~~~~l~~i~~~~l~~p~~-~~~s~~l~d 525 (611)
.+.....||-+|+|||++....-..++||+||||++|+.++| ..||... .+...+|+.+....-.- +....+++|
T Consensus 669 -~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~--~~R~~NIl~~~~~L~~L~~~~d~eA~d 745 (903)
T KOG1027|consen 669 -SRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS--LERQANILTGNYTLVHLEPLPDCEAKD 745 (903)
T ss_pred -hcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch--HHhhhhhhcCccceeeeccCchHHHHH
Confidence 112334699999999999999999999999999999999985 9999864 34445666665433221 112228999
Q ss_pred HHHHhhhcCccccCCchhcHHHHHcCCCCCC
Q 007260 526 LIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 526 LI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
||.+||..+|..||+ |.++|.||||-.
T Consensus 746 LI~~ml~~dP~~RPs----a~~VL~HPlFW~ 772 (903)
T KOG1027|consen 746 LISRMLNPDPQLRPS----ATDVLNHPLFWD 772 (903)
T ss_pred HHHHhcCCCcccCCC----HHHHhCCCccCC
Confidence 999999999999999 999999999954
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=267.87 Aligned_cols=217 Identities=27% Similarity=0.378 Sum_probs=176.0
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeeccceeeEE
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~~~~~LV 294 (611)
++..-+..||+|+||.|-+.++..+|...|+|.+...-. .+...+..+|+++..+. .+|++|++|+.+..+..++|.
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn--~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc 123 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN--SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC 123 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC--hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence 455566889999999999999999999999999865432 23445667788876555 799999999999999999999
Q ss_pred eeeCCCCCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHc-CeeccCCCCCcEEEccCCcEEEEeccccccccCC
Q 007260 295 MEFCPGGDLHTLRQK--QPGKYFPEQAVRFYVAEVLLALEYLHML-GIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 295 mE~~~gg~L~~ll~~--~~~~~l~e~~~~~i~~qll~aL~yLH~~-gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~ 371 (611)
||.| ..+|..+..+ ..++.++|..+-.++..|+.||+|||++ .|||||+||+||||+.+|+||+||||++-.+..+
T Consensus 124 ME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 124 MELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS 202 (282)
T ss_pred HHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence 9999 6677765442 2357899999999999999999999975 8999999999999999999999999998333211
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
-..
T Consensus 203 iAk----------------------------------------------------------------------------- 205 (282)
T KOG0984|consen 203 IAK----------------------------------------------------------------------------- 205 (282)
T ss_pred hHH-----------------------------------------------------------------------------
Confidence 000
Q ss_pred cccccCCCccchhhhccC----CCCChhhHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHcCCCC
Q 007260 452 MSFVGTHEYLAPEIIKGE----GHGSAVDWWTFGIFLYELLFGKTPFKGS-GNRATLFNVVGQPLR 512 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~~----~~~~~sDIWSLGviL~ELltG~~PF~~~-~~~~~l~~i~~~~l~ 512 (611)
+--.|--.|||||.+..+ +|+-++||||||++++||.+++.||... +..+++..++..+..
T Consensus 206 t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P 271 (282)
T KOG0984|consen 206 TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSP 271 (282)
T ss_pred HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCC
Confidence 001366789999998643 6899999999999999999999999864 566777788877643
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=308.41 Aligned_cols=261 Identities=24% Similarity=0.372 Sum_probs=210.6
Q ss_pred cccCeEEEeEecccCcEEEEEEEECC-------CCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCccccccee
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSG-------TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHF 285 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~-------t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~ 285 (611)
..++..+.+.||.|.||.||+|...+ ....||||.++..... .....+..|+++|+.+ .|+||+.|++++
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 33455677899999999999998532 2567999998765433 4455678899999999 599999999999
Q ss_pred eccceeeEEeeeCCCCCHHHHHHhCC------C--------CCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEE
Q 007260 286 ETEKFSCLVMEFCPGGDLHTLRQKQP------G--------KYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLV 351 (611)
Q Consensus 286 ~~~~~~~LVmE~~~gg~L~~ll~~~~------~--------~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv 351 (611)
...+.+++|+|||..|+|..+++... . ..++......++.||+.|++||++..+|||||-..||||
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLI 451 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEe
Confidence 99999999999999999999988764 0 138889999999999999999999999999999999999
Q ss_pred ccCCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccc
Q 007260 352 REDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNE 431 (611)
Q Consensus 352 ~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (611)
..+..+||+|||+|+.......+..
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y~~------------------------------------------------------- 476 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYYRT------------------------------------------------------- 476 (609)
T ss_pred cCCCEEEEccccceeccCCCCceEe-------------------------------------------------------
Confidence 9999999999999954321111100
Q ss_pred cCCCCCCCcccccCcccccccccccCC--CccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHc
Q 007260 432 IGNQVSPLPELIAEPTEARSMSFVGTH--EYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVG 508 (611)
Q Consensus 432 ~~~~~~~~~~~~~~~~~~~~~~~vGT~--~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~ 508 (611)
..-.||+ .|||||.+....|+.++|||||||+|||+.+ |..||.+......+.+.+.
T Consensus 477 --------------------~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~ 536 (609)
T KOG0200|consen 477 --------------------KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLK 536 (609)
T ss_pred --------------------cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHh
Confidence 0001222 3999999999999999999999999999996 9999998663444455666
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcC
Q 007260 509 QPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 509 ~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~H 551 (611)
...+...+..++.++.++++.||..+|++||++....+.+-.|
T Consensus 537 ~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 537 EGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 6666666667999999999999999999999965544444443
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-32 Score=284.19 Aligned_cols=243 Identities=25% Similarity=0.344 Sum_probs=186.8
Q ss_pred cccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC--CCCCcccccceeeccc--
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL--DHPFLPTLYTHFETEK-- 289 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l--~HpnIv~l~~~~~~~~-- 289 (611)
.+....++++||+|.||.||+|.... +.||||++.... ...+++|.+|+... .|+||+++++.-+...
T Consensus 208 ~l~pl~l~eli~~Grfg~V~KaqL~~--~~VAVKifp~~~------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~ 279 (534)
T KOG3653|consen 208 ELDPLQLLELIGRGRFGCVWKAQLDN--RLVAVKIFPEQE------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD 279 (534)
T ss_pred cCCchhhHHHhhcCccceeehhhccC--ceeEEEecCHHH------HHHHHhHHHHHhccCccchhHHHhhchhccCCcc
Confidence 34567788999999999999998875 789999997543 33567888887754 7999999999876554
Q ss_pred --eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc---------CeeccCCCCCcEEEccCCcEE
Q 007260 290 --FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHML---------GIIYRDLKPENVLVREDGHIM 358 (611)
Q Consensus 290 --~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~---------gIVHRDLKPeNILv~~~g~vk 358 (611)
.++||+||.+.|+|.+++..+ .+++....+++.-+++||+|||+- .|+|||||..||||..|+...
T Consensus 280 ~~eywLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTcc 356 (534)
T KOG3653|consen 280 RMEYWLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCC 356 (534)
T ss_pred ccceeEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEE
Confidence 889999999999999999885 589999999999999999999972 399999999999999999999
Q ss_pred EEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCC
Q 007260 359 LSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSP 438 (611)
Q Consensus 359 L~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (611)
|+|||||.++.+...
T Consensus 357 IaDFGLAl~~~p~~~----------------------------------------------------------------- 371 (534)
T KOG3653|consen 357 IADFGLALRLEPGKP----------------------------------------------------------------- 371 (534)
T ss_pred eeccceeEEecCCCC-----------------------------------------------------------------
Confidence 999999977652110
Q ss_pred CcccccCcccccccccccCCCccchhhhccCCC-C-----ChhhHHHHHHHHHHHHhCCC------------CCCC----
Q 007260 439 LPELIAEPTEARSMSFVGTHEYLAPEIIKGEGH-G-----SAVDWWTFGIFLYELLFGKT------------PFKG---- 496 (611)
Q Consensus 439 ~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~-~-----~~sDIWSLGviL~ELltG~~------------PF~~---- 496 (611)
.......|||..|||||++.|.-. . .+.||||+|.+||||++.-. ||..
T Consensus 372 ---------~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 372 ---------QGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred ---------CcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 000112589999999999987632 2 36899999999999996433 2321
Q ss_pred CCcHHHHHHHHcCCCCCCCCC------CCCHHHHHHHHHhhhcCccccCCc
Q 007260 497 SGNRATLFNVVGQPLRFPESP------VVSFAARDLIRGLLVKEPQHRLAY 541 (611)
Q Consensus 497 ~~~~~~l~~i~~~~l~~p~~~------~~s~~l~dLI~~~L~~dP~~Rpt~ 541 (611)
....+.+++.+-.....|..+ .--..+++.|..||..|++.|+|.
T Consensus 443 hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA 493 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTA 493 (534)
T ss_pred CCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhh
Confidence 122334444332222222211 123468899999999999999993
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=278.59 Aligned_cols=248 Identities=23% Similarity=0.323 Sum_probs=191.7
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC--CCCCcccccceeecc----c
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL--DHPFLPTLYTHFETE----K 289 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l--~HpnIv~l~~~~~~~----~ 289 (611)
.+..+.+.||+|.||.||+|++++. .||||++...... ...+|.+|++.+ +|+||+.+++.-..+ .
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrGe--~VAVKiF~srdE~------SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRGE--DVAVKIFSSRDER------SWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred heeEEEEEecCccccceeeccccCC--ceEEEEecccchh------hhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 4788999999999999999999865 4999999754422 345688888764 999999999876543 4
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc--------CeeccCCCCCcEEEccCCcEEEEe
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHML--------GIIYRDLKPENVLVREDGHIMLSD 361 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~--------gIVHRDLKPeNILv~~~g~vkL~D 361 (611)
.+|||.+|-+.|+|++++.++ .++.+....++..++.||+|||.. .|.|||||..||||..+|...|+|
T Consensus 283 QLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred EEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 689999999999999999984 589999999999999999999973 299999999999999999999999
Q ss_pred ccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcc
Q 007260 362 FDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPE 441 (611)
Q Consensus 362 FGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (611)
+|||.+.......
T Consensus 360 LGLAv~h~~~t~~------------------------------------------------------------------- 372 (513)
T KOG2052|consen 360 LGLAVRHDSDTDT------------------------------------------------------------------- 372 (513)
T ss_pred ceeeEEecccCCc-------------------------------------------------------------------
Confidence 9999665422111
Q ss_pred cccCcccccccccccCCCccchhhhccCC------CCChhhHHHHHHHHHHHHh----------CCCCCCC----CCcHH
Q 007260 442 LIAEPTEARSMSFVGTHEYLAPEIIKGEG------HGSAVDWWTFGIFLYELLF----------GKTPFKG----SGNRA 501 (611)
Q Consensus 442 ~~~~~~~~~~~~~vGT~~Y~APEil~~~~------~~~~sDIWSLGviL~ELlt----------G~~PF~~----~~~~~ 501 (611)
.+...+..|||-.|||||++...- .-..+||||||.++||++. -++||.+ +...+
T Consensus 373 -----idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~e 447 (513)
T KOG2052|consen 373 -----IDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFE 447 (513)
T ss_pred -----ccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHH
Confidence 111223458999999999997542 1346899999999999984 2678865 45667
Q ss_pred HHHHHHcC-CCCCCCCCC-CC----HHHHHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 502 TLFNVVGQ-PLRFPESPV-VS----FAARDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 502 ~l~~i~~~-~l~~p~~~~-~s----~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
.+.+++-- .++...+.. -+ ..+..||+.||..||.-|+| |-.|++
T Consensus 448 eMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRlt----ALriKK 498 (513)
T KOG2052|consen 448 EMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLT----ALRIKK 498 (513)
T ss_pred HHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhH----HHHHHH
Confidence 77776643 333222211 12 24557899999999999999 555543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-32 Score=296.78 Aligned_cols=253 Identities=23% Similarity=0.318 Sum_probs=210.1
Q ss_pred eEEEeEecccCcEEEEEEEECCCC----eEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeE
Q 007260 218 FRLLKRLGCGDIGSVYLSELSGTK----CYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCL 293 (611)
Q Consensus 218 y~l~~~LG~G~fG~Vy~a~~~~t~----~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~L 293 (611)
.+..++||+|+||+||+|.+-..+ -.||||++.... ..+....+..|+-+|.+|+||||++|++++.... +-|
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 445678999999999999885544 368999886543 3445556788999999999999999999998766 889
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcc
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 373 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~ 373 (611)
|++|+++|.|.++++.+. ..+--+....|..||++||.|||.+++|||||-..||||..-.+|||.|||+|+.+.....
T Consensus 775 vtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 999999999999988764 4577788889999999999999999999999999999999999999999999966543322
Q ss_pred ccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccc
Q 007260 374 LIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMS 453 (611)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (611)
...+. .
T Consensus 854 ey~~~--------------------------------------------------------------------------~ 859 (1177)
T KOG1025|consen 854 EYSAP--------------------------------------------------------------------------G 859 (1177)
T ss_pred ccccc--------------------------------------------------------------------------c
Confidence 11110 0
Q ss_pred cccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007260 454 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLV 532 (611)
Q Consensus 454 ~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~ 532 (611)
.---+.|||-|.+....|+.++|||||||++|||+| |..|+.+... +.+.+.+..+.+++.++.++-++.-++.+||.
T Consensus 860 gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~-~eI~dlle~geRLsqPpiCtiDVy~~mvkCwm 938 (1177)
T KOG1025|consen 860 GKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA-EEIPDLLEKGERLSQPPICTIDVYMVMVKCWM 938 (1177)
T ss_pred cccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH-HHhhHHHhccccCCCCCCccHHHHHHHHHHhc
Confidence 012346999999999999999999999999999996 9999998754 45667777777888888899999999999999
Q ss_pred cCccccCCchhcHHHHH
Q 007260 533 KEPQHRLAYKRGATEIK 549 (611)
Q Consensus 533 ~dP~~Rpt~~~~a~elL 549 (611)
.|+..||+++..++++.
T Consensus 939 id~~~rp~fkel~~~fs 955 (1177)
T KOG1025|consen 939 IDADSRPTFKELAEEFS 955 (1177)
T ss_pred cCcccCccHHHHHHHHH
Confidence 99999999766655543
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=255.75 Aligned_cols=215 Identities=43% Similarity=0.678 Sum_probs=180.2
Q ss_pred eEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEeee
Q 007260 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEF 297 (611)
Q Consensus 218 y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE~ 297 (611)
|++.+.||.|++|.||++.+..++..+|||.+...... .....+.+|++.++.++|+||+++++++......++||||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 67889999999999999999998899999999865433 2345677899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccccc
Q 007260 298 CPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKA 377 (611)
Q Consensus 298 ~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~ 377 (611)
+++++|.+++..... .+++..+..++.+++.+|.|||.+|++|+||+|.||+++.++.++|+|||++.......
T Consensus 79 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~----- 152 (225)
T smart00221 79 CEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL----- 152 (225)
T ss_pred cCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc-----
Confidence 999999999887632 28999999999999999999999999999999999999999999999999874322100
Q ss_pred ccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccC
Q 007260 378 SSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGT 457 (611)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT 457 (611)
........++
T Consensus 153 ----------------------------------------------------------------------~~~~~~~~~~ 162 (225)
T smart00221 153 ----------------------------------------------------------------------AALLKTVKGT 162 (225)
T ss_pred ----------------------------------------------------------------------cccccceecc
Confidence 0011234588
Q ss_pred CCccchhhh-ccCCCCChhhHHHHHHHHHHHHhCCCCCCC-CCcHHHHHHHHcCC
Q 007260 458 HEYLAPEII-KGEGHGSAVDWWTFGIFLYELLFGKTPFKG-SGNRATLFNVVGQP 510 (611)
Q Consensus 458 ~~Y~APEil-~~~~~~~~sDIWSLGviL~ELltG~~PF~~-~~~~~~l~~i~~~~ 510 (611)
..|++||.+ ....++.++|||+||+++|+|++|+.||.. ..+...+.+.+...
T Consensus 163 ~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~ 217 (225)
T smart00221 163 PFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFG 217 (225)
T ss_pred CCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcC
Confidence 899999999 666778899999999999999999999987 55555555554443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=249.13 Aligned_cols=213 Identities=39% Similarity=0.632 Sum_probs=184.2
Q ss_pred ecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEeeeCCCCCH
Q 007260 224 LGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDL 303 (611)
Q Consensus 224 LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE~~~gg~L 303 (611)
||.|.+|.||++.+..+++.+++|++....... ....+.+|+.+++.+.|++|+++++++......++||||++|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999999889999999997654321 234678899999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEcc-CCcEEEEeccccccccCCccccccccCCC
Q 007260 304 HTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRE-DGHIMLSDFDLSLRCAVSPTLIKASSLDA 382 (611)
Q Consensus 304 ~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~-~g~vkL~DFGlA~~~~~~~~~~~~~~~~~ 382 (611)
.+++.... ..+++..+..++.+++.+|.|||..|++|+||+|.||+++. ++.++|+|||++........
T Consensus 79 ~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--------- 148 (215)
T cd00180 79 KDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--------- 148 (215)
T ss_pred HHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---------
Confidence 99987642 35899999999999999999999999999999999999999 89999999998743221000
Q ss_pred CcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCccc
Q 007260 383 EPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLA 462 (611)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~A 462 (611)
......+...|++
T Consensus 149 -------------------------------------------------------------------~~~~~~~~~~~~~ 161 (215)
T cd00180 149 -------------------------------------------------------------------LLKTIVGTPAYMA 161 (215)
T ss_pred -------------------------------------------------------------------hhhcccCCCCccC
Confidence 0112347788999
Q ss_pred hhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccCCc
Q 007260 463 PEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAY 541 (611)
Q Consensus 463 PEil~~~-~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~ 541 (611)
||.+... .++.+.|+|+||+++|+| ..+.++|.+||..||.+||+
T Consensus 162 pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~~~l~~~p~~R~~- 207 (215)
T cd00180 162 PEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------PELKDLIRKMLQKDPEKRPS- 207 (215)
T ss_pred hhHhcccCCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHHHHhhCCcccCcC-
Confidence 9999887 788999999999999999 67899999999999999999
Q ss_pred hhcHHHHHcCC
Q 007260 542 KRGATEIKQHP 552 (611)
Q Consensus 542 ~~~a~elL~Hp 552 (611)
+.++++|+
T Consensus 208 ---~~~l~~~~ 215 (215)
T cd00180 208 ---AKEILEHL 215 (215)
T ss_pred ---HHHHhhCC
Confidence 89998874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-33 Score=300.83 Aligned_cols=260 Identities=43% Similarity=0.709 Sum_probs=222.3
Q ss_pred EecccCcEEEEEEEE---CCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC-CCCcccccceeeccceeeEEeeeC
Q 007260 223 RLGCGDIGSVYLSEL---SGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD-HPFLPTLYTHFETEKFSCLVMEFC 298 (611)
Q Consensus 223 ~LG~G~fG~Vy~a~~---~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~-HpnIv~l~~~~~~~~~~~LVmE~~ 298 (611)
.+|.|.||.|++++. ...+..||+|++.+.....+... +...|..++..++ ||++|+++..|+.+..+|++++|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 379999999998864 34577899999988776554444 6677999999997 999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccc
Q 007260 299 PGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKAS 378 (611)
Q Consensus 299 ~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~ 378 (611)
.||+|+..+... ..+.+..++.|..+++.+++++|..||+|||+|++||+++.+|++++.|||+++.....
T Consensus 80 rgg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~------- 150 (612)
T KOG0603|consen 80 RGGDLFTRLSKE--VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE------- 150 (612)
T ss_pred ccchhhhccccC--CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhh-------
Confidence 999999877665 56899999999999999999999999999999999999999999999999997432100
Q ss_pred cCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCC
Q 007260 379 SLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTH 458 (611)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~ 458 (611)
. ..|||.
T Consensus 151 --------------------------------------------------------------------~-----~~cgt~ 157 (612)
T KOG0603|consen 151 --------------------------------------------------------------------K-----IACGTY 157 (612)
T ss_pred --------------------------------------------------------------------h-----hcccch
Confidence 0 017999
Q ss_pred CccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCcccc
Q 007260 459 EYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHR 538 (611)
Q Consensus 459 ~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~R 538 (611)
.|||||++. ++..++||||||++++||++|..||.+ +++.+|....+.+|.. ++..++++++.++.++|..|
T Consensus 158 eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~--l~~~a~~~~~~l~~r~p~nr 229 (612)
T KOG0603|consen 158 EYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRE--LSAEARSLFRQLFKRNPENR 229 (612)
T ss_pred hhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchh--hhHHHHHHHHHHHhhCHHHH
Confidence 999999999 788999999999999999999999987 6777787777666665 99999999999999999999
Q ss_pred CCch-hcHHHHHcCCCCCCCchhhhccCCCCCCCCC
Q 007260 539 LAYK-RGATEIKQHPFFEGVNWALIRCATPPEIPKP 573 (611)
Q Consensus 539 pt~~-~~a~elL~Hp~f~~~~~~~~~~~~~p~~p~p 573 (611)
+... +++.++++|+||+.++|..+.....+.+.+|
T Consensus 230 Lg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp 265 (612)
T KOG0603|consen 230 LGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKP 265 (612)
T ss_pred hccCcchhHHHhccchheeeeHhhHhhcCCCCCCCC
Confidence 9864 6899999999999999996554444444443
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=311.04 Aligned_cols=233 Identities=16% Similarity=0.207 Sum_probs=158.0
Q ss_pred CCC-CCccccccee-------eccceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCC
Q 007260 273 LDH-PFLPTLYTHF-------ETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDL 344 (611)
Q Consensus 273 l~H-pnIv~l~~~~-------~~~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDL 344 (611)
+.| +||+.++++| .....++++|||+ +++|++++... ...+++..++.|+.||+.||+|||++|||||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 445 6888888888 2335678899988 77999999754 356999999999999999999999999999999
Q ss_pred CCCcEEEccCCcEEEEeccccccccCCccc-cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccc
Q 007260 345 KPENVLVREDGHIMLSDFDLSLRCAVSPTL-IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSK 423 (611)
Q Consensus 345 KPeNILv~~~g~vkL~DFGlA~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (611)
||+||||+..|.+||+|||++......... .+-..++.. +......
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a--------------------------------~~~~~~~- 153 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSS--------------------------------RREEILS- 153 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccc--------------------------------ccccccc-
Confidence 999999999999999999987432211000 000000000 0000000
Q ss_pred cCCCCccccCCCCCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Q 007260 424 KDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATL 503 (611)
Q Consensus 424 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l 503 (611)
.. ... .+......+........+||++|||||++.+..|+.++|||||||+||||++|.+||.... ..+
T Consensus 154 -~~-~~~-------~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~ 222 (793)
T PLN00181 154 -ER-RIE-------KLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTM 222 (793)
T ss_pred -cc-chh-------hhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHH
Confidence 00 000 0000000001111223579999999999999999999999999999999999999986432 122
Q ss_pred HHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCC
Q 007260 504 FNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 504 ~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
..+....+ .+........+.+++.+||.+||.+||+ +.||++||||..
T Consensus 223 ~~~~~~~~-~~~~~~~~~~~~~~~~~~L~~~P~~Rps----~~eil~h~~~~~ 270 (793)
T PLN00181 223 SSLRHRVL-PPQILLNWPKEASFCLWLLHPEPSCRPS----MSELLQSEFINE 270 (793)
T ss_pred HHHHHhhc-ChhhhhcCHHHHHHHHHhCCCChhhCcC----hHHHhhchhhhh
Confidence 22221111 1111123456779999999999999999 999999999975
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=258.47 Aligned_cols=253 Identities=24% Similarity=0.331 Sum_probs=193.2
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccce-eeccceeeE
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTH-FETEKFSCL 293 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~-~~~~~~~~L 293 (611)
+.|.|.+.||+|-||.+-+|+|++++..+++|.+.+.... ...|++|..---.| .|.||+.-|++ |++.+.+++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt----~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT----QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh----HHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 5799999999999999999999999999999999876533 34566777654444 58999998874 778889999
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEcc--CCcEEEEeccccccccCC
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRE--DGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~--~g~vkL~DFGlA~~~~~~ 371 (611)
+|||++-|||.+-+.. ..+-|...+.++.|++.||+|||+.++||||||.+||||-. ..+|||||||+.+..+..
T Consensus 100 ~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t 176 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT 176 (378)
T ss_pred eeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence 9999999999876655 34889999999999999999999999999999999999963 448999999997433211
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
-.
T Consensus 177 V~------------------------------------------------------------------------------ 178 (378)
T KOG1345|consen 177 VK------------------------------------------------------------------------------ 178 (378)
T ss_pred eh------------------------------------------------------------------------------
Confidence 00
Q ss_pred cccccCCCccchhhhccC---C--CCChhhHHHHHHHHHHHHhCCCCCCCCC----cHHHHHHHHcCC-CCCCC-CCCCC
Q 007260 452 MSFVGTHEYLAPEIIKGE---G--HGSAVDWWTFGIFLYELLFGKTPFKGSG----NRATLFNVVGQP-LRFPE-SPVVS 520 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~~---~--~~~~sDIWSLGviL~ELltG~~PF~~~~----~~~~l~~i~~~~-l~~p~-~~~~s 520 (611)
..--+..|.+||++... . ..+..|+|.|||++|.+|+|.+||.... ....+..+.++. ...|. ...++
T Consensus 179 -~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs 257 (378)
T KOG1345|consen 179 -YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFS 257 (378)
T ss_pred -hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccC
Confidence 01134569999987533 2 3678999999999999999999997532 222333333332 22332 23488
Q ss_pred HHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCC
Q 007260 521 FAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFE 555 (611)
Q Consensus 521 ~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 555 (611)
+.+..+.++-|..++++|--.. .+.......|.+
T Consensus 258 ~~a~r~Fkk~lt~~~~drcki~-~~kk~rk~~w~E 291 (378)
T KOG1345|consen 258 EKALRLFKKSLTPRFKDRCKIW-TAKKMRKCLWKE 291 (378)
T ss_pred HHHHHHHHHhcCCcccccchhH-HHHHHHHHHHHH
Confidence 9999999999999999993311 155555666654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-30 Score=290.93 Aligned_cols=251 Identities=39% Similarity=0.634 Sum_probs=193.4
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
++|..++.|..|+||.||+++|+.+.+.||+| |++..+.-+ .||.....|++|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lilR----------nilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLILR----------NILTFAGNPFVV---------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccchhhh----------ccccccCCccee----------------
Confidence 47899999999999999999999999999995 444332211 155555666666
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
||-.+++... +.++.+. +.+++|||+.||||||+||+|+||..-|++||.|||++....-..+..
T Consensus 136 -----gDc~tllk~~--g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 -----GDCATLLKNI--GPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred -----chhhhhcccC--CCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 5656655553 3344433 789999999999999999999999999999999999984432111100
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccc-cccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTE-ARSMSF 454 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 454 (611)
... ..+...+. ......
T Consensus 201 l~e--------------------------------------------------------------g~I~k~t~Ef~dKqv 218 (1205)
T KOG0606|consen 201 LKE--------------------------------------------------------------GHIEKDTHEFQDKQV 218 (1205)
T ss_pred hhh--------------------------------------------------------------cchHHHHHHhhhccc
Confidence 000 00000011 111235
Q ss_pred ccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCC-CCCCHHHHHHHHHhhhc
Q 007260 455 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPES-PVVSFAARDLIRGLLVK 533 (611)
Q Consensus 455 vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~-~~~s~~l~dLI~~~L~~ 533 (611)
+|||+|+|||++...+||..+|||++|+|+||.|.|..||.+++.++.+-.++...+.||+. ..++.+++++|..||+.
T Consensus 219 cgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~q 298 (1205)
T KOG0606|consen 219 CGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQ 298 (1205)
T ss_pred cCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHh
Confidence 89999999999999999999999999999999999999999999999998888888888775 34889999999999999
Q ss_pred CccccCCchhcHHHHHcCCCCCCCchhhhccCCCCCCC
Q 007260 534 EPQHRLAYKRGATEIKQHPFFEGVNWALIRCATPPEIP 571 (611)
Q Consensus 534 dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~p~~p 571 (611)
+|.+|.... ++-++++|+||+.++|.-+.....+.+|
T Consensus 299 np~~Rlgt~-ga~evk~h~ff~~LDw~~llRqkaefvp 335 (1205)
T KOG0606|consen 299 NPLCRLGTG-GALEVKQHGFFQLLDWKSLLRQKAEFVP 335 (1205)
T ss_pred ChHhhcccc-hhhhhhhccceeecccchhhhhhccccc
Confidence 999998754 7999999999999999854444444444
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-27 Score=238.03 Aligned_cols=261 Identities=39% Similarity=0.592 Sum_probs=204.8
Q ss_pred eEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCC-CcccccceeeccceeeEEee
Q 007260 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHP-FLPTLYTHFETEKFSCLVME 296 (611)
Q Consensus 218 y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~Hp-nIv~l~~~~~~~~~~~LVmE 296 (611)
|.+.+.||.|+||.||++.+. ..+++|++.............+.+|+.++..+.|+ +|+++++++......++|++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 788999999999999999988 67999999876544434566788899999999988 79999999988888899999
Q ss_pred eCCCCCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCC-cEEEEeccccccccCCccc
Q 007260 297 FCPGGDLHTLRQKQPG-KYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDG-HIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 297 ~~~gg~L~~ll~~~~~-~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g-~vkL~DFGlA~~~~~~~~~ 374 (611)
|+.+++|.+++..... ..+.+..+..++.|++.+|+|+|..|++||||||+|||++..+ .++++|||++.........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 9999999977665421 2689999999999999999999999999999999999999988 7999999998422100000
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
. .........
T Consensus 159 ~----------------------------------------------------------------------~~~~~~~~~ 168 (384)
T COG0515 159 S----------------------------------------------------------------------SIPALPSTS 168 (384)
T ss_pred c----------------------------------------------------------------------ccccccccc
Confidence 0 000122356
Q ss_pred ccCCCccchhhhcc---CCCCChhhHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHcCCCC-CCCC--CCC----C
Q 007260 455 VGTHEYLAPEIIKG---EGHGSAVDWWTFGIFLYELLFGKTPFKGSGN----RATLFNVVGQPLR-FPES--PVV----S 520 (611)
Q Consensus 455 vGT~~Y~APEil~~---~~~~~~sDIWSLGviL~ELltG~~PF~~~~~----~~~l~~i~~~~l~-~p~~--~~~----s 520 (611)
+||..|++||++.+ ..+....|+|++|++++++++|..||..... ......+...... .... ... .
T Consensus 169 ~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (384)
T COG0515 169 VGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELIS 248 (384)
T ss_pred ccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhh
Confidence 79999999999998 5779999999999999999999999887764 2333333333322 2211 111 2
Q ss_pred HHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCC
Q 007260 521 FAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFE 555 (611)
Q Consensus 521 ~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 555 (611)
..+.+++..++..+|..|.+ ..+...++|+.
T Consensus 249 ~~~~~~~~~~~~~~~~~r~~----~~~~~~~~~~~ 279 (384)
T COG0515 249 KAASDLLKKLLAKDPKNRLS----SSSDLSHDLLA 279 (384)
T ss_pred HHHHHHHHHHHhcCchhcCC----HHHHhhchHhh
Confidence 57899999999999999999 66666665554
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=250.51 Aligned_cols=257 Identities=26% Similarity=0.332 Sum_probs=198.2
Q ss_pred CeEEEeEecccCcEEEEEEEECCCC-eEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCC----CCccccccee-eccce
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTK-CYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH----PFLPTLYTHF-ETEKF 290 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~-~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~H----pnIv~l~~~~-~~~~~ 290 (611)
+|++.+.||+|+||.||++.+..++ ..+|+|+.......... .+..|+.+|..+.+ .+++.+++.+ ..+.+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~---~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS---VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc---cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999988774 68999988664322211 34568888888863 6999999999 58889
Q ss_pred eeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccC-----CcEEEEecccc
Q 007260 291 SCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRED-----GHIMLSDFDLS 365 (611)
Q Consensus 291 ~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~-----g~vkL~DFGlA 365 (611)
-||||+.+ |.+|.+++...+.+.|+...+..++.|++.+|++||+.|+|||||||+|+++... -.+.|.|||++
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999999 9999999988777889999999999999999999999999999999999999864 35999999999
Q ss_pred ccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccC
Q 007260 366 LRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAE 445 (611)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (611)
++......... .-+.
T Consensus 175 r~~~~~~~~~~-----------------------------------------------~~~~------------------ 189 (322)
T KOG1164|consen 175 RRFKYVGDSGG-----------------------------------------------NLRP------------------ 189 (322)
T ss_pred ccccccCCCCc-----------------------------------------------cccc------------------
Confidence 73221100000 0000
Q ss_pred cccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCC--CC-CCCCCCHH
Q 007260 446 PTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLR--FP-ESPVVSFA 522 (611)
Q Consensus 446 ~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~--~p-~~~~~s~~ 522 (611)
.......+.||..|+++.++.+...+.+.|+||++.++.||+.|..||.+.........+...... .. .....+.+
T Consensus 190 -~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (322)
T KOG1164|consen 190 -PRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEE 268 (322)
T ss_pred -CCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhccccccCCChHH
Confidence 000012467999999999999999999999999999999999999999876643333222222111 11 22335678
Q ss_pred HHHHHHHhhhcCccccCCchh
Q 007260 523 ARDLIRGLLVKEPQHRLAYKR 543 (611)
Q Consensus 523 l~dLI~~~L~~dP~~Rpt~~~ 543 (611)
+..+...+-..+...+|.+..
T Consensus 269 ~~~~~~~~~~~~~~~~Pdy~~ 289 (322)
T KOG1164|consen 269 FAKILEYIDSLDYEDKPDYEK 289 (322)
T ss_pred HHHHHHHhhccCCcCCCCHHH
Confidence 888888888899999999654
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.7e-28 Score=246.92 Aligned_cols=255 Identities=18% Similarity=0.240 Sum_probs=200.5
Q ss_pred CccccccCeEEEeEecccCcEEEEEEEECCCC-----eEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccce
Q 007260 210 DGVLGLSHFRLLKRLGCGDIGSVYLSELSGTK-----CYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTH 284 (611)
Q Consensus 210 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~-----~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~ 284 (611)
+..+...++++...+-+|.||.||.|.++..+ +.|-+|.++.. ...-.+.++..|.-+|..+.|||+..+.++
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 33444567899999999999999999765432 33555655322 344556677889999999999999999998
Q ss_pred ee-ccceeeEEeeeCCCCCHHHHHHhC------CCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcE
Q 007260 285 FE-TEKFSCLVMEFCPGGDLHTLRQKQ------PGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHI 357 (611)
Q Consensus 285 ~~-~~~~~~LVmE~~~gg~L~~ll~~~------~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~v 357 (611)
.. +....++++.+..-|+|..+++.. ..+.++..+...++.||..|++|||..||||.||...|++|++.-+|
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqV 435 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQV 435 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeE
Confidence 65 456778889999889999998832 22457778888899999999999999999999999999999999999
Q ss_pred EEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCC
Q 007260 358 MLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVS 437 (611)
Q Consensus 358 kL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (611)
||+|-.|++.+-+. ++. |.+
T Consensus 436 kltDsaLSRDLFP~-DYh------------------------------------cLG----------------------- 455 (563)
T KOG1024|consen 436 KLTDSALSRDLFPG-DYH------------------------------------CLG----------------------- 455 (563)
T ss_pred EeccchhccccCcc-ccc------------------------------------ccC-----------------------
Confidence 99999888543211 000 000
Q ss_pred CCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCC
Q 007260 438 PLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPES 516 (611)
Q Consensus 438 ~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~ 516 (611)
... --...||+||.+....|+.++|+|||||+||||++ |+.|+...+..+.. ..+....+...+
T Consensus 456 --------DnE------nRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~-~ylkdGyRlaQP 520 (563)
T KOG1024|consen 456 --------DNE------NRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME-HYLKDGYRLAQP 520 (563)
T ss_pred --------CCC------CCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH-HHHhccceecCC
Confidence 000 02245999999999999999999999999999997 99999887666544 445555667667
Q ss_pred CCCCHHHHHHHHHhhhcCccccCCc
Q 007260 517 PVVSFAARDLIRGLLVKEPQHRLAY 541 (611)
Q Consensus 517 ~~~s~~l~dLI~~~L~~dP~~Rpt~ 541 (611)
.++++++..++..||+.+|++||++
T Consensus 521 ~NCPDeLf~vMacCWallpeeRPsf 545 (563)
T KOG1024|consen 521 FNCPDELFTVMACCWALLPEERPSF 545 (563)
T ss_pred CCCcHHHHHHHHHHHhcCcccCCCH
Confidence 7799999999999999999999994
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-29 Score=280.74 Aligned_cols=261 Identities=26% Similarity=0.377 Sum_probs=203.7
Q ss_pred EEEeEecccCcEEEEEEEECCCCeEEEEEEecc---hhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 219 RLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDK---ASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 219 ~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k---~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
.....+|.|++|.|+.+........++.|.... .....++....+..|..+-..|.||||+..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 456789999999999998877776677775542 22223333333667888888899999998888887776666679
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
|||++ ||+.++... ..+....+..++.||+.||+|||..||.|||||++|+|+..+|.+||+|||.+..+...
T Consensus 401 E~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~---- 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYP---- 473 (601)
T ss_pred hcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccC----
Confidence 99999 999998875 46899999999999999999999999999999999999999999999999987322110
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
.+........++
T Consensus 474 --------------------------------------------------------------------~e~~~~~~~g~~ 485 (601)
T KOG0590|consen 474 --------------------------------------------------------------------WEKNIHESSGIV 485 (601)
T ss_pred --------------------------------------------------------------------cchhhhhhcCcc
Confidence 001112234578
Q ss_pred cCCCccchhhhccCCCCC-hhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH--HHHcCCCC-----CCCCCCCCHHHHHHH
Q 007260 456 GTHEYLAPEIIKGEGHGS-AVDWWTFGIFLYELLFGKTPFKGSGNRATLF--NVVGQPLR-----FPESPVVSFAARDLI 527 (611)
Q Consensus 456 GT~~Y~APEil~~~~~~~-~sDIWSLGviL~ELltG~~PF~~~~~~~~l~--~i~~~~l~-----~p~~~~~s~~l~dLI 527 (611)
|+-.|+|||++.+..|.+ .+||||.||+++.|++|+.||......+..+ ........ ......++...+.+|
T Consensus 486 gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~ 565 (601)
T KOG0590|consen 486 GSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIII 565 (601)
T ss_pred cCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchhhHHHHH
Confidence 999999999999999954 6899999999999999999998755443321 11111111 111234788999999
Q ss_pred HHhhhcCccccCCchhcHHHHHcCCCCCCCc
Q 007260 528 RGLLVKEPQHRLAYKRGATEIKQHPFFEGVN 558 (611)
Q Consensus 528 ~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 558 (611)
.+||+.||.+|.+ +++|++.+||+.++
T Consensus 566 ~~~l~~~P~~R~t----i~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 566 YRMLQLDPTKRIT----IEQILNDEWIRSIE 592 (601)
T ss_pred HHHccCChhheec----HHHHhhChHhhhcc
Confidence 9999999999999 99999999998753
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.1e-28 Score=229.44 Aligned_cols=161 Identities=24% Similarity=0.218 Sum_probs=128.6
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccccC
Q 007260 301 GDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSL 380 (611)
Q Consensus 301 g~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~ 380 (611)
|+|.+++... +..+++..++.|+.||+.||+|||+++ ||+|||++.++.+|+ ||++.....
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~---------- 61 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTP---------- 61 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecc----------
Confidence 6899998864 356999999999999999999999999 999999999999999 998732110
Q ss_pred CCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCc
Q 007260 381 DAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEY 460 (611)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y 460 (611)
....||+.|
T Consensus 62 -----------------------------------------------------------------------~~~~g~~~y 70 (176)
T smart00750 62 -----------------------------------------------------------------------EQSRVDPYF 70 (176)
T ss_pred -----------------------------------------------------------------------ccCCCcccc
Confidence 011489999
Q ss_pred cchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHcCCCCC-----CCCCCCCH--HHHHHHHHhhh
Q 007260 461 LAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRA-TLFNVVGQPLRF-----PESPVVSF--AARDLIRGLLV 532 (611)
Q Consensus 461 ~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~-~l~~i~~~~l~~-----p~~~~~s~--~l~dLI~~~L~ 532 (611)
||||++.+..++.++|||||||++|||++|+.||....... .+..+....... +....++. .+++||.+||.
T Consensus 71 ~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~ 150 (176)
T smart00750 71 MAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCAS 150 (176)
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHh
Confidence 99999999999999999999999999999999997654432 233333222111 11122333 69999999999
Q ss_pred cCccccCCchhcHHHHHcCCCCC
Q 007260 533 KEPQHRLAYKRGATEIKQHPFFE 555 (611)
Q Consensus 533 ~dP~~Rpt~~~~a~elL~Hp~f~ 555 (611)
.||.+||+ +.++++|+|+.
T Consensus 151 ~~p~~Rp~----~~~ll~~~~~~ 169 (176)
T smart00750 151 RLPQRREA----ANHYLAHCRAL 169 (176)
T ss_pred cccccccC----HHHHHHHHHHH
Confidence 99999999 99999999874
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-25 Score=228.30 Aligned_cols=250 Identities=22% Similarity=0.323 Sum_probs=192.6
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeeccceeeEE
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~~~~~LV 294 (611)
-+|+++++||+|+||.+++++..-+++.||||.-.+...+ -++.-|-...+.| ..++|+.+|.+...+.+-.||
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A-----PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV 102 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA-----PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV 102 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCCc-----chHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence 3899999999999999999999999999999986544322 1345577777777 579999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCC-----cEEEEecccccccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDG-----HIMLSDFDLSLRCA 369 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g-----~vkL~DFGlA~~~~ 369 (611)
||++ |.+|.++..-. ++.|+...+..++.|++.-++|+|++.+|+|||||+|+||..-+ .|.|+|||+|+.+.
T Consensus 103 idLL-GPSLEDLFD~C-gR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 103 IDLL-GPSLEDLFDLC-GRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred hhhh-CcCHHHHHHHh-cCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 9999 99999987765 57899999999999999999999999999999999999997544 58999999997654
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
...+.. ..| -.
T Consensus 181 Dp~Tkq--------------------------------------------------HIP-------------------Yr 191 (449)
T KOG1165|consen 181 DPKTKQ--------------------------------------------------HIP-------------------YR 191 (449)
T ss_pred Cccccc--------------------------------------------------cCc-------------------cc
Confidence 322210 000 11
Q ss_pred cccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC---CcHHHHHHHHcCCCCCCC---CCCCCHHH
Q 007260 450 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGS---GNRATLFNVVGQPLRFPE---SPVVSFAA 523 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~---~~~~~l~~i~~~~l~~p~---~~~~s~~l 523 (611)
...+..||-.||+-.-+.|...+.+.|+=|||-++++.|-|.+||.|. ++.+...+|-.....-|. ...++.++
T Consensus 192 E~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc~g~P~ef 271 (449)
T KOG1165|consen 192 EHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVLCEGFPEEF 271 (449)
T ss_pred cccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHHHhcCHHHH
Confidence 123456999999999999999999999999999999999999999873 444445444333222111 12355566
Q ss_pred HHHHHHhhhcCccccCCc
Q 007260 524 RDLIRGLLVKEPQHRLAY 541 (611)
Q Consensus 524 ~dLI~~~L~~dP~~Rpt~ 541 (611)
...++-.-..+-.+-|.|
T Consensus 272 a~Yl~yvR~L~F~E~PDY 289 (449)
T KOG1165|consen 272 ATYLRYVRRLDFFETPDY 289 (449)
T ss_pred HHHHHHHHhcCcccCCCH
Confidence 555555555555555554
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=245.46 Aligned_cols=141 Identities=22% Similarity=0.157 Sum_probs=114.0
Q ss_pred ccCeEEEeEecccCcEEEEEEEECC-CCeEEEEEEecchhh--hhHHHHHHHHHHHHHHHhCCCCCccc-ccceeeccce
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSG-TKCYFAMKVMDKASL--AGRKKLLRAQTEREILQSLDHPFLPT-LYTHFETEKF 290 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~-t~~~vAvKii~k~~~--~~~~~~~~~~~E~~iL~~l~HpnIv~-l~~~~~~~~~ 290 (611)
.++|.+.+.||+|+||+||+|.+.. +++.||||++..... ........+.+|+++|+.|+|+||+. ++++ +.
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~ 92 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GK 92 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CC
Confidence 3689999999999999999999876 677889998753311 12223456789999999999999985 5432 45
Q ss_pred eeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCC-CCCcEEEccCCcEEEEeccccccc
Q 007260 291 SCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDL-KPENVLVREDGHIMLSDFDLSLRC 368 (611)
Q Consensus 291 ~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDL-KPeNILv~~~g~vkL~DFGlA~~~ 368 (611)
.|||||||+|++|.. +.. .. ...++.|++.||.|||++||+|||| ||+|||++.++.+||+|||+|..+
T Consensus 93 ~~LVmE~~~G~~L~~-~~~-----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~ 162 (365)
T PRK09188 93 DGLVRGWTEGVPLHL-ARP-----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF 162 (365)
T ss_pred cEEEEEccCCCCHHH-hCc-----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence 799999999999973 211 11 1467899999999999999999999 999999999999999999999654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.1e-26 Score=220.18 Aligned_cols=275 Identities=18% Similarity=0.254 Sum_probs=208.1
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC-CCCcccccceeecccee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD-HPFLPTLYTHFETEKFS 291 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~-HpnIv~l~~~~~~~~~~ 291 (611)
+..+.|+++++||+|+||.+|+|.....|..||||+-....- ..++..|..+.+.|+ ...|+.+..++.+..+-
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-----CcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 445799999999999999999999999999999998654321 113456999999886 47899999999999999
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccC---CcEEEEeccccccc
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRED---GHIMLSDFDLSLRC 368 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~---g~vkL~DFGlA~~~ 368 (611)
.|||+++ |.+|.++..-. .+.|+...+..++-|++.-|+|+|.+++|||||||+|+|+.-+ ..+.|+|||||+++
T Consensus 87 vlVMdLL-GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred eeeeecc-CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence 9999999 99999887654 3669999999999999999999999999999999999999744 35899999999776
Q ss_pred cCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccc
Q 007260 369 AVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTE 448 (611)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (611)
-...+-.. ..-
T Consensus 165 ~d~~t~~H---------------------------------------------------------------------Ipy 175 (341)
T KOG1163|consen 165 RDIRTRQH---------------------------------------------------------------------IPY 175 (341)
T ss_pred cccccccc---------------------------------------------------------------------Ccc
Confidence 43221100 011
Q ss_pred ccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHcCCCCCCC---CCCCCHH
Q 007260 449 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGN---RATLFNVVGQPLRFPE---SPVVSFA 522 (611)
Q Consensus 449 ~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~---~~~l~~i~~~~l~~p~---~~~~s~~ 522 (611)
.......||-.|.+-..+.|...+.+.|+-|+|.+|.++.-|..||.+... .+...+|.......+. ...++.+
T Consensus 176 re~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G~P~E 255 (341)
T KOG1163|consen 176 REDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKGFPAE 255 (341)
T ss_pred ccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHH
Confidence 122345799999999888888889999999999999999999999998532 3334555555544433 2346778
Q ss_pred HHHHHHHhhhcCccccCCchhcHHHH-------HcCCCCCCCchhhhcc
Q 007260 523 ARDLIRGLLVKEPQHRLAYKRGATEI-------KQHPFFEGVNWALIRC 564 (611)
Q Consensus 523 l~dLI~~~L~~dP~~Rpt~~~~a~el-------L~Hp~f~~~~~~~~~~ 564 (611)
+.-.|.-|-..-=++-|.+.- +.++ |+|-+=--.+|..+..
T Consensus 256 F~myl~Y~R~L~F~E~Pdy~y-lrqlFriLfr~ln~~~d~iyDW~~lkq 303 (341)
T KOG1163|consen 256 FAMYLNYCRGLGFEEKPDYMY-LRQLFRILFRTLNHQYDYIYDWTMLKQ 303 (341)
T ss_pred HHHHHHHHhhcCCCCCCcHHH-HHHHHHHHHhhccccCCeEeeHHHHHH
Confidence 888888877666666666431 2222 2333322357877643
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.8e-24 Score=210.29 Aligned_cols=141 Identities=21% Similarity=0.207 Sum_probs=110.4
Q ss_pred EeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHH-----------------------HHHHHHHHHHHHHhCCCCC
Q 007260 221 LKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRK-----------------------KLLRAQTEREILQSLDHPF 277 (611)
Q Consensus 221 ~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~-----------------------~~~~~~~E~~iL~~l~Hpn 277 (611)
.+.||+|+||.||+|.+. +|+.||||+++........ ......+|+.+|..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999987 8999999999765321110 0112345999999998888
Q ss_pred cccccceeeccceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHH-HHcCeeccCCCCCcEEEccCCc
Q 007260 278 LPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYL-HMLGIIYRDLKPENVLVREDGH 356 (611)
Q Consensus 278 Iv~l~~~~~~~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yL-H~~gIVHRDLKPeNILv~~~g~ 356 (611)
|...+.+... ..||||||++|++|...+... ..+++..+..++.|++.+|.|| |..|||||||||+|||++ ++.
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCc
Confidence 7544433222 238999999988776554332 4689999999999999999999 799999999999999998 588
Q ss_pred EEEEecccccc
Q 007260 357 IMLSDFDLSLR 367 (611)
Q Consensus 357 vkL~DFGlA~~ 367 (611)
++|+|||+|..
T Consensus 156 v~LiDFG~a~~ 166 (190)
T cd05147 156 LYIIDVSQSVE 166 (190)
T ss_pred EEEEEcccccc
Confidence 99999999843
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.8e-24 Score=212.10 Aligned_cols=137 Identities=17% Similarity=0.209 Sum_probs=114.8
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHH------HHHHHHHHHhCCCCCcccccceeecc-
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLR------AQTEREILQSLDHPFLPTLYTHFETE- 288 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~------~~~E~~iL~~l~HpnIv~l~~~~~~~- 288 (611)
++|++++.||.|+||.||++... +..+|||+++...........+ +.+|+..+.+|.|++|+.+.+++...
T Consensus 31 ~~y~~~~~l~~~~f~~v~l~~~~--~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 31 YNIKTIKVFRNIDDTKVSLIDTD--YGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred CceEEEEEecCCCceEEEEEecC--CCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 69999999999999999998663 4569999997665444444444 47899999999999999999987643
Q ss_pred -------ceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEe
Q 007260 289 -------KFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSD 361 (611)
Q Consensus 289 -------~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~D 361 (611)
...+|||||++|.+|.++.. +++. .+.+++.+|..||..||+||||||+|||++.+| ++|+|
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liD 177 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE------ISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIID 177 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh------ccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEE
Confidence 35799999999999987632 3332 456999999999999999999999999999999 99999
Q ss_pred cccc
Q 007260 362 FDLS 365 (611)
Q Consensus 362 FGlA 365 (611)
||..
T Consensus 178 fg~~ 181 (232)
T PRK10359 178 LSGK 181 (232)
T ss_pred CCCc
Confidence 9976
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-23 Score=213.27 Aligned_cols=236 Identities=25% Similarity=0.305 Sum_probs=152.0
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCC----------CCcccccce--
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH----------PFLPTLYTH-- 284 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~H----------pnIv~l~~~-- 284 (611)
.+...+.||.|+++.||.+.+..|++.+|||++.-.........+.+++|.-....+.+ -.++-.++.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 45677899999999999999999999999999865544555556666666654444322 112211221
Q ss_pred -------eecc---c-----eeeEEeeeCCCCCHHHHHHh---CCCCC-CCHHHHHH-HHHHHHHHHHHHHHcCeeccCC
Q 007260 285 -------FETE---K-----FSCLVMEFCPGGDLHTLRQK---QPGKY-FPEQAVRF-YVAEVLLALEYLHMLGIIYRDL 344 (611)
Q Consensus 285 -------~~~~---~-----~~~LVmE~~~gg~L~~ll~~---~~~~~-l~e~~~~~-i~~qll~aL~yLH~~gIVHRDL 344 (611)
+... . ..+++|+-+ -+||.+++.- ..... -....++. +..|+++.+++||..||||+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 2211 1 347888888 6788887542 21111 12233433 4489999999999999999999
Q ss_pred CCCcEEEccCCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCccccccccc
Q 007260 345 KPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKK 424 (611)
Q Consensus 345 KPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (611)
||+|+|++.+|.++|+||+...+.+...
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~---------------------------------------------------- 199 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRY---------------------------------------------------- 199 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEE----------------------------------------------------
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCcee----------------------------------------------------
Confidence 9999999999999999999764432100
Q ss_pred CCCCccccCCCCCCCcccccCcccccccccccCCCccchhhhccC--------CCCChhhHHHHHHHHHHHHhCCCCCCC
Q 007260 425 DRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGE--------GHGSAVDWWTFGIFLYELLFGKTPFKG 496 (611)
Q Consensus 425 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~--------~~~~~sDIWSLGviL~ELltG~~PF~~ 496 (611)
.....+..|.+||..... .++.+.|.|+||++||.|+||+.||..
T Consensus 200 ---------------------------~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~ 252 (288)
T PF14531_consen 200 ---------------------------RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGL 252 (288)
T ss_dssp ---------------------------EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCC
T ss_pred ---------------------------eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCC
Confidence 001245679999987543 368899999999999999999999986
Q ss_pred CCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCcccc
Q 007260 497 SGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHR 538 (611)
Q Consensus 497 ~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~R 538 (611)
........ ..|.....+++.+++||.++|.+||.+|
T Consensus 253 ~~~~~~~~------~~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 253 SSPEADPE------WDFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp CGGGSTSG------GGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred CCcccccc------ccchhcCCcCHHHHHHHHHHccCCcccC
Confidence 54332111 1333334699999999999999999988
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.3e-23 Score=201.59 Aligned_cols=143 Identities=20% Similarity=0.216 Sum_probs=112.7
Q ss_pred EeEecccCcEEEEEEEECCCCeEEEEEEecchhhhh-----------------------HHHHHHHHHHHHHHHhCCCCC
Q 007260 221 LKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAG-----------------------RKKLLRAQTEREILQSLDHPF 277 (611)
Q Consensus 221 ~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~-----------------------~~~~~~~~~E~~iL~~l~Hpn 277 (611)
.+.||+|+||.||+|.+. +|+.||||+++...... ......+.+|...+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 578999999999999987 89999999998652110 001223467999999999998
Q ss_pred cccccceeeccceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCeeccCCCCCcEEEccCCc
Q 007260 278 LPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHM-LGIIYRDLKPENVLVREDGH 356 (611)
Q Consensus 278 Iv~l~~~~~~~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~-~gIVHRDLKPeNILv~~~g~ 356 (611)
|.....+.... .||||||++|+++....... ..+++..+..++.|++.+|.+||. +||+||||||+|||++ ++.
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~ 155 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCC
Confidence 86555443332 48999999888654332222 457888999999999999999999 9999999999999999 899
Q ss_pred EEEEecccccccc
Q 007260 357 IMLSDFDLSLRCA 369 (611)
Q Consensus 357 vkL~DFGlA~~~~ 369 (611)
++|+|||++....
T Consensus 156 ~~liDFG~a~~~~ 168 (190)
T cd05145 156 PYIIDVSQAVELD 168 (190)
T ss_pred EEEEEcccceecC
Confidence 9999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=198.42 Aligned_cols=200 Identities=21% Similarity=0.204 Sum_probs=141.9
Q ss_pred EEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhH-HHHHHHHHHHHHHHhCC-CCCcccccceeeccceeeEEee
Q 007260 219 RLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGR-KKLLRAQTEREILQSLD-HPFLPTLYTHFETEKFSCLVME 296 (611)
Q Consensus 219 ~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~-~~~~~~~~E~~iL~~l~-HpnIv~l~~~~~~~~~~~LVmE 296 (611)
.+...|++|+||+||++.. .+..|+.+.+.....-.+ -...++++|+++|++|. |++|++++++ +..|+|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 3567899999999998866 455677666654332111 11225789999999995 5889999886 34699999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCC-CCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 297 FCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDL-KPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 297 ~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDL-KPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
|+.|.+|...+.. . ...++.|++.+|++||.+||||||| ||+|||++.+|.++|+|||+|..........
T Consensus 79 yI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 79 YLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred eecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 9999999754321 1 1347889999999999999999999 7999999999999999999984322110000
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCccccc-C-cccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIA-E-PTEARSMS 453 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~ 453 (611)
+... . -..-...-
T Consensus 150 -----------------------------------------------------------------r~L~~rDl~~llk~~ 164 (218)
T PRK12274 150 -----------------------------------------------------------------RLLAREDLRHLLKHK 164 (218)
T ss_pred -----------------------------------------------------------------HHHHHHHHHHHHHHH
Confidence 0000 0 00000011
Q ss_pred cccCCCccchhhhccC-CCC-ChhhHHHHHHHHHHHHhCCCCCCCCC
Q 007260 454 FVGTHEYLAPEIIKGE-GHG-SAVDWWTFGIFLYELLFGKTPFKGSG 498 (611)
Q Consensus 454 ~vGT~~Y~APEil~~~-~~~-~~sDIWSLGviL~ELltG~~PF~~~~ 498 (611)
...++.|+.|+...-. ..+ .+.+|++.|+-+|.++|++.++.+++
T Consensus 165 ~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 165 RMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 2378899999976644 334 67899999999999999999987654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.6e-23 Score=212.49 Aligned_cols=274 Identities=22% Similarity=0.272 Sum_probs=186.0
Q ss_pred cccccCeEEEeEecccCcEEEEEEEECCCC-----------------------------------eEEEEEEecchhhh-
Q 007260 212 VLGLSHFRLLKRLGCGDIGSVYLSELSGTK-----------------------------------CYFAMKVMDKASLA- 255 (611)
Q Consensus 212 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~-----------------------------------~~vAvKii~k~~~~- 255 (611)
.+.+++|.|+..||+|.-..||.|.....+ -..|||.|-.-...
T Consensus 153 kFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s 232 (598)
T KOG4158|consen 153 KFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDS 232 (598)
T ss_pred ccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCC
Confidence 345689999999999999999999754311 13577766322211
Q ss_pred hHHH-HHHHHHHHH------H--------HHh--------CCCCCcccccceeec-------------------------
Q 007260 256 GRKK-LLRAQTERE------I--------LQS--------LDHPFLPTLYTHFET------------------------- 287 (611)
Q Consensus 256 ~~~~-~~~~~~E~~------i--------L~~--------l~HpnIv~l~~~~~~------------------------- 287 (611)
+... +..+-+|.- + .+. -.|||||+++++|.+
T Consensus 233 ~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~ 312 (598)
T KOG4158|consen 233 GDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGA 312 (598)
T ss_pred chHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceeccccc
Confidence 1111 222222221 1 111 269999999998842
Q ss_pred --cceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEc--cCC--cEEEEe
Q 007260 288 --EKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVR--EDG--HIMLSD 361 (611)
Q Consensus 288 --~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~--~~g--~vkL~D 361 (611)
...+||||... .-+|+.++-.+ ..+....+.++.|+++|+.|||.+||.|||||.+||||. +|+ .+.|+|
T Consensus 313 g~~~tlylvMkrY-~~tLr~yl~~~---~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaD 388 (598)
T KOG4158|consen 313 GEPKTLYLVMKRY-RQTLREYLWTR---HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVAD 388 (598)
T ss_pred CCCceEEEehhcc-hhhHHHHHhcC---CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcc
Confidence 24679999988 45899888764 477888899999999999999999999999999999995 344 589999
Q ss_pred ccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcc
Q 007260 362 FDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPE 441 (611)
Q Consensus 362 FGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (611)
||++.-+....-.+....
T Consensus 389 FGCcLAd~~hGlqlpy~S-------------------------------------------------------------- 406 (598)
T KOG4158|consen 389 FGCCLADDNHGLQLPYES-------------------------------------------------------------- 406 (598)
T ss_pred cceeeecccccccccccc--------------------------------------------------------------
Confidence 998754332111111000
Q ss_pred cccCcccccccccccCCCccchhhhccCC------CCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCC
Q 007260 442 LIAEPTEARSMSFVGTHEYLAPEIIKGEG------HGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPE 515 (611)
Q Consensus 442 ~~~~~~~~~~~~~vGT~~Y~APEil~~~~------~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~ 515 (611)
.....-|.-..||||+....+ ...++|.|+.|.+.||++....||.+.+....-.+-.++.--.+.
T Consensus 407 --------~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPal 478 (598)
T KOG4158|consen 407 --------DEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPAL 478 (598)
T ss_pred --------ccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCC
Confidence 001122666789999987543 145899999999999999999999985443221111211111223
Q ss_pred CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCchh
Q 007260 516 SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWA 560 (611)
Q Consensus 516 ~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~ 560 (611)
+..+++.+++||..+|..||.+|++ .+.|..+|+.--|..-+|-
T Consensus 479 p~~vpp~~rqlV~~lL~r~pskRvs-p~iAANvl~LsLw~~~~~v 522 (598)
T KOG4158|consen 479 PSRVPPVARQLVFDLLKRDPSKRVS-PNIAANVLNLSLWRMGEDV 522 (598)
T ss_pred cccCChHHHHHHHHHhcCCccccCC-ccHHHhHHHHHHhcCchHH
Confidence 3459999999999999999999998 4457777776555555553
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.7e-23 Score=231.81 Aligned_cols=251 Identities=22% Similarity=0.285 Sum_probs=181.2
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchh--hhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKAS--LAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~--~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
.|...+.||++.|=+|.+|++... .|+||++-+.. +.-+... +...|++ +..++|||++.+.-+-+.++..|||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG--~vVvKVFvk~~p~~sL~~~~-qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREG--LVVVKVFVKQDPTISLRPFK-QRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCc--eEEEEEEeccCCCCCchHHH-HHHHHHH-HHhhcCCcccchHHHHHhhHHHHHH
Confidence 688889999999999999988754 39999986543 2222233 3334555 6677999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
-+|+ .-+|++.+..+ ..+..-+.+.|+.||+.||.-+|..||+|+|||.|||||+.-..+.|+||.-.+ |++
T Consensus 100 Rqyv-khnLyDRlSTR--PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFK-----PtY 171 (1431)
T KOG1240|consen 100 RQYV-KHNLYDRLSTR--PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFK-----PTY 171 (1431)
T ss_pred HHHH-hhhhhhhhccc--hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccC-----Ccc
Confidence 9999 55999988776 357888889999999999999999999999999999999998899999997541 111
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
.... +|-.......+..|
T Consensus 172 LPeD----------------------------------------------------------NPadf~fFFDTSrR---- 189 (1431)
T KOG1240|consen 172 LPED----------------------------------------------------------NPADFTFFFDTSRR---- 189 (1431)
T ss_pred CCCC----------------------------------------------------------CcccceEEEecCCc----
Confidence 1110 00000111111111
Q ss_pred ccCCCccchhhhccCC-----------CCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCC---CCC
Q 007260 455 VGTHEYLAPEIIKGEG-----------HGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPES---PVV 519 (611)
Q Consensus 455 vGT~~Y~APEil~~~~-----------~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~---~~~ 519 (611)
-..|+|||.+.... ..++.||||+||+++||++ |++||.- .++.....+.-..++. ..-
T Consensus 190 --RtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~~~~~~~e~~Le~Ie 263 (1431)
T KOG1240|consen 190 --RTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRSGNADDPEQLLEKIE 263 (1431)
T ss_pred --eeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhccCccCHHHHHHhCc
Confidence 13699999886422 4678999999999999997 8999952 2222222221111100 012
Q ss_pred CHHHHHHHHHhhhcCccccCCchhcHHHHHcC
Q 007260 520 SFAARDLIRGLLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 520 s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~H 551 (611)
+..++.||..|++.||.+|++ |++.|+-
T Consensus 264 d~~~Rnlil~Mi~rdPs~RlS----AedyL~~ 291 (1431)
T KOG1240|consen 264 DVSLRNLILSMIQRDPSKRLS----AEDYLQK 291 (1431)
T ss_pred CccHHHHHHHHHccCchhccC----HHHHHHh
Confidence 336899999999999999999 9999975
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.1e-23 Score=233.74 Aligned_cols=313 Identities=30% Similarity=0.494 Sum_probs=243.4
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
...+.+.+-+-+|.++.++.+.-..++..+++|+..+..............+..++-...||.+++..--|......+||
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 45788889999999999999999999988899887766544444444555666677667788888887777788899999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
|+|+.|++|...++..+ ..+++.++.++..+..+++|||...++|||++|.|+|+..+|+.++.|||+......-+..
T Consensus 883 ~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred hHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCc
Confidence 99999999999888763 5788899999999999999999999999999999999999999999999965332211111
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
.... +...--.++.+....+... +... ...+....
T Consensus 961 ~~~s-----------------------------g~~~~~~~~~~~~~~~~~~---------------l~~~-~~~~~~~~ 995 (1205)
T KOG0606|consen 961 TDLS-----------------------------GPSSSGTPRRLSRSERRPQ---------------LSAD-EARRKHAV 995 (1205)
T ss_pred CCcc-----------------------------cccccCccccccccccccc---------------cccc-hhhccccc
Confidence 0000 0000001111111111000 0000 12334567
Q ss_pred ccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCC-CCCHHHHHHHHHhhhc
Q 007260 455 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESP-VVSFAARDLIRGLLVK 533 (611)
Q Consensus 455 vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~-~~s~~l~dLI~~~L~~ 533 (611)
+||+.|++||++.+..++.++|||++|++++|.++|.+||........+.++.+....+|..+ ..+.++++++..+|..
T Consensus 996 ~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~ 1075 (1205)
T KOG0606|consen 996 VGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTE 1075 (1205)
T ss_pred cCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhcc
Confidence 899999999999999999999999999999999999999999999999999999988888754 4789999999999999
Q ss_pred CccccCCchhcHHHHHcCCCCCCCchhhhccCCCCCCCCCCC
Q 007260 534 EPQHRLAYKRGATEIKQHPFFEGVNWALIRCATPPEIPKPVE 575 (611)
Q Consensus 534 dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~p~~p~p~~ 575 (611)
+|.+|.+. .++.++..|+||+.++|..+..+..+.+|.+..
T Consensus 1076 ~~~qr~~a-~~~~e~k~~~~~~~~~~~~l~~q~~~~~p~~~s 1116 (1205)
T KOG0606|consen 1076 EPTQRLGA-KGAAEVKGHPFFQDVDWENLALQKAEFVPQPES 1116 (1205)
T ss_pred CchhccCc-ccccccccCCccCCCCccccccccCccCCCCCC
Confidence 99999983 235599999999999999887776666666543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.2e-21 Score=190.52 Aligned_cols=134 Identities=20% Similarity=0.241 Sum_probs=106.3
Q ss_pred EeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-----CCCCcccccceeeccc---eee
Q 007260 221 LKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-----DHPFLPTLYTHFETEK---FSC 292 (611)
Q Consensus 221 ~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-----~HpnIv~l~~~~~~~~---~~~ 292 (611)
.+.||+|+||.||. +..+... +||++...... ....+.+|+.+|+.+ +||||+++|++++++. .+|
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~---~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDG---GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccccc---hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 46899999999995 6666555 69988764322 234568899999999 6799999999999863 434
Q ss_pred -EEeee--CCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHH-HHHHHcCeeccCCCCCcEEEccC----CcEEEEeccc
Q 007260 293 -LVMEF--CPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLAL-EYLHMLGIIYRDLKPENVLVRED----GHIMLSDFDL 364 (611)
Q Consensus 293 -LVmE~--~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL-~yLH~~gIVHRDLKPeNILv~~~----g~vkL~DFGl 364 (611)
+|||| +.+++|.+++.+. .+++. ..++.|++.++ +|||+++||||||||+|||++.. +.++|+||+-
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 78999 5579999999663 36666 35678888888 99999999999999999999743 3799999544
Q ss_pred c
Q 007260 365 S 365 (611)
Q Consensus 365 A 365 (611)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 4
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=190.25 Aligned_cols=146 Identities=25% Similarity=0.251 Sum_probs=114.3
Q ss_pred CeEEEeEecccCcEEEEEEE-ECCCCeEEEEEEecchhhhh---------------------HHHHHHHHHHHHHHHhCC
Q 007260 217 HFRLLKRLGCGDIGSVYLSE-LSGTKCYFAMKVMDKASLAG---------------------RKKLLRAQTEREILQSLD 274 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~-~~~t~~~vAvKii~k~~~~~---------------------~~~~~~~~~E~~iL~~l~ 274 (611)
.|++.+.||.|+||.||+|. +..+++.||||+++...... ......+.+|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 68899999999999999999 66789999999987543110 011234578999999997
Q ss_pred CCC--cccccceeeccceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC-eeccCCCCCcEEE
Q 007260 275 HPF--LPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLG-IIYRDLKPENVLV 351 (611)
Q Consensus 275 Hpn--Iv~l~~~~~~~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~g-IVHRDLKPeNILv 351 (611)
+.+ ++.++++ ...||||||++|++|..+.... ..+.+..+..++.||+.+|.|||.+| |+||||||+|||+
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli 182 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV 182 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence 633 3344432 2358999999998887654332 34667778899999999999999999 9999999999999
Q ss_pred ccCCcEEEEecccccccc
Q 007260 352 REDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 352 ~~~g~vkL~DFGlA~~~~ 369 (611)
+ ++.++|+|||++....
T Consensus 183 ~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 183 H-DGKVVIIDVSQSVELD 199 (237)
T ss_pred E-CCCEEEEEChhhhccC
Confidence 9 8899999999985443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.7e-20 Score=213.42 Aligned_cols=200 Identities=27% Similarity=0.385 Sum_probs=157.1
Q ss_pred CccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC---CCCcccccceee
Q 007260 210 DGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD---HPFLPTLYTHFE 286 (611)
Q Consensus 210 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~---HpnIv~l~~~~~ 286 (611)
+..++...|.|-+.||.|+||+||+|.+.. ++.||||+-..... .+.. -=.+++.+|+ -+.|..+...+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~--WEfY----I~~q~~~RLk~~~~~~~~~~~~a~~ 764 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP--WEFY----ICLQVMERLKPQMLPSIMHISSAHV 764 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc--eeee----ehHHHHHhhchhhhcchHHHHHHHc
Confidence 345566889999999999999999999988 99999998654321 1110 0112233333 245666666666
Q ss_pred ccceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccC-------CcEEE
Q 007260 287 TEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRED-------GHIML 359 (611)
Q Consensus 287 ~~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~-------g~vkL 359 (611)
..+..+||+||.+.|+|.+++.. .+.++|..+.++..|+|.-|++||..||||+||||+|+||+.. --++|
T Consensus 765 ~~~~S~lv~ey~~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 765 FQNASVLVSEYSPYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred cCCcceeeeeccccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEE
Confidence 67788999999999999999984 4789999999999999999999999999999999999999631 24899
Q ss_pred EeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCC
Q 007260 360 SDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPL 439 (611)
Q Consensus 360 ~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (611)
+|||.+..+..-
T Consensus 843 IDfG~siDm~lf-------------------------------------------------------------------- 854 (974)
T KOG1166|consen 843 IDFGRSIDMKLF-------------------------------------------------------------------- 854 (974)
T ss_pred EecccceeeeEc--------------------------------------------------------------------
Confidence 999987433211
Q ss_pred cccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCC
Q 007260 440 PELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKT 492 (611)
Q Consensus 440 ~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~ 492 (611)
+...+...+++|-.+-.+|+..|..++..+|.|.|+.++|-||+|+.
T Consensus 855 ------p~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 855 ------PDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ------CCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 11223345678999999999999999999999999999999999864
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.2e-20 Score=185.16 Aligned_cols=241 Identities=18% Similarity=0.300 Sum_probs=197.8
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
.++..++.+|.....|..|++++.++. ++.|++.-..... .....|..|.-.|+-..||||+.+++.+....++.++
T Consensus 189 ~~~lnl~tkl~e~hsgelwrgrwqgnd--ivakil~vr~~t~-risrdfneefp~lrifshpnilpvlgacnsppnlv~i 265 (448)
T KOG0195|consen 189 VSSLNLITKLAESHSGELWRGRWQGND--IVAKILNVREVTA-RISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVII 265 (448)
T ss_pred hhhhhhhhhhccCCCcccccccccCcc--hhhhhhhhhhcch-hhcchhhhhCcceeeecCCchhhhhhhccCCCCceEe
Confidence 345667778899999999999998876 6778876544433 2334577788889999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--eeccCCCCCcEEEccCCcEEE--EeccccccccC
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLG--IIYRDLKPENVLVREDGHIML--SDFDLSLRCAV 370 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~g--IVHRDLKPeNILv~~~g~vkL--~DFGlA~~~~~ 370 (611)
..|++-|+|+.++..+.+-..+..++..++.++++|++|||+.. |----|....|+|+++-+.+| +|--++..+.
T Consensus 266 sq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe~- 344 (448)
T KOG0195|consen 266 SQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQEV- 344 (448)
T ss_pred eeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeecc-
Confidence 99999999999999887667788889999999999999999975 444467888899998876554 3433221110
Q ss_pred CccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccc
Q 007260 371 SPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEAR 450 (611)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (611)
T Consensus 345 -------------------------------------------------------------------------------- 344 (448)
T KOG0195|consen 345 -------------------------------------------------------------------------------- 344 (448)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccccccCCCccchhhhccCCC---CChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 007260 451 SMSFVGTHEYLAPEIIKGEGH---GSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLI 527 (611)
Q Consensus 451 ~~~~vGT~~Y~APEil~~~~~---~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI 527 (611)
...-.|.||+||.+...+- -.++|+|||.++||||.|...||...++.+.-.+|.-..++...++.++.....|+
T Consensus 345 --gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm 422 (448)
T KOG0195|consen 345 --GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLM 422 (448)
T ss_pred --ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHH
Confidence 0124678999999987764 35799999999999999999999999998888888888888878888999999999
Q ss_pred HHhhhcCccccCCc
Q 007260 528 RGLLVKEPQHRLAY 541 (611)
Q Consensus 528 ~~~L~~dP~~Rpt~ 541 (611)
.-|+..||.+||.+
T Consensus 423 ~icmnedpgkrpkf 436 (448)
T KOG0195|consen 423 NICMNEDPGKRPKF 436 (448)
T ss_pred HHHhcCCCCcCCCc
Confidence 99999999999984
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.9e-19 Score=177.42 Aligned_cols=136 Identities=23% Similarity=0.239 Sum_probs=113.7
Q ss_pred eEecccCcEEEEEEEECCCCeEEEEEEecchhh-----hhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEee
Q 007260 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASL-----AGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVME 296 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~-----~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE 296 (611)
+.||+|++|.||+|.+ .+..|++|+...... .......++.+|+.++..+.|++|+....++......+||||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 6799999999999987 445689997653221 112223467789999999999999888888777788999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccc
Q 007260 297 FCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSL 366 (611)
Q Consensus 297 ~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~ 366 (611)
|++|++|.+++.... . ....++.+++.+|.+||..||+||||+|.|||++ ++.++|+|||++.
T Consensus 80 ~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~ 142 (211)
T PRK14879 80 YIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAE 142 (211)
T ss_pred EeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCccc
Confidence 999999999886541 2 7788899999999999999999999999999999 8899999999984
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.4e-20 Score=201.95 Aligned_cols=254 Identities=24% Similarity=0.313 Sum_probs=167.5
Q ss_pred CeEEEeEecccCcEEEEEEEECCC---CeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccc-------eee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGT---KCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYT-------HFE 286 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t---~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~-------~~~ 286 (611)
.+.+.+-++..+++.++..+-... ...++-|..+.+.+ .......+++-.+....|.+..-+.+ .+.
T Consensus 245 s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~---~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~ 321 (516)
T KOG1033|consen 245 SSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSL---CACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSK 321 (516)
T ss_pred cccccccccccccCCchhhhhcccchhhhhccchhhhccch---hhhhhhhhhhhheeccccCCcccccCCCCchhhhcc
Confidence 445556666666666665543332 33444443332221 12223344555555444444333322 111
Q ss_pred -----ccceeeEEeeeCCCCCHHHHHHh-CCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEE
Q 007260 287 -----TEKFSCLVMEFCPGGDLHTLRQK-QPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLS 360 (611)
Q Consensus 287 -----~~~~~~LVmE~~~gg~L~~ll~~-~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~ 360 (611)
...++||.|++|.-.+|.+++.+ ..+...+......++.|+..|++| +|.+|||+||.||++..++.+||.
T Consensus 322 ~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIg 398 (516)
T KOG1033|consen 322 RNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIG 398 (516)
T ss_pred ccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhh
Confidence 12468999999999999999974 445567788899999999999999 999999999999999999999999
Q ss_pred eccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCc
Q 007260 361 DFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLP 440 (611)
Q Consensus 361 DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (611)
|||+.......++
T Consensus 399 DFgl~ts~~~~~~------------------------------------------------------------------- 411 (516)
T KOG1033|consen 399 DFGLVTSQDKDET------------------------------------------------------------------- 411 (516)
T ss_pred hhhheeecccCCc-------------------------------------------------------------------
Confidence 9999743321110
Q ss_pred ccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCC
Q 007260 441 ELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVV 519 (611)
Q Consensus 441 ~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~ 519 (611)
..+.....+..+||++||+||.|.+..|+.++||||||+||+||+. =...|.- ..++..+-.+.+........
T Consensus 412 ---~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er---~~t~~d~r~g~ip~~~~~d~ 485 (516)
T KOG1033|consen 412 ---VAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER---IATLTDIRDGIIPPEFLQDY 485 (516)
T ss_pred ---ccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH---HHhhhhhhcCCCChHHhhcC
Confidence 0011223445689999999999999999999999999999999996 3344332 12222222222221112122
Q ss_pred CHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCC
Q 007260 520 SFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 520 s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f 554 (611)
+ .-.+|+..||...|.+||+ +.+.-.|.|.
T Consensus 486 p-~e~~ll~~lls~~p~~RP~----~~~~~~~~~~ 515 (516)
T KOG1033|consen 486 P-EEYTLLQQLLSPSPEERPS----AIEVALHEFL 515 (516)
T ss_pred c-HHHHHHHHhcCCCcccCch----HHHHhhhhhc
Confidence 2 3458999999999999997 6666666664
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.7e-21 Score=220.49 Aligned_cols=263 Identities=24% Similarity=0.362 Sum_probs=209.5
Q ss_pred cCeEEEeEecccCcEEEEEEEEC-CCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC-CCCcccccceeeccceeeE
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELS-GTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD-HPFLPTLYTHFETEKFSCL 293 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~-~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~-HpnIv~l~~~~~~~~~~~L 293 (611)
..|++.+.||.|+|+.|-++... .....+|+|.+.... .......+...|..+-..+. |.|++.+++...+.+..++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 36788888999999999998874 445677888776543 23344556667888888886 9999999999999999999
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH-HcCeeccCCCCCcEEEccCC-cEEEEeccccccccCC
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLH-MLGIIYRDLKPENVLVREDG-HIMLSDFDLSLRCAVS 371 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH-~~gIVHRDLKPeNILv~~~g-~vkL~DFGlA~~~~~~ 371 (611)
++||..|++++..+.......++...+..++.|+..+|.|+| ..++.||||||+|.+++..+ .++++|||+|..+..-
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 999999999998874322226788888999999999999999 99999999999999999999 9999999998433210
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
.......
T Consensus 179 -------------------------------------------------------------------------~g~~~~~ 185 (601)
T KOG0590|consen 179 -------------------------------------------------------------------------NGAERSL 185 (601)
T ss_pred -------------------------------------------------------------------------CCcceee
Confidence 0011112
Q ss_pred ccccc-CCCccchhhhccCC-CCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHH-HHHHcCC--CCCCCCCCCCHHHHHH
Q 007260 452 MSFVG-THEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSGNRATL-FNVVGQP--LRFPESPVVSFAARDL 526 (611)
Q Consensus 452 ~~~vG-T~~Y~APEil~~~~-~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l-~~i~~~~--l~~p~~~~~s~~l~dL 526 (611)
...+| ++.|+|||...+.. .+...|+||+|+++.-+++|..||......... ..+.... .....+..++..+.++
T Consensus 186 ~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (601)
T KOG0590|consen 186 KDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDL 265 (601)
T ss_pred ecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccCChhhhhc
Confidence 23468 99999999999964 488999999999999999999999765443322 2222222 2344556789999999
Q ss_pred HHHhhhcCccccCCchhcHHHHHcCCCCCC
Q 007260 527 IRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 527 I~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
+.++|..+|..|.+ .+++..++|+..
T Consensus 266 l~k~l~~~~~~r~s----~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 266 LHKILKENPSNRLS----IEELKLDNWLSS 291 (601)
T ss_pred ccccccCCchhccc----cccccccccccc
Confidence 99999999999999 899999999987
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.9e-19 Score=176.59 Aligned_cols=140 Identities=25% Similarity=0.231 Sum_probs=109.8
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhh------H-------------HHHHHHHHHHHHHHhCCCCC
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAG------R-------------KKLLRAQTEREILQSLDHPF 277 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~------~-------------~~~~~~~~E~~iL~~l~Hpn 277 (611)
.|.+.+.||.|+||.||++.+. +++.||||+++...... . .....+.+|..++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 3888899999999999999875 68899999976532100 0 01123567899999998874
Q ss_pred --cccccceeeccceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCC
Q 007260 278 --LPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDG 355 (611)
Q Consensus 278 --Iv~l~~~~~~~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g 355 (611)
++.+++ ....|+||||++|++|..+... .....++.+++.+|.++|..||+||||||+|||++.++
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC
Confidence 444443 2345899999999999765321 34567889999999999999999999999999999999
Q ss_pred cEEEEecccccccc
Q 007260 356 HIMLSDFDLSLRCA 369 (611)
Q Consensus 356 ~vkL~DFGlA~~~~ 369 (611)
.++|+|||++..+.
T Consensus 163 ~~~liDfg~~~~~~ 176 (198)
T cd05144 163 KIYIIDWPQMVSTD 176 (198)
T ss_pred cEEEEECCccccCC
Confidence 99999999996554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.7e-19 Score=172.12 Aligned_cols=132 Identities=23% Similarity=0.259 Sum_probs=107.1
Q ss_pred EecccCcEEEEEEEECCCCeEEEEEEecchh-----hhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEeee
Q 007260 223 RLGCGDIGSVYLSELSGTKCYFAMKVMDKAS-----LAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEF 297 (611)
Q Consensus 223 ~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~-----~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE~ 297 (611)
.||+|+||.||++... +..|++|+..... ........++.+|+++++.+.|++|....-++......+|||||
T Consensus 1 ~ig~G~~~~vy~~~~~--~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL--GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeecC--CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 4899999999999854 4568999864322 11222345678899999999988776666566667778999999
Q ss_pred CCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccc
Q 007260 298 CPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSL 366 (611)
Q Consensus 298 ~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~ 366 (611)
++|++|.+++.... . .++.|++.+|.+||..||+||||+|+|||++ ++.++|+|||++.
T Consensus 79 ~~g~~l~~~~~~~~---~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~ 137 (199)
T TIGR03724 79 IEGKPLKDVIEEGN---D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGK 137 (199)
T ss_pred ECCccHHHHHhhcH---H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCc
Confidence 99999998875531 0 7789999999999999999999999999999 8999999999873
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.6e-19 Score=197.13 Aligned_cols=141 Identities=23% Similarity=0.249 Sum_probs=112.5
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecc---hhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceee
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDK---ASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSC 292 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k---~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~ 292 (611)
..|...+.||+|+||+||++.+......+.+++... ..........++.+|+++++.++|++|+..+.++......+
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 345678999999999999998866553332222211 11122223456789999999999999998887777777889
Q ss_pred EEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccc
Q 007260 293 LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLR 367 (611)
Q Consensus 293 LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~ 367 (611)
|||||++|++|.+++. ....++.|++.+|.|||++||+||||||+|||+ .++.++|+|||++..
T Consensus 413 lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 9999999999998775 346789999999999999999999999999999 688999999999843
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.3e-18 Score=165.45 Aligned_cols=139 Identities=22% Similarity=0.231 Sum_probs=99.4
Q ss_pred EeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHH---------------------HHHHHHHHHHhCCCCC--
Q 007260 221 LKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLL---------------------RAQTEREILQSLDHPF-- 277 (611)
Q Consensus 221 ~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~---------------------~~~~E~~iL~~l~Hpn-- 277 (611)
++.||+|+||+||+|.+. +++.||||++............ ....|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 468999999999999987 7889999998754322111110 1134666666664433
Q ss_pred cccccceeeccceeeEEeeeCCCCCHHH-HHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCeeccCCCCCcEEEccCC
Q 007260 278 LPTLYTHFETEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQAVRFYVAEVLLALEYLHM-LGIIYRDLKPENVLVREDG 355 (611)
Q Consensus 278 Iv~l~~~~~~~~~~~LVmE~~~gg~L~~-ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~-~gIVHRDLKPeNILv~~~g 355 (611)
++.+++. ...+|||||++|+.+.. .+... ... ..++.++.+++.++.++|. +||+||||||+|||++ ++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~---~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV---RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhh---hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC
Confidence 4444433 24589999999854421 11111 011 6678899999999999999 9999999999999999 89
Q ss_pred cEEEEecccccccc
Q 007260 356 HIMLSDFDLSLRCA 369 (611)
Q Consensus 356 ~vkL~DFGlA~~~~ 369 (611)
.++|+|||.+.+..
T Consensus 152 ~~~liDfg~a~~~~ 165 (187)
T cd05119 152 KVYIIDVPQAVEID 165 (187)
T ss_pred cEEEEECccccccc
Confidence 99999999996544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.73 E-value=3e-17 Score=166.40 Aligned_cols=136 Identities=21% Similarity=0.289 Sum_probs=104.4
Q ss_pred eEec-ccCcEEEEEEEECCCCeEEEEEEecchhhh----------hHHHHHHHHHHHHHHHhCCCCCc--ccccceeecc
Q 007260 222 KRLG-CGDIGSVYLSELSGTKCYFAMKVMDKASLA----------GRKKLLRAQTEREILQSLDHPFL--PTLYTHFETE 288 (611)
Q Consensus 222 ~~LG-~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~----------~~~~~~~~~~E~~iL~~l~HpnI--v~l~~~~~~~ 288 (611)
..|| .||.|+||.+... +..++||.+.+.... ......++.+|++++..|.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 7888888888775 557999988653321 11223567889999999998885 6666664432
Q ss_pred -ce---eeEEeeeCCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecc
Q 007260 289 -KF---SCLVMEFCPG-GDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFD 363 (611)
Q Consensus 289 -~~---~~LVmE~~~g-g~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFG 363 (611)
.. .+|||||++| .+|.+++... .+++.. +.||+.+|.+||++||+||||||+|||++.++.++|+|||
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg 187 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA---PLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFD 187 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC---CCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECC
Confidence 22 2599999997 6999887653 355543 5689999999999999999999999999999999999999
Q ss_pred ccc
Q 007260 364 LSL 366 (611)
Q Consensus 364 lA~ 366 (611)
.+.
T Consensus 188 ~~~ 190 (239)
T PRK01723 188 RGE 190 (239)
T ss_pred Ccc
Confidence 884
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.70 E-value=6.2e-17 Score=148.19 Aligned_cols=131 Identities=24% Similarity=0.292 Sum_probs=111.4
Q ss_pred EEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCC--CCcccccceeeccceeeEEeee
Q 007260 220 LLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH--PFLPTLYTHFETEKFSCLVMEF 297 (611)
Q Consensus 220 l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~H--pnIv~l~~~~~~~~~~~LVmE~ 297 (611)
+++.||.|.++.||++...+ ..+++|++..... ...+.+|+.+++.+.| .++++++.++...+..|++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 45789999999999999865 5799999866432 2356789999999976 5899999998888899999999
Q ss_pred CCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc---CeeccCCCCCcEEEccCCcEEEEeccccc
Q 007260 298 CPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHML---GIIYRDLKPENVLVREDGHIMLSDFDLSL 366 (611)
Q Consensus 298 ~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~---gIVHRDLKPeNILv~~~g~vkL~DFGlA~ 366 (611)
+.|+.+..+ +......++.+++.+|++||.. +|+|+||+|+|||++.++.++|+|||++.
T Consensus 75 ~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 75 IEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred cCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence 988877643 4556677889999999999985 79999999999999998999999999984
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.2e-16 Score=169.48 Aligned_cols=198 Identities=22% Similarity=0.267 Sum_probs=149.4
Q ss_pred HHhCCCCCcccccceeeccceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCe-eccCCCCCc
Q 007260 270 LQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGI-IYRDLKPEN 348 (611)
Q Consensus 270 L~~l~HpnIv~l~~~~~~~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gI-VHRDLKPeN 348 (611)
|+.+.|.|+.++++.+.++...++|.+||.-|+|.+.+.... ..++.--...++++|+.||+|||.--| +|+.|+..|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~-~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED-IKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc-cCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence 456889999999999999999999999999999999988742 457777788889999999999998765 999999999
Q ss_pred EEEccCCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCC
Q 007260 349 VLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKP 428 (611)
Q Consensus 349 ILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 428 (611)
++++..+.+||+|||+....... |.
T Consensus 80 Clvd~~w~lklt~~Gl~~~~~~~----------------------------------------~~--------------- 104 (484)
T KOG1023|consen 80 CLVDSRWVLKLTDFGLNSLLEET----------------------------------------AE--------------- 104 (484)
T ss_pred ceeeeeEEEEechhhhccccccc----------------------------------------cc---------------
Confidence 99999999999999986322100 00
Q ss_pred ccccCCCCCCCcccccCcccccccccccCCCccchhhhccCC-------CCChhhHHHHHHHHHHHHhCCCCCCCCC---
Q 007260 429 KNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEG-------HGSAVDWWTFGIFLYELLFGKTPFKGSG--- 498 (611)
Q Consensus 429 ~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~-------~~~~sDIWSLGviL~ELltG~~PF~~~~--- 498 (611)
.... ....-..-|.|||++.+.. .+.+.||||||++++|+++...||....
T Consensus 105 -------------~~~~------~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~ 165 (484)
T KOG1023|consen 105 -------------PEAH------HPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVE 165 (484)
T ss_pred -------------cccc------chhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccC
Confidence 0000 0001234599999998752 2567999999999999999999997632
Q ss_pred -cHHHHHHHHcCCC--CCCCC---CCCCHHHHHHHHHhhhcCccccCCch
Q 007260 499 -NRATLFNVVGQPL--RFPES---PVVSFAARDLIRGLLVKEPQHRLAYK 542 (611)
Q Consensus 499 -~~~~l~~i~~~~l--~~p~~---~~~s~~l~dLI~~~L~~dP~~Rpt~~ 542 (611)
..+.+..+..... -.|.. ..+.+++..++..||..+|..||++.
T Consensus 166 ~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~ 215 (484)
T KOG1023|consen 166 DPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIE 215 (484)
T ss_pred ChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHH
Confidence 2234444444111 11211 13566899999999999999999953
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.8e-15 Score=167.20 Aligned_cols=146 Identities=20% Similarity=0.257 Sum_probs=99.5
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhh-------------------------------HHHHHHH
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAG-------------------------------RKKLLRA 263 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~-------------------------------~~~~~~~ 263 (611)
+..|.. +.||+|++|.||+|+++.+|+.||||++++.-... .+....+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 356776 89999999999999999889999999997542110 0112223
Q ss_pred HHHHHHHHhCCCCCcccccceeec-------------cceeeEEeeeCCCCCHHHHH--HhCC--CCCCCHHHHHHHHHH
Q 007260 264 QTEREILQSLDHPFLPTLYTHFET-------------EKFSCLVMEFCPGGDLHTLR--QKQP--GKYFPEQAVRFYVAE 326 (611)
Q Consensus 264 ~~E~~iL~~l~HpnIv~l~~~~~~-------------~~~~~LVmE~~~gg~L~~ll--~~~~--~~~l~e~~~~~i~~q 326 (611)
.+|+++++.. .|+.++...|.+ ....+||||||.|+.|.++. .... ...+.+..+..++.|
T Consensus 198 ~~ElD~~~Ea--~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 198 HDELDLMREA--ANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred HHhhCHHHHH--HHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 3344443333 244444433332 33456999999999998742 2221 013555556666666
Q ss_pred HHHHHHHHHHcCeeccCCCCCcEEEccCC----cEEEEeccccccccC
Q 007260 327 VLLALEYLHMLGIIYRDLKPENVLVREDG----HIMLSDFDLSLRCAV 370 (611)
Q Consensus 327 ll~aL~yLH~~gIVHRDLKPeNILv~~~g----~vkL~DFGlA~~~~~ 370 (611)
++ ..|++|+|+||.||+|+.+| +++++|||+..++..
T Consensus 276 if-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 VF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 65 59999999999999999988 999999999876643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.2e-15 Score=162.63 Aligned_cols=259 Identities=23% Similarity=0.274 Sum_probs=193.6
Q ss_pred CeEEEeEecc--cCcEEEEEEEE--CCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC-CCCcccccceeecccee
Q 007260 217 HFRLLKRLGC--GDIGSVYLSEL--SGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD-HPFLPTLYTHFETEKFS 291 (611)
Q Consensus 217 ~y~l~~~LG~--G~fG~Vy~a~~--~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~-HpnIv~l~~~~~~~~~~ 291 (611)
.|.+.+.+|. |.+|.||.+.. ..+...+|+|.=+. .........+-.+|+.-...++ |+|.++.+..++..+..
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~-p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKI-PFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccC-CCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 5667789999 99999999998 88888999997321 1111122223345777777774 99999999999999999
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHH----HHHHHHHcCeeccCCCCCcEEEccC-CcEEEEeccccc
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLL----ALEYLHMLGIIYRDLKPENVLVRED-GHIMLSDFDLSL 366 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~----aL~yLH~~gIVHRDLKPeNILv~~~-g~vkL~DFGlA~ 366 (611)
|+-+|+| |.+|.++.... ...+++..++.++.+.+. ||.++|..+|+|-|+||+||++..+ ...+++|||+..
T Consensus 194 fiqtE~~-~~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 194 FIQTELC-GESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred eeeeccc-cchhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeE
Confidence 9999999 68888876653 456899999999999999 9999999999999999999999999 789999999985
Q ss_pred cccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCc
Q 007260 367 RCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEP 446 (611)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (611)
.+.... |.+..+..
T Consensus 272 ~i~~~~---------------------------------------------~~~~~~~~--------------------- 285 (524)
T KOG0601|consen 272 KISDGN---------------------------------------------FSSVFKVS--------------------- 285 (524)
T ss_pred EccCCc---------------------------------------------cccceeee---------------------
Confidence 443211 00000000
Q ss_pred ccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC--CcHHHHHHHHcCCCCCCCCCCCCHHHH
Q 007260 447 TEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGS--GNRATLFNVVGQPLRFPESPVVSFAAR 524 (611)
Q Consensus 447 ~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~--~~~~~l~~i~~~~l~~p~~~~~s~~l~ 524 (611)
..-.|...|++||.+.+. ++...||++||.++.+..+|..++... .....+.++. +........+.++.
T Consensus 286 -----~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~---ip~e~~~~~s~~l~ 356 (524)
T KOG0601|consen 286 -----KRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY---IPLEFCEGGSSSLR 356 (524)
T ss_pred -----ecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc---CchhhhcCcchhhh
Confidence 011366789999998755 788999999999999999887776543 3333332222 11122233666777
Q ss_pred HHHHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 525 DLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 525 dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
..+..|+..+|-.|++ +..+++|++....
T Consensus 357 ~~~~~~~d~~~~~~~~----~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 357 SVTSQMLDEDPRLRLT----AQILTALNVIHSK 385 (524)
T ss_pred hHHHHhcCcchhhhhH----HHHHhccccccch
Confidence 7999999999999999 8999999887643
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.54 E-value=3.2e-14 Score=156.33 Aligned_cols=141 Identities=23% Similarity=0.251 Sum_probs=96.9
Q ss_pred eEecccCcEEEEEEEECCCCeEEEEEEecchhhhhH-------------------------------HHH------HHHH
Q 007260 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGR-------------------------------KKL------LRAQ 264 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~-------------------------------~~~------~~~~ 264 (611)
+.||.|++|.||+|+.. +|+.||||+.+......- +.. ..+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 67999999999999986 578999999865421100 000 0133
Q ss_pred HHHHHHHhC----C-CCCc--ccccceeeccceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHH-HHHHHHH
Q 007260 265 TEREILQSL----D-HPFL--PTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLL-ALEYLHM 336 (611)
Q Consensus 265 ~E~~iL~~l----~-HpnI--v~l~~~~~~~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~-aL~yLH~ 336 (611)
+|+..+.++ . +++| ++++. ......+|||||++|++|.++...... .+. ...++.+++. .+..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~--~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYW--DRTSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEeh--hhcCCceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHHHHHHHHHh
Confidence 455554444 2 3332 23332 223456899999999999887653211 122 2345555555 4788999
Q ss_pred cCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 337 LGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 337 ~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
.|++|+|+||.||+++.+|.++|+|||++..+.
T Consensus 276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 999999999999999999999999999986654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.3e-13 Score=130.84 Aligned_cols=127 Identities=22% Similarity=0.279 Sum_probs=95.8
Q ss_pred EeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCC-cccccceeeccceeeEEeeeCC
Q 007260 221 LKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF-LPTLYTHFETEKFSCLVMEFCP 299 (611)
Q Consensus 221 ~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~Hpn-Iv~l~~~~~~~~~~~LVmE~~~ 299 (611)
++.|+.|.++.||+++.. +..|++|+...... ....+.+|+.+++.+.+.+ +++++.++. ...++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 467899999999999875 56799999765421 1123467999999886544 455655443 34579999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCe-----eccCCCCCcEEEccCCcEEEEeccccc
Q 007260 300 GGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGI-----IYRDLKPENVLVREDGHIMLSDFDLSL 366 (611)
Q Consensus 300 gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gI-----VHRDLKPeNILv~~~g~vkL~DFGlA~ 366 (611)
|.++... ......++.+++.+|..||..++ +|+|++|.|||++ ++.++|+|||.+.
T Consensus 75 G~~l~~~----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 75 GSELLTE----------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCccccc----------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9888642 01123456899999999999985 9999999999999 6789999999883
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.45 E-value=6.3e-14 Score=153.49 Aligned_cols=253 Identities=20% Similarity=0.259 Sum_probs=188.0
Q ss_pred cccccCeEEEeEecccCcEEEEEEEEC-CCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeeccc
Q 007260 212 VLGLSHFRLLKRLGCGDIGSVYLSELS-GTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEK 289 (611)
Q Consensus 212 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~-~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~~ 289 (611)
...+.+|.++..||.|.|+.|+....+ .++..|++|-+.+........+ ....|+-+...+ .|.+++..+..|...+
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di-~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDI-FSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhh-cchhhhhHhhHhhcccccCCCCCCccccc
Confidence 344578999999999999999998765 6788999998765543332222 234577776666 5999999999998888
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccC-CcEEEEeccccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRED-GHIMLSDFDLSLRC 368 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~-g~vkL~DFGlA~~~ 368 (611)
..||-.|||.++++...+.-. ..+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||++.++
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~~--~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVTS--QMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred cccCchhhhcCcchhhhhHHH--HhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccc
Confidence 899999999999887544221 357888899999999999999999999999999999999886 67899999987442
Q ss_pred cCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccc
Q 007260 369 AVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTE 448 (611)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (611)
....
T Consensus 418 ~~~~---------------------------------------------------------------------------- 421 (524)
T KOG0601|consen 418 AFSS---------------------------------------------------------------------------- 421 (524)
T ss_pred ceec----------------------------------------------------------------------------
Confidence 2110
Q ss_pred ccccccccCCCcc--chhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 007260 449 ARSMSFVGTHEYL--APEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDL 526 (611)
Q Consensus 449 ~~~~~~vGT~~Y~--APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dL 526 (611)
+.+.++-+|. +++......+..+.|+++||..+++.++|...-....+ ...+..+. .|..+.....+..+
T Consensus 422 ---~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i~~~~--~p~~~~~~~~~q~~ 493 (524)
T KOG0601|consen 422 ---GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLTIRSGD--TPNLPGLKLQLQVL 493 (524)
T ss_pred ---ccccccccccccchhhccccccccccccccccccccccccCcccCccccc---ceeeeccc--ccCCCchHHhhhhh
Confidence 0112223333 55555566789999999999999999998765333222 22222222 23333355889999
Q ss_pred HHHhhhcCccccCCchhcHHHHHcCCCCC
Q 007260 527 IRGLLVKEPQHRLAYKRGATEIKQHPFFE 555 (611)
Q Consensus 527 I~~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 555 (611)
...++..++..|+. +.++..|.-|.
T Consensus 494 ~kv~~~~~~~~~~l----~~~l~~~~~~~ 518 (524)
T KOG0601|consen 494 LKVMINPDRKRRPS----AVELSLHSEFY 518 (524)
T ss_pred hhhhcCCccccchh----hhhhcccchhh
Confidence 99999999999999 88888887764
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.45 E-value=9.9e-13 Score=145.51 Aligned_cols=122 Identities=20% Similarity=0.213 Sum_probs=100.3
Q ss_pred EEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEeeeCCCCCHHHHHHhCCCC
Q 007260 234 LSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGK 313 (611)
Q Consensus 234 ~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE~~~gg~L~~ll~~~~~~ 313 (611)
.|..+.++..|.|.+.+...- .....+.+-++-|+.|+||||+++++.++.++.+|||+|.+. -|..++...
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l--- 101 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL--- 101 (690)
T ss_pred ccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh---
Confidence 355566777888887765442 333345667888999999999999999999999999999984 466666653
Q ss_pred CCCHHHHHHHHHHHHHHHHHHH-HcCeeccCCCCCcEEEccCCcEEEEecccc
Q 007260 314 YFPEQAVRFYVAEVLLALEYLH-MLGIIYRDLKPENVLVREDGHIMLSDFDLS 365 (611)
Q Consensus 314 ~l~e~~~~~i~~qll~aL~yLH-~~gIVHRDLKPeNILv~~~g~vkL~DFGlA 365 (611)
....+..-+.||+.||.||| ..+++|++|.-.-|+|+..|+.||++|.++
T Consensus 102 --~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v 152 (690)
T KOG1243|consen 102 --GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELV 152 (690)
T ss_pred --HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEE
Confidence 36777788999999999997 678999999999999999999999999886
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.1e-12 Score=128.74 Aligned_cols=139 Identities=19% Similarity=0.232 Sum_probs=100.8
Q ss_pred eEecccCcEEEEEEEECC------CCeEEEEEEecchhh--h-------------------hHHHHH--HHHHHHHHHHh
Q 007260 222 KRLGCGDIGSVYLSELSG------TKCYFAMKVMDKASL--A-------------------GRKKLL--RAQTEREILQS 272 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~~~------t~~~vAvKii~k~~~--~-------------------~~~~~~--~~~~E~~iL~~ 272 (611)
..||.|.-+.||.|.... .+..+|||+.+-... . +...+. -+++|...|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 578999999999998653 356899999763211 0 001111 13479999999
Q ss_pred CCC--CCcccccceeeccceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHH-HHcCeeccCCCCCcE
Q 007260 273 LDH--PFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYL-HMLGIIYRDLKPENV 349 (611)
Q Consensus 273 l~H--pnIv~l~~~~~~~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yL-H~~gIVHRDLKPeNI 349 (611)
|.. -+++.++++ ..-+|||||+.+..+..-+-+. ..+++..+..++.+++.+|.+| |..||||+||++.||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI 156 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM 156 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 853 466777764 4568999999665443222222 2356667778889999999999 899999999999999
Q ss_pred EEccCCcEEEEecccccc
Q 007260 350 LVREDGHIMLSDFDLSLR 367 (611)
Q Consensus 350 Lv~~~g~vkL~DFGlA~~ 367 (611)
|+. +|.+.|+|||.+..
T Consensus 157 L~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 157 LWH-DGKVWFIDVSQSVE 173 (197)
T ss_pred EEE-CCcEEEEECCCcee
Confidence 997 57899999998843
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.7e-12 Score=132.66 Aligned_cols=204 Identities=24% Similarity=0.308 Sum_probs=144.3
Q ss_pred HHhCCCCCcccccceeeccc-----eeeEEeeeCCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcC--ee
Q 007260 270 LQSLDHPFLPTLYTHFETEK-----FSCLVMEFCPGGDLHTLRQKQ--PGKYFPEQAVRFYVAEVLLALEYLHMLG--II 340 (611)
Q Consensus 270 L~~l~HpnIv~l~~~~~~~~-----~~~LVmE~~~gg~L~~ll~~~--~~~~l~e~~~~~i~~qll~aL~yLH~~g--IV 340 (611)
|..+.|.|||+++.|+.+.+ ...++.||+.-|+|..++++. ....+.+...++|+.||+.||.|||+.. |+
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii 200 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII 200 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence 45567999999999987644 478999999999999988753 3467899999999999999999999986 99
Q ss_pred ccCCCCCcEEEccCCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCccccc
Q 007260 341 YRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSS 420 (611)
Q Consensus 341 HRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (611)
|+++.-.-|++..+|-+|+. ... |...+++. .+-+
T Consensus 201 hgnlTc~tifiq~ngLIkig---~~a---------------------------------p~s~h~s~-----~~~~---- 235 (458)
T KOG1266|consen 201 HGNLTCDTIFIQHNGLIKIG---SVA---------------------------------PDSTHPSV-----NSTR---- 235 (458)
T ss_pred cCCcchhheeecCCceEEec---ccC---------------------------------ccccchhh-----hhhh----
Confidence 99999999999999888874 210 00000000 0000
Q ss_pred ccccCCCCccccCCCCCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC-CCc
Q 007260 421 KSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKG-SGN 499 (611)
Q Consensus 421 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~-~~~ 499 (611)
......-.|-++|.+||.=.....+.++|||+||.+.+||..|..--.. .+.
T Consensus 236 ---------------------------~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~ 288 (458)
T KOG1266|consen 236 ---------------------------EAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESK 288 (458)
T ss_pred ---------------------------HhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcce
Confidence 0000011366789999976666677899999999999999987764222 221
Q ss_pred ---HHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 500 ---RATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 500 ---~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
.+.+.+++.. + -..--+++|.+||.-+|..||+ |.+++.||-.-+|
T Consensus 289 ~~~ee~ia~~i~~-l-------en~lqr~~i~kcl~~eP~~rp~----ar~llfHpllfeV 337 (458)
T KOG1266|consen 289 VEVEENIANVIIG-L-------ENGLQRGSITKCLEGEPNGRPD----ARLLLFHPLLFEV 337 (458)
T ss_pred eehhhhhhhheee-c-------cCccccCcCcccccCCCCCCcc----hhhhhcCceeeec
Confidence 1222222211 0 1112357999999999999999 9999999987544
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.9e-11 Score=117.17 Aligned_cols=133 Identities=22% Similarity=0.239 Sum_probs=102.1
Q ss_pred eEecccCcEEEEEEEECCCCeEEEEEEecc-----hhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEee
Q 007260 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDK-----ASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVME 296 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k-----~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE 296 (611)
..+++|+-+.+|++...+-. +.+|.=.+ ..+..+-...+..+|+.+|.++.--.|..-+=++.+.....||||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~--av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLP--AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeeccCcc--eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 35789999999999765433 66664322 233444445567889999999876666666656677778889999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccc
Q 007260 297 FCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSL 366 (611)
Q Consensus 297 ~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~ 366 (611)
|++|..|.+++... .-.++..|-.-+.-||.+||||+||.++||++..++ +.++||||+.
T Consensus 80 ~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~ 139 (204)
T COG3642 80 YIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGE 139 (204)
T ss_pred EeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccc
Confidence 99999998887764 134667777888899999999999999999998654 9999999984
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.6e-11 Score=115.73 Aligned_cols=144 Identities=22% Similarity=0.214 Sum_probs=108.2
Q ss_pred EEeEecccCcEEEEEEEECCCCeEEEEEE-----ecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 220 LLKRLGCGDIGSVYLSELSGTKCYFAMKV-----MDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 220 l~~~LG~G~fG~Vy~a~~~~t~~~vAvKi-----i~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
.+..|-+|+-+.|+++...+ +...||. .+...+...-...|..+|+.+|.++.--.|.--.-+|.+...-+|+
T Consensus 11 ~l~likQGAEArv~~~~~~G--e~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSG--EAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccCC--ceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 56788999999999998765 4456664 2223344444556778899999998655555444466677777899
Q ss_pred eeeCCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCC---cEEEEecccc
Q 007260 295 MEFCPG-GDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDG---HIMLSDFDLS 365 (611)
Q Consensus 295 mE~~~g-g~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g---~vkL~DFGlA 365 (611)
|||++| .++.+++...............++.+|-..|.-||.++|||+||..+|||+..+| .+.|+|||++
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecch
Confidence 999976 4777877765433333444478889999999999999999999999999998766 3589999997
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.1e-11 Score=120.25 Aligned_cols=138 Identities=20% Similarity=0.235 Sum_probs=104.6
Q ss_pred eEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCC--CCcccccceeecc---ceeeEEee
Q 007260 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH--PFLPTLYTHFETE---KFSCLVME 296 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~H--pnIv~l~~~~~~~---~~~~LVmE 296 (611)
+.||.|.++.||+++... +..|++|+....... .....+.+|.++++.+.+ .++++++.+.... +..|+|||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 678999999999998754 567999998654321 122356789999999975 4467777776653 36789999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 007260 297 FCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHM---------------------------------------- 336 (611)
Q Consensus 297 ~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~---------------------------------------- 336 (611)
|++|.+|...+.. ..+++.....++.+++.+|.+||+
T Consensus 81 ~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 81 RVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred EeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 9999888764421 236677777777788888888873
Q ss_pred ----------------cCeeccCCCCCcEEEcc--CCcEEEEecccc
Q 007260 337 ----------------LGIIYRDLKPENVLVRE--DGHIMLSDFDLS 365 (611)
Q Consensus 337 ----------------~gIVHRDLKPeNILv~~--~g~vkL~DFGlA 365 (611)
..+||+|++|.|||++. ++.+.|+||+.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~ 204 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELA 204 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccc
Confidence 23699999999999998 667899999987
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.5e-09 Score=111.95 Aligned_cols=134 Identities=17% Similarity=0.094 Sum_probs=95.3
Q ss_pred EEEEEEEECCCCeEEEEEEecchhhhh-HHH-------HHHHHHHHHHHHhCCCCCcc--cccceeec-----cceeeEE
Q 007260 230 GSVYLSELSGTKCYFAMKVMDKASLAG-RKK-------LLRAQTEREILQSLDHPFLP--TLYTHFET-----EKFSCLV 294 (611)
Q Consensus 230 G~Vy~a~~~~t~~~vAvKii~k~~~~~-~~~-------~~~~~~E~~iL~~l~HpnIv--~l~~~~~~-----~~~~~LV 294 (611)
..|++.+.. |+.|.||......... .+. ...+.+|...+.+|..-+|. .++.+++. ....|||
T Consensus 36 rrvvr~~~~--g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 36 RRTLRFELA--GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred ceEEEEEEC--CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 345565543 4578888664322110 000 11367899998888555554 34555543 2357899
Q ss_pred eeeCCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEcc-------CCcEEEEecccc
Q 007260 295 MEFCPGG-DLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRE-------DGHIMLSDFDLS 365 (611)
Q Consensus 295 mE~~~gg-~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~-------~g~vkL~DFGlA 365 (611)
||+++|. +|.+++........++.....++.+|+..+.-||.+||+|+||++.||||+. ++.+.|+||+.+
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~ 192 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA 192 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence 9999875 7988876432234567778899999999999999999999999999999985 468999999977
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.10 E-value=3.8e-10 Score=110.21 Aligned_cols=127 Identities=23% Similarity=0.268 Sum_probs=84.3
Q ss_pred EEEEEEECCCCeEEEEEEecchhhh-----------------------hHHHHHHHHHHHHHHHhCCCC--Cccccccee
Q 007260 231 SVYLSELSGTKCYFAMKVMDKASLA-----------------------GRKKLLRAQTEREILQSLDHP--FLPTLYTHF 285 (611)
Q Consensus 231 ~Vy~a~~~~t~~~vAvKii~k~~~~-----------------------~~~~~~~~~~E~~iL~~l~Hp--nIv~l~~~~ 285 (611)
.||.|... .+..+|||+.+..... .......+++|.+.|.++..- ++++++++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 38988774 4668999997642110 011234567899999999755 577777553
Q ss_pred eccceeeEEeeeCC--CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHH-HHHcCeeccCCCCCcEEEccCCcEEEEec
Q 007260 286 ETEKFSCLVMEFCP--GGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEY-LHMLGIIYRDLKPENVLVREDGHIMLSDF 362 (611)
Q Consensus 286 ~~~~~~~LVmE~~~--gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~y-LH~~gIVHRDLKPeNILv~~~g~vkL~DF 362 (611)
.-+|||||++ |..|..+.... ++......++.+++..+.. +|..||||+||.+.|||++++ .+.|+||
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--G
T ss_pred ----CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEec
Confidence 3469999998 66666554432 2345567778889886666 579999999999999999977 8999999
Q ss_pred ccccc
Q 007260 363 DLSLR 367 (611)
Q Consensus 363 GlA~~ 367 (611)
|.+..
T Consensus 151 ~qav~ 155 (188)
T PF01163_consen 151 GQAVD 155 (188)
T ss_dssp TTEEE
T ss_pred Cccee
Confidence 98843
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.10 E-value=2.3e-09 Score=115.97 Aligned_cols=134 Identities=19% Similarity=0.203 Sum_probs=108.4
Q ss_pred cEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec----cceeeEEeeeCCC-CCH
Q 007260 229 IGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET----EKFSCLVMEFCPG-GDL 303 (611)
Q Consensus 229 fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~----~~~~~LVmE~~~g-g~L 303 (611)
-.+.|+|....+|..|++|.++-.+.....+. ..-+++++++.|+|||.+.++|.. +..++||++|.++ ++|
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~---t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKD---TSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccc---hHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 35789999999999999999955443332221 235788999999999999999973 5678999999876 577
Q ss_pred HHHHHhC-------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccc
Q 007260 304 HTLRQKQ-------------PGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365 (611)
Q Consensus 304 ~~ll~~~-------------~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA 365 (611)
.++.... .+...+|..+|.|+.||..||.++|+.|+.-+-|.|.+||++.+-+++|...|+.
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~ 440 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIM 440 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccce
Confidence 7654322 1345789999999999999999999999999999999999998888999877765
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=9.9e-11 Score=130.28 Aligned_cols=165 Identities=21% Similarity=0.356 Sum_probs=117.8
Q ss_pred HHHHHHHHHHHHH-cCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCc
Q 007260 324 VAEVLLALEYLHM-LGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSC 402 (611)
Q Consensus 324 ~~qll~aL~yLH~-~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (611)
+.+++.||.|+|. .++||++|.|++|.++.+|.+||+.|+.+...... .|.+.
T Consensus 105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~------------------------~~~p~-- 158 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGP------------------------TEYPF-- 158 (700)
T ss_pred hhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCC------------------------Ccccc--
Confidence 3456699999996 58999999999999999999999999976221100 00000
Q ss_pred CCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHH
Q 007260 403 IQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGI 482 (611)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGv 482 (611)
.+.+. +++ --..-...|.|||++.+.-.+.++|++||||
T Consensus 159 ---------------------------~~yd~---~lp-----------~~~~~~~~f~apE~~~~~~~~~~sd~fSlG~ 197 (700)
T KOG2137|consen 159 ---------------------------SEYDP---PLP-----------LLLQPHLNFLAPEYLLGTTNTPASDVFSLGV 197 (700)
T ss_pred ---------------------------ccCCC---CCC-----------hhhccCcccccchhhccccccccccceeeee
Confidence 00000 000 0112446799999999988899999999999
Q ss_pred HHHHHH-hCCCCCCCCCcHHHHH--HHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCch
Q 007260 483 FLYELL-FGKTPFKGSGNRATLF--NVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNW 559 (611)
Q Consensus 483 iL~ELl-tG~~PF~~~~~~~~l~--~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 559 (611)
++|-+. .|+..|.+.+...... ....+--.+-....++.++++=|.++|..++.-||+ +.+++.-|||.+..-
T Consensus 198 li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~----~~~l~~~~ff~D~~~ 273 (700)
T KOG2137|consen 198 LIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPT----LDLLLSIPFFSDPGL 273 (700)
T ss_pred EEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcc----hhhhhcccccCCchh
Confidence 999999 6777776654433221 111222233444679999999999999999999998 999999999987543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=6.2e-09 Score=105.44 Aligned_cols=152 Identities=25% Similarity=0.243 Sum_probs=111.5
Q ss_pred cchHHHHHHhhccCccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhh-------------------H
Q 007260 197 DLRWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAG-------------------R 257 (611)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~-------------------~ 257 (611)
.+..-++..+..++.. +.++..||-|.-+.||.|.+. .+..+|||.-+-....- .
T Consensus 77 GyD~LAL~~l~~r~~v-----e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~ 150 (304)
T COG0478 77 GYDALALHALVKRGIV-----EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLY 150 (304)
T ss_pred chhHHHHHHHHHcChH-----HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhh
Confidence 3445566666665543 456789999999999999876 56789999754322110 0
Q ss_pred HHHHHHHHHHHHHHhCCCC--CcccccceeeccceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 007260 258 KKLLRAQTEREILQSLDHP--FLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLH 335 (611)
Q Consensus 258 ~~~~~~~~E~~iL~~l~Hp--nIv~l~~~~~~~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH 335 (611)
-....+++|.++|++|.-. .|+..+++ +.-.+||||++|-.|..+.. .......++..|+.-+.-+-
T Consensus 151 ~sRl~A~rEf~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r~-------~~en~~~il~~il~~~~~~~ 219 (304)
T COG0478 151 VSRLAAEREFEALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLRL-------DVENPDEILDKILEEVRKAY 219 (304)
T ss_pred hHHHHHHHHHHHHHHhhhcCCCCCCcccc----ccceeeeehcccceeecccC-------cccCHHHHHHHHHHHHHHHH
Confidence 1133468899999999654 78888776 34569999999988865431 23445556667777777666
Q ss_pred HcCeeccCCCCCcEEEccCCcEEEEecccc
Q 007260 336 MLGIIYRDLKPENVLVREDGHIMLSDFDLS 365 (611)
Q Consensus 336 ~~gIVHRDLKPeNILv~~~g~vkL~DFGlA 365 (611)
..||||+|+.+=||||++||.+.++||--+
T Consensus 220 ~~GiVHGDlSefNIlV~~dg~~~vIDwPQ~ 249 (304)
T COG0478 220 RRGIVHGDLSEFNILVTEDGDIVVIDWPQA 249 (304)
T ss_pred HcCccccCCchheEEEecCCCEEEEeCccc
Confidence 999999999999999999999999999754
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.86 E-value=3e-08 Score=105.04 Aligned_cols=236 Identities=19% Similarity=0.235 Sum_probs=151.6
Q ss_pred EEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCccc--------ccceeeccce
Q 007260 220 LLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPT--------LYTHFETEKF 290 (611)
Q Consensus 220 l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~--------l~~~~~~~~~ 290 (611)
+++.||+|+-+.+|-...-.+ -+-|+..+-...... .-++.|... .||-+-. |++-- ....
T Consensus 15 ~gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~~a------qk~a~la~~p~~p~~~~rvaWPqa~L~G~~-~~~~ 84 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAAQA------QKVAELAATPDAPLLNYRVAWPQATLHGGR-RGKV 84 (637)
T ss_pred CCccccCCccceeeecchhhc---hhheeecCCCchHHH------HHHHHhccCCCCcchhhhhcccHHHhhCCC-ccce
Confidence 457899999999996543332 245777654332211 123333333 5664432 22211 1233
Q ss_pred eeEEeeeCCCCC-HHHHHH----hCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccc
Q 007260 291 SCLVMEFCPGGD-LHTLRQ----KQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365 (611)
Q Consensus 291 ~~LVmE~~~gg~-L~~ll~----~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA 365 (611)
+-+.|..++|.. +..+.. ++.-..+.++-+.++++.|+.+.+-||..|.+-+|+.++|+||.+++.|.|.|-+-.
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 778999987752 222211 222245778889999999999999999999999999999999999999999986543
Q ss_pred ccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccC
Q 007260 366 LRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAE 445 (611)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (611)
..+...
T Consensus 165 qi~~ng-------------------------------------------------------------------------- 170 (637)
T COG4248 165 QINANG-------------------------------------------------------------------------- 170 (637)
T ss_pred eeccCC--------------------------------------------------------------------------
Confidence 111100
Q ss_pred cccccccccccCCCccchhhhc-----cCCCCChhhHHHHHHHHHHHHhC-CCCCCCCC-------cHH-HHH-------
Q 007260 446 PTEARSMSFVGTHEYLAPEIIK-----GEGHGSAVDWWTFGIFLYELLFG-KTPFKGSG-------NRA-TLF------- 504 (611)
Q Consensus 446 ~~~~~~~~~vGT~~Y~APEil~-----~~~~~~~sDIWSLGviL~ELltG-~~PF~~~~-------~~~-~l~------- 504 (611)
....--||..+|.+||.-. +..-+...|.|.|||++++||.| +.||.|.. ..+ .+.
T Consensus 171 ---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya 247 (637)
T COG4248 171 ---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYA 247 (637)
T ss_pred ---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeec
Confidence 0011237999999999865 33456789999999999999986 99998732 111 110
Q ss_pred HHHcCCCCC----CCCCCCCHHHHHHHHHhhhcC--ccccCCch
Q 007260 505 NVVGQPLRF----PESPVVSFAARDLIRGLLVKE--PQHRLAYK 542 (611)
Q Consensus 505 ~i~~~~l~~----p~~~~~s~~l~dLI~~~L~~d--P~~Rpt~~ 542 (611)
..-+.+++. +.+..+++++..|..+|+..- +.-||+.+
T Consensus 248 ~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 248 SDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred hhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 000111111 112347888999999999763 56899853
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.85 E-value=2e-08 Score=99.55 Aligned_cols=104 Identities=31% Similarity=0.309 Sum_probs=83.2
Q ss_pred HHHHHHHHHHHhCCCCC--cccccceeecc----ceeeEEeeeCCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHH
Q 007260 261 LRAQTEREILQSLDHPF--LPTLYTHFETE----KFSCLVMEFCPGG-DLHTLRQKQPGKYFPEQAVRFYVAEVLLALEY 333 (611)
Q Consensus 261 ~~~~~E~~iL~~l~Hpn--Iv~l~~~~~~~----~~~~LVmE~~~gg-~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~y 333 (611)
.++.+|...+..|..-. ++..+.+.+.. ...|||+|+++|. +|.+++..... ++......++.++...+.-
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAK 133 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHH
Confidence 35778888888775444 45556665542 3458999999884 89998887422 6677788999999999999
Q ss_pred HHHcCeeccCCCCCcEEEccCC---cEEEEeccccc
Q 007260 334 LHMLGIIYRDLKPENVLVREDG---HIMLSDFDLSL 366 (611)
Q Consensus 334 LH~~gIVHRDLKPeNILv~~~g---~vkL~DFGlA~ 366 (611)
||.+||+|+|+++.||||+.++ .+.|+||+-+.
T Consensus 134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~ 169 (206)
T PF06293_consen 134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR 169 (206)
T ss_pred HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence 9999999999999999999887 89999999763
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.75 E-value=2.9e-08 Score=110.71 Aligned_cols=145 Identities=21% Similarity=0.209 Sum_probs=89.9
Q ss_pred eEecccCcEEEEEEEECCCCeEEEEEEecchhhhh-------------------------------HHHHHH------HH
Q 007260 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAG-------------------------------RKKLLR------AQ 264 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~-------------------------------~~~~~~------~~ 264 (611)
..|+.++.|.||+|+... |+.||||+.+..-... .+...+ +.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 679999999999999986 8899999987542110 000111 22
Q ss_pred HHHHHHHhC-----CCCCcccccceeeccceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCe
Q 007260 265 TEREILQSL-----DHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGI 339 (611)
Q Consensus 265 ~E~~iL~~l-----~HpnIv~l~~~~~~~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gI 339 (611)
+|..-+.++ +.++|.--.=|++....-.|+|||++|.-+.++..... ..++...+...+.++ -+..+-..|+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~--f~~q~~~dgf 286 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRA--FLRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHH--HHHHHHhcCc
Confidence 333333333 12332211112233456689999999988887632221 224422222211111 1233334899
Q ss_pred eccCCCCCcEEEccCCcEEEEeccccccccC
Q 007260 340 IYRDLKPENVLVREDGHIMLSDFDLSLRCAV 370 (611)
Q Consensus 340 VHRDLKPeNILv~~~g~vkL~DFGlA~~~~~ 370 (611)
+|.|..|.||+|+.+|++.+.|||+..++..
T Consensus 287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 287 FHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred cccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 9999999999999999999999999866553
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.67 E-value=2.9e-07 Score=91.51 Aligned_cols=137 Identities=18% Similarity=0.241 Sum_probs=92.0
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHH------HHHHHHHHhCC---CCCcccccceee
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRA------QTEREILQSLD---HPFLPTLYTHFE 286 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~------~~E~~iL~~l~---HpnIv~l~~~~~ 286 (611)
.+|.+++++-......|.+-+-. +..+.+|..+......+..+..+ .+++..+.++. --.+..++.+.+
T Consensus 31 ~~~~~~kv~k~~~r~~ValIei~--~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALIEID--GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred CCceEEEeecCCCccEEEEEEEC--CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 68999999998887778777655 45699998865432222222222 33444444442 223333332222
Q ss_pred -----ccceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEe
Q 007260 287 -----TEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSD 361 (611)
Q Consensus 287 -----~~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~D 361 (611)
.....+|||||++|..|.++.. +++. +...|..+|.-||..|++|+|+.|.|++++.++ ++++|
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID 177 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED------IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIID 177 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh------cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEE
Confidence 2345579999999998876532 2332 345677889999999999999999999999555 99999
Q ss_pred cccc
Q 007260 362 FDLS 365 (611)
Q Consensus 362 FGlA 365 (611)
|+..
T Consensus 178 ~~~k 181 (229)
T PF06176_consen 178 TQGK 181 (229)
T ss_pred Cccc
Confidence 9865
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.64 E-value=2.8e-07 Score=91.19 Aligned_cols=139 Identities=16% Similarity=0.145 Sum_probs=99.0
Q ss_pred ecccCcEEEEEEEECCCCeEEEEEEecchhhhh---HHHHHHHHHHHHHHHhCCCCC--cccccceeec-----cceeeE
Q 007260 224 LGCGDIGSVYLSELSGTKCYFAMKVMDKASLAG---RKKLLRAQTEREILQSLDHPF--LPTLYTHFET-----EKFSCL 293 (611)
Q Consensus 224 LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~---~~~~~~~~~E~~iL~~l~Hpn--Iv~l~~~~~~-----~~~~~L 293 (611)
-|.||.+-|+.....+. .|-+|.-....... ..-...+.+|...|+.|..-+ ++++. ++.. .-..+|
T Consensus 26 ~~rgG~SgV~r~~~~g~--~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVERNGK--KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEeCCc--EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 36689999999876654 47777653110000 011234677988888885333 45555 3321 234689
Q ss_pred EeeeCCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCc--EEEEecccc
Q 007260 294 VMEFCPG-GDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGH--IMLSDFDLS 365 (611)
Q Consensus 294 VmE~~~g-g~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~--vkL~DFGlA 365 (611)
|+|-+.| .+|.+++....-...++.....++.+|+..|.-||..|+.|+|+-+.|||++.+|. ++++||.-+
T Consensus 103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~ 177 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKS 177 (216)
T ss_pred EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence 9998843 68988876643345677777899999999999999999999999999999987777 999999865
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.51 E-value=9.4e-09 Score=113.59 Aligned_cols=242 Identities=18% Similarity=0.176 Sum_probs=163.4
Q ss_pred eEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCC-cccccceeeccceeeEEee
Q 007260 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF-LPTLYTHFETEKFSCLVME 296 (611)
Q Consensus 218 y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~Hpn-Iv~l~~~~~~~~~~~LVmE 296 (611)
|...+.+++|+++++|+.+...++..+ .+++... ....-++++|.+++||| .+..++-++.+.+.+++|+
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence 444567889999999999988877666 7776543 12345899999999999 6666677777889999999
Q ss_pred eCCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 297 FCPGG-DLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 297 ~~~gg-~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
++.++ +-...+... ...|.+-+...+.+.-+++|+|||+.-=+||| |||..+ +.+++.||+....+..
T Consensus 315 i~s~~rs~~~~~~~s-e~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~----- 383 (829)
T KOG0576|consen 315 ICSTGRSSALEMTVS-EIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTR----- 383 (829)
T ss_pred hhcCCccccccCChh-hHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCc-----
Confidence 99777 222111110 01133334445566777899999998779999 888775 6789999997622210
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
. ....++.
T Consensus 384 -----------------------------------------------------------------------~-~~~~t~~ 391 (829)
T KOG0576|consen 384 -----------------------------------------------------------------------T-MKPRTAI 391 (829)
T ss_pred -----------------------------------------------------------------------c-cccccCC
Confidence 0 0223567
Q ss_pred cCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCC--CCCCH-HHHHHHHHhhh
Q 007260 456 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPES--PVVSF-AARDLIRGLLV 532 (611)
Q Consensus 456 GT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~--~~~s~-~l~dLI~~~L~ 532 (611)
||+.++|||++....+....|.|++|+-..+|.-|-+|-.. .......+-..+-.+... ...+. .-+++...|+.
T Consensus 392 ~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~--P~~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~ 469 (829)
T KOG0576|consen 392 GTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS--PPAVLPMIGNGPNSPMLTDKSAWSPVFHRDFPAPCLN 469 (829)
T ss_pred CCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC--CccccCCCCCCCCccccchhhhcCcccccCCcccccC
Confidence 99999999999999999999999999988888878777543 111111111111000000 00111 11257788899
Q ss_pred cCccccCCchhcHHHHHcCCCCCCC
Q 007260 533 KEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 533 ~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
..|..|+. +..++-|-+|++.
T Consensus 470 g~P~~pkv----~mgacfsKvfngC 490 (829)
T KOG0576|consen 470 GLPPTPKV----HMGACFSKVFNGC 490 (829)
T ss_pred CCCCCCcc----hhhHHHHHHhccC
Confidence 99998888 8888888888764
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.46 E-value=2e-06 Score=86.54 Aligned_cols=136 Identities=24% Similarity=0.271 Sum_probs=90.6
Q ss_pred eEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHH-------------------HHHH--HHHHHHHHHhCC--CCCc
Q 007260 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRK-------------------KLLR--AQTEREILQSLD--HPFL 278 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~-------------------~~~~--~~~E~~iL~~l~--HpnI 278 (611)
..|..|.-+.||+|.. ..+..||+|+.+......+. .+.. ...|..-|+++. +-.+
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 3666788889999976 45778999998654322111 1111 234555566662 4444
Q ss_pred ccccceeeccceeeEEeeeCCCCCHH-HHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCeeccCCCCCcEEEccCCc
Q 007260 279 PTLYTHFETEKFSCLVMEFCPGGDLH-TLRQKQPGKYFPEQAVRFYVAEVLLALEYLHM-LGIIYRDLKPENVLVREDGH 356 (611)
Q Consensus 279 v~l~~~~~~~~~~~LVmE~~~gg~L~-~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~-~gIVHRDLKPeNILv~~~g~ 356 (611)
++-+.++ .-.|||||+...-+. -.+.. -.+....+..+..++++.+.-|-. .|+||+||..=|||+. +|.
T Consensus 133 P~Pi~~~----~nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~ 204 (268)
T COG1718 133 PEPIAFR----NNVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGE 204 (268)
T ss_pred CCceeec----CCeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCe
Confidence 5555443 346999999433111 11111 123334678888899999998876 9999999999999999 889
Q ss_pred EEEEeccccc
Q 007260 357 IMLSDFDLSL 366 (611)
Q Consensus 357 vkL~DFGlA~ 366 (611)
+.|+|||-|.
T Consensus 205 p~iID~~QaV 214 (268)
T COG1718 205 PYIIDVSQAV 214 (268)
T ss_pred EEEEECcccc
Confidence 9999999874
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.7e-06 Score=85.34 Aligned_cols=138 Identities=25% Similarity=0.367 Sum_probs=82.5
Q ss_pred EeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCC--Ccccccceeec---cceeeEEe
Q 007260 221 LKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHP--FLPTLYTHFET---EKFSCLVM 295 (611)
Q Consensus 221 ~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~Hp--nIv~l~~~~~~---~~~~~LVm 295 (611)
++.|+.|..+.||+..... + .+++|+.... .....+.+|..+++.|... -+++++.+... ....|++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~-~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-G-RYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-S-EEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC-c-EEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 5789999999999998877 3 7999997654 2233556788888887433 35677764432 34578999
Q ss_pred eeCCCCCHHH----------------HHH---hC--CCCCCCHHH------HHHH---------------HHHHHH-HHH
Q 007260 296 EFCPGGDLHT----------------LRQ---KQ--PGKYFPEQA------VRFY---------------VAEVLL-ALE 332 (611)
Q Consensus 296 E~~~gg~L~~----------------ll~---~~--~~~~l~e~~------~~~i---------------~~qll~-aL~ 332 (611)
++++|..+.. ++. .. ....+.... .... +..+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999987776 111 11 111111100 0000 111222 333
Q ss_pred HHHH-------cCeeccCCCCCcEEEc-cCCcEEEEecccc
Q 007260 333 YLHM-------LGIIYRDLKPENVLVR-EDGHIMLSDFDLS 365 (611)
Q Consensus 333 yLH~-------~gIVHRDLKPeNILv~-~~g~vkL~DFGlA 365 (611)
.++. ..++|+|+.|.|||++ .++.+.|+||+.+
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a 195 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDA 195 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccc
Confidence 4432 4599999999999999 6777789999987
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.3e-06 Score=87.93 Aligned_cols=133 Identities=13% Similarity=0.103 Sum_probs=82.9
Q ss_pred eEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCC--cccccceeeccceeeEEeeeCC
Q 007260 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF--LPTLYTHFETEKFSCLVMEFCP 299 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~Hpn--Iv~l~~~~~~~~~~~LVmE~~~ 299 (611)
..||.|..+.||+. . +..+++|+....... ....+|.++++.+..-. +++.+++.+..+..++|||+++
T Consensus 7 ~~i~~G~t~~~y~~---~-~~~~VlR~~~~~~~~-----~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH---K-TGKWMLKLYNPGFDK-----ETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe---c-CCCEEEEeCCCCCCH-----HHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 57899999999984 2 335789987653311 23467999999886443 4777888777788899999998
Q ss_pred CCC-HHHH------------------H---HhC--CCCCCCHHHHHHHHH----------HHHH-HHHHHHH----cCee
Q 007260 300 GGD-LHTL------------------R---QKQ--PGKYFPEQAVRFYVA----------EVLL-ALEYLHM----LGII 340 (611)
Q Consensus 300 gg~-L~~l------------------l---~~~--~~~~l~e~~~~~i~~----------qll~-aL~yLH~----~gIV 340 (611)
|.+ +... + ... ....++... ..+.. .+.. ...+|.. ..++
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~-~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYK-EKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHH-HHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 864 1110 0 110 111111111 11100 1111 1222221 2478
Q ss_pred ccCCCCCcEEEccCCcEEEEecccc
Q 007260 341 YRDLKPENVLVREDGHIMLSDFDLS 365 (611)
Q Consensus 341 HRDLKPeNILv~~~g~vkL~DFGlA 365 (611)
|+|+.|.||++++++ +.|+||+.+
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a 180 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDF 180 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhc
Confidence 999999999999888 999999987
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.38 E-value=2.1e-06 Score=86.85 Aligned_cols=135 Identities=18% Similarity=0.124 Sum_probs=82.7
Q ss_pred EecccCc-EEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC-CCCcccccceeeccceeeEEeeeCCC
Q 007260 223 RLGCGDI-GSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD-HPFLPTLYTHFETEKFSCLVMEFCPG 300 (611)
Q Consensus 223 ~LG~G~f-G~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~-HpnIv~l~~~~~~~~~~~LVmE~~~g 300 (611)
.|-.|.. ..||+....+ ..+.||+..... ...+.+|+++++.+. +--++++++++..++..+||||+++|
T Consensus 5 ~~~~g~~~~~v~~~~~~~--~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 5 RVTEGQSGATVYRLDGKN--PGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred ecCCCCCcCeEEEEcCCC--CcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 3444554 7899996543 568889875542 123456888888883 44567888877776778999999999
Q ss_pred CCHHHHH-------------------HhCC--CCCCCHH------HHHHHHH----------------HHHHHHHHH---
Q 007260 301 GDLHTLR-------------------QKQP--GKYFPEQ------AVRFYVA----------------EVLLALEYL--- 334 (611)
Q Consensus 301 g~L~~ll-------------------~~~~--~~~l~e~------~~~~i~~----------------qll~aL~yL--- 334 (611)
..|.... ...+ +..+... .....+. .+...+..|
T Consensus 77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 156 (244)
T cd05150 77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT 156 (244)
T ss_pred ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence 8776431 1111 1111110 0000000 011112222
Q ss_pred ----HHcCeeccCCCCCcEEEccCCcEEEEecccc
Q 007260 335 ----HMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365 (611)
Q Consensus 335 ----H~~gIVHRDLKPeNILv~~~g~vkL~DFGlA 365 (611)
....++|+|+.|.|||++.++.+.|+||+.+
T Consensus 157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a 191 (244)
T cd05150 157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRL 191 (244)
T ss_pred CCCcCceEEECCCCCCccEEEeCCcEEEEEEcccc
Confidence 1234899999999999999877899999987
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.27 E-value=5.2e-06 Score=98.73 Aligned_cols=81 Identities=17% Similarity=0.313 Sum_probs=56.9
Q ss_pred EEeEecccCcEEEEEEEECCCC--eEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC-CCCc--ccccceeecc---cee
Q 007260 220 LLKRLGCGDIGSVYLSELSGTK--CYFAMKVMDKASLAGRKKLLRAQTEREILQSLD-HPFL--PTLYTHFETE---KFS 291 (611)
Q Consensus 220 l~~~LG~G~fG~Vy~a~~~~t~--~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~-HpnI--v~l~~~~~~~---~~~ 291 (611)
-++.|+.|.++.+|+......+ ..+++|+........ ....+.+|..+|+.|. |.+| ++++.++.+. +..
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 3578899999999998876533 357778764432111 1124568999999995 6765 7777776653 467
Q ss_pred eEEeeeCCCCC
Q 007260 292 CLVMEFCPGGD 302 (611)
Q Consensus 292 ~LVmE~~~gg~ 302 (611)
|+||||++|..
T Consensus 120 flVME~v~G~~ 130 (822)
T PLN02876 120 FYIMEYLEGRI 130 (822)
T ss_pred eEEEEecCCcc
Confidence 89999998864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.26 E-value=6.6e-06 Score=96.87 Aligned_cols=204 Identities=24% Similarity=0.298 Sum_probs=138.4
Q ss_pred HHHHHHHHHHHHHHhCCCCCcccccceeeccc----eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHH
Q 007260 258 KKLLRAQTEREILQSLDHPFLPTLYTHFETEK----FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEY 333 (611)
Q Consensus 258 ~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~----~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~y 333 (611)
+.+.....|++.+..+.|+|++.++.|..... ...+..|+|...++..+++.- ...+...++.+..+++.||+|
T Consensus 224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v--~~i~~~~~r~~~~~~~~GL~~ 301 (1351)
T KOG1035|consen 224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV--GSIPLETLRILHQKLLEGLAY 301 (1351)
T ss_pred HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc--cccCHHHHHHHHHHHhhhHHH
Confidence 34444556777888899999999998875433 335667899999999988875 568899999999999999999
Q ss_pred HHHcCeeccCCCCC---cEEEccCCcEEEE--eccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCC
Q 007260 334 LHMLGIIYRDLKPE---NVLVREDGHIMLS--DFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCV 408 (611)
Q Consensus 334 LH~~gIVHRDLKPe---NILv~~~g~vkL~--DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (611)
+|.+...|.-|-.. +-.++.++.+.+. ||+....+..
T Consensus 302 ~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d-------------------------------------- 343 (1351)
T KOG1035|consen 302 LHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPD-------------------------------------- 343 (1351)
T ss_pred HHHhccceeEEecccccccccCccceeecchhhhcccccCCC--------------------------------------
Confidence 99995444433333 2223334445544 6665422210
Q ss_pred CCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCccchhhhccCCCCC--hhhHHHHHHHHHH
Q 007260 409 TPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGS--AVDWWTFGIFLYE 486 (611)
Q Consensus 409 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~--~sDIWSLGviL~E 486 (611)
........-+..|.++|......+.. ..|+|.+|..+..
T Consensus 344 ---------------------------------------~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~ 384 (1351)
T KOG1035|consen 344 ---------------------------------------NEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQ 384 (1351)
T ss_pred ---------------------------------------cccchhhcCccccccccccccccchhhhhhHHHHHHHHHhh
Confidence 00111223455677888877766644 4699999999999
Q ss_pred HHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCC
Q 007260 487 LLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFE 555 (611)
Q Consensus 487 LltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 555 (611)
+..|..+-... .....+.... ......+++.+|+.-++++|+. +.+++.|+|..
T Consensus 385 ~~~~~~i~~~~---~~~~~~l~~~--------~~~~~~d~~~~~~~~~~~~Rl~----~~~ll~~~f~~ 438 (1351)
T KOG1035|consen 385 LSQGEDISEKS---AVPVSLLDVL--------STSELLDALPKCLDEDSEERLS----ALELLTHPFLR 438 (1351)
T ss_pred hhhcCcccccc---cchhhhhccc--------cchhhhhhhhhhcchhhhhccc----hhhhhhchhcc
Confidence 99876653221 1111111111 1116779999999999999999 99999999975
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.13 E-value=1.3e-05 Score=89.45 Aligned_cols=139 Identities=21% Similarity=0.242 Sum_probs=86.0
Q ss_pred eEecccCcEEEEEEEECCCCeEEEEEEecchhhhh----------------------------HHHHHH------HHHHH
Q 007260 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAG----------------------------RKKLLR------AQTER 267 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~----------------------------~~~~~~------~~~E~ 267 (611)
+.||.-+.|.||+|+.+. |+.||||+-+..-... .+..+. +.+|+
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 679999999999999988 8899999976432110 011111 12222
Q ss_pred H----HHHhCCCCC------cccccceeeccceeeEEeeeCCCCCHHHH--HHhCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 007260 268 E----ILQSLDHPF------LPTLYTHFETEKFSCLVMEFCPGGDLHTL--RQKQPGKYFPEQAVRFYVAEVLLALEYLH 335 (611)
Q Consensus 268 ~----iL~~l~Hpn------Iv~l~~~~~~~~~~~LVmE~~~gg~L~~l--l~~~~~~~l~e~~~~~i~~qll~aL~yLH 335 (611)
+ +.+.+.|-+ |+++|-.+ .....|+||||+|.-+.++ +.+. .++...+...+.++. ++-|-
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~---gi~~~~i~~~l~~~~--~~qIf 318 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKR---GISPHDILNKLVEAY--LEQIF 318 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHc---CCCHHHHHHHHHHHH--HHHHH
Confidence 2 222233444 44444322 3456899999999876654 3332 255544333222221 12233
Q ss_pred HcCeeccCCCCCcEEEcc----CCcEEEEeccccccc
Q 007260 336 MLGIIYRDLKPENVLVRE----DGHIMLSDFDLSLRC 368 (611)
Q Consensus 336 ~~gIVHRDLKPeNILv~~----~g~vkL~DFGlA~~~ 368 (611)
..|++|.|-.|.||||+. ++.+.|.|||+...+
T Consensus 319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 478999999999999994 568999999998443
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.13 E-value=2.5e-05 Score=77.13 Aligned_cols=130 Identities=21% Similarity=0.261 Sum_probs=91.6
Q ss_pred eEecccCcEEEEEEEECCCCeEEEEEEecchhhh-------------hHHHHHHHHHHHHHHHhCC------CCCccccc
Q 007260 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLA-------------GRKKLLRAQTEREILQSLD------HPFLPTLY 282 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~-------------~~~~~~~~~~E~~iL~~l~------HpnIv~l~ 282 (611)
..||+|+.-.||.--+. ....||++...... .........+|+.-...+. +.+|.++|
T Consensus 7 ~~i~~G~~R~cy~HP~d---p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQHPDD---PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEECCCC---CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 57999999999975333 33688998776510 0111234455666555554 78999999
Q ss_pred ceeeccceeeEEeeeCCC------CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCC-
Q 007260 283 THFETEKFSCLVMEFCPG------GDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDG- 355 (611)
Q Consensus 283 ~~~~~~~~~~LVmE~~~g------g~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g- 355 (611)
|+.+++..+-+|+|.+.+ .+|.+++... .+++ .. ...+-.-.+||-.++|+.+||+|.||++..++
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~ 156 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDS 156 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEecCC
Confidence 999999999999998733 3577777553 3655 32 33444556788999999999999999997532
Q ss_pred ---cEEEEe
Q 007260 356 ---HIMLSD 361 (611)
Q Consensus 356 ---~vkL~D 361 (611)
.+.|+|
T Consensus 157 ~~~~lvlID 165 (199)
T PF10707_consen 157 GEFRLVLID 165 (199)
T ss_pred CceEEEEEe
Confidence 578888
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.10 E-value=1.9e-05 Score=79.66 Aligned_cols=72 Identities=13% Similarity=0.130 Sum_probs=45.9
Q ss_pred eEecccCcE-EEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCC---Ccccccceeecc---ceeeEE
Q 007260 222 KRLGCGDIG-SVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHP---FLPTLYTHFETE---KFSCLV 294 (611)
Q Consensus 222 ~~LG~G~fG-~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~Hp---nIv~l~~~~~~~---~~~~LV 294 (611)
+.|+.|+.. .||+.. ..+++|+..... ....+.+|.++|+.|... -++.+++..... ...|+|
T Consensus 3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 3 EPVDSGGTDNATFRLG-----DDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred eeccCCCcccceEEcC-----CceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 567777776 599762 247788765422 122567799999888532 345555544332 245899
Q ss_pred eeeCCCCCH
Q 007260 295 MEFCPGGDL 303 (611)
Q Consensus 295 mE~~~gg~L 303 (611)
||+++|.+|
T Consensus 73 ~~~i~G~~l 81 (235)
T cd05155 73 YRWLEGETA 81 (235)
T ss_pred EEeecCCCC
Confidence 999999776
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.10 E-value=2.6e-05 Score=78.27 Aligned_cols=75 Identities=24% Similarity=0.383 Sum_probs=49.5
Q ss_pred EeEecccCcEEEEEEEECC-CCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC-CCCcccccceeeccceeeEEeeeC
Q 007260 221 LKRLGCGDIGSVYLSELSG-TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD-HPFLPTLYTHFETEKFSCLVMEFC 298 (611)
Q Consensus 221 ~~~LG~G~fG~Vy~a~~~~-t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~-HpnIv~l~~~~~~~~~~~LVmE~~ 298 (611)
++.|..|-...||++.... .+..|++|+...... ......+|+.+++.+. +..+++++..+. -.+||||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~----~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE----LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc----ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEee
Confidence 4678888889999997653 345788998754321 1112246888888884 334556655443 24899999
Q ss_pred CCCCH
Q 007260 299 PGGDL 303 (611)
Q Consensus 299 ~gg~L 303 (611)
+|..|
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 98765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=98.07 E-value=1.4e-06 Score=104.06 Aligned_cols=252 Identities=12% Similarity=-0.025 Sum_probs=164.5
Q ss_pred cCeEEEeEecccCcEEEEEEEECCC-CeEEEEEEecchhhhh--HHHHHHHHHHHHHHHhCCCCCcccccceeec--cce
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGT-KCYFAMKVMDKASLAG--RKKLLRAQTEREILQSLDHPFLPTLYTHFET--EKF 290 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t-~~~vAvKii~k~~~~~--~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~--~~~ 290 (611)
.+|++.=-+|.|.++ ++.+... -..|.+|+.+...+.. +...+....|+.-++...|+++...+.-... ...
T Consensus 1229 e~~EV~l~i~~~~~~---R~k~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~e 1305 (2724)
T KOG1826|consen 1229 EHSEVNLGISNHFHF---RNKWLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTE 1305 (2724)
T ss_pred hhhheeeecccceee---ccchHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChH
Confidence 466655555554443 3333221 1246777776544432 1222333456666777889999887766543 456
Q ss_pred eeEEeeeCCCCCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHcC-----eeccCCCCCcEEEccCCcEEEEecc
Q 007260 291 SCLVMEFCPGGDLHTLRQKQPG--KYFPEQAVRFYVAEVLLALEYLHMLG-----IIYRDLKPENVLVREDGHIMLSDFD 363 (611)
Q Consensus 291 ~~LVmE~~~gg~L~~ll~~~~~--~~l~e~~~~~i~~qll~aL~yLH~~g-----IVHRDLKPeNILv~~~g~vkL~DFG 363 (611)
.|.+++||.+|++++.+-+.-. ..+.+.-+.....+.+.+..-+|.+. .||++||+-|.+|..+..+|+.++|
T Consensus 1306 e~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~g 1385 (2724)
T KOG1826|consen 1306 EYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGG 1385 (2724)
T ss_pred HHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccc
Confidence 7899999999999998876422 23444445555555588888888642 7999999999999999999999999
Q ss_pred ccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccc
Q 007260 364 LSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELI 443 (611)
Q Consensus 364 lA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 443 (611)
+.+-.
T Consensus 1386 LdKIk--------------------------------------------------------------------------- 1390 (2724)
T KOG1826|consen 1386 LDKIK--------------------------------------------------------------------------- 1390 (2724)
T ss_pred ccccc---------------------------------------------------------------------------
Confidence 97310
Q ss_pred cCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCC----CCCCCC
Q 007260 444 AEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRF----PESPVV 519 (611)
Q Consensus 444 ~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~----p~~~~~ 519 (611)
.+.......+++++.|+.+++...-.++.++|+|..|+-+|++--|..+|. ..++.+..+.++. ......
T Consensus 1391 -np~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi-----~flq~~Lkgiidn~tf~sIe~l~ 1464 (2724)
T KOG1826|consen 1391 -NPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFI-----FFLQPALKGIIDNHTFFSIEKLK 1464 (2724)
T ss_pred -CchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHH-----HHHHHHHcCcccccccccccccC
Confidence 011112235678999999999999999999999999999999998888874 3344444443322 111122
Q ss_pred CHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCC
Q 007260 520 SFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFE 555 (611)
Q Consensus 520 s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 555 (611)
+.++-.+...+|-+.-.+||. -...+.-+.|.
T Consensus 1465 pgdaNve~~~~Ll~K~~~rp~----q~isls~d~~a 1496 (2724)
T KOG1826|consen 1465 PGDANVEALHRLLWKYMERPG----QYISLSRDHFA 1496 (2724)
T ss_pred CCcccHHHHHHHHHHhhhcch----hhhhccccccc
Confidence 334444555555566678887 55666655553
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.05 E-value=1.5e-05 Score=76.53 Aligned_cols=129 Identities=29% Similarity=0.337 Sum_probs=91.1
Q ss_pred eEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCc-ccccceeeccceeeEEee
Q 007260 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFL-PTLYTHFETEKFSCLVME 296 (611)
Q Consensus 218 y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnI-v~l~~~~~~~~~~~LVmE 296 (611)
-+..+.||.|.+|.||++.+.+. .+|+|+-+.+.. ...++.|+++|..+.--++ +++|.|.+ .+++||
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~~~--~~a~Kvrr~ds~-----r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me 92 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWRGG--EVALKVRRRDSP-----RRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRME 92 (201)
T ss_pred hhhhhhhhcccccEEEEeeccCc--eEEEEEecCCcc-----hhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhh
Confidence 34567899999999999998754 699998765432 2245679999999976555 56666543 345599
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCC-CCcEEEccCCcEEEEeccccc
Q 007260 297 FCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLK-PENVLVREDGHIMLSDFDLSL 366 (611)
Q Consensus 297 ~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLK-PeNILv~~~g~vkL~DFGlA~ 366 (611)
|+.|..|.++-... . +.-+..+++.---|-..||-|..|. |..++|-.++.+.|+||.-|.
T Consensus 93 ~i~G~~L~~~~~~~-----~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 93 YIDGRPLGKLEIGG-----D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred hhcCcchhhhhhcc-----c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchh
Confidence 99998887653321 1 2234456666555677899999886 555555556699999999874
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.04 E-value=4.3e-05 Score=75.30 Aligned_cols=128 Identities=27% Similarity=0.341 Sum_probs=89.8
Q ss_pred cCeEEEeEecccCc-EEEEEEEECCCCeEEEEEEecchhh----------hhH--------HHHHHHHHHHHHHHhC---
Q 007260 216 SHFRLLKRLGCGDI-GSVYLSELSGTKCYFAMKVMDKASL----------AGR--------KKLLRAQTEREILQSL--- 273 (611)
Q Consensus 216 ~~y~l~~~LG~G~f-G~Vy~a~~~~t~~~vAvKii~k~~~----------~~~--------~~~~~~~~E~~iL~~l--- 273 (611)
.+++.++.||.|.- |.||+++..+ +.||||++..-.. ... ....-+..|.....+|
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g--~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDG--RIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECC--eEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 58999999999999 9999998875 4799999432111 100 1222345677665555
Q ss_pred CCCCc--ccccceeecc------------------ceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHH
Q 007260 274 DHPFL--PTLYTHFETE------------------KFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEY 333 (611)
Q Consensus 274 ~HpnI--v~l~~~~~~~------------------~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~y 333 (611)
++.++ |++++|+.-. ...-||.||++... .+... -+.++++-|..
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~~----~~~~~~~dl~~ 179 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQIR----DIPQMLRDLKI 179 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccchh----HHHHHHHHHHH
Confidence 56677 9999987311 12357889886544 12222 25678888999
Q ss_pred HHHcCeeccCCCCCcEEEccCCcEEEEecccc
Q 007260 334 LHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365 (611)
Q Consensus 334 LH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA 365 (611)
+|..||+-+|+|+.|.. + -+|+|||.+
T Consensus 180 ~~k~gI~~~Dv~~~ny~---~--G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLGIVPRDVKPRNYR---G--GKLVDFSSS 206 (207)
T ss_pred HHHCCeeeccCcccccc---C--CEEEecccC
Confidence 99999999999999987 3 489999854
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00014 Score=76.28 Aligned_cols=77 Identities=17% Similarity=0.039 Sum_probs=54.6
Q ss_pred EEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCC---CCcccccceeec---cceeeE
Q 007260 220 LLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH---PFLPTLYTHFET---EKFSCL 293 (611)
Q Consensus 220 l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~H---pnIv~l~~~~~~---~~~~~L 293 (611)
-.+.||.|.++.||+....+. .+.+|+.+..... ..+.+|.+.|+.|.- -.++++++++.. .+..||
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~--~~~~k~~~~~~~~-----~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQG--NPMPLMARSFSTP-----GVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred eeeecCCccceeEEEEEcCCC--CEEEEEecccccc-----hHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence 356899999999999865443 3677875331111 245679999988843 367888877654 466899
Q ss_pred EeeeCCCCCH
Q 007260 294 VMEFCPGGDL 303 (611)
Q Consensus 294 VmE~~~gg~L 303 (611)
|||+++|+.+
T Consensus 91 VmE~i~G~~~ 100 (297)
T PRK10593 91 LLERLRGVSV 100 (297)
T ss_pred EEeccCCEec
Confidence 9999998754
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00042 Score=75.48 Aligned_cols=81 Identities=20% Similarity=0.170 Sum_probs=56.2
Q ss_pred EEeEecccCcEEEEEEEECCCCeEEEEEEecchhh---hh-HHHHHHHHHHHHHHHhCC---CCCcccccceeeccceee
Q 007260 220 LLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASL---AG-RKKLLRAQTEREILQSLD---HPFLPTLYTHFETEKFSC 292 (611)
Q Consensus 220 l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~---~~-~~~~~~~~~E~~iL~~l~---HpnIv~l~~~~~~~~~~~ 292 (611)
-.+.||.|.+..||++.+...++.|+||.-....- .. .-...+...|.+.|+.+. -.++++++.+.. ...+
T Consensus 30 ~~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~ 107 (401)
T PRK09550 30 TAREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAV 107 (401)
T ss_pred eeeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCE
Confidence 35789999999999999876546799998532110 00 113346677888888763 356888887643 5578
Q ss_pred EEeeeCCCCC
Q 007260 293 LVMEFCPGGD 302 (611)
Q Consensus 293 LVmE~~~gg~ 302 (611)
|||||+++..
T Consensus 108 lVME~L~~~~ 117 (401)
T PRK09550 108 TVMEDLSDHK 117 (401)
T ss_pred EEEecCCCcc
Confidence 9999997643
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00026 Score=74.30 Aligned_cols=143 Identities=20% Similarity=0.190 Sum_probs=83.0
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCC--ccccccee------ec
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF--LPTLYTHF------ET 287 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~Hpn--Iv~l~~~~------~~ 287 (611)
+...-++.|+.|....||+.... ++ .+++|+..... ... .+..|.+++..|.... +++++... ..
T Consensus 22 ~~~~~i~~~~~G~~n~~y~v~t~-~~-~~vLK~~~~~~--~~~---~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~ 94 (307)
T TIGR00938 22 GELLSLKGIAEGVENSNYLLTTD-VG-RYILTLYEKRV--KAE---ELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTL 94 (307)
T ss_pred CCceeccccCCccccceEEEEeC-CC-cEEEEEecCCC--CHH---HHHHHHHHHHHHHHCCCCCCccccCCCCCeehhc
Confidence 34455677888888899998754 33 47889875521 111 2345677777763222 34443321 22
Q ss_pred cceeeEEeeeCCCCCHH-----------HH---HHhC-CCC--------CCCH-HH--HH----------HHHHHHHHHH
Q 007260 288 EKFSCLVMEFCPGGDLH-----------TL---RQKQ-PGK--------YFPE-QA--VR----------FYVAEVLLAL 331 (611)
Q Consensus 288 ~~~~~LVmE~~~gg~L~-----------~l---l~~~-~~~--------~l~e-~~--~~----------~i~~qll~aL 331 (611)
.+..|+||||++|..+. .. ++.. .+- .+.. .. .. .....+...+
T Consensus 95 ~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~ 174 (307)
T TIGR00938 95 AGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKEL 174 (307)
T ss_pred CCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHH
Confidence 45678999999885531 01 1110 000 0010 00 00 0111233455
Q ss_pred HHHHH-------cCeeccCCCCCcEEEccCCcEEEEecccc
Q 007260 332 EYLHM-------LGIIYRDLKPENVLVREDGHIMLSDFDLS 365 (611)
Q Consensus 332 ~yLH~-------~gIVHRDLKPeNILv~~~g~vkL~DFGlA 365 (611)
+++.. .++||+|+.+.||+++.++.+.|+||+.+
T Consensus 175 ~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~ 215 (307)
T TIGR00938 175 DYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFA 215 (307)
T ss_pred HHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccc
Confidence 55543 67999999999999998887789999986
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.75 E-value=7.5e-05 Score=73.14 Aligned_cols=98 Identities=24% Similarity=0.239 Sum_probs=77.9
Q ss_pred HHHHHHHHhCCC-CCcccccceeeccceeeEEeeeCCCCCHHHHHHh-CCCCCCCHHHHHHHHHHHHHHHHHHHH---cC
Q 007260 264 QTEREILQSLDH-PFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQK-QPGKYFPEQAVRFYVAEVLLALEYLHM---LG 338 (611)
Q Consensus 264 ~~E~~iL~~l~H-pnIv~l~~~~~~~~~~~LVmE~~~gg~L~~ll~~-~~~~~l~e~~~~~i~~qll~aL~yLH~---~g 338 (611)
..|.-+|+.+.+ +++++++|++- .++|.||++.+.+...... ..-...++..+..++.+++..+++|+. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458888999975 69999999882 3679999987766421000 000235889999999999999999997 45
Q ss_pred eeccCCCCCcEEEccCCcEEEEecccc
Q 007260 339 IIYRDLKPENVLVREDGHIMLSDFDLS 365 (611)
Q Consensus 339 IVHRDLKPeNILv~~~g~vkL~DFGlA 365 (611)
+.-.|++++|+-|+++|++|++|.+.+
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v 109 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDV 109 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhc
Confidence 888999999999999999999999976
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00013 Score=76.17 Aligned_cols=76 Identities=21% Similarity=0.330 Sum_probs=49.6
Q ss_pred EeEecccCcEEEEEEEECC------CCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCC-CcccccceeeccceeeE
Q 007260 221 LKRLGCGDIGSVYLSELSG------TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHP-FLPTLYTHFETEKFSCL 293 (611)
Q Consensus 221 ~~~LG~G~fG~Vy~a~~~~------t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~Hp-nIv~l~~~~~~~~~~~L 293 (611)
++.|..|-...||+..... .++.|++|+...... ......+|.+++..+... -.++++.++.. .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE----LLIDRERELVVFARLSERNLGPKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc----ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence 3566777778999987654 256799999765321 112345688888888432 34566666542 36
Q ss_pred EeeeCCCCCHH
Q 007260 294 VMEFCPGGDLH 304 (611)
Q Consensus 294 VmE~~~gg~L~ 304 (611)
||||++|..|.
T Consensus 75 v~e~i~G~~l~ 85 (302)
T cd05156 75 IEEFIPSRTLT 85 (302)
T ss_pred hhheeCCCcCC
Confidence 89999887653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00053 Score=71.27 Aligned_cols=139 Identities=19% Similarity=0.155 Sum_probs=82.9
Q ss_pred EEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCC--cccccce------eeccce
Q 007260 219 RLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF--LPTLYTH------FETEKF 290 (611)
Q Consensus 219 ~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~Hpn--Iv~l~~~------~~~~~~ 290 (611)
.-++.|..|....+|+....+ ..+++|+..... . ..+..|+.++..|.+.+ +++++.. ...++.
T Consensus 17 ~~i~~i~~G~~n~~y~v~~~~--~~~vLr~~~~~~---~---~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~ 88 (296)
T cd05153 17 LSFEGISAGIENTNYFVTTDS--GRYVLTLFEKVS---A---EELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGK 88 (296)
T ss_pred hheecccCccccceEEEEeCC--CcEEEEEcCCCC---h---HhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCc
Confidence 335678888888999986543 358999876411 1 23455788777774332 4454432 223456
Q ss_pred eeEEeeeCCCCCHHH--------H---H---Hh----CCCC----CC-CHHH--HH--------HHHHHHHHHHHHHHH-
Q 007260 291 SCLVMEFCPGGDLHT--------L---R---QK----QPGK----YF-PEQA--VR--------FYVAEVLLALEYLHM- 336 (611)
Q Consensus 291 ~~LVmE~~~gg~L~~--------l---l---~~----~~~~----~l-~e~~--~~--------~i~~qll~aL~yLH~- 336 (611)
.++||+|++|..+.. + + +. .... .. .+.. .. .....+..++.++..
T Consensus 89 ~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~ 168 (296)
T cd05153 89 PAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAF 168 (296)
T ss_pred eEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhh
Confidence 789999999876421 0 0 10 0000 00 0000 00 011122334455543
Q ss_pred ------cCeeccCCCCCcEEEccCCcEEEEecccc
Q 007260 337 ------LGIIYRDLKPENVLVREDGHIMLSDFDLS 365 (611)
Q Consensus 337 ------~gIVHRDLKPeNILv~~~g~vkL~DFGlA 365 (611)
.++||+|+.|.|||++.++.+.|+||+.+
T Consensus 169 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a 203 (296)
T cd05153 169 DPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFA 203 (296)
T ss_pred hhhcCCCcCCccCcCcccEEEeCCceEEEeehhhh
Confidence 47999999999999998877899999987
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00042 Score=70.68 Aligned_cols=133 Identities=21% Similarity=0.220 Sum_probs=76.8
Q ss_pred EecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCC-cccccceeeccceeeEEeeeCCCC
Q 007260 223 RLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF-LPTLYTHFETEKFSCLVMEFCPGG 301 (611)
Q Consensus 223 ~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~Hpn-Iv~l~~~~~~~~~~~LVmE~~~gg 301 (611)
.+..|-.+.+|+... ++..+++|+....... ......+|..+|+.+..-. .++++.++. -++||||++|.
T Consensus 3 ~~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~---~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~ 73 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH--PGISFVWRPQSPVCKA---LGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE 73 (256)
T ss_pred cCCCcCcCCeEEEEe--CCccEEEeeCCccccc---ccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence 345677788998873 3556888976543211 1012356889999885433 355554432 36899999986
Q ss_pred CHHH--------------HHHh---C--CCCCCCH-HHHHHHHHHH---------HHHHHHHHH--------cCeeccCC
Q 007260 302 DLHT--------------LRQK---Q--PGKYFPE-QAVRFYVAEV---------LLALEYLHM--------LGIIYRDL 344 (611)
Q Consensus 302 ~L~~--------------ll~~---~--~~~~l~e-~~~~~i~~ql---------l~aL~yLH~--------~gIVHRDL 344 (611)
.+.. ++.+ . .+..++. ..+..+..++ ...++.+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 6531 1111 1 1112221 1222222222 111222222 24899999
Q ss_pred CCCcEEEccCCcEEEEecccc
Q 007260 345 KPENVLVREDGHIMLSDFDLS 365 (611)
Q Consensus 345 KPeNILv~~~g~vkL~DFGlA 365 (611)
.|.|||++.++ +.|+||..|
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a 173 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYA 173 (256)
T ss_pred CcCcEEEeCCC-CEEEecccc
Confidence 99999999877 789999987
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.0014 Score=68.91 Aligned_cols=137 Identities=16% Similarity=0.153 Sum_probs=74.3
Q ss_pred EeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCC--cccccc------eeeccceee
Q 007260 221 LKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF--LPTLYT------HFETEKFSC 292 (611)
Q Consensus 221 ~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~Hpn--Iv~l~~------~~~~~~~~~ 292 (611)
++.|+.|....+|+..... + .+++|++... . .. .+..|..+++.|...+ +++.+. +....+..+
T Consensus 27 ~~~l~~G~~n~~y~v~t~~-g-~~vLK~~~~~--~-~~---~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~ 98 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQ-G-EYVLTLFERL--T-AE---DLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPA 98 (319)
T ss_pred cchhccccccceEEEEeCC-C-cEEEEEeccC--C-hH---HhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEE
Confidence 4567788888999987543 3 5899987521 1 11 2223555555553212 333332 122345678
Q ss_pred EEeeeCCCCCHH-----------HHHH---hC-CC--------CCCCH--HHH-----------HHHHHH-HHHHHHHHH
Q 007260 293 LVMEFCPGGDLH-----------TLRQ---KQ-PG--------KYFPE--QAV-----------RFYVAE-VLLALEYLH 335 (611)
Q Consensus 293 LVmE~~~gg~L~-----------~ll~---~~-~~--------~~l~e--~~~-----------~~i~~q-ll~aL~yLH 335 (611)
++|||++|..+. ..+. .. .+ ..+.. ... ...+.+ +-..++.+.
T Consensus 99 ~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 178 (319)
T PRK05231 99 AIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLA 178 (319)
T ss_pred EEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhh
Confidence 999999887431 1111 00 00 00001 000 011111 111223332
Q ss_pred -------HcCeeccCCCCCcEEEccCCcEEEEecccc
Q 007260 336 -------MLGIIYRDLKPENVLVREDGHIMLSDFDLS 365 (611)
Q Consensus 336 -------~~gIVHRDLKPeNILv~~~g~vkL~DFGlA 365 (611)
..|+||+|+.|.|||++.+...-|+||+.+
T Consensus 179 ~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~ 215 (319)
T PRK05231 179 SAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFA 215 (319)
T ss_pred ccccccCCcccCCCCCCCCcEEEECCceEEEEecccc
Confidence 237999999999999986655689999987
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.00017 Score=75.27 Aligned_cols=149 Identities=20% Similarity=0.295 Sum_probs=100.5
Q ss_pred chHHHHHHhhccCccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhh-----------------HHH-
Q 007260 198 LRWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAG-----------------RKK- 259 (611)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~-----------------~~~- 259 (611)
+..-++..+..+.. -|.+++.||-|.-+.||.+-+.. |..+++|+-+-....- +-.
T Consensus 79 yDyLAlktL~~R~~-----v~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyL 152 (465)
T KOG2268|consen 79 YDYLALKTLSNRGS-----VESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYL 152 (465)
T ss_pred chHHHHHHHHhcch-----hhhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhh
Confidence 44455555555443 35678899999999999997753 5578888644322111 111
Q ss_pred -HHHHHHHHHHHHhCC-CCC-cccccceeeccceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH
Q 007260 260 -LLRAQTEREILQSLD-HPF-LPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHM 336 (611)
Q Consensus 260 -~~~~~~E~~iL~~l~-Hpn-Iv~l~~~~~~~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~ 336 (611)
...+.+|...|..|. |-+ |+..+++ +.-|+|||++.|-.|..+.+.. + +..+...+..-+--|-.
T Consensus 153 SRlaa~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~-----d---~~~ly~~lm~~Iv~la~ 220 (465)
T KOG2268|consen 153 SRLAATKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHVE-----D---PPTLYDDLMGLIVRLAN 220 (465)
T ss_pred HHHHHHHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeecC-----C---hHHHHHHHHHHHHHHHH
Confidence 122467888888774 322 4444443 4568999999998887654332 2 23344455555667888
Q ss_pred cCeeccCCCCCcEEEccCCcEEEEeccc
Q 007260 337 LGIIYRDLKPENVLVREDGHIMLSDFDL 364 (611)
Q Consensus 337 ~gIVHRDLKPeNILv~~~g~vkL~DFGl 364 (611)
+|+||+|..-=||+|.++++++++||--
T Consensus 221 ~GlIHgDFNEFNimv~dd~~i~vIDFPQ 248 (465)
T KOG2268|consen 221 HGLIHGDFNEFNIMVKDDDKIVVIDFPQ 248 (465)
T ss_pred cCceecccchheeEEecCCCEEEeechH
Confidence 9999999999999999999999999964
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0014 Score=70.27 Aligned_cols=138 Identities=16% Similarity=0.204 Sum_probs=82.7
Q ss_pred EEeEecccCcEEEEEEEECC----CCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCC-cccccceeeccceeeEE
Q 007260 220 LLKRLGCGDIGSVYLSELSG----TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF-LPTLYTHFETEKFSCLV 294 (611)
Q Consensus 220 l~~~LG~G~fG~Vy~a~~~~----t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~Hpn-Iv~l~~~~~~~~~~~LV 294 (611)
-+..|-.|-.-.+|++.... .++.|++|+..... ...+. ..+|..+++.+..-+ -++++++|..+ .|
T Consensus 40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v 111 (344)
T PLN02236 40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RV 111 (344)
T ss_pred EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eE
Confidence 34566568888999987532 24679999886542 12222 267999998885433 45667766443 58
Q ss_pred eeeCCCCCHHHH--------------HHh---C--CCC--CCCHHHHHHHHHHH-----------------HHHHHHH--
Q 007260 295 MEFCPGGDLHTL--------------RQK---Q--PGK--YFPEQAVRFYVAEV-----------------LLALEYL-- 334 (611)
Q Consensus 295 mE~~~gg~L~~l--------------l~~---~--~~~--~l~e~~~~~i~~ql-----------------l~aL~yL-- 334 (611)
+||++|..|... +.+ . ++. ......+..++.++ ...+..|
T Consensus 112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~ 191 (344)
T PLN02236 112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK 191 (344)
T ss_pred EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence 999988776311 110 0 111 11123333333221 1111122
Q ss_pred --H----HcCeeccCCCCCcEEEcc-CCcEEEEecccc
Q 007260 335 --H----MLGIIYRDLKPENVLVRE-DGHIMLSDFDLS 365 (611)
Q Consensus 335 --H----~~gIVHRDLKPeNILv~~-~g~vkL~DFGlA 365 (611)
. ...++|+|+++.|||+++ ++.+.|+||..+
T Consensus 192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya 229 (344)
T PLN02236 192 ELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYA 229 (344)
T ss_pred HhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhc
Confidence 1 235899999999999986 468999999987
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0024 Score=67.99 Aligned_cols=137 Identities=14% Similarity=0.217 Sum_probs=80.0
Q ss_pred EeEecccCcEEEEEEEECCC---CeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCc-ccccceeeccceeeEEee
Q 007260 221 LKRLGCGDIGSVYLSELSGT---KCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFL-PTLYTHFETEKFSCLVME 296 (611)
Q Consensus 221 ~~~LG~G~fG~Vy~a~~~~t---~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnI-v~l~~~~~~~~~~~LVmE 296 (611)
++.|..|=...+|+....+. +..|.+|+...... ....-.+|..+++.+..-+| +++++++..+ +|.+
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~----~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~ 90 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD----YVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQS 90 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC----eEechHHHHHHHHHHHhcCCCCceeEEeCCc----Eeeh
Confidence 34555577778998875542 23788998765321 12223568999998865444 5677666432 5899
Q ss_pred eCCCCCHHH--------------HHHh---C--CCC-CC-CHHHHHHHHHHH----------------------HHHHHH
Q 007260 297 FCPGGDLHT--------------LRQK---Q--PGK-YF-PEQAVRFYVAEV----------------------LLALEY 333 (611)
Q Consensus 297 ~~~gg~L~~--------------ll~~---~--~~~-~l-~e~~~~~i~~ql----------------------l~aL~y 333 (611)
|++|..|.. .+.+ . +.. .+ ....+..|+.++ ..-+..
T Consensus 91 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (330)
T PLN02421 91 FINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVE 170 (330)
T ss_pred hhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHH
Confidence 998776521 1111 1 011 11 122333333222 111222
Q ss_pred HH----HcC----eeccCCCCCcEEEcc-CCcEEEEecccc
Q 007260 334 LH----MLG----IIYRDLKPENVLVRE-DGHIMLSDFDLS 365 (611)
Q Consensus 334 LH----~~g----IVHRDLKPeNILv~~-~g~vkL~DFGlA 365 (611)
+. ..+ ++|.||-+.|||+++ ++.++|+||..|
T Consensus 171 l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYa 211 (330)
T PLN02421 171 LKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYG 211 (330)
T ss_pred HHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEccccc
Confidence 21 112 799999999999975 578999999987
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.0041 Score=64.63 Aligned_cols=28 Identities=29% Similarity=0.485 Sum_probs=24.3
Q ss_pred CeeccCCCCCcEEEccCCc-EEEEecccc
Q 007260 338 GIIYRDLKPENVLVREDGH-IMLSDFDLS 365 (611)
Q Consensus 338 gIVHRDLKPeNILv~~~g~-vkL~DFGlA 365 (611)
.+||+|+.|.|||++.++. +-|+||+.+
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a 214 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEA 214 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhc
Confidence 3899999999999997565 569999987
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.0071 Score=63.16 Aligned_cols=28 Identities=25% Similarity=0.519 Sum_probs=25.1
Q ss_pred cCeeccCCCCCcEEEccCCcEEEEecccc
Q 007260 337 LGIIYRDLKPENVLVREDGHIMLSDFDLS 365 (611)
Q Consensus 337 ~gIVHRDLKPeNILv~~~g~vkL~DFGlA 365 (611)
.++||+|+.+.|||++. +.+.|+||+.+
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccc
Confidence 57999999999999987 67899999965
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.0049 Score=64.46 Aligned_cols=76 Identities=21% Similarity=0.242 Sum_probs=47.8
Q ss_pred eEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC---CCCCcccccceeeccceeeEE
Q 007260 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL---DHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 218 y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l---~HpnIv~l~~~~~~~~~~~LV 294 (611)
-.-.+.|+.|....+|+.. .++..|.||+-..... ..+..|.+-|+.| .--.+++++.+....+..|||
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~------~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLl 90 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGR------DMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLL 90 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGC------CHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEE
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecChhhH------HHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEE
Confidence 3445789999999999987 5667899998763221 1456688777777 345688999998887788999
Q ss_pred eeeCCCC
Q 007260 295 MEFCPGG 301 (611)
Q Consensus 295 mE~~~gg 301 (611)
|||++.+
T Consensus 91 le~l~~~ 97 (288)
T PF03881_consen 91 LEFLEMG 97 (288)
T ss_dssp EE-----
T ss_pred EEeecCC
Confidence 9999766
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0038 Score=66.98 Aligned_cols=76 Identities=18% Similarity=0.172 Sum_probs=49.6
Q ss_pred EecccCcEEEEEEEECCCCeEEEEEEecchh-h---hhHHHHHHHHHHHHHHHhCC--CC-CcccccceeeccceeeEEe
Q 007260 223 RLGCGDIGSVYLSELSGTKCYFAMKVMDKAS-L---AGRKKLLRAQTEREILQSLD--HP-FLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 223 ~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~-~---~~~~~~~~~~~E~~iL~~l~--Hp-nIv~l~~~~~~~~~~~LVm 295 (611)
.||.|....||++.+...+.-|+||.-.... . .-.-...|...|.+.|+... -| +++++|.+ +.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 5799999999999986544679999643211 0 11223446667888887763 23 56666543 445556999
Q ss_pred eeCCC
Q 007260 296 EFCPG 300 (611)
Q Consensus 296 E~~~g 300 (611)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99954
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.0072 Score=64.39 Aligned_cols=137 Identities=21% Similarity=0.277 Sum_probs=90.7
Q ss_pred eEecccCcEEEEEEEECCCCeEEEEEEecchhhh---------------------hHHHHHH--HHHHHHHHHhCCCCCc
Q 007260 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLA---------------------GRKKLLR--AQTEREILQSLDHPFL 278 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~---------------------~~~~~~~--~~~E~~iL~~l~HpnI 278 (611)
..|..|.-+-||.|... .|..|||||++-.-+. +..++.+ +..|+.-|.+|+...|
T Consensus 150 GCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred cccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 45667888899998655 4667999998532110 1122223 3456666777765554
Q ss_pred ccccceeeccceeeEEeeeCCCCCHHH-HHHhCCCCCCCHHHHHHHHHHHHHHHHHH-HHcCeeccCCCCCcEEEccCCc
Q 007260 279 PTLYTHFETEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQAVRFYVAEVLLALEYL-HMLGIIYRDLKPENVLVREDGH 356 (611)
Q Consensus 279 v~l~~~~~~~~~~~LVmE~~~gg~L~~-ll~~~~~~~l~e~~~~~i~~qll~aL~yL-H~~gIVHRDLKPeNILv~~~g~ 356 (611)
+----+.. ..-.|||+|+.+..... .+.. ..++...++.+-.|++.-+.-| |.+++||.||.-=|+|+. +|.
T Consensus 229 P~PePIlL--k~hVLVM~FlGrdgw~aPkLKd---~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG~ 302 (520)
T KOG2270|consen 229 PCPEPILL--KNHVLVMEFLGRDGWAAPKLKD---ASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DGK 302 (520)
T ss_pred CCCCceee--ecceEeeeeccCCCCcCccccc---ccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CCE
Confidence 42221111 23369999994322221 1222 3477888888888888888877 567999999999999996 788
Q ss_pred EEEEecccc
Q 007260 357 IMLSDFDLS 365 (611)
Q Consensus 357 vkL~DFGlA 365 (611)
+.|+|-+-+
T Consensus 303 lyiIDVSQS 311 (520)
T KOG2270|consen 303 LYIIDVSQS 311 (520)
T ss_pred EEEEEcccc
Confidence 999998876
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.01 Score=64.86 Aligned_cols=77 Identities=21% Similarity=0.238 Sum_probs=52.8
Q ss_pred EEeEecccCcEEEEEEEECCCCeEEEEEEecchhh-hhH---HHHHHHHHHHHHHHhCC---CCCcccccceeeccceee
Q 007260 220 LLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASL-AGR---KKLLRAQTEREILQSLD---HPFLPTLYTHFETEKFSC 292 (611)
Q Consensus 220 l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~-~~~---~~~~~~~~E~~iL~~l~---HpnIv~l~~~~~~~~~~~ 292 (611)
..+.||.|....||+..+. +..|+||.-..... .+. -...|...|.+.|+.+. ..+++++|.+.. +..+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 4678999999999998874 34588997542111 110 13445566777777664 358888988776 4467
Q ss_pred EEeeeCCC
Q 007260 293 LVMEFCPG 300 (611)
Q Consensus 293 LVmE~~~g 300 (611)
|||||+++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 89999976
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.011 Score=64.32 Aligned_cols=78 Identities=21% Similarity=0.282 Sum_probs=51.9
Q ss_pred EeEecccCcEEEEEEEECCCCeEEEEEEecchh---hhhHHHHHHHHHHHHHHHhCC--CC-CcccccceeeccceeeEE
Q 007260 221 LKRLGCGDIGSVYLSELSGTKCYFAMKVMDKAS---LAGRKKLLRAQTEREILQSLD--HP-FLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 221 ~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~---~~~~~~~~~~~~E~~iL~~l~--Hp-nIv~l~~~~~~~~~~~LV 294 (611)
++.||.|.-.-||++.+...+.-|+||.-.... ..-.-...|...|.++|+.+. -| +++++|.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 688999999999999985334568888642211 111223456777888888763 23 56677643 45556789
Q ss_pred eeeCCC
Q 007260 295 MEFCPG 300 (611)
Q Consensus 295 mE~~~g 300 (611)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999854
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.0031 Score=62.39 Aligned_cols=29 Identities=34% Similarity=0.612 Sum_probs=20.8
Q ss_pred CeeccCCCCCcEEE-ccCCcEEEEeccccc
Q 007260 338 GIIYRDLKPENVLV-REDGHIMLSDFDLSL 366 (611)
Q Consensus 338 gIVHRDLKPeNILv-~~~g~vkL~DFGlA~ 366 (611)
.++|.||.+.|||+ ..++.++|+||..|.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 48999999999999 789999999999873
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.0095 Score=64.79 Aligned_cols=77 Identities=17% Similarity=0.260 Sum_probs=48.0
Q ss_pred EEeEecccCcEEEEEEEECCCC-e-----EEEEEEecchhhhhHHHHHHHHHHHHHHHhCCC-CCcccccceeeccceee
Q 007260 220 LLKRLGCGDIGSVYLSELSGTK-C-----YFAMKVMDKASLAGRKKLLRAQTEREILQSLDH-PFLPTLYTHFETEKFSC 292 (611)
Q Consensus 220 l~~~LG~G~fG~Vy~a~~~~t~-~-----~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~H-pnIv~l~~~~~~~~~~~ 292 (611)
.++.|..|-...+|++...... . .|.+++... .......-.+|+.+++.|.. -.-+++++.|.. +
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~----~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g 125 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST----YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----F 125 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccC----CCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----E
Confidence 4456666888899999754331 2 244443211 11111222568999999954 455778887753 5
Q ss_pred EEeeeCCCCCHH
Q 007260 293 LVMEFCPGGDLH 304 (611)
Q Consensus 293 LVmE~~~gg~L~ 304 (611)
+|.||++|..|.
T Consensus 126 ~l~efIeGr~l~ 137 (383)
T PTZ00384 126 TIQEWVEGNTMG 137 (383)
T ss_pred EEEEEeccccCC
Confidence 999999987763
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.027 Score=59.60 Aligned_cols=149 Identities=12% Similarity=0.168 Sum_probs=82.9
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCc--ccccceeeccc--ee
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFL--PTLYTHFETEK--FS 291 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnI--v~l~~~~~~~~--~~ 291 (611)
....+++.+-.|---.+|..... ++.++|. ... ............+|..+|+.+.--.| +..++.+..+. ..
T Consensus 25 ~~~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~p 100 (321)
T COG3173 25 AGLLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTP 100 (321)
T ss_pred CCCceeeeccCCcccceEEEecC--CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCc
Confidence 34555566644444455555444 6678888 332 11122233345678888887753333 34455555444 56
Q ss_pred eEEeeeCCCCCHHH----------HHH--------h---C-------CCC--CCCHHHHHHHHHHH--------------
Q 007260 292 CLVMEFCPGGDLHT----------LRQ--------K---Q-------PGK--YFPEQAVRFYVAEV-------------- 327 (611)
Q Consensus 292 ~LVmE~~~gg~L~~----------ll~--------~---~-------~~~--~l~e~~~~~i~~ql-------------- 327 (611)
|.||+|+.|..+.+ +.. . - .+. .+....+..+..+.
T Consensus 101 f~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~ 180 (321)
T COG3173 101 FYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA 180 (321)
T ss_pred eEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence 99999998833211 111 0 0 000 01111222222222
Q ss_pred HHHHHHHHHc--------CeeccCCCCCcEEEccCCcEEEEeccccccc
Q 007260 328 LLALEYLHML--------GIIYRDLKPENVLVREDGHIMLSDFDLSLRC 368 (611)
Q Consensus 328 l~aL~yLH~~--------gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~ 368 (611)
..-..||+.+ .+||+|+.+.||||+.++-+=+.||+++..-
T Consensus 181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 2234566543 3899999999999999888999999998443
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.31 E-value=0.0062 Score=67.22 Aligned_cols=81 Identities=20% Similarity=0.190 Sum_probs=57.7
Q ss_pred ChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCC----------CCCCCHHHHHHHHHhhhcCccccCCch
Q 007260 473 SAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPE----------SPVVSFAARDLIRGLLVKEPQHRLAYK 542 (611)
Q Consensus 473 ~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~----------~~~~s~~l~dLI~~~L~~dP~~Rpt~~ 542 (611)
+++|||++|.++.|+..|...|....+.+.+..+..-...... ...++....++..+|+...|..||.
T Consensus 110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l-- 187 (725)
T KOG1093|consen 110 PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPL-- 187 (725)
T ss_pred cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccc--
Confidence 4899999999999999999888766555544333221110000 0125566778999999999999997
Q ss_pred hcHHHHHcCCCCCCC
Q 007260 543 RGATEIKQHPFFEGV 557 (611)
Q Consensus 543 ~~a~elL~Hp~f~~~ 557 (611)
..++.+|+-|.++
T Consensus 188 --~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 188 --PMELSKRCSFTEV 200 (725)
T ss_pred --hhHHhcCccHHHH
Confidence 7788888888754
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.26 E-value=0.064 Score=56.41 Aligned_cols=28 Identities=14% Similarity=0.161 Sum_probs=26.6
Q ss_pred CeeccCCCCCcEEEccCCcEEEEecccc
Q 007260 338 GIIYRDLKPENVLVREDGHIMLSDFDLS 365 (611)
Q Consensus 338 gIVHRDLKPeNILv~~~g~vkL~DFGlA 365 (611)
++||+|+.+.|||++.++.+.|+||..+
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~ 224 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKA 224 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhc
Confidence 7999999999999999999999999987
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.89 E-value=0.047 Score=60.58 Aligned_cols=76 Identities=16% Similarity=0.272 Sum_probs=48.9
Q ss_pred EEeEecccCcEEEEEEEECCC--------CeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCc-ccccceeeccce
Q 007260 220 LLKRLGCGDIGSVYLSELSGT--------KCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFL-PTLYTHFETEKF 290 (611)
Q Consensus 220 l~~~LG~G~fG~Vy~a~~~~t--------~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnI-v~l~~~~~~~~~ 290 (611)
-++.|..|=.-.+|++..... ++.|.+|+..... +.+....+|..+++.+..-+| +++++.|.
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t----e~lIdR~~E~~v~~~ls~~gi~P~l~~~f~---- 180 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV----DELYNPISEFEVYKTMSKYRIAPQLLNTFS---- 180 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc----cceeCHHHHHHHHHHHHHCCCCCceEEEeC----
Confidence 566777777788999876422 4578999876532 111122568888888754444 46666553
Q ss_pred eeEEeeeCCCCCH
Q 007260 291 SCLVMEFCPGGDL 303 (611)
Q Consensus 291 ~~LVmE~~~gg~L 303 (611)
-+.|.||++|..|
T Consensus 181 gg~I~efi~g~~l 193 (442)
T PTZ00296 181 GGRIEEWLYGDPL 193 (442)
T ss_pred CCEEEEeeCCccC
Confidence 2457999988744
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.82 E-value=0.022 Score=60.78 Aligned_cols=91 Identities=21% Similarity=0.259 Sum_probs=62.9
Q ss_pred CCCccccccee-eccceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CeeccCCCCCcEEEc
Q 007260 275 HPFLPTLYTHF-ETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHML-GIIYRDLKPENVLVR 352 (611)
Q Consensus 275 HpnIv~l~~~~-~~~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~-gIVHRDLKPeNILv~ 352 (611)
-++..+++-+- ....+.|++|++- |+.|..+ . .-...++..++++.+.-|.-+..+ .+=|||+.-.||||+
T Consensus 284 ~~~~e~~~vv~~de~~y~yl~~kdh-gt~is~i-k-----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId 356 (488)
T COG5072 284 SVFLETLKVVSLDETLYLYLHFKDH-GTPISII-K-----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID 356 (488)
T ss_pred chhhhcceEEecCCceEEEEEEecC-Cceeeee-e-----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee
Confidence 34444433332 3456778999987 7777532 2 134566777788887777666653 589999999999999
Q ss_pred cCCcEEEEeccccccccCCccc
Q 007260 353 EDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 353 ~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
+|.|.|+||-+++ +..+...
T Consensus 357 -~GnvtLIDfklsR-l~~~q~~ 376 (488)
T COG5072 357 -EGNVTLIDFKLSR-LSYSQGI 376 (488)
T ss_pred -cCceEEEEeeeee-cccCCce
Confidence 9999999999996 4444333
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.60 E-value=0.15 Score=54.47 Aligned_cols=135 Identities=25% Similarity=0.337 Sum_probs=79.0
Q ss_pred EecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCC------ccccccee--eccc--eee
Q 007260 223 RLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF------LPTLYTHF--ETEK--FSC 292 (611)
Q Consensus 223 ~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~Hpn------Iv~l~~~~--~~~~--~~~ 292 (611)
.|.+ .-..||+......+ +++|+.+.. ... . .+.-|...|+.|.-.. |+.+-+-. .-.. +.+
T Consensus 33 ~l~s-~eN~~f~~~~~~g~--~iLki~~~~-~~~-~---~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a 104 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGR--YILKIYRPG-WTR-A---EIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPA 104 (331)
T ss_pred cccc-ccCceEEEEecCCC--eEEEEecCC-CCH-H---HHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeE
Confidence 3444 55679998876655 499998775 222 1 3345777887773222 22222211 1233 778
Q ss_pred EEeeeCCCCCHHH------------HH---H----hC----CC--CCCCHH----H---------HHHHHHHHHHHHHHH
Q 007260 293 LVMEFCPGGDLHT------------LR---Q----KQ----PG--KYFPEQ----A---------VRFYVAEVLLALEYL 334 (611)
Q Consensus 293 LVmE~~~gg~L~~------------ll---~----~~----~~--~~l~e~----~---------~~~i~~qll~aL~yL 334 (611)
-|++|++|..+.. ++ . .. ++ ....+. . -.....++...++.+
T Consensus 105 ~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~ 184 (331)
T COG2334 105 ALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRL 184 (331)
T ss_pred EEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHH
Confidence 8999999987761 00 0 01 00 011111 0 001233444555555
Q ss_pred HH--------cC--eeccCCCCCcEEEccCCc-EEEEecccc
Q 007260 335 HM--------LG--IIYRDLKPENVLVREDGH-IMLSDFDLS 365 (611)
Q Consensus 335 H~--------~g--IVHRDLKPeNILv~~~g~-vkL~DFGlA 365 (611)
.+ .+ |||+|+.|.|||++.+.. +.++|||-+
T Consensus 185 ~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa 226 (331)
T COG2334 185 LARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDA 226 (331)
T ss_pred HhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccc
Confidence 53 33 999999999999998874 899999976
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.53 E-value=0.17 Score=61.94 Aligned_cols=30 Identities=33% Similarity=0.432 Sum_probs=25.7
Q ss_pred cCeeccCCCCCcEEEccCC--cEE-EEeccccc
Q 007260 337 LGIIYRDLKPENVLVREDG--HIM-LSDFDLSL 366 (611)
Q Consensus 337 ~gIVHRDLKPeNILv~~~g--~vk-L~DFGlA~ 366 (611)
.+|||.|+.+.|||++.++ ++. |+|||-+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 5799999999999999875 565 99999873
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.24 E-value=0.29 Score=51.95 Aligned_cols=71 Identities=11% Similarity=0.018 Sum_probs=40.7
Q ss_pred cCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCC--ccc---ccc--eeeccceeeEEeeeCC
Q 007260 227 GDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF--LPT---LYT--HFETEKFSCLVMEFCP 299 (611)
Q Consensus 227 G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~Hpn--Iv~---l~~--~~~~~~~~~LVmE~~~ 299 (611)
+.-..||+..... +..+++|+.+...... ..+..|++++..|.... |+. .-+ ++..++..+.|+++++
T Consensus 36 s~eN~vy~v~~~~-~~~~vlKv~r~~~~~~----~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~ 110 (325)
T PRK11768 36 SYENRVYQFGDED-GRRVVAKFYRPERWSD----AQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRG 110 (325)
T ss_pred cccceEEEEecCC-CCEEEEEEcCcccCCH----HHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeC
Confidence 3446799887543 4469999886433221 23345777776663211 222 112 2233567788999998
Q ss_pred CCC
Q 007260 300 GGD 302 (611)
Q Consensus 300 gg~ 302 (611)
|..
T Consensus 111 G~~ 113 (325)
T PRK11768 111 GRA 113 (325)
T ss_pred CCC
Confidence 764
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.02 E-value=0.16 Score=51.34 Aligned_cols=80 Identities=21% Similarity=0.278 Sum_probs=56.5
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC---CCCCcccccceeeccceeeE
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL---DHPFLPTLYTHFETEKFSCL 293 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l---~HpnIv~l~~~~~~~~~~~L 293 (611)
+.+..+.+-.|..-..|...+.. ..|-||+-.+ .....+..|+.-|..| +.-.+++++.+.....+.||
T Consensus 17 ~i~er~~v~gG~inea~~v~dg~--~~~FvK~n~~------~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~syl 88 (286)
T COG3001 17 EIKEREEVSGGDINEAWRLRDGT--DPFFVKCNQR------EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYL 88 (286)
T ss_pred hhhcccccCCccccceeEeecCC--cceEEEecch------hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEE
Confidence 44445667777777777765543 3588887543 3344566787777666 34568889999999999999
Q ss_pred EeeeCCCCCHH
Q 007260 294 VMEFCPGGDLH 304 (611)
Q Consensus 294 VmE~~~gg~L~ 304 (611)
||||++-+.+.
T Consensus 89 Vle~L~~~~~d 99 (286)
T COG3001 89 VLEYLPTGPLD 99 (286)
T ss_pred EEeeccCCCCC
Confidence 99999875553
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.01 E-value=0.073 Score=57.69 Aligned_cols=61 Identities=25% Similarity=0.225 Sum_probs=44.8
Q ss_pred eeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH-HcCeeccCCCCCcEEEccC
Q 007260 291 SCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLH-MLGIIYRDLKPENVLVRED 354 (611)
Q Consensus 291 ~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH-~~gIVHRDLKPeNILv~~~ 354 (611)
..||=+|..|..+..++... ..+|...+.++.--+.||--+- -.+++|.|+.|.||++.-+
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~---~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWK---SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred ceeeeeccccccHHhhhhcc---cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 45677789898988887753 3567677777665566655443 4689999999999999743
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 611 | ||||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-32 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-18 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-32 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-18 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-32 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-18 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-31 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-19 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-28 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-22 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-27 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-16 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-27 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-16 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-27 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-16 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-26 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-17 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-26 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-16 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-26 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 9e-17 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-26 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-15 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-26 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-16 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-26 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-16 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-26 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-16 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-26 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-16 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-26 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-16 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-26 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-16 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-26 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-17 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-26 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-16 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-26 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-16 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-26 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-16 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-26 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-16 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-26 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-16 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-26 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-16 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-26 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-16 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-26 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-16 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-26 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-16 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-26 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-16 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-26 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-16 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-26 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-16 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-26 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-16 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-26 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-16 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-26 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-16 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-26 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-16 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-26 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-16 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-26 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-16 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-26 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-18 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-26 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-16 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-26 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-16 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-26 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-16 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-26 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-18 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 9e-26 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-18 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 9e-26 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-17 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-25 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-18 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-25 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-18 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-25 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-25 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-18 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-25 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-16 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-25 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-17 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-25 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-17 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-25 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 9e-16 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-25 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-16 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-25 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-16 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-25 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-18 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-25 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-15 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-25 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-15 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-25 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-15 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-25 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-16 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-25 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-16 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-25 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-15 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-25 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-15 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-25 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-16 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-25 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-16 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-25 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-16 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-25 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-16 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-25 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-15 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-25 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-16 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 7e-25 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-16 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 7e-25 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-13 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-25 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-16 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-25 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-16 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 8e-25 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-16 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 9e-25 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-18 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 9e-25 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-18 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-25 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-16 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-24 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-18 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-23 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-15 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-23 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-15 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-23 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-15 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-23 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-14 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-23 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-18 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-22 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-22 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-22 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-18 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-22 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-15 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-22 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-15 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-22 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-16 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-22 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-15 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-22 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-22 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-18 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-22 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-22 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-22 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-22 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-22 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-22 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-22 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-22 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-22 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-22 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-22 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-22 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-22 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-22 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-22 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-15 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-22 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-22 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-14 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-21 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-21 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-15 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-21 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-17 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-19 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-14 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-19 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-18 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-18 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-18 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-14 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-18 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-18 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-18 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-14 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-18 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-14 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-18 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-14 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-18 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-14 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-18 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-17 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-18 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 9e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-18 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-18 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-18 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-14 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-18 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-18 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-11 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-18 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-18 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-18 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-18 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-18 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-17 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-17 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-17 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-17 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-17 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-17 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-17 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-17 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-17 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-17 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-17 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-17 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-17 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-17 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-17 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-17 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-17 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-17 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-17 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 9e-17 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-16 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-16 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-16 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-16 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-16 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-16 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-16 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-16 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 9e-16 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-16 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 9e-16 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-15 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-15 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-15 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-15 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-15 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-04 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-15 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-15 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-14 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-14 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-14 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-06 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-04 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-14 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-14 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-14 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-14 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-14 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-08 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-07 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-13 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-07 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-13 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-07 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-13 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-07 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 7e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-06 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-04 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 7e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-12 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 9e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 9e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-11 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 8e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-04 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-04 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-04 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 8e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 9e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 9e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-04 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-10 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 5e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 8e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 8e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 9e-06 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-08 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-09 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 5e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-04 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-09 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 7e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-09 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-09 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 8e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 8e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-04 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 9e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-04 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 9e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 9e-06 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-04 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-05 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-04 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-08 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-08 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-04 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-08 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-08 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-08 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-08 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-08 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-08 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-08 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-08 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-08 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-08 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-08 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-08 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-08 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-08 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-08 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-08 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-08 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-08 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-04 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-05 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-05 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-05 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-04 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 8e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-07 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 7e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 7e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 7e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 8e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-04 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 9e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-08 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 9e-08 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-07 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 1e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 9e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-07 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-07 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-05 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-07 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-05 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-07 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-07 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-05 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-05 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-04 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-07 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-07 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-07 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-07 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-07 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-06 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-07 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-07 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-07 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-07 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-07 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 8e-07 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-07 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-07 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 9e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-05 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 9e-07 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 9e-07 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 9e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-06 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-06 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-06 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-06 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-06 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-06 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 1e-06 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-06 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-06 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-06 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-04 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-06 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-06 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-06 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-06 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-06 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-06 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-06 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-06 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-06 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-06 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-06 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-05 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-06 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-05 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-06 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-06 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-06 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-06 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-06 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-06 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-06 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-06 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-06 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-06 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-06 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-05 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-06 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-05 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-06 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-06 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-06 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-06 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-06 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-06 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 8e-06 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-06 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-05 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-06 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-05 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 5e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 5e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 5e-06 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-04 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-05 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 5e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 5e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 6e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 6e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 6e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 6e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 6e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 7e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 7e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 7e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-04 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 7e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 7e-06 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 7e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 8e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 8e-06 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 8e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 8e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 8e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 8e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 8e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-05 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 8e-06 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 9e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-05 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 9e-06 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 9e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 9e-06 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 9e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-05 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 9e-06 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 9e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 9e-06 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 9e-06 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 9e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 9e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 9e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 9e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-05 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 9e-06 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 9e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 9e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-05 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 9e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-05 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-05 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-05 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-05 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 1e-05 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-05 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-05 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 2e-05 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-05 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-05 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-05 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-05 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 2e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-05 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-05 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 8e-04 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-05 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-05 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 3e-05 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-05 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-05 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-05 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-05 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-05 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-05 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-05 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-04 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-05 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-05 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 4e-05 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-05 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-05 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-05 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-05 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-05 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-05 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-05 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-05 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-05 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-05 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-05 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-05 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-05 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-05 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-05 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 5e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-04 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-05 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-05 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-05 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 7e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-05 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-05 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-05 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-05 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 8e-05 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-05 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 8e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 8e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 9e-05 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 9e-05 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 9e-05 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 9e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 9e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 9e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 9e-05 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 1e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-04 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-04 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-04 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-04 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-04 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-04 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-04 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 1e-04 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-04 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-04 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-04 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-04 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-04 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-04 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-04 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-04 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-04 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-04 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-04 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-04 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-04 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-04 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-04 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-04 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-04 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-04 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-04 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-04 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-04 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-04 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-04 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 8e-04 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-04 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-04 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-04 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-04 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-04 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-04 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-04 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-04 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-04 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-04 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-04 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-04 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-04 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-04 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-04 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-04 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-04 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-04 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-04 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-04 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 4e-04 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-04 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 4e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-04 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 4e-04 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 4e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-04 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 4e-04 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-04 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 4e-04 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 4e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-04 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-04 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-04 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-04 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-04 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-04 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 4e-04 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-04 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-04 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-04 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-04 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-04 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-04 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-04 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-04 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-04 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-04 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-04 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-04 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-04 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-04 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-04 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-04 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-04 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-04 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-04 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-04 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-04 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-04 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-04 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-04 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-04 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 7e-04 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 7e-04 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-04 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-04 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-04 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-04 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 7e-04 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 8e-04 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-04 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-04 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-04 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 8e-04 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-04 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 9e-04 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 9e-04 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 9e-04 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 9e-04 |
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 5e-61
Identities = 62/184 (33%), Positives = 105/184 (57%), Gaps = 1/184 (0%)
Query: 184 SFSSSINKPHKANDLRWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCY 243
S + A+ L+W VR ++ L F +LK +G G V + ++ T
Sbjct: 29 GASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQV 88
Query: 244 FAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDL 303
+AMK+M+K + R ++ + ER++L + D ++ L+ F+ E + LVME+ GGDL
Sbjct: 89 YAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDL 148
Query: 304 HTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFD 363
TL K G+ P + RFY+AE+++A++ +H LG ++RD+KP+N+L+ GHI L+DF
Sbjct: 149 LTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFG 207
Query: 364 LSLR 367
L+
Sbjct: 208 SCLK 211
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-39
Identities = 52/183 (28%), Positives = 80/183 (43%), Gaps = 22/183 (12%)
Query: 448 EARSMSFVGTHEYLAPEIIKGEG-------HGSAVDWWTFGIFLYELLFGKTPFKGSGNR 500
RS+ VGT +YL+PEI++ G +G DWW G+F YE+ +G+TPF
Sbjct: 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA 276
Query: 501 ATLFNVVG--QPLRFPESPV-VSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557
T +V + L P V ARD I+ LL P+ RL GA + + HPFF G+
Sbjct: 277 ETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLL-CPPETRLGR-GGAGDFRTHPFFFGL 334
Query: 558 NWALIRCATPPEIPK----------PVEIERIPAPTSSTSEKTAPTMVPPNQRGSDNYLE 607
+W +R + PP P + + + A S E + ++
Sbjct: 335 DWDGLRDSVPPFTPDFEGATDTCNFDLVEDGLTAMVSGGGETLSDIREGAPLGVHLPFVG 394
Query: 608 FDF 610
+ +
Sbjct: 395 YSY 397
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 2e-60
Identities = 57/184 (30%), Positives = 97/184 (52%), Gaps = 3/184 (1%)
Query: 184 SFSSSINKPHKANDLRWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCY 243
F + + N L + RD + + ++K +G G G V L T+
Sbjct: 37 DFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKV 96
Query: 244 FAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDL 303
+AMK++ K + R ER+I+ + P++ L+ F+ +++ +VME+ PGGDL
Sbjct: 97 YAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL 156
Query: 304 HTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFD 363
L PE+ RFY AEV+LAL+ +H +G I+RD+KP+N+L+ + GH+ L+DF
Sbjct: 157 VNLMSNYD---VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG 213
Query: 364 LSLR 367
++
Sbjct: 214 TCMK 217
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 7e-41
Identities = 46/131 (35%), Positives = 70/131 (53%), Gaps = 10/131 (7%)
Query: 450 RSMSFVGTHEYLAPEIIKGEG----HGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFN 505
R + VGT +Y++PE++K +G +G DWW+ G+FLYE+L G TPF T
Sbjct: 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK 284
Query: 506 VVG--QPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWA--L 561
++ L FP+ +S A++LI L + + RL + G EIK+H FF+ WA
Sbjct: 285 IMNHKNSLTFPDDNDISKEAKNLICAFL-TDREVRLG-RNGVEEIKRHLFFKNDQWAWET 342
Query: 562 IRCATPPEIPK 572
+R P +P
Sbjct: 343 LRDTVAPVVPD 353
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 3e-58
Identities = 58/185 (31%), Positives = 101/185 (54%), Gaps = 1/185 (0%)
Query: 183 SSFSSSINKPHKANDLRWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKC 242
+ S + + L W + + L F +LK +G G G V + +L
Sbjct: 41 CNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADK 100
Query: 243 YFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGD 302
FAMK+++K + R + + ER++L + D ++ TL+ F+ + LVM++ GGD
Sbjct: 101 VFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGD 160
Query: 303 LHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDF 362
L TL K + PE+ RFY+AE+++A++ +H L ++RD+KP+N+L+ +GHI L+DF
Sbjct: 161 LLTLLSKFEDR-LPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADF 219
Query: 363 DLSLR 367
L+
Sbjct: 220 GSCLK 224
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-38
Identities = 57/180 (31%), Positives = 86/180 (47%), Gaps = 24/180 (13%)
Query: 448 EARSMSFVGTHEYLAPEIIKGE-----GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRAT 502
+S VGT +Y++PEI++ +G DWW+ G+ +YE+L+G+TPF T
Sbjct: 230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET 289
Query: 503 LFNVVGQPLRFP---ESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNW 559
++ RF + VS A+DLIR L+ +HRL G + K+HPFF G++W
Sbjct: 290 YGKIMNHKERFQFPTQVTDVSENAKDLIRRLICS-REHRLGQ-NGIEDFKKHPFFSGIDW 347
Query: 560 ALIRCATPPEIPKPVEIERIPAPTSS-------TSEKTAPTMVPPNQRGSDNY-LEFDFF 611
IR P IP+ + +PT + K + TM PP + L F F
Sbjct: 348 DNIRNCEAPYIPE------VSSPTDTSNFDVDDDCLKNSETMPPPTHTAFSGHHLPFVGF 401
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 5e-58
Identities = 57/168 (33%), Positives = 88/168 (52%), Gaps = 2/168 (1%)
Query: 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQS 272
F+ K LG G +V L+ T +A+K+++K + K+ ER+++
Sbjct: 27 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 86
Query: 273 LDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALE 332
LDHPF LY F+ ++ + + G+L +K F E RFY AE++ ALE
Sbjct: 87 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALE 144
Query: 333 YLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSL 380
YLH GII+RDLKPEN+L+ ED HI ++DF + + +A+S
Sbjct: 145 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 192
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 3e-46
Identities = 46/134 (34%), Positives = 68/134 (50%), Gaps = 6/134 (4%)
Query: 441 ELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNR 500
L E +AR+ SFVGT +Y++PE++ + + D W G +Y+L+ G PF+ GN
Sbjct: 179 VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA-GNE 237
Query: 501 ATLF-NVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAY--KRGATEIKQHPFFEGV 557
+F ++ FP ARDL+ LLV + RL G +K HPFFE V
Sbjct: 238 YLIFQKIIKLEYDFP--EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295
Query: 558 NWALIRCATPPEIP 571
W + TPP++
Sbjct: 296 TWENLHQQTPPKLT 309
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 4e-57
Identities = 54/160 (33%), Positives = 96/160 (60%), Gaps = 2/160 (1%)
Query: 206 VRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQT 265
V + + HF +L+ +G G G V + + + TK +AMK M+K R ++
Sbjct: 5 VFDENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFK 64
Query: 266 EREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVA 325
E +I+Q L+HPFL L+ F+ E+ +V++ GGDL Q+ +F E+ V+ ++
Sbjct: 65 ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFIC 122
Query: 326 EVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
E+++AL+YL II+RD+KP+N+L+ E GH+ ++DF+++
Sbjct: 123 ELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIA 162
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-37
Identities = 37/135 (27%), Positives = 62/135 (45%), Gaps = 13/135 (9%)
Query: 446 PTEARSMSFVGTHEYLAPEII---KGEGHGSAVDWWTFGIFLYELLFGKTPF--KGSGNR 500
P E + + GT Y+APE+ KG G+ AVDWW+ G+ YELL G+ P+ + S +
Sbjct: 166 PRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS 225
Query: 501 ATLF-NVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNW 559
+ + +P S L++ LL P R + ++++ P+ +NW
Sbjct: 226 KEIVHTFETTVVTYP--SAWSQEMVSLLKKLLEPNPDQRFS---QLSDVQNFPYMNDINW 280
Query: 560 ALI--RCATPPEIPK 572
+ + P IP
Sbjct: 281 DAVFQKRLIPGFIPN 295
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 1e-55
Identities = 59/153 (38%), Positives = 91/153 (59%), Gaps = 2/153 (1%)
Query: 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQS 272
L F++L+ LG G G V+L Y+AMKV+ K + K++ ER +L
Sbjct: 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62
Query: 273 LDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALE 332
+ HPF+ ++ F+ + ++M++ GG+L +L +K + FP +FY AEV LALE
Sbjct: 63 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALE 120
Query: 333 YLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
YLH IIYRDLKPEN+L+ ++GHI ++DF +
Sbjct: 121 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFA 153
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-41
Identities = 48/168 (28%), Positives = 82/168 (48%), Gaps = 13/168 (7%)
Query: 448 EARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLF-NV 506
+ + GT +Y+APE++ + + ++DWW+FGI +YE+L G TPF S N + +
Sbjct: 157 PDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS-NTMKTYEKI 215
Query: 507 VGQPLRFPESPVVSFAARDLIRGLLVKEPQHRL-AYKRGATEIKQHPFFEGVNWALI--R 563
+ LRFP P + +DL+ L+ ++ RL + G ++K HP+F+ V W + R
Sbjct: 216 LNAELRFP--PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSR 273
Query: 564 CATPPEIPKPVEIERIPAPTS---STSEKTAPTMVPPNQRGSDNYLEF 608
P P I++ TS E+ V +D + +F
Sbjct: 274 NIETPYEPP---IQQGQGDTSQFDKYPEEDINYGVQGEDPYADLFRDF 318
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 1e-54
Identities = 59/153 (38%), Positives = 89/153 (58%), Gaps = 2/153 (1%)
Query: 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQS 272
+ ++ F LK LG G G V L T Y+AMK++ K + + ++ TE +LQ+
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 273 LDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALE 332
HPFL L F+T C VME+ GG+L ++ + F E+ RFY AE++ ALE
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALE 119
Query: 333 YLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
YLH ++YRD+K EN+++ +DGHI ++DF L
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC 152
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 7e-41
Identities = 47/129 (36%), Positives = 74/129 (57%), Gaps = 7/129 (5%)
Query: 448 EARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLF-NV 506
A +F GT EYLAPE+++ +G AVDWW G+ +YE++ G+ PF + LF +
Sbjct: 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-DHERLFELI 217
Query: 507 VGQPLRFPESPVVSFAARDLIRGLLVKEPQHRL-AYKRGATEIKQHPFFEGVNWALI--R 563
+ + +RFP + +S A+ L+ GLL K+P+ RL A E+ +H FF +NW + +
Sbjct: 218 LMEEIRFPRT--LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQK 275
Query: 564 CATPPEIPK 572
PP P+
Sbjct: 276 KLLPPFKPQ 284
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 2e-54
Identities = 60/193 (31%), Positives = 98/193 (50%), Gaps = 7/193 (3%)
Query: 173 SSDVSDESTCSSFSSSINKPHKANDLRWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSV 232
++ S S + K + +WE L F +K LG G G V
Sbjct: 3 AAAAKKGSEQESVKEFLAKAKEDFLKKWE-----TPSQNTAQLDQFDRIKTLGTGSFGRV 57
Query: 233 YLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSC 292
L + + ++AMK++DK + K++ E+ ILQ+++ PFL L F+
Sbjct: 58 MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117
Query: 293 LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVR 352
+VME+ GG++ + ++ F E RFY A+++L EYLH L +IYRDLKPEN+L+
Sbjct: 118 MVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175
Query: 353 EDGHIMLSDFDLS 365
+ G+I ++DF +
Sbjct: 176 QQGYIQVTDFGFA 188
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 4e-40
Identities = 46/129 (35%), Positives = 64/129 (49%), Gaps = 7/129 (5%)
Query: 448 EARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLF-NV 506
+ R+ + GT E LAPEII +G+ AVDWW G+ +YE+ G PF ++ +
Sbjct: 192 KGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD-QPIQIYEKI 250
Query: 507 VGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAY-KRGATEIKQHPFFEGVNWALI--R 563
V +RFP S +DL+R LL + R K G +IK H +F +W I R
Sbjct: 251 VSGKVRFP--SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR 308
Query: 564 CATPPEIPK 572
P IPK
Sbjct: 309 KVEAPFIPK 317
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 6e-54
Identities = 75/165 (45%), Positives = 105/165 (63%), Gaps = 6/165 (3%)
Query: 204 QAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSE---LSGTKCYFAMKVMDKASLAGRKKL 260
V+ S F LLK LG G G V+L + S + +AMKV+ KA+L R ++
Sbjct: 12 HHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRV 71
Query: 261 LRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAV 320
R + ER+IL ++HPF+ L+ F+TE L+++F GGDL T K+ F E+ V
Sbjct: 72 -RTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDV 128
Query: 321 RFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+FY+AE+ LAL++LH LGIIYRDLKPEN+L+ E+GHI L+DF LS
Sbjct: 129 KFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS 173
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-42
Identities = 47/129 (36%), Positives = 72/129 (55%), Gaps = 7/129 (5%)
Query: 448 EARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLF-NV 506
E ++ SF GT EY+APE++ GH + DWW+FG+ ++E+L G PF+G +R +
Sbjct: 180 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK-DRKETMTMI 238
Query: 507 VGQPLRFPESPVVSFAARDLIRGLLVKEPQHRL-AYKRGATEIKQHPFFEGVNWALI--R 563
+ L P+ +S A+ L+R L + P +RL A G EIK+H FF ++W + R
Sbjct: 239 LKAKLGMPQF--LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRR 296
Query: 564 CATPPEIPK 572
PP P
Sbjct: 297 EIHPPFKPA 305
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 7e-54
Identities = 59/157 (37%), Positives = 86/157 (54%), Gaps = 6/157 (3%)
Query: 213 LGLSHFRLLKRLGCGDIGSVYLSE---LSGTKCYFAMKVMDKASLAGRKKLL-RAQTERE 268
+ F LL+ LG G G V+ + T FAMKV+ KA + K + ER
Sbjct: 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERN 73
Query: 269 ILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVL 328
IL+ + HPF+ L F+T L++E+ GG+L +++ F E FY+AE+
Sbjct: 74 ILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEIS 131
Query: 329 LALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+AL +LH GIIYRDLKPEN+++ GH+ L+DF L
Sbjct: 132 MALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLC 168
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 7e-42
Identities = 48/129 (37%), Positives = 67/129 (51%), Gaps = 7/129 (5%)
Query: 448 EARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLF-NV 506
+ +F GT EY+APEI+ GH AVDWW+ G +Y++L G PF G NR +
Sbjct: 175 GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE-NRKKTIDKI 233
Query: 507 VGQPLRFPESPVVSFAARDLIRGLLVKEPQHRL-AYKRGATEIKQHPFFEGVNWALI--R 563
+ L P ++ ARDL++ LL + RL A A E++ HPFF +NW + R
Sbjct: 234 LKCKLNLPPY--LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLAR 291
Query: 564 CATPPEIPK 572
PP P
Sbjct: 292 KVEPPFKPL 300
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 2e-53
Identities = 66/154 (42%), Positives = 92/154 (59%), Gaps = 3/154 (1%)
Query: 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREIL-Q 271
LGL F LL+ +G G V L L T +AMKV+ K + + + QTE+ + Q
Sbjct: 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 65
Query: 272 SLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLAL 331
+ +HPFL L++ F+TE V+E+ GGDL Q+Q + PE+ RFY AE+ LAL
Sbjct: 66 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLAL 123
Query: 332 EYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
YLH GIIYRDLK +NVL+ +GHI L+D+ +
Sbjct: 124 NYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 157
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-38
Identities = 44/138 (31%), Positives = 75/138 (54%), Gaps = 15/138 (10%)
Query: 448 EARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSG--------N 499
+ +F GT Y+APEI++GE +G +VDWW G+ ++E++ G++PF G
Sbjct: 164 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT 223
Query: 500 RATLF-NVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRL--AYKRGATEIKQHPFFEG 556
LF ++ + +R P S +S A +++ L K+P+ RL + G +I+ HPFF
Sbjct: 224 EDYLFQVILEKQIRIPRS--LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281
Query: 557 VNWALI--RCATPPEIPK 572
V+W ++ + PP P
Sbjct: 282 VDWDMMEQKQVVPPFKPN 299
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 3e-53
Identities = 63/370 (17%), Positives = 125/370 (33%), Gaps = 85/370 (22%)
Query: 212 VLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQ 271
++ H+ +++LG G V L E ++A+K + R++ R E ++ +
Sbjct: 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQR---EADMHR 81
Query: 272 SLDHPFLPTLYTHFETEKFS----CLVMEFCPGGDLHTL--RQKQPGKYFPEQAVRFYVA 325
+HP + L + E+ + L++ F G L R K G + E + + +
Sbjct: 82 LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLL 141
Query: 326 EVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPL 385
+ LE +H G +RDLKP N+L+ ++G +L D + + + + +
Sbjct: 142 GICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWA 201
Query: 386 RKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAE 445
+ T + +P LFS +S +
Sbjct: 202 AQ-------------------RCTISYRAPELFSVQSHCVIDER---------------- 226
Query: 446 PTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRA-TLF 504
D W+ G LY ++FG+ P+ + ++
Sbjct: 227 -----------------------------TDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA 257
Query: 505 NVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIRC 564
V L P+SP S A L+ ++ +P R + ++
Sbjct: 258 LAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRP----HIPLLLSQLEA-------LQP 306
Query: 565 ATPPEIPKPV 574
P + +
Sbjct: 307 PAPGQHTTQI 316
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 6e-53
Identities = 62/191 (32%), Positives = 101/191 (52%), Gaps = 7/191 (3%)
Query: 176 VSDESTCSSFSSSINKPHKANDLRWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLS 235
+S +++ P + + I + + S F LK +G G G V L+
Sbjct: 2 ISQPQEPELMNANPAPPPAPS----QQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLA 57
Query: 236 ELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREIL-QSLDHPFLPTLYTHFETEKFSCLV 294
+ ++A+KV+ K ++ +K+ +ER +L +++ HPFL L+ F+T V
Sbjct: 58 RHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117
Query: 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRED 354
+++ GG+L Q++ + F E RFY AE+ AL YLH L I+YRDLKPEN+L+
Sbjct: 118 LDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ 175
Query: 355 GHIMLSDFDLS 365
GHI+L+DF L
Sbjct: 176 GHIVLTDFGLC 186
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-42
Identities = 49/128 (38%), Positives = 72/128 (56%), Gaps = 6/128 (4%)
Query: 448 EARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLF-NV 506
+ + +F GT EYLAPE++ + + VDWW G LYE+L+G PF N A ++ N+
Sbjct: 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR-NTAEMYDNI 251
Query: 507 VGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALI--RC 564
+ +PL+ P ++ +AR L+ GLL K+ RL K EIK H FF +NW + +
Sbjct: 252 LNKPLQLK--PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKK 309
Query: 565 ATPPEIPK 572
TPP P
Sbjct: 310 ITPPFNPN 317
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 188 bits (478), Expect = 1e-52
Identities = 61/183 (33%), Positives = 94/183 (51%), Gaps = 7/183 (3%)
Query: 185 FSSSINKPHKANDLRWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYF 244
F ++ + L+W+ ++A +G F + LG G G V+ ++ T +
Sbjct: 159 FQEFLDSLYFLRFLQWKWLEAQP-----MGEDWFLDFRVLGRGGFGEVFACQMKATGKLY 213
Query: 245 AMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDL- 303
A K ++K L RK A E++IL + F+ +L FET+ CLVM GGD+
Sbjct: 214 ACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIR 273
Query: 304 -HTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDF 362
H + F E FY A+++ LE+LH IIYRDLKPENVL+ +DG++ +SD
Sbjct: 274 YHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDL 333
Query: 363 DLS 365
L+
Sbjct: 334 GLA 336
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-39
Identities = 40/171 (23%), Positives = 78/171 (45%), Gaps = 13/171 (7%)
Query: 448 EARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRAT---LF 504
+ ++ + GT ++APE++ GE + +VD++ G+ LYE++ + PF+ G + L
Sbjct: 343 QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402
Query: 505 -NVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRL-AYKRGATEIKQHPFFEGVNWALI 562
V+ Q + +P+ S A++D LL K+P+ RL ++ HP F ++W +
Sbjct: 403 QRVLEQAVTYPDK--FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQL 460
Query: 563 --RCATPPEIPKPVEI-ERIPAPTSSTSEKTAPTMVPPNQRGSDNYLEFDF 610
TPP +P + + + S + + + EF
Sbjct: 461 EAGMLTPPFVPDSRTVYAKNIQDVGAFSTVKGVAFEKADT---EFFQEFAS 508
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 1e-52
Identities = 65/154 (42%), Positives = 92/154 (59%), Gaps = 3/154 (1%)
Query: 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREIL-Q 271
LGL F LL+ +G G V L L T +AM+V+ K + + + QTE+ + Q
Sbjct: 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQ 108
Query: 272 SLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLAL 331
+ +HPFL L++ F+TE V+E+ GGDL Q+Q + PE+ RFY AE+ LAL
Sbjct: 109 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLAL 166
Query: 332 EYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
YLH GIIYRDLK +NVL+ +GHI L+D+ +
Sbjct: 167 NYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 200
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 5e-37
Identities = 44/138 (31%), Positives = 75/138 (54%), Gaps = 15/138 (10%)
Query: 448 EARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSG--------N 499
+ +F GT Y+APEI++GE +G +VDWW G+ ++E++ G++PF G
Sbjct: 207 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT 266
Query: 500 RATLF-NVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRL--AYKRGATEIKQHPFFEG 556
LF ++ + +R P S +S A +++ L K+P+ RL + G +I+ HPFF
Sbjct: 267 EDYLFQVILEKQIRIPRS--LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324
Query: 557 VNWALI--RCATPPEIPK 572
V+W ++ + PP P
Sbjct: 325 VDWDMMEQKQVVPPFKPN 342
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 3e-52
Identities = 56/154 (36%), Positives = 86/154 (55%), Gaps = 3/154 (1%)
Query: 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQ- 271
L + F L K LG G G V+L+E T +FA+K + K + + E+ +L
Sbjct: 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 73
Query: 272 SLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLAL 331
+ +HPFL ++ F+T++ VME+ GGDL Q F FY AE++L L
Sbjct: 74 AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGL 131
Query: 332 EYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
++LH GI+YRDLK +N+L+ +DGHI ++DF +
Sbjct: 132 QFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC 165
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 54/172 (31%), Positives = 87/172 (50%), Gaps = 18/172 (10%)
Query: 448 EARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLF-NV 506
+A++ +F GT +Y+APEI+ G+ + +VDWW+FG+ LYE+L G++PF G + LF ++
Sbjct: 172 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ-DEEELFHSI 230
Query: 507 VGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALI--RC 564
+P + A+DL+ L V+EP+ RL +I+QHP F +NW + +
Sbjct: 231 RMDNPFYPRW--LEKEAKDLLVKLFVREPEKRLG---VRGDIRQHPLFREINWEELERKE 285
Query: 565 ATPPEIPKPVEIERIPAPTSS-----TSEKTAPTMVPPNQRGSDNYLEFDFF 611
PP PK P S+ +EK + S + F F
Sbjct: 286 IDPPFRPKVKS----PFDCSNFDKEFLNEKPRLSFADRALINSMDQNMFRNF 333
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 5e-52
Identities = 66/158 (41%), Positives = 101/158 (63%), Gaps = 7/158 (4%)
Query: 213 LGLSHFRLLKRLGCGDIGSVYLSE---LSGTKCYFAMKVMDKASLAGRKKLL-RAQTERE 268
+G+ +F LLK LG G G V+L T +AMKV+ KA++ + K +TER+
Sbjct: 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 110
Query: 269 ILQSLDH-PFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEV 327
+L+ + PFL TL+ F+TE L++++ GG+L T ++ + F E V+ YV E+
Sbjct: 111 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEI 168
Query: 328 LLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+LALE+LH LGIIYRD+K EN+L+ +GH++L+DF LS
Sbjct: 169 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 206
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 7e-40
Identities = 55/141 (39%), Positives = 84/141 (59%), Gaps = 12/141 (8%)
Query: 441 ELIAEPTEARSMSFVGTHEYLAPEIIKGE--GHGSAVDWWTFGIFLYELLFGKTPFKGSG 498
E +A+ TE R+ F GT EY+AP+I++G GH AVDWW+ G+ +YELL G +PF G
Sbjct: 208 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 266
Query: 499 ---NRATLF-NVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRL-AYKRGATEIKQHPF 553
++A + ++ +P+ +S A+DLI+ LL+K+P+ RL R A EIK+H F
Sbjct: 267 EKNSQAEISRRILKSEPPYPQE--MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324
Query: 554 FEGVNWALI--RCATPPEIPK 572
F+ +NW + + P P
Sbjct: 325 FQKINWDDLAAKKVPAPFKPV 345
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 1e-51
Identities = 62/168 (36%), Positives = 89/168 (52%), Gaps = 7/168 (4%)
Query: 201 EAIQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKL 260
E LG+ +F ++ LG G G V L+ + T +A+KV+ K + +
Sbjct: 8 EGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDV 67
Query: 261 LRAQTEREILQ-SLDHPFLPTLYTHFETEKFSCLVMEFCPGGDL--HTLRQKQPGKYFPE 317
TE+ IL + +HPFL L+ F+T VMEF GGDL H + ++ F E
Sbjct: 68 ECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR----FDE 123
Query: 318 QAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
RFY AE++ AL +LH GIIYRDLK +NVL+ +GH L+DF +
Sbjct: 124 ARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMC 171
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-39
Identities = 43/130 (33%), Positives = 69/130 (53%), Gaps = 8/130 (6%)
Query: 448 EARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLF-NV 506
+ +F GT +Y+APEI++ +G AVDWW G+ LYE+L G PF+ N LF +
Sbjct: 178 GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE-NEDDLFEAI 236
Query: 507 VGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAY--KRGATEIKQHPFFEGVNWALI-- 562
+ + +P + A +++ + K P RL + G I +HPFF+ ++WA +
Sbjct: 237 LNDEVVYPTW--LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNH 294
Query: 563 RCATPPEIPK 572
R PP P+
Sbjct: 295 RQIEPPFRPR 304
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 1e-51
Identities = 55/156 (35%), Positives = 81/156 (51%), Gaps = 7/156 (4%)
Query: 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQS 272
+ L+ F L LG G G V LSE GT +A+K++ K + + E+ +L
Sbjct: 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 76
Query: 273 LD-HPFLPTLYTHFETEKFSCLVMEFCPGGDL--HTLRQKQPGKYFPEQAVRFYVAEVLL 329
PFL L++ F+T VME+ GGDL H + + F E FY AE+ +
Sbjct: 77 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR----FKEPHAVFYAAEIAI 132
Query: 330 ALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
L +L GIIYRDLK +NV++ +GHI ++DF +
Sbjct: 133 GLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC 168
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-39
Identities = 47/129 (36%), Positives = 75/129 (58%), Gaps = 7/129 (5%)
Query: 448 EARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLF-NV 506
+ +F GT +Y+APEII + +G +VDWW FG+ LYE+L G+ PF+G + LF ++
Sbjct: 175 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE-DEDELFQSI 233
Query: 507 VGQPLRFPESPVVSFAARDLIRGLLVKEPQHRL-AYKRGATEIKQHPFFEGVNWALI--R 563
+ + +P+S +S A + +GL+ K P RL G +IK+H FF ++W + +
Sbjct: 234 MEHNVAYPKS--MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERK 291
Query: 564 CATPPEIPK 572
PP PK
Sbjct: 292 EIQPPYKPK 300
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 2e-51
Identities = 58/183 (31%), Positives = 93/183 (50%), Gaps = 5/183 (2%)
Query: 183 SSFSSSINKPHKANDLRWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKC 242
+ F+ ++ + L+W+ ++ + + FR + LG G G V ++ T
Sbjct: 156 APFADYLDSIYFNRFLQWKWLERQP-----VTKNTFRQYRVLGKGGFGEVCACQVRATGK 210
Query: 243 YFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGD 302
+A K ++K + RK A E++IL+ ++ F+ +L +ET+ CLV+ GGD
Sbjct: 211 MYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGD 270
Query: 303 LHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDF 362
L FPE FY AE+ LE LH I+YRDLKPEN+L+ + GHI +SD
Sbjct: 271 LKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDL 330
Query: 363 DLS 365
L+
Sbjct: 331 GLA 333
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-38
Identities = 44/135 (32%), Positives = 64/135 (47%), Gaps = 9/135 (6%)
Query: 446 PTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATL-- 503
P VGT Y+APE++K E + + DWW G LYE++ G++PF+ +
Sbjct: 337 PEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE 396
Query: 504 --FNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYK-RGATEIKQHPFFEGVNWA 560
V P + E S AR L LL K+P RL + A E+K+HP F+ +N+
Sbjct: 397 VERLVKEVPEEYSER--FSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFK 454
Query: 561 LI--RCATPPEIPKP 573
+ PP P P
Sbjct: 455 RLGAGMLEPPFKPDP 469
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 6e-51
Identities = 66/214 (30%), Positives = 106/214 (49%), Gaps = 5/214 (2%)
Query: 155 DRLDYVESGKSSICRGSTSSDVSDESTCSSFSSSINKPHKANDLRWEAIQAVRARDGV-- 212
+R +VE+ + + V+D + + + +D V
Sbjct: 85 ERTFHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHR 144
Query: 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQS 272
+ ++ F LK LG G G V L + T Y+AMK++ K + + ++ TE +LQ+
Sbjct: 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 204
Query: 273 LDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALE 332
HPFL L F+T C VME+ GG+L ++ + F E RFY AE++ AL+
Sbjct: 205 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALD 262
Query: 333 YLHM-LGIIYRDLKPENVLVREDGHIMLSDFDLS 365
YLH ++YRDLK EN+++ +DGHI ++DF L
Sbjct: 263 YLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC 296
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 4e-39
Identities = 48/129 (37%), Positives = 74/129 (57%), Gaps = 7/129 (5%)
Query: 448 EARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLF-NV 506
A +F GT EYLAPE+++ +G AVDWW G+ +YE++ G+ PF + LF +
Sbjct: 303 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-DHEKLFELI 361
Query: 507 VGQPLRFPESPVVSFAARDLIRGLLVKEPQHRL-AYKRGATEIKQHPFFEGVNWALI--R 563
+ + +RFP + + A+ L+ GLL K+P+ RL A EI QH FF G+ W + +
Sbjct: 362 LMEEIRFPRT--LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEK 419
Query: 564 CATPPEIPK 572
+PP P+
Sbjct: 420 KLSPPFKPQ 428
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 185 bits (470), Expect = 1e-50
Identities = 59/256 (23%), Positives = 111/256 (43%), Gaps = 12/256 (4%)
Query: 113 DVSVDQEKKTSEYGSVKNSSVSGKVSDGTSSLAKTSGSAKISDRLDYVESGKSSICRGST 172
+ +E++ + ++ + ++ + +K S + L +
Sbjct: 93 EKLETEEERLVCSREIFDTYIMKELLACSHPFSK-SAIEHVQGHLVKKQVPPD--LFQPY 149
Query: 173 SSDVSDESTCSSFSSSINKPHKANDLRWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSV 232
++ F I +W+ ++ + L ++ F + + +G G G V
Sbjct: 150 IEEICQNLRGDVFQKFIESDKFTRFCQWKNVE----LNIHLTMNDFSVHRIIGRGGFGEV 205
Query: 233 YLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQ---SLDHPFLPTLYTHFETEK 289
Y + T +AMK +DK + ++ A ER +L + D PF+ + F T
Sbjct: 206 YGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 265
Query: 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENV 349
+++ GGDLH + F E +RFY AE++L LE++H ++YRDLKP N+
Sbjct: 266 KLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANI 323
Query: 350 LVREDGHIMLSDFDLS 365
L+ E GH+ +SD L+
Sbjct: 324 LLDEHGHVRISDLGLA 339
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 150 bits (379), Expect = 2e-38
Identities = 47/173 (27%), Positives = 85/173 (49%), Gaps = 9/173 (5%)
Query: 445 EPTEARSMSFVGTHEYLAPEII-KGEGHGSAVDWWTFGIFLYELLFGKTPFKGSG--NRA 501
+ ++ + + VGTH Y+APE++ KG + S+ DW++ G L++LL G +PF+ ++
Sbjct: 341 DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 400
Query: 502 TLF-NVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRL-AYKRGATEIKQHPFFEGVNW 559
+ + + P+S S R L+ GLL ++ RL RGA E+K+ PFF ++W
Sbjct: 401 EIDRMTLTMAVELPDS--FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 458
Query: 560 ALI--RCATPPEIPKPVEIERIPAPTSSTSEKTAPTMVPPNQRGSDNYLEFDF 610
++ + PP IP E+ A + ++ + + Y F
Sbjct: 459 QMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTKGIKLLDSDQELYRNFPL 511
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 3e-47
Identities = 45/387 (11%), Positives = 89/387 (22%), Gaps = 117/387 (30%)
Query: 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKL---------------- 260
LG D + + T F + V +
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 261 ---------LRAQTEREILQSLDHPFLPTLYTHFETEKFS--CLVMEFCPGGDLHTL--- 306
LR ++++ + + + +L T
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEV 192
Query: 307 --RQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDL 364
K A +V+ L LH G+++ L+P ++++ + G + L+ F+
Sbjct: 193 LLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEH 252
Query: 365 SLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKK 424
+R S V+
Sbjct: 253 LVRDGARVV--------------------------------SSVSRGFEP---------- 270
Query: 425 DRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFL 484
PEL A ++ + + D W G+ +
Sbjct: 271 ---------------PELEAR------------RATISYHRDRRTLMTFSFDAWALGLVI 303
Query: 485 YELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRG 544
Y + P + P+ R L+ G L + RL
Sbjct: 304 YWIWCADLPITKDAALGGSEWIFRSCKNIPQP------VRALLEGFLRYPKEDRL----L 353
Query: 545 ATEIKQHPFFEGVNWALIRCATPPEIP 571
+ + P +E +R +P
Sbjct: 354 PLQAMETPEYEQ-----LRTELSAALP 375
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 6e-47
Identities = 51/151 (33%), Positives = 79/151 (52%), Gaps = 2/151 (1%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD 274
+ F + + LG G G+VYL+ K A+KV+ K+ L + + E EI L
Sbjct: 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 72
Query: 275 HPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYL 334
HP + +Y +F K L++EF P G+L+ QK F EQ ++ E+ AL Y
Sbjct: 73 HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYC 130
Query: 335 HMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
H +I+RD+KPEN+L+ G + ++DF S
Sbjct: 131 HERKVIHRDIKPENLLMGYKGELKIADFGWS 161
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 40/117 (34%), Positives = 55/117 (47%), Gaps = 10/117 (8%)
Query: 456 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPE 515
GT +YL PE+I+G+ H VD W G+ YE L G PF + T +V L+FP
Sbjct: 174 GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP- 232
Query: 516 SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIRCATPPEIPK 572
P +S ++DLI LL P RL + +HP+ + A R PP
Sbjct: 233 -PFLSDGSKDLISKLLRYHPPQRL----PLKGVMEHPWVK----ANSRRVLPPVYQS 280
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 6e-47
Identities = 52/158 (32%), Positives = 80/158 (50%), Gaps = 2/158 (1%)
Query: 208 ARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTER 267
++ L F + + LG G G+VYL+ +K A+KV+ KA L + + E
Sbjct: 1 SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60
Query: 268 EILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEV 327
EI L HP + LY +F L++E+ P G ++ QK F EQ Y+ E+
Sbjct: 61 EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITEL 118
Query: 328 LLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
AL Y H +I+RD+KPEN+L+ G + ++DF S
Sbjct: 119 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 156
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 4e-30
Identities = 39/131 (29%), Positives = 55/131 (41%), Gaps = 6/131 (4%)
Query: 442 LIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRA 501
+R GT +YL PE+I+G H VD W+ G+ YE L GK PF+ + +
Sbjct: 155 WSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 214
Query: 502 TLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWAL 561
T + FP+ V+ ARDLI LL P R E+ +HP+ +
Sbjct: 215 TYKRISRVEFTFPDF--VTEGARDLISRLLKHNPSQRP----MLREVLEHPWITANSSKP 268
Query: 562 IRCATPPEIPK 572
C K
Sbjct: 269 SNCQNKESASK 279
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 6e-47
Identities = 58/199 (29%), Positives = 90/199 (45%), Gaps = 7/199 (3%)
Query: 170 GSTSSDVSDESTCSSFSSSINKPHKANDLRWEAIQAVRARDGVLGLSHFRLLKRLGCGDI 229
GS ++ + + K + + + L+ F L LG G
Sbjct: 295 GSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSF 354
Query: 230 GSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQ-SLDHPFLPTLYTHFETE 288
G V LSE GT +A+K++ K + + E+ +L PFL L++ F+T
Sbjct: 355 GKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 414
Query: 289 KFSCLVMEFCPGGDL--HTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKP 346
VME+ GGDL H + + F E FY AE+ + L +L GIIYRDLK
Sbjct: 415 DRLYFVMEYVNGGDLMYHIQQVGR----FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKL 470
Query: 347 ENVLVREDGHIMLSDFDLS 365
+NV++ +GHI ++DF +
Sbjct: 471 DNVMLDSEGHIKIADFGMC 489
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 4e-37
Identities = 47/129 (36%), Positives = 75/129 (58%), Gaps = 7/129 (5%)
Query: 448 EARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLF-NV 506
+ +F GT +Y+APEII + +G +VDWW FG+ LYE+L G+ PF+G + LF ++
Sbjct: 496 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE-DEDELFQSI 554
Query: 507 VGQPLRFPESPVVSFAARDLIRGLLVKEPQHRL-AYKRGATEIKQHPFFEGVNWALI--R 563
+ + +P+S +S A + +GL+ K P RL G +IK+H FF ++W + +
Sbjct: 555 MEHNVAYPKS--MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERK 612
Query: 564 CATPPEIPK 572
PP PK
Sbjct: 613 EIQPPYKPK 621
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 4e-44
Identities = 88/364 (24%), Positives = 132/364 (36%), Gaps = 107/364 (29%)
Query: 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLR-------------- 262
+ L +G G G V L+ Y+AMKV+ K L + R
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 263 -------AQTEREI--LQSLDHPFLPTLYTHFE--TEKFSCLVMEFCPGGDLHTLRQKQP 311
Q +EI L+ LDHP + L + E +V E G + + +P
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP 133
Query: 312 GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371
E RFY +++ +EYLH II+RD+KP N+LV EDGHI ++DF +S
Sbjct: 134 ---LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVS------ 184
Query: 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNE 431
++ L N + TP F
Sbjct: 185 -----NEFKGSDALLSN-----------------TVGTP-AFMA---------------- 205
Query: 432 IGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGK 491
PE ++E + + D W G+ LY +FG+
Sbjct: 206 --------PESLSE----------TRKIFSGKAL----------DVWAMGVTLYCFVFGQ 237
Query: 492 TPFKGSGNRATLFN-VVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQ 550
PF L + + Q L FP+ P ++ +DLI +L K P+ R+ EIK
Sbjct: 238 CPFMDE-RIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVP----EIKL 292
Query: 551 HPFF 554
HP+
Sbjct: 293 HPWV 296
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 7e-42
Identities = 45/160 (28%), Positives = 63/160 (39%), Gaps = 4/160 (2%)
Query: 207 RARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTE 266
+R F+ L RLG G G V+ +A+K G K R E
Sbjct: 48 PSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSP-FRGPKDRARKLAE 106
Query: 267 REILQSL-DHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVA 325
+ + HP L +E L E C G L + G PE V Y+
Sbjct: 107 VGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAW-GASLPEAQVWGYLR 164
Query: 326 EVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+ LLAL +LH G+++ D+KP N+ + G L DF L
Sbjct: 165 DTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLL 204
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 6e-22
Identities = 22/102 (21%), Positives = 40/102 (39%), Gaps = 8/102 (7%)
Query: 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLR 512
G Y+APE+++G +G+A D ++ G+ + E+ G L P
Sbjct: 215 VQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGY-LPPE 272
Query: 513 FPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
F +S R ++ +L +P+ R A + P
Sbjct: 273 FTAG--LSSELRSVLVMMLEPDPKLRA----TAEALLALPVL 308
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-41
Identities = 83/363 (22%), Positives = 135/363 (37%), Gaps = 88/363 (24%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD 274
+ ++RLLK +G G+ V L+ T A+K++DK L L + E I++ L+
Sbjct: 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILN 72
Query: 275 HPFLPTLYTHFETEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQAVRFYVAEVLLALEY 333
HP + L+ ETEK L+ME+ GG++ L E+ R +++ A++Y
Sbjct: 73 HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQY 129
Query: 334 LHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCV 393
H I++RDLK EN+L+ D +I ++DF S L
Sbjct: 130 CHQKRIVHRDLKAENLLLDADMNIKIADFGFS-----------NEFTVGGKLDA------ 172
Query: 394 QPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMS 453
C P +P LF K
Sbjct: 173 ------------FCGAPPYAAPELFQGK-------------------------------- 188
Query: 454 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRF 513
+Y PE VD W+ G+ LY L+ G PF G N L V + ++
Sbjct: 189 -----KYDGPE----------VDVWSLGVILYTLVSGSLPFDGQ-NLKELRERVLRG-KY 231
Query: 514 PESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF-EGVNWALIRCATPPEIPK 572
+S +L++ LV P R + +I + + G ++ PE+
Sbjct: 232 RIPFYMSTDCENLLKRFLVLNPIKRGTLE----QIMKDRWINAGHEEDELKPFVEPELDI 287
Query: 573 PVE 575
+
Sbjct: 288 SDQ 290
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-41
Identities = 69/396 (17%), Positives = 115/396 (29%), Gaps = 94/396 (23%)
Query: 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQS 272
LG R+ + L G VY ++ G+ +A+K + + +++ E ++
Sbjct: 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQ---EVCFMKK 81
Query: 273 L-DHPFLPTLYTHFETEKFS--------CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFY 323
L HP + + K L+ E C G + L++ + V
Sbjct: 82 LSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKI 141
Query: 324 VAEVLLALEYLHMLG--IIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLD 381
+ A++++H II+RDLK EN+L+ G I L DF + + P ++
Sbjct: 142 FYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQ-- 199
Query: 382 AEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPE 441
+ A +E + TP +P + S P E
Sbjct: 200 ------------RRALVEEEITR--NTTPMYRTPEIIDLYSN---FPIGE---------- 232
Query: 442 LIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRA 501
D W G LY L F + PF+
Sbjct: 233 --------------------------------KQDIWALGCILYLLCFRQHPFEDGAKLR 260
Query: 502 TLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWAL 561
+V P LIR +L P+ RL E+
Sbjct: 261 ----IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERL----SIAEVVHQLQ-------- 304
Query: 562 IRCATPPEIPKPVEIERIPAPTSSTSEKTAPTMVPP 597
A + I + T P
Sbjct: 305 -EIAAARNVNPKSPITELLEQNGGYGSATLSR--GP 337
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-40
Identities = 82/369 (22%), Positives = 132/369 (35%), Gaps = 88/369 (23%)
Query: 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREI--LQSLD 274
+ + LG G G V S T C A+K++ K L R A ++EI L+ L
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLR-RIPNGEANVKKEIQLLRRLR 64
Query: 275 HPFLPTLYT--HFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALE 332
H + L + E ++ +VME+C G + + P K FP Y +++ LE
Sbjct: 65 HKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLE 123
Query: 333 YLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYC 392
YLH GI+++D+KP N+L+ G + +S ++ +
Sbjct: 124 YLHSQGIVHKDIKPGNLLLTTGGTLKISALGVA---EALHPFAADDTCRT---------- 170
Query: 393 VQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452
S +P F P PE+
Sbjct: 171 -------------SQGSP-AFQP------------------------PEIAN-------- 184
Query: 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLF-NVVGQPL 511
G + ++ D W+ G+ LY + G PF+G N LF N+
Sbjct: 185 ---GLDTFSGFKV----------DIWSAGVTLYNITTGLYPFEGD-NIYKLFENIGKGSY 230
Query: 512 RFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF-EGVNWALIRCATPPEI 570
P DL++G+L EP R + + +I+QH +F + A PP
Sbjct: 231 AIPGD--CGPPLSDLLKGMLEYEPAKRFSIR----QIRQHSWFRKKHPPAEAPVPIPPS- 283
Query: 571 PKPVEIERI 579
P + R
Sbjct: 284 PDTKDRWRS 292
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-40
Identities = 33/172 (19%), Positives = 71/172 (41%), Gaps = 23/172 (13%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQT--------- 265
++ +R+++ L G + L E +A+K +K+ L ++ ++
Sbjct: 30 INDYRIIRTLNQGKFNKIILCEKDNKF--YALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87
Query: 266 -----EREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDL------HTLRQKQPGKY 314
E +I+ + + + T ++ E+ + + K +
Sbjct: 88 DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147
Query: 315 FPEQAVRFYVAEVLLALEYLHM-LGIIYRDLKPENVLVREDGHIMLSDFDLS 365
P Q ++ + VL + Y+H I +RD+KP N+L+ ++G + LSDF S
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES 199
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 30/141 (21%), Positives = 55/141 (39%), Gaps = 24/141 (17%)
Query: 456 GTHEYLAPEIIKGEG--HGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLF-NVVGQPLR 512
GT+E++ PE E +G+ VD W+ GI LY + + PF + LF N+ + +
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIE 271
Query: 513 FPESPV-----------------VSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFE 555
+P +S D ++ L K P R+ + + +H +
Sbjct: 272 YPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI----TSEDALKHEWLA 327
Query: 556 GVNWALIRCATPPEIPKPVEI 576
N +R + K ++
Sbjct: 328 DTNIEDLREFSKELYKKRKKL 348
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-40
Identities = 46/169 (27%), Positives = 81/169 (47%), Gaps = 2/169 (1%)
Query: 199 RWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRK 258
+++ +A+R G L++FR+ K++G G VY + A+K + L K
Sbjct: 15 QFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAK 74
Query: 259 KLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTL--RQKQPGKYFP 316
E ++L+ L+HP + Y F + +V+E GDL + K+ + P
Sbjct: 75 ARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIP 134
Query: 317 EQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
E+ V Y ++ ALE++H +++RD+KP NV + G + L D L
Sbjct: 135 ERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG 183
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 7e-15
Identities = 28/104 (26%), Positives = 41/104 (39%), Gaps = 8/104 (7%)
Query: 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKG-SGNRATLFN--VVGQ 509
S VGT Y++PE I G+ D W+ G LYE+ ++PF G N +L
Sbjct: 195 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD 254
Query: 510 PLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPF 553
P S S R L+ + +P+ R T +
Sbjct: 255 YPPLP-SDHYSEELRQLVNMCINPDPEKR----PDVTYVYDVAK 293
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-40
Identities = 42/164 (25%), Positives = 71/164 (43%), Gaps = 18/164 (10%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD 274
S F + LG G G V + + Y+A+K + +KL +E +L SL+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLN 60
Query: 275 HPFLPTLYTHF-------------ETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVR 321
H ++ Y + + + + ME+C G L+ L +
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYW 119
Query: 322 FYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
++L AL Y+H GII+RDLKP N+ + E ++ + DF L+
Sbjct: 120 RLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLA 163
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 4e-22
Identities = 24/106 (22%), Positives = 44/106 (41%), Gaps = 11/106 (10%)
Query: 453 SFVGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVV-GQP 510
S +GT Y+A E++ G GH +D ++ GI +E+++ G R + +
Sbjct: 189 SAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGM-ERVNILKKLRSVS 245
Query: 511 LRFPE--SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
+ FP + +IR L+ +P R GA + +
Sbjct: 246 IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRP----GARTLLNSGWL 287
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 7e-40
Identities = 40/166 (24%), Positives = 85/166 (51%), Gaps = 3/166 (1%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD 274
+ + L+++G G G L + + + +K ++ + ++ K+ ++ E +L ++
Sbjct: 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS-SKEREESRREVAVLANMK 81
Query: 275 HPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYL 334
HP + FE +VM++C GGDL Q G F E + + ++ LAL+++
Sbjct: 82 HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 335 HMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSL 380
H I++RD+K +N+ + +DG + L DF ++ ++ T+ A +
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGTVQLGDFGIA--RVLNSTVELARAC 185
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 4e-20
Identities = 30/151 (19%), Positives = 56/151 (37%), Gaps = 10/151 (6%)
Query: 443 IAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRAT 502
+ T + + +GT YL+PEI + + + + D W G LYEL K F+ +
Sbjct: 174 VLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL 233
Query: 503 LFNVV-GQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWAL 561
+ ++ G S+ R L+ L + P+ R + I + F +
Sbjct: 234 VLKIISGSFPPVSLH--YSYDLRSLVSQLFKRNPRDRPS----VNSILEKGFIAK---RI 284
Query: 562 IRCATPPEIPKPVEIERIPAPTSSTSEKTAP 592
+ +P I + ++ S P
Sbjct: 285 EKFLSPQLIAEEFCLKTFSKFGSQPIPAKRP 315
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-39
Identities = 84/347 (24%), Positives = 133/347 (38%), Gaps = 86/347 (24%)
Query: 209 RDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTERE 268
DG + + H+ L LG G G V + E T A+K++++ + + + + E +
Sbjct: 4 HDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQ 63
Query: 269 ILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVL 328
L+ HP + LY T +VME+ GG+L K G+ E R ++L
Sbjct: 64 NLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKH-GR-VEEMEARRLFQQIL 121
Query: 329 LALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKN 388
A++Y H +++RDLKPENVL+ + ++DF LS D E LR
Sbjct: 122 SAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS-----------NMMSDGEFLRT- 169
Query: 389 PVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTE 448
SC +P +P + S +
Sbjct: 170 -----------------SCGSPNYAAPEVISGR--------------------------- 185
Query: 449 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFN-VV 507
Y PE VD W+ G+ LY LL G PF + TLF +
Sbjct: 186 ----------LYAGPE----------VDIWSCGVILYALLCGTLPFDDE-HVPTLFKKIR 224
Query: 508 GQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
G PE ++ + L+ +L +P R K +I++H +F
Sbjct: 225 GGVFYIPEY--LNRSVATLLMHMLQVDPLKRATIK----DIREHEWF 265
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 8e-39
Identities = 44/153 (28%), Positives = 81/153 (52%), Gaps = 5/153 (3%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREI--LQS 272
+ F++ LG G VY +E T A+K++DK ++ K + + + E+
Sbjct: 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAM--YKAGMVQRVQNEVKIHCQ 67
Query: 273 LDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALE 332
L HP + LY +FE + LV+E C G+++ + + K F E R ++ +++ +
Sbjct: 68 LKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGML 126
Query: 333 YLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
YLH GI++RDL N+L+ + +I ++DF L+
Sbjct: 127 YLHSHGILHRDLTLSNLLLTRNMNIKIADFGLA 159
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 9e-25
Identities = 35/99 (35%), Positives = 45/99 (45%), Gaps = 6/99 (6%)
Query: 456 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPE 515
GT Y++PEI HG D W+ G Y LL G+ PF + TL VV P
Sbjct: 174 GTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPS 233
Query: 516 SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
+S A+DLI LL + P RL+ + HPF
Sbjct: 234 F--LSIEAKDLIHQLLRRNPADRLSLS----SVLDHPFM 266
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 7e-37
Identities = 81/340 (23%), Positives = 134/340 (39%), Gaps = 89/340 (26%)
Query: 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHP 276
+ + + LG G G V L+ T+ A+K + + L +R + E L+ L HP
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 277 FLPTLYTHFETEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQAVRFYVAEVLLALEYLH 335
+ LY T +V+E+ GG+L + +K+ E R + +++ A+EY H
Sbjct: 70 HIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKR---MTEDEGRRFFQQIICAIEYCH 125
Query: 336 MLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQP 395
I++RDLKPEN+L+ ++ ++ ++DF LS D L+
Sbjct: 126 RHKIVHRDLKPENLLLDDNLNVKIADFGLS-----------NIMTDGNFLKT-------- 166
Query: 396 ACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455
SC +P +P + + K
Sbjct: 167 ----------SCGSPNYAAPEVINGK---------------------------------- 182
Query: 456 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFN-VVGQPLRFP 514
Y PE VD W+ GI LY +L G+ PF LF V P
Sbjct: 183 ---LYAGPE----------VDVWSCGIVLYVMLVGRLPFDDE-FIPNLFKKVNSCVYVMP 228
Query: 515 ESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
+ +S A+ LIR ++V +P R+ + EI++ P+F
Sbjct: 229 DF--LSPGAQSLIRRMIVADPMQRITIQ----EIRRDPWF 262
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-36
Identities = 42/151 (27%), Positives = 72/151 (47%), Gaps = 2/151 (1%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD 274
+ + LG G + + TK FA K++ K+ L + + E I +SL
Sbjct: 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 73
Query: 275 HPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYL 334
H + + FE F +V+E C L L +++ K E R+Y+ +++L +YL
Sbjct: 74 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYL 131
Query: 335 HMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
H +I+RDLK N+ + ED + + DF L+
Sbjct: 132 HRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 162
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 6e-22
Identities = 31/99 (31%), Positives = 47/99 (47%), Gaps = 6/99 (6%)
Query: 456 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPE 515
GT Y+APE++ +GH VD W+ G +Y LL GK PF+ S + T + P+
Sbjct: 177 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK 236
Query: 516 SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
++ A LI+ +L +P R E+ FF
Sbjct: 237 H--INPVAASLIQKMLQTDPTARPTIN----ELLNDEFF 269
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-36
Identities = 33/167 (19%), Positives = 65/167 (38%), Gaps = 23/167 (13%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD 274
F+ ++ +G G G V+ ++ + +K + +K R E + L LD
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN----NEKAER---EVKALAKLD 62
Query: 275 HPFLPTLYTHFETEKFS----------------CLVMEFCPGGDLHTLRQKQPGKYFPEQ 318
H + ++ + + MEFC G L +K+ G+ +
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 319 AVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
++ ++Y+H +I RDLKP N+ + + + + DF L
Sbjct: 123 LALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLV 169
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 26/104 (25%), Positives = 42/104 (40%), Gaps = 12/104 (11%)
Query: 452 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQP 510
GT Y++PE I + +G VD + G+ L ELL T F + F +
Sbjct: 179 TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF----ETSKFFTDLRDG 234
Query: 511 LRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
S + + L++ LL K+P+ R +EI +
Sbjct: 235 ---IISDIFDKKEKTLLQKLLSKKPEDRPN----TSEILRTLTV 271
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-36
Identities = 42/211 (19%), Positives = 69/211 (32%), Gaps = 26/211 (12%)
Query: 178 DESTCSSFSSSINKPHKANDLRWEAIQAV----RARDGVLGLSHFRLLKRLGCGDIGSVY 233
D+ S ++KP + +E + + LG + LG G VY
Sbjct: 23 DDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVY 82
Query: 234 L-----SELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE 288
+ K F +KV A+ + E L+ Y+ +
Sbjct: 83 EATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139
Query: 289 KFSCLVMEFCPGGDLHTL---RQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLK 345
S LV E G L + P K P+ V + +L +E +H II+ D+K
Sbjct: 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIK 199
Query: 346 PENVLVR-----------EDGHIMLSDFDLS 365
P+N ++ + L D S
Sbjct: 200 PDNFILGNGFLEQDDEDDLSAGLALIDLGQS 230
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 13/99 (13%), Positives = 32/99 (32%), Gaps = 6/99 (6%)
Query: 441 ELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNR 500
++ P + T + E++ + +D++ +Y +LFG +
Sbjct: 232 DMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291
Query: 501 ATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRL 539
+ + R P + + + +L H L
Sbjct: 292 ECKPEGLFR--RLPHLDMWN----EFFHVMLNIPDCHHL 324
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-36
Identities = 40/160 (25%), Positives = 69/160 (43%), Gaps = 10/160 (6%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD 274
+ +L +G G G K +D S+ + +E +L+ L
Sbjct: 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELK 63
Query: 275 HPFLPTLYTHF--ETEKFSCLVMEFCPGGDLHTL--RQKQPGKYFPEQAVRFYVAEVLLA 330
HP + Y T +VME+C GGDL ++ + + +Y E+ V + ++ LA
Sbjct: 64 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 331 LEYLH-----MLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
L+ H +++RDLKP NV + ++ L DF L+
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 29/114 (25%), Positives = 48/114 (42%), Gaps = 9/114 (7%)
Query: 443 IAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRAT 502
I + + +FVGT Y++PE + + D W+ G LYEL PF ++
Sbjct: 165 ILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF-SQKE 223
Query: 503 LFNVV--GQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
L + G+ R P S ++I +L + HR + EI ++P
Sbjct: 224 LAGKIREGKFRRIPYR--YSDELNEIITRMLNLKDYHRPS----VEEILENPLI 271
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 80/420 (19%), Positives = 135/420 (32%), Gaps = 111/420 (26%)
Query: 173 SSDVSDESTCSSFSSSINKPHKANDLRWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSV 232
S S + NDL + + ++ + +++ LG G GSV
Sbjct: 2 GSSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLES--QYQVGPLLGSGGFGSV 59
Query: 233 YLSELSGTKCYFAMKVMDKASLAGRKKLLR-AQTEREI--LQSLDHPFLP---TLYTHFE 286
Y A+K ++K ++ +L + E+ L+ + F L FE
Sbjct: 60 YSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF-SGVIRLLDWFE 118
Query: 287 TEKFSCLVMEFC-PGGDL-HTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDL 344
L++E P DL + ++ E+ R + +VL A+ + H G+++RD+
Sbjct: 119 RPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCHNCGVLHRDI 175
Query: 345 KPENVLV-REDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCI 403
K EN+L+ G + L DF L+K +
Sbjct: 176 KDENILIDLNRGELKLIDFGSG-------ALLKDTVYTD--------------------- 207
Query: 404 QPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAP 463
T +SP PE I H Y
Sbjct: 208 --FDGTR-VYSP------------------------PEWIRY------------HRYHGR 228
Query: 464 EIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAA 523
W+ GI LY+++ G PF+ ++ + F VS
Sbjct: 229 S----------AAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR--QRVSSEC 270
Query: 524 RDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIRCATPPEIPKPVEIERIPAPT 583
+ LIR L P R ++ EI+ HP+ + V P E + P P+
Sbjct: 271 QHLIRWCLALRPSDRPTFE----EIQNHPWMQDVL-------LPQETAEIHLHSLSPGPS 319
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 8e-36
Identities = 42/151 (27%), Positives = 72/151 (47%), Gaps = 2/151 (1%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD 274
+ + LG G + + TK FA K++ K+ L + + E I +SL
Sbjct: 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 99
Query: 275 HPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYL 334
H + + FE F +V+E C L L +++ K E R+Y+ +++L +YL
Sbjct: 100 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYL 157
Query: 335 HMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
H +I+RDLK N+ + ED + + DF L+
Sbjct: 158 HRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 188
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 31/99 (31%), Positives = 47/99 (47%), Gaps = 6/99 (6%)
Query: 456 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPE 515
GT Y+APE++ +GH VD W+ G +Y LL GK PF+ S + T + P+
Sbjct: 203 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK 262
Query: 516 SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
++ A LI+ +L +P R E+ FF
Sbjct: 263 H--INPVAASLIQKMLQTDPTARPTIN----ELLNDEFF 295
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-35
Identities = 77/339 (22%), Positives = 129/339 (38%), Gaps = 86/339 (25%)
Query: 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHP 276
H+ L LG G G V + + T A+K++++ + + + + E + L+ HP
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 277 FLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHM 336
+ LY T +VME+ GG+L K G+ E+ R ++L ++Y H
Sbjct: 77 HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKN-GR-LDEKESRRLFQQILSGVDYCHR 134
Query: 337 LGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPA 396
+++RDLKPENVL+ + ++DF LS D E LR
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFGLS-----------NMMSDGEFLRT--------- 174
Query: 397 CIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVG 456
SC +P +P + S +
Sbjct: 175 ---------SCGSPNYAAPEVISGR----------------------------------- 190
Query: 457 THEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFN-VVGQPLRFPE 515
Y PE+ D W+ G+ LY LL G PF + TLF + P+
Sbjct: 191 --LYAGPEV----------DIWSSGVILYALLCGTLPFDDD-HVPTLFKKICDGIFYTPQ 237
Query: 516 SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
++ + L++ +L +P R K +I++H +F
Sbjct: 238 Y--LNPSVISLLKHMLQVDPMKRATIK----DIREHEWF 270
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 8e-35
Identities = 42/155 (27%), Positives = 71/155 (45%), Gaps = 9/155 (5%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF 277
+ L LG G +V+ T FA+KV + S + + E E+L+ L+H
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKN 68
Query: 278 LPTLYTHFE--TEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQAVRFYVAEVLLALEYL 334
+ L+ E T + L+MEFCP G L+T L + PE + +V+ + +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 335 HMLGIIYRDLKPENVLVR----EDGHIMLSDFDLS 365
GI++R++KP N++ L+DF +
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 23/138 (16%), Positives = 43/138 (31%), Gaps = 39/138 (28%)
Query: 452 MSFVGTHEYLAPEIIKG--------EGHGSAVDWWTFGIFLYELLFGKTPF--------- 494
+S GT EYL P++ + + +G+ VD W+ G+ Y G PF
Sbjct: 173 VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232
Query: 495 ----------KGSGNRATLFNVVGQPLRFPE--------SPVVSFAARDLIRGLLVKEPQ 536
K SG + + P+ + S + ++ +L + +
Sbjct: 233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE 292
Query: 537 HRLAYKRGATEIKQHPFF 554
G +
Sbjct: 293 KCW----GFDQFFAETSD 306
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 46/166 (27%), Positives = 71/166 (42%), Gaps = 7/166 (4%)
Query: 207 RARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTE 266
A D VL + L + +G G V T FA+K++D A L +
Sbjct: 15 MADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLK 74
Query: 267 RE--ILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDL--HTLRQKQPGKYFPEQAVRF 322
RE I L HP + L + ++ +V EF G DL +++ G + E
Sbjct: 75 REASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASH 134
Query: 323 YVAEVLLALEYLHMLGIIYRDLKPENVLVR---EDGHIMLSDFDLS 365
Y+ ++L AL Y H II+RD+KP VL+ + L F ++
Sbjct: 135 YMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 7e-18
Identities = 40/130 (30%), Positives = 63/130 (48%), Gaps = 17/130 (13%)
Query: 454 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVV--GQPL 511
VGT ++APE++K E +G VD W G+ L+ LL G PF G+ R LF + G+
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER--LFEGIIKGK-Y 249
Query: 512 RFPESP--VVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIRCATPPE 569
+ +S +A+DL+R +L+ +P R+ E HP W R +
Sbjct: 250 KMNPRQWSHISESAKDLVRRMLMLDPAERIT----VYEALNHP------WLKERDRYAYK 299
Query: 570 IPKPVEIERI 579
I P +E++
Sbjct: 300 IHLPETVEQL 309
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-34
Identities = 49/154 (31%), Positives = 77/154 (50%), Gaps = 7/154 (4%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH 275
++ + LG G G V L + T A+KV+ K + + E ++L+ LDH
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 276 PFLPTLYTHFETEKFSCLVMEFCPGGDL-HTLRQKQPGKYFPEQAVRFYVAEVLLALEYL 334
P + LY FE + + LV E GG+L + + K F E + +VL + Y+
Sbjct: 86 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYM 142
Query: 335 HMLGIIYRDLKPENVLVR---EDGHIMLSDFDLS 365
H I++RDLKPEN+L+ +D +I + DF LS
Sbjct: 143 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLS 176
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 5e-18
Identities = 33/108 (30%), Positives = 49/108 (45%), Gaps = 7/108 (6%)
Query: 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLR 512
+GT Y+APE++ G + D W+ G+ LY LL G PF G+ L V
Sbjct: 187 DKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT 245
Query: 513 FPESP--VVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVN 558
F VS +A+DLIR +L P R++ A + H + +
Sbjct: 246 FELPQWKKVSESAKDLIRKMLTYVPSMRIS----ARDALDHEWIQTYT 289
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-34
Identities = 42/155 (27%), Positives = 71/155 (45%), Gaps = 9/155 (5%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF 277
+ L LG G +V+ T FA+KV + S + + E E+L+ L+H
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKN 68
Query: 278 LPTLYTHFE--TEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQAVRFYVAEVLLALEYL 334
+ L+ E T + L+MEFCP G L+T L + PE + +V+ + +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 335 HMLGIIYRDLKPENVLVR----EDGHIMLSDFDLS 365
GI++R++KP N++ L+DF +
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 22/127 (17%), Positives = 43/127 (33%), Gaps = 35/127 (27%)
Query: 452 MSFVGTHEYLAPEIIKG--------EGHGSAVDWWTFGIFLYELLFGKTPF--------- 494
+S GT EYL P++ + + +G+ VD W+ G+ Y G PF
Sbjct: 173 VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232
Query: 495 ----------KGSGNRATLFNVVGQPLRFPE--------SPVVSFAARDLIRGLLVKEPQ 536
K SG + + P+ + S + ++ +L + +
Sbjct: 233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE 292
Query: 537 HRLAYKR 543
+ +
Sbjct: 293 KCWGFDQ 299
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 9e-34
Identities = 46/155 (29%), Positives = 76/155 (49%), Gaps = 7/155 (4%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH 275
F ++LG G G V+L E + +K ++K + + E E+L+SLDH
Sbjct: 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIE--AEIEVLKSLDH 79
Query: 276 PFLPTLYTHFETEKFSCLVMEFCPGGDL--HTLRQKQPGKYFPEQAVRFYVAEVLLALEY 333
P + ++ FE +VME C GG+L + + GK E V + +++ AL Y
Sbjct: 80 PNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAY 139
Query: 334 LHMLGIIYRDLKPENVLVR---EDGHIMLSDFDLS 365
H ++++DLKPEN+L + I + DF L+
Sbjct: 140 FHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 27/103 (26%), Positives = 48/103 (46%), Gaps = 6/103 (5%)
Query: 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLR 512
+ GT Y+APE+ K + D W+ G+ +Y LL G PF G+ +
Sbjct: 185 NAAGTALYMAPEVFKRD-VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPN 243
Query: 513 FPESP-VVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
+ ++ A DL++ +L K+P+ R + A ++ H +F
Sbjct: 244 YAVECRPLTPQAVDLLKQMLTKDPERRPS----AAQVLHHEWF 282
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-33
Identities = 52/154 (33%), Positives = 75/154 (48%), Gaps = 10/154 (6%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH 275
++ L +G G G V ++ GT+ A K + K + + + E EI++SLDH
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQ---EIEIMKSLDH 65
Query: 276 PFLPTLYTHFETEKFSCLVMEFCPGGDL-HTLRQKQPGKYFPEQAVRFYVAEVLLALEYL 334
P + LY FE LVME C GG+L + K + F E + +VL A+ Y
Sbjct: 66 PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYC 122
Query: 335 HMLGIIYRDLKPENVLVR---EDGHIMLSDFDLS 365
H L + +RDLKPEN L D + L DF L+
Sbjct: 123 HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLA 156
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 3e-18
Identities = 33/106 (31%), Positives = 53/106 (50%), Gaps = 7/106 (6%)
Query: 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLR 512
+ VGT Y++P++++G +G D W+ G+ +Y LL G PF + + +
Sbjct: 167 TKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFT 225
Query: 513 FPESP--VVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556
FPE VS A LIR LL K P+ R+ + + +H +FE
Sbjct: 226 FPEKDWLNVSPQAESLIRRLLTKSPKQRIT----SLQALEHEWFEK 267
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 79/377 (20%), Positives = 127/377 (33%), Gaps = 105/377 (27%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQT-EREIL--- 270
+ +RL LG G G+V+ + A+KV+ + + G L + T E+
Sbjct: 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLW 89
Query: 271 ---QSLDHPFLPTLYTHFETEKFSCLVMEF-CPGGDL-HTLRQKQPGKYFPEQAVRFYVA 325
HP + L FET++ LV+E P DL + +K P E R +
Sbjct: 90 KVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP---LGEGPSRCFFG 146
Query: 326 EVLLALEYLHMLGIIYRDLKPENVLV-REDGHIMLSDFDLSLRCAVSPTLIKASSLDAEP 384
+V+ A+++ H G+++RD+K EN+L+ G L DF L+
Sbjct: 147 QVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG-------ALLHDEPYTD-- 197
Query: 385 LRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIA 444
T +SP PE I+
Sbjct: 198 ---------------------FDGTR-VYSP------------------------PEWIS 211
Query: 445 EPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLF 504
H+Y A W+ GI LY+++ G PF+
Sbjct: 212 ------------RHQYHALP----------ATVWSLGILLYDMVCGDIPFERDQ------ 243
Query: 505 NVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF-EGVNWALIR 563
++ L FP VS LIR L +P R + + EI P+ +
Sbjct: 244 EILEAELHFP--AHVSPDCCALIRRCLAPKPSSRPSLE----EILLDPWMQTPAEDVPLN 297
Query: 564 CATPPEIPKPVEIERIP 580
+ P P+ +P
Sbjct: 298 PSKGG--PAPLAWSLLP 312
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 33/164 (20%), Positives = 69/164 (42%), Gaps = 15/164 (9%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD 274
L+ F ++ LG G G V+ ++ C +A+K + + ++ + E + L L+
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELARE--KVMREVKALAKLE 61
Query: 275 HPFLPTLYTHFETE------------KFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQAVR 321
HP + + + + + + M+ C +L + + +
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 322 FYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
++ A+E+LH G+++RDLKP N+ D + + DF L
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLV 165
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 6e-18
Identities = 33/118 (27%), Positives = 50/118 (42%), Gaps = 9/118 (7%)
Query: 442 LIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRA 501
L P AR VGT Y++PE I G + VD ++ G+ L+ELL PF R
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YPFSTQMERV 234
Query: 502 TLFNVVGQPLRFPESPV-VSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVN 558
V + L+FP +++ +L P R A I ++ FE ++
Sbjct: 235 RTLTDV-RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPE----AINIIENAVFEDLD 287
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 42/166 (25%), Positives = 75/166 (45%), Gaps = 7/166 (4%)
Query: 204 QAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRA 263
Q V + G + ++ +L+ LG G G V+ T F K ++ + +
Sbjct: 40 QPVEVKQGSVY-DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKN- 97
Query: 264 QTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFY 323
E I+ L HP L L+ FE + L++EF GG+L R E V Y
Sbjct: 98 --EISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFD-RIAAEDYKMSEAEVINY 154
Query: 324 VAEVLLALEYLHMLGIIYRDLKPENVLV--REDGHIMLSDFDLSLR 367
+ + L+++H I++ D+KPEN++ ++ + + DF L+ +
Sbjct: 155 MRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATK 200
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 6e-19
Identities = 39/104 (37%), Positives = 51/104 (49%), Gaps = 6/104 (5%)
Query: 455 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFP 514
T E+ APEI+ E G D W G+ Y LL G +PF G + TL NV F
Sbjct: 211 TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD 270
Query: 515 ES--PVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556
E VS A+D I+ LL KEP+ RL + +HP+ +G
Sbjct: 271 EDAFSSVSPEAKDFIKNLLQKEPRKRLT----VHDALEHPWLKG 310
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 6e-33
Identities = 48/154 (31%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH 275
F ++ LG G V+L + T FA+K + K+ L E +L+ + H
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLEN---EIAVLKKIKH 65
Query: 276 PFLPTLYTHFETEKFSCLVMEFCPGGDL-HTLRQKQPGKYFPEQAVRFYVAEVLLALEYL 334
+ TL +E+ LVM+ GG+L + ++ + E+ + +VL A++YL
Sbjct: 66 ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYL 122
Query: 335 HMLGIIYRDLKPENVLVR---EDGHIMLSDFDLS 365
H GI++RDLKPEN+L E+ IM++DF LS
Sbjct: 123 HENGIVHRDLKPENLLYLTPEENSKIMITDFGLS 156
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 1e-18
Identities = 33/109 (30%), Positives = 50/109 (45%), Gaps = 10/109 (9%)
Query: 452 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVV--GQ 509
+ GT Y+APE++ + + AVD W+ G+ Y LL G PF + LF + G
Sbjct: 165 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE-TESKLFEKIKEGY 223
Query: 510 PLRFPESP--VVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556
F +S +A+D I LL K+P R + HP+ +G
Sbjct: 224 -YEFESPFWDDISESAKDFICHLLEKDPNERYT----CEKALSHPWIDG 267
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-32
Identities = 48/154 (31%), Positives = 76/154 (49%), Gaps = 8/154 (5%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH 275
+ ++ LG G G V + T+ +A+KV++KAS K E E+L+ LDH
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDH 80
Query: 276 PFLPTLYTHFETEKFSCLVMEFCPGGDL-HTLRQKQPGKYFPEQAVRFYVAEVLLALEYL 334
P + L+ E +V E GG+L + ++ K F E + +V + Y+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYM 137
Query: 335 HMLGIIYRDLKPENVLVR---EDGHIMLSDFDLS 365
H I++RDLKPEN+L+ +D I + DF LS
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 5e-18
Identities = 34/108 (31%), Positives = 51/108 (47%), Gaps = 7/108 (6%)
Query: 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLR 512
+GT Y+APE+++G + D W+ G+ LY LL G PF G L V
Sbjct: 182 DRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYA 240
Query: 513 FPESP--VVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVN 558
F +S A+DLIR +L P R+ AT+ +HP+ + +
Sbjct: 241 FDLPQWRTISDDAKDLIRKMLTFHPSLRIT----ATQCLEHPWIQKYS 284
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-32
Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 8/154 (5%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH 275
++ +K+LG G G V L T A+K++ K S++ + E +L+ LDH
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDH 95
Query: 276 PFLPTLYTHFETEKFSCLVMEFCPGGDL-HTLRQKQPGKYFPEQAVRFYVAEVLLALEYL 334
P + LY FE ++ LVME GG+L + + F E + +VL + YL
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYL 152
Query: 335 HMLGIIYRDLKPENVLVR---EDGHIMLSDFDLS 365
H I++RDLKPEN+L+ +D I + DF LS
Sbjct: 153 HKHNIVHRDLKPENLLLESKEKDALIKIVDFGLS 186
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-18
Identities = 32/122 (26%), Positives = 56/122 (45%), Gaps = 7/122 (5%)
Query: 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLR 512
+GT Y+APE+++ + + D W+ G+ L+ LL G PF G ++ L V
Sbjct: 197 ERLGTAYYIAPEVLRKK-YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYT 255
Query: 513 FPESP--VVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIRCATPPEI 570
F VS A+DLI+ +L + Q R++ A + +HP+ + + P +
Sbjct: 256 FDSPEWKNVSEGAKDLIKQMLQFDSQRRIS----AQQALEHPWIKEMCSKKESGIELPSL 311
Query: 571 PK 572
Sbjct: 312 AN 313
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 42/152 (27%), Positives = 73/152 (48%), Gaps = 10/152 (6%)
Query: 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHP 276
+ +LK++G G V+ L+ K +A+K ++ + L + E L L
Sbjct: 29 IYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQH 86
Query: 277 FLP--TLYTHFETEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQAVRFYVAEVLLALEY 333
LY + T+++ +VME C DL++ L++K K + Y +L A+
Sbjct: 87 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHT 142
Query: 334 LHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+H GI++ DLKP N L+ DG + L DF ++
Sbjct: 143 IHQHGIVHSDLKPANFLI-VDGMLKLIDFGIA 173
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 7e-21
Identities = 28/114 (24%), Positives = 49/114 (42%), Gaps = 16/114 (14%)
Query: 453 SFVGTHEYLAPEIIKGEG-----------HGSAVDWWTFGIFLYELLFGKTPFKGSGNR- 500
S VGT Y+ PE IK D W+ G LY + +GKTPF+ N+
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 246
Query: 501 ATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
+ L ++ + +D+++ L ++P+ R++ E+ HP+
Sbjct: 247 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRIS----IPELLAHPYV 296
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 48/154 (31%), Positives = 76/154 (49%), Gaps = 8/154 (5%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH 275
+ ++ LG G G V + T+ +A+KV++KAS K E E+L+ LDH
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDH 80
Query: 276 PFLPTLYTHFETEKFSCLVMEFCPGGDL-HTLRQKQPGKYFPEQAVRFYVAEVLLALEYL 334
P + L+ E +V E GG+L + ++ K F E + +V + Y+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYM 137
Query: 335 HMLGIIYRDLKPENVLVR---EDGHIMLSDFDLS 365
H I++RDLKPEN+L+ +D I + DF LS
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 7e-17
Identities = 34/104 (32%), Positives = 49/104 (47%), Gaps = 7/104 (6%)
Query: 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLR 512
+GT Y+APE+++G + D W+ G+ LY LL G PF G L V
Sbjct: 182 DRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYA 240
Query: 513 FPESP--VVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
F +S A+DLIR +L P R+ AT+ +HP+
Sbjct: 241 FDLPQWRTISDDAKDLIRKMLTFHPSLRIT----ATQCLEHPWI 280
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-32
Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 11/158 (6%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAG-RKKLLRAQTERE--ILQS 272
H+ + + LG G V GT +A K + K L+ R+ + R + ERE IL+
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 273 LDHPFLPTLYTHFETEKFSCLVMEFCPGGDL-HTLRQKQPGKYFPEQAVRFYVAEVLLAL 331
+ HP + TL+ FE + L++E GG+L L +K + E ++ ++L +
Sbjct: 65 IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGV 121
Query: 332 EYLHMLGIIYRDLKPENVLV----REDGHIMLSDFDLS 365
YLH I + DLKPEN+++ + I L DF ++
Sbjct: 122 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 4e-19
Identities = 36/105 (34%), Positives = 52/105 (49%), Gaps = 6/105 (5%)
Query: 454 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRF 513
GT E++APEI+ E G D W+ G+ Y LL G +PF G + TL N+ F
Sbjct: 171 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDF 230
Query: 514 PESP--VVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556
E S A+D IR LLVK+P+ R+ + +H + +
Sbjct: 231 DEEYFSNTSELAKDFIRRLLVKDPKRRMT----IAQSLEHSWIKA 271
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 5e-32
Identities = 35/164 (21%), Positives = 67/164 (40%), Gaps = 4/164 (2%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL- 273
+ F L+++G G+ GSV+ C +A+K K LAG A E L
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKK-PLAGSVDEQNALREVYAHAVLG 68
Query: 274 DHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTL--RQKQPGKYFPEQAVRFYVAEVLLAL 331
H + ++ + + + E+C GG L + YF E ++ + +V L
Sbjct: 69 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 332 EYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375
Y+H + +++ D+KP N+ + + + S ++
Sbjct: 129 RYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVM 172
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 4e-12
Identities = 16/104 (15%), Positives = 38/104 (36%), Gaps = 11/104 (10%)
Query: 452 MSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVV-GQ 509
G +LA E+++ H D + + + + + N + G+
Sbjct: 188 QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR---NGDQWHEIRQGR 244
Query: 510 PLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPF 553
R P+ +S +L++ ++ +P+ R A + +H
Sbjct: 245 LPRIPQV--LSQEFTELLKVMIHPDPERRP----SAMALVKHSV 282
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 6e-32
Identities = 47/158 (29%), Positives = 74/158 (46%), Gaps = 11/158 (6%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRK----KLLRAQTERE--I 269
++ + LG G V T +A+K++D + LR T +E I
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 270 LQSLD-HPFLPTLYTHFETEKFSCLVMEFCPGGDL-HTLRQKQPGKYFPEQAVRFYVAEV 327
L+ + HP + L +ET F LV + G+L L +K E+ R + +
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRAL 133
Query: 328 LLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
L + LH L I++RDLKPEN+L+ +D +I L+DF S
Sbjct: 134 LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 171
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 38/118 (32%), Positives = 51/118 (43%), Gaps = 12/118 (10%)
Query: 454 FVGTHEYLAPEIIKG------EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVV 507
GT YLAPEII+ G+G VD W+ G+ +Y LL G PF L ++
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 242
Query: 508 GQPLRFPESP--VVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIR 563
+F S +DL+ LV +PQ R A E HPFF+ +R
Sbjct: 243 SGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYT----AEEALAHPFFQQYVVEEVR 296
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 9e-32
Identities = 36/154 (23%), Positives = 68/154 (44%), Gaps = 11/154 (7%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTERE--ILQSL 273
+ + + LG G+ G V+ + +K + K + K + ++E IL
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV------KGTDQVLVKKEISILNIA 58
Query: 274 DHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEY 333
H + L+ FE+ + ++ EF G D+ R E+ + YV +V AL++
Sbjct: 59 RHRNILHLHESFESMEELVMIFEFISGLDIFE-RINTSAFELNEREIVSYVHQVCEALQF 117
Query: 334 LHMLGIIYRDLKPENVLV--REDGHIMLSDFDLS 365
LH I + D++PEN++ R I + +F +
Sbjct: 118 LHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQA 151
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 33/100 (33%), Positives = 48/100 (48%), Gaps = 6/100 (6%)
Query: 455 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFP 514
EY APE+ + + +A D W+ G +Y LL G PF N+ + N++ F
Sbjct: 164 FTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD 223
Query: 515 ESP--VVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHP 552
E +S A D + LLVKE + R+ A+E QHP
Sbjct: 224 EEAFKEISIEAMDFVDRLLVKERKSRMT----ASEALQHP 259
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 9e-32
Identities = 54/158 (34%), Positives = 81/158 (51%), Gaps = 13/158 (8%)
Query: 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAG-----RKKLLRAQTEREILQ 271
+ + K LG G G V L+ T A+K++ K A L +TE EIL+
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 272 SLDHPFLPTLYTHFETEKFSCLVMEFCPGGDL-HTLRQKQPGKYFPEQAVRFYVAEVLLA 330
L+HP + + F+ E + +V+E GG+L + + E + Y ++LLA
Sbjct: 71 KLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLA 126
Query: 331 LEYLHMLGIIYRDLKPENVLVR---EDGHIMLSDFDLS 365
++YLH GII+RDLKPENVL+ ED I ++DF S
Sbjct: 127 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 6e-17
Identities = 34/110 (30%), Positives = 52/110 (47%), Gaps = 12/110 (10%)
Query: 454 FVGTHEYLAPEIIKG---EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVV--G 508
GT YLAPE++ G+ AVD W+ G+ L+ L G PF + +L + + G
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 235
Query: 509 QPLRFPESP--VVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556
+ F VS A DL++ LLV +P+ R E +HP+ +
Sbjct: 236 K-YNFIPEVWAEVSEKALDLVKKLLVVDPKARFT----TEEALRHPWLQD 280
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-31
Identities = 42/147 (28%), Positives = 71/147 (48%), Gaps = 6/147 (4%)
Query: 224 LGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYT 283
LG G G V+ E + T A K++ + ++++ E ++ LDH L LY
Sbjct: 97 LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKN---EISVMNQLDHANLIQLYD 153
Query: 284 HFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRD 343
FE++ LVME+ GG+L R E ++ ++ + ++H + I++ D
Sbjct: 154 AFESKNDIVLVMEYVDGGELFD-RIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLD 212
Query: 344 LKPENVLV--REDGHIMLSDFDLSLRC 368
LKPEN+L R+ I + DF L+ R
Sbjct: 213 LKPENILCVNRDAKQIKIIDFGLARRY 239
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 2e-18
Identities = 32/100 (32%), Positives = 51/100 (51%), Gaps = 6/100 (6%)
Query: 455 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFP 514
GT E+LAPE++ + D W+ G+ Y LL G +PF G + TL N++
Sbjct: 249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLE 308
Query: 515 ES--PVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHP 552
+ +S A++ I LL+KE R++ A+E +HP
Sbjct: 309 DEEFQDISEEAKEFISKLLIKEKSWRIS----ASEALKHP 344
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-31
Identities = 50/242 (20%), Positives = 93/242 (38%), Gaps = 21/242 (8%)
Query: 129 KNSSVSGKVSDGTSSLAKTSGSAKISDRLDYVESGKSSICRGSTSSDVSDESTCSSFSSS 188
+N K + T+ + K D E GK +G+ SS+ + F
Sbjct: 85 ENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYV----FDIW 140
Query: 189 INKPHKANDLRWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKV 248
+ +++ + + H+ + + LG G G V+ T FA K
Sbjct: 141 KQYYPQPVEIKHDHVL-----------DHYDIHEELGTGAFGVVHRVTERATGNNFAAKF 189
Query: 249 MDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQ 308
+ + ++ + + E + + L HP L L+ FE + ++ EF GG+L +
Sbjct: 190 VMTPHESDKETVRK---EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFE-KV 245
Query: 309 KQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLV--REDGHIMLSDFDLSL 366
E Y+ +V L ++H ++ DLKPEN++ + + L DF L+
Sbjct: 246 ADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA 305
Query: 367 RC 368
Sbjct: 306 HL 307
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 4e-18
Identities = 41/148 (27%), Positives = 60/148 (40%), Gaps = 12/148 (8%)
Query: 455 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFP 514
GT E+ APE+ +G+ G D W+ G+ Y LL G +PF G + TL NV
Sbjct: 317 TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD 376
Query: 515 ES--PVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIRCATPPEIPK 572
+S +S +D IR LL+ +P R+ + +HP W A +
Sbjct: 377 DSAFSGISEDGKDFIRKLLLADPNTRMT----IHQALEHP------WLTPGNAPGRDSQI 426
Query: 573 PVEIERIPAPTSSTSEKTAPTMVPPNQR 600
P + T P +PP R
Sbjct: 427 PSSRYTKIRDSIKTKYDAWPEPLPPLGR 454
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-31
Identities = 54/158 (34%), Positives = 81/158 (51%), Gaps = 13/158 (8%)
Query: 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGR-----KKLLRAQTEREILQ 271
+ + K LG G G V L+ T A++++ K A L +TE EIL+
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 272 SLDHPFLPTLYTHFETEKFSCLVMEFCPGGDL-HTLRQKQPGKYFPEQAVRFYVAEVLLA 330
L+HP + + F+ E + +V+E GG+L + K E + Y ++LLA
Sbjct: 196 KLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLA 251
Query: 331 LEYLHMLGIIYRDLKPENVLVR---EDGHIMLSDFDLS 365
++YLH GII+RDLKPENVL+ ED I ++DF S
Sbjct: 252 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 8e-17
Identities = 34/110 (30%), Positives = 52/110 (47%), Gaps = 12/110 (10%)
Query: 454 FVGTHEYLAPEIIKG---EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVV--G 508
GT YLAPE++ G+ AVD W+ G+ L+ L G PF + +L + + G
Sbjct: 301 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 360
Query: 509 QPLRFPESP--VVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556
+ F VS A DL++ LLV +P+ R E +HP+ +
Sbjct: 361 K-YNFIPEVWAEVSEKALDLVKKLLVVDPKARFT----TEEALRHPWLQD 405
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 12/156 (7%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGR--KKLLRAQTEREILQSL 273
++ + + LG G V T FA K+++ L+ R +KL R E I + L
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER---EARICRKL 62
Query: 274 DHPFLPTLYTHFETEKFSCLVMEFCPGGDL-HTLRQKQPGKYFPEQAVRFYVAEVLLALE 332
HP + L+ + E F LV + GG+L + + +++ E + ++L ++
Sbjct: 63 QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIA 119
Query: 333 YLHMLGIIYRDLKPENVLVR---EDGHIMLSDFDLS 365
Y H GI++R+LKPEN+L+ + + L+DF L+
Sbjct: 120 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA 155
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 6e-19
Identities = 31/126 (24%), Positives = 50/126 (39%), Gaps = 12/126 (9%)
Query: 454 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRF 513
F GT YL+PE++K + + VD W G+ LY LL G PF + +
Sbjct: 167 FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY 226
Query: 514 PESP--VVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIRCATPPEIP 571
P V+ A+ LI +L P+ R+ A + + P+ R I
Sbjct: 227 PSPEWDTVTPEAKSLIDSMLTVNPKKRIT----ADQALKVPWICN------RERVASAIH 276
Query: 572 KPVEIE 577
+ ++
Sbjct: 277 RQDTVD 282
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 41/151 (27%), Positives = 72/151 (47%), Gaps = 8/151 (5%)
Query: 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHP 276
+ +LK++G G V+ L+ K +A+K ++ + L + E L L
Sbjct: 10 IYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQH 67
Query: 277 FLP--TLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYL 334
LY + T+++ +VME C DL++ +K+ K + Y +L A+ +
Sbjct: 68 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTI 124
Query: 335 HMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
H GI++ DLKP N L+ DG + L DF ++
Sbjct: 125 HQHGIVHSDLKPANFLI-VDGMLKLIDFGIA 154
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 28/114 (24%), Positives = 49/114 (42%), Gaps = 16/114 (14%)
Query: 453 SFVGTHEYLAPEIIKGEG-----------HGSAVDWWTFGIFLYELLFGKTPFKGSGNR- 500
S VGT Y+ PE IK D W+ G LY + +GKTPF+ N+
Sbjct: 168 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 227
Query: 501 ATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
+ L ++ + +D+++ L ++P+ R++ E+ HP+
Sbjct: 228 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRIS----IPELLAHPYV 277
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 48/192 (25%), Positives = 77/192 (40%), Gaps = 42/192 (21%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTERE--ILQSL 273
+ L +G G G V ++ + T+ A+K+M+K + + + E +++ L
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 274 DHPFLPTLYTHFETEKFSCLVMEFCPGGDL------------------------------ 303
HP + LY +E E++ CLVME C GG L
Sbjct: 86 HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145
Query: 304 --------HTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLV--RE 353
++ E+ + + ++ AL YLH GI +RD+KPEN L +
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK 205
Query: 354 DGHIMLSDFDLS 365
I L DF LS
Sbjct: 206 SFEIKLVDFGLS 217
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 1e-20
Identities = 35/115 (30%), Positives = 51/115 (44%), Gaps = 9/115 (7%)
Query: 445 EPTEARSMS-FVGTHEYLAPEIIKGEGH--GSAVDWWTFGIFLYELLFGKTPFKGSGNRA 501
E M+ GT ++APE++ G D W+ G+ L+ LL G PF G +
Sbjct: 224 NNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDAD 283
Query: 502 TLFNVVGQPLRFPESP--VVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
T+ V+ + L F V+S ARDL+ LL + R A QHP+
Sbjct: 284 TISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERF----DAMRALQHPWI 334
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 46/158 (29%), Positives = 74/158 (46%), Gaps = 11/158 (6%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAG-RKKLLRAQTERE--ILQS 272
+ + + LG G V T +A K + K R+ + R + ERE IL+
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 273 LDHPFLPTLYTHFETEKFSCLVMEFCPGGDL-HTLRQKQPGKYFPEQAVRFYVAEVLLAL 331
+ HP + TL+ +E L++E GG+L L QK+ E+ ++ ++L +
Sbjct: 72 VLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGV 128
Query: 332 EYLHMLGIIYRDLKPENVLVR----EDGHIMLSDFDLS 365
YLH I + DLKPEN+++ HI L DF L+
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 7e-19
Identities = 39/105 (37%), Positives = 51/105 (48%), Gaps = 6/105 (5%)
Query: 454 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRF 513
GT E++APEI+ E G D W+ G+ Y LL G +PF G + TL N+ F
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDF 237
Query: 514 PESP--VVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556
E S A+D IR LLVKE + RL E +HP+
Sbjct: 238 DEEFFSQTSELAKDFIRKLLVKETRKRLT----IQEALRHPWITP 278
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 44/161 (27%), Positives = 73/161 (45%), Gaps = 11/161 (6%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLL-RAQTERE--ILQS 272
+ + + LG G V T +A K + K ++ + R + ERE IL+
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 273 LDHPFLPTLYTHFETEKFSCLVMEFCPGGDL-HTLRQKQPGKYFPEQAVRFYVAEVLLAL 331
+ H + TL+ +E L++E GG+L L QK+ E+ ++ ++L +
Sbjct: 72 VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGV 128
Query: 332 EYLHMLGIIYRDLKPENVLVR----EDGHIMLSDFDLSLRC 368
YLH I + DLKPEN+++ HI L DF L+
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 39/105 (37%), Positives = 51/105 (48%), Gaps = 6/105 (5%)
Query: 454 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRF 513
GT E++APEI+ E G D W+ G+ Y LL G +PF G + TL N+ F
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDF 237
Query: 514 PESP--VVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556
E S A+D IR LLVKE + RL E +HP+
Sbjct: 238 DEEFFSHTSELAKDFIRKLLVKETRKRLT----IQEALRHPWITP 278
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-31
Identities = 44/158 (27%), Positives = 74/158 (46%), Gaps = 11/158 (6%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAG-RKKLLRAQTERE--ILQS 272
++ + LG G V T +A K + K R+ + R ERE IL+
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 273 LDHPFLPTLYTHFETEKFSCLVMEFCPGGDL-HTLRQKQPGKYFPEQAVRFYVAEVLLAL 331
+ HP + TL+ +E + L++E GG+L L +K + E+ ++ ++L +
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGV 127
Query: 332 EYLHMLGIIYRDLKPENVLVR----EDGHIMLSDFDLS 365
YLH L I + DLKPEN+++ I + DF L+
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 38/105 (36%), Positives = 53/105 (50%), Gaps = 6/105 (5%)
Query: 454 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRF 513
GT E++APEI+ E G D W+ G+ Y LL G +PF G + TL NV F
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236
Query: 514 PESP--VVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556
+ S A+D IR LLVK+P+ R+ + QHP+ +
Sbjct: 237 EDEYFSNTSALAKDFIRRLLVKDPKKRMT----IQDSLQHPWIKP 277
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 7e-31
Identities = 47/198 (23%), Positives = 86/198 (43%), Gaps = 11/198 (5%)
Query: 171 STSSDVSDESTCSSFSSSINKPHKANDLRWEAIQAVRARDGVLGLSHFRLLKRLGCGDIG 230
S + + + ++ P D +A + V G + +LK++G G
Sbjct: 12 PRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKG-RIYSILKQIGSGGSS 70
Query: 231 SVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLP--TLYTHFETE 288
V+ L+ K +A+K ++ + L + E L L LY + T+
Sbjct: 71 KVFQV-LNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 128
Query: 289 KFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPE 347
++ +VME C DL++ L++K+ + Y +L A+ +H GI++ DLKP
Sbjct: 129 QYIYMVME-CGNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPA 184
Query: 348 NVLVREDGHIMLSDFDLS 365
N L+ DG + L DF ++
Sbjct: 185 NFLI-VDGMLKLIDFGIA 201
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 7e-20
Identities = 27/114 (23%), Positives = 48/114 (42%), Gaps = 16/114 (14%)
Query: 453 SFVGTHEYLAPEIIKGEG-----------HGSAVDWWTFGIFLYELLFGKTPFKGSGNR- 500
S VG Y+ PE IK D W+ G LY + +GKTPF+ N+
Sbjct: 215 SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 274
Query: 501 ATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
+ L ++ + +D+++ L ++P+ R++ E+ HP+
Sbjct: 275 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRIS----IPELLAHPYV 324
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-31
Identities = 47/164 (28%), Positives = 76/164 (46%), Gaps = 17/164 (10%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRA----------QT 265
+ +++LG G G V L + A+KV+ K+ +
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 266 EREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDL-HTLRQKQPGKYFPEQAVRFYV 324
E +L+SLDHP + L+ FE +K+ LV EF GG+L + + F E +
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIM 152
Query: 325 AEVLLALEYLHMLGIIYRDLKPENVLVR---EDGHIMLSDFDLS 365
++L + YLH I++RD+KPEN+L+ +I + DF LS
Sbjct: 153 KQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLS 196
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-17
Identities = 27/106 (25%), Positives = 48/106 (45%), Gaps = 7/106 (6%)
Query: 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLR 512
+GT Y+APE++K + + D W+ G+ +Y LL G PF G ++ + V
Sbjct: 207 DRLGTAYYIAPEVLKKK-YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYY 265
Query: 513 FPESP--VVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556
F + +S A++LI+ +L + R A E + +
Sbjct: 266 FDFNDWKNISDEAKELIKLMLTYDYNKRCT----AEEALNSRWIKK 307
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 12/156 (7%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGR--KKLLRAQTEREILQSL 273
++ + + LG G V T FA K+++ L+ R +KL R E I + L
Sbjct: 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER---EARICRKL 85
Query: 274 DHPFLPTLYTHFETEKFSCLVMEFCPGGDL-HTLRQKQPGKYFPEQAVRFYVAEVLLALE 332
HP + L+ + E F LV + GG+L + + +++ E + ++L ++
Sbjct: 86 QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIA 142
Query: 333 YLHMLGIIYRDLKPENVLVR---EDGHIMLSDFDLS 365
Y H GI++R+LKPEN+L+ + + L+DF L+
Sbjct: 143 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA 178
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 5e-18
Identities = 29/105 (27%), Positives = 45/105 (42%), Gaps = 6/105 (5%)
Query: 454 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRF 513
F GT YL+PE++K + + VD W G+ LY LL G PF + +
Sbjct: 190 FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY 249
Query: 514 PESP--VVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556
P V+ A+ LI +L P+ R+ A + + P+
Sbjct: 250 PSPEWDTVTPEAKSLIDSMLTVNPKKRIT----ADQALKVPWICN 290
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 10/157 (6%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLL---RAQTERE--IL 270
+ +G G V T FA+K+M+ + + L R T RE IL
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 271 QSL-DHPFLPTLYTHFETEKFSCLVMEFCPGGDL-HTLRQKQPGKYFPEQAVRFYVAEVL 328
+ + HP + TL +E+ F LV + G+L L +K E+ R + +L
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLL 210
Query: 329 LALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
A+ +LH I++RDLKPEN+L+ ++ I LSDF S
Sbjct: 211 EAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFS 247
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 38/111 (34%), Positives = 52/111 (46%), Gaps = 14/111 (12%)
Query: 454 FVGTHEYLAPEIIKG------EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVV 507
GT YLAPEI+K G+G VD W G+ L+ LL G PF + + ++
Sbjct: 259 LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR-RQILMLRMI 317
Query: 508 GQ-PLRFPESP--VVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFE 555
+ +F S +DLI LL +P+ RL A + QHPFFE
Sbjct: 318 MEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLT----AEQALQHPFFE 364
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 5e-30
Identities = 38/156 (24%), Positives = 73/156 (46%), Gaps = 12/156 (7%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAG--RKKLLRAQTEREILQSL 273
++L + LG G V +A +++ L+ +KL R E I + L
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLER---EARICRLL 67
Query: 274 DHPFLPTLYTHFETEKFSCLVMEFCPGGDL-HTLRQKQPGKYFPEQAVRFYVAEVLLALE 332
HP + L+ E L+ + GG+L + + +Y+ E + ++L A+
Sbjct: 68 KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVL 124
Query: 333 YLHMLGIIYRDLKPENVLVR---EDGHIMLSDFDLS 365
+ H +G+++R+LKPEN+L+ + + L+DF L+
Sbjct: 125 HCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLA 160
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-17
Identities = 35/107 (32%), Positives = 52/107 (48%), Gaps = 10/107 (9%)
Query: 454 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVV--GQPL 511
F GT YL+PE+++ + +G VD W G+ LY LL G PF ++ L+ + G
Sbjct: 173 FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE-DQHRLYQQIKAGA-Y 230
Query: 512 RFPESP--VVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556
FP V+ A+DLI +L P R+ A E +HP+
Sbjct: 231 DFPSPEWDTVTPEAKDLINKMLTINPSKRIT----AAEALKHPWISH 273
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 67/398 (16%), Positives = 121/398 (30%), Gaps = 98/398 (24%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-- 273
+ ++++LG G +V+LS K + AMKV+ K++ + A E +L+S+
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV-KSAEHYTE---TALDEIRLLKSVRN 92
Query: 274 ---DHP---FLPTLYTHFETE----KFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFY 323
+ P + L F+ C+V E G L K + P V+
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKI 151
Query: 324 VAEVLLALEYLHM-LGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDA 382
+ +VL L+YLH II+ D+KPEN+L+ + + +A
Sbjct: 152 IQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAA-----------------EA 194
Query: 383 EPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPEL 442
+++ + + + P+ K N
Sbjct: 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGN------------ 242
Query: 443 IAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGN--- 499
A + T +Y + E++ G G+ + D W+ +EL G F+
Sbjct: 243 -ACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEY 301
Query: 500 ---------------------------RATLFNVVGQPLRFPESPVVSF----------- 521
F G +
Sbjct: 302 TRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWS 361
Query: 522 -----AARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
D + +L P+ R A E +HP+
Sbjct: 362 QEEAAGFTDFLLPMLELIPEKRAT----AAECLRHPWL 395
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 39/157 (24%), Positives = 70/157 (44%), Gaps = 10/157 (6%)
Query: 216 SHFRLLKR-LGCGDIGSVYLSELSGTKCYFAMKVMDKASLAG--RKKLLRAQTEREILQS 272
+ + L + LG G V T +A K + K R ++L E +L+
Sbjct: 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILH---EIAVLEL 84
Query: 273 LDH-PFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLAL 331
P + L+ +E L++E+ GG++ +L + + E V + ++L +
Sbjct: 85 AKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGV 144
Query: 332 EYLHMLGIIYRDLKPENVLV---REDGHIMLSDFDLS 365
YLH I++ DLKP+N+L+ G I + DF +S
Sbjct: 145 YYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS 181
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 8e-19
Identities = 37/109 (33%), Positives = 52/109 (47%), Gaps = 6/109 (5%)
Query: 454 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRF 513
+GT EYLAPEI+ + +A D W GI Y LL +PF G N+ T N+ + +
Sbjct: 193 IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDY 252
Query: 514 PESP--VVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWA 560
E VS A D I+ LLVK P+ R A H + + ++
Sbjct: 253 SEETFSSVSQLATDFIQSLLVKNPEKRPT----AEICLSHSWLQQWDFE 297
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 5e-29
Identities = 43/151 (28%), Positives = 75/151 (49%), Gaps = 8/151 (5%)
Query: 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREI--LQSLD 274
+ L++ LG G G V L+ T+ A+K++D ++EI + L+
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD----CPENIKKEICINKMLN 63
Query: 275 HPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYL 334
H + Y H L +E+C GG+L R + PE + + +++ + YL
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFD-RIEPDIG-MPEPDAQRFFHQLMAGVVYL 121
Query: 335 HMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
H +GI +RD+KPEN+L+ E ++ +SDF L+
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLA 152
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 3e-16
Identities = 25/104 (24%), Positives = 44/104 (42%), Gaps = 6/104 (5%)
Query: 453 SFVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSGNR-ATLFNVVGQP 510
GT Y+APE++K H VD W+ GI L +L G+ P+ + + +
Sbjct: 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 225
Query: 511 LRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
+ A L+ +LV+ P R+ +IK+ ++
Sbjct: 226 TYLNPWKKIDSAPLALLHKILVENPSARITIP----DIKKDRWY 265
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 6e-29
Identities = 57/199 (28%), Positives = 87/199 (43%), Gaps = 12/199 (6%)
Query: 171 STSSDVSDESTCSSFSSSINKPHKANDLRWEAIQAVRARDGVLGLSHFRLLKRLGCGDIG 230
S+ D+ E+ SS+ + + F + LG G
Sbjct: 8 SSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATS 67
Query: 231 SVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKF 290
VY + GT+ +A+KV+ K +TE +L L HP + L FET
Sbjct: 68 IVYRCKQKGTQKPYALKVLKK-----TVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTE 122
Query: 291 SCLVMEFCPGGDL-HTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENV 349
LV+E GG+L + +K Y+ E+ V ++L A+ YLH GI++RDLKPEN+
Sbjct: 123 ISLVLELVTGGELFDRIVEK---GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENL 179
Query: 350 LVR---EDGHIMLSDFDLS 365
L D + ++DF LS
Sbjct: 180 LYATPAPDAPLKIADFGLS 198
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 37/110 (33%), Positives = 52/110 (47%), Gaps = 9/110 (8%)
Query: 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVV--GQP 510
+ GT Y APEI++G +G VD W+ GI Y LL G PF +F + +
Sbjct: 209 TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCE- 267
Query: 511 LRFPESP--VVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVN 558
F VS A+DL+R L+V +P+ RL + QHP+ G
Sbjct: 268 YYFISPWWDEVSLNAKDLVRKLIVLDPKKRLT----TFQALQHPWVTGKA 313
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 9e-29
Identities = 40/149 (26%), Positives = 73/149 (48%), Gaps = 14/149 (9%)
Query: 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD-HPFLPT 280
K LG G + FA+K++ K + Q E L+ + HP +
Sbjct: 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISK------RMEANTQKEITALKLCEGHPNIVK 70
Query: 281 LYTHFETEKFSCLVMEFCPGGDL-HTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGI 339
L+ F + + LVME GG+L +++K K+F E + + +++ A+ ++H +G+
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGELFERIKKK---KHFSETEASYIMRKLVSAVSHMHDVGV 127
Query: 340 IYRDLKPENVLVR---EDGHIMLSDFDLS 365
++RDLKPEN+L ++ I + DF +
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFA 156
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 5e-19
Identities = 29/114 (25%), Positives = 51/114 (44%), Gaps = 13/114 (11%)
Query: 452 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRAT------LFN 505
+ T Y APE++ G+ + D W+ G+ LY +L G+ PF+ T +
Sbjct: 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMK 226
Query: 506 VVGQ-PLRFPESP--VVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556
+ + F VS A+DLI+GLL +P RL + ++ + + +
Sbjct: 227 KIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLK----MSGLRYNEWLQD 276
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 9e-29
Identities = 43/159 (27%), Positives = 68/159 (42%), Gaps = 12/159 (7%)
Query: 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHP 276
+ + +RLG G G V T A+K + K R E +I++ L+HP
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSP--KNRERWCLEIQIMKKLNHP 72
Query: 277 FLPTLY------THFETEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQAVRFYVAEVLL 329
+ + L ME+C GGDL L Q + E +R ++++
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 330 ALEYLHMLGIIYRDLKPENVLVREDGH---IMLSDFDLS 365
AL YLH II+RDLKPEN++++ + D +
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 74.3 bits (182), Expect = 4e-14
Identities = 24/128 (18%), Positives = 49/128 (38%), Gaps = 26/128 (20%)
Query: 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVV----- 507
FVGT +YLAPE+++ + + VD+W+FG +E + G PF + V
Sbjct: 182 EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSN 241
Query: 508 ---------GQPLRFPE--------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQ 550
++F S +++ ++ +L+ + R +
Sbjct: 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRG----TDPQNPN 297
Query: 551 HPFFEGVN 558
F+ ++
Sbjct: 298 VGCFQALD 305
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 45/149 (30%), Positives = 68/149 (45%), Gaps = 11/149 (7%)
Query: 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPT 280
LG G V T +A+K+++K R ++ R E E+L H +
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFR---EVEMLYQCQGHRNVLE 75
Query: 281 LYTHFETEKFSCLVMEFCPGGDL-HTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGI 339
L FE E LV E GG + + ++ ++F E V +V AL++LH GI
Sbjct: 76 LIEFFEEEDRFYLVFEKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKGI 132
Query: 340 IYRDLKPENVLVR---EDGHIMLSDFDLS 365
+RDLKPEN+L + + + DFDL
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFDLG 161
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 40/149 (26%), Positives = 67/149 (44%), Gaps = 33/149 (22%)
Query: 452 MSFVGTHEYLAPEIIKG-----EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNV 506
++ G+ EY+APE+++ + D W+ G+ LY LL G PF G ++
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR 238
Query: 507 VGQP---------------LRFPESP--VVSFAARDLIRGLLVKEPQHRLAYKRGATEIK 549
FP+ +S AA+DLI LLV++ + RL+ A ++
Sbjct: 239 GEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLS----AAQVL 294
Query: 550 QHPFFEGVNWALIRCATPPEIPKPVEIER 578
QHP+ +G CA +P P+ ++R
Sbjct: 295 QHPWVQG-------CAPENTLPTPMVLQR 316
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 43/151 (28%), Positives = 75/151 (49%), Gaps = 8/151 (5%)
Query: 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREI--LQSLD 274
+ L++ LG G G V L+ T+ A+K++D ++EI + L+
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD----CPENIKKEICINKMLN 63
Query: 275 HPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYL 334
H + Y H L +E+C GG+L R + PE + + +++ + YL
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFD-RIEPDIG-MPEPDAQRFFHQLMAGVVYL 121
Query: 335 HMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
H +GI +RD+KPEN+L+ E ++ +SDF L+
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLA 152
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 25/104 (24%), Positives = 44/104 (42%), Gaps = 6/104 (5%)
Query: 453 SFVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSGN-RATLFNVVGQP 510
GT Y+APE++K H VD W+ GI L +L G+ P+ + + +
Sbjct: 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 225
Query: 511 LRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
+ A L+ +LV+ P R+ +IK+ ++
Sbjct: 226 TYLNPWKKIDSAPLALLHKILVENPSARITIP----DIKKDRWY 265
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 7e-28
Identities = 48/223 (21%), Positives = 75/223 (33%), Gaps = 27/223 (12%)
Query: 148 SGSAKISDRLDYVESGKSSICRGSTSSDVSDESTCSSFSSSINKPHKANDLRWEAIQAVR 207
SGS K+ + + E+ + K + E +
Sbjct: 2 SGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVH--- 58
Query: 208 ARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTER 267
R+G G G V+ + T A+K + L
Sbjct: 59 ---------WMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR----------LEVFRVE 99
Query: 268 EI--LQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVA 325
E+ L P + LY + + ME GG L L ++ PE +Y+
Sbjct: 100 ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQ--MGCLPEDRALYYLG 157
Query: 326 EVLLALEYLHMLGIIYRDLKPENVLVREDG-HIMLSDFDLSLR 367
+ L LEYLH I++ D+K +NVL+ DG L DF +L
Sbjct: 158 QALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALC 200
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 25/116 (21%), Positives = 44/116 (37%), Gaps = 5/116 (4%)
Query: 439 LPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSG 498
L + GT ++APE++ G+ + VD W+ + +L G P+
Sbjct: 201 LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF 260
Query: 499 NRATLFNVVGQPLRFPESP-VVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPF 553
+ +P E P + I+ L KEP HR + A E+++
Sbjct: 261 RGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRAS----AMELRRKVG 312
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 43/168 (25%), Positives = 72/168 (42%), Gaps = 9/168 (5%)
Query: 204 QAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAG-----RK 258
+ + A +G + + LG G G V+ + +K + K +
Sbjct: 13 EGLAACEGEY-SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDP 71
Query: 259 KLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEF-CPGGDLHTLRQKQPGKYFPE 317
KL + E IL ++H + + FE + F LVME G DL + P E
Sbjct: 72 KLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP--RLDE 129
Query: 318 QAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+ +++ A+ YL + II+RD+K EN+++ ED I L DF +
Sbjct: 130 PLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSA 177
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 35/124 (28%), Positives = 53/124 (42%), Gaps = 14/124 (11%)
Query: 454 FVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLR 512
F GT EY APE++ G G ++ W+ G+ LY L+F + PF L V +
Sbjct: 189 FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEAAIH 242
Query: 513 FPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF-EGVNWALIRCATPPEIP 571
P +VS L+ GLL P+ R + ++ P+ + VN A +
Sbjct: 243 PP--YLVSKELMSLVSGLLQPVPERRTTLE----KLVTDPWVTQPVNLADYTWEEVFRVN 296
Query: 572 KPVE 575
KP
Sbjct: 297 KPES 300
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-27
Identities = 40/155 (25%), Positives = 72/155 (46%), Gaps = 16/155 (10%)
Query: 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREIL-QSLDH 275
+ + + +G G T FA+K++DK+ + E EIL + H
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE-------EIEILLRYGQH 75
Query: 276 PFLPTLYTHFETEKFSCLVMEFCPGGDL-HTLRQKQPGKYFPEQAVRFYVAEVLLALEYL 334
P + TL ++ K+ +V E GG+L + ++ K+F E+ + + +EYL
Sbjct: 76 PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQ---KFFSEREASAVLFTITKTVEYL 132
Query: 335 HMLGIIYRDLKPENVLVREDGH----IMLSDFDLS 365
H G+++RDLKP N+L ++ I + DF +
Sbjct: 133 HAQGVVHRDLKPSNILYVDESGNPESIRICDFGFA 167
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 30/117 (25%), Positives = 51/117 (43%), Gaps = 9/117 (7%)
Query: 445 EPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSG--NRAT 502
M+ T ++APE+++ +G+ +A D W+ G+ LY +L G TPF
Sbjct: 171 RAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEE 230
Query: 503 LFNVVGQ-PLRFPESP--VVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556
+ +G VS A+DL+ +L +P RL A + +HP+
Sbjct: 231 ILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLT----AALVLRHPWIVH 283
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 31/182 (17%), Positives = 51/182 (28%), Gaps = 32/182 (17%)
Query: 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHP 276
+L++ L GD V+L FA+KV + R +L R L
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 277 FLPTLYTHFETEKFS--------------------------CLVMEFCPGGDLHTL---- 306
S L+M DL L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTL 181
Query: 307 -RQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
A+ A+++ L G+++ P+N+ + DG +ML D
Sbjct: 182 DFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSAL 241
Query: 366 LR 367
+
Sbjct: 242 WK 243
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 97.8 bits (243), Expect = 4e-22
Identities = 21/121 (17%), Positives = 34/121 (28%), Gaps = 13/121 (10%)
Query: 443 IAEPTEARSMSFVGTHEYLAPEIIKGEG--HGSAVDWWTFGIFLYELLFGKTPFKGSGN- 499
R + Y E + A++ W G+ +Y + PF
Sbjct: 240 ALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPG 299
Query: 500 ------RATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPF 553
R +L L F + + LI L + + RL E + P
Sbjct: 300 IKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRL----LPLEAMETPE 355
Query: 554 F 554
F
Sbjct: 356 F 356
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 42/153 (27%), Positives = 69/153 (45%), Gaps = 12/153 (7%)
Query: 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREI--LQSLD 274
+ +K +G G+ G L TK A+K +++ + +REI +SL
Sbjct: 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIER------GAAIDENVQREIINHRSLR 74
Query: 275 HPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYL 334
HP + T ++ME+ GG+L+ R G+ F E RF+ ++L + Y
Sbjct: 75 HPNIVRFKEVILTPTHLAIIMEYASGGELYE-RICNAGR-FSEDEARFFFQQLLSGVSYC 132
Query: 335 HMLGIIYRDLKPENVLVRED--GHIMLSDFDLS 365
H + I +RDLK EN L+ + + DF S
Sbjct: 133 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYS 165
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 6e-17
Identities = 31/108 (28%), Positives = 48/108 (44%), Gaps = 11/108 (10%)
Query: 453 SFVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPL 511
S VGT Y+APE++ + G D W+ G+ LY +L G PF+ + Q +
Sbjct: 176 STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDP-EEPRDYRKTIQRI 234
Query: 512 -----RFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
P+ +S LI + V +P R++ EIK H +F
Sbjct: 235 LSVKYSIPDDIRISPECCHLISRIFVADPATRISIP----EIKTHSWF 278
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 44/146 (30%), Positives = 66/146 (45%), Gaps = 5/146 (3%)
Query: 224 LGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYT 283
LG G G VY + A+K + + + L E + + L H +
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPL---HEEIALHKHLKHKNIVQYLG 86
Query: 284 HFETEKFSCLVMEFCPGGDLHTLRQKQPGKY-FPEQAVRFYVAEVLLALEYLHMLGIIYR 342
F F + ME PGG L L + + G EQ + FY ++L L+YLH I++R
Sbjct: 87 SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHR 146
Query: 343 DLKPENVLV-REDGHIMLSDFDLSLR 367
D+K +NVL+ G + +SDF S R
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKR 172
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 32/130 (24%), Positives = 53/130 (40%), Gaps = 15/130 (11%)
Query: 447 TEARSMSFVGTHEYLAPEIIKG--EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNR-ATL 503
+ +F GT +Y+APEII G+G A D W+ G + E+ GK PF G A +
Sbjct: 176 INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM 235
Query: 504 FNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIR 563
F V + +S A+ I +P R A ++ F ++
Sbjct: 236 FKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRAC----ANDLLVDEF--------LK 283
Query: 564 CATPPEIPKP 573
++ + +P
Sbjct: 284 VSSKKKKTQP 293
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 35/152 (23%), Positives = 66/152 (43%), Gaps = 16/152 (10%)
Query: 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPT 280
+ LG G G V T A+K++ + A + E + P +
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ--------EVDHHWQASGGPHIVC 86
Query: 281 LYTHFETEKFSC----LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHM 336
+ +E ++ME GG+L + Q++ + F E+ + ++ A+++LH
Sbjct: 87 ILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS 146
Query: 337 LGIIYRDLKPENVLV---REDGHIMLSDFDLS 365
I +RD+KPEN+L +D + L+DF +
Sbjct: 147 HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 32/111 (28%), Positives = 49/111 (44%), Gaps = 10/111 (9%)
Query: 452 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRAT---LFNVVG 508
+ T Y+APE++ E + + D W+ G+ +Y LL G PF + +A + +
Sbjct: 187 QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIR 246
Query: 509 Q-PLRFPESP--VVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556
FP VS A+ LIR LL +P RL T+ HP+
Sbjct: 247 LGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLT----ITQFMNHPWINQ 293
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-26
Identities = 34/149 (22%), Positives = 65/149 (43%), Gaps = 3/149 (2%)
Query: 216 SHFRLLKRLGCG--DIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL 273
+ LL +G G D+ +V L+ T Y ++ ++ + + + Q E + +
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEA-CSNEMVTFLQGELHVSKLF 83
Query: 274 DHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEY 333
+HP + F + +V F G L E A+ + + VL AL+Y
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143
Query: 334 LHMLGIIYRDLKPENVLVREDGHIMLSDF 362
+H +G ++R +K ++L+ DG + LS
Sbjct: 144 IHHMGYVHRSVKASHILISVDGKVYLSGL 172
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 25/148 (16%), Positives = 41/148 (27%), Gaps = 50/148 (33%)
Query: 453 SFVGTHEYLAPEIIK--GEGHGSAVDWWTFGIFLYELLFGKTPF---------------- 494
V +L+PE+++ +G+ + D ++ GI EL G PF
Sbjct: 194 YSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT 253
Query: 495 ----------------------------KGSGNRATLFNVVGQPLRFPESPVVSFAARDL 526
S +T G P S
Sbjct: 254 VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHF 313
Query: 527 IRGLLVKEPQHRLAYKRGATEIKQHPFF 554
+ L + P R + A+ + H FF
Sbjct: 314 VEQCLQRNPDARPS----ASTLLNHSFF 337
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 41/147 (27%), Positives = 70/147 (47%), Gaps = 5/147 (3%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH 275
F L+++G G G V+ + T+ A+K++D + + Q E +L D
Sbjct: 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI--QQEITVLSQCDS 79
Query: 276 PFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLH 335
P++ Y + + ++ME+ GG L + P E + + E+L L+YLH
Sbjct: 80 PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLH 136
Query: 336 MLGIIYRDLKPENVLVREDGHIMLSDF 362
I+RD+K NVL+ E G + L+DF
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADF 163
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 34/133 (25%), Positives = 53/133 (39%), Gaps = 15/133 (11%)
Query: 447 TEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTP-FKGSGNRATLFN 505
T+ + +FVGT ++APE+IK + S D W+ GI EL G+ P + +
Sbjct: 172 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI 231
Query: 506 VVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIRCA 565
P + S ++ + L KEP R A E+ +H F R A
Sbjct: 232 PKNNPPTLEGN--YSKPLKEFVEACLNKEPSFRPT----AKELLKHKFIL-------RNA 278
Query: 566 TPPEIPKPVEIER 578
+ I+R
Sbjct: 279 KKTSYLTEL-IDR 290
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 40/151 (26%), Positives = 66/151 (43%), Gaps = 16/151 (10%)
Query: 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPT 280
+ LG G G V T+ FA+K++ A R E E+ P +
Sbjct: 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVELHWRASQCPHIVR 75
Query: 281 LYTHFET----EKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHM 336
+ +E K +VME GG+L + Q + + F E+ + + A++YLH
Sbjct: 76 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 135
Query: 337 LGIIYRDLKPENVLVR---EDGHIMLSDFDL 364
+ I +RD+KPEN+L + + L+DF
Sbjct: 136 INIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 29/102 (28%), Positives = 40/102 (39%), Gaps = 11/102 (10%)
Query: 461 LAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRAT---LFNVVGQ-PLRFPES 516
A E E + + D W+ G+ +Y LL G PF + A + + FP
Sbjct: 166 FAKETTG-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 224
Query: 517 P--VVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556
VS + LIR LL EP R+ TE HP+
Sbjct: 225 EWSEVSEEVKMLIRNLLKTEPTQRMT----ITEFMNHPWIMQ 262
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 45/146 (30%), Positives = 74/146 (50%), Gaps = 4/146 (2%)
Query: 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHP 276
+ ++ LG G G VY ++ T A KV++ ++L E EIL + DHP
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE---TKSEEELEDYIVEIEILATCDHP 76
Query: 277 FLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHM 336
++ L + + +++EFCPGG + + + E ++ ++L AL +LH
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG-LTEPQIQVVCRQMLEALNFLHS 135
Query: 337 LGIIYRDLKPENVLVREDGHIMLSDF 362
II+RDLK NVL+ +G I L+DF
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADF 161
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 32/141 (22%), Positives = 57/141 (40%), Gaps = 25/141 (17%)
Query: 447 TEARSMSFVGTHEYLAPEII-----KGEGHGSAVDWWTFGIFLYELLFGKTP-FKGSGNR 500
T + SF+GT ++APE++ K + D W+ GI L E+ + P + + R
Sbjct: 170 TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR 229
Query: 501 ATLFNVVGQP---LRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557
L + L P S RD ++ L K P+ R + A ++ +HPF
Sbjct: 230 V-LLKIAKSDPPTLLTPSK--WSVEFRDFLKIALDKNPETRPS----AAQLLEHPF---- 278
Query: 558 NWALIRCATPPEIPKPVEIER 578
+ T + + + +
Sbjct: 279 ----VSSITSNKALREL-VAE 294
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 7e-25
Identities = 38/155 (24%), Positives = 68/155 (43%), Gaps = 10/155 (6%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHP- 276
+ +G G +VY + T A + L + + R + E E+L+ L HP
Sbjct: 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPN 86
Query: 277 ---FLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEY 333
F + + + +K LV E G L T ++ K + +R + ++L L++
Sbjct: 87 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQF 144
Query: 334 LH--MLGIIYRDLKPENVLV-REDGHIMLSDFDLS 365
LH II+RDLK +N+ + G + + D L+
Sbjct: 145 LHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 25/111 (22%), Positives = 52/111 (46%), Gaps = 10/111 (9%)
Query: 447 TEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNV 506
+ + + +GT E++APE+ + E + +VD + FG+ + E+ + P+ N A ++
Sbjct: 183 RASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR 241
Query: 507 VGQ---PLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
V P F + V +++I G + + R + ++ H FF
Sbjct: 242 VTSGVKPASFDK--VAIPEVKEIIEGCIRQNKDERYS----IKDLLNHAFF 286
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 9e-25
Identities = 43/209 (20%), Positives = 80/209 (38%), Gaps = 22/209 (10%)
Query: 171 STSSDVSDESTCSSFSSSINKPHKANDLRWEAIQAVRARDGVLG-----LSHFRLLKR-L 224
+ + P + + + G+ + +++ + L
Sbjct: 11 PVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVL 70
Query: 225 GCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYT 283
G G G V T+ FA+K++ A R E E+ P + +
Sbjct: 71 GLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVELHWRASQCPHIVRIVD 122
Query: 284 HFET----EKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGI 339
+E K +VME GG+L + Q + + F E+ + + A++YLH + I
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 182
Query: 340 IYRDLKPENVLV---REDGHIMLSDFDLS 365
+RD+KPEN+L R + + L+DF +
Sbjct: 183 AHRDVKPENLLYTSKRPNAILKLTDFGFA 211
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 8e-18
Identities = 32/107 (29%), Positives = 46/107 (42%), Gaps = 10/107 (9%)
Query: 452 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRAT---LFNVVG 508
+ T Y+APE++ E + + D W+ G+ +Y LL G PF + A + +
Sbjct: 221 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 280
Query: 509 Q-PLRFPESP--VVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHP 552
FP VS + LIR LL EP R+ TE HP
Sbjct: 281 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT----ITEFMNHP 323
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 1e-24
Identities = 35/154 (22%), Positives = 60/154 (38%), Gaps = 15/154 (9%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD-HP 276
F LG G G++ + + A+K + + A E ++L+ D HP
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDV-AVKRILPECFSF------ADREVQLLRESDEHP 78
Query: 277 FLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHM 336
+ + + +F + +E C L +Q + + L +LH
Sbjct: 79 NVIRYFCTEKDRQFQYIAIELC-AATLQE-YVEQKDFAHLGLEPITLLQQTTSGLAHLHS 136
Query: 337 LGIIYRDLKPENVLVREDGH-----IMLSDFDLS 365
L I++RDLKP N+L+ M+SDF L
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 3e-16
Identities = 29/115 (25%), Positives = 47/115 (40%), Gaps = 9/115 (7%)
Query: 445 EPTEARSMSFVGTHEYLAPEIIKG---EGHGSAVDWWTFGIFLYELL-FGKTPFKGSGNR 500
+ +R GT ++APE++ E VD ++ G Y ++ G PF S R
Sbjct: 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR 236
Query: 501 ATLFNVVGQPLRFPE-SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
+ L AR+LI ++ +PQ R + A + +HPFF
Sbjct: 237 QANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPS----AKHVLKHPFF 287
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 47/167 (28%), Positives = 75/167 (44%), Gaps = 7/167 (4%)
Query: 198 LRWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMD-KASLAG 256
R EA + + G L F + LG G+ G V+ + A K++ + A
Sbjct: 15 KRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI 74
Query: 257 RKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFP 316
R +++R E ++L + P++ Y F ++ + ME GG L + +K P
Sbjct: 75 RNQIIR---ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIP 129
Query: 317 EQAVRFYVAEVLLALEYLH-MLGIIYRDLKPENVLVREDGHIMLSDF 362
EQ + V+ L YL I++RD+KP N+LV G I L DF
Sbjct: 130 EQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDF 176
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 18/88 (20%), Positives = 31/88 (35%)
Query: 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLR 512
SFVGT Y++PE ++G + D W+ G+ L E+ G+ P + Q
Sbjct: 189 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 248
Query: 513 FPESPVVSFAARDLIRGLLVKEPQHRLA 540
+ + +A
Sbjct: 249 DAAETPPRPRTPGRPLNKFGMDSRPPMA 276
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 40/153 (26%), Positives = 67/153 (43%), Gaps = 8/153 (5%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH 275
+ L + +G G V + + K A+K ++ L E + + H
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDEL--LKEIQAMSQCHH 72
Query: 276 PFLPTLYTHFETEKFSCLVMEFCPGGDLHTL------RQKQPGKYFPEQAVRFYVAEVLL 329
P + + YT F + LVM+ GG + + + + E + + EVL
Sbjct: 73 PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 330 ALEYLHMLGIIYRDLKPENVLVREDGHIMLSDF 362
LEYLH G I+RD+K N+L+ EDG + ++DF
Sbjct: 133 GLEYLHKNGQIHRDVKAGNILLGEDGSVQIADF 165
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 8e-08
Identities = 31/112 (27%), Positives = 48/112 (42%), Gaps = 15/112 (13%)
Query: 453 SFVGTHEYLAPEIIK-GEGHGSAVDWWTFGIFLYELLFGKTPF-KGSGNRATLFNVVGQP 510
+FVGT ++APE+++ G+ D W+FGI EL G P+ K + L +
Sbjct: 185 TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV-LMLTLQND 243
Query: 511 ---LRFPESPVV-----SFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
L + R +I L K+P+ R A E+ +H FF
Sbjct: 244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT----AAELLRHKFF 291
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 5e-24
Identities = 44/169 (26%), Positives = 67/169 (39%), Gaps = 27/169 (15%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQ-SLD 274
+ K LG G G+V A+K M A E ++L S D
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSF-QGRPVAVKRMLI------DFCDIALMEIKLLTESDD 67
Query: 275 HPFLPTLYTHFETEKFSCLVMEFCPGGDLHTL-----RQKQPGKYFPEQAVRFYVAEVLL 329
HP + Y T++F + +E C +L L + K E + ++
Sbjct: 68 HPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 330 ALEYLHMLGIIYRDLKPENVLV-------------REDGHIMLSDFDLS 365
+ +LH L II+RDLKP+N+LV E+ I++SDF L
Sbjct: 127 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 175
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 24/113 (21%), Positives = 46/113 (40%), Gaps = 15/113 (13%)
Query: 453 SFVGTHEYLAPEIIKGEGH-------GSAVDWWTFGIFLYELL-FGKTPFKGSGNRATLF 504
+ GT + APE+++ + ++D ++ G Y +L GK PF +R +
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI 250
Query: 505 ---NVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
++ + A DLI ++ +P R A ++ +HP F
Sbjct: 251 IRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPT----AMKVLRHPLF 299
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 41/145 (28%), Positives = 68/145 (46%), Gaps = 6/145 (4%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF 277
F +L++LG G GSVY + T A+K + + + + E I+Q D P
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP---VESDLQEI--IKEISIMQQCDSPH 85
Query: 278 LPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHML 337
+ Y + +VME+C G + + + + E + + L LEYLH +
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT-LTEDEIATILQSTLKGLEYLHFM 144
Query: 338 GIIYRDLKPENVLVREDGHIMLSDF 362
I+RD+K N+L+ +GH L+DF
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADF 169
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 41/137 (29%), Positives = 61/137 (44%), Gaps = 20/137 (14%)
Query: 446 PTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTP-FKGSGNRATLF 504
T A+ + +GT ++APE+I+ G+ D W+ GI E+ GK P RA +F
Sbjct: 177 DTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA-IF 235
Query: 505 NVVGQP---LRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWAL 561
+ P R PE S D ++ LVK P+ R AT++ QHPF
Sbjct: 236 MIPTNPPPTFRKPEL--WSDNFTDFVKQCLVKSPEQRAT----ATQLLQHPF-------- 281
Query: 562 IRCATPPEIPKPVEIER 578
+R A I + + I
Sbjct: 282 VRSAKGVSILRDL-INE 297
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 42/166 (25%), Positives = 78/166 (46%), Gaps = 10/166 (6%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH 275
+ +++G G G+VY + T A++ M+ +K+L+ E +++ +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELI--INEILVMRENKN 76
Query: 276 PFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLH 335
P + + +VME+ GG L + + E + E L ALE+LH
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLH 133
Query: 336 MLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA-VSPTLIKASSL 380
+I+RD+K +N+L+ DG + L+DF CA ++P K S++
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGF---CAQITPEQSKRSTM 176
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 6e-09
Identities = 36/137 (26%), Positives = 63/137 (45%), Gaps = 20/137 (14%)
Query: 446 PTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTP-FKGSGNRATLF 504
P +++ + VGT ++APE++ + +G VD W+ GI E++ G+ P + RA L+
Sbjct: 168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LY 226
Query: 505 NVVGQP---LRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWAL 561
+ L+ PE +S RD + L + + R + A E+ QH F
Sbjct: 227 LIATNGTPELQNPEK--LSAIFRDFLNRCLEMDVEKRGS----AKELLQHQF-------- 272
Query: 562 IRCATPPEIPKPVEIER 578
++ A P P+ I
Sbjct: 273 LKIAKPLSSLTPL-IAA 288
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 48/163 (29%), Positives = 70/163 (42%), Gaps = 23/163 (14%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQ---- 271
F L++ +G G G VY T A+KVMD + E EI Q
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----------VTGDEEEEIKQEINM 73
Query: 272 ---SLDHPFLPTLYTHFETEKFSC------LVMEFCPGGDLHTLRQKQPGKYFPEQAVRF 322
H + T Y F + LVMEFC G + L + G E+ + +
Sbjct: 74 LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY 133
Query: 323 YVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
E+L L +LH +I+RD+K +NVL+ E+ + L DF +S
Sbjct: 134 ICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 35/139 (25%), Positives = 52/139 (37%), Gaps = 19/139 (13%)
Query: 447 TEARSMSFVGTHEYLAPEIIKGE-----GHGSAVDWWTFGIFLYELLFGKTP-FKGSGNR 500
T R +F+GT ++APE+I + + D W+ GI E+ G P R
Sbjct: 182 TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR 241
Query: 501 ATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWA 560
A LF + P +S S + I LVK R A ++ +HPF
Sbjct: 242 A-LFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPA----TEQLMKHPF------- 289
Query: 561 LIRCATPPEIPKPVEIERI 579
IR + + I
Sbjct: 290 -IRDQPNERQVRIQLKDHI 307
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 48/164 (29%), Positives = 78/164 (47%), Gaps = 10/164 (6%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF 277
++G G G V L+ + A+K+MD R++LL E I++ H
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK-QQRRELL--FNEVVIMRDYQHFN 103
Query: 278 LPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHML 337
+ +Y + + ++MEF GG L + + E+ + VL AL YLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR---LNEEQIATVCEAVLQALAYLHAQ 160
Query: 338 GIIYRDLKPENVLVREDGHIMLSDFDLSLRCA-VSPTLIKASSL 380
G+I+RD+K +++L+ DG + LSDF CA +S + K SL
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGF---CAQISKDVPKRKSL 201
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 39/137 (28%), Positives = 62/137 (45%), Gaps = 20/137 (14%)
Query: 446 PTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTP-FKGSGNRATLF 504
+ S VGT ++APE+I + + VD W+ GI + E++ G+ P F S +A +
Sbjct: 193 KDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA-MK 251
Query: 505 NVVGQP---LRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWAL 561
+ P L+ VS RD + +LV++PQ R A E+ HPF
Sbjct: 252 RLRDSPPPKLKNSHK--VSPVLRDFLERMLVRDPQERAT----AQELLDHPF-------- 297
Query: 562 IRCATPPEIPKPVEIER 578
+ PE P+ I+
Sbjct: 298 LLQTGLPECLVPL-IQL 313
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 46/166 (27%), Positives = 68/166 (40%), Gaps = 12/166 (7%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH 275
F L+ +G G G+VY + A+K M + +K E LQ L H
Sbjct: 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113
Query: 276 PFLPTLYTHFETEKFSCLVMEFCPGG--DLHTLRQKQPGKYFPEQAVRFYVAEVLLALEY 333
P + E + LVME+C G DL + +K E + L L Y
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAVTHGALQGLAY 169
Query: 334 LHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASS 379
LH +I+RD+K N+L+ E G + L DF + + A+S
Sbjct: 170 LHSHNMIHRDVKAGNILLSEPGLVKLGDF------GSASIMAPANS 209
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 8e-06
Identities = 36/140 (25%), Positives = 54/140 (38%), Gaps = 38/140 (27%)
Query: 453 SFVGTHEYLAPEII---KGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ 509
SFVGT ++APE+I + VD W+ GI EL K P LFN+
Sbjct: 209 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---------LFNM--N 257
Query: 510 PLR--F-------P--ESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVN 558
+ + P +S S R+ + L K PQ R + + +H F
Sbjct: 258 AMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPT----SEVLLKHRF----- 308
Query: 559 WALIRCATPPEIPKPVEIER 578
+ PP + + I+R
Sbjct: 309 ---VLRERPPTVIMDL-IQR 324
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 3e-23
Identities = 27/160 (16%), Positives = 43/160 (26%), Gaps = 17/160 (10%)
Query: 445 EPTEARSMSFVGTHEYLAPEIIKGEGHG-----SAVDWWTFGIFLYELLFGKTPFKGSGN 499
+ E A ++ H A D WT G+ +Y + P
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAA 322
Query: 500 RATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNW 559
+ P+ R L+ G L + RL + + P +E +
Sbjct: 323 LGGSEWIFRSCKNIPQ------PVRALLEGFLRYPKEDRL----LPLQAMETPEYEQLRT 372
Query: 560 ALIRC--ATPPEIPKPVEIERIPAPTSSTSEKTAPTMVPP 597
L + E P+ TS E A V
Sbjct: 373 ELSAALPLYQTDGEPTREGGAPPSGTSQPDEAGAAEAVTA 412
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 30/183 (16%), Positives = 57/183 (31%), Gaps = 34/183 (18%)
Query: 219 RLLKR---LGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-- 273
R L R LG D + + T F + V + + + E L+ L
Sbjct: 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRG 137
Query: 274 --------------------DHPFLPTLYTHFETEKFSCLVMEF----CPGGDLHTL--- 306
P + E+ ++ F +L T
Sbjct: 138 IKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEV 197
Query: 307 --RQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDL 364
K A +V+ L LH G+++ L+P ++++ + G + L+ F+
Sbjct: 198 LLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEH 257
Query: 365 SLR 367
+R
Sbjct: 258 LVR 260
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 4e-23
Identities = 40/153 (26%), Positives = 75/153 (49%), Gaps = 17/153 (11%)
Query: 218 FRLLKRLGCGDIGSVYLSE---LSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD 274
+ + + G +G +YL+ ++G +K + + A + A ER+ L +
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRP--VVLKGLVHSGDAEAQA--MAMAERQFLAEVV 137
Query: 275 HPFLPTLYTHFETEKFSC-----LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLL 329
HP + ++ E +VME+ G +L++ + K +A+ Y+ E+L
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGG---QSLKRSKGQKLPVAEAIA-YLLEILP 193
Query: 330 ALEYLHMLGIIYRDLKPENVLVREDGHIMLSDF 362
AL YLH +G++Y DLKPEN+++ E+ + L D
Sbjct: 194 ALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDL 225
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 7e-11
Identities = 29/153 (18%), Positives = 43/153 (28%), Gaps = 18/153 (11%)
Query: 449 ARSM----SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLF 504
+ GT + APEI++ G A D +T G L L G +
Sbjct: 228 VSRINSFGYLYGTPGFQAPEIVRT-GPTVATDIYTVGRTLAALTLDLPTRNG----RYVD 282
Query: 505 NVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIRC 564
+ L+R + +P+ R A E+ GV ++
Sbjct: 283 GLPEDDPVLKTYDSY----GRLLRRAIDPDPRQRFT---TAEEMSAQ--LTGVLREVVAQ 333
Query: 565 ATPPEIPKPVEIERIPAPTSSTSEKTAPTMVPP 597
T P I T A T V
Sbjct: 334 DTGVPRPGLSTIFSPSRSTFGVDLLVAHTDVYL 366
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 41/153 (26%), Positives = 70/153 (45%), Gaps = 8/153 (5%)
Query: 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMD-KASLAGRKKLLRAQTEREIL- 270
++ L +G G G V+ T A+K M + K++L + +++
Sbjct: 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILM---DLDVVL 78
Query: 271 QSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLA 330
+S D P++ + F T + ME G L+++ G PE+ + ++ A
Sbjct: 79 KSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGP-IPERILGKMTVAIVKA 136
Query: 331 LEYLH-MLGIIYRDLKPENVLVREDGHIMLSDF 362
L YL G+I+RD+KP N+L+ E G I L DF
Sbjct: 137 LYYLKEKHGVIHRDVKPSNILLDERGQIKLCDF 169
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 27/109 (24%), Positives = 42/109 (38%), Gaps = 11/109 (10%)
Query: 453 SFVGTHEYLAPEIIK-----GEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNR-ATLFNV 506
G Y+APE I + D W+ GI L EL G+ P+K L V
Sbjct: 183 RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV 242
Query: 507 V-GQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
+ +P P S + ++ L K+ + R Y ++ +H F
Sbjct: 243 LQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYN----KLLEHSFI 287
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-22
Identities = 37/155 (23%), Positives = 62/155 (40%), Gaps = 8/155 (5%)
Query: 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMD-KASLAGRKKLLRAQTEREI-L 270
+ L +G G GSV + A+K + +K+LL + ++ +
Sbjct: 19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLM---DLDVVM 75
Query: 271 QSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQ--KQPGKYFPEQAVRFYVAEVL 328
+S D P++ Y E + ME + PE+ + +
Sbjct: 76 RSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATV 135
Query: 329 LALEYLH-MLGIIYRDLKPENVLVREDGHIMLSDF 362
AL +L L II+RD+KP N+L+ G+I L DF
Sbjct: 136 KALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDF 170
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 4e-11
Identities = 31/109 (28%), Positives = 42/109 (38%), Gaps = 12/109 (11%)
Query: 454 FVGTHEYLAPEIIKGEGHGSA----VDWWTFGIFLYELLFGKTPFKGSGN-RATLFNVVG 508
G Y+APE I D W+ GI LYEL G+ P+ + L VV
Sbjct: 185 DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK 244
Query: 509 QP---LRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
L E S + + + L K+ R YK E+ +HPF
Sbjct: 245 GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYK----ELLKHPFI 289
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 5e-22
Identities = 23/152 (15%), Positives = 51/152 (33%), Gaps = 2/152 (1%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD 274
L H +++ + + + + D L+ + + +
Sbjct: 61 LEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDW-PLSSPSPMDAPSVKIRRMDPFS 119
Query: 275 HPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPE-QAVRFYVAEVLLALEY 333
+ + + M+ C +L ++ E ++ A+E+
Sbjct: 120 TKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEF 179
Query: 334 LHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
LH G+++RDLKP N+ D + + DF L
Sbjct: 180 LHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLV 211
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 81.9 bits (202), Expect = 5e-17
Identities = 30/114 (26%), Positives = 49/114 (42%), Gaps = 9/114 (7%)
Query: 445 EPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLF 504
P A VGT Y++PE I G + VD ++ G+ L+ELL+ F R +
Sbjct: 227 MPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY---SFSTQMERVRII 283
Query: 505 NVVGQPLRFPESPVVSF-AARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557
V +FP + +++ +L P R AT+I ++ FE +
Sbjct: 284 TDVRNL-KFPLLFTQKYPQEHMMVQDMLSPSPTERP----EATDIIENAIFENL 332
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 15/84 (17%), Positives = 34/84 (40%), Gaps = 2/84 (2%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD 274
L+ F ++ +G G G V+ ++ C +A+K + + ++ + E + L L+
Sbjct: 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELARE--KVMREVKALAKLE 62
Query: 275 HPFLPTLYTHFETEKFSCLVMEFC 298
HP + + + E
Sbjct: 63 HPGIVRYFNAWLETPPEKWQEEMD 86
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 6e-22
Identities = 29/152 (19%), Positives = 52/152 (34%), Gaps = 4/152 (2%)
Query: 211 GVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREIL 270
+ +RLL G + + + A+ +D + L + L
Sbjct: 26 ARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRL 85
Query: 271 QSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLA 330
+D P + + T +V E+ GG L + P P A+R + + A
Sbjct: 86 SRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPS---PVGAIR-AMQSLAAA 141
Query: 331 LEYLHMLGIIYRDLKPENVLVREDGHIMLSDF 362
+ H G+ P V V DG ++L+
Sbjct: 142 ADAAHRAGVALSIDHPSRVRVSIDGDVVLAYP 173
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 14/91 (15%), Positives = 23/91 (25%), Gaps = 12/91 (13%)
Query: 455 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATL---FNVVGQPL 511
+ + D G LY LL + P +G R+ L
Sbjct: 170 LAYPATMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQP 222
Query: 512 RFPES--PVVSFAARDLIRGLLVKEPQHRLA 540
P + F + + + R A
Sbjct: 223 IEPADIDRDIPFQISAVAARSVQGDGGIRSA 253
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 6e-22
Identities = 40/152 (26%), Positives = 66/152 (43%), Gaps = 7/152 (4%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMD-KASLAGRKKLLRAQTEREI-LQS 272
+ LG G G V + A+K + + +K+LL + +I +++
Sbjct: 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLM---DLDISMRT 62
Query: 273 LDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQ-KQPGKYFPEQAVRFYVAEVLLAL 331
+D PF T Y E + ME +Q G+ PE + ++ AL
Sbjct: 63 VDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKAL 122
Query: 332 EYLHM-LGIIYRDLKPENVLVREDGHIMLSDF 362
E+LH L +I+RD+KP NVL+ G + + DF
Sbjct: 123 EHLHSKLSVIHRDVKPSNVLINALGQVKMCDF 154
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 2e-11
Identities = 31/108 (28%), Positives = 40/108 (37%), Gaps = 11/108 (10%)
Query: 453 SFVGTHEYLAPEIIKGEGHGSA----VDWWTFGIFLYELLFGKTPFKGSGN-RATLFNVV 507
G Y+APE I E + D W+ GI + EL + P+ G L VV
Sbjct: 168 IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV 227
Query: 508 -GQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
+ P S D L K + R Y E+ QHPFF
Sbjct: 228 EEPSPQLPADK-FSAEFVDFTSQCLKKNSKERPTYP----ELMQHPFF 270
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 37/159 (23%), Positives = 65/159 (40%), Gaps = 20/159 (12%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTERE--ILQS 272
+ + +G G G V ++ A+K + + R E L
Sbjct: 7 YKEIEVEEVVGRGAFGVVCKAKWRAKDV--AIKQI-------ESESERKAFIVELRQLSR 57
Query: 273 LDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTL--RQKQPGKYFPEQAVRFYVAEVLLA 330
++HP + LY CLVME+ GG L+ + + Y A+ + +
Sbjct: 58 VNHPNIVKLYG-ACLNPV-CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW-CLQCSQG 114
Query: 331 LEYLHML---GIIYRDLKPENVLVREDGHIM-LSDFDLS 365
+ YLH + +I+RDLKP N+L+ G ++ + DF +
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 153
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 9e-11
Identities = 20/88 (22%), Positives = 38/88 (43%), Gaps = 1/88 (1%)
Query: 452 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKG-SGNRATLFNVVGQP 510
+ G+ ++APE+ +G + D +++GI L+E++ + PF G + V
Sbjct: 161 TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG 220
Query: 511 LRFPESPVVSFAARDLIRGLLVKEPQHR 538
R P + L+ K+P R
Sbjct: 221 TRPPLIKNLPKPIESLMTRCWSKDPSQR 248
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 38/150 (25%), Positives = 68/150 (45%), Gaps = 4/150 (2%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH 275
S + LG G G T MK + + ++ L+ E ++++ L+H
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLK---EVKVMRCLEH 66
Query: 276 PFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLH 335
P + +K + E+ GG L + + +Y Q V F ++ + YLH
Sbjct: 67 PNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSF-AKDIASGMAYLH 125
Query: 336 MLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+ II+RDL N LVRE+ +++++DF L+
Sbjct: 126 SMNIIHRDLNSHNCLVRENKNVVVADFGLA 155
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 18/72 (25%), Positives = 30/72 (41%)
Query: 446 PTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFN 505
P + + VG ++APE+I G + VD ++FGI L E++ R F
Sbjct: 174 PDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG 233
Query: 506 VVGQPLRFPESP 517
+ + P
Sbjct: 234 LNVRGFLDRYCP 245
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 7e-20
Identities = 49/180 (27%), Positives = 79/180 (43%), Gaps = 6/180 (3%)
Query: 186 SSSINKPHKANDLRWEAIQAVRARDGVLG--LSHFRLLKRLGCGDIGSVYLSELSGTKCY 243
SS + H ++ L + G +RL + +G G +G VY +E + +
Sbjct: 2 GSSHHHHHHSSGLVPRGSHMDGTAESREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERI 61
Query: 244 FAMKVMDKASLAGRKKLL-RAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGD 302
A+K+M +L+ R Q E L P + ++ E + + M G D
Sbjct: 62 VALKLM-SETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVD 120
Query: 303 LHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDF 362
L + ++Q G P +AV V ++ AL+ H G +RD+KPEN+LV D L DF
Sbjct: 121 LAAMLRRQ-GPLAPPRAVA-IVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDF 178
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 9e-08
Identities = 27/128 (21%), Positives = 46/128 (35%), Gaps = 15/128 (11%)
Query: 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLR 512
+ VGT Y+APE D + LYE L G P++G + + + Q +
Sbjct: 194 NTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD-QLSVMGAHINQAIP 252
Query: 513 FPES--PVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIRCATPPEI 570
P + P + A +I + K P+ R Y ++ A +
Sbjct: 253 RPSTVRPGIPVAFDAVIARGMAKNPEDR--YVT-CGDLSA---------AAHAALATADQ 300
Query: 571 PKPVEIER 578
+ +I R
Sbjct: 301 DRATDILR 308
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 9e-20
Identities = 39/162 (24%), Positives = 69/162 (42%), Gaps = 14/162 (8%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRA----QTEREIL 270
+ K++G G G V+ L K A+K + G +++ Q E I+
Sbjct: 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIM 77
Query: 271 QSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLA 330
+L+HP + LY +VMEF P GDL+ + +R + ++ L
Sbjct: 78 SNLNHPNIVKLYG-LMHNPP-RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRL-MLDIALG 134
Query: 331 LEYLHMLG--IIYRDLKPENVLVREDG-----HIMLSDFDLS 365
+EY+ I++RDL+ N+ ++ ++DF LS
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS 176
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 21/92 (22%), Positives = 38/92 (41%), Gaps = 4/92 (4%)
Query: 451 SMSFVGTHEYLAPEIIKGEG--HGSAVDWWTFGIFLYELLFGKTPFKG--SGNRATLFNV 506
+G +++APE I E + D ++F + LY +L G+ PF G + +
Sbjct: 183 VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242
Query: 507 VGQPLRFPESPVVSFAARDLIRGLLVKEPQHR 538
+ LR R++I +P+ R
Sbjct: 243 REEGLRPTIPEDCPPRLRNVIELCWSGDPKKR 274
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 2e-19
Identities = 81/465 (17%), Positives = 133/465 (28%), Gaps = 132/465 (28%)
Query: 163 GKSSICRGSTSSDVSDESTCSSFSSSINKPHKANDLRWEAIQAVRARDGVLGLSHFRLLK 222
G S + + + T S + + + + A D + + +
Sbjct: 1 GSSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIP-DRYEIRH 59
Query: 223 RLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREI--LQSLDHPFLPT 280
+G G G V + K A+K K + + REI L L+H +
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIK---KILRVFEDLIDCKRILREIAILNRLNHDHVVK 116
Query: 281 LYTHFETEKFSC-----LVMEFCPGGDLHT-LRQKQPGKYFPEQAVRFYVAEVLLALEYL 334
+ + +V+E D R E ++ + +L+ ++Y+
Sbjct: 117 VLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVY---LTELHIKTLLYNLLVGVKYV 172
Query: 335 HMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQ 394
H GI++RDLKP N LV +D + + DF L+
Sbjct: 173 HSAGILHRDLKPANCLVNQDCSVKVCDFGLA----------------------------- 203
Query: 395 PACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMS- 453
R + + L R ++
Sbjct: 204 ---------------------RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTG 242
Query: 454 FVGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELL-----------FGKTPFKGSGNRA 501
V T Y APE+I + + A+D W+ G ELL F GS
Sbjct: 243 HVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFP 302
Query: 502 TL-----------------------FNVVGQP-----------------LRFPESPVVSF 521
FN++G P FP+
Sbjct: 303 LSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDL 362
Query: 522 A---------ARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557
A A L++ +LV P R+ E HPFF+ V
Sbjct: 363 AERFPASSADAIHLLKRMLVFNPNKRIT----INECLAHPFFKEV 403
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 31/158 (19%), Positives = 54/158 (34%), Gaps = 11/158 (6%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD 274
L +L G ++ G +KV+ + RK E L+
Sbjct: 9 FKQLNFLTKLNENHSGELWKGRWQGNDI--VVKVLKVRDWSTRK-SRDFNEECPRLRIFS 65
Query: 275 HPFLPTLY---THFETEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQAVRFYVAEVLLA 330
HP + + L+ + P G L+ L + QAV+F ++
Sbjct: 66 HPNVLPVLGACQSPPAPHP-TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKF-ALDMARG 123
Query: 331 LEYLHMLG--IIYRDLKPENVLVREDGHIMLSDFDLSL 366
+ +LH L I L +V++ ED +S D+
Sbjct: 124 MAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF 161
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 6e-10
Identities = 21/91 (23%), Positives = 41/91 (45%), Gaps = 3/91 (3%)
Query: 451 SMSFVGTHEYLAPEIIKGEGHGS---AVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVV 507
S + ++APE ++ + + + D W+F + L+EL+ + PF N V
Sbjct: 165 SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVA 224
Query: 508 GQPLRFPESPVVSFAARDLIRGLLVKEPQHR 538
+ LR P +S L++ + ++P R
Sbjct: 225 LEGLRPTIPPGISPHVSKLMKICMNEDPAKR 255
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 35/146 (23%), Positives = 73/146 (50%), Gaps = 4/146 (2%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLL-RAQTEREILQSLDHP 276
++++ +LG G + +VYL+E + A+K + +++ L R + E L H
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAI-FIPPREKEETLKRFEREVHNSSQLSHQ 71
Query: 277 FLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHM 336
+ ++ E + LVME+ G L + G + A+ F ++L +++ H
Sbjct: 72 NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH-GPLSVDTAINF-TNQILDGIKHAHD 129
Query: 337 LGIIYRDLKPENVLVREDGHIMLSDF 362
+ I++RD+KP+N+L+ + + + DF
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDF 155
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 1e-08
Identities = 23/99 (23%), Positives = 45/99 (45%), Gaps = 3/99 (3%)
Query: 443 IAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRAT 502
++E + ++ +GT +Y +PE KGE D ++ GI LYE+L G+ PF G +
Sbjct: 161 LSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI 220
Query: 503 LFNVVGQPLRFPES---PVVSFAARDLIRGLLVKEPQHR 538
+ + + + + ++I K+ +R
Sbjct: 221 AIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANR 259
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 4e-19
Identities = 36/155 (23%), Positives = 67/155 (43%), Gaps = 11/155 (7%)
Query: 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH- 275
+RL +++G G G +YL A+K+ + + L E +I + +
Sbjct: 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHI--ESKIYKMMQGG 64
Query: 276 PFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLH 335
+PT+ ++ +VME G L L K F + V +++ +EY+H
Sbjct: 65 VGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRK-FSLKTVLLLADQMISRIEYIH 122
Query: 336 MLGIIYRDLKPENVLVREDGH---IMLSDFDLSLR 367
I+RD+KP+N L+ + + DF L+ +
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 6e-19
Identities = 37/164 (22%), Positives = 70/164 (42%), Gaps = 26/164 (15%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD 274
+ +++G G G+V+ +E G+ A+K++ + +++ E I++ L
Sbjct: 36 WCDLNIKEKIGAGSFGTVHRAEWHGSDV--AVKILMEQDFHA-ERVNEFLREVAIMKRLR 92
Query: 275 HP----FL------PTLYTHFETEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQAVRFY 323
HP F+ P L +V E+ G L+ L + + E+
Sbjct: 93 HPNIVLFMGAVTQPPNL----------SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSM 142
Query: 324 VAEVLLALEYLHMLG--IIYRDLKPENVLVREDGHIMLSDFDLS 365
+V + YLH I++R+LK N+LV + + + DF LS
Sbjct: 143 AYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 5e-12
Identities = 24/92 (26%), Positives = 40/92 (43%)
Query: 447 TEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNV 506
T S S GT E++APE+++ E D ++FG+ L+EL + P+ + V
Sbjct: 192 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV 251
Query: 507 VGQPLRFPESPVVSFAARDLIRGLLVKEPQHR 538
+ R ++ +I G EP R
Sbjct: 252 GFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKR 283
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 34/151 (22%), Positives = 69/151 (45%), Gaps = 8/151 (5%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRA-QTEREILQSLD 274
+ +R+G G G+VY + G A+K+++ + + L+A + E +L+
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAP--TPQQLQAFKNEVGVLRKTR 78
Query: 275 HPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYL 334
H + + + +V ++C G L+ K+ ++ + + ++YL
Sbjct: 79 HVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDI-ARQTARGMDYL 136
Query: 335 HMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
H II+RDLK N+ + ED + + DF L+
Sbjct: 137 HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLA 167
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 9e-11
Identities = 25/98 (25%), Positives = 43/98 (43%), Gaps = 7/98 (7%)
Query: 448 EARSMSFVGTHEYLAPEIIKGEGHG---SAVDWWTFGIFLYELLFGKTPFKGSGNRATLF 504
+ G+ ++APE+I+ + D + FGI LYEL+ G+ P+ NR +
Sbjct: 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII 235
Query: 505 NVVGQPLRFPESPVVSF----AARDLIRGLLVKEPQHR 538
+VG+ P+ V + L+ L K+ R
Sbjct: 236 EMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDER 273
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 6e-18
Identities = 44/155 (28%), Positives = 74/155 (47%), Gaps = 19/155 (12%)
Query: 216 SHFRLLKRLGCGDIGSVY--LSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL 273
++L+++LG G V+ ++ + K +K +KK+ R E +IL++L
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKV--VVK---ILKPVKKKKIKR---EIKILENL 87
Query: 274 -DHPFLPTLY--THFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLA 330
P + TL + LV E D L Q + +RFY+ E+L A
Sbjct: 88 RGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKA 142
Query: 331 LEYLHMLGIIYRDLKPENVLV-REDGHIMLSDFDL 364
L+Y H +GI++RD+KP NV++ E + L D+ L
Sbjct: 143 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 177
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 4e-06
Identities = 29/140 (20%), Positives = 44/140 (31%), Gaps = 41/140 (29%)
Query: 455 VGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTP-FKGSGNRATL---FNVVGQ 509
V + + PE++ ++D W+ G L ++F K P F G N L V+G
Sbjct: 191 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 250
Query: 510 P------------------LRFPESPVVSFA--------------ARDLIRGLLVKEPQH 537
+ A D + LL + Q
Sbjct: 251 EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQS 310
Query: 538 RLAYKRGATEIKQHPFFEGV 557
RL A E +HP+F V
Sbjct: 311 RLT----AREAMEHPYFYTV 326
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 32/169 (18%), Positives = 62/169 (36%), Gaps = 19/169 (11%)
Query: 217 HFRLLKRLGCGDIGSVYL--------SELSGTKCYFAMKV--MDKASLAGRKKLLRAQTE 266
++L + G +Y + K F++K+ D + RA
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKP 102
Query: 267 REI-----LQSLDHPFLPTLYTHFETE-KFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAV 320
++ L S +PT + K+ LV+ G L + P E++V
Sbjct: 103 LQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSV 161
Query: 321 RFYVAEVLLALEYLHMLGIIYRDLKPENVLV--REDGHIMLSDFDLSLR 367
+L ALE+LH ++ ++ EN+ V + + L+ + + R
Sbjct: 162 LQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 40/157 (25%), Positives = 69/157 (43%), Gaps = 12/157 (7%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSG----TKCYFAMKVMDKASLAGRKKLLRAQTEREILQ 271
H + L++LG G+ GSV + T A+K + ++ + R E EIL+
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER---EIEILK 97
Query: 272 SLDHPFLPTLY---THFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVL 328
SL H + L+ME+ P G L QK + + +++ +++
Sbjct: 98 SLQHDNIVKYKGVCYSAGRRNL-KLIMEYLPYGSLRDYLQKHKERIDHIKLLQY-TSQIC 155
Query: 329 LALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+EYL I+RDL N+LV + + + DF L+
Sbjct: 156 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 192
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 36/174 (20%), Positives = 65/174 (37%), Gaps = 25/174 (14%)
Query: 220 LLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREI--LQSLDHP- 276
LL+ +G G G V+ G A+K+ E E+ L H
Sbjct: 12 LLECVGKGRYGEVWRGSWQGE--NVAVKIFSSRDEK------SWFRETELYNTVMLRHEN 63
Query: 277 ---FLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEY 333
F+ + T + L+ + G L+ Q +R V + L +
Sbjct: 64 ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRI-VLSIASGLAH 120
Query: 334 LHML--------GIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASS 379
LH+ I +RDLK +N+LV+++G ++D L++ + S + +
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN 174
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 14/57 (24%), Positives = 22/57 (38%), Gaps = 6/57 (10%)
Query: 446 PTEARSMSFVGTHEYLAPEIIKGEGHGSA------VDWWTFGIFLYELLFGKTPFKG 496
+ + VGT Y+APE++ VD W FG+ L+E+
Sbjct: 169 QLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGI 225
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 44/230 (19%), Positives = 77/230 (33%), Gaps = 42/230 (18%)
Query: 164 KSSICRGSTSSDVSDESTCSSFSSSINKPHKANDLRWEAIQAVRARDGVLGLSHFRLLKR 223
+ I G+T D+ + +S S S L I L +
Sbjct: 7 RPFISEGTTLKDLIYDM-TTSGSGS-----GLPLLVQRTI-----------ARTIVLQES 49
Query: 224 LGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREI--LQSLDHPFLPTL 281
+G G G V+ + G + A+K+ E EI L H +
Sbjct: 50 IGKGRFGEVWRGKWRGEE--VAVKIFSSREERS------WFREAEIYQTVMLRHENILGF 101
Query: 282 YTHFETEKFS----CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHM- 336
+ + LV ++ G L + E ++ L +LHM
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKL-ALSTASGLAHLHME 158
Query: 337 -------LGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASS 379
I +RDLK +N+LV+++G ++D L++R + I +
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 208
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 33/162 (20%), Positives = 66/162 (40%), Gaps = 28/162 (17%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRA-QTEREILQSL 273
+ + +G G G VY G A++++D + L+A + E +
Sbjct: 32 FEQLEIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDN--EDQLKAFKREVMAYRQT 86
Query: 274 DHP----FL------PTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFY 323
H F+ P L ++ C G L+++ + + +
Sbjct: 87 RHENVVLFMGACMSPPHL----------AIITSLCKGRTLYSVVRDAKIVLDVNKTRQI- 135
Query: 324 VAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
E++ + YLH GI+++DLK +NV ++G ++++DF L
Sbjct: 136 AQEIVKGMGYLHAKGILHKDLKSKNVFY-DNGKVVITDFGLF 176
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 21/97 (21%), Positives = 36/97 (37%), Gaps = 11/97 (11%)
Query: 452 MSFVGTHEYLAPEIIKGEGHGS---------AVDWWTFGIFLYELLFGKTPFKGSGNRAT 502
G +LAPEII+ + D + G YEL + PFK A
Sbjct: 192 RIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI 251
Query: 503 LFNVVGQPLRFPESPV-VSFAARDLIRGLLVKEPQHR 538
++ +G ++ S + + D++ E + R
Sbjct: 252 IW-QMGTGMKPNLSQIGMGKEISDILLFCWAFEQEER 287
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 34/157 (21%), Positives = 63/157 (40%), Gaps = 13/157 (8%)
Query: 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH- 275
H+++ +R+G G G ++ A+K + S LR E + L
Sbjct: 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLR--DEYRTYKLLAGC 65
Query: 276 PFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLH 335
+P +Y + + LV++ G L L K F + V ++L ++ +H
Sbjct: 66 TGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRK-FSVKTVAMAAKQMLARVQSIH 123
Query: 336 MLGIIYRDLKPENVLVREDGH-----IMLSDFDLSLR 367
++YRD+KP+N L+ I + DF +
Sbjct: 124 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 40/157 (25%), Positives = 69/157 (43%), Gaps = 12/157 (7%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSG----TKCYFAMKVMDKASLAGRKKLLRAQTEREILQ 271
H + L++LG G+ GSV + T A+K + ++ + R E EIL+
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER---EIEILK 66
Query: 272 SLDHPFLPTLY---THFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVL 328
SL H + L+ME+ P G L QK + + +++ +++
Sbjct: 67 SLQHDNIVKYKGVCYSAGRRNL-KLIMEYLPYGSLRDYLQKHKERIDHIKLLQY-TSQIC 124
Query: 329 LALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+EYL I+RDL N+LV + + + DF L+
Sbjct: 125 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 161
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 4e-17
Identities = 45/153 (29%), Positives = 75/153 (49%), Gaps = 6/153 (3%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREI--LQS 272
+ +F+ ++++G G G VY + T A+K K L + + + REI L+
Sbjct: 2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALK---KIRLDTETEGVPSTAIREISLLKE 58
Query: 273 LDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALE 332
L+HP + L TE LV EF DL P ++ Y+ ++L L
Sbjct: 59 LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 333 YLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+ H +++RDLKP+N+L+ +G I L+DF L+
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 150
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 5e-17
Identities = 40/150 (26%), Positives = 71/150 (47%), Gaps = 8/150 (5%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLL-RAQTEREILQSLDHP 276
+ L + LG G + V+L+ A+KV+ +A LA R + E + +L+HP
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHP 72
Query: 277 FLPTLY----THFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALE 332
+ +Y +VME+ G L + + G P++A+ +A+ AL
Sbjct: 73 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIE-VIADACQALN 130
Query: 333 YLHMLGIIYRDLKPENVLVREDGHIMLSDF 362
+ H GII+RD+KP N+++ + + DF
Sbjct: 131 FSHQNGIIHRDVKPANIMISATNAVKVMDF 160
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 5e-09
Identities = 34/145 (23%), Positives = 62/145 (42%), Gaps = 17/145 (11%)
Query: 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLR 512
+ +GT +YL+PE +G+ + D ++ G LYE+L G+ PF G + + V +
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI 237
Query: 513 FPES--PVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIRCATPPEI 570
P + +S ++ L K P++R Y+ A E++ L+R
Sbjct: 238 PPSARHEGLSADLDAVVLKALAKNPENR--YQ-TAAEMRA---------DLVRVHNGEPP 285
Query: 571 PKP---VEIERIPAPTSSTSEKTAP 592
P + ER +S+ + P
Sbjct: 286 EAPKVLTDAERTSLLSSAAGNLSGP 310
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 5e-17
Identities = 42/148 (28%), Positives = 67/148 (45%), Gaps = 11/148 (7%)
Query: 221 LKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREI--LQSLDHPFL 278
+ ++G G G V+ T A+K K + +++ REI L+ L HP L
Sbjct: 8 IGKIGEGSYGVVFKCRNRDTGQIVAIK---KFLESEDDPVIKKIALREIRMLKQLKHPNL 64
Query: 279 PTLYTHFETEKFSCLVMEFCPGGDLHTLRQ--KQPGKYFPEQAVRFYVAEVLLALEYLHM 336
L F ++ LV E+C HT+ + + PE V+ + L A+ + H
Sbjct: 65 VNLLEVFRRKRRLHLVFEYCD----HTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK 120
Query: 337 LGIIYRDLKPENVLVREDGHIMLSDFDL 364
I+RD+KPEN+L+ + I L DF
Sbjct: 121 HNCIHRDVKPENILITKHSVIKLCDFGF 148
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 2e-06
Identities = 31/137 (22%), Positives = 50/137 (36%), Gaps = 39/137 (28%)
Query: 457 THE-----YLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSGNRATL---FNVV 507
E Y +PE++ G+ G VD W G ELL G + G + L +
Sbjct: 160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTL 219
Query: 508 GQP----------------LRFPES----------PVVSFAARDLIRGLLVKEPQHRLAY 541
G ++ P+ P +S+ A L++G L +P RL
Sbjct: 220 GDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLT- 278
Query: 542 KRGATEIKQHPFFEGVN 558
++ HP+FE +
Sbjct: 279 ---CEQLLHHPYFENIR 292
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 6e-17
Identities = 74/413 (17%), Positives = 127/413 (30%), Gaps = 139/413 (33%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREI--LQS 272
++ + +G G G VYL+ T+ A+K K + + + REI L
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK---KVNRMFEDLIDCKRILREITILNR 81
Query: 273 LDHP--------FLPTLYTHFETEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQAVRFY 323
L +P F+ E + +V+E DL + E+ ++
Sbjct: 82 LKSDYIIRLYDLIIPDDLLKFD-ELY--IVLEIA-DSDLKKLFKTPIF---LTEEHIKTI 134
Query: 324 VAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAE 383
+ +LL ++H GII+RDLKP N L+ +D + + DF L+
Sbjct: 135 LYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLA------------------ 176
Query: 384 PLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELI 443
R +S+ + E + P + +
Sbjct: 177 --------------------------------RTINSEKDTNIVNDLEENEEPGPHNKNL 204
Query: 444 AEP-TEARSMSFVGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTP-------- 493
+ T V T Y APE+I + + ++D W+ G ELL
Sbjct: 205 KKQLTS-----HVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR 259
Query: 494 ---FKGSGNRATL--------------------FNVVGQP-----------------LRF 513
F GS FN++G P F
Sbjct: 260 FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLF 319
Query: 514 PESPVVSFA---------ARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557
P ++ +L+ +L P R+ + HP+ + V
Sbjct: 320 PHRKPINLKQKYPSISDDGINLLESMLKFNPNKRIT----IDQALDHPYLKDV 368
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 8e-17
Identities = 51/211 (24%), Positives = 89/211 (42%), Gaps = 30/211 (14%)
Query: 169 RGSTSSDVSDESTCSSFSSSINKPHKANDLRWEAIQAVRARDGVLGLSH----FRLLKRL 224
R T+S ++ S+ + D + V A G + K +
Sbjct: 4 RPRTTSF-AESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVI 62
Query: 225 GCGDIGSVYLSELSGTKCYFAMK-VMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYT 283
G G G VY ++L + A+K V+ R E +I++ LDH + L
Sbjct: 63 GNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKLDHCNIVRLRY 114
Query: 284 HF------ETEKFSCLVMEFCPGGDLHTL-----RQKQPGKYFPEQAVRFYVAEVLLALE 332
F + E + LV+++ P ++ + R KQ P V+ Y+ ++ +L
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQT---LPVIYVKLYMYQLFRSLA 170
Query: 333 YLHMLGIIYRDLKPENVLVREDGHIM-LSDF 362
Y+H GI +RD+KP+N+L+ D ++ L DF
Sbjct: 171 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDF 201
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 34/124 (27%), Positives = 44/124 (35%), Gaps = 32/124 (25%)
Query: 460 YLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSGNRATL---FNVVGQP----- 510
Y APE+I G S++D W+ G L ELL G+ F G L V+G P
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 281
Query: 511 ---------LRFPESPVVSFA----------ARDLIRGLLVKEPQHRLAYKRGATEIKQH 551
+FP+ + A L LL P RL E H
Sbjct: 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT----PLEACAH 337
Query: 552 PFFE 555
FF+
Sbjct: 338 SFFD 341
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 9e-17
Identities = 45/161 (27%), Positives = 72/161 (44%), Gaps = 24/161 (14%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTE-------- 266
+ + L +LG G +VY + T A+K +R + E
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKE------------IRLEHEEGAPCTAI 48
Query: 267 REI--LQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYV 324
RE+ L+ L H + TL+ TEK LV E+ DL G V+ ++
Sbjct: 49 REVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQY-LDDCGNIINMHNVKLFL 106
Query: 325 AEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
++L L Y H +++RDLKP+N+L+ E G + L+DF L+
Sbjct: 107 FQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLA 147
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 4e-08
Identities = 36/180 (20%), Positives = 62/180 (34%), Gaps = 53/180 (29%)
Query: 457 THE-----YLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSGNRATL---FNVV 507
+E Y P+I+ G + +D W G YE+ G+ F GS L F ++
Sbjct: 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRIL 217
Query: 508 GQP----------------LRFPESPVVSF---------AARDLIRGLLVKEPQHRLAYK 542
G P +P+ + DL+ LL E ++R++
Sbjct: 218 GTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRIS-- 275
Query: 543 RGATEIKQHPFFEGVNWALIRCATPPEIPKPVEIERIPAPTSSTSEKTAPTMVPPNQRGS 602
A + +HPFF + + I ++P TS + K + R +
Sbjct: 276 --AEDAMKHPFFL-------------SLGER--IHKLPDTTSIFALKEIQLQKEASLRSA 318
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 9e-17
Identities = 81/393 (20%), Positives = 129/393 (32%), Gaps = 117/393 (29%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREI--LQS 272
L + L+K+LG G G V+ S T A+K K A + +T REI L
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVK---KIFDAFQNSTDAQRTFREIMILTE 64
Query: 273 L-DHPFLPTLYTHFETEKFSC--LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLL 329
L H + L + LV ++ DLH + + ++ V +++
Sbjct: 65 LSGHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRANI---LEPVHKQYVVYQLIK 120
Query: 330 ALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNP 389
++YLH G+++RD+KP N+L+ + H+ ++DF LS
Sbjct: 121 VIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLS------------------------ 156
Query: 390 VYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449
R F + + I + T+
Sbjct: 157 --------------------------RSFVNIRRVTNNIPLSINENTENFDDDQPILTD- 189
Query: 450 RSMSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATL---FN 505
+V T Y APEI+ G + +D W+ G L E+L GK F GS L
Sbjct: 190 ----YVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245
Query: 506 VVGQP-----------------LRFPESPVVSFA-------------------------A 523
V+ P E + + A
Sbjct: 246 VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEA 305
Query: 524 RDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556
DL+ LL P R++ A + +HPF
Sbjct: 306 LDLLDKLLQFNPNKRIS----ANDALKHPFVSI 334
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 9e-17
Identities = 40/163 (24%), Positives = 67/163 (41%), Gaps = 17/163 (10%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRA-QTEREILQSL 273
+ L + +G G G VY + G + A+K + + + E ++ L
Sbjct: 6 FAELTLEEIIGIGGFGKVYRAFWIGDEV--AVKAARHDPDEDISQTIENVRQEAKLFAML 63
Query: 274 DHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEY 333
HP + L E CLVMEF GG L+ + + P+ V + ++ + Y
Sbjct: 64 KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIP--PDILVNW-AVQIARGMNY 120
Query: 334 LHMLG---IIYRDLKPENVLVREDGHIM--------LSDFDLS 365
LH II+RDLK N+L+ + ++DF L+
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 25/88 (28%), Positives = 39/88 (44%)
Query: 451 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQP 510
MS G + ++APE+I+ D W++G+ L+ELL G+ PF+G A + V
Sbjct: 171 KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK 230
Query: 511 LRFPESPVVSFAARDLIRGLLVKEPQHR 538
L P L+ +P R
Sbjct: 231 LALPIPSTCPEPFAKLMEDCWNPDPHSR 258
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 42/159 (26%), Positives = 64/159 (40%), Gaps = 17/159 (10%)
Query: 216 SHFRLLKRLGCGDIGSVYLSEL----SGTKCYFAMKVM-DKASLAGRKKLLRAQTEREIL 270
+ + ++ LG G G V L GT A+K + A R + E +IL
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQ---EIDIL 87
Query: 271 QSLDHPFLPTLY---THFETEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQAVRFYVAE 326
++L H + LVME+ P G L L + G Q + F +
Sbjct: 88 RTLYHEHIIKYKGCCEDAGAASL-QLVMEYVPLGSLRDYLPRHSIG---LAQLLLF-AQQ 142
Query: 327 VLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+ + YLH I+RDL NVL+ D + + DF L+
Sbjct: 143 ICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLA 181
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 1e-16
Identities = 45/182 (24%), Positives = 68/182 (37%), Gaps = 29/182 (15%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREI--LQS 272
L + +LL+ +G G G+VY L A+KV A+ E+ I +
Sbjct: 12 LDNLKLLELIGRGRYGAVYKGSLDER--PVAVKVFSFANRQN------FINEKNIYRVPL 63
Query: 273 LDHPFLPTLY-----THFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVA-E 326
++H + + LVME+ P G L + +A
Sbjct: 64 MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHS 119
Query: 327 VLLALEYLHM---------LGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKA 377
V L YLH I +RDL NVLV+ DG ++SDF LS+R + +
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPG 179
Query: 378 SS 379
Sbjct: 180 EE 181
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 15/70 (21%), Positives = 29/70 (41%), Gaps = 7/70 (10%)
Query: 437 SPLPELIAEPTEARSMSFVGTHEYLAPEIIKG-------EGHGSAVDWWTFGIFLYELLF 489
+ + + ++S VGT Y+APE+++G E VD + G+ +E+
Sbjct: 171 TGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230
Query: 490 GKTPFKGSGN 499
T +
Sbjct: 231 RCTDLFPGES 240
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 39/224 (17%), Positives = 78/224 (34%), Gaps = 42/224 (18%)
Query: 170 GSTSSDVSDESTCSSFSSSINKPHKANDLRWEAIQAVRARDGVLGLSHFRLLKRLGCGDI 229
G + D+ ++S S S + L I +++K++G G
Sbjct: 8 GESLRDLIEQSQSSGSGSGLPL------LVQRTI-----------AKQIQMVKQIGKGRY 50
Query: 230 GSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREI--LQSLDHPFLPTLYTHFET 287
G V++ + G A+KV A + E EI + H +
Sbjct: 51 GEVWMGKWRGE--KVAVKVFFTTEEASWFR------ETEIYQTVLMRHENILGFIAADIK 102
Query: 288 EKFS----CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHML------ 337
S L+ ++ G L+ + + ++ + L +LH
Sbjct: 103 GTGSWTQLYLITDYHENGSLYDYLKSTTLD--AKSMLKL-AYSSVSGLCHLHTEIFSTQG 159
Query: 338 --GIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASS 379
I +RDLK +N+LV+++G ++D L+++ +
Sbjct: 160 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPP 203
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 45/164 (27%), Positives = 71/164 (43%), Gaps = 27/164 (16%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTE--------R 267
S F+ L++LG G +VY T Y A+K ++ +E R
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKE------------VKLDSEEGTPSTAIR 52
Query: 268 EI--LQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTL----RQKQPGKYFPEQAVR 321
EI ++ L H + LY TE LV EF DL + V+
Sbjct: 53 EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVK 111
Query: 322 FYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
++ ++L L + H I++RDLKP+N+L+ + G + L DF L+
Sbjct: 112 YFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 1e-06
Identities = 31/167 (18%), Positives = 54/167 (32%), Gaps = 55/167 (32%)
Query: 457 THE-----YLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSGNRATL---FNVV 507
+ E Y AP+++ G +++D W+ G L E++ GK F G+ + L F+++
Sbjct: 166 SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIM 225
Query: 508 GQP-----------------------------LRFPESPVVSFAARDLIRGLLVKEPQHR 538
G P L+ + D + GLL P R
Sbjct: 226 GTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMR 285
Query: 539 LAYKRGATEIKQHPFFEGVNWALIRCATPPEIPKPVEIERIPAPTSS 585
L+ A + HP+F E + +
Sbjct: 286 LS----AKQALHHPWFA-------------EYYHHASMGGSRSHHHH 315
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 40/154 (25%), Positives = 65/154 (42%), Gaps = 11/154 (7%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVM-DKASLAGRKKLLRAQTEREILQSLD 274
L +++G G+ G V+ L A+K + + K L+ E IL+
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQ---EARILKQYS 170
Query: 275 HPFLPTLY---THFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLAL 331
HP + L T + +VME GGD T + + + + ++ V + +
Sbjct: 171 HPNIVRLIGVCTQKQP---IYIVMELVQGGDFLTFLRTEGARLRVKTLLQM-VGDAAAGM 226
Query: 332 EYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
EYL I+RDL N LV E + +SDF +S
Sbjct: 227 EYLESKCCIHRDLAARNCLVTEKNVLKISDFGMS 260
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 37/158 (23%), Positives = 62/158 (39%), Gaps = 13/158 (8%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKV-----MDKASLAGRKKLLRAQTEREIL 270
+ ++ LG G G V L +V ++ L + E EIL
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKK---EIEIL 77
Query: 271 QSLDHPFLPTLY---THFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEV 327
++L H + T L+MEF P G L K K +Q +++ ++
Sbjct: 78 RNLYHENIVKYKGICTEDGGNGI-KLIMEFLPSGSLKEYLPKNKNKINLKQQLKY-AVQI 135
Query: 328 LLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
++YL ++RDL NVLV + + + DF L+
Sbjct: 136 CKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 173
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 43/152 (28%), Positives = 68/152 (44%), Gaps = 11/152 (7%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREI--LQSLDH 275
+ L +G G G V T A+K K + K+++ REI L+ L H
Sbjct: 27 YENLGLVGEGSYGMVMKCRNKDTGRIVAIK---KFLESDDDKMVKKIAMREIKLLKQLRH 83
Query: 276 PFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQ--KQPGKYFPEQAVRFYVAEVLLALEY 333
L L + +K LV EF HT+ + Q V+ Y+ +++ + +
Sbjct: 84 ENLVNLLEVCKKKKRWYLVFEFVD----HTILDDLELFPNGLDYQVVQKYLFQIINGIGF 139
Query: 334 LHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
H II+RD+KPEN+LV + G + L DF +
Sbjct: 140 CHSHNIIHRDIKPENILVSQSGVVKLCDFGFA 171
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 4e-07
Identities = 34/157 (21%), Positives = 51/157 (32%), Gaps = 44/157 (28%)
Query: 457 THE-----YLAPEIIKGEGH-GSAVDWWTFG-IFLYELLFGKTPFKGSGNRATL---FNV 506
E Y APE++ G+ G AVD W G + E+ G+ F G + L
Sbjct: 182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLV-TEMFMGEPLFPGDSDIDQLYHIMMC 240
Query: 507 VGQP----------------LRFPES----------PVVSFAARDLIRGLLVKEPQHRLA 540
+G +R PE P +S DL + L +P R
Sbjct: 241 LGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPF 300
Query: 541 YKRGATEIKQHPFFEGVNWALIRCATPPEIPKPVEIE 577
E+ H FF+ E+ V+ +
Sbjct: 301 ----CAELLHHDFFQMDG---FAERFSQELQLKVQKD 330
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 4e-16
Identities = 34/182 (18%), Positives = 62/182 (34%), Gaps = 31/182 (17%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREI--LQSL 273
+LL+ G G V+ ++L Y A+K+ Q E E+ L +
Sbjct: 24 MPLQLLEVKARGRFGCVWKAQLLNE--YVAVKIFPIQDKQS------WQNEYEVYSLPGM 75
Query: 274 DHPFLPTLY------THFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEV 327
H + T + + L+ F G L + + + +
Sbjct: 76 KHENILQFIGAEKRGTSVDVDL--WLITAFHEKGSLSDFLKANVVSW--NELCHIAE-TM 130
Query: 328 LLALEYLHM----------LGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKA 377
L YLH I +RD+K +NVL++ + ++DF L+L+ +
Sbjct: 131 ARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDT 190
Query: 378 SS 379
Sbjct: 191 HG 192
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 9e-04
Identities = 22/102 (21%), Positives = 38/102 (37%), Gaps = 9/102 (8%)
Query: 447 TEARSMSFVGTHEYLAPEIIKGEGHGSA-----VDWWTFGIFLYELLFGKTPFKGS--GN 499
+ + VGT Y+APE+++G + +D + G+ L+EL T G
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 500 RATLFNVVGQPLRFPE--SPVVSFAARDLIRGLLVKEPQHRL 539
+GQ + VV R ++R K +
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAM 287
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 38/151 (25%), Positives = 64/151 (42%), Gaps = 6/151 (3%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH 275
+ + +LG G G VY A+K + K ++ L+ E +++ + H
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLK---EAAVMKEIKH 68
Query: 276 PFLPTLYTHFETEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQAVRFYVAEVLLALEYL 334
P L L E ++ EF G+L LR+ + + ++ A+EYL
Sbjct: 69 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM-ATQISSAMEYL 127
Query: 335 HMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
I+RDL N LV E+ + ++DF LS
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLS 158
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 7e-16
Identities = 38/157 (24%), Positives = 70/157 (44%), Gaps = 12/157 (7%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSG----TKCYFAMKVMDKASLAGRKKLLRAQTEREILQ 271
H + + +LG G+ GSV L T A+K + + ++ R E +IL+
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQR---EIQILK 79
Query: 272 SLDHPFLPTLY---THFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVL 328
+L F+ + LVME+ P G L Q+ + + + + +++
Sbjct: 80 ALHSDFIVKYRGVSYGPGRQSL-RLVMEYLPSGCLRDFLQRHRARLDASRLLLY-SSQIC 137
Query: 329 LALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+EYL ++RDL N+LV + H+ ++DF L+
Sbjct: 138 KGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLA 174
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 7e-16
Identities = 35/171 (20%), Positives = 70/171 (40%), Gaps = 23/171 (13%)
Query: 217 HFRLLKRLGCGDIGSVYL-----SELSGTKCYFAMKVMDKAS---LAGRKKLLRAQTERE 268
+++ +G G G +YL SE G+ +KV + K RA +
Sbjct: 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95
Query: 269 I-----LQSLDHPFLPTLY----THFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQA 319
I + L + +P + + + ++M+ G DL + + + F +
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKR-FSRKT 153
Query: 320 VRFYVAEVLL-ALEYLHMLGIIYRDLKPENVLV--REDGHIMLSDFDLSLR 367
V ++ +L LEY+H ++ D+K N+L+ + + L D+ L+ R
Sbjct: 154 V-LQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYR 203
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 9e-16
Identities = 31/101 (30%), Positives = 51/101 (50%), Gaps = 4/101 (3%)
Query: 267 REI--LQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYV 324
REI L+ L H + LY T+K LV E DL L G + ++
Sbjct: 49 REISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGG-LESVTAKSFL 106
Query: 325 AEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
++L + Y H +++RDLKP+N+L+ +G + ++DF L+
Sbjct: 107 LQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLA 147
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 5e-07
Identities = 28/135 (20%), Positives = 49/135 (36%), Gaps = 37/135 (27%)
Query: 457 THE-----YLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSGNRATL---FNVV 507
THE Y AP+++ G + +D W+ G E++ G F G L F ++
Sbjct: 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRIL 217
Query: 508 GQP---------------LRFPESPVVSF---------AARDLIRGLLVKEPQHRLAYKR 543
G P F + + + DL+ +L +P R+
Sbjct: 218 GTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT--- 274
Query: 544 GATEIKQHPFFEGVN 558
A + +H +F+ N
Sbjct: 275 -AKQALEHAYFKENN 288
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 46/170 (27%), Positives = 82/170 (48%), Gaps = 13/170 (7%)
Query: 202 AIQAVRARDGVLGLSHFRLL-KRLGCGDIGSVYLSELSGTKCYF--AMKVM--DKASLAG 256
A++ +R ++ L L K LG G+ G+V K A+K++ + A
Sbjct: 2 ALEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL 61
Query: 257 RKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHT-LRQKQPGKYF 315
+ +LL E ++Q LD+P++ + E E + LVME G L+ L+Q ++
Sbjct: 62 KDELLA---EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQ---NRHV 114
Query: 316 PEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
++ + V +V + ++YL ++RDL NVL+ + +SDF LS
Sbjct: 115 KDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS 164
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 1e-15
Identities = 37/151 (24%), Positives = 64/151 (42%), Gaps = 6/151 (3%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH 275
+ + +LG G G VY A+K + K ++ L+ E +++ + H
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLK---EAAVMKEIKH 275
Query: 276 PFLPTLYTHFETEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQAVRFYVAEVLLALEYL 334
P L L E ++ EF G+L LR+ + + ++ A+EYL
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM-ATQISSAMEYL 334
Query: 335 HMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
I+R+L N LV E+ + ++DF LS
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLS 365
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 45/154 (29%), Positives = 68/154 (44%), Gaps = 14/154 (9%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH 275
+LL+ +G G+ G V L + G K A+K + K A + L E ++ L H
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYRGNKV--AVKCI-KND-ATAQAFLA---EASVMTQLRH 245
Query: 276 PFLPTLY---THFETEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQAVRFYVAEVLLAL 331
L L E + +V E+ G L LR + + ++F +V A+
Sbjct: 246 SNLVQLLGVIV--EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF-SLDVCEAM 302
Query: 332 EYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
EYL ++RDL NVLV ED +SDF L+
Sbjct: 303 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 336
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 1e-15
Identities = 32/101 (31%), Positives = 55/101 (54%), Gaps = 4/101 (3%)
Query: 267 REI--LQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYV 324
REI L+ L HP + +L +E+ LV EF DL + + + ++ Y+
Sbjct: 68 REISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTG-LQDSQIKIYL 125
Query: 325 AEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
++L + + H I++RDLKP+N+L+ DG + L+DF L+
Sbjct: 126 YQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLA 166
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 4e-07
Identities = 30/136 (22%), Positives = 53/136 (38%), Gaps = 38/136 (27%)
Query: 457 THE-----YLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSGNRATL---FNVV 507
THE Y AP+++ G ++VD W+ G E++ GK F G + L F+++
Sbjct: 177 THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSIL 236
Query: 508 GQP----------------LRFPESPVVSF---------AARDLIRGLLVKEPQHRLAYK 542
G P F + DL+ +L +P R++
Sbjct: 237 GTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRIS-- 294
Query: 543 RGATEIKQHPFFEGVN 558
A + HP+F+ ++
Sbjct: 295 --ARDAMNHPYFKDLD 308
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 2e-15
Identities = 45/152 (29%), Positives = 68/152 (44%), Gaps = 10/152 (6%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH 275
+LL+ +G G+ G V L + G K A+K + K A + L E ++ L H
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDYRGNKV--AVKCI-KND-ATAQAFLA---EASVMTQLRH 73
Query: 276 PFLPTLY-THFETEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQAVRFYVAEVLLALEY 333
L L E + +V E+ G L LR + + ++F +V A+EY
Sbjct: 74 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF-SLDVCEAMEY 132
Query: 334 LHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
L ++RDL NVLV ED +SDF L+
Sbjct: 133 LEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 164
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 2e-15
Identities = 41/160 (25%), Positives = 75/160 (46%), Gaps = 21/160 (13%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTE-------R 267
+ + L+++G G G+V+ ++ T A+K + L E R
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALK----------RVRLDDDDEGVPSSALR 50
Query: 268 EI--LQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVA 325
EI L+ L H + L+ ++K LV EFC DL G + V+ ++
Sbjct: 51 EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGD-LDPEIVKSFLF 108
Query: 326 EVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
++L L + H +++RDLKP+N+L+ +G + L++F L+
Sbjct: 109 QLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLA 148
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 1e-05
Identities = 31/132 (23%), Positives = 50/132 (37%), Gaps = 38/132 (28%)
Query: 457 THE-----YLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTP-FKGSGNRATL---FNV 506
+ E Y P+++ G +++D W+ G EL P F G+ L F +
Sbjct: 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL 218
Query: 507 VGQP--------------LRFPES----------PVVSFAARDLIRGLLVKEPQHRLAYK 542
+G P +P P ++ RDL++ LL P R++
Sbjct: 219 LGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS-- 276
Query: 543 RGATEIKQHPFF 554
A E QHP+F
Sbjct: 277 --AEEALQHPYF 286
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 44/155 (28%), Positives = 72/155 (46%), Gaps = 13/155 (8%)
Query: 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH- 275
+FR+ K++GCG+ G + L + T Y A+K+ S R L E + L
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS---RAPQLH--LEYRFYKQLGSG 64
Query: 276 PFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLH 335
+P +Y K++ +V+E G L L F + V +++ +EY+H
Sbjct: 65 DGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRT-FSLKTVLMIAIQLISRMEYVH 122
Query: 336 MLGIIYRDLKPENVLVREDGH-----IMLSDFDLS 365
+IYRD+KPEN L+ G+ I + DF L+
Sbjct: 123 SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 48/194 (24%), Positives = 74/194 (38%), Gaps = 14/194 (7%)
Query: 179 ESTCSSFSSSINKPHKANDLRWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSVY---LS 235
E+ + + E +A R+ + S + K +G GD G V L
Sbjct: 12 ENLYFQGKLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLR 71
Query: 236 ELSGTKCYFAMKVM-DKASLAGRKKLLRAQTEREILQSLDHPFLPTLY---THFETEKFS 291
A+K + + R+ L E I+ DHP + L T +
Sbjct: 72 VPGQRDVPVAIKALKAGYTERQRRDFLS---EASIMGQFDHPNIIRLEGVVTRGRL---A 125
Query: 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLV 351
+V E+ G L T + G++ Q V + V + YL LG ++RDL NVLV
Sbjct: 126 MIVTEYMENGSLDTFLRTHDGQFTIMQLVGM-LRGVGAGMRYLSDLGYVHRDLAARNVLV 184
Query: 352 REDGHIMLSDFDLS 365
+ +SDF LS
Sbjct: 185 DSNLVCKVSDFGLS 198
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 35/158 (22%), Positives = 63/158 (39%), Gaps = 15/158 (9%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDK-----ASLAGRKKLLRAQTEREIL 270
S K +G G+ G VY L + + V K + R L E I+
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLG---EAGIM 100
Query: 271 QSLDHPFLPTLY---THFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEV 327
H + L + ++ ++ E+ G L +++ G++ Q V + +
Sbjct: 101 GQFSHHNIIRLEGVISKYKP---MMIITEYMENGALDKFLREKDGEFSVLQLVGM-LRGI 156
Query: 328 LLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
++YL + ++RDL N+LV + +SDF LS
Sbjct: 157 AAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS 194
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 4e-15
Identities = 38/152 (25%), Positives = 70/152 (46%), Gaps = 10/152 (6%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSG-TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD 274
+L K+LG G G V+++ + TK A+K M K + L E ++++L
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKV--AVKTM-KPGSMSVEAFLA---EANVMKTLQ 241
Query: 275 HPFLPTLYTHFETEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQAVRFYVAEVLLALEY 333
H L L+ T++ ++ EF G L L+ + K + + F A++ + +
Sbjct: 242 HDKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF-SAQIAEGMAF 299
Query: 334 LHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+ I+RDL+ N+LV ++DF L+
Sbjct: 300 IEQRNYIHRDLRAANILVSASLVCKIADFGLA 331
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 5e-15
Identities = 39/152 (25%), Positives = 71/152 (46%), Gaps = 10/152 (6%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSG-TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD 274
RL +LG G G V++ +G T+ A+K + K + L+ E ++++ L
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRV--AIKTL-KPGTMSPEAFLQ---EAQVMKKLR 237
Query: 275 HPFLPTLYTHFETEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQAVRFYVAEVLLALEY 333
H L LY +E+ +V E+ G L L+ + Q V A++ + Y
Sbjct: 238 HEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM-AAQIASGMAY 295
Query: 334 LHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+ + ++RDL+ N+LV E+ ++DF L+
Sbjct: 296 VERMNYVHRDLRAANILVGENLVCKVADFGLA 327
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 5e-15
Identities = 42/153 (27%), Positives = 61/153 (39%), Gaps = 5/153 (3%)
Query: 216 SHFRLLKRLGCGDIGSVY---LSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQS 272
RLL++LG G G V SG A+K + L+ + + E + S
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 273 LDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALE 332
LDH L LY T +V E P G L +K G + R+ +V +
Sbjct: 78 LDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFLLGTLSRY-AVQVAEGMG 135
Query: 333 YLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
YL I+RDL N+L+ + + DF L
Sbjct: 136 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLM 168
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 5e-15
Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 11/108 (10%)
Query: 267 REI-----LQSLDHPFLPTLY-----THFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFP 316
RE+ L++ +HP + L + + E LV E DL T K P P
Sbjct: 60 REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLP 118
Query: 317 EQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDL 364
+ ++ + + L L++LH I++RDLKPEN+LV G + L+DF L
Sbjct: 119 AETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGL 166
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 50.6 bits (122), Expect = 6e-07
Identities = 26/128 (20%), Positives = 42/128 (32%), Gaps = 34/128 (26%)
Query: 457 THE-----YLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATL---FNVVG 508
T Y APE++ + + VD W+ G E+ K F G+ L F+++G
Sbjct: 177 TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 236
Query: 509 QP-------------LRFPESPVVSF---------AARDLIRGLLVKEPQHRLAYKRGAT 546
P FP + L+ +L P R++ A
Sbjct: 237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRIS----AF 292
Query: 547 EIKQHPFF 554
QH +
Sbjct: 293 RALQHSYL 300
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 41/179 (22%), Positives = 78/179 (43%), Gaps = 24/179 (13%)
Query: 196 NDLRWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMK-VMDKASL 254
+ + + A + G + K +G G G V+ ++L + A+K V+
Sbjct: 20 DPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESD-EVAIKKVLQDKRF 78
Query: 255 AGRKKLLRAQTEREILQSLDHP--------FLPTLYTHFETEKFSCLVMEFCPGGDLHTL 306
R E +I++ + HP F + E F LV+E+ P ++
Sbjct: 79 KNR--------ELQIMRIVKHPNVVDLKAFFYSN--GDKKDEVFLNLVLEYVPE-TVYRA 127
Query: 307 --RQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLV-REDGHIMLSDF 362
+ + P ++ Y+ ++L +L Y+H +GI +RD+KP+N+L+ G + L DF
Sbjct: 128 SRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDF 186
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 39/142 (27%), Positives = 54/142 (38%), Gaps = 32/142 (22%)
Query: 460 YLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSGNRATL---FNVVGQP----- 510
Y APE+I G + + +D W+ G + EL+ G+ F G L V+G P
Sbjct: 207 YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266
Query: 511 ---------LRFPESPVVSFA----------ARDLIRGLLVKEPQHRLAYKRGATEIKQH 551
+FP+ F+ A DLI LL P RL A E H
Sbjct: 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLT----AIEALCH 322
Query: 552 PFFEGVNWALIRCATPPEIPKP 573
PFF+ + R E+P
Sbjct: 323 PFFDELRTGEARMPNGRELPPL 344
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 6e-15
Identities = 37/100 (37%), Positives = 51/100 (51%), Gaps = 4/100 (4%)
Query: 267 REI--LQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYV 324
REI LQ L HP + L F + LV +F DL + K ++ Y+
Sbjct: 61 REIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVI-IKDNSLVLTPSHIKAYM 118
Query: 325 AEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDL 364
L LEYLH I++RDLKP N+L+ E+G + L+DF L
Sbjct: 119 LMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGL 158
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 1e-07
Identities = 40/182 (21%), Positives = 59/182 (32%), Gaps = 52/182 (28%)
Query: 457 THE-----YLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSGNRATL---FNVV 507
TH+ Y APE++ G G VD W G L ELL G + L F +
Sbjct: 170 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETL 229
Query: 508 GQP--------------LRFPESPVVSF---------AARDLIRGLLVKEPQHRLAYKRG 544
G P + F P + DLI+GL + P R+
Sbjct: 230 GTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT---- 285
Query: 545 ATEIKQHPFFEGVNWALIRCATPPEIPKPVEIERIPAPTSST---SEKTAPTMVPPNQRG 601
AT+ + +F P P ++P P E++ P + +R
Sbjct: 286 ATQALKMKYFS-------------NRPGPTPGCQLPRPNCPVETLKEQSNPALAIKRKRT 332
Query: 602 SD 603
Sbjct: 333 EA 334
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 76.2 bits (187), Expect = 8e-15
Identities = 35/155 (22%), Positives = 67/155 (43%), Gaps = 11/155 (7%)
Query: 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DH 275
FRL +++G G G +YL T A+K+ + + + L E +I + L
Sbjct: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLY--ESKIYRILQGG 62
Query: 276 PFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLH 335
+P + ++ LVM+ G L L K + V +++ +E++H
Sbjct: 63 TGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVH 120
Query: 336 MLGIIYRDLKPENVLVREDGH---IMLSDFDLSLR 367
++RD+KP+N L+ + + DF L+ +
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 1e-14
Identities = 37/154 (24%), Positives = 62/154 (40%), Gaps = 9/154 (5%)
Query: 216 SHFRLLKRLGCGDIGSVY---LSELSGTKCYFAMKVM-DKASLAGRKKLLRAQTEREILQ 271
L + +G G G V+ A+K + S + R+K L+ E ++
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ---EALTMR 71
Query: 272 SLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLAL 331
DHP + L ++ME C G+L + Q + + + ++ AL
Sbjct: 72 QFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILY-AYQLSTAL 129
Query: 332 EYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
YL ++RD+ NVLV + + L DF LS
Sbjct: 130 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 163
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 46/158 (29%), Positives = 76/158 (48%), Gaps = 15/158 (9%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREI--LQSL 273
++ L +G G GSV + + T A+K K S + + +T RE+ L+ +
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK---KLSRPFQSIIHAKRTYRELRLLKHM 85
Query: 274 DHPFLPTLYTHF----ETEKFSC--LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEV 327
H + L F E+F+ LV G DL+ + + Q + V+F + ++
Sbjct: 86 KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK---LTDDHVQFLIYQI 141
Query: 328 LLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
L L+Y+H II+RDLKP N+ V ED + + DF L+
Sbjct: 142 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 179
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 9e-08
Identities = 37/142 (26%), Positives = 55/142 (38%), Gaps = 39/142 (27%)
Query: 449 ARSMS-----FVGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSGNRAT 502
AR + +V T Y APEI+ H VD W+ G + ELL G+T F G+ +
Sbjct: 179 ARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 238
Query: 503 L---FNVVGQP-----------------LRFPESPVVSFA---------ARDLIRGLLVK 533
L +VG P + P ++FA A DL+ +LV
Sbjct: 239 LKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVL 298
Query: 534 EPQHRLAYKRGATEIKQHPFFE 555
+ R+ A + H +F
Sbjct: 299 DSDKRIT----AAQALAHAYFA 316
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 38/155 (24%), Positives = 71/155 (45%), Gaps = 10/155 (6%)
Query: 216 SHFRLLKRLGCGDIGSVY----LSELSGTKCYFAMKVM-DKASLAGRKKLLRAQTEREIL 270
+ F+ +K LG G G+VY + E K A+K + + S K++L E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD---EAYVM 71
Query: 271 QSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLA 330
S+D+P + L T L+ + P G L ++ + + + ++
Sbjct: 72 ASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYLLNW-CVQIAKG 129
Query: 331 LEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+ YL +++RDL NVLV+ H+ ++DF L+
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 38/164 (23%), Positives = 68/164 (41%), Gaps = 25/164 (15%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMK-VMDKASLAGRKKLLRAQTEREI--LQ 271
+ F++ + G G G+V L + T A+K V+ R + + L
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNR-------ELQIMQDLA 74
Query: 272 SLDHP--------FLPTLYTHFETEKFSCLVMEFCPGGDLHTL--RQKQPGKYFPEQAVR 321
L HP F + + +VME+ P LH + P ++
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRR-DIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIK 132
Query: 322 FYVAEVLLALEYLHM--LGIIYRDLKPENVLV-REDGHIMLSDF 362
++ +++ ++ LH+ + + +RD+KP NVLV DG + L DF
Sbjct: 133 VFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDF 176
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 34/144 (23%), Positives = 59/144 (40%), Gaps = 36/144 (25%)
Query: 443 IAEPTEARSMSFVGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSGNRA 501
P+E +++++ + Y APE+I G H +AVD W+ G E++ G+ F+G +
Sbjct: 181 KLSPSEP-NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG 239
Query: 502 TL---FNVVGQP--------------LRFPESPVVSFA-------------ARDLIRGLL 531
L V+G P + S + ++ A DL+ LL
Sbjct: 240 QLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALL 299
Query: 532 VKEPQHRLAYKRGATEIKQHPFFE 555
P+ R+ E HP+F+
Sbjct: 300 QYLPEERMK----PYEALCHPYFD 319
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 48/158 (30%), Positives = 76/158 (48%), Gaps = 15/158 (9%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREI--LQSL 273
+ +R L+ +G G G+V + T A+K K + +L + RE+ L+ +
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK---KLYRPFQSELFAKRAYRELRLLKHM 81
Query: 274 DHPFLPTLYTHF----ETEKFSC--LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEV 327
H + L F + F+ LVM F G DL L + + E ++F V ++
Sbjct: 82 RHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEK---LGEDRIQFLVYQM 137
Query: 328 LLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
L L Y+H GII+RDLKP N+ V ED + + DF L+
Sbjct: 138 LKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 175
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 40/143 (27%), Positives = 54/143 (37%), Gaps = 39/143 (27%)
Query: 449 ARSMS-----FVGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSGNRAT 502
AR +V T Y APE+I VD W+ G + E++ GKT FKGS +
Sbjct: 175 ARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ 234
Query: 503 L---FNVVGQP-----------------LRFPESPVVSFA---------ARDLIRGLLVK 533
L V G P PE FA A +L+ +LV
Sbjct: 235 LKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVL 294
Query: 534 EPQHRLAYKRGATEIKQHPFFEG 556
+ + R+ A E HP+FE
Sbjct: 295 DAEQRVT----AGEALAHPYFES 313
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 42/167 (25%), Positives = 75/167 (44%), Gaps = 27/167 (16%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL---- 273
+ L+++LG G +V+L++ + AMK++ + + A+ E ++LQ +
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTE---AAEDEIKLLQRVNDAD 76
Query: 274 ----DHPFLP---TLYTHFETEKFS----CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRF 322
D L HF + + +V E G +L L +K + P V+
Sbjct: 77 NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ 135
Query: 323 YVAEVLLALEYLH-MLGIIYRDLKPENVLVRE------DGHIMLSDF 362
++LL L+Y+H GII+ D+KPENVL+ I ++D
Sbjct: 136 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADL 182
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 9e-08
Identities = 27/177 (15%), Positives = 53/177 (29%), Gaps = 56/177 (31%)
Query: 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKG---------------- 496
+ + T EY +PE++ G G D W+ ++EL+ G F+
Sbjct: 194 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 253
Query: 497 -------------SGNRATLF-------------------NVVGQPLRFPESPVVSFAAR 524
+G F +V+ + +F + +
Sbjct: 254 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS-- 311
Query: 525 DLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIRCATPPEIPKPVEIERIPA 581
D + +L +P+ R A + HP+ + + P+ IP
Sbjct: 312 DFLSPMLQLDPRKRAD----AGGLVNHPWLKDT--LGMEEIRVPDRELYGSGSDIPG 362
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 3e-14
Identities = 34/108 (31%), Positives = 56/108 (51%), Gaps = 11/108 (10%)
Query: 267 REI-----LQSLDHPFLPTLY-----THFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFP 316
RE+ L++ +HP + L+ + + E LV E DL T K P P
Sbjct: 60 REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVP 118
Query: 317 EQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDL 364
+ ++ + ++L L++LH +++RDLKP+N+LV G I L+DF L
Sbjct: 119 TETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 166
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 1e-07
Identities = 31/161 (19%), Positives = 51/161 (31%), Gaps = 47/161 (29%)
Query: 457 THE-----YLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATL---FNVVG 508
T Y APE++ + + VD W+ G E+ K F+GS + L +V+G
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 236
Query: 509 QP-------------LRFPESPVVSF---------AARDLIRGLLVKEPQHRLAYKRGAT 546
P F +DL+ L P R++ A
Sbjct: 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS----AY 292
Query: 547 EIKQHPFFEGVNWALIRCATPPEIPKPVEIERIPAPTSSTS 587
HP+F+ ++ + E P S +
Sbjct: 293 SALSHPYFQ-------------DLERCKENLDSHLPPSQNT 320
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 42/168 (25%), Positives = 71/168 (42%), Gaps = 20/168 (11%)
Query: 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVM-----DKASLAGRKKLL-RAQTEREI- 269
+ L K++G G G +YL+ + A V+ + L K R + I
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97
Query: 270 ----LQSLDHPFLPTLY----THFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVR 321
+ LD+ +P Y T F+ + +VME G DL + + G F + V
Sbjct: 98 KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN-GT-FKKSTVL 154
Query: 322 FYVAEVLLALEYLHMLGIIYRDLKPENVLV--REDGHIMLSDFDLSLR 367
+L LEY+H ++ D+K N+L+ + + L+D+ LS R
Sbjct: 155 QLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYR 202
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 41/155 (26%), Positives = 68/155 (43%), Gaps = 17/155 (10%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLR-AQTEREILQSL--- 273
+ +LK +G G G V + + A+K+ + K+ R A E IL+ L
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKM-----VRNEKRFHRQAAEEIRILEHLRKQ 153
Query: 274 ----DHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLL 329
+ + +F C+ E +L+ L +K + F VR + +L
Sbjct: 154 DKDNTMNVI-HMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQ 211
Query: 330 ALEYLHMLGIIYRDLKPENVLVREDGH--IMLSDF 362
L+ LH II+ DLKPEN+L+++ G I + DF
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDF 246
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 8e-05
Identities = 16/41 (39%), Positives = 20/41 (48%)
Query: 460 YLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNR 500
Y APE+I G +G +D W+ G L ELL G G
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEG 305
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 3e-14
Identities = 39/152 (25%), Positives = 71/152 (46%), Gaps = 10/152 (6%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSG-TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD 274
RL +LG G G V++ +G T+ A+K + K + L+ E ++++ L
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRV--AIKTL-KPGTMSPEAFLQ---EAQVMKKLR 320
Query: 275 HPFLPTLYTHFETEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQAVRFYVAEVLLALEY 333
H L LY +E+ +V E+ G L L+ + Q V A++ + Y
Sbjct: 321 HEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM-AAQIASGMAY 378
Query: 334 LHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+ + ++RDL+ N+LV E+ ++DF L+
Sbjct: 379 VERMNYVHRDLRAANILVGENLVCKVADFGLA 410
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 43/159 (27%), Positives = 72/159 (45%), Gaps = 18/159 (11%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREI--LQSL 273
+ +G G GSV + + A+K K S + ++ + RE+ L+ +
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK---KLSRPFQSEIFAKRAYRELLLLKHM 80
Query: 274 DHPFLPTLYTHF----ETEKFSC--LVMEFCPGGDLHT-LRQKQPGKYFPEQAVRFYVAE 326
H + L F F LVM F DL + K F E+ +++ V +
Sbjct: 81 QHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLK-----FSEEKIQYLVYQ 134
Query: 327 VLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+L L+Y+H G+++RDLKP N+ V ED + + DF L+
Sbjct: 135 MLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA 173
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 8e-08
Identities = 41/143 (28%), Positives = 52/143 (36%), Gaps = 39/143 (27%)
Query: 449 ARSMS-----FVGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSGNRAT 502
AR +V T Y APE+I H VD W+ G + E+L GKT FKG
Sbjct: 173 ARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ 232
Query: 503 L---FNVVGQP-----------------LRFPESPVVSFA---------ARDLIRGLLVK 533
L V G P P++P F A DL+ +L
Sbjct: 233 LTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLEL 292
Query: 534 EPQHRLAYKRGATEIKQHPFFEG 556
+ RL A + HPFFE
Sbjct: 293 DVDKRLT----AAQALTHPFFEP 311
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 36/164 (21%), Positives = 68/164 (41%), Gaps = 27/164 (16%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTE-------R 267
+ +R + +LG G G VY + + T A+K + L + E R
Sbjct: 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIK----------RIRLEHEEEGVPGTAIR 82
Query: 268 EI--LQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVA 325
E+ L+ L H + L + L+ E+ DL K P + ++ ++
Sbjct: 83 EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPD--VSMRVIKSFLY 139
Query: 326 EVLLALEYLHMLGIIYRDLKPENVLV-----REDGHIMLSDFDL 364
+++ + + H ++RDLKP+N+L+ E + + DF L
Sbjct: 140 QLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 32/132 (24%), Positives = 47/132 (35%), Gaps = 38/132 (28%)
Query: 457 THE-----YLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSGNRATL---FNVV 507
THE Y PEI+ G H ++VD W+ E+L F G L F V+
Sbjct: 195 THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVL 254
Query: 508 GQP---------------LRFPESPVVSF----------AARDLIRGLLVKEPQHRLAYK 542
G P FP+ + DL+ +L +P R++
Sbjct: 255 GLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRIS-- 312
Query: 543 RGATEIKQHPFF 554
A +HP+F
Sbjct: 313 --AKNALEHPYF 322
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 6e-14
Identities = 34/163 (20%), Positives = 64/163 (39%), Gaps = 27/163 (16%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMK---VMDKASLAGRKKLLRAQTEREI--L 270
+ L +G G G V + + K A+K + + R T REI L
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQR-------TLREIKIL 79
Query: 271 QSLDHP--------FLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRF 322
H + + + +V + DL+ L + Q + +
Sbjct: 80 LRFRHENIIGINDIIRAPTIEQMK-DVY--IVQDLM-ETDLYKLLKTQH---LSNDHICY 132
Query: 323 YVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
++ ++L L+Y+H +++RDLKP N+L+ + + DF L+
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 175
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 30/132 (22%), Positives = 44/132 (33%), Gaps = 34/132 (25%)
Query: 455 VGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSGNRATL---FNVVGQP 510
V T Y APEI+ ++D W+ G L E+L + F G L ++G P
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 251
Query: 511 -----------------LRFPESPVVSFA---------ARDLIRGLLVKEPQHRLAYKRG 544
L P V + A DL+ +L P R+
Sbjct: 252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE---- 307
Query: 545 ATEIKQHPFFEG 556
+ HP+ E
Sbjct: 308 VEQALAHPYLEQ 319
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 6e-14
Identities = 38/154 (24%), Positives = 62/154 (40%), Gaps = 9/154 (5%)
Query: 216 SHFRLLKRLGCGDIGSVY---LSELSGTKCYFAMKVM-DKASLAGRKKLLRAQTEREILQ 271
L + +G G G V+ A+K + S + R+K L+ E ++
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ---EALTMR 446
Query: 272 SLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLAL 331
DHP + L ++ME C G+L + Q + + Y ++ AL
Sbjct: 447 QFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLIL-YAYQLSTAL 504
Query: 332 EYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
YL ++RD+ NVLV + + L DF LS
Sbjct: 505 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 538
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 6e-14
Identities = 45/183 (24%), Positives = 74/183 (40%), Gaps = 28/183 (15%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMK---VMDKASLAGRKKLLRAQTEREI-- 269
S F+L LG G G V + T A+K DK A R T REI
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALR-------TLREIKI 62
Query: 270 LQSLDHP--------FLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVR 321
L+ H P + +F E + ++ E DLH + Q + ++
Sbjct: 63 LKHFKHENIITIFNIQRPDSFENFN-EVY--IIQELM-QTDLHRVISTQM---LSDDHIQ 115
Query: 322 FYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLD 381
+++ + L A++ LH +I+RDLKP N+L+ + + + DF L+ R +
Sbjct: 116 YFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLA-RIIDESAADNSEPTG 174
Query: 382 AEP 384
+
Sbjct: 175 QQS 177
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 32/133 (24%), Positives = 47/133 (35%), Gaps = 35/133 (26%)
Query: 455 VGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSGNRATL---FNVVGQP 510
V T Y APE++ A+D W+ G L EL + F G R L F ++G P
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242
Query: 511 ------------------LRFPESPVVSFA---------ARDLIRGLLVKEPQHRLAYKR 543
P P DL++ +LV +P R+
Sbjct: 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRIT--- 299
Query: 544 GATEIKQHPFFEG 556
A E +HP+ +
Sbjct: 300 -AKEALEHPYLQT 311
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 9e-14
Identities = 37/154 (24%), Positives = 66/154 (42%), Gaps = 8/154 (5%)
Query: 216 SHFRLLKRLGCGDIGSVYLSEL---SGTKCYFAMKVM-DKASLAGRKKLLRAQTEREILQ 271
++ + K +G G+ G V L S + A+K + + R+ L E I+
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG---EASIMG 101
Query: 272 SLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLAL 331
DHP + L K +V E+ G L + +K ++ Q V + + +
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGM-LRGIASGM 160
Query: 332 EYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+YL +G ++RDL N+L+ + +SDF L
Sbjct: 161 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLG 194
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 73.1 bits (179), Expect = 1e-13
Identities = 41/147 (27%), Positives = 67/147 (45%), Gaps = 8/147 (5%)
Query: 222 KRLGCGDIGSVYLSELSGTKCYF--AMKVM-DKASLAGRKKLLRAQTEREILQSLDHPFL 278
LGCG+ GSV K A+KV+ A ++++R E +I+ LD+P++
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR---EAQIMHQLDNPYI 398
Query: 279 PTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLG 338
L + E LVME GG LH + + + +V + ++YL
Sbjct: 399 VRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAEL-LHQVSMGMKYLEEKN 456
Query: 339 IIYRDLKPENVLVREDGHIMLSDFDLS 365
++R+L NVL+ + +SDF LS
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLS 483
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 42/154 (27%), Positives = 69/154 (44%), Gaps = 9/154 (5%)
Query: 216 SHFRLLK-RLGCGDIGSVYLSELSGTKCYF--AMKVM-DKASLAGRKKLLRAQTEREILQ 271
+ + LGCG+ GSV K A+KV+ A ++++R E +I+
Sbjct: 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR---EAQIMH 65
Query: 272 SLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLAL 331
LD+P++ L + E LVME GG LH + + + +V + +
Sbjct: 66 QLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAEL-LHQVSMGM 123
Query: 332 EYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+YL ++RDL NVL+ + +SDF LS
Sbjct: 124 KYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLS 157
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 36/155 (23%), Positives = 68/155 (43%), Gaps = 10/155 (6%)
Query: 216 SHFRLLKRLGCGDIGSVY----LSELSGTKCYFAMKVM-DKASLAGRKKLLRAQTEREIL 270
+ R LK LG G G+V+ + E K +KV+ DK+ + + +
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTD---HMLAI 69
Query: 271 QSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLA 330
SLDH + L LV ++ P G L ++ G P+ + + ++
Sbjct: 70 GSLDHAHIVRLLGLCPGSSL-QLVTQYLPLGSLLDHVRQHRGALGPQLLLNW-GVQIAKG 127
Query: 331 LEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+ YL G+++R+L NVL++ + ++DF ++
Sbjct: 128 MYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVA 162
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 47/226 (20%), Positives = 86/226 (38%), Gaps = 11/226 (4%)
Query: 146 KTSGSAKISDRLDYVESGKSSICRGSTSSDVSDESTCSSFSSSINKPHKANDLRWEAIQA 205
+ + + R G SI STS S F + + L E +QA
Sbjct: 19 ASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQA 78
Query: 206 VRARDGVLGLSHFRLLKRLGCGDIGSVY---LSELSGTKCYFAMKVM-DKASLAGRKKLL 261
V+ + +G G G VY L + G K + A+K + + + L
Sbjct: 79 VQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL 138
Query: 262 RAQTEREILQSLDHPFLPTLY-THFETEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQA 319
E I++ HP + +L +E +V+ + GDL +R + +
Sbjct: 139 T---EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDL 194
Query: 320 VRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+ F +V +++L ++RDL N ++ E + ++DF L+
Sbjct: 195 IGF-GLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 239
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 1e-13
Identities = 42/150 (28%), Positives = 65/150 (43%), Gaps = 6/150 (4%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH 275
S ++ +G G G V+L K A+K + + + + E E++ L H
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTI-REGAMSEEDFIE---EAEVMMKLSH 62
Query: 276 PFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLH 335
P L LY + CLV EF G L + Q G + E + +V + YL
Sbjct: 63 PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGM-CLDVCEGMAYLE 121
Query: 336 MLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+I+RDL N LV E+ I +SDF ++
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMT 151
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 33/152 (21%), Positives = 64/152 (42%), Gaps = 9/152 (5%)
Query: 219 RLLKRLGCGDIGSVY---LSELSGTKCYFAMKVM-DKASLAGRKKLLRAQTEREILQSLD 274
+ +G G G VY L + G K + A+K + + + L E I++
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLT---EGIIMKDFS 84
Query: 275 HPFLPTLY-THFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEY 333
HP + +L +E +V+ + GDL + + + + F +V ++Y
Sbjct: 85 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF-GLQVAKGMKY 143
Query: 334 LHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
L ++RDL N ++ E + ++DF L+
Sbjct: 144 LASKKFVHRDLAARNCMLDEKFTVKVADFGLA 175
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 41/159 (25%), Positives = 77/159 (48%), Gaps = 16/159 (10%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREI--LQS 272
L ++ LK +G G G V + + A+K K S + + + RE+ ++
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK---KLSRPFQNQTHAKRAYRELVLMKC 117
Query: 273 LDHPFLPTLYTHF----ETEKFSC--LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAE 326
++H + +L F E+F LVME +L + Q + + + + + +
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME----LDHERMSYLLYQ 172
Query: 327 VLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+L +++LH GII+RDLKP N++V+ D + + DF L+
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 34/155 (21%), Positives = 53/155 (34%), Gaps = 51/155 (32%)
Query: 449 ARSMS-------FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRA 501
AR+ +V T Y APE+I G G+ VD W+ G + E++ K F G
Sbjct: 211 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 270
Query: 502 TL---FNVVGQP----------------LRFPESPVVSFA-------------------- 522
+G P P+ ++F
Sbjct: 271 QWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKAS 330
Query: 523 -ARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556
ARDL+ +LV +P R++ + QHP+
Sbjct: 331 QARDLLSKMLVIDPAKRIS----VDDALQHPYINV 361
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 2e-13
Identities = 41/154 (26%), Positives = 67/154 (43%), Gaps = 9/154 (5%)
Query: 216 SHFRLLKRLGCGDIGSVY---LSELSGTKCYFAMKVM-DKASLAGRKKLLRAQTEREILQ 271
L + LG G G VY + G K A+K +L ++K + E I++
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMS---EAVIMK 68
Query: 272 SLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLAL 331
+LDHP + L E E ++ME P G+L ++ V + ++ A+
Sbjct: 69 NLDHPHIVKLIGIIEEEPT-WIIMELYPYGELGHYLERNKNSLKVLTLVLY-SLQICKAM 126
Query: 332 EYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
YL + ++RD+ N+LV + L DF LS
Sbjct: 127 AYLESINCVHRDIAVRNILVASPECVKLGDFGLS 160
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 38/155 (24%), Positives = 71/155 (45%), Gaps = 10/155 (6%)
Query: 216 SHFRLLKRLGCGDIGSVY----LSELSGTKCYFAMKVM-DKASLAGRKKLLRAQTEREIL 270
+ F+ +K LG G G+VY + E K A+K + + S K++L E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD---EAYVM 71
Query: 271 QSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLA 330
S+D+P + L T L+ + P G L ++ + + + ++
Sbjct: 72 ASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYLLNW-CVQIAKG 129
Query: 331 LEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+ YL +++RDL NVLV+ H+ ++DF L+
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 35/169 (20%), Positives = 69/169 (40%), Gaps = 27/169 (15%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSG-------TKCYFAMKVM-DKASLAGRKKLLRAQTER 267
+ + LG G G VY G T+ A+K + + AS+ R + L E
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV--AIKTVNEAASMRERIEFLN---EA 79
Query: 268 EILQSLDHPFLPTLY---THFETEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQAVRFY 323
+++ + + L + + + ++ME GDL + LR +P
Sbjct: 80 SVMKEFNCHHVVRLLGVVS--QGQPT-LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136
Query: 324 VAEVLL-------ALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+++++ + YL+ ++RDL N +V ED + + DF ++
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT 185
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 3e-13
Identities = 37/152 (24%), Positives = 66/152 (43%), Gaps = 10/152 (6%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSG-TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD 274
+L++RLG G G V++ +G TK A+K + K L E +++ L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKV--AVKSL-KQGSMSPDAFLA---EANLMKQLQ 66
Query: 275 HPFLPTLYTHFETEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQAVRFYVAEVLLALEY 333
H L LY E ++ E+ G L L+ K + + A++ + +
Sbjct: 67 HQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDM-AAQIAEGMAF 124
Query: 334 LHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+ I+RDL+ N+LV + ++DF L+
Sbjct: 125 IEERNYIHRDLRAANILVSDTLSCKIADFGLA 156
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 3e-13
Identities = 30/165 (18%), Positives = 54/165 (32%), Gaps = 19/165 (11%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYF-------AMKVMDKASLAGRKKLLRAQTERE 268
+ LG G ++ Y +KV+DKA +
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE---AAS 64
Query: 269 ILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVL 328
++ L H L Y + LV EF G L T +K + ++
Sbjct: 65 MMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEV-AKQLA 123
Query: 329 LALEYLHMLGIIYRDLKPENVLVREDGHIM--------LSDFDLS 365
A+ +L +I+ ++ +N+L+ + LSD +S
Sbjct: 124 AAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS 168
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 3e-13
Identities = 39/151 (25%), Positives = 59/151 (39%), Gaps = 8/151 (5%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSG-TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD 274
LLK LG G G V L + G A+K++ K + + E + + L
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDV--AVKMI-KEGSMSEDEFFQ---EAQTMMKLS 61
Query: 275 HPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYL 334
HP L Y E +V E+ G L + P Q + +V + +L
Sbjct: 62 HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEM-CYDVCEGMAFL 120
Query: 335 HMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
I+RDL N LV D + +SDF ++
Sbjct: 121 ESHQFIHRDLAARNCLVDRDLCVKVSDFGMT 151
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 3e-13
Identities = 44/163 (26%), Positives = 72/163 (44%), Gaps = 21/163 (12%)
Query: 219 RLLKRLGCGDIGSVYLSELSG-----TKCYFAMKVM--DKASLAGRKKLLRAQTEREILQ 271
L K LG G+ GSV L K A+K M D +S ++ L E ++
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKV--AVKTMKLDNSSQREIEEFLS---EAACMK 91
Query: 272 SLDHPFLPTLY---THFETEKFSCL--VMEFCPGGDLHT-LRQKQP---GKYFPEQAVRF 322
HP + L ++ ++ F GDLHT L + K+ P Q +
Sbjct: 92 DFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLK 151
Query: 323 YVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
++ ++ L +EYL ++RDL N ++R+D + ++DF LS
Sbjct: 152 FMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLS 194
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 39/158 (24%), Positives = 66/158 (41%), Gaps = 17/158 (10%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLR-AQTEREILQSL- 273
+ + +G G G V + + + A+K++ K +K L AQ E +L+ +
Sbjct: 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-KN----KKAFLNQAQIEVRLLELMN 108
Query: 274 -----DHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVL 328
++ L HF CLV E +L+ L + + R + ++
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMC 167
Query: 329 LALEYLHM--LGIIYRDLKPENVLVREDGH--IMLSDF 362
AL +L L II+ DLKPEN+L+ I + DF
Sbjct: 168 TALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF 205
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 13/41 (31%), Positives = 22/41 (53%)
Query: 460 YLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNR 500
Y +PE++ G + A+D W+ G L E+ G+ F G+
Sbjct: 224 YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEV 264
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 6e-13
Identities = 40/164 (24%), Positives = 72/164 (43%), Gaps = 22/164 (13%)
Query: 219 RLLKRLGCGDIGSVYLSELSG-----TKCYFAMKVM--DKASLAGRKKLLRAQTEREILQ 271
L + LG G+ GSV ++L K A+K++ D + + ++ LR E ++
Sbjct: 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKV--AVKMLKADIIASSDIEEFLR---EAACMK 80
Query: 272 SLDHPFLPTLY------THFETEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQAVR--- 321
DHP + L +++ F GDLH L + G+ ++
Sbjct: 81 EFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLV 140
Query: 322 FYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
++ ++ +EYL I+RDL N ++ ED + ++DF LS
Sbjct: 141 RFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS 184
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 8e-13
Identities = 40/164 (24%), Positives = 70/164 (42%), Gaps = 18/164 (10%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRK-----KLLRAQ-TEREI 269
S + + + + G G+V + + A+K + GR + REI
Sbjct: 22 SPYTVQRFISSGSYGAVC-AGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 270 --LQSLDHPFLPTLY---THFETEKFSC--LVMEFCPGGDLHT-LRQKQPGKYFPEQAVR 321
L HP + L HFE LV E DL + ++ Q ++
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQR--IVISPQHIQ 137
Query: 322 FYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+++ +LL L LH G+++RDL P N+L+ ++ I + DF+L+
Sbjct: 138 YFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA 181
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 34/146 (23%), Positives = 50/146 (34%), Gaps = 42/146 (28%)
Query: 449 ARSMS-------FVGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSGNR 500
AR + +V Y APE++ VD W+ G + E+ K F+GS
Sbjct: 181 AREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY 240
Query: 501 ATL---FNVVGQP------------------LRFPESPVVSFA---------ARDLIRGL 530
L VVG P P ++ A DLI +
Sbjct: 241 NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKM 300
Query: 531 LVKEPQHRLAYKRGATEIKQHPFFEG 556
L PQ R++ + +HP+FE
Sbjct: 301 LEFNPQRRIS----TEQALRHPYFES 322
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 9e-13
Identities = 42/172 (24%), Positives = 63/172 (36%), Gaps = 28/172 (16%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGT-----KCYFAMKVMDKASLAGRKKLLRAQTEREIL 270
L + LG G G V+L+E K A+K + +LA RK R E E+L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQR---EAELL 71
Query: 271 QSLDHPFLPTLY---THFETEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQAVRFYVAE 326
+L H + Y + +V E+ GDL+ LR P
Sbjct: 72 TNLQHEHIVKFYGVCGDGDP---LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 128
Query: 327 VLLALEYLHM-------------LGIIYRDLKPENVLVREDGHIMLSDFDLS 365
L + LH+ ++RDL N LV + + + DF +S
Sbjct: 129 ELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 9e-13
Identities = 40/173 (23%), Positives = 67/173 (38%), Gaps = 29/173 (16%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYF-----AMKVM-DKASLAGRKKLLRAQTEREI 269
S R ++ LG G VY L G A+K + DKA R++ E +
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRH---EAML 65
Query: 270 LQSLDHPFLPTLY---THFETEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQAVRFYVA 325
L HP + L T ++ ++ +C GDLH L + P V
Sbjct: 66 RARLQHPNVVCLLGVVTK---DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122
Query: 326 EVLLALEYLHML-------------GIIYRDLKPENVLVREDGHIMLSDFDLS 365
L +++H++ ++++DL NVLV + ++ +SD L
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF 175
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 9e-13
Identities = 46/160 (28%), Positives = 70/160 (43%), Gaps = 15/160 (9%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREI--LQS 272
+S + L ++G G G V+ + T A+K K + K+ REI LQ
Sbjct: 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK---KVLMENEKEGFPITALREIKILQL 72
Query: 273 LDHPFLPTLY-------THFETEKFSC-LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYV 324
L H + L + + K S LV +FC DL L F ++ +
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGL-LSNVLVKFTLSEIKRVM 130
Query: 325 AEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDL 364
+L L Y+H I++RD+K NVL+ DG + L+DF L
Sbjct: 131 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL 170
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 34/173 (19%), Positives = 55/173 (31%), Gaps = 54/173 (31%)
Query: 457 THE-----YLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSGNRATL---FNVV 507
T+ Y PE++ GE G +D W G + E+ +G+ + L +
Sbjct: 186 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 245
Query: 508 GQP----------------LRFPESP-----------VVSFAARDLIRGLLVKEPQHRLA 540
G L + V A DLI LLV +P R+
Sbjct: 246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 305
Query: 541 YKRGATEIKQHPFFEGVNWALIRCATPPEIPKPVEIERIPA-PTSSTSEKTAP 592
+ + H FF P P +++ + + +S E AP
Sbjct: 306 ----SDDALNHDFFW-------------SDPMPSDLKGMLSTHLTSMFEYLAP 341
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 38/150 (25%), Positives = 67/150 (44%), Gaps = 6/150 (4%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH 275
LK LG G G V + G + A+K++ K + + E +++ +L H
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMI-KEGSMSEDEFIE---EAKVMMNLSH 78
Query: 276 PFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLH 335
L LY ++ ++ E+ G L ++ ++ +Q + +V A+EYL
Sbjct: 79 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM-CKDVCEAMEYLE 137
Query: 336 MLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
++RDL N LV + G + +SDF LS
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLS 167
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 43/168 (25%), Positives = 70/168 (41%), Gaps = 21/168 (12%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELS--GTKCYFAMKVM-DKASLAGRKKLLRAQTEREILQS 272
+ + +G G+ G V + + G + A+K M + AS + E E+L
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG---ELEVLCK 81
Query: 273 L-DHPFLPTLYTHFETEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQAVRFYVAEVLLA 330
L HP + L E + L +E+ P G+L LR+ + + P A+ A L +
Sbjct: 82 LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 141
Query: 331 LEYLHML-------------GIIYRDLKPENVLVREDGHIMLSDFDLS 365
+ LH I+RDL N+LV E+ ++DF LS
Sbjct: 142 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 189
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 39/160 (24%), Positives = 77/160 (48%), Gaps = 18/160 (11%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREI--LQS 272
L ++ LK +G G G V + + + A+K K S + + + RE+ ++
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIK---KLSRPFQNQTHAKRAYRELVLMKC 80
Query: 273 LDHPFLPTLYTHF----ETEKFSC--LVMEFCPGGDLHT-LRQKQPGKYFPEQAVRFYVA 325
++H + L F E+F +VME +L ++ + + + + +
Sbjct: 81 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME-----LDHERMSYLLY 134
Query: 326 EVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
++L +++LH GII+RDLKP N++V+ D + + DF L+
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 174
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 8e-07
Identities = 35/155 (22%), Positives = 53/155 (34%), Gaps = 51/155 (32%)
Query: 449 ARSMS-------FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRA 501
AR+ +V T Y APE+I G G+ VD W+ G + E++ G F G+ +
Sbjct: 174 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID 233
Query: 502 TL---FNVVGQP----------------LRFPESPVVSFA-------------------- 522
+G P P+ SF
Sbjct: 234 QWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKAS 293
Query: 523 -ARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556
ARDL+ +LV + R++ E QHP+
Sbjct: 294 QARDLLSKMLVIDASKRIS----VDEALQHPYINV 324
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 40/169 (23%), Positives = 74/169 (43%), Gaps = 14/169 (8%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLR-AQTEREILQSL--- 273
F +++++G G G V L + K Y+A+KV + KK R A+ E +IL+ +
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKV-----VRNIKKYTRSAKIEADILKKIQND 91
Query: 274 ---DHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLA 330
++ + + F CL+ E G L+ + + F + ++ Y E+L A
Sbjct: 92 DINNNNIV-KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKA 149
Query: 331 LEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASS 379
L YL + + + DLKPEN+L+ + + + + S
Sbjct: 150 LNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKS 198
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 28/140 (20%), Positives = 43/140 (30%), Gaps = 48/140 (34%)
Query: 460 YLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATL---------------- 503
Y APE+I G + D W+FG L EL G F+ + L
Sbjct: 225 YRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLY 284
Query: 504 ----------FNVVGQPLRFPESPVVSFAAR------------------DLIRGLLVKEP 535
N L +PE+ + + D + +L +P
Sbjct: 285 EATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDP 344
Query: 536 QHRLAYKRGATEIKQHPFFE 555
R + E+ +H F E
Sbjct: 345 TLRPS----PAELLKHKFLE 360
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 35/155 (22%), Positives = 64/155 (41%), Gaps = 15/155 (9%)
Query: 219 RLLKRLGCGDIGSVYLSELSG-----TKCYFAMKVM-DKASLAGRKKLLRAQTEREILQS 272
+ +G G G VY E +C A+K + + + LR E +++
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQC--AIKSLSRITEMQQVEAFLR---EGLLMRG 78
Query: 273 LDHPFLPTLY-THFETEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQAVRFYVAEVLLA 330
L+HP + L E +++ + GDL +R Q + + F +V
Sbjct: 79 LNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL-ISF-GLQVARG 136
Query: 331 LEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+EYL ++RDL N ++ E + ++DF L+
Sbjct: 137 MEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLA 171
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 44/192 (22%), Positives = 72/192 (37%), Gaps = 57/192 (29%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMK-VMDKASLAGRKKLLRAQTEREILQSLD 274
+ L K LG G G V + FA+K V+ R E +I++ LD
Sbjct: 7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR--------ELDIMKVLD 58
Query: 275 HPFLPTLYTHF--------------------------------------ETEKFSCLVME 296
H + L +F K+ ++ME
Sbjct: 59 HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118
Query: 297 FCPGGDLHTL-----RQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLV 351
+ P LH + R + P + Y+ ++ A+ ++H LGI +RD+KP+N+LV
Sbjct: 119 YVPD-TLHKVLKSFIRSGRS---IPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLV 174
Query: 352 -REDGHIMLSDF 362
+D + L DF
Sbjct: 175 NSKDNTLKLCDF 186
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 32/131 (24%), Positives = 51/131 (38%), Gaps = 32/131 (24%)
Query: 453 SFVGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSGNRATL---FNVVG 508
+++ + Y APE++ G ++D W+ G EL+ GK F G + L ++G
Sbjct: 200 AYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMG 259
Query: 509 QP--------------LRFPESPVVSFA----------ARDLIRGLLVKEPQHRLAYKRG 544
P +RFP + A DL+ +L EP R+
Sbjct: 260 TPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN---- 315
Query: 545 ATEIKQHPFFE 555
E HPFF+
Sbjct: 316 PYEAMAHPFFD 326
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 41/170 (24%), Positives = 71/170 (41%), Gaps = 30/170 (17%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMK--VMDKASLAGRKKLLRAQTEREI--L 270
S + LK LGCG G V+ + + A+K V+ REI +
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKH-------ALREIKII 62
Query: 271 QSLDHP--------FLPTLYTHFETEKFSC------LVMEFCPGGDLHTLRQKQPGKYFP 316
+ LDH P+ + +V E+ DL + ++ P
Sbjct: 63 RRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGP---LL 118
Query: 317 EQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLV-REDGHIMLSDFDLS 365
E+ R ++ ++L L+Y+H +++RDLKP N+ + ED + + DF L+
Sbjct: 119 EEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLA 168
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 26/142 (18%), Positives = 41/142 (28%), Gaps = 34/142 (23%)
Query: 445 EPTEARSMS-FVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRAT 502
+ +S + T Y +P ++ + A+D W G E+L GKT F G+
Sbjct: 174 HYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ 233
Query: 503 L---FNVVGQP----------------LRFPESPVVSFA---------ARDLIRGLLVKE 534
+ + P A D + +L
Sbjct: 234 MQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFS 293
Query: 535 PQHRLAYKRGATEIKQHPFFEG 556
P RL A E HP+
Sbjct: 294 PMDRLT----AEEALSHPYMSI 311
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 6e-12
Identities = 41/168 (24%), Positives = 64/168 (38%), Gaps = 21/168 (12%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGT-----KCYFAMKVMDKASLAGRKKLLRAQTEREIL 270
L LG G G V+L+E K A+K + +AS + R+ R E E+L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQR---EAELL 97
Query: 271 QSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQAVRF------- 322
L H + + + +V E+ GDL+ LR P
Sbjct: 98 TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 157
Query: 323 -----YVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
++V + YL L ++RDL N LV + + + DF +S
Sbjct: 158 GQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 35/169 (20%), Positives = 65/169 (38%), Gaps = 17/169 (10%)
Query: 218 FRLLKRLGCGDIGSVYL-SELSGTKCYFAMKVMDKASLAGRKKLLR-AQTEREILQSL-- 273
+ ++ LG G G V + + K A+K++ + K A+ E +L+ +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKII-RN----VGKYREAARLEINVLKKIKE 75
Query: 274 -----DHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVL 328
+ + F C+ E G + ++ + +P VR ++
Sbjct: 76 KDKENKFLCV-LMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLC 133
Query: 329 LALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRC-AVSPTLIK 376
AL +LH + + DLKPEN+L L + S +V T I+
Sbjct: 134 HALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIR 182
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 8e-07
Identities = 30/140 (21%), Positives = 45/140 (32%), Gaps = 46/140 (32%)
Query: 460 YLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNR---ATLFNVVGQP------ 510
Y PE+I G D W+ G L+E G T F+ NR + ++G
Sbjct: 205 YRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIH 264
Query: 511 ------------LRFPESPVVSFAAR---------------------DLIRGLLVKEPQH 537
L + E+ + DL+R +L +P
Sbjct: 265 RTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324
Query: 538 RLAYKRGATEIKQHPFFEGV 557
R+ E HPFF G+
Sbjct: 325 RIT----LAEALLHPFFAGL 340
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 40/174 (22%), Positives = 70/174 (40%), Gaps = 29/174 (16%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSG-------TKCYFAMKVM-DKASLAGRKKLLRAQTER 267
+L K LG G G V ++ G A+K++ + A+ + + L+ E
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTV--AVKMLKEGATHSEHRALMS---EL 81
Query: 268 EILQSLD-HPFLPTLYTH-FETEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQAVRFYV 324
+IL + H + L + +++EFC G+L T LR K+ + A
Sbjct: 82 KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 141
Query: 325 AEVL-------------LALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+ L +E+L I+RDL N+L+ E + + DF L+
Sbjct: 142 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 195
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 32/176 (18%), Positives = 65/176 (36%), Gaps = 31/176 (17%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCY--------FAMKVMDKASLAGRKKLLR-AQTERE 268
+ ++ LG G G V +C A+K++ K + A++E +
Sbjct: 16 YEIVDTLGEGAFGKVV-------ECIDHKAGGRHVAVKIV-KN----VDRYCEAARSEIQ 63
Query: 269 ILQSL-------DHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVR 321
+L+ L + + FE C+V E G + ++ F +R
Sbjct: 64 VLEHLNTTDPNSTFRCV-QMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIR 121
Query: 322 FYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDL-SLRCAVSPTLIK 376
++ ++ +LH + + DLKPEN+L + + + + + IK
Sbjct: 122 KMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIK 177
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 4e-06
Identities = 29/140 (20%), Positives = 44/140 (31%), Gaps = 46/140 (32%)
Query: 460 YLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNR---ATLFNVVGQP------ 510
Y APE+I G D W+ G L E G T F ++ A + ++G
Sbjct: 200 YRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQ 259
Query: 511 ------------LRFPESPVVSFAAR---------------------DLIRGLLVKEPQH 537
L + E DLI+ +L +P
Sbjct: 260 KTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319
Query: 538 RLAYKRGATEIKQHPFFEGV 557
R+ E +HPFF+ +
Sbjct: 320 RIT----LREALKHPFFDLL 335
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 38/180 (21%), Positives = 64/180 (35%), Gaps = 41/180 (22%)
Query: 219 RLLKRLGCGDIGSVYLSELSG-------TKCYFAMKVM-DKASLAGRKKLLRAQTEREIL 270
++ +G G G V+ + G T A+K++ ++AS + R E ++
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMV--AVKMLKEEASADMQADFQR---EAALM 104
Query: 271 QSLDHPFLPTLY---THFETEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQAVRFYVAE 326
D+P + L K CL+ E+ GDL+ LR P
Sbjct: 105 AEFDNPNIVKLLGVCAV---GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 161
Query: 327 VLLAL---------------------EYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+ + YL ++RDL N LV E+ + ++DF LS
Sbjct: 162 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 221
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 40/173 (23%), Positives = 69/173 (39%), Gaps = 26/173 (15%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYF-------AMKVM-DKASLAGRKKLLRAQTER 267
L K LG G G V ++E G A+K++ D A+ L+ E
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVS---EM 91
Query: 268 EILQSL-DHPFLPTLYTHFETEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQAVRFYVA 325
E+++ + H + L + +++E+ G+L LR ++P +
Sbjct: 92 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 326 EVLL-------------ALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
E + +EYL I+RDL NVLV E+ + ++DF L+
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 3e-11
Identities = 40/183 (21%), Positives = 74/183 (40%), Gaps = 41/183 (22%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSG-------TKCYFAMKVM-DKASLAGRKKLLRAQTER 267
+ L K LG G+ G V + T A+K++ + AS + + LL E
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTV--AVKMLKENASPSELRDLLS---EF 77
Query: 268 EILQSLDHPFLPTLY---THFETEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQAVRF- 322
+L+ ++HP + LY + + L++E+ G L LR+ + +
Sbjct: 78 NVLKQVNHPHVIKLYGACSQ---DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 323 --------------------YVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDF 362
+ ++ ++YL + +++RDL N+LV E + +SDF
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDF 194
Query: 363 DLS 365
LS
Sbjct: 195 GLS 197
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 5e-11
Identities = 35/169 (20%), Positives = 62/169 (36%), Gaps = 27/169 (15%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSG-------TKCYFAMKVM-DKASLAGRKKLLRAQTER 267
+ L++ LG G G VY ++SG + A+K + + S L E
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQV--AVKTLPEVCSEQDELDFLM---EA 84
Query: 268 EILQSLDHPFLPTLY---THFETEKFSCLVMEFCPGGDLHT-LRQKQP----GKYFPEQA 319
I+ +H + ++ME GGDL + LR+ +P
Sbjct: 85 LIISKFNHQNIVRCIGVSLQSLP---RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLD 141
Query: 320 VRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIML---SDFDLS 365
+ ++ +YL I+RD+ N L+ G + DF ++
Sbjct: 142 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 34/163 (20%), Positives = 70/163 (42%), Gaps = 25/163 (15%)
Query: 219 RLLKRLGCGDIGSVY--LSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHP 276
++G G G VY + +A+K ++ + + A E +L+ L HP
Sbjct: 24 YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHP 78
Query: 277 FLPTLY----THFETEKFSCLVMEFCPGGDLHTL-------RQKQPGKYFPEQAVRFYVA 325
+ +L +H + + + L+ ++ DL + + + P V+ +
Sbjct: 79 NVISLQKVFLSHADRKVW--LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLY 135
Query: 326 EVLLALEYLHMLGIIYRDLKPENVLVRED----GHIMLSDFDL 364
++L + YLH +++RDLKP N+LV + G + ++D
Sbjct: 136 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 178
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 6e-11
Identities = 44/211 (20%), Positives = 79/211 (37%), Gaps = 47/211 (22%)
Query: 183 SSFSSSINKPHKANDLRWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSG--- 239
+ + +++ D +WE L K LG G G V ++E G
Sbjct: 59 TPMLAGVSEYELPEDPKWE-----------FPRDKLTLGKPLGEGCFGQVVMAEAVGIDK 107
Query: 240 ------TKCYFAMKVM-DKASLAGRKKLLRAQTEREILQSL-DHPFLPTLY---THFETE 288
A+K++ D A+ L+ E E+++ + H + L T +
Sbjct: 108 DKPKEAVTV--AVKMLKDDATEKDLSDLVS---EMEMMKMIGKHKNIINLLGACT--QDG 160
Query: 289 KFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQAVRFYVAEVLL-------------ALEYL 334
+++E+ G+L LR ++P + E + +EYL
Sbjct: 161 PL-YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL 219
Query: 335 HMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
I+RDL NVLV E+ + ++DF L+
Sbjct: 220 ASQKCIHRDLAARNVLVTENNVMKIADFGLA 250
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 8e-11
Identities = 35/168 (20%), Positives = 65/168 (38%), Gaps = 25/168 (14%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSG-------TKCYFAMKVM-DKASLAGRKKLLRAQTER 267
+ L++ LG G G VY ++SG + A+K + + S L E
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQV--AVKTLPEVCSEQDELDFLM---EA 125
Query: 268 EILQSLDHPFLPTLY-THFETEKFSCLVMEFCPGGDLHT-LRQKQPGKYFP-----EQAV 320
I+ +H + ++ +++E GGDL + LR+ +P P +
Sbjct: 126 LIISKFNHQNIVRCIGVSLQSLPR-FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLL 184
Query: 321 RFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIML---SDFDLS 365
++ +YL I+RD+ N L+ G + DF ++
Sbjct: 185 HV-ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 2e-10
Identities = 37/175 (21%), Positives = 64/175 (36%), Gaps = 30/175 (17%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSG-------TKCYFAMKVM-DKASLAGRKKLLRAQTER 267
+ K LG G G V + G A+K++ A L R+ L+ E
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTV--AVKMLKPSAHLTEREALMS---EL 77
Query: 268 EILQSL-DHPFLPTLYTHFETEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQAVRFYV- 324
++L L +H + L + ++ E+C GDL LR+K+ + +
Sbjct: 78 KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 325 --------------AEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+V + +L I+RDL N+L+ + DF L+
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 192
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 3e-10
Identities = 44/153 (28%), Positives = 64/153 (41%), Gaps = 12/153 (7%)
Query: 218 FRLLKRLGCGDIGSVYLSELS-GTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHP 276
F +G G G VY L G K A+K S G ++ +TE E L HP
Sbjct: 41 FDHKFLIGHGVFGKVYKGVLRDGAK--VALKRRTPESSQGIEEF---ETEIETLSFCRHP 95
Query: 277 FLPTLYTHFETEKFSCLVMEFCPGGDL--HTLRQKQPGKYFP-EQAVRFYVA-EVLLALE 332
L +L + L+ ++ G+L H P EQ R + L
Sbjct: 96 HLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQ--RLEICIGAARGLH 153
Query: 333 YLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
YLH II+RD+K N+L+ E+ ++DF +S
Sbjct: 154 YLHTRAIIHRDVKSINILLDENFVPKITDFGIS 186
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 42/172 (24%), Positives = 69/172 (40%), Gaps = 30/172 (17%)
Query: 219 RLLKRLGCGDIGSVYLSELSG---------TKCYFAMKVM-DKASLAGRKKLLRAQTERE 268
L K LG G G V L+E G TK A+K++ A+ L+ E E
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKV--AVKMLKSDATEKDLSDLIS---EME 126
Query: 269 ILQSL-DHPFLPTLYTHFETEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQAVRF---- 322
+++ + H + L + +++E+ G+L L+ ++P
Sbjct: 127 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186
Query: 323 ---------YVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+V +EYL I+RDL NVLV ED + ++DF L+
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 238
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 4e-10
Identities = 44/154 (28%), Positives = 66/154 (42%), Gaps = 12/154 (7%)
Query: 218 FRLLKRLGCGDIGSVYLSELS-GTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHP 276
F LG G G VY L+ GT A+K + + G + QTE E++ H
Sbjct: 32 FSNKNILGRGGFGKVYKGRLADGTL--VAVKRLKEERTQGGELQF--QTEVEMISMAVHR 87
Query: 277 FLPTLYTHFETEKFSCLVMEFCPGGDL-HTLRQKQPGKYFPEQAVRFYVAEVLLA--LEY 333
L L T LV + G + LR++ + + R +A + A L Y
Sbjct: 88 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA-LGSARGLAY 146
Query: 334 LH---MLGIIYRDLKPENVLVREDGHIMLSDFDL 364
LH II+RD+K N+L+ E+ ++ DF L
Sbjct: 147 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 44/211 (20%), Positives = 76/211 (36%), Gaps = 43/211 (20%)
Query: 179 ESTCSSFSSSINKPHKANDLRWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELS 238
ES + + I+ + +WE R+ + + K LG G G V +
Sbjct: 20 ESYEGNSYTFIDPTQLPYNEKWE-----FPRNNL------QFGKTLGAGAFGKVVEATAF 68
Query: 239 G-------TKCYFAMKVM-DKASLAGRKKLLRAQTEREILQSLD-HPFLPTLY---THFE 286
G K A+K++ A ++ L+ E +I+ L H + L TH
Sbjct: 69 GLGKEDAVLKV--AVKMLKSTAHADEKEALMS---ELKIMSHLGQHENIVNLLGACTH-- 121
Query: 287 TEKFSCLVMEFCPGGDLHT-LRQKQPGKYFPEQAVRF-----------YVAEVLLALEYL 334
++ E+C GDL LR+K + ++V + +L
Sbjct: 122 GGPV-LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL 180
Query: 335 HMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
I+RD+ NVL+ + DF L+
Sbjct: 181 ASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 45/209 (21%), Positives = 72/209 (34%), Gaps = 48/209 (22%)
Query: 188 SINKPHKANDLRWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSG-TKCYFAM 246
++ DL+WE + K LG G G V + G +K ++
Sbjct: 28 YVDFREYEYDLKWE-----------FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSI 76
Query: 247 KV---M--DKASLAGRKKLLRAQTEREILQSL-DHPFLPTLY---THFETEKFSCLVMEF 297
+V M +KA + R+ L+ E +++ L H + L T + L+ E+
Sbjct: 77 QVAVKMLKEKADSSEREALMS---ELKMMTQLGSHENIVNLLGACT--LSGPI-YLIFEY 130
Query: 298 CPGGDLHT-LRQKQPGKYFPEQAVRFYVAEVLLAL--------------------EYLHM 336
C GDL LR K+ E E+L
Sbjct: 131 CCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF 190
Query: 337 LGIIYRDLKPENVLVREDGHIMLSDFDLS 365
++RDL NVLV + + DF L+
Sbjct: 191 KSCVHRDLAARNVLVTHGKVVKICDFGLA 219
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 2e-07
Identities = 36/150 (24%), Positives = 63/150 (42%), Gaps = 16/150 (10%)
Query: 223 RLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRA-QTEREILQSLDHPFLPTL 281
++G G G VY ++ T A+K + ++L + E +++ H L L
Sbjct: 38 KMGEGGFGVVYKGYVNNTT--VAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 282 --YTHFETEKFSCLVMEFCPGGD----LHTLRQKQPGKYFPEQAVRFYVAE-VLLALEYL 334
++ + CLV + P G L L P + +R +A+ + +L
Sbjct: 96 LGFSSDGDDL--CLVYVYMPNGSLLDRLSCLDGTPPLSW----HMRCKIAQGAANGINFL 149
Query: 335 HMLGIIYRDLKPENVLVREDGHIMLSDFDL 364
H I+RD+K N+L+ E +SDF L
Sbjct: 150 HENHHIHRDIKSANILLDEAFTAKISDFGL 179
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 51.4 bits (122), Expect = 4e-07
Identities = 34/196 (17%), Positives = 62/196 (31%), Gaps = 52/196 (26%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVM-----DKASLAGRKKLLRAQTEREIL 270
+ +++G G G V+ + T A+K++ D + + +K E I
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTIADHTP--VAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 271 QSLDH--------------------------PFLPTLYTHFETEKFSC------------ 292
+ L P L + H+ + K S
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 293 -LVMEFCPGG-DLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLH-MLGIIYRDLKPENV 349
+V+EF GG DL + K + + ++ +L L +RDL NV
Sbjct: 138 FIVLEFEFGGIDLE----QMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNV 193
Query: 350 LVREDGHIMLSDFDLS 365
L+++ L
Sbjct: 194 LLKKTSLKKLHYTLNG 209
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 44.2 bits (104), Expect = 7e-05
Identities = 25/102 (24%), Positives = 42/102 (41%), Gaps = 14/102 (13%)
Query: 261 LRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAV 320
A+ E LQ L +P +Y ++ME +L+ +R + P +
Sbjct: 149 RSARNEFRALQKLQGLAVPKVYAWEGN----AVLMELIDAKELYRVRVENPDEVL----- 199
Query: 321 RFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDF 362
+L + + GI++ DL NVLV E+ I + DF
Sbjct: 200 ----DMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDF 236
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 611 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.87 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.78 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.46 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.34 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.24 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.22 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.95 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.78 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.71 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.62 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.48 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.47 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.36 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.18 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.96 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.92 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.91 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.78 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.57 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.56 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.55 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.53 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.53 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.48 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.41 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.39 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.05 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.74 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.58 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.13 | |
| 2x6h_A | 696 | GH13170P, VPS34, phosphotidylinositol 3 kinase 59F | 87.89 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 83.36 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 80.86 | |
| 3ls8_A | 614 | Phosphatidylinositol 3-kinase catalytic subunit ty | 80.1 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-68 Score=554.92 Aligned_cols=278 Identities=35% Similarity=0.628 Sum_probs=249.2
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
.++|++++.||+|+||+||+|++..+++.||||++.+..+.......++.+|+++|+.|+|||||+++++|++++.+|||
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 35899999999999999999999999999999999987766555667889999999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
||||+||+|.+++.+. +.++|..++.|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+...
T Consensus 111 mEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~--- 185 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE--- 185 (311)
T ss_dssp ECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT---
T ss_pred EecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC---
Confidence 9999999999999875 56999999999999999999999999999999999999999999999999999544211
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
.......++
T Consensus 186 -----------------------------------------------------------------------~~~~~~~~~ 194 (311)
T 4aw0_A 186 -----------------------------------------------------------------------SKQARANSF 194 (311)
T ss_dssp -----------------------------------------------------------------------TTCCCBCCC
T ss_pred -----------------------------------------------------------------------CCcccccCc
Confidence 011223467
Q ss_pred ccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcC
Q 007260 455 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKE 534 (611)
Q Consensus 455 vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~d 534 (611)
+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+.+.+|+...+.+|.. +++++++||.+||++|
T Consensus 195 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~--~s~~~~dli~~lL~~d 272 (311)
T 4aw0_A 195 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEK--FFPKARDLVEKLLVLD 272 (311)
T ss_dssp CSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT--CCHHHHHHHHHHSCSS
T ss_pred ccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc--cCHHHHHHHHHHccCC
Confidence 89999999999999999999999999999999999999999998888899999988888764 9999999999999999
Q ss_pred ccccCCchh--cHHHHHcCCCCCCCchhhhccCCCCCC
Q 007260 535 PQHRLAYKR--GATEIKQHPFFEGVNWALIRCATPPEI 570 (611)
Q Consensus 535 P~~Rpt~~~--~a~elL~Hp~f~~~~~~~~~~~~~p~~ 570 (611)
|.+|+|..+ ...+|++||||++++|..++..+||.+
T Consensus 273 p~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~~~~pP~l 310 (311)
T 4aw0_A 273 ATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 310 (311)
T ss_dssp GGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCCCCC
T ss_pred HhHCcChHHHcCCHHHHCCCCcCCCCHHHhcCCCCCCC
Confidence 999999543 345689999999999998877766543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-65 Score=533.59 Aligned_cols=269 Identities=43% Similarity=0.775 Sum_probs=231.9
Q ss_pred cccCeEEEeEecccCcEEEEEEEEC---CCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccce
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELS---GTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKF 290 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~---~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~ 290 (611)
..++|++++.||+|+||+||+|++. .+++.||||++++...... ...++.+|+++|+.|+|||||+++++|++++.
T Consensus 22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 100 (304)
T 3ubd_A 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVNHPFIVKLHYAFQTEGK 100 (304)
T ss_dssp CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence 3468999999999999999999984 4688999999986543321 12356789999999999999999999999999
Q ss_pred eeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccC
Q 007260 291 SCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAV 370 (611)
Q Consensus 291 ~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~ 370 (611)
+|||||||+||+|.+++.+. +.+++..++.|+.||+.||+|||++|||||||||+|||++.+|++||+|||+|+....
T Consensus 101 ~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 101 LYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EEEEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 99999999999999999876 5699999999999999999999999999999999999999999999999999843211
Q ss_pred CccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccc
Q 007260 371 SPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEAR 450 (611)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (611)
....
T Consensus 179 ----------------------------------------------------------------------------~~~~ 182 (304)
T 3ubd_A 179 ----------------------------------------------------------------------------HEKK 182 (304)
T ss_dssp ------------------------------------------------------------------------------CC
T ss_pred ----------------------------------------------------------------------------CCcc
Confidence 0112
Q ss_pred ccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 007260 451 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGL 530 (611)
Q Consensus 451 ~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~ 530 (611)
..+++||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+.+.++....+.+|.. +|+++++||.+|
T Consensus 183 ~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~--~s~~~~~li~~~ 260 (304)
T 3ubd_A 183 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF--LSPEAQSLLRML 260 (304)
T ss_dssp CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT--SCHHHHHHHHHH
T ss_pred ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCc--CCHHHHHHHHHH
Confidence 235689999999999999999999999999999999999999999999888899999888877764 999999999999
Q ss_pred hhcCccccCCch-hcHHHHHcCCCCCCCchhhhc
Q 007260 531 LVKEPQHRLAYK-RGATEIKQHPFFEGVNWALIR 563 (611)
Q Consensus 531 L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~ 563 (611)
|++||++||+.. ..++||++||||++++|..+.
T Consensus 261 L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~ 294 (304)
T 3ubd_A 261 FKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLY 294 (304)
T ss_dssp TCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHH
T ss_pred cccCHHHCCCCCcCCHHHHHcCccccCCCHHHHH
Confidence 999999999853 347899999999999998764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-64 Score=534.78 Aligned_cols=261 Identities=25% Similarity=0.461 Sum_probs=229.0
Q ss_pred cccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeE
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCL 293 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~L 293 (611)
.+++|++++.||+|+||+||+|++..+++.||||++.+..... ....++.+|+.+|+.|+|||||+++++|++++.+||
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi 100 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMKHPNIVQYRESFEENGSLYI 100 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH-HHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 3579999999999999999999999999999999998765443 446678999999999999999999999999999999
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcc
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 373 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~ 373 (611)
|||||+||+|.+++..+.+..++|..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+..
T Consensus 101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--- 177 (350)
T 4b9d_A 101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--- 177 (350)
T ss_dssp EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH---
T ss_pred EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecC---
Confidence 99999999999999887667789999999999999999999999999999999999999999999999999943320
Q ss_pred ccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccc
Q 007260 374 LIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMS 453 (611)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (611)
......+
T Consensus 178 -------------------------------------------------------------------------~~~~~~~ 184 (350)
T 4b9d_A 178 -------------------------------------------------------------------------TVELARA 184 (350)
T ss_dssp -------------------------------------------------------------------------HHHHHHH
T ss_pred -------------------------------------------------------------------------Ccccccc
Confidence 1112235
Q ss_pred cccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007260 454 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVK 533 (611)
Q Consensus 454 ~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~ 533 (611)
++||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+.+.+++..... +.+..++.++++||.+||++
T Consensus 185 ~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~-~~~~~~s~~~~~li~~~L~~ 263 (350)
T 4b9d_A 185 CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP-PVSLHYSYDLRSLVSQLFKR 263 (350)
T ss_dssp HHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-CCCTTSCHHHHHHHHHHTCS
T ss_pred cCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-CCCccCCHHHHHHHHHHccC
Confidence 78999999999999999999999999999999999999999999888888888877643 33456999999999999999
Q ss_pred CccccCCchhcHHHHHcCCCCCC
Q 007260 534 EPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 534 dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
||.+||+ ++|||+||||+.
T Consensus 264 dP~~R~s----~~e~l~hp~~~~ 282 (350)
T 4b9d_A 264 NPRDRPS----VNSILEKGFIAK 282 (350)
T ss_dssp SGGGSCC----HHHHHTSHHHHT
T ss_pred ChhHCcC----HHHHhcCHHhhc
Confidence 9999999 999999999975
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-63 Score=527.30 Aligned_cols=256 Identities=28% Similarity=0.440 Sum_probs=228.0
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
.++|+++++||+|+||+||+|++..+++.||||++++...... ..+.+|+.+|+.|+|||||+++++|++++.+|||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~---~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv 149 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR---ELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 149 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSG---GGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHH---HHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 3679999999999999999999999999999999976543332 3467899999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
||||+||+|.+++.+. .+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+...
T Consensus 150 mEy~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--- 223 (346)
T 4fih_A 150 MEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--- 223 (346)
T ss_dssp ECCCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS---
T ss_pred EeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCC---
Confidence 9999999999999863 5999999999999999999999999999999999999999999999999998543211
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
.....++
T Consensus 224 -------------------------------------------------------------------------~~~~~~~ 230 (346)
T 4fih_A 224 -------------------------------------------------------------------------VPRRKSL 230 (346)
T ss_dssp -------------------------------------------------------------------------SCCBCCC
T ss_pred -------------------------------------------------------------------------CCccccc
Confidence 1122357
Q ss_pred ccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCC-CCCCCCCCCCHHHHHHHHHhhhc
Q 007260 455 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQP-LRFPESPVVSFAARDLIRGLLVK 533 (611)
Q Consensus 455 vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~-l~~p~~~~~s~~l~dLI~~~L~~ 533 (611)
+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+.+..+.... ..++.+..+++++++||.+||++
T Consensus 231 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~ 310 (346)
T 4fih_A 231 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVR 310 (346)
T ss_dssp CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCS
T ss_pred ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcCC
Confidence 89999999999999999999999999999999999999999988888877776653 34455567999999999999999
Q ss_pred CccccCCchhcHHHHHcCCCCCC
Q 007260 534 EPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 534 dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
||++||| +.|||+||||+.
T Consensus 311 dP~~R~t----a~e~l~Hp~~~~ 329 (346)
T 4fih_A 311 DPAQRAT----AAELLKHPFLAK 329 (346)
T ss_dssp STTTSCC----HHHHTTCGGGGG
T ss_pred ChhHCcC----HHHHhcCHhhcC
Confidence 9999999 999999999974
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-63 Score=510.95 Aligned_cols=255 Identities=30% Similarity=0.492 Sum_probs=217.0
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
+++|++++.||+|+||+||+|++..+++.||||++++..........++.+|+++|+.++|||||+++++|++++.+|||
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 46999999999999999999999999999999999887666555566788999999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
|||| +|+|.+++.+. +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 92 mEy~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~---- 164 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD---- 164 (275)
T ss_dssp EECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred EeCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCC----
Confidence 9999 78999998876 5699999999999999999999999999999999999999999999999999843220
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
.....++
T Consensus 165 -------------------------------------------------------------------------~~~~~~~ 171 (275)
T 3hyh_A 165 -------------------------------------------------------------------------GNFLKTS 171 (275)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred -------------------------------------------------------------------------CCccCCe
Confidence 0112246
Q ss_pred ccCCCccchhhhccCCC-CChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007260 455 VGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVK 533 (611)
Q Consensus 455 vGT~~Y~APEil~~~~~-~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~ 533 (611)
+||+.|||||++.+..| +.++|||||||+||||++|++||.+.+....+.++......+|.. +++++++||.+||++
T Consensus 172 ~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~--~s~~~~~li~~~L~~ 249 (275)
T 3hyh_A 172 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKF--LSPGAAGLIKRMLIV 249 (275)
T ss_dssp ---CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT--SCHHHHHHHHHHSCS
T ss_pred eECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCHHHHHHHHHHccC
Confidence 89999999999999887 689999999999999999999999988888888888888777754 999999999999999
Q ss_pred CccccCCchhcHHHHHcCCCCC
Q 007260 534 EPQHRLAYKRGATEIKQHPFFE 555 (611)
Q Consensus 534 dP~~Rpt~~~~a~elL~Hp~f~ 555 (611)
||++||| ++|+|+||||+
T Consensus 250 dP~~R~s----~~eil~hpw~k 267 (275)
T 3hyh_A 250 NPLNRIS----IHEIMQDDWFK 267 (275)
T ss_dssp SGGGSCC----HHHHHHCHHHH
T ss_pred ChhHCcC----HHHHHcCcccc
Confidence 9999999 99999999996
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-61 Score=525.47 Aligned_cols=256 Identities=28% Similarity=0.440 Sum_probs=228.4
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
.++|+++++||+|+||+||+|++..+++.||||++.+...... ..+.+|+.+|+.|+|||||+++++|++++.+|||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~---~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV 226 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR---ELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 226 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSG---GGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHH---HHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence 4689999999999999999999999999999999976543332 3567899999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
||||+||+|.+++... .+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+...
T Consensus 227 mEy~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~--- 300 (423)
T 4fie_A 227 MEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--- 300 (423)
T ss_dssp EECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS---
T ss_pred EeCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCC---
Confidence 9999999999998764 4999999999999999999999999999999999999999999999999998543210
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
.....++
T Consensus 301 -------------------------------------------------------------------------~~~~~~~ 307 (423)
T 4fie_A 301 -------------------------------------------------------------------------VPRRKSL 307 (423)
T ss_dssp -------------------------------------------------------------------------CCCBCCC
T ss_pred -------------------------------------------------------------------------Ccccccc
Confidence 1122357
Q ss_pred ccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCC-CCCCCCCCCCHHHHHHHHHhhhc
Q 007260 455 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQP-LRFPESPVVSFAARDLIRGLLVK 533 (611)
Q Consensus 455 vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~-l~~p~~~~~s~~l~dLI~~~L~~ 533 (611)
+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+.+..+.... ..++.+..++.++++||.+||++
T Consensus 308 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~ 387 (423)
T 4fie_A 308 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVR 387 (423)
T ss_dssp EECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSCS
T ss_pred ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcCC
Confidence 89999999999999999999999999999999999999999988888887776653 34555567999999999999999
Q ss_pred CccccCCchhcHHHHHcCCCCCC
Q 007260 534 EPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 534 dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
||.+|++ |.|||+||||+.
T Consensus 388 dP~~R~t----a~ell~Hp~~~~ 406 (423)
T 4fie_A 388 DPAQRAT----AAELLKHPFLAK 406 (423)
T ss_dssp STTTSCC----HHHHTTCGGGGG
T ss_pred ChhHCcC----HHHHhcCHHhcC
Confidence 9999999 999999999974
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-60 Score=494.27 Aligned_cols=255 Identities=24% Similarity=0.430 Sum_probs=219.5
Q ss_pred cCe-EEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec----cce
Q 007260 216 SHF-RLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET----EKF 290 (611)
Q Consensus 216 ~~y-~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~----~~~ 290 (611)
++| ++.++||+|+||+||+|.+..+++.||||++.+..... ....++.+|+++|+.|+|||||+++++|++ ++.
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence 455 78889999999999999999999999999997765433 345678899999999999999999999875 467
Q ss_pred eeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--eeccCCCCCcEEEc-cCCcEEEEecccccc
Q 007260 291 SCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLG--IIYRDLKPENVLVR-EDGHIMLSDFDLSLR 367 (611)
Q Consensus 291 ~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~g--IVHRDLKPeNILv~-~~g~vkL~DFGlA~~ 367 (611)
+|||||||+||+|.+++.+. +.+++..++.|+.||+.||+|||++| ||||||||+||||+ .+|++||+|||+|+.
T Consensus 104 ~~lvmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 89999999999999999875 56999999999999999999999999 99999999999998 489999999999832
Q ss_pred ccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcc
Q 007260 368 CAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPT 447 (611)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (611)
..
T Consensus 182 ~~------------------------------------------------------------------------------ 183 (290)
T 3fpq_A 182 KR------------------------------------------------------------------------------ 183 (290)
T ss_dssp CC------------------------------------------------------------------------------
T ss_pred CC------------------------------------------------------------------------------
Confidence 11
Q ss_pred cccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCC-CCCCCCCHHHHHH
Q 007260 448 EARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRF-PESPVVSFAARDL 526 (611)
Q Consensus 448 ~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~-p~~~~~s~~l~dL 526 (611)
.....+++||+.|||||++.+ .|+.++|||||||+||||++|++||.+..+...+.+.+...... .....+++++++|
T Consensus 184 ~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l 262 (290)
T 3fpq_A 184 ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI 262 (290)
T ss_dssp TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHH
T ss_pred CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHH
Confidence 011235689999999999875 59999999999999999999999999877777776666544332 2334588999999
Q ss_pred HHHhhhcCccccCCchhcHHHHHcCCCCCC
Q 007260 527 IRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 527 I~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
|.+||++||.+||| +.|+|+||||+.
T Consensus 263 i~~~L~~dP~~R~s----~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 263 IEGCIRQNKDERYS----IKDLLNHAFFQE 288 (290)
T ss_dssp HHHHSCSSGGGSCC----HHHHHTSGGGC-
T ss_pred HHHHccCChhHCcC----HHHHhcCccccC
Confidence 99999999999999 999999999974
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-60 Score=540.61 Aligned_cols=281 Identities=32% Similarity=0.606 Sum_probs=239.0
Q ss_pred ccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHH---HHHHHHHHHHHHhCCCCCcccccceeec
Q 007260 211 GVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKK---LLRAQTEREILQSLDHPFLPTLYTHFET 287 (611)
Q Consensus 211 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~---~~~~~~E~~iL~~l~HpnIv~l~~~~~~ 287 (611)
..+.+++|++++.||+|+||+||+|++..+++.||||+|.+..+..... ....+.++.+++.++|||||+|+++|++
T Consensus 184 ~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~ 263 (689)
T 3v5w_A 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 263 (689)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred CCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE
Confidence 3456789999999999999999999999999999999998876543332 2233445667778899999999999999
Q ss_pred cceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccc
Q 007260 288 EKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLR 367 (611)
Q Consensus 288 ~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~ 367 (611)
.+.+|||||||+||+|++++.+. +.|++..++.|++||+.||+|||++|||||||||+||||+.+|++||+|||+|..
T Consensus 264 ~~~lylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 264 PDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeee
Confidence 99999999999999999999876 5699999999999999999999999999999999999999999999999999854
Q ss_pred ccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcc
Q 007260 368 CAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPT 447 (611)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (611)
+..
T Consensus 342 ~~~----------------------------------------------------------------------------- 344 (689)
T 3v5w_A 342 FSK----------------------------------------------------------------------------- 344 (689)
T ss_dssp CSS-----------------------------------------------------------------------------
T ss_pred cCC-----------------------------------------------------------------------------
Confidence 320
Q ss_pred cccccccccCCCccchhhhc-cCCCCChhhHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHcCCCCCCCCCCCCHHH
Q 007260 448 EARSMSFVGTHEYLAPEIIK-GEGHGSAVDWWTFGIFLYELLFGKTPFKGSG---NRATLFNVVGQPLRFPESPVVSFAA 523 (611)
Q Consensus 448 ~~~~~~~vGT~~Y~APEil~-~~~~~~~sDIWSLGviL~ELltG~~PF~~~~---~~~~l~~i~~~~l~~p~~~~~s~~l 523 (611)
....+++||+.|||||++. +..|+.++|||||||+||||++|++||.+.+ .......+....+.+|.. +|.++
T Consensus 345 -~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~--~S~~a 421 (689)
T 3v5w_A 345 -KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS--FSPEL 421 (689)
T ss_dssp -CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTT--SCHHH
T ss_pred -CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCcc--CCHHH
Confidence 1123568999999999996 5689999999999999999999999997642 234456677777777764 99999
Q ss_pred HHHHHHhhhcCccccCCc-hhcHHHHHcCCCCCCCchhhhcc--CCCCCCCCC
Q 007260 524 RDLIRGLLVKEPQHRLAY-KRGATEIKQHPFFEGVNWALIRC--ATPPEIPKP 573 (611)
Q Consensus 524 ~dLI~~~L~~dP~~Rpt~-~~~a~elL~Hp~f~~~~~~~~~~--~~~p~~p~p 573 (611)
++||.+||++||.+|++. ..+|+||++||||++++|..+.. ..||-+|..
T Consensus 422 ~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~pP~~P~~ 474 (689)
T 3v5w_A 422 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPR 474 (689)
T ss_dssp HHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSCCSCCCCT
T ss_pred HHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCcCccCCC
Confidence 999999999999999985 35799999999999999987643 355555543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-61 Score=507.22 Aligned_cols=258 Identities=25% Similarity=0.352 Sum_probs=222.1
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
.+.|++.++||+|+||+||+|++..+++.||||++++.... .+|+.+|+.|+|||||+++++|++++.+|||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 46799999999999999999999999999999999865432 3699999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCC-cEEEEeccccccccCCcc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDG-HIMLSDFDLSLRCAVSPT 373 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g-~vkL~DFGlA~~~~~~~~ 373 (611)
||||+||+|.+++.+. +.|++..++.|+.||+.||+|||++|||||||||+||||+.+| ++||+|||+|+.+.....
T Consensus 129 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp ECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred EeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 9999999999999875 5699999999999999999999999999999999999999988 699999999954431100
Q ss_pred ccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccc
Q 007260 374 LIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMS 453 (611)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (611)
.........
T Consensus 207 -----------------------------------------------------------------------~~~~~~~~~ 215 (336)
T 4g3f_A 207 -----------------------------------------------------------------------GKSLLTGDY 215 (336)
T ss_dssp ------------------------------------------------------------------------------CC
T ss_pred -----------------------------------------------------------------------ccceecCCc
Confidence 000111234
Q ss_pred cccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCC-CCCCCCHHHHHHHHHhhh
Q 007260 454 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFP-ESPVVSFAARDLIRGLLV 532 (611)
Q Consensus 454 ~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p-~~~~~s~~l~dLI~~~L~ 532 (611)
++||+.|||||++.+..|+.++|||||||+||||++|++||.+.+....+.++...+..+. .+..+++++++||.+||+
T Consensus 216 ~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~ 295 (336)
T 4g3f_A 216 IPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLR 295 (336)
T ss_dssp CCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTC
T ss_pred cccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHHHHHHHcc
Confidence 6899999999999999999999999999999999999999998887777788887765432 345699999999999999
Q ss_pred cCccccCCchhcHHHH-------------HcCCCCCCC
Q 007260 533 KEPQHRLAYKRGATEI-------------KQHPFFEGV 557 (611)
Q Consensus 533 ~dP~~Rpt~~~~a~el-------------L~Hp~f~~~ 557 (611)
+||.+||| +.|| |+|||+...
T Consensus 296 ~dP~~R~s----a~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 296 KEPVHRAS----AMELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp SSGGGSCC----HHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred CCHhHCcC----HHHHHHHHHHHHhhhhhccCCCcCCC
Confidence 99999999 7776 578998653
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-59 Score=502.16 Aligned_cols=263 Identities=25% Similarity=0.371 Sum_probs=221.0
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec------cc
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET------EK 289 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~------~~ 289 (611)
++|++++.||+|+||+||+|++..+++.||||++++... ......++.+|+++|+.|+|||||++++++.. .+
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 589999999999999999999999999999999976543 33445677899999999999999999998753 46
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
.+||||||| +|+|.+++.+. +.+++..++.|++||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.+.
T Consensus 133 ~~~ivmE~~-~g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 133 SVYVVLDLM-ESDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp CEEEEEECC-SEEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEEEEeCC-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 889999999 57899998765 579999999999999999999999999999999999999999999999999995432
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
.... ....
T Consensus 210 ~~~~------------------------------------------------------------------------~~~~ 217 (398)
T 4b99_A 210 TSPA------------------------------------------------------------------------EHQY 217 (398)
T ss_dssp ------------------------------------------------------------------------------CC
T ss_pred cCcc------------------------------------------------------------------------cccc
Confidence 1100 0111
Q ss_pred cccccccCCCccchhhhccCC-CCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCC----------------
Q 007260 450 RSMSFVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLR---------------- 512 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~~~-~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~---------------- 512 (611)
...+++||++|||||++.+.. |+.++||||||||||||++|++||.+.+..+.+..|......
T Consensus 218 ~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~ 297 (398)
T 4b99_A 218 FMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRA 297 (398)
T ss_dssp CCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHH
T ss_pred ccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhh
Confidence 234578999999999998864 699999999999999999999999999888877666532111
Q ss_pred ----CCC---------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCc
Q 007260 513 ----FPE---------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVN 558 (611)
Q Consensus 513 ----~p~---------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 558 (611)
++. .+.++.+++|||.+||++||.+|+| |.|+|+||||+...
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t----a~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 298 YIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARIS----AAAALRHPFLAKYH 352 (398)
T ss_dssp HHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCC----HHHHTTSGGGTTTC
T ss_pred hhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcC----HHHHhcCHhhCcCC
Confidence 111 1347899999999999999999999 99999999998754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-59 Score=487.49 Aligned_cols=270 Identities=24% Similarity=0.414 Sum_probs=204.7
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc------
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK------ 289 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~------ 289 (611)
++|++++.||+|+||+||+|+++.+++.||||++.... ......++.+|+.+|+.|+|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 57999999999999999999999999999999997643 2234457789999999999999999999987543
Q ss_pred ------eeeEEeeeCCCCCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEec
Q 007260 290 ------FSCLVMEFCPGGDLHTLRQKQPG-KYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDF 362 (611)
Q Consensus 290 ------~~~LVmE~~~gg~L~~ll~~~~~-~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DF 362 (611)
++|||||||+||+|.+++..... ....+..++.|+.||+.||+|||++|||||||||+||||+.+|++||+||
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccC
Confidence 47999999999999999986532 23456678999999999999999999999999999999999999999999
Q ss_pred cccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCccc
Q 007260 363 DLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPEL 442 (611)
Q Consensus 363 GlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (611)
|+|+.+......... .
T Consensus 163 Gla~~~~~~~~~~~~----------------------------------------------------------------~ 178 (299)
T 4g31_A 163 GLVTAMDQDEEEQTV----------------------------------------------------------------L 178 (299)
T ss_dssp CCC-----------------------------------------------------------------------------
T ss_pred ccceecCCCcccccc----------------------------------------------------------------c
Confidence 999654321110000 0
Q ss_pred ccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHcCCCCCC-CCCCCC
Q 007260 443 IAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRA-TLFNVVGQPLRFP-ESPVVS 520 (611)
Q Consensus 443 ~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~-~l~~i~~~~l~~p-~~~~~s 520 (611)
.......+..+++||+.|||||++.+..|+.++|||||||+||||++ ||.+..+.. .+..+.... +| .....+
T Consensus 179 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~~~--~p~~~~~~~ 253 (299)
T 4g31_A 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNLK--FPPLFTQKY 253 (299)
T ss_dssp -------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHTTC--CCHHHHHHC
T ss_pred cccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhcCC--CCCCCcccC
Confidence 00011223446789999999999999999999999999999999996 887543322 233333322 22 223356
Q ss_pred HHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCchh
Q 007260 521 FAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWA 560 (611)
Q Consensus 521 ~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~ 560 (611)
+.+++||.+||++||.+||+ +.|||+||||++++|.
T Consensus 254 ~~~~~li~~~L~~dP~~Rps----~~eil~h~~~~~~~~p 289 (299)
T 4g31_A 254 PCEYVMVQDMLSPSPMERPE----AINIIENAVFEDLDFP 289 (299)
T ss_dssp HHHHHHHHHHTCSSGGGSCC----HHHHHTSGGGCCC---
T ss_pred HHHHHHHHHHcCCChhHCcC----HHHHhcCHhhCCCCCC
Confidence 77899999999999999999 9999999999999883
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-57 Score=484.52 Aligned_cols=281 Identities=25% Similarity=0.380 Sum_probs=211.4
Q ss_pred cCeEEEeEecccCcEEEEEEEEC---CCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeecccee
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELS---GTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEKFS 291 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~---~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~~~~ 291 (611)
++|++++.||+|+||+||+|+++ .+++.||||++.+... ..++.+|+++|+.+ +|||||+++++|++.+++
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-----PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-----HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-----HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 68999999999999999999875 5688999999876532 23567899999998 699999999999999999
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccC-CcEEEEeccccccccC
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRED-GHIMLSDFDLSLRCAV 370 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~-g~vkL~DFGlA~~~~~ 370 (611)
|||||||+||+|.+++. .+++..++.|++||+.||+|||++|||||||||+||||+.+ +++||+|||+|+....
T Consensus 96 ~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp EEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred EEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 99999999999999884 38999999999999999999999999999999999999876 8999999999965543
Q ss_pred CccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccc
Q 007260 371 SPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEAR 450 (611)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (611)
............ .. . ..+.+. .| .........
T Consensus 171 ~~~~~~~~~~~~-~~--------~-----~~~~~~-----~~-----------------------------~~~~~~~~~ 202 (361)
T 4f9c_A 171 TKIELLKFVQSE-AQ--------Q-----ERCSQN-----KC-----------------------------SICLSRRQQ 202 (361)
T ss_dssp CSCGGGGGC-----------------------------------------------------------------------
T ss_pred cccccccccccc-cc--------c-----cccccc-----cc-----------------------------ccccccccc
Confidence 221110000000 00 0 000000 00 000011122
Q ss_pred ccccccCCCccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHc---C----------------
Q 007260 451 SMSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSG-NRATLFNVVG---Q---------------- 509 (611)
Q Consensus 451 ~~~~vGT~~Y~APEil~~~-~~~~~sDIWSLGviL~ELltG~~PF~~~~-~~~~l~~i~~---~---------------- 509 (611)
..+.+||++|||||++.+. .|+.++|||||||++|||++|+.||.+.. +.+.+..|.. .
T Consensus 203 ~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~ 282 (361)
T 4f9c_A 203 VAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILC 282 (361)
T ss_dssp ---CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEE
T ss_pred ccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccc
Confidence 3457899999999999886 48999999999999999999999996544 3344433321 0
Q ss_pred ---------------------------------CCCCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCC
Q 007260 510 ---------------------------------PLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 510 ---------------------------------~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
....+.+..++++++|||.+||++||.+|+| |+|+|+||||++
T Consensus 283 ~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~t----a~eaL~Hp~f~~ 358 (361)
T 4f9c_A 283 SKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRIT----AEEALLHPFFKD 358 (361)
T ss_dssp SSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCC----HHHHHTSGGGTT
T ss_pred cccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcC----HHHHhcCcccCC
Confidence 0011223468999999999999999999999 999999999998
Q ss_pred Cc
Q 007260 557 VN 558 (611)
Q Consensus 557 ~~ 558 (611)
++
T Consensus 359 i~ 360 (361)
T 4f9c_A 359 MS 360 (361)
T ss_dssp C-
T ss_pred CC
Confidence 64
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-57 Score=509.61 Aligned_cols=261 Identities=28% Similarity=0.426 Sum_probs=233.5
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
+++|++++.||+|+||+||+|+++.+++.||||++.+..... ...+++|+.+|+.|+|||||+|+++|++++.+|||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~---~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv 232 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH---HHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhh---HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 469999999999999999999999999999999997654332 34567899999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccC--CcEEEEeccccccccCCc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRED--GHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~--g~vkL~DFGlA~~~~~~~ 372 (611)
||||+||+|++++.... ..|++..++.|++||+.||+|||++|||||||||+||||+.+ |++||+|||+|+.+...
T Consensus 233 ~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~- 310 (573)
T 3uto_A 233 YEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 310 (573)
T ss_dssp EECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-
T ss_pred EeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC-
Confidence 99999999999887543 469999999999999999999999999999999999999854 89999999999543211
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
....
T Consensus 311 ----------------------------------------------------------------------------~~~~ 314 (573)
T 3uto_A 311 ----------------------------------------------------------------------------QSVK 314 (573)
T ss_dssp ----------------------------------------------------------------------------SEEE
T ss_pred ----------------------------------------------------------------------------Ccee
Confidence 1123
Q ss_pred ccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCC--CCCCCHHHHHHHHHh
Q 007260 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPE--SPVVSFAARDLIRGL 530 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~--~~~~s~~l~dLI~~~ 530 (611)
.++||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+.+.++......++. +..++.++++||.+|
T Consensus 315 ~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~ 394 (573)
T 3uto_A 315 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKL 394 (573)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTT
T ss_pred eeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHH
Confidence 468999999999999999999999999999999999999999999999999999888776654 356999999999999
Q ss_pred hhcCccccCCchhcHHHHHcCCCCCCCchh
Q 007260 531 LVKEPQHRLAYKRGATEIKQHPFFEGVNWA 560 (611)
Q Consensus 531 L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~ 560 (611)
|++||.+||+ +.|+|+||||+..+|.
T Consensus 395 L~~dp~~R~t----~~e~l~Hpw~~~~~~~ 420 (573)
T 3uto_A 395 LLADPNTRMT----IHQALEHPWLTPGNAP 420 (573)
T ss_dssp SCSSGGGSCC----HHHHHHSTTTSCCCCT
T ss_pred ccCChhHCcC----HHHHhcCcCcCCCCCC
Confidence 9999999999 9999999999988774
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-56 Score=462.63 Aligned_cols=260 Identities=21% Similarity=0.330 Sum_probs=218.4
Q ss_pred ccccCeEEEeEecccCcEEEEEEEEC-----CCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELS-----GTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET 287 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~-----~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~ 287 (611)
+..++|.+.+.||+|+||+||+|++. .++..||||+++... ......+.+|+++|++|+|||||++++++.+
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 86 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVE 86 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC---hHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence 44578999999999999999999975 357899999997643 2344578899999999999999999999999
Q ss_pred cceeeEEeeeCCCCCHHHHHHhC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCc
Q 007260 288 EKFSCLVMEFCPGGDLHTLRQKQ-----------PGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGH 356 (611)
Q Consensus 288 ~~~~~LVmE~~~gg~L~~ll~~~-----------~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~ 356 (611)
++.+|||||||+||+|.+++... ....+++..+..|+.||+.||+|||+++||||||||+||||+.+++
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL 166 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc
Confidence 99999999999999999999764 2357999999999999999999999999999999999999999999
Q ss_pred EEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCC
Q 007260 357 IMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQV 436 (611)
Q Consensus 357 vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (611)
+||+|||+|+......
T Consensus 167 ~Ki~DFGla~~~~~~~---------------------------------------------------------------- 182 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTD---------------------------------------------------------------- 182 (299)
T ss_dssp EEECCCSCHHHHTGGG----------------------------------------------------------------
T ss_pred EEECCcccceecCCCC----------------------------------------------------------------
Confidence 9999999995432110
Q ss_pred CCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCC
Q 007260 437 SPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPE 515 (611)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~ 515 (611)
........+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+.+..+..+.. .+.
T Consensus 183 ----------~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~-~~~ 251 (299)
T 4asz_A 183 ----------YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV-LQR 251 (299)
T ss_dssp ----------CEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCC-CCC
T ss_pred ----------ceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-CCC
Confidence 0011123469999999999999999999999999999999998 9999999888887777766542 333
Q ss_pred CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCC
Q 007260 516 SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 516 ~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
+..++.++.+||.+||..||++||+ +.+|+ +|++.
T Consensus 252 p~~~~~~~~~li~~cl~~dP~~RPs----~~~i~--~~L~~ 286 (299)
T 4asz_A 252 PRTCPQEVYELMLGCWQREPHMRKN----IKGIH--TLLQN 286 (299)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCC----HHHHH--HHHHH
T ss_pred CccchHHHHHHHHHHcCCChhHCcC----HHHHH--HHHHH
Confidence 4459999999999999999999999 77874 36653
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-56 Score=463.43 Aligned_cols=263 Identities=22% Similarity=0.350 Sum_probs=214.3
Q ss_pred ccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccce
Q 007260 211 GVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKF 290 (611)
Q Consensus 211 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~ 290 (611)
+++..++|+++++||+|+||+||+|++.+ .||||+++.... ..+...++.+|+.+|++|+|||||++++++.. +.
T Consensus 31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~ 105 (307)
T 3omv_A 31 WEIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DN 105 (307)
T ss_dssp CBCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS
T ss_pred cEEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-Ce
Confidence 45667899999999999999999998654 489999975432 33456688999999999999999999998764 56
Q ss_pred eeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccC
Q 007260 291 SCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAV 370 (611)
Q Consensus 291 ~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~ 370 (611)
+|||||||+||+|.+++.... ..+++..+..|+.||+.||+|||++|||||||||+||||++++++||+|||+|+....
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 899999999999999997653 5699999999999999999999999999999999999999999999999999843221
Q ss_pred CccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccc
Q 007260 371 SPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEAR 450 (611)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (611)
.. ....
T Consensus 185 ~~--------------------------------------------------------------------------~~~~ 190 (307)
T 3omv_A 185 WS--------------------------------------------------------------------------GSQQ 190 (307)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred CC--------------------------------------------------------------------------ccee
Confidence 00 0111
Q ss_pred ccccccCCCccchhhhccC---CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCC----CCCCCHHH
Q 007260 451 SMSFVGTHEYLAPEIIKGE---GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPE----SPVVSFAA 523 (611)
Q Consensus 451 ~~~~vGT~~Y~APEil~~~---~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~----~~~~s~~l 523 (611)
....+||+.|||||++.+. .|+.++|||||||+||||++|+.||.+.++...+..++......|. ...++.++
T Consensus 191 ~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l 270 (307)
T 3omv_A 191 VEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAM 270 (307)
T ss_dssp ---CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHH
T ss_pred ecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHH
Confidence 2345799999999999754 4889999999999999999999999998887777777665544432 34589999
Q ss_pred HHHHHHhhhcCccccCCchhcHH--HHHcCCC
Q 007260 524 RDLIRGLLVKEPQHRLAYKRGAT--EIKQHPF 553 (611)
Q Consensus 524 ~dLI~~~L~~dP~~Rpt~~~~a~--elL~Hp~ 553 (611)
++||.+||+.||++||++.+.+. ++|+|++
T Consensus 271 ~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 271 KRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp HHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 99999999999999999443221 3456665
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-55 Score=465.43 Aligned_cols=257 Identities=22% Similarity=0.312 Sum_probs=213.7
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECC-----CCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSG-----TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET 287 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~-----t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~ 287 (611)
+..++|.+.++||+|+||+||+|++.. +++.||||+++... ......+.+|+++|++|+|||||+++++|.+
T Consensus 38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 114 (329)
T 4aoj_A 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTMLQHQHIVRFFGVCTE 114 (329)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 344689999999999999999999753 68899999997654 3344578899999999999999999999999
Q ss_pred cceeeEEeeeCCCCCHHHHHHhCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccC
Q 007260 288 EKFSCLVMEFCPGGDLHTLRQKQP-------------GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRED 354 (611)
Q Consensus 288 ~~~~~LVmE~~~gg~L~~ll~~~~-------------~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~ 354 (611)
.+.+|||||||+||+|.+++.... ...+++..+..|+.||+.||+|||+++||||||||+||||+.+
T Consensus 115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~ 194 (329)
T 4aoj_A 115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG 194 (329)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCC
Confidence 999999999999999999987642 2469999999999999999999999999999999999999999
Q ss_pred CcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCC
Q 007260 355 GHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGN 434 (611)
Q Consensus 355 g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (611)
+++||+|||+|+......
T Consensus 195 ~~~Ki~DFGla~~~~~~~-------------------------------------------------------------- 212 (329)
T 4aoj_A 195 LVVKIGDFGMSRDIYSTD-------------------------------------------------------------- 212 (329)
T ss_dssp TEEEECCCC-----------------------------------------------------------------------
T ss_pred CcEEEcccccceeccCCC--------------------------------------------------------------
Confidence 999999999985432110
Q ss_pred CCCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCC
Q 007260 435 QVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRF 513 (611)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~ 513 (611)
........+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.++.+.+..+..+. +.
T Consensus 213 ------------~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~-~~ 279 (329)
T 4aoj_A 213 ------------YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR-EL 279 (329)
T ss_dssp -------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTC-CC
T ss_pred ------------cceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-CC
Confidence 0011123579999999999999999999999999999999998 999999988887777766542 33
Q ss_pred CCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcC
Q 007260 514 PESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 514 p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~H 551 (611)
+.+..+++++.+||.+||..||++||+ +.||+++
T Consensus 280 ~~p~~~~~~~~~li~~cl~~dP~~RPs----~~ei~~~ 313 (329)
T 4aoj_A 280 ERPRACPPEVYAIMRGCWQREPQQRHS----IKDVHAR 313 (329)
T ss_dssp CCCTTCCHHHHHHHHHHCCSSTTTSCC----HHHHHHH
T ss_pred CCcccccHHHHHHHHHHcCcChhHCcC----HHHHHHH
Confidence 444569999999999999999999999 7777753
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-55 Score=461.48 Aligned_cols=279 Identities=37% Similarity=0.695 Sum_probs=242.2
Q ss_pred cccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeE
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCL 293 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~L 293 (611)
.+++|++++.||+|+||+||+|++..+++.||||++.+..........++.+|+.+|+.++||||++++++|.+.+.+||
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 46799999999999999999999999999999999987654444455677889999999999999999999999999999
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcc
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 373 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~ 373 (611)
|||||+||+|..++.+. +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||++.....
T Consensus 83 v~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~--- 157 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--- 157 (337)
T ss_dssp EEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---
T ss_pred EEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhccc---
Confidence 99999999999988875 5699999999999999999999999999999999999999999999999999842110
Q ss_pred ccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccc
Q 007260 374 LIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMS 453 (611)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (611)
.......
T Consensus 158 -------------------------------------------------------------------------~~~~~~~ 164 (337)
T 1o6l_A 158 -------------------------------------------------------------------------DGATMKT 164 (337)
T ss_dssp -------------------------------------------------------------------------TTCCBCC
T ss_pred -------------------------------------------------------------------------CCCcccc
Confidence 0011234
Q ss_pred cccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007260 454 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVK 533 (611)
Q Consensus 454 ~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~ 533 (611)
++||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+....+..+....+.+|.. ++.++++||.+||.+
T Consensus 165 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~--~s~~~~~li~~lL~~ 242 (337)
T 1o6l_A 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT--LSPEAKSLLAGLLKK 242 (337)
T ss_dssp CEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT--SCHHHHHHHHHHTCS
T ss_pred cccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCHHHHHHHHHHhhc
Confidence 679999999999999999999999999999999999999999988888888888888777764 999999999999999
Q ss_pred CccccCCch-hcHHHHHcCCCCCCCchhhhc--cCCCCCCCC
Q 007260 534 EPQHRLAYK-RGATEIKQHPFFEGVNWALIR--CATPPEIPK 572 (611)
Q Consensus 534 dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~--~~~~p~~p~ 572 (611)
||.+||+.. ..+.+|++||||.+++|..+. ...||..|.
T Consensus 243 dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~~~~~~pp~~p~ 284 (337)
T 1o6l_A 243 DPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQ 284 (337)
T ss_dssp STTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred CHHHhcCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCCCCC
Confidence 999999211 129999999999999998653 334444443
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-55 Score=467.05 Aligned_cols=280 Identities=36% Similarity=0.684 Sum_probs=241.4
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeecccee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEKFS 291 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~~~~ 291 (611)
+.+++|++++.||+|+||+||+|++..+++.||||++.+...........+.+|+.+|+.+ +||||++++++|.+.+.+
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 4567999999999999999999999999999999999887655555666778899999988 799999999999999999
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCC
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~ 371 (611)
|||||||+||+|..++.+. +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||++.....
T Consensus 100 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~- 176 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC- 176 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc-
Confidence 9999999999999998875 5699999999999999999999999999999999999999999999999999842110
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
.....
T Consensus 177 ---------------------------------------------------------------------------~~~~~ 181 (353)
T 3txo_A 177 ---------------------------------------------------------------------------NGVTT 181 (353)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ---------------------------------------------------------------------------CCccc
Confidence 01112
Q ss_pred cccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 007260 452 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLL 531 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L 531 (611)
..++||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+.+.++....+.+|.. ++.++++||.+||
T Consensus 182 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~--~~~~~~~li~~lL 259 (353)
T 3txo_A 182 ATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTW--LHEDATGILKSFM 259 (353)
T ss_dssp ----CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT--SCHHHHHHHHHHT
T ss_pred cccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCHHHHHHHHHHh
Confidence 34679999999999999999999999999999999999999999999888899999988888765 9999999999999
Q ss_pred hcCccccCCc--hhcHHHHHcCCCCCCCchhhhcc--CCCCCCCC
Q 007260 532 VKEPQHRLAY--KRGATEIKQHPFFEGVNWALIRC--ATPPEIPK 572 (611)
Q Consensus 532 ~~dP~~Rpt~--~~~a~elL~Hp~f~~~~~~~~~~--~~~p~~p~ 572 (611)
.+||.+||+. ..++.+|++||||++++|..+.. ..||-.|.
T Consensus 260 ~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~~~p~~p~ 304 (353)
T 3txo_A 260 TKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPR 304 (353)
T ss_dssp CSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred hhCHHHccCCcccCCHHHHhhCCcccCCCHHHHhcCcCCCCccCC
Confidence 9999999994 23449999999999999987643 34444443
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-55 Score=458.41 Aligned_cols=258 Identities=21% Similarity=0.291 Sum_probs=216.5
Q ss_pred cccccCeEEEeEecccCcEEEEEEEEC-----CCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceee
Q 007260 212 VLGLSHFRLLKRLGCGDIGSVYLSELS-----GTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFE 286 (611)
Q Consensus 212 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~-----~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~ 286 (611)
.+..++++++++||+|+||+||+|++. .+++.||||+++.... ......+.+|+.+|++|+|||||++++++.
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~--~~~~~~f~~E~~il~~l~HpNIV~l~g~~~ 99 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE--GPLREEFRHEAMLRARLQHPNVVCLLGVVT 99 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC--C-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC--hHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence 345678999999999999999999974 3578999999975432 123346789999999999999999999999
Q ss_pred ccceeeEEeeeCCCCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEc
Q 007260 287 TEKFSCLVMEFCPGGDLHTLRQKQP--------------GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVR 352 (611)
Q Consensus 287 ~~~~~~LVmE~~~gg~L~~ll~~~~--------------~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~ 352 (611)
+++.+|||||||++|+|.+++.... ...+++..+..|+.||+.||+|||+++||||||||+||||+
T Consensus 100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY 179 (308)
T ss_dssp SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence 9999999999999999999986532 24589999999999999999999999999999999999999
Q ss_pred cCCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCcccc
Q 007260 353 EDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEI 432 (611)
Q Consensus 353 ~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (611)
+++++||+|||+|+.+....
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~------------------------------------------------------------ 199 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAAD------------------------------------------------------------ 199 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGG------------------------------------------------------------
T ss_pred CCCCEEECCcccceeccCCC------------------------------------------------------------
Confidence 99999999999985432110
Q ss_pred CCCCCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCC
Q 007260 433 GNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPL 511 (611)
Q Consensus 433 ~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l 511 (611)
........+||+.|||||++.+..|+.++|||||||+||||++ |+.||.+.+..+.+..+..+.
T Consensus 200 --------------~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~- 264 (308)
T 4gt4_A 200 --------------YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQ- 264 (308)
T ss_dssp --------------CBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTC-
T ss_pred --------------ceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-
Confidence 0011223579999999999999999999999999999999998 999999988877776666543
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 512 RFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 512 ~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
..|.+..++.++.+||.+||..||.+||+ +.||++
T Consensus 265 ~~~~p~~~~~~~~~li~~C~~~dP~~RPs----~~ei~~ 299 (308)
T 4gt4_A 265 VLPCPDDCPAWVYALMIECWNEFPSRRPR----FKDIHS 299 (308)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred CCCCcccchHHHHHHHHHHcCCChhHCcC----HHHHHH
Confidence 34555569999999999999999999999 666655
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-54 Score=453.21 Aligned_cols=267 Identities=36% Similarity=0.712 Sum_probs=238.6
Q ss_pred cccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeE
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCL 293 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~L 293 (611)
.+++|++++.||+|+||.||+|++..+++.||||++.+...........+.+|+.+|+.++||||++++++|.+...+||
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 45799999999999999999999999999999999987654443445567889999999999999999999999999999
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcc
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 373 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~ 373 (611)
|||||+||+|.+++... ..+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||++.....
T Consensus 84 v~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~--- 158 (318)
T 1fot_A 84 IMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--- 158 (318)
T ss_dssp EECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS---
T ss_pred EEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC---
Confidence 99999999999999875 5699999999999999999999999999999999999999999999999999843210
Q ss_pred ccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccc
Q 007260 374 LIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMS 453 (611)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (611)
....
T Consensus 159 ----------------------------------------------------------------------------~~~~ 162 (318)
T 1fot_A 159 ----------------------------------------------------------------------------VTYT 162 (318)
T ss_dssp ----------------------------------------------------------------------------CBCC
T ss_pred ----------------------------------------------------------------------------cccc
Confidence 0123
Q ss_pred cccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007260 454 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVK 533 (611)
Q Consensus 454 ~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~ 533 (611)
.+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+....+.+++...+.+|.. ++.++++||.+||..
T Consensus 163 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~--~~~~~~~li~~lL~~ 240 (318)
T 1fot_A 163 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPF--FNEDVKDLLSRLITR 240 (318)
T ss_dssp CCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTT--SCHHHHHHHHHHTCS
T ss_pred ccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCC--CCHHHHHHHHHHhcc
Confidence 579999999999999999999999999999999999999999988888888898888777754 899999999999999
Q ss_pred CccccCCchh-cHHHHHcCCCCCCCchhhhc
Q 007260 534 EPQHRLAYKR-GATEIKQHPFFEGVNWALIR 563 (611)
Q Consensus 534 dP~~Rpt~~~-~a~elL~Hp~f~~~~~~~~~ 563 (611)
||.+|++... .+++|++||||++++|..+.
T Consensus 241 dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~~ 271 (318)
T 1fot_A 241 DLSQRLGNLQNGTEDVKNHPWFKEVVWEKLL 271 (318)
T ss_dssp CTTTCTTSSTTTTHHHHTSGGGSSCCHHHHH
T ss_pred CHHHcCCCcCCCHHHHhcCccccCCCHHHHH
Confidence 9999994221 38999999999999998764
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-54 Score=471.00 Aligned_cols=282 Identities=34% Similarity=0.649 Sum_probs=242.7
Q ss_pred CccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc
Q 007260 210 DGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK 289 (611)
Q Consensus 210 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~ 289 (611)
+..+..++|++++.||+|+||+||+|++..+++.||||++.+...........+.+|+.+|+.++|||||+++++|.+++
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 34556789999999999999999999999999999999998755433333345678999999999999999999999999
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
.+|||||||+||+|.+++... .+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||++....
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~ 219 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 219 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeec
Confidence 999999999999999998764 49999999999999999999999999999999999999999999999999985432
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
.. ...
T Consensus 220 ~~---------------------------------------------------------------------------~~~ 224 (410)
T 3v8s_A 220 KE---------------------------------------------------------------------------GMV 224 (410)
T ss_dssp TT---------------------------------------------------------------------------SEE
T ss_pred cC---------------------------------------------------------------------------Ccc
Confidence 11 011
Q ss_pred cccccccCCCccchhhhccCC----CCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCC--CCCCCCCCCCHHH
Q 007260 450 RSMSFVGTHEYLAPEIIKGEG----HGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQP--LRFPESPVVSFAA 523 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~~~----~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~--l~~p~~~~~s~~l 523 (611)
...+.+||+.|+|||++.+.. |+.++|||||||+||||++|++||.+.+....+.+++... +.+|....++.++
T Consensus 225 ~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~ 304 (410)
T 3v8s_A 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEA 304 (410)
T ss_dssp ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHH
T ss_pred cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHH
Confidence 123467999999999998876 7899999999999999999999999988888888887643 6677777799999
Q ss_pred HHHHHHhhhcCccc--cCCchhcHHHHHcCCCCCCCchhh--hccCCCCCCCCC
Q 007260 524 RDLIRGLLVKEPQH--RLAYKRGATEIKQHPFFEGVNWAL--IRCATPPEIPKP 573 (611)
Q Consensus 524 ~dLI~~~L~~dP~~--Rpt~~~~a~elL~Hp~f~~~~~~~--~~~~~~p~~p~p 573 (611)
++||.+||..+|.+ |++ ++||++||||++++|.. .+...||-+|..
T Consensus 305 ~~li~~lL~~~~~rlgR~~----~~ei~~Hp~f~~~~w~~~~~~~~~~p~~p~~ 354 (410)
T 3v8s_A 305 KNLICAFLTDREVRLGRNG----VEEIKRHLFFKNDQWAWETLRDTVAPVVPDL 354 (410)
T ss_dssp HHHHHHHSSCGGGCTTSSC----HHHHHTSGGGCCSSCCSTTGGGSCCSCCCCC
T ss_pred HHHHHHHccChhhhCCCCC----HHHHhcCccccCCCHHHHhhcccCCCCCCcC
Confidence 99999999988888 999 99999999999999864 344556666643
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=465.09 Aligned_cols=279 Identities=38% Similarity=0.678 Sum_probs=236.0
Q ss_pred cccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHH-HHhCCCCCcccccceeeccceee
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREI-LQSLDHPFLPTLYTHFETEKFSC 292 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~i-L~~l~HpnIv~l~~~~~~~~~~~ 292 (611)
..++|++++.||+|+||.||+|++..+++.||||++.+...........+.+|..+ ++.++|||||+++++|.+.+.+|
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 45799999999999999999999999999999999988766555555666778877 57789999999999999999999
Q ss_pred EEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCc
Q 007260 293 LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 293 LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~ 372 (611)
||||||+||+|.+++.+. +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+++....
T Consensus 116 lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~-- 191 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE-- 191 (373)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC--
T ss_pred EEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc--
Confidence 999999999999998875 5699999999999999999999999999999999999999999999999999843210
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
......
T Consensus 192 --------------------------------------------------------------------------~~~~~~ 197 (373)
T 2r5t_A 192 --------------------------------------------------------------------------HNSTTS 197 (373)
T ss_dssp --------------------------------------------------------------------------CCCCCC
T ss_pred --------------------------------------------------------------------------CCCccc
Confidence 001123
Q ss_pred ccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007260 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLV 532 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~ 532 (611)
.++||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+.+.+++...+.++. .++.++++||.+||.
T Consensus 198 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~lL~ 275 (373)
T 2r5t_A 198 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKP--NITNSARHLLEGLLQ 275 (373)
T ss_dssp SBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCS--SSCHHHHHHHHHHTC
T ss_pred cccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHHHHHHHcc
Confidence 467999999999999999999999999999999999999999998888888888888877765 499999999999999
Q ss_pred cCccccCCchhcHHHHHcCCCCCCCchhhhc--cCCCCCCCC
Q 007260 533 KEPQHRLAYKRGATEIKQHPFFEGVNWALIR--CATPPEIPK 572 (611)
Q Consensus 533 ~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~--~~~~p~~p~ 572 (611)
+||.+||+...++.+|++||||++++|..+. ...||-.|.
T Consensus 276 ~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~pp~~p~ 317 (373)
T 2r5t_A 276 KDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITPPFNPN 317 (373)
T ss_dssp SSGGGSTTTTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCS
T ss_pred cCHHhCCCCCCCHHHHhCCccccCCCHHHHHhCCCCCCCCCC
Confidence 9999999987778999999999999998763 334554443
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-55 Score=475.50 Aligned_cols=286 Identities=34% Similarity=0.628 Sum_probs=245.1
Q ss_pred ccCccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 007260 208 ARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET 287 (611)
Q Consensus 208 ~~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~ 287 (611)
..+..+..++|++++.||+|+||+||+|++..+++.||||++.+...........+.+|+.+|..++||||++++++|.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 34455667899999999999999999999999999999999987554433333447789999999999999999999999
Q ss_pred cceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccc
Q 007260 288 EKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLR 367 (611)
Q Consensus 288 ~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~ 367 (611)
++.+|||||||+||+|.+++.+. ...+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+++.
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~ 224 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLK 224 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhh
Confidence 99999999999999999999874 35699999999999999999999999999999999999999999999999999854
Q ss_pred ccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcc
Q 007260 368 CAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPT 447 (611)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (611)
.....
T Consensus 225 ~~~~~--------------------------------------------------------------------------- 229 (437)
T 4aw2_A 225 LMEDG--------------------------------------------------------------------------- 229 (437)
T ss_dssp CCTTS---------------------------------------------------------------------------
T ss_pred cccCC---------------------------------------------------------------------------
Confidence 32110
Q ss_pred cccccccccCCCccchhhhc-----cCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCC--CCCCCC-CCC
Q 007260 448 EARSMSFVGTHEYLAPEIIK-----GEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQP--LRFPES-PVV 519 (611)
Q Consensus 448 ~~~~~~~vGT~~Y~APEil~-----~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~--l~~p~~-~~~ 519 (611)
.......+||+.|+|||++. +..|+.++|||||||+||||++|++||.+.+..+.+.+++... +.+|.. ..+
T Consensus 230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 309 (437)
T 4aw2_A 230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDV 309 (437)
T ss_dssp CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCS
T ss_pred CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccC
Confidence 01122357999999999997 4568999999999999999999999999988888888777543 445543 458
Q ss_pred CHHHHHHHHHhhhcCccc--cCCchhcHHHHHcCCCCCCCchhhhccCCCCCCCCC
Q 007260 520 SFAARDLIRGLLVKEPQH--RLAYKRGATEIKQHPFFEGVNWALIRCATPPEIPKP 573 (611)
Q Consensus 520 s~~l~dLI~~~L~~dP~~--Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~p~~p~p 573 (611)
+.++++||++||+.+|++ |++ ++|+++||||++++|..++...||-+|..
T Consensus 310 s~~~~dLi~~lL~~~~~r~~r~~----~~eil~Hpff~~i~w~~l~~~~~p~~P~~ 361 (437)
T 4aw2_A 310 SENAKDLIRRLICSREHRLGQNG----IEDFKKHPFFSGIDWDNIRNCEAPYIPEV 361 (437)
T ss_dssp CHHHHHHHHTTSSCGGGCTTTTT----THHHHTSGGGTTCCTTTGGGSCCSCCCCC
T ss_pred CHHHHHHHHHHhcccccccCCCC----HHHHhCCCccCCCCHHHHhhCCCCCCCcC
Confidence 999999999999998888 888 99999999999999999887777766654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-54 Score=465.45 Aligned_cols=280 Identities=38% Similarity=0.727 Sum_probs=237.5
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeecccee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEKFS 291 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~~~~ 291 (611)
+.+++|++++.||+|+||+||+|++..+++.||||++.+...........+.+|+.+|..+ +|||||+++++|.+.+.+
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 128 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 128 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence 4567999999999999999999999999999999999887666556666778899999877 899999999999999999
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCC
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~ 371 (611)
|||||||+||+|..++.+. +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+++....
T Consensus 129 ~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~- 205 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR- 205 (396)
T ss_dssp EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred EEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc-
Confidence 9999999999999998875 5699999999999999999999999999999999999999999999999999842110
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
.....
T Consensus 206 ---------------------------------------------------------------------------~~~~~ 210 (396)
T 4dc2_A 206 ---------------------------------------------------------------------------PGDTT 210 (396)
T ss_dssp ---------------------------------------------------------------------------TTCCB
T ss_pred ---------------------------------------------------------------------------CCCcc
Confidence 01112
Q ss_pred cccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC---------cHHHHHHHHcCCCCCCCCCCCCHH
Q 007260 452 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSG---------NRATLFNVVGQPLRFPESPVVSFA 522 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~---------~~~~l~~i~~~~l~~p~~~~~s~~ 522 (611)
..++||+.|+|||++.+..|+.++|||||||+||||++|++||.+.. .......+....+.+|.. ++.+
T Consensus 211 ~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~--~s~~ 288 (396)
T 4dc2_A 211 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS--LSVK 288 (396)
T ss_dssp CCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTT--SCHH
T ss_pred ccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCc--CCHH
Confidence 34689999999999999999999999999999999999999996432 223445667777777765 9999
Q ss_pred HHHHHHHhhhcCccccCCch--hcHHHHHcCCCCCCCchhhhcc--CCCCCCCC
Q 007260 523 ARDLIRGLLVKEPQHRLAYK--RGATEIKQHPFFEGVNWALIRC--ATPPEIPK 572 (611)
Q Consensus 523 l~dLI~~~L~~dP~~Rpt~~--~~a~elL~Hp~f~~~~~~~~~~--~~~p~~p~ 572 (611)
+++||.+||.+||.+||+.. .++.||++||||++++|..+.. ..||-.|.
T Consensus 289 ~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~~~pp~~p~ 342 (396)
T 4dc2_A 289 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPN 342 (396)
T ss_dssp HHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTCSCCSCCCC
T ss_pred HHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCCCCcCC
Confidence 99999999999999999953 3468999999999999987643 34444443
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-54 Score=458.64 Aligned_cols=280 Identities=36% Similarity=0.656 Sum_probs=243.5
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeecccee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEKFS 291 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~~~~ 291 (611)
+.+++|++++.||+|+||.||+|++..+++.||||++.+...........+.+|+.+|..+ +||||++++++|.+.+.+
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 4567999999999999999999999999999999999876554444556678899999988 899999999999999999
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCC
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~ 371 (611)
|||||||+||+|.+++... +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||++.....
T Consensus 97 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~- 173 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW- 173 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc-
Confidence 9999999999999998875 4599999999999999999999999999999999999999999999999999842110
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
.....
T Consensus 174 ---------------------------------------------------------------------------~~~~~ 178 (353)
T 2i0e_A 174 ---------------------------------------------------------------------------DGVTT 178 (353)
T ss_dssp ---------------------------------------------------------------------------TTCCB
T ss_pred ---------------------------------------------------------------------------CCccc
Confidence 00112
Q ss_pred cccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 007260 452 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLL 531 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L 531 (611)
..++||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+.++....+.+|.. ++.++++||.+||
T Consensus 179 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~--~s~~~~~li~~lL 256 (353)
T 2i0e_A 179 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS--MSKEAVAICKGLM 256 (353)
T ss_dssp CCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT--SCHHHHHHHHHHT
T ss_pred ccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCC--CCHHHHHHHHHHh
Confidence 34679999999999999999999999999999999999999999988888888898888877764 9999999999999
Q ss_pred hcCccccCCch-hcHHHHHcCCCCCCCchhhhc--cCCCCCCCC
Q 007260 532 VKEPQHRLAYK-RGATEIKQHPFFEGVNWALIR--CATPPEIPK 572 (611)
Q Consensus 532 ~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~--~~~~p~~p~ 572 (611)
.+||.+||+.. ..+.+|++||||++++|..+. ...||-.|.
T Consensus 257 ~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~~p~~p~ 300 (353)
T 2i0e_A 257 TKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPK 300 (353)
T ss_dssp CSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred hcCHHHcCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCcCCC
Confidence 99999999752 358999999999999998764 334444443
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=452.78 Aligned_cols=278 Identities=36% Similarity=0.656 Sum_probs=245.4
Q ss_pred cccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecccee
Q 007260 212 VLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFS 291 (611)
Q Consensus 212 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~ 291 (611)
...+++|++++.||+|+||.||+|++..+++.||||++.+..........++.+|+.+|+.++||||++++++|.+...+
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 116 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 34568999999999999999999999999999999999876655445556778899999999999999999999999999
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCC
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~ 371 (611)
|||||||+||+|.+++.+. +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||++.....
T Consensus 117 ~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~- 193 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG- 193 (350)
T ss_dssp EEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS-
T ss_pred EEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC-
Confidence 9999999999999999875 4599999999999999999999999999999999999999999999999999843210
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
..
T Consensus 194 ------------------------------------------------------------------------------~~ 195 (350)
T 1rdq_E 194 ------------------------------------------------------------------------------RT 195 (350)
T ss_dssp ------------------------------------------------------------------------------CB
T ss_pred ------------------------------------------------------------------------------Cc
Confidence 01
Q ss_pred cccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 007260 452 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLL 531 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L 531 (611)
..++||+.|+|||++.+..++.++|||||||++|||++|++||.+.+....+.++....+.+|.. ++.++++||.+||
T Consensus 196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~--~~~~~~~li~~lL 273 (350)
T 1rdq_E 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLL 273 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT--CCHHHHHHHHHHS
T ss_pred ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCHHHHHHHHHHh
Confidence 23579999999999999999999999999999999999999999988888888888888777754 8999999999999
Q ss_pred hcCccccCCc-hhcHHHHHcCCCCCCCchhhhc--cCCCCCCCC
Q 007260 532 VKEPQHRLAY-KRGATEIKQHPFFEGVNWALIR--CATPPEIPK 572 (611)
Q Consensus 532 ~~dP~~Rpt~-~~~a~elL~Hp~f~~~~~~~~~--~~~~p~~p~ 572 (611)
..||.+||+. ..++++|++||||++++|..+. ...+|.+|.
T Consensus 274 ~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~~~~~~~p~~p~ 317 (350)
T 1rdq_E 274 QVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPK 317 (350)
T ss_dssp CSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred hcCHHhccCCccCCHHHHHhCcCcCCCCHHHHhhccCCCCCCCC
Confidence 9999999973 3458999999999999997653 334555554
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-54 Score=468.33 Aligned_cols=291 Identities=36% Similarity=0.662 Sum_probs=245.0
Q ss_pred HhhccCccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccce
Q 007260 205 AVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTH 284 (611)
Q Consensus 205 ~~~~~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~ 284 (611)
.+...+..+..++|++++.||+|+||+||+|++..+++.||||++.+...........+.+|+.+|..++||||++++++
T Consensus 50 ~~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~ 129 (412)
T 2vd5_A 50 VVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFA 129 (412)
T ss_dssp HHHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred hhhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence 34444556677899999999999999999999999999999999987655444445567889999999999999999999
Q ss_pred eeccceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccc
Q 007260 285 FETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDL 364 (611)
Q Consensus 285 ~~~~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGl 364 (611)
|.+.+.+|||||||+||+|.+++.+. +..+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+
T Consensus 130 ~~~~~~~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGl 208 (412)
T 2vd5_A 130 FQDENYLYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGS 208 (412)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EeeCCEEEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechh
Confidence 99999999999999999999999875 24699999999999999999999999999999999999999999999999999
Q ss_pred cccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCccccc
Q 007260 365 SLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIA 444 (611)
Q Consensus 365 A~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (611)
+.......
T Consensus 209 a~~~~~~~------------------------------------------------------------------------ 216 (412)
T 2vd5_A 209 CLKLRADG------------------------------------------------------------------------ 216 (412)
T ss_dssp CEECCTTS------------------------------------------------------------------------
T ss_pred heeccCCC------------------------------------------------------------------------
Confidence 85432110
Q ss_pred CcccccccccccCCCccchhhhc-------cCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcC--CCCCCC
Q 007260 445 EPTEARSMSFVGTHEYLAPEIIK-------GEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ--PLRFPE 515 (611)
Q Consensus 445 ~~~~~~~~~~vGT~~Y~APEil~-------~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~--~l~~p~ 515 (611)
......++||+.|+|||++. +..|+.++|||||||++|||++|+.||.+.+..+.+.+++.. .+.+|.
T Consensus 217 ---~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 293 (412)
T 2vd5_A 217 ---TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPL 293 (412)
T ss_dssp ---CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC-
T ss_pred ---ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCc
Confidence 01122457999999999998 356899999999999999999999999998888887777753 244443
Q ss_pred -CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCchhhhccCCCCCCCCC
Q 007260 516 -SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIRCATPPEIPKP 573 (611)
Q Consensus 516 -~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~p~~p~p 573 (611)
...++.++++||.+||+ +|.+|++ +..++||++||||++++|..++...||-+|..
T Consensus 294 ~~~~~s~~~~dli~~lL~-~p~~Rlg-r~~~~ei~~Hpff~~i~w~~l~~~~~p~~p~~ 350 (412)
T 2vd5_A 294 VDEGVPEEARDFIQRLLC-PPETRLG-RGGAGDFRTHPFFFGLDWDGLRDSVPPFTPDF 350 (412)
T ss_dssp ---CCCHHHHHHHHTTSS-CGGGCTT-TTTHHHHHTSGGGTTCCSTTSTTSCCSCCCC-
T ss_pred cccCCCHHHHHHHHHHcC-ChhhcCC-CCCHHHHhcCCCcCCCCHHHHhhcCCCCCCcC
Confidence 24699999999999999 9999963 12399999999999999998877777766653
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-54 Score=458.43 Aligned_cols=267 Identities=36% Similarity=0.720 Sum_probs=235.8
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeecccee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEKFS 291 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~~~~ 291 (611)
+.+++|++++.||+|+||.||+|++..+++.||||++.+...........+.+|+.+|..+ +||||++++++|.+.+.+
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 4567999999999999999999999999999999999876544334455677899999876 999999999999999999
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCC
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~ 371 (611)
|||||||+||+|.+++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||++.....
T Consensus 94 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~- 170 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML- 170 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc-
Confidence 9999999999999998875 4699999999999999999999999999999999999999999999999999842110
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
.....
T Consensus 171 ---------------------------------------------------------------------------~~~~~ 175 (345)
T 1xjd_A 171 ---------------------------------------------------------------------------GDAKT 175 (345)
T ss_dssp ---------------------------------------------------------------------------TTCCB
T ss_pred ---------------------------------------------------------------------------CCCcc
Confidence 00112
Q ss_pred cccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 007260 452 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLL 531 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L 531 (611)
..++||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+....+.++......+|.. ++.++++||.+||
T Consensus 176 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~--~s~~~~~li~~lL 253 (345)
T 1xjd_A 176 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW--LEKEAKDLLVKLF 253 (345)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT--SCHHHHHHHHHHS
T ss_pred cCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcc--cCHHHHHHHHHHh
Confidence 34679999999999999999999999999999999999999999988888888888877777654 9999999999999
Q ss_pred hcCccccCCchhcHH-HHHcCCCCCCCchhhhc
Q 007260 532 VKEPQHRLAYKRGAT-EIKQHPFFEGVNWALIR 563 (611)
Q Consensus 532 ~~dP~~Rpt~~~~a~-elL~Hp~f~~~~~~~~~ 563 (611)
..||.+||+ +. +|++||||++++|..+.
T Consensus 254 ~~dp~~R~~----~~~~i~~hp~f~~~~w~~l~ 282 (345)
T 1xjd_A 254 VREPEKRLG----VRGDIRQHPLFREINWEELE 282 (345)
T ss_dssp CSSGGGSBT----TBSCGGGSGGGTTCCHHHHH
T ss_pred cCCHhHcCC----ChHHHHcCccccCCCHHHHh
Confidence 999999999 65 99999999999998764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=461.81 Aligned_cols=260 Identities=22% Similarity=0.311 Sum_probs=219.1
Q ss_pred cccccCeEEEeEecccCcEEEEEEEECCC-----CeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCC-CCccccccee
Q 007260 212 VLGLSHFRLLKRLGCGDIGSVYLSELSGT-----KCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH-PFLPTLYTHF 285 (611)
Q Consensus 212 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t-----~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~H-pnIv~l~~~~ 285 (611)
++..++|++++.||+|+||+||+|++.++ ++.||||++...... .....+.+|+++|.++.| ||||+++++|
T Consensus 60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~--~~~~~~~~E~~il~~l~hhpnIV~l~g~~ 137 (353)
T 4ase_A 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGAC 137 (353)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccCh--HHHHHHHHHHHHHHHcCCCCcEEEEEEEE
Confidence 45567999999999999999999998654 468999999765432 334567899999999965 8999999998
Q ss_pred ec-cceeeEEeeeCCCCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEE
Q 007260 286 ET-EKFSCLVMEFCPGGDLHTLRQKQP--------------GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVL 350 (611)
Q Consensus 286 ~~-~~~~~LVmE~~~gg~L~~ll~~~~--------------~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNIL 350 (611)
.. ++.+|||||||+||+|.++++... ...+++..+..|+.||+.||+|||+++||||||||+|||
T Consensus 138 ~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NIL 217 (353)
T 4ase_A 138 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 217 (353)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred EecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcccee
Confidence 65 567999999999999999997642 245899999999999999999999999999999999999
Q ss_pred EccCCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCcc
Q 007260 351 VREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKN 430 (611)
Q Consensus 351 v~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 430 (611)
|++++++||+|||+|+.+....
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~---------------------------------------------------------- 239 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDP---------------------------------------------------------- 239 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCT----------------------------------------------------------
T ss_pred eCCCCCEEECcchhhhhcccCC----------------------------------------------------------
Confidence 9999999999999995432111
Q ss_pred ccCCCCCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcC
Q 007260 431 EIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQ 509 (611)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~ 509 (611)
........+||+.|||||++.+..|+.++|||||||+||||++ |+.||.+....+.+.+++..
T Consensus 240 ----------------~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~ 303 (353)
T 4ase_A 240 ----------------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 303 (353)
T ss_dssp ----------------TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH
T ss_pred ----------------CceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHc
Confidence 1112234579999999999999999999999999999999997 99999987766666666655
Q ss_pred CCCCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcC
Q 007260 510 PLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 510 ~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~H 551 (611)
..+++.+..+++++.+||.+||+.||.+||| +.||++|
T Consensus 304 g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt----~~eil~~ 341 (353)
T 4ase_A 304 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPT----FSELVEH 341 (353)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCCCCCCccCCHHHHHHHHHHcCcChhHCcC----HHHHHHH
Confidence 5555555669999999999999999999999 8888876
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-53 Score=451.34 Aligned_cols=271 Identities=38% Similarity=0.720 Sum_probs=235.7
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeecccee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEKFS 291 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~~~~ 291 (611)
+.+++|++++.||+|+||.||+|++..+++.||||++.+...........+.+|+.+|..+ +|||||+++++|.+.+.+
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 85 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 85 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence 4567999999999999999999999999999999999887666666677788999999988 899999999999999999
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCC
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~ 371 (611)
|||||||+||+|.+++.+. ..+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||++.....
T Consensus 86 ~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~- 162 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR- 162 (345)
T ss_dssp EEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC-
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC-
Confidence 9999999999999998875 4699999999999999999999999999999999999999999999999999842110
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
.....
T Consensus 163 ---------------------------------------------------------------------------~~~~~ 167 (345)
T 3a8x_A 163 ---------------------------------------------------------------------------PGDTT 167 (345)
T ss_dssp ---------------------------------------------------------------------------TTCCB
T ss_pred ---------------------------------------------------------------------------CCCcc
Confidence 00112
Q ss_pred cccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC---------CcHHHHHHHHcCCCCCCCCCCCCHH
Q 007260 452 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGS---------GNRATLFNVVGQPLRFPESPVVSFA 522 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~---------~~~~~l~~i~~~~l~~p~~~~~s~~ 522 (611)
..++||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+....+.+|. .++.+
T Consensus 168 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~~s~~ 245 (345)
T 3a8x_A 168 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLSVK 245 (345)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCT--TSCHH
T ss_pred cccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCC--CCCHH
Confidence 3457999999999999999999999999999999999999999752 223344556667777765 49999
Q ss_pred HHHHHHHhhhcCccccCCch--hcHHHHHcCCCCCCCchhhhc
Q 007260 523 ARDLIRGLLVKEPQHRLAYK--RGATEIKQHPFFEGVNWALIR 563 (611)
Q Consensus 523 l~dLI~~~L~~dP~~Rpt~~--~~a~elL~Hp~f~~~~~~~~~ 563 (611)
+++||.+||.+||.+||+.. .++.++++||||++++|..+.
T Consensus 246 ~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~~ 288 (345)
T 3a8x_A 246 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMME 288 (345)
T ss_dssp HHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHHH
T ss_pred HHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHHH
Confidence 99999999999999999952 346899999999999998764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-52 Score=438.83 Aligned_cols=260 Identities=30% Similarity=0.496 Sum_probs=231.6
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSC 292 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~ 292 (611)
..+++|++++.||+|+||.||+|++..+++.||||++.+.... .....++.+|+.+|+.++||||+++++++...+.+|
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 90 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-PTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY 90 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence 3457999999999999999999999999999999999776433 345567789999999999999999999999999999
Q ss_pred EEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCc
Q 007260 293 LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 293 LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~ 372 (611)
||||||+||+|.+++... +.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||++..+...
T Consensus 91 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~- 167 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG- 167 (328)
T ss_dssp EEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-
T ss_pred EEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC-
Confidence 999999999999998775 45999999999999999999999999999999999999999999999999998433210
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
....
T Consensus 168 ----------------------------------------------------------------------------~~~~ 171 (328)
T 3fe3_A 168 ----------------------------------------------------------------------------GKLD 171 (328)
T ss_dssp ----------------------------------------------------------------------------CGGG
T ss_pred ----------------------------------------------------------------------------Cccc
Confidence 0112
Q ss_pred ccccCCCccchhhhccCCC-CChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 007260 453 SFVGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLL 531 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~~-~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L 531 (611)
..+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+......+|.. ++.++.+||.+||
T Consensus 172 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~--~s~~~~~li~~~L 249 (328)
T 3fe3_A 172 AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFY--MSTDCENLLKRFL 249 (328)
T ss_dssp TTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT--SCHHHHHHHHHHC
T ss_pred cccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCC--CCHHHHHHHHHHC
Confidence 4579999999999999887 479999999999999999999999988888888888887777764 8999999999999
Q ss_pred hcCccccCCchhcHHHHHcCCCCCCCc
Q 007260 532 VKEPQHRLAYKRGATEIKQHPFFEGVN 558 (611)
Q Consensus 532 ~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 558 (611)
..||.+||| ++|+++||||+...
T Consensus 250 ~~dP~~R~t----~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 250 VLNPIKRGT----LEQIMKDRWINAGH 272 (328)
T ss_dssp CSSTTTSCC----HHHHTTCTTTTTTC
T ss_pred CCChhHCcC----HHHHhcCHhhcCCC
Confidence 999999999 99999999998643
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-52 Score=448.52 Aligned_cols=279 Identities=31% Similarity=0.623 Sum_probs=238.2
Q ss_pred CccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc
Q 007260 210 DGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK 289 (611)
Q Consensus 210 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~ 289 (611)
.+.+.+++|++++.||+|+||.||+|++..+++.||||++.+...........+.+|+.+|+.++|||||+++++|.+.+
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 88 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE 88 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 45566789999999999999999999999999999999998776555555667889999999999999999999999999
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
.+|||||||.||+|..++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||++..+.
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 999999999999999998875 569999999999999999999999999999999999999999999999999984321
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
. ..
T Consensus 167 ~-----------------------------------------------------------------------------~~ 169 (384)
T 4fr4_A 167 R-----------------------------------------------------------------------------ET 169 (384)
T ss_dssp T-----------------------------------------------------------------------------TC
T ss_pred C-----------------------------------------------------------------------------CC
Confidence 0 01
Q ss_pred cccccccCCCccchhhhcc---CCCCChhhHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHcCCCCCCCCCCCCHHH
Q 007260 450 RSMSFVGTHEYLAPEIIKG---EGHGSAVDWWTFGIFLYELLFGKTPFKGSG---NRATLFNVVGQPLRFPESPVVSFAA 523 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~---~~~~~~sDIWSLGviL~ELltG~~PF~~~~---~~~~l~~i~~~~l~~p~~~~~s~~l 523 (611)
....++||+.|+|||++.+ ..|+.++|||||||+||||++|+.||.+.. ....+..+......+|.. ++..+
T Consensus 170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~--~s~~~ 247 (384)
T 4fr4_A 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSA--WSQEM 247 (384)
T ss_dssp CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTT--SCHHH
T ss_pred ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCc--CCHHH
Confidence 1224579999999999974 458999999999999999999999997532 334445555666666654 89999
Q ss_pred HHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCchhhhcc--CCCCCCCC
Q 007260 524 RDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIRC--ATPPEIPK 572 (611)
Q Consensus 524 ~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~--~~~p~~p~ 572 (611)
.+||.+||..||.+||+. +++|++||||.+++|..+.. ..||.+|.
T Consensus 248 ~~li~~lL~~dP~~R~s~---~~~l~~hp~f~~~~w~~~~~~~~~p~~~p~ 295 (384)
T 4fr4_A 248 VSLLKKLLEPNPDQRFSQ---LSDVQNFPYMNDINWDAVFQKRLIPGFIPN 295 (384)
T ss_dssp HHHHHHHSCSSGGGSCCS---HHHHHTSGGGTTCCHHHHHTTCSCCCCCCS
T ss_pred HHHHHHHhcCCHhHhccc---HHHHHcChhhhcCCHHHHHhCCCCCCCCCC
Confidence 999999999999999984 78999999999999977643 34444444
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=458.37 Aligned_cols=267 Identities=38% Similarity=0.728 Sum_probs=228.7
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSC 292 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~ 292 (611)
+..++|++++.||+|+||.||+|++..+++.||||++.+..........++.+|+.+|+.++||||++++++|...+.+|
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 224 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 224 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence 44578999999999999999999999999999999998766555556667788999999999999999999999999999
Q ss_pred EEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCeeccCCCCCcEEEccCCcEEEEeccccccccCC
Q 007260 293 LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHM-LGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 293 LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~-~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~ 371 (611)
||||||+||+|..++... ..+++..++.++.||+.||+|||+ +|||||||||+||||+.+|++||+|||++.....
T Consensus 225 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~- 301 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK- 301 (446)
T ss_dssp EEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred EEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC-
Confidence 999999999999988775 569999999999999999999998 9999999999999999999999999999842110
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
.....
T Consensus 302 ---------------------------------------------------------------------------~~~~~ 306 (446)
T 4ejn_A 302 ---------------------------------------------------------------------------DGATM 306 (446)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ---------------------------------------------------------------------------CCccc
Confidence 00112
Q ss_pred cccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 007260 452 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLL 531 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L 531 (611)
..++||+.|+|||++.+..++.++|||||||+||||++|+.||.+......+..+......+|.. ++.++++||.+||
T Consensus 307 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~--~~~~~~~li~~~L 384 (446)
T 4ejn_A 307 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT--LGPEAKSLLSGLL 384 (446)
T ss_dssp CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT--SCHHHHHHHHHHT
T ss_pred ccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCcc--CCHHHHHHHHHHc
Confidence 24579999999999999999999999999999999999999999988888888888888777764 8999999999999
Q ss_pred hcCccccC-----CchhcHHHHHcCCCCCCCchhhhc
Q 007260 532 VKEPQHRL-----AYKRGATEIKQHPFFEGVNWALIR 563 (611)
Q Consensus 532 ~~dP~~Rp-----t~~~~a~elL~Hp~f~~~~~~~~~ 563 (611)
.+||.+|| + +.|+++||||++++|..+.
T Consensus 385 ~~dP~~R~~~~~~t----~~ell~hp~f~~~~~~~~~ 417 (446)
T 4ejn_A 385 KKDPKQRLGGGSED----AKEIMQHRFFAGIVWQHVY 417 (446)
T ss_dssp CSSTTTSTTCSTTT----HHHHHTSGGGTTCCHHHHH
T ss_pred ccCHHHhCCCCCCC----HHHHHhCccccCCCHHHHh
Confidence 99999999 7 9999999999999998754
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-52 Score=435.99 Aligned_cols=271 Identities=37% Similarity=0.686 Sum_probs=227.4
Q ss_pred ccccCeEEEeEecccCcEEEEEEEEC---CCCeEEEEEEecchhhh-hHHHHHHHHHHHHHHHhCCCCCcccccceeecc
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELS---GTKCYFAMKVMDKASLA-GRKKLLRAQTEREILQSLDHPFLPTLYTHFETE 288 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~---~t~~~vAvKii~k~~~~-~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~ 288 (611)
+..++|++++.||+|+||.||+|++. .+++.||||++.+.... .......+.+|+.+|+.++||||++++++|..+
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 93 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG 93 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence 34579999999999999999999985 68899999999875432 223345567899999999999999999999999
Q ss_pred ceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccc
Q 007260 289 KFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRC 368 (611)
Q Consensus 289 ~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~ 368 (611)
+.+|||||||+|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||++...
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred CEEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 9999999999999999998875 46999999999999999999999999999999999999999999999999998422
Q ss_pred cCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccc
Q 007260 369 AVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTE 448 (611)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (611)
... .
T Consensus 172 ~~~----------------------------------------------------------------------------~ 175 (327)
T 3a62_A 172 IHD----------------------------------------------------------------------------G 175 (327)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccC----------------------------------------------------------------------------C
Confidence 100 0
Q ss_pred ccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 007260 449 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIR 528 (611)
Q Consensus 449 ~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~ 528 (611)
.....++||+.|+|||++.+..++.++|||||||++|||++|+.||.+......+.++......+|. .++.++++||.
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~ 253 (327)
T 3a62_A 176 TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPP--YLTQEARDLLK 253 (327)
T ss_dssp ---CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCT--TSCHHHHHHHH
T ss_pred ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCHHHHHHHH
Confidence 0112357999999999999999999999999999999999999999998888888888888777665 48999999999
Q ss_pred HhhhcCccccCCch-hcHHHHHcCCCCCCCchhhhc
Q 007260 529 GLLVKEPQHRLAYK-RGATEIKQHPFFEGVNWALIR 563 (611)
Q Consensus 529 ~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~ 563 (611)
+||..||.+||+.. ..+.++++||||++++|..+.
T Consensus 254 ~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~~ 289 (327)
T 3a62_A 254 KLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELL 289 (327)
T ss_dssp HHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHHH
T ss_pred HHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHHh
Confidence 99999999999532 139999999999999997653
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-52 Score=478.88 Aligned_cols=281 Identities=36% Similarity=0.653 Sum_probs=245.7
Q ss_pred cccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeeccce
Q 007260 212 VLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEKF 290 (611)
Q Consensus 212 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~~~ 290 (611)
.+.+++|++++.||+|+||.||+|++..+++.||||++.+...........+.+|+.+|..+ +||||+.++++|++.+.
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 34568999999999999999999999999999999999876554445556678899999988 79999999999999999
Q ss_pred eeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccC
Q 007260 291 SCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAV 370 (611)
Q Consensus 291 ~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~ 370 (611)
+||||||++||+|..++... +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+++....
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred EEEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 99999999999999999875 4699999999999999999999999999999999999999999999999999843210
Q ss_pred CccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccc
Q 007260 371 SPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEAR 450 (611)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (611)
....
T Consensus 495 ----------------------------------------------------------------------------~~~~ 498 (674)
T 3pfq_A 495 ----------------------------------------------------------------------------DGVT 498 (674)
T ss_dssp ----------------------------------------------------------------------------TTCC
T ss_pred ----------------------------------------------------------------------------CCcc
Confidence 0011
Q ss_pred ccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 007260 451 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGL 530 (611)
Q Consensus 451 ~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~ 530 (611)
...++||+.|+|||++.+..|+.++|||||||+||||++|++||.+.+..+.+..|+...+.+|.. ++.++++||.+|
T Consensus 499 ~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~--~s~~~~~li~~l 576 (674)
T 3pfq_A 499 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS--MSKEAVAICKGL 576 (674)
T ss_dssp BCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTT--SCHHHHHHHHHH
T ss_pred cccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCcc--CCHHHHHHHHHH
Confidence 234689999999999999999999999999999999999999999999888999999988888865 999999999999
Q ss_pred hhcCccccCCc-hhcHHHHHcCCCCCCCchhhhcc--CCCCCCCC
Q 007260 531 LVKEPQHRLAY-KRGATEIKQHPFFEGVNWALIRC--ATPPEIPK 572 (611)
Q Consensus 531 L~~dP~~Rpt~-~~~a~elL~Hp~f~~~~~~~~~~--~~~p~~p~ 572 (611)
|.+||.+||+. ..+++||++||||++++|..+.. ..||..|.
T Consensus 577 L~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p~ 621 (674)
T 3pfq_A 577 MTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPK 621 (674)
T ss_dssp SCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCSCCCB
T ss_pred ccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCCCCCCc
Confidence 99999999995 34569999999999999987643 34444444
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-52 Score=443.87 Aligned_cols=263 Identities=30% Similarity=0.465 Sum_probs=231.8
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhH---HHHHHHHHHHHHHHhCCCCCcccccceeeccceee
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGR---KKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSC 292 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~---~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~ 292 (611)
++|++++.||+|+||+||+|++..+++.||||++.+...... .....+.+|+.+|+.++||||++++++|.+...+|
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 689999999999999999999999999999999987543211 11345678999999999999999999999999999
Q ss_pred EEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCC----cEEEEeccccccc
Q 007260 293 LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDG----HIMLSDFDLSLRC 368 (611)
Q Consensus 293 LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g----~vkL~DFGlA~~~ 368 (611)
||||||+||+|.+++... ..+++..++.++.||+.||+|||++|||||||||+|||++.++ ++||+|||++...
T Consensus 92 lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 92 LILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp EEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 999999999999998764 5699999999999999999999999999999999999998877 7999999998433
Q ss_pred cCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccc
Q 007260 369 AVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTE 448 (611)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (611)
...
T Consensus 170 ~~~----------------------------------------------------------------------------- 172 (361)
T 2yab_A 170 EDG----------------------------------------------------------------------------- 172 (361)
T ss_dssp CTT-----------------------------------------------------------------------------
T ss_pred CCC-----------------------------------------------------------------------------
Confidence 210
Q ss_pred ccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCC--CCCCCHHHHHH
Q 007260 449 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPE--SPVVSFAARDL 526 (611)
Q Consensus 449 ~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~--~~~~s~~l~dL 526 (611)
......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+.++......++. +..++.++++|
T Consensus 173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 252 (361)
T 2yab_A 173 VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDF 252 (361)
T ss_dssp CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHH
T ss_pred CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHHHHH
Confidence 0112346999999999999999999999999999999999999999999888888888887776653 24689999999
Q ss_pred HHHhhhcCccccCCchhcHHHHHcCCCCCCCchhh
Q 007260 527 IRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWAL 561 (611)
Q Consensus 527 I~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~ 561 (611)
|.+||..||.+||+ +.|+|+||||.+++|..
T Consensus 253 i~~~L~~dP~~R~t----~~e~l~hp~~~~~~~~~ 283 (361)
T 2yab_A 253 IRKLLVKETRKRLT----IQEALRHPWITPVDTQQ 283 (361)
T ss_dssp HHHHSCSSTTTSCC----HHHHHTSTTTSCSSHHH
T ss_pred HHHHCCCChhHCcC----HHHHhcCcCcCCCchhh
Confidence 99999999999999 99999999999988854
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-52 Score=465.39 Aligned_cols=283 Identities=33% Similarity=0.621 Sum_probs=243.0
Q ss_pred cccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecccee
Q 007260 212 VLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFS 291 (611)
Q Consensus 212 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~ 291 (611)
.+..++|++++.||+|+||.||+|++..+++.||||++.+...........+.+|+.+|+.++||||++++++|.+...+
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 260 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL 260 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence 34568999999999999999999999999999999999877655444556778899999999999999999999999999
Q ss_pred eEEeeeCCCCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 292 CLVMEFCPGGDLHTLRQKQP--GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~--~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
|||||||+||+|..++.... ...+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||++..+.
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999999987643 3469999999999999999999999999999999999999999999999999985432
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
.. ..
T Consensus 341 ~~----------------------------------------------------------------------------~~ 344 (543)
T 3c4z_A 341 AG----------------------------------------------------------------------------QT 344 (543)
T ss_dssp TT----------------------------------------------------------------------------CC
T ss_pred CC----------------------------------------------------------------------------Cc
Confidence 10 00
Q ss_pred cccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC----cHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 007260 450 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSG----NRATLFNVVGQPLRFPESPVVSFAARD 525 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~----~~~~l~~i~~~~l~~p~~~~~s~~l~d 525 (611)
....++||+.|+|||++.+..|+.++|||||||+||||++|++||.+.. .......+......+|. .++.++++
T Consensus 345 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~ 422 (543)
T 3c4z_A 345 KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD--KFSPASKD 422 (543)
T ss_dssp CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCT--TSCHHHHH
T ss_pred ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCc--ccCHHHHH
Confidence 1123579999999999999999999999999999999999999998753 34555667777776664 49999999
Q ss_pred HHHHhhhcCccccCCchh-cHHHHHcCCCCCCCchhhhcc--CCCCCCCC
Q 007260 526 LIRGLLVKEPQHRLAYKR-GATEIKQHPFFEGVNWALIRC--ATPPEIPK 572 (611)
Q Consensus 526 LI~~~L~~dP~~Rpt~~~-~a~elL~Hp~f~~~~~~~~~~--~~~p~~p~ 572 (611)
||.+||.+||.+||++.. ++++|++||||++++|..+.. ..||.+|.
T Consensus 423 li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l~~~~~~pp~~P~ 472 (543)
T 3c4z_A 423 FCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPD 472 (543)
T ss_dssp HHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred HHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHHHHcCCCCCCCCCC
Confidence 999999999999998653 589999999999999987643 34555544
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-52 Score=466.14 Aligned_cols=283 Identities=34% Similarity=0.566 Sum_probs=240.2
Q ss_pred ccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccce
Q 007260 211 GVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKF 290 (611)
Q Consensus 211 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~ 290 (611)
..+..++|++++.||+|+||.||+|++..+++.||||++.+...........+.+|+.+|+.++|||||+++++|.+.+.
T Consensus 179 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 258 (576)
T 2acx_A 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA 258 (576)
T ss_dssp SCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cCccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCE
Confidence 34566899999999999999999999999999999999987665544445567889999999999999999999999999
Q ss_pred eeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccC
Q 007260 291 SCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAV 370 (611)
Q Consensus 291 ~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~ 370 (611)
+|||||||+||+|.+++.......+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||++.....
T Consensus 259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 99999999999999999876556699999999999999999999999999999999999999999999999999843220
Q ss_pred CccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccc
Q 007260 371 SPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEAR 450 (611)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (611)
. ..
T Consensus 339 ~-----------------------------------------------------------------------------~~ 341 (576)
T 2acx_A 339 G-----------------------------------------------------------------------------QT 341 (576)
T ss_dssp T-----------------------------------------------------------------------------CC
T ss_pred C-----------------------------------------------------------------------------cc
Confidence 0 01
Q ss_pred ccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 007260 451 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGN----RATLFNVVGQPLRFPESPVVSFAARDL 526 (611)
Q Consensus 451 ~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~----~~~l~~i~~~~l~~p~~~~~s~~l~dL 526 (611)
....+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+... ......+...+..++. .++.++++|
T Consensus 342 ~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~--~~s~~~~dL 419 (576)
T 2acx_A 342 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSE--RFSPQARSL 419 (576)
T ss_dssp EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCT--TSCHHHHHH
T ss_pred ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCc--cCCHHHHHH
Confidence 1234799999999999999999999999999999999999999987542 3334455556666654 499999999
Q ss_pred HHHhhhcCccccCCch-hcHHHHHcCCCCCCCchhhhcc--CCCCCCCC
Q 007260 527 IRGLLVKEPQHRLAYK-RGATEIKQHPFFEGVNWALIRC--ATPPEIPK 572 (611)
Q Consensus 527 I~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~~--~~~p~~p~ 572 (611)
|.+||.+||.+||+.. ..+.||++||||++++|..+.. ..||..|.
T Consensus 420 I~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l~~~~~~pp~~p~ 468 (576)
T 2acx_A 420 CSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPD 468 (576)
T ss_dssp HHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred HHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHHhcCCCCCCCCCC
Confidence 9999999999999432 1389999999999999987653 23444443
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=427.16 Aligned_cols=250 Identities=20% Similarity=0.231 Sum_probs=192.3
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc----ee
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK----FS 291 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~----~~ 291 (611)
.+|.+.+.||+|+||+||+|++. ++.||||+++..... ....+.|+.++..++|||||++++++..++ .+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~~~----~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREER----SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccchh----hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 47899999999999999999984 678999999765321 112245666677889999999999998653 68
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc--------CeeccCCCCCcEEEccCCcEEEEecc
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHML--------GIIYRDLKPENVLVREDGHIMLSDFD 363 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~--------gIVHRDLKPeNILv~~~g~vkL~DFG 363 (611)
|||||||+||+|.+++... .+++..+..++.|++.||+|||++ +||||||||+||||+.+|++||+|||
T Consensus 77 ~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG 153 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence 9999999999999999874 489999999999999999999987 99999999999999999999999999
Q ss_pred ccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccc
Q 007260 364 LSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELI 443 (611)
Q Consensus 364 lA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 443 (611)
+|+........
T Consensus 154 la~~~~~~~~~--------------------------------------------------------------------- 164 (303)
T 3hmm_A 154 LAVRHDSATDT--------------------------------------------------------------------- 164 (303)
T ss_dssp TCEEEETTTTE---------------------------------------------------------------------
T ss_pred CCccccCCCCc---------------------------------------------------------------------
Confidence 99654311100
Q ss_pred cCcccccccccccCCCccchhhhccC------CCCChhhHHHHHHHHHHHHhCCCCCCCC--------------CcHHHH
Q 007260 444 AEPTEARSMSFVGTHEYLAPEIIKGE------GHGSAVDWWTFGIFLYELLFGKTPFKGS--------------GNRATL 503 (611)
Q Consensus 444 ~~~~~~~~~~~vGT~~Y~APEil~~~------~~~~~sDIWSLGviL~ELltG~~PF~~~--------------~~~~~l 503 (611)
........+||+.|||||++.+. .|+.++|||||||+||||++|.+||... .....+
T Consensus 165 ---~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~ 241 (303)
T 3hmm_A 165 ---IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241 (303)
T ss_dssp ---ESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHH
T ss_pred ---eeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHH
Confidence 01112245799999999999875 3567999999999999999998766431 123334
Q ss_pred HHH-HcCCCCCCCCC-----CCCHHHHHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 504 FNV-VGQPLRFPESP-----VVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 504 ~~i-~~~~l~~p~~~-----~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
.+. ..+.++.+.+. ..+..+.+||.+||..||.+||| +.||++
T Consensus 242 ~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt----~~ei~~ 290 (303)
T 3hmm_A 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT----ALRIKK 290 (303)
T ss_dssp HHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCC----HHHHHH
T ss_pred HHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcC----HHHHHH
Confidence 443 34433322211 13457889999999999999999 667665
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=419.63 Aligned_cols=257 Identities=24% Similarity=0.405 Sum_probs=223.9
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
.++|++++.||+|+||+||+|++..+++.||||++........ ..+.+|+.+|+.++||||++++++|..++.+|||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCH---HHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHH---HHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 4689999999999999999999999999999999976543332 3467899999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
||||+||+|.+++... .+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||++......
T Consensus 96 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 169 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--- 169 (297)
T ss_dssp EECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST---
T ss_pred EECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc---
Confidence 9999999999999874 4999999999999999999999999999999999999999999999999998433210
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
.......
T Consensus 170 -------------------------------------------------------------------------~~~~~~~ 176 (297)
T 3fxz_A 170 -------------------------------------------------------------------------QSKRSTM 176 (297)
T ss_dssp -------------------------------------------------------------------------TCCBCCC
T ss_pred -------------------------------------------------------------------------ccccCCc
Confidence 0011234
Q ss_pred ccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcC-CCCCCCCCCCCHHHHHHHHHhhhc
Q 007260 455 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ-PLRFPESPVVSFAARDLIRGLLVK 533 (611)
Q Consensus 455 vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~-~l~~p~~~~~s~~l~dLI~~~L~~ 533 (611)
+||+.|+|||++.+..++.++|||||||++|||++|+.||.+......+..+... ...+.....++..+++||.+||..
T Consensus 177 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 256 (297)
T 3fxz_A 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEM 256 (297)
T ss_dssp CSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHSCS
T ss_pred cCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHccC
Confidence 6999999999999999999999999999999999999999988777666655433 333444456999999999999999
Q ss_pred CccccCCchhcHHHHHcCCCCCCC
Q 007260 534 EPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 534 dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
||.+||+ +.|+++||||+..
T Consensus 257 dp~~Rps----~~ell~h~~~~~~ 276 (297)
T 3fxz_A 257 DVEKRGS----AKELLQHQFLKIA 276 (297)
T ss_dssp STTTSCC----HHHHTTCGGGGGC
T ss_pred ChhHCcC----HHHHhhChhhccc
Confidence 9999999 9999999999753
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=424.55 Aligned_cols=263 Identities=29% Similarity=0.464 Sum_probs=229.0
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhH---HHHHHHHHHHHHHHhCCCCCcccccceeeccceee
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGR---KKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSC 292 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~---~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~ 292 (611)
++|++++.||+|+||.||+|++..+++.||||++.+...... .....+.+|+.+|+.++||||++++++|.+...+|
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 579999999999999999999999999999999976543211 12345678999999999999999999999999999
Q ss_pred EEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCC----cEEEEeccccccc
Q 007260 293 LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDG----HIMLSDFDLSLRC 368 (611)
Q Consensus 293 LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g----~vkL~DFGlA~~~ 368 (611)
||||||+|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 91 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 999999999999998764 5699999999999999999999999999999999999999887 8999999998543
Q ss_pred cCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccc
Q 007260 369 AVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTE 448 (611)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (611)
....
T Consensus 169 ~~~~---------------------------------------------------------------------------- 172 (326)
T 2y0a_A 169 DFGN---------------------------------------------------------------------------- 172 (326)
T ss_dssp CTTS----------------------------------------------------------------------------
T ss_pred CCCC----------------------------------------------------------------------------
Confidence 2100
Q ss_pred ccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCC--CCCCCHHHHHH
Q 007260 449 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPE--SPVVSFAARDL 526 (611)
Q Consensus 449 ~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~--~~~~s~~l~dL 526 (611)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+......+..+......++. ...++..+++|
T Consensus 173 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 251 (326)
T 2y0a_A 173 -EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDF 251 (326)
T ss_dssp -CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHH
T ss_pred -ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHHHH
Confidence 011246999999999999999999999999999999999999999998888887777766555543 24589999999
Q ss_pred HHHhhhcCccccCCchhcHHHHHcCCCCCCCchhh
Q 007260 527 IRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWAL 561 (611)
Q Consensus 527 I~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~ 561 (611)
|.+||..||.+||+ +.++|+||||...+|..
T Consensus 252 i~~~L~~dP~~Rpt----~~e~l~hp~~~~~~~~~ 282 (326)
T 2y0a_A 252 IRRLLVKDPKKRMT----IQDSLQHPWIKPKDTQQ 282 (326)
T ss_dssp HHHHSCSSGGGSCC----HHHHHHSTTTSCCSHHH
T ss_pred HHHHccCChhhCCC----HHHHhcCCCccCCcchh
Confidence 99999999999999 99999999999888754
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-51 Score=425.44 Aligned_cols=257 Identities=26% Similarity=0.392 Sum_probs=227.4
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
.++|++++.||+|+||.||+|.+..+++.||+|++..... ....+.+|+.+|+.++||||++++++|.+.+.+|||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH----HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcc----cHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 3689999999999999999999999999999999975432 233567899999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEcc--CCcEEEEeccccccccCCc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRE--DGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~--~g~vkL~DFGlA~~~~~~~ 372 (611)
||||+|++|.+++... +..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++..+...
T Consensus 80 ~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~- 157 (321)
T 1tki_A 80 FEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp ECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred EEeCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-
Confidence 9999999999988764 346999999999999999999999999999999999999997 789999999998443210
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
....
T Consensus 158 ----------------------------------------------------------------------------~~~~ 161 (321)
T 1tki_A 158 ----------------------------------------------------------------------------DNFR 161 (321)
T ss_dssp ----------------------------------------------------------------------------CEEE
T ss_pred ----------------------------------------------------------------------------Cccc
Confidence 0112
Q ss_pred ccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCC--CCCCCHHHHHHHHHh
Q 007260 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPE--SPVVSFAARDLIRGL 530 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~--~~~~s~~l~dLI~~~ 530 (611)
..+||+.|+|||++.+..++.++|||||||++|+|++|..||.+......+.++......++. +..++.++++||.+|
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 241 (321)
T 1tki_A 162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRL 241 (321)
T ss_dssp EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTT
T ss_pred cccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHH
Confidence 346999999999999998999999999999999999999999999888888888887776653 246899999999999
Q ss_pred hhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 531 LVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 531 L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
|..||.+||+ +.|+|+||||+..
T Consensus 242 L~~dp~~Rpt----~~e~l~hp~~~~~ 264 (321)
T 1tki_A 242 LVKERKSRMT----ASEALQHPWLKQK 264 (321)
T ss_dssp SCSSGGGSCC----HHHHHHSHHHHSC
T ss_pred cCCChhHCcC----HHHHhcChhhccC
Confidence 9999999999 9999999999764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=430.90 Aligned_cols=257 Identities=27% Similarity=0.499 Sum_probs=226.8
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
++|++++.||+|+||.||+|.+..+++.||||++...... ......+.+|+.+|+.++|||||+++++|.+++..||||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5899999999999999999999999999999999765543 334557789999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccC---CcEEEEeccccccccCCc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRED---GHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~---g~vkL~DFGlA~~~~~~~ 372 (611)
|||+||+|.+++... ..+++..++.++.||+.||+|||++|||||||||+||||+.+ +.+||+|||++......
T Consensus 108 e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~- 184 (362)
T 2bdw_A 108 DLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS- 184 (362)
T ss_dssp CCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC-
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC-
Confidence 999999999988765 569999999999999999999999999999999999999865 45999999998432100
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
....
T Consensus 185 ----------------------------------------------------------------------------~~~~ 188 (362)
T 2bdw_A 185 ----------------------------------------------------------------------------EAWH 188 (362)
T ss_dssp ----------------------------------------------------------------------------CSCC
T ss_pred ----------------------------------------------------------------------------cccc
Confidence 0012
Q ss_pred ccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCC--CCCCHHHHHHHHHh
Q 007260 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPES--PVVSFAARDLIRGL 530 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~--~~~s~~l~dLI~~~ 530 (611)
..+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+....+..+......++.. ..++.++++||.+|
T Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~ 268 (362)
T 2bdw_A 189 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSM 268 (362)
T ss_dssp CSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHH
T ss_pred cCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHH
Confidence 3469999999999999999999999999999999999999999988888888888777666543 46899999999999
Q ss_pred hhcCccccCCchhcHHHHHcCCCCCC
Q 007260 531 LVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 531 L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
|..||.+||+ +.++|+||||..
T Consensus 269 L~~dP~~R~t----~~e~l~hp~~~~ 290 (362)
T 2bdw_A 269 LTVNPKKRIT----ADQALKVPWICN 290 (362)
T ss_dssp SCSSGGGSCC----HHHHTTSHHHHT
T ss_pred cCCChhhCcC----HHHHhcCcccCC
Confidence 9999999999 999999999964
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=433.16 Aligned_cols=272 Identities=22% Similarity=0.331 Sum_probs=223.1
Q ss_pred ccCeEEEeEeccc--CcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceee
Q 007260 215 LSHFRLLKRLGCG--DIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSC 292 (611)
Q Consensus 215 ~~~y~l~~~LG~G--~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~ 292 (611)
.++|++++.||+| +||.||+|++..+++.||||++...... ......+.+|+.+|+.++|||||+++++|.+++.+|
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 4689999999999 9999999999999999999999765433 345667888999999999999999999999999999
Q ss_pred EEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCc
Q 007260 293 LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 293 LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~ 372 (611)
||||||+||+|.+++.......+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||++.......
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~ 182 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG 182 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETT
T ss_pred EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecccc
Confidence 99999999999999988766779999999999999999999999999999999999999999999999999885432110
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
... ........
T Consensus 183 ~~~---------------------------------------------------------------------~~~~~~~~ 193 (389)
T 3gni_B 183 QRQ---------------------------------------------------------------------RVVHDFPK 193 (389)
T ss_dssp EEC---------------------------------------------------------------------SCBCCCCT
T ss_pred ccc---------------------------------------------------------------------cccccccc
Confidence 000 00001112
Q ss_pred ccccCCCccchhhhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCC------------------
Q 007260 453 SFVGTHEYLAPEIIKG--EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLR------------------ 512 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~--~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~------------------ 512 (611)
..+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+......+..++.....
T Consensus 194 ~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (389)
T 3gni_B 194 YSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPS 273 (389)
T ss_dssp TCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------------------------
T ss_pred cccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccccccccccccccc
Confidence 3469999999999998 57899999999999999999999999887665555443332211
Q ss_pred --------------------------CCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCchh
Q 007260 513 --------------------------FPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWA 560 (611)
Q Consensus 513 --------------------------~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~ 560 (611)
.+....++.++++||.+||..||.+||+ +.|+|+||||+.+.|.
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt----a~ell~hp~f~~~~~~ 343 (389)
T 3gni_B 274 RSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPS----ASTLLNHSFFKQIKRR 343 (389)
T ss_dssp --------------------------------CCHHHHHHHHHHTCSCTTTSCC----HHHHTTSGGGGGC---
T ss_pred ccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCC----HHHHhcCHHHHHHhhc
Confidence 1123447899999999999999999999 9999999999988764
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=412.72 Aligned_cols=260 Identities=34% Similarity=0.566 Sum_probs=228.9
Q ss_pred cccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecccee
Q 007260 212 VLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFS 291 (611)
Q Consensus 212 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~ 291 (611)
.+.+++|++++.||+|+||.||+|++..++..||||++.+...........+.+|+.+++.++||||++++++|.+....
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 84 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence 34567999999999999999999999999999999999876555444455678899999999999999999999999999
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCC
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~ 371 (611)
|+||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 85 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~- 161 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS- 161 (279)
T ss_dssp EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc-
Confidence 9999999999999988875 4599999999999999999999999999999999999999999999999998732110
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
...
T Consensus 162 -----------------------------------------------------------------------------~~~ 164 (279)
T 3fdn_A 162 -----------------------------------------------------------------------------SRR 164 (279)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred -----------------------------------------------------------------------------ccc
Confidence 001
Q ss_pred cccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 007260 452 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLL 531 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L 531 (611)
...+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+......+|.. ++..+++||.+||
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~li~~~l 242 (279)
T 3fdn_A 165 TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF--VTEGARDLISRLL 242 (279)
T ss_dssp ---CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTT--SCHHHHHHHHHHC
T ss_pred cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCc--CCHHHHHHHHHHh
Confidence 13469999999999999999999999999999999999999999988877777777776666654 8999999999999
Q ss_pred hcCccccCCchhcHHHHHcCCCCCCC
Q 007260 532 VKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 532 ~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
..||.+||+ +.||++||||+..
T Consensus 243 ~~~p~~Rps----~~e~l~h~~~~~~ 264 (279)
T 3fdn_A 243 KHNPSQRPM----LREVLEHPWITAN 264 (279)
T ss_dssp CSSGGGSCC----HHHHHHCHHHHHH
T ss_pred ccChhhCCC----HHHHhhCccccCC
Confidence 999999999 9999999999753
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-51 Score=418.79 Aligned_cols=259 Identities=34% Similarity=0.575 Sum_probs=219.8
Q ss_pred cccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhh-----------------------HHHHHHHHHHHHHH
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAG-----------------------RKKLLRAQTEREIL 270 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~-----------------------~~~~~~~~~E~~iL 270 (611)
.+++|++++.||+|+||.||+|++..+++.||||++.+..... .....++.+|+++|
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 4579999999999999999999999999999999997654321 12235678899999
Q ss_pred HhCCCCCcccccceeec--cceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCc
Q 007260 271 QSLDHPFLPTLYTHFET--EKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPEN 348 (611)
Q Consensus 271 ~~l~HpnIv~l~~~~~~--~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeN 348 (611)
+.++||||+++++++.+ ...+||||||+++++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 99999999999999986 6789999999999999875433 469999999999999999999999999999999999
Q ss_pred EEEccCCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCC
Q 007260 349 VLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKP 428 (611)
Q Consensus 349 ILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 428 (611)
|||+.+|.+||+|||++.......
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~-------------------------------------------------------- 191 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSD-------------------------------------------------------- 191 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSS--------------------------------------------------------
T ss_pred EEECCCCCEEEecCCCcccccccc--------------------------------------------------------
Confidence 999999999999999984432100
Q ss_pred ccccCCCCCCCcccccCcccccccccccCCCccchhhhccCC---CCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Q 007260 429 KNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEG---HGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFN 505 (611)
Q Consensus 429 ~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~---~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~ 505 (611)
......+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.........
T Consensus 192 --------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 251 (298)
T 2zv2_A 192 --------------------ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSK 251 (298)
T ss_dssp --------------------CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred --------------------ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHH
Confidence 0011346999999999998776 37889999999999999999999998877777777
Q ss_pred HHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCC
Q 007260 506 VVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFE 555 (611)
Q Consensus 506 i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 555 (611)
+......++....++.++++||.+||..||.+||+ +.|+++||||+
T Consensus 252 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s----~~e~l~hp~~~ 297 (298)
T 2zv2_A 252 IKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIV----VPEIKLHPWVT 297 (298)
T ss_dssp HHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCC----HHHHTTCHHHH
T ss_pred HhcccCCCCCccccCHHHHHHHHHHhhcChhhCCC----HHHHhcCcccc
Confidence 77777778877789999999999999999999999 99999999985
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-50 Score=439.37 Aligned_cols=258 Identities=26% Similarity=0.489 Sum_probs=226.8
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
++|++++.||+|+||+||+|.+..+++.||+|++.+..... .....+.+|+.+|+.++|||||+++++|.+++..||||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA-RDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHH-HHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 58999999999999999999999999999999998765433 34456789999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEc---cCCcEEEEeccccccccCCc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVR---EDGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~---~~g~vkL~DFGlA~~~~~~~ 372 (611)
|||.||+|.+++... ..+++..++.++.||+.||+|||++|||||||||+|||++ .++.+||+|||++......
T Consensus 90 E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~- 166 (444)
T 3soa_A 90 DLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE- 166 (444)
T ss_dssp CCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT-
T ss_pred EeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC-
Confidence 999999999988876 5699999999999999999999999999999999999998 4678999999998432210
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
.....
T Consensus 167 ---------------------------------------------------------------------------~~~~~ 171 (444)
T 3soa_A 167 ---------------------------------------------------------------------------QQAWF 171 (444)
T ss_dssp ---------------------------------------------------------------------------CCBCC
T ss_pred ---------------------------------------------------------------------------Cceee
Confidence 00112
Q ss_pred ccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCC--CCCCCHHHHHHHHHh
Q 007260 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPE--SPVVSFAARDLIRGL 530 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~--~~~~s~~l~dLI~~~ 530 (611)
..+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+....+..+......++. +..+++++++||.+|
T Consensus 172 ~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 251 (444)
T 3soa_A 172 GFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKM 251 (444)
T ss_dssp CSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHH
T ss_pred cccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHH
Confidence 357999999999999999999999999999999999999999998888888888877766554 456899999999999
Q ss_pred hhcCccccCCchhcHHHHHcCCCCCC
Q 007260 531 LVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 531 L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
|..||.+||+ +.|+|+||||..
T Consensus 252 L~~dP~~Rpt----a~e~L~hp~~~~ 273 (444)
T 3soa_A 252 LTINPSKRIT----AAEALKHPWISH 273 (444)
T ss_dssp SCSSTTTSCC----HHHHHHSCTTHH
T ss_pred cCCChhHCCC----HHHHhcCccccC
Confidence 9999999999 999999999974
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-50 Score=411.94 Aligned_cols=260 Identities=25% Similarity=0.423 Sum_probs=213.3
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
+++|++++.||+|+||+||+|++..+++.||||++...... ......+.+|+.+|+.++||||+++++++.+++.+|||
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCc-CCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence 36899999999999999999999999999999999765432 23345667899999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
||||++ +|.+.+... ...+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||++......
T Consensus 80 ~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 154 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP--- 154 (292)
T ss_dssp EECCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC---
T ss_pred EecCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc---
Confidence 999965 666655553 256999999999999999999999999999999999999999999999999998443210
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
.......
T Consensus 155 -------------------------------------------------------------------------~~~~~~~ 161 (292)
T 3o0g_A 155 -------------------------------------------------------------------------VRCYSAE 161 (292)
T ss_dssp -------------------------------------------------------------------------CSCCCSC
T ss_pred -------------------------------------------------------------------------cccccCC
Confidence 0011134
Q ss_pred ccCCCccchhhhccCC-CCChhhHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHc---CCCC--------------C--
Q 007260 455 VGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTP-FKGSGNRATLFNVVG---QPLR--------------F-- 513 (611)
Q Consensus 455 vGT~~Y~APEil~~~~-~~~~sDIWSLGviL~ELltG~~P-F~~~~~~~~l~~i~~---~~l~--------------~-- 513 (611)
+||+.|+|||++.+.. ++.++|||||||++|||++|..| |.+.+..+.+..+.. .+.. +
T Consensus 162 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (292)
T 3o0g_A 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241 (292)
T ss_dssp CSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCC
T ss_pred ccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccccccc
Confidence 6899999999998876 79999999999999999988777 555555555544432 1110 0
Q ss_pred --------CCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 514 --------PESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 514 --------p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
.....++.++++||.+||..||.+||+ ++|+|+||||+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS----AEEALQHPYFSDF 289 (292)
T ss_dssp CCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGTTC
T ss_pred ccCCcchhhcccccChHHHHHHHHHhccChhhCCC----HHHHhcCcccccC
Confidence 011347899999999999999999999 9999999999864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-50 Score=440.52 Aligned_cols=292 Identities=27% Similarity=0.389 Sum_probs=206.4
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceee-----ccc
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFE-----TEK 289 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~-----~~~ 289 (611)
.++|++++.||.|+||+||+|++..+++.||||++.+.. .......++.+|+.+|+.++|||||+++++|. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 368999999999999999999999999999999996542 33445567889999999999999999999984 346
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
.+||||||+ +++|..++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.++++||+|||+++...
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp CEEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred eEEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 799999999 67999988765 569999999999999999999999999999999999999999999999999996543
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
........ . ...++.. ...............
T Consensus 208 ~~~~~~~~-------~--------------------------~~~~~~~----------------~~~~~~~~~~~~~~~ 238 (458)
T 3rp9_A 208 YPENGNSQ-------L--------------------------PISPRED----------------DMNLVTFPHTKNLKR 238 (458)
T ss_dssp SCTTCCCC-------C--------------------------C-------------------------------------
T ss_pred Cccccccc-------c--------------------------ccCcccc----------------ccccccccccccccc
Confidence 21110000 0 0000000 000000000000112
Q ss_pred cccccccCCCccchhhh-ccCCCCChhhHHHHHHHHHHHHh-----------CCCCCCCCCc------------------
Q 007260 450 RSMSFVGTHEYLAPEII-KGEGHGSAVDWWTFGIFLYELLF-----------GKTPFKGSGN------------------ 499 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil-~~~~~~~~sDIWSLGviL~ELlt-----------G~~PF~~~~~------------------ 499 (611)
.....+||++|+|||++ .+..|+.++||||||||||||++ |+++|.+.+.
T Consensus 239 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~ 318 (458)
T 3rp9_A 239 QLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTR 318 (458)
T ss_dssp ------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CH
T ss_pred cccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCcccccccccccccccccccc
Confidence 23467899999999987 45679999999999999999998 7888877541
Q ss_pred --HHH---HHHHHcCCCC-----------------CC---------CCCCCCHHHHHHHHHhhhcCccccCCchhcHHHH
Q 007260 500 --RAT---LFNVVGQPLR-----------------FP---------ESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEI 548 (611)
Q Consensus 500 --~~~---l~~i~~~~l~-----------------~p---------~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~el 548 (611)
.+. +.++++.+.. ++ ..+.++.++.+||.+||.+||.+||| ++|+
T Consensus 319 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t----~~e~ 394 (458)
T 3rp9_A 319 GNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRIT----INEC 394 (458)
T ss_dssp HHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCC----HHHH
T ss_pred CCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCC----HHHH
Confidence 122 2223322210 01 12346999999999999999999999 9999
Q ss_pred HcCCCCCCCchhhhc
Q 007260 549 KQHPFFEGVNWALIR 563 (611)
Q Consensus 549 L~Hp~f~~~~~~~~~ 563 (611)
|+||||+++.|....
T Consensus 395 L~Hp~f~~~~~~~~e 409 (458)
T 3rp9_A 395 LAHPFFKEVRIAEVE 409 (458)
T ss_dssp HHSGGGTTTCCGGGC
T ss_pred hcCHhhhhcCCCccC
Confidence 999999999987654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-50 Score=418.42 Aligned_cols=263 Identities=26% Similarity=0.438 Sum_probs=215.2
Q ss_pred cccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeE
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCL 293 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~L 293 (611)
..++|++++.||+|+||+||+|++.. ++.||||++..... .......+.+|+++|+.++||||+++++++.+++.+||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 34799999999999999999999864 88999999975432 22334567789999999999999999999999999999
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcc
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 373 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~ 373 (611)
|||||+ ++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 97 v~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-- 172 (311)
T 3niz_A 97 VFEFME-KDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP-- 172 (311)
T ss_dssp EEECCS-EEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC--
T ss_pred EEcCCC-CCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCC--
Confidence 999996 58888777653 56999999999999999999999999999999999999999999999999998443210
Q ss_pred ccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccc
Q 007260 374 LIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMS 453 (611)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (611)
......
T Consensus 173 --------------------------------------------------------------------------~~~~~~ 178 (311)
T 3niz_A 173 --------------------------------------------------------------------------VRSYTH 178 (311)
T ss_dssp --------------------------------------------------------------------------CC---C
T ss_pred --------------------------------------------------------------------------cccccC
Confidence 000112
Q ss_pred cccCCCccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH---cCCCCC--C-------------
Q 007260 454 FVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVV---GQPLRF--P------------- 514 (611)
Q Consensus 454 ~vGT~~Y~APEil~~-~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~---~~~l~~--p------------- 514 (611)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+.+..+. +.+... +
T Consensus 179 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (311)
T 3niz_A 179 EVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTF 258 (311)
T ss_dssp CCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCC
T ss_pred CcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhccc
Confidence 368999999999987 458999999999999999999999999876655554433 322110 0
Q ss_pred ----------CCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCchh
Q 007260 515 ----------ESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWA 560 (611)
Q Consensus 515 ----------~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~ 560 (611)
....++.++++||.+||++||.+||| +.|+|+||||+++++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~f~~~~~~ 310 (311)
T 3niz_A 259 QVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRIS----ARDAMNHPYFKDLDPQ 310 (311)
T ss_dssp CCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCC----HHHHHTSGGGTTSCTT
T ss_pred ccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCC----HHHHhcCcccccCCcc
Confidence 01246789999999999999999999 9999999999988764
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-51 Score=430.50 Aligned_cols=256 Identities=30% Similarity=0.496 Sum_probs=219.1
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
+++|++++.||+|+||.||+|++..+++.||||++.+..........++.+|+.+|+.++||||+++++++.+...+|||
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 57999999999999999999999999999999999876544333345678899999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
|||+ +|+|.+++... +.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||++......
T Consensus 88 ~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~--- 161 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG--- 161 (336)
T ss_dssp ECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS---
T ss_pred EECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC---
Confidence 9999 78999888765 46999999999999999999999999999999999999999999999999998432100
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
......
T Consensus 162 --------------------------------------------------------------------------~~~~~~ 167 (336)
T 3h4j_B 162 --------------------------------------------------------------------------NFLKTS 167 (336)
T ss_dssp --------------------------------------------------------------------------BTTCCC
T ss_pred --------------------------------------------------------------------------cccccc
Confidence 011234
Q ss_pred ccCCCccchhhhccCCC-CChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007260 455 VGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVK 533 (611)
Q Consensus 455 vGT~~Y~APEil~~~~~-~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~ 533 (611)
+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.........+......+| ..++.++++||.+||..
T Consensus 168 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p--~~~s~~~~~li~~~L~~ 245 (336)
T 3h4j_B 168 CGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMP--DFLSPGAQSLIRRMIVA 245 (336)
T ss_dssp TTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCC--TTSCHHHHHHHHTTSCS
T ss_pred cCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCc--ccCCHHHHHHHHHHcCC
Confidence 69999999999998887 7899999999999999999999987654433333333333334 34899999999999999
Q ss_pred CccccCCchhcHHHHHcCCCCCC
Q 007260 534 EPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 534 dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
||.+||| +.|+++||||+.
T Consensus 246 dP~~Rpt----~~eil~hp~~~~ 264 (336)
T 3h4j_B 246 DPMQRIT----IQEIRRDPWFNV 264 (336)
T ss_dssp SGGGSCC----HHHHTTCHHHHT
T ss_pred ChhHCcC----HHHHHhChhhcc
Confidence 9999999 999999999974
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-50 Score=429.13 Aligned_cols=279 Identities=28% Similarity=0.433 Sum_probs=211.3
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC-CCCcccccceeecc--cee
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD-HPFLPTLYTHFETE--KFS 291 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~-HpnIv~l~~~~~~~--~~~ 291 (611)
.++|++++.||+|+||.||+|.+..+++.||||++.+.. .......++.+|+.+|+.+. ||||++++++|..+ ..+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 479999999999999999999999999999999986542 33445567788999999997 99999999999754 478
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCC
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~ 371 (611)
|||||||+ ++|..++... .+++..++.++.||+.||+|||++|||||||||+||||+.++++||+|||+++.+...
T Consensus 87 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred EEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 99999995 6999988763 5999999999999999999999999999999999999999999999999999654321
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
....... +.. .... ...........
T Consensus 163 ~~~~~~~-----~~~-------------------------------~~~~-------------------~~~~~~~~~~~ 187 (388)
T 3oz6_A 163 RRVTNNI-----PLS-------------------------------INEN-------------------TENFDDDQPIL 187 (388)
T ss_dssp CCCCCCG-----GGC-------------------------------CC--------------------------------
T ss_pred ccccccc-----ccc-------------------------------cccc-------------------ccccccccccc
Confidence 1100000 000 0000 00000011223
Q ss_pred cccccCCCccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCC----------------
Q 007260 452 MSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFP---------------- 514 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~-~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p---------------- 514 (611)
..++||++|+|||++.+ ..|+.++|||||||+||||++|++||.+.+....+..+++. +.+|
T Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~~p~~~~~~~~~~~~~~~~ 266 (388)
T 3oz6_A 188 TDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGV-IDFPSNEDVESIQSPFAKTM 266 (388)
T ss_dssp --CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH-HCCCCHHHHHTSCCSSHHHH
T ss_pred cCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh-cCCCCHHHHHhccCHHHHHH
Confidence 45689999999999987 57899999999999999999999999998887777665421 1111
Q ss_pred ------------------------------CCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCc
Q 007260 515 ------------------------------ESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVN 558 (611)
Q Consensus 515 ------------------------------~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 558 (611)
....++.++++||.+||..||.+||| +.|+|+||||+.+.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t----~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 267 IESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS----ANDALKHPFVSIFH 336 (388)
T ss_dssp HHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC----HHHHTTSTTTTTTC
T ss_pred HHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC----HHHHhCCHHHHHhc
Confidence 11257899999999999999999999 99999999997653
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=427.20 Aligned_cols=263 Identities=28% Similarity=0.450 Sum_probs=221.7
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhH--HHHHHHHHHHHHHHhCCCCCcccccceeeccceeeE
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGR--KKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCL 293 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~--~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~L 293 (611)
++|++++.||+|+||+||+|.+..+++.||||++........ .....+.+|+.+|+.++||||++++++|.+++.+||
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 589999999999999999999999999999999976543211 123457789999999999999999999999999999
Q ss_pred EeeeCCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCc---EEEEeccccccc
Q 007260 294 VMEFCPGGDLHTLRQKQ--PGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGH---IMLSDFDLSLRC 368 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~--~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~---vkL~DFGlA~~~ 368 (611)
|||||+|++|.+++... .+..+++..++.++.||+.||+|||++|||||||||+||||+.++. +||+|||++...
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 183 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence 99999999998876542 2346899999999999999999999999999999999999987654 999999998543
Q ss_pred cCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccc
Q 007260 369 AVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTE 448 (611)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (611)
....
T Consensus 184 ~~~~---------------------------------------------------------------------------- 187 (351)
T 3c0i_A 184 GESG---------------------------------------------------------------------------- 187 (351)
T ss_dssp CTTS----------------------------------------------------------------------------
T ss_pred cCCC----------------------------------------------------------------------------
Confidence 2100
Q ss_pred ccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCC--CCCCCHHHHHH
Q 007260 449 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPE--SPVVSFAARDL 526 (611)
Q Consensus 449 ~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~--~~~~s~~l~dL 526 (611)
......+||+.|+|||++.+..++.++|||||||+||+|++|+.||.+. ....+..+......++. +..++.++++|
T Consensus 188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 266 (351)
T 3c0i_A 188 LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWSHISESAKDL 266 (351)
T ss_dssp CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHTTSCHHHHHH
T ss_pred eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCccccccCCHHHHHH
Confidence 0012346999999999999999999999999999999999999999875 34455566655554432 24589999999
Q ss_pred HHHhhhcCccccCCchhcHHHHHcCCCCCCCch
Q 007260 527 IRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNW 559 (611)
Q Consensus 527 I~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 559 (611)
|.+||..||.+||+ +.++|+||||++.++
T Consensus 267 i~~~L~~dP~~R~s----~~e~l~hp~~~~~~~ 295 (351)
T 3c0i_A 267 VRRMLMLDPAERIT----VYEALNHPWLKERDR 295 (351)
T ss_dssp HHHHTCSSTTTSCC----HHHHHTSHHHHTHHH
T ss_pred HHHHCCCChhHCcC----HHHHhcChhhcCCcc
Confidence 99999999999999 999999999987654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=420.93 Aligned_cols=261 Identities=26% Similarity=0.427 Sum_probs=220.2
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
+++|++++.||+|+||+||+|++..+++.||||++...... .....+.+|+.+++.++||||+++++++.+++..|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 46999999999999999999999999999999999754332 2234567899999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
||||+|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-- 159 (323)
T 3tki_A 84 LEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN-- 159 (323)
T ss_dssp EECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT--
T ss_pred EEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCC--
Confidence 9999999999988654 569999999999999999999999999999999999999999999999999985432110
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
........
T Consensus 160 ------------------------------------------------------------------------~~~~~~~~ 167 (323)
T 3tki_A 160 ------------------------------------------------------------------------RERLLNKM 167 (323)
T ss_dssp ------------------------------------------------------------------------EECCBCSC
T ss_pred ------------------------------------------------------------------------cccccCCC
Confidence 00111235
Q ss_pred ccCCCccchhhhccCCC-CChhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007260 455 VGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSGNR-ATLFNVVGQPLRFPESPVVSFAARDLIRGLLV 532 (611)
Q Consensus 455 vGT~~Y~APEil~~~~~-~~~sDIWSLGviL~ELltG~~PF~~~~~~-~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~ 532 (611)
+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.... ..+..+.......+....++..+.+||.+||.
T Consensus 168 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 247 (323)
T 3tki_A 168 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILV 247 (323)
T ss_dssp CSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSC
T ss_pred ccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHHHHcc
Confidence 79999999999998876 77899999999999999999999876554 33444445555555556799999999999999
Q ss_pred cCccccCCchhcHHHHHcCCCCCCC
Q 007260 533 KEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 533 ~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
.||.+||+ +.|+++||||...
T Consensus 248 ~dP~~R~t----~~eil~h~~~~~~ 268 (323)
T 3tki_A 248 ENPSARIT----IPDIKKDRWYNKP 268 (323)
T ss_dssp SSTTTSCC----HHHHTTCTTTTCC
T ss_pred CChhhCcC----HHHHhhChhhccc
Confidence 99999999 9999999999864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-50 Score=420.88 Aligned_cols=262 Identities=23% Similarity=0.374 Sum_probs=214.2
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
+++|++++.||+|+||+||+|++..+++.||||++..... .......+.+|+.+|+.++||||+++++++.+++.+|||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 4689999999999999999999999999999999976542 223344567899999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEc-----cCCcEEEEecccccccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVR-----EDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~-----~~g~vkL~DFGlA~~~~ 369 (611)
||||+ ++|.+++... ..+++..++.++.||+.||+|||++|||||||||+||||+ .++.+||+|||++..+.
T Consensus 112 ~e~~~-~~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp EECCS-EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred EecCC-CCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 99996 5999999876 4599999999999999999999999999999999999994 45569999999985432
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
... .
T Consensus 189 ~~~----------------------------------------------------------------------------~ 192 (329)
T 3gbz_A 189 IPI----------------------------------------------------------------------------R 192 (329)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred Ccc----------------------------------------------------------------------------c
Confidence 110 0
Q ss_pred cccccccCCCccchhhhccCC-CCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcC---CCC--C----------
Q 007260 450 RSMSFVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ---PLR--F---------- 513 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~~~-~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~---~l~--~---------- 513 (611)
.....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+....+.+..+... +.. +
T Consensus 193 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (329)
T 3gbz_A 193 QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWK 272 (329)
T ss_dssp -------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhh
Confidence 112346899999999998855 799999999999999999999999998887777665532 110 0
Q ss_pred ---CCC----------CCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCchh
Q 007260 514 ---PES----------PVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWA 560 (611)
Q Consensus 514 ---p~~----------~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~ 560 (611)
+.. ..++.++++||.+||..||.+||+ +.|+|+||||++.+|.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~f~~~~~~ 328 (329)
T 3gbz_A 273 QSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRIS----AKNALEHPYFSHNDFD 328 (329)
T ss_dssp TTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCC----HHHHHTSGGGSSSCSC
T ss_pred hhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCC----HHHHhCCcccCCCCCC
Confidence 000 117899999999999999999999 9999999999999885
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-50 Score=422.01 Aligned_cols=265 Identities=27% Similarity=0.411 Sum_probs=223.4
Q ss_pred HHHhhccCccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC-----CCC
Q 007260 203 IQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD-----HPF 277 (611)
Q Consensus 203 ~~~~~~~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~-----Hpn 277 (611)
+..+..+.+.+..++|++++.||+|+||+||+|++..+++.||||++.... .....+..|+.+|+.+. |||
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~h~~ 97 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQNDDINNNN 97 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH----HHHHHHHHHHHHHHHTCCCSTTGGG
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch----hhhhhhHHHHHHHHHhcccCCCCCC
Confidence 444556677777889999999999999999999999999999999997533 23335567999999986 999
Q ss_pred cccccceeeccceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEcc----
Q 007260 278 LPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRE---- 353 (611)
Q Consensus 278 Iv~l~~~~~~~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~---- 353 (611)
||+++++|...+..||||||+ |++|.+++.......+++..++.++.||+.||+|||++|||||||||+||||+.
T Consensus 98 iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 98 IVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp BCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCC
T ss_pred eecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccc
Confidence 999999999999999999999 999999999876667999999999999999999999999999999999999975
Q ss_pred ---------------------CCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCC
Q 007260 354 ---------------------DGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTC 412 (611)
Q Consensus 354 ---------------------~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (611)
++.+||+|||++.....
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~------------------------------------------ 214 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD------------------------------------------ 214 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS------------------------------------------
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCC------------------------------------------
Confidence 78999999999842110
Q ss_pred CCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCC
Q 007260 413 FSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKT 492 (611)
Q Consensus 413 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~ 492 (611)
.....+||+.|+|||++.+..++.++|||||||+||+|++|+.
T Consensus 215 -------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 257 (360)
T 3llt_A 215 -------------------------------------YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL 257 (360)
T ss_dssp -------------------------------------CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred -------------------------------------CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCC
Confidence 0113469999999999999999999999999999999999999
Q ss_pred CCCCCCcHHHHHHHHcCCCCC--------------------------CCC------------------CCCCHHHHHHHH
Q 007260 493 PFKGSGNRATLFNVVGQPLRF--------------------------PES------------------PVVSFAARDLIR 528 (611)
Q Consensus 493 PF~~~~~~~~l~~i~~~~l~~--------------------------p~~------------------~~~s~~l~dLI~ 528 (611)
||.+....+.+..+......+ |.. ...++.+.+||.
T Consensus 258 pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 337 (360)
T 3llt_A 258 LFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLY 337 (360)
T ss_dssp SCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHH
T ss_pred CCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHH
Confidence 999887766654443221111 111 012477889999
Q ss_pred HhhhcCccccCCchhcHHHHHcCCCCC
Q 007260 529 GLLVKEPQHRLAYKRGATEIKQHPFFE 555 (611)
Q Consensus 529 ~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 555 (611)
+||+.||.+||+ +.|||+||||+
T Consensus 338 ~~L~~dP~~Rpt----a~elL~hp~f~ 360 (360)
T 3llt_A 338 SILQIDPTLRPS----PAELLKHKFLE 360 (360)
T ss_dssp HHCCSSGGGSCC----HHHHTTSGGGC
T ss_pred HHhcCChhhCCC----HHHHhcCcccC
Confidence 999999999999 99999999995
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-50 Score=442.96 Aligned_cols=263 Identities=27% Similarity=0.453 Sum_probs=232.6
Q ss_pred cCccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecc
Q 007260 209 RDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE 288 (611)
Q Consensus 209 ~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~ 288 (611)
..+.+.+++|++++.||+|+||.||+|++..+++.||||++.+..........++.+|+.+|+.++||||+++++++.+.
T Consensus 9 ~~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~ 88 (476)
T 2y94_A 9 HDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP 88 (476)
T ss_dssp CCSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cCCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 34556678999999999999999999999999999999999876554434456778999999999999999999999999
Q ss_pred ceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccc
Q 007260 289 KFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRC 368 (611)
Q Consensus 289 ~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~ 368 (611)
+.+|||||||+||+|.+++... +.+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||++...
T Consensus 89 ~~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~ 166 (476)
T 2y94_A 89 SDIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 166 (476)
T ss_dssp SEEEEEEECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred CEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhc
Confidence 9999999999999999998764 56999999999999999999999999999999999999999999999999998432
Q ss_pred cCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccc
Q 007260 369 AVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTE 448 (611)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (611)
...
T Consensus 167 ~~~----------------------------------------------------------------------------- 169 (476)
T 2y94_A 167 SDG----------------------------------------------------------------------------- 169 (476)
T ss_dssp CTT-----------------------------------------------------------------------------
T ss_pred ccc-----------------------------------------------------------------------------
Confidence 200
Q ss_pred ccccccccCCCccchhhhccCCC-CChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 007260 449 ARSMSFVGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLI 527 (611)
Q Consensus 449 ~~~~~~vGT~~Y~APEil~~~~~-~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI 527 (611)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+......+.++.......|. .++.++++||
T Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~Li 247 (476)
T 2y94_A 170 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQ--YLNPSVISLL 247 (476)
T ss_dssp CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCT--TCCHHHHHHH
T ss_pred ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCc--cCCHHHHHHH
Confidence 01123469999999999998876 78999999999999999999999998888888888877766654 4899999999
Q ss_pred HHhhhcCccccCCchhcHHHHHcCCCCCC
Q 007260 528 RGLLVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 528 ~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
.+||..||.+||+ +.+|++||||+.
T Consensus 248 ~~~L~~dP~~Rpt----~~eil~hp~~~~ 272 (476)
T 2y94_A 248 KHMLQVDPMKRAT----IKDIREHEWFKQ 272 (476)
T ss_dssp HHHTCSSTTTSCC----HHHHHTCHHHHT
T ss_pred HHHcCCCchhCcC----HHHHHhCHHhhh
Confidence 9999999999999 999999999974
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-50 Score=408.09 Aligned_cols=258 Identities=34% Similarity=0.570 Sum_probs=228.5
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSC 292 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~ 292 (611)
+.+++|++++.||+|+||.||+|++..++..||||++.+...........+.+|+++++.++||||+++++++.+.+..|
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 90 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIY 90 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEE
Confidence 44679999999999999999999999999999999997765443333456788999999999999999999999999999
Q ss_pred EEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCc
Q 007260 293 LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 293 LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~ 372 (611)
+||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 91 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~-- 166 (284)
T 2vgo_A 91 LMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS-- 166 (284)
T ss_dssp EEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS--
T ss_pred EEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcc--
Confidence 999999999999998875 4599999999999999999999999999999999999999999999999998733210
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
....
T Consensus 167 ----------------------------------------------------------------------------~~~~ 170 (284)
T 2vgo_A 167 ----------------------------------------------------------------------------LRRR 170 (284)
T ss_dssp ----------------------------------------------------------------------------SCBC
T ss_pred ----------------------------------------------------------------------------cccc
Confidence 0011
Q ss_pred ccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007260 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLV 532 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~ 532 (611)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+......+|. .++.++++||.+||.
T Consensus 171 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~ 248 (284)
T 2vgo_A 171 TMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP--FLSDGSKDLISKLLR 248 (284)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT--TSCHHHHHHHHHHSC
T ss_pred cccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCC--cCCHHHHHHHHHHhh
Confidence 346999999999999999999999999999999999999999998888777778777666654 489999999999999
Q ss_pred cCccccCCchhcHHHHHcCCCCCC
Q 007260 533 KEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 533 ~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
.||.+||+ +.++++||||+.
T Consensus 249 ~~p~~Rps----~~~ll~h~~~~~ 268 (284)
T 2vgo_A 249 YHPPQRLP----LKGVMEHPWVKA 268 (284)
T ss_dssp SSGGGSCC----HHHHHTCHHHHH
T ss_pred cCHhhCCC----HHHHhhCHHHHh
Confidence 99999999 999999999974
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-50 Score=424.70 Aligned_cols=255 Identities=27% Similarity=0.458 Sum_probs=214.9
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
.++|++++.||+|+||+||+|++..+++.||||++.+..... ..+++|+.+++.++||||++++++|.+...+|||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 94 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAII 94 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEE
Confidence 468999999999999999999999999999999997654332 2466899999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCc--EEEEeccccccccCCc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGH--IMLSDFDLSLRCAVSP 372 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~--vkL~DFGlA~~~~~~~ 372 (611)
||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+||||+.++. +||+|||++.....
T Consensus 95 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~-- 170 (361)
T 3uc3_A 95 MEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-- 170 (361)
T ss_dssp EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred EEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc--
Confidence 9999999999998765 45999999999999999999999999999999999999987665 99999999832110
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
.....
T Consensus 171 ---------------------------------------------------------------------------~~~~~ 175 (361)
T 3uc3_A 171 ---------------------------------------------------------------------------HSQPK 175 (361)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ---------------------------------------------------------------------------cCCCC
Confidence 00112
Q ss_pred ccccCCCccchhhhccCCCCCh-hhHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 007260 453 SFVGTHEYLAPEIIKGEGHGSA-VDWWTFGIFLYELLFGKTPFKGSGN----RATLFNVVGQPLRFPESPVVSFAARDLI 527 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~~~~~-sDIWSLGviL~ELltG~~PF~~~~~----~~~l~~i~~~~l~~p~~~~~s~~l~dLI 527 (611)
..+||+.|+|||++.+..+..+ +|||||||++|+|++|+.||.+... ...+..+......+|....++.++++||
T Consensus 176 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 255 (361)
T 3uc3_A 176 STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLI 255 (361)
T ss_dssp -----CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHH
T ss_pred CCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHH
Confidence 3469999999999999888655 8999999999999999999987443 4555667777778888778999999999
Q ss_pred HHhhhcCccccCCchhcHHHHHcCCCCCC
Q 007260 528 RGLLVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 528 ~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
.+||..||.+||+ +.||++||||..
T Consensus 256 ~~~L~~dP~~Rps----~~ell~hp~f~~ 280 (361)
T 3uc3_A 256 SRIFVADPATRIS----IPEIKTHSWFLK 280 (361)
T ss_dssp HHHSCSCTTTSCC----HHHHHTSHHHHT
T ss_pred HHHccCChhHCcC----HHHHHhCcchhc
Confidence 9999999999999 999999999953
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=401.10 Aligned_cols=263 Identities=26% Similarity=0.477 Sum_probs=229.5
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
.++|++++.||+|+||.||+|.+..+++.||+|++...... .....++.+|+.+++.++||||+++++++..++..|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 36899999999999999999999999999999999765543 34456778999999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCc---EEEEeccccccccCC
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGH---IMLSDFDLSLRCAVS 371 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~---vkL~DFGlA~~~~~~ 371 (611)
|||++|++|.+.+... ..+++..++.++.||+.||+|||++||+||||||+||||+.++. +||+|||++......
T Consensus 84 ~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 9999999999888765 56999999999999999999999999999999999999987655 999999998432210
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
...
T Consensus 162 -----------------------------------------------------------------------------~~~ 164 (284)
T 3kk8_A 162 -----------------------------------------------------------------------------EAW 164 (284)
T ss_dssp -----------------------------------------------------------------------------CBC
T ss_pred -----------------------------------------------------------------------------ccc
Confidence 001
Q ss_pred cccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCC--CCCCCHHHHHHHHH
Q 007260 452 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPE--SPVVSFAARDLIRG 529 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~--~~~~s~~l~dLI~~ 529 (611)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+......++. ...++.++.+||.+
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 244 (284)
T 3kk8_A 165 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS 244 (284)
T ss_dssp CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHH
T ss_pred cCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHHH
Confidence 1246999999999999999999999999999999999999999998888777777776655543 34689999999999
Q ss_pred hhhcCccccCCchhcHHHHHcCCCCCCCchhh
Q 007260 530 LLVKEPQHRLAYKRGATEIKQHPFFEGVNWAL 561 (611)
Q Consensus 530 ~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~ 561 (611)
||..||.+||+ +.|+++||||.+..+..
T Consensus 245 ~l~~dp~~Rps----~~~~l~h~~~~~~~~~~ 272 (284)
T 3kk8_A 245 MLTVNPKKRIT----ADQALKVPWICNRERVA 272 (284)
T ss_dssp HSCSSTTTSCC----HHHHTTSHHHHSCCCGG
T ss_pred HcccChhhCCC----HHHHhcCccccCChhHH
Confidence 99999999999 99999999998776544
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=425.61 Aligned_cols=261 Identities=30% Similarity=0.445 Sum_probs=227.2
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
.++|++++.||+|+||.||+|.+..+++.||+|++...... ....+.+|+.+|+.++|||||+++++|.+...+|||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~---~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL---DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchh---hHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 36899999999999999999999999999999999765422 233567899999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEcc--CCcEEEEeccccccccCCc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRE--DGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~--~g~vkL~DFGlA~~~~~~~ 372 (611)
||||+||+|.+++... +..+++..++.++.||+.||+|||++|||||||||+|||++. ++.+||+|||++......
T Consensus 127 ~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~- 204 (387)
T 1kob_A 127 LEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 204 (387)
T ss_dssp EECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred EEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC-
Confidence 9999999999988764 346999999999999999999999999999999999999974 578999999998543210
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
....
T Consensus 205 ----------------------------------------------------------------------------~~~~ 208 (387)
T 1kob_A 205 ----------------------------------------------------------------------------EIVK 208 (387)
T ss_dssp ----------------------------------------------------------------------------SCEE
T ss_pred ----------------------------------------------------------------------------ccee
Confidence 0011
Q ss_pred ccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCC--CCCCCHHHHHHHHHh
Q 007260 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPE--SPVVSFAARDLIRGL 530 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~--~~~~s~~l~dLI~~~ 530 (611)
..+||+.|+|||++.+..++.++|||||||++|||++|+.||.+......+.++......++. ...++.++++||.+|
T Consensus 209 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 288 (387)
T 1kob_A 209 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNL 288 (387)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTT
T ss_pred eeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHH
Confidence 346999999999999999999999999999999999999999998888888887776655443 346899999999999
Q ss_pred hhcCccccCCchhcHHHHHcCCCCCCCchh
Q 007260 531 LVKEPQHRLAYKRGATEIKQHPFFEGVNWA 560 (611)
Q Consensus 531 L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~ 560 (611)
|..||.+||+ +.++|+||||++..+.
T Consensus 289 L~~dP~~Rpt----~~ell~hp~~~~~~~~ 314 (387)
T 1kob_A 289 LQKEPRKRLT----VHDALEHPWLKGDHSN 314 (387)
T ss_dssp SCSSGGGSCC----HHHHHTSTTTSSCCTT
T ss_pred cCCChhHCcC----HHHHhhCccccCCccc
Confidence 9999999999 9999999999876543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-50 Score=413.25 Aligned_cols=263 Identities=26% Similarity=0.420 Sum_probs=212.3
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhh--HHHHHHHHHHHHHHHhC---CCCCcccccceeec
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAG--RKKLLRAQTEREILQSL---DHPFLPTLYTHFET 287 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~--~~~~~~~~~E~~iL~~l---~HpnIv~l~~~~~~ 287 (611)
+..++|++++.||+|+||+||+|++..+++.||||++....... ......+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 34579999999999999999999999999999999997533110 01112344577776666 59999999999976
Q ss_pred cc-----eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEec
Q 007260 288 EK-----FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDF 362 (611)
Q Consensus 288 ~~-----~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DF 362 (611)
.. .+|+||||+. ++|.+++.......+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence 54 6899999995 69999998876666999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCccc
Q 007260 363 DLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPEL 442 (611)
Q Consensus 363 GlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (611)
|++.....
T Consensus 165 g~a~~~~~------------------------------------------------------------------------ 172 (308)
T 3g33_A 165 GLARIYSY------------------------------------------------------------------------ 172 (308)
T ss_dssp SCTTTSTT------------------------------------------------------------------------
T ss_pred ccccccCC------------------------------------------------------------------------
Confidence 99843210
Q ss_pred ccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcC---CC--CCCC--
Q 007260 443 IAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ---PL--RFPE-- 515 (611)
Q Consensus 443 ~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~---~l--~~p~-- 515 (611)
.......+||+.|+|||++.+..++.++|||||||++|||++|++||.+......+.++... +. .++.
T Consensus 173 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 247 (308)
T 3g33_A 173 -----QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 247 (308)
T ss_dssp -----CCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSC
T ss_pred -----CcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchh
Confidence 00112357999999999999999999999999999999999999999998887777665431 11 0110
Q ss_pred ------------------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 516 ------------------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 516 ------------------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
.+.++.++.+||.+||++||.+||+ +.|+|+||||+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~h~~~~~~ 303 (308)
T 3g33_A 248 SLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRIS----AFRALQHSYLHKD 303 (308)
T ss_dssp SSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCC----HHHHHTSTTC---
T ss_pred hccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCC----HHHHhcCccccCC
Confidence 1347899999999999999999999 9999999999853
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=438.40 Aligned_cols=256 Identities=27% Similarity=0.409 Sum_probs=210.9
Q ss_pred cccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecc-----
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE----- 288 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~----- 288 (611)
..++|++++.||+|+||+||+|++..+++.||||++.+.. .......++.+|+.+|+.++|||||+++++|...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 3579999999999999999999999999999999997653 3345566788999999999999999999999654
Q ss_pred -ceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccc
Q 007260 289 -KFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLR 367 (611)
Q Consensus 289 -~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~ 367 (611)
..+|||||||++ +|...+.. .+++..++.++.||+.||+|||++|||||||||+||||+.++++||+|||+++.
T Consensus 139 ~~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 139 FQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp CCEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred CCeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 467999999965 57666643 389999999999999999999999999999999999999999999999999843
Q ss_pred ccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcc
Q 007260 368 CAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPT 447 (611)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (611)
...
T Consensus 214 ~~~----------------------------------------------------------------------------- 216 (464)
T 3ttj_A 214 AGT----------------------------------------------------------------------------- 216 (464)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cCC-----------------------------------------------------------------------------
Confidence 210
Q ss_pred cccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHc---CCC-------------
Q 007260 448 EARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG---QPL------------- 511 (611)
Q Consensus 448 ~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~---~~l------------- 511 (611)
.......+||++|+|||++.+..|+.++|||||||+||||++|++||.+.+..+.+..++. .+.
T Consensus 217 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~ 296 (464)
T 3ttj_A 217 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 296 (464)
T ss_dssp CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHH
T ss_pred CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhh
Confidence 0011235799999999999999999999999999999999999999999887777665543 110
Q ss_pred ---CCCCCCC---------------------CCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCC
Q 007260 512 ---RFPESPV---------------------VSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 512 ---~~p~~~~---------------------~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
..+.... .+.++++||.+||.+||.+||| ++|+|+||||+.
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t----a~e~L~Hp~~~~ 361 (464)
T 3ttj_A 297 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS----VDDALQHPYINV 361 (464)
T ss_dssp HHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCC----HHHHHTSTTTGG
T ss_pred HhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCC----HHHHhcChhhhh
Confidence 0000000 1567999999999999999999 999999999984
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=408.95 Aligned_cols=259 Identities=24% Similarity=0.397 Sum_probs=213.1
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
+++|++++.||+|+||+||+|++ .+++.||||++...... ......+.+|+.+|+.++||||+++++++.+.+.+|||
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccc-cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence 36899999999999999999998 67889999999654322 12223567899999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
|||+++ +|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 79 ~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 154 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-- 154 (288)
T ss_dssp EECCSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EEecCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc--
Confidence 999965 9999887653 569999999999999999999999999999999999999999999999999985432100
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
......
T Consensus 155 --------------------------------------------------------------------------~~~~~~ 160 (288)
T 1ob3_A 155 --------------------------------------------------------------------------RKYTHE 160 (288)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------cccccc
Confidence 011124
Q ss_pred ccCCCccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHc---CCCC--CC--------------
Q 007260 455 VGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG---QPLR--FP-------------- 514 (611)
Q Consensus 455 vGT~~Y~APEil~~~-~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~---~~l~--~p-------------- 514 (611)
+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+.+..+.. .+.. ++
T Consensus 161 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T 1ob3_A 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240 (288)
T ss_dssp -CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCC
T ss_pred cccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccccccc
Confidence 689999999999875 489999999999999999999999999887776655542 1100 00
Q ss_pred --------CCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 515 --------ESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 515 --------~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
....++.++++||.+||..||.+||+ +.|+|+||||++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT----AKQALEHAYFKEN 287 (288)
T ss_dssp CCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCC----HHHHHTSGGGGC-
T ss_pred ccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCC----HHHHhcCcchhhc
Confidence 01347899999999999999999999 9999999999864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=413.29 Aligned_cols=263 Identities=30% Similarity=0.459 Sum_probs=229.2
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhH---HHHHHHHHHHHHHHhCCCCCcccccceeeccceee
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGR---KKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSC 292 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~---~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~ 292 (611)
++|++++.||+|+||.||+|++..+++.||||++.+...... .....+.+|+.+|+.++||||+++++++.+...+|
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 579999999999999999999999999999999976543211 11345678999999999999999999999999999
Q ss_pred EEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCC----cEEEEeccccccc
Q 007260 293 LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDG----HIMLSDFDLSLRC 368 (611)
Q Consensus 293 LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g----~vkL~DFGlA~~~ 368 (611)
|||||++|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ ++||+|||++...
T Consensus 92 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~ 169 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (321)
T ss_dssp EEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence 999999999999999864 5699999999999999999999999999999999999999888 7999999998433
Q ss_pred cCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccc
Q 007260 369 AVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTE 448 (611)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (611)
...
T Consensus 170 ~~~----------------------------------------------------------------------------- 172 (321)
T 2a2a_A 170 EDG----------------------------------------------------------------------------- 172 (321)
T ss_dssp CTT-----------------------------------------------------------------------------
T ss_pred Ccc-----------------------------------------------------------------------------
Confidence 210
Q ss_pred ccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCC--CCCCHHHHHH
Q 007260 449 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPES--PVVSFAARDL 526 (611)
Q Consensus 449 ~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~--~~~s~~l~dL 526 (611)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+......+..+......++.. ..++..+++|
T Consensus 173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 252 (321)
T 2a2a_A 173 VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDF 252 (321)
T ss_dssp CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHH
T ss_pred ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHHHHHH
Confidence 00112469999999999999999999999999999999999999999988888888877766555432 4589999999
Q ss_pred HHHhhhcCccccCCchhcHHHHHcCCCCCCCchhh
Q 007260 527 IRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWAL 561 (611)
Q Consensus 527 I~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~ 561 (611)
|.+||..||.+||+ +.|+++||||..++|..
T Consensus 253 i~~~l~~dp~~Rps----~~e~l~hp~~~~~~~~~ 283 (321)
T 2a2a_A 253 IRKLLVKETRKRLT----IQEALRHPWITPVDNQQ 283 (321)
T ss_dssp HHTTSCSSTTTSCC----HHHHHHSTTTSCSSHHH
T ss_pred HHHHcCCChhhCcC----HHHHhcCccccCCCccc
Confidence 99999999999999 99999999999988754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-50 Score=416.30 Aligned_cols=263 Identities=28% Similarity=0.427 Sum_probs=204.2
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
.++|++++.||+|+||.||+|.+..+++.||||++...... .....+.+|+.+|+.++||||+++++++..++.+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE--GTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTT--CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc--ccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 46899999999999999999999999999999999754321 1223567899999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccC
Q 007260 295 MEFCPGGDLHTLRQKQP----GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAV 370 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~----~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~ 370 (611)
||||+ ++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||++.....
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 99996 69998876531 24589999999999999999999999999999999999999999999999999844321
Q ss_pred CccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccc
Q 007260 371 SPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEAR 450 (611)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (611)
.. ..
T Consensus 161 ~~----------------------------------------------------------------------------~~ 164 (317)
T 2pmi_A 161 PV----------------------------------------------------------------------------NT 164 (317)
T ss_dssp CC----------------------------------------------------------------------------CC
T ss_pred Cc----------------------------------------------------------------------------cc
Confidence 00 00
Q ss_pred ccccccCCCccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHc---CCCC--------------
Q 007260 451 SMSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG---QPLR-------------- 512 (611)
Q Consensus 451 ~~~~vGT~~Y~APEil~~~-~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~---~~l~-------------- 512 (611)
....+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+.+..+.. .+..
T Consensus 165 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 244 (317)
T 2pmi_A 165 FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNP 244 (317)
T ss_dssp CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCT
T ss_pred CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhccc
Confidence 1123689999999999875 589999999999999999999999999887766655432 1100
Q ss_pred -C--------------CCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCchh
Q 007260 513 -F--------------PESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWA 560 (611)
Q Consensus 513 -~--------------p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~ 560 (611)
+ .....++.++++||.+||..||.+||+ +.|+|+||||++..|.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt----~~e~l~hp~f~~~~~~ 303 (317)
T 2pmi_A 245 NIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLS----AKQALHHPWFAEYYHH 303 (317)
T ss_dssp TCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCC----HHHHTTSGGGGGGCC-
T ss_pred ccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCC----HHHHhCChhhhcccch
Confidence 0 011247889999999999999999999 9999999999876553
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-50 Score=419.56 Aligned_cols=270 Identities=31% Similarity=0.495 Sum_probs=226.0
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhh--hHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeE
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLA--GRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCL 293 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~--~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~L 293 (611)
++|++++.||+|+||.||+|++..++..||||++.+.... ......++.+|+.+|+.++||||++++++|.+.+..||
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 5899999999999999999999999999999999875432 23445677899999999999999999999999999999
Q ss_pred EeeeCCCCCHHHHHHhC--------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHH
Q 007260 294 VMEFCPGGDLHTLRQKQ--------------------------------------PGKYFPEQAVRFYVAEVLLALEYLH 335 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~--------------------------------------~~~~l~e~~~~~i~~qll~aL~yLH 335 (611)
|||||+||+|.+++... ....+++..++.++.||+.||+|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 99999999999987521 0123468889999999999999999
Q ss_pred HcCeeccCCCCCcEEEccCC--cEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCC
Q 007260 336 MLGIIYRDLKPENVLVREDG--HIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCF 413 (611)
Q Consensus 336 ~~gIVHRDLKPeNILv~~~g--~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (611)
++||+||||||+||||+.++ .+||+|||++..+.....
T Consensus 186 ~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~---------------------------------------- 225 (345)
T 3hko_A 186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNN---------------------------------------- 225 (345)
T ss_dssp HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTC----------------------------------------
T ss_pred HCCccccCCChhhEEEecCCCceEEEeeccccccccccCc----------------------------------------
Confidence 99999999999999998777 899999999854321100
Q ss_pred CCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCccchhhhcc--CCCCChhhHHHHHHHHHHHHhCC
Q 007260 414 SPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKG--EGHGSAVDWWTFGIFLYELLFGK 491 (611)
Q Consensus 414 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~--~~~~~~sDIWSLGviL~ELltG~ 491 (611)
.........+||+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 226 --------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~ 273 (345)
T 3hko_A 226 --------------------------------GEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273 (345)
T ss_dssp --------------------------------C--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSS
T ss_pred --------------------------------cccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 00001123469999999999976 67899999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHcCCCCCCCC--CCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCchhh
Q 007260 492 TPFKGSGNRATLFNVVGQPLRFPES--PVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWAL 561 (611)
Q Consensus 492 ~PF~~~~~~~~l~~i~~~~l~~p~~--~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~ 561 (611)
.||.+....+.+..++.....++.. ..++.++++||.+||..||.+||+ +.++|+||||+++.|.+
T Consensus 274 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~~l~hp~~~~~~~~~ 341 (345)
T 3hko_A 274 VPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFD----AMRALQHPWISQFSDKI 341 (345)
T ss_dssp CSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCC----HHHHHHSHHHHTTSSCS
T ss_pred CCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCC----HHHHhcChhhccChHhh
Confidence 9999998888888888777655443 348999999999999999999999 99999999999876543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=409.24 Aligned_cols=264 Identities=28% Similarity=0.444 Sum_probs=216.8
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
+++|++++.||+|+||+||+|++..+++.||||++.... ........+.+|+.+|+.++||||+++++++...+..|||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 468999999999999999999999999999999986653 2333445677899999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
||||++++|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 156 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS-- 156 (311)
T ss_dssp EECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc--
Confidence 9999999999988765 569999999999999999999999999999999999999999999999999984332100
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
......
T Consensus 157 --------------------------------------------------------------------------~~~~~~ 162 (311)
T 4agu_A 157 --------------------------------------------------------------------------DYYDDE 162 (311)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------cccCCC
Confidence 011134
Q ss_pred ccCCCccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHc---C----------------CCCCC
Q 007260 455 VGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG---Q----------------PLRFP 514 (611)
Q Consensus 455 vGT~~Y~APEil~~-~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~---~----------------~l~~p 514 (611)
+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+.+..+.. . ....+
T Consensus 163 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (311)
T 4agu_A 163 VATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIP 242 (311)
T ss_dssp ---GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCC
T ss_pred cCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCC
Confidence 69999999999987 5679999999999999999999999999877666544321 1 01111
Q ss_pred C----------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCchhh
Q 007260 515 E----------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWAL 561 (611)
Q Consensus 515 ~----------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~ 561 (611)
. ...++..+.+||.+||..||.+||+ +.|+|+||||+++.|..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~f~~~~~~~ 295 (311)
T 4agu_A 243 DPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLT----CEQLLHHPYFENIREIE 295 (311)
T ss_dssp CCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCC----HHHHHTSGGGTTCC---
T ss_pred CccccchhhhhcccccHHHHHHHHHHccCChhhcCC----HHHHhcChHHHhccCHH
Confidence 1 1358899999999999999999999 99999999999887654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=416.70 Aligned_cols=265 Identities=28% Similarity=0.429 Sum_probs=227.2
Q ss_pred cCeEEE-eEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeeccceeeE
Q 007260 216 SHFRLL-KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEKFSCL 293 (611)
Q Consensus 216 ~~y~l~-~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~~~~~L 293 (611)
++|.+. +.||+|+||.||+|++..+++.||||++.+..... .....+.+|+.+|+.+ +||||++++++|...+.+||
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l 106 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL 106 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence 578888 89999999999999999999999999997654322 2234567899999999 56999999999999999999
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEcc---CCcEEEEeccccccccC
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRE---DGHIMLSDFDLSLRCAV 370 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~---~g~vkL~DFGlA~~~~~ 370 (611)
|||||.||+|.+++.......+++..++.++.||+.||+|||++||+||||||+||||+. ++.+||+|||++.....
T Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 186 (327)
T 3lm5_A 107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186 (327)
T ss_dssp EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence 999999999999887665677999999999999999999999999999999999999997 78999999999854321
Q ss_pred CccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccc
Q 007260 371 SPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEAR 450 (611)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (611)
. ..
T Consensus 187 ~-----------------------------------------------------------------------------~~ 189 (327)
T 3lm5_A 187 A-----------------------------------------------------------------------------CE 189 (327)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred c-----------------------------------------------------------------------------cc
Confidence 0 00
Q ss_pred ccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCC--CCCCCHHHHHHHH
Q 007260 451 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPE--SPVVSFAARDLIR 528 (611)
Q Consensus 451 ~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~--~~~~s~~l~dLI~ 528 (611)
....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+......+..+......++. ...++..+++||.
T Consensus 190 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 269 (327)
T 3lm5_A 190 LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQ 269 (327)
T ss_dssp ----CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHH
T ss_pred cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHHHH
Confidence 11346999999999999999999999999999999999999999998888777777665544433 3568999999999
Q ss_pred HhhhcCccccCCchhcHHHHHcCCCCCCCchhhh
Q 007260 529 GLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALI 562 (611)
Q Consensus 529 ~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~ 562 (611)
+||..||.+||+ +++||+||||++.+|...
T Consensus 270 ~~L~~dP~~Rpt----~~~ll~h~~~~~~~~~~~ 299 (327)
T 3lm5_A 270 SLLVKNPEKRPT----AEICLSHSWLQQWDFENL 299 (327)
T ss_dssp HHSCSSGGGSCC----HHHHTTCGGGCCCCTTCC
T ss_pred HHcCCChhhCcC----HHHHhCCHhhcccccccc
Confidence 999999999999 999999999999998654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-50 Score=422.24 Aligned_cols=256 Identities=28% Similarity=0.497 Sum_probs=217.8
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeeccceeeE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEKFSCL 293 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~~~~~L 293 (611)
.++|++++.||.|+||.||+|++..+++.||||++.+.... ..+|+++|.++ +||||++++++|.+++.+||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 36899999999999999999999999999999999765422 24588888887 79999999999999999999
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccC----CcEEEEecccccccc
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRED----GHIMLSDFDLSLRCA 369 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~----g~vkL~DFGlA~~~~ 369 (611)
|||||+||+|.+++.+. +.+++..++.++.||+.||+|||++|||||||||+|||+..+ +.+||+|||++....
T Consensus 94 v~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp EECCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 99999999999998875 569999999999999999999999999999999999998543 359999999985432
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
.. ..
T Consensus 172 ~~----------------------------------------------------------------------------~~ 175 (342)
T 2qr7_A 172 AE----------------------------------------------------------------------------NG 175 (342)
T ss_dssp CT----------------------------------------------------------------------------TC
T ss_pred CC----------------------------------------------------------------------------CC
Confidence 10 00
Q ss_pred cccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC---CcHHHHHHHHcCCCCCCC--CCCCCHHHH
Q 007260 450 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGS---GNRATLFNVVGQPLRFPE--SPVVSFAAR 524 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~---~~~~~l~~i~~~~l~~p~--~~~~s~~l~ 524 (611)
.....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+. ...+.+..+....+.++. +..++.+++
T Consensus 176 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 255 (342)
T 2qr7_A 176 LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAK 255 (342)
T ss_dssp CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHH
T ss_pred ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHH
Confidence 112347999999999999988999999999999999999999999863 344555666666655543 356999999
Q ss_pred HHHHHhhhcCccccCCchhcHHHHHcCCCCCCCchhh
Q 007260 525 DLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWAL 561 (611)
Q Consensus 525 dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~ 561 (611)
+||.+||..||.+||+ +.++++||||. +|..
T Consensus 256 ~li~~~L~~dP~~R~t----~~~il~hp~~~--~~~~ 286 (342)
T 2qr7_A 256 DLVSKMLHVDPHQRLT----AALVLRHPWIV--HWDQ 286 (342)
T ss_dssp HHHHHHTCSSTTTSCC----HHHHTTSHHHH--TGGG
T ss_pred HHHHHHCCCChhHCcC----HHHHhcCCeec--Cccc
Confidence 9999999999999999 99999999995 4544
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=429.03 Aligned_cols=253 Identities=28% Similarity=0.443 Sum_probs=208.7
Q ss_pred ccCeEEE-eEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHH-HhCCCCCcccccceeec----c
Q 007260 215 LSHFRLL-KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREIL-QSLDHPFLPTLYTHFET----E 288 (611)
Q Consensus 215 ~~~y~l~-~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL-~~l~HpnIv~l~~~~~~----~ 288 (611)
+++|.+. +.||.|+||+||+|.+..+++.||||++.... .+.+|+.++ +.++||||++++++|.. .
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--------~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~ 131 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCPHIVRIVDVYENLYAGR 131 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSH--------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcch--------hHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence 4688887 78999999999999999999999999996432 345788887 45589999999999875 6
Q ss_pred ceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEcc---CCcEEEEecccc
Q 007260 289 KFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRE---DGHIMLSDFDLS 365 (611)
Q Consensus 289 ~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~---~g~vkL~DFGlA 365 (611)
.++|||||||+||+|.+++.......+++..++.|+.||+.||+|||++|||||||||+||||+. ++.+||+|||++
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred cEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence 78999999999999999998765567999999999999999999999999999999999999997 789999999998
Q ss_pred ccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccC
Q 007260 366 LRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAE 445 (611)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (611)
......
T Consensus 212 ~~~~~~-------------------------------------------------------------------------- 217 (400)
T 1nxk_A 212 KETTSH-------------------------------------------------------------------------- 217 (400)
T ss_dssp EECC----------------------------------------------------------------------------
T ss_pred cccCCC--------------------------------------------------------------------------
Confidence 432100
Q ss_pred cccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHH----HHHHHHcCCCCCC--CCCCC
Q 007260 446 PTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRA----TLFNVVGQPLRFP--ESPVV 519 (611)
Q Consensus 446 ~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~----~l~~i~~~~l~~p--~~~~~ 519 (611)
......+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+..... ....+....+.++ .+..+
T Consensus 218 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 294 (400)
T 1nxk_A 218 ---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 294 (400)
T ss_dssp ------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTS
T ss_pred ---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccC
Confidence 01123579999999999999999999999999999999999999998754321 3344444544444 34569
Q ss_pred CHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCC
Q 007260 520 SFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 520 s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
+.++++||.+||..||.+||+ +.+|++||||..
T Consensus 295 s~~~~~li~~~L~~dP~~Rpt----~~eil~hp~~~~ 327 (400)
T 1nxk_A 295 SEEVKMLIRNLLKTEPTQRMT----ITEFMNHPWIMQ 327 (400)
T ss_dssp CHHHHHHHHTTSCSSGGGSCC----HHHHHHSHHHHT
T ss_pred CHHHHHHHHHHCCCChhHCcC----HHHHhcCccccC
Confidence 999999999999999999999 999999999964
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-49 Score=414.06 Aligned_cols=259 Identities=29% Similarity=0.485 Sum_probs=229.8
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
.++|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|||
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 36899999999999999999999999999999999876555555666788999999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
||||+|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 120 ~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-- 195 (335)
T 2owb_A 120 LELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-- 195 (335)
T ss_dssp ECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred EecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc--
Confidence 9999999999988775 569999999999999999999999999999999999999999999999999984332100
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
......
T Consensus 196 --------------------------------------------------------------------------~~~~~~ 201 (335)
T 2owb_A 196 --------------------------------------------------------------------------ERKKVL 201 (335)
T ss_dssp --------------------------------------------------------------------------CCBCCC
T ss_pred --------------------------------------------------------------------------cccccc
Confidence 001134
Q ss_pred ccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcC
Q 007260 455 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKE 534 (611)
Q Consensus 455 vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~d 534 (611)
+||+.|+|||++.+..++.++|||||||++|+|++|+.||......+.+..+......++. .++..+.+||.+||..|
T Consensus 202 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~d 279 (335)
T 2owb_A 202 CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK--HINPVAASLIQKMLQTD 279 (335)
T ss_dssp CSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT--TSCHHHHHHHHHHTCSS
T ss_pred CCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCc--cCCHHHHHHHHHHccCC
Confidence 6999999999999999999999999999999999999999988877777777777666655 48999999999999999
Q ss_pred ccccCCchhcHHHHHcCCCCCCC
Q 007260 535 PQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 535 P~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
|.+||+ +.++++||||...
T Consensus 280 p~~Rps----~~ell~~~~~~~~ 298 (335)
T 2owb_A 280 PTARPT----INELLNDEFFTSG 298 (335)
T ss_dssp GGGSCC----GGGGGGSHHHHTS
T ss_pred hhHCcC----HHHHhcCccccCC
Confidence 999999 8999999999753
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=425.43 Aligned_cols=286 Identities=27% Similarity=0.415 Sum_probs=215.7
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecc-----c
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE-----K 289 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~-----~ 289 (611)
.++|++++.||+|+||.||+|++..+++.||||++.+.. .......++.+|+.+|+.++||||+++++++... .
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 369999999999999999999999999999999997542 3344556788999999999999999999999766 6
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
.+||||||+ +++|.+++... ..+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+++...
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 104 ELYIVLEIA-DSDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp CEEEEEECC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred eEEEEEecC-CcCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 799999999 56999998765 569999999999999999999999999999999999999999999999999996543
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
............ .+ . .+.........
T Consensus 181 ~~~~~~~~~~~~-----~~------------------------------------------~-------~~~~~~~~~~~ 206 (432)
T 3n9x_A 181 SEKDTNIVNDLE-----EN------------------------------------------E-------EPGPHNKNLKK 206 (432)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cccccccccccc-----cc------------------------------------------c-------cccccccchhc
Confidence 211100000000 00 0 00000000112
Q ss_pred cccccccCCCccchhhh-ccCCCCChhhHHHHHHHHHHHHh-----------CCCCCCCCCc-----------------H
Q 007260 450 RSMSFVGTHEYLAPEII-KGEGHGSAVDWWTFGIFLYELLF-----------GKTPFKGSGN-----------------R 500 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil-~~~~~~~~sDIWSLGviL~ELlt-----------G~~PF~~~~~-----------------~ 500 (611)
.....+||++|+|||++ .+..|+.++|||||||+||||++ |+++|.+.+. .
T Consensus 207 ~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~ 286 (432)
T 3n9x_A 207 QLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNR 286 (432)
T ss_dssp ----CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHH
T ss_pred cccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchH
Confidence 23467899999999997 45568999999999999999998 5555655431 1
Q ss_pred HHH---HHHHcCCC---------------------CCCC-----CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcC
Q 007260 501 ATL---FNVVGQPL---------------------RFPE-----SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 501 ~~l---~~i~~~~l---------------------~~p~-----~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~H 551 (611)
+.+ .++++.+. ..+. .+.+++++++||.+||..||.+||| ++|+|+|
T Consensus 287 ~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t----a~e~L~H 362 (432)
T 3n9x_A 287 DQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRIT----IDQALDH 362 (432)
T ss_dssp HHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCC----HHHHHTC
T ss_pred HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCC----HHHHhcC
Confidence 222 22222221 1111 1358999999999999999999999 9999999
Q ss_pred CCCCCCchhhh
Q 007260 552 PFFEGVNWALI 562 (611)
Q Consensus 552 p~f~~~~~~~~ 562 (611)
|||+++.|...
T Consensus 363 p~f~~~~~~~~ 373 (432)
T 3n9x_A 363 PYLKDVRKKKL 373 (432)
T ss_dssp GGGTTTCCTTT
T ss_pred hhhhhccCccc
Confidence 99999988654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=403.49 Aligned_cols=260 Identities=31% Similarity=0.572 Sum_probs=201.3
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
+++|++++.||+|+||.||+|++..+++.||||++.+..........++.+|+.+++.++||||+++++++.+.+..|||
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46899999999999999999999999999999999766544333456778999999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
|||+++++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~--- 165 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP--- 165 (278)
T ss_dssp EECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred EecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC---
Confidence 9999999999998865 356999999999999999999999999999999999999999999999999998432200
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
.......
T Consensus 166 -------------------------------------------------------------------------~~~~~~~ 172 (278)
T 3cok_A 166 -------------------------------------------------------------------------HEKHYTL 172 (278)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred -------------------------------------------------------------------------CCcceec
Confidence 0001134
Q ss_pred ccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcC
Q 007260 455 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKE 534 (611)
Q Consensus 455 vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~d 534 (611)
+||+.|+|||++.+..++.++|||||||++|+|++|+.||........+..+.......| ..++.++++||.+||..|
T Consensus 173 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~d 250 (278)
T 3cok_A 173 CGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMP--SFLSIEAKDLIHQLLRRN 250 (278)
T ss_dssp -------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCC--TTSCHHHHHHHHHHSCSS
T ss_pred cCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCc--cccCHHHHHHHHHHcccC
Confidence 699999999999999999999999999999999999999988766555555444444443 348999999999999999
Q ss_pred ccccCCchhcHHHHHcCCCCCCC
Q 007260 535 PQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 535 P~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
|.+||+ +.++++||||...
T Consensus 251 p~~Rps----~~~~l~h~~~~~~ 269 (278)
T 3cok_A 251 PADRLS----LSSVLDHPFMSRN 269 (278)
T ss_dssp GGGSCC----HHHHTTSTTTC--
T ss_pred HhhCCC----HHHHhcCccccCC
Confidence 999999 9999999999753
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=416.53 Aligned_cols=264 Identities=28% Similarity=0.444 Sum_probs=214.4
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
+++|++++.||+|+||+||+|++..+++.||||++...... .....+.+|+.+|+.++||||+++++++..++..|||
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc--ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence 36899999999999999999999999999999999754321 1112345699999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
|||++ ++|.+++... +..+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||++......
T Consensus 79 ~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--- 153 (324)
T 3mtl_A 79 FEYLD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP--- 153 (324)
T ss_dssp EECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred ecccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC---
Confidence 99996 5899888775 356999999999999999999999999999999999999999999999999998432100
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
.......
T Consensus 154 -------------------------------------------------------------------------~~~~~~~ 160 (324)
T 3mtl_A 154 -------------------------------------------------------------------------TKTYDNE 160 (324)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred -------------------------------------------------------------------------ccccccc
Confidence 0011134
Q ss_pred ccCCCccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH---cCCCC--CC--------------
Q 007260 455 VGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVV---GQPLR--FP-------------- 514 (611)
Q Consensus 455 vGT~~Y~APEil~~-~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~---~~~l~--~p-------------- 514 (611)
+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+.+..+. +.+.. ++
T Consensus 161 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (324)
T 3mtl_A 161 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYP 240 (324)
T ss_dssp --CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCC
T ss_pred cCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccc
Confidence 68999999999987 568999999999999999999999999988776665443 22211 11
Q ss_pred ---------CCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCchhhh
Q 007260 515 ---------ESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALI 562 (611)
Q Consensus 515 ---------~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~ 562 (611)
....++.++++||.+||..||.+||+ +.|+|+||||.++.+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~f~~~~~~~~ 293 (324)
T 3mtl_A 241 KYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRIS----AEDAMKHPFFLSLGERIH 293 (324)
T ss_dssp CCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCC----HHHHTTSGGGGGGCSTTS
T ss_pred cccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCC----HHHHhcChhhhhcccccc
Confidence 01347899999999999999999999 999999999998765543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=416.74 Aligned_cols=257 Identities=34% Similarity=0.504 Sum_probs=211.0
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
.++|++.+.||+|+||.||+|++..+++.||||++.+.. ....+.+|+.+|+.++||||++++++|...+.+|||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 368999999999999999999999999999999997643 123567899999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEcc---CCcEEEEeccccccccCC
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRE---DGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~---~g~vkL~DFGlA~~~~~~ 371 (611)
|||++|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+. ++.+||+|||++......
T Consensus 127 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 127 LELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp ECCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred EEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 9999999999988765 56999999999999999999999999999999999999975 889999999998432100
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
...
T Consensus 205 -----------------------------------------------------------------------------~~~ 207 (349)
T 2w4o_A 205 -----------------------------------------------------------------------------VLM 207 (349)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred -----------------------------------------------------------------------------ccc
Confidence 001
Q ss_pred cccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHcCCCCCC--CCCCCCHHHHHHHH
Q 007260 452 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRA-TLFNVVGQPLRFP--ESPVVSFAARDLIR 528 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~-~l~~i~~~~l~~p--~~~~~s~~l~dLI~ 528 (611)
...+||+.|+|||++.+..++.++|||||||++|||++|+.||.+..... .+..+......++ ....++.++++||.
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 287 (349)
T 2w4o_A 208 KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVR 287 (349)
T ss_dssp -----CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHH
T ss_pred ccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHH
Confidence 23469999999999999999999999999999999999999998776655 4455666554443 33568999999999
Q ss_pred HhhhcCccccCCchhcHHHHHcCCCCCCCch
Q 007260 529 GLLVKEPQHRLAYKRGATEIKQHPFFEGVNW 559 (611)
Q Consensus 529 ~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 559 (611)
+||..||.+||+ +.++|+||||.+..+
T Consensus 288 ~~L~~dP~~Rpt----~~e~l~hp~~~~~~~ 314 (349)
T 2w4o_A 288 KLIVLDPKKRLT----TFQALQHPWVTGKAA 314 (349)
T ss_dssp TTSCSSGGGSCC----HHHHHHSTTTTSTTC
T ss_pred HHccCChhhCcC----HHHHhcCcccCCCcc
Confidence 999999999999 999999999986543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=420.69 Aligned_cols=274 Identities=42% Similarity=0.760 Sum_probs=222.6
Q ss_pred ccccCeEEEeEecccCcEEEEEEEEC---CCCeEEEEEEecchhhh-hHHHHHHHHHHHHHHHhC-CCCCcccccceeec
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELS---GTKCYFAMKVMDKASLA-GRKKLLRAQTEREILQSL-DHPFLPTLYTHFET 287 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~---~t~~~vAvKii~k~~~~-~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~ 287 (611)
+.+++|++++.||+|+||.||+|++. .+++.||||++.+.... .......+.+|+.+|+.+ +||||+++++++..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 44679999999999999999999984 57899999999764321 111122456799999999 79999999999999
Q ss_pred cceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccc
Q 007260 288 EKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLR 367 (611)
Q Consensus 288 ~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~ 367 (611)
+..+|||||||+|++|.+++... ..+++..++.++.||+.||+|||++|||||||||+||||+.++++||+|||++..
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred CceEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 99999999999999999998875 4699999999999999999999999999999999999999999999999999854
Q ss_pred ccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcc
Q 007260 368 CAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPT 447 (611)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (611)
+... .
T Consensus 209 ~~~~---------------------------------------------------------------------------~ 213 (355)
T 1vzo_A 209 FVAD---------------------------------------------------------------------------E 213 (355)
T ss_dssp CCGG---------------------------------------------------------------------------G
T ss_pred cccC---------------------------------------------------------------------------C
Confidence 3210 0
Q ss_pred cccccccccCCCccchhhhccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCC----cHHHHHHHHcCCCCCCCCCCCCH
Q 007260 448 EARSMSFVGTHEYLAPEIIKGE--GHGSAVDWWTFGIFLYELLFGKTPFKGSG----NRATLFNVVGQPLRFPESPVVSF 521 (611)
Q Consensus 448 ~~~~~~~vGT~~Y~APEil~~~--~~~~~sDIWSLGviL~ELltG~~PF~~~~----~~~~l~~i~~~~l~~p~~~~~s~ 521 (611)
......++||+.|+|||++.+. .++.++|||||||+||||++|+.||.... .......+......++. .++.
T Consensus 214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 291 (355)
T 1vzo_A 214 TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--EMSA 291 (355)
T ss_dssp GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT--TSCH
T ss_pred CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCc--ccCH
Confidence 1112245799999999999864 47899999999999999999999997543 22333444555444443 4899
Q ss_pred HHHHHHHHhhhcCccccCCch-hcHHHHHcCCCCCCCchhhhccC
Q 007260 522 AARDLIRGLLVKEPQHRLAYK-RGATEIKQHPFFEGVNWALIRCA 565 (611)
Q Consensus 522 ~l~dLI~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~~~ 565 (611)
.+++||.+||..||.+||+.. ..++++++||||+.++|..+...
T Consensus 292 ~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~~~ 336 (355)
T 1vzo_A 292 LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAK 336 (355)
T ss_dssp HHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTT
T ss_pred HHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHhhhc
Confidence 999999999999999999211 11999999999999999876543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=413.34 Aligned_cols=262 Identities=24% Similarity=0.374 Sum_probs=220.7
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccce----
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKF---- 290 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~---- 290 (611)
.++|++++.||+|+||.||+|++..+++.||||++............++.+|+.+++.++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 4689999999999999999999999999999999987665566667788999999999999999999999886543
Q ss_pred eeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccC
Q 007260 291 SCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAV 370 (611)
Q Consensus 291 ~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~ 370 (611)
.|||||||+|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+..
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 168 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred cEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence 49999999999999998875 4699999999999999999999999999999999999999999999999999844321
Q ss_pred CccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccc
Q 007260 371 SPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEAR 450 (611)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (611)
... ....
T Consensus 169 ~~~-------------------------------------------------------------------------~~~~ 175 (311)
T 3ork_A 169 SGN-------------------------------------------------------------------------SVTQ 175 (311)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccc-------------------------------------------------------------------------cccc
Confidence 100 0011
Q ss_pred ccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCC--CCCCCHHHHHHHH
Q 007260 451 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPE--SPVVSFAARDLIR 528 (611)
Q Consensus 451 ~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~--~~~~s~~l~dLI~ 528 (611)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+.......+. ...++.++.+||.
T Consensus 176 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 255 (311)
T 3ork_A 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVL 255 (311)
T ss_dssp ------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHH
T ss_pred ccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHH
Confidence 12356999999999999999999999999999999999999999998887777766665443321 2458999999999
Q ss_pred HhhhcCccccCCchhcHHHHHcCCCCC
Q 007260 529 GLLVKEPQHRLAYKRGATEIKQHPFFE 555 (611)
Q Consensus 529 ~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 555 (611)
+||..||.+||+ +.+++.|+|++
T Consensus 256 ~~l~~dP~~R~~----~~~~l~~~l~~ 278 (311)
T 3ork_A 256 KALAKNPENRYQ----TAAEMRADLVR 278 (311)
T ss_dssp HHTCSSGGGSCS----SHHHHHHHHHH
T ss_pred HHHhcCHhhChh----hHHHHHHHHHH
Confidence 999999999999 88999999985
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=401.54 Aligned_cols=258 Identities=29% Similarity=0.491 Sum_probs=228.9
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
.++|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+..|||
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 36899999999999999999999999999999999876555555566788899999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
|||++|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 94 ~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-- 169 (294)
T 2rku_A 94 LELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-- 169 (294)
T ss_dssp EECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc--
Confidence 9999999999988775 469999999999999999999999999999999999999999999999999984322000
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
......
T Consensus 170 --------------------------------------------------------------------------~~~~~~ 175 (294)
T 2rku_A 170 --------------------------------------------------------------------------ERKKVL 175 (294)
T ss_dssp --------------------------------------------------------------------------CCBCCC
T ss_pred --------------------------------------------------------------------------cccccc
Confidence 001124
Q ss_pred ccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcC
Q 007260 455 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKE 534 (611)
Q Consensus 455 vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~d 534 (611)
+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....+.+..+......++. .++..+.+||.+||..|
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~ 253 (294)
T 2rku_A 176 CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK--HINPVAASLIQKMLQTD 253 (294)
T ss_dssp CSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT--TSCHHHHHHHHHHTCSS
T ss_pred cCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCcc--ccCHHHHHHHHHHcccC
Confidence 6999999999999999999999999999999999999999998877777777777666554 48999999999999999
Q ss_pred ccccCCchhcHHHHHcCCCCCC
Q 007260 535 PQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 535 P~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
|.+||+ +.++++||||..
T Consensus 254 p~~Rps----~~~ll~~~~~~~ 271 (294)
T 2rku_A 254 PTARPT----INELLNDEFFTS 271 (294)
T ss_dssp GGGSCC----GGGGGGSHHHHT
T ss_pred hhhCcC----HHHHhhChheec
Confidence 999999 899999999975
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=438.68 Aligned_cols=261 Identities=32% Similarity=0.476 Sum_probs=228.8
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
.++|++++.||+|+||.||+|++..+++.||||++.+...........+.+|+.+|+.++|||||+++++|.+.+.+|||
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 36899999999999999999999999999999999765543333345678899999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEE---ccCCcEEEEeccccccccCC
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLV---REDGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv---~~~g~vkL~DFGlA~~~~~~ 371 (611)
||||.||+|.+++... ..+++..++.++.||+.||+|||++|||||||||+|||| +.++.+||+|||++..+...
T Consensus 105 ~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 105 GEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp ECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 9999999999988765 569999999999999999999999999999999999999 46789999999998543211
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
...
T Consensus 183 -----------------------------------------------------------------------------~~~ 185 (484)
T 3nyv_A 183 -----------------------------------------------------------------------------KKM 185 (484)
T ss_dssp -----------------------------------------------------------------------------CSH
T ss_pred -----------------------------------------------------------------------------ccc
Confidence 011
Q ss_pred cccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCC--CCCCCCHHHHHHHHH
Q 007260 452 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFP--ESPVVSFAARDLIRG 529 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p--~~~~~s~~l~dLI~~ 529 (611)
...+||+.|+|||++.+ .++.++|||||||++|+|++|++||.+....+.+..+......++ .+..++.++++||.+
T Consensus 186 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 264 (484)
T 3nyv_A 186 KDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRK 264 (484)
T ss_dssp HHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHH
T ss_pred ccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHH
Confidence 23469999999999987 689999999999999999999999999988888888887766554 445699999999999
Q ss_pred hhhcCccccCCchhcHHHHHcCCCCCCCch
Q 007260 530 LLVKEPQHRLAYKRGATEIKQHPFFEGVNW 559 (611)
Q Consensus 530 ~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 559 (611)
||.+||.+||+ +.|+|+||||+...+
T Consensus 265 ~L~~dp~~R~s----~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 265 MLTYVPSMRIS----ARDALDHEWIQTYTK 290 (484)
T ss_dssp HTCSSGGGSCC----HHHHHTSHHHHHHTC
T ss_pred HCCCChhHCcC----HHHHhhChhhccccc
Confidence 99999999999 999999999976543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-49 Score=421.63 Aligned_cols=260 Identities=28% Similarity=0.455 Sum_probs=220.7
Q ss_pred CeEE--EeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 217 HFRL--LKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 217 ~y~l--~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
.|++ .+.||+|+||.||+|++..+++.||||++...... ....+.+|+.+|+.++|||||+++++|...+.+|||
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 164 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK---DKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV 164 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccc---cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 4555 67899999999999999999999999999865432 334677899999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEE--ccCCcEEEEeccccccccCCc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLV--REDGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv--~~~g~vkL~DFGlA~~~~~~~ 372 (611)
||||+|++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||++..+....
T Consensus 165 ~E~~~~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp EECCTTCEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred EeCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence 9999999999988764 2459999999999999999999999999999999999999 456789999999985432100
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
...
T Consensus 244 -----------------------------------------------------------------------------~~~ 246 (373)
T 2x4f_A 244 -----------------------------------------------------------------------------KLK 246 (373)
T ss_dssp -----------------------------------------------------------------------------BCC
T ss_pred -----------------------------------------------------------------------------ccc
Confidence 011
Q ss_pred ccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCC--CCCCCHHHHHHHHHh
Q 007260 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPE--SPVVSFAARDLIRGL 530 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~--~~~~s~~l~dLI~~~ 530 (611)
..+||+.|+|||++.+..++.++|||||||+||||++|+.||.+......+.+++.....++. ...++.++++||.+|
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~ 326 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKL 326 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTT
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHH
Confidence 236999999999999999999999999999999999999999999888888888877665543 246899999999999
Q ss_pred hhcCccccCCchhcHHHHHcCCCCCCCchhh
Q 007260 531 LVKEPQHRLAYKRGATEIKQHPFFEGVNWAL 561 (611)
Q Consensus 531 L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~ 561 (611)
|..||.+||+ +.|+|+||||.+..|..
T Consensus 327 L~~dp~~Rps----~~e~l~hp~~~~~~~~~ 353 (373)
T 2x4f_A 327 LIKEKSWRIS----ASEALKHPWLSDHKLHS 353 (373)
T ss_dssp SCSSGGGSCC----HHHHHHSHHHHCHHHHH
T ss_pred cCCChhhCCC----HHHHhcCcCcCCCchhh
Confidence 9999999999 99999999999877643
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=397.70 Aligned_cols=266 Identities=30% Similarity=0.436 Sum_probs=226.2
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchh------hhhHHHHHHHHHHHHHHHhCC-CCCcccccceeec
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKAS------LAGRKKLLRAQTEREILQSLD-HPFLPTLYTHFET 287 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~------~~~~~~~~~~~~E~~iL~~l~-HpnIv~l~~~~~~ 287 (611)
.++|++++.||+|+||.||+|.+..+++.||||++.... .........+.+|+.+|+++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 469999999999999999999999999999999997543 112334456788999999995 9999999999999
Q ss_pred cceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccc
Q 007260 288 EKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLR 367 (611)
Q Consensus 288 ~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~ 367 (611)
.+..||||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 99999999999999999998875 4699999999999999999999999999999999999999999999999999843
Q ss_pred ccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcc
Q 007260 368 CAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPT 447 (611)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (611)
....
T Consensus 174 ~~~~---------------------------------------------------------------------------- 177 (298)
T 1phk_A 174 LDPG---------------------------------------------------------------------------- 177 (298)
T ss_dssp CCTT----------------------------------------------------------------------------
T ss_pred cCCC----------------------------------------------------------------------------
Confidence 3210
Q ss_pred cccccccccCCCccchhhhc------cCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCC--CCCC
Q 007260 448 EARSMSFVGTHEYLAPEIIK------GEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPE--SPVV 519 (611)
Q Consensus 448 ~~~~~~~vGT~~Y~APEil~------~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~--~~~~ 519 (611)
.......||+.|+|||++. ...++.++|||||||++|+|++|+.||.+......+..+......++. ...+
T Consensus 178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (298)
T 1phk_A 178 -EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDY 256 (298)
T ss_dssp -CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGS
T ss_pred -cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCccccccc
Confidence 0011246899999999986 456789999999999999999999999988877777777776655543 3468
Q ss_pred CHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCchhhhc
Q 007260 520 SFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIR 563 (611)
Q Consensus 520 s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~ 563 (611)
+..+++||.+||..||.+||+ +.++++||||++..|..++
T Consensus 257 ~~~l~~li~~~l~~dp~~Rps----~~~ll~h~~~~~~~~~~~~ 296 (298)
T 1phk_A 257 SDTVKDLVSRFLVVQPQKRYT----AEEALAHPFFQQYVVEEVR 296 (298)
T ss_dssp CHHHHHHHHHHCCSSGGGSCC----HHHHTTSGGGCTTC-----
T ss_pred CHHHHHHHHHHccCCcccCCC----HHHHHhChHhhhccchhhc
Confidence 999999999999999999999 9999999999988776543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=398.00 Aligned_cols=254 Identities=34% Similarity=0.546 Sum_probs=223.8
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
++|++.+.||+|+||.||+|.+..++..||+|++.+..... ..++.+|+++|+.++||||++++++|.+....|+||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 58999999999999999999999999999999997654333 345678999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEE---ccCCcEEEEeccccccccCCc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLV---REDGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv---~~~g~vkL~DFGlA~~~~~~~ 372 (611)
||++|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 86 e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~- 162 (277)
T 3f3z_A 86 ELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG- 162 (277)
T ss_dssp ECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT-
T ss_pred eccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc-
Confidence 999999999988775 559999999999999999999999999999999999999 77889999999998443210
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
....
T Consensus 163 ----------------------------------------------------------------------------~~~~ 166 (277)
T 3f3z_A 163 ----------------------------------------------------------------------------KMMR 166 (277)
T ss_dssp ----------------------------------------------------------------------------SCBC
T ss_pred ----------------------------------------------------------------------------cchh
Confidence 0011
Q ss_pred ccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCC--CCCCHHHHHHHHHh
Q 007260 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPES--PVVSFAARDLIRGL 530 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~--~~~s~~l~dLI~~~ 530 (611)
..+||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+....+.+..+......++.. ..++..+.+||.+|
T Consensus 167 ~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 245 (277)
T 3f3z_A 167 TKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRL 245 (277)
T ss_dssp CCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHH
T ss_pred ccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHHH
Confidence 24699999999999765 8999999999999999999999999988888888888777666542 35899999999999
Q ss_pred hhcCccccCCchhcHHHHHcCCCCCC
Q 007260 531 LVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 531 L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
|..||.+||+ +.++|+||||+.
T Consensus 246 l~~dp~~R~s----~~~~l~h~~~~~ 267 (277)
T 3f3z_A 246 LTKSPKQRIT----SLQALEHEWFEK 267 (277)
T ss_dssp TCSSTTTSCC----HHHHTTSHHHHH
T ss_pred ccCChhhCcC----HHHHhcCHHHhc
Confidence 9999999999 999999999974
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-49 Score=398.06 Aligned_cols=262 Identities=29% Similarity=0.468 Sum_probs=220.6
Q ss_pred CccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc
Q 007260 210 DGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK 289 (611)
Q Consensus 210 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~ 289 (611)
.+.+..++|++++.||+|+||.||+|++..+++.||||++............++.+|+.+|+.++||||+++++++...+
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 84 (276)
T 2h6d_A 5 DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT 84 (276)
T ss_dssp --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred cCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 45556789999999999999999999999999999999997765444444557788999999999999999999999999
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
..||||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred eEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 999999999999999998775 459999999999999999999999999999999999999999999999999984321
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
.. .
T Consensus 163 ~~-----------------------------------------------------------------------------~ 165 (276)
T 2h6d_A 163 DG-----------------------------------------------------------------------------E 165 (276)
T ss_dssp C-------------------------------------------------------------------------------
T ss_pred CC-----------------------------------------------------------------------------c
Confidence 00 0
Q ss_pred cccccccCCCccchhhhccCCC-CChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 007260 450 RSMSFVGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIR 528 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~~~~-~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~ 528 (611)
......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+......+..+......+|. .++..+.+||.
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~ 243 (276)
T 2h6d_A 166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPE--YLNRSVATLLM 243 (276)
T ss_dssp -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHH
T ss_pred ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCch--hcCHHHHHHHH
Confidence 0112358999999999998876 68999999999999999999999988777767666666555554 48999999999
Q ss_pred HhhhcCccccCCchhcHHHHHcCCCCCC
Q 007260 529 GLLVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 529 ~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
+||..||.+||+ +.++++||||+.
T Consensus 244 ~~l~~~p~~Rps----~~~~l~h~~~~~ 267 (276)
T 2h6d_A 244 HMLQVDPLKRAT----IKDIREHEWFKQ 267 (276)
T ss_dssp HHTCSSGGGSCC----HHHHHHSHHHHT
T ss_pred HHccCChhhCCC----HHHHHhChhhcc
Confidence 999999999999 999999999964
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=416.90 Aligned_cols=258 Identities=31% Similarity=0.444 Sum_probs=212.8
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecc------
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE------ 288 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~------ 288 (611)
.++|++++.||+|+||.||+|.+..+++.||||++.+.. .......++.+|+.+|+.++||||+++++++...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 368999999999999999999999999999999996543 3344556788999999999999999999999865
Q ss_pred ceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccc
Q 007260 289 KFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRC 368 (611)
Q Consensus 289 ~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~ 368 (611)
..+||||||+ |++|.+++... .+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++..
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 3469999999 89999998873 5999999999999999999999999999999999999999999999999998432
Q ss_pred cCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccc
Q 007260 369 AVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTE 448 (611)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (611)
..
T Consensus 179 ~~------------------------------------------------------------------------------ 180 (367)
T 1cm8_A 179 DS------------------------------------------------------------------------------ 180 (367)
T ss_dssp CS------------------------------------------------------------------------------
T ss_pred cc------------------------------------------------------------------------------
Confidence 10
Q ss_pred ccccccccCCCccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHc---CCC-------------
Q 007260 449 ARSMSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG---QPL------------- 511 (611)
Q Consensus 449 ~~~~~~vGT~~Y~APEil~~-~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~---~~l------------- 511 (611)
.....+||++|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+.+..++. .+.
T Consensus 181 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~ 259 (367)
T 1cm8_A 181 -EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 259 (367)
T ss_dssp -SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHH
T ss_pred -ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHH
Confidence 0123479999999999988 6789999999999999999999999999887776655432 110
Q ss_pred ------------CC-CCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCchh
Q 007260 512 ------------RF-PESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWA 560 (611)
Q Consensus 512 ------------~~-p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~ 560 (611)
.+ .....++..+.+||.+||..||.+||| +.++|+||||+.+.+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t----~~e~l~hp~f~~~~~~ 317 (367)
T 1cm8_A 260 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT----AGEALAHPYFESLHDT 317 (367)
T ss_dssp HHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCC----HHHHHHSGGGTTTC--
T ss_pred HHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCC----HHHHhcChHHHhhcCC
Confidence 00 012347899999999999999999999 9999999999876543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=422.27 Aligned_cols=258 Identities=28% Similarity=0.471 Sum_probs=211.8
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec------cc
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET------EK 289 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~------~~ 289 (611)
.+|++++.||+|+||+||+|++..+++.||||++.+... ...+|+++|+.++|||||+++++|.. ..
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 479999999999999999999999999999999865431 12369999999999999999999853 34
Q ss_pred eeeEEeeeCCCCCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccC-CcEEEEeccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQK--QPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRED-GHIMLSDFDLSL 366 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~--~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~-g~vkL~DFGlA~ 366 (611)
++||||||+++ +|..++.. .....+++..++.|+.||+.||+|||++|||||||||+||||+.+ +.+||+|||+++
T Consensus 127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 57899999965 66665542 224679999999999999999999999999999999999999965 578999999985
Q ss_pred cccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCc
Q 007260 367 RCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEP 446 (611)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (611)
.+...
T Consensus 206 ~~~~~--------------------------------------------------------------------------- 210 (420)
T 1j1b_A 206 QLVRG--------------------------------------------------------------------------- 210 (420)
T ss_dssp ECCTT---------------------------------------------------------------------------
T ss_pred hcccC---------------------------------------------------------------------------
Confidence 43210
Q ss_pred ccccccccccCCCccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHc---C-------------
Q 007260 447 TEARSMSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG---Q------------- 509 (611)
Q Consensus 447 ~~~~~~~~vGT~~Y~APEil~~~-~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~---~------------- 509 (611)
......+||+.|+|||++.+. .|+.++|||||||+||||++|++||.+.+..+.+.+++. .
T Consensus 211 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~ 288 (420)
T 1j1b_A 211 --EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 288 (420)
T ss_dssp --CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCC
T ss_pred --CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh
Confidence 011235799999999999875 689999999999999999999999999887777665543 1
Q ss_pred -CCCCCC----------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCchhhh
Q 007260 510 -PLRFPE----------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALI 562 (611)
Q Consensus 510 -~l~~p~----------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~ 562 (611)
.+.+|. ...++.++++||.+||.+||.+||+ +.|+++||||+++.+...
T Consensus 289 ~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t----~~e~l~hp~f~~~~~~~~ 348 (420)
T 1j1b_A 289 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT----PLEACAHSFFDELRDPNV 348 (420)
T ss_dssp CCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGGGGGCTTC
T ss_pred hhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCC----HHHHhCCHhhcccccccc
Confidence 122222 1347899999999999999999999 999999999988766543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-48 Score=402.34 Aligned_cols=255 Identities=26% Similarity=0.423 Sum_probs=210.0
Q ss_pred cccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC-CCCcccccceeec--cce
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD-HPFLPTLYTHFET--EKF 290 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~-HpnIv~l~~~~~~--~~~ 290 (611)
..++|++++.||+|+||+||+|++..+++.||||++.... ...+.+|+.+|+.+. ||||+++++++.+ ...
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 107 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence 3478999999999999999999999999999999997543 135678999999997 9999999999987 678
Q ss_pred eeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCC-cEEEEecccccccc
Q 007260 291 SCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDG-HIMLSDFDLSLRCA 369 (611)
Q Consensus 291 ~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g-~vkL~DFGlA~~~~ 369 (611)
.||||||+.+++|.+++.. +++..++.++.||+.||+|||++||+||||||+||||+.++ .+||+|||++..+.
T Consensus 108 ~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EEEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eEEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 8999999999999988753 89999999999999999999999999999999999999777 89999999984332
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
...
T Consensus 183 ~~~----------------------------------------------------------------------------- 185 (330)
T 3nsz_A 183 PGQ----------------------------------------------------------------------------- 185 (330)
T ss_dssp TTC-----------------------------------------------------------------------------
T ss_pred CCC-----------------------------------------------------------------------------
Confidence 100
Q ss_pred cccccccCCCccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHc-------------CCCC--
Q 007260 450 RSMSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSG-NRATLFNVVG-------------QPLR-- 512 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~-~~~~~~sDIWSLGviL~ELltG~~PF~~~~-~~~~l~~i~~-------------~~l~-- 512 (611)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... ..+.+..+.. ....
T Consensus 186 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 265 (330)
T 3nsz_A 186 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265 (330)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccc
Confidence 0112368999999999988 568999999999999999999999995433 3333322111 1110
Q ss_pred --------------------CCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCchh
Q 007260 513 --------------------FPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWA 560 (611)
Q Consensus 513 --------------------~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~ 560 (611)
......++.++++||.+||..||.+||| +.|+|+||||+++.|.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----a~e~l~hp~f~~~~~~ 329 (330)
T 3nsz_A 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT----AREAMEHPYFYTVVKD 329 (330)
T ss_dssp THHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCC----HHHHHTSGGGTTCC--
T ss_pred cchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCC----HHHHhcCccHhhhccC
Confidence 1111237999999999999999999999 9999999999988764
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=413.51 Aligned_cols=259 Identities=27% Similarity=0.389 Sum_probs=210.5
Q ss_pred cccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc----
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK---- 289 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~---- 289 (611)
..++|++++.||+|+||.||+|.+..+++.||||++.+.. .......++.+|+.+|+.++||||++++++|....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 3579999999999999999999999999999999997643 23345567789999999999999999999997654
Q ss_pred --eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccc
Q 007260 290 --FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLR 367 (611)
Q Consensus 290 --~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~ 367 (611)
.+|||||||+ ++|.+++.. .+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..
T Consensus 102 ~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 102 FQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp CCEEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred ccceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 7899999995 578887763 389999999999999999999999999999999999999999999999999843
Q ss_pred ccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcc
Q 007260 368 CAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPT 447 (611)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (611)
....
T Consensus 177 ~~~~---------------------------------------------------------------------------- 180 (371)
T 2xrw_A 177 AGTS---------------------------------------------------------------------------- 180 (371)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cccc----------------------------------------------------------------------------
Confidence 2100
Q ss_pred cccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCC--------------
Q 007260 448 EARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRF-------------- 513 (611)
Q Consensus 448 ~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~-------------- 513 (611)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+....+..++......
T Consensus 181 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 259 (371)
T 2xrw_A 181 -FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT 259 (371)
T ss_dssp ----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHH
T ss_pred -cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHH
Confidence 01123469999999999999999999999999999999999999999988877776665432110
Q ss_pred -----CCCC---------------------CCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCch
Q 007260 514 -----PESP---------------------VVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNW 559 (611)
Q Consensus 514 -----p~~~---------------------~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 559 (611)
+... ..+.++++||.+||..||.+||| +.|+|+||||+....
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t----~~e~l~hp~~~~~~~ 327 (371)
T 2xrw_A 260 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS----VDEALQHPYINVWYD 327 (371)
T ss_dssp HHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCC----HHHHHHSHHHHTTCC
T ss_pred HHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCC----HHHHhCCcchhhhcC
Confidence 0000 01568999999999999999999 999999999985433
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=414.22 Aligned_cols=272 Identities=26% Similarity=0.407 Sum_probs=226.2
Q ss_pred HHHhhccCccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCccccc
Q 007260 203 IQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLY 282 (611)
Q Consensus 203 ~~~~~~~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~ 282 (611)
+.......+.+..++|++++.||+|+||.||+|++..++..||+|++.... .......+.+|+.+|+.++||||++++
T Consensus 20 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~ 97 (360)
T 3eqc_A 20 FLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFY 97 (360)
T ss_dssp HHHHHHTCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEE
T ss_pred HhhhhhcccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEe
Confidence 333344556677789999999999999999999999999999999997643 233445678999999999999999999
Q ss_pred ceeeccceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CeeccCCCCCcEEEccCCcEEEEe
Q 007260 283 THFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHML-GIIYRDLKPENVLVREDGHIMLSD 361 (611)
Q Consensus 283 ~~~~~~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~-gIVHRDLKPeNILv~~~g~vkL~D 361 (611)
+++..++.+|||||||+|++|.+++... ..+++..++.++.||+.||+|||+. ||+||||||+||||+.++.+||+|
T Consensus 98 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~D 175 (360)
T 3eqc_A 98 GAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCD 175 (360)
T ss_dssp EEEEETTEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECC
T ss_pred EEEEECCEEEEEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEE
Confidence 9999999999999999999999999875 4599999999999999999999995 999999999999999999999999
Q ss_pred ccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcc
Q 007260 362 FDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPE 441 (611)
Q Consensus 362 FGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (611)
||++.....
T Consensus 176 fg~~~~~~~----------------------------------------------------------------------- 184 (360)
T 3eqc_A 176 FGVSGQLID----------------------------------------------------------------------- 184 (360)
T ss_dssp CCCCHHHHH-----------------------------------------------------------------------
T ss_pred CCCCccccc-----------------------------------------------------------------------
Confidence 999843210
Q ss_pred cccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH-----------------
Q 007260 442 LIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLF----------------- 504 (611)
Q Consensus 442 ~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~----------------- 504 (611)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||..........
T Consensus 185 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (360)
T 3eqc_A 185 -------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257 (360)
T ss_dssp -------HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------
T ss_pred -------ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCc
Confidence 01123469999999999999999999999999999999999999998765433211
Q ss_pred -------------------------HHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCch
Q 007260 505 -------------------------NVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNW 559 (611)
Q Consensus 505 -------------------------~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 559 (611)
.+............++.++++||.+||..||.+||+ +.|+|+||||+..+|
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~~~~~~~ 333 (360)
T 3eqc_A 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD----LKQLMVHAFIKRSDA 333 (360)
T ss_dssp ----------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCC----HHHHHTSHHHHHHHH
T ss_pred ccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCC----HHHHhhChHhhcchH
Confidence 112222222222347899999999999999999999 999999999987665
Q ss_pred h
Q 007260 560 A 560 (611)
Q Consensus 560 ~ 560 (611)
.
T Consensus 334 ~ 334 (360)
T 3eqc_A 334 E 334 (360)
T ss_dssp S
T ss_pred h
Confidence 4
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=433.17 Aligned_cols=260 Identities=32% Similarity=0.484 Sum_probs=220.7
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
++|++++.||+|+||+||+|++..++..||||++.+..... .....+.+|+.+|+.++|||||+++++|.+...+||||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999999999999999997654322 12345678999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEcc---CCcEEEEeccccccccCCc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRE---DGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~---~g~vkL~DFGlA~~~~~~~ 372 (611)
|||+||+|.+++... ..+++..++.++.||+.||+|||++|||||||||+||||+. ++.+||+|||++..+...
T Consensus 116 e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~- 192 (494)
T 3lij_A 116 ECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ- 192 (494)
T ss_dssp ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT-
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC-
Confidence 999999999988765 45999999999999999999999999999999999999976 456999999998443210
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
....
T Consensus 193 ----------------------------------------------------------------------------~~~~ 196 (494)
T 3lij_A 193 ----------------------------------------------------------------------------KKMK 196 (494)
T ss_dssp ----------------------------------------------------------------------------BCBC
T ss_pred ----------------------------------------------------------------------------cccc
Confidence 0112
Q ss_pred ccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCC--CCCCCHHHHHHHHHh
Q 007260 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPE--SPVVSFAARDLIRGL 530 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~--~~~~s~~l~dLI~~~ 530 (611)
..+||+.|+|||++.+ .|+.++|||||||++|+|++|++||.+....+.+..+......++. +..++..+++||.+|
T Consensus 197 ~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 275 (494)
T 3lij_A 197 ERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQM 275 (494)
T ss_dssp CCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHH
T ss_pred ccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHH
Confidence 3469999999999874 6899999999999999999999999999888888888877666543 456999999999999
Q ss_pred hhcCccccCCchhcHHHHHcCCCCCCCchh
Q 007260 531 LVKEPQHRLAYKRGATEIKQHPFFEGVNWA 560 (611)
Q Consensus 531 L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~ 560 (611)
|..||.+||+ +.++|+||||+...+.
T Consensus 276 L~~dp~~R~s----~~e~l~hp~~~~~~~~ 301 (494)
T 3lij_A 276 LQFDSQRRIS----AQQALEHPWIKEMCSK 301 (494)
T ss_dssp TCSSTTTSCC----HHHHHTCHHHHHHHHH
T ss_pred CCCChhhCcc----HHHHhcCcccccCccc
Confidence 9999999999 9999999999865443
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-49 Score=407.21 Aligned_cols=270 Identities=22% Similarity=0.360 Sum_probs=208.4
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc-----
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK----- 289 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~----- 289 (611)
+++|++++.||+|+||.||+|++..+++.||||++...... .....+.+|+.+|+.++|||||+++++|.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE--LAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTT--THHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 35899999999999999999999999999999999754322 23456788999999999999999999885432
Q ss_pred ----------------------------------------------------eeeEEeeeCCCCCHHHHHHhCCC-CCCC
Q 007260 290 ----------------------------------------------------FSCLVMEFCPGGDLHTLRQKQPG-KYFP 316 (611)
Q Consensus 290 ----------------------------------------------------~~~LVmE~~~gg~L~~ll~~~~~-~~l~ 316 (611)
++|||||||+|++|.+++..... ....
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 162 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence 38999999999999999987532 2346
Q ss_pred HHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCC
Q 007260 317 EQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPA 396 (611)
Q Consensus 317 e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (611)
+..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||++............
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~------------------- 223 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV------------------- 223 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC-------------------------
T ss_pred hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccc-------------------
Confidence 6678999999999999999999999999999999999999999999998654321110000
Q ss_pred CCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCccchhhhccCCCCChhh
Q 007260 397 CIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVD 476 (611)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sD 476 (611)
.............+||+.|+|||++.+..++.++|
T Consensus 224 ---------------------------------------------~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 258 (332)
T 3qd2_B 224 ---------------------------------------------LTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVD 258 (332)
T ss_dssp -----------------------------------------------------CCCSCC-CGGGSCHHHHHCCCCCTHHH
T ss_pred ---------------------------------------------cccccccccccccCCCcCccChHHhcCCCCcchhh
Confidence 00000011223457999999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCC
Q 007260 477 WWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 477 IWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
||||||++|||++|..|+.. ....+..+...... ......+..+++||.+||..||.+||+ +.|+++||||++
T Consensus 259 i~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~~l~~~~f~~ 331 (332)
T 3qd2_B 259 IFSLGLILFELLYSFSTQME--RVRIITDVRNLKFP-LLFTQKYPQEHMMVQDMLSPSPTERPE----ATDIIENAIFEN 331 (332)
T ss_dssp HHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCC-HHHHHHCHHHHHHHHHHHCSSGGGSCC----HHHHHHSTTCCC
T ss_pred HHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCC-cccccCChhHHHHHHHHccCCCCcCCC----HHHHhhchhhhc
Confidence 99999999999999877532 11222222222211 111236778899999999999999999 999999999986
Q ss_pred C
Q 007260 557 V 557 (611)
Q Consensus 557 ~ 557 (611)
+
T Consensus 332 ~ 332 (332)
T 3qd2_B 332 L 332 (332)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=400.25 Aligned_cols=263 Identities=27% Similarity=0.448 Sum_probs=221.0
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhh-HHHHHHHHHHHHHHHhCCCCCccccccee--ecccee
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAG-RKKLLRAQTEREILQSLDHPFLPTLYTHF--ETEKFS 291 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~-~~~~~~~~~E~~iL~~l~HpnIv~l~~~~--~~~~~~ 291 (611)
.++|++++.||+|+||.||+|.+..+++.||||++.+..... ......+.+|+.+|+.++||||+++++++ ......
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 368999999999999999999999999999999998754322 23345678899999999999999999998 456789
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCC
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~ 371 (611)
||||||++++ |.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9999999776 888887766678999999999999999999999999999999999999999999999999998433210
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
. .....
T Consensus 163 ~--------------------------------------------------------------------------~~~~~ 168 (305)
T 2wtk_C 163 A--------------------------------------------------------------------------ADDTC 168 (305)
T ss_dssp C--------------------------------------------------------------------------SSCEE
T ss_pred c--------------------------------------------------------------------------ccccc
Confidence 0 00011
Q ss_pred cccccCCCccchhhhccCCC--CChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHH
Q 007260 452 MSFVGTHEYLAPEIIKGEGH--GSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRG 529 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~~~~--~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~ 529 (611)
....||+.|+|||++.+... +.++|||||||++|||++|+.||.+......+..+......++. .++..+.+||.+
T Consensus 169 ~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~--~~~~~l~~li~~ 246 (305)
T 2wtk_C 169 RTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPG--DCGPPLSDLLKG 246 (305)
T ss_dssp CCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCS--SSCHHHHHHHHH
T ss_pred ccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCC--ccCHHHHHHHHH
Confidence 23459999999999987554 78999999999999999999999988777777777766655554 489999999999
Q ss_pred hhhcCccccCCchhcHHHHHcCCCCCCCc
Q 007260 530 LLVKEPQHRLAYKRGATEIKQHPFFEGVN 558 (611)
Q Consensus 530 ~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 558 (611)
||..||.+||+ +.++++||||+...
T Consensus 247 ~l~~dp~~Rps----~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 247 MLEYEPAKRFS----IRQIRQHSWFRKKH 271 (305)
T ss_dssp HTCSSTTTSCC----HHHHHHSHHHHSCC
T ss_pred HccCChhhCCC----HHHHhcCcccccCC
Confidence 99999999999 99999999997643
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-48 Score=398.06 Aligned_cols=251 Identities=22% Similarity=0.357 Sum_probs=214.8
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSC 292 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~ 292 (611)
+..++|++++.||+|+||.||+|++..++..||||++............++.+|+.+++.++||||+++++++..++.+|
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 87 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY 87 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence 34579999999999999999999999999999999997655555566778899999999999999999999999999999
Q ss_pred EEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCc
Q 007260 293 LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 293 LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~ 372 (611)
|||||++|++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||++......
T Consensus 88 lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 164 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET- 164 (294)
T ss_dssp EEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc-
Confidence 999999999999999875 46999999999999999999999999999999999999999999999999998432100
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
......
T Consensus 165 --------------------------------------------------------------------------~~~~~~ 170 (294)
T 4eqm_A 165 --------------------------------------------------------------------------SLTQTN 170 (294)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------cccccC
Confidence 001112
Q ss_pred ccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCC---CCCCCCHHHHHHHHH
Q 007260 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFP---ESPVVSFAARDLIRG 529 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p---~~~~~s~~l~dLI~~ 529 (611)
..+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+........+.+....... ....++..+.++|.+
T Consensus 171 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 250 (294)
T 4eqm_A 171 HVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILR 250 (294)
T ss_dssp ----CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHH
T ss_pred ccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHH
Confidence 35699999999999999999999999999999999999999999888777766666543321 234589999999999
Q ss_pred hhhcCccccCC
Q 007260 530 LLVKEPQHRLA 540 (611)
Q Consensus 530 ~L~~dP~~Rpt 540 (611)
||.+||.+||+
T Consensus 251 ~l~~dp~~R~~ 261 (294)
T 4eqm_A 251 ATEKDKANRYK 261 (294)
T ss_dssp HSCSSGGGSCS
T ss_pred HhcCCHhHccc
Confidence 99999999996
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=405.02 Aligned_cols=267 Identities=30% Similarity=0.449 Sum_probs=213.2
Q ss_pred cCeEEE-eEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeeccceeeE
Q 007260 216 SHFRLL-KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEKFSCL 293 (611)
Q Consensus 216 ~~y~l~-~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~~~~~L 293 (611)
++|++. +.||+|+||.||+|++..+++.||||++.+..... ..++.+|+.+|.++ +||||++++++|.+++.+||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l 88 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI---RSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL 88 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCC---HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchh---HHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 579985 78999999999999999999999999997653222 23567899999885 79999999999999999999
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCc---EEEEeccccccccC
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGH---IMLSDFDLSLRCAV 370 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~---vkL~DFGlA~~~~~ 370 (611)
|||||+|++|.+++... ..+++..++.++.||+.||+|||++|||||||||+|||++.++. +||+|||++.....
T Consensus 89 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp EEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred EEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 99999999999998875 46999999999999999999999999999999999999998775 99999999843321
Q ss_pred CccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccc
Q 007260 371 SPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEAR 450 (611)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (611)
..... ......
T Consensus 167 ~~~~~---------------------------------------------------------------------~~~~~~ 177 (316)
T 2ac3_A 167 NGDCS---------------------------------------------------------------------PISTPE 177 (316)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred CCccc---------------------------------------------------------------------cccccc
Confidence 10000 000011
Q ss_pred ccccccCCCccchhhhcc-----CCCCChhhHHHHHHHHHHHHhCCCCCCCCCc---------------HHHHHHHHcCC
Q 007260 451 SMSFVGTHEYLAPEIIKG-----EGHGSAVDWWTFGIFLYELLFGKTPFKGSGN---------------RATLFNVVGQP 510 (611)
Q Consensus 451 ~~~~vGT~~Y~APEil~~-----~~~~~~sDIWSLGviL~ELltG~~PF~~~~~---------------~~~l~~i~~~~ 510 (611)
....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+... ...+..+....
T Consensus 178 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 257 (316)
T 2ac3_A 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGK 257 (316)
T ss_dssp ----CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCC
T ss_pred cccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccC
Confidence 123469999999999986 4578999999999999999999999987542 22344555565
Q ss_pred CCCCCC--CCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCchh
Q 007260 511 LRFPES--PVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWA 560 (611)
Q Consensus 511 l~~p~~--~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~ 560 (611)
..++.. ..++.++++||.+||..||.+||+ +.|+|+||||++..|.
T Consensus 258 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps----~~e~l~hp~~~~~~~~ 305 (316)
T 2ac3_A 258 YEFPDKDWAHISCAAKDLISKLLVRDAKQRLS----AAQVLQHPWVQGCAPE 305 (316)
T ss_dssp CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCC----HHHHHHSTTCC-----
T ss_pred cccCchhcccCCHHHHHHHHHHhhCChhhCCC----HHHHhcChhhcCCCCc
Confidence 555532 458999999999999999999999 9999999999876543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-48 Score=403.64 Aligned_cols=255 Identities=28% Similarity=0.447 Sum_probs=220.9
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVME 296 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE 296 (611)
.|...+.||+|+||.||+|++..+++.||||++....... ...+.+|+.+|+.++||||+++++++...+..|||||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS---HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 4888899999999999999999999999999997654332 2356789999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccc
Q 007260 297 FCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIK 376 (611)
Q Consensus 297 ~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~ 376 (611)
|++|++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++......
T Consensus 123 ~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~----- 194 (321)
T 2c30_A 123 FLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD----- 194 (321)
T ss_dssp CCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS-----
T ss_pred cCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccC-----
Confidence 9999999998875 35999999999999999999999999999999999999999999999999998433210
Q ss_pred cccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccccc
Q 007260 377 ASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVG 456 (611)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vG 456 (611)
.......+|
T Consensus 195 -----------------------------------------------------------------------~~~~~~~~g 203 (321)
T 2c30_A 195 -----------------------------------------------------------------------VPKRKSLVG 203 (321)
T ss_dssp -----------------------------------------------------------------------SCCBCCCCS
T ss_pred -----------------------------------------------------------------------ccccccccC
Confidence 001123469
Q ss_pred CCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCC-CCCCCCCCCHHHHHHHHHhhhcCc
Q 007260 457 THEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPL-RFPESPVVSFAARDLIRGLLVKEP 535 (611)
Q Consensus 457 T~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l-~~p~~~~~s~~l~dLI~~~L~~dP 535 (611)
|+.|+|||++.+..++.++|||||||++|||++|+.||.+......+..+..... .+.....++..+++||.+||..||
T Consensus 204 t~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 283 (321)
T 2c30_A 204 TPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDP 283 (321)
T ss_dssp CGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSST
T ss_pred CccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccCCh
Confidence 9999999999999999999999999999999999999998877777666655433 233344589999999999999999
Q ss_pred cccCCchhcHHHHHcCCCCCCC
Q 007260 536 QHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 536 ~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
.+||+ +.++++||||...
T Consensus 284 ~~Rps----~~ell~hp~~~~~ 301 (321)
T 2c30_A 284 QERAT----AQELLDHPFLLQT 301 (321)
T ss_dssp TTSCC----HHHHHTSGGGGGC
T ss_pred hhCcC----HHHHhcChhhccC
Confidence 99999 9999999999753
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=410.06 Aligned_cols=255 Identities=29% Similarity=0.378 Sum_probs=223.4
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
..|++++.||+|+||+||+|++..+++.||||++.............+.+|+++|+.++||||+++++++..++..||||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 46999999999999999999999999999999997655445556667889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
|||. |+|.+++... ...+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||++....
T Consensus 134 e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~------ 205 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------ 205 (348)
T ss_dssp ECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS------
T ss_pred ecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecC------
Confidence 9996 6888877643 2569999999999999999999999999999999999999999999999999983221
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
....++
T Consensus 206 --------------------------------------------------------------------------~~~~~~ 211 (348)
T 1u5q_A 206 --------------------------------------------------------------------------PANSFV 211 (348)
T ss_dssp --------------------------------------------------------------------------SBCCCC
T ss_pred --------------------------------------------------------------------------CCCccc
Confidence 001346
Q ss_pred cCCCccchhhhc---cCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007260 456 GTHEYLAPEIIK---GEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLV 532 (611)
Q Consensus 456 GT~~Y~APEil~---~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~ 532 (611)
||+.|+|||++. +..++.++|||||||++|||++|+.||.+......+..+............++..+++||.+||.
T Consensus 212 gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 291 (348)
T 1u5q_A 212 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQ 291 (348)
T ss_dssp SCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTC
T ss_pred CCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcc
Confidence 999999999996 45689999999999999999999999999888777777776654444445689999999999999
Q ss_pred cCccccCCchhcHHHHHcCCCCCC
Q 007260 533 KEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 533 ~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
.||.+||+ +.++++||||..
T Consensus 292 ~dP~~Rps----~~~ll~h~~~~~ 311 (348)
T 1u5q_A 292 KIPQDRPT----SEVLLKHRFVLR 311 (348)
T ss_dssp SSGGGSCC----HHHHTTCHHHHS
T ss_pred cChhhCcC----HHHHhhChhhhc
Confidence 99999999 999999999964
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-49 Score=410.75 Aligned_cols=254 Identities=28% Similarity=0.463 Sum_probs=198.4
Q ss_pred cCeEEE---eEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC-CCCcccccceeecccee
Q 007260 216 SHFRLL---KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD-HPFLPTLYTHFETEKFS 291 (611)
Q Consensus 216 ~~y~l~---~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~-HpnIv~l~~~~~~~~~~ 291 (611)
.+|.+. +.||+|+||+||+|.+..+++.||||++.+.. ...+.+|+.+|+.+. ||||++++++|.++...
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~ 81 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEGHPNIVKLHEVFHDQLHT 81 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEE
Confidence 367765 78999999999999999999999999997643 124567999999997 99999999999999999
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCC---cEEEEeccccccc
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDG---HIMLSDFDLSLRC 368 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g---~vkL~DFGlA~~~ 368 (611)
|||||||+||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 82 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 82 FLVMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp EEEECCCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EEEEEccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 9999999999999999875 5699999999999999999999999999999999999998766 8999999998432
Q ss_pred cCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccc
Q 007260 369 AVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTE 448 (611)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (611)
... .
T Consensus 160 ~~~----------------------------------------------------------------------------~ 163 (325)
T 3kn6_A 160 PPD----------------------------------------------------------------------------N 163 (325)
T ss_dssp CC------------------------------------------------------------------------------
T ss_pred CCC----------------------------------------------------------------------------C
Confidence 210 0
Q ss_pred ccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCc-------HHHHHHHHcCCCCCCCC--CCC
Q 007260 449 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGN-------RATLFNVVGQPLRFPES--PVV 519 (611)
Q Consensus 449 ~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~-------~~~l~~i~~~~l~~p~~--~~~ 519 (611)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+... .+.+..+......++.. ..+
T Consensus 164 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (325)
T 3kn6_A 164 QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNV 243 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTS
T ss_pred CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCC
Confidence 011234689999999999999999999999999999999999999986432 34455555555544432 358
Q ss_pred CHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 520 SFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 520 s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
+.++++||.+||..||.+||+ +.++++||||++.
T Consensus 244 s~~~~~li~~~L~~dP~~Rpt----~~ell~h~w~~~~ 277 (325)
T 3kn6_A 244 SQEAKDLIQGLLTVDPNKRLK----MSGLRYNEWLQDG 277 (325)
T ss_dssp CHHHHHHHHHHHCCCTTTCCC----TTTSTTCGGGCTT
T ss_pred CHHHHHHHHHHCCCChhHCCC----HHHHhcChhhccC
Confidence 999999999999999999999 8999999999853
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=411.66 Aligned_cols=264 Identities=28% Similarity=0.405 Sum_probs=213.4
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhh--HHHHHHHHHHHHHHHhCCCCCcccccceeeccceee
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAG--RKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSC 292 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~--~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~ 292 (611)
.++|++++.||+|+||.||+|++..+++.||||++....... ......+.+|+.+|+.++||||++++++|.+.+..|
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 468999999999999999999999999999999997543221 112235678999999999999999999999999999
Q ss_pred EEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCc
Q 007260 293 LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 293 LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~ 372 (611)
|||||+++ +|..++... ...+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||++......
T Consensus 89 lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~- 165 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP- 165 (346)
T ss_dssp EEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC-
T ss_pred EEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC-
Confidence 99999965 888887764 356899999999999999999999999999999999999999999999999998432200
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
.....
T Consensus 166 ---------------------------------------------------------------------------~~~~~ 170 (346)
T 1ua2_A 166 ---------------------------------------------------------------------------NRAYT 170 (346)
T ss_dssp ---------------------------------------------------------------------------CCCCC
T ss_pred ---------------------------------------------------------------------------cccCC
Confidence 00112
Q ss_pred ccccCCCccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcC---CC--CCCC-----------
Q 007260 453 SFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ---PL--RFPE----------- 515 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~-~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~---~l--~~p~----------- 515 (611)
..+||+.|+|||++.+. .++.++|||||||++|||++|.+||.+....+.+.++... +. .++.
T Consensus 171 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (346)
T 1ua2_A 171 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 250 (346)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred cccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCccccccc
Confidence 34699999999999765 4799999999999999999999999998887777666532 11 1110
Q ss_pred ----------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCchh
Q 007260 516 ----------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWA 560 (611)
Q Consensus 516 ----------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~ 560 (611)
...++.++++||.+||..||.+||+ +.|+|+||||....|.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~h~~f~~~~~~ 301 (346)
T 1ua2_A 251 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT----ATQALKMKYFSNRPGP 301 (346)
T ss_dssp CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCC----HHHHHTSGGGTSSSCC
T ss_pred ccCCCChHHhhccCCHHHHHHHHHHhccChhhCCC----HHHHhcChhhhcCCCC
Confidence 1346789999999999999999999 9999999999876543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-49 Score=433.38 Aligned_cols=257 Identities=33% Similarity=0.511 Sum_probs=223.3
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
++|++++.||+|+||+||+|++..+++.||||++.+..... .....+.+|+++|+.++|||||++++++.+...+||||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 58999999999999999999999999999999997654322 22346678999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEc---cCCcEEEEeccccccccCCc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVR---EDGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~---~~g~vkL~DFGlA~~~~~~~ 372 (611)
|||.|++|.+++... ..+++..++.++.||+.||.|||++|||||||||+||||+ .++.+||+|||++..+...
T Consensus 101 e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~- 177 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN- 177 (486)
T ss_dssp CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred EcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC-
Confidence 999999999988765 4699999999999999999999999999999999999995 4568999999998432110
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
....
T Consensus 178 ----------------------------------------------------------------------------~~~~ 181 (486)
T 3mwu_A 178 ----------------------------------------------------------------------------TKMK 181 (486)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ----------------------------------------------------------------------------CccC
Confidence 0112
Q ss_pred ccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCC--CCCCCCCHHHHHHHHHh
Q 007260 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRF--PESPVVSFAARDLIRGL 530 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~--p~~~~~s~~l~dLI~~~ 530 (611)
..+||+.|+|||++.+ .|+.++|||||||++|+|++|++||.+....+.+..+......+ +.+..++.++++||.+|
T Consensus 182 ~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 260 (486)
T 3mwu_A 182 DRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKM 260 (486)
T ss_dssp CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHH
T ss_pred CCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHH
Confidence 3469999999999987 48999999999999999999999999998888888887776554 44456899999999999
Q ss_pred hhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 531 LVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 531 L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
|..||.+||+ +.++|+||||+..
T Consensus 261 L~~dp~~R~t----~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 261 LTFHPSLRIT----ATQCLEHPWIQKY 283 (486)
T ss_dssp TCSSTTTSCC----HHHHHHCHHHHHT
T ss_pred cCCChhhCcC----HHHHhcCHhhccC
Confidence 9999999999 9999999999754
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=398.13 Aligned_cols=263 Identities=29% Similarity=0.490 Sum_probs=225.6
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhH---HHHHHHHHHHHHHHhCCCCCcccccceeeccceee
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGR---KKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSC 292 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~---~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~ 292 (611)
++|++++.||+|+||.||+|++..+++.||+|++.+...... .....+.+|+.+|+.++||||+++++++.+....|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 579999999999999999999999999999999976543211 12345678999999999999999999999999999
Q ss_pred EEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCC----cEEEEeccccccc
Q 007260 293 LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDG----HIMLSDFDLSLRC 368 (611)
Q Consensus 293 LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g----~vkL~DFGlA~~~ 368 (611)
+||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 85 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 999999999999998764 4699999999999999999999999999999999999999877 8999999998432
Q ss_pred cCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccc
Q 007260 369 AVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTE 448 (611)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (611)
...
T Consensus 163 ~~~----------------------------------------------------------------------------- 165 (283)
T 3bhy_A 163 EAG----------------------------------------------------------------------------- 165 (283)
T ss_dssp C-------------------------------------------------------------------------------
T ss_pred cCC-----------------------------------------------------------------------------
Confidence 210
Q ss_pred ccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCC--CCCCCHHHHHH
Q 007260 449 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPE--SPVVSFAARDL 526 (611)
Q Consensus 449 ~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~--~~~~s~~l~dL 526 (611)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+......+..+......++. ...++..+.+|
T Consensus 166 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 245 (283)
T 3bhy_A 166 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDF 245 (283)
T ss_dssp ------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHH
T ss_pred CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHHH
Confidence 0011245999999999999999999999999999999999999999998887777777666554432 24589999999
Q ss_pred HHHhhhcCccccCCchhcHHHHHcCCCCCCCchhh
Q 007260 527 IRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWAL 561 (611)
Q Consensus 527 I~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~ 561 (611)
|.+||..||.+||+ +.++++||||+.+.|..
T Consensus 246 i~~~l~~dp~~Rps----~~~~l~h~~~~~~~~~~ 276 (283)
T 3bhy_A 246 IRRLLVKDPKRRMT----IAQSLEHSWIKAIRRRN 276 (283)
T ss_dssp HHTTSCSSGGGSCC----HHHHHHCHHHHHHHHCC
T ss_pred HHHHccCCHhHCcC----HHHHHhCHHHHHHHHHh
Confidence 99999999999999 99999999999876654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=431.47 Aligned_cols=259 Identities=29% Similarity=0.438 Sum_probs=222.0
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhH----------HHHHHHHHHHHHHHhCCCCCcccccce
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGR----------KKLLRAQTEREILQSLDHPFLPTLYTH 284 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~----------~~~~~~~~E~~iL~~l~HpnIv~l~~~ 284 (611)
.++|++++.||+|+||+||+|++..++..||||++.+...... .....+.+|+.+|+.++|||||+++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 3689999999999999999999999999999999986543321 224567889999999999999999999
Q ss_pred eeccceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCC---cEEEEe
Q 007260 285 FETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDG---HIMLSD 361 (611)
Q Consensus 285 ~~~~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g---~vkL~D 361 (611)
|.+...+|||||||+||+|.+++... ..+++..++.++.||+.||+|||++|||||||||+||||+.++ .+||+|
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 99999999999999999999988765 4699999999999999999999999999999999999999776 699999
Q ss_pred ccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcc
Q 007260 362 FDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPE 441 (611)
Q Consensus 362 FGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (611)
||++..+...
T Consensus 193 fg~a~~~~~~---------------------------------------------------------------------- 202 (504)
T 3q5i_A 193 FGLSSFFSKD---------------------------------------------------------------------- 202 (504)
T ss_dssp CTTCEECCTT----------------------------------------------------------------------
T ss_pred CCCCEEcCCC----------------------------------------------------------------------
Confidence 9998433210
Q ss_pred cccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCC--CCCC
Q 007260 442 LIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPE--SPVV 519 (611)
Q Consensus 442 ~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~--~~~~ 519 (611)
......+||+.|+|||++.+ .++.++|||||||++|+|++|++||.+....+.+..+......++. +..+
T Consensus 203 -------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 274 (504)
T 3q5i_A 203 -------YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNI 274 (504)
T ss_dssp -------SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTS
T ss_pred -------CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCCC
Confidence 01123469999999999874 5899999999999999999999999999888888888877765542 3568
Q ss_pred CHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 520 SFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 520 s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
+.++++||.+||.+||.+||+ +.|+|+||||+..
T Consensus 275 s~~~~~li~~~L~~dp~~R~t----~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 275 SDEAKELIKLMLTYDYNKRCT----AEEALNSRWIKKY 308 (504)
T ss_dssp CHHHHHHHHHHTCSSTTTSCC----HHHHHTSHHHHHT
T ss_pred CHHHHHHHHHHcCCChhHCCC----HHHHhcCHhhhhc
Confidence 999999999999999999999 9999999999753
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=396.97 Aligned_cols=257 Identities=29% Similarity=0.464 Sum_probs=216.0
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
++|++.+.||+|+||.||+|++..++..||+|++.+.... .....+.+|+++|+.++||||+++++++.+....|+||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ--VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc--hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 5899999999999999999999999999999999765422 12346678999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEc---cCCcEEEEeccccccccC
Q 007260 296 EFCPGGDLHTLRQKQ--PGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVR---EDGHIMLSDFDLSLRCAV 370 (611)
Q Consensus 296 E~~~gg~L~~ll~~~--~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~---~~g~vkL~DFGlA~~~~~ 370 (611)
||++|++|.+++... .+..+++..++.++.||+.||+|||++||+||||||+||||+ .++.+||+|||++..+..
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 179 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence 999999999887542 235699999999999999999999999999999999999994 567899999999843210
Q ss_pred CccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccc
Q 007260 371 SPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEAR 450 (611)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (611)
. ..
T Consensus 180 ~-----------------------------------------------------------------------------~~ 182 (285)
T 3is5_A 180 D-----------------------------------------------------------------------------EH 182 (285)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred c-----------------------------------------------------------------------------cc
Confidence 0 00
Q ss_pred ccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCC-CCCCCHHHHHHHHH
Q 007260 451 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPE-SPVVSFAARDLIRG 529 (611)
Q Consensus 451 ~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~-~~~~s~~l~dLI~~ 529 (611)
....+||+.|+|||++. ..++.++|||||||++|||++|+.||.+.........+......++. ...+++++.+||.+
T Consensus 183 ~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 261 (285)
T 3is5_A 183 STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQ 261 (285)
T ss_dssp ----CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHHHHHH
T ss_pred CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHHHHHHH
Confidence 12346999999999986 46889999999999999999999999988777666665554443332 23489999999999
Q ss_pred hhhcCccccCCchhcHHHHHcCCCCCC
Q 007260 530 LLVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 530 ~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
||..||.+||+ +.|+|+||||+.
T Consensus 262 ~L~~dP~~Rps----~~e~l~hp~f~~ 284 (285)
T 3is5_A 262 MLTKDPERRPS----AAQVLHHEWFKQ 284 (285)
T ss_dssp HTCSCTTTSCC----HHHHHTSGGGGC
T ss_pred HccCChhhCcC----HHHHhcCHHhhc
Confidence 99999999999 999999999975
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=403.26 Aligned_cols=253 Identities=25% Similarity=0.347 Sum_probs=206.6
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHh-CCCCCcccccceeeccceeeEE
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQS-LDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~-l~HpnIv~l~~~~~~~~~~~LV 294 (611)
++|+++++||+|+||+||+|++..+++.||||++......... ..+...|+..+.. ++||||++++++|.+++.+|||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKD-RARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHH-HHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 5899999999999999999999999999999998654333322 3334445555544 4999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
|||| +++|.+++... +..+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||++......
T Consensus 136 ~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~--- 210 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA--- 210 (311)
T ss_dssp EECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred Eecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC---
Confidence 9999 77998887765 356999999999999999999999999999999999999999999999999998433210
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
......
T Consensus 211 --------------------------------------------------------------------------~~~~~~ 216 (311)
T 3p1a_A 211 --------------------------------------------------------------------------GAGEVQ 216 (311)
T ss_dssp ------------------------------------------------------------------------------CC
T ss_pred --------------------------------------------------------------------------CCCccc
Confidence 001123
Q ss_pred ccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcC
Q 007260 455 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKE 534 (611)
Q Consensus 455 vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~d 534 (611)
.||+.|+|||++.+ .++.++|||||||++|||++|..||.+.. ....+............++.++.+||.+||..|
T Consensus 217 ~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 292 (311)
T 3p1a_A 217 EGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---GWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPD 292 (311)
T ss_dssp CCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTTCCCHHHHTTSCHHHHHHHHHHSCSS
T ss_pred CCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhccCCCcccccCCCHHHHHHHHHHcCCC
Confidence 59999999999987 68999999999999999999987776532 233333333222223458999999999999999
Q ss_pred ccccCCchhcHHHHHcCCCCCC
Q 007260 535 PQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 535 P~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
|.+||+ +.|||+||||+.
T Consensus 293 P~~Rpt----~~ell~hp~~~~ 310 (311)
T 3p1a_A 293 PKLRAT----AEALLALPVLRQ 310 (311)
T ss_dssp TTTSCC----HHHHHTSGGGSC
T ss_pred hhhCcC----HHHHHhCccccC
Confidence 999999 999999999974
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=402.29 Aligned_cols=262 Identities=29% Similarity=0.418 Sum_probs=220.7
Q ss_pred cccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeec-----
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFET----- 287 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~----- 287 (611)
..++|++++.||.|+||.||+|++..+++.||||++....... ..+.+|+.+|+.+ +||||+++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE----EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTT----HHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccH----HHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence 4579999999999999999999999999999999997543222 3567799999998 89999999999976
Q ss_pred -cceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccc
Q 007260 288 -EKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSL 366 (611)
Q Consensus 288 -~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~ 366 (611)
...+||||||+++++|.+++....+..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++.
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 177 (326)
T 2x7f_A 98 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 177 (326)
T ss_dssp CCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC
T ss_pred ccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCce
Confidence 5689999999999999999987655679999999999999999999999999999999999999999999999999984
Q ss_pred cccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCc
Q 007260 367 RCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEP 446 (611)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (611)
.....
T Consensus 178 ~~~~~--------------------------------------------------------------------------- 182 (326)
T 2x7f_A 178 QLDRT--------------------------------------------------------------------------- 182 (326)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ecCcC---------------------------------------------------------------------------
Confidence 32100
Q ss_pred ccccccccccCCCccchhhhc-----cCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCH
Q 007260 447 TEARSMSFVGTHEYLAPEIIK-----GEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSF 521 (611)
Q Consensus 447 ~~~~~~~~vGT~~Y~APEil~-----~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~ 521 (611)
.......+||+.|+|||++. +..++.++|||||||++|+|++|+.||.+......+..+............++.
T Consensus 183 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (326)
T 2x7f_A 183 -VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSK 261 (326)
T ss_dssp ---------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCSCSCH
T ss_pred -ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCccccCH
Confidence 00112346999999999997 556899999999999999999999999988877777776666554444556899
Q ss_pred HHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCch
Q 007260 522 AARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNW 559 (611)
Q Consensus 522 ~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 559 (611)
.+++||.+||..||.+||+ +.++++||||+...+
T Consensus 262 ~l~~li~~~l~~dp~~Rps----~~~ll~hp~~~~~~~ 295 (326)
T 2x7f_A 262 KFQSFIESCLVKNHSQRPA----TEQLMKHPFIRDQPN 295 (326)
T ss_dssp HHHHHHHHHCCSSGGGSCC----HHHHHTSHHHHCCTT
T ss_pred HHHHHHHHHhccChhhCCC----HHHHhhChHHhhCcc
Confidence 9999999999999999999 999999999987654
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-48 Score=411.03 Aligned_cols=257 Identities=32% Similarity=0.486 Sum_probs=222.7
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchh-----hhhHHHHHHHHHHHHHHHhC-CCCCcccccceeeccc
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKAS-----LAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEK 289 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~-----~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~~ 289 (611)
++|++.+.||.|+||.||+|++..+++.||||++.... .........+.+|+.+|+.+ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 57999999999999999999999999999999987543 11233345678899999999 8999999999999999
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
..||||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+.
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 999999999999999998864 469999999999999999999999999999999999999999999999999984432
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
.. .
T Consensus 252 ~~-----------------------------------------------------------------------------~ 254 (365)
T 2y7j_A 252 PG-----------------------------------------------------------------------------E 254 (365)
T ss_dssp TT-----------------------------------------------------------------------------C
T ss_pred CC-----------------------------------------------------------------------------c
Confidence 10 0
Q ss_pred cccccccCCCccchhhhccC------CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCC--CCCCCCH
Q 007260 450 RSMSFVGTHEYLAPEIIKGE------GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFP--ESPVVSF 521 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~~------~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p--~~~~~s~ 521 (611)
.....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+......+..+......++ .+..++.
T Consensus 255 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 334 (365)
T 2y7j_A 255 KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSS 334 (365)
T ss_dssp CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSCH
T ss_pred ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCH
Confidence 11234699999999999743 578899999999999999999999998887777777776665543 2346899
Q ss_pred HHHHHHHHhhhcCccccCCchhcHHHHHcCCCCC
Q 007260 522 AARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFE 555 (611)
Q Consensus 522 ~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 555 (611)
.+.+||.+||..||.+||+ +.++|+||||+
T Consensus 335 ~~~~li~~~L~~dP~~Rps----~~ell~hp~f~ 364 (365)
T 2y7j_A 335 TVKDLISRLLQVDPEARLT----AEQALQHPFFE 364 (365)
T ss_dssp HHHHHHHHHSCSSTTTSCC----HHHHHHSGGGC
T ss_pred HHHHHHHHHcCCChhHCcC----HHHHhcCcccC
Confidence 9999999999999999999 99999999996
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=405.14 Aligned_cols=266 Identities=28% Similarity=0.386 Sum_probs=221.5
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSC 292 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~ 292 (611)
..+++|++++.||+|+||.||+|++..+++.||||++..... .......+.+|+.+|+.++||||+++++++.+.+..|
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 100 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWY 100 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEE
Confidence 346799999999999999999999999999999999865432 2334456678999999999999999999999999999
Q ss_pred EEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCc
Q 007260 293 LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 293 LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~ 372 (611)
|||||+++++|..++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 101 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 101 LVFEFVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp EEEECCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred EEEecCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 999999999998876654 459999999999999999999999999999999999999999999999999984322100
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
....
T Consensus 179 ----------------------------------------------------------------------------~~~~ 182 (331)
T 4aaa_A 179 ----------------------------------------------------------------------------EVYD 182 (331)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ----------------------------------------------------------------------------cccC
Confidence 0011
Q ss_pred ccccCCCccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcC-------------------CCC
Q 007260 453 SFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ-------------------PLR 512 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~-~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~-------------------~l~ 512 (611)
..+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....+.+..+... ...
T Consensus 183 ~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (331)
T 4aaa_A 183 DEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR 262 (331)
T ss_dssp -CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCC
T ss_pred CCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccccc
Confidence 23699999999999886 6899999999999999999999999998877766554321 111
Q ss_pred CCC----------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCchhh
Q 007260 513 FPE----------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWAL 561 (611)
Q Consensus 513 ~p~----------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~ 561 (611)
++. .+.++..+.+||.+||..||.+||+ +.|||+||||+...++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt----~~ell~hp~f~~~~~~~ 317 (331)
T 4aaa_A 263 LPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPF----CAELLHHDFFQMDGFAE 317 (331)
T ss_dssp CCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCC----GGGGGGSHHHHGGGHHH
T ss_pred CccccccchhhhcccchhHHHHHHHHHHhccCcccCCC----HHHHhcCchhccCChhh
Confidence 111 1357899999999999999999999 99999999999876643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-48 Score=406.61 Aligned_cols=259 Identities=26% Similarity=0.411 Sum_probs=214.5
Q ss_pred cccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCC--CCcccccceeecccee
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH--PFLPTLYTHFETEKFS 291 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~H--pnIv~l~~~~~~~~~~ 291 (611)
...+|++++.||+|+||.||+|.+. +++.||||++..... .......+.+|+.+|+.+.| |||+++++++..++.+
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 3468999999999999999999885 588999999976543 33455678899999999976 9999999999999999
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCC
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~ 371 (611)
|||||++ +++|.+++... ..+++..++.|+.||+.||+|||++|||||||||+||||+ ++.+||+|||++......
T Consensus 85 ~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 85 YMVMECG-NIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EEEECCC-SEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EEEEeCC-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 9999954 88999999886 5699999999999999999999999999999999999996 788999999998433211
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
. .....
T Consensus 161 ~--------------------------------------------------------------------------~~~~~ 166 (343)
T 3dbq_A 161 T--------------------------------------------------------------------------TSVVK 166 (343)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred c--------------------------------------------------------------------------ccccC
Confidence 0 00011
Q ss_pred cccccCCCccchhhhcc-----------CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHcCCCCCCCCCCC
Q 007260 452 MSFVGTHEYLAPEIIKG-----------EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNR-ATLFNVVGQPLRFPESPVV 519 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~-----------~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~-~~l~~i~~~~l~~p~~~~~ 519 (611)
...+||+.|+|||++.+ ..++.++|||||||+||||++|+.||.+..+. ..+..++............
T Consensus 167 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T 3dbq_A 167 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 246 (343)
T ss_dssp ---CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCS
T ss_pred CCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCcccC
Confidence 23579999999999976 66789999999999999999999999875544 4555666555555555568
Q ss_pred CHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCC
Q 007260 520 SFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 520 s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
+.++.+||.+||..||.+||+ +.|+|+||||+.
T Consensus 247 ~~~l~~li~~~L~~dp~~Rpt----~~e~l~hp~~~~ 279 (343)
T 3dbq_A 247 EKDLQDVLKCCLKRDPKQRIS----IPELLAHPYVQI 279 (343)
T ss_dssp CHHHHHHHHHHTCSSTTTSCC----HHHHHTSHHHHS
T ss_pred CHHHHHHHHHHcCCChhHCCC----HHHHHhCccccc
Confidence 899999999999999999999 999999999974
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=392.23 Aligned_cols=255 Identities=24% Similarity=0.426 Sum_probs=217.3
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec----ccee
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET----EKFS 291 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~----~~~~ 291 (611)
..|++.+.||+|+||.||+|.+..++..||+|++...... .....++.+|+.+|+.++||||++++++|.. ...+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 4699999999999999999999999999999999765443 3445678899999999999999999998875 4778
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--eeccCCCCCcEEEc-cCCcEEEEeccccccc
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLG--IIYRDLKPENVLVR-EDGHIMLSDFDLSLRC 368 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~g--IVHRDLKPeNILv~-~~g~vkL~DFGlA~~~ 368 (611)
||||||+++++|.+++... ..+++..++.++.||+.||+|||++| |+||||||+||||+ .++.+||+|||++...
T Consensus 105 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 9999999999999999875 46999999999999999999999999 99999999999998 7899999999998321
Q ss_pred cCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccc
Q 007260 369 AVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTE 448 (611)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (611)
..
T Consensus 183 ~~------------------------------------------------------------------------------ 184 (290)
T 1t4h_A 183 RA------------------------------------------------------------------------------ 184 (290)
T ss_dssp CT------------------------------------------------------------------------------
T ss_pred cc------------------------------------------------------------------------------
Confidence 10
Q ss_pred ccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCC-CCCCCCCHHHHHHH
Q 007260 449 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRF-PESPVVSFAARDLI 527 (611)
Q Consensus 449 ~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~-p~~~~~s~~l~dLI 527 (611)
......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+...+...... ......++++.+||
T Consensus 185 ~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 263 (290)
T 1t4h_A 185 SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 263 (290)
T ss_dssp TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHH
T ss_pred cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHHHH
Confidence 00113469999999998875 58999999999999999999999999877766665555443322 22344788999999
Q ss_pred HHhhhcCccccCCchhcHHHHHcCCCCCC
Q 007260 528 RGLLVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 528 ~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
.+||..||.+||+ +.++++||||++
T Consensus 264 ~~~l~~dp~~Rps----~~ell~h~~f~~ 288 (290)
T 1t4h_A 264 EGCIRQNKDERYS----IKDLLNHAFFQE 288 (290)
T ss_dssp HHHSCSSGGGSCC----HHHHHTSGGGC-
T ss_pred HHHccCChhhCCC----HHHHhhCccccc
Confidence 9999999999999 999999999975
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=417.50 Aligned_cols=254 Identities=26% Similarity=0.401 Sum_probs=214.3
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC------CCCCcccccceeecc
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL------DHPFLPTLYTHFETE 288 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l------~HpnIv~l~~~~~~~ 288 (611)
..+|++++.||+|+||+||+|++..+++.||||++.... .....+.+|+.+|+.+ +|+||++++++|...
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 358999999999999999999999999999999997643 2233556788887776 678999999999999
Q ss_pred ceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCc--EEEEeccccc
Q 007260 289 KFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGH--IMLSDFDLSL 366 (611)
Q Consensus 289 ~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~--vkL~DFGlA~ 366 (611)
+.+||||||+ +++|.+++.......+++..++.|+.||+.||+|||++|||||||||+||||+.++. +||+|||++.
T Consensus 172 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 172 NHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp TEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred CeEEEEEecc-CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 9999999999 569999998876667999999999999999999999999999999999999999887 9999999983
Q ss_pred cccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCc
Q 007260 367 RCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEP 446 (611)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (611)
...
T Consensus 251 ~~~----------------------------------------------------------------------------- 253 (429)
T 3kvw_A 251 YEH----------------------------------------------------------------------------- 253 (429)
T ss_dssp ETT-----------------------------------------------------------------------------
T ss_pred ecC-----------------------------------------------------------------------------
Confidence 211
Q ss_pred ccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcC---CC------------
Q 007260 447 TEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ---PL------------ 511 (611)
Q Consensus 447 ~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~---~l------------ 511 (611)
......+||+.|+|||++.+..++.++|||||||+||||++|++||.+.+..+.+..++.. +.
T Consensus 254 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~ 331 (429)
T 3kvw_A 254 --QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKN 331 (429)
T ss_dssp --CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHH
T ss_pred --CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhh
Confidence 0112347999999999999999999999999999999999999999998877766544421 10
Q ss_pred -----CCC-----------------------------C--------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHH
Q 007260 512 -----RFP-----------------------------E--------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIK 549 (611)
Q Consensus 512 -----~~p-----------------------------~--------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL 549 (611)
.+| . ....+..+++||.+||++||.+||| +.|+|
T Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpt----a~e~L 407 (429)
T 3kvw_A 332 FVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT----PGQAL 407 (429)
T ss_dssp HBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCC----HHHHH
T ss_pred ccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCC----HHHHh
Confidence 000 0 0124788999999999999999999 99999
Q ss_pred cCCCCCC
Q 007260 550 QHPFFEG 556 (611)
Q Consensus 550 ~Hp~f~~ 556 (611)
+||||+.
T Consensus 408 ~Hpw~~~ 414 (429)
T 3kvw_A 408 RHPWLRR 414 (429)
T ss_dssp TSTTTC-
T ss_pred CChhhcc
Confidence 9999985
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=407.04 Aligned_cols=260 Identities=24% Similarity=0.378 Sum_probs=215.5
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecc-----c
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE-----K 289 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~-----~ 289 (611)
.++|++++.||+|+||.||+|++..+++.||||++.... ......++.+|+.+|+.++||||+++++++... .
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 368999999999999999999999999999999997533 234445678899999999999999999998754 4
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
..||||||+. ++|.+++... .+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||++....
T Consensus 104 ~~~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp CEEEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 7899999995 6999988764 49999999999999999999999999999999999999999999999999985432
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
.... ...
T Consensus 180 ~~~~-------------------------------------------------------------------------~~~ 186 (364)
T 3qyz_A 180 PDHD-------------------------------------------------------------------------HTG 186 (364)
T ss_dssp GGGC-------------------------------------------------------------------------BCC
T ss_pred CCCC-------------------------------------------------------------------------ccc
Confidence 1100 000
Q ss_pred cccccccCCCccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHc---CCC--------------
Q 007260 450 RSMSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG---QPL-------------- 511 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~~-~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~---~~l-------------- 511 (611)
.....+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+....+.+..+.. .+.
T Consensus 187 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 266 (364)
T 3qyz_A 187 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 266 (364)
T ss_dssp TTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHH
T ss_pred cccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHH
Confidence 11235799999999987654 589999999999999999999999998876666554432 110
Q ss_pred ---CCC---------CCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 512 ---RFP---------ESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 512 ---~~p---------~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
.++ ....++.++.+||.+||..||.+||+ +.|+|+||||+..
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 267 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE----VEQALAHPYLEQY 320 (364)
T ss_dssp HHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCC----HHHHHTSGGGTTT
T ss_pred HHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCC----HHHHhcCcchhhc
Confidence 000 01347899999999999999999999 9999999999875
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=407.71 Aligned_cols=264 Identities=27% Similarity=0.355 Sum_probs=213.4
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec-------
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET------- 287 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~------- 287 (611)
+++|++++.||+|+||.||+|++..+++.||||++....... .....+.+|+.+|+.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 469999999999999999999999999999999986543221 222345689999999999999999999876
Q ss_pred -cceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccc
Q 007260 288 -EKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSL 366 (611)
Q Consensus 288 -~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~ 366 (611)
.+.+|||||||+ ++|...+.... ..+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||++.
T Consensus 95 ~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 95 CKGSIYLVFDFCE-HDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp --CEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CCceEEEEEeccC-CCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 457899999996 47777776543 469999999999999999999999999999999999999999999999999985
Q ss_pred cccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCc
Q 007260 367 RCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEP 446 (611)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (611)
.+..... .
T Consensus 173 ~~~~~~~------------------------------------------------------------------------~ 180 (351)
T 3mi9_A 173 AFSLAKN------------------------------------------------------------------------S 180 (351)
T ss_dssp ECCCCSS------------------------------------------------------------------------S
T ss_pred ccccccc------------------------------------------------------------------------c
Confidence 4321100 0
Q ss_pred ccccccccccCCCccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcC--CCCCCCCCC-----
Q 007260 447 TEARSMSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ--PLRFPESPV----- 518 (611)
Q Consensus 447 ~~~~~~~~vGT~~Y~APEil~~~-~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~--~l~~p~~~~----- 518 (611)
........+||+.|+|||++.+. .++.++|||||||++|||++|++||.+......+..+... ......++.
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 260 (351)
T 3mi9_A 181 QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYE 260 (351)
T ss_dssp SCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCG
T ss_pred cccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccch
Confidence 00111234699999999999874 5799999999999999999999999998877666554321 111111111
Q ss_pred -----------------------CCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 519 -----------------------VSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 519 -----------------------~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
.++.+++||.+||..||.+||+ +.|+|+||||.+.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~f~~~ 318 (351)
T 3mi9_A 261 LYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID----SDDALNHDFFWSD 318 (351)
T ss_dssp GGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGGSS
T ss_pred hhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCC----HHHHhCCCCcCCC
Confidence 2778999999999999999999 9999999999764
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-48 Score=391.44 Aligned_cols=261 Identities=26% Similarity=0.427 Sum_probs=220.5
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
.++|++++.||+|+||.||+|++..+++.||||++...... .....+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence 35899999999999999999999999999999999755432 2334667899999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
|||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-- 159 (276)
T 2yex_A 84 LEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN-- 159 (276)
T ss_dssp EECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT--
T ss_pred EEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc--
Confidence 9999999999987654 569999999999999999999999999999999999999999999999999984332100
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
........
T Consensus 160 ------------------------------------------------------------------------~~~~~~~~ 167 (276)
T 2yex_A 160 ------------------------------------------------------------------------RERLLNKM 167 (276)
T ss_dssp ------------------------------------------------------------------------EECCBCCC
T ss_pred ------------------------------------------------------------------------chhcccCC
Confidence 00011234
Q ss_pred ccCCCccchhhhccCCC-CChhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007260 455 VGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSGNR-ATLFNVVGQPLRFPESPVVSFAARDLIRGLLV 532 (611)
Q Consensus 455 vGT~~Y~APEil~~~~~-~~~sDIWSLGviL~ELltG~~PF~~~~~~-~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~ 532 (611)
+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.... ..+..+.......+....++..+++||.+||.
T Consensus 168 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 247 (276)
T 2yex_A 168 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILV 247 (276)
T ss_dssp CSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSC
T ss_pred ccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHHHHCC
Confidence 69999999999988775 77999999999999999999999876543 33344444444444455689999999999999
Q ss_pred cCccccCCchhcHHHHHcCCCCCCC
Q 007260 533 KEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 533 ~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
.||.+||+ +.|+++||||+..
T Consensus 248 ~~p~~Rps----~~~il~~~~~~~~ 268 (276)
T 2yex_A 248 ENPSARIT----IPDIKKDRWYNKP 268 (276)
T ss_dssp SSTTTSCC----HHHHTTCTTTTCC
T ss_pred CCchhCCC----HHHHhcCccccCh
Confidence 99999999 9999999999753
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=408.25 Aligned_cols=267 Identities=22% Similarity=0.400 Sum_probs=228.0
Q ss_pred cccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHH--------------HHHHHHHHHHHHHhCCCCC
Q 007260 212 VLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRK--------------KLLRAQTEREILQSLDHPF 277 (611)
Q Consensus 212 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~--------------~~~~~~~E~~iL~~l~Hpn 277 (611)
....++|++++.||+|+||.||+|++ +++.||||++......... ....+.+|+.+|+.++|||
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 104 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEY 104 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTT
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCC
Confidence 34457999999999999999999999 8899999999765432211 1146788999999999999
Q ss_pred cccccceeeccceeeEEeeeCCCCCHHHH------HHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCeeccCCCCCcEE
Q 007260 278 LPTLYTHFETEKFSCLVMEFCPGGDLHTL------RQKQPGKYFPEQAVRFYVAEVLLALEYLHM-LGIIYRDLKPENVL 350 (611)
Q Consensus 278 Iv~l~~~~~~~~~~~LVmE~~~gg~L~~l------l~~~~~~~l~e~~~~~i~~qll~aL~yLH~-~gIVHRDLKPeNIL 350 (611)
|+++++++.+.+..||||||++|++|.++ +.......+++..++.++.||+.||+|||+ +||+||||||+|||
T Consensus 105 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL 184 (348)
T ss_dssp BCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred cceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence 99999999999999999999999999988 655445789999999999999999999999 99999999999999
Q ss_pred EccCCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCcc
Q 007260 351 VREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKN 430 (611)
Q Consensus 351 v~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 430 (611)
++.++.+||+|||++......
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~----------------------------------------------------------- 205 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK----------------------------------------------------------- 205 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT-----------------------------------------------------------
T ss_pred EcCCCcEEEeccccccccccc-----------------------------------------------------------
Confidence 999999999999998432110
Q ss_pred ccCCCCCCCcccccCcccccccccccCCCccchhhhccC-CCCC-hhhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHH
Q 007260 431 EIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGE-GHGS-AVDWWTFGIFLYELLFGKTPFKGSGN-RATLFNVV 507 (611)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~-~~~~-~sDIWSLGviL~ELltG~~PF~~~~~-~~~l~~i~ 507 (611)
......||+.|+|||++.+. .++. ++|||||||++|||++|+.||.+... ...+..+.
T Consensus 206 -------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~ 266 (348)
T 2pml_X 206 -------------------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR 266 (348)
T ss_dssp -------------------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHT
T ss_pred -------------------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh
Confidence 11134699999999999988 5666 99999999999999999999998777 66666676
Q ss_pred cCCCCCCCC-----------------CCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCchhhh
Q 007260 508 GQPLRFPES-----------------PVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALI 562 (611)
Q Consensus 508 ~~~l~~p~~-----------------~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~ 562 (611)
.....++.. ..++.++.+||.+||..||.+||+ +.|+++||||++.+|..+
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps----~~e~l~hp~f~~~~~~~~ 334 (348)
T 2pml_X 267 TKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERIT----SEDALKHEWLADTNIEDL 334 (348)
T ss_dssp SCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCC----HHHHHTSGGGTTCCHHHH
T ss_pred ccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCC----HHHHhcCccccCCCHHHH
Confidence 666666632 458999999999999999999999 999999999999988654
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-48 Score=414.89 Aligned_cols=261 Identities=28% Similarity=0.479 Sum_probs=210.7
Q ss_pred cccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecc-----
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE----- 288 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~----- 288 (611)
...+|++++.||+|+||+||+|++..++. ||+|.+...... ..+|+++|+.++|||||+++++|...
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 109 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKD 109 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSS
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCCCC
Confidence 34689999999999999999999988876 777776543211 13599999999999999999999543
Q ss_pred -ceeeEEeeeCCCCCHHHHHH-hCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEc-cCCcEEEEecccc
Q 007260 289 -KFSCLVMEFCPGGDLHTLRQ-KQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVR-EDGHIMLSDFDLS 365 (611)
Q Consensus 289 -~~~~LVmE~~~gg~L~~ll~-~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~-~~g~vkL~DFGlA 365 (611)
.++|||||||+++.+..+.. ......+++..++.|+.||+.||+|||++||+||||||+||||+ .++++||+|||++
T Consensus 110 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 110 EVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp CEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred ceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 34899999997654444332 11235699999999999999999999999999999999999999 7999999999998
Q ss_pred ccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccC
Q 007260 366 LRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAE 445 (611)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (611)
..+...
T Consensus 190 ~~~~~~-------------------------------------------------------------------------- 195 (394)
T 4e7w_A 190 KILIAG-------------------------------------------------------------------------- 195 (394)
T ss_dssp EECCTT--------------------------------------------------------------------------
T ss_pred ccccCC--------------------------------------------------------------------------
Confidence 543210
Q ss_pred cccccccccccCCCccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHc---CC-----------
Q 007260 446 PTEARSMSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG---QP----------- 510 (611)
Q Consensus 446 ~~~~~~~~~vGT~~Y~APEil~~~-~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~---~~----------- 510 (611)
......+||+.|+|||++.+. .++.++|||||||+||||++|++||.+.+..+.+..++. .+
T Consensus 196 ---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 272 (394)
T 4e7w_A 196 ---EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPN 272 (394)
T ss_dssp ---CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGG
T ss_pred ---CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChh
Confidence 011234699999999999876 489999999999999999999999999887777665543 11
Q ss_pred ---CCCCC----------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCchhhhc
Q 007260 511 ---LRFPE----------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIR 563 (611)
Q Consensus 511 ---l~~p~----------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~ 563 (611)
..++. ...++.++++||.+||.+||.+||+ +.|+++||||+++.|....
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~f~~~~~~~~~ 334 (394)
T 4e7w_A 273 YMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLT----AIEALCHPFFDELRTGEAR 334 (394)
T ss_dssp GSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC----HHHHHTSGGGSTTTSSCCC
T ss_pred hhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCC----HHHHhcChhhhhhcccccc
Confidence 11111 1248899999999999999999999 9999999999998876544
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=414.47 Aligned_cols=256 Identities=30% Similarity=0.512 Sum_probs=212.0
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec-------
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET------- 287 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~------- 287 (611)
.++|++++.||+|+||+||+|++..+++.||||++...... ..+|+.+|+.++|||||+++++|..
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 46899999999999999999999999999999998654321 2369999999999999999999843
Q ss_pred -------------------------------cceeeEEeeeCCCCCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHH
Q 007260 288 -------------------------------EKFSCLVMEFCPGGDLHTLRQK--QPGKYFPEQAVRFYVAEVLLALEYL 334 (611)
Q Consensus 288 -------------------------------~~~~~LVmE~~~gg~L~~ll~~--~~~~~l~e~~~~~i~~qll~aL~yL 334 (611)
..++|||||||+ ++|.+++.. ..+..+++..++.|+.||+.||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 345899999996 588776653 2346799999999999999999999
Q ss_pred HHcCeeccCCCCCcEEEc-cCCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCC
Q 007260 335 HMLGIIYRDLKPENVLVR-EDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCF 413 (611)
Q Consensus 335 H~~gIVHRDLKPeNILv~-~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (611)
|++||+||||||+||||+ .++.+||+|||++..+...
T Consensus 158 H~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~------------------------------------------ 195 (383)
T 3eb0_A 158 HSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS------------------------------------------ 195 (383)
T ss_dssp HTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT------------------------------------------
T ss_pred HHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC------------------------------------------
Confidence 999999999999999998 6899999999998543210
Q ss_pred CCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCccchhhhccCC-CCChhhHHHHHHHHHHHHhCCC
Q 007260 414 SPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKT 492 (611)
Q Consensus 414 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~-~~~~sDIWSLGviL~ELltG~~ 492 (611)
......+||+.|+|||++.+.. ++.++|||||||++|||++|++
T Consensus 196 -----------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 240 (383)
T 3eb0_A 196 -----------------------------------EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP 240 (383)
T ss_dssp -----------------------------------SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred -----------------------------------CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCC
Confidence 0112346899999999998765 8999999999999999999999
Q ss_pred CCCCCCcHHHHHHHHc---CC--------------CCCCC----------CCCCCHHHHHHHHHhhhcCccccCCchhcH
Q 007260 493 PFKGSGNRATLFNVVG---QP--------------LRFPE----------SPVVSFAARDLIRGLLVKEPQHRLAYKRGA 545 (611)
Q Consensus 493 PF~~~~~~~~l~~i~~---~~--------------l~~p~----------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a 545 (611)
||.+....+.+..++. .+ ..++. ...++.++++||.+||..||.+||| +
T Consensus 241 pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~ 316 (383)
T 3eb0_A 241 LFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN----P 316 (383)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC----H
T ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCC----H
Confidence 9999888777766543 11 11221 2347899999999999999999999 9
Q ss_pred HHHHcCCCCCCCch
Q 007260 546 TEIKQHPFFEGVNW 559 (611)
Q Consensus 546 ~elL~Hp~f~~~~~ 559 (611)
.|+|+||||+.+.+
T Consensus 317 ~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 317 YEAMAHPFFDHLRN 330 (383)
T ss_dssp HHHHTSGGGHHHHH
T ss_pred HHHhcCHHHHHHHh
Confidence 99999999987654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-48 Score=392.71 Aligned_cols=261 Identities=25% Similarity=0.325 Sum_probs=206.8
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSC 292 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~ 292 (611)
+..++|++++.||+|+||.||+|++..+++.||||++...... ......+..+..+++.++||||+++++++.+++..|
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS-QEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 82 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CH-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCc-HHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence 4457999999999999999999999999999999999765322 223333445556688899999999999999999999
Q ss_pred EEeeeCCCCCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHc-CeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 293 LVMEFCPGGDLHTLRQK--QPGKYFPEQAVRFYVAEVLLALEYLHML-GIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 293 LVmE~~~gg~L~~ll~~--~~~~~l~e~~~~~i~~qll~aL~yLH~~-gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
|||||++ |+|.+++.. ..+..+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||++....
T Consensus 83 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 83 ICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred EEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9999996 588776653 2346799999999999999999999998 99999999999999999999999999984322
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
.. .
T Consensus 162 ~~-----------------------------------------------------------------------------~ 164 (290)
T 3fme_A 162 DD-----------------------------------------------------------------------------V 164 (290)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cc-----------------------------------------------------------------------------c
Confidence 10 0
Q ss_pred cccccccCCCccchhhh----ccCCCCChhhHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHcCCCCCCCCCCCCHHHH
Q 007260 450 RSMSFVGTHEYLAPEII----KGEGHGSAVDWWTFGIFLYELLFGKTPFKGS-GNRATLFNVVGQPLRFPESPVVSFAAR 524 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil----~~~~~~~~sDIWSLGviL~ELltG~~PF~~~-~~~~~l~~i~~~~l~~p~~~~~s~~l~ 524 (611)
......||+.|+|||++ .+..++.++|||||||++|+|++|+.||... .....+..++...........++.++.
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (290)
T 3fme_A 165 AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFV 244 (290)
T ss_dssp -----CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCHHHH
T ss_pred cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCCHHHH
Confidence 01123599999999997 4556899999999999999999999999874 344455555555444444456899999
Q ss_pred HHHHHhhhcCccccCCchhcHHHHHcCCCCCC
Q 007260 525 DLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 525 dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
+||.+||..||.+||+ +.|+++||||+.
T Consensus 245 ~li~~~l~~~p~~Rpt----~~e~l~hp~f~~ 272 (290)
T 3fme_A 245 DFTSQCLKKNSKERPT----YPELMQHPFFTL 272 (290)
T ss_dssp HHHHHHTCSSGGGSCC----HHHHTTSHHHHH
T ss_pred HHHHHHhhcChhhCcC----HHHHHhCccccc
Confidence 9999999999999999 999999999974
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=423.07 Aligned_cols=263 Identities=32% Similarity=0.507 Sum_probs=210.4
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhh-----hHHHHHHHHHHHHHHHhCCCCCcccccceeeccc
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLA-----GRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK 289 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~-----~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~ 289 (611)
.++|++++.||+|+||+||+|.+..+++.||||++.+.... .......+.+|+.+|+.++|||||++++++..+
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~- 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE- 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS-
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence 36899999999999999999999999999999999865432 122233467899999999999999999998654
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCC---cEEEEeccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDG---HIMLSDFDLSL 366 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g---~vkL~DFGlA~ 366 (611)
..|||||||+||+|.+++... ..+++..++.++.||+.||+|||++|||||||||+||||+.++ .+||+|||++.
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred ceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 479999999999999887664 5699999999999999999999999999999999999997544 59999999984
Q ss_pred cccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCc
Q 007260 367 RCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEP 446 (611)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (611)
....
T Consensus 291 ~~~~---------------------------------------------------------------------------- 294 (419)
T 3i6u_A 291 ILGE---------------------------------------------------------------------------- 294 (419)
T ss_dssp SCC-----------------------------------------------------------------------------
T ss_pred ecCC----------------------------------------------------------------------------
Confidence 3210
Q ss_pred ccccccccccCCCccchhhhcc---CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH-HHHcCCCCCCC--CCCCC
Q 007260 447 TEARSMSFVGTHEYLAPEIIKG---EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLF-NVVGQPLRFPE--SPVVS 520 (611)
Q Consensus 447 ~~~~~~~~vGT~~Y~APEil~~---~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~-~i~~~~l~~p~--~~~~s 520 (611)
.......+||+.|+|||++.+ ..++.++|||||||+||+|++|+.||.+......+. .+......+.. +..++
T Consensus 295 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 373 (419)
T 3i6u_A 295 -TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 373 (419)
T ss_dssp -----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSC
T ss_pred -CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcccC
Confidence 001123579999999999864 567889999999999999999999998755443333 33344333321 24589
Q ss_pred HHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCchhh
Q 007260 521 FAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWAL 561 (611)
Q Consensus 521 ~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~ 561 (611)
..+++||.+||..||.+||+ +.|+|+||||++.+|..
T Consensus 374 ~~~~~li~~~L~~dP~~Rps----~~e~l~hp~~~~~~~~~ 410 (419)
T 3i6u_A 374 EKALDLVKKLLVVDPKARFT----TEEALRHPWLQDEDMKR 410 (419)
T ss_dssp HHHHHHHHHHSCSSTTTSCC----HHHHHHSGGGCCHHHHH
T ss_pred HHHHHHHHHHccCChhHCcC----HHHHhCCcccCChhHHH
Confidence 99999999999999999999 99999999999877643
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=410.93 Aligned_cols=250 Identities=28% Similarity=0.447 Sum_probs=212.9
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhH-----HHHHHHHHHHHHHHhCCCCCcccccceeeccce
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGR-----KKLLRAQTEREILQSLDHPFLPTLYTHFETEKF 290 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~-----~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~ 290 (611)
++|++++.||+|+||.||+|++..+++.||||++.+...... ....++.+|+.+|+.++||||++++++|.+.+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 589999999999999999999999999999999976542211 122345679999999999999999999999999
Q ss_pred eeEEeeeCCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 291 SCLVMEFCPGG-DLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 291 ~~LVmE~~~gg-~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
+||||||+.+| +|.+++... ..+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||++....
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence 99999998666 999998875 469999999999999999999999999999999999999999999999999984322
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
.. .
T Consensus 182 ~~-----------------------------------------------------------------------------~ 184 (335)
T 3dls_A 182 RG-----------------------------------------------------------------------------K 184 (335)
T ss_dssp TT-----------------------------------------------------------------------------C
T ss_pred CC-----------------------------------------------------------------------------C
Confidence 10 0
Q ss_pred cccccccCCCccchhhhccCCC-CChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 007260 450 RSMSFVGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIR 528 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~~~~-~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~ 528 (611)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..... ........+ ..++.++++||.
T Consensus 185 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~~~~--~~~~~~l~~li~ 256 (335)
T 3dls_A 185 LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAIHPP--YLVSKELMSLVS 256 (335)
T ss_dssp CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTCCCCS--SCCCHHHHHHHH
T ss_pred ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhccCCC--cccCHHHHHHHH
Confidence 1123569999999999998887 8899999999999999999999976322 222223333 348999999999
Q ss_pred HhhhcCccccCCchhcHHHHHcCCCCCC
Q 007260 529 GLLVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 529 ~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
+||..||.+||+ +.++++||||+.
T Consensus 257 ~~L~~dP~~Rps----~~ell~hp~~~~ 280 (335)
T 3dls_A 257 GLLQPVPERRTT----LEKLVTDPWVTQ 280 (335)
T ss_dssp HHTCSSGGGSCC----HHHHHHCTTTTC
T ss_pred HHccCChhhCcC----HHHHhcCccccC
Confidence 999999999999 999999999975
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-48 Score=397.82 Aligned_cols=255 Identities=30% Similarity=0.475 Sum_probs=221.5
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
++|++++.||+|+||.||+|++..+++.||||++....... ...+.+|+.+|+.++||||+++++++.+....|+||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccc---hHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 58999999999999999999999999999999997654222 235678999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEE---ccCCcEEEEeccccccccCCc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLV---REDGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv---~~~g~vkL~DFGlA~~~~~~~ 372 (611)
||++|++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 86 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~-- 161 (304)
T 2jam_A 86 QLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-- 161 (304)
T ss_dssp CCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC--
T ss_pred EcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC--
Confidence 999999999988765 469999999999999999999999999999999999999 6788999999998732110
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
....
T Consensus 162 ----------------------------------------------------------------------------~~~~ 165 (304)
T 2jam_A 162 ----------------------------------------------------------------------------GIMS 165 (304)
T ss_dssp ----------------------------------------------------------------------------BTTH
T ss_pred ----------------------------------------------------------------------------Cccc
Confidence 0012
Q ss_pred ccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCC--CCCCCCHHHHHHHHHh
Q 007260 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFP--ESPVVSFAARDLIRGL 530 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p--~~~~~s~~l~dLI~~~ 530 (611)
..+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+......+..+......++ ....++.++++||.+|
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~ 245 (304)
T 2jam_A 166 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHL 245 (304)
T ss_dssp HHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHH
T ss_pred cccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHH
Confidence 34699999999999999999999999999999999999999999888777777777665543 3356899999999999
Q ss_pred hhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 531 LVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 531 L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
|..||.+||+ +.++++||||++.
T Consensus 246 l~~dp~~Rps----~~~~l~h~~~~~~ 268 (304)
T 2jam_A 246 LEKDPNERYT----CEKALSHPWIDGN 268 (304)
T ss_dssp HCSSTTTSCC----HHHHHTSHHHHSS
T ss_pred cCCChhHCcC----HHHHhcCccccCC
Confidence 9999999999 9999999999753
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-48 Score=413.80 Aligned_cols=258 Identities=26% Similarity=0.428 Sum_probs=215.9
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC--CCCcccccceeeccceeeE
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD--HPFLPTLYTHFETEKFSCL 293 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~--HpnIv~l~~~~~~~~~~~L 293 (611)
.+|++++.||+|+||.||+|.+.. ++.||||++..... .......+.+|+.+|+.|. |||||++++++..++.+||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 579999999999999999999875 88999999976543 3345567889999999996 5999999999999999999
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcc
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 373 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~ 373 (611)
||| +.+++|.+++... ..+++..++.|+.||+.||+|||++|||||||||+||||+ ++.+||+|||++..+.....
T Consensus 134 v~E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp EEE-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred EEe-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 999 5589999999876 4689999999999999999999999999999999999995 68999999999843321100
Q ss_pred ccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccc
Q 007260 374 LIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMS 453 (611)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (611)
......
T Consensus 210 --------------------------------------------------------------------------~~~~~~ 215 (390)
T 2zmd_A 210 --------------------------------------------------------------------------SVVKDS 215 (390)
T ss_dssp ------------------------------------------------------------------------------CC
T ss_pred --------------------------------------------------------------------------cccCCC
Confidence 001123
Q ss_pred cccCCCccchhhhcc-----------CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHcCCCCCCCCCCCCH
Q 007260 454 FVGTHEYLAPEIIKG-----------EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNR-ATLFNVVGQPLRFPESPVVSF 521 (611)
Q Consensus 454 ~vGT~~Y~APEil~~-----------~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~-~~l~~i~~~~l~~p~~~~~s~ 521 (611)
.+||+.|+|||++.+ ..++.++|||||||+||||++|+.||.+..+. ..+..++.....++.....+.
T Consensus 216 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (390)
T 2zmd_A 216 QVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEK 295 (390)
T ss_dssp SCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCCCSCH
T ss_pred CCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCccchH
Confidence 579999999999976 36889999999999999999999999876543 556667766655555556789
Q ss_pred HHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 522 AARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 522 ~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
++++||.+||..||.+||+ +.|+|+||||+..
T Consensus 296 ~~~~li~~~L~~dP~~Rps----~~ell~hp~~~~~ 327 (390)
T 2zmd_A 296 DLQDVLKCCLKRDPKQRIS----IPELLAHPYVQIQ 327 (390)
T ss_dssp HHHHHHHHHTCSSTTTSCC----HHHHHTSHHHHSC
T ss_pred HHHHHHHHHcccChhhCCC----HHHHhhCcCcccc
Confidence 9999999999999999999 9999999999754
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-48 Score=411.49 Aligned_cols=257 Identities=28% Similarity=0.410 Sum_probs=202.7
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecc------
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE------ 288 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~------ 288 (611)
.++|++++.||+|+||.||+|.+..+++.||||++.... .......++.+|+.+|+.++||||++++++|...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 379999999999999999999999999999999996543 2334556778999999999999999999998653
Q ss_pred ceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccc
Q 007260 289 KFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRC 368 (611)
Q Consensus 289 ~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~ 368 (611)
..+||||||+ +++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++..
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp CCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred CeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 6689999999 8899998875 35999999999999999999999999999999999999999999999999998432
Q ss_pred cCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccc
Q 007260 369 AVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTE 448 (611)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (611)
..
T Consensus 183 ~~------------------------------------------------------------------------------ 184 (367)
T 2fst_X 183 AD------------------------------------------------------------------------------ 184 (367)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cc------------------------------------------------------------------------------
Confidence 10
Q ss_pred ccccccccCCCccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHc---CC--------------
Q 007260 449 ARSMSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG---QP-------------- 510 (611)
Q Consensus 449 ~~~~~~vGT~~Y~APEil~~-~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~---~~-------------- 510 (611)
.....+||++|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+.+..++. .+
T Consensus 185 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~ 263 (367)
T 2fst_X 185 -EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 263 (367)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHH
T ss_pred -cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHH
Confidence 0123479999999999987 6789999999999999999999999999887766654432 11
Q ss_pred ------CCCCC------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCch
Q 007260 511 ------LRFPE------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNW 559 (611)
Q Consensus 511 ------l~~p~------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 559 (611)
...+. ...++..+++||.+||..||.+||+ +.|+|+||||+....
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t----~~e~L~hp~~~~~~~ 320 (367)
T 2fst_X 264 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT----AAQALAHAYFAQYHD 320 (367)
T ss_dssp HHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGTTTCC
T ss_pred HHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcC----HHHHhcChhhhhccC
Confidence 00111 1246889999999999999999999 999999999987644
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=406.46 Aligned_cols=256 Identities=30% Similarity=0.421 Sum_probs=214.7
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecccee----
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFS---- 291 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~---- 291 (611)
++|++++.||+|+||.||+|.+..+++.||||++.... .......++.+|+.+|+.++||||++++++|...+..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 69999999999999999999999999999999997643 3334556778999999999999999999999877655
Q ss_pred --eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 292 --CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 292 --~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
||||||+. ++|.+++. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++....
T Consensus 121 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred eEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 99999995 68887764 349999999999999999999999999999999999999999999999999984221
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
.
T Consensus 196 ~------------------------------------------------------------------------------- 196 (371)
T 4exu_A 196 A------------------------------------------------------------------------------- 196 (371)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred c-------------------------------------------------------------------------------
Confidence 0
Q ss_pred cccccccCCCccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcC---C---------------
Q 007260 450 RSMSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ---P--------------- 510 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~-~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~---~--------------- 510 (611)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..++.. +
T Consensus 197 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 276 (371)
T 4exu_A 197 EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKS 276 (371)
T ss_dssp ---CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHH
T ss_pred CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhh
Confidence 0113468999999999988 67899999999999999999999999998877666555321 1
Q ss_pred -----CCCC------CCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCchh
Q 007260 511 -----LRFP------ESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWA 560 (611)
Q Consensus 511 -----l~~p------~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~ 560 (611)
...+ ....++.++++||.+||..||.+||+ +.|+|+||||+.+.+.
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~f~~~~~~ 333 (371)
T 4exu_A 277 YIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT----AAQALTHPFFEPFRDP 333 (371)
T ss_dssp HHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCC----HHHHHTSGGGTTTCCG
T ss_pred hhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCC----HHHHhcCcccccCCCc
Confidence 0000 01347899999999999999999999 9999999999876543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=399.17 Aligned_cols=261 Identities=24% Similarity=0.357 Sum_probs=215.4
Q ss_pred CccccccCeEEEeEecccCcEEEEEEEE-CCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCC------Cccccc
Q 007260 210 DGVLGLSHFRLLKRLGCGDIGSVYLSEL-SGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHP------FLPTLY 282 (611)
Q Consensus 210 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~-~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~Hp------nIv~l~ 282 (611)
.+....++|++++.||+|+||.||+|.+ ..+++.||||++.... .....+.+|+.+++.++|+ +|++++
T Consensus 8 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~ 83 (339)
T 1z57_A 8 SGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLNTTDPNSTFRCVQML 83 (339)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred cCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC----chhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence 3444557999999999999999999998 5688999999997543 3344667899999888655 499999
Q ss_pred ceeeccceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEcc---------
Q 007260 283 THFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRE--------- 353 (611)
Q Consensus 283 ~~~~~~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~--------- 353 (611)
++|...+.+||||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+||||+.
T Consensus 84 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~ 162 (339)
T 1z57_A 84 EWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNP 162 (339)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC-
T ss_pred cccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCC
Confidence 9999999999999999 899999998876567999999999999999999999999999999999999987
Q ss_pred ----------CCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccc
Q 007260 354 ----------DGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSK 423 (611)
Q Consensus 354 ----------~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (611)
++.+||+|||++.....
T Consensus 163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~----------------------------------------------------- 189 (339)
T 1z57_A 163 KIKRDERTLINPDIKVVDFGSATYDDE----------------------------------------------------- 189 (339)
T ss_dssp ---CEEEEESCCCEEECCCSSCEETTS-----------------------------------------------------
T ss_pred ccccccccccCCCceEeeCcccccCcc-----------------------------------------------------
Confidence 66899999999842110
Q ss_pred cCCCCccccCCCCCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Q 007260 424 KDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATL 503 (611)
Q Consensus 424 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l 503 (611)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+
T Consensus 190 --------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 243 (339)
T 1z57_A 190 --------------------------HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243 (339)
T ss_dssp --------------------------CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred --------------------------ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 011346999999999999999999999999999999999999999987766544
Q ss_pred HHH---HcCCC------------------CCC---------------------CCCCCCHHHHHHHHHhhhcCccccCCc
Q 007260 504 FNV---VGQPL------------------RFP---------------------ESPVVSFAARDLIRGLLVKEPQHRLAY 541 (611)
Q Consensus 504 ~~i---~~~~l------------------~~p---------------------~~~~~s~~l~dLI~~~L~~dP~~Rpt~ 541 (611)
..+ .+... .+. .....++++.+||.+||..||.+||+
T Consensus 244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt- 322 (339)
T 1z57_A 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT- 322 (339)
T ss_dssp HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC-
T ss_pred HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC-
Confidence 332 21100 000 01123577899999999999999999
Q ss_pred hhcHHHHHcCCCCCCCc
Q 007260 542 KRGATEIKQHPFFEGVN 558 (611)
Q Consensus 542 ~~~a~elL~Hp~f~~~~ 558 (611)
+.|+++||||+.+.
T Consensus 323 ---~~ell~hp~f~~~~ 336 (339)
T 1z57_A 323 ---LREALKHPFFDLLK 336 (339)
T ss_dssp ---HHHHTTSGGGGGGG
T ss_pred ---HHHHhcCHHHHHHh
Confidence 99999999998654
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-48 Score=410.58 Aligned_cols=255 Identities=25% Similarity=0.391 Sum_probs=208.3
Q ss_pred cccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC--------CCCccccccee
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD--------HPFLPTLYTHF 285 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~--------HpnIv~l~~~~ 285 (611)
..++|++++.||+|+||+||+|++..+++.||||++.... .....+.+|+.+|+.+. |+||++++++|
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~ 110 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF 110 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC----cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence 3479999999999999999999999999999999997543 33446678999999885 78899999999
Q ss_pred e----ccceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CeeccCCCCCcEEEccCC-----
Q 007260 286 E----TEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHML-GIIYRDLKPENVLVREDG----- 355 (611)
Q Consensus 286 ~----~~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~-gIVHRDLKPeNILv~~~g----- 355 (611)
. ....+||||||+ +++|.+.+.......+++..++.|+.||+.||+|||++ |||||||||+||||+.++
T Consensus 111 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 111 KISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp EEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHH
T ss_pred eecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhh
Confidence 8 667899999999 67777777665556799999999999999999999998 999999999999999775
Q ss_pred --------------------------------------------cEEEEeccccccccCCccccccccCCCCcCcCCCcc
Q 007260 356 --------------------------------------------HIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVY 391 (611)
Q Consensus 356 --------------------------------------------~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (611)
.+||+|||++.....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--------------------- 248 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--------------------- 248 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB---------------------
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc---------------------
Confidence 799999999843210
Q ss_pred ccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCccchhhhccCCC
Q 007260 392 CVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGH 471 (611)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~ 471 (611)
.....+||+.|+|||++.+..+
T Consensus 249 ----------------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~ 270 (397)
T 1wak_A 249 ----------------------------------------------------------HFTEDIQTRQYRSLEVLIGSGY 270 (397)
T ss_dssp ----------------------------------------------------------CSCSCCSCGGGCCHHHHHTSCC
T ss_pred ----------------------------------------------------------cCccCCCCCcccCChhhcCCCC
Confidence 0112369999999999999999
Q ss_pred CChhhHHHHHHHHHHHHhCCCCCCCCCc------HHHH---HHHHcCCCC------------------------------
Q 007260 472 GSAVDWWTFGIFLYELLFGKTPFKGSGN------RATL---FNVVGQPLR------------------------------ 512 (611)
Q Consensus 472 ~~~sDIWSLGviL~ELltG~~PF~~~~~------~~~l---~~i~~~~l~------------------------------ 512 (611)
+.++|||||||+||||++|+.||.+... ...+ ..+.+....
T Consensus 271 ~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (397)
T 1wak_A 271 NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGL 350 (397)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCH
T ss_pred CcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcch
Confidence 9999999999999999999999986542 2222 222222100
Q ss_pred -------CCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCC
Q 007260 513 -------FPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 513 -------~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
+......+..+++||.+||..||.+||+ +.|||+||||++
T Consensus 351 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~e~l~hp~~~~ 397 (397)
T 1wak_A 351 FEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRAT----AAECLRHPWLNS 397 (397)
T ss_dssp HHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCC----HHHHHTSGGGGC
T ss_pred hHhhhhhcccchhhHHHHHHHHHHHhccChhhcCC----HHHHhhCccccC
Confidence 0011123567899999999999999999 999999999963
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=399.42 Aligned_cols=270 Identities=27% Similarity=0.418 Sum_probs=216.8
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecc-----c
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE-----K 289 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~-----~ 289 (611)
.++|++++.||+|+||.||+|++..+++.||||++.... ......++.+|+.+|+.++||||+++++++..+ .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 479999999999999999999999999999999996532 233445677899999999999999999987654 7
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
..||||||+. ++|.+++... .+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++....
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 7899999995 6999988763 59999999999999999999999999999999999999999999999999985543
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
........ ......
T Consensus 164 ~~~~~~~~------------------------------------------------------------------~~~~~~ 177 (353)
T 2b9h_A 164 ESAADNSE------------------------------------------------------------------PTGQQS 177 (353)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cccccccC------------------------------------------------------------------cccccc
Confidence 11100000 000001
Q ss_pred cccccccCCCccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH---cCCC--------------
Q 007260 450 RSMSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVV---GQPL-------------- 511 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~-~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~---~~~l-------------- 511 (611)
....++||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+. +.+.
T Consensus 178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (353)
T 2b9h_A 178 GMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAR 257 (353)
T ss_dssp --CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHH
T ss_pred chhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhh
Confidence 1224579999999999875 678999999999999999999999999887665554332 2211
Q ss_pred -------CCCC------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCchh
Q 007260 512 -------RFPE------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWA 560 (611)
Q Consensus 512 -------~~p~------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~ 560 (611)
..+. ...++.++++||.+||..||.+||+ +.++++||||+...+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~~~~~~~~ 315 (353)
T 2b9h_A 258 EYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRIT----AKEALEHPYLQTYHDP 315 (353)
T ss_dssp HHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGTTTCCT
T ss_pred HHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCC----HHHHhcCccccccCCc
Confidence 0111 1358899999999999999999999 9999999999876553
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=394.34 Aligned_cols=264 Identities=28% Similarity=0.434 Sum_probs=220.7
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSC 292 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~ 292 (611)
...++|++++.||+|+||.||+|++..+++.||+|++...... ...++.+|+.+|+.++||||+++++++..++..|
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 92 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE---ELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLW 92 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----C---CHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHH---HHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEE
Confidence 3457999999999999999999999999999999999764322 2346678999999999999999999999999999
Q ss_pred EEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCc
Q 007260 293 LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 293 LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~ 372 (611)
+||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 93 lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 170 (302)
T 2j7t_A 93 IMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT- 170 (302)
T ss_dssp EEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-
T ss_pred EEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc-
Confidence 9999999999999887642 56999999999999999999999999999999999999999999999999987322100
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
.....
T Consensus 171 ---------------------------------------------------------------------------~~~~~ 175 (302)
T 2j7t_A 171 ---------------------------------------------------------------------------LQKRD 175 (302)
T ss_dssp ---------------------------------------------------------------------------HHC--
T ss_pred ---------------------------------------------------------------------------ccccc
Confidence 00012
Q ss_pred ccccCCCccchhhhc-----cCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCC-CCCCCCCCCHHHHHH
Q 007260 453 SFVGTHEYLAPEIIK-----GEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPL-RFPESPVVSFAARDL 526 (611)
Q Consensus 453 ~~vGT~~Y~APEil~-----~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l-~~p~~~~~s~~l~dL 526 (611)
..+||+.|+|||++. +..++.++|||||||++|+|++|+.||........+..+..... .......++..+.+|
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (302)
T 2j7t_A 176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDF 255 (302)
T ss_dssp ---CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHH
T ss_pred cccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHHHH
Confidence 346999999999984 66789999999999999999999999998887777666655432 233345689999999
Q ss_pred HHHhhhcCccccCCchhcHHHHHcCCCCCCCchh
Q 007260 527 IRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWA 560 (611)
Q Consensus 527 I~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~ 560 (611)
|.+||..||.+||+ +.++++||||+++.|.
T Consensus 256 i~~~l~~dp~~Rps----~~~ll~h~~~~~~~~~ 285 (302)
T 2j7t_A 256 LKIALDKNPETRPS----AAQLLEHPFVSSITSN 285 (302)
T ss_dssp HHHHSCSCTTTSCC----HHHHTTSTTTTTCCCC
T ss_pred HHHHcccChhhCCC----HHHHhcChHHhhhccc
Confidence 99999999999999 9999999999987764
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=405.55 Aligned_cols=258 Identities=19% Similarity=0.276 Sum_probs=215.6
Q ss_pred ccccCeEEEeEecccCcEEEEEEEEC-------CCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccce
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELS-------GTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTH 284 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~-------~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~ 284 (611)
+..++|++++.||+|+||.||+|++. .++..||||++.... ......++.+|+.+|+.+ +|||||+++++
T Consensus 78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 155 (370)
T 2psq_A 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGA 155 (370)
T ss_dssp CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 44579999999999999999999975 346689999997653 234556788999999999 89999999999
Q ss_pred eeccceeeEEeeeCCCCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEE
Q 007260 285 FETEKFSCLVMEFCPGGDLHTLRQKQP--------------GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVL 350 (611)
Q Consensus 285 ~~~~~~~~LVmE~~~gg~L~~ll~~~~--------------~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNIL 350 (611)
|...+.+||||||++||+|.+++.... ...+++..+..++.||+.||+|||++|||||||||+|||
T Consensus 156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl 235 (370)
T 2psq_A 156 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 235 (370)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred EccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEE
Confidence 999999999999999999999988653 235899999999999999999999999999999999999
Q ss_pred EccCCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCcc
Q 007260 351 VREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKN 430 (611)
Q Consensus 351 v~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 430 (611)
|+.+|++||+|||++..+.....
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~--------------------------------------------------------- 258 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDY--------------------------------------------------------- 258 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCT---------------------------------------------------------
T ss_pred ECCCCCEEEccccCCcccCcccc---------------------------------------------------------
Confidence 99999999999999854321100
Q ss_pred ccCCCCCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcC
Q 007260 431 EIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQ 509 (611)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~ 509 (611)
........||+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+.+..+...
T Consensus 259 -----------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 321 (370)
T 2psq_A 259 -----------------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 321 (370)
T ss_dssp -----------------TCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT
T ss_pred -----------------eecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Confidence 000112358899999999999999999999999999999998 99999987766555444433
Q ss_pred CCCCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcC
Q 007260 510 PLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 510 ~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~H 551 (611)
...+....++.++.+||.+||..||.+||+ +.|++++
T Consensus 322 -~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt----~~ell~~ 358 (370)
T 2psq_A 322 -HRMDKPANCTNELYMMMRDCWHAVPSQRPT----FKQLVED 358 (370)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 334444569999999999999999999999 7777753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=394.49 Aligned_cols=258 Identities=23% Similarity=0.317 Sum_probs=213.2
Q ss_pred CccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc
Q 007260 210 DGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK 289 (611)
Q Consensus 210 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~ 289 (611)
+..+..++|++.+.||+|+||+||+|++. +..||||++...... .....++.+|+.+|+.++||||+++++++....
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFH-AERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP 107 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCCS-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 34455679999999999999999999874 677999999765433 344567889999999999999999999999999
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHcC--eeccCCCCCcEEEccCCcEEEEeccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPG-KYFPEQAVRFYVAEVLLALEYLHMLG--IIYRDLKPENVLVREDGHIMLSDFDLSL 366 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~-~~l~e~~~~~i~~qll~aL~yLH~~g--IVHRDLKPeNILv~~~g~vkL~DFGlA~ 366 (611)
.+|||||||+||+|.+++..... ..+++..++.++.||+.||+|||++| ||||||||+||||+.++.+||+|||++.
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 187 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence 99999999999999999886521 23899999999999999999999999 9999999999999999999999999984
Q ss_pred cccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCc
Q 007260 367 RCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEP 446 (611)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (611)
.....
T Consensus 188 ~~~~~--------------------------------------------------------------------------- 192 (309)
T 3p86_A 188 LKAST--------------------------------------------------------------------------- 192 (309)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccccc---------------------------------------------------------------------------
Confidence 21100
Q ss_pred ccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 007260 447 TEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDL 526 (611)
Q Consensus 447 ~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dL 526 (611)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+......+..+.......+....++.++.+|
T Consensus 193 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 271 (309)
T 3p86_A 193 -FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAI 271 (309)
T ss_dssp ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHH
T ss_pred -ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHH
Confidence 0011234699999999999999999999999999999999999999999887777766654444445555699999999
Q ss_pred HHHhhhcCccccCCchhcHHHHHc
Q 007260 527 IRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 527 I~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
|.+||..||.+||+ +.++++
T Consensus 272 i~~~l~~dP~~Rps----~~~ll~ 291 (309)
T 3p86_A 272 IEGCWTNEPWKRPS----FATIMD 291 (309)
T ss_dssp HHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHccCChhhCcC----HHHHHH
Confidence 99999999999999 777776
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=386.62 Aligned_cols=253 Identities=19% Similarity=0.319 Sum_probs=208.6
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeeccceeeEE
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~~~~~LV 294 (611)
++|++++.||+|+||+||+|++..+++.||||++....... ....++.+|+.++..+ +||||+++++++.+.+..|||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS-HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 58999999999999999999999999999999997643322 2344667899999999 999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCC-----------------
Q 007260 295 MEFCPGGDLHTLRQKQP--GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDG----------------- 355 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~--~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g----------------- 355 (611)
|||++|++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+||||+.++
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 99999999999987642 24689999999999999999999999999999999999998544
Q ss_pred --cEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccC
Q 007260 356 --HIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIG 433 (611)
Q Consensus 356 --~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 433 (611)
.+||+|||++.....
T Consensus 170 ~~~~kl~Dfg~~~~~~~--------------------------------------------------------------- 186 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISS--------------------------------------------------------------- 186 (289)
T ss_dssp CCCEEECCCTTCEETTC---------------------------------------------------------------
T ss_pred ceEEEEcccccccccCC---------------------------------------------------------------
Confidence 799999998843210
Q ss_pred CCCCCCcccccCcccccccccccCCCccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCC
Q 007260 434 NQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLR 512 (611)
Q Consensus 434 ~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~-~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~ 512 (611)
.....||+.|+|||++.+. .++.++|||||||++|+|++|.++|.... ....+......
T Consensus 187 -----------------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~~~~~~~ 246 (289)
T 1x8b_A 187 -----------------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEIRQGRLP 246 (289)
T ss_dssp -----------------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHHHHTTCCC
T ss_pred -----------------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHHHHcCCCC
Confidence 0112489999999999876 55789999999999999999998876543 23333433321
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 513 FPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 513 ~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
.....++.++++||.+||..||.+||+ +.++++||||.+.
T Consensus 247 -~~~~~~~~~~~~li~~~l~~dp~~Rps----~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 247 -RIPQVLSQEFTELLKVMIHPDPERRPS----AMALVKHSVLLSA 286 (289)
T ss_dssp -CCSSCCCHHHHHHHHHHTCSSGGGSCC----HHHHHTCTTC---
T ss_pred -CCCcccCHHHHHHHHHHhCCCcccCCC----HHHHhhChHhhhh
Confidence 223458999999999999999999999 9999999999753
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=415.71 Aligned_cols=262 Identities=19% Similarity=0.218 Sum_probs=201.6
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC--CCCCcccccc-------eee
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL--DHPFLPTLYT-------HFE 286 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l--~HpnIv~l~~-------~~~ 286 (611)
..|++++.||+|+||.||+|++..+++.||||++.+...........+++|+.+++.| +||||++++. ++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 3599999999999999999999999999999999886655555666777885554444 6999887653 332
Q ss_pred cc-----------------ceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHH------HHHHHHHHHHHHHHHHcCeeccC
Q 007260 287 TE-----------------KFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAV------RFYVAEVLLALEYLHMLGIIYRD 343 (611)
Q Consensus 287 ~~-----------------~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~------~~i~~qll~aL~yLH~~gIVHRD 343 (611)
.. ..+|||||||+ |+|.+++.... ..+.+... ..++.||+.||+|||++||||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 22 45899999997 89999988642 23444444 56669999999999999999999
Q ss_pred CCCCcEEEccCCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccc
Q 007260 344 LKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSK 423 (611)
Q Consensus 344 LKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (611)
|||+||||+.+|.+||+|||++.....
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~----------------------------------------------------- 246 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGT----------------------------------------------------- 246 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTC-----------------------------------------------------
T ss_pred CCHHHEEECCCCCEEEEecceeeecCC-----------------------------------------------------
Confidence 999999999999999999999843210
Q ss_pred cCCCCccccCCCCCCCcccccCcccccccccccCCCccchhhhcc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHH
Q 007260 424 KDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKG--EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRA 501 (611)
Q Consensus 424 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~--~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~ 501 (611)
......||+.|+|||++.+ ..++.++|||||||+||||++|+.||.+.....
T Consensus 247 --------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~ 300 (371)
T 3q60_A 247 --------------------------RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300 (371)
T ss_dssp --------------------------EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTC
T ss_pred --------------------------CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCccc
Confidence 0012357799999999988 678999999999999999999999998763321
Q ss_pred H--H-----HHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCchhhh
Q 007260 502 T--L-----FNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALI 562 (611)
Q Consensus 502 ~--l-----~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~ 562 (611)
. + .......+.++....++..+++||.+||..||.+||+ +.++|+||||+++.|...
T Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~e~l~hp~f~~~~~~~~ 364 (371)
T 3q60_A 301 KGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLL----PLEAMETPEFLQLQNEIS 364 (371)
T ss_dssp TTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCC----HHHHTTSHHHHHHHHHHH
T ss_pred ccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCC----HHHHhcCHHHHHHHHHHh
Confidence 0 0 0111223445555679999999999999999999999 999999999999988754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=421.53 Aligned_cols=252 Identities=16% Similarity=0.197 Sum_probs=202.3
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHH---HHHhCCCCCccccc-------ce
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTERE---ILQSLDHPFLPTLY-------TH 284 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~---iL~~l~HpnIv~l~-------~~ 284 (611)
.++|++++.||+|+||+||+|++..+++.||||++.+...........+.+|+. +|+.++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 368999999999999999999999999999999998654444445567788995 45555899999998 55
Q ss_pred eeccc-----------------eeeEEeeeCCCCCHHHHHHhCCCCCCC-------HHHHHHHHHHHHHHHHHHHHcCee
Q 007260 285 FETEK-----------------FSCLVMEFCPGGDLHTLRQKQPGKYFP-------EQAVRFYVAEVLLALEYLHMLGII 340 (611)
Q Consensus 285 ~~~~~-----------------~~~LVmE~~~gg~L~~ll~~~~~~~l~-------e~~~~~i~~qll~aL~yLH~~gIV 340 (611)
++..+ ..||||||| +|+|.+++... +.++ +..+..|+.||+.||+|||++|||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~--~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv 228 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVL--LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV 228 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHH--HHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhc--cccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence 54443 389999999 78999998864 2244 488888999999999999999999
Q ss_pred ccCCCCCcEEEccCCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCccccc
Q 007260 341 YRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSS 420 (611)
Q Consensus 341 HRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (611)
||||||+||||+.+|.+||+|||+++...
T Consensus 229 HrDikp~NIll~~~~~~kL~DFG~a~~~~--------------------------------------------------- 257 (377)
T 3byv_A 229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDG--------------------------------------------------- 257 (377)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETT---------------------------------------------------
T ss_pred cCCCCHHHEEEcCCCCEEEEechhheecC---------------------------------------------------
Confidence 99999999999999999999999984311
Q ss_pred ccccCCCCccccCCCCCCCcccccCcccccccccccCCCccchhhhccC-----------CCCChhhHHHHHHHHHHHHh
Q 007260 421 KSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGE-----------GHGSAVDWWTFGIFLYELLF 489 (611)
Q Consensus 421 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~-----------~~~~~sDIWSLGviL~ELlt 489 (611)
......+| +.|+|||++.+. .++.++|||||||+||||++
T Consensus 258 ----------------------------~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ellt 308 (377)
T 3byv_A 258 ----------------------------ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308 (377)
T ss_dssp ----------------------------CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHH
T ss_pred ----------------------------CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHH
Confidence 01123468 999999999988 89999999999999999999
Q ss_pred CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCch
Q 007260 490 GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNW 559 (611)
Q Consensus 490 G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 559 (611)
|+.||.+......+..+.. ....++.++++||.+||..||.+||+ +.++++||||+++..
T Consensus 309 g~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt----~~e~l~hp~f~~~~~ 368 (377)
T 3byv_A 309 ADLPITKDAALGGSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLL----PLQAMETPEYEQLRT 368 (377)
T ss_dssp SSCCC------CCSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCC----HHHHHTSHHHHHHHH
T ss_pred CCCCCcccccccchhhhhh------hccCCCHHHHHHHHHHcCCCchhCCC----HHHHhhChHHHHHHH
Confidence 9999987554433322222 22458999999999999999999999 999999999987643
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=399.63 Aligned_cols=261 Identities=33% Similarity=0.525 Sum_probs=212.4
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhh-----hHHHHHHHHHHHHHHHhCCCCCcccccceeeccce
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLA-----GRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKF 290 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~-----~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~ 290 (611)
++|++++.||+|+||.||+|++..+++.||||++.+.... .......+.+|+.+|+.++||||+++++++..+.
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 5899999999999999999999999999999999765432 1122345678999999999999999999987665
Q ss_pred eeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCc---EEEEecccccc
Q 007260 291 SCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGH---IMLSDFDLSLR 367 (611)
Q Consensus 291 ~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~---vkL~DFGlA~~ 367 (611)
.|+||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++. +||+|||++..
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 89999999999999988764 56999999999999999999999999999999999999987664 99999999843
Q ss_pred ccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcc
Q 007260 368 CAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPT 447 (611)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (611)
....
T Consensus 167 ~~~~---------------------------------------------------------------------------- 170 (322)
T 2ycf_A 167 LGET---------------------------------------------------------------------------- 170 (322)
T ss_dssp CCCC----------------------------------------------------------------------------
T ss_pred cccc----------------------------------------------------------------------------
Confidence 2100
Q ss_pred cccccccccCCCccchhhhc---cCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHH-HHHHcCCCCCCC--CCCCCH
Q 007260 448 EARSMSFVGTHEYLAPEIIK---GEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATL-FNVVGQPLRFPE--SPVVSF 521 (611)
Q Consensus 448 ~~~~~~~vGT~~Y~APEil~---~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l-~~i~~~~l~~p~--~~~~s~ 521 (611)
......+||+.|+|||++. ...++.++|||||||++|+|++|+.||........+ ..+......+.. ...++.
T Consensus 171 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (322)
T 2ycf_A 171 -SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 249 (322)
T ss_dssp -HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSCH
T ss_pred -cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhcCH
Confidence 0112346999999999985 456899999999999999999999999875543222 233333333221 235899
Q ss_pred HHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCchh
Q 007260 522 AARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWA 560 (611)
Q Consensus 522 ~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~ 560 (611)
.+.+||.+||..||.+||+ +.++|+||||++.+|.
T Consensus 250 ~~~~li~~~l~~dP~~Rps----~~~~l~h~~~~~~~~~ 284 (322)
T 2ycf_A 250 KALDLVKKLLVVDPKARFT----TEEALRHPWLQDEDMK 284 (322)
T ss_dssp HHHHHHHHHSCSSTTTSCC----HHHHHTSGGGCCHHHH
T ss_pred HHHHHHHHHcccCHhhCCC----HHHHhhCcCcCCHHHH
Confidence 9999999999999999999 9999999999987764
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=393.71 Aligned_cols=263 Identities=26% Similarity=0.410 Sum_probs=217.4
Q ss_pred ccCeEEEeEecccCcEEEEEEEEC-CCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC---CCCCcccccceee----
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELS-GTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL---DHPFLPTLYTHFE---- 286 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~-~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l---~HpnIv~l~~~~~---- 286 (611)
.++|++++.||+|+||.||+|++. .+++.||||++....... .....+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 368999999999999999999995 678999999987543211 1111334577776665 8999999999987
Q ss_pred -ccceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccc
Q 007260 287 -TEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365 (611)
Q Consensus 287 -~~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA 365 (611)
....+||||||+. |+|.+++.......+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||++
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence 6688999999996 69999998876667999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccC
Q 007260 366 LRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAE 445 (611)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (611)
......
T Consensus 168 ~~~~~~-------------------------------------------------------------------------- 173 (326)
T 1blx_A 168 RIYSFQ-------------------------------------------------------------------------- 173 (326)
T ss_dssp CCCCGG--------------------------------------------------------------------------
T ss_pred ccccCC--------------------------------------------------------------------------
Confidence 432100
Q ss_pred cccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcC---C--CCCC------
Q 007260 446 PTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ---P--LRFP------ 514 (611)
Q Consensus 446 ~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~---~--l~~p------ 514 (611)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+......+..++.. + ..++
T Consensus 174 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 250 (326)
T 1blx_A 174 ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 250 (326)
T ss_dssp ---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSC
T ss_pred ---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccc
Confidence 0112346999999999999999999999999999999999999999998877776665521 1 0000
Q ss_pred --------------CCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCchh
Q 007260 515 --------------ESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWA 560 (611)
Q Consensus 515 --------------~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~ 560 (611)
....++..+++||.+||..||.+||+ +.++++||||+.+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~e~l~hp~~~~~~~~ 306 (326)
T 1blx_A 251 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS----AYSALSHPYFQDLERC 306 (326)
T ss_dssp GGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCC----HHHHHTSGGGTTCCCC
T ss_pred hhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCC----HHHHhcCccccccchh
Confidence 12358899999999999999999999 9999999999987654
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=397.35 Aligned_cols=255 Identities=30% Similarity=0.421 Sum_probs=212.7
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccce-----
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKF----- 290 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~----- 290 (611)
++|.+.+.||+|+||.||+|++..+++.||||++.... .......++.+|+.+|+.++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 68999999999999999999999999999999997643 333455677899999999999999999999987654
Q ss_pred -eeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 291 -SCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 291 -~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
+|+||||+. ++|.+++.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred eEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 499999995 688776543 49999999999999999999999999999999999999999999999999983211
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
.
T Consensus 178 ~------------------------------------------------------------------------------- 178 (353)
T 3coi_A 178 A------------------------------------------------------------------------------- 178 (353)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred C-------------------------------------------------------------------------------
Confidence 0
Q ss_pred cccccccCCCccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcC---C---------------
Q 007260 450 RSMSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ---P--------------- 510 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~-~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~---~--------------- 510 (611)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+... +
T Consensus 179 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 258 (353)
T 3coi_A 179 EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKS 258 (353)
T ss_dssp -----CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHH
T ss_pred CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHH
Confidence 0112468999999999987 67899999999999999999999999988766655544321 0
Q ss_pred ----------CCC-CCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCch
Q 007260 511 ----------LRF-PESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNW 559 (611)
Q Consensus 511 ----------l~~-p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 559 (611)
..+ .....++.++++||.+||..||.+||+ +.++|+||||+.+.+
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt----~~e~l~hp~f~~~~~ 314 (353)
T 3coi_A 259 YIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT----AAQALTHPFFEPFRD 314 (353)
T ss_dssp HHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCC----HHHHHTSGGGTTTCC
T ss_pred HHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCC----HHHHhcCcchhhccC
Confidence 011 112357999999999999999999999 999999999987644
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=402.87 Aligned_cols=260 Identities=27% Similarity=0.442 Sum_probs=199.7
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc-----
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK----- 289 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~----- 289 (611)
+++|++++.||+|+||.||+|++..+++.||||++....... .+..+|+..|..++||||++++++|....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~ 97 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence 579999999999999999999999999999999986543222 23456788888899999999999986533
Q ss_pred --eeeEEeeeCCCCCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHH--HcCeeccCCCCCcEEEcc-CCcEEEEec
Q 007260 290 --FSCLVMEFCPGGDLHTLRQK--QPGKYFPEQAVRFYVAEVLLALEYLH--MLGIIYRDLKPENVLVRE-DGHIMLSDF 362 (611)
Q Consensus 290 --~~~LVmE~~~gg~L~~ll~~--~~~~~l~e~~~~~i~~qll~aL~yLH--~~gIVHRDLKPeNILv~~-~g~vkL~DF 362 (611)
++||||||+++ +|...+.. .....+++..++.++.||+.||.||| ++|||||||||+||||+. ++.+||+||
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Df 176 (360)
T 3e3p_A 98 DIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDF 176 (360)
T ss_dssp CEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCC
T ss_pred ceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeC
Confidence 38999999976 55443332 23467899999999999999999999 999999999999999997 899999999
Q ss_pred cccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCccc
Q 007260 363 DLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPEL 442 (611)
Q Consensus 363 GlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (611)
|++..+...
T Consensus 177 g~a~~~~~~----------------------------------------------------------------------- 185 (360)
T 3e3p_A 177 GSAKKLSPS----------------------------------------------------------------------- 185 (360)
T ss_dssp TTCBCCCTT-----------------------------------------------------------------------
T ss_pred CCceecCCC-----------------------------------------------------------------------
Confidence 998432210
Q ss_pred ccCcccccccccccCCCccchhhhccCC-CCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcC---CC-------
Q 007260 443 IAEPTEARSMSFVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ---PL------- 511 (611)
Q Consensus 443 ~~~~~~~~~~~~vGT~~Y~APEil~~~~-~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~---~l------- 511 (611)
......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+......+..++.. +.
T Consensus 186 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (360)
T 3e3p_A 186 ------EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKL 259 (360)
T ss_dssp ------SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred ------CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhc
Confidence 0011346899999999997765 799999999999999999999999998877766655431 10
Q ss_pred -------CC-------------CCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCchh
Q 007260 512 -------RF-------------PESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWA 560 (611)
Q Consensus 512 -------~~-------------p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~ 560 (611)
.+ ......+.++++||.+||+.||.+||+ +.|+|+||||+++.+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~e~l~hp~f~~~~~~ 324 (360)
T 3e3p_A 260 NPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMK----PYEALCHPYFDELHDP 324 (360)
T ss_dssp CTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCC----HHHHTTSGGGGGGGCT
T ss_pred ccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCC----HHHHhcCccccccCCc
Confidence 00 011225689999999999999999999 9999999999987553
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=393.24 Aligned_cols=270 Identities=26% Similarity=0.386 Sum_probs=201.0
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSC 292 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~ 292 (611)
+..++|++++.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+|+.++||||+++++++...+..|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence 345799999999999999999999998999999999875432 223446778999999999999999999999999999
Q ss_pred EEeeeCCCCCHHHHHHh------CCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccc
Q 007260 293 LVMEFCPGGDLHTLRQK------QPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSL 366 (611)
Q Consensus 293 LVmE~~~gg~L~~ll~~------~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~ 366 (611)
+||||++|++|.+++.. .....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 99999999999998874 123569999999999999999999999999999999999999999999999999985
Q ss_pred cccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCc
Q 007260 367 RCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEP 446 (611)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (611)
.........
T Consensus 170 ~~~~~~~~~----------------------------------------------------------------------- 178 (303)
T 2vwi_A 170 FLATGGDIT----------------------------------------------------------------------- 178 (303)
T ss_dssp HCC-----------------------------------------------------------------------------
T ss_pred eeccCCCcc-----------------------------------------------------------------------
Confidence 432110000
Q ss_pred ccccccccccCCCccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCC--------CCCC
Q 007260 447 TEARSMSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRF--------PESP 517 (611)
Q Consensus 447 ~~~~~~~~vGT~~Y~APEil~~-~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~--------p~~~ 517 (611)
........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+......+.......... ....
T Consensus 179 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (303)
T 2vwi_A 179 RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLK 258 (303)
T ss_dssp ---------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCC
T ss_pred chhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccccchhhh
Confidence 0001123469999999999976 568999999999999999999999999877666655554432211 1124
Q ss_pred CCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCch
Q 007260 518 VVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNW 559 (611)
Q Consensus 518 ~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 559 (611)
.++.++++||.+||..||.+||+ +.++++||||+...+
T Consensus 259 ~~~~~~~~li~~~l~~dp~~Rps----~~~ll~h~~~~~~~~ 296 (303)
T 2vwi_A 259 KYGKSFRKMISLCLQKDPEKRPT----AAELLRHKFFQKAKN 296 (303)
T ss_dssp CCCHHHHHHHHHHCCSSGGGSCC----HHHHHTSTTC-----
T ss_pred hhhHHHHHHHHHHccCChhhCcC----HHHHhhChhhhcCCC
Confidence 57899999999999999999999 999999999987654
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=398.82 Aligned_cols=264 Identities=24% Similarity=0.353 Sum_probs=216.3
Q ss_pred ccccccCeEEEeEecccCcEEEEEEEECCCC-eEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCC------cccccc
Q 007260 211 GVLGLSHFRLLKRLGCGDIGSVYLSELSGTK-CYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF------LPTLYT 283 (611)
Q Consensus 211 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~-~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~Hpn------Iv~l~~ 283 (611)
+....++|++++.||+|+||+||+|.+..++ ..||||++.... .....+.+|+.+|+.+.|++ |+.+++
T Consensus 14 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~ 89 (355)
T 2eu9_A 14 GDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----KYREAARLEINVLKKIKEKDKENKFLCVLMSD 89 (355)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEE
T ss_pred CceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc----cchhHHHHHHHHHHHHhhcCCCCceeEEEeee
Confidence 3334579999999999999999999998776 799999997543 23345677999999887655 899999
Q ss_pred eeeccceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEE------------
Q 007260 284 HFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLV------------ 351 (611)
Q Consensus 284 ~~~~~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv------------ 351 (611)
++...+.+||||||+ +++|.+++.......+++..++.++.||+.||+|||++|||||||||+||||
T Consensus 90 ~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 90 WFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC
T ss_pred eeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccc
Confidence 999999999999999 7778777776655679999999999999999999999999999999999999
Q ss_pred -------ccCCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCccccccccc
Q 007260 352 -------REDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKK 424 (611)
Q Consensus 352 -------~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (611)
+.++.+||+|||++.....
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~------------------------------------------------------ 194 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHE------------------------------------------------------ 194 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTS------------------------------------------------------
T ss_pred ccccccccCCCcEEEeecCccccccc------------------------------------------------------
Confidence 5678999999999843110
Q ss_pred CCCCccccCCCCCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Q 007260 425 DRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLF 504 (611)
Q Consensus 425 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~ 504 (611)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+......+.
T Consensus 195 -------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 249 (355)
T 2eu9_A 195 -------------------------HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV 249 (355)
T ss_dssp -------------------------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred -------------------------cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 0113469999999999999999999999999999999999999999877665543
Q ss_pred HHHcCCCCCC------------------------------------------CCCCCCHHHHHHHHHhhhcCccccCCch
Q 007260 505 NVVGQPLRFP------------------------------------------ESPVVSFAARDLIRGLLVKEPQHRLAYK 542 (611)
Q Consensus 505 ~i~~~~l~~p------------------------------------------~~~~~s~~l~dLI~~~L~~dP~~Rpt~~ 542 (611)
.+......+| .....+.++.+||.+||..||.+||+
T Consensus 250 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt-- 327 (355)
T 2eu9_A 250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT-- 327 (355)
T ss_dssp HHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC--
T ss_pred HHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC--
Confidence 3221100000 11123458899999999999999999
Q ss_pred hcHHHHHcCCCCCCCchhhh
Q 007260 543 RGATEIKQHPFFEGVNWALI 562 (611)
Q Consensus 543 ~~a~elL~Hp~f~~~~~~~~ 562 (611)
+.|+|+||||++++|...
T Consensus 328 --~~e~l~hp~f~~~~~~~~ 345 (355)
T 2eu9_A 328 --LAEALLHPFFAGLTPEER 345 (355)
T ss_dssp --HHHHTTSGGGGGCCHHHH
T ss_pred --HHHHhcChhhcCCChhhc
Confidence 999999999999888654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-47 Score=391.31 Aligned_cols=260 Identities=29% Similarity=0.468 Sum_probs=218.6
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
.++|++++.||.|+||.||+|.+..+++.||||++..... ...+.+|+.+|+.++||||+++++++...+.+|||
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 4689999999999999999999999999999999976432 23567899999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
|||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 103 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--- 178 (314)
T 3com_A 103 MEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT--- 178 (314)
T ss_dssp EECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT---
T ss_pred eecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh---
Confidence 9999999999998743 256999999999999999999999999999999999999999999999999998433210
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
.......
T Consensus 179 -------------------------------------------------------------------------~~~~~~~ 185 (314)
T 3com_A 179 -------------------------------------------------------------------------MAKRNTV 185 (314)
T ss_dssp -------------------------------------------------------------------------BSCBCCC
T ss_pred -------------------------------------------------------------------------ccccCcc
Confidence 0011234
Q ss_pred ccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCC-CCCCCCCCCCHHHHHHHHHhhhc
Q 007260 455 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQP-LRFPESPVVSFAARDLIRGLLVK 533 (611)
Q Consensus 455 vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~-l~~p~~~~~s~~l~dLI~~~L~~ 533 (611)
.||+.|+|||++.+..++.++|||||||++|+|++|+.||........+..+.... ..+.....++..+.+||.+||..
T Consensus 186 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 265 (314)
T 3com_A 186 IGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVK 265 (314)
T ss_dssp CSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHTCS
T ss_pred CCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHHHccC
Confidence 69999999999999999999999999999999999999999877766665554433 33334445899999999999999
Q ss_pred CccccCCchhcHHHHHcCCCCCCCchh
Q 007260 534 EPQHRLAYKRGATEIKQHPFFEGVNWA 560 (611)
Q Consensus 534 dP~~Rpt~~~~a~elL~Hp~f~~~~~~ 560 (611)
||.+||+ +.++++||||++..+.
T Consensus 266 dp~~Rpt----~~~ll~~~~~~~~~~~ 288 (314)
T 3com_A 266 SPEQRAT----ATQLLQHPFVRSAKGV 288 (314)
T ss_dssp CTTTSCC----HHHHTTSHHHHTCCCG
T ss_pred ChhhCcC----HHHHHhCHHHhcCCcc
Confidence 9999999 9999999999876543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-47 Score=393.98 Aligned_cols=275 Identities=22% Similarity=0.335 Sum_probs=205.8
Q ss_pred cCccccccCeEEEeEecccCcEEEEEEEECCCCe---EEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCccccccee
Q 007260 209 RDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKC---YFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHF 285 (611)
Q Consensus 209 ~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~---~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~ 285 (611)
.+..+..++|++++.||+|+||.||+|++..++. .||||++....... ....++.+|+.+|+.++||||+++++++
T Consensus 16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 94 (323)
T 3qup_A 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKLVGVS 94 (323)
T ss_dssp CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehhhcee
Confidence 3455566899999999999999999999887765 89999997654332 3456788999999999999999999999
Q ss_pred ecccee------eEEeeeCCCCCHHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCC
Q 007260 286 ETEKFS------CLVMEFCPGGDLHTLRQKQP----GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDG 355 (611)
Q Consensus 286 ~~~~~~------~LVmE~~~gg~L~~ll~~~~----~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g 355 (611)
...... |+||||+.+|+|.+++.... ...+++..++.++.||+.||+|||++||+||||||+||||+.++
T Consensus 95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM 174 (323)
T ss_dssp ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS
T ss_pred eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC
Confidence 876655 99999999999999886532 12589999999999999999999999999999999999999999
Q ss_pred cEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCC
Q 007260 356 HIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQ 435 (611)
Q Consensus 356 ~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (611)
.+||+|||++........
T Consensus 175 ~~kl~Dfg~a~~~~~~~~-------------------------------------------------------------- 192 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDY-------------------------------------------------------------- 192 (323)
T ss_dssp CEEECCCCC-----------------------------------------------------------------------
T ss_pred CEEEeecccccccccccc--------------------------------------------------------------
Confidence 999999999844321100
Q ss_pred CCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCC
Q 007260 436 VSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFP 514 (611)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p 514 (611)
........||+.|+|||++.+..++.++|||||||++|||++ |+.||.+......+..+.... ..+
T Consensus 193 ------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~-~~~ 259 (323)
T 3qup_A 193 ------------YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN-RLK 259 (323)
T ss_dssp --------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CCC
T ss_pred ------------ccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC-CCC
Confidence 000112347889999999999999999999999999999999 999999988777766666543 334
Q ss_pred CCCCCCHHHHHHHHHhhhcCccccCCch---hcHHHHHcCCCCCCCch
Q 007260 515 ESPVVSFAARDLIRGLLVKEPQHRLAYK---RGATEIKQHPFFEGVNW 559 (611)
Q Consensus 515 ~~~~~s~~l~dLI~~~L~~dP~~Rpt~~---~~a~elL~Hp~f~~~~~ 559 (611)
....++.++.+||.+||..||.+||++. ..+++++.|+|+....+
T Consensus 260 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~ 307 (323)
T 3qup_A 260 QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ 307 (323)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--------
T ss_pred CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCC
Confidence 4456899999999999999999999954 34677889999976433
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=391.67 Aligned_cols=263 Identities=25% Similarity=0.364 Sum_probs=210.9
Q ss_pred cccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceee-------
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFE------- 286 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~------- 286 (611)
..++|++++.||+|+||.||+|++..+++.||||++.... .....++.+|+.+|+.++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 85 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT 85 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC---hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence 3479999999999999999999999999999999987543 344556788999999999999999998873
Q ss_pred -------ccceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEc-cCCcEE
Q 007260 287 -------TEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVR-EDGHIM 358 (611)
Q Consensus 287 -------~~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~-~~g~vk 358 (611)
.....||||||+. |+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+|
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 86 DDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp C----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEE
T ss_pred cccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEE
Confidence 4478899999996 699998865 4599999999999999999999999999999999999997 567999
Q ss_pred EEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCC
Q 007260 359 LSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSP 438 (611)
Q Consensus 359 L~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (611)
|+|||++........
T Consensus 162 l~Dfg~~~~~~~~~~----------------------------------------------------------------- 176 (320)
T 2i6l_A 162 IGDFGLARIMDPHYS----------------------------------------------------------------- 176 (320)
T ss_dssp ECCCTTCBCC----------------------------------------------------------------------
T ss_pred EccCccccccCCCcc-----------------------------------------------------------------
Confidence 999999843321000
Q ss_pred CcccccCcccccccccccCCCccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCC-----
Q 007260 439 LPELIAEPTEARSMSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLR----- 512 (611)
Q Consensus 439 ~~~~~~~~~~~~~~~~vGT~~Y~APEil~~-~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~----- 512 (611)
.........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+......+..+......
T Consensus 177 --------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (320)
T 2i6l_A 177 --------HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEED 248 (320)
T ss_dssp -----------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHH
T ss_pred --------cccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhh
Confidence 0001123458999999999876 67899999999999999999999999998877666555432110
Q ss_pred -----------------CC------CCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCchh
Q 007260 513 -----------------FP------ESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWA 560 (611)
Q Consensus 513 -----------------~p------~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~ 560 (611)
.+ ....++.++++||.+||..||.+||+ +.++|+||||+...|.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~~~~~~~p 315 (320)
T 2i6l_A 249 RQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLT----AEEALSHPYMSIYSFP 315 (320)
T ss_dssp HHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCC----HHHHHTSHHHHTTCC-
T ss_pred hhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCC----HHHHhCCcccccccCc
Confidence 01 01348999999999999999999999 9999999999877654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=401.15 Aligned_cols=260 Identities=22% Similarity=0.316 Sum_probs=216.4
Q ss_pred cccccCeEEEeEecccCcEEEEEEE-----ECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCccccccee
Q 007260 212 VLGLSHFRLLKRLGCGDIGSVYLSE-----LSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHF 285 (611)
Q Consensus 212 ~~~~~~y~l~~~LG~G~fG~Vy~a~-----~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~ 285 (611)
.+..++|++++.||+|+||.||+|+ +..+++.||||++..... ......+.+|+++|..+ +|||||++++++
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 95 (359)
T 3vhe_A 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGAC 95 (359)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCC--HHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence 3455799999999999999999999 456678999999976432 23445678999999999 799999999998
Q ss_pred ecc-ceeeEEeeeCCCCCHHHHHHhCCC----------------------------------------------------
Q 007260 286 ETE-KFSCLVMEFCPGGDLHTLRQKQPG---------------------------------------------------- 312 (611)
Q Consensus 286 ~~~-~~~~LVmE~~~gg~L~~ll~~~~~---------------------------------------------------- 312 (611)
... ..+|+|||||+||+|.+++.....
T Consensus 96 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3vhe_A 96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175 (359)
T ss_dssp CSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred ecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence 875 458999999999999999986532
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccccccC
Q 007260 313 ------------KYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSL 380 (611)
Q Consensus 313 ------------~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~ 380 (611)
..+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||++.......
T Consensus 176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~-------- 247 (359)
T 3vhe_A 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP-------- 247 (359)
T ss_dssp --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT--------
T ss_pred hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccc--------
Confidence 128999999999999999999999999999999999999999999999999984332110
Q ss_pred CCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCc
Q 007260 381 DAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEY 460 (611)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y 460 (611)
.........||+.|
T Consensus 248 ------------------------------------------------------------------~~~~~~~~~~t~~y 261 (359)
T 3vhe_A 248 ------------------------------------------------------------------DYVRKGDARLPLKW 261 (359)
T ss_dssp ------------------------------------------------------------------TCEEC--CEECGGG
T ss_pred ------------------------------------------------------------------cchhccccCCCcee
Confidence 00111234689999
Q ss_pred cchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccC
Q 007260 461 LAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRL 539 (611)
Q Consensus 461 ~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rp 539 (611)
+|||++.+..++.++|||||||++|||++ |+.||.+......+...+......+....+++++.+||.+||..||.+||
T Consensus 262 ~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 341 (359)
T 3vhe_A 262 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 341 (359)
T ss_dssp CCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred EChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCC
Confidence 99999999999999999999999999998 99999987766666555554444555556999999999999999999999
Q ss_pred CchhcHHHHHcC
Q 007260 540 AYKRGATEIKQH 551 (611)
Q Consensus 540 t~~~~a~elL~H 551 (611)
+ +.++++|
T Consensus 342 s----~~ell~~ 349 (359)
T 3vhe_A 342 T----FSELVEH 349 (359)
T ss_dssp C----HHHHHHH
T ss_pred C----HHHHHHH
Confidence 9 8888875
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=393.13 Aligned_cols=259 Identities=25% Similarity=0.322 Sum_probs=216.6
Q ss_pred ccccccCeEEEeEecccCcEEEEEEEECCCC---eEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 007260 211 GVLGLSHFRLLKRLGCGDIGSVYLSELSGTK---CYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET 287 (611)
Q Consensus 211 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~---~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~ 287 (611)
..+..++|++.+.||+|+||.||+|++..++ ..||||++.... .......+.+|+.+|+.++||||+++++++.+
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 3455679999999999999999999997554 459999997543 22344567889999999999999999999999
Q ss_pred cceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccc
Q 007260 288 EKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLR 367 (611)
Q Consensus 288 ~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~ 367 (611)
++..||||||++|++|.+++.... ..+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||++..
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred CCccEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 999999999999999999987653 5699999999999999999999999999999999999999999999999999854
Q ss_pred ccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcc
Q 007260 368 CAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPT 447 (611)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (611)
.......
T Consensus 201 ~~~~~~~------------------------------------------------------------------------- 207 (325)
T 3kul_A 201 LEDDPDA------------------------------------------------------------------------- 207 (325)
T ss_dssp CC----C-------------------------------------------------------------------------
T ss_pred cccCccc-------------------------------------------------------------------------
Confidence 3211100
Q ss_pred cccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 007260 448 EARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDL 526 (611)
Q Consensus 448 ~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dL 526 (611)
........||+.|+|||++.+..++.++|||||||++|||++ |+.||.+......+..+... ...+....++.++.+|
T Consensus 208 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~l 286 (325)
T 3kul_A 208 AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG-YRLPAPMGCPHALHQL 286 (325)
T ss_dssp CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT-CCCCCCTTCCHHHHHH
T ss_pred eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-CCCCCCCCcCHHHHHH
Confidence 000112247889999999999999999999999999999998 99999998877766665544 4555556799999999
Q ss_pred HHHhhhcCccccCCchhcHHHHHc
Q 007260 527 IRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 527 I~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
|.+||..||.+||+ +.+|++
T Consensus 287 i~~~l~~dp~~Rps----~~eil~ 306 (325)
T 3kul_A 287 MLDCWHKDRAQRPR----FSQIVS 306 (325)
T ss_dssp HHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHccCChhhCcC----HHHHHH
Confidence 99999999999999 677665
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=406.14 Aligned_cols=268 Identities=17% Similarity=0.244 Sum_probs=220.6
Q ss_pred ccccCeEEEeEecccCcEEEEEEEE-----CCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSEL-----SGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET 287 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~-----~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~ 287 (611)
+..++|++++.||+|+||+||+|++ ..+++.||||++.... ......++.+|+.+|+.++|||||++++++..
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 145 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 145 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 3456899999999999999999994 4577899999996532 22334467789999999999999999999999
Q ss_pred cceeeEEeeeCCCCCHHHHHHhCC-----CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCC---cEEE
Q 007260 288 EKFSCLVMEFCPGGDLHTLRQKQP-----GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDG---HIML 359 (611)
Q Consensus 288 ~~~~~LVmE~~~gg~L~~ll~~~~-----~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g---~vkL 359 (611)
....|||||||+||+|.+++.... ...+++..++.++.||+.||+|||++|||||||||+||||+.+| .+||
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence 999999999999999999988642 24589999999999999999999999999999999999999655 5999
Q ss_pred EeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCC
Q 007260 360 SDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPL 439 (611)
Q Consensus 360 ~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (611)
+|||+++.+....
T Consensus 226 ~DFG~a~~~~~~~------------------------------------------------------------------- 238 (367)
T 3l9p_A 226 GDFGMARDIYRAG------------------------------------------------------------------- 238 (367)
T ss_dssp CCCHHHHHHHHHS-------------------------------------------------------------------
T ss_pred CCCcccccccccc-------------------------------------------------------------------
Confidence 9999985432100
Q ss_pred cccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCC
Q 007260 440 PELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPV 518 (611)
Q Consensus 440 ~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~ 518 (611)
........+||+.|+|||++.+..++.++|||||||+||||++ |..||.+......+..+.... ..+....
T Consensus 239 -------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~ 310 (367)
T 3l9p_A 239 -------YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG-RMDPPKN 310 (367)
T ss_dssp -------SCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-CCCCCTT
T ss_pred -------ccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCcc
Confidence 0001123468999999999999999999999999999999998 999999988777666665543 3333456
Q ss_pred CCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCchhh
Q 007260 519 VSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWAL 561 (611)
Q Consensus 519 ~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~ 561 (611)
++..+.+||.+||..||.+||+ +.+|++|.|+-..+...
T Consensus 311 ~~~~l~~li~~~l~~dP~~Rps----~~eil~~l~~~~~~~~~ 349 (367)
T 3l9p_A 311 CPGPVYRIMTQCWQHQPEDRPN----FAIILERIEYCTQDPDV 349 (367)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCC----HHHHHHHHHHHHHCHHH
T ss_pred CCHHHHHHHHHHcCCCHhHCcC----HHHHHHHHHHHhhChhh
Confidence 8999999999999999999999 99999987765444433
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=395.11 Aligned_cols=255 Identities=24% Similarity=0.397 Sum_probs=209.4
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc--eee
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK--FSC 292 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~--~~~ 292 (611)
.++|++++.||+|+||+||+|++..+++.||||++....... ....+.+|+++|+.++||||+++++++.... ..|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence 468999999999999999999999999999999997654322 2335578999999999999999999988654 789
Q ss_pred EEeeeCCCCCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEE----ccCCcEEEEecccccc
Q 007260 293 LVMEFCPGGDLHTLRQKQPG-KYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLV----REDGHIMLSDFDLSLR 367 (611)
Q Consensus 293 LVmE~~~gg~L~~ll~~~~~-~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv----~~~g~vkL~DFGlA~~ 367 (611)
||||||+|++|.+++..... ..+++..++.++.||+.||+|||++|||||||||+|||| +.++.+||+|||++..
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 99999999999999886432 349999999999999999999999999999999999999 7777899999999854
Q ss_pred ccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcc
Q 007260 368 CAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPT 447 (611)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (611)
+...
T Consensus 166 ~~~~---------------------------------------------------------------------------- 169 (319)
T 4euu_A 166 LEDD---------------------------------------------------------------------------- 169 (319)
T ss_dssp CCTT----------------------------------------------------------------------------
T ss_pred cCCC----------------------------------------------------------------------------
Confidence 3210
Q ss_pred cccccccccCCCccchhhhc--------cCCCCChhhHHHHHHHHHHHHhCCCCCCCCC----cHHHHHHHHcCCC----
Q 007260 448 EARSMSFVGTHEYLAPEIIK--------GEGHGSAVDWWTFGIFLYELLFGKTPFKGSG----NRATLFNVVGQPL---- 511 (611)
Q Consensus 448 ~~~~~~~vGT~~Y~APEil~--------~~~~~~~sDIWSLGviL~ELltG~~PF~~~~----~~~~l~~i~~~~l---- 511 (611)
......+||+.|+|||++. +..++.++|||||||++|||++|+.||.... ..+.+.+++....
T Consensus 170 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~ 248 (319)
T 4euu_A 170 -EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI 248 (319)
T ss_dssp -CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCC
T ss_pred -CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccc
Confidence 0111346999999999997 5678999999999999999999999997533 3445555554322
Q ss_pred ---------------CCCCC----CCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCC
Q 007260 512 ---------------RFPES----PVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHP 552 (611)
Q Consensus 512 ---------------~~p~~----~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp 552 (611)
.++.. ..++..+.+||.+||..||++||+ ++|+|+||
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s----~~ell~h~ 304 (319)
T 4euu_A 249 SGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG----FDQFFAET 304 (319)
T ss_dssp EEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCC----HHHHHHHH
T ss_pred hhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhcc----HHHhhhcc
Confidence 11221 124567889999999999999999 99999985
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=380.12 Aligned_cols=255 Identities=24% Similarity=0.352 Sum_probs=217.1
Q ss_pred ccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccce
Q 007260 211 GVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKF 290 (611)
Q Consensus 211 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~ 290 (611)
..+..++|++++.||+|+||.||+|++.. +..||||++....... ..+.+|+++|+.++||||+++++++.+++.
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 79 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 79 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTSBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred EEeChhhceeeheecCCCccEEEEEEecC-CCeEEEEEecccccCH----HHHHHHHHHHHhCCCCCEeeEEEEEecCCc
Confidence 34556799999999999999999999875 5679999998655333 246789999999999999999999999999
Q ss_pred eeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccC
Q 007260 291 SCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAV 370 (611)
Q Consensus 291 ~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~ 370 (611)
.|+||||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred eEEEEEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence 999999999999999987653 5699999999999999999999999999999999999999999999999999843321
Q ss_pred CccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccc
Q 007260 371 SPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEAR 450 (611)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (611)
.. ...
T Consensus 159 ~~---------------------------------------------------------------------------~~~ 163 (269)
T 4hcu_A 159 DQ---------------------------------------------------------------------------YTS 163 (269)
T ss_dssp HH---------------------------------------------------------------------------HHS
T ss_pred cc---------------------------------------------------------------------------ccc
Confidence 00 001
Q ss_pred ccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHH
Q 007260 451 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRG 529 (611)
Q Consensus 451 ~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~ 529 (611)
.....||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+......+..+... ........++..+.+||.+
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~ 242 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRLYKPRLASTHVYQIMNH 242 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CCCCCCTTSCHHHHHHHHH
T ss_pred ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC-ccCCCCCcCCHHHHHHHHH
Confidence 112347889999999999999999999999999999999 99999998877777666554 3333445589999999999
Q ss_pred hhhcCccccCCchhcHHHHHcC
Q 007260 530 LLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 530 ~L~~dP~~Rpt~~~~a~elL~H 551 (611)
||..||.+||+ +.++++|
T Consensus 243 ~l~~~p~~Rps----~~~ll~~ 260 (269)
T 4hcu_A 243 CWRERPEDRPA----FSRLLRQ 260 (269)
T ss_dssp HTCSSGGGSCC----HHHHHHH
T ss_pred HccCCcccCcC----HHHHHHH
Confidence 99999999999 8888775
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=410.05 Aligned_cols=262 Identities=25% Similarity=0.367 Sum_probs=195.9
Q ss_pred cCeEE-EeEecccCcEEEEEEEEC--CCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceee--ccce
Q 007260 216 SHFRL-LKRLGCGDIGSVYLSELS--GTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFE--TEKF 290 (611)
Q Consensus 216 ~~y~l-~~~LG~G~fG~Vy~a~~~--~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~--~~~~ 290 (611)
+.|++ +++||+|+||+||+|++. .+++.||||++....... .+.+|+.+|+.|+|||||+++++|. .+..
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISM-----SACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCH-----HHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCH-----HHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 46777 458999999999999976 568899999997654332 4567999999999999999999994 4788
Q ss_pred eeEEeeeCCCCCHHHHHHhC-------CCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEE----ccCCcEEE
Q 007260 291 SCLVMEFCPGGDLHTLRQKQ-------PGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLV----REDGHIML 359 (611)
Q Consensus 291 ~~LVmE~~~gg~L~~ll~~~-------~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv----~~~g~vkL 359 (611)
+||||||+. ++|.+++... ....+++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||
T Consensus 95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999999995 5888776532 12349999999999999999999999999999999999999 67789999
Q ss_pred EeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCC
Q 007260 360 SDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPL 439 (611)
Q Consensus 360 ~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (611)
+|||++..+.....
T Consensus 174 ~Dfg~a~~~~~~~~------------------------------------------------------------------ 187 (405)
T 3rgf_A 174 ADMGFARLFNSPLK------------------------------------------------------------------ 187 (405)
T ss_dssp CCTTCCC-------------------------------------------------------------------------
T ss_pred EECCCceecCCCCc------------------------------------------------------------------
Confidence 99999854321000
Q ss_pred cccccCcccccccccccCCCccchhhhccCC-CCChhhHHHHHHHHHHHHhCCCCCCCCCc---------HHHHHH---H
Q 007260 440 PELIAEPTEARSMSFVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSGN---------RATLFN---V 506 (611)
Q Consensus 440 ~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~-~~~~sDIWSLGviL~ELltG~~PF~~~~~---------~~~l~~---i 506 (611)
........+||+.|+|||++.+.. ++.++|||||||+||||++|++||.+... .+.+.. .
T Consensus 188 -------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~ 260 (405)
T 3rgf_A 188 -------PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 260 (405)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHH
T ss_pred -------ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHh
Confidence 001112357999999999998854 89999999999999999999999986543 233333 2
Q ss_pred HcCCCCC--C-------------------------------CCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCC
Q 007260 507 VGQPLRF--P-------------------------------ESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPF 553 (611)
Q Consensus 507 ~~~~l~~--p-------------------------------~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~ 553 (611)
++.+... + .....+..+.+||.+||..||.+||| +.|+|+|||
T Consensus 261 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~t----a~e~L~hp~ 336 (405)
T 3rgf_A 261 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT----SEQAMQDPY 336 (405)
T ss_dssp HCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCC----HHHHHTSGG
T ss_pred hCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCC----HHHHhcChh
Confidence 3322110 0 00112778999999999999999999 999999999
Q ss_pred CCCCchh
Q 007260 554 FEGVNWA 560 (611)
Q Consensus 554 f~~~~~~ 560 (611)
|.+..|.
T Consensus 337 f~~~~~~ 343 (405)
T 3rgf_A 337 FLEDPLP 343 (405)
T ss_dssp GTSSSCC
T ss_pred hccCCCC
Confidence 9876553
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-47 Score=383.78 Aligned_cols=260 Identities=25% Similarity=0.384 Sum_probs=219.8
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceee--ccceee
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFE--TEKFSC 292 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~--~~~~~~ 292 (611)
.++|++++.||+|+||.||+|++..+++.||+|++...... ......+.+|+.+|+.++||||+++++++. ....+|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 46899999999999999999999999999999999765433 234557789999999999999999999874 467899
Q ss_pred EEeeeCCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcC-----eeccCCCCCcEEEccCCcEEEEecccc
Q 007260 293 LVMEFCPGGDLHTLRQKQ--PGKYFPEQAVRFYVAEVLLALEYLHMLG-----IIYRDLKPENVLVREDGHIMLSDFDLS 365 (611)
Q Consensus 293 LVmE~~~gg~L~~ll~~~--~~~~l~e~~~~~i~~qll~aL~yLH~~g-----IVHRDLKPeNILv~~~g~vkL~DFGlA 365 (611)
|||||++|++|.+++... ....+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 999999999999988753 2345999999999999999999999999 999999999999999999999999998
Q ss_pred ccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccC
Q 007260 366 LRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAE 445 (611)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (611)
.......
T Consensus 164 ~~~~~~~------------------------------------------------------------------------- 170 (279)
T 2w5a_A 164 RILNHDT------------------------------------------------------------------------- 170 (279)
T ss_dssp HHC---C-------------------------------------------------------------------------
T ss_pred eeecccc-------------------------------------------------------------------------
Confidence 4332100
Q ss_pred cccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 007260 446 PTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARD 525 (611)
Q Consensus 446 ~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~d 525 (611)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+...... +....++.++.+
T Consensus 171 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~-~~~~~~~~~l~~ 246 (279)
T 2w5a_A 171 ---SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR-RIPYRYSDELNE 246 (279)
T ss_dssp ---HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-CCCTTSCHHHHH
T ss_pred ---ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccc-cCCcccCHHHHH
Confidence 0012346999999999999999999999999999999999999999988776666666555432 223358999999
Q ss_pred HHHHhhhcCccccCCchhcHHHHHcCCCCCC
Q 007260 526 LIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 526 LI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
||.+||..||.+||+ +.+|++|+||.+
T Consensus 247 li~~~l~~~p~~Rps----~~~ll~~~~~~~ 273 (279)
T 2w5a_A 247 IITRMLNLKDYHRPS----VEEILENPLILE 273 (279)
T ss_dssp HHHHHTCSSGGGSCC----HHHHHTSTTCCG
T ss_pred HHHHHcCCCcccCCC----HHHHHhChhhhh
Confidence 999999999999999 999999999964
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=404.70 Aligned_cols=261 Identities=25% Similarity=0.377 Sum_probs=213.5
Q ss_pred ccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC-CC-----Ccccccce
Q 007260 211 GVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD-HP-----FLPTLYTH 284 (611)
Q Consensus 211 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~-Hp-----nIv~l~~~ 284 (611)
+....++|++++.||+|+||+||+|++..+++.||||++.... .....+.+|+.+++.+. |+ +|+.++++
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~ 124 (382)
T 2vx3_A 49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH 124 (382)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence 3444679999999999999999999999999999999997543 23445677888888884 55 49999999
Q ss_pred eeccceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--HcCeeccCCCCCcEEEc--cCCcEEEE
Q 007260 285 FETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLH--MLGIIYRDLKPENVLVR--EDGHIMLS 360 (611)
Q Consensus 285 ~~~~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH--~~gIVHRDLKPeNILv~--~~g~vkL~ 360 (611)
|...+.+||||||+. ++|.+++.......+++..++.++.||+.||.||| .+|||||||||+||||+ .++.+||+
T Consensus 125 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 125 FMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp EEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred eccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEE
Confidence 999999999999995 59999998876567999999999999999999999 57999999999999995 47789999
Q ss_pred eccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCc
Q 007260 361 DFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLP 440 (611)
Q Consensus 361 DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (611)
|||++.....
T Consensus 204 DFG~a~~~~~---------------------------------------------------------------------- 213 (382)
T 2vx3_A 204 DFGSSCQLGQ---------------------------------------------------------------------- 213 (382)
T ss_dssp CCTTCEETTC----------------------------------------------------------------------
T ss_pred eccCceeccc----------------------------------------------------------------------
Confidence 9999843210
Q ss_pred ccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCC--------
Q 007260 441 ELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLR-------- 512 (611)
Q Consensus 441 ~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~-------- 512 (611)
.....+||+.|+|||++.+..++.++|||||||+||||++|++||.+.+..+.+..++.....
T Consensus 214 ---------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 284 (382)
T 2vx3_A 214 ---------RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQ 284 (382)
T ss_dssp ---------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred ---------ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 011346999999999999999999999999999999999999999998877776655431000
Q ss_pred ----------CCC-------------------CCC-------------------------CCHHHHHHHHHhhhcCcccc
Q 007260 513 ----------FPE-------------------SPV-------------------------VSFAARDLIRGLLVKEPQHR 538 (611)
Q Consensus 513 ----------~p~-------------------~~~-------------------------~s~~l~dLI~~~L~~dP~~R 538 (611)
.+. ... ...++++||.+||..||.+|
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 364 (382)
T 2vx3_A 285 APKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTR 364 (382)
T ss_dssp CTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTS
T ss_pred hHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhC
Confidence 000 000 01478999999999999999
Q ss_pred CCchhcHHHHHcCCCCCCCch
Q 007260 539 LAYKRGATEIKQHPFFEGVNW 559 (611)
Q Consensus 539 pt~~~~a~elL~Hp~f~~~~~ 559 (611)
|| +.|+|+||||+...|
T Consensus 365 pt----a~e~L~hp~f~~~~~ 381 (382)
T 2vx3_A 365 IQ----PYYALQHSFFKKTAD 381 (382)
T ss_dssp CC----HHHHTTSGGGCC---
T ss_pred CC----HHHHhcCcccccCCC
Confidence 99 999999999986543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=388.52 Aligned_cols=259 Identities=32% Similarity=0.487 Sum_probs=221.6
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
++|++++.||+|+||.||+|++..+++.||||++.+.... ......+.+|+.+|+.++||||+++++++...+..|+||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 5899999999999999999999999999999999765432 123346778999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccC---CcEEEEeccccccccCCc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRED---GHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~---g~vkL~DFGlA~~~~~~~ 372 (611)
||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.+ +.+||+|||++......
T Consensus 101 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~- 177 (287)
T 2wei_A 101 ELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN- 177 (287)
T ss_dssp CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC-
T ss_pred EccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC-
Confidence 999999999888765 459999999999999999999999999999999999999754 47999999998432100
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
....
T Consensus 178 ----------------------------------------------------------------------------~~~~ 181 (287)
T 2wei_A 178 ----------------------------------------------------------------------------TKMK 181 (287)
T ss_dssp ----------------------------------------------------------------------------SSCS
T ss_pred ----------------------------------------------------------------------------Cccc
Confidence 0011
Q ss_pred ccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCC--CCCCCCHHHHHHHHHh
Q 007260 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFP--ESPVVSFAARDLIRGL 530 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p--~~~~~s~~l~dLI~~~ 530 (611)
...||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+......+..+......++ ....++.++++||.+|
T Consensus 182 ~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 260 (287)
T 2wei_A 182 DRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKM 260 (287)
T ss_dssp CHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHH
T ss_pred cccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHH
Confidence 23589999999999865 89999999999999999999999999887777777776655443 3356899999999999
Q ss_pred hhcCccccCCchhcHHHHHcCCCCCCCch
Q 007260 531 LVKEPQHRLAYKRGATEIKQHPFFEGVNW 559 (611)
Q Consensus 531 L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 559 (611)
|..||.+||+ +.++++||||+...|
T Consensus 261 l~~dp~~Rps----~~ell~hp~~~~~~~ 285 (287)
T 2wei_A 261 LTFHPSLRIT----ATQCLEHPWIQKYSS 285 (287)
T ss_dssp TCSSGGGSCC----HHHHHHSHHHHHHCC
T ss_pred cccChhhCcC----HHHHhcCHHHhcccc
Confidence 9999999999 999999999986543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=385.65 Aligned_cols=255 Identities=27% Similarity=0.423 Sum_probs=220.1
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
+.|++++.||+|+||.||+|.+..+++.||||++...... .....+.+|+.+|+.++||||+++++++..+..+||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS--TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 5799999999999999999999999999999999765422 23456788999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
||++|++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 100 e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~---- 172 (303)
T 3a7i_A 100 EYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT---- 172 (303)
T ss_dssp ECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT----
T ss_pred EeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcc----
Confidence 99999999998875 45999999999999999999999999999999999999999999999999998433210
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
.......+
T Consensus 173 ------------------------------------------------------------------------~~~~~~~~ 180 (303)
T 3a7i_A 173 ------------------------------------------------------------------------QIKRNTFV 180 (303)
T ss_dssp ------------------------------------------------------------------------BCCBCCCC
T ss_pred ------------------------------------------------------------------------ccccCccC
Confidence 00112346
Q ss_pred cCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCc
Q 007260 456 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEP 535 (611)
Q Consensus 456 GT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP 535 (611)
||+.|+|||++.+..++.++|||||||++|+|++|+.||........+..+..... ......++..+.+||.+||..||
T Consensus 181 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp 259 (303)
T 3a7i_A 181 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-PTLEGNYSKPLKEFVEACLNKEP 259 (303)
T ss_dssp SCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CCCCSSCCHHHHHHHHHHCCSSG
T ss_pred CCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCC-CCCccccCHHHHHHHHHHcCCCh
Confidence 99999999999999999999999999999999999999998777666655544322 22234589999999999999999
Q ss_pred cccCCchhcHHHHHcCCCCCC
Q 007260 536 QHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 536 ~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
.+||+ +.++++||||..
T Consensus 260 ~~Rps----~~~ll~~~~~~~ 276 (303)
T 3a7i_A 260 SFRPT----AKELLKHKFILR 276 (303)
T ss_dssp GGSCC----HHHHTTCHHHHH
T ss_pred hhCcC----HHHHhhChhhhc
Confidence 99999 999999999953
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=397.58 Aligned_cols=259 Identities=27% Similarity=0.427 Sum_probs=209.4
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchh--------hhhHHHHHHHHHHHHHHHhCCCCCcccccceee
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKAS--------LAGRKKLLRAQTEREILQSLDHPFLPTLYTHFE 286 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~--------~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~ 286 (611)
.++|++++.||+|+||.||+|.+.. +..||||++.... ........++.+|+.+|+.++||||++++++|.
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred ccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 4699999999999999999999865 8899999986532 223344567889999999999999999999984
Q ss_pred -----ccceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEe
Q 007260 287 -----TEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSD 361 (611)
Q Consensus 287 -----~~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~D 361 (611)
....+||||||+. |+|.+++... ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|
T Consensus 100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp ECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred eccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence 3457899999996 6888877754 35699999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcc
Q 007260 362 FDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPE 441 (611)
Q Consensus 362 FGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (611)
||++......
T Consensus 178 fg~~~~~~~~---------------------------------------------------------------------- 187 (362)
T 3pg1_A 178 FNLAREDTAD---------------------------------------------------------------------- 187 (362)
T ss_dssp TTC-----------------------------------------------------------------------------
T ss_pred cCcccccccc----------------------------------------------------------------------
Confidence 9998421100
Q ss_pred cccCcccccccccccCCCccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHc---CC-------
Q 007260 442 LIAEPTEARSMSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG---QP------- 510 (611)
Q Consensus 442 ~~~~~~~~~~~~~vGT~~Y~APEil~~-~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~---~~------- 510 (611)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+......+..++. .+
T Consensus 188 -------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 260 (362)
T 3pg1_A 188 -------ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVM 260 (362)
T ss_dssp ---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred -------cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhh
Confidence 01123469999999999987 6789999999999999999999999999877666655432 11
Q ss_pred --------------CCCCC------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 511 --------------LRFPE------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 511 --------------l~~p~------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
...+. ...++..+.+||.+||..||.+||+ +.|+|+||||+.+
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~f~~~ 323 (362)
T 3pg1_A 261 FSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIS----TEQALRHPYFESL 323 (362)
T ss_dssp TSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHTSGGGTTT
T ss_pred ccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCC----HHHHHcCchhhhc
Confidence 01111 1346889999999999999999999 9999999999876
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=393.48 Aligned_cols=260 Identities=18% Similarity=0.284 Sum_probs=218.9
Q ss_pred cccccCeEEEeEecccCcEEEEEEEE-----CCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCccccccee
Q 007260 212 VLGLSHFRLLKRLGCGDIGSVYLSEL-----SGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHF 285 (611)
Q Consensus 212 ~~~~~~y~l~~~LG~G~fG~Vy~a~~-----~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~ 285 (611)
.+..++|++++.||+|+||.||+|++ ..++..||||++.... ......++.+|+.+|+.+ +||||+++++++
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 34567999999999999999999997 3467789999997543 223345678899999999 899999999999
Q ss_pred eccceeeEEeeeCCCCCHHHHHHhCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHcCeeccCC
Q 007260 286 ETEKFSCLVMEFCPGGDLHTLRQKQPG---------------------KYFPEQAVRFYVAEVLLALEYLHMLGIIYRDL 344 (611)
Q Consensus 286 ~~~~~~~LVmE~~~gg~L~~ll~~~~~---------------------~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDL 344 (611)
...+.+|||||||+||+|.+++..... ..+++..++.++.||+.||+|||++||+||||
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Di 198 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 198 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 999999999999999999999987532 23799999999999999999999999999999
Q ss_pred CCCcEEEccCCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCccccccccc
Q 007260 345 KPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKK 424 (611)
Q Consensus 345 KPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (611)
||+||||+.++.+||+|||++..+.....
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~--------------------------------------------------- 227 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSN--------------------------------------------------- 227 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTT---------------------------------------------------
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCcc---------------------------------------------------
Confidence 99999999999999999999843321100
Q ss_pred CCCCccccCCCCCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHH
Q 007260 425 DRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATL 503 (611)
Q Consensus 425 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l 503 (611)
........||+.|+|||++.+..++.++|||||||+||||++ |..||.+......+
T Consensus 228 -----------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 284 (344)
T 1rjb_A 228 -----------------------YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF 284 (344)
T ss_dssp -----------------------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred -----------------------ceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHH
Confidence 001123458899999999999999999999999999999998 99999988777777
Q ss_pred HHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcC
Q 007260 504 FNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 504 ~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~H 551 (611)
..++......+....++.++.+||.+||..||.+||+ +.+|++|
T Consensus 285 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~~l~~~ 328 (344)
T 1rjb_A 285 YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPS----FPNLTSF 328 (344)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcC----HHHHHHH
Confidence 7777776666666679999999999999999999999 8888875
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=377.60 Aligned_cols=252 Identities=26% Similarity=0.443 Sum_probs=209.8
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhh-HHHHHHHHHHHHHHHhCCCCCcccccceeecccee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAG-RKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFS 291 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~-~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~ 291 (611)
+..++|++.+.||+|+||.||+|.+. +..||||++....... ......+.+|+++++.++||||+++++++..++..
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred cchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 34579999999999999999999986 6789999987654322 23345678899999999999999999999999999
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC---eeccCCCCCcEEEcc--------CCcEEEE
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLG---IIYRDLKPENVLVRE--------DGHIMLS 360 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~g---IVHRDLKPeNILv~~--------~g~vkL~ 360 (611)
||||||++|++|.+++.. ..+++..++.++.||+.||+|||++| |+||||||+|||++. ++.+||+
T Consensus 82 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp EEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 999999999999998864 46999999999999999999999999 999999999999986 7789999
Q ss_pred eccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCc
Q 007260 361 DFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLP 440 (611)
Q Consensus 361 DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (611)
|||++......
T Consensus 159 Dfg~~~~~~~~--------------------------------------------------------------------- 169 (271)
T 3dtc_A 159 DFGLAREWHRT--------------------------------------------------------------------- 169 (271)
T ss_dssp CCCC----------------------------------------------------------------------------
T ss_pred cCCcccccccc---------------------------------------------------------------------
Confidence 99998432100
Q ss_pred ccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCC
Q 007260 441 ELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVS 520 (611)
Q Consensus 441 ~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s 520 (611)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.......+....++
T Consensus 170 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (271)
T 3dtc_A 170 ---------TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCP 240 (271)
T ss_dssp ---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred ---------cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcccC
Confidence 01123599999999999999999999999999999999999999999888888888887777777777799
Q ss_pred HHHHHHHHHhhhcCccccCCchhcHHHHHcC
Q 007260 521 FAARDLIRGLLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 521 ~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~H 551 (611)
..+.+||.+||..||.+||+ +.|+++|
T Consensus 241 ~~~~~li~~~l~~~p~~Rps----~~e~l~~ 267 (271)
T 3dtc_A 241 EPFAKLMEDCWNPDPHSRPS----FTNILDQ 267 (271)
T ss_dssp HHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHHHHHhcCCcccCcC----HHHHHHH
Confidence 99999999999999999999 8888764
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=375.83 Aligned_cols=251 Identities=18% Similarity=0.285 Sum_probs=217.8
Q ss_pred cccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecc--c
Q 007260 212 VLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE--K 289 (611)
Q Consensus 212 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~--~ 289 (611)
.+..++|++++.||+|+||.||+|++. +..||||++...... ......+.+|+.+|+.++||||+++++++.+. .
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 82 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWS-TRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCC-HHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSS
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccC-HHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCC
Confidence 345679999999999999999999986 677999999765433 23445688999999999999999999999876 8
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--eeccCCCCCcEEEccCCcEEEEecccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLG--IIYRDLKPENVLVREDGHIMLSDFDLSLR 367 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~g--IVHRDLKPeNILv~~~g~vkL~DFGlA~~ 367 (611)
..||||||++||+|.+++.......+++..++.++.||+.||+|||++| |+||||||+|||++.+|.++|+|||++..
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceee
Confidence 8899999999999999998876557999999999999999999999999 99999999999999999999999998621
Q ss_pred ccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcc
Q 007260 368 CAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPT 447 (611)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (611)
..
T Consensus 163 ~~------------------------------------------------------------------------------ 164 (271)
T 3kmu_A 163 FQ------------------------------------------------------------------------------ 164 (271)
T ss_dssp TS------------------------------------------------------------------------------
T ss_pred ec------------------------------------------------------------------------------
Confidence 10
Q ss_pred cccccccccCCCccchhhhccCCCCC---hhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHH
Q 007260 448 EARSMSFVGTHEYLAPEIIKGEGHGS---AVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAAR 524 (611)
Q Consensus 448 ~~~~~~~vGT~~Y~APEil~~~~~~~---~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~ 524 (611)
....+||+.|+|||++.+..++. ++|||||||++|||++|+.||.+.........+.......+....++.++.
T Consensus 165 ---~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (271)
T 3kmu_A 165 ---SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVS 241 (271)
T ss_dssp ---CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHHH
T ss_pred ---ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 01235899999999999876654 799999999999999999999998888887777777666666667999999
Q ss_pred HHHHHhhhcCccccCCchhcHHHHHc
Q 007260 525 DLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 525 dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
+||.+||..||.+||+ +.++++
T Consensus 242 ~li~~~l~~~p~~Rps----~~~il~ 263 (271)
T 3kmu_A 242 KLMKICMNEDPAKRPK----FDMIVP 263 (271)
T ss_dssp HHHHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHHHcCCChhhCcC----HHHHHH
Confidence 9999999999999999 777765
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=376.12 Aligned_cols=254 Identities=23% Similarity=0.308 Sum_probs=215.7
Q ss_pred cccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecccee
Q 007260 212 VLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFS 291 (611)
Q Consensus 212 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~ 291 (611)
.+..++|++++.||+|+||.||+|++.. +..||||++....... ..+.+|+.+|+.++||||+++++++..++..
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKEGSMSE----DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECBTTBCH----HHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred EechhheeeeeeeccCCCceEEEEEecC-ceeEEEEEeccCCCcH----HHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence 4556799999999999999999998874 5679999998765433 2467899999999999999999999999999
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCC
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~ 371 (611)
|+||||++|++|.+++... +..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 79 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp EEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred EEEEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 9999999999999998775 245999999999999999999999999999999999999999999999999998433211
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
.. ...
T Consensus 158 ~~---------------------------------------------------------------------------~~~ 162 (268)
T 3sxs_A 158 QY---------------------------------------------------------------------------VSS 162 (268)
T ss_dssp CE---------------------------------------------------------------------------EEC
T ss_pred hh---------------------------------------------------------------------------hcc
Confidence 00 001
Q ss_pred cccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 007260 452 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGL 530 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~ 530 (611)
....||+.|+|||++.+..++.++|||||||++|+|++ |+.||...........+..... ......+++.+.+||.+|
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~ 241 (268)
T 3sxs_A 163 VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHR-LYRPHLASDTIYQIMYSC 241 (268)
T ss_dssp CSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC-CCCCTTSCHHHHHHHHHT
T ss_pred cCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCC-CCCCCcChHHHHHHHHHH
Confidence 12247888999999999999999999999999999998 9999998887777766665442 333345899999999999
Q ss_pred hhcCccccCCchhcHHHHHcC
Q 007260 531 LVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 531 L~~dP~~Rpt~~~~a~elL~H 551 (611)
|..||.+||+ +.++++|
T Consensus 242 l~~~p~~Rps----~~~ll~~ 258 (268)
T 3sxs_A 242 WHELPEKRPT----FQQLLSS 258 (268)
T ss_dssp TCSSGGGSCC----HHHHHHH
T ss_pred cCCChhhCcC----HHHHHHH
Confidence 9999999999 8888875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=384.68 Aligned_cols=261 Identities=20% Similarity=0.289 Sum_probs=217.3
Q ss_pred CccccccCeEEEeEecccCcEEEEEEEEC-----CCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccce
Q 007260 210 DGVLGLSHFRLLKRLGCGDIGSVYLSELS-----GTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTH 284 (611)
Q Consensus 210 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~-----~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~ 284 (611)
...+..++|++++.||+|+||.||+|++. .++..||||++.... ......++.+|+.+|+.++||||++++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 94 (314)
T 2ivs_A 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGA 94 (314)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence 34455679999999999999999999983 456899999997543 23445677899999999999999999999
Q ss_pred eeccceeeEEeeeCCCCCHHHHHHhCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCeecc
Q 007260 285 FETEKFSCLVMEFCPGGDLHTLRQKQPG----------------------KYFPEQAVRFYVAEVLLALEYLHMLGIIYR 342 (611)
Q Consensus 285 ~~~~~~~~LVmE~~~gg~L~~ll~~~~~----------------------~~l~e~~~~~i~~qll~aL~yLH~~gIVHR 342 (611)
+...+..||||||++|++|.+++..... ..+++..++.++.||+.||+|||++||+||
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~ 174 (314)
T 2ivs_A 95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR 174 (314)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence 9999999999999999999999987532 348999999999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCccccccc
Q 007260 343 DLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKS 422 (611)
Q Consensus 343 DLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (611)
||||+||||+.++.+||+|||++.........
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~------------------------------------------------ 206 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSY------------------------------------------------ 206 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSCE------------------------------------------------
T ss_pred ccchheEEEcCCCCEEEccccccccccccccc------------------------------------------------
Confidence 99999999999999999999998543211000
Q ss_pred ccCCCCccccCCCCCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHH
Q 007260 423 KKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRA 501 (611)
Q Consensus 423 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~ 501 (611)
.......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.....
T Consensus 207 --------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 260 (314)
T 2ivs_A 207 --------------------------VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER 260 (314)
T ss_dssp --------------------------ECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred --------------------------eeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 00112357889999999999999999999999999999999 999999877655
Q ss_pred HHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcC
Q 007260 502 TLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 502 ~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~H 551 (611)
....+. .....+....++.++.+||.+||..||.+||+ +.+++++
T Consensus 261 ~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps----~~~l~~~ 305 (314)
T 2ivs_A 261 LFNLLK-TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPV----FADISKD 305 (314)
T ss_dssp HHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHhh-cCCcCCCCccCCHHHHHHHHHHccCChhhCcC----HHHHHHH
Confidence 554443 33344444569999999999999999999999 7777764
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=378.52 Aligned_cols=256 Identities=22% Similarity=0.314 Sum_probs=213.6
Q ss_pred CccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc
Q 007260 210 DGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK 289 (611)
Q Consensus 210 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~ 289 (611)
...+..++|++++.||+|+||.||+|.+. ++..||||++....... ..+.+|+++|+.++||||+++++++.+.+
T Consensus 18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 92 (283)
T 3gen_A 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGVCTKQR 92 (283)
T ss_dssp TTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCH----HHHHHHHHHHhcCCCCCEeeEEEEEecCC
Confidence 33455679999999999999999999887 46679999998655433 24678999999999999999999999999
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
..||||||++|++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++....
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 93 PIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp SEEEEECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred CeEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 9999999999999999987642 459999999999999999999999999999999999999999999999999985432
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
... ..
T Consensus 172 ~~~---------------------------------------------------------------------------~~ 176 (283)
T 3gen_A 172 DDE---------------------------------------------------------------------------YT 176 (283)
T ss_dssp CHH---------------------------------------------------------------------------HH
T ss_pred ccc---------------------------------------------------------------------------cc
Confidence 100 00
Q ss_pred cccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 007260 450 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIR 528 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~ 528 (611)
......||+.|+|||++.+..++.++|||||||++|+|++ |+.||...........+... ........++..+.+||.
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~ 255 (283)
T 3gen_A 177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-LRLYRPHLASEKVYTIMY 255 (283)
T ss_dssp STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHH
T ss_pred cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcc-cCCCCCCcCCHHHHHHHH
Confidence 0112247889999999999999999999999999999998 99999988877766666554 333344568999999999
Q ss_pred HhhhcCccccCCchhcHHHHHcC
Q 007260 529 GLLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 529 ~~L~~dP~~Rpt~~~~a~elL~H 551 (611)
+||..||.+||+ +.++++|
T Consensus 256 ~~l~~~p~~Rps----~~~ll~~ 274 (283)
T 3gen_A 256 SCWHEKADERPT----FKILLSN 274 (283)
T ss_dssp HTTCSSGGGSCC----HHHHHHH
T ss_pred HHccCChhHCcC----HHHHHHH
Confidence 999999999999 7787765
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=388.55 Aligned_cols=270 Identities=20% Similarity=0.300 Sum_probs=213.6
Q ss_pred cccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecccee
Q 007260 212 VLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFS 291 (611)
Q Consensus 212 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~ 291 (611)
.+..++|++++.||+|+||+||+|++..+++.||+|++.... ......+.+|+++|+.++||||+++++++.+++..
T Consensus 6 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 82 (310)
T 3s95_A 6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD---EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRL 82 (310)
T ss_dssp EECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred eeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCee
Confidence 345679999999999999999999999999999999986543 33445678899999999999999999999999999
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCC
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~ 371 (611)
||||||++|++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++......
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp EEEEECCTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEecCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 99999999999999998753 56999999999999999999999999999999999999999999999999998554321
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
....... .....+.....
T Consensus 162 ~~~~~~~--------------------------------------------------------------~~~~~~~~~~~ 179 (310)
T 3s95_A 162 KTQPEGL--------------------------------------------------------------RSLKKPDRKKR 179 (310)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccccccc--------------------------------------------------------------ccccccccccc
Confidence 1100000 00000111122
Q ss_pred cccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHH-----HHHHHHcCCCCCCCCCCCCHHHHHH
Q 007260 452 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRA-----TLFNVVGQPLRFPESPVVSFAARDL 526 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~-----~l~~i~~~~l~~p~~~~~s~~l~dL 526 (611)
..++||+.|+|||++.+..++.++|||||||++|||++|..||....... ........ .....++..+.+|
T Consensus 180 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~l 255 (310)
T 3s95_A 180 YTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR----YCPPNCPPSFFPI 255 (310)
T ss_dssp CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH----TCCTTCCTTHHHH
T ss_pred cccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc----cCCCCCCHHHHHH
Confidence 35689999999999999999999999999999999999999987532211 01111111 1123478899999
Q ss_pred HHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 527 IRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 527 I~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
|.+||..||.+||+ +.+|++ |++.+
T Consensus 256 i~~~l~~dP~~Rps----~~~l~~--~L~~l 280 (310)
T 3s95_A 256 TVRCCDLDPEKRPS----FVKLEH--WLETL 280 (310)
T ss_dssp HHHHTCSSGGGSCC----HHHHHH--HHHHH
T ss_pred HHHHccCChhhCcC----HHHHHH--HHHHH
Confidence 99999999999999 778876 55544
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=388.30 Aligned_cols=258 Identities=20% Similarity=0.303 Sum_probs=217.3
Q ss_pred cccccCeEEEeEecccCcEEEEEEEECC-----CCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceee
Q 007260 212 VLGLSHFRLLKRLGCGDIGSVYLSELSG-----TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFE 286 (611)
Q Consensus 212 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~-----t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~ 286 (611)
.+..++|++++.||+|+||.||+|++.. +++.||||++.+.. .......+.+|+.+|+.++||||+++++++.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 4456799999999999999999999974 55899999997643 2334557789999999999999999999999
Q ss_pred ccceeeEEeeeCCCCCHHHHHHhCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCC
Q 007260 287 TEKFSCLVMEFCPGGDLHTLRQKQP----------------------GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDL 344 (611)
Q Consensus 287 ~~~~~~LVmE~~~gg~L~~ll~~~~----------------------~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDL 344 (611)
+++..||||||++||+|.+++.... ...+++..++.++.||+.||+|||++||+||||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl 200 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 9999999999999999999988742 156999999999999999999999999999999
Q ss_pred CCCcEEEccCCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCccccccccc
Q 007260 345 KPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKK 424 (611)
Q Consensus 345 KPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (611)
||+||||+.++.+||+|||++........
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--------------------------------------------------- 229 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADY--------------------------------------------------- 229 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGC---------------------------------------------------
T ss_pred CcceEEECCCCeEEEeecCCCcccccCcc---------------------------------------------------
Confidence 99999999999999999999854321100
Q ss_pred CCCCccccCCCCCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHH
Q 007260 425 DRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATL 503 (611)
Q Consensus 425 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l 503 (611)
........||+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+.+
T Consensus 230 -----------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 286 (343)
T 1luf_A 230 -----------------------YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVI 286 (343)
T ss_dssp -----------------------BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred -----------------------ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHH
Confidence 000112358999999999999999999999999999999998 99999998877777
Q ss_pred HHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 504 FNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 504 ~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
..+..... .+....++.++.+||.+||..||.+||+ +.++++
T Consensus 287 ~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps----~~~~~~ 328 (343)
T 1luf_A 287 YYVRDGNI-LACPENCPLELYNLMRLCWSKLPADRPS----FCSIHR 328 (343)
T ss_dssp HHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHhCCCc-CCCCCCCCHHHHHHHHHHcccCcccCCC----HHHHHH
Confidence 66665543 2233458999999999999999999999 777765
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=379.03 Aligned_cols=271 Identities=25% Similarity=0.411 Sum_probs=209.5
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec--------
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET-------- 287 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~-------- 287 (611)
++|++++.||+|+||.||+|++..+++.||||++.... .....+.+|+.+|+.++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH----HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH----HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 58999999999999999999999999999999996542 344567889999999999999999998754
Q ss_pred -----cceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEec
Q 007260 288 -----EKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDF 362 (611)
Q Consensus 288 -----~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DF 362 (611)
...+||||||++|++|.+++... +..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeC
Confidence 57789999999999999999865 346889999999999999999999999999999999999999999999999
Q ss_pred cccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCccc
Q 007260 363 DLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPEL 442 (611)
Q Consensus 363 GlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (611)
|++.............. .
T Consensus 161 g~~~~~~~~~~~~~~~~--------------------------------------------------------------~ 178 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDS--------------------------------------------------------------Q 178 (303)
T ss_dssp CCCSCTTC------------------------------------------------------------------------
T ss_pred cchhhcccccchhcccc--------------------------------------------------------------c
Confidence 99854321110000000 0
Q ss_pred ccCcccccccccccCCCccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHcCCCCCCC--CCC
Q 007260 443 IAEPTEARSMSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGN-RATLFNVVGQPLRFPE--SPV 518 (611)
Q Consensus 443 ~~~~~~~~~~~~vGT~~Y~APEil~~~-~~~~~sDIWSLGviL~ELltG~~PF~~~~~-~~~l~~i~~~~l~~p~--~~~ 518 (611)
............+||+.|+|||++.+. .++.++|||||||++|||++ ||..... ...+..+......+|. ...
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (303)
T 1zy4_A 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPPDFDDN 255 (303)
T ss_dssp ---------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCTTCCTT
T ss_pred cccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccccccCcccccc
Confidence 000001112345799999999999876 68999999999999999998 6654322 3333444444444433 245
Q ss_pred CCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCchh
Q 007260 519 VSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWA 560 (611)
Q Consensus 519 ~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~ 560 (611)
.+..+++||.+||..||.+||+ +.++++||||....+.
T Consensus 256 ~~~~~~~li~~~l~~dp~~Rps----~~~ll~h~~~~~~~~~ 293 (303)
T 1zy4_A 256 KMKVEKKIIRLLIDHDPNKRPG----ARTLLNSGWLPVKHQD 293 (303)
T ss_dssp TSHHHHHHHHHHTCSSGGGSCC----HHHHHHSSCSCCCCHH
T ss_pred chHHHHHHHHHHHhcCcccCcC----HHHHhCCCCcCCCChH
Confidence 7788999999999999999999 9999999999876654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=384.16 Aligned_cols=259 Identities=20% Similarity=0.285 Sum_probs=219.4
Q ss_pred ccccCeEEEeEecccCcEEEEEEEE-----CCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSEL-----SGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFE 286 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~-----~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~ 286 (611)
+..++|++++.||+|+||.||+|++ ..+++.||||++..... ......+.+|+.+|+.+ +||||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh--HHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 4457999999999999999999985 45788999999976532 23345678899999999 9999999999999
Q ss_pred ccceeeEEeeeCCCCCHHHHHHhCCC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEE
Q 007260 287 TEKFSCLVMEFCPGGDLHTLRQKQPG----------------KYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVL 350 (611)
Q Consensus 287 ~~~~~~LVmE~~~gg~L~~ll~~~~~----------------~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNIL 350 (611)
.++..||||||+++|+|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil 177 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL 177 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEE
Confidence 99999999999999999999987542 24899999999999999999999999999999999999
Q ss_pred EccCCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCcc
Q 007260 351 VREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKN 430 (611)
Q Consensus 351 v~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 430 (611)
++.++.+||+|||++........
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~--------------------------------------------------------- 200 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSN--------------------------------------------------------- 200 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTT---------------------------------------------------------
T ss_pred EcCCCCEEEcccccccccccccc---------------------------------------------------------
Confidence 99999999999999843321100
Q ss_pred ccCCCCCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcC
Q 007260 431 EIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQ 509 (611)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~ 509 (611)
........||+.|+|||++.+..++.++|||||||++|||++ |+.||.+......+..++..
T Consensus 201 -----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 263 (313)
T 1t46_A 201 -----------------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKE 263 (313)
T ss_dssp -----------------SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHH
T ss_pred -----------------ceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhcc
Confidence 000112358899999999999999999999999999999998 99999987766666666665
Q ss_pred CCCCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcC
Q 007260 510 PLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 510 ~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~H 551 (611)
....+....++..+.+||.+||..||.+||+ +.+++++
T Consensus 264 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~ell~~ 301 (313)
T 1t46_A 264 GFRMLSPEHAPAEMYDIMKTCWDADPLKRPT----FKQIVQL 301 (313)
T ss_dssp TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCCCCCcccCCHHHHHHHHHHcCCCchhCcC----HHHHHHH
Confidence 5555555679999999999999999999999 7787764
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=398.33 Aligned_cols=257 Identities=25% Similarity=0.409 Sum_probs=207.8
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC-----------CCCcccc
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD-----------HPFLPTL 281 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~-----------HpnIv~l 281 (611)
+..++|++++.||+|+||+||+|++..+++.||||++..... ....+.+|+.+|+.+. ||||+++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~ 91 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 91 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCcc----chhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence 345799999999999999999999999999999999975432 2335677999988876 8999999
Q ss_pred cceeeccc----eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CeeccCCCCCcEEEcc---
Q 007260 282 YTHFETEK----FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHML-GIIYRDLKPENVLVRE--- 353 (611)
Q Consensus 282 ~~~~~~~~----~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~-gIVHRDLKPeNILv~~--- 353 (611)
++++...+ .+||||||+ |++|.+++.......+++..++.++.||+.||+|||++ |||||||||+||||+.
T Consensus 92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC
Confidence 99998654 899999999 99999999886666799999999999999999999998 9999999999999954
Q ss_pred ---CCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCcc
Q 007260 354 ---DGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKN 430 (611)
Q Consensus 354 ---~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 430 (611)
.+.+||+|||++.....
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~------------------------------------------------------------ 190 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDE------------------------------------------------------------ 190 (373)
T ss_dssp TTTEEEEEECCCTTCEETTB------------------------------------------------------------
T ss_pred CcCcceEEEcccccccccCC------------------------------------------------------------
Confidence 33799999999843210
Q ss_pred ccCCCCCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC------cHHHHH
Q 007260 431 EIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSG------NRATLF 504 (611)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~------~~~~l~ 504 (611)
.....+||+.|+|||++.+..++.++|||||||+||||++|+.||.+.. ....+.
T Consensus 191 -------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 251 (373)
T 1q8y_A 191 -------------------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 251 (373)
T ss_dssp -------------------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred -------------------CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHH
Confidence 0112368999999999999999999999999999999999999998654 222222
Q ss_pred HH---HcCCC-------------------------------------CCCCCCCCCHHHHHHHHHhhhcCccccCCchhc
Q 007260 505 NV---VGQPL-------------------------------------RFPESPVVSFAARDLIRGLLVKEPQHRLAYKRG 544 (611)
Q Consensus 505 ~i---~~~~l-------------------------------------~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~ 544 (611)
.+ ++... .+.....++.++++||.+||..||.+||+
T Consensus 252 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---- 327 (373)
T 1q8y_A 252 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD---- 327 (373)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC----
T ss_pred HHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC----
Confidence 22 21110 00111235678999999999999999999
Q ss_pred HHHHHcCCCCCCC
Q 007260 545 ATEIKQHPFFEGV 557 (611)
Q Consensus 545 a~elL~Hp~f~~~ 557 (611)
+.|||+||||++.
T Consensus 328 ~~ell~hp~f~~~ 340 (373)
T 1q8y_A 328 AGGLVNHPWLKDT 340 (373)
T ss_dssp HHHHHTCGGGTTC
T ss_pred HHHHhhChhhhcc
Confidence 9999999999863
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=380.07 Aligned_cols=257 Identities=21% Similarity=0.296 Sum_probs=219.7
Q ss_pred CccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc
Q 007260 210 DGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK 289 (611)
Q Consensus 210 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~ 289 (611)
++.+...+|++.+.||+|+||.||+|.+..++..||||++..... ....+.+|+.+|+.++||||+++++++.+++
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 82 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 82 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST----HHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 445566899999999999999999999999999999999976542 2345678999999999999999999999999
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
..|+||||++|++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 99999999999999999988766779999999999999999999999999999999999999999999999999984332
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
... ..
T Consensus 163 ~~~---------------------------------------------------------------------------~~ 167 (288)
T 3kfa_A 163 GDT---------------------------------------------------------------------------YT 167 (288)
T ss_dssp SSS---------------------------------------------------------------------------SE
T ss_pred CCc---------------------------------------------------------------------------cc
Confidence 110 00
Q ss_pred cccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 007260 450 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIR 528 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~ 528 (611)
......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+......... +......+....++..+.+||.
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~ 246 (288)
T 3kfa_A 168 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-LEKDYRMERPEGCPEKVYELMR 246 (288)
T ss_dssp EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-HHTTCCCCCCTTCCHHHHHHHH
T ss_pred cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HhccCCCCCCCCCCHHHHHHHH
Confidence 1112357889999999999999999999999999999999 9999988765554443 4444455555679999999999
Q ss_pred HhhhcCccccCCchhcHHHHHc
Q 007260 529 GLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 529 ~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
+||..||.+||+ +.++++
T Consensus 247 ~~l~~dp~~Rps----~~~~~~ 264 (288)
T 3kfa_A 247 ACWQWNPSDRPS----FAEIHQ 264 (288)
T ss_dssp HHTCSSGGGSCC----HHHHHH
T ss_pred HHhCCChhhCcC----HHHHHH
Confidence 999999999999 777765
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=386.80 Aligned_cols=269 Identities=19% Similarity=0.272 Sum_probs=222.5
Q ss_pred cccccCeEEEeEecccCcEEEEEEEEC-----CCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceee
Q 007260 212 VLGLSHFRLLKRLGCGDIGSVYLSELS-----GTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFE 286 (611)
Q Consensus 212 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~-----~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~ 286 (611)
.+..++|++.+.||+|+||.||+|++. .++..||||++..... .....++.+|+.+|+.++||||+++++++.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC--HHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccC--HHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 445579999999999999999999886 3578899999975432 233446788999999999999999999999
Q ss_pred ccceeeEEeeeCCCCCHHHHHHhCC--------CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEE
Q 007260 287 TEKFSCLVMEFCPGGDLHTLRQKQP--------GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIM 358 (611)
Q Consensus 287 ~~~~~~LVmE~~~gg~L~~ll~~~~--------~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vk 358 (611)
+.+..||||||++||+|.+++.... ...+++..+..++.||+.||+|||++||+||||||+||||+.++.+|
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEE
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEE
Confidence 9999999999999999999887531 13579999999999999999999999999999999999999999999
Q ss_pred EEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCC
Q 007260 359 LSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSP 438 (611)
Q Consensus 359 L~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (611)
|+|||++.......
T Consensus 179 l~Dfg~~~~~~~~~------------------------------------------------------------------ 192 (322)
T 1p4o_A 179 IGDFGMTRDIYETD------------------------------------------------------------------ 192 (322)
T ss_dssp ECCTTCCCGGGGGG------------------------------------------------------------------
T ss_pred ECcCcccccccccc------------------------------------------------------------------
Confidence 99999984332100
Q ss_pred CcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCC
Q 007260 439 LPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESP 517 (611)
Q Consensus 439 ~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~ 517 (611)
.........||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.........+..... .+...
T Consensus 193 --------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~ 263 (322)
T 1p4o_A 193 --------YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL-LDKPD 263 (322)
T ss_dssp --------CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC-CCCCT
T ss_pred --------ccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCc-CCCCC
Confidence 0001123358999999999999999999999999999999999 8999998877766666655443 23344
Q ss_pred CCCHHHHHHHHHhhhcCccccCCchhcHHHHHcC------CCCCCCchhh
Q 007260 518 VVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQH------PFFEGVNWAL 561 (611)
Q Consensus 518 ~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~H------p~f~~~~~~~ 561 (611)
.++..+.+||.+||..||.+||+ +.++++| +||+.+.|..
T Consensus 264 ~~~~~l~~li~~~l~~dp~~Rps----~~e~l~~L~~~~~~~~~~~~~~~ 309 (322)
T 1p4o_A 264 NCPDMLFELMRMCWQYNPKMRPS----FLEIISSIKEEMEPGFREVSFYY 309 (322)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCC----HHHHHHHHGGGSCTTHHHHCSTT
T ss_pred CCCHHHHHHHHHHcCCCcccCcC----HHHHHHHHHHhhccCCccccccc
Confidence 68999999999999999999999 6666654 7877766654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-46 Score=379.90 Aligned_cols=258 Identities=22% Similarity=0.301 Sum_probs=208.9
Q ss_pred cccccCeEEEeEecccCcEEEEEEE----ECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 007260 212 VLGLSHFRLLKRLGCGDIGSVYLSE----LSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET 287 (611)
Q Consensus 212 ~~~~~~y~l~~~LG~G~fG~Vy~a~----~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~ 287 (611)
.+..++|++++.||+|+||+||+|+ +..+++.||||++.... ......+.+|+.+|+.++||||+++++++..
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS 82 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 3445799999999999999999999 56789999999997643 3344567889999999999999999999865
Q ss_pred --cceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccc
Q 007260 288 --EKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365 (611)
Q Consensus 288 --~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA 365 (611)
...+|||||||++++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 456899999999999999998763 45999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccC
Q 007260 366 LRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAE 445 (611)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (611)
.........
T Consensus 162 ~~~~~~~~~----------------------------------------------------------------------- 170 (295)
T 3ugc_A 162 KVLPQDKEF----------------------------------------------------------------------- 170 (295)
T ss_dssp C-------------------------------------------------------------------------------
T ss_pred ccccCCcce-----------------------------------------------------------------------
Confidence 543211000
Q ss_pred cccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcH---------------HHHHHHHcCC
Q 007260 446 PTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNR---------------ATLFNVVGQP 510 (611)
Q Consensus 446 ~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~---------------~~l~~i~~~~ 510 (611)
........||..|+|||++.+..++.++|||||||++|||++|..||...... ..+...+...
T Consensus 171 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (295)
T 3ugc_A 171 --FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 248 (295)
T ss_dssp -------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT
T ss_pred --eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhcc
Confidence 00011234788899999999999999999999999999999999998753211 1122333344
Q ss_pred CCCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 511 LRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 511 l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
...+....++.++.+||.+||..||.+||+ +.++++
T Consensus 249 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~el~~ 284 (295)
T 3ugc_A 249 GRLPRPDGCPDEIYMIMTECWNNNVNQRPS----FRDLAL 284 (295)
T ss_dssp CCCCCCTTCCHHHHHHHHHHSCSSGGGSCC----HHHHHH
T ss_pred CcCCCCcCcCHHHHHHHHHHcCCChhhCCC----HHHHHH
Confidence 455556679999999999999999999999 666664
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=380.48 Aligned_cols=260 Identities=28% Similarity=0.396 Sum_probs=211.5
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
..+|.....||+|+||.||+|++..+++.||||++..... .....+.+|+.+++.++||||+++++++...+..|||
T Consensus 21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 97 (295)
T 2clq_A 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS---RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIF 97 (295)
T ss_dssp BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC------HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch---HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEE
Confidence 3455556699999999999999999999999999976532 2334677899999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEcc-CCcEEEEeccccccccCCc
Q 007260 295 MEFCPGGDLHTLRQKQPG-KYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRE-DGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~-~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~-~g~vkL~DFGlA~~~~~~~ 372 (611)
|||+++++|.+++....+ ..+++..++.++.||+.||+|||++||+||||||+||||+. ++.+||+|||++......
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~- 176 (295)
T 2clq_A 98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI- 176 (295)
T ss_dssp EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCC-
Confidence 999999999999887532 35679999999999999999999999999999999999997 899999999998433210
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
.....
T Consensus 177 ---------------------------------------------------------------------------~~~~~ 181 (295)
T 2clq_A 177 ---------------------------------------------------------------------------NPCTE 181 (295)
T ss_dssp -------------------------------------------------------------------------------C
T ss_pred ---------------------------------------------------------------------------CCccc
Confidence 00011
Q ss_pred ccccCCCccchhhhccCC--CCChhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHcCCCCCCCCCCCCHHHHHHHHH
Q 007260 453 SFVGTHEYLAPEIIKGEG--HGSAVDWWTFGIFLYELLFGKTPFKGSGNRAT-LFNVVGQPLRFPESPVVSFAARDLIRG 529 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~--~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~-l~~i~~~~l~~p~~~~~s~~l~dLI~~ 529 (611)
...||+.|+|||++.+.. ++.++|||||||++|+|++|+.||........ +...............++.++.+||.+
T Consensus 182 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 261 (295)
T 2clq_A 182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILK 261 (295)
T ss_dssp CCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHH
T ss_pred ccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHHHH
Confidence 346999999999998754 78999999999999999999999986544332 222221122222234589999999999
Q ss_pred hhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 530 LLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 530 ~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
||..||++||+ +.++++||||+..
T Consensus 262 ~l~~dp~~Rps----~~~ll~~~~~~~~ 285 (295)
T 2clq_A 262 CFEPDPDKRAC----ANDLLVDEFLKVS 285 (295)
T ss_dssp TTCSSTTTSCC----HHHHHTSGGGCC-
T ss_pred HccCChhhCCC----HHHHhcChhhhhc
Confidence 99999999999 9999999999753
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=376.39 Aligned_cols=257 Identities=25% Similarity=0.348 Sum_probs=206.9
Q ss_pred CccccccCeEEEeEecccCcEEEEEEEECCC---CeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceee
Q 007260 210 DGVLGLSHFRLLKRLGCGDIGSVYLSELSGT---KCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFE 286 (611)
Q Consensus 210 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t---~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~ 286 (611)
+..+..++|++++.||+|+||.||+|.+..+ +..||||++.... ......++.+|+.+|+.++||||+++++++.
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 86 (281)
T 1mp8_A 9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT 86 (281)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc
Confidence 3445567999999999999999999998653 5679999987543 2344556788999999999999999999984
Q ss_pred ccceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccc
Q 007260 287 TEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSL 366 (611)
Q Consensus 287 ~~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~ 366 (611)
++..||||||+++++|.+++... +..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 87 -~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 87 -ENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred -cCccEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccc
Confidence 56789999999999999999865 3469999999999999999999999999999999999999999999999999984
Q ss_pred cccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCc
Q 007260 367 RCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEP 446 (611)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (611)
......
T Consensus 165 ~~~~~~-------------------------------------------------------------------------- 170 (281)
T 1mp8_A 165 YMEDST-------------------------------------------------------------------------- 170 (281)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccCccc--------------------------------------------------------------------------
Confidence 332100
Q ss_pred ccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 007260 447 TEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARD 525 (611)
Q Consensus 447 ~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~d 525 (611)
........||+.|+|||++.+..++.++|||||||++|||++ |..||.+....+.+..+.... ..+....++..+.+
T Consensus 171 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~l~~ 248 (281)
T 1mp8_A 171 -YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNCPPTLYS 248 (281)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CCCCCTTCCHHHHH
T ss_pred -ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCC-CCCCCCCCCHHHHH
Confidence 000112347889999999999999999999999999999996 999999887776666655443 33444569999999
Q ss_pred HHHHhhhcCccccCCchhcHHHHHc
Q 007260 526 LIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 526 LI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
||.+||..||.+||+ +.++++
T Consensus 249 li~~~l~~~p~~Rps----~~~l~~ 269 (281)
T 1mp8_A 249 LMTKCWAYDPSRRPR----FTELKA 269 (281)
T ss_dssp HHHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHHccCChhhCcC----HHHHHH
Confidence 999999999999999 777775
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=387.70 Aligned_cols=265 Identities=22% Similarity=0.323 Sum_probs=211.3
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeeccceeeE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEKFSCL 293 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~~~~~L 293 (611)
.++|++++.||+|+||.||+|++..+++.||||++...... ..+.+|+.+|+.| +||||+++++++..++..||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 82 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM 82 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence 36899999999999999999999999999999998754322 2466799999999 99999999999999999999
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCc-----EEEEeccccccc
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGH-----IMLSDFDLSLRC 368 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~-----vkL~DFGlA~~~ 368 (611)
||||+ |++|.+++... ...+++..++.++.||+.||+|||++|||||||||+||||+.++. +||+|||++..+
T Consensus 83 v~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 83 VLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp EEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 99999 99999999875 357999999999999999999999999999999999999998887 999999998543
Q ss_pred cCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccc
Q 007260 369 AVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTE 448 (611)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (611)
....... ....
T Consensus 161 ~~~~~~~---------------------------------------------------------------------~~~~ 171 (330)
T 2izr_A 161 IDPETKK---------------------------------------------------------------------HIPY 171 (330)
T ss_dssp BCTTTCC---------------------------------------------------------------------BCCC
T ss_pred ecCCCCc---------------------------------------------------------------------cccc
Confidence 2111000 0000
Q ss_pred ccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHcCCCCCCC---CCCCCHH
Q 007260 449 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGN---RATLFNVVGQPLRFPE---SPVVSFA 522 (611)
Q Consensus 449 ~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~---~~~l~~i~~~~l~~p~---~~~~s~~ 522 (611)
.....++||+.|+|||++.+..++.++|||||||++|||++|+.||.+... .+.+..+.......+. ...++ +
T Consensus 172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~ 250 (330)
T 2izr_A 172 REHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFP-E 250 (330)
T ss_dssp CCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-H
T ss_pred cccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHhccCh-H
Confidence 112345799999999999999999999999999999999999999987432 2333333332222221 11244 9
Q ss_pred HHHHHHHhhhcCccccCCchhcHHHHHc----------CCCCCCCchh
Q 007260 523 ARDLIRGLLVKEPQHRLAYKRGATEIKQ----------HPFFEGVNWA 560 (611)
Q Consensus 523 l~dLI~~~L~~dP~~Rpt~~~~a~elL~----------Hp~f~~~~~~ 560 (611)
+.+||..||..||.+||+ +++|++ ..+...++|.
T Consensus 251 ~~~li~~~l~~~p~~RP~----~~~l~~~l~~~~~~~~~~~~~~~dw~ 294 (330)
T 2izr_A 251 MATYLRYVRRLDFFEKPD----YDYLRKLFTDLFDRKGYMFDYEYDWI 294 (330)
T ss_dssp HHHHHHHHHHCCTTCCCC----HHHHHHHHHHHHHHTTCCCSCCCTTT
T ss_pred HHHHHHHHHhCCCCCCCC----HHHHHHHHHHHHHHcCCCCCCCccCC
Confidence 999999999999999999 444432 3445567776
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=392.21 Aligned_cols=258 Identities=22% Similarity=0.302 Sum_probs=216.1
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECC-------CCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccce
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSG-------TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTH 284 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~-------t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~ 284 (611)
+..++|++++.||+|+||+||+|++.. .+..||||++.... ......++.+|+++|+.+ +|||||+++++
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 143 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGA 143 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence 345799999999999999999999754 34689999997653 234456778999999999 99999999999
Q ss_pred eeccceeeEEeeeCCCCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEE
Q 007260 285 FETEKFSCLVMEFCPGGDLHTLRQKQP--------------GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVL 350 (611)
Q Consensus 285 ~~~~~~~~LVmE~~~gg~L~~ll~~~~--------------~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNIL 350 (611)
+..++..|||||||+||+|.+++.... ...+++..++.++.||+.||+|||++|||||||||+|||
T Consensus 144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 223 (382)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEE
Confidence 999999999999999999999998753 245999999999999999999999999999999999999
Q ss_pred EccCCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCcc
Q 007260 351 VREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKN 430 (611)
Q Consensus 351 v~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 430 (611)
|+.++.+||+|||++........
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~--------------------------------------------------------- 246 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDY--------------------------------------------------------- 246 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCT---------------------------------------------------------
T ss_pred EcCCCcEEEcccCcccccccccc---------------------------------------------------------
Confidence 99999999999999843321000
Q ss_pred ccCCCCCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcC
Q 007260 431 EIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQ 509 (611)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~ 509 (611)
........||+.|+|||++.+..++.++|||||||++|||++ |..||.+....+.+..+. .
T Consensus 247 -----------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~-~ 308 (382)
T 3tt0_A 247 -----------------YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK-E 308 (382)
T ss_dssp -----------------TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-T
T ss_pred -----------------cccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-c
Confidence 000112357899999999999999999999999999999999 999999877665554444 3
Q ss_pred CCCCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcC
Q 007260 510 PLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 510 ~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~H 551 (611)
.........++.++.+||.+||..||.+||+ +.+|+++
T Consensus 309 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps----~~ell~~ 346 (382)
T 3tt0_A 309 GHRMDKPSNCTNELYMMMRDCWHAVPSQRPT----FKQLVED 346 (382)
T ss_dssp TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCCCCCCccCCHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 3444445569999999999999999999999 7787764
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=393.14 Aligned_cols=253 Identities=27% Similarity=0.395 Sum_probs=187.2
Q ss_pred ccCeEEEe-EecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec----cc
Q 007260 215 LSHFRLLK-RLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET----EK 289 (611)
Q Consensus 215 ~~~y~l~~-~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~----~~ 289 (611)
.++|++++ .||.|+||+||+|++..+++.||||++..... . .......++.++||||++++++|.. ..
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK----A---RQEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH----H---HHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH----H---HHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 46899966 69999999999999999999999999965421 1 1123334677899999999999976 56
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEcc---CCcEEEEeccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRE---DGHIMLSDFDLSL 366 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~---~g~vkL~DFGlA~ 366 (611)
.+|||||||+||+|.+++.......+++..++.++.||+.||+|||++||+||||||+||||+. ++.+||+|||++.
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 7899999999999999999876668999999999999999999999999999999999999986 4569999999984
Q ss_pred cccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCc
Q 007260 367 RCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEP 446 (611)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (611)
....
T Consensus 180 ~~~~---------------------------------------------------------------------------- 183 (336)
T 3fhr_A 180 ETTQ---------------------------------------------------------------------------- 183 (336)
T ss_dssp EC------------------------------------------------------------------------------
T ss_pred eccc----------------------------------------------------------------------------
Confidence 3210
Q ss_pred ccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHH----HHHHcCC--CCCCCCCCCC
Q 007260 447 TEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATL----FNVVGQP--LRFPESPVVS 520 (611)
Q Consensus 447 ~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l----~~i~~~~--l~~p~~~~~s 520 (611)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....... ..+.... ...+....++
T Consensus 184 --~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (336)
T 3fhr_A 184 --NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVS 261 (336)
T ss_dssp ----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCC
T ss_pred --cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCC
Confidence 0011236899999999999888999999999999999999999999876544321 1222222 2333445689
Q ss_pred HHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCC
Q 007260 521 FAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 521 ~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
.++++||.+||..||.+||+ +.|+|+||||++
T Consensus 262 ~~~~~li~~~L~~dP~~Rpt----~~ell~hp~~~~ 293 (336)
T 3fhr_A 262 EDAKQLIRLLLKTDPTERLT----ITQFMNHPWINQ 293 (336)
T ss_dssp HHHHHHHHHHSCSSGGGSCC----HHHHHHSHHHHT
T ss_pred HHHHHHHHHHCCCChhHCcC----HHHHhcCccccc
Confidence 99999999999999999999 999999999975
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=396.17 Aligned_cols=258 Identities=26% Similarity=0.326 Sum_probs=216.2
Q ss_pred ccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccce
Q 007260 211 GVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKF 290 (611)
Q Consensus 211 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~ 290 (611)
..+..++|++++.||+|+||.||+|++..+++.||||++.... .......+.+|+.+|+.++|||||++++++..++.
T Consensus 109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 186 (377)
T 3cbl_A 109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP 186 (377)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCC
Confidence 3455679999999999999999999999999999999987542 22344467789999999999999999999999999
Q ss_pred eeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccC
Q 007260 291 SCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAV 370 (611)
Q Consensus 291 ~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~ 370 (611)
+|||||||+||+|.+++... +..+++..+..++.||+.||+|||++|||||||||+||||+.++.+||+|||+++....
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred cEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 99999999999999998764 24589999999999999999999999999999999999999999999999999843221
Q ss_pred CccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccc
Q 007260 371 SPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEAR 450 (611)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (611)
... ...
T Consensus 266 ~~~--------------------------------------------------------------------------~~~ 271 (377)
T 3cbl_A 266 GVY--------------------------------------------------------------------------AAS 271 (377)
T ss_dssp SEE--------------------------------------------------------------------------ECC
T ss_pred Cce--------------------------------------------------------------------------eec
Confidence 000 000
Q ss_pred ccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHH
Q 007260 451 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRG 529 (611)
Q Consensus 451 ~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~ 529 (611)
.....+++.|+|||++.+..++.++|||||||+||||++ |+.||.+.........+ ....+.+....++.++.+||.+
T Consensus 272 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~ 350 (377)
T 3cbl_A 272 GGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV-EKGGRLPCPELCPDAVFRLMEQ 350 (377)
T ss_dssp SSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHH-HTTCCCCCCTTCCHHHHHHHHH
T ss_pred CCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHHHHH
Confidence 011236778999999999999999999999999999998 99999988766555444 3444555556699999999999
Q ss_pred hhhcCccccCCchhcHHHHHc
Q 007260 530 LLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 530 ~L~~dP~~Rpt~~~~a~elL~ 550 (611)
||..||.+||+ +.+|++
T Consensus 351 cl~~dP~~Rps----~~~i~~ 367 (377)
T 3cbl_A 351 CWAYEPGQRPS----FSTIYQ 367 (377)
T ss_dssp HTCSSGGGSCC----HHHHHH
T ss_pred HcCCCchhCcC----HHHHHH
Confidence 99999999999 666654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=368.67 Aligned_cols=255 Identities=24% Similarity=0.341 Sum_probs=215.9
Q ss_pred ccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccce
Q 007260 211 GVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKF 290 (611)
Q Consensus 211 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~ 290 (611)
..+..++|++++.||+|+||.||+|.+. ++..||||++....... ..+.+|+++++.++||||+++++++.+.+.
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 77 (267)
T 3t9t_A 3 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 77 (267)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred eEEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCH----HHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3455679999999999999999999987 46789999998755332 356789999999999999999999999999
Q ss_pred eeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccC
Q 007260 291 SCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAV 370 (611)
Q Consensus 291 ~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~ 370 (611)
.|+||||++|++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 78 ICLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp CEEEECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred eEEEEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccc
Confidence 999999999999999998753 5689999999999999999999999999999999999999999999999999843321
Q ss_pred CccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccc
Q 007260 371 SPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEAR 450 (611)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (611)
.. ...
T Consensus 157 ~~---------------------------------------------------------------------------~~~ 161 (267)
T 3t9t_A 157 DQ---------------------------------------------------------------------------YTS 161 (267)
T ss_dssp HH---------------------------------------------------------------------------HHS
T ss_pred cc---------------------------------------------------------------------------ccc
Confidence 00 000
Q ss_pred ccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHH
Q 007260 451 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRG 529 (611)
Q Consensus 451 ~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~ 529 (611)
.....||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+......+..+.... .......++..+.+||.+
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~l~~li~~ 240 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF-RLYKPRLASTHVYQIMNH 240 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-CCCCCTTSCHHHHHHHHH
T ss_pred cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC-cCCCCccCcHHHHHHHHH
Confidence 112347889999999999999999999999999999999 999999887777666665542 333344589999999999
Q ss_pred hhhcCccccCCchhcHHHHHcC
Q 007260 530 LLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 530 ~L~~dP~~Rpt~~~~a~elL~H 551 (611)
||..||.+||+ +.+++++
T Consensus 241 ~l~~~p~~Rps----~~~ll~~ 258 (267)
T 3t9t_A 241 CWRERPEDRPA----FSRLLRQ 258 (267)
T ss_dssp HTCSSGGGSCC----HHHHHHH
T ss_pred HccCChhhCcC----HHHHHHH
Confidence 99999999999 7777763
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=375.03 Aligned_cols=252 Identities=24% Similarity=0.344 Sum_probs=209.1
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHH----HHHHHHHHHHHHhCCCCCcccccceeecc
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKK----LLRAQTEREILQSLDHPFLPTLYTHFETE 288 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~----~~~~~~E~~iL~~l~HpnIv~l~~~~~~~ 288 (611)
+..++|++.+.||+|+||+||+|++..+++.||||++.......... ..++.+|+.+++.++||||+++++++.+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 34579999999999999999999999999999999986544322211 25678899999999999999999999766
Q ss_pred ceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--eeccCCCCCcEEEccCCc-----EEEEe
Q 007260 289 KFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLG--IIYRDLKPENVLVREDGH-----IMLSD 361 (611)
Q Consensus 289 ~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~g--IVHRDLKPeNILv~~~g~-----vkL~D 361 (611)
. +|||||+++++|.+++... ...+++..++.++.||+.||+|||++| |+||||||+||||+.++. +||+|
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred C--eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 5 6999999999999888765 356999999999999999999999999 999999999999988776 99999
Q ss_pred ccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcc
Q 007260 362 FDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPE 441 (611)
Q Consensus 362 FGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (611)
||++.....
T Consensus 173 fg~~~~~~~----------------------------------------------------------------------- 181 (287)
T 4f0f_A 173 FGLSQQSVH----------------------------------------------------------------------- 181 (287)
T ss_dssp CTTCBCCSS-----------------------------------------------------------------------
T ss_pred CCccccccc-----------------------------------------------------------------------
Confidence 999832110
Q ss_pred cccCcccccccccccCCCccchhhhc--cCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHcCCCCCCCCC
Q 007260 442 LIAEPTEARSMSFVGTHEYLAPEIIK--GEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRAT--LFNVVGQPLRFPESP 517 (611)
Q Consensus 442 ~~~~~~~~~~~~~vGT~~Y~APEil~--~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~--l~~i~~~~l~~p~~~ 517 (611)
.....+||+.|+|||++. +..++.++|||||||++|||++|+.||........ ...+...........
T Consensus 182 --------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (287)
T 4f0f_A 182 --------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPE 253 (287)
T ss_dssp --------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCT
T ss_pred --------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCCc
Confidence 011346999999999994 44568899999999999999999999987654332 444455555555556
Q ss_pred CCCHHHHHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 518 VVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 518 ~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
.++.++.+||.+||..||.+||+ +.++++
T Consensus 254 ~~~~~l~~li~~~l~~dp~~Rps----~~~ll~ 282 (287)
T 4f0f_A 254 DCPPRLRNVIELCWSGDPKKRPH----FSYIVK 282 (287)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred ccCHHHHHHHHHHhcCChhhCcC----HHHHHH
Confidence 69999999999999999999999 777765
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=382.54 Aligned_cols=259 Identities=22% Similarity=0.321 Sum_probs=214.7
Q ss_pred ccccCeEEEeEecccCcEEEEEEEE-----CCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSEL-----SGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFE 286 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~-----~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~ 286 (611)
+..++|++++.||.|+||.||+|++ ..+++.||||++..... ......+.+|+.+|+.+ +||||+++++++.
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 101 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACT 101 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCC--cHHHHHHHHHHHHHHhcccCCCeeeEEEEEe
Confidence 4457999999999999999999985 35678999999976532 23445678899999999 7999999999987
Q ss_pred cc-ceeeEEeeeCCCCCHHHHHHhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEE
Q 007260 287 TE-KFSCLVMEFCPGGDLHTLRQKQPG--------------KYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLV 351 (611)
Q Consensus 287 ~~-~~~~LVmE~~~gg~L~~ll~~~~~--------------~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv 351 (611)
.. ..+|+|||||+|++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+||||
T Consensus 102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~ 181 (316)
T 2xir_A 102 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 181 (316)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE
Confidence 65 459999999999999999987542 228999999999999999999999999999999999999
Q ss_pred ccCCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccc
Q 007260 352 REDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNE 431 (611)
Q Consensus 352 ~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (611)
+.++.+||+|||++.......
T Consensus 182 ~~~~~~kl~Dfg~~~~~~~~~----------------------------------------------------------- 202 (316)
T 2xir_A 182 SEKNVVKICDFGLARDIYKDP----------------------------------------------------------- 202 (316)
T ss_dssp CGGGCEEECCCGGGSCTTTCT-----------------------------------------------------------
T ss_pred CCCCCEEECCCccccccccCc-----------------------------------------------------------
Confidence 999999999999984332110
Q ss_pred cCCCCCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCC
Q 007260 432 IGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQP 510 (611)
Q Consensus 432 ~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~ 510 (611)
.........||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+......+...+...
T Consensus 203 ---------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~ 267 (316)
T 2xir_A 203 ---------------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 267 (316)
T ss_dssp ---------------TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHT
T ss_pred ---------------cceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccC
Confidence 0011123468999999999999999999999999999999998 999998876555555444444
Q ss_pred CCCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcC
Q 007260 511 LRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 511 l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~H 551 (611)
...+....++..+.+||.+||..||.+||+ +.++++|
T Consensus 268 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~ell~~ 304 (316)
T 2xir_A 268 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPT----FSELVEH 304 (316)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred ccCCCCCCCCHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 444444568999999999999999999999 8888875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=386.29 Aligned_cols=259 Identities=19% Similarity=0.284 Sum_probs=218.4
Q ss_pred cccccCeEEEeEecccCcEEEEEEEECCCCe-----EEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCccccccee
Q 007260 212 VLGLSHFRLLKRLGCGDIGSVYLSELSGTKC-----YFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHF 285 (611)
Q Consensus 212 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~-----~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~ 285 (611)
.+..++|++++.||.|+||.||+|.+..++. .||+|++..... ......+.+|+.+|+.+ +||||+++++++
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH--ADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccC--hHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 3445799999999999999999999977654 799999976432 23445678899999999 899999999999
Q ss_pred eccceeeEEeeeCCCCCHHHHHHhCC------------CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEcc
Q 007260 286 ETEKFSCLVMEFCPGGDLHTLRQKQP------------GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRE 353 (611)
Q Consensus 286 ~~~~~~~LVmE~~~gg~L~~ll~~~~------------~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~ 353 (611)
.+.+.+|||||||++|+|.+++.... ...+++..++.++.||+.||+|||++||+||||||+||||+.
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN 199 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEG
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECC
Confidence 99999999999999999999887531 346899999999999999999999999999999999999999
Q ss_pred CCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccC
Q 007260 354 DGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIG 433 (611)
Q Consensus 354 ~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 433 (611)
++.+||+|||++........
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~------------------------------------------------------------ 219 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSN------------------------------------------------------------ 219 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTT------------------------------------------------------------
T ss_pred CCeEEECccccccccccccc------------------------------------------------------------
Confidence 99999999999843321100
Q ss_pred CCCCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCC
Q 007260 434 NQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLR 512 (611)
Q Consensus 434 ~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~ 512 (611)
........||+.|+|||++.+..++.++|||||||++|||++ |..||.+......+..++.....
T Consensus 220 --------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 285 (333)
T 2i1m_A 220 --------------YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQ 285 (333)
T ss_dssp --------------SEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCC
T ss_pred --------------eeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCC
Confidence 000112358899999999999999999999999999999998 99999987766666666666555
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 513 FPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 513 ~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
.+....++..+.+||.+||..||.+||+ +.++++
T Consensus 286 ~~~~~~~~~~l~~li~~~l~~~p~~Rps----~~~l~~ 319 (333)
T 2i1m_A 286 MAQPAFAPKNIYSIMQACWALEPTHRPT----FQQICS 319 (333)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHhccChhhCcC----HHHHHH
Confidence 5555668999999999999999999999 778776
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=380.89 Aligned_cols=254 Identities=24% Similarity=0.320 Sum_probs=207.0
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
+++|++++.||+|+||.||+|++..+++.||||++............++.+|+.+++.++||||+++++++..++.+|||
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 46999999999999999999999999999999999876655555667788999999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
|||++|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++......
T Consensus 113 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--- 187 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE--- 187 (309)
T ss_dssp EECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred EEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc---
Confidence 9999999999998875 46999999999999999999999999999999999999999999999999998432100
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
........
T Consensus 188 ------------------------------------------------------------------------~~~~~~~~ 195 (309)
T 2h34_A 188 ------------------------------------------------------------------------KLTQLGNT 195 (309)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ------------------------------------------------------------------------cccccccc
Confidence 00011234
Q ss_pred ccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCC--CCCCCCCHHHHHHHHHhhh
Q 007260 455 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRF--PESPVVSFAARDLIRGLLV 532 (611)
Q Consensus 455 vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~--p~~~~~s~~l~dLI~~~L~ 532 (611)
+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... .+...+...... .....++.++.+||.+||.
T Consensus 196 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 274 (309)
T 2h34_A 196 VGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQAIPRPSTVRPGIPVAFDAVIARGMA 274 (309)
T ss_dssp -CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTC
T ss_pred CCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhccCCCCccccCCCCCHHHHHHHHHhcc
Confidence 6999999999999999999999999999999999999999886554 333434333222 2234589999999999999
Q ss_pred cCccccC-CchhcHHHHHc
Q 007260 533 KEPQHRL-AYKRGATEIKQ 550 (611)
Q Consensus 533 ~dP~~Rp-t~~~~a~elL~ 550 (611)
.||.+|| + ++++++
T Consensus 275 ~dP~~Rp~s----~~~l~~ 289 (309)
T 2h34_A 275 KNPEDRYVT----CGDLSA 289 (309)
T ss_dssp SSGGGSCSS----HHHHHH
T ss_pred CCHHHHHHh----HHHHHH
Confidence 9999999 6 555553
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=375.83 Aligned_cols=249 Identities=20% Similarity=0.225 Sum_probs=207.7
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCC-------eEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCccccccee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTK-------CYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHF 285 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~-------~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~ 285 (611)
+..++|++.+.||+|+||+||+|++..++ ..||+|++.+.... ...++.+|+.+|+.++||||+++++++
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRN---YSESFFEAASMMSKLSHKHLVLNYGVC 81 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGG---GHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHH---HHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 34579999999999999999999988766 57999999765433 234567899999999999999999999
Q ss_pred eccceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCc--------E
Q 007260 286 ETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGH--------I 357 (611)
Q Consensus 286 ~~~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~--------v 357 (611)
..++..||||||++|++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||||+.++. +
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence 99999999999999999999998753 44999999999999999999999999999999999999999887 9
Q ss_pred EEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCC
Q 007260 358 MLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVS 437 (611)
Q Consensus 358 kL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (611)
||+|||++....
T Consensus 161 kl~Dfg~~~~~~-------------------------------------------------------------------- 172 (289)
T 4fvq_A 161 KLSDPGISITVL-------------------------------------------------------------------- 172 (289)
T ss_dssp EECCCCSCTTTS--------------------------------------------------------------------
T ss_pred eeccCccccccc--------------------------------------------------------------------
Confidence 999999873211
Q ss_pred CCcccccCcccccccccccCCCccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCC
Q 007260 438 PLPELIAEPTEARSMSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPES 516 (611)
Q Consensus 438 ~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~-~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~ 516 (611)
......||+.|+|||++.+ ..++.++|||||||++|||++|..|+...........+......++..
T Consensus 173 ------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (289)
T 4fvq_A 173 ------------PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAP 240 (289)
T ss_dssp ------------CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC
T ss_pred ------------CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCCCCC
Confidence 0112358999999999998 678999999999999999999554444444444444445554444443
Q ss_pred CCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcC
Q 007260 517 PVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 517 ~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~H 551 (611)
.+.++.+||.+||..||.+||+ +.++++|
T Consensus 241 --~~~~l~~li~~~l~~dp~~Rps----~~~ll~~ 269 (289)
T 4fvq_A 241 --KAAELANLINNCMDYEPDHRPS----FRAIIRD 269 (289)
T ss_dssp --SSCTTHHHHHHHSCSSGGGSCC----HHHHHHH
T ss_pred --CCHHHHHHHHHHcCCChhHCcC----HHHHHHH
Confidence 6788999999999999999999 8888875
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=380.86 Aligned_cols=262 Identities=26% Similarity=0.400 Sum_probs=214.2
Q ss_pred ccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC--CCCcccccceeecc
Q 007260 211 GVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD--HPFLPTLYTHFETE 288 (611)
Q Consensus 211 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~--HpnIv~l~~~~~~~ 288 (611)
..+...+|++++.||+|+||.||+|.+.. ++.||||++..... .......+.+|+.+|+.+. ||||+++++++..+
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 100 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 100 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence 34455789999999999999999999864 78899999975443 2345567789999999997 59999999999999
Q ss_pred ceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccc
Q 007260 289 KFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRC 368 (611)
Q Consensus 289 ~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~ 368 (611)
+.+|||||+ .+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...
T Consensus 101 ~~~~lv~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 101 QYIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 176 (313)
T ss_dssp SEEEEEECC-CSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC-
T ss_pred CEEEEEEec-CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccc
Confidence 999999995 588999999875 5699999999999999999999999999999999999996 589999999998433
Q ss_pred cCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccc
Q 007260 369 AVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTE 448 (611)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (611)
..... .
T Consensus 177 ~~~~~--------------------------------------------------------------------------~ 182 (313)
T 3cek_A 177 QPDTT--------------------------------------------------------------------------S 182 (313)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cCccc--------------------------------------------------------------------------c
Confidence 21000 0
Q ss_pred ccccccccCCCccchhhhcc-----------CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHcCCCCCCCC
Q 007260 449 ARSMSFVGTHEYLAPEIIKG-----------EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNR-ATLFNVVGQPLRFPES 516 (611)
Q Consensus 449 ~~~~~~vGT~~Y~APEil~~-----------~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~-~~l~~i~~~~l~~p~~ 516 (611)
......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+..++.........
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 262 (313)
T 3cek_A 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 262 (313)
T ss_dssp -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCC
T ss_pred ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCc
Confidence 01123469999999999986 46788999999999999999999999876543 4455556555554444
Q ss_pred CCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCC
Q 007260 517 PVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 517 ~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
...+.++.+||.+||..||.+||+ +.++++||||+.
T Consensus 263 ~~~~~~l~~li~~~l~~dp~~Rps----~~ell~h~~~~~ 298 (313)
T 3cek_A 263 DIPEKDLQDVLKCCLKRDPKQRIS----IPELLAHPYVQI 298 (313)
T ss_dssp CCSCHHHHHHHHHHTCSSTTTSCC----HHHHHTSHHHHC
T ss_pred ccchHHHHHHHHHHccCCcccCcC----HHHHhcCccccC
Confidence 557899999999999999999999 999999999975
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=384.29 Aligned_cols=256 Identities=21% Similarity=0.311 Sum_probs=206.2
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEE----EEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecc
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYF----AMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE 288 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~v----AvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~ 288 (611)
+..++|++++.||+|+||+||+|++..+++.+ |+|.+.... ......++.+|+.+|+.++||||+++++++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 44578999999999999999999998777654 777765432 223345678899999999999999999999876
Q ss_pred ceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccc
Q 007260 289 KFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRC 368 (611)
Q Consensus 289 ~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~ 368 (611)
. .++||||+.+|+|.+++.... ..+++..++.|+.||+.||+|||++|||||||||+||||+.++++||+|||++...
T Consensus 90 ~-~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 90 T-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp S-EEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred C-eEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 4 789999999999999988753 56999999999999999999999999999999999999999999999999998544
Q ss_pred cCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccc
Q 007260 369 AVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTE 448 (611)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (611)
..... .
T Consensus 168 ~~~~~--------------------------------------------------------------------------~ 173 (327)
T 3poz_A 168 GAEEK--------------------------------------------------------------------------E 173 (327)
T ss_dssp TTTCC---------------------------------------------------------------------------
T ss_pred cCCcc--------------------------------------------------------------------------c
Confidence 21110 0
Q ss_pred ccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 007260 449 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLI 527 (611)
Q Consensus 449 ~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI 527 (611)
.......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+....... .++......+....++..+.+||
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li 252 (327)
T 3poz_A 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERLPQPPICTIDVYMIM 252 (327)
T ss_dssp ------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-HHHHTTCCCCCCTTBCHHHHHHH
T ss_pred ccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH-HHHHcCCCCCCCccCCHHHHHHH
Confidence 00112357889999999999999999999999999999999 99999987665544 44444445556667999999999
Q ss_pred HHhhhcCccccCCchhcHHHHHcC
Q 007260 528 RGLLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 528 ~~~L~~dP~~Rpt~~~~a~elL~H 551 (611)
.+||..||.+||+ +.+++++
T Consensus 253 ~~~l~~~p~~Rps----~~ell~~ 272 (327)
T 3poz_A 253 VKCWMIDADSRPK----FRELIIE 272 (327)
T ss_dssp HHHTCSCGGGSCC----HHHHHHH
T ss_pred HHHcCCChhhCCC----HHHHHHH
Confidence 9999999999999 7777764
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=386.37 Aligned_cols=263 Identities=25% Similarity=0.330 Sum_probs=193.6
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHH-HHHhCCCCCcccccceeecccee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTERE-ILQSLDHPFLPTLYTHFETEKFS 291 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~-iL~~l~HpnIv~l~~~~~~~~~~ 291 (611)
+..++|++++.||+|+||.||+|.+..+++.||||++...... ....++..|+. +++.++||||+++++++...+..
T Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~ 96 (327)
T 3aln_A 19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE--KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDC 96 (327)
T ss_dssp CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCH--HHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEE
T ss_pred cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCc--hHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCce
Confidence 4567999999999999999999999999999999999764322 22234445555 77888999999999999999999
Q ss_pred eEEeeeCCCCCHHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHHc-CeeccCCCCCcEEEccCCcEEEEecccccc
Q 007260 292 CLVMEFCPGGDLHTLRQK---QPGKYFPEQAVRFYVAEVLLALEYLHML-GIIYRDLKPENVLVREDGHIMLSDFDLSLR 367 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~---~~~~~l~e~~~~~i~~qll~aL~yLH~~-gIVHRDLKPeNILv~~~g~vkL~DFGlA~~ 367 (611)
||||||+.| +|.+++.. .....+++..++.++.|++.||.|||++ ||+||||||+||||+.++.+||+|||++..
T Consensus 97 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 97 WICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp EEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 999999965 88777653 2246799999999999999999999999 999999999999999999999999999843
Q ss_pred ccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcc
Q 007260 368 CAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPT 447 (611)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (611)
....
T Consensus 176 ~~~~---------------------------------------------------------------------------- 179 (327)
T 3aln_A 176 LVDS---------------------------------------------------------------------------- 179 (327)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cccc----------------------------------------------------------------------------
Confidence 2100
Q ss_pred cccccccccCCCccchhhh----ccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHcCC-CCCC--CCCCC
Q 007260 448 EARSMSFVGTHEYLAPEII----KGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNR-ATLFNVVGQP-LRFP--ESPVV 519 (611)
Q Consensus 448 ~~~~~~~vGT~~Y~APEil----~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~-~~l~~i~~~~-l~~p--~~~~~ 519 (611)
.......||+.|+|||++ .+..++.++|||||||++|+|++|+.||.+.... +.+..+.... ..++ ....+
T Consensus 180 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (327)
T 3aln_A 180 -IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREF 258 (327)
T ss_dssp ---------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCCC
T ss_pred -cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccccC
Confidence 001123599999999999 4667899999999999999999999999875432 2222222221 1122 12358
Q ss_pred CHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCch
Q 007260 520 SFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNW 559 (611)
Q Consensus 520 s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 559 (611)
+..+.+||.+||..||.+||+ +.+|++||||...++
T Consensus 259 ~~~l~~li~~~l~~dp~~Rps----~~ell~hp~~~~~~~ 294 (327)
T 3aln_A 259 SPSFINFVNLCLTKDESKRPK----YKELLKHPFILMYEE 294 (327)
T ss_dssp CHHHHHHHHHHTCSSGGGSCC----HHHHTTSHHHHHHHH
T ss_pred CHHHHHHHHHHhhCChhhCcC----HHHHHhChHHHHhHh
Confidence 999999999999999999999 999999999986554
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=380.31 Aligned_cols=262 Identities=26% Similarity=0.383 Sum_probs=203.3
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSC 292 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~ 292 (611)
..+++|++++.||.|+||.||+|++..+++.||||++....... .....+..+..+++.++||||+++++++..++.+|
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 100 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKE-ENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF 100 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHH-HHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccch-HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence 34679999999999999999999999999999999997654322 22233445556788889999999999999999999
Q ss_pred EEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CeeccCCCCCcEEEccCCcEEEEeccccccccCC
Q 007260 293 LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHML-GIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 293 LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~-gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~ 371 (611)
|||||+ ++.+..++... ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++......
T Consensus 101 lv~e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 101 IAMELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp EEECCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred EEEecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 999999 66777666543 35699999999999999999999995 9999999999999999999999999998432100
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
...
T Consensus 179 -----------------------------------------------------------------------------~~~ 181 (318)
T 2dyl_A 179 -----------------------------------------------------------------------------KAK 181 (318)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred -----------------------------------------------------------------------------ccc
Confidence 001
Q ss_pred cccccCCCccchhhhc-----cCCCCChhhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHcC-CCCCCCCCCCCHHHH
Q 007260 452 MSFVGTHEYLAPEIIK-----GEGHGSAVDWWTFGIFLYELLFGKTPFKGSG-NRATLFNVVGQ-PLRFPESPVVSFAAR 524 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~-----~~~~~~~sDIWSLGviL~ELltG~~PF~~~~-~~~~l~~i~~~-~l~~p~~~~~s~~l~ 524 (611)
....||+.|+|||++. +..++.++|||||||++|||++|+.||.... ....+..+... ...++....++.++.
T Consensus 182 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 261 (318)
T 2dyl_A 182 DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQ 261 (318)
T ss_dssp -----CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHH
T ss_pred cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHHHH
Confidence 1235999999999995 4567899999999999999999999998744 44445555444 334455556899999
Q ss_pred HHHHHhhhcCccccCCchhcHHHHHcCCCCCCCc
Q 007260 525 DLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVN 558 (611)
Q Consensus 525 dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 558 (611)
+||.+||..||.+||+ +.+|++||||+..+
T Consensus 262 ~li~~~l~~dp~~Rps----~~~ll~h~~~~~~~ 291 (318)
T 2dyl_A 262 SFVKDCLTKDHRKRPK----YNKLLEHSFIKRYE 291 (318)
T ss_dssp HHHHHHTCSCTTTSCC----HHHHTTSHHHHHHH
T ss_pred HHHHHHccCChhHCcC----HHHHhhCHHHHhcc
Confidence 9999999999999999 99999999997543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=376.45 Aligned_cols=258 Identities=26% Similarity=0.389 Sum_probs=206.3
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSC 292 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~ 292 (611)
..+++|++.+.||+|+||.||+|++..+++.||||++............++.+|+.+|+.++||||+++++++..++..|
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence 34578999999999999999999999999999999998655444556667889999999999999999999999999999
Q ss_pred EEeeeCCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccC
Q 007260 293 LVMEFCPGGDLHTLRQKQ--PGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAV 370 (611)
Q Consensus 293 LVmE~~~gg~L~~ll~~~--~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~ 370 (611)
|||||+++++|.+++... ....+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++.....
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 999999999999988642 235699999999999999999999999999999999999999999999999999843210
Q ss_pred CccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccc
Q 007260 371 SPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEAR 450 (611)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (611)
. ...
T Consensus 189 ~----------------------------------------------------------------------------~~~ 192 (310)
T 2wqm_A 189 K----------------------------------------------------------------------------TTA 192 (310)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred C----------------------------------------------------------------------------Ccc
Confidence 0 000
Q ss_pred ccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC-cH-HHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 007260 451 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSG-NR-ATLFNVVGQPLRFPESPVVSFAARDLIR 528 (611)
Q Consensus 451 ~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~-~~-~~l~~i~~~~l~~p~~~~~s~~l~dLI~ 528 (611)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.. +. .....+............++.++++||.
T Consensus 193 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 272 (310)
T 2wqm_A 193 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVN 272 (310)
T ss_dssp ------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHHHHH
T ss_pred ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHHHHH
Confidence 113469999999999999999999999999999999999999997643 22 3333344433332233568999999999
Q ss_pred HhhhcCccccCCchhcHHHHHc
Q 007260 529 GLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 529 ~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
+||..||.+||+ +.++++
T Consensus 273 ~~l~~dp~~Rps----~~~il~ 290 (310)
T 2wqm_A 273 MCINPDPEKRPD----VTYVYD 290 (310)
T ss_dssp HHTCSSGGGSCC----HHHHHH
T ss_pred HHcCCChhhCCC----HHHHHH
Confidence 999999999999 788876
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-46 Score=383.25 Aligned_cols=253 Identities=28% Similarity=0.420 Sum_probs=204.9
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhH---HHHHHHHHHHHHHHhC----CCCCcccccceeec
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGR---KKLLRAQTEREILQSL----DHPFLPTLYTHFET 287 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~---~~~~~~~~E~~iL~~l----~HpnIv~l~~~~~~ 287 (611)
.++|++++.||+|+||.||+|++..+++.||||++........ .....+.+|+.++..+ +||||+++++++..
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~ 109 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET 109 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence 4689999999999999999999999999999999976543321 1223345799999988 89999999999999
Q ss_pred cceeeEEeee-CCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEc-cCCcEEEEecccc
Q 007260 288 EKFSCLVMEF-CPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVR-EDGHIMLSDFDLS 365 (611)
Q Consensus 288 ~~~~~LVmE~-~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~-~~g~vkL~DFGlA 365 (611)
.+..|+|||| +.+++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++
T Consensus 110 ~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~ 187 (312)
T 2iwi_A 110 QEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG 187 (312)
T ss_dssp ---CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred CCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchh
Confidence 9999999999 7899999998875 4699999999999999999999999999999999999999 8999999999998
Q ss_pred ccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccC
Q 007260 366 LRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAE 445 (611)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (611)
......
T Consensus 188 ~~~~~~-------------------------------------------------------------------------- 193 (312)
T 2iwi_A 188 ALLHDE-------------------------------------------------------------------------- 193 (312)
T ss_dssp EECCSS--------------------------------------------------------------------------
T ss_pred hhcccC--------------------------------------------------------------------------
Confidence 433210
Q ss_pred cccccccccccCCCccchhhhccCCC-CChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHH
Q 007260 446 PTEARSMSFVGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAAR 524 (611)
Q Consensus 446 ~~~~~~~~~vGT~~Y~APEil~~~~~-~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~ 524 (611)
......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... .+......++. .++..++
T Consensus 194 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~~--~~~~~~~ 261 (312)
T 2iwi_A 194 ----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFPA--HVSPDCC 261 (312)
T ss_dssp ----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCCT--TSCHHHH
T ss_pred ----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCcc--cCCHHHH
Confidence 0112459999999999988776 458999999999999999999997531 23334444443 4899999
Q ss_pred HHHHHhhhcCccccCCchhcHHHHHcCCCCCCCch
Q 007260 525 DLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNW 559 (611)
Q Consensus 525 dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 559 (611)
+||.+||..||.+||+ +.|+++||||+....
T Consensus 262 ~li~~~l~~~p~~Rps----~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 262 ALIRRCLAPKPSSRPS----LEEILLDPWMQTPAE 292 (312)
T ss_dssp HHHHHHTCSSTTTSCC----HHHHHHSTTTCC---
T ss_pred HHHHHHccCChhhCcC----HHHHhcChhhcCchh
Confidence 9999999999999999 999999999986543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=373.21 Aligned_cols=253 Identities=19% Similarity=0.239 Sum_probs=206.0
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeecccee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEKFS 291 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~~~~ 291 (611)
+..++|++++.||+|+||.||+|++..+++.||||++...... ..+.+|+.+++.+ +|+||+.+++++......
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 81 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 81 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc-----HHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence 3457899999999999999999999999999999998654322 2456799999999 799999999999999999
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCc-----EEEEeccccc
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGH-----IMLSDFDLSL 366 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~-----vkL~DFGlA~ 366 (611)
||||||+ |++|.+++... +..+++..++.++.||+.||+|||++||+||||||+||||+.++. +||+|||++.
T Consensus 82 ~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EEEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 9999999 99999999875 346999999999999999999999999999999999999987776 9999999985
Q ss_pred cccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCc
Q 007260 367 RCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEP 446 (611)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (611)
......... ..
T Consensus 160 ~~~~~~~~~---------------------------------------------------------------------~~ 170 (298)
T 1csn_A 160 FYRDPVTKQ---------------------------------------------------------------------HI 170 (298)
T ss_dssp ESBCTTTCC---------------------------------------------------------------------BC
T ss_pred ccccccccc---------------------------------------------------------------------cc
Confidence 443111000 00
Q ss_pred ccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHcCCCCCC---CCCCCC
Q 007260 447 TEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSG---NRATLFNVVGQPLRFP---ESPVVS 520 (611)
Q Consensus 447 ~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~---~~~~l~~i~~~~l~~p---~~~~~s 520 (611)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.. ....+..+.......+ ....++
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
T 1csn_A 171 PYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFP 250 (298)
T ss_dssp CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSC
T ss_pred cccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCc
Confidence 0011234579999999999999999999999999999999999999998743 3333333332221111 123589
Q ss_pred HHHHHHHHHhhhcCccccCCc
Q 007260 521 FAARDLIRGLLVKEPQHRLAY 541 (611)
Q Consensus 521 ~~l~dLI~~~L~~dP~~Rpt~ 541 (611)
.++.+||.+||..||.+||++
T Consensus 251 ~~l~~li~~~l~~dp~~RP~~ 271 (298)
T 1csn_A 251 EEFYKYMHYARNLAFDATPDY 271 (298)
T ss_dssp HHHHHHHHHHHHCCTTCCCCH
T ss_pred HHHHHHHHHHhcCCcccCCCH
Confidence 999999999999999999994
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=388.39 Aligned_cols=254 Identities=27% Similarity=0.391 Sum_probs=213.5
Q ss_pred cccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhH---HHHHHHHHHHHHHHhCC--CCCcccccceeecc
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGR---KKLLRAQTEREILQSLD--HPFLPTLYTHFETE 288 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~---~~~~~~~~E~~iL~~l~--HpnIv~l~~~~~~~ 288 (611)
..++|++++.||+|+||.||+|++..+++.||||++........ ....++.+|+.+|+.+. |+||+++++++...
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 35789999999999999999999999999999999976543210 01124457999999996 59999999999999
Q ss_pred ceeeEEeeeCCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEc-cCCcEEEEeccccc
Q 007260 289 KFSCLVMEFCPG-GDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVR-EDGHIMLSDFDLSL 366 (611)
Q Consensus 289 ~~~~LVmE~~~g-g~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~-~~g~vkL~DFGlA~ 366 (611)
+..|+||||+.+ ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+ .++.+||+|||++.
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~ 198 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 198 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred CcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence 999999999976 8999998875 5699999999999999999999999999999999999999 78999999999984
Q ss_pred cccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCc
Q 007260 367 RCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEP 446 (611)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (611)
.....
T Consensus 199 ~~~~~--------------------------------------------------------------------------- 203 (320)
T 3a99_A 199 LLKDT--------------------------------------------------------------------------- 203 (320)
T ss_dssp ECCSS---------------------------------------------------------------------------
T ss_pred ccccc---------------------------------------------------------------------------
Confidence 32200
Q ss_pred ccccccccccCCCccchhhhccCCC-CChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 007260 447 TEARSMSFVGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARD 525 (611)
Q Consensus 447 ~~~~~~~~vGT~~Y~APEil~~~~~-~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~d 525 (611)
......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... .+......++ ..++.++.+
T Consensus 204 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~--~~~~~~~~~ 272 (320)
T 3a99_A 204 ---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR--QRVSSECQH 272 (320)
T ss_dssp ---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCS--SCCCHHHHH
T ss_pred ---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhccccccc--ccCCHHHHH
Confidence 0112459999999999988776 788999999999999999999997532 2233333333 348999999
Q ss_pred HHHHhhhcCccccCCchhcHHHHHcCCCCCCCch
Q 007260 526 LIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNW 559 (611)
Q Consensus 526 LI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 559 (611)
||.+||..||.+||+ +.+|++||||+++.+
T Consensus 273 li~~~l~~dp~~Rps----~~~ll~hp~~~~~~~ 302 (320)
T 3a99_A 273 LIRWCLALRPSDRPT----FEEIQNHPWMQDVLL 302 (320)
T ss_dssp HHHHHTCSSGGGSCC----HHHHHTSGGGSSCCC
T ss_pred HHHHHccCChhhCcC----HHHHhcCHhhcCccC
Confidence 999999999999999 999999999998754
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=383.35 Aligned_cols=262 Identities=18% Similarity=0.241 Sum_probs=213.3
Q ss_pred cccCeEEEeEecccCcEEEEEEE-----ECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecc
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSE-----LSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE 288 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~-----~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~ 288 (611)
..++|++++.||+|+||.||+|+ +..++..||||++.... ......++.+|+.+|+.++||||+++++++...
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence 34689999999999999999999 55678899999996432 223344678899999999999999999999999
Q ss_pred ceeeEEeeeCCCCCHHHHHHhCCC-----CCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEcc---CCcEEEE
Q 007260 289 KFSCLVMEFCPGGDLHTLRQKQPG-----KYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRE---DGHIMLS 360 (611)
Q Consensus 289 ~~~~LVmE~~~gg~L~~ll~~~~~-----~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~---~g~vkL~ 360 (611)
...||||||++|++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999999987532 35899999999999999999999999999999999999994 4469999
Q ss_pred eccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCc
Q 007260 361 DFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLP 440 (611)
Q Consensus 361 DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (611)
|||++........
T Consensus 186 Dfg~~~~~~~~~~------------------------------------------------------------------- 198 (327)
T 2yfx_A 186 DFGMARDIYRASY------------------------------------------------------------------- 198 (327)
T ss_dssp CCHHHHHHHC----------------------------------------------------------------------
T ss_pred ccccccccccccc-------------------------------------------------------------------
Confidence 9999853321100
Q ss_pred ccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCC
Q 007260 441 ELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVV 519 (611)
Q Consensus 441 ~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~ 519 (611)
........||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+......+..+.... .......+
T Consensus 199 -------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~ 270 (327)
T 2yfx_A 199 -------YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG-RMDPPKNC 270 (327)
T ss_dssp ----------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-CCCCCTTC
T ss_pred -------cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC-CCCCCCCC
Confidence 001123468999999999999999999999999999999998 999999887766665555443 33334568
Q ss_pred CHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCC
Q 007260 520 SFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 520 s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
+..+.+||.+||..||.+||+ +.+|++|.|+-.
T Consensus 271 ~~~l~~li~~~l~~dp~~Rps----~~~ll~~l~~~~ 303 (327)
T 2yfx_A 271 PGPVYRIMTQCWQHQPEDRPN----FAIILERIEYCT 303 (327)
T ss_dssp CHHHHHHHHHHTCSSGGGSCC----HHHHHHHHHHHH
T ss_pred CHHHHHHHHHHhcCChhhCcC----HHHHHHHHHHHh
Confidence 999999999999999999999 999999988643
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=381.38 Aligned_cols=255 Identities=23% Similarity=0.330 Sum_probs=211.6
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEE--EEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeeccc
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYF--AMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEK 289 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~v--AvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~~ 289 (611)
+..++|++.+.||+|+||.||+|++..++..+ |||++.... ......++.+|+++|+++ +||||+++++++.+.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 34579999999999999999999998888755 999986532 223445678899999999 8999999999999999
Q ss_pred eeeEEeeeCCCCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCC
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQP--------------GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDG 355 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~--------------~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g 355 (611)
.+||||||+++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+||||+.++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 9999999999999999987652 24699999999999999999999999999999999999999999
Q ss_pred cEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCC
Q 007260 356 HIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQ 435 (611)
Q Consensus 356 ~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (611)
.+||+|||++......
T Consensus 180 ~~kL~Dfg~~~~~~~~---------------------------------------------------------------- 195 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVY---------------------------------------------------------------- 195 (327)
T ss_dssp CEEECCTTCEESSCEE----------------------------------------------------------------
T ss_pred eEEEcccCcCcccccc----------------------------------------------------------------
Confidence 9999999998421100
Q ss_pred CCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCC
Q 007260 436 VSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFP 514 (611)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p 514 (611)
.......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.........+.. ....+
T Consensus 196 -------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~-~~~~~ 261 (327)
T 1fvr_A 196 -------------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYRLE 261 (327)
T ss_dssp -------------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG-TCCCC
T ss_pred -------------ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhc-CCCCC
Confidence 00112247889999999999999999999999999999998 9999998876665554443 33444
Q ss_pred CCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcC
Q 007260 515 ESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 515 ~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~H 551 (611)
....++..+++||.+||..||.+||+ +.++++|
T Consensus 262 ~~~~~~~~l~~li~~~l~~dp~~Rps----~~ell~~ 294 (327)
T 1fvr_A 262 KPLNCDDEVYDLMRQCWREKPYERPS----FAQILVS 294 (327)
T ss_dssp CCTTBCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcC----HHHHHHH
Confidence 45568999999999999999999999 7777764
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=387.16 Aligned_cols=258 Identities=18% Similarity=0.237 Sum_probs=209.0
Q ss_pred ccccccCeEEEeEecccCcEEEEEEEECCCCeE----EEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceee
Q 007260 211 GVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCY----FAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFE 286 (611)
Q Consensus 211 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~----vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~ 286 (611)
..+..++|++++.||+|+||+||+|++..++.. ||+|++..... .....++.+|+.+++.++||||+++++++.
T Consensus 8 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 85 (325)
T 3kex_A 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP 85 (325)
T ss_dssp CBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS--CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc
Confidence 445568999999999999999999999888765 67777643321 112234567999999999999999999886
Q ss_pred ccceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccc
Q 007260 287 TEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSL 366 (611)
Q Consensus 287 ~~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~ 366 (611)
+...|+||||+++|+|.+++... ...+++..++.++.||+.||+|||++|||||||||+||||+.++++||+|||++.
T Consensus 86 -~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 86 -GSSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVAD 163 (325)
T ss_dssp -BSSEEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred -CCccEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccc
Confidence 56689999999999999998765 3468999999999999999999999999999999999999999999999999985
Q ss_pred cccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCc
Q 007260 367 RCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEP 446 (611)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (611)
.+.....
T Consensus 164 ~~~~~~~------------------------------------------------------------------------- 170 (325)
T 3kex_A 164 LLPPDDK------------------------------------------------------------------------- 170 (325)
T ss_dssp GSCCCTT-------------------------------------------------------------------------
T ss_pred ccCcccc-------------------------------------------------------------------------
Confidence 4321100
Q ss_pred ccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 007260 447 TEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARD 525 (611)
Q Consensus 447 ~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~d 525 (611)
........||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.........+... ...+....++.++.+
T Consensus 171 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 248 (325)
T 3kex_A 171 -QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG-ERLAQPQICTIDVYM 248 (325)
T ss_dssp -CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTT-CBCCCCTTBCTTTTH
T ss_pred -cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcC-CCCCCCCcCcHHHHH
Confidence 001123458889999999999999999999999999999999 99999987666555444433 333444458889999
Q ss_pred HHHHhhhcCccccCCchhcHHHHHcC
Q 007260 526 LIRGLLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 526 LI~~~L~~dP~~Rpt~~~~a~elL~H 551 (611)
||.+||..||.+||+ +.++++|
T Consensus 249 li~~~l~~dp~~Rps----~~el~~~ 270 (325)
T 3kex_A 249 VMVKCWMIDENIRPT----FKELANE 270 (325)
T ss_dssp HHHHHTCSCTTTSCC----HHHHHHH
T ss_pred HHHHHcCCChhhCcC----HHHHHHH
Confidence 999999999999999 7777765
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=374.16 Aligned_cols=260 Identities=23% Similarity=0.333 Sum_probs=210.3
Q ss_pred cccccCeEEEeEecccCcEEEEEEEECC-C--CeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecc
Q 007260 212 VLGLSHFRLLKRLGCGDIGSVYLSELSG-T--KCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE 288 (611)
Q Consensus 212 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~-t--~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~ 288 (611)
.+..++|++++.||+|+||+||+|++.. + +..||||++............++.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 93 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence 4456799999999999999999998643 3 346999999876544445566788999999999999999999999876
Q ss_pred ceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccc
Q 007260 289 KFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRC 368 (611)
Q Consensus 289 ~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~ 368 (611)
. .++||||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 94 ~-~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 94 P-MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp S-CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred C-ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 5 899999999999999887642 45899999999999999999999999999999999999999999999999998543
Q ss_pred cCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccc
Q 007260 369 AVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTE 448 (611)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (611)
...... .
T Consensus 172 ~~~~~~-------------------------------------------------------------------------~ 178 (291)
T 1u46_A 172 PQNDDH-------------------------------------------------------------------------Y 178 (291)
T ss_dssp CC-CCE-------------------------------------------------------------------------E
T ss_pred cccccc-------------------------------------------------------------------------h
Confidence 211000 0
Q ss_pred ccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 007260 449 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLI 527 (611)
Q Consensus 449 ~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI 527 (611)
.......||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+......+..+......++....++.++.+||
T Consensus 179 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 258 (291)
T 1u46_A 179 VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVM 258 (291)
T ss_dssp EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHH
T ss_pred hhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCHHHHHHH
Confidence 00112358889999999999999999999999999999999 99999998888888888777666777777999999999
Q ss_pred HHhhhcCccccCCchhcHHHHHc
Q 007260 528 RGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 528 ~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
.+||..||.+||+ +.++++
T Consensus 259 ~~~l~~~p~~Rps----~~~l~~ 277 (291)
T 1u46_A 259 VQCWAHKPEDRPT----FVALRD 277 (291)
T ss_dssp HHHTCSSGGGSCC----HHHHHH
T ss_pred HHHccCCcccCcC----HHHHHH
Confidence 9999999999999 788876
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=374.04 Aligned_cols=257 Identities=23% Similarity=0.265 Sum_probs=209.2
Q ss_pred cccCeEEEeEecccCcEEEEEEE----ECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecc-
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSE----LSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE- 288 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~----~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~- 288 (611)
...+|++++.||+|+||.||+|+ +..+++.||||++..... .....++.+|+.+|+.++||||+++++++...
T Consensus 19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (302)
T 4e5w_A 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGICTEDG 96 (302)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 34579999999999999999999 567899999999975432 22335678899999999999999999999876
Q ss_pred -ceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccc
Q 007260 289 -KFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLR 367 (611)
Q Consensus 289 -~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~ 367 (611)
..+|+||||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccc
Confidence 77899999999999999986543 4599999999999999999999999999999999999999999999999999854
Q ss_pred ccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcc
Q 007260 368 CAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPT 447 (611)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (611)
.......
T Consensus 176 ~~~~~~~------------------------------------------------------------------------- 182 (302)
T 4e5w_A 176 IETDKEY------------------------------------------------------------------------- 182 (302)
T ss_dssp CCTTCCE-------------------------------------------------------------------------
T ss_pred ccCCCcc-------------------------------------------------------------------------
Confidence 3211100
Q ss_pred cccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC--------------CCcHHHHHHHHcCCCCC
Q 007260 448 EARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKG--------------SGNRATLFNVVGQPLRF 513 (611)
Q Consensus 448 ~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~--------------~~~~~~l~~i~~~~l~~ 513 (611)
........||..|+|||++.+..++.++|||||||++|+|++|..||.. ......+...+......
T Consensus 183 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (302)
T 4e5w_A 183 YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRL 262 (302)
T ss_dssp EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCC
T ss_pred eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCC
Confidence 0011123588999999999999999999999999999999999998643 22233344445555556
Q ss_pred CCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 514 PESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 514 p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
+....++.++.+||.+||..||.+||+ +.++++
T Consensus 263 ~~~~~~~~~l~~li~~~l~~dp~~Rps----~~~ll~ 295 (302)
T 4e5w_A 263 PCPPNCPDEVYQLMRKCWEFQPSNRTS----FQNLIE 295 (302)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCC----HHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCCCCCCC----HHHHHH
Confidence 666679999999999999999999999 777764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=391.24 Aligned_cols=259 Identities=22% Similarity=0.302 Sum_probs=206.8
Q ss_pred ccccccCeEEEeEecccCcEEEEEEEEC---CCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 007260 211 GVLGLSHFRLLKRLGCGDIGSVYLSELS---GTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET 287 (611)
Q Consensus 211 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~---~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~ 287 (611)
..+...+|++.+.||+|+||.||+|++. .++..||||++.... .......+.+|+.+|+.++||||+++++++..
T Consensus 40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 117 (373)
T 2qol_A 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117 (373)
T ss_dssp CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence 3455679999999999999999999886 567789999997543 22344567899999999999999999999999
Q ss_pred cceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccc
Q 007260 288 EKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLR 367 (611)
Q Consensus 288 ~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~ 367 (611)
.+.+|||||||+||+|.+++... +..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++..
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred CCceEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 99999999999999999999865 35699999999999999999999999999999999999999999999999999854
Q ss_pred ccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcc
Q 007260 368 CAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPT 447 (611)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (611)
.......
T Consensus 197 ~~~~~~~------------------------------------------------------------------------- 203 (373)
T 2qol_A 197 LEDDPEA------------------------------------------------------------------------- 203 (373)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cccCCcc-------------------------------------------------------------------------
Confidence 3211000
Q ss_pred cccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 007260 448 EARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDL 526 (611)
Q Consensus 448 ~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dL 526 (611)
........||+.|+|||++.+..++.++|||||||+||||++ |+.||.+......+..+. .....+....++..+.+|
T Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~l 282 (373)
T 2qol_A 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYRLPPPMDCPAALYQL 282 (373)
T ss_dssp ----------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHH-TTEECCCCTTCBHHHHHH
T ss_pred ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCccccHHHHHH
Confidence 000011236789999999999999999999999999999997 999999887766555444 444555556789999999
Q ss_pred HHHhhhcCccccCCchhcHHHHHc
Q 007260 527 IRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 527 I~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
|.+||..||.+||+ +.+|++
T Consensus 283 i~~cl~~dp~~RPs----~~~i~~ 302 (373)
T 2qol_A 283 MLDCWQKDRNNRPK----FEQIVS 302 (373)
T ss_dssp HHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHhCcChhhCcC----HHHHHH
Confidence 99999999999999 566554
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=383.76 Aligned_cols=254 Identities=21% Similarity=0.276 Sum_probs=201.7
Q ss_pred CccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc
Q 007260 210 DGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK 289 (611)
Q Consensus 210 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~ 289 (611)
+..+..++|++++.||+|+||+||+|++. ++.||||++..... ......+|+.+|+.++|||||++++++....
T Consensus 18 n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 91 (322)
T 3soc_A 18 NLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDK----QSWQNEYEVYSLPGMKHENILQFIGAEKRGT 91 (322)
T ss_dssp CEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred ccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCch----HHHHHHHHHHHHhcCCCCCchhhcceeccCC
Confidence 44566789999999999999999999886 67899999976532 2234456899999999999999999998743
Q ss_pred ----eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc----------CeeccCCCCCcEEEccCC
Q 007260 290 ----FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHML----------GIIYRDLKPENVLVREDG 355 (611)
Q Consensus 290 ----~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~----------gIVHRDLKPeNILv~~~g 355 (611)
.+|||||||++|+|.+++... .+++..++.++.||+.||+|||++ |||||||||+||||+.++
T Consensus 92 ~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~ 168 (322)
T 3soc_A 92 SVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL 168 (322)
T ss_dssp SSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC
T ss_pred CCCceEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC
Confidence 479999999999999999874 499999999999999999999999 999999999999999999
Q ss_pred cEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCC
Q 007260 356 HIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQ 435 (611)
Q Consensus 356 ~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (611)
.+||+|||++..+.....
T Consensus 169 ~~kL~DFg~a~~~~~~~~-------------------------------------------------------------- 186 (322)
T 3soc_A 169 TACIADFGLALKFEAGKS-------------------------------------------------------------- 186 (322)
T ss_dssp CEEECCCTTCEEECTTSC--------------------------------------------------------------
T ss_pred eEEEccCCcccccccccC--------------------------------------------------------------
Confidence 999999999854421100
Q ss_pred CCCCcccccCcccccccccccCCCccchhhhccC-----CCCChhhHHHHHHHHHHHHhCCCCCCCCCc-----------
Q 007260 436 VSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGE-----GHGSAVDWWTFGIFLYELLFGKTPFKGSGN----------- 499 (611)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~-----~~~~~sDIWSLGviL~ELltG~~PF~~~~~----------- 499 (611)
.......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+...
T Consensus 187 ------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 187 ------------AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp ------------CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred ------------ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 0011234699999999999874 346688999999999999999999976432
Q ss_pred ----HHHHHHHHcCCCCCCCCC------CCCHHHHHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 500 ----RATLFNVVGQPLRFPESP------VVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 500 ----~~~l~~i~~~~l~~p~~~------~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
...+...+......+... ..+.++.+||.+||..||.+||+ +.+|++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~ell~ 311 (322)
T 3soc_A 255 QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS----AGCVGE 311 (322)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred cCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcC----HHHHHH
Confidence 223333332222222211 13456999999999999999999 777765
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=379.38 Aligned_cols=258 Identities=19% Similarity=0.278 Sum_probs=213.2
Q ss_pred ccccCeEEEeEecccCcEEEEEEEEC-------CCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccce
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELS-------GTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTH 284 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~-------~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~ 284 (611)
+..++|++++.||+|+||.||+|++. .++..||||++.... ......++.+|+.+|+.+ +||||++++++
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 109 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGA 109 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence 34579999999999999999999986 356789999997543 234456778999999999 89999999999
Q ss_pred eeccceeeEEeeeCCCCCHHHHHHhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEE
Q 007260 285 FETEKFSCLVMEFCPGGDLHTLRQKQPG--------------KYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVL 350 (611)
Q Consensus 285 ~~~~~~~~LVmE~~~gg~L~~ll~~~~~--------------~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNIL 350 (611)
+...+.+||||||++||+|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 110 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 189 (334)
T ss_dssp ECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred EccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEE
Confidence 9999999999999999999999986531 34899999999999999999999999999999999999
Q ss_pred EccCCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCcc
Q 007260 351 VREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKN 430 (611)
Q Consensus 351 v~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 430 (611)
|+.++.+||+|||++........
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~--------------------------------------------------------- 212 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDY--------------------------------------------------------- 212 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSS---------------------------------------------------------
T ss_pred EcCCCCEEEcccccccccccccc---------------------------------------------------------
Confidence 99999999999999854321100
Q ss_pred ccCCCCCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcC
Q 007260 431 EIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQ 509 (611)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~ 509 (611)
........||+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+....+...
T Consensus 213 -----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 275 (334)
T 2pvf_A 213 -----------------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275 (334)
T ss_dssp -----------------EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT
T ss_pred -----------------ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcC
Confidence 000112347889999999999999999999999999999999 99999988766655544443
Q ss_pred CCCCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcC
Q 007260 510 PLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 510 ~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~H 551 (611)
...+....++.++.+||.+||..||.+||+ +.+++++
T Consensus 276 -~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~ell~~ 312 (334)
T 2pvf_A 276 -HRMDKPANCTNELYMMMRDCWHAVPSQRPT----FKQLVED 312 (334)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred -CCCCCCccCCHHHHHHHHHHccCChhhCcC----HHHHHHH
Confidence 233444568999999999999999999999 7777763
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=404.68 Aligned_cols=256 Identities=21% Similarity=0.299 Sum_probs=218.5
Q ss_pred ccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccce
Q 007260 211 GVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKF 290 (611)
Q Consensus 211 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~ 290 (611)
..+...+|++.+.||+|+||.||+|.+..++..||||++...... ...+.+|+.+|+.++|||||++++++.....
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 290 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 290 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc----hHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 445567899999999999999999999999999999999765432 3456789999999999999999999999999
Q ss_pred eeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccC
Q 007260 291 SCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAV 370 (611)
Q Consensus 291 ~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~ 370 (611)
+|||||||++|+|.+++.......+++..+..++.||+.||+|||++|||||||||+||||+.++.+||+|||+++....
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 99999999999999999886666799999999999999999999999999999999999999999999999999854321
Q ss_pred CccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccc
Q 007260 371 SPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEAR 450 (611)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (611)
... ..
T Consensus 371 ~~~---------------------------------------------------------------------------~~ 375 (495)
T 1opk_A 371 DTY---------------------------------------------------------------------------TA 375 (495)
T ss_dssp CCE---------------------------------------------------------------------------EC
T ss_pred Cce---------------------------------------------------------------------------ee
Confidence 000 00
Q ss_pred ccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHH
Q 007260 451 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRG 529 (611)
Q Consensus 451 ~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~ 529 (611)
.....||+.|+|||++.+..++.++|||||||+||||++ |+.||.+........ .+....+.+....++..+.+||.+
T Consensus 376 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~ 454 (495)
T 1opk_A 376 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKDYRMERPEGCPEKVYELMRA 454 (495)
T ss_dssp CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH-HHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHcCCCCCCCCCCCHHHHHHHHH
Confidence 012247788999999999999999999999999999998 999999877655444 444455555566799999999999
Q ss_pred hhhcCccccCCchhcHHHHHc
Q 007260 530 LLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 530 ~L~~dP~~Rpt~~~~a~elL~ 550 (611)
||..||.+||+ +.+|++
T Consensus 455 cl~~dP~~RPs----~~el~~ 471 (495)
T 1opk_A 455 CWQWNPSDRPS----FAEIHQ 471 (495)
T ss_dssp HTCSSGGGSCC----HHHHHH
T ss_pred HcCcChhHCcC----HHHHHH
Confidence 99999999999 666654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=372.40 Aligned_cols=257 Identities=23% Similarity=0.369 Sum_probs=203.2
Q ss_pred CccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc
Q 007260 210 DGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK 289 (611)
Q Consensus 210 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~ 289 (611)
.+.+..++|++++.||+|+||+||+|++.. .||||++..... .......+.+|+.+|+.++||||+++++++ ...
T Consensus 18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~ 92 (289)
T 3og7_A 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAP 92 (289)
T ss_dssp CCBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSS
T ss_pred CCccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCC
Confidence 455666899999999999999999998654 499999975432 334556788999999999999999999965 556
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
..|+|||||+|++|.+++... ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++....
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp SCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred ccEEEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccc
Confidence 789999999999999988655 3569999999999999999999999999999999999999999999999999984322
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
... ...
T Consensus 172 ~~~--------------------------------------------------------------------------~~~ 177 (289)
T 3og7_A 172 RWS--------------------------------------------------------------------------GSH 177 (289)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccc--------------------------------------------------------------------------ccc
Confidence 100 000
Q ss_pred cccccccCCCccchhhhc---cCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCC----CCCCCHH
Q 007260 450 RSMSFVGTHEYLAPEIIK---GEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPE----SPVVSFA 522 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~---~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~----~~~~s~~ 522 (611)
......||+.|+|||++. +..++.++|||||||++|+|++|+.||.+......+..++......+. ...++..
T Consensus 178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (289)
T 3og7_A 178 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKR 257 (289)
T ss_dssp ------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHH
T ss_pred cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHH
Confidence 112346999999999997 566788999999999999999999999987777766665543322221 2358899
Q ss_pred HHHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 523 ARDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 523 l~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
+++||.+||..||.+||+ +.++++
T Consensus 258 l~~li~~~l~~~p~~Rps----~~ell~ 281 (289)
T 3og7_A 258 MKRLMAECLKKKRDERPS----FPRILA 281 (289)
T ss_dssp HHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHHHHHccCChhhCCC----HHHHHH
Confidence 999999999999999999 677765
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=380.22 Aligned_cols=259 Identities=22% Similarity=0.344 Sum_probs=214.1
Q ss_pred ccccccCeEEEeEecccCcEEEEEEE----ECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceee
Q 007260 211 GVLGLSHFRLLKRLGCGDIGSVYLSE----LSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFE 286 (611)
Q Consensus 211 ~~~~~~~y~l~~~LG~G~fG~Vy~a~----~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~ 286 (611)
..+..++|++++.||+|+||.||+|+ +..+++.||||++.... ......+.+|+++|+.++||||+++++++.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 94 (327)
T 3lxl_A 18 TIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVSY 94 (327)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEEe
Confidence 34556899999999999999999999 46788999999997654 233456788999999999999999999886
Q ss_pred --ccceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccc
Q 007260 287 --TEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDL 364 (611)
Q Consensus 287 --~~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGl 364 (611)
....+||||||++|++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 95 GPGRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGL 173 (327)
T ss_dssp CSSSCEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred cCCCceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccc
Confidence 5677999999999999999987642 3599999999999999999999999999999999999999999999999999
Q ss_pred cccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCccccc
Q 007260 365 SLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIA 444 (611)
Q Consensus 365 A~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (611)
+.........
T Consensus 174 ~~~~~~~~~~---------------------------------------------------------------------- 183 (327)
T 3lxl_A 174 AKLLPLDKDY---------------------------------------------------------------------- 183 (327)
T ss_dssp CEECCTTCSE----------------------------------------------------------------------
T ss_pred ceecccCCcc----------------------------------------------------------------------
Confidence 8543211100
Q ss_pred CcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCc--------------HHHHHHHHcCC
Q 007260 445 EPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGN--------------RATLFNVVGQP 510 (611)
Q Consensus 445 ~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~--------------~~~l~~i~~~~ 510 (611)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ...+...+...
T Consensus 184 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (327)
T 3lxl_A 184 ---YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEG 260 (327)
T ss_dssp ---EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTT
T ss_pred ---ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcc
Confidence 0011123589999999999999999999999999999999999999965322 12334445555
Q ss_pred CCCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 511 LRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 511 l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
...+....++..+.+||.+||..||.+||+ +.+|++
T Consensus 261 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps----~~ell~ 296 (327)
T 3lxl_A 261 QRLPAPPACPAEVHELMKLCWAPSPQDRPS----FSALGP 296 (327)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred cCCCCCCcccHHHHHHHHHHcCCChhhCcC----HHHHHH
Confidence 556666679999999999999999999999 667654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=370.81 Aligned_cols=262 Identities=21% Similarity=0.271 Sum_probs=211.0
Q ss_pred hccCccccccCeEEEe-EecccCcEEEEEEEE--CCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccc
Q 007260 207 RARDGVLGLSHFRLLK-RLGCGDIGSVYLSEL--SGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYT 283 (611)
Q Consensus 207 ~~~~~~~~~~~y~l~~-~LG~G~fG~Vy~a~~--~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~ 283 (611)
+..+..+..++|++.+ .||+|+||.||+|.+ ..+++.||||++..... ......++.+|+.+|+.++||||+++++
T Consensus 7 ~~~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 85 (291)
T 1xbb_A 7 RPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIG 85 (291)
T ss_dssp ----CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred CcceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 3345556678999999 999999999999954 56788999999976532 2234556789999999999999999999
Q ss_pred eeeccceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecc
Q 007260 284 HFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFD 363 (611)
Q Consensus 284 ~~~~~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFG 363 (611)
++ ..+..|+||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||
T Consensus 86 ~~-~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg 162 (291)
T 1xbb_A 86 IC-EAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFG 162 (291)
T ss_dssp EE-ESSSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred EE-CCCCcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCC
Confidence 99 566789999999999999999875 569999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccc
Q 007260 364 LSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELI 443 (611)
Q Consensus 364 lA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 443 (611)
++.........
T Consensus 163 ~~~~~~~~~~~--------------------------------------------------------------------- 173 (291)
T 1xbb_A 163 LSKALRADENY--------------------------------------------------------------------- 173 (291)
T ss_dssp TCEECCTTCSE---------------------------------------------------------------------
T ss_pred cceeeccCCCc---------------------------------------------------------------------
Confidence 98543211100
Q ss_pred cCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHH
Q 007260 444 AEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFA 522 (611)
Q Consensus 444 ~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~ 522 (611)
........||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.........+... ...+....++..
T Consensus 174 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 248 (291)
T 1xbb_A 174 ----YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-ERMGCPAGCPRE 248 (291)
T ss_dssp ----EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCCTTCCHH
T ss_pred ----ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHH
Confidence 000112247889999999999999999999999999999999 99999988776655554443 233344568999
Q ss_pred HHHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 523 ARDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 523 l~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
+.+||.+||..||.+||+ +.++++
T Consensus 249 l~~li~~~l~~dp~~Rps----~~~l~~ 272 (291)
T 1xbb_A 249 MYDLMNLCWTYDVENRPG----FAAVEL 272 (291)
T ss_dssp HHHHHHHHTCSSTTTSCC----HHHHHH
T ss_pred HHHHHHHHcCCChhhCcC----HHHHHH
Confidence 999999999999999999 666664
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=368.46 Aligned_cols=259 Identities=23% Similarity=0.329 Sum_probs=214.3
Q ss_pred ccccccCeEEEe-EecccCcEEEEEEEEC--CCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 007260 211 GVLGLSHFRLLK-RLGCGDIGSVYLSELS--GTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET 287 (611)
Q Consensus 211 ~~~~~~~y~l~~-~LG~G~fG~Vy~a~~~--~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~ 287 (611)
..+..++|.+++ .||+|+||.||+|.+. .++..||||++.... ......++.+|+.+|+.++||||+++++++ .
T Consensus 4 ~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~ 80 (287)
T 1u59_A 4 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-Q 80 (287)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-E
T ss_pred ccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-c
Confidence 345567899888 9999999999999864 467889999997643 234455778899999999999999999999 4
Q ss_pred cceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccc
Q 007260 288 EKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLR 367 (611)
Q Consensus 288 ~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~ 367 (611)
.+..|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 81 AEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp SSSEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CCCcEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceee
Confidence 56689999999999999998754 35699999999999999999999999999999999999999999999999999854
Q ss_pred ccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcc
Q 007260 368 CAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPT 447 (611)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (611)
.......
T Consensus 160 ~~~~~~~------------------------------------------------------------------------- 166 (287)
T 1u59_A 160 LGADDSY------------------------------------------------------------------------- 166 (287)
T ss_dssp CTTCSCE-------------------------------------------------------------------------
T ss_pred eccCcce-------------------------------------------------------------------------
Confidence 3211000
Q ss_pred cccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 007260 448 EARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDL 526 (611)
Q Consensus 448 ~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dL 526 (611)
........||+.|+|||++.+..++.++|||||||++|||++ |+.||.+......+..+.... ..+....++.++.+|
T Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~l~~l 245 (287)
T 1u59_A 167 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-RMECPPECPPELYAL 245 (287)
T ss_dssp ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC-CCCCCTTCCHHHHHH
T ss_pred eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC-cCCCCCCcCHHHHHH
Confidence 000112347899999999999999999999999999999998 999999887776665555432 233345699999999
Q ss_pred HHHhhhcCccccCCchhcHHHHHcC
Q 007260 527 IRGLLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 527 I~~~L~~dP~~Rpt~~~~a~elL~H 551 (611)
|.+||..||.+||+ +.++++|
T Consensus 246 i~~~l~~~p~~Rps----~~~l~~~ 266 (287)
T 1u59_A 246 MSDCWIYKWEDRPD----FLTVEQR 266 (287)
T ss_dssp HHHTTCSSGGGSCC----HHHHHHH
T ss_pred HHHHcCCChhhCcC----HHHHHHH
Confidence 99999999999999 8888876
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=366.76 Aligned_cols=254 Identities=18% Similarity=0.235 Sum_probs=205.7
Q ss_pred CeEEEeEecccCcEEEEEEEECCCC---eEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecccee-e
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTK---CYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFS-C 292 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~---~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~-~ 292 (611)
.|++.+.||+|+||+||+|++..++ ..||+|++.... .......+.+|+.+|+.++||||+++++++.+.+.. |
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 5778899999999999999975544 379999987533 334456778999999999999999999999876555 9
Q ss_pred EEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCc
Q 007260 293 LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 293 LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~ 372 (611)
+||||+.+++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 100 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp EEECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EEEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 999999999999998764 3678999999999999999999999999999999999999999999999999984332110
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
.. ......
T Consensus 179 ~~------------------------------------------------------------------------~~~~~~ 186 (298)
T 3pls_A 179 YY------------------------------------------------------------------------SVQQHR 186 (298)
T ss_dssp GG------------------------------------------------------------------------CSCCSS
T ss_pred cc------------------------------------------------------------------------ccccCc
Confidence 00 000112
Q ss_pred ccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCC-CCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 007260 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGK-TPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLL 531 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~-~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L 531 (611)
...||+.|+|||++.+..++.++|||||||++|+|++|. +||....... +...+......+....++..+.+||.+||
T Consensus 187 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l 265 (298)
T 3pls_A 187 HARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-LTHFLAQGRRLPQPEYCPDSLYQVMQQCW 265 (298)
T ss_dssp CTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG-HHHHHHTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred CCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH-HHHHhhcCCCCCCCccchHHHHHHHHHHc
Confidence 345899999999999999999999999999999999954 5555544444 43444444455555669999999999999
Q ss_pred hcCccccCCchhcHHHHHc
Q 007260 532 VKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 532 ~~dP~~Rpt~~~~a~elL~ 550 (611)
..||.+||+ +.++++
T Consensus 266 ~~~p~~Rps----~~~ll~ 280 (298)
T 3pls_A 266 EADPAVRPT----FRVLVG 280 (298)
T ss_dssp CSSGGGSCC----HHHHHH
T ss_pred cCChhhCcC----HHHHHH
Confidence 999999999 666665
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=367.36 Aligned_cols=255 Identities=21% Similarity=0.319 Sum_probs=211.7
Q ss_pred CccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc
Q 007260 210 DGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK 289 (611)
Q Consensus 210 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~ 289 (611)
+..+..++|++++.||+|+||.||+|.+.. +..||||++...... ...+.+|+++|+.++||||+++++++.. +
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~ 80 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcC-CcEEEEEEecCCccc----HHHHHHHHHHHHhCCCcCcceEEEEEcC-C
Confidence 345556899999999999999999999864 567999999765432 2356789999999999999999998874 5
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
..|+||||++|++|.+++....+..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 68999999999999999876433469999999999999999999999999999999999999999999999999985432
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
.... .
T Consensus 161 ~~~~---------------------------------------------------------------------------~ 165 (279)
T 1qpc_A 161 DNEY---------------------------------------------------------------------------T 165 (279)
T ss_dssp SSCE---------------------------------------------------------------------------E
T ss_pred Cccc---------------------------------------------------------------------------c
Confidence 1100 0
Q ss_pred cccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 007260 450 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIR 528 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~ 528 (611)
......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+.+..+... ........++.++.+||.
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~ 244 (279)
T 1qpc_A 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-YRMVRPDNCPEELYQLMR 244 (279)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHH
T ss_pred cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcc-cCCCCcccccHHHHHHHH
Confidence 0012347889999999999999999999999999999999 99999988777666655543 333444568999999999
Q ss_pred HhhhcCccccCCchhcHHHHHc
Q 007260 529 GLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 529 ~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
+||..||.+||+ +.++++
T Consensus 245 ~~l~~~p~~Rps----~~~l~~ 262 (279)
T 1qpc_A 245 LCWKERPEDRPT----FDYLRS 262 (279)
T ss_dssp HHTCSSGGGSCC----HHHHHH
T ss_pred HHhccChhhCCC----HHHHHH
Confidence 999999999999 666664
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=380.73 Aligned_cols=255 Identities=22% Similarity=0.312 Sum_probs=206.4
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEE----EEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecc
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYF----AMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE 288 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~v----AvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~ 288 (611)
+..++|++++.||+|+||.||+|++..+++.| |+|.+..... .....++.+|+.+|+.++||||+++++++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSS--CCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 44579999999999999999999998887655 6666543221 12334667899999999999999999999876
Q ss_pred ceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccc
Q 007260 289 KFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRC 368 (611)
Q Consensus 289 ~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~ 368 (611)
. .++||||+.+|+|.+++.... ..+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||++..+
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred C-ceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 5 789999999999999988753 56999999999999999999999999999999999999999999999999998543
Q ss_pred cCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccc
Q 007260 369 AVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTE 448 (611)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (611)
..... .
T Consensus 168 ~~~~~--------------------------------------------------------------------------~ 173 (327)
T 3lzb_A 168 GAEEK--------------------------------------------------------------------------E 173 (327)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cCccc--------------------------------------------------------------------------c
Confidence 21100 0
Q ss_pred ccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 007260 449 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLI 527 (611)
Q Consensus 449 ~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI 527 (611)
.......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+........ ++......+....++.++.+||
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li 252 (327)
T 3lzb_A 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLPQPPICTIDVYMIM 252 (327)
T ss_dssp ------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH-HHHTTCCCCCCTTBCHHHHHHH
T ss_pred ccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH-HHHcCCCCCCCccCCHHHHHHH
Confidence 00112347889999999999999999999999999999999 999999876655444 4444445555667999999999
Q ss_pred HHhhhcCccccCCchhcHHHHHc
Q 007260 528 RGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 528 ~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
.+||..||.+||+ +.|+++
T Consensus 253 ~~~l~~dp~~Rps----~~ell~ 271 (327)
T 3lzb_A 253 RKCWMIDADSRPK----FRELII 271 (327)
T ss_dssp HHHTCSSGGGSCC----HHHHHH
T ss_pred HHHcCCChhHCcC----HHHHHH
Confidence 9999999999999 777775
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=393.93 Aligned_cols=252 Identities=22% Similarity=0.326 Sum_probs=213.3
Q ss_pred ccCccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 007260 208 ARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET 287 (611)
Q Consensus 208 ~~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~ 287 (611)
.....+..++|++++.||+|+||.||+|.+. ++.||||+++... ....+.+|+.+|+.++|||||++++++..
T Consensus 185 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 257 (450)
T 1k9a_A 185 RSGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVE 257 (450)
T ss_dssp HTTCBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred ccccccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEc
Confidence 3456677889999999999999999999986 5689999997654 22356789999999999999999999776
Q ss_pred cc-eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccc
Q 007260 288 EK-FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSL 366 (611)
Q Consensus 288 ~~-~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~ 366 (611)
.. .+|||||||++|+|.+++.......+++..+..++.||+.||+|||++|||||||||+||||+.++.+||+|||+++
T Consensus 258 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~ 337 (450)
T 1k9a_A 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 337 (450)
T ss_dssp TTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcc
Confidence 54 79999999999999999987655568999999999999999999999999999999999999999999999999984
Q ss_pred cccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCc
Q 007260 367 RCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEP 446 (611)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (611)
.....
T Consensus 338 ~~~~~--------------------------------------------------------------------------- 342 (450)
T 1k9a_A 338 EASST--------------------------------------------------------------------------- 342 (450)
T ss_dssp ECC-----------------------------------------------------------------------------
T ss_pred ccccc---------------------------------------------------------------------------
Confidence 22100
Q ss_pred ccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 007260 447 TEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARD 525 (611)
Q Consensus 447 ~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~d 525 (611)
.....+|+.|+|||++.+..++.++|||||||+||||++ |+.||.+....+.+..+..+ .+.+....++.++.+
T Consensus 343 ----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~-~~~~~p~~~~~~l~~ 417 (450)
T 1k9a_A 343 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPDGCPPAVYD 417 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTT-CCCCCCTTCCHHHHH
T ss_pred ----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCCcCCHHHHH
Confidence 001247889999999999999999999999999999998 99999987766666555433 445555669999999
Q ss_pred HHHHhhhcCccccCCchhcHHHHHc
Q 007260 526 LIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 526 LI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
||.+||..||.+||+ +.+|++
T Consensus 418 li~~cl~~dp~~Rpt----~~~l~~ 438 (450)
T 1k9a_A 418 VMKNCWHLDAATRPT----FLQLRE 438 (450)
T ss_dssp HHHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHHcCCChhHCcC----HHHHHH
Confidence 999999999999999 555553
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-46 Score=385.44 Aligned_cols=257 Identities=21% Similarity=0.213 Sum_probs=206.5
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSC 292 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~ 292 (611)
...++|++.+.||+|+||.||+|++. +++.||||++...... ....+.+|+.+|+.++||||+++++++...+..|
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 111 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQ---GIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI 111 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSS---HHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred HHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChH---HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 34579999999999999999999965 5789999998765422 3446778999999999999999999999999999
Q ss_pred EEeeeCCCCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccC
Q 007260 293 LVMEFCPGGDLHTLRQKQP--GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAV 370 (611)
Q Consensus 293 LVmE~~~gg~L~~ll~~~~--~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~ 370 (611)
+||||++||+|.+++.... ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTE 191 (321)
T ss_dssp EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9999999999999886543 23589999999999999999999999999999999999999999999999999843210
Q ss_pred CccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccc
Q 007260 371 SPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEAR 450 (611)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (611)
.. ....
T Consensus 192 ~~--------------------------------------------------------------------------~~~~ 197 (321)
T 2qkw_B 192 LD--------------------------------------------------------------------------QTHL 197 (321)
T ss_dssp SS--------------------------------------------------------------------------CCCC
T ss_pred cc--------------------------------------------------------------------------cccc
Confidence 00 0001
Q ss_pred ccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHH-----H-H-HHHcCCC--------CCCC
Q 007260 451 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRAT-----L-F-NVVGQPL--------RFPE 515 (611)
Q Consensus 451 ~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~-----l-~-~i~~~~l--------~~p~ 515 (611)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+...... . . ......+ ....
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (321)
T 2qkw_B 198 STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKI 277 (321)
T ss_dssp BCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCS
T ss_pred ccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhcccc
Confidence 1234699999999999999999999999999999999999999976433211 0 1 1111111 1111
Q ss_pred CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcC
Q 007260 516 SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 516 ~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~H 551 (611)
...++..+.+||.+||..||++||+ +.++++|
T Consensus 278 ~~~~~~~l~~li~~~l~~dP~~Rps----~~ell~~ 309 (321)
T 2qkw_B 278 RPESLRKFGDTAVKCLALSSEDRPS----MGDVLWK 309 (321)
T ss_dssp CHHHHHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CHHHHHHHHHHHHHHcCCCcccCcC----HHHHHHH
Confidence 1234577899999999999999999 8888875
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=368.31 Aligned_cols=255 Identities=24% Similarity=0.320 Sum_probs=209.5
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECC---CCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSG---TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK 289 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~---t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~ 289 (611)
+..++|++.+.||+|+||.||+|++.. ++..||||++.+... .....++.+|+.+|+.++||||+++++++.++
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 85 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT--LDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE- 85 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSC--HHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccC--chHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-
Confidence 345799999999999999999998653 456799999976532 23445678899999999999999999998754
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
..|+||||+++++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 86 ~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 86 PTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp SCEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred CCEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 5689999999999999987653 468999999999999999999999999999999999999999999999999984322
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
... ..
T Consensus 165 ~~~---------------------------------------------------------------------------~~ 169 (281)
T 3cc6_A 165 DED---------------------------------------------------------------------------YY 169 (281)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccc---------------------------------------------------------------------------cc
Confidence 100 00
Q ss_pred cccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 007260 450 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIR 528 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~ 528 (611)
......||+.|+|||++.+..++.++|||||||++|||++ |+.||...........+... ...+....+++.+.+||.
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~ 248 (281)
T 3cc6_A 170 KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG-DRLPKPDLCPPVLYTLMT 248 (281)
T ss_dssp ---CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHT-CCCCCCTTCCHHHHHHHH
T ss_pred ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcC-CCCCCCCCCCHHHHHHHH
Confidence 0112347889999999999999999999999999999998 99999877666555444433 233444568999999999
Q ss_pred HhhhcCccccCCchhcHHHHHcC
Q 007260 529 GLLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 529 ~~L~~dP~~Rpt~~~~a~elL~H 551 (611)
+||..||.+||+ +.+++++
T Consensus 249 ~~l~~~p~~Rps----~~ell~~ 267 (281)
T 3cc6_A 249 RCWDYDPSDRPR----FTELVCS 267 (281)
T ss_dssp HHTCSSGGGSCC----HHHHHHH
T ss_pred HHccCCchhCcC----HHHHHHH
Confidence 999999999999 7777764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=396.92 Aligned_cols=254 Identities=21% Similarity=0.319 Sum_probs=213.3
Q ss_pred ccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccce
Q 007260 211 GVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKF 290 (611)
Q Consensus 211 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~ 290 (611)
..+..++|++.+.||+|+||.||+|.+.. +..||||++...... ...+.+|+.+|+.++|||||++++++. .+.
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~ 256 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVKLHAVVT-KEP 256 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTSBC----HHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCCcc----HHHHHHHHHHHhhCCCCCEeeEEEEEe-CCc
Confidence 34556799999999999999999999875 567999999765432 346778999999999999999999986 667
Q ss_pred eeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccC
Q 007260 291 SCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAV 370 (611)
Q Consensus 291 ~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~ 370 (611)
+|||||||++|+|.+++....+..+++..+..++.||+.||+|||++|||||||||+||||+.++.+||+|||+++....
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 89999999999999999865444689999999999999999999999999999999999999999999999999854321
Q ss_pred CccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccc
Q 007260 371 SPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEAR 450 (611)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (611)
... ..
T Consensus 337 ~~~---------------------------------------------------------------------------~~ 341 (454)
T 1qcf_A 337 NEY---------------------------------------------------------------------------TA 341 (454)
T ss_dssp HHH---------------------------------------------------------------------------HT
T ss_pred Cce---------------------------------------------------------------------------ec
Confidence 000 00
Q ss_pred ccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHH
Q 007260 451 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRG 529 (611)
Q Consensus 451 ~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~ 529 (611)
.....+|+.|+|||++.+..++.++|||||||+||||++ |+.||.+....+.+..+... .+.+....++.++.+||.+
T Consensus 342 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~-~~~~~~~~~~~~l~~li~~ 420 (454)
T 1qcf_A 342 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMPRPENCPEELYNIMMR 420 (454)
T ss_dssp TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT-CCCCCCTTSCHHHHHHHHH
T ss_pred cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHH
Confidence 011247788999999999999999999999999999999 99999998877766655543 4555566799999999999
Q ss_pred hhhcCccccCCchhcHHHHHc
Q 007260 530 LLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 530 ~L~~dP~~Rpt~~~~a~elL~ 550 (611)
||..||.+||+ +.+|++
T Consensus 421 cl~~dp~~RPt----~~~i~~ 437 (454)
T 1qcf_A 421 CWKNRPEERPT----FEYIQS 437 (454)
T ss_dssp HTCSSGGGSCC----HHHHHH
T ss_pred HccCChhHCcC----HHHHHH
Confidence 99999999999 555543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=366.88 Aligned_cols=256 Identities=17% Similarity=0.250 Sum_probs=207.5
Q ss_pred ccCeEEEeEecccCcEEEEEEEECC---CCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCccccccee-eccce
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSG---TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHF-ETEKF 290 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~---t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~-~~~~~ 290 (611)
..+|++.+.||+|+||+||+|++.. +...||+|++.... ......++.+|+.+|+.++||||+++++++ ..++.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 101 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence 3579999999999999999999754 34468999987533 334456778999999999999999999985 56678
Q ss_pred eeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccC
Q 007260 291 SCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAV 370 (611)
Q Consensus 291 ~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~ 370 (611)
.|+||||+++++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred eEEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence 89999999999999999764 35689999999999999999999999999999999999999999999999999854321
Q ss_pred CccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccc
Q 007260 371 SPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEAR 450 (611)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (611)
.... ....
T Consensus 181 ~~~~------------------------------------------------------------------------~~~~ 188 (298)
T 3f66_A 181 KEYY------------------------------------------------------------------------SVHN 188 (298)
T ss_dssp GGGC------------------------------------------------------------------------BC--
T ss_pred cchh------------------------------------------------------------------------cccc
Confidence 1000 0001
Q ss_pred ccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHH
Q 007260 451 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRG 529 (611)
Q Consensus 451 ~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~ 529 (611)
.....||+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.........+..... ......++..+.+||.+
T Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~ 267 (298)
T 3f66_A 189 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR-LLQPEYCPDPLYEVMLK 267 (298)
T ss_dssp ---CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC-CCCCTTCCHHHHHHHHH
T ss_pred ccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC-CCCCccCCHHHHHHHHH
Confidence 123458899999999999999999999999999999999 7778877766666555555433 23334589999999999
Q ss_pred hhhcCccccCCchhcHHHHHc
Q 007260 530 LLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 530 ~L~~dP~~Rpt~~~~a~elL~ 550 (611)
||..||.+||+ +.++++
T Consensus 268 ~l~~~p~~Rps----~~ell~ 284 (298)
T 3f66_A 268 CWHPKAEMRPS----FSELVS 284 (298)
T ss_dssp HTCSSGGGSCC----HHHHHH
T ss_pred HcCCChhhCcC----HHHHHH
Confidence 99999999999 666665
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=369.06 Aligned_cols=245 Identities=23% Similarity=0.367 Sum_probs=207.6
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec--------
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET-------- 287 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~-------- 287 (611)
.+|++++.||+|+||.||+|++..+++.||||++.... ..+.+|+++|+.++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 58999999999999999999999999999999997643 134679999999999999999998864
Q ss_pred --------cceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEE
Q 007260 288 --------EKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIML 359 (611)
Q Consensus 288 --------~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL 359 (611)
...+||||||+++++|.+++....+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEE
Confidence 556899999999999999998765567999999999999999999999999999999999999999999999
Q ss_pred EeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCC
Q 007260 360 SDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPL 439 (611)
Q Consensus 360 ~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (611)
+|||++.......
T Consensus 164 ~Dfg~~~~~~~~~------------------------------------------------------------------- 176 (284)
T 2a19_B 164 GDFGLVTSLKNDG------------------------------------------------------------------- 176 (284)
T ss_dssp CCCTTCEESSCCS-------------------------------------------------------------------
T ss_pred Ccchhheeccccc-------------------------------------------------------------------
Confidence 9999984432100
Q ss_pred cccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCC
Q 007260 440 PELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVV 519 (611)
Q Consensus 440 ~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~ 519 (611)
......||+.|+|||++.+..++.++|||||||++|+|++|..||... ......+.... + ...+
T Consensus 177 ----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~~--~--~~~~ 240 (284)
T 2a19_B 177 ----------KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDGI--I--SDIF 240 (284)
T ss_dssp ----------CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTTC--C--CTTS
T ss_pred ----------cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhccc--c--cccC
Confidence 011235999999999999999999999999999999999999998532 12222222222 2 2348
Q ss_pred CHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCC
Q 007260 520 SFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 520 s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f 554 (611)
+..+++||.+||..||.+||+ +.++++|.|+
T Consensus 241 ~~~~~~li~~~l~~dp~~Rps----~~e~l~~l~~ 271 (284)
T 2a19_B 241 DKKEKTLLQKLLSKKPEDRPN----TSEILRTLTV 271 (284)
T ss_dssp CHHHHHHHHHHTCSSGGGSCC----HHHHHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCcC----HHHHHHHHHH
Confidence 899999999999999999999 9999998765
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=376.75 Aligned_cols=259 Identities=22% Similarity=0.280 Sum_probs=211.7
Q ss_pred ccccccCeEEEeEecccCcEEEEEEEECCC----CeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceee
Q 007260 211 GVLGLSHFRLLKRLGCGDIGSVYLSELSGT----KCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFE 286 (611)
Q Consensus 211 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t----~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~ 286 (611)
..+..++|++.+.||+|+||.||+|++..+ +..||||++.... .......+.+|+.+|+.++||||+++++++.
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 116 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 116 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 345567999999999999999999998654 3469999997543 2233446788999999999999999999999
Q ss_pred ccceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccc
Q 007260 287 TEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSL 366 (611)
Q Consensus 287 ~~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~ 366 (611)
..+..||||||++|++|.+++... ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++.
T Consensus 117 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 117 KYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred cCCCcEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcch
Confidence 999999999999999999998765 3569999999999999999999999999999999999999999999999999985
Q ss_pred cccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCc
Q 007260 367 RCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEP 446 (611)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (611)
........
T Consensus 196 ~~~~~~~~------------------------------------------------------------------------ 203 (333)
T 1mqb_A 196 VLEDDPEA------------------------------------------------------------------------ 203 (333)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred hhcccccc------------------------------------------------------------------------
Confidence 43211000
Q ss_pred ccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 007260 447 TEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARD 525 (611)
Q Consensus 447 ~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~d 525 (611)
........||+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+.+..+... ...+....++..+.+
T Consensus 204 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~ 281 (333)
T 1mqb_A 204 -TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-FRLPTPMDCPSAIYQ 281 (333)
T ss_dssp --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CCCCCCTTCBHHHHH
T ss_pred -ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCC-CcCCCcccCCHHHHH
Confidence 000112247889999999999999999999999999999998 99999988776666555443 445555669999999
Q ss_pred HHHHhhhcCccccCCchhcHHHHHc
Q 007260 526 LIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 526 LI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
||.+||..||.+||+ +.++++
T Consensus 282 li~~~l~~~p~~Rps----~~~l~~ 302 (333)
T 1mqb_A 282 LMMQCWQQERARRPK----FADIVS 302 (333)
T ss_dssp HHHHHTCSSTTTSCC----HHHHHH
T ss_pred HHHHHcCCChhhCcC----HHHHHH
Confidence 999999999999999 666665
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=386.86 Aligned_cols=277 Identities=14% Similarity=0.193 Sum_probs=204.8
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCC-----CeEEEEEEecchhhhhHHHH--------HHHHHHHHHHHhCCCCCcccc
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGT-----KCYFAMKVMDKASLAGRKKL--------LRAQTEREILQSLDHPFLPTL 281 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t-----~~~vAvKii~k~~~~~~~~~--------~~~~~E~~iL~~l~HpnIv~l 281 (611)
.++|++++.||+|+||.||+|.+..+ ++.||||++........... ..+..|+.++..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 35899999999999999999998765 57899999876542111111 112346667788899999999
Q ss_pred cceeecc----ceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEc--cCC
Q 007260 282 YTHFETE----KFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVR--EDG 355 (611)
Q Consensus 282 ~~~~~~~----~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~--~~g 355 (611)
++++... .+.||||||| |++|.+++... +..+++..++.|+.||+.||+|||++|||||||||+||||+ .++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence 9998764 6689999999 99999999875 35699999999999999999999999999999999999999 889
Q ss_pred cEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCC
Q 007260 356 HIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQ 435 (611)
Q Consensus 356 ~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (611)
.+||+|||++..+.......
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~------------------------------------------------------------ 211 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHK------------------------------------------------------------ 211 (364)
T ss_dssp CEEECCCTTCEESSGGGCCC------------------------------------------------------------
T ss_pred eEEEEECCcceecccCCccc------------------------------------------------------------
Confidence 99999999996543111000
Q ss_pred CCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHc----CCC
Q 007260 436 VSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG----QPL 511 (611)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~----~~l 511 (611)
.........++||+.|+|||++.+..++.++|||||||+||||++|+.||.+......+..... ..+
T Consensus 212 ---------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 282 (364)
T 3op5_A 212 ---------AYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENI 282 (364)
T ss_dssp ---------CSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCH
T ss_pred ---------ccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhH
Confidence 0000111245799999999999999999999999999999999999999986432222211111 000
Q ss_pred C-----CCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHH------HcCCCCCCCchhhh
Q 007260 512 R-----FPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEI------KQHPFFEGVNWALI 562 (611)
Q Consensus 512 ~-----~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~el------L~Hp~f~~~~~~~~ 562 (611)
. ......++.++.+||..||..||.+||++......+ +...+...++|...
T Consensus 283 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~~ 344 (364)
T 3op5_A 283 ASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSVV 344 (364)
T ss_dssp HHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC---
T ss_pred HHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccceEec
Confidence 0 001135789999999999999999999943322111 12455556667654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=371.60 Aligned_cols=262 Identities=22% Similarity=0.301 Sum_probs=208.8
Q ss_pred CccccccCeEEEeEecccCcEEEEEEEECC---CCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceee
Q 007260 210 DGVLGLSHFRLLKRLGCGDIGSVYLSELSG---TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFE 286 (611)
Q Consensus 210 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~---t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~ 286 (611)
+..+..++|++++.||+|+||.||+|.+.. ++..||||++...... ......+.+|+.+|+.++||||+++++++.
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSS-QREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCC-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccc-hhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 445566899999999999999999998765 5678999999765432 344567789999999999999999999998
Q ss_pred ccc-----eeeEEeeeCCCCCHHHHHHhC----CCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcE
Q 007260 287 TEK-----FSCLVMEFCPGGDLHTLRQKQ----PGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHI 357 (611)
Q Consensus 287 ~~~-----~~~LVmE~~~gg~L~~ll~~~----~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~v 357 (611)
... ..|+||||+++++|.+++... ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~ 186 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTV 186 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCE
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcE
Confidence 654 459999999999999988532 23569999999999999999999999999999999999999999999
Q ss_pred EEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCC
Q 007260 358 MLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVS 437 (611)
Q Consensus 358 kL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (611)
||+|||++........
T Consensus 187 kl~Dfg~~~~~~~~~~---------------------------------------------------------------- 202 (313)
T 3brb_A 187 CVADFGLSKKIYSGDY---------------------------------------------------------------- 202 (313)
T ss_dssp EECSCSCC------------------------------------------------------------------------
T ss_pred EEeecCcceecccccc----------------------------------------------------------------
Confidence 9999999844321000
Q ss_pred CCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCC
Q 007260 438 PLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPES 516 (611)
Q Consensus 438 ~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~ 516 (611)
........|++.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+.... ..+..
T Consensus 203 ----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~ 271 (313)
T 3brb_A 203 ----------YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH-RLKQP 271 (313)
T ss_dssp ------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-CCCCB
T ss_pred ----------cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC-CCCCC
Confidence 000112347889999999999999999999999999999999 999999887776666555443 33334
Q ss_pred CCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcC
Q 007260 517 PVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 517 ~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~H 551 (611)
..++..+.+||.+||..||.+||+ +.+|+++
T Consensus 272 ~~~~~~l~~li~~~l~~dp~~Rps----~~~l~~~ 302 (313)
T 3brb_A 272 EDCLDELYEIMYSCWRTDPLDRPT----FSVLRLQ 302 (313)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCC----HHHHHHH
T ss_pred ccccHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 568999999999999999999999 7777764
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=377.97 Aligned_cols=265 Identities=22% Similarity=0.355 Sum_probs=209.4
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceee----cc
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFE----TE 288 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~----~~ 288 (611)
+..++|++++.||+|+||.||+|++..+++.||||++.... ......+.+|+.+++.++||||+++++++. ..
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK 102 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC---HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence 34468999999999999999999999999999999986543 234456788999999999999999999987 35
Q ss_pred ceeeEEeeeCCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccc
Q 007260 289 KFSCLVMEFCPGGDLHTLRQKQ--PGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSL 366 (611)
Q Consensus 289 ~~~~LVmE~~~gg~L~~ll~~~--~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~ 366 (611)
...|+||||+++++|.+++... .+..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++.
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 6889999999999999988752 34679999999999999999999999999999999999999999999999999884
Q ss_pred cccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCc
Q 007260 367 RCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEP 446 (611)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (611)
.......... ...
T Consensus 183 ~~~~~~~~~~-------------------------------------------------------------------~~~ 195 (317)
T 2buj_A 183 QACIHVEGSR-------------------------------------------------------------------QAL 195 (317)
T ss_dssp ESCEEEESHH-------------------------------------------------------------------HHH
T ss_pred hccccccccc-------------------------------------------------------------------ccc
Confidence 4321000000 000
Q ss_pred ccccccccccCCCccchhhhccCC---CCChhhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHcCCCCCCCCCCCCHH
Q 007260 447 TEARSMSFVGTHEYLAPEIIKGEG---HGSAVDWWTFGIFLYELLFGKTPFKGSGN-RATLFNVVGQPLRFPESPVVSFA 522 (611)
Q Consensus 447 ~~~~~~~~vGT~~Y~APEil~~~~---~~~~sDIWSLGviL~ELltG~~PF~~~~~-~~~l~~i~~~~l~~p~~~~~s~~ 522 (611)
.........||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... ...+...+.....++....++.+
T Consensus 196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (317)
T 2buj_A 196 TLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSA 275 (317)
T ss_dssp HHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--CCCCTTSCHH
T ss_pred cccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCCCCccccCCHH
Confidence 001112346899999999998765 68999999999999999999999964110 01122233345566666779999
Q ss_pred HHHHHHHhhhcCccccCCchhcHHHHHcC
Q 007260 523 ARDLIRGLLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 523 l~dLI~~~L~~dP~~Rpt~~~~a~elL~H 551 (611)
+.+||.+||..||.+||+ +.++++|
T Consensus 276 l~~li~~~l~~dp~~Rps----~~~ll~~ 300 (317)
T 2buj_A 276 LWQLLNSMMTVDPHQRPH----IPLLLSQ 300 (317)
T ss_dssp HHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHHHhhcChhhCCC----HHHHHHH
Confidence 999999999999999999 8888875
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=366.86 Aligned_cols=250 Identities=21% Similarity=0.317 Sum_probs=205.1
Q ss_pred CccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec-c
Q 007260 210 DGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET-E 288 (611)
Q Consensus 210 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~-~ 288 (611)
...+..++|++++.||+|+||.||+|++. ++.||||++.... ...++.+|+.+|+.++||||+++++++.. .
T Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (278)
T 1byg_A 15 GWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 87 (278)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred cccCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 34456789999999999999999999885 6789999997643 23456789999999999999999998654 4
Q ss_pred ceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccc
Q 007260 289 KFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRC 368 (611)
Q Consensus 289 ~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~ 368 (611)
+..|+||||+++++|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 167 (278)
T 1byg_A 88 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 167 (278)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred CceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccc
Confidence 58999999999999999988753344899999999999999999999999999999999999999999999999987322
Q ss_pred cCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccc
Q 007260 369 AVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTE 448 (611)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (611)
...
T Consensus 168 ~~~----------------------------------------------------------------------------- 170 (278)
T 1byg_A 168 SST----------------------------------------------------------------------------- 170 (278)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccc-----------------------------------------------------------------------------
Confidence 100
Q ss_pred ccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 007260 449 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLI 527 (611)
Q Consensus 449 ~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI 527 (611)
.....||+.|+|||++.+..++.++|||||||++|+|++ |+.||...........+.. ....+....++..+.+||
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li 247 (278)
T 1byg_A 171 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDAPDGCPPAVYEVM 247 (278)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT-TCCCCCCTTCCHHHHHHH
T ss_pred --ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCCCCCcccCCHHHHHHH
Confidence 011247889999999999999999999999999999998 9999998766555554433 334444556899999999
Q ss_pred HHhhhcCccccCCchhcHHHHHc
Q 007260 528 RGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 528 ~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
.+||..||.+||+ +.++++
T Consensus 248 ~~~l~~~p~~Rps----~~~l~~ 266 (278)
T 1byg_A 248 KNCWHLDAAMRPS----FLQLRE 266 (278)
T ss_dssp HHHTCSSGGGSCC----HHHHHH
T ss_pred HHHhcCChhhCCC----HHHHHH
Confidence 9999999999999 666664
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=368.03 Aligned_cols=249 Identities=24% Similarity=0.322 Sum_probs=196.5
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHh--CCCCCcccccceeec----c
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQS--LDHPFLPTLYTHFET----E 288 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~--l~HpnIv~l~~~~~~----~ 288 (611)
.++|++++.||+|+||+||+|++ +++.||||++..... ..+.+|.+++.. ++||||+++++++.. .
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~------~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~ 78 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDE------KSWFRETELYNTVMLRHENILGFIASDMTSRHSS 78 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGH------HHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccc------hhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence 46899999999999999999988 578899999976432 233456676666 799999999998654 4
Q ss_pred ceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--------HcCeeccCCCCCcEEEccCCcEEEE
Q 007260 289 KFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLH--------MLGIIYRDLKPENVLVREDGHIMLS 360 (611)
Q Consensus 289 ~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH--------~~gIVHRDLKPeNILv~~~g~vkL~ 360 (611)
..+||||||+++|+|.++++. ..+++..+..++.||+.||+||| ++|||||||||+||||+.++.+||+
T Consensus 79 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 79 TQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred ceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEe
Confidence 678999999999999999965 45999999999999999999999 9999999999999999999999999
Q ss_pred eccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCc
Q 007260 361 DFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLP 440 (611)
Q Consensus 361 DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (611)
|||++.........
T Consensus 156 Dfg~a~~~~~~~~~------------------------------------------------------------------ 169 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQ------------------------------------------------------------------ 169 (301)
T ss_dssp CCTTCEEEETTTTE------------------------------------------------------------------
T ss_pred eCCCeeeccccccc------------------------------------------------------------------
Confidence 99998543211100
Q ss_pred ccccCcccccccccccCCCccchhhhccC------CCCChhhHHHHHHHHHHHHhC----------CCCCCCC----CcH
Q 007260 441 ELIAEPTEARSMSFVGTHEYLAPEIIKGE------GHGSAVDWWTFGIFLYELLFG----------KTPFKGS----GNR 500 (611)
Q Consensus 441 ~~~~~~~~~~~~~~vGT~~Y~APEil~~~------~~~~~sDIWSLGviL~ELltG----------~~PF~~~----~~~ 500 (611)
........+||+.|+|||++.+. .++.++|||||||++|||++| +.||... ...
T Consensus 170 ------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~ 243 (301)
T 3q4u_A 170 ------LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243 (301)
T ss_dssp ------EECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred ------ccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcch
Confidence 00011234699999999999887 345799999999999999999 8898653 233
Q ss_pred HHHHHHHcCCCCCCCC------CCCCHHHHHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 501 ATLFNVVGQPLRFPES------PVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 501 ~~l~~i~~~~l~~p~~------~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
..+..++......+.. ..++.++.+||.+||..||.+||+ +.+|++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~~i~~ 295 (301)
T 3q4u_A 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLT----ALRIKK 295 (301)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCC----HHHHHH
T ss_pred hhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCC----HHHHHH
Confidence 4444444332222221 125578999999999999999999 777765
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=366.13 Aligned_cols=266 Identities=17% Similarity=0.253 Sum_probs=206.3
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCccccccee-eccceeeEE
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHF-ETEKFSCLV 294 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~-~~~~~~~LV 294 (611)
++|++++.||+|+||.||+|++..+++.||||++...... ..+.+|+.+++.+.|++++..+.++ ......|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 6899999999999999999999999999999987654322 2456799999999888877666655 667888999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEE---ccCCcEEEEeccccccccCC
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLV---REDGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv---~~~g~vkL~DFGlA~~~~~~ 371 (611)
|||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++......
T Consensus 84 ~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEcc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 9999 999999988643 469999999999999999999999999999999999999 78999999999998543311
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
..... ......
T Consensus 162 ~~~~~---------------------------------------------------------------------~~~~~~ 172 (296)
T 4hgt_A 162 RTHQH---------------------------------------------------------------------IPYREN 172 (296)
T ss_dssp TTCCB---------------------------------------------------------------------CCCCCS
T ss_pred ccCcc---------------------------------------------------------------------CCCCcc
Confidence 10000 000111
Q ss_pred cccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHcCCCCCCC---CCCCCHHHHH
Q 007260 452 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNR---ATLFNVVGQPLRFPE---SPVVSFAARD 525 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~---~~l~~i~~~~l~~p~---~~~~s~~l~d 525 (611)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.... ..+..+.......+. ...++.++.+
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 252 (296)
T 4hgt_A 173 KNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFAT 252 (296)
T ss_dssp CCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHH
T ss_pred cccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhccCCHHHHH
Confidence 2356999999999999999999999999999999999999999874322 223333322222221 1347899999
Q ss_pred HHHHhhhcCccccCCchhcHHHHHc----------CCCCCCCchhh
Q 007260 526 LIRGLLVKEPQHRLAYKRGATEIKQ----------HPFFEGVNWAL 561 (611)
Q Consensus 526 LI~~~L~~dP~~Rpt~~~~a~elL~----------Hp~f~~~~~~~ 561 (611)
||.+||..||.+||+ +.++++ ..|...++|..
T Consensus 253 li~~~l~~~p~~Rpt----~~~l~~~l~~~~~~~~~~~~~~~dw~~ 294 (296)
T 4hgt_A 253 YLNFCRSLRFDDKPD----YSYLRQLFRNLFHRQGFSYDYVFDWNM 294 (296)
T ss_dssp HHHHHHTSCTTCCCC----HHHHHHHHHHHHHHHTCCTTCCCGGGG
T ss_pred HHHHHHhcCCCCCCC----HHHHHHHHHHHHHHhCCCccCccchhh
Confidence 999999999999999 555543 45555566654
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=395.95 Aligned_cols=263 Identities=25% Similarity=0.375 Sum_probs=202.6
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeecccee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEKFS 291 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~~~~ 291 (611)
++..+|++.+.||+|+||+||.. ...+++.||||++.+.... .+.+|+.+|+.+ +|||||++++++.+....
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 93 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQFQ 93 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEE
T ss_pred EccEEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCEE
Confidence 34457999999999999997643 4456788999999764332 245799999999 799999999999999999
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEcc---CC--cEEEEeccccc
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRE---DG--HIMLSDFDLSL 366 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~---~g--~vkL~DFGlA~ 366 (611)
|||||||. |+|.+++.... ..+.+..++.++.||+.||+|||++|||||||||+||||+. ++ .+||+|||++.
T Consensus 94 ~lv~E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 94 YIAIELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp EEEEECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred EEEEECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 99999995 69999988753 34566677889999999999999999999999999999953 33 58899999985
Q ss_pred cccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCc
Q 007260 367 RCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEP 446 (611)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (611)
.......
T Consensus 172 ~~~~~~~------------------------------------------------------------------------- 178 (432)
T 3p23_A 172 KLAVGRH------------------------------------------------------------------------- 178 (432)
T ss_dssp CC------------------------------------------------------------------------------
T ss_pred eccCCCc-------------------------------------------------------------------------
Confidence 4321100
Q ss_pred ccccccccccCCCccchhhhcc---CCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCC-CCCCCCH
Q 007260 447 TEARSMSFVGTHEYLAPEIIKG---EGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFP-ESPVVSF 521 (611)
Q Consensus 447 ~~~~~~~~vGT~~Y~APEil~~---~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p-~~~~~s~ 521 (611)
........+||+.|+|||++.+ ..++.++|||||||++|||++ |..||...........+........ .....+.
T Consensus 179 ~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (432)
T 3p23_A 179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDV 258 (432)
T ss_dssp -------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHHHH
T ss_pred ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccccccH
Confidence 0011223579999999999984 567889999999999999999 9999976554433322222222211 1223466
Q ss_pred HHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCchhh
Q 007260 522 AARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWAL 561 (611)
Q Consensus 522 ~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~ 561 (611)
.+++||.+||..||.+||+ +.+|++||||.+++|.+
T Consensus 259 ~~~~li~~~L~~dP~~Rps----~~evl~hp~f~~~~~~~ 294 (432)
T 3p23_A 259 IARELIEKMIAMDPQKRPS----AKHVLKHPFFWSLEKQL 294 (432)
T ss_dssp HHHHHHHHHSCSSGGGSCC----HHHHHTSTTTCCHHHHH
T ss_pred HHHHHHHHHHhCCHhhCCC----HHHHHhCccccChHHHH
Confidence 7899999999999999999 99999999999998854
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=393.31 Aligned_cols=254 Identities=25% Similarity=0.348 Sum_probs=211.3
Q ss_pred ccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccce
Q 007260 211 GVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKF 290 (611)
Q Consensus 211 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~ 290 (611)
..+..++|++.+.||+|+||.||+|.+..+ ..||||++...... ...+.+|+.+|+.++||||+++++++.. +.
T Consensus 179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~ 252 (452)
T 1fmk_A 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP 252 (452)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred cccChhHceeeeeecCCCCeEEEEEEECCC-ceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cc
Confidence 345567899999999999999999999865 56999999765432 2356789999999999999999999876 67
Q ss_pred eeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccC
Q 007260 291 SCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAV 370 (611)
Q Consensus 291 ~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~ 370 (611)
+|||||||++|+|.+++....+..+++..+..++.||+.||+|||++|||||||||+||||+.++.+||+|||+++....
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 89999999999999999765445699999999999999999999999999999999999999999999999999843321
Q ss_pred CccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccc
Q 007260 371 SPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEAR 450 (611)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (611)
.. ...
T Consensus 333 ~~---------------------------------------------------------------------------~~~ 337 (452)
T 1fmk_A 333 NE---------------------------------------------------------------------------YTA 337 (452)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred Cc---------------------------------------------------------------------------eec
Confidence 00 000
Q ss_pred ccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHH
Q 007260 451 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRG 529 (611)
Q Consensus 451 ~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~ 529 (611)
.....||+.|+|||++.+..++.++|||||||+||||++ |+.||.+....+.+..+.. ..+.+....++..+.+||.+
T Consensus 338 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~ 416 (452)
T 1fmk_A 338 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPECPESLHDLMCQ 416 (452)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCCCCTTSCHHHHHHHHH
T ss_pred ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHH
Confidence 012247889999999999999999999999999999999 9999999887776665544 34555556799999999999
Q ss_pred hhhcCccccCCchhcHHHHHc
Q 007260 530 LLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 530 ~L~~dP~~Rpt~~~~a~elL~ 550 (611)
||..||.+||+ +.+|++
T Consensus 417 cl~~dP~~Rpt----~~~l~~ 433 (452)
T 1fmk_A 417 CWRKEPEERPT----FEYLQA 433 (452)
T ss_dssp HTCSSGGGSCC----HHHHHH
T ss_pred HccCChhhCcC----HHHHHH
Confidence 99999999999 666665
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=390.64 Aligned_cols=248 Identities=24% Similarity=0.421 Sum_probs=202.5
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc--eee
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK--FSC 292 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~--~~~ 292 (611)
.++|++.+.||+|+||+||+|++..+++.||||++....... ....+.+|+++|+.++||||+++++++.... ..|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 85 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence 468999999999999999999999999999999997654322 2335578999999999999999999998654 789
Q ss_pred EEeeeCCCCCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEE----ccCCcEEEEecccccc
Q 007260 293 LVMEFCPGGDLHTLRQKQPG-KYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLV----REDGHIMLSDFDLSLR 367 (611)
Q Consensus 293 LVmE~~~gg~L~~ll~~~~~-~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv----~~~g~vkL~DFGlA~~ 367 (611)
||||||+||+|.+++..... ..+++..++.++.||+.||+|||++|||||||||+|||| +.++.+||+|||++..
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 99999999999999876432 349999999999999999999999999999999999999 6777899999999854
Q ss_pred ccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcc
Q 007260 368 CAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPT 447 (611)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (611)
....
T Consensus 166 ~~~~---------------------------------------------------------------------------- 169 (396)
T 4eut_A 166 LEDD---------------------------------------------------------------------------- 169 (396)
T ss_dssp CCCG----------------------------------------------------------------------------
T ss_pred ccCC----------------------------------------------------------------------------
Confidence 3210
Q ss_pred cccccccccCCCccchhhhcc--------CCCCChhhHHHHHHHHHHHHhCCCCCCC----CCcHHHHHHHHcCCCC---
Q 007260 448 EARSMSFVGTHEYLAPEIIKG--------EGHGSAVDWWTFGIFLYELLFGKTPFKG----SGNRATLFNVVGQPLR--- 512 (611)
Q Consensus 448 ~~~~~~~vGT~~Y~APEil~~--------~~~~~~sDIWSLGviL~ELltG~~PF~~----~~~~~~l~~i~~~~l~--- 512 (611)
......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.. ....+.+.+++.....
T Consensus 170 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~ 248 (396)
T 4eut_A 170 -EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI 248 (396)
T ss_dssp -GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCC
T ss_pred -CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccc
Confidence 01123469999999999976 4578899999999999999999999975 3345566666654321
Q ss_pred ----------------CCCC----CCCCHHHHHHHHHhhhcCccccCCc
Q 007260 513 ----------------FPES----PVVSFAARDLIRGLLVKEPQHRLAY 541 (611)
Q Consensus 513 ----------------~p~~----~~~s~~l~dLI~~~L~~dP~~Rpt~ 541 (611)
++.. ..++..+.+||.+||..||++||++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~ 297 (396)
T 4eut_A 249 SGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF 297 (396)
T ss_dssp EEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCH
T ss_pred hhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccH
Confidence 1111 1245678899999999999999993
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=395.86 Aligned_cols=275 Identities=18% Similarity=0.260 Sum_probs=215.7
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCC-CCcccccceeeccceeeE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH-PFLPTLYTHFETEKFSCL 293 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~H-pnIv~l~~~~~~~~~~~L 293 (611)
.++|++++.||+|+||.||+|++..+++.||||++....... .+.+|+++++.|.| ++|+.+..++...+..||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~-----~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-----QLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSC-----CHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccH-----HHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 368999999999999999999999999999999987543222 35679999999976 566666666778889999
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEE---ccCCcEEEEeccccccccC
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLV---REDGHIMLSDFDLSLRCAV 370 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv---~~~g~vkL~DFGlA~~~~~ 370 (611)
||||+ |++|.+++.... ..+++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||++..+..
T Consensus 81 vme~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 81 VMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp EEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEECC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 99999 999999998643 569999999999999999999999999999999999999 6889999999999865432
Q ss_pred CccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccc
Q 007260 371 SPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEAR 450 (611)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (611)
...... .....
T Consensus 159 ~~~~~~---------------------------------------------------------------------~~~~~ 169 (483)
T 3sv0_A 159 TSTHQH---------------------------------------------------------------------IPYRE 169 (483)
T ss_dssp TTTCCB---------------------------------------------------------------------CCCCC
T ss_pred Cccccc---------------------------------------------------------------------ccccc
Confidence 110000 00011
Q ss_pred ccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHcCCCCCC---CCCCCCHHHH
Q 007260 451 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGN---RATLFNVVGQPLRFP---ESPVVSFAAR 524 (611)
Q Consensus 451 ~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~---~~~l~~i~~~~l~~p---~~~~~s~~l~ 524 (611)
...++||+.|+|||++.+..++.++|||||||+||||++|+.||.+... ...+..+....+... ....++.++.
T Consensus 170 ~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~ 249 (483)
T 3sv0_A 170 NKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFA 249 (483)
T ss_dssp CCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHH
T ss_pred ccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHH
Confidence 1245799999999999999999999999999999999999999987543 233333322211111 1134789999
Q ss_pred HHHHHhhhcCccccCCchhcH---HHH---HcCCCCCCCchhhhccC
Q 007260 525 DLIRGLLVKEPQHRLAYKRGA---TEI---KQHPFFEGVNWALIRCA 565 (611)
Q Consensus 525 dLI~~~L~~dP~~Rpt~~~~a---~el---L~Hp~f~~~~~~~~~~~ 565 (611)
+||..||..||++||++.... .++ +.++|+..++|......
T Consensus 250 ~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~~~~~ 296 (483)
T 3sv0_A 250 SYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQ 296 (483)
T ss_dssp HHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHHHTC-
T ss_pred HHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchhhccc
Confidence 999999999999999954322 122 35899999999987554
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=384.01 Aligned_cols=260 Identities=22% Similarity=0.242 Sum_probs=205.1
Q ss_pred cccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecccee
Q 007260 212 VLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFS 291 (611)
Q Consensus 212 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~ 291 (611)
.+..++|++.+.||+|+||.||+|++. +++.||||++....... ...++.+|+.+|+.++||||+++++++......
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 102 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCC
T ss_pred HHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCch--HHHHHHHHHHHHHhccCCCccceEEEEecCCce
Confidence 344579999999999999999999854 57889999997654221 122567899999999999999999999999999
Q ss_pred eEEeeeCCCCCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHc---CeeccCCCCCcEEEccCCcEEEEeccccc
Q 007260 292 CLVMEFCPGGDLHTLRQKQPG--KYFPEQAVRFYVAEVLLALEYLHML---GIIYRDLKPENVLVREDGHIMLSDFDLSL 366 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~--~~l~e~~~~~i~~qll~aL~yLH~~---gIVHRDLKPeNILv~~~g~vkL~DFGlA~ 366 (611)
||||||++||+|.+++..... ..+++..++.++.||+.||+|||++ ||+||||||+||||+.++.+||+|||++.
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~ 182 (326)
T 3uim_A 103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182 (326)
T ss_dssp EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccc
Confidence 999999999999999987532 3599999999999999999999999 99999999999999999999999999985
Q ss_pred cccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCc
Q 007260 367 RCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEP 446 (611)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (611)
......
T Consensus 183 ~~~~~~-------------------------------------------------------------------------- 188 (326)
T 3uim_A 183 LMDYKD-------------------------------------------------------------------------- 188 (326)
T ss_dssp ECCSSS--------------------------------------------------------------------------
T ss_pred ccCccc--------------------------------------------------------------------------
Confidence 432110
Q ss_pred ccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCC----CCcHHHHHHHHcCCCCC---------
Q 007260 447 TEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKG----SGNRATLFNVVGQPLRF--------- 513 (611)
Q Consensus 447 ~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~----~~~~~~l~~i~~~~l~~--------- 513 (611)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.. ......+...+......
T Consensus 189 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (326)
T 3uim_A 189 -THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDV 267 (326)
T ss_dssp -SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCT
T ss_pred -ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcCh
Confidence 0111234699999999999999999999999999999999999999962 11111112222211110
Q ss_pred ----CCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCC
Q 007260 514 ----PESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPF 553 (611)
Q Consensus 514 ----p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~ 553 (611)
......+..+.+||.+||..||.+||+ +.+|++|-+
T Consensus 268 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~ell~~L~ 307 (326)
T 3uim_A 268 DLQGNYKDEEVEQLIQVALLCTQSSPMERPK----MSEVVRMLE 307 (326)
T ss_dssp TCTTSCCHHHHHHHHHHHHHHTCSCGGGSCC----HHHHHHHHH
T ss_pred hhccccCHHHHHHHHHHHHHHhCcCCccCCC----HHHHHHHhc
Confidence 111123468999999999999999999 888887643
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=372.45 Aligned_cols=256 Identities=23% Similarity=0.294 Sum_probs=208.8
Q ss_pred ccccCeEEEeEecccCcEEEEEEEE----CCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec-
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSEL----SGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET- 287 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~----~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~- 287 (611)
+....|++++.||+|+||+||++.. ..+++.||||++.... .......+.+|+++|+.++||||+++++++.+
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA 105 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence 3333459999999999999988764 4578899999997653 23445567899999999999999999999987
Q ss_pred -cceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccc
Q 007260 288 -EKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSL 366 (611)
Q Consensus 288 -~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~ 366 (611)
...+||||||+++++|.+++... .+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++.
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 106 GAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp TTTEEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred CCceEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccc
Confidence 47889999999999999998775 39999999999999999999999999999999999999999999999999985
Q ss_pred cccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCc
Q 007260 367 RCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEP 446 (611)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (611)
........
T Consensus 183 ~~~~~~~~------------------------------------------------------------------------ 190 (318)
T 3lxp_A 183 AVPEGHEY------------------------------------------------------------------------ 190 (318)
T ss_dssp ECCTTCSE------------------------------------------------------------------------
T ss_pred cccccccc------------------------------------------------------------------------
Confidence 43211000
Q ss_pred ccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcH--------------HHHHHHHcCCCC
Q 007260 447 TEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNR--------------ATLFNVVGQPLR 512 (611)
Q Consensus 447 ~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~--------------~~l~~i~~~~l~ 512 (611)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ..+...+.....
T Consensus 191 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (318)
T 3lxp_A 191 -YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGER 269 (318)
T ss_dssp -EEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCC
T ss_pred -cccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccC
Confidence 00111235888999999999999999999999999999999999999753211 123344455555
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 513 FPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 513 ~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
.+....++.++.+||.+||..||.+||+ +.++++
T Consensus 270 ~~~~~~~~~~l~~li~~~l~~dP~~Rps----~~ell~ 303 (318)
T 3lxp_A 270 LPRPDKCPAEVYHLMKNCWETEASFRPT----FENLIP 303 (318)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred CCCCccccHHHHHHHHHHcCCCcccCcC----HHHHHH
Confidence 6666679999999999999999999999 777775
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=362.40 Aligned_cols=256 Identities=18% Similarity=0.247 Sum_probs=203.3
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCccccccee-eccceeeE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHF-ETEKFSCL 293 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~-~~~~~~~L 293 (611)
.++|++++.||+|+||.||+|++..+++.||||++....... .+.+|+.+++.+.|++++..+.++ ......||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-----QLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCC-----HHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchh-----HHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 368999999999999999999999999999999987544222 467899999999988866665554 56788899
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEE---ccCCcEEEEeccccccccC
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLV---REDGHIMLSDFDLSLRCAV 370 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv---~~~g~vkL~DFGlA~~~~~ 370 (611)
||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||++.....
T Consensus 83 v~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 99999 999999998543 569999999999999999999999999999999999999 4889999999999854331
Q ss_pred CccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccc
Q 007260 371 SPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEAR 450 (611)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (611)
...... .....
T Consensus 161 ~~~~~~---------------------------------------------------------------------~~~~~ 171 (296)
T 3uzp_A 161 ARTHQH---------------------------------------------------------------------IPYRE 171 (296)
T ss_dssp TTTCCB---------------------------------------------------------------------CCCCC
T ss_pred cccccc---------------------------------------------------------------------ccccc
Confidence 110000 00011
Q ss_pred ccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHcCCCCCC---CCCCCCHHHH
Q 007260 451 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGN---RATLFNVVGQPLRFP---ESPVVSFAAR 524 (611)
Q Consensus 451 ~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~---~~~l~~i~~~~l~~p---~~~~~s~~l~ 524 (611)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ...+..+.......+ ....++.++.
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 251 (296)
T 3uzp_A 172 NKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFA 251 (296)
T ss_dssp SCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHH
T ss_pred ccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHH
Confidence 2245799999999999999999999999999999999999999987432 223333333222222 1134899999
Q ss_pred HHHHHhhhcCccccCCchhcHHHHHc
Q 007260 525 DLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 525 dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
+||.+||..||.+||+ +.++++
T Consensus 252 ~li~~~l~~dp~~Rps----~~~l~~ 273 (296)
T 3uzp_A 252 TYLNFCRSLRFDDKPD----YSYLRQ 273 (296)
T ss_dssp HHHHHHHTSCTTCCCC----HHHHHH
T ss_pred HHHHHHHhcCcCcCCC----HHHHHH
Confidence 9999999999999999 555553
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=378.56 Aligned_cols=253 Identities=19% Similarity=0.288 Sum_probs=202.7
Q ss_pred cCeEEEeEecccCcEEEEEEEECCC--------CeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCccc-------
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGT--------KCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPT------- 280 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t--------~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~------- 280 (611)
++|++++.||+|+||.||+|++..+ ++.||||++.+.. .+.+|+++|+.++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~--------~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDG--------RLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTS--------THHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccc--------hHHHHHHHHHHhcccchhhhhhhhcc
Confidence 6899999999999999999999874 7899999997652 4667999999999999988
Q ss_pred --------ccceeec-cceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEE
Q 007260 281 --------LYTHFET-EKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLV 351 (611)
Q Consensus 281 --------l~~~~~~-~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv 351 (611)
+++++.. +...||||||+ |++|.+++....+..+++..++.++.||+.||+|||++||+||||||+||||
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence 4556554 78899999999 9999999988655679999999999999999999999999999999999999
Q ss_pred ccCC--cEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCc
Q 007260 352 REDG--HIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPK 429 (611)
Q Consensus 352 ~~~g--~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 429 (611)
+.++ .+||+|||++..+.......
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~------------------------------------------------------ 218 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHV------------------------------------------------------ 218 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCC------------------------------------------------------
T ss_pred cCCCCceEEEecCcceeeccCCCccc------------------------------------------------------
Confidence 9988 89999999985443111000
Q ss_pred cccCCCCCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHH--
Q 007260 430 NEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSG-NRATLFNV-- 506 (611)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~-~~~~l~~i-- 506 (611)
...........||+.|+|||++.+..++.++|||||||+||||++|+.||.+.. ....+...
T Consensus 219 ---------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 283 (352)
T 2jii_A 219 ---------------AYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQ 283 (352)
T ss_dssp ---------------CCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHH
T ss_pred ---------------cccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHH
Confidence 000011123479999999999999999999999999999999999999998764 33333322
Q ss_pred --HcCCCCCCC----CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 507 --VGQPLRFPE----SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 507 --~~~~l~~p~----~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
......++. +..++.++.+||.+||..||.+||+ +.+|++
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~~l~~ 329 (352)
T 2jii_A 284 KFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPP----YAMLRN 329 (352)
T ss_dssp HHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCC----HHHHHH
T ss_pred hccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCC----HHHHHH
Confidence 222222221 1247999999999999999999999 666654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=364.32 Aligned_cols=246 Identities=24% Similarity=0.393 Sum_probs=199.1
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSC 292 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~ 292 (611)
+..++|++.+.||+|+||+||+|++. ++.||||++.... ....+.+|+.+|++++||||+++++++.+ ..|
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 75 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESES-----ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVC 75 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSSTT-----HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecChh-----HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcE
Confidence 34578999999999999999999986 5679999996543 23466789999999999999999998874 489
Q ss_pred EEeeeCCCCCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHH---cCeeccCCCCCcEEEccCCc-EEEEecccccc
Q 007260 293 LVMEFCPGGDLHTLRQKQPG-KYFPEQAVRFYVAEVLLALEYLHM---LGIIYRDLKPENVLVREDGH-IMLSDFDLSLR 367 (611)
Q Consensus 293 LVmE~~~gg~L~~ll~~~~~-~~l~e~~~~~i~~qll~aL~yLH~---~gIVHRDLKPeNILv~~~g~-vkL~DFGlA~~ 367 (611)
|||||++|++|.+++..... ..+++..+..++.||+.||+|||+ +||+||||||+||||+.++. +||+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 99999999999999886532 247899999999999999999999 89999999999999998886 79999999832
Q ss_pred ccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcc
Q 007260 368 CAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPT 447 (611)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (611)
...
T Consensus 156 ~~~----------------------------------------------------------------------------- 158 (307)
T 2eva_A 156 IQT----------------------------------------------------------------------------- 158 (307)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccc-----------------------------------------------------------------------------
Confidence 210
Q ss_pred cccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHcCCCCCCCCCCCCHHHHHH
Q 007260 448 EARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNR-ATLFNVVGQPLRFPESPVVSFAARDL 526 (611)
Q Consensus 448 ~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~-~~l~~i~~~~l~~p~~~~~s~~l~dL 526 (611)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+...+......+....++..+.+|
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 236 (307)
T 2eva_A 159 --HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESL 236 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHHH
T ss_pred --ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHHH
Confidence 001235999999999999999999999999999999999999999864332 22222222333334445689999999
Q ss_pred HHHhhhcCccccCCchhcHHHHHc
Q 007260 527 IRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 527 I~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
|.+||..||.+||+ +.++++
T Consensus 237 i~~~l~~dp~~Rps----~~ell~ 256 (307)
T 2eva_A 237 MTRCWSKDPSQRPS----MEEIVK 256 (307)
T ss_dssp HHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHhcCChhhCcC----HHHHHH
Confidence 99999999999999 777776
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=372.72 Aligned_cols=263 Identities=25% Similarity=0.340 Sum_probs=190.2
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC-CCCccccccee------
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD-HPFLPTLYTHF------ 285 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~-HpnIv~l~~~~------ 285 (611)
+...+|++.+.||+|+||.||+|++..+++.||||++.... ......+.+|+.+|+.+. ||||+++++++
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 101 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE 101 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence 34458999999999999999999999999999999986543 233446678999999995 99999999998
Q ss_pred --eccceeeEEeeeCCCCCHHHHHHh-CCCCCCCHHHHHHHHHHHHHHHHHHHHcC--eeccCCCCCcEEEccCCcEEEE
Q 007260 286 --ETEKFSCLVMEFCPGGDLHTLRQK-QPGKYFPEQAVRFYVAEVLLALEYLHMLG--IIYRDLKPENVLVREDGHIMLS 360 (611)
Q Consensus 286 --~~~~~~~LVmE~~~gg~L~~ll~~-~~~~~l~e~~~~~i~~qll~aL~yLH~~g--IVHRDLKPeNILv~~~g~vkL~ 360 (611)
.....+||||||+ +|+|.+++.. .....+++..++.++.||+.||+|||++| |+||||||+||||+.++.+||+
T Consensus 102 ~~~~~~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~ 180 (337)
T 3ll6_A 102 SDTGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLC 180 (337)
T ss_dssp STTSSEEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred cccCCceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEe
Confidence 3456789999999 5789887764 22356999999999999999999999999 9999999999999999999999
Q ss_pred eccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCc
Q 007260 361 DFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLP 440 (611)
Q Consensus 361 DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (611)
|||++.............
T Consensus 181 Dfg~~~~~~~~~~~~~~~-------------------------------------------------------------- 198 (337)
T 3ll6_A 181 DFGSATTISHYPDYSWSA-------------------------------------------------------------- 198 (337)
T ss_dssp CCTTCBCCSSCC--------------------------------------------------------------------
T ss_pred cCccceeccccCcccccc--------------------------------------------------------------
Confidence 999985443211100000
Q ss_pred ccccCcccccccccccCCCccchhhh---ccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCC
Q 007260 441 ELIAEPTEARSMSFVGTHEYLAPEII---KGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESP 517 (611)
Q Consensus 441 ~~~~~~~~~~~~~~vGT~~Y~APEil---~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~ 517 (611)
............+||+.|+|||++ .+..++.++|||||||++|+|++|+.||.+.... .++......+...
T Consensus 199 --~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~~~~~ 272 (337)
T 3ll6_A 199 --QRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL----RIVNGKYSIPPHD 272 (337)
T ss_dssp ---------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------------CCCCTTC
T ss_pred --cccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH----HhhcCcccCCccc
Confidence 000000111245699999999999 5667889999999999999999999999865443 2334444555556
Q ss_pred CCCHHHHHHHHHhhhcCccccCCchhcHHHHHcC
Q 007260 518 VVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 518 ~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~H 551 (611)
..+..+.+||.+||..||.+||+ +.|+++|
T Consensus 273 ~~~~~~~~li~~~l~~~p~~Rps----~~e~l~~ 302 (337)
T 3ll6_A 273 TQYTVFHSLIRAMLQVNPEERLS----IAEVVHQ 302 (337)
T ss_dssp CSSGGGHHHHHHHSCSSGGGSCC----HHHHHHH
T ss_pred ccchHHHHHHHHHccCChhhCcC----HHHHHHH
Confidence 68888999999999999999999 8888886
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=368.89 Aligned_cols=233 Identities=29% Similarity=0.461 Sum_probs=192.4
Q ss_pred ccCeEEE-eEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHH-HhCCCCCcccccceeec----c
Q 007260 215 LSHFRLL-KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREIL-QSLDHPFLPTLYTHFET----E 288 (611)
Q Consensus 215 ~~~y~l~-~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL-~~l~HpnIv~l~~~~~~----~ 288 (611)
+++|.++ +.||+|+||.||+|.+..+++.||||++.... .+.+|+.++ +.++||||++++++|.. .
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 87 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCPHIVRIVDVYENLYAGR 87 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSH--------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecccH--------HHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence 4688888 78999999999999999999999999996532 345688887 66699999999999987 7
Q ss_pred ceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEcc---CCcEEEEecccc
Q 007260 289 KFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRE---DGHIMLSDFDLS 365 (611)
Q Consensus 289 ~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~---~g~vkL~DFGlA 365 (611)
..+||||||++|++|.+++....+..+++..++.++.||+.||+|||++||+||||||+||||+. ++.+||+|||++
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 88 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred ceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 88999999999999999999876668999999999999999999999999999999999999998 789999999987
Q ss_pred ccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccC
Q 007260 366 LRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAE 445 (611)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (611)
....
T Consensus 168 ~~~~---------------------------------------------------------------------------- 171 (299)
T 3m2w_A 168 KETT---------------------------------------------------------------------------- 171 (299)
T ss_dssp EECT----------------------------------------------------------------------------
T ss_pred cccc----------------------------------------------------------------------------
Confidence 3210
Q ss_pred cccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH----cCCCCCCC--CCCC
Q 007260 446 PTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVV----GQPLRFPE--SPVV 519 (611)
Q Consensus 446 ~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~----~~~l~~p~--~~~~ 519 (611)
+..++.++|||||||++|||++|+.||.+.........+. .....++. ...+
T Consensus 172 ----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (299)
T 3m2w_A 172 ----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 229 (299)
T ss_dssp ----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTS
T ss_pred ----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccC
Confidence 1335678999999999999999999998765443221111 11112221 1458
Q ss_pred CHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 520 SFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 520 s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
+.++++||.+||..||.+||+ +.|+++||||...
T Consensus 230 ~~~~~~li~~~l~~dP~~Rps----~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 230 SEEVKMLIRNLLKTEPTQRMT----ITEFMNHPWIMQS 263 (299)
T ss_dssp CHHHHHHHHHHTCSSTTTSCC----HHHHHTSHHHHTG
T ss_pred CHHHHHHHHHHcccChhhCCC----HHHHhcChhhccc
Confidence 999999999999999999999 9999999999753
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=379.43 Aligned_cols=260 Identities=20% Similarity=0.216 Sum_probs=198.6
Q ss_pred ccCeEEEeEecccCcEEEEEEEECC---CCeEEEEEEecchhhhhHH--------HHHHHHHHHHHHHhCCCCCcccccc
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSG---TKCYFAMKVMDKASLAGRK--------KLLRAQTEREILQSLDHPFLPTLYT 283 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~---t~~~vAvKii~k~~~~~~~--------~~~~~~~E~~iL~~l~HpnIv~l~~ 283 (611)
.++|++++.||+|+||.||+|++.. ++..||||++......... ....+.+|+.+++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 3689999999999999999999987 7889999998764321111 1122457888999999999999999
Q ss_pred eeec----cceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCC--cE
Q 007260 284 HFET----EKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDG--HI 357 (611)
Q Consensus 284 ~~~~----~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g--~v 357 (611)
++.. ....||||||| |++|.+++... +.+++..++.++.||+.||+|||++||+||||||+||||+.++ .+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN--GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG--GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence 9987 78999999999 99999998765 3699999999999999999999999999999999999999887 99
Q ss_pred EEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCC
Q 007260 358 MLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVS 437 (611)
Q Consensus 358 kL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (611)
||+|||++..+.......
T Consensus 193 kL~Dfg~a~~~~~~~~~~-------------------------------------------------------------- 210 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHK-------------------------------------------------------------- 210 (345)
T ss_dssp EECCCTTCEESSGGGCCC--------------------------------------------------------------
T ss_pred EEEeCCCceecccccccc--------------------------------------------------------------
Confidence 999999986543111000
Q ss_pred CCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHcC-CCCCC-
Q 007260 438 PLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGS-GNRATLFNVVGQ-PLRFP- 514 (611)
Q Consensus 438 ~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~-~~~~~l~~i~~~-~l~~p- 514 (611)
..........+||+.|+|||++.+..++.++|||||||+||||++|+.||.+. .....+...... ...++
T Consensus 211 -------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 283 (345)
T 2v62_A 211 -------QYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQ 283 (345)
T ss_dssp -------CCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTH
T ss_pred -------cchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccH
Confidence 00011123457999999999999999999999999999999999999999652 222222211111 01111
Q ss_pred ------CCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 515 ------ESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 515 ------~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
....++.++++||.+||..||.+||+ +.+|++
T Consensus 284 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~~l~~ 321 (345)
T 2v62_A 284 SVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPN----YQALKK 321 (345)
T ss_dssp HHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCC----HHHHHH
T ss_pred HHHhhccccccHHHHHHHHHHHhhcCcccCCC----HHHHHH
Confidence 11258999999999999999999999 677665
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=379.37 Aligned_cols=244 Identities=20% Similarity=0.232 Sum_probs=196.4
Q ss_pred cccccCeEEEeEecccCcEEEEEE-----EECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC---CCCcccccc
Q 007260 212 VLGLSHFRLLKRLGCGDIGSVYLS-----ELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD---HPFLPTLYT 283 (611)
Q Consensus 212 ~~~~~~y~l~~~LG~G~fG~Vy~a-----~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~---HpnIv~l~~ 283 (611)
.+..++|++.+.||+|+||+||+| .+..+++.||||++..... ..+.+|+.+++.++ |+||+.+++
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP------WEFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH------HHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh------hHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 345578999999999999999999 4677889999999976531 24566788888776 999999999
Q ss_pred eeeccceeeEEeeeCCCCCHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEcc-------
Q 007260 284 HFETEKFSCLVMEFCPGGDLHTLRQKQ---PGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRE------- 353 (611)
Q Consensus 284 ~~~~~~~~~LVmE~~~gg~L~~ll~~~---~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~------- 353 (611)
++...+..|||||||+||+|.+++... ....+++..++.|+.||+.||+|||++|||||||||+||||+.
T Consensus 135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC--
T ss_pred eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccc
Confidence 999999999999999999999998742 3467999999999999999999999999999999999999998
Q ss_pred ----CCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCc
Q 007260 354 ----DGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPK 429 (611)
Q Consensus 354 ----~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 429 (611)
++.+||+|||+|+.+....
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~--------------------------------------------------------- 237 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFP--------------------------------------------------------- 237 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSC---------------------------------------------------------
T ss_pred cccccCCEEEeeCchhhhhhccC---------------------------------------------------------
Confidence 8999999999985432100
Q ss_pred cccCCCCCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcC
Q 007260 430 NEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ 509 (611)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~ 509 (611)
........+||+.|+|||++.+..++.++|||||||+||||++|+.||......... +..
T Consensus 238 -----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~~~ 297 (365)
T 3e7e_A 238 -----------------KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK---PEG 297 (365)
T ss_dssp -----------------TTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE---ECS
T ss_pred -----------------CCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee---ech
Confidence 011123457999999999999999999999999999999999999999653221100 011
Q ss_pred CCCCCCCCCCCHHHHHHHHHhhhcCccccCCc
Q 007260 510 PLRFPESPVVSFAARDLIRGLLVKEPQHRLAY 541 (611)
Q Consensus 510 ~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~ 541 (611)
. ++. ...++.+.+++..||..+|.+|+..
T Consensus 298 ~--~~~-~~~~~~~~~~~~~~l~~~p~~r~~~ 326 (365)
T 3e7e_A 298 L--FRR-LPHLDMWNEFFHVMLNIPDCHHLPS 326 (365)
T ss_dssp C--CTT-CSSHHHHHHHHHHHHCCCCTTCCCC
T ss_pred h--ccc-cCcHHHHHHHHHHHcCCCCCCcchH
Confidence 1 111 1357789999999999999999774
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=398.78 Aligned_cols=255 Identities=25% Similarity=0.347 Sum_probs=214.1
Q ss_pred CccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc
Q 007260 210 DGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK 289 (611)
Q Consensus 210 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~ 289 (611)
...+..++|++.+.||+|+||.||+|.+..+ ..||||++....... ..+.+|+.+|+.|+|||||++++++.. +
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~-~ 334 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYAVVSE-E 334 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETTT-EEEEEEEECTTSSCH----HHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECCC-ceEEEEEeCCCCCCH----HHHHHHHHHHHhCCCCCEeeEEEEEee-c
Confidence 3445667899999999999999999999865 569999997654322 356789999999999999999999876 6
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
.+|||||||.+|+|.+++....+..+++..+..++.||+.||+|||++|||||||||+||||+.++.+||+|||+++...
T Consensus 335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 78999999999999999976544569999999999999999999999999999999999999999999999999984332
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
... ..
T Consensus 415 ~~~---------------------------------------------------------------------------~~ 419 (535)
T 2h8h_A 415 DNE---------------------------------------------------------------------------YT 419 (535)
T ss_dssp CHH---------------------------------------------------------------------------HH
T ss_pred CCc---------------------------------------------------------------------------ee
Confidence 100 00
Q ss_pred cccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 007260 450 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIR 528 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~ 528 (611)
......||..|+|||++.+..++.++|||||||+||||++ |+.||.+....+.+..+.. ..+.+....++..+.+||.
T Consensus 420 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~ 498 (535)
T 2h8h_A 420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPECPESLHDLMC 498 (535)
T ss_dssp TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHH
T ss_pred cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHH
Confidence 0012247889999999999999999999999999999999 9999999887776665544 3455555679999999999
Q ss_pred HhhhcCccccCCchhcHHHHHc
Q 007260 529 GLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 529 ~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
+||..||++||+ +.+|++
T Consensus 499 ~cl~~dP~~RPt----~~~l~~ 516 (535)
T 2h8h_A 499 QCWRKEPEERPT----FEYLQA 516 (535)
T ss_dssp HHTCSSGGGSCC----HHHHHH
T ss_pred HHcCCChhHCcC----HHHHHH
Confidence 999999999999 666654
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=387.07 Aligned_cols=256 Identities=27% Similarity=0.347 Sum_probs=196.1
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeeccceeeEE
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~~~~~LV 294 (611)
+.|.+.+.||+|+||+||.+. ..+++.||||++..... ..+.+|+.+|+.+ +|||||++++++.+++.+|||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv 87 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFC------DIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA 87 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGGH------HHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred heeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence 456778899999999998764 45688999999875431 2456799999876 899999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCC-----CCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccC-------------Cc
Q 007260 295 MEFCPGGDLHTLRQKQPGK-----YFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRED-------------GH 356 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~-----~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~-------------g~ 356 (611)
||||. |+|.+++...... ...+..++.++.||+.||+|||++|||||||||+||||+.+ ++
T Consensus 88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceE
Confidence 99995 6999999865321 11334567899999999999999999999999999999754 48
Q ss_pred EEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCC
Q 007260 357 IMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQV 436 (611)
Q Consensus 357 vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (611)
+||+|||++.........
T Consensus 167 ~kL~DFG~a~~~~~~~~~-------------------------------------------------------------- 184 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSS-------------------------------------------------------------- 184 (434)
T ss_dssp EEECCCTTCEECCC------------------------------------------------------------------
T ss_pred EEEcccccceecCCCCcc--------------------------------------------------------------
Confidence 999999998543211000
Q ss_pred CCCcccccCcccccccccccCCCccchhhhcc-------CCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHc
Q 007260 437 SPLPELIAEPTEARSMSFVGTHEYLAPEIIKG-------EGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVG 508 (611)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~-------~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~ 508 (611)
........+||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+..... .+++.
T Consensus 185 ----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~ 252 (434)
T 2rio_A 185 ----------FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIR 252 (434)
T ss_dssp --------------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHH
T ss_pred ----------ceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHhc
Confidence 0001123469999999999976 568999999999999999998 999998765443 33444
Q ss_pred CCCCCCCC-----CCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 509 QPLRFPES-----PVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 509 ~~l~~p~~-----~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
....++.. ..++.++++||.+||..||.+||+ +.++++||||...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps----~~eil~hp~f~~~ 302 (434)
T 2rio_A 253 GIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPT----AMKVLRHPLFWPK 302 (434)
T ss_dssp TCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCC----HHHHHTSGGGSCH
T ss_pred CCCCcccccccccccchHHHHHHHHHHhhCChhhCCC----HHHHHhCCccCCc
Confidence 44333322 234688999999999999999999 9999999999764
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=379.69 Aligned_cols=255 Identities=17% Similarity=0.250 Sum_probs=201.2
Q ss_pred cCeEEEeEecccCcEEEEEEEECCC---CeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceee-cccee
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGT---KCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFE-TEKFS 291 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t---~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~-~~~~~ 291 (611)
..|++.+.||+|+||+||+|++..+ +..||||++.... ......++.+|+.+|+.++||||+++++++. .++..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS--CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 3588999999999999999987533 3578999986532 2234557789999999999999999999864 56788
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCC
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~ 371 (611)
||||||+++|+|.+++... +..+++..+..++.||+.||+|||++|||||||||+||||+.++.+||+|||++..+...
T Consensus 167 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EEEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence 9999999999999998765 356899999999999999999999999999999999999999999999999998543211
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
... .....
T Consensus 246 ~~~------------------------------------------------------------------------~~~~~ 253 (373)
T 3c1x_A 246 EFD------------------------------------------------------------------------SVHNK 253 (373)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccc------------------------------------------------------------------------ccccc
Confidence 000 00011
Q ss_pred cccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 007260 452 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGL 530 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~ 530 (611)
....||+.|+|||++.+..++.++|||||||++|||++ |.+||.+....+....+.... .......++..+.+||.+|
T Consensus 254 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~-~~~~p~~~~~~l~~li~~c 332 (373)
T 3c1x_A 254 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPLYEVMLKC 332 (373)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC-CCCCCTTCCHHHHHHHHHH
T ss_pred CCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHHHHHHHH
Confidence 12358889999999999999999999999999999999 788998876665555554443 2333446899999999999
Q ss_pred hhcCccccCCchhcHHHHHc
Q 007260 531 LVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 531 L~~dP~~Rpt~~~~a~elL~ 550 (611)
|..||.+||+ +.++++
T Consensus 333 l~~dp~~RPs----~~ell~ 348 (373)
T 3c1x_A 333 WHPKAEMRPS----FSELVS 348 (373)
T ss_dssp TCSSGGGSCC----HHHHHH
T ss_pred cCCChhhCcC----HHHHHH
Confidence 9999999999 667665
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=367.54 Aligned_cols=257 Identities=23% Similarity=0.304 Sum_probs=208.6
Q ss_pred ccccCeEEEeEecccCcEEEEEEEE----CCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecc
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSEL----SGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE 288 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~----~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~ 288 (611)
+..++|++++.||+|+||.||+|+. ..+++.||||++.... ......+.+|+.+|+.++||||+++++++...
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC---SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 3456899999999999999999994 5689999999997643 23445678899999999999999999988764
Q ss_pred --ceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccc
Q 007260 289 --KFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSL 366 (611)
Q Consensus 289 --~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~ 366 (611)
..+||||||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++.
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred CCCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 47899999999999999998763 459999999999999999999999999999999999999999999999999985
Q ss_pred cccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCc
Q 007260 367 RCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEP 446 (611)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (611)
.........
T Consensus 194 ~~~~~~~~~----------------------------------------------------------------------- 202 (326)
T 2w1i_A 194 VLPQDKEYY----------------------------------------------------------------------- 202 (326)
T ss_dssp ECCSSCSEE-----------------------------------------------------------------------
T ss_pred hcccccccc-----------------------------------------------------------------------
Confidence 432111000
Q ss_pred ccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCc---------------HHHHHHHHcCCC
Q 007260 447 TEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGN---------------RATLFNVVGQPL 511 (611)
Q Consensus 447 ~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~---------------~~~l~~i~~~~l 511 (611)
.......||..|+|||++.+..++.++|||||||++|||++|..||..... ...+...+....
T Consensus 203 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (326)
T 2w1i_A 203 --KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG 280 (326)
T ss_dssp --ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTC
T ss_pred --ccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCC
Confidence 001123478889999999999999999999999999999999999864211 011223334444
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 512 RFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 512 ~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
..+....++.++.+||.+||..||.+||+ +.+|++
T Consensus 281 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~el~~ 315 (326)
T 2w1i_A 281 RLPRPDGCPDEIYMIMTECWNNNVNQRPS----FRDLAL 315 (326)
T ss_dssp CCCCCTTCCHHHHHHHHHHSCSSGGGSCC----HHHHHH
T ss_pred CCCCCCcccHHHHHHHHHHcCCChhhCcC----HHHHHH
Confidence 45555679999999999999999999999 777764
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=366.17 Aligned_cols=249 Identities=22% Similarity=0.340 Sum_probs=195.8
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC--CCCCcccccceeecc----c
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL--DHPFLPTLYTHFETE----K 289 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l--~HpnIv~l~~~~~~~----~ 289 (611)
++|++++.||+|+||.||+|++. ++.||||++..... ....+|.+++..+ +||||+++++++... .
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~------~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE------ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH------HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc------chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 58999999999999999999986 78899999965432 1234466666554 899999999999876 7
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc--------CeeccCCCCCcEEEccCCcEEEEe
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHML--------GIIYRDLKPENVLVREDGHIMLSD 361 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~--------gIVHRDLKPeNILv~~~g~vkL~D 361 (611)
.+|||||||+||+|.+++... .+++..++.++.||+.||+|||++ |||||||||+||||+.++.+||+|
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D 185 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred ceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence 899999999999999999764 499999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcc
Q 007260 362 FDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPE 441 (611)
Q Consensus 362 FGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (611)
||++..+......
T Consensus 186 fg~a~~~~~~~~~------------------------------------------------------------------- 198 (337)
T 3mdy_A 186 LGLAVKFISDTNE------------------------------------------------------------------- 198 (337)
T ss_dssp CTTCEECC------------------------------------------------------------------------
T ss_pred CCCceeecccccc-------------------------------------------------------------------
Confidence 9998543211100
Q ss_pred cccCcccccccccccCCCccchhhhccCCCCCh------hhHHHHHHHHHHHHhC----------CCCCCCC----CcHH
Q 007260 442 LIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSA------VDWWTFGIFLYELLFG----------KTPFKGS----GNRA 501 (611)
Q Consensus 442 ~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~------sDIWSLGviL~ELltG----------~~PF~~~----~~~~ 501 (611)
........+||+.|+|||++.+..+... +|||||||++|||++| +.||... ....
T Consensus 199 -----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~ 273 (337)
T 3mdy_A 199 -----VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYE 273 (337)
T ss_dssp ---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred -----ccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchh
Confidence 0001123479999999999998877664 9999999999999999 7777653 2233
Q ss_pred HHHHHHcCC-CC--CCC---CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcC
Q 007260 502 TLFNVVGQP-LR--FPE---SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 502 ~l~~i~~~~-l~--~p~---~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~H 551 (611)
.+...+... .. ++. ...++.++.+||.+||..||.+||+ +.+|++|
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps----~~ell~~ 325 (337)
T 3mdy_A 274 DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLT----ALRVKKT 325 (337)
T ss_dssp HHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCC----HHHHHHH
T ss_pred hhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCC----HHHHHHH
Confidence 343333222 22 221 1235678999999999999999999 8888775
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=367.35 Aligned_cols=262 Identities=26% Similarity=0.376 Sum_probs=193.3
Q ss_pred cccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHH--HHhCCCCCcccccceee---
Q 007260 212 VLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREI--LQSLDHPFLPTLYTHFE--- 286 (611)
Q Consensus 212 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~i--L~~l~HpnIv~l~~~~~--- 286 (611)
.+.+++|++++.||+|+||.||+|++ +++.||||++...... .+..|.++ +..++||||+++++++.
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~------~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 80 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQ------NFINEKNIYRVPLMEHDNIARFIVGDERVT 80 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHH------HHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred CcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchh------hHHHHHHHHHHHhccCcchhhheecccccc
Confidence 34568999999999999999999977 5788999999754321 22334444 55689999999997543
Q ss_pred --ccceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc---------CeeccCCCCCcEEEccCC
Q 007260 287 --TEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHML---------GIIYRDLKPENVLVREDG 355 (611)
Q Consensus 287 --~~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~---------gIVHRDLKPeNILv~~~g 355 (611)
....+|||||||++|+|.+++... .+++..+..++.||+.||+|||++ |||||||||+||||+.++
T Consensus 81 ~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~ 157 (336)
T 3g2f_A 81 ADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG 157 (336)
T ss_dssp TTSCEEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS
T ss_pred cCCCceEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC
Confidence 345789999999999999999875 358999999999999999999999 999999999999999999
Q ss_pred cEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCC
Q 007260 356 HIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQ 435 (611)
Q Consensus 356 ~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (611)
.+||+|||++..+.......
T Consensus 158 ~~kL~DFG~a~~~~~~~~~~------------------------------------------------------------ 177 (336)
T 3g2f_A 158 TCVISDFGLSMRLTGNRLVR------------------------------------------------------------ 177 (336)
T ss_dssp CEEECCCTTCEECSSSSCC-------------------------------------------------------------
T ss_pred cEEEeeccceeecccccccC------------------------------------------------------------
Confidence 99999999985543111000
Q ss_pred CCCCcccccCcccccccccccCCCccchhhhcc-------CCCCChhhHHHHHHHHHHHHhCCCCCCCCC----------
Q 007260 436 VSPLPELIAEPTEARSMSFVGTHEYLAPEIIKG-------EGHGSAVDWWTFGIFLYELLFGKTPFKGSG---------- 498 (611)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~-------~~~~~~sDIWSLGviL~ELltG~~PF~~~~---------- 498 (611)
...........+||+.|+|||++.+ ..++.++|||||||++|||++|..||....
T Consensus 178 --------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~ 249 (336)
T 3g2f_A 178 --------PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQ 249 (336)
T ss_dssp ----------------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTH
T ss_pred --------ccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhh
Confidence 0000111224579999999999987 345678999999999999999977653321
Q ss_pred -------cHHHHHHHHcCCC---CCCC----CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHH------cCCCCCC
Q 007260 499 -------NRATLFNVVGQPL---RFPE----SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIK------QHPFFEG 556 (611)
Q Consensus 499 -------~~~~l~~i~~~~l---~~p~----~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL------~Hp~f~~ 556 (611)
....+...+.... .++. ...++.++.+||.+||..||.+||+ +.|++ .++|-++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~e~l~~L~~ll~~~~~~ 323 (336)
T 3g2f_A 250 TEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLT----AQXAEERMAELMMIWERN 323 (336)
T ss_dssp HHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCC----HHHHHHHHHHHHHCCCC-
T ss_pred cccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcc----hHHHHHHHHHHHHHHHhc
Confidence 1222222222221 2221 1224568999999999999999999 66663 3566543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=391.52 Aligned_cols=255 Identities=18% Similarity=0.185 Sum_probs=199.7
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCC-CCcccccc-----------
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH-PFLPTLYT----------- 283 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~H-pnIv~l~~----------- 283 (611)
..|++.+.||+|+||+||+|++..+++.||||++.............+++|+.+++.+.| .|+..++.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 458899999999999999999999999999999985444444445677889999999987 33222211
Q ss_pred ----------eeec-----cceeeEEeeeCCCCCHHHHHH-----hCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccC
Q 007260 284 ----------HFET-----EKFSCLVMEFCPGGDLHTLRQ-----KQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRD 343 (611)
Q Consensus 284 ----------~~~~-----~~~~~LVmE~~~gg~L~~ll~-----~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRD 343 (611)
++.. ...+|++|+++ +++|.++++ ...+..+++..+..++.||+.||+|||++||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD 236 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 236 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 1121 22467888877 789999885 23345688889999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccc
Q 007260 344 LKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSK 423 (611)
Q Consensus 344 LKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 423 (611)
|||+||||+.+|.+||+|||+++....
T Consensus 237 iKp~NILl~~~~~~kL~DFG~a~~~~~----------------------------------------------------- 263 (413)
T 3dzo_A 237 LRPVDIVLDQRGGVFLTGFEHLVRDGA----------------------------------------------------- 263 (413)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTE-----------------------------------------------------
T ss_pred cccceEEEecCCeEEEEeccceeecCC-----------------------------------------------------
Confidence 999999999999999999999843210
Q ss_pred cCCCCccccCCCCCCCcccccCcccccccccccCCCccchhhh----------ccCCCCChhhHHHHHHHHHHHHhCCCC
Q 007260 424 KDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEII----------KGEGHGSAVDWWTFGIFLYELLFGKTP 493 (611)
Q Consensus 424 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil----------~~~~~~~~sDIWSLGviL~ELltG~~P 493 (611)
.....+| +.|+|||++ .+..++.++|||||||+||||++|+.|
T Consensus 264 --------------------------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~P 316 (413)
T 3dzo_A 264 --------------------------SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316 (413)
T ss_dssp --------------------------EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCC
T ss_pred --------------------------ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCC
Confidence 0123468 999999999 455578899999999999999999999
Q ss_pred CCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCchhh
Q 007260 494 FKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWAL 561 (611)
Q Consensus 494 F~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~ 561 (611)
|.+.........+ +.....++.++++||.+||..||.+||+ +.++++||||+.+...+
T Consensus 317 f~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~dP~~Rpt----~~~~l~~~~~~~~~~~~ 374 (413)
T 3dzo_A 317 NTDDAALGGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLL----PLQAMETPEYEQLRTEL 374 (413)
T ss_dssp CCTTGGGSCSGGG------GSSCCCCCHHHHHHHHHHTCSSGGGSCC----HHHHTTSHHHHHHHHHH
T ss_pred CCCcchhhhHHHH------HhhcccCCHHHHHHHHHHccCChhhCcC----HHHHHhCHHHHHHHHHH
Confidence 9876544332222 2223458899999999999999999999 99999999998876543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=398.11 Aligned_cols=252 Identities=23% Similarity=0.337 Sum_probs=205.9
Q ss_pred cccccCeEEEe-EecccCcEEEEEEEEC--CCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecc
Q 007260 212 VLGLSHFRLLK-RLGCGDIGSVYLSELS--GTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE 288 (611)
Q Consensus 212 ~~~~~~y~l~~-~LG~G~fG~Vy~a~~~--~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~ 288 (611)
.+...+|.+.+ .||+|+||.||+|.+. .++..||||+++..... .....+.+|+.+|+.++|||||++++++..
T Consensus 331 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~~~~~~- 407 (613)
T 2ozo_A 331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK--ADTEEMMREAQIMHQLDNPYIVRLIGVCQA- 407 (613)
T ss_dssp BCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSS--TTHHHHHHHHHHHTTCCCTTBCCEEEEEES-
T ss_pred eccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEecc-
Confidence 34456777777 8999999999999875 45678999999764321 233467789999999999999999999976
Q ss_pred ceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccc
Q 007260 289 KFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRC 368 (611)
Q Consensus 289 ~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~ 368 (611)
+.+|||||||+||+|.+++... ...+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+++.+
T Consensus 408 ~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 408 EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp SSEEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred CCeEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 5689999999999999998764 356999999999999999999999999999999999999999999999999998543
Q ss_pred cCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccc
Q 007260 369 AVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTE 448 (611)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (611)
...... .
T Consensus 487 ~~~~~~-------------------------------------------------------------------------~ 493 (613)
T 2ozo_A 487 GADDSY-------------------------------------------------------------------------Y 493 (613)
T ss_dssp C-------------------------------------------------------------------------------
T ss_pred cCCCce-------------------------------------------------------------------------e
Confidence 211000 0
Q ss_pred ccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 007260 449 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLI 527 (611)
Q Consensus 449 ~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI 527 (611)
.......||+.|+|||++.+..++.++|||||||+||||++ |+.||.+....+.+..+..+ .+.+....++.++.+||
T Consensus 494 ~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~-~~~~~p~~~~~~l~~li 572 (613)
T 2ozo_A 494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-KRMECPPECPPELYALM 572 (613)
T ss_dssp --------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTT-CCCCCCTTCCHHHHHHH
T ss_pred eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CCCCCCCcCCHHHHHHH
Confidence 00011236789999999999999999999999999999998 99999998887776665544 33444456999999999
Q ss_pred HHhhhcCccccCCc
Q 007260 528 RGLLVKEPQHRLAY 541 (611)
Q Consensus 528 ~~~L~~dP~~Rpt~ 541 (611)
.+||..||.+||++
T Consensus 573 ~~cl~~dP~~RPs~ 586 (613)
T 2ozo_A 573 SDCWIYKWEDRPDF 586 (613)
T ss_dssp HHTTCSSTTTSCCH
T ss_pred HHHcCCChhHCcCH
Confidence 99999999999994
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=399.66 Aligned_cols=256 Identities=21% Similarity=0.281 Sum_probs=206.5
Q ss_pred ccccCeEEE-eEecccCcEEEEEEEE--CCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc
Q 007260 213 LGLSHFRLL-KRLGCGDIGSVYLSEL--SGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK 289 (611)
Q Consensus 213 ~~~~~y~l~-~~LG~G~fG~Vy~a~~--~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~ 289 (611)
+....+.+. +.||+|+||.||+|.+ ..+++.||||+++..... ......+.+|+.+|+.++|||||++++++.. +
T Consensus 365 ~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~ 442 (635)
T 4fl3_A 365 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-PALKDELLAEANVMQQLDNPYIVRMIGICEA-E 442 (635)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGC-GGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred ccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 333455554 4899999999999955 456789999999765322 2334567889999999999999999999975 4
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
.+|||||||++|+|.+++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+++.+.
T Consensus 443 ~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~ 520 (635)
T 4fl3_A 443 SWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 520 (635)
T ss_dssp SEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTT
T ss_pred CEEEEEEccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccc
Confidence 588999999999999999875 569999999999999999999999999999999999999999999999999985443
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
...... .
T Consensus 521 ~~~~~~-------------------------------------------------------------------------~ 527 (635)
T 4fl3_A 521 ADENYY-------------------------------------------------------------------------K 527 (635)
T ss_dssp C-------------------------------------------------------------------------------
T ss_pred cCcccc-------------------------------------------------------------------------c
Confidence 111000 0
Q ss_pred cccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 007260 450 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIR 528 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~ 528 (611)
......||+.|+|||++.+..++.++|||||||+||||++ |+.||.+....+....+... ...+....++.++.+||.
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~-~~~~~p~~~~~~l~~li~ 606 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-ERMGCPAGCPREMYDLMN 606 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHH
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHHH
Confidence 0112347889999999999999999999999999999998 99999998777666555443 344444569999999999
Q ss_pred HhhhcCccccCCchhcHHHHHc
Q 007260 529 GLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 529 ~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
.||..||++||+ +.+|++
T Consensus 607 ~cl~~dP~~RPs----~~~l~~ 624 (635)
T 4fl3_A 607 LCWTYDVENRPG----FAAVEL 624 (635)
T ss_dssp HHTCSSTTTSCC----HHHHHH
T ss_pred HHcCCCHhHCcC----HHHHHH
Confidence 999999999999 556553
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=369.86 Aligned_cols=260 Identities=20% Similarity=0.264 Sum_probs=208.9
Q ss_pred CccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc
Q 007260 210 DGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK 289 (611)
Q Consensus 210 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~ 289 (611)
...+..++|++++.||+|+||.||+|++... ||+|++...... ......+.+|+.+++.++||||+++++++.+..
T Consensus 27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~---~avk~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDN-EDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GSSSCCSCEECCCBCCCSSSSEEEEEEESSS---EEEEECCCCSCC-CCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccCCHHHeEEeeEeccCCceEEEEEEEcCe---EEEEEeecCCCC-HHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 3445568999999999999999999998753 999998754321 112234567999999999999999999999999
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
.+|+||||++|++|.+++... +..+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred ceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 999999999999999998765 35699999999999999999999999999999999999998 7899999999974321
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
.... .....
T Consensus 181 ~~~~-----------------------------------------------------------------------~~~~~ 189 (319)
T 2y4i_B 181 VLQA-----------------------------------------------------------------------GRRED 189 (319)
T ss_dssp ------------------------------------------------------------------------------CC
T ss_pred cccc-----------------------------------------------------------------------ccccc
Confidence 1000 00001
Q ss_pred cccccccCCCccchhhhcc---------CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCC
Q 007260 450 RSMSFVGTHEYLAPEIIKG---------EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVS 520 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~---------~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s 520 (611)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+......+..+............++
T Consensus 190 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (319)
T 2y4i_B 190 KLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMG 269 (319)
T ss_dssp SCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCCCSSCC
T ss_pred ccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCCcCCCC
Confidence 1123459999999999975 3478899999999999999999999998887777766666544444444688
Q ss_pred HHHHHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 521 FAARDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 521 ~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
.++.+||.+||..||.+||+ +.++++
T Consensus 270 ~~l~~li~~~l~~~p~~Rpt----~~~l~~ 295 (319)
T 2y4i_B 270 KEISDILLFCWAFEQEERPT----FTKLMD 295 (319)
T ss_dssp TTHHHHHHHHHCSSTTTSCC----HHHHHH
T ss_pred HHHHHHHHHHhcCChhhCcC----HHHHHH
Confidence 99999999999999999999 777776
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=383.72 Aligned_cols=245 Identities=18% Similarity=0.199 Sum_probs=191.6
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhh-----hHHHHHHHHHHHHHHHhCC---------------
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLA-----GRKKLLRAQTEREILQSLD--------------- 274 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~-----~~~~~~~~~~E~~iL~~l~--------------- 274 (611)
.++|++++.||+|+||+||+|++ +++.||||++.+.... .......+.+|+.+|+.++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 46899999999999999999998 5789999999865321 1122345678999988886
Q ss_pred -----------CCCcccccceeec-------------cceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHH
Q 007260 275 -----------HPFLPTLYTHFET-------------EKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLA 330 (611)
Q Consensus 275 -----------HpnIv~l~~~~~~-------------~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~a 330 (611)
||||++++++|.+ .+.+|||||||++|+|.+.+.+ ..+++..++.|+.||+.|
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHH
Confidence 6666666666665 7899999999999976655533 458999999999999999
Q ss_pred HHHHH-HcCeeccCCCCCcEEEccCC--------------------cEEEEeccccccccCCccccccccCCCCcCcCCC
Q 007260 331 LEYLH-MLGIIYRDLKPENVLVREDG--------------------HIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNP 389 (611)
Q Consensus 331 L~yLH-~~gIVHRDLKPeNILv~~~g--------------------~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~ 389 (611)
|+||| ++|||||||||+||||+.+| .+||+|||+|+....
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------------------- 234 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------------------- 234 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------------------
T ss_pred HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------------------
Confidence 99999 99999999999999999987 899999999843210
Q ss_pred ccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCCccchhhhccC
Q 007260 390 VYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGE 469 (611)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~ 469 (611)
...+||+.|+|||++.+.
T Consensus 235 --------------------------------------------------------------~~~~gt~~y~aPE~~~g~ 252 (336)
T 2vuw_A 235 --------------------------------------------------------------GIVVFCDVSMDEDLFTGD 252 (336)
T ss_dssp --------------------------------------------------------------TEEECCCCTTCSGGGCCC
T ss_pred --------------------------------------------------------------CcEEEeecccChhhhcCC
Confidence 123699999999999987
Q ss_pred CCCChhhHHHHHHH-HHHHHhCCCCCCCCCcHH-HHHHHHcC-CCCCC----CCCCCCHHHHHHHHHhhhcCccccCCch
Q 007260 470 GHGSAVDWWTFGIF-LYELLFGKTPFKGSGNRA-TLFNVVGQ-PLRFP----ESPVVSFAARDLIRGLLVKEPQHRLAYK 542 (611)
Q Consensus 470 ~~~~~sDIWSLGvi-L~ELltG~~PF~~~~~~~-~l~~i~~~-~l~~p----~~~~~s~~l~dLI~~~L~~dP~~Rpt~~ 542 (611)
. +.++||||||++ .++++.|..||.+..... ....+... ..... ....+++++++||.+||++| |
T Consensus 253 ~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----s-- 324 (336)
T 2vuw_A 253 G-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----S-- 324 (336)
T ss_dssp S-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----S--
T ss_pred C-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----C--
Confidence 7 889999998777 788889999996421111 12222211 11111 11247889999999999987 7
Q ss_pred hcHHHHH-cCCCCC
Q 007260 543 RGATEIK-QHPFFE 555 (611)
Q Consensus 543 ~~a~elL-~Hp~f~ 555 (611)
|.|+| +||||+
T Consensus 325 --a~e~l~~Hp~f~ 336 (336)
T 2vuw_A 325 --ATDLLCQHSLFK 336 (336)
T ss_dssp --HHHHHHHCGGGC
T ss_pred --HHHHHhcCCCcC
Confidence 99999 999995
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=363.35 Aligned_cols=255 Identities=19% Similarity=0.225 Sum_probs=200.6
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhh-hhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASL-AGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~-~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
..|...+.||+|+||.||+|.+ ++..||||++..... .......++.+|+.+|+.++||||+++++++.+.+..|+|
T Consensus 31 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 108 (307)
T 2nru_A 31 PISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLV 108 (307)
T ss_dssp BTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred cccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEE
Confidence 3455668999999999999986 467899999865321 2233445678899999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcc
Q 007260 295 MEFCPGGDLHTLRQKQP-GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 373 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~-~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~ 373 (611)
|||++|++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++........
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 188 (307)
T 2nru_A 109 YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188 (307)
T ss_dssp EECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSS
T ss_pred EEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccc
Confidence 99999999999887432 34699999999999999999999999999999999999999999999999999843221000
Q ss_pred ccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccc
Q 007260 374 LIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMS 453 (611)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (611)
......
T Consensus 189 --------------------------------------------------------------------------~~~~~~ 194 (307)
T 2nru_A 189 --------------------------------------------------------------------------TVMTSR 194 (307)
T ss_dssp --------------------------------------------------------------------------CEECSS
T ss_pred --------------------------------------------------------------------------cccccc
Confidence 001123
Q ss_pred cccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHH----HHHHcCCC--------CC-CCCCCCC
Q 007260 454 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATL----FNVVGQPL--------RF-PESPVVS 520 (611)
Q Consensus 454 ~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l----~~i~~~~l--------~~-p~~~~~s 520 (611)
.+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+ ..+..... .+ ......+
T Consensus 195 ~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (307)
T 2nru_A 195 IVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSV 273 (307)
T ss_dssp CCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHH
T ss_pred cCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHH
Confidence 469999999999876 4789999999999999999999999875432211 11111110 01 1122355
Q ss_pred HHHHHHHHHhhhcCccccCCchhcHHHHHcC
Q 007260 521 FAARDLIRGLLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 521 ~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~H 551 (611)
..+.+||.+||..||.+||+ +.+++++
T Consensus 274 ~~l~~li~~cl~~~p~~Rps----~~~l~~~ 300 (307)
T 2nru_A 274 EAMYSVASQCLHEKKNKRPD----IKKVQQL 300 (307)
T ss_dssp HHHHHHHHHHTCSSTTTSCC----HHHHHHH
T ss_pred HHHHHHHHHHcCCCcccCcC----HHHHHHH
Confidence 78999999999999999999 7777753
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=361.65 Aligned_cols=249 Identities=22% Similarity=0.277 Sum_probs=198.9
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHh--CCCCCcccccceeeccc----
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQS--LDHPFLPTLYTHFETEK---- 289 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~--l~HpnIv~l~~~~~~~~---- 289 (611)
++|++.+.||+|+||.||+|++. ++.||||++..... ..+.+|++++.. ++||||+++++++....
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~------~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREE------RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGGGH------HHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCchhH------HHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 58999999999999999999984 78899999975431 245678888887 79999999999998775
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--------HcCeeccCCCCCcEEEccCCcEEEEe
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLH--------MLGIIYRDLKPENVLVREDGHIMLSD 361 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH--------~~gIVHRDLKPeNILv~~~g~vkL~D 361 (611)
.+||||||+++|+|.+++.+. .+++..++.++.||+.||+||| ++|||||||||+||||+.++.+||+|
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 190 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 190 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECC
T ss_pred eeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEE
Confidence 899999999999999999874 4899999999999999999999 89999999999999999999999999
Q ss_pred ccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcc
Q 007260 362 FDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPE 441 (611)
Q Consensus 362 FGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (611)
||++.........
T Consensus 191 fg~~~~~~~~~~~------------------------------------------------------------------- 203 (342)
T 1b6c_B 191 LGLAVRHDSATDT------------------------------------------------------------------- 203 (342)
T ss_dssp CTTCEEEETTTTE-------------------------------------------------------------------
T ss_pred CCCceeccccccc-------------------------------------------------------------------
Confidence 9998543211100
Q ss_pred cccCcccccccccccCCCccchhhhccCCC------CChhhHHHHHHHHHHHHhC----------CCCCCCCC----cHH
Q 007260 442 LIAEPTEARSMSFVGTHEYLAPEIIKGEGH------GSAVDWWTFGIFLYELLFG----------KTPFKGSG----NRA 501 (611)
Q Consensus 442 ~~~~~~~~~~~~~vGT~~Y~APEil~~~~~------~~~sDIWSLGviL~ELltG----------~~PF~~~~----~~~ 501 (611)
........+||+.|+|||++.+... +.++|||||||++|||++| ..||.... ...
T Consensus 204 -----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~ 278 (342)
T 1b6c_B 204 -----IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 278 (342)
T ss_dssp -----EEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred -----cccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHH
Confidence 0001123469999999999987632 3689999999999999999 88987642 233
Q ss_pred HHHHHH-cCCCCCCCC-----CCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcC
Q 007260 502 TLFNVV-GQPLRFPES-----PVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 502 ~l~~i~-~~~l~~p~~-----~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~H 551 (611)
.+...+ ...++.... ..++..+.+||.+||..||.+||+ +.+|++|
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps----~~~i~~~ 330 (342)
T 1b6c_B 279 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT----ALRIKKT 330 (342)
T ss_dssp HHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCC----HHHHHHH
Confidence 444433 333222211 124468999999999999999999 7888764
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=390.76 Aligned_cols=256 Identities=24% Similarity=0.343 Sum_probs=211.3
Q ss_pred ccccccCeEEEeEecccCcEEEEEEEECCC---CeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 007260 211 GVLGLSHFRLLKRLGCGDIGSVYLSELSGT---KCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET 287 (611)
Q Consensus 211 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t---~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~ 287 (611)
..+..++|++++.||+|+||.||+|.+..+ +..||||++.... ......++.+|+.+|+.++|||||++++++.
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 461 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 461 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence 344557899999999999999999998653 5679999986532 2334456788999999999999999999985
Q ss_pred cceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccc
Q 007260 288 EKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLR 367 (611)
Q Consensus 288 ~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~ 367 (611)
++..|||||||++|+|.+++... +..+++..++.++.||+.||+|||++|||||||||+||||+.+|++||+|||++..
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred cCceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCee
Confidence 46689999999999999999865 34689999999999999999999999999999999999999999999999999843
Q ss_pred ccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcc
Q 007260 368 CAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPT 447 (611)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (611)
.....
T Consensus 541 ~~~~~--------------------------------------------------------------------------- 545 (656)
T 2j0j_A 541 MEDST--------------------------------------------------------------------------- 545 (656)
T ss_dssp CCC-----------------------------------------------------------------------------
T ss_pred cCCCc---------------------------------------------------------------------------
Confidence 32100
Q ss_pred cccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 007260 448 EARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDL 526 (611)
Q Consensus 448 ~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dL 526 (611)
........||+.|+|||++.+..++.++|||||||++|||++ |..||.+....+.+..+.... ..+....++..+.+|
T Consensus 546 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~l~~l 624 (656)
T 2j0j_A 546 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNCPPTLYSL 624 (656)
T ss_dssp --------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTC-CCCCCTTCCHHHHHH
T ss_pred ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-CCCCCccccHHHHHH
Confidence 000112347889999999999999999999999999999997 999999988777776665543 333445699999999
Q ss_pred HHHhhhcCccccCCchhcHHHHHc
Q 007260 527 IRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 527 I~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
|.+||..||.+||+ +.+|++
T Consensus 625 i~~~l~~dP~~RPs----~~el~~ 644 (656)
T 2j0j_A 625 MTKCWAYDPSRRPR----FTELKA 644 (656)
T ss_dssp HHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHcCCChhHCcC----HHHHHH
Confidence 99999999999999 677664
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=404.68 Aligned_cols=263 Identities=24% Similarity=0.372 Sum_probs=209.4
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec------c
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET------E 288 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~------~ 288 (611)
.++|++++.||.|+||.||+|.+..+++.||||++.... ......++.+|+.+|+.++||||+++++++.. .
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 368999999999999999999999999999999987542 23445567889999999999999999998765 7
Q ss_pred ceeeEEeeeCCCCCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCc---EEEEeccc
Q 007260 289 KFSCLVMEFCPGGDLHTLRQKQP-GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGH---IMLSDFDL 364 (611)
Q Consensus 289 ~~~~LVmE~~~gg~L~~ll~~~~-~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~---vkL~DFGl 364 (611)
+..|||||||+||+|.+++.... ...+++..++.++.||+.||+|||++|||||||||+||||+.++. +||+|||+
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 78899999999999999988743 236999999999999999999999999999999999999997765 99999999
Q ss_pred cccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCccccc
Q 007260 365 SLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIA 444 (611)
Q Consensus 365 A~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (611)
+......
T Consensus 171 a~~~~~~------------------------------------------------------------------------- 177 (676)
T 3qa8_A 171 AKELDQG------------------------------------------------------------------------- 177 (676)
T ss_dssp CCBTTSC-------------------------------------------------------------------------
T ss_pred ccccccc-------------------------------------------------------------------------
Confidence 8432100
Q ss_pred CcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH--------------HcCC
Q 007260 445 EPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNV--------------VGQP 510 (611)
Q Consensus 445 ~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i--------------~~~~ 510 (611)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+......+... ..+.
T Consensus 178 ----~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~ 253 (676)
T 3qa8_A 178 ----ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGA 253 (676)
T ss_dssp ----CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSS
T ss_pred ----cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccc
Confidence 0112346999999999999999999999999999999999999999875433322110 1111
Q ss_pred CCCCC--------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCchh
Q 007260 511 LRFPE--------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWA 560 (611)
Q Consensus 511 l~~p~--------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~ 560 (611)
..+.. ...++..+.+||.+||..||.+||+ +.++++||||+.++..
T Consensus 254 ~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPT----a~elL~hp~F~~l~~i 307 (676)
T 3qa8_A 254 VKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGT----DPQNPNVGCFQALDSI 307 (676)
T ss_dssp CCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---C----CTTCCCCTTHHHHHHH
T ss_pred cccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcC----HHHHhcCHHHHHHHHH
Confidence 11111 1236789999999999999999999 8999999999876543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=355.76 Aligned_cols=226 Identities=17% Similarity=0.171 Sum_probs=189.5
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSC 292 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~ 292 (611)
+..++|++++.||+|+||.||+|++..+++.||||++............++.+|+.++..++||||+++++++.+++..|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 33478999999999999999999999999999999998765555566677889999999999999999999999999999
Q ss_pred EEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCc
Q 007260 293 LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 293 LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~ 372 (611)
||||||+|++|.+++... .....+..++.||+.||+|||++||+||||||+||||+.+|.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~--------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA--------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred EEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc---------
Confidence 999999999999998543 3556788899999999999999999999999999999999999998554
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
T Consensus 175 -------------------------------------------------------------------------------- 174 (286)
T 3uqc_A 175 -------------------------------------------------------------------------------- 174 (286)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH---HHHcCCCCCC--CCCCCCHHHHHHH
Q 007260 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLF---NVVGQPLRFP--ESPVVSFAARDLI 527 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~---~i~~~~l~~p--~~~~~s~~l~dLI 527 (611)
|++ .++.++|||||||+||||++|+.||.+.+....+. ..+......+ ....++.++++||
T Consensus 175 -------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 240 (286)
T 3uqc_A 175 -------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVA 240 (286)
T ss_dssp -------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHH
T ss_pred -------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHH
Confidence 222 26789999999999999999999999865543221 1111111111 1245899999999
Q ss_pred HHhhhcCccccCCchhcHHHHHc
Q 007260 528 RGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 528 ~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
.+||.+||.+| + +.|+++
T Consensus 241 ~~~l~~dP~~R-s----~~el~~ 258 (286)
T 3uqc_A 241 ARSVQGDGGIR-S----ASTLLN 258 (286)
T ss_dssp HHHHCTTSSCC-C----HHHHHH
T ss_pred HHHcccCCccC-C----HHHHHH
Confidence 99999999999 9 777776
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=390.08 Aligned_cols=243 Identities=23% Similarity=0.332 Sum_probs=197.4
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECC-CCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccce-
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSG-TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKF- 290 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~-t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~- 290 (611)
+..++|++++.||+|+||+||+|.+.. +++.||||++.... .......+.+|+.+|+.++|||||+++++|...+.
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence 334799999999999999999999976 78999999986532 23344567889999999999999999999987655
Q ss_pred ----eeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccc
Q 007260 291 ----SCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSL 366 (611)
Q Consensus 291 ----~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~ 366 (611)
.|||||||+|++|.+++.. .+++..++.|+.||+.||+|||++|||||||||+||||+.+ .+||+|||++.
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp SCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred CCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccch
Confidence 7999999999999987654 59999999999999999999999999999999999999875 89999999984
Q ss_pred cccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCc
Q 007260 367 RCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEP 446 (611)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (611)
....
T Consensus 230 ~~~~---------------------------------------------------------------------------- 233 (681)
T 2pzi_A 230 RINS---------------------------------------------------------------------------- 233 (681)
T ss_dssp ETTC----------------------------------------------------------------------------
T ss_pred hccc----------------------------------------------------------------------------
Confidence 3210
Q ss_pred ccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 007260 447 TEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDL 526 (611)
Q Consensus 447 ~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dL 526 (611)
....+||+.|+|||++.+.. +.++|||||||+||+|++|.+||.+.... ..........++..+.+|
T Consensus 234 ----~~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~--------~~~~~~~~~~~~~~l~~l 300 (681)
T 2pzi_A 234 ----FGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD--------GLPEDDPVLKTYDSYGRL 300 (681)
T ss_dssp ----CSCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS--------SCCTTCHHHHHCHHHHHH
T ss_pred ----CCccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc--------cccccccccccCHHHHHH
Confidence 01346999999999998764 88999999999999999999998753110 000000011246789999
Q ss_pred HHHhhhcCccccCCchhcHHHHHcCCCCC
Q 007260 527 IRGLLVKEPQHRLAYKRGATEIKQHPFFE 555 (611)
Q Consensus 527 I~~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 555 (611)
|.+||.+||.+||+ ..+++.|+|+.
T Consensus 301 i~~~l~~dP~~R~~----~~~~l~~~l~~ 325 (681)
T 2pzi_A 301 LRRAIDPDPRQRFT----TAEEMSAQLTG 325 (681)
T ss_dssp HHHHTCSSGGGSCS----SHHHHHHHHHH
T ss_pred HhhhccCChhhCCC----HHHHHHHHHHH
Confidence 99999999999999 67788888875
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=325.59 Aligned_cols=192 Identities=17% Similarity=0.108 Sum_probs=136.7
Q ss_pred EEeEecccCcEEEEEEEECCCCeEEEEEEecchhh-------hhHHHHHHHHHHHHHHHhC-CCCCcccccceeecccee
Q 007260 220 LLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASL-------AGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEKFS 291 (611)
Q Consensus 220 l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~-------~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~~~~ 291 (611)
....++.|++|.+..++....++.||+|++.+... ........+.+|+++|+++ .|+||++++++|++++.+
T Consensus 238 w~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~ 317 (569)
T 4azs_A 238 WQNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSG 317 (569)
T ss_dssp EECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEE
T ss_pred hhhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEE
Confidence 34457788888888888888888999999976421 2234456788999999999 799999999999999999
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCC
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~ 371 (611)
|||||||+|++|.+++.+. +.+++. .|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 318 yLVMEyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~- 391 (569)
T 4azs_A 318 WLVMEKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ- 391 (569)
T ss_dssp EEEEECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred EEEEecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCC-
Confidence 9999999999999999875 557664 4789999999999999999999999999999999999999999853221
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
.....
T Consensus 392 ---------------------------------------------------------------------------~~~~~ 396 (569)
T 4azs_A 392 ---------------------------------------------------------------------------DCSWP 396 (569)
T ss_dssp -----------------------------------------------------------------------------CCS
T ss_pred ---------------------------------------------------------------------------CCccc
Confidence 01122
Q ss_pred cccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCC
Q 007260 452 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTP 493 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~P 493 (611)
.+.+||+.|||||++.+. +..++|+|++|+++++|++|..+
T Consensus 397 ~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 397 TNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp HHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred cCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 357899999999999865 56789999999998887665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-29 Score=280.72 Aligned_cols=194 Identities=15% Similarity=0.110 Sum_probs=146.4
Q ss_pred EEEeEecccCcEEEEEEEECCCCeEEEEEEecchhh-----hhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeE
Q 007260 219 RLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASL-----AGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCL 293 (611)
Q Consensus 219 ~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~-----~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~L 293 (611)
...+.||+|+||.||+|... +..+|+|++..... .......++.+|+++|++++||||+++..++...+..||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~--~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL--DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEECS--SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEEEC--CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 34578999999999999443 56789988644322 223335568899999999999999977777777788899
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcc
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 373 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~ 373 (611)
|||||+|++|.+++.. +..|+.||+.||+|||++|||||||||+|||++. ++||+|||+++.......
T Consensus 417 VmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 417 MMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp EEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred EEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 9999999999998765 5688999999999999999999999999999998 999999999954431100
Q ss_pred ccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccc
Q 007260 374 LIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMS 453 (611)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (611)
.. .........
T Consensus 485 ~~---------------------------------------------------------------------~~~~~~~~~ 495 (540)
T 3en9_A 485 KA---------------------------------------------------------------------VDLIVFKKA 495 (540)
T ss_dssp HH---------------------------------------------------------------------HHHHHHHHH
T ss_pred cc---------------------------------------------------------------------cchhhhhhh
Confidence 00 000001235
Q ss_pred cccCCCccchhhhcc--CCCCChhhHHHHHHHHHHHHhCCCCCC
Q 007260 454 FVGTHEYLAPEIIKG--EGHGSAVDWWTFGIFLYELLFGKTPFK 495 (611)
Q Consensus 454 ~vGT~~Y~APEil~~--~~~~~~sDIWSLGviL~ELltG~~PF~ 495 (611)
++||+.|||||++.+ ..|+..+|+|+..+-.++...++.+|.
T Consensus 496 ~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 496 VLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred hcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 789999999999987 668888999999999999888777764
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.4e-27 Score=241.50 Aligned_cols=135 Identities=19% Similarity=0.133 Sum_probs=111.5
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhH---------------HHHHHHHHHHHHHHhCCCCCccc
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGR---------------KKLLRAQTEREILQSLDHPFLPT 280 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~---------------~~~~~~~~E~~iL~~l~HpnIv~ 280 (611)
..|.+++.||.|+||.||+|++ .+++.||||+++....... .....+.+|+.+|+.++ | +.
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~ 165 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA 165 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence 4677889999999999999999 8899999999975432111 23456789999999999 5 77
Q ss_pred ccceeeccceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEE
Q 007260 281 LYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLS 360 (611)
Q Consensus 281 l~~~~~~~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~ 360 (611)
+++++.. +..|||||||+|++|.+ +.. .....++.||+.||+|||++|||||||||+||||+ +|++||+
T Consensus 166 v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~ 234 (282)
T 1zar_A 166 VPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWII 234 (282)
T ss_dssp SCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEEC
T ss_pred cCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEE
Confidence 7776544 66799999999999987 311 23557999999999999999999999999999999 9999999
Q ss_pred ecccc
Q 007260 361 DFDLS 365 (611)
Q Consensus 361 DFGlA 365 (611)
|||+|
T Consensus 235 DFG~a 239 (282)
T 1zar_A 235 DFPQS 239 (282)
T ss_dssp CCTTC
T ss_pred ECCCC
Confidence 99998
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.5e-22 Score=205.15 Aligned_cols=140 Identities=17% Similarity=0.172 Sum_probs=109.2
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeE--EEEEEecchhhhh---------------------HHHHHHHHHHHHHHHhC
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCY--FAMKVMDKASLAG---------------------RKKLLRAQTEREILQSL 273 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~--vAvKii~k~~~~~---------------------~~~~~~~~~E~~iL~~l 273 (611)
-|.+.+.||+|+||.||+|.+..+++. ||||+++...... ......+.+|+.+|..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 378999999999999999999777888 9999975432110 11223567899999999
Q ss_pred CCCCc--ccccceeeccceeeEEeeeCCC-C----CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH-HcCeeccCCC
Q 007260 274 DHPFL--PTLYTHFETEKFSCLVMEFCPG-G----DLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLH-MLGIIYRDLK 345 (611)
Q Consensus 274 ~HpnI--v~l~~~~~~~~~~~LVmE~~~g-g----~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH-~~gIVHRDLK 345 (611)
.|++| +.++++ ...||||||+.+ | .|.++... +++..+..++.||+.||.||| .+||||||||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlk 198 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHADLS 198 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCS
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCC
Confidence 88865 333332 467899999932 3 67665432 235678889999999999999 9999999999
Q ss_pred CCcEEEccCCcEEEEecccccc
Q 007260 346 PENVLVREDGHIMLSDFDLSLR 367 (611)
Q Consensus 346 PeNILv~~~g~vkL~DFGlA~~ 367 (611)
|+||||+. .++|+|||+|..
T Consensus 199 p~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEE
T ss_pred HHHEEEcC--cEEEEECccccc
Confidence 99999998 999999999853
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.78 E-value=3.6e-19 Score=190.43 Aligned_cols=139 Identities=16% Similarity=0.197 Sum_probs=100.7
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhh-----------------hHHHH--HHHHHHHHHHHhCCCCC
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLA-----------------GRKKL--LRAQTEREILQSLDHPF 277 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~-----------------~~~~~--~~~~~E~~iL~~l~Hpn 277 (611)
-|++++.||.|+||.||+|.+. +|+.||||+++..... ..... ..+.+|...|.+|.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 3999999999999999999875 5889999997642110 00011 12345667777775544
Q ss_pred cccccceeeccceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCC--
Q 007260 278 LPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDG-- 355 (611)
Q Consensus 278 Iv~l~~~~~~~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g-- 355 (611)
+.... .+.. ...+|||||++|+.|..+. ....+..++.||+.+|.|||.+|||||||||.||||+++|
T Consensus 175 v~vp~-p~~~-~~~~LVME~i~G~~L~~l~--------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 175 FPVPE-PIAQ-SRHTIVMSLVDALPMRQVS--------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp CSCCC-EEEE-ETTEEEEECCSCEEGGGCC--------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred CCCCe-eeec-cCceEEEEecCCccHhhhc--------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence 43221 1211 2337999999998886532 1224567889999999999999999999999999999877
Q ss_pred --------cEEEEeccccc
Q 007260 356 --------HIMLSDFDLSL 366 (611)
Q Consensus 356 --------~vkL~DFGlA~ 366 (611)
.+.|+||+-+.
T Consensus 245 ~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp SCTTSEEEEEEECCCTTCE
T ss_pred ccccccccceEEEEeCCcc
Confidence 38999999773
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=1.4e-13 Score=138.24 Aligned_cols=139 Identities=17% Similarity=0.151 Sum_probs=111.1
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC-CCCcccccceeeccceeeE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD-HPFLPTLYTHFETEKFSCL 293 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~-HpnIv~l~~~~~~~~~~~L 293 (611)
+..|++...+|.|+++.||++... +..+++|+........ ...+.+|+.+|+.|. |..++++++++...+..|+
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred hccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 357999999999999999999754 5679999986532111 124677999999884 6788899999998899999
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHM------------------------------------- 336 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~------------------------------------- 336 (611)
||||++|.+|.+... +......++.++..+|..||.
T Consensus 88 v~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 88 LMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 999999999976521 122344678899999999999
Q ss_pred ----------------------cCeeccCCCCCcEEEccCCcEEEEecccc
Q 007260 337 ----------------------LGIIYRDLKPENVLVREDGHIMLSDFDLS 365 (611)
Q Consensus 337 ----------------------~gIVHRDLKPeNILv~~~g~vkL~DFGlA 365 (611)
.+++|+|++|.|||++.++.+.|+||+.+
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a 211 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence 45999999999999986555679999987
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.34 E-value=1.6e-12 Score=129.26 Aligned_cols=134 Identities=16% Similarity=0.054 Sum_probs=98.7
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCC--cccccceeeccceeeE
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF--LPTLYTHFETEKFSCL 293 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~Hpn--Iv~l~~~~~~~~~~~L 293 (611)
.+|.+....+.|..+.||++.. .++..|++|+...... ..+.+|+.+|+.+.+.+ +++++.++..++..|+
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~~------~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~ 92 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL 92 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcccc------hhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEE
Confidence 4566655545666799999964 4566799999765421 24567999999885444 5678888888888999
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC-----------------------------------
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLG----------------------------------- 338 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~g----------------------------------- 338 (611)
||||++|.+|. ... .. ...++.++...|..||...
T Consensus 93 v~e~i~G~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 93 LLGEVPGQDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp EEECCSSEETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EEEecCCcccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 99999998884 111 11 2245677777778887643
Q ss_pred -----------------------eeccCCCCCcEEEccCCcEEEEeccccc
Q 007260 339 -----------------------IIYRDLKPENVLVREDGHIMLSDFDLSL 366 (611)
Q Consensus 339 -----------------------IVHRDLKPeNILv~~~g~vkL~DFGlA~ 366 (611)
++|+|++|.|||++.++.+.|+|||.+.
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999876667799999873
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.24 E-value=1e-11 Score=130.78 Aligned_cols=142 Identities=16% Similarity=0.210 Sum_probs=106.0
Q ss_pred eEEEeEecccCcEEEEEEEECCCCeEEEEEEec--chhhhhHHHHHHHHHHHHHHHhCC--CCCcccccceeecc---ce
Q 007260 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMD--KASLAGRKKLLRAQTEREILQSLD--HPFLPTLYTHFETE---KF 290 (611)
Q Consensus 218 y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~--k~~~~~~~~~~~~~~E~~iL~~l~--HpnIv~l~~~~~~~---~~ 290 (611)
...++.|+.|.++.||++...+ ..+++|+.. ..... .....+.+|..+|+.|. +..+++++.++.+. +.
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~~--~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~ 115 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTPG--QTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGR 115 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECSS--CEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSS
T ss_pred CceEEEcCCcccceEEEEEECC--ceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCC
Confidence 3456889999999999997653 468888875 33211 11235677999999986 45578898888766 45
Q ss_pred eeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------
Q 007260 291 SCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHM---------------------------------- 336 (611)
Q Consensus 291 ~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~---------------------------------- 336 (611)
.|+||||++|..|.+.. -..+++.....++.+++..|..||.
T Consensus 116 ~~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (359)
T 3dxp_A 116 AFYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSET 191 (359)
T ss_dssp CEEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCC
T ss_pred eEEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCC
Confidence 89999999998874311 1236788888999999999999997
Q ss_pred ------------------------cCeeccCCCCCcEEEccCCc--EEEEecccccc
Q 007260 337 ------------------------LGIIYRDLKPENVLVREDGH--IMLSDFDLSLR 367 (611)
Q Consensus 337 ------------------------~gIVHRDLKPeNILv~~~g~--vkL~DFGlA~~ 367 (611)
.++||+|++|.|||++.++. +.|+||+.+..
T Consensus 192 ~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 192 ESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp SCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred cCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36999999999999997753 68999998843
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.22 E-value=6.4e-12 Score=129.43 Aligned_cols=133 Identities=17% Similarity=0.150 Sum_probs=98.5
Q ss_pred EeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC-CCC--cccccceeeccc---eeeEE
Q 007260 221 LKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD-HPF--LPTLYTHFETEK---FSCLV 294 (611)
Q Consensus 221 ~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~-Hpn--Iv~l~~~~~~~~---~~~LV 294 (611)
++.|+.|.+..||++. ..+++|+.... ....++.+|.++|+.+. +.. ++.++.+..... ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 3569999999999873 34889986543 22346778999998873 333 445555544333 45899
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHM-------------------------------------- 336 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~-------------------------------------- 336 (611)
||+++|..|...... .++......++.|+...|..||.
T Consensus 95 m~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (304)
T 3sg8_A 95 FTKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM 170 (304)
T ss_dssp EECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred EcccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence 999999988754333 26777888888899998888886
Q ss_pred --------------------cCeeccCCCCCcEEEcc--CCcEEEEecccccc
Q 007260 337 --------------------LGIIYRDLKPENVLVRE--DGHIMLSDFDLSLR 367 (611)
Q Consensus 337 --------------------~gIVHRDLKPeNILv~~--~g~vkL~DFGlA~~ 367 (611)
..++|+|++|.|||++. ++.+.|+||+.+..
T Consensus 171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~ 223 (304)
T 3sg8_A 171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAI 223 (304)
T ss_dssp HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCcc
Confidence 13799999999999998 45678999998743
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.78 E-value=4.1e-08 Score=101.35 Aligned_cols=132 Identities=15% Similarity=0.109 Sum_probs=92.8
Q ss_pred EeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCC---Ccccccceee-ccceeeEEee
Q 007260 221 LKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHP---FLPTLYTHFE-TEKFSCLVME 296 (611)
Q Consensus 221 ~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~Hp---nIv~l~~~~~-~~~~~~LVmE 296 (611)
++.++.|....||+. +..+++|+-... ....++.+|..+|+.|.+. .|++++.+.. ..+..|+|||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~-----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQ-----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSH-----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCc-----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 456889999999998 345888985332 2334677899999999653 3567776664 4566789999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc---------------------------------------
Q 007260 297 FCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHML--------------------------------------- 337 (611)
Q Consensus 297 ~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~--------------------------------------- 337 (611)
|++|..|....-. .++......++.++...|..||..
T Consensus 94 ~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~ 169 (306)
T 3tdw_A 94 KVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR 169 (306)
T ss_dssp CCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred ccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence 9999888763221 134455555555555555555542
Q ss_pred ---------------------CeeccCCCCCcEEEcc---CCc-EEEEeccccc
Q 007260 338 ---------------------GIIYRDLKPENVLVRE---DGH-IMLSDFDLSL 366 (611)
Q Consensus 338 ---------------------gIVHRDLKPeNILv~~---~g~-vkL~DFGlA~ 366 (611)
.+||+|++|.|||++. ++. +.|+||+.+.
T Consensus 170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 3599999999999997 455 4899999874
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.71 E-value=1.2e-07 Score=95.21 Aligned_cols=132 Identities=19% Similarity=0.139 Sum_probs=94.4
Q ss_pred EecccCcE-EEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC-CCCcccccceeeccceeeEEeeeCCC
Q 007260 223 RLGCGDIG-SVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD-HPFLPTLYTHFETEKFSCLVMEFCPG 300 (611)
Q Consensus 223 ~LG~G~fG-~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~-HpnIv~l~~~~~~~~~~~LVmE~~~g 300 (611)
.+..|..| .||+......+..+.+|+-.... ...+.+|..+|+.|. +--+++++.++.+++..|||||+++|
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~------~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSV------ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETHH------HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCCC------HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence 34445544 79998877777789999875432 224567999998884 33367889999888999999999999
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHc-------------------------------------------
Q 007260 301 GDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHML------------------------------------------- 337 (611)
Q Consensus 301 g~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~------------------------------------------- 337 (611)
.++.+...... .....++.++...|.-||..
T Consensus 105 ~~~~~~~~~~~------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 105 KTAFQVLEEYP------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp EEHHHHHHHCG------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred ccccccccCCH------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 88876554321 12233445555555555531
Q ss_pred ---------------CeeccCCCCCcEEEccCCcEEEEeccccc
Q 007260 338 ---------------GIIYRDLKPENVLVREDGHIMLSDFDLSL 366 (611)
Q Consensus 338 ---------------gIVHRDLKPeNILv~~~g~vkL~DFGlA~ 366 (611)
.++|+|+.+.|||++.++.+-|+||+.+.
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 17899999999999977777899999873
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.48 E-value=4.6e-07 Score=96.53 Aligned_cols=80 Identities=18% Similarity=0.203 Sum_probs=50.5
Q ss_pred EEeEecccCcEEEEEEEECCCCeEEEEEEecchhh-hhH---HHHHHHHHHHHHHHhCCC--C-Ccccccceeeccceee
Q 007260 220 LLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASL-AGR---KKLLRAQTEREILQSLDH--P-FLPTLYTHFETEKFSC 292 (611)
Q Consensus 220 l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~-~~~---~~~~~~~~E~~iL~~l~H--p-nIv~l~~~~~~~~~~~ 292 (611)
-++.||.|.++.||++.+...++.|+||....... ... ....++..|.++|+.+.. + .+++++.+ +....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 46789999999999997665667899998653211 000 012345678899887732 3 45566644 344568
Q ss_pred EEeeeCCCC
Q 007260 293 LVMEFCPGG 301 (611)
Q Consensus 293 LVmE~~~gg 301 (611)
|||||++|.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.47 E-value=1.4e-06 Score=89.81 Aligned_cols=137 Identities=14% Similarity=0.162 Sum_probs=78.6
Q ss_pred EEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC--CCCcccccc------eeecccee
Q 007260 220 LLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD--HPFLPTLYT------HFETEKFS 291 (611)
Q Consensus 220 l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~--HpnIv~l~~------~~~~~~~~ 291 (611)
-++.|+.|..+.||++...+ + .+++|+..... . ++..|..+++.|. .-.+++++. +....+..
T Consensus 36 ~~~~l~gG~~n~~~~v~~~~-~-~~vlk~~~~~~----~---~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~ 106 (346)
T 2q83_A 36 KIDVIQGNQMALVWKVHTDS-G-AVCLKRIHRPE----K---KALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFL 106 (346)
T ss_dssp EEEECC----CEEEEEEETT-E-EEEEEEECSCH----H---HHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEE
T ss_pred EeeeccccccCcEEEEEeCC-C-CEEEEecCCCH----H---HHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEE
Confidence 34567777889999997643 3 48999987521 1 2233555555442 113444443 12345678
Q ss_pred eEEeeeCCCCCHH---------------HHHHhCCCC--C--------C-CHHH--------------------------
Q 007260 292 CLVMEFCPGGDLH---------------TLRQKQPGK--Y--------F-PEQA-------------------------- 319 (611)
Q Consensus 292 ~LVmE~~~gg~L~---------------~ll~~~~~~--~--------l-~e~~-------------------------- 319 (611)
|+||||++|..+. .+.....+. . + .+..
T Consensus 107 ~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 186 (346)
T 2q83_A 107 FVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQ 186 (346)
T ss_dssp EEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHH
T ss_pred EEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHH
Confidence 9999999986531 111111000 0 0 1100
Q ss_pred -----HHHHHHHHHHHHHHHHH-------------cCeeccCCCCCcEEEccCCcEEEEecccc
Q 007260 320 -----VRFYVAEVLLALEYLHM-------------LGIIYRDLKPENVLVREDGHIMLSDFDLS 365 (611)
Q Consensus 320 -----~~~i~~qll~aL~yLH~-------------~gIVHRDLKPeNILv~~~g~vkL~DFGlA 365 (611)
+..++.++..++++|+. .++||+|+++.|||++.++.+.|+||+.+
T Consensus 187 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a 250 (346)
T 2q83_A 187 LYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTV 250 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTC
T ss_pred HHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhc
Confidence 11122234446666653 57999999999999988889999999987
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.18 E-value=3.4e-06 Score=88.12 Aligned_cols=82 Identities=11% Similarity=0.079 Sum_probs=55.9
Q ss_pred EEEeEe-cccCcEEEEEEEEC---C---CCeEEEEEEecchh---hhhHHHHHHHHHHHHHHHhCC-C--CCccccccee
Q 007260 219 RLLKRL-GCGDIGSVYLSELS---G---TKCYFAMKVMDKAS---LAGRKKLLRAQTEREILQSLD-H--PFLPTLYTHF 285 (611)
Q Consensus 219 ~l~~~L-G~G~fG~Vy~a~~~---~---t~~~vAvKii~k~~---~~~~~~~~~~~~E~~iL~~l~-H--pnIv~l~~~~ 285 (611)
..++.| +.|....+|+.... . .+..+++|+..... ... ...+.+|..+|+.|. + -.+++++.+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~~ 99 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWIE 99 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEEE
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEEc
Confidence 445788 89999999998754 1 15678999875432 100 023467888888874 2 3577888877
Q ss_pred ecc---ceeeEEeeeCCCCCH
Q 007260 286 ETE---KFSCLVMEFCPGGDL 303 (611)
Q Consensus 286 ~~~---~~~~LVmE~~~gg~L 303 (611)
.+. +..|+||||++|..|
T Consensus 100 ~~~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 100 TTGDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp CSSTTTSSCEEEEECCCCBCC
T ss_pred cCCCccCCceEEEEecCCCCh
Confidence 654 456899999988654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.96 E-value=3.6e-05 Score=79.84 Aligned_cols=77 Identities=16% Similarity=0.168 Sum_probs=59.7
Q ss_pred EEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC---CCCcccccceeeccceeeEEe
Q 007260 219 RLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD---HPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 219 ~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~---HpnIv~l~~~~~~~~~~~LVm 295 (611)
.-++.|+.|.+..+|+... .+..+++|+..... ...+..|...|+.|. ...+++++.+....+..|+||
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvm 110 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERSY------RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLL 110 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGGG------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEE
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCccc------HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEE
Confidence 3467899999999999875 35578899876432 234567988888873 357889998888788899999
Q ss_pred eeCCCCCH
Q 007260 296 EFCPGGDL 303 (611)
Q Consensus 296 E~~~gg~L 303 (611)
||++|..+
T Consensus 111 e~l~G~~~ 118 (312)
T 3jr1_A 111 EALNKSKN 118 (312)
T ss_dssp ECCCCCCC
T ss_pred EeccCCCC
Confidence 99998764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.92 E-value=2.3e-05 Score=84.22 Aligned_cols=31 Identities=26% Similarity=0.392 Sum_probs=27.2
Q ss_pred HHcCeeccCCCCCcEEEccCCcEEEEeccccc
Q 007260 335 HMLGIIYRDLKPENVLVREDGHIMLSDFDLSL 366 (611)
Q Consensus 335 H~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~ 366 (611)
+...++|+|++|.|||++.++ ++|+||+.+.
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~ 260 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSF 260 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccc
Confidence 346799999999999999877 9999999874
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.91 E-value=9.2e-05 Score=75.90 Aligned_cols=143 Identities=18% Similarity=0.162 Sum_probs=80.8
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCC--cccccce------eec
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF--LPTLYTH------FET 287 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~Hpn--Iv~l~~~------~~~ 287 (611)
+...-++.|+.|....||+....+. .+++|+...... ...+..|+.+++.|...+ +++++.. ...
T Consensus 22 ~~~~~~~~i~~G~~n~~~~v~~~~g--~~vlk~~~~~~~-----~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~ 94 (322)
T 2ppq_A 22 GSLTSYKGIAEGVENSNFLLHTTKD--PLILTLYEKRVE-----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGEL 94 (322)
T ss_dssp CCEEEEEEECC---EEEEEEEESSC--CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEE
T ss_pred CcceEeeccCCCcccceEEEEeCCc--cEEEEEeCCCCC-----HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEE
Confidence 4455567888899999999986543 588999875211 113345777777663212 3444422 123
Q ss_pred cceeeEEeeeCCCCCHH---------------HHHHhCCC--CC----CCHHHHHH---------------HHHHHHHHH
Q 007260 288 EKFSCLVMEFCPGGDLH---------------TLRQKQPG--KY----FPEQAVRF---------------YVAEVLLAL 331 (611)
Q Consensus 288 ~~~~~LVmE~~~gg~L~---------------~ll~~~~~--~~----l~e~~~~~---------------i~~qll~aL 331 (611)
.+..++||+|++|..+. .+-..... .. ........ +...+...+
T Consensus 95 ~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~ 174 (322)
T 2ppq_A 95 SGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEI 174 (322)
T ss_dssp TTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHH
T ss_pred CCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHH
Confidence 45678999999886531 11111000 00 11000000 001234455
Q ss_pred HHHHH-------cCeeccCCCCCcEEEccCCcEEEEecccc
Q 007260 332 EYLHM-------LGIIYRDLKPENVLVREDGHIMLSDFDLS 365 (611)
Q Consensus 332 ~yLH~-------~gIVHRDLKPeNILv~~~g~vkL~DFGlA 365 (611)
++++. .++||+|+.+.|||++.++.+.|+||+.+
T Consensus 175 ~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a 215 (322)
T 2ppq_A 175 DYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFA 215 (322)
T ss_dssp HHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred HHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhc
Confidence 66653 36999999999999987766689999987
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.78 E-value=3.8e-05 Score=78.42 Aligned_cols=132 Identities=12% Similarity=0.081 Sum_probs=75.2
Q ss_pred EeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC-CCCcccccceeeccceeeEEeeeC-
Q 007260 221 LKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD-HPFLPTLYTHFETEKFSCLVMEFC- 298 (611)
Q Consensus 221 ~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~-HpnIv~l~~~~~~~~~~~LVmE~~- 298 (611)
++.|+.|....+|++ ..+++|+...... ......+|..+++.+. +...++++.++ ...-++|+||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~----~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE----EYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCcc----ceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence 688999999999998 3488998764311 1112245888777774 22225666544 33357899999
Q ss_pred CCCCHHH--H-------------H---HhCCCCCC----C-HHHHHHHHHH--------------HHHHHHHHH----H-
Q 007260 299 PGGDLHT--L-------------R---QKQPGKYF----P-EQAVRFYVAE--------------VLLALEYLH----M- 336 (611)
Q Consensus 299 ~gg~L~~--l-------------l---~~~~~~~l----~-e~~~~~i~~q--------------ll~aL~yLH----~- 336 (611)
+|..|.. + + +..+ ..+ . ...+..+..+ +...+..|. .
T Consensus 91 ~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~ 169 (301)
T 3dxq_A 91 GAQTMSPEKFKTRPGSPARAGEAFRKLHGSG-AVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAH 169 (301)
T ss_dssp TCEECCHHHHHHSTTHHHHHHHHHHHHHTSC-CCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSS
T ss_pred CCccCCHhhHhhhHHHHHHHHHHHHHHhCCC-CCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhc
Confidence 7655431 0 0 1111 101 1 1112222111 111222221 1
Q ss_pred ---cCeeccCCCCCcEEEccCCcEEEEeccccc
Q 007260 337 ---LGIIYRDLKPENVLVREDGHIMLSDFDLSL 366 (611)
Q Consensus 337 ---~gIVHRDLKPeNILv~~~g~vkL~DFGlA~ 366 (611)
..++|+|+.+.||| ..++.+.|+||..+.
T Consensus 170 ~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~ 201 (301)
T 3dxq_A 170 PLPLAACHCDPLCENFL-DTGERMWIVDWEYSG 201 (301)
T ss_dssp CCCCEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred CCCceeeccCCCcCCEE-ECCCCEEEEeccccc
Confidence 23899999999999 567789999999873
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00014 Score=78.51 Aligned_cols=74 Identities=20% Similarity=0.258 Sum_probs=50.2
Q ss_pred EEeEecccCcEEEEEEEECC-------CCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC-CCCcccccceeecccee
Q 007260 220 LLKRLGCGDIGSVYLSELSG-------TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD-HPFLPTLYTHFETEKFS 291 (611)
Q Consensus 220 l~~~LG~G~fG~Vy~a~~~~-------t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~-HpnIv~l~~~~~~~~~~ 291 (611)
-++.|+.|-...||++.... .+..|.+|+...... . ..+.+|..+++.|. +...+++++.+.+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~---~~li~E~~~l~~L~~~g~~P~l~~~~~~---- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--E---SHLVAESVIFTLLSERHLGPKLYGIFSG---- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--H---HHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--H---HHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence 45778889999999998753 256799999843211 0 12336888888874 3334777776653
Q ss_pred eEEeeeCCCCC
Q 007260 292 CLVMEFCPGGD 302 (611)
Q Consensus 292 ~LVmE~~~gg~ 302 (611)
.+||||++|..
T Consensus 148 g~v~e~l~G~~ 158 (429)
T 1nw1_A 148 GRLEEYIPSRP 158 (429)
T ss_dssp EEEECCCCEEE
T ss_pred CEEEEEeCCcc
Confidence 28999998744
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.56 E-value=7.9e-05 Score=79.32 Aligned_cols=138 Identities=17% Similarity=0.200 Sum_probs=83.5
Q ss_pred EeEecccCcEEEEEEEECC-------CCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC-CCCcccccceeeccceee
Q 007260 221 LKRLGCGDIGSVYLSELSG-------TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD-HPFLPTLYTHFETEKFSC 292 (611)
Q Consensus 221 ~~~LG~G~fG~Vy~a~~~~-------t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~-HpnIv~l~~~~~~~~~~~ 292 (611)
++.|..|-...+|++.... .+..|.||+..... .. ...+.+|..+++.|. +.-.+++++++.++
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~---~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g---- 126 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QG---VDSLVLESVMFAILAERSLGPQLYGVFPEG---- 126 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CC---HHHHHHHHHHHHHHHHTTSSCCEEEEETTE----
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-ch---HHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----
Confidence 3567778888999998642 34679999864321 11 123357888888773 43457888776642
Q ss_pred EEeeeCCCCCHHH--------------HHH---hC---CCCCC--CHHHHHHHHHHHHH-------------------HH
Q 007260 293 LVMEFCPGGDLHT--------------LRQ---KQ---PGKYF--PEQAVRFYVAEVLL-------------------AL 331 (611)
Q Consensus 293 LVmE~~~gg~L~~--------------ll~---~~---~~~~l--~e~~~~~i~~qll~-------------------aL 331 (611)
+||||++|..|.. .+. .. .++.. -+..+..|+.++.. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 9999998855421 111 11 01112 24556666655422 23
Q ss_pred HHHHH--------cCeeccCCCCCcEEEccC----CcEEEEeccccc
Q 007260 332 EYLHM--------LGIIYRDLKPENVLVRED----GHIMLSDFDLSL 366 (611)
Q Consensus 332 ~yLH~--------~gIVHRDLKPeNILv~~~----g~vkL~DFGlA~ 366 (611)
+.|.. ..++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 44432 249999999999999876 789999999873
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00018 Score=74.41 Aligned_cols=137 Identities=12% Similarity=0.048 Sum_probs=70.9
Q ss_pred EeEecccCcEE-EEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC-C-CCcccccceeeccceeeEEeee
Q 007260 221 LKRLGCGDIGS-VYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD-H-PFLPTLYTHFETEKFSCLVMEF 297 (611)
Q Consensus 221 ~~~LG~G~fG~-Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~-H-pnIv~l~~~~~~~~~~~LVmE~ 297 (611)
++.|+.|+... +|+.... ++..+++|....... ..+..|+.+++.|. + -.+++++.+....+ ++|||+
T Consensus 23 ~~~l~gg~s~~~~~r~~~~-~~~~~vlk~~~~~~~------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~ 93 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSP-TGAKAVLMDWSPEEG------GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIED 93 (333)
T ss_dssp ECC--------CCEEEECT-TCCEEEEEECCTTTT------CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECC
T ss_pred eeECCCCCCCceEEEEEcC-CCCeEEEEECCCCCC------ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEee
Confidence 35666665554 6676532 245677776543210 12344777777663 2 23566776533333 789999
Q ss_pred CCCCCHHHHHHhC---------------------CC---CCCCHHHHH--------HHH------------HHHHHHHHH
Q 007260 298 CPGGDLHTLRQKQ---------------------PG---KYFPEQAVR--------FYV------------AEVLLALEY 333 (611)
Q Consensus 298 ~~gg~L~~ll~~~---------------------~~---~~l~e~~~~--------~i~------------~qll~aL~y 333 (611)
+.|..+.+.+... .. ..+...... .+. ..+...++.
T Consensus 94 l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~ 173 (333)
T 3csv_A 94 LGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQ 173 (333)
T ss_dssp CCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHH
T ss_pred CCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence 9776665433211 00 112221110 000 111222333
Q ss_pred H------HHcCeeccCCCCCcEEEccC----CcEEEEeccccc
Q 007260 334 L------HMLGIIYRDLKPENVLVRED----GHIMLSDFDLSL 366 (611)
Q Consensus 334 L------H~~gIVHRDLKPeNILv~~~----g~vkL~DFGlA~ 366 (611)
| +...+||||+.+.|||++.+ +.+.|+||+.+.
T Consensus 174 l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~ 216 (333)
T 3csv_A 174 ILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK 216 (333)
T ss_dssp HHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred HHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence 3 12469999999999999875 689999999874
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.53 E-value=9.6e-05 Score=77.70 Aligned_cols=75 Identities=16% Similarity=0.230 Sum_probs=45.4
Q ss_pred EEeEecccCcEEEEEEEECCC--------CeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCC-cccccceeeccce
Q 007260 220 LLKRLGCGDIGSVYLSELSGT--------KCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF-LPTLYTHFETEKF 290 (611)
Q Consensus 220 l~~~LG~G~fG~Vy~a~~~~t--------~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~Hpn-Iv~l~~~~~~~~~ 290 (611)
-++.|+.|....||++..... +..|++|+....... +.....|..+|+.|...+ ++++++.+.
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~----~~~~~~E~~~l~~L~~~g~~P~~~~~~~---- 108 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE----LYNTISEFEVYKTMSKYKIAPQLLNTFN---- 108 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG----TSCHHHHHHHHHHHHHTTSSCCEEEEET----
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc----eecHHHHHHHHHHHHhcCCCCceEEecC----
Confidence 356788888899999987541 257899987543211 111246888888774223 557775542
Q ss_pred eeEEeeeCCCCC
Q 007260 291 SCLVMEFCPGGD 302 (611)
Q Consensus 291 ~~LVmE~~~gg~ 302 (611)
-++||||++|..
T Consensus 109 ~~~v~e~i~G~~ 120 (369)
T 3c5i_A 109 GGRIEEWLYGDP 120 (369)
T ss_dssp TEEEEECCCSEE
T ss_pred CcEEEEEecCCc
Confidence 368999998854
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00031 Score=72.16 Aligned_cols=75 Identities=13% Similarity=0.100 Sum_probs=46.0
Q ss_pred eEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCC--Ccccccce-----eeccceeeEE
Q 007260 222 KRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHP--FLPTLYTH-----FETEKFSCLV 294 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~Hp--nIv~l~~~-----~~~~~~~~LV 294 (611)
..|+ |....||+.... +++.+++|+....... . ..+..|..+++.|... .+++++.. ...++..++|
T Consensus 32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~~-~---~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERWT-A---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTSC-H---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCCC-H---HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 4566 888899988653 3456899998643211 1 1344577777776321 24455443 2234566899
Q ss_pred eeeCCCCC
Q 007260 295 MEFCPGGD 302 (611)
Q Consensus 295 mE~~~gg~ 302 (611)
|||++|..
T Consensus 106 ~~~i~G~~ 113 (328)
T 1zyl_A 106 FPSVGGRQ 113 (328)
T ss_dssp EECCCCEE
T ss_pred EEecCCCC
Confidence 99998754
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00045 Score=69.92 Aligned_cols=80 Identities=16% Similarity=0.047 Sum_probs=55.1
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCC---CCcccccceeeccceee
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH---PFLPTLYTHFETEKFSC 292 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~H---pnIv~l~~~~~~~~~~~ 292 (611)
....-++.+|.|..+.||+.+.. +|+.|.+|+-........ ..+.+|...|+.|.- --+++++.+. .-+
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~---~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~ 86 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALD---GLFRAEALGLDWLGRSFGSPVPQVAGWD----DRT 86 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCT---THHHHHHHHHHHHTCSTTCCSCCEEEEE----TTE
T ss_pred CCeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchh---hHHHHHHHHHHHHHhhCCCCcceEEecc----Cce
Confidence 45667889999999999999875 467899998654322111 135679999988842 2345555542 347
Q ss_pred EEeeeCCCCCH
Q 007260 293 LVMEFCPGGDL 303 (611)
Q Consensus 293 LVmE~~~gg~L 303 (611)
+||||++++..
T Consensus 87 lv~e~l~~~~~ 97 (288)
T 3f7w_A 87 LAMEWVDERPP 97 (288)
T ss_dssp EEEECCCCCCC
T ss_pred EEEEeecccCC
Confidence 99999987653
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00068 Score=70.67 Aligned_cols=30 Identities=27% Similarity=0.423 Sum_probs=26.9
Q ss_pred cCeeccCCCCCcEEEccCCcEEEEeccccc
Q 007260 337 LGIIYRDLKPENVLVREDGHIMLSDFDLSL 366 (611)
Q Consensus 337 ~gIVHRDLKPeNILv~~~g~vkL~DFGlA~ 366 (611)
.+++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~ 235 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPM 235 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence 359999999999999988889999998773
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00055 Score=74.64 Aligned_cols=76 Identities=13% Similarity=0.199 Sum_probs=49.9
Q ss_pred EEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCc-ccccceeeccceeeEEeeeC
Q 007260 220 LLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFL-PTLYTHFETEKFSCLVMEFC 298 (611)
Q Consensus 220 l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnI-v~l~~~~~~~~~~~LVmE~~ 298 (611)
-++.|+.|-...+|++.....+..|++|+....... +....+|..+|+.|...+| ++++++|.. .+||||+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~----~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I 183 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE----IINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFM 183 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS----CSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh----hcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEee
Confidence 456788899999999988664577899987542110 0011468999988864444 678877742 2599999
Q ss_pred CCCCH
Q 007260 299 PGGDL 303 (611)
Q Consensus 299 ~gg~L 303 (611)
+|..|
T Consensus 184 ~G~~l 188 (458)
T 2qg7_A 184 DGYAL 188 (458)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 87443
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.74 E-value=0.009 Score=58.46 Aligned_cols=59 Identities=14% Similarity=0.037 Sum_probs=44.9
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCeeccCCCCCcEEEccCCcEEEEe
Q 007260 302 DLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHM-LGIIYRDLKPENVLVREDGHIMLSD 361 (611)
Q Consensus 302 ~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~-~gIVHRDLKPeNILv~~~g~vkL~D 361 (611)
+|.++++.. +.+++|++++.++.|.+.+|.-+-. ..-..+=+-|..|+|..+|.|.+.+
T Consensus 34 SL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~ 93 (229)
T 2yle_A 34 SLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP 93 (229)
T ss_dssp EHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC
T ss_pred cHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc
Confidence 688888876 4789999999999999999877621 1222344457899999999887763
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.58 E-value=0.0064 Score=65.52 Aligned_cols=76 Identities=16% Similarity=0.297 Sum_probs=49.7
Q ss_pred EEeEecccCcEEEEEEEECCC-------CeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC-CCCcccccceeecccee
Q 007260 220 LLKRLGCGDIGSVYLSELSGT-------KCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD-HPFLPTLYTHFETEKFS 291 (611)
Q Consensus 220 l~~~LG~G~fG~Vy~a~~~~t-------~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~-HpnIv~l~~~~~~~~~~ 291 (611)
-++.|..|-...+|+...... +..|++|+..... .......+|..+++.|. +.-.+++++.+. -
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t----~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~ 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV----GKFYDSKVELDVFRYLSNINIAPNIIADFP----E 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-----CCCCHHHHHHHHHHHHHTTSSCCEEEEET----T
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc----chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----C
Confidence 356777788899999987531 4679999865422 11111246888888774 334567776443 2
Q ss_pred eEEeeeCCCCCH
Q 007260 292 CLVMEFCPGGDL 303 (611)
Q Consensus 292 ~LVmE~~~gg~L 303 (611)
++||||++|..|
T Consensus 146 ~~I~efI~G~~l 157 (424)
T 3mes_A 146 GRIEEFIDGEPL 157 (424)
T ss_dssp EEEEECCCSEEC
T ss_pred CEEEEEeCCccC
Confidence 789999998653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.13 E-value=0.061 Score=57.10 Aligned_cols=28 Identities=32% Similarity=0.470 Sum_probs=24.3
Q ss_pred eeccCCCCCcEEEc------cCCcEEEEeccccc
Q 007260 339 IIYRDLKPENVLVR------EDGHIMLSDFDLSL 366 (611)
Q Consensus 339 IVHRDLKPeNILv~------~~g~vkL~DFGlA~ 366 (611)
++|+|+.+.|||+. +++.++++||.+|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 68999999999993 45679999999883
|
| >2x6h_A GH13170P, VPS34, phosphotidylinositol 3 kinase 59F; transferase; 2.90A {Drosophila melanogaster} PDB: 2x6f_A 2x6i_A* 2x6j_A* 2x6k_A* | Back alignment and structure |
|---|
Probab=87.89 E-value=4.2 Score=46.11 Aligned_cols=82 Identities=17% Similarity=0.342 Sum_probs=48.2
Q ss_pred ccccceeeccceeeEEeeeCCCCCHHHHHHhCC-----------C--CCC--CHHHHHHHHHHHH--HHHHHHHHcCeec
Q 007260 279 PTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQP-----------G--KYF--PEQAVRFYVAEVL--LALEYLHMLGIIY 341 (611)
Q Consensus 279 v~l~~~~~~~~~~~LVmE~~~gg~L~~ll~~~~-----------~--~~l--~e~~~~~i~~qll--~aL~yLH~~gIVH 341 (611)
++.|.+.......- ++|+++..+|.+++.+.. . ..+ .......|+..++ .-+.|+ .||
T Consensus 476 i~~Y~Vipls~~~G-LIE~V~s~tl~~i~~~~~~l~~~f~~~~p~~~~~~~~~~~ar~nF~~SlA~~Svv~YI--LGl-- 550 (696)
T 2x6h_A 476 LTPYKVLATSSKHG-FLQYVDSCTVAEVLAREGNIHNFFRKHHPCDNGPYGISAEVMDTYIKSCAGYCVITYL--LGV-- 550 (696)
T ss_dssp CCCCCEEESSTTCE-EEECCCCEEHHHHHHHSSSHHHHHHHHSBCTTSSSSBCHHHHHHHHHHHHHHHHHHHH--HTC--
T ss_pred EeccEEEeccCCCC-eeeeCCCccHHHHHHhcChHHHHHHHHCCCccchhhhHHHHHHHHHHHHHHHHHHHHH--ccC--
Confidence 34444444333332 346666666666654431 0 111 1234455555554 334444 333
Q ss_pred cCCCCCcEEEccCCcEEEEecccc
Q 007260 342 RDLKPENVLVREDGHIMLSDFDLS 365 (611)
Q Consensus 342 RDLKPeNILv~~~g~vkL~DFGlA 365 (611)
+|-.++||||+.+|++.-+|||..
T Consensus 551 GDRH~~NILid~tG~v~HIDFG~~ 574 (696)
T 2x6h_A 551 GDRHLDNLLLTTNGKLFHIDFGYI 574 (696)
T ss_dssp CCCCTTTEEECTTSCEEECCCCSC
T ss_pred CCCCCcceEEeCCCCEEEEeehhh
Confidence 688999999999999999999987
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=83.36 E-value=0.072 Score=57.90 Aligned_cols=64 Identities=6% Similarity=0.039 Sum_probs=18.3
Q ss_pred EEEeEecccCcEEEEEEEECCCCeEEEE------EEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceee
Q 007260 219 RLLKRLGCGDIGSVYLSELSGTKCYFAM------KVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFE 286 (611)
Q Consensus 219 ~l~~~LG~G~fG~Vy~a~~~~t~~~vAv------Kii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~ 286 (611)
.+.+.|| ||.||++........||+ |.+..... .++....+.+|..+++.++|||+++.+.+-.
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~-~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGV-SEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccc-cccccccccccccccccccccccCCCcceEE
Confidence 3456676 999999998776567888 66543332 2344445677889999999999999988754
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=80.86 E-value=1.8 Score=41.88 Aligned_cols=83 Identities=12% Similarity=0.091 Sum_probs=58.7
Q ss_pred CCCCcccccceeeccceeeEEeeeCC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEc
Q 007260 274 DHPFLPTLYTHFETEKFSCLVMEFCP-GGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVR 352 (611)
Q Consensus 274 ~HpnIv~l~~~~~~~~~~~LVmE~~~-gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~ 352 (611)
.||+++.. .+-+.++.+.|.++.-+ +-++.. ++ .++.....+++.+|+...++++ .=+|=-|.|+||+++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik-----~~~~~eKlr~l~ni~~l~~~~~--~r~tf~L~P~NL~f~ 113 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK-----SFTKNEKLRYLLNIKNLEEVNR--TRYTFVLAPDELFFT 113 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG-----GSCHHHHHHHHHHGGGGGGGGG--SSEECCCSGGGEEEC
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH-----hcCHHHHHHHHHHHHHHHHHhc--CceEEEEecceEEEc
Confidence 68888876 45566666666666543 223332 22 2678888888888888775443 346677899999999
Q ss_pred cCCcEEEEecccc
Q 007260 353 EDGHIMLSDFDLS 365 (611)
Q Consensus 353 ~~g~vkL~DFGlA 365 (611)
.++.+++.-.|+-
T Consensus 114 ~~~~p~i~~RGik 126 (215)
T 4ann_A 114 RDGLPIAKTRGLQ 126 (215)
T ss_dssp TTSCEEESCCEET
T ss_pred CCCCEEEEEccCc
Confidence 9999999988863
|
| >3ls8_A Phosphatidylinositol 3-kinase catalytic subunit type 3; alpha/beta protein, PIK3C3, compound 15E, structural genomics, SGC stockholm; HET: AJZ; 2.25A {Homo sapiens} PDB: 3ihy_A | Back alignment and structure |
|---|
Probab=80.10 E-value=28 Score=38.75 Aligned_cols=116 Identities=18% Similarity=0.289 Sum_probs=61.9
Q ss_pred EEEEEEecchhhhhHHHHHHHHHHHH-HHHhCCCCCcccccceeeccceeeEEeeeCCCCCHHHHHHhC-----------
Q 007260 243 YFAMKVMDKASLAGRKKLLRAQTERE-ILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQ----------- 310 (611)
Q Consensus 243 ~vAvKii~k~~~~~~~~~~~~~~E~~-iL~~l~HpnIv~l~~~~~~~~~~~LVmE~~~gg~L~~ll~~~----------- 310 (611)
.+++|. .+.+.......++.+-++ +|++-+-.--++.|.+.......- ++|++++.++.+++...
T Consensus 367 ~~i~K~--gDDLRQD~~~~Ql~~l~n~il~~~~ldL~i~~Y~Vipls~~~G-lIE~V~~~tl~~il~~~~~l~~~f~~~~ 443 (614)
T 3ls8_A 367 PVIFKH--GDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHG-FMQFIQSVPVAEVLDTEGSIQNFFRKYA 443 (614)
T ss_dssp EEEEEE--SSCCHHHHHHHHHHHHHHHHHHHTTCCCCCCCCCEEESSSSEE-EEECCCCEEHHHHHHHTSSHHHHHHHHS
T ss_pred EEEEec--CCcchHHHHHHHHHHHHHHHHHhcCCCceeeccEEEEecCCCc-eEEEeCCccHHHHHHccChHHHHHHHhC
Confidence 456665 233333333333333333 233222222245555554444333 35777765665554322
Q ss_pred CCCC----CCHHHHHHHHHHHHH--HHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccc
Q 007260 311 PGKY----FPEQAVRFYVAEVLL--ALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365 (611)
Q Consensus 311 ~~~~----l~e~~~~~i~~qll~--aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA 365 (611)
+... ..+.....|++.++- -+.|+ .|| +|=.++||||+.+|++.=+|||..
T Consensus 444 ~~~~~~~~~~~~a~~nF~~S~A~ySvv~YI--LGi--gDRH~~NILld~tG~v~HIDFG~~ 500 (614)
T 3ls8_A 444 PSENGPNGISAEVMDTYVKSCAGYCVITYI--LGV--GDRHLDNLLLTKTGKLFHIDFGYI 500 (614)
T ss_dssp BCTTSGGGBCHHHHHHHHHHHHHHHHHHHH--HTC--CCCCTTSEEECTTSCEEECCCSSC
T ss_pred CCccccccccHHHHHHHHHHHHHHhHhhee--eec--cCCCCcceeEcCCCCEeeeehHHh
Confidence 1100 123455566665543 34444 444 588899999999999999999987
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 611 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-49 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-45 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-23 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-43 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-42 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-27 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-42 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-35 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-40 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-28 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-40 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-26 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-40 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-23 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 9e-40 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-24 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-39 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-29 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-39 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-38 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 9e-24 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-38 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-22 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-38 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-38 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-38 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-38 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-25 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-38 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-30 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-37 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-17 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-37 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-36 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-31 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-36 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-36 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-20 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-27 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-36 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-26 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-36 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-32 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 9e-36 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-16 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-35 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-35 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-16 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-27 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-35 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-35 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-15 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-35 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-13 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-35 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-17 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-35 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-15 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-35 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-15 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-35 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-34 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-24 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-34 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-26 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-33 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-17 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-33 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-20 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-33 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-16 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-33 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-11 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-33 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-17 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-32 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-19 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-31 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-15 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-31 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-29 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 8e-31 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 9e-31 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 9e-22 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-30 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-13 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-30 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-15 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-30 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-16 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-29 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-12 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-29 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-16 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-28 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-14 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 9e-28 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-13 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-27 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-27 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-07 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 9e-27 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-14 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-26 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-13 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-26 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-15 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-16 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 2e-49
Identities = 62/345 (17%), Positives = 113/345 (32%), Gaps = 47/345 (13%)
Query: 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHP 276
F + LG G+ G V+ + A K++ + + E ++L + P
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN--QIIRELQVLHECNSP 64
Query: 277 FLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLH- 335
++ Y F ++ + ME GG L + +K PEQ + V+ L YL
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLRE 122
Query: 336 MLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQP 395
I++RD+KP N+LV G I L DF +S + ++ + +
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDSMANS-------------FVGTR 167
Query: 396 ACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455
+ + P +Q + + ++S + + E R
Sbjct: 168 SYMSPERLQGTHYSVQSD---IWS-------------------MGLSLVEMAVGRYPIPP 205
Query: 456 GTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFP 514
+ L EG + +G L +V +P
Sbjct: 206 PDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKL 265
Query: 515 ESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNW 559
S V S +D + L+K P R ++ H F + +
Sbjct: 266 PSGVFSLEFQDFVNKCLIKNPAERA----DLKQLMVHAFIKRSDA 306
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 4e-45
Identities = 51/200 (25%), Positives = 85/200 (42%), Gaps = 17/200 (8%)
Query: 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHP 276
+ ++ LG G G VY ++ T A KV+D S + + E +IL S DHP
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMV---EIDILASCDHP 69
Query: 277 FLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHM 336
+ L F E +++EFC GG + + + + E ++ + L AL YLH
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHD 128
Query: 337 LGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPA 396
II+RDLK N+L DG I L+DF + S+ + +++ + P
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGV-------------SAKNTRTIQRRDSFIGTPY 175
Query: 397 CIEPSCIQPSCVTPTCFSPR 416
+ P + + +
Sbjct: 176 WMAPEVVMCETSKDRPYDYK 195
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.4 bits (242), Expect = 5e-23
Identities = 30/125 (24%), Positives = 49/125 (39%), Gaps = 10/125 (8%)
Query: 445 EPTEARSMSFVGTHEYLAPEII-----KGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGN 499
T R SF+GT ++APE++ K + D W+ GI L E+ + P
Sbjct: 161 TRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP 220
Query: 500 RATLFNVV-GQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVN 558
L + +P + S +D ++ L K R +++ QHPF +
Sbjct: 221 MRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARW----TTSQLLQHPFVTVDS 276
Query: 559 WALIR 563
IR
Sbjct: 277 NKPIR 281
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 156 bits (395), Expect = 2e-43
Identities = 75/348 (21%), Positives = 124/348 (35%), Gaps = 61/348 (17%)
Query: 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DH 275
++L+++LG G V+ + +K++ +KK+ R E +IL++L
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKR---EIKILENLRGG 89
Query: 276 PFLPTLYTHFE--TEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEY 333
P + TL + + LV E D L Q + +RFY+ E+L AL+Y
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDY 144
Query: 334 LHMLGIIYRDLKPENVLV-REDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYC 392
H +GI++RD+KP NV++ E + L D+ L+ P ++ V
Sbjct: 145 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY--------------HPGQEYNVRV 190
Query: 393 VQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452
P + + D + L ++A +
Sbjct: 191 ASRYFKGPELLVDYQMYDY-----------SLD----------MWSLGCMLASMIFRKEP 229
Query: 453 SFVGTHEYLAPE-IIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPL 511
F G Y I K G D+ + F + S R F +
Sbjct: 230 FFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERF------V 283
Query: 512 RFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNW 559
+VS A D + LL + Q RL A E +HP+F V
Sbjct: 284 HSENQHLVSPEALDFLDKLLRYDHQSRL----TAREAMEHPYFYTVVK 327
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 3e-42
Identities = 52/151 (34%), Positives = 78/151 (51%), Gaps = 2/151 (1%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD 274
L F + + LG G G+VYL+ +K A+KV+ KA L + + E EI L
Sbjct: 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64
Query: 275 HPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYL 334
HP + LY +F L++E+ P G ++ QK F EQ Y+ E+ AL Y
Sbjct: 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYC 122
Query: 335 HMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
H +I+RD+KPEN+L+ G + ++DF S
Sbjct: 123 HSKRVIHRDIKPENLLLGSAGELKIADFGWS 153
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 2e-27
Identities = 37/113 (32%), Positives = 53/113 (46%), Gaps = 6/113 (5%)
Query: 442 LIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRA 501
+R + GT +YL PE+I+G H VD W+ G+ YE L GK PF+ + +
Sbjct: 152 WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 211
Query: 502 TLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
T + FP+ V+ ARDLI LL P R E+ +HP+
Sbjct: 212 TYKRISRVEFTFPDF--VTEGARDLISRLLKHNPSQRP----MLREVLEHPWI 258
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 4e-42
Identities = 57/168 (33%), Positives = 88/168 (52%), Gaps = 2/168 (1%)
Query: 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHP 276
F+ K LG G +V L+ T +A+K+++K + K+ ER+++ LDHP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 277 FLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHM 336
F LY F+ ++ + + G+L +K F E RFY AE++ ALEYLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHG 126
Query: 337 LGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEP 384
GII+RDLKPEN+L+ ED HI ++DF + + +A+S
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 174
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 6e-35
Identities = 43/129 (33%), Positives = 65/129 (50%), Gaps = 4/129 (3%)
Query: 445 EPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLF 504
E +AR+ SFVGT +Y++PE++ + + D W G +Y+L+ G PF+
Sbjct: 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ 220
Query: 505 NVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYK--RGATEIKQHPFFEGVNWALI 562
++ FPE ARDL+ LLV + RL + G +K HPFFE V W +
Sbjct: 221 KIIKLEYDFPEK--FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 278
Query: 563 RCATPPEIP 571
TPP++
Sbjct: 279 HQQTPPKLT 287
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 149 bits (376), Expect = 1e-40
Identities = 40/153 (26%), Positives = 69/153 (45%), Gaps = 6/153 (3%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD 274
L H+ + + LG G G V+ T FA K + + ++ + + E + + L
Sbjct: 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRK---EIQTMSVLR 81
Query: 275 HPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYL 334
HP L L+ FE + ++ EF GG+L + K E Y+ +V L ++
Sbjct: 82 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHM 140
Query: 335 HMLGIIYRDLKPENVLV--REDGHIMLSDFDLS 365
H ++ DLKPEN++ + + L DF L+
Sbjct: 141 HENNYVHLDLKPENIMFTTKRSNELKLIDFGLT 173
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 113 bits (284), Expect = 4e-28
Identities = 39/152 (25%), Positives = 59/152 (38%), Gaps = 7/152 (4%)
Query: 450 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ 509
GT E+ APE+ +G+ G D W+ G+ Y LL G +PF G + TL NV
Sbjct: 181 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC 240
Query: 510 PLRFPES--PVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIRCATP 567
+S +S +D IR LL+ +P R+ + +HP+ N P
Sbjct: 241 DWNMDDSAFSGISEDGKDFIRKLLLADPNTRM----TIHQALEHPWLTPGNAPGRDSQIP 296
Query: 568 PEIPKPVEIERIPAPTSSTSEKTAPTMVPPNQ 599
+ + I + E P N
Sbjct: 297 SSRYTKI-RDSIKTKYDAWPEPLPPLGRISNY 327
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 148 bits (375), Expect = 2e-40
Identities = 42/169 (24%), Positives = 75/169 (44%), Gaps = 7/169 (4%)
Query: 199 RWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRK 258
+ Q V + G + ++ +L+ LG G G V+ T F K ++ +
Sbjct: 13 KKYVPQPVEVKQGSV-YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY 71
Query: 259 KLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQ 318
+ E I+ L HP L L+ FE + L++EF GG+L + K E
Sbjct: 72 TVKN---EISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEA 127
Query: 319 AVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVR--EDGHIMLSDFDLS 365
V Y+ + L+++H I++ D+KPEN++ + + + DF L+
Sbjct: 128 EVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLA 176
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 106 bits (266), Expect = 8e-26
Identities = 44/171 (25%), Positives = 69/171 (40%), Gaps = 11/171 (6%)
Query: 447 TEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNV 506
+ T E+ APEI+ E G D W G+ Y LL G +PF G + TL NV
Sbjct: 181 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV 240
Query: 507 VGQPLRFPES--PVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIRC 564
F E VS A+D I+ LL KEP+ RL + +HP+ +G + + +
Sbjct: 241 KRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL----TVHDALEHPWLKG-DHSNLTS 295
Query: 565 ATP----PEIPKPVEIERIPAPTSSTSEKTAPTMVPPNQRGSDNYLEFDFF 611
P +I + ++ + P + + Y +D +
Sbjct: 296 RIPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRKHRPQEYQIYDSY 346
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 146 bits (370), Expect = 3e-40
Identities = 43/150 (28%), Positives = 62/150 (41%), Gaps = 2/150 (1%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH 275
F L+ +G G G+VY + A+K M + +K E LQ L H
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 276 PFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLH 335
P + E + LVME+C G L + K E + L L YLH
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLH 132
Query: 336 MLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+I+RD+K N+L+ E G + L DF +
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSA 162
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 97.4 bits (242), Expect = 7e-23
Identities = 30/108 (27%), Positives = 45/108 (41%), Gaps = 7/108 (6%)
Query: 450 RSMSFVGTHEYLAPEIIKGEGHG---SAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNV 506
+ SFVGT ++APE+I G VD W+ GI EL K P + L+++
Sbjct: 167 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226
Query: 507 VGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
+S S R+ + L K PQ R + + +H F
Sbjct: 227 AQNESPALQSGHWSEYFRNFVDSCLQKIPQDRP----TSEVLLKHRFV 270
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 9e-40
Identities = 42/151 (27%), Positives = 75/151 (49%), Gaps = 4/151 (2%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD 274
+ + L++ LG G G V L+ T+ A+K++D + + E I + L+
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICINKMLN 61
Query: 275 HPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYL 334
H + Y H L +E+C GG+L + PE + + +++ + YL
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYL 119
Query: 335 HMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
H +GI +RD+KPEN+L+ E ++ +SDF L+
Sbjct: 120 HGIGITHRDIKPENLLLDERDNLKISDFGLA 150
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 1e-24
Identities = 31/141 (21%), Positives = 56/141 (39%), Gaps = 14/141 (9%)
Query: 424 KDRKPKNEIGNQVSPL--------PELIAEPTEARSMSFVGTHEYLAPEIIKGEG-HGSA 474
+D KP+N + ++ L E GT Y+APE++K H
Sbjct: 127 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 186
Query: 475 VDWWTFGIFLYELLFGKTPFKGSGNRATLF-NVVGQPLRFPESPVVSFAARDLIRGLLVK 533
VD W+ GI L +L G+ P+ + + + + + A L+ +LV+
Sbjct: 187 VDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVE 246
Query: 534 EPQHRLAYKRGATEIKQHPFF 554
P R+ +IK+ ++
Sbjct: 247 NPSARI----TIPDIKKDRWY 263
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 144 bits (365), Expect = 6e-39
Identities = 51/156 (32%), Positives = 83/156 (53%), Gaps = 5/156 (3%)
Query: 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTERE---I 269
L ++ F + + +G G G VY + T +AMK +DK + ++ A ER +
Sbjct: 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 60
Query: 270 LQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLL 329
+ + D PF+ + F T +++ GGDLH + F E +RFY AE++L
Sbjct: 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIIL 118
Query: 330 ALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
LE++H ++YRDLKP N+L+ E GH+ +SD L+
Sbjct: 119 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 154
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 116 bits (291), Expect = 5e-29
Identities = 54/197 (27%), Positives = 91/197 (46%), Gaps = 13/197 (6%)
Query: 425 DRKPKN----EIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEII-KGEGHGSAVDWWT 479
D KP N E G+ L + ++ + + VGTH Y+APE++ KG + S+ DW++
Sbjct: 132 DLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFS 191
Query: 480 FGIFLYELLFGKTPFKGSGNR---ATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQ 536
G L++LL G +PF+ + + + P+S S R L+ GLL ++
Sbjct: 192 LGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS--FSPELRSLLEGLLQRDVN 249
Query: 537 HRL-AYKRGATEIKQHPFFEGVNWALI--RCATPPEIPKPVEIERIPAPTSSTSEKTAPT 593
RL RGA E+K+ PFF ++W ++ + PP IP E+ A + ++
Sbjct: 250 RRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTK 309
Query: 594 MVPPNQRGSDNYLEFDF 610
+ + Y F
Sbjct: 310 GIKLLDSDQELYRNFPL 326
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 8e-39
Identities = 72/357 (20%), Positives = 112/357 (31%), Gaps = 63/357 (17%)
Query: 220 LLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTERE--ILQSLDHPF 277
L LG G +VY + T A+K + + K + RE +LQ L HP
Sbjct: 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPN 61
Query: 278 LPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHML 337
+ L F + LV +F ++ ++ Y+ L LEYLH
Sbjct: 62 IIGLLDAFGHKSNISLVFDFMETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 338 GIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPAC 397
I++RDLKP N+L+ E+G + L+DF L+
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS--------------------------- 152
Query: 398 IEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGT 457
VT +P L ++ L EL+ R G
Sbjct: 153 -PNRAYTHQVVTRWYRAPELLFGARMYG--VGVDMWAVGCILAELL-----LRVPFLPGD 204
Query: 458 HEY-LAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPES 516
+ I + G + W + F P G PL
Sbjct: 205 SDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP--------------GIPLH-HIF 249
Query: 517 PVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIRCATPPEIPKP 573
DLI+GL + P R+ AT+ + +F ++P+P
Sbjct: 250 SAAGDDLLDLIQGLFLFNPCARI----TATQALKMKYFSNRPGP----TPGCQLPRP 298
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 141 bits (357), Expect = 1e-38
Identities = 42/156 (26%), Positives = 69/156 (44%), Gaps = 9/156 (5%)
Query: 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLL------RAQTEREIL 270
++ + LG G V T +A+K++D E +IL
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 271 QSL-DHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLL 329
+ + HP + L +ET F LV + G+L ++ E+ R + +L
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLE 121
Query: 330 ALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+ LH L I++RDLKPEN+L+ +D +I L+DF S
Sbjct: 122 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 157
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 99.0 bits (246), Expect = 9e-24
Identities = 39/114 (34%), Positives = 52/114 (45%), Gaps = 12/114 (10%)
Query: 450 RSMSFVGTHEYLAPEIIKGE------GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATL 503
+ GT YLAPEII+ G+G VD W+ G+ +Y LL G PF L
Sbjct: 165 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 224
Query: 504 FNVVGQPLRF--PESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFE 555
++ +F PE S +DL+ LV +PQ R A E HPFF+
Sbjct: 225 RMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY----TAEEALAHPFFQ 274
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (355), Expect = 2e-38
Identities = 40/157 (25%), Positives = 69/157 (43%), Gaps = 10/157 (6%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF 277
+ +L +G G G K +D S+ + +E +L+ L HP
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPN 64
Query: 278 LPTLYTHF--ETEKFSCLVMEFCPGGDLHTL--RQKQPGKYFPEQAVRFYVAEVLLALEY 333
+ Y T +VME+C GGDL ++ + + +Y E+ V + ++ LAL+
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 334 LHMLG-----IIYRDLKPENVLVREDGHIMLSDFDLS 365
H +++RDLKP NV + ++ L DF L+
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.3 bits (234), Expect = 4e-22
Identities = 28/112 (25%), Positives = 45/112 (40%), Gaps = 7/112 (6%)
Query: 443 IAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRAT 502
I + + +FVGT Y++PE + + D W+ G LYEL PF +
Sbjct: 163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL 222
Query: 503 LFNVV-GQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPF 553
+ G+ R P S ++I +L + HR EI ++P
Sbjct: 223 AGKIREGKFRRIPYR--YSDELNEIITRMLNLKDYHRP----SVEEILENPL 268
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 2e-38
Identities = 70/391 (17%), Positives = 124/391 (31%), Gaps = 71/391 (18%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF 277
+ K +G G G VY ++L + A+K + + E +I++ LDH
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLDHCN 74
Query: 278 LPTLYTHFET------EKFSCLVMEFCPGGDLHTLRQ-KQPGKYFPEQAVRFYVAEVLLA 330
+ L F + E + LV+++ P R + + P V+ Y+ ++ +
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 331 LEYLHMLGIIYRDLKPENVLVREDGHIM-LSDFDLSLRCAVSPTLIKASSLDAEPLRKNP 389
L Y+H GI +RD+KP+N+L+ D ++ L DF + +
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-------------------- 174
Query: 390 VYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449
+ +P L + V ++AE
Sbjct: 175 ---------RGEPNVSYICSRYYRAPELIFGATDYTSS------IDVWSAGCVLAELLLG 219
Query: 450 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ 509
+ + + EIIK G + E F +
Sbjct: 220 QPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK--------------AH 265
Query: 510 PLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIRCATPPE 569
P P A L LL P RL E H FF+ + ++ +
Sbjct: 266 PWTKVFRPRTPPEAIALCSRLLEYTPTARL----TPLEACAHSFFDELRDPNVKLPNGRD 321
Query: 570 IPKPVEIERIPAPTSSTSEKTAPTMVPPNQR 600
P S++ A ++PP+ R
Sbjct: 322 TPALFNFTTQEL---SSNPPLATILIPPHAR 349
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 2e-38
Identities = 62/370 (16%), Positives = 111/370 (30%), Gaps = 58/370 (15%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH 275
+ L +G G G V + + K A+K + + R E +IL H
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ--RTLREIKILLRFRH 65
Query: 276 PFLPTLYTHFETEKFS----CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLAL 331
+ + ++ G DL+ L + Q + +++ ++L L
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH---LSNDHICYFLYQILRGL 122
Query: 332 EYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVY 391
+Y+H +++RDLKP N+L+ + + DF L+ + + D + Y
Sbjct: 123 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA----------RVADPDHDHTGFLTEY 172
Query: 392 CVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451
P + S +I + L E++ +
Sbjct: 173 VATRWYRAPEIMLNSKGYT-----------------KSIDIWSVGCILAEML-----SNR 210
Query: 452 MSFVGTHEY-LAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQP 510
F G H I+ G S D P K LF
Sbjct: 211 PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLF------ 264
Query: 511 LRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIRCATPPEI 570
P A DL+ +L P R+ + HP+ E
Sbjct: 265 ------PNADSKALDLLDKMLTFNPHKRI----EVEQALAHPYLEQYYDPSDEPIAEAPF 314
Query: 571 PKPVEIERIP 580
+E++ +P
Sbjct: 315 KFDMELDDLP 324
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (357), Expect = 5e-38
Identities = 65/363 (17%), Positives = 123/363 (33%), Gaps = 53/363 (14%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD 274
L ++ LK +G G G V + + A+K + + + RA E +++ ++
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 74
Query: 275 HPFLPTLYTHFETEKFS------CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVL 328
H + +L F +K LVME ++ + + + + ++L
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-----MELDHERMSYLLYQML 129
Query: 329 LALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKN 388
+++LH GII+RDLKP N++V+ D + + DF L+
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---------------------- 167
Query: 389 PVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTE 448
+ P VT +P + K+ +G + E++
Sbjct: 168 -------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG---CIMGEMV----- 212
Query: 449 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG 508
+ F G + + ++ P LF
Sbjct: 213 RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSL 272
Query: 509 QPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIRCATPP 568
P + + + ARDL+ +LV +P R+ + QHP+ A PP
Sbjct: 273 FPADSEHNKLKASQARDLLSKMLVIDPAKRI----SVDDALQHPYINVWYDPAEVEAPPP 328
Query: 569 EIP 571
+I
Sbjct: 329 QIY 331
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 6e-38
Identities = 35/149 (23%), Positives = 68/149 (45%), Gaps = 6/149 (4%)
Query: 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHP 276
+ +++G G G+VY + T A++ M+ ++ ++ E +++ +P
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN---EILVMRENKNP 77
Query: 277 FLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHM 336
+ + +VME+ GG L + + E + E L ALE+LH
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHS 134
Query: 337 LGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+I+RD+K +N+L+ DG + L+DF
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFC 163
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 2e-25
Identities = 33/143 (23%), Positives = 58/143 (40%), Gaps = 17/143 (11%)
Query: 445 EPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLF 504
P +++ + VGT ++APE++ + +G VD W+ GI E++ G+ P+ L+
Sbjct: 167 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 226
Query: 505 NVV-GQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIR 563
+ +S RD + L + + R A E+ QH F +
Sbjct: 227 LIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRG----SAKELLQHQFL--------K 274
Query: 564 CATPPEIPKPVEIERIPAPTSST 586
A P P+ I A +T
Sbjct: 275 IAKPLSSLTPL----IAAAKEAT 293
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 140 bits (354), Expect = 7e-38
Identities = 59/151 (39%), Positives = 90/151 (59%), Gaps = 2/151 (1%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD 274
L F++L+ LG G G V+L Y+AMKV+ K + K++ ER +L +
Sbjct: 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62
Query: 275 HPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYL 334
HPF+ ++ F+ + ++M++ GG+L +L +K FP +FY AEV LALEYL
Sbjct: 63 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYL 120
Query: 335 HMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
H IIYRDLKPEN+L+ ++GHI ++DF +
Sbjct: 121 HSKDIIYRDLKPENILLDKNGHIKITDFGFA 151
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 119 bits (298), Expect = 2e-30
Identities = 43/137 (31%), Positives = 72/137 (52%), Gaps = 5/137 (3%)
Query: 444 AEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATL 503
A+ + + GT +Y+APE++ + + ++DWW+FGI +YE+L G TPF S T
Sbjct: 151 AKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY 210
Query: 504 FNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKR-GATEIKQHPFFEGVNWA-- 560
++ LRFP P + +DL+ L+ ++ RL + G ++K HP+F+ V W
Sbjct: 211 EKILNAELRFP--PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKL 268
Query: 561 LIRCATPPEIPKPVEIE 577
L R P P + +
Sbjct: 269 LSRNIETPYEPPIQQGQ 285
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 1e-37
Identities = 35/150 (23%), Positives = 66/150 (44%), Gaps = 6/150 (4%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH 275
+ +R+G G G+VY + G A+K+++ + ++L + E +L+ H
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRH 63
Query: 276 PFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLH 335
+ + T +V ++C G L+ K F + + ++YLH
Sbjct: 64 VNILLFM-GYSTAPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLH 121
Query: 336 MLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
II+RDLK N+ + ED + + DF L+
Sbjct: 122 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLA 151
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.8 bits (199), Expect = 2e-17
Identities = 26/112 (23%), Positives = 45/112 (40%), Gaps = 11/112 (9%)
Query: 447 TEARSMSFVGTHEYLAPEIIKGEGHG---SAVDWWTFGIFLYELLFGKTPFKGSGNRATL 503
+ G+ ++APE+I+ + D + FGI LYEL+ G+ P+ NR +
Sbjct: 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 218
Query: 504 FNVVGQPLRFPE----SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQH 551
+VG+ P+ A + L+ L K+ R +I
Sbjct: 219 IFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPL----FPQILAS 266
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 2e-37
Identities = 63/341 (18%), Positives = 112/341 (32%), Gaps = 56/341 (16%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD 274
+ + L+++G G G+V+ ++ T A+K + A E +L+ L
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK 59
Query: 275 HPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYL 334
H + L+ ++K LV EFC + V+ ++ ++L L +
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKY--FDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 335 HMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQ 394
H +++RDLKP+N+L+ +G + L++F L+ +
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--------------------- 156
Query: 395 PACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454
C VT P + + + AE A F
Sbjct: 157 -------CYSAEVVTLWYRPPDVLFGAKLYSTS------IDMWSAGCIFAELANAGRPLF 203
Query: 455 VGTHEY-LAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRF 513
G I + G + W + + P S
Sbjct: 204 PGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTS--------------LV 249
Query: 514 PESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
P ++ RDL++ LL P R+ A E QHP+F
Sbjct: 250 NVVPKLNATGRDLLQNLLKCNPVQRI----SAEEALQHPYF 286
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 2e-36
Identities = 55/152 (36%), Positives = 85/152 (55%), Gaps = 3/152 (1%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQ-SL 273
+ F L K LG G G V+L+E T +FA+K + K + + E+ +L +
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 274 DHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEY 333
+HPFL ++ F+T++ VME+ GGDL Q F FY AE++L L++
Sbjct: 61 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQF 118
Query: 334 LHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
LH GI+YRDLK +N+L+ +DGHI ++DF +
Sbjct: 119 LHSKGIVYRDLKLDNILLDKDGHIKIADFGMC 150
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 1e-31
Identities = 45/131 (34%), Positives = 73/131 (55%), Gaps = 7/131 (5%)
Query: 445 EPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLF 504
+A++ +F GT +Y+APEI+ G+ + +VDWW+FG+ LYE+L G++PF G
Sbjct: 154 MLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 213
Query: 505 NVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALI-- 562
++ +P + A+DL+ L V+EP+ RL +I+QHP F +NW +
Sbjct: 214 SIRMDNPFYPRW--LEKEAKDLLVKLFVREPEKRLGV---RGDIRQHPLFREINWEELER 268
Query: 563 RCATPPEIPKP 573
+ PP PK
Sbjct: 269 KEIDPPFRPKV 279
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 4e-36
Identities = 67/348 (19%), Positives = 114/348 (32%), Gaps = 56/348 (16%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD 274
+S + L ++G G G V+ + T A+K + + + A E +ILQ L
Sbjct: 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLK 67
Query: 275 HPFLPTLYTHFETEKFS--------CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAE 326
H + L T+ LV +FC L E ++ +
Sbjct: 68 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE--IKRVMQM 125
Query: 327 VLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLR 386
+L L Y+H I++RD+K NVL+ DG + L+DF L+ +++
Sbjct: 126 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK-------------- 171
Query: 387 KNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEP 446
+P+ VT P L + + ++AE
Sbjct: 172 ----------NSQPNRYTNRVVTLWYRPPELLLGERDYGPP------IDLWGAGCIMAEM 215
Query: 447 TEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNV 506
+ T ++ I + G + W + + + L
Sbjct: 216 WTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAY 275
Query: 507 VGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
V P A DLI LLV +P R+ + + H FF
Sbjct: 276 VRDPY-----------ALDLIDKLLVLDPAQRI----DSDDALNHDFF 308
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 134 bits (337), Expect = 5e-36
Identities = 39/161 (24%), Positives = 69/161 (42%), Gaps = 6/161 (3%)
Query: 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHP 276
+ L + LG G + V+L+ A+KV+ LR + E + +L+HP
Sbjct: 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 67
Query: 277 FLPTLYTHFETE----KFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALE 332
+ +Y E E +VME+ G L + + + +A+ AL
Sbjct: 68 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALN 125
Query: 333 YLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 373
+ H GII+RD+KP N+++ + + DF ++ A S
Sbjct: 126 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 166
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 89.0 bits (220), Expect = 3e-20
Identities = 24/96 (25%), Positives = 47/96 (48%), Gaps = 2/96 (2%)
Query: 447 TEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNV 506
+ ++ + +GT +YL+PE +G+ + D ++ G LYE+L G+ PF G + +
Sbjct: 167 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH 226
Query: 507 VGQPLRFPES--PVVSFAARDLIRGLLVKEPQHRLA 540
V + P + +S ++ L K P++R
Sbjct: 227 VREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQ 262
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 136 bits (342), Expect = 5e-36
Identities = 60/186 (32%), Positives = 96/186 (51%), Gaps = 7/186 (3%)
Query: 183 SSFSSSINKPHKANDLRWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKC 242
S + K + +WE L F +K LG G G V L + +
Sbjct: 13 ESVKEFLAKAKEDFLKKWE-----TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGN 67
Query: 243 YFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGD 302
++AMK++DK + K++ E+ ILQ+++ PFL L F+ +VME+ GG+
Sbjct: 68 HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE 127
Query: 303 LHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDF 362
+ + ++ F E RFY A+++L EYLH L +IYRDLKPEN+L+ + G+I ++DF
Sbjct: 128 MFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 363 DLSLRC 368
+ R
Sbjct: 186 GFAKRV 191
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 109 bits (273), Expect = 9e-27
Identities = 46/133 (34%), Positives = 64/133 (48%), Gaps = 5/133 (3%)
Query: 443 IAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRAT 502
A+ + R+ + GT E LAPEII +G+ AVDWW G+ +YE+ G PF
Sbjct: 187 FAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 503 LFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKR-GATEIKQHPFFEGVNWAL 561
+V +RFP S +DL+R LL + R + G +IK H +F +W
Sbjct: 247 YEKIVSGKVRFPSH--FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 304
Query: 562 I--RCATPPEIPK 572
I R P IPK
Sbjct: 305 IYQRKVEAPFIPK 317
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 134 bits (339), Expect = 6e-36
Identities = 50/152 (32%), Positives = 80/152 (52%), Gaps = 7/152 (4%)
Query: 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHP 276
+ LG G V L+E T+ A+K + K +L G++ + E +L + HP
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEG--SMENEIAVLHKIKHP 67
Query: 277 FLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHM 336
+ L +E+ L+M+ GG+L ++ ++ E+ + +VL A++YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHD 125
Query: 337 LGIIYRDLKPENVLVR---EDGHIMLSDFDLS 365
LGI++RDLKPEN+L ED IM+SDF LS
Sbjct: 126 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLS 157
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 107 bits (267), Expect = 3e-26
Identities = 38/153 (24%), Positives = 62/153 (40%), Gaps = 13/153 (8%)
Query: 450 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ 509
+ GT Y+APE++ + + AVD W+ G+ Y LL G PF + ++
Sbjct: 165 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA 224
Query: 510 PLRF--PESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIRCATP 567
F P +S +A+D IR L+ K+P+ R + QHP+ G
Sbjct: 225 EYEFDSPYWDDISDSAKDFIRHLMEKDPEKRF----TCEQALQHPWIAGDTA------LD 274
Query: 568 PEIPKPVEIERIPAPTSSTSEKTAPTMVPPNQR 600
I + V E+I + + K A +
Sbjct: 275 KNIHQSVS-EQIKKNFAKSKWKQAFNATAVVRH 306
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 6e-36
Identities = 59/153 (38%), Positives = 88/153 (57%), Gaps = 2/153 (1%)
Query: 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQS 272
+ ++ F LK LG G G V L T Y+AMK++ K + + ++ TE +LQ+
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 273 LDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALE 332
HPFL L F+T C VME+ GG+L ++ F E+ RFY AE++ ALE
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALE 119
Query: 333 YLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
YLH ++YRD+K EN+++ +DGHI ++DF L
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC 152
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 1e-32
Identities = 53/170 (31%), Positives = 84/170 (49%), Gaps = 12/170 (7%)
Query: 446 PTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFN 505
A +F GT EYLAPE+++ +G AVDWW G+ +YE++ G+ PF +
Sbjct: 157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 216
Query: 506 VVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKR-GATEIKQHPFFEGVNWALI-- 562
++ + +RFP + +S A+ L+ GLL K+P+ RL A E+ +H FF +NW +
Sbjct: 217 ILMEEIRFPRT--LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQ 274
Query: 563 RCATPPEIPKPVEIERIPAPTS---STSEKTAPTMVPPNQRGSDNYLEFD 609
+ PP P+ T + T+ PP++ S LE D
Sbjct: 275 KKLLPPFKPQV----TSEVDTRYFDDEFTAQSITITPPDRYDSLGLLELD 320
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 9e-36
Identities = 39/150 (26%), Positives = 67/150 (44%), Gaps = 6/150 (4%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH 275
LK LG G G V + G A+K++ + S+ + + E +++ +L H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSM-SEDEFIE---EAKVMMNLSH 58
Query: 276 PFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLH 335
L LY ++ ++ E+ G L ++ + F Q + +V A+EYL
Sbjct: 59 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLE 117
Query: 336 MLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
++RDL N LV + G + +SDF LS
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLS 147
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.4 bits (190), Expect = 2e-16
Identities = 20/114 (17%), Positives = 41/114 (35%), Gaps = 6/114 (5%)
Query: 439 LPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELL-FGKTPFKGS 497
L + + S+ + PE++ S D W FG+ ++E+ GK P++
Sbjct: 146 LSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 205
Query: 498 GNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQH 551
N T ++ Q LR + S ++ ++ R + +
Sbjct: 206 TNSETAEHIA-QGLRLYRPHLASEKVYTIMYSCWHEKADERPT----FKILLSN 254
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 1e-35
Identities = 71/364 (19%), Positives = 128/364 (35%), Gaps = 68/364 (18%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH 275
+ +R L+ +G G G+V + T A+K + + RA E +L+ + H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMRH 76
Query: 276 PFLPTLYTHFETEKFS------CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLL 329
+ L F ++ LVM F ++ ++ E ++F V ++L
Sbjct: 77 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK----LGEDRIQFLVYQMLK 132
Query: 330 ALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNP 389
L Y+H GII+RDLKP N+ V ED + + DF L
Sbjct: 133 GLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL------------------------- 167
Query: 390 VYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449
A S + VT +P + + + + + + ++AE
Sbjct: 168 ------ARQADSEMTGYVVTRWYRAPEVILNWMRYTQT------VDIWSVGCIMAEMITG 215
Query: 450 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ 509
+++ H EI+K G A + P + A++
Sbjct: 216 KTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASIL----- 270
Query: 510 PLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIRCATPPE 569
S A +L+ +LV + + R+ A E HP+FE ++ P+
Sbjct: 271 -------TNASPLAVNLLEKMLVLDAEQRV----TAGEALAHPYFESLHDT----EDEPQ 315
Query: 570 IPKP 573
+ K
Sbjct: 316 VQKY 319
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 1e-35
Identities = 40/151 (26%), Positives = 64/151 (42%), Gaps = 8/151 (5%)
Query: 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQS 272
L + +LL+ +G G+ G V L + G K A+K + + + L E ++
Sbjct: 4 LNMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDAT--AQAFLA---EASVMTQ 56
Query: 273 LDHPFLPTLYTHF-ETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLAL 331
L H L L E + +V E+ G L + + + + +V A+
Sbjct: 57 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 116
Query: 332 EYLHMLGIIYRDLKPENVLVREDGHIMLSDF 362
EYL ++RDL NVLV ED +SDF
Sbjct: 117 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDF 147
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.4 bits (190), Expect = 2e-16
Identities = 13/102 (12%), Positives = 36/102 (35%), Gaps = 4/102 (3%)
Query: 450 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ 509
+ ++ APE ++ + + D W+FGI L+E+ + V +
Sbjct: 156 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 215
Query: 510 PLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQH 551
+ A ++++ + R + ++++
Sbjct: 216 GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPS----FLQLREQ 253
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 2e-35
Identities = 60/352 (17%), Positives = 109/352 (30%), Gaps = 67/352 (19%)
Query: 217 HFRLLKRLGCGDIGSVYL-SELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-- 273
+ + +G G G V+ +L + A+K + + L E +L+ L
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT-GEEGMPLSTIREVAVLRHLET 66
Query: 274 -DHPFLPTLYTHFETEKFS-----CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEV 327
+HP + L+ + LV E K P P + ++ + ++
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT-YLDKVPEPGVPTETIKDMMFQL 125
Query: 328 LLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRK 387
L L++LH +++RDLKP+N+LV G I L+DF L+
Sbjct: 126 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY--------------SFQMA 171
Query: 388 NPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPT 447
V P + S + + + AE
Sbjct: 172 LTSVVVTLWYRAPEVLLQSSYATPV----------------------DLWSVGCIFAEMF 209
Query: 448 EARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVV 507
+ + + +I+ G DW P + R +
Sbjct: 210 RRKPLFRGSSDVDQLGKILDVIGLPGEEDW---------------PRDVALPRQAFHSKS 254
Query: 508 GQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNW 559
QP+ + +DL+ L P R+ A HP+F+ +
Sbjct: 255 AQPIE-KFVTDIDELGKDLLLKCLTFNPAKRI----SAYSALSHPYFQDLER 301
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 2e-35
Identities = 67/166 (40%), Positives = 101/166 (60%), Gaps = 7/166 (4%)
Query: 213 LGLSHFRLLKRLGCGDIGSVYLSEL---SGTKCYFAMKVMDKASLAGRKKLL-RAQTERE 268
+G+ +F LLK LG G G V+L T +AMKV+ KA++ + K +TER+
Sbjct: 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 80
Query: 269 ILQSLDH-PFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEV 327
+L+ + PFL TL+ F+TE L++++ GG+L T ++ F E V+ YV E+
Sbjct: 81 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEI 138
Query: 328 LLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 373
+LALE+LH LGIIYRD+K EN+L+ +GH++L+DF LS T
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET 184
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 3e-27
Identities = 50/129 (38%), Positives = 75/129 (58%), Gaps = 7/129 (5%)
Query: 451 SMSFVGTHEYLAPEIIKG--EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG 508
+ F GT EY+AP+I++G GH AVDWW+ G+ +YELL G +PF G + + +
Sbjct: 187 AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR 246
Query: 509 QPLRF--PESPVVSFAARDLIRGLLVKEPQHRL-AYKRGATEIKQHPFFEGVNWALI--R 563
+ L+ P +S A+DLI+ LL+K+P+ RL R A EIK+H FF+ +NW + +
Sbjct: 247 RILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAK 306
Query: 564 CATPPEIPK 572
P P
Sbjct: 307 KVPAPFKPV 315
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 2e-35
Identities = 71/345 (20%), Positives = 118/345 (34%), Gaps = 56/345 (16%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD 274
+ +F+ ++++G G G VY + T A+K + + A E +L+ L+
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELN 59
Query: 275 HPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYL 334
HP + L TE LV EF DL P ++ Y+ ++L L +
Sbjct: 60 HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 335 HMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQ 394
H +++RDLKP+N+L+ +G I L+DF L+ P+R V
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-------------GVPVRTYTHEVVT 165
Query: 395 PACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454
P + K +I + E++ R F
Sbjct: 166 LWYRAPEILL-----------------GCKYYSTAVDIWSLGCIFAEMV-----TRRALF 203
Query: 455 VGTHEY-LAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRF 513
G E I + G V W G+ P + + +
Sbjct: 204 PGDSEIDQLFRIFRTLGTPDEVVWP--GVTSMPDYKPSFPKWARQDFSKVV--------- 252
Query: 514 PESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVN 558
P + R L+ +L +P R+ A HPFF+ V
Sbjct: 253 ---PPLDEDGRSLLSQMLHYDPNKRI----SAKAALAHPFFQDVT 290
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 132 bits (334), Expect = 3e-35
Identities = 37/177 (20%), Positives = 73/177 (41%), Gaps = 10/177 (5%)
Query: 192 PHKANDLRWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGT---KCYFAMKV 248
P D +AVR + +S ++ + +G G+ G V L + + A+K
Sbjct: 6 PFTFEDPN----EAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKT 61
Query: 249 MDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQ 308
+ +++ +E I+ DHP + L ++ EF G L + +
Sbjct: 62 LKSGYTEKQRR--DFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR 119
Query: 309 KQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+ G++ + + + ++YL + ++RDL N+LV + +SDF LS
Sbjct: 120 QNDGQF-TVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLS 175
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 73.6 bits (180), Expect = 6e-15
Identities = 26/118 (22%), Positives = 51/118 (43%), Gaps = 5/118 (4%)
Query: 439 LPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELL-FGKTPFKGS 497
L + ++PT ++ + APE I+ SA D W++GI ++E++ +G+ P+
Sbjct: 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 237
Query: 498 GNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYK---RGATEIKQHP 552
+ N + Q R P A L+ K+ HR + ++ ++P
Sbjct: 238 -TNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 132 bits (332), Expect = 3e-35
Identities = 37/222 (16%), Positives = 74/222 (33%), Gaps = 27/222 (12%)
Query: 192 PHKANDLRWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDK 251
P N +WE + + + +LG G G VY A+K + +
Sbjct: 4 PSSPNYDKWE-----------MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE 52
Query: 252 ASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQP 311
++ E +++ + HP L L E ++ EF G+L ++
Sbjct: 53 DTMEVE----EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN 108
Query: 312 GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371
+ + + ++ A+EYL I+RDL N LV E+ + ++DF
Sbjct: 109 RQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADF--------- 159
Query: 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCF 413
+ + + + P + + +
Sbjct: 160 ---GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 198
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 67.1 bits (163), Expect = 7e-13
Identities = 16/98 (16%), Positives = 32/98 (32%)
Query: 441 ELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNR 500
L+ T ++ APE + D W FG+ L+E+ +
Sbjct: 163 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 222
Query: 501 ATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHR 538
+ ++ ++ + R +L+R P R
Sbjct: 223 SQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 260
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 4e-35
Identities = 49/204 (24%), Positives = 75/204 (36%), Gaps = 15/204 (7%)
Query: 212 VLGLSHFRLLKRLGCGDIGSVYLSEL---SGTKCYFAMKVMDKASLAGRKKLLRAQTERE 268
++G RLL++LG G G V E SG A+K + L+ + + E
Sbjct: 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 63
Query: 269 ILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVL 328
+ SLDH L LY T +V E P G L +K G F + Y +V
Sbjct: 64 AMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVA 121
Query: 329 LALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKN 388
+ YL I+RDL N+L+ + + DF L +A + +
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM----------RALPQNDDHYVMQ 171
Query: 389 PVYCVQPACIEPSCIQPSCVTPTC 412
V A P ++ +
Sbjct: 172 EHRKVPFAWCAPESLKTRTFSHAS 195
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.0 bits (199), Expect = 1e-17
Identities = 19/95 (20%), Positives = 35/95 (36%), Gaps = 1/95 (1%)
Query: 445 EPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELL-FGKTPFKGSGNRATL 503
+ + APE +K A D W FG+ L+E+ +G+ P+ G L
Sbjct: 165 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL 224
Query: 504 FNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHR 538
+ + R P +++ +P+ R
Sbjct: 225 HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDR 259
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 4e-35
Identities = 47/191 (24%), Positives = 73/191 (38%), Gaps = 16/191 (8%)
Query: 224 LGCGDIGSVYLSEL--SGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTL 281
LGCG+ GSV + A+KV+ + + + E +I+ LD+P++ L
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE--EMMREAQIMHQLDNPYIVRL 74
Query: 282 YTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIY 341
+ E LVME GG LH + + P V + +V + ++YL ++
Sbjct: 75 IGVCQAEAL-MLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEKNFVH 132
Query: 342 RDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPS 401
RDL NVL+ + +SDF LS KA D P
Sbjct: 133 RDLAARNVLLVNRHYAKISDFGLS----------KALGADDSYYTARSAGKWPLKWYAPE 182
Query: 402 CIQPSCVTPTC 412
CI +
Sbjct: 183 CINFRKFSSRS 193
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.4 bits (182), Expect = 3e-15
Identities = 17/113 (15%), Positives = 42/113 (37%), Gaps = 5/113 (4%)
Query: 445 EPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELL-FGKTPFKGSGNRATL 503
+ + ++ APE I S D W++G+ ++E L +G+ P+K +
Sbjct: 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM 222
Query: 504 FNVV-GQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFE 555
+ G+ + P L+ + + + R + + + ++
Sbjct: 223 AFIEQGKRMECPPE--CPPELYALMSDCWIYKWEDRPDFLT-VEQRMRACYYS 272
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 4e-35
Identities = 34/150 (22%), Positives = 64/150 (42%), Gaps = 6/150 (4%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH 275
+L++RLG G G V++ +G A+K + + S+ L E +++ L H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHT-KVAVKSLKQGSM-SPDAFLA---EANLMKQLQH 67
Query: 276 PFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLH 335
L LY E ++ E+ G L + G + A++ + ++
Sbjct: 68 QRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 336 MLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
I+RDL+ N+LV + ++DF L+
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLA 156
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.5 bits (180), Expect = 5e-15
Identities = 23/140 (16%), Positives = 41/140 (29%), Gaps = 13/140 (9%)
Query: 424 KDRKPKN----EIGNQV---SPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVD 476
+D + N + + L LI + ++ APE I D
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 477 WWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQ 536
W+FGI L E++ + + + R L+R + P+
Sbjct: 193 VWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPE 252
Query: 537 HRLAYKRGATEIKQ--HPFF 554
R ++ FF
Sbjct: 253 DRPT----FDYLRSVLEDFF 268
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 131 bits (330), Expect = 6e-35
Identities = 62/342 (18%), Positives = 117/342 (34%), Gaps = 58/342 (16%)
Query: 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD 274
+ + L+++G G G VY ++ + FA+K + E IL+ L
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELK 58
Query: 275 HPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYL 334
H + LY T+K LV E L + G + ++ ++L + Y
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYC 116
Query: 335 HMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQ 394
H +++RDLKP+N+L+ +G + ++DF L+ P+RK V
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAF-------------GIPVRKYTHEIVT 163
Query: 395 PACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454
P + S T D + + + AE +
Sbjct: 164 LWYRAPDVLMGSKKYST-----------TID----------IWSVGCIFAEMVNGTPLFP 202
Query: 455 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFP 514
+ I + G ++ +W P + V +PL +
Sbjct: 203 GVSEADQLMRIFRILGTPNSKNW---------------PNVTELPKYDPNFTVYEPLPWE 247
Query: 515 E-SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFE 555
+ + DL+ +L +P R+ A + +H +F+
Sbjct: 248 SFLKGLDESGIDLLSKMLKLDPNQRI----TAKQALEHAYFK 285
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 4e-34
Identities = 34/151 (22%), Positives = 66/151 (43%), Gaps = 7/151 (4%)
Query: 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHP 276
+ + + LG G+ G V+ + +K + K + + + E IL H
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHR 61
Query: 277 FLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHM 336
+ L+ FE+ + ++ EF G D+ + E+ + YV +V AL++LH
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLHS 120
Query: 337 LGIIYRDLKPENVLV--REDGHIMLSDFDLS 365
I + D++PEN++ R I + +F +
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQA 151
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 4e-24
Identities = 38/144 (26%), Positives = 60/144 (41%), Gaps = 10/144 (6%)
Query: 450 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ 509
EY APE+ + + +A D W+ G +Y LL G PF N+ + N++
Sbjct: 159 NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNA 218
Query: 510 PLRFPES--PVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF----EGVNWALIR 563
F E +S A D + LLVKE + R+ A+E QHP+ E V+ +IR
Sbjct: 219 EYTFDEEAFKEISIEAMDFVDRLLVKERKSRM----TASEALQHPWLKQKIERVSTKVIR 274
Query: 564 CATPPEIPKPVEIERIPAPTSSTS 587
+ + + S+
Sbjct: 275 TLKHRRYYHTLIKKDLNMVVSAAR 298
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 8e-34
Identities = 41/164 (25%), Positives = 74/164 (45%), Gaps = 14/164 (8%)
Query: 213 LGLSH----FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTERE 268
+G+S+ + +G G +VY + T A + L + + R + E E
Sbjct: 2 VGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAE 60
Query: 269 ILQSLDHPFLPTLYTHFET----EKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYV 324
+L+ L HP + Y +E+ +K LV E G L T ++ K + +R +
Sbjct: 61 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWC 118
Query: 325 AEVLLALEYLHMLG--IIYRDLKPENVLVR-EDGHIMLSDFDLS 365
++L L++LH II+RDLK +N+ + G + + D L+
Sbjct: 119 RQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 162
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 8e-26
Identities = 22/107 (20%), Positives = 49/107 (45%), Gaps = 6/107 (5%)
Query: 450 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ 509
+ + +GT E++APE+ + + +VD + FG+ + E+ + P+ N A ++ V
Sbjct: 169 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS 227
Query: 510 PLRFPESP-VVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFE 555
++ V +++I G + + R ++ H FF+
Sbjct: 228 GVKPASFDKVAIPEVKEIIEGCIRQNKDERY----SIKDLLNHAFFQ 270
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 1e-33
Identities = 41/153 (26%), Positives = 66/153 (43%), Gaps = 6/153 (3%)
Query: 212 VLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQ 271
V+ S ++ +G G G V+L A+K + + ++ + + E E++
Sbjct: 1 VIDPSELTFVQEIGSGQFGLVHLGYWLNKD-KVAIKTIREGAM-SEEDFIE---EAEVMM 55
Query: 272 SLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLAL 331
L HP L LY + CLV EF G L + Q F + + +V +
Sbjct: 56 KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGM 114
Query: 332 EYLHMLGIIYRDLKPENVLVREDGHIMLSDFDL 364
YL +I+RDL N LV E+ I +SDF +
Sbjct: 115 AYLEEACVIHRDLAARNCLVGENQVIKVSDFGM 147
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.1 bits (197), Expect = 2e-17
Identities = 14/113 (12%), Positives = 41/113 (36%), Gaps = 4/113 (3%)
Query: 439 LPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSG 498
+ + + S ++ +PE+ + S D W+FG+ ++E+ +
Sbjct: 147 MTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 206
Query: 499 NRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQH 551
+ + + + R + + S ++ + P+ R A + + +
Sbjct: 207 SNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPA----FSRLLRQ 255
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 2e-33
Identities = 40/160 (25%), Positives = 75/160 (46%), Gaps = 17/160 (10%)
Query: 215 LSHFRLLKR-LGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREIL-QS 272
+ +++ + LG G G V T+ FA+K++ +A+ E E+ ++
Sbjct: 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRA 61
Query: 273 LDHPFLPTLYTHFET----EKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVL 328
P + + +E K +VME GG+L + Q + + F E+ + +
Sbjct: 62 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 121
Query: 329 LALEYLHMLGIIYRDLKPENVLV---REDGHIMLSDFDLS 365
A++YLH + I +RD+KPEN+L R + + L+DF +
Sbjct: 122 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.2 bits (223), Expect = 3e-20
Identities = 32/111 (28%), Positives = 47/111 (42%), Gaps = 10/111 (9%)
Query: 450 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ 509
+ T Y+APE++ E + + D W+ G+ +Y LL G PF + A + +
Sbjct: 169 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 228
Query: 510 ------PLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
PE VS + LIR LL EP R+ TE HP+
Sbjct: 229 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM----TITEFMNHPWI 275
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 4e-33
Identities = 39/240 (16%), Positives = 76/240 (31%), Gaps = 40/240 (16%)
Query: 197 DLRWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTK-----CYFAMKVMDK 251
DL+WE + K LG G G V + G A+K++ +
Sbjct: 29 DLKWE-----------FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE 77
Query: 252 ASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQ 310
+ + ++ +E +++ L H + L L+ E+C GDL + +
Sbjct: 78 KADSSERE--ALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSK 135
Query: 311 PGKY---------------------FPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENV 349
K+ + + + +V +E+L ++RDL NV
Sbjct: 136 REKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV 195
Query: 350 LVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVT 409
LV + + DF L+ + + P + S + +
Sbjct: 196 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGIL 255
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.7 bits (188), Expect = 7e-16
Identities = 14/112 (12%), Positives = 43/112 (38%), Gaps = 5/112 (4%)
Query: 441 ELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELL-FGKTPFKGSGN 499
+++++ + +++APE + + D W++GI L+E+ G P+ G
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272
Query: 500 RATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQH 551
A + ++ + + + +++ + + R + +
Sbjct: 273 DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPS----FPNLTSF 320
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 5e-33
Identities = 34/199 (17%), Positives = 69/199 (34%), Gaps = 35/199 (17%)
Query: 189 INKPHKANDLRWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSG-----TKCY 243
I+ D +WE + K LG G G V + G
Sbjct: 7 IDPTQLPYDHKWE-----------FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMT 55
Query: 244 FAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEKFSCLVMEFCPGGD 302
A+K++ ++ ++ +E ++L L +H + L + ++ E+C GD
Sbjct: 56 VAVKMLKPSAHLTERE--ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGD 113
Query: 303 LHTLRQKQPGKY----------------FPEQAVRFYVAEVLLALEYLHMLGIIYRDLKP 346
L +++ + + + + +V + +L I+RDL
Sbjct: 114 LLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173
Query: 347 ENVLVREDGHIMLSDFDLS 365
N+L+ + DF L+
Sbjct: 174 RNILLTHGRITKICDFGLA 192
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.7 bits (154), Expect = 1e-11
Identities = 19/99 (19%), Positives = 41/99 (41%), Gaps = 1/99 (1%)
Query: 441 ELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELL-FGKTPFKGSGN 499
++ + + +++APE I + D W++GIFL+EL G +P+ G
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253
Query: 500 RATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHR 538
+ + ++ + R D+++ +P R
Sbjct: 254 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (316), Expect = 6e-33
Identities = 38/150 (25%), Positives = 70/150 (46%), Gaps = 6/150 (4%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH 275
RL +LG G G V++ +GT A+K + ++ + L+ E ++++ L H
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTM-SPEAFLQ---EAQVMKKLRH 71
Query: 276 PFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLH 335
L LY E +V E+ G L + + GKY + A++ + Y+
Sbjct: 72 EKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 130
Query: 336 MLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+ ++RDL+ N+LV E+ ++DF L+
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLA 160
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.1 bits (197), Expect = 4e-17
Identities = 25/118 (21%), Positives = 38/118 (32%), Gaps = 6/118 (5%)
Query: 439 LPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSG 498
L LI + ++ APE D W+FGI L EL
Sbjct: 159 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 218
Query: 499 NRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQ--HPFF 554
+ + V + R P P + DL+ KEP+ R ++ +F
Sbjct: 219 VNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPT----FEYLQAFLEDYF 272
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 4e-32
Identities = 39/146 (26%), Positives = 68/146 (46%), Gaps = 6/146 (4%)
Query: 222 KRLGCGDIGSVYLSELSGTKC--YFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLP 279
K LG G+ G+V K A+K++ + K E ++Q LD+P++
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD-ELLAEANVMQQLDNPYIV 71
Query: 280 TLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGI 339
+ E E + LVME G L+ Q+ ++ ++ + V +V + ++YL
Sbjct: 72 RMIGICEAESW-MLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNF 128
Query: 340 IYRDLKPENVLVREDGHIMLSDFDLS 365
++RDL NVL+ + +SDF LS
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLS 154
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.3 bits (213), Expect = 2e-19
Identities = 21/114 (18%), Positives = 45/114 (39%), Gaps = 11/114 (9%)
Query: 451 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELL-FGKTPFKGSGNRATLFNVV-G 508
++ APE I S D W+FG+ ++E +G+ P++G + G
Sbjct: 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG 226
Query: 509 QPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIK---QHPFFEGVNW 559
+ + P DL+ + ++R G ++ ++ +++ VN
Sbjct: 227 ERMGCPAG--CPREMYDLMNLCWTYDVENRP----GFAAVELRLRNYYYDVVNE 274
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 1e-31
Identities = 36/153 (23%), Positives = 62/153 (40%), Gaps = 7/153 (4%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTK---CYFAMKVMDKASLAGRKKLLRAQTEREILQS 272
L + +G G G V+ + A+K + ++ + E ++
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE--KFLQEALTMRQ 64
Query: 273 LDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALE 332
DHP + L TE ++ME C G+L + Q + ++ Y ++ AL
Sbjct: 65 FDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALA 122
Query: 333 YLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
YL ++RD+ NVLV + + L DF LS
Sbjct: 123 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 155
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.2 bits (184), Expect = 1e-15
Identities = 23/113 (20%), Positives = 39/113 (34%), Gaps = 4/113 (3%)
Query: 439 LPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSG 498
L + + T ++ +++APE I SA D W FG+ ++E+L
Sbjct: 154 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 213
Query: 499 NRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQH 551
+ + R P P L+ +P R TE+K
Sbjct: 214 KNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPR----FTELKAQ 262
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 3e-31
Identities = 38/159 (23%), Positives = 73/159 (45%), Gaps = 9/159 (5%)
Query: 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLL---RAQTEREILQSL 273
++ + LG G V T +A K + K ++ + + E IL+ +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 274 DHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEY 333
HP + TL+ +E + L++E GG+L ++ + E+ ++ ++L + Y
Sbjct: 71 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYY 128
Query: 334 LHMLGIIYRDLKPENVLVREDG----HIMLSDFDLSLRC 368
LH L I + DLKPEN+++ + I + DF L+ +
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 3e-29
Identities = 41/125 (32%), Positives = 60/125 (48%), Gaps = 8/125 (6%)
Query: 450 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ 509
+ GT E++APEI+ E G D W+ G+ Y LL G +PF G + TL NV
Sbjct: 172 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 231
Query: 510 PLRFPES--PVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNW--ALIRCA 565
F + S A+D IR LLVK+P+ R+ + QHP+ + + AL
Sbjct: 232 NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM----TIQDSLQHPWIKPKDTQQALSSAW 287
Query: 566 TPPEI 570
+ P+
Sbjct: 288 SHPQF 292
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 8e-31
Identities = 64/344 (18%), Positives = 111/344 (32%), Gaps = 64/344 (18%)
Query: 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHP 276
++ L +G G GSV + + T A+K + + R E +L+ + H
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHE 77
Query: 277 FLPTLYTHFET-----EKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLAL 331
+ L F E ++ G DL+ + + Q + V+F + ++L L
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGL 134
Query: 332 EYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVY 391
+Y+H II+RDLKP N+ V ED + + DF L
Sbjct: 135 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGL--------------------------- 167
Query: 392 CVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451
A + T +P + + + +I + + EL+
Sbjct: 168 ----ARHTDDEMTGYVATRWYRAPEIMLNWMHYN--QTVDIWSVGCIMAELL-----TGR 216
Query: 452 MSFVGTHEY-LAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQP 510
F GT I++ G A N A +F
Sbjct: 217 TLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVF------ 270
Query: 511 LRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF 554
+ A DL+ +LV + R+ A + H +F
Sbjct: 271 ------IGANPLAVDLLEKMLVLDSDKRI----TAAQALAHAYF 304
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 9e-31
Identities = 38/156 (24%), Positives = 67/156 (42%), Gaps = 7/156 (4%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKL---LRAQTEREILQS 272
S +++ LG G GSVY A+K ++K ++ +L R E +L+
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 273 LD--HPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLA 330
+ + L FE L++E + G E+ R + +VL A
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEA 122
Query: 331 LEYLHMLGIIYRDLKPENVLVRED-GHIMLSDFDLS 365
+ + H G+++RD+K EN+L+ + G + L DF
Sbjct: 123 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 158
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.2 bits (231), Expect = 9e-22
Identities = 31/112 (27%), Positives = 47/112 (41%), Gaps = 13/112 (11%)
Query: 447 TEARSMSFVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFN 505
+ F GT Y PE I+ HG + W+ GI LY+++ G PF+
Sbjct: 162 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------E 215
Query: 506 VVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557
++ + F + VS + LIR L P R EI+ HP+ + V
Sbjct: 216 IIRGQVFFRQR--VSSECQHLIRWCLALRPSDRP----TFEEIQNHPWMQDV 261
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 119 bits (299), Expect = 1e-30
Identities = 43/214 (20%), Positives = 74/214 (34%), Gaps = 30/214 (14%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSG-----TKCYFAMKVMDKASLAGRKKLLRAQTEREIL 270
++ ++ +G G G V+ + G A+K++ + + A + Q E ++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA--DFQREAALM 70
Query: 271 QSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKY---------------- 314
D+P + L K CL+ E+ GDL+ +
Sbjct: 71 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130
Query: 315 ------FPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRC 368
+V + YL ++RDL N LV E+ + ++DF LS R
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS-RN 189
Query: 369 AVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSC 402
S KA DA P+R P +
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTES 223
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 69.9 bits (170), Expect = 1e-13
Identities = 21/91 (23%), Positives = 38/91 (41%), Gaps = 4/91 (4%)
Query: 450 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELL-FGKTPFKGSGNRATLFNVV- 507
+ ++ PE I + + D W +G+ L+E+ +G P+ G + ++ V
Sbjct: 198 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRD 257
Query: 508 GQPLRFPESPVVSFAARDLIRGLLVKEPQHR 538
G L PE+ +L+R K P R
Sbjct: 258 GNILACPEN--CPLELYNLMRLCWSKLPADR 286
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 5e-30
Identities = 38/169 (22%), Positives = 63/169 (37%), Gaps = 15/169 (8%)
Query: 212 VLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQ 271
VL + + +G G+ G V + + + A + E E+L
Sbjct: 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 65
Query: 272 SL-DHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQK--------------QPGKYFP 316
L HP + L E + L +E+ P G+L +K
Sbjct: 66 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125
Query: 317 EQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
Q + + A+V ++YL I+RDL N+LV E+ ++DF LS
Sbjct: 126 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 174
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.1 bits (181), Expect = 5e-15
Identities = 17/106 (16%), Positives = 37/106 (34%), Gaps = 4/106 (3%)
Query: 446 PTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFN 505
+ ++A E + + + D W++G+ L+E++ A L+
Sbjct: 178 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 237
Query: 506 VVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQH 551
+ Q R + DL+R ++P R + +I
Sbjct: 238 KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPS----FAQILVS 279
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 8e-30
Identities = 36/156 (23%), Positives = 64/156 (41%), Gaps = 4/156 (2%)
Query: 212 VLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKA--SLAGRKKLLRAQTEREI 269
+L + F+ +K LG G G+VY + V K K E +
Sbjct: 5 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 64
Query: 270 LQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLL 329
+ S+D+P + L T L+ + P G L ++ Q + + ++
Sbjct: 65 MASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNI-GSQYLLNWCVQIAK 122
Query: 330 ALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+ YL +++RDL NVLV+ H+ ++DF L+
Sbjct: 123 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 158
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.5 bits (190), Expect = 4e-16
Identities = 27/166 (16%), Positives = 58/166 (34%), Gaps = 11/166 (6%)
Query: 442 LIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELL-FGKTPFKGSGNR 500
L AE E + +++A E I + D W++G+ ++EL+ FG P+ G
Sbjct: 161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PA 219
Query: 501 ATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWA 560
+ + +++ + R P+ P+ + ++ + + R E+ +
Sbjct: 220 SEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPK----FRELIIEFSKMARDPQ 275
Query: 561 LIRCATPPEIPKPVEIERIPAPTSSTSEKTAPTMVPPNQRGSDNYL 606
E + E+ +V +D YL
Sbjct: 276 RYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVD-----ADEYL 316
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 116 bits (290), Expect = 2e-29
Identities = 35/187 (18%), Positives = 70/187 (37%), Gaps = 14/187 (7%)
Query: 212 VLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQ 271
V+G H+++ +R+G G G ++ A+K + R + + E +
Sbjct: 2 VVG-VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-----RSDAPQLRDEYRTYK 55
Query: 272 SLDH-PFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLA 330
L +P +Y + + LV++ L G+ F + V ++L
Sbjct: 56 LLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLC--GRKFSVKTVAMAAKQMLAR 113
Query: 331 LEYLHMLGIIYRDLKPENVLVRE-----DGHIMLSDFDLSLRCAVSPTLIKASSLDAEPL 385
++ +H ++YRD+KP+N L+ I + DF + T + + L
Sbjct: 114 VQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL 173
Query: 386 RKNPVYC 392
Y
Sbjct: 174 SGTARYM 180
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 64.8 bits (157), Expect = 5e-12
Identities = 12/99 (12%), Positives = 21/99 (21%), Gaps = 6/99 (6%)
Query: 450 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ 509
+ GT Y++ G D G L G P++G
Sbjct: 169 EKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 228
Query: 510 PLRFPESPV------VSFAARDLIRGLLVKEPQHRLAYK 542
+ +P+ + Y
Sbjct: 229 GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYD 267
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 114 bits (286), Expect = 7e-29
Identities = 35/180 (19%), Positives = 70/180 (38%), Gaps = 11/180 (6%)
Query: 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHP 276
+RL +++G G G +YL A+K+ + K + E +I + +
Sbjct: 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-----KTKHPQLHIESKIYKMMQGG 62
Query: 277 -FLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLH 335
+PT+ ++ +VME + F + V +++ +EY+H
Sbjct: 63 VGIPTIRWCGAEGDYNVMVMELLGPSLED--LFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 336 MLGIIYRDLKPENVLVREDGH---IMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYC 392
I+RD+KP+N L+ + + DF L+ + + T + + L Y
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 76.8 bits (188), Expect = 5e-16
Identities = 14/117 (11%), Positives = 32/117 (27%), Gaps = 8/117 (6%)
Query: 450 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ 509
+ + GT Y + G D + G L G P++G
Sbjct: 169 ENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 228
Query: 510 PLRFPESPV------VSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFF-EGVNW 559
+ +P+ + + Y ++ ++ F +G ++
Sbjct: 229 SEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSY-LRQLFRNLFHRQGFSY 284
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 5e-28
Identities = 44/191 (23%), Positives = 71/191 (37%), Gaps = 35/191 (18%)
Query: 197 DLRWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTK-------CYFAMKVM 249
D RWE L L K LG G G V L+E G A+K++
Sbjct: 5 DPRWE-----------LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML 53
Query: 250 DKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTL-- 306
+ K L +E E+++ + H + L + +++E+ G+L
Sbjct: 54 KSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQ 111
Query: 307 ------------RQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRED 354
P + + + +V +EYL I+RDL NVLV ED
Sbjct: 112 ARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED 171
Query: 355 GHIMLSDFDLS 365
+ ++DF L+
Sbjct: 172 NVMKIADFGLA 182
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.6 bits (177), Expect = 1e-14
Identities = 18/95 (18%), Positives = 39/95 (41%), Gaps = 2/95 (2%)
Query: 445 EPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELL-FGKTPFKGSGNRATL 503
++ + +++APE + + D W+FG+ L+E+ G +P+ G L
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEEL 246
Query: 504 FNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHR 538
F ++ + R + + ++R P R
Sbjct: 247 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQR 281
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 9e-28
Identities = 36/185 (19%), Positives = 70/185 (37%), Gaps = 23/185 (12%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSG-----TKCYFAMKVMDKASLAGRKKLLRAQTEREIL 270
+L K LG G G V ++ G T A+K++ + + + +E +IL
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR--ALMSELKIL 70
Query: 271 QSLDHPFLPTLYTH--FETEKFSCLVMEFCPGGDLHTLRQKQPGKY-------------- 314
+ H + +++EFC G+L T + + ++
Sbjct: 71 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 315 FPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374
+ + Y +V +E+L I+RDL N+L+ E + + DF L+ P
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190
Query: 375 IKASS 379
++
Sbjct: 191 VRKGD 195
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.6 bits (164), Expect = 6e-13
Identities = 20/111 (18%), Positives = 39/111 (35%), Gaps = 5/111 (4%)
Query: 442 LIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFG-KTPFKGSGNR 500
+ +P R +++APE I + D W+FG+ L+E+ +P+ G
Sbjct: 184 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243
Query: 501 ATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQH 551
+ + R + + EP R +E+ +H
Sbjct: 244 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPT----FSELVEH 290
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 110 bits (275), Expect = 6e-27
Identities = 60/377 (15%), Positives = 129/377 (34%), Gaps = 50/377 (13%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREI-------L 270
+ L+++LG G +V+L++ + AMK++ + + + +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 271 QSLDHPFLPTLYTHFETEKFSCLVMEF---CPGGDLHTLRQKQPGKYFPEQAVRFYVAEV 327
S+ + L HF + + + + G +L L +K + P V+ ++
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 328 LLALEYLHM-LGIIYRDLKPENVLVREDGHIM-LSDFDLSLRCAVSPTLIKASSLDAEPL 385
LL L+Y+H GII+ D+KPENVL+ L ++ ++
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 386 RKNP-VYCVQPACIEPSCIQPSCVTPTCFSPR-LFSSKSKKDRKPKNEIGNQVSPLPELI 443
++P V P +C+ + LF ++ ++ + EL+
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD---HIAQIIELL 251
Query: 444 AEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATL 503
E P + G + + + G+ P +
Sbjct: 252 GEL----------------PSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLE-------- 287
Query: 504 FNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIR 563
+V+ + +F + + D + +L +P+ R A + HP+ + + +
Sbjct: 288 -DVLTEKYKFSKD--EAKEISDFLSPMLQLDPRKRA----DAGGLVNHPWLK--DTLGME 338
Query: 564 CATPPEIPKPVEIERIP 580
P+ IP
Sbjct: 339 EIRVPDRELYGSGSDIP 355
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 8e-27
Identities = 31/163 (19%), Positives = 60/163 (36%), Gaps = 21/163 (12%)
Query: 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPF 277
L + +G G G V+ + G + A+K+ ++ + E L H
Sbjct: 5 IVLQESIGKGRFGEVWRGKWRGEE--VAVKIFSSRE----ERSWFREAEIYQTVMLRHEN 58
Query: 278 LPTLYTHFETEKFS----CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEY 333
+ + + LV ++ G L + + + L +
Sbjct: 59 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAH 115
Query: 334 LHM--------LGIIYRDLKPENVLVREDGHIMLSDFDLSLRC 368
LHM I +RDLK +N+LV+++G ++D L++R
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.4 bits (122), Expect = 1e-07
Identities = 21/132 (15%), Positives = 38/132 (28%), Gaps = 30/132 (22%)
Query: 445 EPTEARSMSFVGTHEYLAPEIIKGEGH------GSAVDWWTFGIFLYELLFGKTPFKGSG 498
+ + VGT Y+APE++ + D + G+ +E+ +
Sbjct: 163 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 222
Query: 499 NRATLFN---------------VVGQPLR-----FPESPVVSFAARDLIRGLLVKEPQHR 538
+ + V Q LR +S ++R R
Sbjct: 223 DYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAAR 282
Query: 539 LAYKRGATEIKQ 550
L A IK+
Sbjct: 283 LT----ALRIKK 290
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (269), Expect = 9e-27
Identities = 33/154 (21%), Positives = 60/154 (38%), Gaps = 7/154 (4%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSGT----KCYFAMKVMDKASLAGRKKLLRAQTEREILQ 271
S K +G G+ G VY L + + A+K + ++ E I+
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV--DFLGEAGIMG 64
Query: 272 SLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLAL 331
H + L K ++ E+ G L +++ G F + + + +
Sbjct: 65 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG-EFSVLQLVGMLRGIAAGM 123
Query: 332 EYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+YL + ++RDL N+LV + +SDF LS
Sbjct: 124 KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS 157
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.2 bits (176), Expect = 1e-14
Identities = 18/88 (20%), Positives = 30/88 (34%)
Query: 451 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQP 510
+ + APE I SA D W+FGI ++E++ + + +
Sbjct: 170 TSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG 229
Query: 511 LRFPESPVVSFAARDLIRGLLVKEPQHR 538
R P A L+ +E R
Sbjct: 230 FRLPTPMDCPSAIYQLMMQCWQQERARR 257
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 3e-26
Identities = 33/211 (15%), Positives = 70/211 (33%), Gaps = 26/211 (12%)
Query: 216 SHFRLLKRLGCGDIGSVYLSELSG-----TKCYFAMKVMDKASLAGRKKLLRAQTEREIL 270
+ + LG G G VY G + A+K +++A+ + E ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVM 77
Query: 271 QSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKY--------FPEQAVRF 322
+ + + L + + ++ME GDL + + +
Sbjct: 78 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137
Query: 323 YVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDA 382
E+ + YL+ ++RDL N +V ED + + DF ++ +
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY-----------ET 186
Query: 383 EPLRKNPVYCVQPACIEPSCIQPSCVTPTCF 413
+ RK + + P ++ T
Sbjct: 187 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSD 217
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.7 bits (167), Expect = 3e-13
Identities = 23/121 (19%), Positives = 50/121 (41%), Gaps = 4/121 (3%)
Query: 441 ELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELL-FGKTPFKGSGN 499
++ + + +++PE +K + D W+FG+ L+E+ + P++G N
Sbjct: 182 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 241
Query: 500 RATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQ--HPFFEGV 557
L V+ + + +L+R P+ R ++ + IK+ P F V
Sbjct: 242 EQVLRFVM-EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 300
Query: 558 N 558
+
Sbjct: 301 S 301
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 4e-26
Identities = 35/153 (22%), Positives = 68/153 (44%), Gaps = 9/153 (5%)
Query: 217 HFRLLKRLGCGDIGSVYLSEL---SGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL 273
HF + +G G G VY L G K + A+K +++ + G + TE I++
Sbjct: 30 HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTEGIIMKDF 85
Query: 274 DHPFLPTLY-THFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALE 332
HP + +L +E +V+ + GDL + + + + F +V ++
Sbjct: 86 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF-GLQVAKGMK 144
Query: 333 YLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+L ++RDL N ++ E + ++DF L+
Sbjct: 145 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 177
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.2 bits (184), Expect = 2e-15
Identities = 15/102 (14%), Positives = 37/102 (36%), Gaps = 4/102 (3%)
Query: 450 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ 509
+++A E ++ + + D W+FG+ L+EL+ P N + + Q
Sbjct: 190 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 249
Query: 510 PLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQH 551
R + +++ + + R + +E+
Sbjct: 250 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPS----FSELVSR 287
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 74.8 bits (183), Expect = 4e-16
Identities = 28/161 (17%), Positives = 50/161 (31%), Gaps = 30/161 (18%)
Query: 220 LLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRK---------------KLLRAQ 264
+ K +G G +V+ +K + +K + A+
Sbjct: 4 IGKLMGEGKESAVFNCYSEKFG-ECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 265 TEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYV 324
E LQ L +P +Y ++ME + +
Sbjct: 63 NEFRALQKLQGLAVPKVYAWEGN----AVLMELIDAK---------ELYRVRVENPDEVL 109
Query: 325 AEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLS 365
+L + + GI++ DL NVLV + I + DF S
Sbjct: 110 DMILEEVAKFYHRGIVHGDLSQYNVLV-SEEGIWIIDFPQS 149
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 611 | |||
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.6 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.15 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.11 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.34 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.12 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.65 |
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-64 Score=515.58 Aligned_cols=279 Identities=35% Similarity=0.624 Sum_probs=245.1
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
.++|++++.||+|+||+||+|++..+++.||||++.+...........+.+|+++|++++|||||+++++|.+++.+|||
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence 36899999999999999999999999999999999877655555566788999999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
||||+||+|.+++... +.+++..++.++.||+.||+|||++|||||||||+||||+++|++||+|||+|+.+....
T Consensus 87 mEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~-- 162 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-- 162 (288)
T ss_dssp ECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCC--
Confidence 9999999999988875 569999999999999999999999999999999999999999999999999985432110
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
......+.
T Consensus 163 ------------------------------------------------------------------------~~~~~~~~ 170 (288)
T d1uu3a_ 163 ------------------------------------------------------------------------KQARANSF 170 (288)
T ss_dssp -------------------------------------------------------------------------------C
T ss_pred ------------------------------------------------------------------------cccccccc
Confidence 11122346
Q ss_pred ccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcC
Q 007260 455 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKE 534 (611)
Q Consensus 455 vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~d 534 (611)
+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+.+.++....+.+|.. +++++++||.+||++|
T Consensus 171 ~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~--~s~~~~~li~~~L~~d 248 (288)
T d1uu3a_ 171 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK--FFPKARDLVEKLLVLD 248 (288)
T ss_dssp CCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTT--CCHHHHHHHHTTSCSS
T ss_pred cCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCcc--CCHHHHHHHHHHccCC
Confidence 79999999999999999999999999999999999999999988888888899888877754 9999999999999999
Q ss_pred ccccCCchh--cHHHHHcCCCCCCCchhhhccCCCCCCC
Q 007260 535 PQHRLAYKR--GATEIKQHPFFEGVNWALIRCATPPEIP 571 (611)
Q Consensus 535 P~~Rpt~~~--~a~elL~Hp~f~~~~~~~~~~~~~p~~p 571 (611)
|.+|||..+ ....+++||||++++|..+...+||.+|
T Consensus 249 P~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~~~pP~l~ 287 (288)
T d1uu3a_ 249 ATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 287 (288)
T ss_dssp GGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCCCCCC
T ss_pred HhHCcCHHHHcCCHHHHcCCccCCCCHHHhhcCCCCCCC
Confidence 999999542 2345899999999999988887777664
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-62 Score=516.47 Aligned_cols=271 Identities=37% Similarity=0.701 Sum_probs=243.9
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSC 292 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~ 292 (611)
+.+++|++++.||+|+||+||+|+++.+++.||||++++..........++.+|+.+|+.++|||||+++++|++++.+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 34679999999999999999999999999999999999876655556677889999999999999999999999999999
Q ss_pred EEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCc
Q 007260 293 LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 293 LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~ 372 (611)
||||||+||+|..++.+. +.+++..++.|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 82 iv~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~- 158 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD- 158 (337)
T ss_dssp EEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-
T ss_pred cceeccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccC-
Confidence 999999999999998876 56999999999999999999999999999999999999999999999999998432100
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
.....
T Consensus 159 ---------------------------------------------------------------------------~~~~~ 163 (337)
T d1o6la_ 159 ---------------------------------------------------------------------------GATMK 163 (337)
T ss_dssp ---------------------------------------------------------------------------TCCBC
T ss_pred ---------------------------------------------------------------------------Ccccc
Confidence 11123
Q ss_pred ccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007260 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLV 532 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~ 532 (611)
.++||+.|||||++.+.+|+.++|||||||+||||++|++||.+.+..+.+..+....+.+|.. ++.++++||.+||+
T Consensus 164 ~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~--~s~~~~dli~~~L~ 241 (337)
T d1o6la_ 164 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT--LSPEAKSLLAGLLK 241 (337)
T ss_dssp CCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT--SCHHHHHHHHHHTC
T ss_pred cceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCcc--CCHHHHHHHHhhcc
Confidence 4689999999999999999999999999999999999999999998888888888888888765 99999999999999
Q ss_pred cCccccCCchh-cHHHHHcCCCCCCCchhhhc
Q 007260 533 KEPQHRLAYKR-GATEIKQHPFFEGVNWALIR 563 (611)
Q Consensus 533 ~dP~~Rpt~~~-~a~elL~Hp~f~~~~~~~~~ 563 (611)
+||.+|++... .+.||++||||++++|..+.
T Consensus 242 ~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~ 273 (337)
T d1o6la_ 242 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVV 273 (337)
T ss_dssp SSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHH
T ss_pred CCchhhcccccccHHHHHcCcccccCCHHHHH
Confidence 99999996432 38999999999999998764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-62 Score=496.34 Aligned_cols=256 Identities=35% Similarity=0.581 Sum_probs=232.5
Q ss_pred cccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeE
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCL 293 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~L 293 (611)
.+++|++++.||+|+||+||+|++..+++.||||++.+..........++.+|+.+|+.++|||||+++++|.+++.+||
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 83 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 83 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEE
Confidence 36799999999999999999999999999999999987766555556678899999999999999999999999999999
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcc
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 373 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~ 373 (611)
|||||+||+|.+++.+. ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|.....
T Consensus 84 vmEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~--- 158 (263)
T d2j4za1 84 ILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--- 158 (263)
T ss_dssp EEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC---
T ss_pred EEeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC---
Confidence 99999999999998875 4699999999999999999999999999999999999999999999999999843210
Q ss_pred ccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccc
Q 007260 374 LIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMS 453 (611)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (611)
.....
T Consensus 159 ---------------------------------------------------------------------------~~~~~ 163 (263)
T d2j4za1 159 ---------------------------------------------------------------------------SRRTT 163 (263)
T ss_dssp ---------------------------------------------------------------------------CCCEE
T ss_pred ---------------------------------------------------------------------------Ccccc
Confidence 01123
Q ss_pred cccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007260 454 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVK 533 (611)
Q Consensus 454 ~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~ 533 (611)
.+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+.+.++......+|.. +++++++||.+||++
T Consensus 164 ~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~--~s~~~~~li~~~L~~ 241 (263)
T d2j4za1 164 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF--VTEGARDLISRLLKH 241 (263)
T ss_dssp TTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTT--SCHHHHHHHHHHTCS
T ss_pred cCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCcc--CCHHHHHHHHHHccC
Confidence 579999999999999999999999999999999999999999988888888888887777654 999999999999999
Q ss_pred CccccCCchhcHHHHHcCCCCC
Q 007260 534 EPQHRLAYKRGATEIKQHPFFE 555 (611)
Q Consensus 534 dP~~Rpt~~~~a~elL~Hp~f~ 555 (611)
||.+||| ++|+|+||||.
T Consensus 242 dp~~R~t----~~eil~hp~~~ 259 (263)
T d2j4za1 242 NPSQRPM----LREVLEHPWIT 259 (263)
T ss_dssp SGGGSCC----HHHHHTCHHHH
T ss_pred CHhHCcC----HHHHHcCcCcC
Confidence 9999999 99999999996
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.7e-61 Score=501.66 Aligned_cols=266 Identities=36% Similarity=0.716 Sum_probs=239.4
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
+++|++++.||+|+||+||+|+++.+++.||||++++..........++.+|+.+|+.++|||||+++++|.+++.+|||
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 57899999999999999999999999999999999877655555567788999999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
||||.||+|..++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|.....
T Consensus 83 mE~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~---- 156 (316)
T d1fota_ 83 MDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---- 156 (316)
T ss_dssp ECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS----
T ss_pred eeecCCcccccccccc--ccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc----
Confidence 9999999999988876 5689999999999999999999999999999999999999999999999999843210
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
...+.
T Consensus 157 ---------------------------------------------------------------------------~~~~~ 161 (316)
T d1fota_ 157 ---------------------------------------------------------------------------VTYTL 161 (316)
T ss_dssp ---------------------------------------------------------------------------CBCCC
T ss_pred ---------------------------------------------------------------------------ccccc
Confidence 01235
Q ss_pred ccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcC
Q 007260 455 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKE 534 (611)
Q Consensus 455 vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~d 534 (611)
+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+.+.++......+|. .++.++++||.+||.+|
T Consensus 162 ~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~d 239 (316)
T d1fota_ 162 CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP--FFNEDVKDLLSRLITRD 239 (316)
T ss_dssp CSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHTCSC
T ss_pred cCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhhhC
Confidence 7999999999999999999999999999999999999999999888888889888877765 49999999999999999
Q ss_pred ccccCCch-hcHHHHHcCCCCCCCchhhhc
Q 007260 535 PQHRLAYK-RGATEIKQHPFFEGVNWALIR 563 (611)
Q Consensus 535 P~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~ 563 (611)
|.+|++.. ..+++||+||||++++|..+.
T Consensus 240 p~~R~~~~r~t~~~il~Hp~f~~i~~~~l~ 269 (316)
T d1fota_ 240 LSQRLGNLQNGTEDVKNHPWFKEVVWEKLL 269 (316)
T ss_dssp TTTCTTSSTTTTHHHHTSGGGSSCCHHHHH
T ss_pred HHhccccchhhHHHHHcCcccccCCHHHHH
Confidence 99997322 239999999999999998653
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.1e-60 Score=499.94 Aligned_cols=277 Identities=36% Similarity=0.659 Sum_probs=243.6
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSC 292 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~ 292 (611)
..+++|++++.||+|+||+||+|+++.+++.||||++.+..........++.+|+.+|+.++|||||+++++|.+...+|
T Consensus 38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 117 (350)
T d1rdqe_ 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccc
Confidence 34579999999999999999999999999999999998776555555667889999999999999999999999999999
Q ss_pred EEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCc
Q 007260 293 LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 293 LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~ 372 (611)
+||||+.||+|..++.+. +.+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+..
T Consensus 118 ~v~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~-- 193 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-- 193 (350)
T ss_dssp EEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS--
T ss_pred cccccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc--
Confidence 999999999999998876 4699999999999999999999999999999999999999999999999999854320
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
...
T Consensus 194 -----------------------------------------------------------------------------~~~ 196 (350)
T d1rdqe_ 194 -----------------------------------------------------------------------------RTW 196 (350)
T ss_dssp -----------------------------------------------------------------------------CBC
T ss_pred -----------------------------------------------------------------------------ccc
Confidence 012
Q ss_pred ccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007260 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLV 532 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~ 532 (611)
.++||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+....+.++......+|. .+++++.+||.+||.
T Consensus 197 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~ 274 (350)
T d1rdqe_ 197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQ 274 (350)
T ss_dssp CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TCCHHHHHHHHHHSC
T ss_pred cccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCc--cCCHHHHHHHHHHhh
Confidence 357999999999999999999999999999999999999999998888888888888877765 499999999999999
Q ss_pred cCccccCC-chhcHHHHHcCCCCCCCchhhhcc--CCCCCCCC
Q 007260 533 KEPQHRLA-YKRGATEIKQHPFFEGVNWALIRC--ATPPEIPK 572 (611)
Q Consensus 533 ~dP~~Rpt-~~~~a~elL~Hp~f~~~~~~~~~~--~~~p~~p~ 572 (611)
+||.+|+. .+..+++||+||||++++|..+.. ..+|.+|.
T Consensus 275 ~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p~~p~ 317 (350)
T d1rdqe_ 275 VDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPK 317 (350)
T ss_dssp SCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred hCHHhccccccccHHHHHcCccccCCCHHHHHhcCCCcCccCC
Confidence 99999962 222399999999999999976543 23444443
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-60 Score=488.59 Aligned_cols=260 Identities=26% Similarity=0.429 Sum_probs=220.7
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
+++|++++.||+|+||+||+|+++.+++.||||++.+.... +...++++|+++|++++|||||+++++|.+++.+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence 36899999999999999999999999999999999765432 2334678999999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
||||+||+|.+++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+....
T Consensus 82 mEy~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~-- 157 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN-- 157 (271)
T ss_dssp EECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT--
T ss_pred EeccCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCC--
Confidence 9999999999988654 569999999999999999999999999999999999999999999999999985432110
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
........
T Consensus 158 ------------------------------------------------------------------------~~~~~~~~ 165 (271)
T d1nvra_ 158 ------------------------------------------------------------------------RERLLNKM 165 (271)
T ss_dssp ------------------------------------------------------------------------EECCBCCC
T ss_pred ------------------------------------------------------------------------ccccccce
Confidence 01112346
Q ss_pred ccCCCccchhhhccCCC-CChhhHHHHHHHHHHHHhCCCCCCCCCcHHHH-HHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007260 455 VGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSGNRATL-FNVVGQPLRFPESPVVSFAARDLIRGLLV 532 (611)
Q Consensus 455 vGT~~Y~APEil~~~~~-~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l-~~i~~~~l~~p~~~~~s~~l~dLI~~~L~ 532 (611)
+||+.|||||++.+..+ +.++|||||||+||||++|++||.+..+.... ..+.......+....++.++++||.+||.
T Consensus 166 ~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~ 245 (271)
T d1nvra_ 166 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILV 245 (271)
T ss_dssp CSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSC
T ss_pred eeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHHHcC
Confidence 89999999999998886 67899999999999999999999876654443 34444444445556799999999999999
Q ss_pred cCccccCCchhcHHHHHcCCCCCC
Q 007260 533 KEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 533 ~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
.||.+||| ++|+|+||||+.
T Consensus 246 ~dP~~R~t----~~eil~hpwf~~ 265 (271)
T d1nvra_ 246 ENPSARIT----IPDIKKDRWYNK 265 (271)
T ss_dssp SSTTTSCC----HHHHTTCTTTTC
T ss_pred CChhHCcC----HHHHhcCHhhCc
Confidence 99999999 999999999963
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-60 Score=487.25 Aligned_cols=255 Identities=24% Similarity=0.409 Sum_probs=225.7
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
++|++++.||+|+||+||+|++..+++.||||++.+...... ..+.+|+.+|+.++|||||+++++|.+++.+||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~---~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCH---HHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHH---HHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 579999999999999999999999999999999986654433 35678999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
|||+||+|.+++.+. .+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|..+...
T Consensus 97 Ey~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~---- 169 (293)
T d1yhwa1 97 EYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---- 169 (293)
T ss_dssp ECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST----
T ss_pred EecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccc----
Confidence 999999999988764 5999999999999999999999999999999999999999999999999998543211
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
.......+
T Consensus 170 ------------------------------------------------------------------------~~~~~~~~ 177 (293)
T d1yhwa1 170 ------------------------------------------------------------------------QSKRSTMV 177 (293)
T ss_dssp ------------------------------------------------------------------------TCCBCCCC
T ss_pred ------------------------------------------------------------------------cccccccc
Confidence 01122457
Q ss_pred cCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcC-CCCCCCCCCCCHHHHHHHHHhhhcC
Q 007260 456 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ-PLRFPESPVVSFAARDLIRGLLVKE 534 (611)
Q Consensus 456 GT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~-~l~~p~~~~~s~~l~dLI~~~L~~d 534 (611)
||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+....+..+... ...++.+..++.++++||.+||.+|
T Consensus 178 gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 257 (293)
T d1yhwa1 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMD 257 (293)
T ss_dssp SCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSS
T ss_pred cCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHccCC
Confidence 999999999999999999999999999999999999999998887777766644 3344555669999999999999999
Q ss_pred ccccCCchhcHHHHHcCCCCCC
Q 007260 535 PQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 535 P~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
|.+||+ +.|+|+||||+.
T Consensus 258 P~~R~s----~~eil~Hp~~~~ 275 (293)
T d1yhwa1 258 VEKRGS----AKELLQHQFLKI 275 (293)
T ss_dssp TTTSCC----HHHHTTCGGGGG
T ss_pred hhHCcC----HHHHhcCHhhCC
Confidence 999999 999999999973
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-59 Score=489.34 Aligned_cols=265 Identities=36% Similarity=0.729 Sum_probs=234.0
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHH-hCCCCCcccccceeeccceeeE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQ-SLDHPFLPTLYTHFETEKFSCL 293 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~-~l~HpnIv~l~~~~~~~~~~~L 293 (611)
+++|++++.||+|+||+||+|++..+++.||||++++...........+.+|+.++. .++|||||+++++|.+++.+||
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 368999999999999999999999999999999998765544444556667777765 6899999999999999999999
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcc
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 373 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~ 373 (611)
|||||+||+|.+++... ..+++..++.|+.||+.||+|||++|||||||||+|||++.+|++||+|||++......
T Consensus 81 vmEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~-- 156 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-- 156 (320)
T ss_dssp EEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--
T ss_pred EEeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc--
Confidence 99999999999999875 56999999999999999999999999999999999999999999999999998432210
Q ss_pred ccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccc
Q 007260 374 LIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMS 453 (611)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (611)
......
T Consensus 157 --------------------------------------------------------------------------~~~~~~ 162 (320)
T d1xjda_ 157 --------------------------------------------------------------------------DAKTNT 162 (320)
T ss_dssp --------------------------------------------------------------------------TCCBCC
T ss_pred --------------------------------------------------------------------------cccccc
Confidence 011123
Q ss_pred cccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007260 454 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVK 533 (611)
Q Consensus 454 ~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~ 533 (611)
.+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+.+.++......+|.. ++.++++||.+||.+
T Consensus 163 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~--~s~~~~dli~~~L~~ 240 (320)
T d1xjda_ 163 FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW--LEKEAKDLLVKLFVR 240 (320)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT--SCHHHHHHHHHHSCS
T ss_pred cCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc--CCHHHHHHHHHhccc
Confidence 469999999999999999999999999999999999999999998888888888887776654 899999999999999
Q ss_pred CccccCCchhcHH-HHHcCCCCCCCchhhhc
Q 007260 534 EPQHRLAYKRGAT-EIKQHPFFEGVNWALIR 563 (611)
Q Consensus 534 dP~~Rpt~~~~a~-elL~Hp~f~~~~~~~~~ 563 (611)
||.+||+ +. ++++||||++++|..+.
T Consensus 241 dP~~R~s----~~~~l~~hpff~~~~~~~l~ 267 (320)
T d1xjda_ 241 EPEKRLG----VRGDIRQHPLFREINWEELE 267 (320)
T ss_dssp SGGGSBT----TBSCGGGSGGGTTCCHHHHH
T ss_pred CCCCCcC----HHHHHHhCchhccCCHHHHH
Confidence 9999999 64 89999999999997653
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-59 Score=486.83 Aligned_cols=256 Identities=32% Similarity=0.516 Sum_probs=214.7
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
++|++++.||+|+||+||+|++..+++.||||++.+...... ...+.+|+.+|+.++|||||+++++|.+++.+||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK--EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 579999999999999999999999999999999987654332 345678999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEc---cCCcEEEEeccccccccCCc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVR---EDGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~---~~g~vkL~DFGlA~~~~~~~ 372 (611)
|||+||+|.+++... +.+++..++.|+.||+.||+|||++|||||||||+|||+. ++|++||+|||+|.....
T Consensus 87 E~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~-- 162 (307)
T d1a06a_ 87 QLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP-- 162 (307)
T ss_dssp CCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred eccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccC--
Confidence 999999999999875 5699999999999999999999999999999999999995 578999999999843210
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
.....
T Consensus 163 ---------------------------------------------------------------------------~~~~~ 167 (307)
T d1a06a_ 163 ---------------------------------------------------------------------------GSVLS 167 (307)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ---------------------------------------------------------------------------CCeee
Confidence 01112
Q ss_pred ccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCC--CCCCCCHHHHHHHHHh
Q 007260 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFP--ESPVVSFAARDLIRGL 530 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p--~~~~~s~~l~dLI~~~ 530 (611)
+.+||+.|||||++.+..|+.++|||||||+||||++|++||.+....+...++......++ ....+|+++++||.+|
T Consensus 168 ~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 247 (307)
T d1a06a_ 168 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHL 247 (307)
T ss_dssp -----CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHH
T ss_pred eeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHH
Confidence 45799999999999999999999999999999999999999999888888888887766554 3456999999999999
Q ss_pred hhcCccccCCchhcHHHHHcCCCCCC
Q 007260 531 LVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 531 L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
|.+||.+||| +.|+|+||||++
T Consensus 248 L~~dP~~R~s----~~eil~hp~~~~ 269 (307)
T d1a06a_ 248 MEKDPEKRFT----CEQALQHPWIAG 269 (307)
T ss_dssp SCSSGGGSCC----HHHHHHSTTTTS
T ss_pred ccCCHhHCcC----HHHHhcCHhhCC
Confidence 9999999999 999999999975
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.8e-59 Score=491.86 Aligned_cols=261 Identities=28% Similarity=0.432 Sum_probs=231.6
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
+++|++++.||+|+||+||+|++..+++.||||++.+.... ....+.+|+.+|+.|+|||||+++++|++++.+|||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES---DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHH---HHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchh---hHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 46999999999999999999999999999999999775533 234677899999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEcc--CCcEEEEeccccccccCCc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRE--DGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~--~g~vkL~DFGlA~~~~~~~ 372 (611)
||||+||+|.+++.... ..+++..++.|+.||+.||+|||++|||||||||+||||+. +|.+||+|||+|..+...
T Consensus 102 mE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~- 179 (350)
T d1koaa2 102 YEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 179 (350)
T ss_dssp ECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-
T ss_pred EEcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc-
Confidence 99999999999886543 46999999999999999999999999999999999999964 678999999998543210
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
....
T Consensus 180 ----------------------------------------------------------------------------~~~~ 183 (350)
T d1koaa2 180 ----------------------------------------------------------------------------QSVK 183 (350)
T ss_dssp ----------------------------------------------------------------------------SCEE
T ss_pred ----------------------------------------------------------------------------cccc
Confidence 1122
Q ss_pred ccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCC--CCCCHHHHHHHHHh
Q 007260 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPES--PVVSFAARDLIRGL 530 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~--~~~s~~l~dLI~~~ 530 (611)
..+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+.+.++......++.. ..+++++++||.+|
T Consensus 184 ~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 263 (350)
T d1koaa2 184 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKL 263 (350)
T ss_dssp EECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHH
T ss_pred eecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHH
Confidence 4579999999999999999999999999999999999999999998888888888777665543 45899999999999
Q ss_pred hhcCccccCCchhcHHHHHcCCCCCCCchh
Q 007260 531 LVKEPQHRLAYKRGATEIKQHPFFEGVNWA 560 (611)
Q Consensus 531 L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~ 560 (611)
|++||.+||| ++|||+||||+..+|.
T Consensus 264 L~~dP~~R~t----~~eil~hp~~~~~~~~ 289 (350)
T d1koaa2 264 LLADPNTRMT----IHQALEHPWLTPGNAP 289 (350)
T ss_dssp CCSSGGGSCC----HHHHHHSTTTSCTTCC
T ss_pred ccCChhHCcC----HHHHhcCcccCCCCCC
Confidence 9999999999 9999999999987764
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.1e-59 Score=494.76 Aligned_cols=269 Identities=31% Similarity=0.602 Sum_probs=225.8
Q ss_pred cccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHH---HHHHHHHHHHHHHhCCCCCcccccceeeccce
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRK---KLLRAQTEREILQSLDHPFLPTLYTHFETEKF 290 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~---~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~ 290 (611)
.+++|++++.||+|+||.||+|++..+++.||||++.+....... ...+...|+.+|+.++|||||+++++|.+++.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 467999999999999999999999999999999999876554332 23333455777888899999999999999999
Q ss_pred eeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccC
Q 007260 291 SCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAV 370 (611)
Q Consensus 291 ~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~ 370 (611)
+|||||||+||+|.+++.+. ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+..
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 99999999999999999875 5689999999999999999999999999999999999999999999999999853321
Q ss_pred CccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccc
Q 007260 371 SPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEAR 450 (611)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (611)
. .
T Consensus 160 ~------------------------------------------------------------------------------~ 161 (364)
T d1omwa3 160 K------------------------------------------------------------------------------K 161 (364)
T ss_dssp S------------------------------------------------------------------------------C
T ss_pred C------------------------------------------------------------------------------c
Confidence 0 1
Q ss_pred ccccccCCCccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHH--HH-HHHHcCCCCCCCCCCCCHHHHHH
Q 007260 451 SMSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRA--TL-FNVVGQPLRFPESPVVSFAARDL 526 (611)
Q Consensus 451 ~~~~vGT~~Y~APEil~~-~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~--~l-~~i~~~~l~~p~~~~~s~~l~dL 526 (611)
....+||+.|+|||++.+ ..|+.++|||||||+||||++|+.||.+..... .+ ..+......+| ..+++++++|
T Consensus 162 ~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~l 239 (364)
T d1omwa3 162 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP--DSFSPELRSL 239 (364)
T ss_dssp CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCC--SSSCHHHHHH
T ss_pred ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCC--CCCCHHHHHH
Confidence 123469999999999974 568999999999999999999999998754322 22 22333333333 4599999999
Q ss_pred HHHhhhcCccccCCch-hcHHHHHcCCCCCCCchhhhcc
Q 007260 527 IRGLLVKEPQHRLAYK-RGATEIKQHPFFEGVNWALIRC 564 (611)
Q Consensus 527 I~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~~ 564 (611)
|.+||.+||.+||+.. ..|+|||+||||++++|..+..
T Consensus 240 i~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~~~ 278 (364)
T d1omwa3 240 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFL 278 (364)
T ss_dssp HHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHHHT
T ss_pred HHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHHhc
Confidence 9999999999999953 4589999999999999986543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-59 Score=480.66 Aligned_cols=264 Identities=29% Similarity=0.462 Sum_probs=228.9
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhH---HHHHHHHHHHHHHHhCCCCCcccccceeeccceee
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGR---KKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSC 292 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~---~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~ 292 (611)
++|++++.||+|+||+||+|+++.+++.||||++.+...... .....+.+|+.+|+.|+|||||+++++|++++.+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 579999999999999999999999999999999976543221 12346788999999999999999999999999999
Q ss_pred EEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCC----cEEEEeccccccc
Q 007260 293 LVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDG----HIMLSDFDLSLRC 368 (611)
Q Consensus 293 LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g----~vkL~DFGlA~~~ 368 (611)
||||||+||+|.+++... +.+++..++.++.||+.||+|||++|||||||||+|||++.+| ++||+|||+|...
T Consensus 90 iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 999999999999998875 4699999999999999999999999999999999999999776 5999999998543
Q ss_pred cCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccc
Q 007260 369 AVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTE 448 (611)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (611)
...
T Consensus 168 ~~~----------------------------------------------------------------------------- 170 (293)
T d1jksa_ 168 DFG----------------------------------------------------------------------------- 170 (293)
T ss_dssp TTS-----------------------------------------------------------------------------
T ss_pred CCC-----------------------------------------------------------------------------
Confidence 211
Q ss_pred ccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCC--CCCCCHHHHHH
Q 007260 449 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPE--SPVVSFAARDL 526 (611)
Q Consensus 449 ~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~--~~~~s~~l~dL 526 (611)
......+||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..+.+.++......++. ...++.++++|
T Consensus 171 ~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 250 (293)
T d1jksa_ 171 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDF 250 (293)
T ss_dssp CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHH
T ss_pred ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHHH
Confidence 0112346999999999999999999999999999999999999999999988888888887766653 24689999999
Q ss_pred HHHhhhcCccccCCchhcHHHHHcCCCCCCCchhhh
Q 007260 527 IRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALI 562 (611)
Q Consensus 527 I~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~ 562 (611)
|.+||.+||.+||+ ++|+|+||||+..+|...
T Consensus 251 i~~~L~~dP~~R~s----~~eil~hp~~~~~~~~~~ 282 (293)
T d1jksa_ 251 IRRLLVKDPKKRMT----IQDSLQHPWIKPKDTQQA 282 (293)
T ss_dssp HHTTSCSSGGGSCC----HHHHHHSTTTCC------
T ss_pred HHHHccCChhHCcC----HHHHhcCcccCCCChhHh
Confidence 99999999999999 999999999999888653
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-59 Score=483.30 Aligned_cols=257 Identities=30% Similarity=0.441 Sum_probs=224.8
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEe
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVM 295 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVm 295 (611)
+.|++++.||+|+||+||+|++..+++.||||++++.... ...++.+|+++|+.++|||||+++++|.+++.+||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE---ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG---GGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH---HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 4799999999999999999999999999999999765322 2346778999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
|||+||+|.+++.+. ++.+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|.....
T Consensus 89 Ey~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~----- 162 (288)
T d2jfla1 89 EFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR----- 162 (288)
T ss_dssp ECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH-----
T ss_pred ecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCC-----
Confidence 999999999987654 25699999999999999999999999999999999999999999999999999843220
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
......+.+
T Consensus 163 -----------------------------------------------------------------------~~~~~~~~~ 171 (288)
T d2jfla1 163 -----------------------------------------------------------------------TIQRRDSFI 171 (288)
T ss_dssp -----------------------------------------------------------------------HHHHHTCCC
T ss_pred -----------------------------------------------------------------------Ccccccccc
Confidence 001123457
Q ss_pred cCCCccchhhhc-----cCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCC-CCCCCCCCCHHHHHHHHH
Q 007260 456 GTHEYLAPEIIK-----GEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPL-RFPESPVVSFAARDLIRG 529 (611)
Q Consensus 456 GT~~Y~APEil~-----~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l-~~p~~~~~s~~l~dLI~~ 529 (611)
||+.|||||++. +..|+.++|||||||+||||++|++||.+.+..+.+.++..... .++....++.++++||.+
T Consensus 172 Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~ 251 (288)
T d2jfla1 172 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKK 251 (288)
T ss_dssp SCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHHHH
T ss_pred cccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHH
Confidence 999999999994 45679999999999999999999999999888888888776543 344455699999999999
Q ss_pred hhhcCccccCCchhcHHHHHcCCCCCC
Q 007260 530 LLVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 530 ~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
||++||.+||| +.|||+||||+.
T Consensus 252 ~L~~dp~~R~t----~~ell~hp~~~~ 274 (288)
T d2jfla1 252 CLEKNVDARWT----TSQLLQHPFVTV 274 (288)
T ss_dssp HSCSSTTTSCC----HHHHTTSGGGCC
T ss_pred HccCChhHCcC----HHHHhcCcccCC
Confidence 99999999999 999999999974
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-60 Score=492.89 Aligned_cols=261 Identities=26% Similarity=0.412 Sum_probs=218.7
Q ss_pred cccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeE
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCL 293 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~L 293 (611)
..++|++++.||+|+||+||+|++..+++.||||++++.... ....++.+|+.+|+.++|||||+++++|.+++.+||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i 81 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP--AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 81 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCT--THHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCH--HHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 346899999999999999999999999999999999764322 233467889999999999999999999999999999
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCeeccCCCCCcEEEccCCcEEEEeccccccccCCc
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHM-LGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~-~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~ 372 (611)
|||||+||+|.+++.+. +.+++..++.++.||+.||.|||+ +|||||||||+||||+.+|++||+|||+|..+..
T Consensus 82 VmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~-- 157 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-- 157 (322)
T ss_dssp EEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH--
T ss_pred EEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC--
Confidence 99999999999999875 469999999999999999999997 5999999999999999999999999999854320
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
....
T Consensus 158 ----------------------------------------------------------------------------~~~~ 161 (322)
T d1s9ja_ 158 ----------------------------------------------------------------------------SMAN 161 (322)
T ss_dssp ----------------------------------------------------------------------------HTC-
T ss_pred ----------------------------------------------------------------------------Cccc
Confidence 1122
Q ss_pred ccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH----------------------------
Q 007260 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLF---------------------------- 504 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~---------------------------- 504 (611)
+++||++|||||++.+..|+.++|||||||++|||++|+.||.+.+......
T Consensus 162 ~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (322)
T d1s9ja_ 162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241 (322)
T ss_dssp --CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------------
T ss_pred cccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccc
Confidence 4689999999999999999999999999999999999999998754322110
Q ss_pred --------------HHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCchh
Q 007260 505 --------------NVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWA 560 (611)
Q Consensus 505 --------------~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~ 560 (611)
.+............++.+++|||.+||++||.+||| |+|+|+||||+..+|.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t----a~e~L~Hpf~~~~~~~ 307 (322)
T d1s9ja_ 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD----LKQLMVHAFIKRSDAE 307 (322)
T ss_dssp ----CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCC----HHHHHTSHHHHHHHHS
T ss_pred cccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcC----HHHHhhCHhhCcCCcc
Confidence 011111111111247899999999999999999999 9999999999877664
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.7e-59 Score=483.87 Aligned_cols=254 Identities=29% Similarity=0.381 Sum_probs=228.9
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEee
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVME 296 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE 296 (611)
.|++++.||+|+||+||+|++..+++.||||++.+..........++.+|+.+|+.|+|||||+++++|.+++.+|||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 59999999999999999999999999999999988766666677788999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccccc
Q 007260 297 FCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIK 376 (611)
Q Consensus 297 ~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~ 376 (611)
||.||+|..++... +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|....
T Consensus 96 ~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~------- 166 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------- 166 (309)
T ss_dssp CCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS-------
T ss_pred ecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccC-------
Confidence 99999998766654 569999999999999999999999999999999999999999999999999984221
Q ss_pred cccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccccc
Q 007260 377 ASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVG 456 (611)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vG 456 (611)
.....+|
T Consensus 167 -------------------------------------------------------------------------~~~~~~G 173 (309)
T d1u5ra_ 167 -------------------------------------------------------------------------PANSFVG 173 (309)
T ss_dssp -------------------------------------------------------------------------SBCCCCS
T ss_pred -------------------------------------------------------------------------CCCcccc
Confidence 0123469
Q ss_pred CCCccchhhhccC---CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007260 457 THEYLAPEIIKGE---GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVK 533 (611)
Q Consensus 457 T~~Y~APEil~~~---~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~ 533 (611)
|+.|||||++.+. .|+.++|||||||++|||++|+.||.+....+.+.++............+++++++||.+||.+
T Consensus 174 T~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~ 253 (309)
T d1u5ra_ 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQK 253 (309)
T ss_dssp CGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCS
T ss_pred CccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcC
Confidence 9999999999753 5789999999999999999999999998888888888877666555667999999999999999
Q ss_pred CccccCCchhcHHHHHcCCCCCC
Q 007260 534 EPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 534 dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
||.+||| ++|||+||||..
T Consensus 254 dP~~Rpt----~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 254 IPQDRPT----SEVLLKHRFVLR 272 (309)
T ss_dssp SGGGSCC----HHHHTTCHHHHS
T ss_pred ChhHCcC----HHHHHhCHHhcC
Confidence 9999999 999999999964
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.1e-58 Score=488.46 Aligned_cols=259 Identities=30% Similarity=0.454 Sum_probs=229.9
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
.++|++++.||+|+||+||+|++..+++.||||++++..... ...+.+|+.+|++|+|||||+++++|++++.+|||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 104 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 104 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH---HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 368999999999999999999999999999999997754332 34667899999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEc--cCCcEEEEeccccccccCCc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVR--EDGHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~--~~g~vkL~DFGlA~~~~~~~ 372 (611)
||||+||+|.+++... +..|++..++.|+.||+.||+|||++|||||||||+||||+ .+|++||+|||+|..+...
T Consensus 105 mE~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~- 182 (352)
T d1koba_ 105 LEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 182 (352)
T ss_dssp EECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred EEcCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC-
Confidence 9999999999877654 35699999999999999999999999999999999999998 5789999999998543211
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
....
T Consensus 183 ----------------------------------------------------------------------------~~~~ 186 (352)
T d1koba_ 183 ----------------------------------------------------------------------------EIVK 186 (352)
T ss_dssp ----------------------------------------------------------------------------SCEE
T ss_pred ----------------------------------------------------------------------------Ccee
Confidence 1122
Q ss_pred ccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCC--CCCCCHHHHHHHHHh
Q 007260 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPE--SPVVSFAARDLIRGL 530 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~--~~~~s~~l~dLI~~~ 530 (611)
..+||+.|+|||++.+..|+.++|||||||+||||++|++||.+.+..+.+.++......++. ...++.++++||.+|
T Consensus 187 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 266 (352)
T d1koba_ 187 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNL 266 (352)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTT
T ss_pred eccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHH
Confidence 456999999999999999999999999999999999999999999988888888887766654 356999999999999
Q ss_pred hhcCccccCCchhcHHHHHcCCCCCCCc
Q 007260 531 LVKEPQHRLAYKRGATEIKQHPFFEGVN 558 (611)
Q Consensus 531 L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 558 (611)
|++||.+||| +.|+|+||||++..
T Consensus 267 L~~dp~~R~s----~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 267 LQKEPRKRLT----VHDALEHPWLKGDH 290 (352)
T ss_dssp SCSSGGGSCC----HHHHHTSTTTSSCC
T ss_pred ccCChhHCcC----HHHHhcCHhhCCCc
Confidence 9999999999 99999999998753
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-58 Score=473.04 Aligned_cols=257 Identities=25% Similarity=0.391 Sum_probs=214.8
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec--cceeeE
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET--EKFSCL 293 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~--~~~~~L 293 (611)
++|++++.||+|+||+||+|+++.+++.||||++.+.... ......+.+|+++|++++|||||++++++.+ ++.+||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 5899999999999999999999999999999999876543 3445678899999999999999999999864 567899
Q ss_pred EeeeCCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcC-----eeccCCCCCcEEEccCCcEEEEeccccc
Q 007260 294 VMEFCPGGDLHTLRQKQ--PGKYFPEQAVRFYVAEVLLALEYLHMLG-----IIYRDLKPENVLVREDGHIMLSDFDLSL 366 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~--~~~~l~e~~~~~i~~qll~aL~yLH~~g-----IVHRDLKPeNILv~~~g~vkL~DFGlA~ 366 (611)
|||||+||+|.+++.+. .+..+++..++.++.||+.||+|||++| ||||||||+||||+.+|.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 99999999999988642 2357999999999999999999999976 9999999999999999999999999985
Q ss_pred cccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCc
Q 007260 367 RCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEP 446 (611)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (611)
.+...
T Consensus 163 ~~~~~--------------------------------------------------------------------------- 167 (269)
T d2java1 163 ILNHD--------------------------------------------------------------------------- 167 (269)
T ss_dssp HC------------------------------------------------------------------------------
T ss_pred ecccC---------------------------------------------------------------------------
Confidence 43211
Q ss_pred ccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 007260 447 TEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDL 526 (611)
Q Consensus 447 ~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dL 526 (611)
.......+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+.+.++...... +.+..+++++++|
T Consensus 168 -~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~s~~l~~l 245 (269)
T d2java1 168 -TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR-RIPYRYSDELNEI 245 (269)
T ss_dssp ---------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-CCCTTSCHHHHHH
T ss_pred -CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC-CCCcccCHHHHHH
Confidence 01122457999999999999999999999999999999999999999998887777777766543 2234589999999
Q ss_pred HHHhhhcCccccCCchhcHHHHHcCCCC
Q 007260 527 IRGLLVKEPQHRLAYKRGATEIKQHPFF 554 (611)
Q Consensus 527 I~~~L~~dP~~Rpt~~~~a~elL~Hp~f 554 (611)
|.+||..||.+||+ ++|||+|||.
T Consensus 246 i~~~L~~dp~~Rps----~~ell~hp~i 269 (269)
T d2java1 246 ITRMLNLKDYHRPS----VEEILENPLI 269 (269)
T ss_dssp HHHHTCSSGGGSCC----HHHHHTSTTC
T ss_pred HHHHcCCChhHCcC----HHHHHhCCcC
Confidence 99999999999999 9999999995
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-58 Score=467.45 Aligned_cols=252 Identities=24% Similarity=0.433 Sum_probs=216.3
Q ss_pred eEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec----cceeeE
Q 007260 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET----EKFSCL 293 (611)
Q Consensus 218 y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~----~~~~~L 293 (611)
|++.++||+|+||+||+|++..+++.||+|++...... .....++.+|+++|++++|||||+++++|++ +..+||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 47888999999999999999999999999999766543 3445678899999999999999999999865 467899
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--eeccCCCCCcEEEc-cCCcEEEEeccccccccC
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLG--IIYRDLKPENVLVR-EDGHIMLSDFDLSLRCAV 370 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~g--IVHRDLKPeNILv~-~~g~vkL~DFGlA~~~~~ 370 (611)
|||||+||+|.+++.+. ..+++..++.|+.||+.||+|||++| ||||||||+||||+ +++.+||+|||+|....
T Consensus 90 vmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~- 166 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR- 166 (270)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC-
T ss_pred EEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc-
Confidence 99999999999998875 56999999999999999999999999 99999999999997 58899999999983211
Q ss_pred CccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccc
Q 007260 371 SPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEAR 450 (611)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (611)
...
T Consensus 167 -----------------------------------------------------------------------------~~~ 169 (270)
T d1t4ha_ 167 -----------------------------------------------------------------------------ASF 169 (270)
T ss_dssp -----------------------------------------------------------------------------TTS
T ss_pred -----------------------------------------------------------------------------CCc
Confidence 011
Q ss_pred ccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCC-CCCCCCCHHHHHHHHH
Q 007260 451 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRF-PESPVVSFAARDLIRG 529 (611)
Q Consensus 451 ~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~-p~~~~~s~~l~dLI~~ 529 (611)
..+.+||+.|||||++.+ .|+.++|||||||+||||++|+.||.+..+...+.+.+...... .....+++++++||.+
T Consensus 170 ~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~ 248 (270)
T d1t4ha_ 170 AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEG 248 (270)
T ss_dssp BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHH
T ss_pred cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHHH
Confidence 224579999999999876 59999999999999999999999998877776666555443332 2334588999999999
Q ss_pred hhhcCccccCCchhcHHHHHcCCCCC
Q 007260 530 LLVKEPQHRLAYKRGATEIKQHPFFE 555 (611)
Q Consensus 530 ~L~~dP~~Rpt~~~~a~elL~Hp~f~ 555 (611)
||.+||++||| ++|||+||||+
T Consensus 249 ~l~~dp~~R~s----~~ell~Hp~fk 270 (270)
T d1t4ha_ 249 CIRQNKDERYS----IKDLLNHAFFQ 270 (270)
T ss_dssp HSCSSGGGSCC----HHHHHTSGGGC
T ss_pred HccCCHhHCcC----HHHHhCCcccC
Confidence 99999999999 99999999995
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=8.3e-57 Score=460.97 Aligned_cols=258 Identities=31% Similarity=0.453 Sum_probs=227.0
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhh------hHHHHHHHHHHHHHHHhCC-CCCcccccceeecc
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLA------GRKKLLRAQTEREILQSLD-HPFLPTLYTHFETE 288 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~------~~~~~~~~~~E~~iL~~l~-HpnIv~l~~~~~~~ 288 (611)
++|++++.||+|+||+||+|++..+++.||||++++.... ......++.+|+.+|++|+ |||||+++++|.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6899999999999999999999999999999999765422 1334456789999999997 99999999999999
Q ss_pred ceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccc
Q 007260 289 KFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRC 368 (611)
Q Consensus 289 ~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~ 368 (611)
+.+|||||||+||+|.+++..+ +.+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||++...
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred cceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEc
Confidence 9999999999999999999875 56999999999999999999999999999999999999999999999999998543
Q ss_pred cCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccc
Q 007260 369 AVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTE 448 (611)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (611)
...
T Consensus 161 ~~~----------------------------------------------------------------------------- 163 (277)
T d1phka_ 161 DPG----------------------------------------------------------------------------- 163 (277)
T ss_dssp CTT-----------------------------------------------------------------------------
T ss_pred cCC-----------------------------------------------------------------------------
Confidence 210
Q ss_pred ccccccccCCCccchhhhcc------CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCC--CCCCCC
Q 007260 449 ARSMSFVGTHEYLAPEIIKG------EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFP--ESPVVS 520 (611)
Q Consensus 449 ~~~~~~vGT~~Y~APEil~~------~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p--~~~~~s 520 (611)
......+||+.|+|||++.+ ..++.++|||||||+||||++|+.||.+.+....+.++......++ ....+|
T Consensus 164 ~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 243 (277)
T d1phka_ 164 EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYS 243 (277)
T ss_dssp CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSC
T ss_pred CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCC
Confidence 01123579999999999974 3468899999999999999999999999988888888887765544 345699
Q ss_pred HHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCC
Q 007260 521 FAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 521 ~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
+++++||.+||..||.+||+ ++|||+||||+.
T Consensus 244 ~~~~~li~~~L~~~p~~R~s----~~eil~h~~~~~ 275 (277)
T d1phka_ 244 DTVKDLVSRFLVVQPQKRYT----AEEALAHPFFQQ 275 (277)
T ss_dssp HHHHHHHHHHCCSSGGGSCC----HHHHTTSGGGCT
T ss_pred HHHHHHHHHHccCChhHCcC----HHHHHcCHHHHH
Confidence 99999999999999999999 999999999975
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-57 Score=472.83 Aligned_cols=256 Identities=26% Similarity=0.398 Sum_probs=227.6
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
.++|++++.||+|+||+||+|.+..+++.||||++++.... ...+.+|+++|+.++|||||+++++|++++.+|||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~----~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH----HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc----HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 46899999999999999999999999999999999876432 23567899999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccC--CcEEEEeccccccccCCc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRED--GHIMLSDFDLSLRCAVSP 372 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~--g~vkL~DFGlA~~~~~~~ 372 (611)
||||+||+|.+++... +..+++..++.|+.||+.||+|||++|||||||||+||||+.+ +.+||+|||++......
T Consensus 80 mE~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~- 157 (321)
T d1tkia_ 80 FEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp ECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred EecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC-
Confidence 9999999999998765 3469999999999999999999999999999999999999854 48999999998443210
Q ss_pred cccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccc
Q 007260 373 TLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSM 452 (611)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (611)
....
T Consensus 158 ----------------------------------------------------------------------------~~~~ 161 (321)
T d1tkia_ 158 ----------------------------------------------------------------------------DNFR 161 (321)
T ss_dssp ----------------------------------------------------------------------------CEEE
T ss_pred ----------------------------------------------------------------------------Cccc
Confidence 1112
Q ss_pred ccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCC--CCCCHHHHHHHHHh
Q 007260 453 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPES--PVVSFAARDLIRGL 530 (611)
Q Consensus 453 ~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~--~~~s~~l~dLI~~~ 530 (611)
..+||+.|+|||++.+..|+.++|||||||+||+|++|++||.+.+..+.+.++......++.. ..++.++++||.+|
T Consensus 162 ~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 241 (321)
T d1tkia_ 162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRL 241 (321)
T ss_dssp EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTT
T ss_pred ccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHH
Confidence 3569999999999999999999999999999999999999999999888888998887776542 45899999999999
Q ss_pred hhcCccccCCchhcHHHHHcCCCCCC
Q 007260 531 LVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 531 L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
|.+||.+||+ ++|+|+||||+.
T Consensus 242 L~~dp~~R~s----~~eil~hp~~~~ 263 (321)
T d1tkia_ 242 LVKERKSRMT----ASEALQHPWLKQ 263 (321)
T ss_dssp SCSSGGGSCC----HHHHHHSHHHHS
T ss_pred ccCChhHCcC----HHHHhcCHhhcc
Confidence 9999999999 999999999964
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-56 Score=463.18 Aligned_cols=256 Identities=29% Similarity=0.397 Sum_probs=210.5
Q ss_pred EEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhh--HHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEeee
Q 007260 220 LLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAG--RKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEF 297 (611)
Q Consensus 220 l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~--~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE~ 297 (611)
.+++||+|+||+||+|++..+++.||||++++..... .....++.+|+.+|+.++|||||+++++|.+++++||||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4689999999999999999999999999997654322 12234678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccccc
Q 007260 298 CPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKA 377 (611)
Q Consensus 298 ~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~ 377 (611)
|.|+++..++.. +..+++..++.|++||+.||+|||++|||||||||+|||++.+|.+||+|||+|......
T Consensus 82 ~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~------ 153 (299)
T d1ua2a_ 82 METDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP------ 153 (299)
T ss_dssp CSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC------
T ss_pred hcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCC------
Confidence 988877765543 367999999999999999999999999999999999999999999999999998432210
Q ss_pred ccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccC
Q 007260 378 SSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGT 457 (611)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT 457 (611)
.......+||
T Consensus 154 ----------------------------------------------------------------------~~~~~~~~gt 163 (299)
T d1ua2a_ 154 ----------------------------------------------------------------------NRAYTHQVVT 163 (299)
T ss_dssp ----------------------------------------------------------------------CCCCCCSCCC
T ss_pred ----------------------------------------------------------------------cccccceecC
Confidence 0111235799
Q ss_pred CCccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHc---CCCC-----------------CCC-
Q 007260 458 HEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG---QPLR-----------------FPE- 515 (611)
Q Consensus 458 ~~Y~APEil~~~-~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~---~~l~-----------------~p~- 515 (611)
+.|+|||++.+. .|+.++|||||||++|||++|++||.+.++.+.+.++.. .+.. ++.
T Consensus 164 ~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (299)
T d1ua2a_ 164 RWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGI 243 (299)
T ss_dssp CTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCC
T ss_pred hhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCC
Confidence 999999999765 579999999999999999999999999988887766543 1110 000
Q ss_pred -----CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 516 -----SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 516 -----~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
...+++++++||.+||++||++||| |.|+|+||||++.
T Consensus 244 ~~~~~~~~~s~~~~dll~~~L~~dP~~R~s----a~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 244 PLHHIFSAAGDDLLDLIQGLFLFNPCARIT----ATQALKMKYFSNR 286 (299)
T ss_dssp CHHHHCTTCCHHHHHHHHHHHCSSTTTSCC----HHHHHTSGGGTSS
T ss_pred ChHHhcccCCHHHHHHHHHHccCChhhCcC----HHHHhCCHhhCCC
Confidence 1246899999999999999999999 9999999999863
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-56 Score=458.20 Aligned_cols=261 Identities=29% Similarity=0.456 Sum_probs=217.7
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
+++|++++.||+|+||+||+|++..+++.||||++..... ......++.+|+++|++++|||||+++++|.+++.+|||
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 3689999999999999999999999999999999976542 223345778899999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
||||. +.+..++.......+++..++.|+.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.....
T Consensus 80 ~e~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~--- 155 (298)
T d1gz8a_ 80 FEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--- 155 (298)
T ss_dssp EECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC---
T ss_pred EeecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCC---
Confidence 99995 55666666555677999999999999999999999999999999999999999999999999998543211
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
.......
T Consensus 156 -------------------------------------------------------------------------~~~~~~~ 162 (298)
T d1gz8a_ 156 -------------------------------------------------------------------------VRTYTHE 162 (298)
T ss_dssp -------------------------------------------------------------------------SBCTTCC
T ss_pred -------------------------------------------------------------------------cccceee
Confidence 0112234
Q ss_pred ccCCCccchhhhccCCC-CChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHc---CCCC---------------CCC
Q 007260 455 VGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG---QPLR---------------FPE 515 (611)
Q Consensus 455 vGT~~Y~APEil~~~~~-~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~---~~l~---------------~p~ 515 (611)
+||+.|+|||++....+ +.++|||||||++|+|++|+.||.+.+..+.+.++.. .+.. ++.
T Consensus 163 ~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (298)
T d1gz8a_ 163 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 242 (298)
T ss_dssp BCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCC
T ss_pred cccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccccccc
Confidence 79999999999888775 8899999999999999999999999888877766542 1100 111
Q ss_pred ---------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 516 ---------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 516 ---------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
...++.++++||.+||.+||.+||| +.|||+||||+++
T Consensus 243 ~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t----~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 243 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRIS----AKAALAHPFFQDV 289 (298)
T ss_dssp CCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCC----HHHHHTSGGGTTC
T ss_pred ccccchhhhccCCCHHHHHHHHHHccCChhHCcC----HHHHhCCHhhccC
Confidence 1247889999999999999999999 9999999999865
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-56 Score=469.32 Aligned_cols=253 Identities=28% Similarity=0.433 Sum_probs=212.5
Q ss_pred ccCeEEEe-EecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHh-CCCCCcccccceeec----c
Q 007260 215 LSHFRLLK-RLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQS-LDHPFLPTLYTHFET----E 288 (611)
Q Consensus 215 ~~~y~l~~-~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~-l~HpnIv~l~~~~~~----~ 288 (611)
+++|++++ .||+|+||+||+|++..+++.||||++++.. .+++|++++.+ ++|||||+++++|++ +
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--------~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECSH--------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCcH--------HHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 46899886 5999999999999999999999999997543 45679998654 589999999999975 5
Q ss_pred ceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEcc---CCcEEEEecccc
Q 007260 289 KFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRE---DGHIMLSDFDLS 365 (611)
Q Consensus 289 ~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~---~g~vkL~DFGlA 365 (611)
.++|||||||+||+|.+++.+.....|++..++.|+.||+.||+|||++|||||||||+|||++. ++++||+|||+|
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccccee
Confidence 78999999999999999998765667999999999999999999999999999999999999985 567999999998
Q ss_pred ccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccC
Q 007260 366 LRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAE 445 (611)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (611)
+.....
T Consensus 162 ~~~~~~-------------------------------------------------------------------------- 167 (335)
T d2ozaa1 162 KETTSH-------------------------------------------------------------------------- 167 (335)
T ss_dssp EECCCC--------------------------------------------------------------------------
T ss_pred eeccCC--------------------------------------------------------------------------
Confidence 543210
Q ss_pred cccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH----HHcCCCCCCCC--CCC
Q 007260 446 PTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFN----VVGQPLRFPES--PVV 519 (611)
Q Consensus 446 ~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~----i~~~~l~~p~~--~~~ 519 (611)
......+||+.|||||++.+..|+.++|||||||+||+|++|++||.+.+....... +......+|.. ..+
T Consensus 168 ---~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 244 (335)
T d2ozaa1 168 ---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 244 (335)
T ss_dssp ---CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHS
T ss_pred ---CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccC
Confidence 011234699999999999999999999999999999999999999988665444333 23333444432 358
Q ss_pred CHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCC
Q 007260 520 SFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 520 s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
++++++||.+||++||.+||+ +.|+|+||||..
T Consensus 245 s~~~~~li~~~L~~dP~~R~s----~~eil~hp~~~~ 277 (335)
T d2ozaa1 245 SEEVKMLIRNLLKTEPTQRMT----ITEFMNHPWIMQ 277 (335)
T ss_dssp CHHHHHHHHHHSCSSTTTSCC----HHHHHHSHHHHT
T ss_pred CHHHHHHHHHHccCChhHCcC----HHHHHcCHHhhC
Confidence 999999999999999999999 999999999964
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.5e-55 Score=450.90 Aligned_cols=256 Identities=20% Similarity=0.275 Sum_probs=222.4
Q ss_pred cccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecccee
Q 007260 212 VLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFS 291 (611)
Q Consensus 212 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~ 291 (611)
++..++|++++.||+|+||+||+|++..+++.||||++++.... ..++.+|+.+|++++|||||+++++|.+++.+
T Consensus 13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (287)
T d1opja_ 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 88 (287)
T ss_dssp BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred EecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch----HHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence 34567899999999999999999999999999999999765433 23577899999999999999999999999999
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCC
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~ 371 (611)
|||||||++|+|.+++.......+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.....
T Consensus 89 ~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 99999999999999998876778999999999999999999999999999999999999999999999999998433211
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
. ....
T Consensus 169 ~---------------------------------------------------------------------------~~~~ 173 (287)
T d1opja_ 169 T---------------------------------------------------------------------------YTAH 173 (287)
T ss_dssp S---------------------------------------------------------------------------SEEE
T ss_pred C---------------------------------------------------------------------------ceee
Confidence 0 0011
Q ss_pred cccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 007260 452 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLL 531 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L 531 (611)
....||+.|+|||++.+..|+.++|||||||+||||++|..||....+...+.+++....+.+.+..+++++++||.+||
T Consensus 174 ~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl 253 (287)
T d1opja_ 174 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 253 (287)
T ss_dssp TTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred ccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHHHHHc
Confidence 12358999999999999999999999999999999999777766666666677777766666666779999999999999
Q ss_pred hcCccccCCchhcHHHHHc
Q 007260 532 VKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 532 ~~dP~~Rpt~~~~a~elL~ 550 (611)
..||.+||| +.||++
T Consensus 254 ~~dP~~Rps----~~ei~~ 268 (287)
T d1opja_ 254 QWNPSDRPS----FAEIHQ 268 (287)
T ss_dssp CSSGGGSCC----HHHHHH
T ss_pred CCCHhHCcC----HHHHHH
Confidence 999999999 788865
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-56 Score=451.57 Aligned_cols=250 Identities=27% Similarity=0.408 Sum_probs=212.6
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhH---HHHHHHHHHHHHHHhCC--CCCcccccceeeccce
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGR---KKLLRAQTEREILQSLD--HPFLPTLYTHFETEKF 290 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~---~~~~~~~~E~~iL~~l~--HpnIv~l~~~~~~~~~ 290 (611)
++|++++.||+|+||+||+|++..+++.||||++.+...... ....++.+|+.+|++++ |||||+++++|++.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 589999999999999999999999999999999986543221 11223567999999986 8999999999999999
Q ss_pred eeEEeeeCCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEcc-CCcEEEEeccccccc
Q 007260 291 SCLVMEFCPG-GDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRE-DGHIMLSDFDLSLRC 368 (611)
Q Consensus 291 ~~LVmE~~~g-g~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~-~g~vkL~DFGlA~~~ 368 (611)
+|+||||+.+ ++|.+++... ..+++..++.|+.||+.||+|||++|||||||||+||||+. ++.+||+|||+|...
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 9999999976 6888887765 56999999999999999999999999999999999999985 579999999998432
Q ss_pred cCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccc
Q 007260 369 AVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTE 448 (611)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (611)
..
T Consensus 162 ~~------------------------------------------------------------------------------ 163 (273)
T d1xwsa_ 162 KD------------------------------------------------------------------------------ 163 (273)
T ss_dssp CS------------------------------------------------------------------------------
T ss_pred cc------------------------------------------------------------------------------
Confidence 10
Q ss_pred ccccccccCCCccchhhhccCCC-CChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 007260 449 ARSMSFVGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLI 527 (611)
Q Consensus 449 ~~~~~~vGT~~Y~APEil~~~~~-~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI 527 (611)
....+++||+.|+|||++.+..+ +.++|||||||+||||++|+.||.+.. ++......++. .+|.++++||
T Consensus 164 ~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~~--~~s~~~~~li 235 (273)
T d1xwsa_ 164 TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQ--RVSSECQHLI 235 (273)
T ss_dssp SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSS--CCCHHHHHHH
T ss_pred ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCCCC--CCCHHHHHHH
Confidence 01124579999999999998776 677999999999999999999998632 34455555554 4999999999
Q ss_pred HHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 528 RGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 528 ~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
.+||.+||.+||| ++|+|+||||+++
T Consensus 236 ~~~L~~dp~~R~s----~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 236 RWCLALRPSDRPT----FEEIQNHPWMQDV 261 (273)
T ss_dssp HHHTCSSGGGSCC----HHHHHTSGGGSSC
T ss_pred HHHccCCHhHCcC----HHHHhcCHhhCCC
Confidence 9999999999999 9999999999875
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-55 Score=450.26 Aligned_cols=261 Identities=25% Similarity=0.390 Sum_probs=212.7
Q ss_pred cCeEEEeEecccCcEEEEEEEECCC-CeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC---CCCCcccccceee-----
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGT-KCYFAMKVMDKASLAGRKKLLRAQTEREILQSL---DHPFLPTLYTHFE----- 286 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t-~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l---~HpnIv~l~~~~~----- 286 (611)
++|++++.||+|+||+||+|++..+ ++.||||+++...... .....+.+|+.+|+.| +|||||+++++|.
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 6899999999999999999999755 6789999997543221 1112345677777665 8999999999985
Q ss_pred ccceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccc
Q 007260 287 TEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSL 366 (611)
Q Consensus 287 ~~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~ 366 (611)
....+|||||||.++++.... ......+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||++.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred cCceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 346789999999777665443 3445679999999999999999999999999999999999999999999999999973
Q ss_pred cccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCc
Q 007260 367 RCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEP 446 (611)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (611)
....
T Consensus 165 ~~~~---------------------------------------------------------------------------- 168 (305)
T d1blxa_ 165 IYSF---------------------------------------------------------------------------- 168 (305)
T ss_dssp CCCG----------------------------------------------------------------------------
T ss_pred hhcc----------------------------------------------------------------------------
Confidence 2110
Q ss_pred ccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHc---CCC--CC--------
Q 007260 447 TEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG---QPL--RF-------- 513 (611)
Q Consensus 447 ~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~---~~l--~~-------- 513 (611)
.......+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+.+.+++. .+. .+
T Consensus 169 -~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 247 (305)
T d1blxa_ 169 -QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 247 (305)
T ss_dssp -GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCG
T ss_pred -cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchh
Confidence 0112245799999999999999999999999999999999999999999888877766542 110 00
Q ss_pred ------------CCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCch
Q 007260 514 ------------PESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNW 559 (611)
Q Consensus 514 ------------p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 559 (611)
.....+++.+++||.+||++||++||| |.|+|+||||+++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~s----a~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 248 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS----AYSALSHPYFQDLER 301 (305)
T ss_dssp GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCC----HHHHHTSGGGTTCCC
T ss_pred hhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcC----HHHHhcChhhcCchh
Confidence 012347899999999999999999999 999999999998764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.1e-54 Score=441.94 Aligned_cols=259 Identities=25% Similarity=0.401 Sum_probs=216.3
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc----ee
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK----FS 291 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~----~~ 291 (611)
++|++++.||+|+||+||+|++..+++.||||++.+..........++.+|+.+|+.++|||||++++++...+ .+
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 57999999999999999999999999999999998876666677778899999999999999999999997643 58
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCC
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~ 371 (611)
|||||||+|++|..++... +.+++..++.|+.||+.||+|||++|||||||||+||||+.++.++|+|||++......
T Consensus 87 ~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp EEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred EEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccc
Confidence 9999999999999988775 56999999999999999999999999999999999999999999999999987432211
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
.. .....
T Consensus 165 ~~-------------------------------------------------------------------------~~~~~ 171 (277)
T d1o6ya_ 165 GN-------------------------------------------------------------------------SVTQT 171 (277)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cc-------------------------------------------------------------------------ccccc
Confidence 00 01122
Q ss_pred cccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCC--CCCCCCHHHHHHHHH
Q 007260 452 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFP--ESPVVSFAARDLIRG 529 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p--~~~~~s~~l~dLI~~ 529 (611)
...+||+.|+|||++.+..|+.++|||||||+||||++|++||.+.+..+.+.+++.....++ ....+|+++++||.+
T Consensus 172 ~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~ 251 (277)
T d1o6ya_ 172 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLK 251 (277)
T ss_dssp -------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHH
T ss_pred ccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHH
Confidence 346799999999999999999999999999999999999999999888888888777655443 235699999999999
Q ss_pred hhhcCccccCCchhcHHHHHcCCC
Q 007260 530 LLVKEPQHRLAYKRGATEIKQHPF 553 (611)
Q Consensus 530 ~L~~dP~~Rpt~~~~a~elL~Hp~ 553 (611)
||++||.+||+. +++++ |+|
T Consensus 252 ~L~~dp~~R~~s---a~~l~-~~l 271 (277)
T d1o6ya_ 252 ALAKNPENRYQT---AAEMR-ADL 271 (277)
T ss_dssp HTCSSGGGSCSS---HHHHH-HHH
T ss_pred HccCCHhHCHhH---HHHHH-HHH
Confidence 999999999941 55544 444
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-54 Score=453.62 Aligned_cols=259 Identities=18% Similarity=0.278 Sum_probs=220.0
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCC-----eEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTK-----CYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFE 286 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~-----~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~ 286 (611)
+..++|++++.||+|+||+||+|++..++ ..||+|++.+... ......+.+|+.+|.++ +|||||+++++|.
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNLLGACT 111 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC--HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence 34578999999999999999999987654 3699999865432 23344678899999988 8999999999999
Q ss_pred ccceeeEEeeeCCCCCHHHHHHhCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCC
Q 007260 287 TEKFSCLVMEFCPGGDLHTLRQKQPG---------------------KYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLK 345 (611)
Q Consensus 287 ~~~~~~LVmE~~~gg~L~~ll~~~~~---------------------~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLK 345 (611)
+.+.+|||||||+||+|.+++..... ..+++..++.|+.||+.||+|||++||||||||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlK 191 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA 191 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCc
Confidence 99999999999999999999976532 358999999999999999999999999999999
Q ss_pred CCcEEEccCCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccC
Q 007260 346 PENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKD 425 (611)
Q Consensus 346 PeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (611)
|+|||++.++++||+|||+|+......
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~----------------------------------------------------- 218 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDS----------------------------------------------------- 218 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCT-----------------------------------------------------
T ss_pred hhccccccCCeEEEeeccccccccCCC-----------------------------------------------------
Confidence 999999999999999999985432110
Q ss_pred CCCccccCCCCCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHH
Q 007260 426 RKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLF 504 (611)
Q Consensus 426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~ 504 (611)
......+.+||+.|||||++.+..|+.++|||||||+||||++ |++||.+.+....+.
T Consensus 219 ---------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~ 277 (325)
T d1rjba_ 219 ---------------------NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY 277 (325)
T ss_dssp ---------------------TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH
T ss_pred ---------------------ceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 0011123568999999999999999999999999999999997 999999988878888
Q ss_pred HHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcC
Q 007260 505 NVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 505 ~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~H 551 (611)
+++....+++.+..+++++++||.+||+.||++||| ++||++|
T Consensus 278 ~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt----~~ei~~~ 320 (325)
T d1rjba_ 278 KLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPS----FPNLTSF 320 (325)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcC----HHHHHHH
Confidence 888887777777789999999999999999999999 8888875
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-54 Score=443.80 Aligned_cols=258 Identities=23% Similarity=0.338 Sum_probs=212.1
Q ss_pred CccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc
Q 007260 210 DGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK 289 (611)
Q Consensus 210 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~ 289 (611)
++++..++|++++.||+|+||+||+|++.+ .||||+++...... .....+++|+.+|++++|||||++++++. +.
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~ 76 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGYST-AP 76 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSCCT-THHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCEeeeeEEEe-cc
Confidence 345667899999999999999999997643 49999997654332 34567889999999999999999999865 45
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
.+|||||||+||+|.+++.... ..+++..+..|+.||+.||+|||++|||||||||+||||+.++++||+|||+|+...
T Consensus 77 ~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 77 QLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp SCEEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred EEEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecc
Confidence 6899999999999999987653 469999999999999999999999999999999999999999999999999984332
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
... ...
T Consensus 156 ~~~--------------------------------------------------------------------------~~~ 161 (276)
T d1uwha_ 156 RWS--------------------------------------------------------------------------GSH 161 (276)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccC--------------------------------------------------------------------------Ccc
Confidence 100 001
Q ss_pred cccccccCCCccchhhhccC---CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCC----CCCCCCHH
Q 007260 450 RSMSFVGTHEYLAPEIIKGE---GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFP----ESPVVSFA 522 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~~---~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p----~~~~~s~~ 522 (611)
...+.+||+.|||||++.+. .|+.++|||||||+||||++|+.||.+.+....+..++......| ....++++
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 241 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 241 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHH
T ss_pred cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHH
Confidence 12245799999999999754 478899999999999999999999999887777766665443333 23458999
Q ss_pred HHHHHHHhhhcCccccCCchhcHHHHHcC
Q 007260 523 ARDLIRGLLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 523 l~dLI~~~L~~dP~~Rpt~~~~a~elL~H 551 (611)
+++||.+||..||.+||| +.||++|
T Consensus 242 l~~li~~cl~~dp~~RPt----~~~il~~ 266 (276)
T d1uwha_ 242 MKRLMAECLKKKRDERPL----FPQILAS 266 (276)
T ss_dssp HHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcC----HHHHHHH
Confidence 999999999999999999 8888875
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.1e-54 Score=443.36 Aligned_cols=258 Identities=23% Similarity=0.381 Sum_probs=214.2
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
+++|++++.||+|+||+||+|++. +++.||||++...... .....++.+|+.+|++++|||||+++++|.+++..|+|
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 368999999999999999999986 6789999999765432 23345778899999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
|||+.++++..+.... +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||++......
T Consensus 79 ~e~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~--- 153 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--- 153 (286)
T ss_dssp EECCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EEeehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccC---
Confidence 9999877777665544 67999999999999999999999999999999999999999999999999998543211
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
.......
T Consensus 154 -------------------------------------------------------------------------~~~~~~~ 160 (286)
T d1ob3a_ 154 -------------------------------------------------------------------------VRKYTHE 160 (286)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred -------------------------------------------------------------------------cccccee
Confidence 0112234
Q ss_pred ccCCCccchhhhccCC-CCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHc---CCC--C-------------C--
Q 007260 455 VGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG---QPL--R-------------F-- 513 (611)
Q Consensus 455 vGT~~Y~APEil~~~~-~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~---~~l--~-------------~-- 513 (611)
+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+..+.+.++.. .+. . +
T Consensus 161 ~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (286)
T d1ob3a_ 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240 (286)
T ss_dssp -CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCC
T ss_pred cccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccccc
Confidence 6999999999998764 59999999999999999999999999887777666542 110 0 0
Q ss_pred -------CCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCC
Q 007260 514 -------PESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 514 -------p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
.....++..++|||++||++||++||| |.|||+||||++
T Consensus 241 ~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s----~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT----AKQALEHAYFKE 286 (286)
T ss_dssp CCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCC----HHHHHTSGGGGC
T ss_pred ccCcchhhhcccCCHHHHHHHHHHccCChhHCcC----HHHHhcCcccCc
Confidence 011347899999999999999999999 999999999973
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-54 Score=440.06 Aligned_cols=260 Identities=20% Similarity=0.312 Sum_probs=215.2
Q ss_pred CccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc
Q 007260 210 DGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK 289 (611)
Q Consensus 210 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~ 289 (611)
++.+..++|++++.||+|+||+||+|+++ ++..||||+++...... ..+.+|+++|++++|||||++++++.+ +
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~----~~~~~E~~~l~~l~HpnIv~~~g~~~~-~ 80 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCH----HHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred CeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCH----HHHHHHHHHHHhCCCCCEeEEEeeecc-C
Confidence 34455679999999999999999999987 46789999997654332 356789999999999999999998754 5
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
.+|||||||++|+|.+++....+..+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.+.
T Consensus 81 ~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEcc
Confidence 67999999999999997765544569999999999999999999999999999999999999999999999999995432
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
... ..
T Consensus 161 ~~~---------------------------------------------------------------------------~~ 165 (272)
T d1qpca_ 161 DNE---------------------------------------------------------------------------YT 165 (272)
T ss_dssp SSC---------------------------------------------------------------------------EE
T ss_pred CCc---------------------------------------------------------------------------cc
Confidence 110 00
Q ss_pred cccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 007260 450 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFG-KTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIR 528 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG-~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~ 528 (611)
......||+.|||||++.+..++.++|||||||+||||++| ++||......+.+..+. ...+.+.+..+++++++||.
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~ 244 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCPEELYQLMR 244 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHH
T ss_pred cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCCCCCcccChHHHHHHHH
Confidence 11234699999999999999999999999999999999995 55566655555555544 44455555679999999999
Q ss_pred HhhhcCccccCCchhcHHHHHc--CCCCC
Q 007260 529 GLLVKEPQHRLAYKRGATEIKQ--HPFFE 555 (611)
Q Consensus 529 ~~L~~dP~~Rpt~~~~a~elL~--Hp~f~ 555 (611)
+||..||++||| +++|++ |+||.
T Consensus 245 ~cl~~~P~~Rpt----~~ei~~~L~~~ft 269 (272)
T d1qpca_ 245 LCWKERPEDRPT----FDYLRSVLEDFFT 269 (272)
T ss_dssp HHTCSSGGGSCC----HHHHHHHHHHHHH
T ss_pred HHcCCCHhHCcC----HHHHHHHhhhhhh
Confidence 999999999999 888887 77875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-53 Score=442.06 Aligned_cols=261 Identities=22% Similarity=0.311 Sum_probs=209.0
Q ss_pred ccccccCeEEEeEecccCcEEEEEEEECCCCe---EEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 007260 211 GVLGLSHFRLLKRLGCGDIGSVYLSELSGTKC---YFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET 287 (611)
Q Consensus 211 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~---~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~ 287 (611)
..+..++|++.+.||+|+||+||+|+++.+++ .||||++..... .....++.+|+++|++|+|||||++++++..
T Consensus 21 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~ 98 (299)
T d1jpaa_ 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASIMGQFDHPNVIHLEGVVTK 98 (299)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred hhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccC--HHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence 34556799999999999999999999976654 689998865432 2344578899999999999999999999999
Q ss_pred cceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccc
Q 007260 288 EKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLR 367 (611)
Q Consensus 288 ~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~ 367 (611)
++.+|||||||+||+|.+++.... +.+++..+..|+.||+.||+|||++|||||||||+||||+.++++||+|||+|+.
T Consensus 99 ~~~~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 177 (299)
T d1jpaa_ 99 STPVMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177 (299)
T ss_dssp SSSCEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred CCEEEEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceE
Confidence 999999999999999999887653 5699999999999999999999999999999999999999999999999999854
Q ss_pred ccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcc
Q 007260 368 CAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPT 447 (611)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (611)
+...... ..
T Consensus 178 ~~~~~~~-----------------------------------------------------------------------~~ 186 (299)
T d1jpaa_ 178 LEDDTSD-----------------------------------------------------------------------PT 186 (299)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccCCCCc-----------------------------------------------------------------------ce
Confidence 4311100 00
Q ss_pred cccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 007260 448 EARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDL 526 (611)
Q Consensus 448 ~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dL 526 (611)
........||+.|||||++.+..++.++|||||||+||||++ |++||.+....+.+..+.. ..+.+.+..++.++.+|
T Consensus 187 ~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~l 265 (299)
T d1jpaa_ 187 YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ-DYRLPPPMDCPSALHQL 265 (299)
T ss_dssp ---------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-TCCCCCCTTCCHHHHHH
T ss_pred eeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCccchHHHHHH
Confidence 011122458999999999999999999999999999999997 8999998887766655544 44555666799999999
Q ss_pred HHHhhhcCccccCCchhcHHHHHc
Q 007260 527 IRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 527 I~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
|.+||..||.+||+ +.||++
T Consensus 266 i~~cl~~~P~~RPs----~~ei~~ 285 (299)
T d1jpaa_ 266 MLDCWQKDRNHRPK----FGQIVN 285 (299)
T ss_dssp HHHHTCSSTTTSCC----HHHHHH
T ss_pred HHHHcCCCHhHCcC----HHHHHH
Confidence 99999999999999 666654
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-53 Score=431.57 Aligned_cols=252 Identities=23% Similarity=0.353 Sum_probs=207.1
Q ss_pred cccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeE
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCL 293 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~L 293 (611)
..++|++++.||+|+||+||+|++.. +..||||++++..... ..+.+|+++|++++|||||++++++..++.+||
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~~~~~----~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~l 77 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL 77 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSSSSCH----HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCCcCcH----HHHHHHHHHHHhcCCCCcccccceeccCCceEE
Confidence 34689999999999999999999874 5679999998755433 256789999999999999999999999999999
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcc
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 373 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~ 373 (611)
|||||++|+|.+++... ...+++..+..|+.||+.||+|||+++||||||||+||||+.++.+||+|||+++.+....
T Consensus 78 v~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~- 155 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ- 155 (263)
T ss_dssp EEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred EEEecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCC-
Confidence 99999999999988765 3568999999999999999999999999999999999999999999999999984332110
Q ss_pred ccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccc
Q 007260 374 LIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMS 453 (611)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (611)
......
T Consensus 156 --------------------------------------------------------------------------~~~~~~ 161 (263)
T d1sm2a_ 156 --------------------------------------------------------------------------YTSSTG 161 (263)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------ceeecc
Confidence 001123
Q ss_pred cccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007260 454 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLV 532 (611)
Q Consensus 454 ~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~ 532 (611)
..||+.|+|||++.+..|+.++|||||||+||||++ |++||...+..+.+..+... .+.+.+..+++++.+||.+||.
T Consensus 162 ~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~-~~~~~p~~~~~~l~~li~~cl~ 240 (263)
T d1sm2a_ 162 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRLYKPRLASTHVYQIMNHCWK 240 (263)
T ss_dssp ---CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHT-CCCCCCTTSCHHHHHHHHHHTC
T ss_pred eecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhc-CCCCCccccCHHHHHHHHHHcc
Confidence 469999999999999999999999999999999998 57777776666666555443 3344445689999999999999
Q ss_pred cCccccCCchhcHHHHHcC
Q 007260 533 KEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 533 ~dP~~Rpt~~~~a~elL~H 551 (611)
.||.+||+ ++||++|
T Consensus 241 ~~p~~Rps----~~~il~~ 255 (263)
T d1sm2a_ 241 ERPEDRPA----FSRLLRQ 255 (263)
T ss_dssp SSGGGSCC----HHHHHHH
T ss_pred CCHhHCcC----HHHHHHH
Confidence 99999999 8888875
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-54 Score=450.94 Aligned_cols=273 Identities=41% Similarity=0.755 Sum_probs=225.3
Q ss_pred cccCeEEEeEecccCcEEEEEEEE---CCCCeEEEEEEecchhhh-hHHHHHHHHHHHHHHHhCCC-CCcccccceeecc
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSEL---SGTKCYFAMKVMDKASLA-GRKKLLRAQTEREILQSLDH-PFLPTLYTHFETE 288 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~---~~t~~~vAvKii~k~~~~-~~~~~~~~~~E~~iL~~l~H-pnIv~l~~~~~~~ 288 (611)
++++|++++.||+|+||+||+|++ ..+++.||||++++.... ......++.+|+++|++++| |||+++++++++.
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~ 101 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence 467999999999999999999997 447899999999765432 11223456789999999966 8999999999999
Q ss_pred ceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccc
Q 007260 289 KFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRC 368 (611)
Q Consensus 289 ~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~ 368 (611)
..+|+||||+.||+|.+++... +.+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||++..+
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred CceeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 9999999999999999998876 56899999999999999999999999999999999999999999999999998543
Q ss_pred cCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccc
Q 007260 369 AVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTE 448 (611)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (611)
... ..
T Consensus 180 ~~~---------------------------------------------------------------------------~~ 184 (322)
T d1vzoa_ 180 VAD---------------------------------------------------------------------------ET 184 (322)
T ss_dssp CGG---------------------------------------------------------------------------GG
T ss_pred ccc---------------------------------------------------------------------------cc
Confidence 211 11
Q ss_pred ccccccccCCCccchhhhccCC--CCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHH----HHHHcCCCCCCCCCCCCHH
Q 007260 449 ARSMSFVGTHEYLAPEIIKGEG--HGSAVDWWTFGIFLYELLFGKTPFKGSGNRATL----FNVVGQPLRFPESPVVSFA 522 (611)
Q Consensus 449 ~~~~~~vGT~~Y~APEil~~~~--~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l----~~i~~~~l~~p~~~~~s~~ 522 (611)
....+..||+.|+|||++.+.. ++.++|||||||+||||++|+.||.+.+..... .........+|. .++.+
T Consensus 185 ~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~--~~s~~ 262 (322)
T d1vzoa_ 185 ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--EMSAL 262 (322)
T ss_dssp GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT--TSCHH
T ss_pred ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcc--cCCHH
Confidence 1123456999999999998754 588999999999999999999999876543332 233344444443 59999
Q ss_pred HHHHHHHhhhcCccccCCchh-cHHHHHcCCCCCCCchhhhccC
Q 007260 523 ARDLIRGLLVKEPQHRLAYKR-GATEIKQHPFFEGVNWALIRCA 565 (611)
Q Consensus 523 l~dLI~~~L~~dP~~Rpt~~~-~a~elL~Hp~f~~~~~~~~~~~ 565 (611)
+++||.+||.+||++||+... .|+|+|+||||++++|..+...
T Consensus 263 ~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~ 306 (322)
T d1vzoa_ 263 AKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAK 306 (322)
T ss_dssp HHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTT
T ss_pred HHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhC
Confidence 999999999999999996532 3899999999999999876543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-53 Score=449.09 Aligned_cols=257 Identities=30% Similarity=0.423 Sum_probs=211.4
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc-----
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK----- 289 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~----- 289 (611)
.++|++++.||+|+||+||+|++..+++.||||++++.. .......++.+|+.+|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 369999999999999999999999999999999997654 34455667889999999999999999999997654
Q ss_pred -eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccc
Q 007260 290 -FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRC 368 (611)
Q Consensus 290 -~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~ 368 (611)
.+||||||| |.+|..++.. ..|++..++.|+.||+.||+|||++|||||||||+|||++.++.+||+|||+|...
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceecc
Confidence 579999999 7788888766 35999999999999999999999999999999999999999999999999998432
Q ss_pred cCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccc
Q 007260 369 AVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTE 448 (611)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (611)
..
T Consensus 172 ~~------------------------------------------------------------------------------ 173 (346)
T d1cm8a_ 172 DS------------------------------------------------------------------------------ 173 (346)
T ss_dssp CS------------------------------------------------------------------------------
T ss_pred CC------------------------------------------------------------------------------
Confidence 10
Q ss_pred ccccccccCCCccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCC----------------
Q 007260 449 ARSMSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPL---------------- 511 (611)
Q Consensus 449 ~~~~~~vGT~~Y~APEil~~~-~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l---------------- 511 (611)
.....+||+.|+|||++.+. .++.++|||||||+||||++|++||.+.+....+..+.....
T Consensus 174 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (346)
T d1cm8a_ 174 -EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252 (346)
T ss_dssp -SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHH
T ss_pred -ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhh
Confidence 01234699999999999875 468999999999999999999999999877666544332100
Q ss_pred -------CC------CCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCch
Q 007260 512 -------RF------PESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNW 559 (611)
Q Consensus 512 -------~~------p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 559 (611)
.. .....++++++|||.+||..||.+||| |.|||+||||+++.+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t----a~eiL~Hp~f~~~~~ 309 (346)
T d1cm8a_ 253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT----AGEALAHPYFESLHD 309 (346)
T ss_dssp HHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCC----HHHHHHSGGGTTTC-
T ss_pred hhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcC----HHHHhcChhhCcCCC
Confidence 00 012347899999999999999999999 999999999998654
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-53 Score=447.17 Aligned_cols=254 Identities=29% Similarity=0.485 Sum_probs=209.5
Q ss_pred CeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec------cce
Q 007260 217 HFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET------EKF 290 (611)
Q Consensus 217 ~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~------~~~ 290 (611)
+|+.+++||+|+||+||+|++..+++.||||++.+... ...+|+++|++++|||||+++++|.. ..+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 79999999999999999999999999999999976542 12469999999999999999999853 346
Q ss_pred eeEEeeeCCCCCHHHHHH-hCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCC-cEEEEeccccccc
Q 007260 291 SCLVMEFCPGGDLHTLRQ-KQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDG-HIMLSDFDLSLRC 368 (611)
Q Consensus 291 ~~LVmE~~~gg~L~~ll~-~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g-~vkL~DFGlA~~~ 368 (611)
+|||||||+++.+..+.. ......+++..++.|+.||+.||+|||++|||||||||+||||+.++ .+||+|||++..+
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 899999997665444432 22346799999999999999999999999999999999999999775 8999999998443
Q ss_pred cCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccc
Q 007260 369 AVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTE 448 (611)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (611)
...
T Consensus 174 ~~~----------------------------------------------------------------------------- 176 (350)
T d1q5ka_ 174 VRG----------------------------------------------------------------------------- 176 (350)
T ss_dssp CTT-----------------------------------------------------------------------------
T ss_pred cCC-----------------------------------------------------------------------------
Confidence 210
Q ss_pred ccccccccCCCccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHc---CC--------------
Q 007260 449 ARSMSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG---QP-------------- 510 (611)
Q Consensus 449 ~~~~~~vGT~~Y~APEil~~~-~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~---~~-------------- 510 (611)
....+.+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+..+.+.+++. .+
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~ 256 (350)
T d1q5ka_ 177 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256 (350)
T ss_dssp SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---C
T ss_pred cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhh
Confidence 011235799999999998765 689999999999999999999999999887777665542 11
Q ss_pred CCCC----------CCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCc
Q 007260 511 LRFP----------ESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVN 558 (611)
Q Consensus 511 l~~p----------~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 558 (611)
..++ ....+++++.+||.+||.+||++||| |.|+|+||||+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t----a~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 257 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT----PLEACAHSFFDELR 310 (350)
T ss_dssp CCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGGGGG
T ss_pred ccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcC----HHHHhcCHhhcccc
Confidence 1111 12347899999999999999999999 99999999998753
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.2e-53 Score=442.85 Aligned_cols=254 Identities=26% Similarity=0.429 Sum_probs=209.3
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC-CCCcccccceeec--ccee
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD-HPFLPTLYTHFET--EKFS 291 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~-HpnIv~l~~~~~~--~~~~ 291 (611)
.++|++++.||+|+||+||+|++..+++.||||++++.. ..++.+|+++|+.+. ||||++++++|.. ...+
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 368999999999999999999999999999999997643 235678999999995 9999999999974 4679
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCC-cEEEEeccccccccC
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDG-HIMLSDFDLSLRCAV 370 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g-~vkL~DFGlA~~~~~ 370 (611)
|+|||||.+++|..+. +.+++..++.++.||+.||+|||++|||||||||+||||+.++ .+||+|||+|.....
T Consensus 108 ~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp EEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccC
Confidence 9999999999997653 3599999999999999999999999999999999999998655 699999999843321
Q ss_pred CccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccc
Q 007260 371 SPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEAR 450 (611)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (611)
. ..
T Consensus 183 ~-----------------------------------------------------------------------------~~ 185 (328)
T d3bqca1 183 G-----------------------------------------------------------------------------QE 185 (328)
T ss_dssp T-----------------------------------------------------------------------------CC
T ss_pred C-----------------------------------------------------------------------------Cc
Confidence 0 01
Q ss_pred ccccccCCCccchhhhccCC-CCChhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHH---HHcC----------C-----
Q 007260 451 SMSFVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSGNRA-TLFN---VVGQ----------P----- 510 (611)
Q Consensus 451 ~~~~vGT~~Y~APEil~~~~-~~~~sDIWSLGviL~ELltG~~PF~~~~~~~-~l~~---i~~~----------~----- 510 (611)
....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||....... .... +++. .
T Consensus 186 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 265 (328)
T d3bqca1 186 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 265 (328)
T ss_dssp CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCG
T ss_pred ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCc
Confidence 12346999999999998765 7999999999999999999999997654332 2211 1110 0
Q ss_pred -----------------CCCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCchh
Q 007260 511 -----------------LRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWA 560 (611)
Q Consensus 511 -----------------l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~ 560 (611)
...+....++++++|||++||++||.+||| |+|||+||||+++.|.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t----a~e~L~Hp~F~~v~~~ 328 (328)
T d3bqca1 266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT----AREAMEHPYFYTVVKD 328 (328)
T ss_dssp GGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGTTSCCC
T ss_pred ccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcC----HHHHhcCcccCCCCCC
Confidence 001112347899999999999999999999 9999999999999884
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-53 Score=433.82 Aligned_cols=264 Identities=22% Similarity=0.332 Sum_probs=216.4
Q ss_pred ccccCeEEEeE-ecccCcEEEEEEEECC--CCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc
Q 007260 213 LGLSHFRLLKR-LGCGDIGSVYLSELSG--TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK 289 (611)
Q Consensus 213 ~~~~~y~l~~~-LG~G~fG~Vy~a~~~~--t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~ 289 (611)
+..++|.+.+. ||+|+||+||+|.++. ++..||||++++.. ......++.+|+++|++++|||||++++++.++
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~- 81 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE- 81 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-
Confidence 44567888885 9999999999998754 45689999997643 234456788999999999999999999998754
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
.+|||||||+||+|.+++... ...+++..+..|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.+.
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred eEEEEEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence 589999999999999987654 3569999999999999999999999999999999999999999999999999995543
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
..... ..
T Consensus 161 ~~~~~-------------------------------------------------------------------------~~ 167 (285)
T d1u59a_ 161 ADDSY-------------------------------------------------------------------------YT 167 (285)
T ss_dssp TCSCE-------------------------------------------------------------------------EC
T ss_pred ccccc-------------------------------------------------------------------------cc
Confidence 11100 00
Q ss_pred cccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 007260 450 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIR 528 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~ 528 (611)
......||+.|+|||++.+..++.++|||||||+||||++ |+.||.+....+.+..+..+ .+.+.+..+++++.+||.
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~-~~~~~p~~~~~~l~~li~ 246 (285)
T d1u59a_ 168 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-KRMECPPECPPELYALMS 246 (285)
T ss_dssp CCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT-CCCCCCTTCCHHHHHHHH
T ss_pred cccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCCcCCHHHHHHHH
Confidence 1123469999999999999999999999999999999997 99999998877766666543 333444569999999999
Q ss_pred HhhhcCccccCCchhcHHHHHcCCCCC
Q 007260 529 GLLVKEPQHRLAYKRGATEIKQHPFFE 555 (611)
Q Consensus 529 ~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 555 (611)
+||..||++||++.. +.+.|+|+|+.
T Consensus 247 ~cl~~~p~~RPs~~~-i~~~L~~~~~~ 272 (285)
T d1u59a_ 247 DCWIYKWEDRPDFLT-VEQRMRACYYS 272 (285)
T ss_dssp HTTCSSGGGSCCHHH-HHHHHHHHHHH
T ss_pred HHcCCCHhHCcCHHH-HHHHHHHHHHH
Confidence 999999999999433 34447788763
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-53 Score=432.96 Aligned_cols=255 Identities=22% Similarity=0.297 Sum_probs=207.8
Q ss_pred eEecccCcEEEEEEEEC--CCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEEeeeCC
Q 007260 222 KRLGCGDIGSVYLSELS--GTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCP 299 (611)
Q Consensus 222 ~~LG~G~fG~Vy~a~~~--~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LVmE~~~ 299 (611)
++||+|+||+||+|.+. .+++.||||+++.... ......++.+|+++|++++|||||+++++++.+ ..|||||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence 47999999999999864 4567899999975432 234456788999999999999999999998754 5789999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccccccc
Q 007260 300 GGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASS 379 (611)
Q Consensus 300 gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~ 379 (611)
||+|.+++... ..+++..+..|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+++.+......
T Consensus 91 ~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~----- 163 (277)
T d1xbba_ 91 LGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY----- 163 (277)
T ss_dssp TEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE-----
T ss_pred CCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccc-----
Confidence 99999998875 56999999999999999999999999999999999999999999999999998543211100
Q ss_pred CCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccccCCC
Q 007260 380 LDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHE 459 (611)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~ 459 (611)
........||+.
T Consensus 164 --------------------------------------------------------------------~~~~~~~~gt~~ 175 (277)
T d1xbba_ 164 --------------------------------------------------------------------YKAQTHGKWPVK 175 (277)
T ss_dssp --------------------------------------------------------------------EEC----CCCGG
T ss_pred --------------------------------------------------------------------cccccccCCCce
Confidence 001123469999
Q ss_pred ccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCcccc
Q 007260 460 YLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHR 538 (611)
Q Consensus 460 Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~R 538 (611)
|||||++.+..++.++|||||||++|||++ |++||.+.+..+....+.. ..+.+.+..++.++++||.+||..||.+|
T Consensus 176 y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~-~~~~~~p~~~~~~~~~li~~cl~~dp~~R 254 (277)
T d1xbba_ 176 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMGCPAGCPREMYDLMNLCWTYDVENR 254 (277)
T ss_dssp GCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSTTTS
T ss_pred ecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHc-CCCCCCCcccCHHHHHHHHHHcCCCHhHC
Confidence 999999999999999999999999999997 9999999877665555544 33444455699999999999999999999
Q ss_pred CCchhcHHHH---HcCCCCCCCc
Q 007260 539 LAYKRGATEI---KQHPFFEGVN 558 (611)
Q Consensus 539 pt~~~~a~el---L~Hp~f~~~~ 558 (611)
|+ +.+| |+|+||+-++
T Consensus 255 Ps----~~~i~~~L~~~~~~~~~ 273 (277)
T d1xbba_ 255 PG----FAAVELRLRNYYYDVVN 273 (277)
T ss_dssp CC----HHHHHHHHHHHHHHHHH
T ss_pred cC----HHHHHHHhhCHHhhcCC
Confidence 99 5555 6787765443
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-53 Score=433.32 Aligned_cols=261 Identities=24% Similarity=0.333 Sum_probs=213.9
Q ss_pred CccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc
Q 007260 210 DGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK 289 (611)
Q Consensus 210 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~ 289 (611)
++.+..++|++++.||+|+||+||+|++..+. .||||++....... ..+.+|+.+|++++|||||++++++.+ +
T Consensus 11 ~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~-~vAiK~l~~~~~~~----~~~~~E~~~l~~l~h~nIv~~~g~~~~-~ 84 (285)
T d1fmka3 11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYAVVSE-E 84 (285)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTTE-EEEEEECCTTSSCH----HHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ceEcCHHHEEEeeEEeeCCCeEEEEEEECCCC-EEEEEEECcccCCH----HHHHHHHHHHHhcccCCEeEEEEEEec-C
Confidence 44566689999999999999999999998764 69999997654332 356789999999999999999999854 5
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
.+|||||||++|+|..++.......+++..+..|+.||+.||+|||.+|||||||||+||||+.++++||+|||+|+...
T Consensus 85 ~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~ 164 (285)
T d1fmka3 85 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 164 (285)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhcc
Confidence 68999999999999988876545679999999999999999999999999999999999999999999999999984332
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
... ..
T Consensus 165 ~~~---------------------------------------------------------------------------~~ 169 (285)
T d1fmka3 165 DNE---------------------------------------------------------------------------YT 169 (285)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred CCC---------------------------------------------------------------------------ce
Confidence 110 00
Q ss_pred cccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 007260 450 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTP-FKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIR 528 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~P-F~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~ 528 (611)
......||+.|+|||++.+..++.++|||||||+||||++|..| |.+....+.+.. +....+.+....++.++++||.
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~-i~~~~~~~~~~~~~~~l~~li~ 248 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRMPCPPECPESLHDLMC 248 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTTCCCCCCTTSCHHHHHHHH
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHH-HHhcCCCCCCcccCHHHHHHHH
Confidence 11234699999999999999999999999999999999996555 555544444444 4444556666779999999999
Q ss_pred HhhhcCccccCCchhcHHHHHc--CCCCCC
Q 007260 529 GLLVKEPQHRLAYKRGATEIKQ--HPFFEG 556 (611)
Q Consensus 529 ~~L~~dP~~Rpt~~~~a~elL~--Hp~f~~ 556 (611)
+||+.||++||+ +++|++ |+||..
T Consensus 249 ~cl~~dP~~Rps----~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 249 QCWRKEPEERPT----FEYLQAFLEDYFTS 274 (285)
T ss_dssp HHTCSSGGGSCC----HHHHHHHHHTTTSC
T ss_pred HHcccCHhHCcC----HHHHHHHHhhhhcC
Confidence 999999999999 888887 788864
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-52 Score=427.96 Aligned_cols=260 Identities=24% Similarity=0.390 Sum_probs=216.6
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
+++|++++.||+|+||+||+|++..+++.||||+++.... ......++++|+.+|+.++|||||+++++|.+....++|
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 3689999999999999999999999999999999976542 334566788999999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
||++.|++|..++... +.+++..++.++.|++.||+|||++|||||||||+|||++.++++||+|||++.......
T Consensus 80 ~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~-- 155 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-- 155 (292)
T ss_dssp EECCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC--
T ss_pred eeeccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC--
Confidence 9999999998887765 678999999999999999999999999999999999999999999999999985432110
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
......
T Consensus 156 --------------------------------------------------------------------------~~~~~~ 161 (292)
T d1unla_ 156 --------------------------------------------------------------------------RCYSAE 161 (292)
T ss_dssp --------------------------------------------------------------------------SCCCSC
T ss_pred --------------------------------------------------------------------------ccceee
Confidence 001123
Q ss_pred ccCCCccchhhhccCC-CCChhhHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHH---cCCCC-----------------
Q 007260 455 VGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGS-GNRATLFNVV---GQPLR----------------- 512 (611)
Q Consensus 455 vGT~~Y~APEil~~~~-~~~~sDIWSLGviL~ELltG~~PF~~~-~~~~~l~~i~---~~~l~----------------- 512 (611)
.+++.|+|||++.+.. ++.++|||||||++|||++|+.||... +..+.+.++. ..+..
T Consensus 162 ~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (292)
T d1unla_ 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241 (292)
T ss_dssp CSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCC
T ss_pred ccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccccc
Confidence 5788999999998776 599999999999999999999986544 4444443332 21100
Q ss_pred -------CCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 513 -------FPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 513 -------~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
......++..+++||.+||++||.+||| |+|||+||||+++
T Consensus 242 ~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~s----a~e~L~Hp~f~~~ 289 (292)
T d1unla_ 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS----AEEALQHPYFSDF 289 (292)
T ss_dssp CCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC----HHHHTTSGGGSSC
T ss_pred ccccchhhhccccCCHHHHHHHHHHccCChhHCcC----HHHHhcChhhcCC
Confidence 0112347889999999999999999999 9999999999864
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-53 Score=439.36 Aligned_cols=263 Identities=26% Similarity=0.325 Sum_probs=208.8
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec-------
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET------- 287 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~------- 287 (611)
+++|++++.||+|+||+||+|++..+++.||||++.+.... .....++.+|+++|+.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 57999999999999999999999999999999998765432 2334467789999999999999999998854
Q ss_pred -cceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccc
Q 007260 288 -EKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSL 366 (611)
Q Consensus 288 -~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~ 366 (611)
+..+|||||||.++.+..+.. ....+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||++.
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~--~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTC--TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCceEEEEEeccCCCccchhhh--cccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceee
Confidence 456899999997766654333 34679999999999999999999999999999999999999999999999999985
Q ss_pred cccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCc
Q 007260 367 RCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEP 446 (611)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (611)
........
T Consensus 166 ~~~~~~~~------------------------------------------------------------------------ 173 (318)
T d3blha1 166 AFSLAKNS------------------------------------------------------------------------ 173 (318)
T ss_dssp ECCC----------------------------------------------------------------------------
T ss_pred eccccccc------------------------------------------------------------------------
Confidence 43211000
Q ss_pred ccccccccccCCCccchhhhccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHc---CCCCCCC-------
Q 007260 447 TEARSMSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG---QPLRFPE------- 515 (611)
Q Consensus 447 ~~~~~~~~vGT~~Y~APEil~~~-~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~---~~l~~p~------- 515 (611)
......+.+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+..+...+..+.. .......
T Consensus 174 ~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 253 (318)
T d3blha1 174 QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYE 253 (318)
T ss_dssp -CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-
T ss_pred ccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhh
Confidence 00111235799999999999876 689999999999999999999999998877766544432 2110000
Q ss_pred ---------C-----------CCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCC
Q 007260 516 ---------S-----------PVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEG 556 (611)
Q Consensus 516 ---------~-----------~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 556 (611)
. ...+.+++|||.+||.+||++||| |+|||+||||+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~s----a~elL~Hpff~~ 310 (318)
T d3blha1 254 LYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID----SDDALNHDFFWS 310 (318)
T ss_dssp ------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCC----HHHHHHSGGGSS
T ss_pred hhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcC----HHHHHcChhhcc
Confidence 0 013678899999999999999999 999999999974
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=425.49 Aligned_cols=251 Identities=22% Similarity=0.329 Sum_probs=216.9
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccceeeEE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~~~LV 294 (611)
.++|++++.||+|+||+||+|+++ +++.||||++++...... .+.+|+.++++++|||||++++++.+++.+|+|
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~----~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv 77 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSED----EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHH----HHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHH----HHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence 368999999999999999999986 677899999987665432 467899999999999999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTL 374 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~ 374 (611)
||||++|+|..++.... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+...
T Consensus 78 ~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~--- 153 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD--- 153 (258)
T ss_dssp EECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS---
T ss_pred EEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCC---
Confidence 99999999999876653 46899999999999999999999999999999999999999999999999998432210
Q ss_pred cccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccccccc
Q 007260 375 IKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSF 454 (611)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (611)
........
T Consensus 154 ------------------------------------------------------------------------~~~~~~~~ 161 (258)
T d1k2pa_ 154 ------------------------------------------------------------------------EYTSSVGS 161 (258)
T ss_dssp ------------------------------------------------------------------------SCCCCCCS
T ss_pred ------------------------------------------------------------------------Cceeeccc
Confidence 00011124
Q ss_pred ccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007260 455 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVK 533 (611)
Q Consensus 455 vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~ 533 (611)
.||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+...++... .+.+.+..++.++++||.+||..
T Consensus 162 ~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~-~~~~~p~~~~~~l~~li~~cl~~ 240 (258)
T d1k2pa_ 162 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-LRLYRPHLASEKVYTIMYSCWHE 240 (258)
T ss_dssp CCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHTTCS
T ss_pred CCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhC-CCCCCcccccHHHHHHHHHHccC
Confidence 69999999999999999999999999999999998 89999999887777666554 45555567999999999999999
Q ss_pred CccccCCchhcHHHHHcC
Q 007260 534 EPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 534 dP~~Rpt~~~~a~elL~H 551 (611)
||++||| +++|++|
T Consensus 241 dP~~RPt----~~eil~~ 254 (258)
T d1k2pa_ 241 KADERPT----FKILLSN 254 (258)
T ss_dssp SGGGSCC----HHHHHHH
T ss_pred CHhHCcC----HHHHHHH
Confidence 9999999 8888876
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-52 Score=439.05 Aligned_cols=259 Identities=25% Similarity=0.395 Sum_probs=209.1
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc-----e
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK-----F 290 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~-----~ 290 (611)
++|++++.||+|+||+||+|++..+++.||||++++.. ......++++|+++|+.|+|||||++++++.... .
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 58999999999999999999999999999999997644 2344567889999999999999999999987543 3
Q ss_pred eeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccC
Q 007260 291 SCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAV 370 (611)
Q Consensus 291 ~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~ 370 (611)
+||| +|+.||+|++++... .+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||++.....
T Consensus 86 ~~l~-~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 86 VYLV-THLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EEEE-EECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEE-EeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 4555 555699999999764 599999999999999999999999999999999999999999999999999854321
Q ss_pred CccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccc
Q 007260 371 SPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEAR 450 (611)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (611)
... ....
T Consensus 162 ~~~-------------------------------------------------------------------------~~~~ 168 (345)
T d1pmea_ 162 DHD-------------------------------------------------------------------------HTGF 168 (345)
T ss_dssp GGC-------------------------------------------------------------------------BCCT
T ss_pred CCc-------------------------------------------------------------------------ccee
Confidence 100 0011
Q ss_pred ccccccCCCccchhhhcc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHc---CC----------------
Q 007260 451 SMSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVG---QP---------------- 510 (611)
Q Consensus 451 ~~~~vGT~~Y~APEil~~-~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~---~~---------------- 510 (611)
....+||+.|+|||++.. ..++.++||||+||++|||++|+.||.+....+....... .+
T Consensus 169 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (345)
T d1pmea_ 169 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 248 (345)
T ss_dssp TCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHH
T ss_pred eccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcc
Confidence 224579999999999854 5679999999999999999999999998876655543321 11
Q ss_pred -CCCC---------CCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 511 -LRFP---------ESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 511 -l~~p---------~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
...+ ....++.++++||.+||.+||.+||+ |+|+|+||||+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t----a~e~L~hpf~~~~ 301 (345)
T d1pmea_ 249 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE----VEQALAHPYLEQY 301 (345)
T ss_dssp HHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCC----HHHHHTSGGGTTT
T ss_pred cccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcC----HHHHhcCHhhccC
Confidence 0011 12357889999999999999999999 9999999999854
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-52 Score=424.36 Aligned_cols=257 Identities=24% Similarity=0.345 Sum_probs=209.5
Q ss_pred ccccccCeEEEeEecccCcEEEEEEEECCC---CeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 007260 211 GVLGLSHFRLLKRLGCGDIGSVYLSELSGT---KCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET 287 (611)
Q Consensus 211 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t---~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~ 287 (611)
+++..++|++++.||+|+||+||+|++..+ +..||||.++... .......+.+|+.+|++++|||||++++++.
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 78 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 78 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 345567999999999999999999998654 4578999886543 2344557889999999999999999999986
Q ss_pred cceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccc
Q 007260 288 EKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLR 367 (611)
Q Consensus 288 ~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~ 367 (611)
++.+|||||||++|+|.+++.... ..+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.
T Consensus 79 ~~~~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 79 ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred cCeEEEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhhee
Confidence 567899999999999999877653 5699999999999999999999999999999999999999999999999999854
Q ss_pred ccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcc
Q 007260 368 CAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPT 447 (611)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (611)
+....
T Consensus 158 ~~~~~--------------------------------------------------------------------------- 162 (273)
T d1mp8a_ 158 MEDST--------------------------------------------------------------------------- 162 (273)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccCCc---------------------------------------------------------------------------
Confidence 32110
Q ss_pred cccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 007260 448 EARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDL 526 (611)
Q Consensus 448 ~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dL 526 (611)
........||+.|+|||++.+..|+.++|||||||+||||++ |.+||.+....+.+.++..+. ..+.+..+++++++|
T Consensus 163 ~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~l 241 (273)
T d1mp8a_ 163 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNCPPTLYSL 241 (273)
T ss_dssp --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CCCCCTTCCHHHHHH
T ss_pred ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHHHH
Confidence 011123468999999999999999999999999999999997 999999988877777766543 345556799999999
Q ss_pred HHHhhhcCccccCCchhcHHHHHcC
Q 007260 527 IRGLLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 527 I~~~L~~dP~~Rpt~~~~a~elL~H 551 (611)
|.+||..||.+||| +.||++|
T Consensus 242 i~~cl~~dp~~Rps----~~ei~~~ 262 (273)
T d1mp8a_ 242 MTKCWAYDPSRRPR----FTELKAQ 262 (273)
T ss_dssp HHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHcCCCHhHCcC----HHHHHHH
Confidence 99999999999999 8888875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-52 Score=424.50 Aligned_cols=259 Identities=20% Similarity=0.239 Sum_probs=209.7
Q ss_pred cccccCeEEEeEecccCcEEEEEEEECCCC----eEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec
Q 007260 212 VLGLSHFRLLKRLGCGDIGSVYLSELSGTK----CYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET 287 (611)
Q Consensus 212 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~----~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~ 287 (611)
++..+.|++.++||+|+||+||+|.++.++ ..||||++...... .....+.+|+++|++++|||||++++++.+
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~~~g~~~~ 80 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE--KQRVDFLGEAGIMGQFSHHNIIRLEGVISK 80 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccCh--HHHHHHHHHHHHHHhcCCCCEeeeeEEEec
Confidence 344578999999999999999999987654 57999999754322 334567899999999999999999999999
Q ss_pred cceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccc
Q 007260 288 EKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLR 367 (611)
Q Consensus 288 ~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~ 367 (611)
.+.+|+|||||.+++|.+++.... ..+++..+..++.||+.||+|||++|||||||||+||||+.++.+||+|||+++.
T Consensus 81 ~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 81 YKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred CCceEEEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhc
Confidence 999999999999999999877653 5699999999999999999999999999999999999999999999999999854
Q ss_pred ccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcc
Q 007260 368 CAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPT 447 (611)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (611)
+......
T Consensus 160 ~~~~~~~------------------------------------------------------------------------- 166 (283)
T d1mqba_ 160 LEDDPEA------------------------------------------------------------------------- 166 (283)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccCCCcc-------------------------------------------------------------------------
Confidence 3211100
Q ss_pred cccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 007260 448 EARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLI 527 (611)
Q Consensus 448 ~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI 527 (611)
........||+.|||||++.+..++.++|||||||+||||++|..||........+...+....+.+.+..++.++++||
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li 246 (283)
T d1mqba_ 167 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLM 246 (283)
T ss_dssp -------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHHH
T ss_pred ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHHHHHH
Confidence 00112345899999999999999999999999999999999965555444444555555666666666677999999999
Q ss_pred HHhhhcCccccCCchhcHHHHHc
Q 007260 528 RGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 528 ~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
.+||..||++||+ +.||++
T Consensus 247 ~~cl~~~p~~RPt----~~eil~ 265 (283)
T d1mqba_ 247 MQCWQQERARRPK----FADIVS 265 (283)
T ss_dssp HHHTCSSTTTSCC----HHHHHH
T ss_pred HHHCcCCHhHCcC----HHHHHH
Confidence 9999999999999 777765
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-52 Score=438.88 Aligned_cols=256 Identities=26% Similarity=0.378 Sum_probs=211.9
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeecc-----c
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETE-----K 289 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~-----~ 289 (611)
.++|++++.||+|+||+||+|++..+++.||||++.+... ......++.+|+.+|+.++|||||+++++|... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 3689999999999999999999999999999999986543 334456788999999999999999999998632 3
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
..++||||+.||+|.+++.. +.+++..++.|+.||+.||+|||++|||||||||+|||++.+|.+||+|||++....
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred ceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC
Confidence 44666777789999999865 359999999999999999999999999999999999999999999999999983211
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
.
T Consensus 173 -------------------------------------------------------------------------------~ 173 (348)
T d2gfsa1 173 -------------------------------------------------------------------------------D 173 (348)
T ss_dssp -------------------------------------------------------------------------------G
T ss_pred -------------------------------------------------------------------------------c
Confidence 0
Q ss_pred cccccccCCCccchhhhccCC-CCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCC-----------------
Q 007260 450 RSMSFVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPL----------------- 511 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~~~-~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l----------------- 511 (611)
...+.+||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+.......+.....
T Consensus 174 ~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 253 (348)
T d2gfsa1 174 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 253 (348)
T ss_dssp GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHH
T ss_pred ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhh
Confidence 112346999999999988765 58999999999999999999999999877766655442211
Q ss_pred ------CCCC------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCC
Q 007260 512 ------RFPE------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGV 557 (611)
Q Consensus 512 ------~~p~------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 557 (611)
..+. ...++.+++|||.+||..||.+||| |.|||+||||+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t----a~elL~Hp~f~~~ 307 (348)
T d2gfsa1 254 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT----AAQALAHAYFAQY 307 (348)
T ss_dssp HHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGTTT
T ss_pred hhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcC----HHHHhcCHhhCCC
Confidence 1111 1347899999999999999999999 9999999999864
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-52 Score=440.97 Aligned_cols=266 Identities=26% Similarity=0.384 Sum_probs=210.0
Q ss_pred hccCccc-cccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCccccccee
Q 007260 207 RARDGVL-GLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHF 285 (611)
Q Consensus 207 ~~~~~~~-~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~ 285 (611)
..++..+ .+++|++++.||+|+||+||+|++..+++.||||++.+... ......++.+|+.+|+.++|||||+++++|
T Consensus 7 ~~~~~~f~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f 85 (355)
T d2b1pa1 7 EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVF 85 (355)
T ss_dssp EETTEEEEEETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred EeCCcceeecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEE
Confidence 3444333 45799999999999999999999999999999999976543 345566788999999999999999999999
Q ss_pred ec------cceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEE
Q 007260 286 ET------EKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIML 359 (611)
Q Consensus 286 ~~------~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL 359 (611)
.. ..++|||||||.| +|.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 86 ~~~~~~~~~~~~~iv~Ey~~~-~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl 160 (355)
T d2b1pa1 86 TPQKTLEEFQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 160 (355)
T ss_dssp CSCCSTTTCCEEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEE
T ss_pred ecccccccCceeEEEEeccch-HHHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceee
Confidence 63 4788999999965 4544443 34899999999999999999999999999999999999999999999
Q ss_pred EeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCC
Q 007260 360 SDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPL 439 (611)
Q Consensus 360 ~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (611)
+|||++.....
T Consensus 161 ~df~~~~~~~~--------------------------------------------------------------------- 171 (355)
T d2b1pa1 161 LDFGLARTAGT--------------------------------------------------------------------- 171 (355)
T ss_dssp CCCCC---------------------------------------------------------------------------
T ss_pred echhhhhcccc---------------------------------------------------------------------
Confidence 99998733210
Q ss_pred cccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcC----------
Q 007260 440 PELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQ---------- 509 (611)
Q Consensus 440 ~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~---------- 509 (611)
.......+||+.|+|||++.+..++.++||||+||++|||++|++||.+.+....+.+++..
T Consensus 172 --------~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (355)
T d2b1pa1 172 --------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_dssp -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred --------ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHH
Confidence 01112346999999999999999999999999999999999999999988766655444311
Q ss_pred ------------CCCCCC------------------CCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcCCCCCCCch
Q 007260 510 ------------PLRFPE------------------SPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNW 559 (611)
Q Consensus 510 ------------~l~~p~------------------~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 559 (611)
...... ...++.++++||++||.+||++||| |+|||+||||+...+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t----a~elL~Hpw~~~~~~ 319 (355)
T d2b1pa1 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS----VDDALQHPYINVWYD 319 (355)
T ss_dssp TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCC----HHHHHTSTTTGGGCC
T ss_pred HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcC----HHHHhcCcccCCCCC
Confidence 000000 0124678899999999999999999 999999999986443
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-52 Score=424.45 Aligned_cols=258 Identities=24% Similarity=0.326 Sum_probs=211.2
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCC---CeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGT---KCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK 289 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t---~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~ 289 (611)
++.++|++++.||+|+||.||+|++... ...||||++.+......+...++.+|+.+|+.++|||||+++++|.+ .
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~ 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence 3457899999999999999999986533 34789999987766555667788999999999999999999999976 4
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
.+|||||||++|+|.+++..+. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+.
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred chheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 6789999999999998777653 469999999999999999999999999999999999999999999999999985443
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
..... ..
T Consensus 163 ~~~~~-------------------------------------------------------------------------~~ 169 (273)
T d1u46a_ 163 QNDDH-------------------------------------------------------------------------YV 169 (273)
T ss_dssp C-CCE-------------------------------------------------------------------------EE
T ss_pred cCCCc-------------------------------------------------------------------------ce
Confidence 11110 01
Q ss_pred cccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 007260 450 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIR 528 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~ 528 (611)
......||..|+|||++.+..++.++|||||||++|||++ |++||.+.+..+.+.++.....+++....++.++++||.
T Consensus 170 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~ 249 (273)
T d1u46a_ 170 MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMV 249 (273)
T ss_dssp C-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHH
T ss_pred ecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHHHHHHH
Confidence 1123458889999999999999999999999999999997 899999999888888888888888777789999999999
Q ss_pred HhhhcCccccCCchhcHHHHH
Q 007260 529 GLLVKEPQHRLAYKRGATEIK 549 (611)
Q Consensus 529 ~~L~~dP~~Rpt~~~~a~elL 549 (611)
+||..||.+||| +.+|+
T Consensus 250 ~cl~~dp~~RPt----~~ei~ 266 (273)
T d1u46a_ 250 QCWAHKPEDRPT----FVALR 266 (273)
T ss_dssp HHTCSSGGGSCC----HHHHH
T ss_pred HHcCCChhHCcC----HHHHH
Confidence 999999999999 77765
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-52 Score=426.33 Aligned_cols=259 Identities=22% Similarity=0.305 Sum_probs=206.4
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECC-----CCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSG-----TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFE 286 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~-----t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~ 286 (611)
+..++|++++.||+|+||.||+|++.. +++.||||+++..... .....+.+|..++.++ +|+|||.+++++.
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~--~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~ 87 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGACT 87 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCc--HHHHHHHHHHHHHHhhcCCCeEEEeeeeec
Confidence 445789999999999999999999754 4578999999754322 3334566777777766 7899999999876
Q ss_pred c-cceeeEEeeeCCCCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEE
Q 007260 287 T-EKFSCLVMEFCPGGDLHTLRQKQP--------------GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLV 351 (611)
Q Consensus 287 ~-~~~~~LVmE~~~gg~L~~ll~~~~--------------~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv 351 (611)
. +..+|+|||||+||+|.+++.... ...+++..++.|+.||+.||+|||++|||||||||+||||
T Consensus 88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl 167 (299)
T d1ywna1 88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 167 (299)
T ss_dssp STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE
Confidence 5 567899999999999999987542 2358999999999999999999999999999999999999
Q ss_pred ccCCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccc
Q 007260 352 REDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNE 431 (611)
Q Consensus 352 ~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (611)
+.++++||+|||+|+.+....
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~----------------------------------------------------------- 188 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDP----------------------------------------------------------- 188 (299)
T ss_dssp CGGGCEEECC------CCSCT-----------------------------------------------------------
T ss_pred CCCCcEEEccCcchhhccccc-----------------------------------------------------------
Confidence 999999999999985432110
Q ss_pred cCCCCCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHcCC
Q 007260 432 IGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFG-KTPFKGSGNRATLFNVVGQP 510 (611)
Q Consensus 432 ~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG-~~PF~~~~~~~~l~~i~~~~ 510 (611)
........+||+.|||||++.+..++.++|||||||++|||++| .+||.+......+..++...
T Consensus 189 ---------------~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~ 253 (299)
T d1ywna1 189 ---------------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 253 (299)
T ss_dssp ---------------TSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHT
T ss_pred ---------------cccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC
Confidence 01112245799999999999999999999999999999999986 67898877666666666655
Q ss_pred CCCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcC
Q 007260 511 LRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 511 l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~H 551 (611)
.+++....+++++++||.+||..||.+||| +.||++|
T Consensus 254 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt----~~eil~~ 290 (299)
T d1ywna1 254 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPT----FSELVEH 290 (299)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCCCCCccCCHHHHHHHHHHcCCChhHCcC----HHHHHHH
Confidence 555655669999999999999999999999 8898886
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-51 Score=426.67 Aligned_cols=254 Identities=21% Similarity=0.300 Sum_probs=206.7
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCe----EEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccce
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKC----YFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKF 290 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~----~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~~ 290 (611)
-++|++++.||+|+||+||+|++..+++ .||+|.+.... ..+...++.+|+.+|++++|||||++++++.++ .
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~ 84 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 84 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-C
Confidence 3689999999999999999999988776 57888776432 223345678999999999999999999999865 5
Q ss_pred eeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccC
Q 007260 291 SCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAV 370 (611)
Q Consensus 291 ~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~ 370 (611)
.++||||+.+|+|.+++... ...+++..++.|+.||+.||+|||++|||||||||+||||+.++++||+|||+|+.+..
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred eeEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 67888999999999887765 36799999999999999999999999999999999999999999999999999854321
Q ss_pred CccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCccccc
Q 007260 371 SPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEAR 450 (611)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (611)
... ...
T Consensus 164 ~~~--------------------------------------------------------------------------~~~ 169 (317)
T d1xkka_ 164 EEK--------------------------------------------------------------------------EYH 169 (317)
T ss_dssp TCC-----------------------------------------------------------------------------
T ss_pred ccc--------------------------------------------------------------------------ccc
Confidence 100 001
Q ss_pred ccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHH
Q 007260 451 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRG 529 (611)
Q Consensus 451 ~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~ 529 (611)
....+||+.|+|||++.+..|+.++|||||||+||||+| |.+||.+.+..+... ++....+.+.+..++.++.+||.+
T Consensus 170 ~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~-~i~~~~~~~~p~~~~~~~~~li~~ 248 (317)
T d1xkka_ 170 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLPQPPICTIDVYMIMVK 248 (317)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHH-HHHHTCCCCCCTTBCHHHHHHHHH
T ss_pred ccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHH-HHHcCCCCCCCcccCHHHHHHHHH
Confidence 123469999999999999999999999999999999998 899999876655444 443444455556799999999999
Q ss_pred hhhcCccccCCchhcHHHHHcC
Q 007260 530 LLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 530 ~L~~dP~~Rpt~~~~a~elL~H 551 (611)
||..||.+||+ +.||++|
T Consensus 249 cl~~dP~~RPs----~~eil~~ 266 (317)
T d1xkka_ 249 CWMIDADSRPK----FRELIIE 266 (317)
T ss_dssp HTCSSGGGSCC----HHHHHHH
T ss_pred hCCCChhhCcC----HHHHHHH
Confidence 99999999999 8888887
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-50 Score=416.81 Aligned_cols=258 Identities=19% Similarity=0.280 Sum_probs=216.4
Q ss_pred cccccCeEEEeEecccCcEEEEEEEECC-----CCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceee
Q 007260 212 VLGLSHFRLLKRLGCGDIGSVYLSELSG-----TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFE 286 (611)
Q Consensus 212 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~-----t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~ 286 (611)
++..++|++++.||+|+||+||+|++.+ +++.||||+++.... .+...++.+|+++|+.++||||+++++++.
T Consensus 9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcC--hHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 3445789999999999999999999864 567899999976432 334557889999999999999999999999
Q ss_pred ccceeeEEeeeCCCCCHHHHHHhCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCC
Q 007260 287 TEKFSCLVMEFCPGGDLHTLRQKQP----------------------GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDL 344 (611)
Q Consensus 287 ~~~~~~LVmE~~~gg~L~~ll~~~~----------------------~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDL 344 (611)
..+..++||||+++|+|.+++.... ...+++..+..|+.||+.||+|||++|||||||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDl 166 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 166 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEE
Confidence 9999999999999999999986532 234899999999999999999999999999999
Q ss_pred CCCcEEEccCCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCccccccccc
Q 007260 345 KPENVLVREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKK 424 (611)
Q Consensus 345 KPeNILv~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (611)
||+||||+.++++||+|||+|+......
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~~---------------------------------------------------- 194 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSAD---------------------------------------------------- 194 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGG----------------------------------------------------
T ss_pred cccceEECCCCcEEEccchhheeccCCc----------------------------------------------------
Confidence 9999999999999999999985432110
Q ss_pred CCCCccccCCCCCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCC-CCCCCCCcHHHH
Q 007260 425 DRKPKNEIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGK-TPFKGSGNRATL 503 (611)
Q Consensus 425 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~-~PF~~~~~~~~l 503 (611)
......+..||+.|+|||++.+..|+.++|||||||+||||++|. +||.+.+..+.+
T Consensus 195 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~ 252 (301)
T d1lufa_ 195 ----------------------YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVI 252 (301)
T ss_dssp ----------------------CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred ----------------------cccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHH
Confidence 011122456999999999999999999999999999999999985 689888888777
Q ss_pred HHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 504 FNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 504 ~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
..+..+. ..+.+..++.++.+||.+||..||.+||| +.||++
T Consensus 253 ~~v~~~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt----~~ev~~ 294 (301)
T d1lufa_ 253 YYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPS----FCSIHR 294 (301)
T ss_dssp HHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcC----HHHHHH
Confidence 7766654 34444569999999999999999999999 777754
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=420.29 Aligned_cols=255 Identities=22% Similarity=0.312 Sum_probs=211.4
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCCeE--EEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceeeccc
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTKCY--FAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFETEK 289 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~--vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~~~~ 289 (611)
+..++|++.+.||+|+||+||+|++..++.. ||||.+.... ..+....+.+|+++|+++ +|||||++++++.+++
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 4457999999999999999999999888764 6777775432 223445678999999999 7999999999999999
Q ss_pred eeeEEeeeCCCCCHHHHHHhC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCC
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQ--------------PGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDG 355 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~--------------~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g 355 (611)
.+|||||||+||+|.++++.. .+..+++..+..++.||+.||.|||++|||||||||+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 999999999999999998754 235799999999999999999999999999999999999999999
Q ss_pred cEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCC
Q 007260 356 HIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQ 435 (611)
Q Consensus 356 ~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (611)
.+||+|||+++.....
T Consensus 165 ~~kl~DfG~a~~~~~~---------------------------------------------------------------- 180 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVY---------------------------------------------------------------- 180 (309)
T ss_dssp CEEECCTTCEESSCEE----------------------------------------------------------------
T ss_pred ceEEcccccccccccc----------------------------------------------------------------
Confidence 9999999998432100
Q ss_pred CCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCC-CCCCCCCcHHHHHHHHcCCCCCC
Q 007260 436 VSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGK-TPFKGSGNRATLFNVVGQPLRFP 514 (611)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~-~PF~~~~~~~~l~~i~~~~l~~p 514 (611)
.......||+.|+|||++.+..|+.++|||||||++|||++|. +||.+.+..+.+..+.. ..+++
T Consensus 181 -------------~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~-~~~~~ 246 (309)
T d1fvra_ 181 -------------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYRLE 246 (309)
T ss_dssp -------------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG-TCCCC
T ss_pred -------------ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh-cCCCC
Confidence 0111345999999999999999999999999999999999965 67887766665555544 34455
Q ss_pred CCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHcC
Q 007260 515 ESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQH 551 (611)
Q Consensus 515 ~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~H 551 (611)
.+..+++++++||.+||..||++||+ +.||++|
T Consensus 247 ~~~~~~~~~~~li~~cl~~dP~~RPs----~~eil~~ 279 (309)
T d1fvra_ 247 KPLNCDDEVYDLMRQCWREKPYERPS----FAQILVS 279 (309)
T ss_dssp CCTTBCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCccCCHHHHHHHHHHcCCChhHCcC----HHHHHHH
Confidence 55679999999999999999999999 8888876
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-51 Score=413.12 Aligned_cols=249 Identities=21% Similarity=0.319 Sum_probs=206.8
Q ss_pred ccccccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec-cc
Q 007260 211 GVLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET-EK 289 (611)
Q Consensus 211 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~-~~ 289 (611)
+.+..++|++++.||+|+||.||+|+++ +..||||++++.. ....+++|+++|++++|||||++++++.+ .+
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 74 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence 3566789999999999999999999985 5679999997653 22357889999999999999999998854 56
Q ss_pred eeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEecccccccc
Q 007260 290 FSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA 369 (611)
Q Consensus 290 ~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~ 369 (611)
.+|||||||++|+|.+++.......+++..++.++.||+.||.|||+++||||||||+|||++.+|.+||+|||+++...
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecC
Confidence 78999999999999999876544468999999999999999999999999999999999999999999999999984321
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
.
T Consensus 155 ~------------------------------------------------------------------------------- 155 (262)
T d1byga_ 155 S------------------------------------------------------------------------------- 155 (262)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred C-------------------------------------------------------------------------------
Confidence 0
Q ss_pred cccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 007260 450 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIR 528 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~ 528 (611)
......||+.|+|||++.+..++.++|||||||++|||++ |++||.+....+.+.++. ...+.+....++.++++||.
T Consensus 156 ~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~li~ 234 (262)
T d1byga_ 156 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAVYEVMK 234 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-TTCCCCCCTTCCHHHHHHHH
T ss_pred CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCccCCHHHHHHHH
Confidence 0112358899999999999999999999999999999998 799998877666665554 33455555569999999999
Q ss_pred HhhhcCccccCCchhcHHHHHc
Q 007260 529 GLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 529 ~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
+||..||.+||+ +.+|++
T Consensus 235 ~cl~~dP~~Rps----~~~l~~ 252 (262)
T d1byga_ 235 NCWHLDAAMRPS----FLQLRE 252 (262)
T ss_dssp HHTCSSGGGSCC----HHHHHH
T ss_pred HHcccCHhHCcC----HHHHHH
Confidence 999999999999 777765
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-50 Score=415.37 Aligned_cols=258 Identities=19% Similarity=0.282 Sum_probs=219.8
Q ss_pred ccccCeEEEeEecccCcEEEEEEEEC-----CCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccceee
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELS-----GTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTHFE 286 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~-----~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~~~ 286 (611)
+..++|++++.||+|+||.||+|++. .+++.||||++++... ......+.+|+.++..+ +|||||++++++.
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC--HHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence 44579999999999999999999863 4678999999976543 23445678899999999 6999999999999
Q ss_pred ccceeeEEeeeCCCCCHHHHHHhCC----------------CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEE
Q 007260 287 TEKFSCLVMEFCPGGDLHTLRQKQP----------------GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVL 350 (611)
Q Consensus 287 ~~~~~~LVmE~~~gg~L~~ll~~~~----------------~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNIL 350 (611)
+.+.+|||||||++|+|.+++.... ...+++..++.|+.||+.||+|||++|||||||||+|||
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl 177 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL 177 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccc
Confidence 9999999999999999999987642 235899999999999999999999999999999999999
Q ss_pred EccCCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCcc
Q 007260 351 VREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKN 430 (611)
Q Consensus 351 v~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 430 (611)
++.++.+||+|||+++.+.....
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~--------------------------------------------------------- 200 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSN--------------------------------------------------------- 200 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTT---------------------------------------------------------
T ss_pred ccccCcccccccchheeccCCCc---------------------------------------------------------
Confidence 99999999999999853321100
Q ss_pred ccCCCCCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcC
Q 007260 431 EIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQ 509 (611)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~ 509 (611)
.......+||+.|+|||++.+..++.++|||||||+||||++ |.+||.+....+.+.+++..
T Consensus 201 -----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~ 263 (311)
T d1t46a_ 201 -----------------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKE 263 (311)
T ss_dssp -----------------SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHH
T ss_pred -----------------ceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc
Confidence 011123579999999999999999999999999999999998 77778887777777788777
Q ss_pred CCCCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 510 PLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 510 ~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
..+......++.++.+||.+||..||.+||+ +.+|++
T Consensus 264 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs----~~~il~ 300 (311)
T d1t46a_ 264 GFRMLSPEHAPAEMYDIMKTCWDADPLKRPT----FKQIVQ 300 (311)
T ss_dssp TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred CCCCCCcccccHHHHHHHHHHcCCChhHCcC----HHHHHH
Confidence 7776666679999999999999999999999 777775
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-50 Score=412.30 Aligned_cols=257 Identities=22% Similarity=0.316 Sum_probs=211.1
Q ss_pred ccccCeEEEeEecccCcEEEEEEEECCCC-------eEEEEEEecchhhhhHHHHHHHHHHHHHHHhC-CCCCcccccce
Q 007260 213 LGLSHFRLLKRLGCGDIGSVYLSELSGTK-------CYFAMKVMDKASLAGRKKLLRAQTEREILQSL-DHPFLPTLYTH 284 (611)
Q Consensus 213 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~t~-------~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l-~HpnIv~l~~~ 284 (611)
+..++|++++.||+|+||.||+|++..++ ..||||++++... ......+.+|..++.++ +|||||+++++
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC--hHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 45679999999999999999999986554 4799999976542 23345677888888888 89999999999
Q ss_pred eeccceeeEEeeeCCCCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEE
Q 007260 285 FETEKFSCLVMEFCPGGDLHTLRQKQP--------------GKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVL 350 (611)
Q Consensus 285 ~~~~~~~~LVmE~~~gg~L~~ll~~~~--------------~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNIL 350 (611)
|.+++.+|+|||||++|+|.+++.... ...+++..++.|+.||+.||+|||++|||||||||+|||
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiL 167 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 167 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccccee
Confidence 999999999999999999999987542 246899999999999999999999999999999999999
Q ss_pred EccCCcEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCcc
Q 007260 351 VREDGHIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKN 430 (611)
Q Consensus 351 v~~~g~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 430 (611)
++.+|.+||+|||+++......
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~---------------------------------------------------------- 189 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHID---------------------------------------------------------- 189 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCC----------------------------------------------------------
T ss_pred ecCCCCeEeccchhhccccccc----------------------------------------------------------
Confidence 9999999999999984332110
Q ss_pred ccCCCCCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHcC
Q 007260 431 EIGNQVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSGNRATLFNVVGQ 509 (611)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELlt-G~~PF~~~~~~~~l~~i~~~ 509 (611)
........+||+.|+|||++.+..|+.++|||||||+||||++ |++||.+.+....+ ..+..
T Consensus 190 ----------------~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~-~~i~~ 252 (299)
T d1fgka_ 190 ----------------YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF-KLLKE 252 (299)
T ss_dssp ----------------TTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-HHHHT
T ss_pred ----------------cccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHH-HHHHc
Confidence 0111224569999999999999999999999999999999997 79999887665544 44445
Q ss_pred CCCCCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 510 PLRFPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 510 ~l~~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
..+++.+..++.++++||.+||+.||.+||| +.||++
T Consensus 253 ~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps----~~eil~ 289 (299)
T d1fgka_ 253 GHRMDKPSNCTNELYMMMRDCWHAVPSQRPT----FKQLVE 289 (299)
T ss_dssp TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred CCCCCCCccchHHHHHHHHHHccCCHhHCcC----HHHHHH
Confidence 5566666679999999999999999999999 888876
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-50 Score=414.42 Aligned_cols=266 Identities=20% Similarity=0.266 Sum_probs=221.9
Q ss_pred ccccccCeEEEeEecccCcEEEEEEEECC-----CCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCccccccee
Q 007260 211 GVLGLSHFRLLKRLGCGDIGSVYLSELSG-----TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHF 285 (611)
Q Consensus 211 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~-----t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~ 285 (611)
+.+..++|++++.||+|+||+||+|.+.+ ++..||||++++.. ..+....+.+|+++|++++|||||++++++
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVV 92 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence 34556799999999999999999999863 35789999997643 234455778999999999999999999999
Q ss_pred eccceeeEEeeeCCCCCHHHHHHhC--------CCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcE
Q 007260 286 ETEKFSCLVMEFCPGGDLHTLRQKQ--------PGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHI 357 (611)
Q Consensus 286 ~~~~~~~LVmE~~~gg~L~~ll~~~--------~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~v 357 (611)
..+...|||||||++|+|.+++... .-..+++..+..|+.||+.||.|||+++||||||||+||||+.++++
T Consensus 93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceE
Confidence 9999999999999999999987642 11347899999999999999999999999999999999999999999
Q ss_pred EEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCC
Q 007260 358 MLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVS 437 (611)
Q Consensus 358 kL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (611)
||+|||+|+.......
T Consensus 173 Kl~DFGla~~~~~~~~---------------------------------------------------------------- 188 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDY---------------------------------------------------------------- 188 (308)
T ss_dssp EECCTTCCCGGGGGGC----------------------------------------------------------------
T ss_pred EEeecccceeccCCcc----------------------------------------------------------------
Confidence 9999999854321110
Q ss_pred CCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHcCCCCCCCC
Q 007260 438 PLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFG-KTPFKGSGNRATLFNVVGQPLRFPES 516 (611)
Q Consensus 438 ~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG-~~PF~~~~~~~~l~~i~~~~l~~p~~ 516 (611)
.......+||+.|+|||.+.+..++.++|||||||+||||++| ++||.+.+..+.+..+..+. ..+..
T Consensus 189 ----------~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~-~~~~p 257 (308)
T d1p4oa_ 189 ----------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG-LLDKP 257 (308)
T ss_dssp ----------EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC-CCCCC
T ss_pred ----------eeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCC-CCCCc
Confidence 1112234699999999999999999999999999999999998 58898888777777666543 34445
Q ss_pred CCCCHHHHHHHHHhhhcCccccCCchhcHHHHHc------CCCCCCC
Q 007260 517 PVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQ------HPFFEGV 557 (611)
Q Consensus 517 ~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~------Hp~f~~~ 557 (611)
..++..+.+||.+||+.||.+||+ +.+|++ +|+|+.+
T Consensus 258 ~~~~~~l~~li~~cl~~~P~~RPs----~~~il~~L~~~~~~~~~~~ 300 (308)
T d1p4oa_ 258 DNCPDMLFELMRMCWQYNPKMRPS----FLEIISSIKEEMEPGFREV 300 (308)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHHHGGGSCTTHHHH
T ss_pred ccchHHHHHHHHHHcCCChhHCcC----HHHHHHHHHHhcCCCCcCC
Confidence 569999999999999999999999 666665 7877654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-48 Score=401.67 Aligned_cols=253 Identities=18% Similarity=0.226 Sum_probs=202.3
Q ss_pred EEeEecccCcEEEEEEEECCC---CeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeec-cceeeEEe
Q 007260 220 LLKRLGCGDIGSVYLSELSGT---KCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFET-EKFSCLVM 295 (611)
Q Consensus 220 l~~~LG~G~fG~Vy~a~~~~t---~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~-~~~~~LVm 295 (611)
+.++||+|+||+||+|++..+ ...||||++++.. ......++.+|+++|++++|||||++++++.. ++.+|+||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 367899999999999998654 3469999997532 34556778999999999999999999998764 57899999
Q ss_pred eeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEeccccccccCCcccc
Q 007260 296 EFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLI 375 (611)
Q Consensus 296 E~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DFGlA~~~~~~~~~~ 375 (611)
|||++|+|.+++... ...+++..+..++.||+.||.|||+.||+||||||+||||++++.+||+|||+++........
T Consensus 109 E~~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~- 186 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD- 186 (311)
T ss_dssp ECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC-
T ss_pred EEeecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccc-
Confidence 999999999988765 356888899999999999999999999999999999999999999999999998543211000
Q ss_pred ccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccccccc
Q 007260 376 KASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARSMSFV 455 (611)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v 455 (611)
.........
T Consensus 187 -----------------------------------------------------------------------~~~~~~~~~ 195 (311)
T d1r0pa_ 187 -----------------------------------------------------------------------SVHNKTGAK 195 (311)
T ss_dssp -----------------------------------------------------------------------CTTCTTCSS
T ss_pred -----------------------------------------------------------------------cceeccccc
Confidence 000111246
Q ss_pred cCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCc
Q 007260 456 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEP 535 (611)
Q Consensus 456 GT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~i~~~~l~~p~~~~~s~~l~dLI~~~L~~dP 535 (611)
||+.|+|||++.+..++.++|||||||+||||++|..||........+...+....+.+.+..+++++.+||.+||..||
T Consensus 196 gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~~cl~~dP 275 (311)
T d1r0pa_ 196 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKA 275 (311)
T ss_dssp CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred ccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHHHHcCCCH
Confidence 99999999999999999999999999999999998777765444433333333333444455689999999999999999
Q ss_pred cccCCchhcHHHHHcC
Q 007260 536 QHRLAYKRGATEIKQH 551 (611)
Q Consensus 536 ~~Rpt~~~~a~elL~H 551 (611)
++||+ +.||++|
T Consensus 276 ~~RPs----~~ei~~~ 287 (311)
T d1r0pa_ 276 EMRPS----FSELVSR 287 (311)
T ss_dssp GGSCC----HHHHHHH
T ss_pred hHCcC----HHHHHHH
Confidence 99999 7888876
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-48 Score=402.91 Aligned_cols=271 Identities=18% Similarity=0.268 Sum_probs=206.1
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCc-ccccceeeccceeeEE
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFL-PTLYTHFETEKFSCLV 294 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnI-v~l~~~~~~~~~~~LV 294 (611)
++|++++.||+|+||+||+|++..+++.||||++...... .++.+|+++++.++|+|+ +.++.++.+.+..|+|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 4799999999999999999999999999999998764322 245679999999987665 5555666788899999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEcc---CCcEEEEeccccccccCC
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRE---DGHIMLSDFDLSLRCAVS 371 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~---~g~vkL~DFGlA~~~~~~ 371 (611)
|||| +++|...+... .+.+++..+..++.||+.||+|||++|||||||||+|||++. +..+||+|||+|+.+...
T Consensus 82 me~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 82 MELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp EECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred EEEc-CCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 9999 66777666554 357999999999999999999999999999999999999864 457999999999654321
Q ss_pred ccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccccc
Q 007260 372 PTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEARS 451 (611)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (611)
.... .......
T Consensus 160 ~~~~---------------------------------------------------------------------~~~~~~~ 170 (299)
T d1ckia_ 160 RTHQ---------------------------------------------------------------------HIPYREN 170 (299)
T ss_dssp TTCC---------------------------------------------------------------------BCCCCBC
T ss_pred cccc---------------------------------------------------------------------ceecccc
Confidence 1100 0001122
Q ss_pred cccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH---HHcCCCCCC---CCCCCCHHHHH
Q 007260 452 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFN---VVGQPLRFP---ESPVVSFAARD 525 (611)
Q Consensus 452 ~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~~~l~~---i~~~~l~~p---~~~~~s~~l~d 525 (611)
..++||+.|||||++.+..++.++|||||||++|||++|+.||.+......... ........+ ....+++++.+
T Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 250 (299)
T d1ckia_ 171 KNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFAT 250 (299)
T ss_dssp CSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHH
T ss_pred CCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHH
Confidence 346799999999999999999999999999999999999999987654433322 111111111 12358999999
Q ss_pred HHHHhhhcCccccCCchhcHHHHHcCCCCC-------CCchhhhc
Q 007260 526 LIRGLLVKEPQHRLAYKRGATEIKQHPFFE-------GVNWALIR 563 (611)
Q Consensus 526 LI~~~L~~dP~~Rpt~~~~a~elL~Hp~f~-------~~~~~~~~ 563 (611)
||..||..||.+||++.. +.++|+|+|.+ ..+|..++
T Consensus 251 li~~cl~~~p~~RP~~~~-i~~~l~~~~~~~~~~~~~~~Dw~~~~ 294 (299)
T d1ckia_ 251 YLNFCRSLRFDDKPDYSY-LRQLFRNLFHRQGFSYDYVFDWNMLK 294 (299)
T ss_dssp HHHHHHHSCTTCCCCHHH-HHHHHHHHHHHHTCCCSCCCHHHHGG
T ss_pred HHHHHccCChhHCcCHHH-HHHHHHHHHHHcCCCCCCCcCchhhc
Confidence 999999999999999543 34667776543 24676654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.5e-47 Score=390.25 Aligned_cols=251 Identities=18% Similarity=0.242 Sum_probs=202.8
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCC-CCcccccceeeccceeeEE
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH-PFLPTLYTHFETEKFSCLV 294 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~H-pnIv~l~~~~~~~~~~~LV 294 (611)
++|++++.||+|+||+||+|++..+++.||||++.+.... ..+++|+++++.|.| +||+.+++++..+...|+|
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 6899999999999999999999999999999998654322 135678999999965 8999999999999999999
Q ss_pred eeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEcc-----CCcEEEEecccccccc
Q 007260 295 MEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVRE-----DGHIMLSDFDLSLRCA 369 (611)
Q Consensus 295 mE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~-----~g~vkL~DFGlA~~~~ 369 (611)
|||| |++|.+++... +..+++..+..++.|++.||+|||++|||||||||+||||+. ++.+||+|||+|+.+.
T Consensus 80 me~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp EECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 9999 88999988765 357999999999999999999999999999999999999974 5789999999996543
Q ss_pred CCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccccCcccc
Q 007260 370 VSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELIAEPTEA 449 (611)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (611)
...... .....
T Consensus 158 ~~~~~~---------------------------------------------------------------------~~~~~ 168 (293)
T d1csna_ 158 DPVTKQ---------------------------------------------------------------------HIPYR 168 (293)
T ss_dssp CTTTCC---------------------------------------------------------------------BCCCC
T ss_pred cCcccc---------------------------------------------------------------------ceeec
Confidence 211000 00011
Q ss_pred cccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHcCCCCCC---CCCCCCHHH
Q 007260 450 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGN---RATLFNVVGQPLRFP---ESPVVSFAA 523 (611)
Q Consensus 450 ~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~---~~~l~~i~~~~l~~p---~~~~~s~~l 523 (611)
....++||+.|||||++.+..++.++|||||||++|||++|+.||.+... ...+..+.......+ ....+++++
T Consensus 169 ~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l 248 (293)
T d1csna_ 169 EKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEF 248 (293)
T ss_dssp CCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHH
T ss_pred ccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHH
Confidence 12356899999999999999999999999999999999999999986433 222333322211111 123488999
Q ss_pred HHHHHHhhhcCccccCCch
Q 007260 524 RDLIRGLLVKEPQHRLAYK 542 (611)
Q Consensus 524 ~dLI~~~L~~dP~~Rpt~~ 542 (611)
.+||..|+..+|++||++.
T Consensus 249 ~~ii~~~~~~~~~~rP~y~ 267 (293)
T d1csna_ 249 YKYMHYARNLAFDATPDYD 267 (293)
T ss_dssp HHHHHHHHHCCTTCCCCHH
T ss_pred HHHHHHHhcCCcccCcCHH
Confidence 9999999999999999854
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=388.55 Aligned_cols=250 Identities=20% Similarity=0.229 Sum_probs=190.9
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcccccceeeccc----ee
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLPTLYTHFETEK----FS 291 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv~l~~~~~~~~----~~ 291 (611)
.+|.+.++||+|+||.||+|++ +++.||||+++..... ....+.|+..+..++|||||++++++.+++ .+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~----~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER----SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh----HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence 4799999999999999999987 4678999999754321 112234555556789999999999997653 68
Q ss_pred eEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH--------cCeeccCCCCCcEEEccCCcEEEEecc
Q 007260 292 CLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHM--------LGIIYRDLKPENVLVREDGHIMLSDFD 363 (611)
Q Consensus 292 ~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~--------~gIVHRDLKPeNILv~~~g~vkL~DFG 363 (611)
|||||||++|+|.+++++. .+++..+..++.|++.||+|||. +|||||||||+||||+.+|++||+|||
T Consensus 77 ~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 9999999999999999875 48999999999999999999996 599999999999999999999999999
Q ss_pred ccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCCCCCCCcccc
Q 007260 364 LSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGNQVSPLPELI 443 (611)
Q Consensus 364 lA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 443 (611)
++..+......
T Consensus 154 l~~~~~~~~~~--------------------------------------------------------------------- 164 (303)
T d1vjya_ 154 LAVRHDSATDT--------------------------------------------------------------------- 164 (303)
T ss_dssp TCEEEETTTTE---------------------------------------------------------------------
T ss_pred ccccccCCCcc---------------------------------------------------------------------
Confidence 98544311100
Q ss_pred cCcccccccccccCCCccchhhhccCC------CCChhhHHHHHHHHHHHHhCCCCCCCCC--------------cHHHH
Q 007260 444 AEPTEARSMSFVGTHEYLAPEIIKGEG------HGSAVDWWTFGIFLYELLFGKTPFKGSG--------------NRATL 503 (611)
Q Consensus 444 ~~~~~~~~~~~vGT~~Y~APEil~~~~------~~~~sDIWSLGviL~ELltG~~PF~~~~--------------~~~~l 503 (611)
........+||+.|+|||++.+.. ++.++|||||||+||||++|.+||.... ....+
T Consensus 165 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (303)
T d1vjya_ 165 ---IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241 (303)
T ss_dssp ---ECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHH
T ss_pred ---eeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHH
Confidence 011122457999999999998753 4678999999999999999998874321 23333
Q ss_pred HHHH-cCCCCCCCC-----CCCCHHHHHHHHHhhhcCccccCCchhcHHHHHc
Q 007260 504 FNVV-GQPLRFPES-----PVVSFAARDLIRGLLVKEPQHRLAYKRGATEIKQ 550 (611)
Q Consensus 504 ~~i~-~~~l~~p~~-----~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~elL~ 550 (611)
.+.+ .+.++.+.. ......+.+||.+||..||.+||+ +.||++
T Consensus 242 ~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps----~~ei~~ 290 (303)
T d1vjya_ 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT----ALRIKK 290 (303)
T ss_dssp HHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCC----HHHHHH
T ss_pred HHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcC----HHHHHH
Confidence 3333 223322111 113346889999999999999999 777765
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9e-46 Score=390.01 Aligned_cols=255 Identities=25% Similarity=0.416 Sum_probs=197.5
Q ss_pred cCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC-----------CCCcccccce
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD-----------HPFLPTLYTH 284 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~-----------HpnIv~l~~~ 284 (611)
++|+++++||+|+||+||+|++..+++.||||++++.... ...+.+|+.+|+.++ |+|||+++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~----~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY----TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHH----HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccc----hHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 5799999999999999999999999999999999876432 235567888888775 5789999998
Q ss_pred eec--cceeeEEeeeCCCCC-HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCeeccCCCCCcEEEccCC-----
Q 007260 285 FET--EKFSCLVMEFCPGGD-LHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHM-LGIIYRDLKPENVLVREDG----- 355 (611)
Q Consensus 285 ~~~--~~~~~LVmE~~~gg~-L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~-~gIVHRDLKPeNILv~~~g----- 355 (611)
+.. ....++||+++..+. ............+++..++.++.||+.||+|||+ +|||||||||+||||+.++
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence 865 356677777765544 3344444455789999999999999999999998 8999999999999998765
Q ss_pred -cEEEEeccccccccCCccccccccCCCCcCcCCCccccCCCCCCCCcCCCCCCCCCCCCCcccccccccCCCCccccCC
Q 007260 356 -HIMLSDFDLSLRCAVSPTLIKASSLDAEPLRKNPVYCVQPACIEPSCIQPSCVTPTCFSPRLFSSKSKKDRKPKNEIGN 434 (611)
Q Consensus 356 -~vkL~DFGlA~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (611)
.++|+|||.+....
T Consensus 169 ~~~kl~dfg~s~~~~----------------------------------------------------------------- 183 (362)
T d1q8ya_ 169 IQIKIADLGNACWYD----------------------------------------------------------------- 183 (362)
T ss_dssp EEEEECCCTTCEETT-----------------------------------------------------------------
T ss_pred ceeeEeecccccccc-----------------------------------------------------------------
Confidence 39999999983221
Q ss_pred CCCCCcccccCcccccccccccCCCccchhhhccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCcH------HHH---HH
Q 007260 435 QVSPLPELIAEPTEARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNR------ATL---FN 505 (611)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~~~vGT~~Y~APEil~~~~~~~~sDIWSLGviL~ELltG~~PF~~~~~~------~~l---~~ 505 (611)
......+||+.|+|||++.+..|+.++|||||||++++|++|+.||...... ..+ ..
T Consensus 184 --------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~ 249 (362)
T d1q8ya_ 184 --------------EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249 (362)
T ss_dssp --------------BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHH
T ss_pred --------------cccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHH
Confidence 0112346999999999999999999999999999999999999999764321 111 12
Q ss_pred HHcCC---------------------CC----------------CCCCCCCCHHHHHHHHHhhhcCccccCCchhcHHHH
Q 007260 506 VVGQP---------------------LR----------------FPESPVVSFAARDLIRGLLVKEPQHRLAYKRGATEI 548 (611)
Q Consensus 506 i~~~~---------------------l~----------------~p~~~~~s~~l~dLI~~~L~~dP~~Rpt~~~~a~el 548 (611)
+++.. .. +......+.+++|||.+||.+||.+||| |+||
T Consensus 250 ~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt----a~e~ 325 (362)
T d1q8ya_ 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD----AGGL 325 (362)
T ss_dssp HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC----HHHH
T ss_pred HhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC----HHHH
Confidence 22211 00 0011224678999999999999999999 9999
Q ss_pred HcCCCCCCC
Q 007260 549 KQHPFFEGV 557 (611)
Q Consensus 549 L~Hp~f~~~ 557 (611)
|+||||+++
T Consensus 326 L~Hp~f~~~ 334 (362)
T d1q8ya_ 326 VNHPWLKDT 334 (362)
T ss_dssp HTCGGGTTC
T ss_pred hcCcccCCC
Confidence 999999854
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=1e-26 Score=222.98 Aligned_cols=135 Identities=22% Similarity=0.228 Sum_probs=107.3
Q ss_pred eEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhh---------------hHHHHHHHHHHHHHHHhCCCCCccccc
Q 007260 218 FRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLA---------------GRKKLLRAQTEREILQSLDHPFLPTLY 282 (611)
Q Consensus 218 y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~---------------~~~~~~~~~~E~~iL~~l~HpnIv~l~ 282 (611)
|.++++||+|+||+||+|++. +++.||||+++..... .......+.+|..+|.++.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 467899999999999999985 5789999997632211 112223456788999999999999887
Q ss_pred ceeeccceeeEEeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCeeccCCCCCcEEEccCCcEEEEec
Q 007260 283 THFETEKFSCLVMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIMLSDF 362 (611)
Q Consensus 283 ~~~~~~~~~~LVmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH~~gIVHRDLKPeNILv~~~g~vkL~DF 362 (611)
++.. .+|||||+++..+.. +++..+..++.||+.+|+|||++||+||||||+|||+++++ ++|+||
T Consensus 81 ~~~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDF 146 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDF 146 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCC
T ss_pred EecC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEEC
Confidence 6532 379999998866532 45566788999999999999999999999999999998654 899999
Q ss_pred ccccc
Q 007260 363 DLSLR 367 (611)
Q Consensus 363 GlA~~ 367 (611)
|+|..
T Consensus 147 G~a~~ 151 (191)
T d1zara2 147 PQSVE 151 (191)
T ss_dssp TTCEE
T ss_pred CCccc
Confidence 99843
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.60 E-value=6.1e-08 Score=94.31 Aligned_cols=139 Identities=17% Similarity=0.177 Sum_probs=92.1
Q ss_pred ccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC-CCCcccccceeeccceeeE
Q 007260 215 LSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD-HPFLPTLYTHFETEKFSCL 293 (611)
Q Consensus 215 ~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~-HpnIv~l~~~~~~~~~~~L 293 (611)
++.|++.+..+.++.+.||+.. ..+..+.||+........ ...+.+|..+|+.|. +--+++++.++..++..|+
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l 87 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred hhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence 3578888877666678999875 344557888876543221 123456888888774 4346888888888899999
Q ss_pred EeeeCCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 007260 294 VMEFCPGGDLHTLRQKQPGKYFPEQAVRFYVAEVLLALEYLH-------------------------------------- 335 (611)
Q Consensus 294 VmE~~~gg~L~~ll~~~~~~~l~e~~~~~i~~qll~aL~yLH-------------------------------------- 335 (611)
||++++|..+....... .....++.++...|..||
T Consensus 88 v~~~l~G~~~~~~~~~~-------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T d1j7la_ 88 LMSEADGVLCSEEYEDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEECCSSEEHHHHTTTC-------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred EEEeccccccccccccc-------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence 99999998775432110 011112222333333333
Q ss_pred ---------------H------cCeeccCCCCCcEEEccCCcEEEEecccc
Q 007260 336 ---------------M------LGIIYRDLKPENVLVREDGHIMLSDFDLS 365 (611)
Q Consensus 336 ---------------~------~gIVHRDLKPeNILv~~~g~vkL~DFGlA 365 (611)
. ..++|+|+.|.|||+++++.+-|+||+.+
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a 211 (263)
T d1j7la_ 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTC
T ss_pred cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhc
Confidence 1 12799999999999997666679999987
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.15 E-value=2.5e-06 Score=88.64 Aligned_cols=81 Identities=17% Similarity=0.200 Sum_probs=50.5
Q ss_pred EEeEecccCcEEEEEEEECCCCeEEEEEEecchh-hhh---HHHHHHHHHHHHHHHhCC-C--CCcccccceeeccceee
Q 007260 220 LLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKAS-LAG---RKKLLRAQTEREILQSLD-H--PFLPTLYTHFETEKFSC 292 (611)
Q Consensus 220 l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~-~~~---~~~~~~~~~E~~iL~~l~-H--pnIv~l~~~~~~~~~~~ 292 (611)
-.+.||.|....||++.+..+++.|+||.-.... ... .....|...|.++|+.+. + ..+++++.+ +....+
T Consensus 30 ~~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~ 107 (392)
T d2pula1 30 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 107 (392)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred eEEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCE
Confidence 3678999999999999988778889999643211 100 011234566888887662 2 356677654 344567
Q ss_pred EEeeeCCCCC
Q 007260 293 LVMEFCPGGD 302 (611)
Q Consensus 293 LVmE~~~gg~ 302 (611)
+|||++.+..
T Consensus 108 lvmE~L~~~~ 117 (392)
T d2pula1 108 TVMEDLSHLK 117 (392)
T ss_dssp EEECCCTTSE
T ss_pred EEEeccCCcc
Confidence 9999997644
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.11 E-value=3.1e-06 Score=81.43 Aligned_cols=136 Identities=15% Similarity=0.053 Sum_probs=82.2
Q ss_pred EecccC-cEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCC--CCcccccceeeccceeeEEeeeCC
Q 007260 223 RLGCGD-IGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDH--PFLPTLYTHFETEKFSCLVMEFCP 299 (611)
Q Consensus 223 ~LG~G~-fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~H--pnIv~l~~~~~~~~~~~LVmE~~~ 299 (611)
.+..|. -+.||+....+ +..+.+|+-...... .+.+|+.+|+.|.. -.+++++.+..+++..|+||||++
T Consensus 17 ~~~~G~s~~~v~r~~~~~-~~~~vlK~~~~~~~~------~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQG-RPVLFVKTDLSGALN------ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp ECSCTTSSCEEEEEECTT-SCCEEEEEECSCTTS------CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred EcCCcccCCeEEEEEeCC-CCEEEEEeCCccCHh------HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence 444444 36899987644 556888987654322 34568888777632 336788888888889999999998
Q ss_pred CCCHHH--------------HHHh-C----CCCCCC--HHHH-----HHH---------------HHHHHHHHHHHHHc-
Q 007260 300 GGDLHT--------------LRQK-Q----PGKYFP--EQAV-----RFY---------------VAEVLLALEYLHML- 337 (611)
Q Consensus 300 gg~L~~--------------ll~~-~----~~~~l~--e~~~-----~~i---------------~~qll~aL~yLH~~- 337 (611)
|.++.. ++.+ + ....+. .... ..+ .......+..+..+
T Consensus 90 G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 169 (255)
T d1nd4a_ 90 GQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARM 169 (255)
T ss_dssp SEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTC
T ss_pred ccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhC
Confidence 866522 1111 0 000010 0000 000 00112223444332
Q ss_pred ------CeeccCCCCCcEEEccCCcEEEEecccc
Q 007260 338 ------GIIYRDLKPENVLVREDGHIMLSDFDLS 365 (611)
Q Consensus 338 ------gIVHRDLKPeNILv~~~g~vkL~DFGlA 365 (611)
.+||+|+.|.|||++.++.+-|+||+.+
T Consensus 170 ~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~ 203 (255)
T d1nd4a_ 170 PDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRL 203 (255)
T ss_dssp CSSCCEEEECSSCCGGGEEEETTEEEEECCCTTC
T ss_pred CccCCceEEeCCCCCcceEEeCCceEEEEEchhc
Confidence 3799999999999997766789999987
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.34 E-value=0.00021 Score=73.50 Aligned_cols=78 Identities=23% Similarity=0.329 Sum_probs=53.7
Q ss_pred cCeEEEeEecccCcEEEEEEEECC-------CCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCC-CCCcccccceeec
Q 007260 216 SHFRLLKRLGCGDIGSVYLSELSG-------TKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLD-HPFLPTLYTHFET 287 (611)
Q Consensus 216 ~~y~l~~~LG~G~fG~Vy~a~~~~-------t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~-HpnIv~l~~~~~~ 287 (611)
+.+++ +.|+.|-.-.+|++.... ....|.+++...... . ....+|..+++.+. +.-.++++++|.+
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~----~-idr~~E~~i~~~ls~~gl~Pkll~~~~~ 116 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET----E-SHLVAESVIFTLLSERHLGPKLYGIFSG 116 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC----H-HHHHHHHHHHHHHHHTTSSSCEEEEETT
T ss_pred cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcch----h-hHHHHHHHHHHHHHhCCCCCeEEEEcCC
Confidence 34444 678889999999998753 345688888753221 1 12356888888884 5556788888754
Q ss_pred cceeeEEeeeCCCCCH
Q 007260 288 EKFSCLVMEFCPGGDL 303 (611)
Q Consensus 288 ~~~~~LVmE~~~gg~L 303 (611)
++||||++|..|
T Consensus 117 ----g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 ----GRLEEYIPSRPL 128 (395)
T ss_dssp ----EEEECCCCEEEC
T ss_pred ----ceEEEEeccccC
Confidence 589999987544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.12 E-value=0.00096 Score=66.54 Aligned_cols=130 Identities=17% Similarity=0.191 Sum_probs=73.5
Q ss_pred cEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCCCcc-----ccc--ceeeccceeeEEeeeCCCC
Q 007260 229 IGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHPFLP-----TLY--THFETEKFSCLVMEFCPGG 301 (611)
Q Consensus 229 fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~HpnIv-----~l~--~~~~~~~~~~LVmE~~~gg 301 (611)
--.||+++.. +|..|++|+.+...-.. ..+..|...|..|....|+ ..- ..++.+...+.|+++++|.
T Consensus 35 EN~vy~v~~~-dg~~~VlK~~rp~~~s~----~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQDE-DRRRFVVKFYRPERWTA----DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECCT-TCCCEEEEEECTTTSCH----HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEcC-CCCEEEEEEeCCCCCCH----HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 3589999764 46679999987654322 2345588887777422221 211 2334567789999999774
Q ss_pred CHH-----HH------H-------HhCC---C-------------------CCCCHHHHHHHHHHHHHHHHHHHH-----
Q 007260 302 DLH-----TL------R-------QKQP---G-------------------KYFPEQAVRFYVAEVLLALEYLHM----- 336 (611)
Q Consensus 302 ~L~-----~l------l-------~~~~---~-------------------~~l~e~~~~~i~~qll~aL~yLH~----- 336 (611)
.+. .+ + .... . ..++......+...+-..++.+..
T Consensus 110 ~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~ 189 (325)
T d1zyla1 110 QFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRED 189 (325)
T ss_dssp ECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSC
T ss_pred CCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhcccc
Confidence 321 11 0 0000 0 111111122222223333334432
Q ss_pred --cCeeccCCCCCcEEEccCCcEEEEecccc
Q 007260 337 --LGIIYRDLKPENVLVREDGHIMLSDFDLS 365 (611)
Q Consensus 337 --~gIVHRDLKPeNILv~~~g~vkL~DFGlA 365 (611)
.++||+|+.+.|||+++ | ..++||+-+
T Consensus 190 ~p~~liHgDlh~~NvL~~~-~-~~~IDFdd~ 218 (325)
T d1zyla1 190 FTVLRLHGDCHAGNILWRD-G-PMFVDLDDA 218 (325)
T ss_dssp SCCEECCSSCSGGGEEESS-S-EEECCCTTC
T ss_pred CCceeecCCCCcccEEEeC-C-ceEEechhc
Confidence 35899999999999974 4 458999976
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.65 E-value=0.0039 Score=61.15 Aligned_cols=145 Identities=16% Similarity=0.066 Sum_probs=76.5
Q ss_pred cccCeEEEeEecccCcEEEEEEEECCCCeEEEEEEecchhhhhHHHHHHHHHHHHHHHhCCCC-----Cccccc-c--ee
Q 007260 214 GLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKASLAGRKKLLRAQTEREILQSLDHP-----FLPTLY-T--HF 285 (611)
Q Consensus 214 ~~~~y~l~~~LG~G~fG~Vy~a~~~~t~~~vAvKii~k~~~~~~~~~~~~~~E~~iL~~l~Hp-----nIv~l~-~--~~ 285 (611)
+++...-.+.|..|---+.|+.+.... .|++|+..+... ...+..|+++|..|... ..+... + +.
T Consensus 16 ~lg~~~~~~~i~~G~~N~ny~v~t~~g--~yVLri~~~~~~-----~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~ 88 (316)
T d2ppqa1 16 DVGSLTSYKGIAEGVENSNFLLHTTKD--PLILTLYEKRVE-----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLG 88 (316)
T ss_dssp CCCCEEEEEEECC---EEEEEEEESSC--CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCE
T ss_pred CCCCceEeecCCCCcccCeEEEEECCC--cEEEEEcCCCCC-----HHHHHHHHHHHHhhhhccccccccceecCCCcce
Confidence 345566667777888889999986643 389999865321 11334467777766322 222211 1 12
Q ss_pred eccceeeEEeeeCCCCCHHH-----H---------HHh---C-C---CCCCCH------------------HHHHHHHHH
Q 007260 286 ETEKFSCLVMEFCPGGDLHT-----L---------RQK---Q-P---GKYFPE------------------QAVRFYVAE 326 (611)
Q Consensus 286 ~~~~~~~LVmE~~~gg~L~~-----l---------l~~---~-~---~~~l~e------------------~~~~~i~~q 326 (611)
......+.++.++.|..... . +.. . . ...... ......+..
T Consensus 89 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 168 (316)
T d2ppqa1 89 ELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRP 168 (316)
T ss_dssp EETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHH
T ss_pred eeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHH
Confidence 23445566777776643310 0 000 0 0 000000 111122222
Q ss_pred HHHHHHHHHH----cCeeccCCCCCcEEEccCCcEEEEecccc
Q 007260 327 VLLALEYLHM----LGIIYRDLKPENVLVREDGHIMLSDFDLS 365 (611)
Q Consensus 327 ll~aL~yLH~----~gIVHRDLKPeNILv~~~g~vkL~DFGlA 365 (611)
+...+.-.+. .||||+|+.+.|||++.+...-|+||+.+
T Consensus 169 ~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~ 211 (316)
T d2ppqa1 169 EIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFA 211 (316)
T ss_dssp HHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred HHHhhhccCccccccccccCCcchhhhhcccccceeEeccccc
Confidence 3333333322 47999999999999998877789999987
|